Citrus Sinensis ID: 035862
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 393 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LTC0 | 410 | Probable receptor-like pr | yes | no | 0.959 | 0.919 | 0.612 | 1e-134 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.877 | 0.699 | 0.504 | 6e-92 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.745 | 0.597 | 0.539 | 2e-89 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.798 | 0.762 | 0.531 | 1e-88 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.737 | 0.707 | 0.550 | 1e-87 | |
| Q06548 | 410 | Protein kinase APK1A, chl | no | no | 0.768 | 0.736 | 0.526 | 2e-87 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.763 | 0.771 | 0.489 | 8e-86 | |
| Q9FM85 | 408 | Probable receptor-like pr | no | no | 0.890 | 0.857 | 0.461 | 2e-85 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.865 | 0.798 | 0.463 | 2e-84 | |
| O48814 | 395 | Serine/threonine-protein | no | no | 0.743 | 0.739 | 0.511 | 2e-82 |
| >sp|Q9LTC0|Y5707_ARATH Probable receptor-like protein kinase At5g47070 OS=Arabidopsis thaliana GN=At5g47070 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 478 bits (1230), Expect = e-134, Method: Compositional matrix adjust.
Identities = 247/403 (61%), Positives = 296/403 (73%), Gaps = 26/403 (6%)
Query: 1 MKCFYIFKDKFKPKKGS---------------NSAPEPRNQNRLDNNSALNRTARSLPSP 45
M C ++FK K KP+K NSAPE NR + +S +T RSLPSP
Sbjct: 1 MNCLFLFKSK-KPRKQQKDNNKNKRKGKELLQNSAPEL--TNRSETSSFNLQTPRSLPSP 57
Query: 46 RSIPELYKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPL-DGRGEPLV 104
RSI +LY E+E +LRVF +EL +AT F+R L IGEGGFG VYKG I D PLV
Sbjct: 58 RSIKDLYTEREQNLRVFSYEELSKATYVFSRKLVIGEGGFGIVYKGKILSNGDSSDPPLV 117
Query: 105 VAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRS 164
VA+KKLN GLQGHKQWLAEVQFLGVV+HPN+VKL+GYCS + E GI+RLLVYEYM NRS
Sbjct: 118 VAIKKLNRQGLQGHKQWLAEVQFLGVVNHPNVVKLIGYCSEDGETGIERLLVYEYMSNRS 177
Query: 165 LEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKL 224
LED LF R TLPWK RLEI+LGAAEGL YLH+ ++VIYRDFK+SNVLLD F PKL
Sbjct: 178 LEDHLFPRRSHTLPWKKRLEIMLGAAEGLTYLHD---LKVIYRDFKSSNVLLDDQFCPKL 234
Query: 225 SDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRV 284
SDFGLAREGP GD+THV+TA VGT+GYAAPEY++TGHL+ +SD++SFGVVLYEI+TGRR
Sbjct: 235 SDFGLAREGPDGDNTHVTTARVGTHGYAAPEYVQTGHLRLKSDVYSFGVVLYEIITGRRT 294
Query: 285 LERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEE 344
+ERN+P E++LL+WVK++PAD ++FSM++DPRLRN Y AR +AKLAD CLKKN +E
Sbjct: 295 IERNKPVAERRLLDWVKEYPADSQRFSMIVDPRLRNNYPAAGARSLAKLADLCLKKNDKE 354
Query: 345 RPTMNQVVESLKLAVQESEQGSSSTTTAAKTPVTSSSRLVDRR 387
RPTM VVE LK ++ES+ S T T S V RR
Sbjct: 355 RPTMEIVVERLKKIIEESD----SEDYPMATTTTKESSQVRRR 393
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 338 bits (866), Expect = 6e-92, Method: Compositional matrix adjust.
Identities = 181/359 (50%), Positives = 236/359 (65%), Gaps = 14/359 (3%)
Query: 17 SNSAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKE--KEHHLRVFDMQELREATNGF 74
S SA E N + S+ T+ + S S P + +E HLR F +L+ +T F
Sbjct: 84 SKSANEKSNDQPVGQVSSTTTTSNA-ESSSSTPVISEELNISSHLRKFTFNDLKLSTRNF 142
Query: 75 NRMLKIGEGGFGSVYKGTIR-----PLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLG 129
+GEGGFG V+KG I P+ G L VAVK LN GLQGHK+WLAE+ FLG
Sbjct: 143 RPESLLGEGGFGCVFKGWIEENGTAPVK-PGTGLTVAVKTLNPDGLQGHKEWLAEINFLG 201
Query: 130 VVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGA 189
+ HPNLVKL+GYC +D QRLLVYE+MP SLE+ LF R+ P LPW R++I LGA
Sbjct: 202 NLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGA 256
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
A+GL++LHE VIYRDFKTSN+LLD ++ KLSDFGLA++ P THVST V+GTY
Sbjct: 257 AKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTY 316
Query: 250 GYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309
GYAAPEY+ TGHL S+SD++SFGVVL E+LTGRR +++NRP E L+EW + D ++
Sbjct: 317 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRR 376
Query: 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSSS 368
F ++DPRL +SI A++V +LA CL ++P+ RP M+ VVE+LK + SSS
Sbjct: 377 FYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMASSS 435
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 329 bits (843), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 164/304 (53%), Positives = 214/304 (70%), Gaps = 11/304 (3%)
Query: 58 HLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIR-----PLDGRGEPLVVAVKKLNN 112
HL+ F +L+ AT F +GEGGFG V+KG + P+ G L VAVK LN
Sbjct: 120 HLKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVK-PGTGLTVAVKTLNP 178
Query: 113 HGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR 172
GLQGHK+WLAE+ +LG + HPNLVKL+GYC +D QRLLVYE+MP SLE+ LF R
Sbjct: 179 DGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRR 234
Query: 173 AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232
+ P LPW R++I LGAA+GL++LHE VIYRDFKTSN+LLDG + KLSDFGLA++
Sbjct: 235 SLP-LPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 293
Query: 233 GPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM 292
P THVST V+GTYGYAAPEY+ TGHL S+SD++SFGVVL E+LTGRR +++NRP
Sbjct: 294 APDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 353
Query: 293 EQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVV 352
E L+EW + D ++F ++DPRL +S+ A++V +LA CL ++ + RP M++VV
Sbjct: 354 EHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVV 413
Query: 353 ESLK 356
E LK
Sbjct: 414 EVLK 417
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 327 bits (837), Expect = 1e-88, Method: Compositional matrix adjust.
Identities = 175/329 (53%), Positives = 228/329 (69%), Gaps = 15/329 (4%)
Query: 44 SPRSIPELYKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTI--RPLDGR-- 99
+PR+ E+ + +L+ F EL+ AT F +GEGGFGSV+KG I + L
Sbjct: 41 NPRTEGEILQSP--NLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKP 98
Query: 100 GEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEY 159
G +V+AVKKLN G QGH++WLAEV +LG SHPNLVKL+GYC EDE RLLVYE+
Sbjct: 99 GTGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYC-LEDE---HRLLVYEF 154
Query: 160 MPNRSLEDRLFSRA---QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL 216
MP SLE+ LF R QP L W RL++ LGAA+GLA+LH E VIYRDFKTSN+LL
Sbjct: 155 MPRGSLENHLFRRGSYFQP-LSWTLRLKVALGAAKGLAFLHNA-ETSVIYRDFKTSNILL 212
Query: 217 DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLY 276
D + KLSDFGLA++GPTGD +HVST ++GTYGYAAPEY+ TGHL ++SD++S+GVVL
Sbjct: 213 DSEYNAKLSDFGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLL 272
Query: 277 EILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADN 336
E+L+GRR +++NRP EQKL+EW + A+ +K +ID RL++QYS+ A +VA LA
Sbjct: 273 EVLSGRRAVDKNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALR 332
Query: 337 CLKKNPEERPTMNQVVESLKLAVQESEQG 365
CL + RP MN+VV L+ +E G
Sbjct: 333 CLTFEIKLRPNMNEVVSHLEHIQTLNEAG 361
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (828), Expect = 1e-87, Method: Compositional matrix adjust.
Identities = 163/296 (55%), Positives = 207/296 (69%), Gaps = 6/296 (2%)
Query: 62 FDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRG-EPLVVAVKKLNNHGLQGHKQ 120
F + EL T F +GEGGFG+VYKG I G + L VAVK LN GLQGH++
Sbjct: 57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHRE 116
Query: 121 WLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWK 180
WL EV FLG + HPNLVKL+GYC +D RLLVYE+M SLE+ LF + L W
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCEDD----HRLLVYEFMLRGSLENHLFRKTTAPLSWS 172
Query: 181 TRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTH 240
R+ I LGAA+GLA+LH E VIYRDFKTSN+LLD ++ KLSDFGLA+ GP GD TH
Sbjct: 173 RRMMIALGAAKGLAFLHNA-ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH 231
Query: 241 VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300
VST V+GTYGYAAPEY+ TGHL ++SD++SFGVVL E+LTGR+ +++ RP+ EQ L++W
Sbjct: 232 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWA 291
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
+ D +K +IDPRL NQYS+ AA++ LA CL +NP+ RP M+ VVE+L+
Sbjct: 292 RPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 347
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 323 bits (827), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 171/325 (52%), Positives = 225/325 (69%), Gaps = 23/325 (7%)
Query: 43 PSPRSIPELYKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTI--------R 94
PSPR+ E+ + +L+ F EL+ AT F +GEGGFG V+KG I R
Sbjct: 39 PSPRTEGEILQSP--NLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASR 96
Query: 95 PLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRL 154
P G LV+AVKKLN G QGH++WLAEV +LG SH +LVKL+GYC EDE RL
Sbjct: 97 P----GTGLVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYC-LEDE---HRL 148
Query: 155 LVYEYMPNRSLEDRLFSRA---QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKT 211
LVYE+MP SLE+ LF R QP L WK RL++ LGAA+GLA+LH E +VIYRDFKT
Sbjct: 149 LVYEFMPRGSLENHLFRRGLYFQP-LSWKLRLKVALGAAKGLAFLHSS-ETRVIYRDFKT 206
Query: 212 SNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSF 271
SN+LLD + KLSDFGLA++GP GD +HVST V+GT+GYAAPEY+ TGHL ++SD++SF
Sbjct: 207 SNILLDSEYNAKLSDFGLAKDGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSF 266
Query: 272 GVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVA 331
GVVL E+L+GRR +++NRP+ E+ L+EW K + + +K +ID RL++QYS+ A +VA
Sbjct: 267 GVVLLELLSGRRAVDKNRPSGERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVA 326
Query: 332 KLADNCLKKNPEERPTMNQVVESLK 356
L+ CL + RP M++VV L+
Sbjct: 327 TLSLRCLTTEIKLRPNMSEVVSHLE 351
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 317 bits (813), Expect = 8e-86, Method: Compositional matrix adjust.
Identities = 158/323 (48%), Positives = 223/323 (69%), Gaps = 23/323 (7%)
Query: 45 PRSIPELYKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTI--------RPL 96
PR+ E+ + +L+ F + EL+ AT F +GEGGFG V+KG I +P
Sbjct: 41 PRTEGEILQNA--NLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKP- 97
Query: 97 DGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLV 156
G +V+AVK+LN G QGH++WLAE+ +LG + HPNLVKL+GYC E+ RLLV
Sbjct: 98 ---GTGIVIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEE----HRLLV 150
Query: 157 YEYMPNRSLEDRLFSRA---QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSN 213
YE+M SLE+ LF R QP L W TR+ + LGAA GLA+LH + QVIYRDFK SN
Sbjct: 151 YEFMTRGSLENHLFRRGTFYQP-LSWNTRVRMALGAARGLAFLHNA-QPQVIYRDFKASN 208
Query: 214 VLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGV 273
+LLD N+ KLSDFGLAR+GP GD++HVST V+GT GYAAPEY+ TGHL +SD++SFGV
Sbjct: 209 ILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGV 268
Query: 274 VLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKL 333
VL E+L+GRR +++N+P E L++W + + + ++ ++DPRL+ QYS+ A ++A L
Sbjct: 269 VLLELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVL 328
Query: 334 ADNCLKKNPEERPTMNQVVESLK 356
A +C+ + + RPTMN++V++++
Sbjct: 329 ALDCISIDAKSRPTMNEIVKTME 351
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 316 bits (810), Expect = 2e-85, Method: Compositional matrix adjust.
Identities = 167/362 (46%), Positives = 239/362 (66%), Gaps = 12/362 (3%)
Query: 37 RTARSLPS-PRSIPELYKEKEHH-LRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIR 94
+ + LPS P+ + +L ++ + L F +EL+ T+ F + +G GGFGSVYKG I+
Sbjct: 37 KEVQKLPSNPKEVEDLRRDSAANPLIAFTYEELKNITSNFRQDRVLGGGGFGSVYKGFIK 96
Query: 95 PLDGRGE---PLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150
G E PL VAVK + ++ QGH++WLAEV FLG +SHPNLVKL+GYC ++
Sbjct: 97 EDLGDQEVPEPLPVAVKVHDGDNSFQGHREWLAEVIFLGQLSHPNLVKLIGYCCEDN--- 153
Query: 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFK 210
R+L+YEYM S+E+ LFSR L W R++I GAA+GLA+LHE + VIYRDFK
Sbjct: 154 -HRVLIYEYMARGSVENNLFSRVLLPLSWAIRMKIAFGAAKGLAFLHEAKK-PVIYRDFK 211
Query: 211 TSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWS 270
TSN+LLD ++ KLSDFGLA++GP GD +HVST ++GTYGYAAPEYI TGHL SD++S
Sbjct: 212 TSNILLDMDYNAKLSDFGLAKDGPVGDKSHVSTRIMGTYGYAAPEYIMTGHLTPGSDVYS 271
Query: 271 FGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRV 330
FGVVL E+LTGR+ L+++RPT EQ L++W + KK ++DP++ +Y + A ++
Sbjct: 272 FGVVLLELLTGRKSLDKSRPTREQNLIDWALPLLKEKKKVLNIVDPKMNCEYPVKAVQKA 331
Query: 331 AKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSSSTTTAAKTPVTSSSRLVDRRSKR 390
A LA +CL +NP+ RP M +V+SL+ +Q +E+ + K +T + K+
Sbjct: 332 AMLAYHCLNRNPKARPLMRDIVDSLE-PLQATEEEALLVPPVQKAVITIIDEMPKNGLKK 390
Query: 391 VQ 392
V+
Sbjct: 391 VE 392
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 313 bits (801), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 166/358 (46%), Positives = 225/358 (62%), Gaps = 18/358 (5%)
Query: 41 SLPSPRSIPELYKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGR- 99
SLP+PR+ E+ +L+ F EL+ AT F +GEGGFG V+KG I DG
Sbjct: 52 SLPTPRTEGEILSSP--NLKAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWI---DGTT 106
Query: 100 ------GEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQR 153
G +VVAVKKL G QGHK+WL EV +LG +SHPNLVKL+GYC G R
Sbjct: 107 LTASKPGSGIVVAVKKLKTEGYQGHKEWLTEVNYLGQLSHPNLVKLVGYCV----EGENR 162
Query: 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSN 213
LLVYE+MP SLE+ LF R L W R+++ +GAA+GL +LH+ + QVIYRDFK +N
Sbjct: 163 LLVYEFMPKGSLENHLFRRGAQPLTWAIRMKVAIGAAKGLTFLHDA-KSQVIYRDFKAAN 221
Query: 214 VLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGV 273
+LLD F KLSDFGLA+ GPTGD THVST V+GT+GYAAPEY+ TG L ++SD++SFGV
Sbjct: 222 ILLDAEFNSKLSDFGLAKAGPTGDKTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGV 281
Query: 274 VLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKL 333
VL E+L+GRR +++++ MEQ L++W + D +K ++D RL QY A A L
Sbjct: 282 VLLELLSGRRAVDKSKVGMEQSLVDWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASL 341
Query: 334 ADNCLKKNPEERPTMNQVVESL-KLAVQESEQGSSSTTTAAKTPVTSSSRLVDRRSKR 390
A CL + + RP M++V+ L +L + G + +P S+ +V + +R
Sbjct: 342 ALQCLNPDAKLRPKMSEVLAKLDQLESTKPGTGVGNRQAQIDSPRGSNGSIVQKSPRR 399
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 306 bits (784), Expect = 2e-82, Method: Compositional matrix adjust.
Identities = 156/305 (51%), Positives = 208/305 (68%), Gaps = 13/305 (4%)
Query: 59 LRVFDMQELREATNGFNRMLKIGEGGFGSVYKG-----TIRPLDGRGEPLVVAVKKLNNH 113
++ F EL+ AT F IGEGGFG V+KG T+ P G LV+AVKKLN
Sbjct: 52 VKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTK-PGTGLVIAVKKLNQE 110
Query: 114 GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRA 173
G QGH++WL E+ +LG +SHPNLVKL+GYC EDE RLLVYE+M SLE+ LF R
Sbjct: 111 GFQGHREWLTEINYLGQLSHPNLVKLIGYC-LEDE---HRLLVYEFMQKGSLENHLFRRG 166
Query: 174 Q--PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231
LPW R+ + L AA+GLA+LH ++VIYRD K SN+LLD ++ KLSDFGLAR
Sbjct: 167 AYFKPLPWFLRVNVALDAAKGLAFLHSD-PVKVIYRDIKASNILLDADYNAKLSDFGLAR 225
Query: 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPT 291
+GP GD ++VST V+GTYGYAAPEY+ +GHL ++SD++SFGV+L EIL+G+R L+ NRP
Sbjct: 226 DGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPA 285
Query: 292 MEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQV 351
E+ L++W + + +K +++D RL QY A R+A +A CL P+ RPTM+QV
Sbjct: 286 KEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQV 345
Query: 352 VESLK 356
V +L+
Sbjct: 346 VRALQ 350
|
Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 393 | ||||||
| 224137992 | 388 | predicted protein [Populus trichocarpa] | 0.969 | 0.981 | 0.770 | 1e-175 | |
| 225427370 | 416 | PREDICTED: probable receptor-like protei | 0.984 | 0.930 | 0.734 | 1e-164 | |
| 90900944 | 412 | NAK-type protein kinase [Nicotiana tabac | 0.946 | 0.902 | 0.701 | 1e-157 | |
| 351726998 | 377 | NAK-type protein kinase [Glycine max] gi | 0.903 | 0.941 | 0.732 | 1e-157 | |
| 255552936 | 366 | Protein kinase APK1B, chloroplast precur | 0.928 | 0.997 | 0.737 | 1e-156 | |
| 356563418 | 381 | PREDICTED: probable receptor-like protei | 0.910 | 0.939 | 0.724 | 1e-154 | |
| 156105187 | 429 | ser/thr protein kinase [Malus x domestic | 0.926 | 0.848 | 0.680 | 1e-150 | |
| 255571079 | 447 | ATP binding protein, putative [Ricinus c | 0.931 | 0.818 | 0.664 | 1e-150 | |
| 357482241 | 351 | NAK-type protein kinase [Medicago trunca | 0.893 | 1.0 | 0.712 | 1e-149 | |
| 224137090 | 404 | predicted protein [Populus trichocarpa] | 0.941 | 0.915 | 0.664 | 1e-148 |
| >gi|224137992|ref|XP_002326491.1| predicted protein [Populus trichocarpa] gi|222833813|gb|EEE72290.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 620 bits (1600), Expect = e-175, Method: Compositional matrix adjust.
Identities = 295/383 (77%), Positives = 334/383 (87%), Gaps = 2/383 (0%)
Query: 1 MKCFYIFKDKFKPKKG-SNSAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHL 59
MKCFYIFKDKFK KKG +NSAPEP + +NS+ RTA+SLPSPRSIPELYKEKEH+L
Sbjct: 1 MKCFYIFKDKFKNKKGQANSAPEPSDHQS-KSNSSPRRTAKSLPSPRSIPELYKEKEHNL 59
Query: 60 RVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK 119
RVF QEL+EATNGFNR+LKIGEGGFGSVYKGT+RP G+G+P+VVA+KKLNNHGLQGHK
Sbjct: 60 RVFSFQELKEATNGFNRLLKIGEGGFGSVYKGTVRPASGQGDPVVVAIKKLNNHGLQGHK 119
Query: 120 QWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPW 179
QWLAEVQFLGVVSHPNLV+LLGYCS + ERGIQRLLVYEYMPNRSLED LF R PTL W
Sbjct: 120 QWLAEVQFLGVVSHPNLVELLGYCSVDSERGIQRLLVYEYMPNRSLEDHLFKRGPPTLSW 179
Query: 180 KTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHT 239
+ RLEIILGAAEGLAYLH G+E+QVIYRDFK+SNVLLD +FKPKLSDFGLAREGPTGD T
Sbjct: 180 RKRLEIILGAAEGLAYLHGGMEVQVIYRDFKSSNVLLDEDFKPKLSDFGLAREGPTGDRT 239
Query: 240 HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW 299
HVSTAVVGTYGYAAPEY+ETGHL SD+WSFGVVLYEILTGRR LERNRP +EQKLL+W
Sbjct: 240 HVSTAVVGTYGYAAPEYVETGHLTIHSDVWSFGVVLYEILTGRRTLERNRPVIEQKLLDW 299
Query: 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359
VKQFP D K+FSM+IDPRL N+YS NAA+++AKLAD+CL KN +ERPTM QVVE LK +
Sbjct: 300 VKQFPVDSKRFSMIIDPRLINEYSFNAAKQIAKLADSCLNKNAKERPTMTQVVERLKQII 359
Query: 360 QESEQGSSSTTTAAKTPVTSSSR 382
Q+ E ++ST A++ +S SR
Sbjct: 360 QDLEGENTSTNRNAESSQSSLSR 382
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225427370|ref|XP_002282904.1| PREDICTED: probable receptor-like protein kinase At5g47070 [Vitis vinifera] gi|297742192|emb|CBI33979.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 583 bits (1502), Expect = e-164, Method: Compositional matrix adjust.
Identities = 290/395 (73%), Positives = 329/395 (83%), Gaps = 8/395 (2%)
Query: 1 MKCFYIFKDKFKPKKGSNSAPEPRNQNRLDNNSA--LNRTARSLPSPRSIPELYKEKEHH 58
MKCF F+DK K K S SAPE +NQN+ D +SA ++A S+ SPRSIPELY+EK
Sbjct: 1 MKCFLYFRDKSK-SKQSKSAPELKNQNKSDTSSASRTTKSAGSMASPRSIPELYREKGQD 59
Query: 59 LRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH 118
LRVF + ELR+ATNGFNR+LKIGEGGFG+VYKGTI P DG+G P VVA+KKLN G QGH
Sbjct: 60 LRVFSLPELRDATNGFNRLLKIGEGGFGNVYKGTISPADGQGNPTVVAIKKLNQQGFQGH 119
Query: 119 KQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLP 178
K+WLAEVQFL VVSHPNLVKLLGYCS + ERGIQRLLVYEYMPN+SLE+ LF+R TLP
Sbjct: 120 KEWLAEVQFLSVVSHPNLVKLLGYCSVDGERGIQRLLVYEYMPNKSLENHLFNRTMSTLP 179
Query: 179 WKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDH 238
WK RL+IILGAAEGLAYLHEGLEIQVIYRDFK+SNVLLD NF PKLSDFGLAREGPTGDH
Sbjct: 180 WKMRLQIILGAAEGLAYLHEGLEIQVIYRDFKSSNVLLDENFNPKLSDFGLAREGPTGDH 239
Query: 239 THVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLE 298
THVSTAVVGT GYAAPEYIETGHL +SDIWSFGVVLYEILTGRR +ERNRP EQKLL+
Sbjct: 240 THVSTAVVGTQGYAAPEYIETGHLTVKSDIWSFGVVLYEILTGRRTVERNRPQSEQKLLD 299
Query: 299 WVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358
WVKQFPADGK+FSM+IDPRLR+QYS+ AARRVA LA++CL KNP++RPTM +VVESLK A
Sbjct: 300 WVKQFPADGKRFSMIIDPRLRDQYSLVAARRVAMLANSCLNKNPKDRPTMREVVESLKKA 359
Query: 359 VQESEQGSSSTTTAAKTPVTSSSRLV--DRRSKRV 391
+QESE G+ S P +S S + DRR ++
Sbjct: 360 IQESEDGNPSDRN---RPESSHSNMANSDRRKDKM 391
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|90900944|gb|ABE01834.1| NAK-type protein kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 561 bits (1446), Expect = e-157, Method: Compositional matrix adjust.
Identities = 263/375 (70%), Positives = 316/375 (84%), Gaps = 3/375 (0%)
Query: 1 MKCFYIFKDKFKPKKGSNSAPEPRNQNRLDNNSALNRTARS---LPSPRSIPELYKEKEH 57
+KCFYIFKDK + ++ SAPE N++R D NS + A+S + S RSIP++Y+EKE
Sbjct: 2 LKCFYIFKDKSRSRRRGESAPELSNESRRDGNSEGKKVAKSTGSVSSARSIPQMYREKEQ 61
Query: 58 HLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG 117
+LRVF + EL+EAT FNRMLKIGEGGFGSVYKGTI+P GRG+P+VVA+KKLN GLQG
Sbjct: 62 NLRVFSLSELKEATRSFNRMLKIGEGGFGSVYKGTIQPPSGRGDPIVVAIKKLNTLGLQG 121
Query: 118 HKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTL 177
H+QW+AEVQFLGV+ HPNLVKLLGYC+T+ ERGIQRLLVYEYM N+SLED LF+RA P +
Sbjct: 122 HRQWVAEVQFLGVLEHPNLVKLLGYCATDGERGIQRLLVYEYMQNKSLEDHLFNRAVPVI 181
Query: 178 PWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGD 237
PWKTRL+IILGAA+G+AYLHEGLE+QVIYRDFK+SNVLLD +F P LSDFGLAREGP GD
Sbjct: 182 PWKTRLKIILGAAQGMAYLHEGLEVQVIYRDFKSSNVLLDEDFNPWLSDFGLAREGPAGD 241
Query: 238 HTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL 297
+HVSTA VGT GYAAPEY+ETGHL +SDIWSFGVVLYEILTGRR LERN P M+QKL+
Sbjct: 242 RSHVSTAPVGTLGYAAPEYVETGHLSVKSDIWSFGVVLYEILTGRRTLERNLPVMQQKLI 301
Query: 298 EWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357
+WVKQFPAD +KFSM+IDPRLRN++S+ AARR+AKLAD+CL K +ERP M++VV+ L
Sbjct: 302 DWVKQFPADSRKFSMIIDPRLRNEFSLVAARRIAKLADSCLNKIAKERPKMSEVVQILTQ 361
Query: 358 AVQESEQGSSSTTTA 372
AVQES++ +S T
Sbjct: 362 AVQESQETTSLEITG 376
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351726998|ref|NP_001238681.1| NAK-type protein kinase [Glycine max] gi|223452359|gb|ACM89507.1| NAK-type protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 560 bits (1442), Expect = e-157, Method: Compositional matrix adjust.
Identities = 266/363 (73%), Positives = 311/363 (85%), Gaps = 8/363 (2%)
Query: 1 MKCFYIFKDKFKPKKGSNSAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHLR 60
MKCF+ FK+K S SAPE + N A N T S+ SP+S+ +LY+EKEH R
Sbjct: 1 MKCFF-FKEK------SKSAPELHKKKTPAVNRAANSTG-SVSSPKSVKDLYREKEHSFR 52
Query: 61 VFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ 120
VF +QELR+ATNGFNRMLK+GEGGFGSVYKG+I LDG+G+P+ VA+K+LN G QGHK+
Sbjct: 53 VFTLQELRDATNGFNRMLKLGEGGFGSVYKGSIAQLDGQGDPIPVAIKRLNTRGFQGHKE 112
Query: 121 WLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWK 180
WLAEVQFLG+V+HPNLVKLLGYCS + ERGIQRLLVYE+MPNRSLED LF++ PTLPWK
Sbjct: 113 WLAEVQFLGIVNHPNLVKLLGYCSVDGERGIQRLLVYEFMPNRSLEDHLFNKKLPTLPWK 172
Query: 181 TRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTH 240
TRLEI+LGAA+GLAYLHEGLEIQVIYRDFK+SNVLLD +F PKLSDFGLAREGP GD TH
Sbjct: 173 TRLEIMLGAAQGLAYLHEGLEIQVIYRDFKSSNVLLDADFHPKLSDFGLAREGPQGDQTH 232
Query: 241 VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300
VSTAVVGT GYAAPEYIETGHLK QSD+WSFGVVLYEILTGRR LERNRPT EQKLL+WV
Sbjct: 233 VSTAVVGTQGYAAPEYIETGHLKVQSDMWSFGVVLYEILTGRRSLERNRPTAEQKLLDWV 292
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360
KQ+PAD +F +++DPRLRNQYS+ AAR++AKLAD+CLKKNPE+RP+M+Q+VESL A+Q
Sbjct: 293 KQYPADTSRFVIIMDPRLRNQYSLPAARKIAKLADSCLKKNPEDRPSMSQIVESLNQALQ 352
Query: 361 ESE 363
S+
Sbjct: 353 YSD 355
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255552936|ref|XP_002517511.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223543522|gb|EEF45053.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 557 bits (1436), Expect = e-156, Method: Compositional matrix adjust.
Identities = 289/392 (73%), Positives = 325/392 (82%), Gaps = 27/392 (6%)
Query: 1 MKCFYIFKDKFKPKKGS-NSAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHL 59
MKCFYIFKDK K KKG SAPE RN++ D S LNRT+RSLPSPRSI ELYKEKEH+L
Sbjct: 1 MKCFYIFKDKSKKKKGDSRSAPELRNRSGPDT-SPLNRTSRSLPSPRSITELYKEKEHNL 59
Query: 60 RVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK 119
R F +ELREAT+GF+R+LKIGEGGFGSVYKGTIRP+DG+GE L+VA+KKLN +GLQGHK
Sbjct: 60 RAFSFEELREATHGFSRLLKIGEGGFGSVYKGTIRPVDGQGESLLVAIKKLNKYGLQGHK 119
Query: 120 QWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPW 179
QWLAEVQFLGVV+HPNLVKLLGYCS ++ERGIQRLLVYEYMPN+SLED LFSRA PTLPW
Sbjct: 120 QWLAEVQFLGVVNHPNLVKLLGYCSVDNERGIQRLLVYEYMPNKSLEDHLFSRALPTLPW 179
Query: 180 KTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHT 239
KTRLEI+LGAAEGLAYLH GLE+QVIYRDFK+SNVLLD NFKPKLSDFGLAREGPT
Sbjct: 180 KTRLEIMLGAAEGLAYLHGGLEVQVIYRDFKSSNVLLDQNFKPKLSDFGLAREGPT---- 235
Query: 240 HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW 299
EY+ETGHL S SDIWSFGVVLYEILTGRR LERNRPT EQKLL+W
Sbjct: 236 ---------------EYVETGHLTSHSDIWSFGVVLYEILTGRRTLERNRPTSEQKLLDW 280
Query: 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359
VKQFPAD KKFSM++DPRLRN YSI AA+RVAKLADNCL KN +ERP M +VV +LKLA+
Sbjct: 281 VKQFPADSKKFSMIMDPRLRNDYSIAAAKRVAKLADNCLNKNSKERPFMTEVVGTLKLAI 340
Query: 360 QESEQGSSSTTTAAKTPVTSSSRLVDRRSKRV 391
Q+SE T+ + + S SRL +R++ RV
Sbjct: 341 QDSE------GTSTSSSIPSQSRLAERKANRV 366
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356563418|ref|XP_003549960.1| PREDICTED: probable receptor-like protein kinase At5g47070-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 551 bits (1420), Expect = e-154, Method: Compositional matrix adjust.
Identities = 266/367 (72%), Positives = 311/367 (84%), Gaps = 9/367 (2%)
Query: 1 MKCFYIFKDKFKPKKGSNSAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHLR 60
MKCF+ FK+K K SAPE + N A N T S+ SP+S+ +LY+EKEH R
Sbjct: 5 MKCFF-FKEKCK------SAPELHKKKTPAVNRAANSTG-SVSSPKSVKDLYREKEHSFR 56
Query: 61 VFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRG-EPLVVAVKKLNNHGLQGHK 119
VF +QELR+ATNGFNRMLK+GEGGFGSVYKG+I DG+G +P+ VA+K+LN G QGHK
Sbjct: 57 VFTLQELRDATNGFNRMLKLGEGGFGSVYKGSITQPDGQGGDPIPVAIKRLNTRGFQGHK 116
Query: 120 QWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPW 179
+WLAEVQFLG+V+HPNLVKLLGYCS + ERGIQRLLVYE+MPNRSLED LF++ PTLPW
Sbjct: 117 EWLAEVQFLGIVNHPNLVKLLGYCSVDAERGIQRLLVYEFMPNRSLEDHLFNKNLPTLPW 176
Query: 180 KTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHT 239
KTRLEI+LGAA+GLAYLHEGLEIQVIYRDFK+SNVLLD +F PKLSDFGLAREGP GD T
Sbjct: 177 KTRLEIMLGAAQGLAYLHEGLEIQVIYRDFKSSNVLLDADFHPKLSDFGLAREGPQGDQT 236
Query: 240 HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW 299
HVSTAVVGT GYAAPEYIETGHLK QSD+WSFGVVLYEILTGRR LERNRPT EQKLL+W
Sbjct: 237 HVSTAVVGTQGYAAPEYIETGHLKVQSDMWSFGVVLYEILTGRRSLERNRPTAEQKLLDW 296
Query: 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359
VKQ+PAD +F +++D RLRNQYS+ AAR++AKLAD+CLKKNPE+RP+M+Q+VESLK A+
Sbjct: 297 VKQYPADTSRFVIIMDARLRNQYSLPAARKIAKLADSCLKKNPEDRPSMSQIVESLKQAL 356
Query: 360 QESEQGS 366
Q S+ S
Sbjct: 357 QYSDTTS 363
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|156105187|gb|ABU49132.1| ser/thr protein kinase [Malus x domestica] | Back alignment and taxonomy information |
|---|
Score = 537 bits (1383), Expect = e-150, Method: Compositional matrix adjust.
Identities = 251/369 (68%), Positives = 307/369 (83%), Gaps = 5/369 (1%)
Query: 1 MKCFYIFKDKFKPKKGSNSAPEPRNQNRLDNNSALNRTARSLPS---PRSIPELYKEKEH 57
MKCF FKDK + ++ SAPE + + + D + +R +S S PR IPE+Y+EK H
Sbjct: 1 MKCFNYFKDKAR-RREQRSAPELKEETKSDYSGGGDRVIKSTCSANSPRGIPEMYEEKAH 59
Query: 58 HLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRG-EPLVVAVKKLNNHGLQ 116
+LR F ELR+ATN F+R+LKIGEGGFG+VYKG+I+ D +G +P+VVA+KKLNN GLQ
Sbjct: 60 NLRAFTFAELRQATNDFSRLLKIGEGGFGNVYKGSIKAADDKGSDPVVVAIKKLNNDGLQ 119
Query: 117 GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPT 176
GHKQW+AEVQFL VV HPNLVKL+GYC+ + ERGIQRLLVYE+MPNRSLED LF++ T
Sbjct: 120 GHKQWVAEVQFLSVVEHPNLVKLIGYCAVDGERGIQRLLVYEFMPNRSLEDHLFNKVYST 179
Query: 177 LPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236
+PW+TRL+IILGAA+GLAYLH+GLE+QVIYRDFK +NVLLD NFKPKLSDFGLAREGP
Sbjct: 180 VPWETRLQIILGAAQGLAYLHQGLEVQVIYRDFKCANVLLDDNFKPKLSDFGLAREGPMV 239
Query: 237 DHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKL 296
HTHVSTAVVGTYGYAAP+YIETGHL ++SD+WSFGVVLYEILTGRR LERNRP EQKL
Sbjct: 240 GHTHVSTAVVGTYGYAAPDYIETGHLTAKSDVWSFGVVLYEILTGRRSLERNRPRREQKL 299
Query: 297 LEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
LEWVKQFP DGKKF +++D RL N+YSI AAR++A LA++CL K+ ++RPTM+QVV+ LK
Sbjct: 300 LEWVKQFPCDGKKFGLIMDSRLENKYSITAARKIANLAESCLSKSAKDRPTMSQVVDKLK 359
Query: 357 LAVQESEQG 365
+Q+SE+G
Sbjct: 360 QIIQDSEEG 368
|
Source: Malus x domestica Species: Malus x domestica Genus: Malus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255571079|ref|XP_002526490.1| ATP binding protein, putative [Ricinus communis] gi|223534165|gb|EEF35881.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 536 bits (1382), Expect = e-150, Method: Compositional matrix adjust.
Identities = 258/388 (66%), Positives = 311/388 (80%), Gaps = 22/388 (5%)
Query: 1 MKCFYIFKDKFKPKKGSNSAPEPRNQNRLDNNSA--LNRTARSLPSPRSIPELYKEKEHH 58
MKCFY FKDK + ++ SAPE + ++R D + A + +++ S SPR IPELYKEK H+
Sbjct: 1 MKCFYYFKDKSRSRQ-QRSAPELKEKSRDDYSEADRITKSSCSETSPRGIPELYKEKAHN 59
Query: 59 LRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH 118
LRVF ELR AT+ F+R+LKIGEGGFGSVYKG+I+P+ G+GEP VVA+KKLN GLQGH
Sbjct: 60 LRVFSFSELRNATSDFSRLLKIGEGGFGSVYKGSIKPVGGKGEPTVVAIKKLNRDGLQGH 119
Query: 119 KQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLP 178
KQW+AEVQFLGVV HPNLVKL+GYC + ERGIQRLLVYE+M N+SLE+ LF RA P L
Sbjct: 120 KQWVAEVQFLGVVEHPNLVKLIGYCGVDGERGIQRLLVYEFMQNKSLEEHLFDRAYPALA 179
Query: 179 WKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDH 238
WKTRL+I+LGAA+GLAYLHEGLE+QVIYRDFK+SNVLLD NFKPKLSDFGLAREGP
Sbjct: 180 WKTRLQILLGAAQGLAYLHEGLEVQVIYRDFKSSNVLLDENFKPKLSDFGLAREGPVAGR 239
Query: 239 THVSTA-------------------VVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEIL 279
THVSTA VVGTYGYAAP+YIETGHL ++SD+WSFGVVLYEIL
Sbjct: 240 THVSTAVALMPKYRANEELSILSDQVVGTYGYAAPDYIETGHLTTKSDVWSFGVVLYEIL 299
Query: 280 TGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLK 339
TGRR LERNRP +EQKLLEWVK + + KKF ++IDPRL NQYSI+AAR++AKLAD+CL
Sbjct: 300 TGRRSLERNRPRVEQKLLEWVKHYTPESKKFGLIIDPRLENQYSISAARKIAKLADSCLL 359
Query: 340 KNPEERPTMNQVVESLKLAVQESEQGSS 367
K+ ++RP M++VVESLK +Q+S++G S
Sbjct: 360 KSAKDRPRMSEVVESLKQIIQDSDEGDS 387
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357482241|ref|XP_003611406.1| NAK-type protein kinase [Medicago truncatula] gi|355512741|gb|AES94364.1| NAK-type protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 533 bits (1372), Expect = e-149, Method: Compositional matrix adjust.
Identities = 258/362 (71%), Positives = 301/362 (83%), Gaps = 11/362 (3%)
Query: 1 MKCFYIFKDKFKPKKGSNSAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHLR 60
MKCF+ FK K S S P+ NR + ++ + SPRSI ELYKEKEH+ R
Sbjct: 1 MKCFF-FKQK------SKSDPD---LNRKKKKNHAKKSISAHSSPRSIKELYKEKEHNFR 50
Query: 61 VFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ 120
VF +QEL +ATNGFN++LKIGEGGFG VY+GTI P +G G P+VVA+KKLN G QGHK+
Sbjct: 51 VFTLQELVDATNGFNKVLKIGEGGFGKVYRGTITPENGIGNPIVVAIKKLNTRGFQGHKE 110
Query: 121 WLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWK 180
WLAEVQFLG+V+HPNLVKLLGYCS + E IQRLLVYE+MPNRSLED LFSR+ PTLPWK
Sbjct: 111 WLAEVQFLGIVNHPNLVKLLGYCSVDGE-SIQRLLVYEFMPNRSLEDHLFSRSLPTLPWK 169
Query: 181 TRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTH 240
RL+I+LGAA+GL YLHEGLEIQVIYRDFK+SNVLLD F PKLSDFGLAREGPTGD TH
Sbjct: 170 IRLQIMLGAAQGLQYLHEGLEIQVIYRDFKSSNVLLDKKFHPKLSDFGLAREGPTGDQTH 229
Query: 241 VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300
VSTAVVGT GYAAPEYIETGHLKS+SDIWSFGVVLYEILTGRR +ER P +EQKL+EWV
Sbjct: 230 VSTAVVGTRGYAAPEYIETGHLKSKSDIWSFGVVLYEILTGRRTIERTLPKVEQKLIEWV 289
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360
K +PAD +FS++IDPRLR QYS++AAR++AKLAD+CLKKN E+RP+M+Q+VESLK A+Q
Sbjct: 290 KNYPADSSRFSLIIDPRLRKQYSLDAARKIAKLADSCLKKNAEDRPSMSQIVESLKQALQ 349
Query: 361 ES 362
S
Sbjct: 350 CS 351
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224137090|ref|XP_002327019.1| predicted protein [Populus trichocarpa] gi|222835334|gb|EEE73769.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 531 bits (1369), Expect = e-148, Method: Compositional matrix adjust.
Identities = 251/378 (66%), Positives = 307/378 (81%), Gaps = 8/378 (2%)
Query: 1 MKCF-YIFKDKFKPKKGSNSAPE------PRNQNRLDNNSALNRTARSLPSPRSIPELYK 53
MKCF Y FKDK + +G SAPE + + L + + +++ S S R I E+Y+
Sbjct: 1 MKCFQYYFKDKSR-SRGRRSAPELKQRSITKTDDSLCTSDGMIKSSCSETSQRGISEMYE 59
Query: 54 EKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH 113
EK H+LRVF ELR ATNGF+R+ KIGEGGFG+VYKG+I+P G G+P+VVA+KKLN
Sbjct: 60 EKAHNLRVFSFSELRNATNGFSRLFKIGEGGFGNVYKGSIKPAGGEGDPIVVAIKKLNAD 119
Query: 114 GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRA 173
G QGHKQW+ EVQFLGV+ HPNLVKLLGYC+ + ERGIQRLLVYE+M N+SL+D LF++A
Sbjct: 120 GFQGHKQWVTEVQFLGVLEHPNLVKLLGYCAVDGERGIQRLLVYEFMRNKSLDDHLFNKA 179
Query: 174 QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233
P LPWKTRL+IILGAA+GLA+LHEGLE+QVIYRDFKTSNVLLD + KPKLSDFGLAREG
Sbjct: 180 YPVLPWKTRLQIILGAAQGLAFLHEGLEVQVIYRDFKTSNVLLDEDLKPKLSDFGLAREG 239
Query: 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTME 293
P THVSTAVVGTYGYAAP+YIETGHL ++SD+WSFGVVLYEILTGRR LERNRP +E
Sbjct: 240 PMAGRTHVSTAVVGTYGYAAPDYIETGHLTARSDVWSFGVVLYEILTGRRSLERNRPKVE 299
Query: 294 QKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
QKLLEWVKQFPAD KKF +++DPRL NQYS++AARR+A+LAD+CL K+ + RP M+QV E
Sbjct: 300 QKLLEWVKQFPADSKKFGLIMDPRLENQYSMSAARRIARLADSCLLKSAKGRPKMSQVAE 359
Query: 354 SLKLAVQESEQGSSSTTT 371
+L+ +Q+S +GS S +
Sbjct: 360 TLEQIIQDSSEGSPSKNS 377
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 393 | ||||||
| TAIR|locus:2151992 | 410 | AT5G47070 [Arabidopsis thalian | 0.956 | 0.917 | 0.611 | 2.2e-121 | |
| TAIR|locus:2129326 | 388 | AT4G17660 [Arabidopsis thalian | 0.900 | 0.912 | 0.603 | 4.9e-108 | |
| TAIR|locus:2064920 | 435 | AT2G39110 [Arabidopsis thalian | 0.984 | 0.889 | 0.507 | 2.4e-99 | |
| TAIR|locus:2053250 | 462 | AT2G28940 [Arabidopsis thalian | 0.877 | 0.746 | 0.543 | 2e-97 | |
| TAIR|locus:2085069 | 418 | AT3G09830 [Arabidopsis thalian | 0.824 | 0.775 | 0.541 | 2.7e-93 | |
| TAIR|locus:2142639 | 420 | AT5G03320 [Arabidopsis thalian | 0.984 | 0.921 | 0.468 | 6.3e-92 | |
| TAIR|locus:2095517 | 453 | AT3G28690 [Arabidopsis thalian | 0.837 | 0.726 | 0.516 | 2.4e-85 | |
| TAIR|locus:2147805 | 493 | AT5G15080 [Arabidopsis thalian | 0.847 | 0.675 | 0.512 | 2.4e-85 | |
| TAIR|locus:2100282 | 490 | AT3G01300 [Arabidopsis thalian | 0.849 | 0.681 | 0.502 | 1.5e-83 | |
| TAIR|locus:2053240 | 423 | PK1B "protein kinase 1B" [Arab | 0.862 | 0.801 | 0.5 | 8.2e-83 |
| TAIR|locus:2151992 AT5G47070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1194 (425.4 bits), Expect = 2.2e-121, P = 2.2e-121
Identities = 247/404 (61%), Positives = 297/404 (73%)
Query: 1 MKCFYIFKDKFKPKK-----------GS----NSAPEPRNQNRLDNNSALN-RTARSLPS 44
M C ++FK K KP+K G NSAPE N++ S+ N +T RSLPS
Sbjct: 1 MNCLFLFKSK-KPRKQQKDNNKNKRKGKELLQNSAPELTNRSE---TSSFNLQTPRSLPS 56
Query: 45 PRSIPELYKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPL-DGRGEPL 103
PRSI +LY E+E +LRVF +EL +AT F+R L IGEGGFG VYKG I D PL
Sbjct: 57 PRSIKDLYTEREQNLRVFSYEELSKATYVFSRKLVIGEGGFGIVYKGKILSNGDSSDPPL 116
Query: 104 VVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNR 163
VVA+KKLN GLQGHKQWLAEVQFLGVV+HPN+VKL+GYCS + E GI+RLLVYEYM NR
Sbjct: 117 VVAIKKLNRQGLQGHKQWLAEVQFLGVVNHPNVVKLIGYCSEDGETGIERLLVYEYMSNR 176
Query: 164 SLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPK 223
SLED LF R TLPWK RLEI+LGAAEGL YLH+ ++VIYRDFK+SNVLLD F PK
Sbjct: 177 SLEDHLFPRRSHTLPWKKRLEIMLGAAEGLTYLHD---LKVIYRDFKSSNVLLDDQFCPK 233
Query: 224 LSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRR 283
LSDFGLAREGP GD+THV+TA VGT+GYAAPEY++TGHL+ +SD++SFGVVLYEI+TGRR
Sbjct: 234 LSDFGLAREGPDGDNTHVTTARVGTHGYAAPEYVQTGHLRLKSDVYSFGVVLYEIITGRR 293
Query: 284 VLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPE 343
+ERN+P E++LL+WVK++PAD ++FSM++DPRLRN Y AR +AKLAD CLKKN +
Sbjct: 294 TIERNKPVAERRLLDWVKEYPADSQRFSMIVDPRLRNNYPAAGARSLAKLADLCLKKNDK 353
Query: 344 ERPTMNQVVESLKLAVQESEQGXXXXXXAAKTPVTSSSRLVDRR 387
ERPTM VVE LK ++ES+ T T S V RR
Sbjct: 354 ERPTMEIVVERLKKIIEESDS----EDYPMATTTTKESSQVRRR 393
|
|
| TAIR|locus:2129326 AT4G17660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1068 (381.0 bits), Expect = 4.9e-108, P = 4.9e-108
Identities = 231/383 (60%), Positives = 275/383 (71%)
Query: 1 MKCFYIFKDKFKPKKGSNSAPEPRN-QNR--LDNNS----------ALNR-TARSLPSPR 46
M C ++F K KPK N E +N + R L ++ + N T RSLPSP
Sbjct: 1 MNCLFLFMSK-KPKSRGNMEKEKKNIRGREFLQKSAPELTTRKTTLSFNLPTPRSLPSPT 59
Query: 47 SIPELYKEKEHH----LRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIR-PL--DGR 99
SI +LY ++E + LRVF +EL +AT F+R LKIGEGGFGSVYK TI P D
Sbjct: 60 SIKDLYTDREQNQNQNLRVFSFKELSDATCEFSRKLKIGEGGFGSVYKATINNPTVGDSH 119
Query: 100 GEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEY 159
PL VAVKKLN LQGHKQWLAEV FLGVV+HPN+V+LLGYCS ED +RLLVYE
Sbjct: 120 SSPLTVAVKKLNRQSLQGHKQWLAEVHFLGVVNHPNVVRLLGYCS-EDR---ERLLVYEL 175
Query: 160 MPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN 219
M NRSLED LF+ TL WK RLEI+LGAA+GLAYLHE IQVIYRDFK+SNVLL+
Sbjct: 176 MSNRSLEDHLFTLRTLTLSWKQRLEIMLGAAQGLAYLHE---IQVIYRDFKSSNVLLNEE 232
Query: 220 FKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEIL 279
F PKLSDFGLAREGP GD+THV+TA VGT GYAAPEY+ TGHLK+ D++SFGVVLYEI+
Sbjct: 233 FHPKLSDFGLAREGPEGDNTHVTTARVGTDGYAAPEYVITGHLKTHCDVYSFGVVLYEII 292
Query: 280 TGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLK 339
TGRR LER +P EQKLLEWVK++P + K+F M++D +L N+Y I RRVAKLAD+C+
Sbjct: 293 TGRRTLERMKPLAEQKLLEWVKKYPINSKRFKMIVDSKLCNKYPIAMVRRVAKLADHCVN 352
Query: 340 KNPEERPTMNQVVESLKLAVQES 362
K +ERPTM VVESL ++ES
Sbjct: 353 KIDKERPTMAFVVESLTNIIEES 375
|
|
| TAIR|locus:2064920 AT2G39110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 986 (352.1 bits), Expect = 2.4e-99, P = 2.4e-99
Identities = 202/398 (50%), Positives = 271/398 (68%)
Query: 1 MKCFYIFKDKFKPKKGSN----SAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKE 56
MKCFY KDK + + SA R + + NS + TA S+ S S+ L +
Sbjct: 16 MKCFYFSKDKTQDDEAKTRKFGSATMARGGSGSEFNSDTS-TATSITS--SLHVLSETHS 72
Query: 57 HHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIR-PLDGRGEPLVVAVKKLNNHGL 115
++L+VF + +L+ AT F+R L IGEGGFG V++G I+ P D R + + +AVK+L+ GL
Sbjct: 73 NNLKVFVLDDLKTATKNFSRSLMIGEGGFGGVFRGVIQNPQDSR-KKIDIAVKQLSRRGL 131
Query: 116 QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQP 175
QGHK+W+ EV LGVV HPNLVKL+GYC+ +DERGIQRLLVYEY+ NRS++D L +R
Sbjct: 132 QGHKEWVTEVNVLGVVEHPNLVKLIGYCAEDDERGIQRLLVYEYVQNRSVQDHLSNRFIV 191
Query: 176 T-LPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGP 234
T LPW TRL+I A GLAYLH+G+E Q+I+RDFK+SN+LLD N+ KLSDFGLAR GP
Sbjct: 192 TPLPWSTRLKIAQDTARGLAYLHQGMEFQIIFRDFKSSNILLDENWNAKLSDFGLARMGP 251
Query: 235 TGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ 294
+ THVSTAVVGT GYAAPEYI+TGHL ++SD+WS+G+ LYE++TGRR +RNRP EQ
Sbjct: 252 SDGITHVSTAVVGTIGYAAPEYIQTGHLTAKSDVWSYGIFLYELITGRRPFDRNRPRNEQ 311
Query: 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354
+LEW++ +D KKF M+IDPRL Y + +A ++A +A+ CL + RPTM+QV E
Sbjct: 312 NILEWIRPHLSDIKKFKMIIDPRLEGNYYLKSALKLAAVANRCLMVKAKARPTMSQVSEM 371
Query: 355 LKLAVQESEQGXXXXXXAAKTPVTSSSRLVDRRSKRVQ 392
L+ V+ S G K+ +T R +RV+
Sbjct: 372 LERIVETSSDGAPSGLPLMKS-LTPKDAFEASRRERVK 408
|
|
| TAIR|locus:2053250 AT2G28940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 968 (345.8 bits), Expect = 2.0e-97, P = 2.0e-97
Identities = 193/355 (54%), Positives = 255/355 (71%)
Query: 17 SNSAPEPRNQNRLDNNSALNRTARSLPSPRS---IPELYKEKEHHLRVFDMQELREATNG 73
S++ +P ++ D++ + + + P P S I L E + L+VF +EL+ AT G
Sbjct: 44 SSTTSDPTRRSEFDSDWSFSPERLTFPKPLSQRWIGGLVPEND--LKVFTFKELKIATKG 101
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRG--EPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV 131
FNR L IGEGGFG VY+G + D G + VAVK+LN GLQGHK+W+ EV FLGVV
Sbjct: 102 FNRGLLIGEGGFGCVYRGVVDVSDSNGFDSKINVAVKQLNRQGLQGHKEWINEVNFLGVV 161
Query: 132 SHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRA-QPTLPWKTRLEIILGAA 190
+HPNLVKL+GYC+ +DERG+QRLLVYE M N+SLED L R +LPW RL+I AA
Sbjct: 162 NHPNLVKLVGYCADDDERGMQRLLVYELMCNKSLEDHLVGRVVSVSLPWMMRLKIAQDAA 221
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
+GLAYLHE ++ Q+I+RDFK+SN+LLD F KLSDFGLAR+GP HVST+VVGT G
Sbjct: 222 QGLAYLHEEMDFQLIFRDFKSSNILLDERFGAKLSDFGLARQGPPEGLGHVSTSVVGTVG 281
Query: 251 YAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310
YAAPEY++TG L ++SD+WSFGVVLYE++TGRR ++RNRP EQKLLEWVK + +D KKF
Sbjct: 282 YAAPEYVQTGKLTAKSDVWSFGVVLYELITGRRAVDRNRPRGEQKLLEWVKPYVSDSKKF 341
Query: 311 SMMIDPRLRNQY-SINAARRVAKLADNCLKKNPEERPTMNQVVESL-KLAVQESE 363
+++DPRL QY + + +RVA LA+ CL K P+ RP M++VV L ++ +E+E
Sbjct: 342 HLIVDPRLEGQYYCMKSVQRVAALANKCLMKQPKSRPKMSEVVSLLGRIIDEEAE 396
|
|
| TAIR|locus:2085069 AT3G09830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 929 (332.1 bits), Expect = 2.7e-93, P = 2.7e-93
Identities = 176/325 (54%), Positives = 235/325 (72%)
Query: 38 TARSLPSPRSIPELYKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLD 97
T S+ S P + + +LR F + +L+ AT F+R + IGEGGFG V++GT+R L+
Sbjct: 49 TESSMGRKNSYPPV-STRASNLREFSITDLKSATKNFSRSVMIGEGGFGCVFRGTVRNLE 107
Query: 98 GRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVY 157
+ VAVK+L GLQGHK+W+ EV FLG+V H NLVKLLGYC+ +DERGIQRLLVY
Sbjct: 108 DSSVKIEVAVKQLGKRGLQGHKEWVTEVNFLGIVEHTNLVKLLGYCAEDDERGIQRLLVY 167
Query: 158 EYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD 217
EYMPNRS+E L R+ L W RL I AA GL YLHE +E Q+I+RDFK+SN+LLD
Sbjct: 168 EYMPNRSVEFHLSPRSLTVLTWDLRLRIAQDAARGLTYLHEEMEFQIIFRDFKSSNILLD 227
Query: 218 GNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYE 277
++K KLSDFGLAR GP+ THVST VVGT GYAAPEYI+TG L S+SD+W +GV LYE
Sbjct: 228 EDWKAKLSDFGLARLGPSEGLTHVSTDVVGTMGYAAPEYIQTGRLTSKSDVWGYGVFLYE 287
Query: 278 ILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNC 337
++TGRR ++RNRP EQKLLEWV+ + +D +KF +++DPRL +Y I + +++A +A+ C
Sbjct: 288 LITGRRPVDRNRPKGEQKLLEWVRPYLSDTRKFKLILDPRLEGKYPIKSVQKLAVVANRC 347
Query: 338 LKKNPEERPTMNQVVESLKLAVQES 362
L +N + RP M++V+E + V+ S
Sbjct: 348 LVRNSKARPKMSEVLEMVNKIVEAS 372
|
|
| TAIR|locus:2142639 AT5G03320 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 916 (327.5 bits), Expect = 6.3e-92, P = 6.3e-92
Identities = 189/403 (46%), Positives = 267/403 (66%)
Query: 1 MKCFYIFKDKFKPKKGSNSAPEPRN--QNRLD-NNSALNRTARSLPSPRSIPELYKE--- 54
MKCF +F KK +P+P + N D N S + + R + ++ +
Sbjct: 1 MKCF-LFP--LGDKKDEQRSPKPVSPTSNFSDVNKSGSDFSPRDVSGTSTVSSTGRNSNT 57
Query: 55 ----KEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL 110
+E++LR F + +L+ AT F+R IGEGGFG V+ GTI+ L+ + + VAVK+L
Sbjct: 58 SMSARENNLREFTIGDLKSATRNFSRSGMIGEGGFGCVFWGTIKNLEDPSKKIEVAVKQL 117
Query: 111 NNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLF 170
GLQGHK+W+ EV FLGVV H NLVKLLG+C+ +DERGIQRLLVYEYMPN+S+E L
Sbjct: 118 GKRGLQGHKEWVTEVNFLGVVEHSNLVKLLGHCAEDDERGIQRLLVYEYMPNQSVEFHLS 177
Query: 171 SRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230
R+ L W RL I AA GL YLHE ++ Q+I+RDFK+SN+LLD N+ KLSDFGLA
Sbjct: 178 PRSPTVLTWDLRLRIAQDAARGLTYLHEEMDFQIIFRDFKSSNILLDENWTAKLSDFGLA 237
Query: 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRP 290
R GP+ +HVST VVGT GYAAPEYI+TG L S+SD+W +GV +YE++TGRR L+RN+P
Sbjct: 238 RLGPSPGSSHVSTDVVGTMGYAAPEYIQTGRLTSKSDVWGYGVFIYELITGRRPLDRNKP 297
Query: 291 TMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQ 350
EQKLLEWV+ + +D ++F +++DPRL +Y I + +++A +A+ CL +N + RP M++
Sbjct: 298 KGEQKLLEWVRPYLSDTRRFRLIVDPRLEGKYMIKSVQKLAVVANLCLTRNAKARPKMSE 357
Query: 351 VVESLKLAVQESEQGXXXXXXAAKTPVTS--SSRLVDRRSKRV 391
V+E + V+ S G P+ S +SR+ + ++K+V
Sbjct: 358 VLEMVTKIVEASSPGNGGKKPQL-VPLKSQETSRVEEGKNKKV 399
|
|
| TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 854 (305.7 bits), Expect = 2.4e-85, P = 2.4e-85
Identities = 177/343 (51%), Positives = 232/343 (67%)
Query: 22 EPRNQ-NRLDNNSALNRTARSLPSPRSIPELYKEKEHH--LRVFDMQELREATNGFNRML 78
EP+ +L+ + A + S S P + E ++ LR+F +L+ AT F
Sbjct: 48 EPKKVIEKLEGHPAPTKDTGCAESGSSTPLMSGELKYSSKLRIFMFNDLKLATRNFRPES 107
Query: 79 KIGEGGFGSVYKGTIRPLDGR-----GEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH 133
+GEGGFG V+KG I +G G L VAVK LN GLQGHK+WLAE+ FLG + H
Sbjct: 108 LLGEGGFGCVFKGWIEE-NGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLVH 166
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGL 193
P+LVKL+GYC ED QRLLVYE+MP SLE+ LF R P LPW R++I LGAA+GL
Sbjct: 167 PSLVKLVGYCMEED----QRLLVYEFMPRGSLENHLFRRTLP-LPWSVRMKIALGAAKGL 221
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAA 253
A+LHE E VIYRDFKTSN+LLDG + KLSDFGLA++ P +HVST V+GTYGYAA
Sbjct: 222 AFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEKKSHVSTRVMGTYGYAA 281
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313
PEY+ TGHL ++SD++SFGVVL EILTGRR ++++RP EQ L+EWV+ D K+F +
Sbjct: 282 PEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPNGEQNLVEWVRPHLLDKKRFYRL 341
Query: 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
+DPRL YSI A++ ++A CL ++ + RP M++VVE+LK
Sbjct: 342 LDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVVEALK 384
|
|
| TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 854 (305.7 bits), Expect = 2.4e-85, P = 2.4e-85
Identities = 178/347 (51%), Positives = 232/347 (66%)
Query: 17 SNSAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKE--HHLRVFDMQELREATNGF 74
S SA E N + S+ T+ + S S P + +E HLR F +L+ +T F
Sbjct: 84 SKSANEKSNDQPVGQVSSTTTTSNA-ESSSSTPVISEELNISSHLRKFTFNDLKLSTRNF 142
Query: 75 NRMLKIGEGGFGSVYKGTIRPLDGR-----GEPLVVAVKKLNNHGLQGHKQWLAEVQFLG 129
+GEGGFG V+KG I +G G L VAVK LN GLQGHK+WLAE+ FLG
Sbjct: 143 RPESLLGEGGFGCVFKGWIEE-NGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLG 201
Query: 130 VVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGA 189
+ HPNLVKL+GYC +D QRLLVYE+MP SLE+ LF R+ P LPW R++I LGA
Sbjct: 202 NLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALGA 256
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
A+GL++LHE VIYRDFKTSN+LLD ++ KLSDFGLA++ P THVST V+GTY
Sbjct: 257 AKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTY 316
Query: 250 GYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309
GYAAPEY+ TGHL S+SD++SFGVVL E+LTGRR +++NRP E L+EW + D ++
Sbjct: 317 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRR 376
Query: 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
F ++DPRL +SI A++V +LA CL ++P+ RP M+ VVE+LK
Sbjct: 377 FYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALK 423
|
|
| TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 837 (299.7 bits), Expect = 1.5e-83, P = 1.5e-83
Identities = 175/348 (50%), Positives = 231/348 (66%)
Query: 16 GSNSAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKE--HHLRVFDMQELREATNG 73
GS SA N + S+ T+ + S S P + +E HL+ F +L+ AT
Sbjct: 77 GSQSAIVQSNDQPVGPVSSTTTTSNA-ESSLSTPIISEELNIYSHLKKFSFIDLKLATRN 135
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGR-----GEPLVVAVKKLNNHGLQGHKQWLAEVQFL 128
F +GEGGFG V+KG + +G G L VAVK LN GLQGHK+WLAE+ +L
Sbjct: 136 FRPESLLGEGGFGCVFKGWVEE-NGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYL 194
Query: 129 GVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILG 188
G + HPNLVKL+GYC +D QRLLVYE+MP SLE+ LF R+ P LPW R++I LG
Sbjct: 195 GNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRSLP-LPWSIRMKIALG 249
Query: 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT 248
AA+GL++LHE VIYRDFKTSN+LLDG + KLSDFGLA++ P THVST V+GT
Sbjct: 250 AAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGT 309
Query: 249 YGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308
YGYAAPEY+ TGHL S+SD++SFGVVL E+LTGRR +++NRP E L+EW + D +
Sbjct: 310 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKR 369
Query: 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
+F ++DPRL +S+ A++V +LA CL ++ + RP M++VVE LK
Sbjct: 370 RFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLK 417
|
|
| TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 830 (297.2 bits), Expect = 8.2e-83, P = 8.2e-83
Identities = 177/354 (50%), Positives = 238/354 (67%)
Query: 19 SAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHLRVFDMQELREATNGFNRML 78
++P+ + D+ + + + +PR+ E+ + +L+ F EL+ AT F
Sbjct: 27 ASPKYMSSEANDSLGSKSSSVSIRTNPRTEGEILQSP--NLKSFTFAELKAATRNFRPDS 84
Query: 79 KIGEGGFGSVYKGTI--RPLDGR--GEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHP 134
+GEGGFGSV+KG I + L G +V+AVKKLN G QGH++WLAEV +LG SHP
Sbjct: 85 VLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQGHQEWLAEVNYLGQFSHP 144
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRA---QPTLPWKTRLEIILGAAE 191
NLVKL+GYC EDE RLLVYE+MP SLE+ LF R QP L W RL++ LGAA+
Sbjct: 145 NLVKLIGYC-LEDEH---RLLVYEFMPRGSLENHLFRRGSYFQP-LSWTLRLKVALGAAK 199
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGY 251
GLA+LH E VIYRDFKTSN+LLD + KLSDFGLA++GPTGD +HVST ++GTYGY
Sbjct: 200 GLAFLHNA-ETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVSTRIMGTYGY 258
Query: 252 AAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311
AAPEY+ TGHL ++SD++S+GVVL E+L+GRR +++NRP EQKL+EW + A+ +K
Sbjct: 259 AAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEWARPLLANKRKLF 318
Query: 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQG 365
+ID RL++QYS+ A +VA LA CL + RP MN+VV L+ +E G
Sbjct: 319 RVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQTLNEAG 372
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LTC0 | Y5707_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6129 | 0.9592 | 0.9195 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 393 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-60 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-60 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-54 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-54 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-53 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-52 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-39 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-35 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-33 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-31 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-30 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-28 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-27 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-27 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-26 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-26 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-25 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-24 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-23 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-23 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 9e-23 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-22 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-22 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-21 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-21 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-21 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-21 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-20 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-20 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 9e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-19 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-19 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-19 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-19 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-18 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-18 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-17 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-17 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-17 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-16 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 8e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-15 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-14 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-14 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-14 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-14 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-13 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-13 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-09 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 7e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.001 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 1e-60
Identities = 93/278 (33%), Positives = 138/278 (49%), Gaps = 26/278 (9%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL-NNHGLQGHKQWLAEVQFLGVVSHPNLV 137
K+GEG FG VYKGT++ G+ + VAVK L + Q +++L E + + + HPN+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGD-GKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
KLLG C+ E+ ++V EYMP L D L L L L A G+ YL
Sbjct: 65 KLLGVCTEEE----PLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE 120
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYI 257
I+RD N L+ N K+SDFGL+R+ D+ V + + APE +
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-PIRWMAPESL 176
Query: 258 ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPR 317
+ G S+SD+WSFGV+L+EI T ++LE++K K + + P
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN--AEVLEYLK------KGYRLPKPP- 227
Query: 318 LRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
N + KL C ++PE+RPT +++VE L
Sbjct: 228 -------NCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 195 bits (499), Expect = 2e-60
Identities = 88/278 (31%), Positives = 135/278 (48%), Gaps = 27/278 (9%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL-NNHGLQGHKQWLAEVQFLGVVSHPNLV 137
K+GEG FG VYKG ++ G + + VAVK L + Q +++L E + + + HPN+V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGG-KKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
KLLG C+ E+ +V EYM L L + +P L L L A G+ YL
Sbjct: 65 KLLGVCTEEEPL----YIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYI 257
I+RD N L+ N K+SDFGL+R+ D+ + + APE +
Sbjct: 120 S---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-PIRWMAPESL 175
Query: 258 ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPR 317
+ G S+SD+WSFGV+L+EI T +++LE++K + + P
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN--EEVLEYLK------NGYRLPQPP- 226
Query: 318 LRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
N + L C ++PE+RPT +++VE L
Sbjct: 227 -------NCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 3e-54
Identities = 84/282 (29%), Positives = 125/282 (44%), Gaps = 36/282 (12%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNL 136
K+G G FG+VYK +G +VAVK L + + E++ L +SHPN+
Sbjct: 6 KLGSGSFGTVYKAK-----HKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
V+L+ +D LV EY L D L L +I L GL YL
Sbjct: 61 VRLIDAFEDKDHL----YLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYL 114
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
H +I+RD K N+LLD N K++DFGLA++ + T VGT Y APE
Sbjct: 115 HS---NGIIHRDLKPENILLDENGVVKIADFGLAKKLLK--SSSSLTTFVGTPWYMAPEV 169
Query: 257 I--ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMI 314
+ G+ D+WS GV+LYE+LTG + ++Q + ++
Sbjct: 170 LLGGNGYGPK-VDVWSLGVILYELLTG-KPPFSGENILDQL------------QLIRRIL 215
Query: 315 DPRLR--NQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354
P L + + L CL K+P +RPT ++++
Sbjct: 216 GPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQH 257
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 3e-54
Identities = 90/286 (31%), Positives = 138/286 (48%), Gaps = 33/286 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL-NNHGLQGHKQWLAEVQFLGVVSHPNLV 137
K+GEG FG VYKG ++ DG + VAVK L + + K +L E + + + HPN+V
Sbjct: 2 KLGEGAFGEVYKGKLKGKDG--KTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVV 59
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRL-------FSRAQPTLPWKTRLEIILGAA 190
+LLG C+ E+ LV EYM L D L S + TL K L + A
Sbjct: 60 RLLGVCTEEEPL----YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
+G+ YL + ++RD N L+ + K+SDFGL+R+ D+ T
Sbjct: 116 KGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 251 YAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310
+ APE ++ G S+SD+WSFGV+L+EI T E +LE+++ G
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--VLEYLR----KGY-- 224
Query: 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
R + +L +C + +PE+RPT +++VE L+
Sbjct: 225 --------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 1e-53
Identities = 93/283 (32%), Positives = 141/283 (49%), Gaps = 36/283 (12%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQGHKQWLAEVQFLGVVSHPNLV 137
K+GEG FG VYKGT++ E VAVK L + +++L E + +SHPN+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTE-TKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
+LLG C+ + +V EYMP L D L + L K L++ L A+G+ YL
Sbjct: 65 RLLGVCTQGE----PLYIVTEYMPGGDLLDFLRKHGEK-LTLKDLLQMALQIAKGMEYLE 119
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG---YAAP 254
++RD N L+ N K+SDFGL+R+ D+ G + AP
Sbjct: 120 S---KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG---GGKLPIKWMAP 173
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME-QKLLEWVKQFPADGKKFSM 312
E ++ G S+SD+WSFGV+L+EI T G + P M +++LE ++ DG + +
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY----PGMSNEEVLELLE----DGYR--L 223
Query: 313 MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
P N + +L C +PE+RPT +++VE L
Sbjct: 224 PR-PE-------NCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 1e-53
Identities = 82/279 (29%), Positives = 119/279 (42%), Gaps = 67/279 (24%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ-WLAEVQFLGVVSHPNLVK 138
+GEGGFG+VY + VA+K + + L E++ L ++HPN+VK
Sbjct: 1 LGEGGFGTVYLARDK-----KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVK 55
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L G E+ + V EY SL+D L + L L I+L EGL YLH
Sbjct: 56 LYGVFEDENHLYL----VMEYCEGGSLKDLLKEN-EGKLSEDEILRILLQILEGLEYLHS 110
Query: 199 GLEIQVIYRDFKTSNVLLD-GNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYI 257
+I+RD K N+LLD N K KL+DFGL++ + +VGT Y APE +
Sbjct: 111 ---NGIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVL 165
Query: 258 E-TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDP 316
G+ +SDIWS GV+LYE+
Sbjct: 166 LGKGYYSEKSDIWSLGVILYEL-------------------------------------- 187
Query: 317 RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
+ L L+K+PE+RP+ +++E L
Sbjct: 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 2e-52
Identities = 79/276 (28%), Positives = 121/276 (43%), Gaps = 32/276 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH-KQWLAEVQFLGVVSHPNLV 137
K+GEG FG VY G+ +VA+K + ++ ++ L E++ L + HPN+V
Sbjct: 6 KLGEGSFGKVYLA-RDKKTGK----LVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
+L ED+ LV EY L D L + + L + L YLH
Sbjct: 61 RLYDVFEDEDKL----YLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEYLH 114
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYI 257
+++RD K N+LLD + KL+DFGLAR+ G+ VGT Y APE +
Sbjct: 115 S---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT---FVGTPEYMAPEVL 168
Query: 258 ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPR 317
DIWS GV+LYE+LTG+ + +L + + + I P
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGKPPFPGD--DQLLELFKKIGKPKPPFPPPEWDISPE 226
Query: 318 LRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
++ L L K+PE+R T + ++
Sbjct: 227 AKD------------LIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 4e-40
Identities = 84/279 (30%), Positives = 124/279 (44%), Gaps = 35/279 (12%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH 133
F + KIG+GGFG VYK + VA+K + + ++ + E+Q L H
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTG-----KEVAIKVIKLESKEKKEKIINEIQILKKCKH 56
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGL 193
PN+VK Y S + + +V E+ SL+D L S Q L + +GL
Sbjct: 57 PNIVKY--YGSYLKKDELW--IVMEFCSGGSLKDLLKSTNQT-LTESQIAYVCKELLKGL 111
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAA 253
YLH +I+RD K +N+LL + + KL DFGL+ + + +VGT + A
Sbjct: 112 EYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNT---MVGTPYWMA 165
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313
PE I ++DIWS G+ E+ G+ P K L +
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALFKIATNGP-------- 214
Query: 314 IDPRLRN--QYSINAARRVAKLADNCLKKNPEERPTMNQ 350
P LRN ++S + K CL+KNPE+RPT Q
Sbjct: 215 --PGLRNPEKWSDEFKDFLKK----CLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 73/286 (25%), Positives = 118/286 (41%), Gaps = 53/286 (18%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKK--LNNHGLQGHKQWLAEVQFLGVVSHPNL 136
+G G FGSVY + G ++AVK L+ + + E++ L + HPN+
Sbjct: 7 LLGRGSFGSVYLALDK-DTGE----LMAVKSVELSGDSEEELEALEREIRILSSLQHPNI 61
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRL--FSRAQPTLPWKTRLEIILGAAEGLA 194
V+ G E++ + + EY+ SL L F + + + IL EGLA
Sbjct: 62 VRYYGSERDEEKNTL--NIFLEYVSGGSLSSLLKKFGKLPEPV-IRKYTRQIL---EGLA 115
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP 254
YLH +++RD K +N+L+D + KL+DFG A+ + + +V GT + AP
Sbjct: 116 YLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL------EWVKQFPAD-- 306
E I +DIWS G + E+ TG+ M L + P
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYKIGSSGEPPEIPEHLS 230
Query: 307 --GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQ 350
K F CL+++P++RPT ++
Sbjct: 231 EEAKDFLRK-----------------------CLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 81/280 (28%), Positives = 134/280 (47%), Gaps = 35/280 (12%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+IG+G FG VY + G+ V+ L+N + + L EV+ L ++HPN++K
Sbjct: 7 QIGKGSFGKVYLVRRK---SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 139 LLGYCSTEDERGIQRLL-VYEYMPNRSLEDRLFSRAQP--TLPWKTRLEIILGAAEGLAY 195
Y S E++ +L V EY L ++ + + P + L+ + L Y
Sbjct: 64 Y--YESFEEK---GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKY 118
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPE 255
LH ++++RD K N+ L N KL DFG+++ ++ VVGT Y +PE
Sbjct: 119 LHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPE 173
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVLE-RNRPTMEQKLLEWVKQFPADGKKFSMMI 314
+ +SDIWS G VLYE+ T + E N + K+L+ Q+P
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK--GQYPP--------- 222
Query: 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354
+ +QYS + L + L+K+PEERP++ Q+++S
Sbjct: 223 ---IPSQYS----SELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 3e-34
Identities = 72/211 (34%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 76 RMLKIGEGGFGSVYKGTIRPL-DGRGEPLVVAVKKLNNHGLQGHKQ-WLAEVQFLGVVSH 133
+ ++GEG FG V PL D GE VAVK LN+ G + H+ + E++ L + H
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGE--QVAVKSLNHSGEEQHRSDFEREIEILRTLDH 65
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGL 193
N+VK G C R ++ L+ EY+P+ SL D L R + + K L +G+
Sbjct: 66 ENIVKYKGVCEKPGGRSLR--LIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQICKGM 122
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAV----VGTY 249
YL + I+RD N+L++ K+SDFGLA+ P + + Y
Sbjct: 123 DYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY 179
Query: 250 GYAAPEYIETGHLKSQSDIWSFGVVLYEILT 280
APE + T S SD+WSFGV LYE+ T
Sbjct: 180 ---APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 4e-34
Identities = 88/278 (31%), Positives = 126/278 (45%), Gaps = 49/278 (17%)
Query: 79 KIGEGGFGSVYKGTIRPLDGR-GEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPN 135
IG G FG VYKG L+ G+ VA+K+++ + + K + E+ L + HPN
Sbjct: 7 LIGRGAFGVVYKG----LNLETGD--FVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRL--FSRAQPTLPWKTRLEIILGAAEGL 193
+VK +G T D I + EY N SL + F +L + +L +GL
Sbjct: 61 IVKYIGSIETSDSLYI----ILEYAENGSLRQIIKKFGPFPESLV-AVYVYQVL---QGL 112
Query: 194 AYLHEGLEIQ-VIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA 252
AYLHE Q VI+RD K +N+L + KL+DFG+A + +VVGT +
Sbjct: 113 AYLHE----QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWM 166
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSM 312
APE IE + SDIWS G + E+LTG N P + + A F +
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTG------NPPYYD------LNPMAA---LFRI 211
Query: 313 MIDPRLRNQYSINAARRVAKLAD---NCLKKNPEERPT 347
+ D I+ L D C +K+P RPT
Sbjct: 212 VQDDHPPLPEGISPE-----LKDFLMQCFQKDPNLRPT 244
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 127 bits (318), Expect = 5e-33
Identities = 90/328 (27%), Positives = 133/328 (40%), Gaps = 38/328 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN---NHGLQGHKQWLAEVQFLGVVSHP- 134
K+GEG FG VY + +VA+K L + +++L E+Q L ++HP
Sbjct: 7 KLGEGSFGEVYLAR--------DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRL-FSRAQPTLPWKTRLEIILGAAEGL 193
N+VKL + E LV EY+ SLED L + L L I+ L
Sbjct: 59 NIVKLYDFFQDEG----SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGN-FKPKLSDFGLAR----EGPTGDHTHVSTAVVGT 248
YLH +I+RD K N+LLD + KL DFGLA+ G T + + VGT
Sbjct: 115 EYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171
Query: 249 YGYAAPEYIE---TGHLKSQSDIWSFGVVLYEILTGRRVLER-NRPTMEQKLLEWVKQFP 304
GY APE + + S SDIWS G+ LYE+LTG E + + L+ + + P
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231
Query: 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364
L ++ + L L K+P+ R + L + +
Sbjct: 232 TPSLA------SPLSPSNPELISKAASDLLKKLLAKDPKNRLSS---SSDLSHDLLAHLK 282
Query: 365 GSSSTTTAAKTPVTSSSRLVDRRSKRVQ 392
S + P S+ +
Sbjct: 283 LKESDLSDLLKPDDSAPLRLSLPPSLEA 310
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 6e-33
Identities = 89/283 (31%), Positives = 128/283 (45%), Gaps = 44/283 (15%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKL 139
IG+G FG V G R G+ VAVK L + + +LAE + + HPNLV+L
Sbjct: 14 IGKGEFGDVMLGDYR---GQK----VAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQL 65
Query: 140 LGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEG 199
LG + + +V EYM SL D L SR + + +L L EG+ YL E
Sbjct: 66 LGVVLQGN--PL--YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK 121
Query: 200 LEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET 259
++RD NVL+ + K+SDFGLA+E G V T APE +
Sbjct: 122 ---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-QDSGKLPVKWT----APEALRE 173
Query: 260 GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLR 319
++SD+WSFG++L+EI + RV P + K + V P +
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRV---PYPRIPLK--DVV---------------PHVE 213
Query: 320 NQYSINAAR----RVAKLADNCLKKNPEERPTMNQVVESLKLA 358
Y + A V K+ +C + +P +RPT Q+ E L L
Sbjct: 214 KGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 7e-32
Identities = 83/276 (30%), Positives = 126/276 (45%), Gaps = 51/276 (18%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQFLGVVSHPNL 136
+G+G FG V + G+ + A+K L + K+ L E L ++HP +
Sbjct: 1 LGKGSFGKVLLVRKK-DTGK----LYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 137 VKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLP-WKTRL---EIILGAAE 191
VKL + + + E +L LV EY P L L + + R EI+L
Sbjct: 56 VKL--HYAFQTEE---KLYLVLEYAPGGELFSHL--SKEGRFSEERARFYAAEIVLA--- 105
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGY 251
L YLH + +IYRD K N+LLD + KL+DFGLA+E + + GT Y
Sbjct: 106 -LEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEY 159
Query: 252 AAPEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVLE-RNRPTMEQKLLEWVKQFPADGKK 309
APE + G+ K+ D WS GV+LYE+LTG+ +R + +K+L+ +FP
Sbjct: 160 LAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEF--- 215
Query: 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
+ P R+ L L+K+P +R
Sbjct: 216 ----LSPEARD------------LISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 78/287 (27%), Positives = 124/287 (43%), Gaps = 53/287 (18%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVS 132
R+ +G+G G VYK +P G+ + A+KK++ + + KQ L E++ L
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKP-TGK----IYALKKIHVDGDEEFRKQLLRELKTLRSCE 57
Query: 133 HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA-- 190
P +VK Y + E I +V EYM SL D L + +P E +L
Sbjct: 58 SPYVVKC--YGAFYKEGEIS--IVLEYMDGGSLADLL--KKVGKIP-----EPVLAYIAR 106
Query: 191 ---EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVG 247
+GL YLH I I+RD K SN+L++ + K++DFG+++ + VG
Sbjct: 107 QILKGLDYLHTKRHI--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVG 162
Query: 248 TYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307
T Y +PE I+ +DIWS G+ L E G+ P
Sbjct: 163 TVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPF----------------LPPGQP 206
Query: 308 KKFSMMI------DPRLR-NQYSINAARRVAKLADNCLKKNPEERPT 347
F +M P L ++S ++ CL+K+P++RP+
Sbjct: 207 SFFELMQAICDGPPPSLPAEEFSPEFRDFISA----CLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-31
Identities = 87/288 (30%), Positives = 136/288 (47%), Gaps = 38/288 (13%)
Query: 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN---NHGLQGHKQWLAEVQFL 128
+ + ++G G G V K RP G ++AVK + N +Q KQ L E+ L
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRP-TG----KIMAVKTIRLEINEAIQ--KQILRELDIL 53
Query: 129 GVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILG 188
+ P +V G + I EYM SL D++ Q +P + +I +
Sbjct: 54 HKCNSPYIVGFYGAFYNNGDISI----CMEYMDGGSL-DKILKEVQGRIPERILGKIAVA 108
Query: 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT 248
+GL YLHE +I I+RD K SN+L++ + KL DFG++ + ++ VGT
Sbjct: 109 VLKGLTYLHEKHKI--IHRDVKPSNILVNSRGQIKLCDFGVSGQ-LVNS---LAKTFVGT 162
Query: 249 YGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVL--ERNRPTMEQKLLEWVKQFPAD 306
Y APE I+ +SDIWS G+ L E+ TGR E + P +LL+++ P
Sbjct: 163 SSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP- 221
Query: 307 GKKFSMMIDPRLRN-QYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
PRL + ++S + V + CL K+P ERP+ +++E
Sbjct: 222 ---------PRLPSGKFSPDFQDFV----NLCLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-30
Identities = 95/291 (32%), Positives = 139/291 (47%), Gaps = 25/291 (8%)
Query: 76 RMLK----IGEGGFGSVYKGTIRPL-DGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLG 129
R LK +GEG FG V P DG GE +VAVK L G Q W E+ L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGE--MVAVKTLKRECGQQNTSGWKKEINILK 61
Query: 130 VVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGA 189
+ H N+VK G CS + +G+Q L+ EY+P SL D L + + L +++L A
Sbjct: 62 TLYHENIVKYKGCCSEQGGKGLQ--LIMEYVPLGSLRDYL-PKHKLNLA-----QLLLFA 113
Query: 190 ---AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG-DHTHVSTAV 245
EG+AYLH I+RD NVLLD + K+ DFGLA+ P G ++ V
Sbjct: 114 QQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 170
Query: 246 VGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305
+ A E ++ SD+WSFGV LYE+LT +++ P ++++ KQ
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIG-PKQGQM 228
Query: 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
+ +++ +R N + V L NC + + RPT ++ LK
Sbjct: 229 TVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 1e-29
Identities = 81/285 (28%), Positives = 134/285 (47%), Gaps = 43/285 (15%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW--LAEVQFLGVVSHPNLV 137
IG G FG V +G ++ L G+ + + VA+K L G ++ L E +G HPN++
Sbjct: 12 IGGGEFGEVCRGRLK-LPGK-KEIDVAIKTLKA-GSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
+L G + + +++ EYM N SL D+ + ++ G A G+ YL
Sbjct: 69 RLEGVVT----KSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG------Y 251
E + ++RD N+L++ N K+SDFGL+R S A T G +
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSR------RLEDSEATYTTKGGKIPIRW 174
Query: 252 AAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKF 310
APE I S SD+WSFG+V++E+++ G E+ + Q D K
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMSYG-----------ERPYWDMSNQ---DVIK- 219
Query: 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
++ RL ++ + +L +C +K+ ERPT +Q+V +L
Sbjct: 220 AVEDGYRL--PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 69/236 (29%), Positives = 111/236 (47%), Gaps = 37/236 (15%)
Query: 59 LRVFDMQELREATNGFNRMLKI-GEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQ 116
LR+ EL +K+ G G FG+VYKG P +G + VA+K L +
Sbjct: 1 LRILKETELE--------KIKVLGSGAFGTVYKGVWIP-EGEKVKIPVAIKVLREETSPK 51
Query: 117 GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSL-------EDRL 169
+K+ L E + V HP++V+LLG C + Q L+ + MP L +D +
Sbjct: 52 ANKEILDEAYVMASVDHPHVVRLLGICLSS-----QVQLITQLMPLGCLLDYVRNHKDNI 106
Query: 170 FSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229
+Q L W ++ A+G++YL E ++++RD NVL+ K++DFGL
Sbjct: 107 --GSQYLLNWCVQI------AKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGL 155
Query: 230 AREGPTG-DHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRR 283
A+ H V + A E I +SD+WS+GV ++E++T G +
Sbjct: 156 AKLLDVDEKEYHAEGGKV-PIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 80/294 (27%), Positives = 129/294 (43%), Gaps = 44/294 (14%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVK 138
+GEG FG V+ G L+ + +VAVK L K + E + L H N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLED----------RLFSRAQPT--LPWKTRLEII 186
G C+ D ++V+EYM + L L S P L L+I
Sbjct: 73 FYGVCTEGD----PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 187 LGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVV 246
+ A G+ YL ++RD T N L+ + K+ DFG++R+ T D+ V +
Sbjct: 129 VQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 247 GTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME---QKLLEWVKQ 302
+ PE I ++SD+WSFGVVL+EI T G+ +P ++++E + Q
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGK------QPWYGLSNEEVIECITQ 239
Query: 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
G+ ++ PR V + C K++P++R + + E L+
Sbjct: 240 ----GR---LLQRPR-------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-28
Identities = 80/280 (28%), Positives = 136/280 (48%), Gaps = 43/280 (15%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA--EVQFLGVV 131
F + KIG+G FG V+K +R D R V A+K+++ + ++ A E + L +
Sbjct: 2 FEILNKIGKGSFGVVFK-VVRKADKR----VYAMKQIDLSKMNRREREEAIDEARVLAKL 56
Query: 132 SHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLP----WKTRLEIIL 187
+++ Y + ++G + +V EY N L L + LP W+ ++I+L
Sbjct: 57 DSSYIIR---YYESFLDKG-KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL 112
Query: 188 GAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVG 247
G LA+LH ++++RD K+ N+ LD K+ D G+A+ D+T+ + +VG
Sbjct: 113 G----LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVG 163
Query: 248 TYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLE-RNRPTMEQKLLEWVKQFPAD 306
T Y +PE E +SD+W+ GVVLYE TG+ + N+ + K++ V FP
Sbjct: 164 TPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV--FPPV 221
Query: 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP 346
+ +S + A+L D CL K+ +RP
Sbjct: 222 SQMYSQQL----------------AQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-28
Identities = 81/289 (28%), Positives = 123/289 (42%), Gaps = 47/289 (16%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ-WLAEVQFLGVVSHPNLV 137
K+G+G FG V +G G+ P VAVK L + L +L E + + H NL+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIP--VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
+L G T ++V E P SL DRL A T + + A G+ YL
Sbjct: 60 RLYGVVLTH-----PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT-YGYAAPEY 256
+ I+RD N+LL + K K+ DFGL R P + +V + + + APE
Sbjct: 115 SK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPES 171
Query: 257 IETGHLKSQSDIWSFGVVLYEI----------LTGRRVLERNRPTMEQKLLEWVKQFPAD 306
+ T SD+W FGV L+E+ L+G ++L+ + E + LE + P D
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK--KIDKEGERLERPEACPQD 229
Query: 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
+++M+ C NP +RPT + E L
Sbjct: 230 --IYNVML---------------------QCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 82/280 (29%), Positives = 126/280 (45%), Gaps = 32/280 (11%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL-NNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+G G FGSV KG G+ VAVK L H G K++L E + + HP +V+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVE--VAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L+G C E +LV E P L + + + +P E+ A G+AYL
Sbjct: 61 LIGVCKGE-----PLMLVMELAPLGPLLK--YLKKRREIPVSDLKELAHQVAMGMAYLES 113
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE-GPTGDHTHVSTAVVGTYGYAAPEYI 257
++RD NVLL + K+SDFG++R G D+ +TA + APE I
Sbjct: 114 ---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 258 ETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDP 316
G S+SD+WS+GV L+E + G +P E K E + M++
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYG------AKPYGEMKGAEVIA-----------MLES 213
Query: 317 RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
R + + + +C K PE+RPT +++ + +
Sbjct: 214 GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-27
Identities = 91/291 (31%), Positives = 136/291 (46%), Gaps = 37/291 (12%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGE-PLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLV 137
+G G FG VY+GT + G G P+ VAVK L Q K++L E + +HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSL-----EDRLFSRAQPTLPWKTRLEIILGAAEG 192
KLLG C + + ++ E M L + R+ P L K L+I L A+G
Sbjct: 63 KLLGVCLLNEPQ----YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLL-----DGNFKPKLSDFGLAREGPTGDHTHVSTAVVG 247
YL + + I+RD N L+ D + K+ DFGLAR+ D+ +
Sbjct: 119 CVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 248 TYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPAD 306
+ APE + G +QSD+WSFGV+++EILT G +P E ++ A
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLG------QQPYPALNNQEVLQHVTAG 229
Query: 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357
G R Q N ++ +L NC ++P ERPT +++ E L+
Sbjct: 230 G-----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 83/281 (29%), Positives = 131/281 (46%), Gaps = 34/281 (12%)
Query: 76 RMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPN 135
+ +IG G FG V+ G VA+K + G + ++ E Q + +SHP
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRK------VAIKTIR-EGAMSEEDFIEEAQVMMKLSHPK 60
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQP-TLPWKTRLEIILGAAEGLA 194
LV+L G C+ LV+E+M + L D + RAQ +T L + L EG+A
Sbjct: 61 LVQLYGVCTERSPI----CLVFEFMEHGCLSD--YLRAQRGKFSQETLLGMCLDVCEGMA 114
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP 254
YL VI+RD N L+ N K+SDFG+ R +T ST +++P
Sbjct: 115 YLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSP 170
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMI 314
E S+SD+WSFGV+++E+ + + NR E V+ A + +
Sbjct: 171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV-----VETINAGFR----LY 221
Query: 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
PRL A++ V +L +C K+ PE+RP+ + ++ L
Sbjct: 222 KPRL-------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 81/314 (25%), Positives = 138/314 (43%), Gaps = 63/314 (20%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW------LAEVQF 127
+ ++ +IGEG +G VYK G +VA+KK+ +++ + E++
Sbjct: 1 YEKIAQIGEGTYGQVYKA-RNKKTGE----LVALKKIRME----NEKEGFPITAIREIKL 51
Query: 128 LGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPN--RSLEDR---LFSRAQPTLPWKTR 182
L + HPN+V+L +++ + I +V+EYM + L D F+ +Q K
Sbjct: 52 LQKLRHPNIVRLKEIVTSKGKGSI--YMVFEYMDHDLTGLLDSPEVKFTESQ----IKCY 105
Query: 183 LEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS 242
++ +L EGL YLH +++RD K SN+L++ + KL+DFGLAR T ++
Sbjct: 106 MKQLL---EGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADY 158
Query: 243 TAVVGTYGYAAPEYI--ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ------ 294
T V T Y PE + T + D+WS G +L E+ G+ + + +EQ
Sbjct: 159 TNRVITLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGKPIF-QGSTELEQLEKIFE 216
Query: 295 -------------KLLEWVKQF-PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKK 340
L W + P K RLR + L D L
Sbjct: 217 LCGSPTDENWPGVSKLPWFENLKPKKPYK------RRLREFFKHLIDPSALDLLDKLLTL 270
Query: 341 NPEERPTMNQVVES 354
+P++R + +Q ++
Sbjct: 271 DPKKRISADQALQH 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-27
Identities = 87/289 (30%), Positives = 132/289 (45%), Gaps = 51/289 (17%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ-WLAEVQFLGVVSHPNLV 137
KIG+G FG VYKG L G E VAVK + K+ +L E + L HPN+V
Sbjct: 2 KIGKGNFGDVYKGV---LKGNTE---VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIV 55
Query: 138 KLLGYCSTEDERGIQR---LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLA 194
KL+G C +Q+ +V E +P SL L + + L K L++ L AA G+
Sbjct: 56 KLIGVC-------VQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGME 107
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT----YG 250
YL I+RD N L+ N K+SDFG++RE + + T G
Sbjct: 108 YLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRE----EEGGIYTVSDGLKQIPIK 160
Query: 251 YAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLER---NRPTMEQKLLEWVKQFPADG 307
+ APE + G S+SD+WS+G++L+E + N+ T E+ +E + PA
Sbjct: 161 WTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER--IESGYRMPA-- 216
Query: 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
P+L + +L C +PE RP+ +++ L+
Sbjct: 217 --------PQL-------CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-27
Identities = 84/290 (28%), Positives = 132/290 (45%), Gaps = 40/290 (13%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+G+G FG VY+G + + VA+K +N N ++ ++L E + + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR-----AQPTLPWKTRLEIILGAAE-- 191
LLG ST G L+V E M L+ L SR P L T + I AAE
Sbjct: 74 LLGVVST----GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 192 -GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
G+AYL + ++RD N ++ + K+ DFG+ R+ D+ +
Sbjct: 130 DGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 251 YAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL----EWVKQFPAD 306
+ APE ++ G ++SD+WSFGVVL+E+ T EQ E V +F D
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT----------LAEQPYQGLSNEEVLKFVID 236
Query: 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
G + P N ++ +L C + NP+ RPT ++V SLK
Sbjct: 237 GG---HLDLP-------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 69/209 (33%), Positives = 92/209 (44%), Gaps = 26/209 (12%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-----GLQGHKQWLAEVQFLGVVSHP 134
+G GGFG V ++ R A+K + G Q H +E + L +HP
Sbjct: 1 LGVGGFGRVELVKVKS-KNR----TFALKCVKKRHIVETGQQEHIF--SEKEILEECNHP 53
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLP-WKTRLEIILGAAEGL 193
+VKL Y + +D++ I L+ EY L L R + R I
Sbjct: 54 FIVKL--YRTFKDKKYIYMLM--EYCLGGELWTILRDRGL--FDEYTARF-YIACVVLAF 106
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAA 253
YLH +IYRD K N+LLD N KL DFG A++ +G T GT Y A
Sbjct: 107 EYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEYVA 160
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEILTGR 282
PE I D WS G++LYE+LTGR
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 80/305 (26%), Positives = 137/305 (44%), Gaps = 48/305 (15%)
Query: 79 KIGEGGFGSV----------YKGTIRPLDGR-GEPLVVAVKKL----NNHGLQGHKQWLA 123
K+GEG FG V + + P++VAVK L +++ + +L
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAR---EDFLK 68
Query: 124 EVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSL---------EDRLFSRAQ 174
EV+ L +S PN+ +LLG C+ + + + EYM N L E +
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCM----IMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 175 PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGP 234
+L + T L + A G+ YL + ++RD T N L+ N+ K++DFG++R
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 235 TGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTME- 293
+ D+ V + A E + G ++SD+W+FGV L+EILT L R +P
Sbjct: 182 SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT----LCREQPYEHL 237
Query: 294 --QKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQV 351
Q+++E F D + + P N + + +L C +++ E+RPT ++
Sbjct: 238 TDQQVIENAGHFFRDDGRQIYLPRPP-------NCPKDIYELMLECWRRDEEDRPTFREI 290
Query: 352 VESLK 356
L+
Sbjct: 291 HLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-26
Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 22/217 (10%)
Query: 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL-NNHGLQGHKQWLAEVQFLGVVSHPN 135
+ ++GEG FG VYKG + + R VA+K L N + +++ E + + + HPN
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPN 69
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRA--------------QPTLPWKT 181
+V LLG C+ E +++EY+ + L + L + + +L
Sbjct: 70 IVCLLGVCTKEQPT----CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 182 RLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHV 241
L I + A G+ YL ++RD N L+ K+SDFGL+R+ + D+ V
Sbjct: 126 FLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182
Query: 242 STAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEI 278
+ + + PE I G ++SDIWSFGVVL+EI
Sbjct: 183 QSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 91/275 (33%), Positives = 120/275 (43%), Gaps = 43/275 (15%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
K+G G FG V+ GT VAVK L G + +L E Q + + H LV+
Sbjct: 13 KLGAGQFGEVWMGTWN------GTTKVAVKTLKP-GTMSPEAFLQEAQIMKKLRHDKLVQ 65
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L CS E+ I V EYM SL D L S L +++ AEG+AYL
Sbjct: 66 LYAVCSEEEPIYI----VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES 121
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT---YGYAAPE 255
I+RD N+L+ N K++DFGLAR TA G + APE
Sbjct: 122 ---RNYIHRDLAARNILVGENLVCKIADFGLARL----IEDDEYTAREGAKFPIKWTAPE 174
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVL---ERNRPTMEQKLLEWVKQFPADGKKFSM 312
G +SD+WSFG++L EI+T RV NR +EQ +E + + M
Sbjct: 175 AANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ--VE---------RGYRM 223
Query: 313 MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT 347
PR N + L C K+PEERPT
Sbjct: 224 ---PRPP-----NCPEELYDLMLQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 81/286 (28%), Positives = 122/286 (42%), Gaps = 41/286 (14%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH-KQWLAEVQFLGVVSHPNLV 137
IG G VY P E VA+K+++ Q + EVQ + +HPN+V
Sbjct: 8 VIGVGATAVVYAAICLP---NNE--KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 138 KLLGYCS-TEDERGIQRLLVYEYMPNRSLEDRL-FSRAQPTLPWKTRLEIILGAAEGLAY 195
K Y S + + LV Y+ SL D + S + L ++ +GL Y
Sbjct: 63 KY--YTSFVVGD---ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR--EGPTGDHTHVSTAVVGTYGYAA 253
LH I+RD K N+LL + K++DFG++ V VGT + A
Sbjct: 118 LHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 254 PEYIETGH-LKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP-----ADG 307
PE +E H ++DIWSFG+ E+ TG P M+ +L P AD
Sbjct: 175 PEVMEQVHGYDFKADIWSFGITAIELATGAAPYS-KYPPMKVLMLTLQNDPPSLETGADY 233
Query: 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
KK+S + R K+ CL+K+P +RPT ++++
Sbjct: 234 KKYS--------------KSFR--KMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-25
Identities = 80/286 (27%), Positives = 128/286 (44%), Gaps = 46/286 (16%)
Query: 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNL 136
+ ++G G FG V+ G R VA+K + G ++ E + + +SHPNL
Sbjct: 9 LKELGSGQFGVVHLGKWRGKID------VAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNL 61
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA----EG 192
V+L G C+ +R I +V EYM N L + L R + K E +L E
Sbjct: 62 VQLYGVCT--KQRPI--FIVTEYMANGCLLNYL--RERKG---KLGTEWLLDMCSDVCEA 112
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT---Y 249
+ YL I+RD N L+ + K+SDFGLAR D + S+ GT
Sbjct: 113 MEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSS--QGTKFPV 165
Query: 250 GYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309
+A PE + S+SD+WSFGV+++E+ + ++ E ++E V G +
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVESVSA----GYR 219
Query: 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
+ P+L A V + +C + PE+RP +++ L
Sbjct: 220 ---LYRPKL-------APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-25
Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
K+G G FG V++G + + VA+K L + L + + EVQ L + H +L+
Sbjct: 13 KLGSGYFGEVWEGLWKNR------VRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L CS + I + E M SL L S LP + +++ AEG+AYL E
Sbjct: 67 LFAVCSVGEPVYI----ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE 258
I+RD N+L+ + K++DFGLAR + ++S+ Y + APE
Sbjct: 123 Q---NSIHRDLAARNILVGEDLVCKVADFGLAR--LIKEDVYLSSDKKIPYKWTAPEAAS 177
Query: 259 TGHLKSQSDIWSFGVVLYEILT 280
G ++SD+WSFG++LYE+ T
Sbjct: 178 HGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 77/291 (26%), Positives = 131/291 (45%), Gaps = 43/291 (14%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVK--KLNNHGLQGHKQWLAEVQFLGVVSHPNLV 137
+GEG FGSV +G + D G L VAVK KL+ H +++L+E + HPN++
Sbjct: 7 LGEGEFGSVMEGQLSQDD--GSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 138 KLLGYCSTEDERG--IQRLLVYEYMPNRSLEDRLFSR---AQPT-LPWKTRLEIILGAAE 191
KL+G C + +++ +M + L L P LP +T L+ ++ A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDH---THVSTAVVGT 248
G+ YL I+RD N +L + ++DFGL+++ +GD+ ++ V
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV-- 179
Query: 249 YGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308
+ A E + S+SD+W+FGV ++EI T Q P G
Sbjct: 180 -KWIAIESLADRVYTSKSDVWAFGVTMWEIAT-------------------RGQTPYPGV 219
Query: 309 KFSMMIDPRLRNQYSINAAR----RVAKLADNCLKKNPEERPTMNQVVESL 355
+ + D LR+ + + L +C + +P++RPT ++ E L
Sbjct: 220 ENHEIYD-YLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 4e-24
Identities = 85/288 (29%), Positives = 143/288 (49%), Gaps = 48/288 (16%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL---NNHGLQGHKQWLA---EVQFLGVVSH 133
+G+G +G+VY G L +G+ ++AVK++ ++ L K++ EV L + H
Sbjct: 8 LGKGAYGTVYCG----LTNQGQ--LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLE---DRLFSRAQPTLPWKTRLEIILGAA 190
N+V+ LG C ++ I E++P S+ +R +P T+ +I+
Sbjct: 62 VNIVQYLGTCLDDNTISI----FMEFVPGGSISSILNRFGPLPEPVFCKYTK-QIL---- 112
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE----GPTGDHTHVSTAVV 246
+G+AYLH V++RD K +NV+L N KL DFG AR G G H+++ ++
Sbjct: 113 DGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169
Query: 247 GTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305
GT + APE I E+G+ + +SDIWS G ++E+ TG+ L + +
Sbjct: 170 GTPYWMAPEVINESGYGR-KSDIWSIGCTVFEMATGKPPLA-SMDRLAAMF--------Y 219
Query: 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
G +M PRL + +S A V +CL ++ ERP+ Q++
Sbjct: 220 IGAHRGLM--PRLPDSFSAAAIDFVT----SCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 5e-24
Identities = 88/293 (30%), Positives = 125/293 (42%), Gaps = 69/293 (23%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--HKQWLAEVQFLGVVSHPNL 136
KIG G FG VY LD GE ++AVK++ K+ E++ L ++ HPNL
Sbjct: 7 KIGGGTFGKVYTAV--NLD-TGE--LMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNL 61
Query: 137 VKLLGYCSTEDERGIQRLLVY-EYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAY 195
VK G E R +++ ++ EY +LE+ L L EGLAY
Sbjct: 62 VKYYG---VEVHR--EKVYIFMEYCSGGTLEE--LLEHGRILDEHVIRVYTLQLLEGLAY 114
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR---EGPTGDHTHVSTAVVGTYGYA 252
LH +++RD K +N+ LD N KL DFG A T V + + GT Y
Sbjct: 115 LHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS-LAGTPAYM 170
Query: 253 APEYI----ETGHLKSQSDIWSFGVVLYEILTGRR--------------VLERNRPTMEQ 294
APE I GH ++ +DIWS G V+ E+ TG+R V ++P +
Sbjct: 171 APEVITGGKGKGHGRA-ADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPD 229
Query: 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT 347
L Q +GK F D CL+ +P++RPT
Sbjct: 230 SL-----QLSPEGKDF-----------------------LDRCLESDPKKRPT 254
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 9e-24
Identities = 84/302 (27%), Positives = 132/302 (43%), Gaps = 44/302 (14%)
Query: 79 KIGEGGFGSVYKGTIR----------PLDGR-GEPLVVAVKKLNNHGLQGHKQ-WLAEVQ 126
K+GEG FG V+ + P + R G PL+VAVK L + + +L EV+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 127 FLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR-------------- 172
L + PN+++LLG C ED ++ EYM N L L S
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPL----CMITEYMENGDLNQFLSSHHLDDKEENGNDAVP 127
Query: 173 ---AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229
P + + + L + L A G+ YL + ++RD T N L+ N K++DFG+
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGM 184
Query: 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNR 289
+R GD+ + V + A E I G + SD+W+FGV L+EIL +
Sbjct: 185 SRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE 244
Query: 290 PTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMN 349
T EQ ++E +F D + + P Q + +L C ++ ERP+ +
Sbjct: 245 LTDEQ-VIENAGEFFRDQGRQVYLFRPPPCPQ-------GLYELMLQCWSRDCRERPSFS 296
Query: 350 QV 351
+
Sbjct: 297 DI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 9e-24
Identities = 76/285 (26%), Positives = 132/285 (46%), Gaps = 41/285 (14%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA--EVQFLGVV 131
+ ++ +G G FG V+ + + +V +K++ + ++ A E Q L ++
Sbjct: 2 YEKIRVVGRGAFGIVHL-----CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL 56
Query: 132 SHPNLVKLLGYCST--EDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGA 189
SHPN++ Y ED+ ++V EY P +L + + R L T L +
Sbjct: 57 SHPNII---EYYENFLEDK---ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQI 110
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGN-FKPKLSDFGLAREGPTGDHTHVSTAVVGT 248
L ++H L +++RD KT N+LLD + K+ DFG+++ + T VVGT
Sbjct: 111 LLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGT 164
Query: 249 YGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLE-RNRPTMEQKLLEWVKQFPADG 307
Y +PE E +SDIW+ G VLYE+ + +R E N P + K++ F
Sbjct: 165 PCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS--GTFAPIS 222
Query: 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVV 352
++S P LR +L + L +P +RP ++Q++
Sbjct: 223 DRYS----PDLR------------QLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 2e-23
Identities = 73/291 (25%), Positives = 132/291 (45%), Gaps = 48/291 (16%)
Query: 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK--QWLAEVQFLGVVSHP 134
+ IG+G FG+V K R DG+ ++ K+++ + + Q ++EV L + HP
Sbjct: 5 LETIGKGSFGTVRK-VRRKSDGK----ILVWKEIDYGNMTEKEKQQLVSEVNILRELKHP 59
Query: 135 NLVKLLGYCSTEDERGIQRL-LVYEY--------MPNRSLEDRLFSRAQPTLPWKTRLEI 185
N+V+ Y +R Q L +V EY + + ++R + W+ ++
Sbjct: 60 NIVR---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER--KYIEEEFIWRILTQL 114
Query: 186 ILGAAEGLAYLHEGLEI--QVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST 243
+L L H + V++RD K +N+ LD N KL DFGLA+ G + +
Sbjct: 115 LLA----LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSFAK 168
Query: 244 AVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLE-RNRPTMEQKLLEWVKQ 302
VGT Y +PE + +SDIWS G ++YE+ RN+ + K+
Sbjct: 169 TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI------ 222
Query: 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
+GK R+ +YS + ++ + L +P++RP+ ++++
Sbjct: 223 --KEGKF------RRIPYRYS----SELNEVIKSMLNVDPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-23
Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
K+G G +G VY+G + L VAVK L ++ ++L E + + HPNLV+
Sbjct: 13 KLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 66
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
LLG C+ E I + E+M +L D L + + L + + + YL +
Sbjct: 67 LLGVCTREPPFYI----ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 122
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT---YGYAAPE 255
I+RD N L+ N K++DFGL+R TGD TA G + APE
Sbjct: 123 K---NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGD---TYTAHAGAKFPIKWTAPE 175
Query: 256 YIETGHLKSQSDIWSFGVVLYEILT 280
+ +SD+W+FGV+L+EI T
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 3e-23
Identities = 77/300 (25%), Positives = 120/300 (40%), Gaps = 53/300 (17%)
Query: 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN---NHGLQGHKQWLAEVQFL 128
+ ++GEG GSV K ++ ++ A+K + N L KQ L E++
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKN-----TGMIFALKTITTDPNPDL--QKQILRELEIN 53
Query: 129 GVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLE---DRLFSRAQPTLPWKTRLEI 185
P +VK G E I + EY SL+ ++ R K +I
Sbjct: 54 KSCKSPYIVKYYGAFLDESSSSIG--IAMEYCEGGSLDSIYKKVKKRGGRIGE-KVLGKI 110
Query: 186 ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAV 245
+GL+YLH ++I+RD K SN+LL + KL DFG++ E ++
Sbjct: 111 AESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS----LAGTF 163
Query: 246 VGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305
GT Y APE I+ SD+WS G+ L E+ R FP
Sbjct: 164 TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRF------------------PFPP 205
Query: 306 DGKKFSMMID----------PRLRNQYS--INAARRVAKLADNCLKKNPEERPTMNQVVE 353
+G+ I+ P L+++ I + CL+K+P RPT ++E
Sbjct: 206 EGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 3e-23
Identities = 86/287 (29%), Positives = 130/287 (45%), Gaps = 53/287 (18%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH---KQWLAEVQFLGVVSHPNL 136
+G G FGSVY+G G+ V L + G G KQ E+ L + HPN+
Sbjct: 8 LGSGSFGSVYEGLNLD---DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 137 VKLLGYCSTEDERGIQRLLVY-EYMPNRSLED---RLFSRAQPTLPWKTRLEIILGAAEG 192
V+ LG ED L ++ E +P SL + S +P + TR +I+LG
Sbjct: 65 VQYLGTEREED-----NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLG---- 114
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST-----AVVG 247
L YLH+ ++RD K +N+L+D N KL+DFG+A+ V + G
Sbjct: 115 LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKG 163
Query: 248 TYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306
+ + APE I + G +DIWS G + E+ TG +P Q LE V
Sbjct: 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG-------KPPWSQ--LEGVAAVFKI 214
Query: 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
G+ + P + + S A + K CL+++P RPT +++E
Sbjct: 215 GRSKEL---PPIPDHLSDEAKDFILK----CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 4e-23
Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 10/203 (4%)
Query: 80 IGEGGFGSVYKGTIRPL-DGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+G+G FGSV PL D GE VVAVKKL + + + + E++ L + H N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGE--VVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
G C + R ++ LV EY+P SL D L + + L + L +G+ YL
Sbjct: 70 YKGVCYSAGRRNLR--LVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG-DHTHVSTAVVGTYGYAAPEYI 257
+ ++RD T N+L++ + K+ DFGL + P ++ V + APE +
Sbjct: 127 ---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESL 183
Query: 258 ETGHLKSQSDIWSFGVVLYEILT 280
SD+WSFGVVLYE+ T
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 5e-23
Identities = 70/215 (32%), Positives = 104/215 (48%), Gaps = 25/215 (11%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGH-KQWLAEVQFLGVV 131
+ ++ KIGEG +G VYK + L G +VA+KK+ +G K L E++ L +
Sbjct: 1 YQKLGKIGEGTYGVVYKARDK-LTGE----IVAIKKIKLRFESEGIPKTALREIKLLKEL 55
Query: 132 SHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA 190
+HPN++KLL + L LV+E+M + L Q LP +
Sbjct: 56 NHPNIIKLLDVFRHK-----GDLYLVFEFMDTDLYK--LIKDRQRGLPESLIKSYLYQLL 108
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE--GPTGDHTHVSTAVVGT 248
+GLA+ H +++RD K N+L++ KL+DFGLAR P +TH V T
Sbjct: 109 QGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTH----YVVT 161
Query: 249 YGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGR 282
Y APE + S DIWS G + E+L+ R
Sbjct: 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 5e-23
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 36/216 (16%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--HKQWLAEVQFLGVVSHPNL 136
+IGEG G V+K R GE VA+KK+ L+G Q L E++ L HP +
Sbjct: 7 RIGEGAHGIVFKAKDR---ETGET--VALKKVALRRLEGGIPNQALREIKALQACQHPYV 61
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTR--LEIILGAAEGLA 194
VKLL + LV EYMP L + L +P + + + ++L +G+A
Sbjct: 62 VKLLD-VFPHGSGFV---LVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLL---KGVA 113
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR---EGPTGDHTHVSTAVVGTYGY 251
Y+H +++RD K +N+L+ + K++DFGLAR E ++H V T Y
Sbjct: 114 YMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH----QVATRWY 166
Query: 252 AAPEYIETGHLKSQS-----DIWSFGVVLYEILTGR 282
APE + ++ D+W+ G + E+L G
Sbjct: 167 RAPELL----YGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 7e-23
Identities = 66/222 (29%), Positives = 97/222 (43%), Gaps = 28/222 (12%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVK 138
IG+G FG V++ L +VAVK L + E + HPN+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRA------------------QPTLPWK 180
LLG C+ G L++EYM L + L R+ LP
Sbjct: 73 LLGVCAV----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 181 T--RLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDH 238
+L I A G+AYL E + ++RD T N L+ N K++DFGL+R + D+
Sbjct: 129 CTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 239 THVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT 280
S + PE I ++SD+W++GVVL+EI +
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 8e-23
Identities = 80/301 (26%), Positives = 141/301 (46%), Gaps = 43/301 (14%)
Query: 79 KIGEGGFGSVY----KGTIR-----PLDGRGEPLVVAVKKLNNHGLQ-GHKQWLAEVQFL 128
K+GEG FG V+ +G + G+P++VAVK L + +L E++ +
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 129 GVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRL--------FSRAQ--PTLP 178
+ +PN+++LLG C ++D ++ EYM N L L F+ A P++
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPL----CMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 179 WKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDH 238
L + + A G+ YL + ++RD T N L+ ++ K++DFG++R +GD+
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184
Query: 239 THVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRP----TMEQ 294
+ V + A E I G + SD+W+FGV L+E+ T L + +P + EQ
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT----LCKEQPYSLLSDEQ 240
Query: 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354
+ + F G++ + P + V KL C ++ ++RPT N++
Sbjct: 241 VIENTGEFFRNQGRQIYLSQTPLCPSP--------VFKLMMRCWSRDIKDRPTFNKIHHF 292
Query: 355 L 355
L
Sbjct: 293 L 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 9e-23
Identities = 80/295 (27%), Positives = 143/295 (48%), Gaps = 38/295 (12%)
Query: 79 KIGEGGFGSVY----KGTIRPLDGR-------GEPLVVAVKKLNNHGLQGHKQ-WLAEVQ 126
K+GEG FG V+ +G + +D +P++VAVK L + + +L E++
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 127 FLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQP----------T 176
+ + PN+++LL C T D ++ EYM N L ++ SR +P T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPL----CMITEYMENGDL-NQFLSRHEPQEAAEKADVVT 126
Query: 177 LPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236
+ + T + + A G+ YL + ++RD T N L+ N+ K++DFG++R +G
Sbjct: 127 ISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183
Query: 237 DHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKL 296
D+ + V + + E I G + SD+W+FGV L+EILT + ++ + EQ +
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-V 242
Query: 297 LEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQV 351
+E +F D + + P L + KL +C ++N +ERP+ ++
Sbjct: 243 IENTGEFFRDQGRQVYLPKPAL-------CPDSLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 9e-23
Identities = 84/282 (29%), Positives = 123/282 (43%), Gaps = 43/282 (15%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
K+G G FG V++G L P VAVK L G K +LAE Q + + HP L++
Sbjct: 13 KLGAGQFGEVWEG----LWNNTTP--VAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQ 65
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L C+ E+ I V E M SL + L A L +++ A G+AYL
Sbjct: 66 LYAVCTLEEPIYI----VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL-- 119
Query: 199 GLEIQ-VIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT---YGYAAP 254
E Q I+RD NVL+ N K++DFGLAR + A G + AP
Sbjct: 120 --EAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE----AREGAKFPIKWTAP 173
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMI 314
E +SD+WSFG++L EI+T R+ P M + +
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVTYGRM---PYPGMT-------------NAEVLQQV 217
Query: 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
D R + + + +C K++P++RPT E+L+
Sbjct: 218 DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTF----ETLQ 255
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 1e-22
Identities = 77/317 (24%), Positives = 122/317 (38%), Gaps = 90/317 (28%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEP-LVVAVKKLNNHGL---QGHKQWLAEVQFLGVVS-HP 134
IGEG F +V + E A+K L+ L + K E + L ++ HP
Sbjct: 9 IGEGSFSTVVLAKEK------ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 135 NLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLED---RLFSRAQPTLPWKTRLEIILGAA 190
++KL Y + +DE + L V EY PN L + S + + EI+L
Sbjct: 63 GIIKL--YYTFQDE---ENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYA-AEILL--- 113
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR-EGPTGDHTHV-------- 241
L YLH +I+RD K N+LLD + K++DFG A+ P
Sbjct: 114 -ALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 242 ---------STAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR---------- 282
+ VGT Y +PE + SD+W+ G ++Y++LTG+
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
Query: 283 ---RVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLK 339
++L+ + FP D K + KL L
Sbjct: 230 TFQKILKLE--------YSFPPNFPPDAKDL-------------------IEKL----LV 258
Query: 340 KNPEERPTMNQVVESLK 356
+P++R +N+ + LK
Sbjct: 259 LDPQDRLGVNEGYDELK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 2e-22
Identities = 71/229 (31%), Positives = 101/229 (44%), Gaps = 59/229 (25%)
Query: 80 IGEGGFGSVY----KGTIRPLDGRGEPLVVAVKKLNNHGLQGH---KQWLAEVQFLGVVS 132
I +G +G V+ K T G+ + A+K + + Q L E L
Sbjct: 1 ISKGAYGRVFLAKKKST-------GD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQ 51
Query: 133 HPNLVKLLGYCSTEDERGIQRLLVYEYMPN---RSL--------ED--RLFSRAQPTLPW 179
P +VKL Y S + ++ + LV EY+P SL ED R++
Sbjct: 52 SPYVVKL--YYSFQGKKNL--YLVMEYLPGGDLASLLENVGSLDEDVARIYIA------- 100
Query: 180 KTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHT 239
EI+L L YLH +I+RD K N+L+D N KL+DFGL++ G
Sbjct: 101 ----EIVLA----LEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI 149
Query: 240 HVSTA------VVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTG 281
+++ +VGT Y APE I GH K+ D WS G +LYE L G
Sbjct: 150 NLNDDEKEDKRIVGTPDYIAPEVILGQGHSKT-VDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-22
Identities = 76/255 (29%), Positives = 123/255 (48%), Gaps = 24/255 (9%)
Query: 124 EVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRL 183
E+ +G + HPN+VKL+G C +E L++EY+ ++L + L + L W+ R
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGA----YLIHEYIEGKNLSEVLRN-----LSWERRR 783
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST 243
+I +G A+ L +LH V+ + +++DG +P L L T +S+
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS 842
Query: 244 AVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303
A Y APE ET + +SDI+ FG++L E+LTG+ + ++EW +
Sbjct: 843 A------YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS-IVEWARYC 895
Query: 304 PADGKKFSMMIDPRLRNQYSINAAR--RVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361
+D M IDP +R S+N V LA +C +P RP N V+++L+ A +
Sbjct: 896 YSDC-HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954
Query: 362 SEQGSSSTTTAAKTP 376
SSS T K
Sbjct: 955 ----SSSCVTGLKFS 965
|
Length = 968 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-22
Identities = 72/287 (25%), Positives = 129/287 (44%), Gaps = 39/287 (13%)
Query: 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQ-WLAEVQFLGV 130
F + K+G+G +GSVYK R D + A+K+++ + Q ++ + E++ L
Sbjct: 1 DFKVLKKLGKGSYGSVYK-VKRLSDNQ----FYALKEVDLGSMSQKEREDAVNEIRILAS 55
Query: 131 VSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRL--EIIL 187
V+HPN++ E +L +V EY P L + R + + I +
Sbjct: 56 VNHPNII-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI 110
Query: 188 GAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVG 247
GL LHE ++++RD K++N+LL N K+ D G+++ ++ +G
Sbjct: 111 QLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIG 163
Query: 248 TYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307
T Y APE + +SDIWS G +LYE+ T P E + ++ ++ G
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATF-------APPFEARSMQDLRYKVQRG 216
Query: 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354
K P + YS + + + L+ P+ RP ++++ S
Sbjct: 217 KY------PPIPPIYS----QDLQNFIRSMLQVKPKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-22
Identities = 83/282 (29%), Positives = 123/282 (43%), Gaps = 46/282 (16%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKL 139
IG+G FG V G D RG VAVK + N + +LAE + + H NLV+L
Sbjct: 14 IGKGEFGDVMLG-----DYRGNK--VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQL 64
Query: 140 LGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEG 199
LG E++ G+ +V EYM SL D L SR + L L+ L E + YL
Sbjct: 65 LGVI-VEEKGGL--YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121
Query: 200 LEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE-GPTGDHTHVSTAVVGTYGYAAPEYIE 258
++RD NVL+ + K+SDFGL +E T D + + APE +
Sbjct: 122 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALR 172
Query: 259 TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRL 318
++SD+WSFG++L+EI + RV P + + PR+
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------------------VVPRV 212
Query: 319 RNQYSINA----ARRVAKLADNCLKKNPEERPTMNQVVESLK 356
Y ++A V + C + RP+ Q+ E L+
Sbjct: 213 EKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 3e-22
Identities = 71/220 (32%), Positives = 106/220 (48%), Gaps = 35/220 (15%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL----NNHGLQGHKQWLAEVQFLG 129
+ ++ K+GEG +G VYK G +VA+KK+ G+ L E+ L
Sbjct: 1 YEKLEKLGEGTYGVVYKA-RDKKTGE----IVALKKIRLDNEEEGIP--STALREISLLK 53
Query: 130 VVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGA 189
+ HPN+VKLL TE + LV+EY + L+ + + L I+
Sbjct: 54 ELKHPNIVKLLDVIHTER----KLYLVFEYC-DMDLK-KYLDKRPGPLSPNLIKSIMYQL 107
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE--GPTGDHTHVSTAVVG 247
GLAY H ++++RD K N+L++ + KL+DFGLAR P +TH VV
Sbjct: 108 LRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE---VV- 160
Query: 248 TYGYAAPEYIETGHLKSQS-----DIWSFGVVLYEILTGR 282
T Y APE + L S+ DIWS G + E++TG+
Sbjct: 161 TLWYRAPEIL----LGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 4e-22
Identities = 70/219 (31%), Positives = 104/219 (47%), Gaps = 38/219 (17%)
Query: 74 FNRMLKIGEGGFGSV----YKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ---WLAEVQ 126
F + +G G FG V +KG+ + A+K L+ + KQ L E +
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGK---------YYALKILSKAKIVKLKQVEHVLNEKR 53
Query: 127 FLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRL--- 183
L + HP LV L G S +D+ + LV EY+P L L + P R
Sbjct: 54 ILQSIRHPFLVNLYG--SFQDDSNL--YLVMEYVPGGELFSHLRKSGRFPEPV-ARFYAA 108
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST 243
+++L L YLH L+I +YRD K N+LLD + K++DFG A+ +T
Sbjct: 109 QVVLA----LEYLH-SLDI--VYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT---- 157
Query: 244 AVVGTYGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTG 281
+ GT Y APE I G+ K+ D W+ G+++YE+L G
Sbjct: 158 -LCGTPEYLAPEIILSKGYGKA-VDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 4e-22
Identities = 85/295 (28%), Positives = 134/295 (45%), Gaps = 45/295 (15%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL-NNHGLQGHKQWLAEVQFLGVV-SHPNLV 137
+GEG FG V K LD E VAVK L ++ + ++E++ + ++ H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQP--------------TLPWKTRL 183
LLG C+ E +V EY + +L D L +R P TL K +
Sbjct: 80 NLLGVCTQEGP----LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST 243
A G+ +L + I+RD NVL+ + K++DFGLAR+ D+ +T
Sbjct: 136 SFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192
Query: 244 AVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT--GRRVLERNRPTME-QKLLEWV 300
+ APE + QSD+WSFGV+L+EI T G P + ++L + +
Sbjct: 193 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY-----PGIPVEELFKLL 247
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
K+ G + M P+ N + + L +C + P +RPT Q+VE L
Sbjct: 248 KE----GYR---MEKPQ-------NCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 7e-22
Identities = 81/281 (28%), Positives = 120/281 (42%), Gaps = 56/281 (19%)
Query: 79 KIGEGGFGSV----YKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHP 134
K+G G FG V Y G + VA+K L G + +LAE + + HP
Sbjct: 13 KLGAGQFGEVWMGYYNGHTK----------VAIKSLKQ-GSMSPEAFLAEANLMKQLQHP 61
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLA 194
LV+L + E ++ EYM N SL D L + L +++ AEG+A
Sbjct: 62 RLVRLYAVVTQE-----PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP 254
++ I+RD + +N+L+ K++DFGLAR ++T A + AP
Sbjct: 117 FIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAP 172
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMI 314
E I G +SD+WSFG++L EI+T R+ P G M
Sbjct: 173 EAINYGTFTIKSDVWSFGILLTEIVTYGRI-------------------PYPG-----MT 208
Query: 315 DPR----LRNQYSI----NAARRVAKLADNCLKKNPEERPT 347
+P L Y + N + +L C K+ PEERPT
Sbjct: 209 NPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 8e-22
Identities = 90/303 (29%), Positives = 141/303 (46%), Gaps = 34/303 (11%)
Query: 75 NRMLKIGEGGFGSVYKGTIRPLDGRGEPLV-VAVKKLNNHG-LQGHKQWLAEVQFLGVVS 132
+ ++G+G FG VY+G R + +GE VAVK +N L+ ++L E + +
Sbjct: 9 TLLRELGQGSFGMVYEGNARDII-KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 67
Query: 133 HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFS-----RAQPTLPWKTRLEIIL 187
++V+LLG S +G L+V E M + L+ L S P P T E+I
Sbjct: 68 CHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 188 GAAE---GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTA 244
AAE G+AYL+ + ++RD N ++ +F K+ DFG+ R+ D+
Sbjct: 124 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 245 VVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP 304
+ + APE ++ G + SD+WSFGVVL+EI + + E+ + E V +F
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS---LAEQPYQGLSN---EQVLKFV 234
Query: 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364
DG + P N RV L C + NP+ RPT ++V LK + S
Sbjct: 235 MDG---GYLDQPD-------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284
Query: 365 GSS 367
S
Sbjct: 285 EVS 287
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 8e-22
Identities = 71/220 (32%), Positives = 100/220 (45%), Gaps = 45/220 (20%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW-----LAEVQFL-GVVS 132
++G+G FGSVY + GE +VA+KK+ + W L EV+ L +
Sbjct: 6 QLGDGTFGSVYLARNKE---TGE--LVAIKKMK----KKFYSWEECMNLREVKSLRKLNE 56
Query: 133 HPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAE 191
HPN+VKL E R L V+EYM +L + R II +
Sbjct: 57 HPNIVKLK-----EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 192 GLAYLHE-GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS---TAVVG 247
GLA++H+ G +RD K N+L+ G K++DFGLARE T V
Sbjct: 111 GLAHIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLARE------IRSRPPYTDYVS 160
Query: 248 TYGYAAPEYIETGHLKSQS-----DIWSFGVVLYEILTGR 282
T Y APE + L+S S DIW+ G ++ E+ T R
Sbjct: 161 TRWYRAPEIL----LRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 1e-21
Identities = 78/272 (28%), Positives = 119/272 (43%), Gaps = 38/272 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
K+GEG +GSVYK + G+ VVA+K + ++ + E+ L P +VK
Sbjct: 10 KLGEGSYGSVYKAIHKE-TGQ----VVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
G +V EY S+ D + TL + I+ +GL YLH
Sbjct: 63 YYGSYFKNT----DLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYI- 257
+ I+RD K N+LL+ + KL+DFG++ G D V+GT + APE I
Sbjct: 118 ---NKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEVIQ 172
Query: 258 ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPR 317
E G+ +++DIWS G+ E+ G+ P + + P P
Sbjct: 173 EIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM---IPNKPP----------PT 218
Query: 318 LRN--QYSINAARRVAKLADNCLKKNPEERPT 347
L + ++S V K CL K+PEERP+
Sbjct: 219 LSDPEKWSPEFNDFVKK----CLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-21
Identities = 79/287 (27%), Positives = 128/287 (44%), Gaps = 52/287 (18%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK-QWLAEVQFLGVVSHPNLVK 138
+G+G FG V+KGT++ + VAVK Q K ++L+E + L HPN+VK
Sbjct: 3 LGKGNFGEVFKGTLK------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVK 56
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRL--FSRAQPTLPWKTRLEIILGAAEGLAYL 196
L+G C+ QR +Y M D L + + L K ++ L AA G+AYL
Sbjct: 57 LIGVCT-------QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL 109
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
I+RD N L+ N K+SDFG++R+ G ++ + + APE
Sbjct: 110 ESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEA 165
Query: 257 IETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDP 316
+ G S+SD+WS+G++L+E + + P G M +
Sbjct: 166 LNYGRYSSESDVWSYGILLWETFS-------------------LGVCPYPG-----MTNQ 201
Query: 317 RLRNQ----YSINAARR----VAKLADNCLKKNPEERPTMNQVVESL 355
+ R Q Y ++ ++ V K+ C PE RP +++ + L
Sbjct: 202 QAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-21
Identities = 64/209 (30%), Positives = 112/209 (53%), Gaps = 17/209 (8%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ-WLAEVQFLGVVSHPNLVK 138
IG G FG V++G ++ + GR E + VA+K L + +Q +L+E +G SH N+++
Sbjct: 13 IGAGEFGEVFRGILK-MPGRKE-VAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L G + +++ EYM N +L+ L ++ + ++ G A G+ YL +
Sbjct: 71 LEGVVTKFKPA----MIITEYMENGALDKYLRDHDGEFSSYQL-VGMLRGIAAGMKYLSD 125
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR---EGPTGDHTHVSTAVVGTYGYAAPE 255
+ ++RD N+L++ N + K+SDFGL+R + P G +T + + APE
Sbjct: 126 ---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPE 180
Query: 256 YIETGHLKSQSDIWSFGVVLYEILT-GRR 283
I S SD+WSFG+V++E+++ G R
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 2e-21
Identities = 86/303 (28%), Positives = 130/303 (42%), Gaps = 55/303 (18%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA--EVQFLGVV 131
+ + KIGEG G VYK T R G+ VA+KK+ L+ + L E+ +
Sbjct: 21 YKNLEKIGEGASGEVYKATDR-ATGK----EVAIKKMR---LRKQNKELIINEILIMKDC 72
Query: 132 SHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRL----FSRAQPTLPWKTRLEIIL 187
HPN+V S + +V EYM SL D + +P + + R E++
Sbjct: 73 KHPNIVDYYD--SYLVGDEL--WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCR-EVL- 126
Query: 188 GAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVG 247
+GL YLH VI+RD K+ N+LL + KL+DFG A + S VVG
Sbjct: 127 ---QGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVG 178
Query: 248 TYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306
T + APE I DIWS G++ E+ G P + + L +
Sbjct: 179 TPYWMAPEVI-KRKDYGPKVDIWSLGIMCIEMAEG------EPPYLREPPLRALFLITTK 231
Query: 307 GKKFSMMIDPRLRNQYSINAARRVAKL----ADNCLKKNPEERPTMNQVVES--LKLAVQ 360
G P L+N + + + CL K+PE+RP+ ++++ LK A
Sbjct: 232 GI-------PPLKN------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278
Query: 361 ESE 363
+ E
Sbjct: 279 KEE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-21
Identities = 84/281 (29%), Positives = 136/281 (48%), Gaps = 40/281 (14%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
++G G FG V G R G+ + VA+K + G +++ E + + +SH LV+
Sbjct: 11 ELGTGQFGVVKYGKWR---GQYD---VAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQ 63
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L G C+ + R I +V EYM N L + L + P + LE+ EG+AYL
Sbjct: 64 LYGVCTKQ--RPI--YIVTEYMSNGCLLNYLREHGKRFQPSQL-LEMCKDVCEGMAYLES 118
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT---YGYAAPE 255
Q I+RD N L+D K+SDFGL+R D + S+ VG+ ++ PE
Sbjct: 119 K---QFIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPE 171
Query: 256 YIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMI 314
+ S+SD+W+FGV+++E+ + G+ ER + +E V Q G + +
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER---FNNSETVEKVSQ----GLR---LY 221
Query: 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
P L A+ +V + +C + EERPT Q++ S+
Sbjct: 222 RPHL-------ASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-21
Identities = 74/211 (35%), Positives = 113/211 (53%), Gaps = 26/211 (12%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN-HGLQGHKQWLAEVQFLGVVSHPNLVK 138
IG+G FG VY GT+ +D G+ + AVK LN L+ +Q+L E + SHPN++
Sbjct: 3 IGKGHFGCVYHGTL--IDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQ---PTLPWKTRLEIILGAAEGLAY 195
LLG C + G L+V YM + L R F R++ PT+ K + L A+G+ Y
Sbjct: 61 LLGICLPSE--GSP-LVVLPYMKHGDL--RNFIRSETHNPTV--KDLIGFGLQVAKGMEY 113
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE------GPTGDHTHVSTAVVGTY 249
L + ++RD N +LD +F K++DFGLAR+ +HT V
Sbjct: 114 LASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPV---- 166
Query: 250 GYAAPEYIETGHLKSQSDIWSFGVVLYEILT 280
+ A E ++T ++SD+WSFGV+L+E++T
Sbjct: 167 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-21
Identities = 79/290 (27%), Positives = 127/290 (43%), Gaps = 46/290 (15%)
Query: 80 IGEGGFGSVYKGTIRPLD-GRGEPLVVAVKKLNNHGLQGHKQWL--------AEVQFLGV 130
IG+G +G VY L+ GE + V +L H +E++ L
Sbjct: 9 IGKGTYGRVYLA----LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLED--RLFSRAQPTLPWKTRLEIILG 188
+ H N+V+ LG+ +TE+ I EY+P S+ R + R + L + E +L
Sbjct: 65 LDHLNIVQYLGFETTEEYLSI----FLEYVPGGSIGSCLRTYGRFEEQLV-RFFTEQVL- 118
Query: 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT 248
EGLAYLH +++RD K N+L+D + K+SDFG++++ + ++ G+
Sbjct: 119 --EGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 249 YGYAAPEYIETGHLKSQS-----DIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303
+ APE I H SQ DIWS G V+ E+ GRR E
Sbjct: 174 VFWMAPEVI---HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD----EE--------AI 218
Query: 304 PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
A K + P + S+N + + C NP+ RPT ++++
Sbjct: 219 AAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-21
Identities = 72/283 (25%), Positives = 132/283 (46%), Gaps = 39/283 (13%)
Query: 80 IGEGGFGS--VYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA--EVQFLGVVSHPN 135
+G+G FG +Y+ R D LVV K++N L ++ A E+ L ++ HPN
Sbjct: 8 LGKGAFGEATLYR---RTEDDS---LVV-WKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAY 195
++ D+ + L+ EY +L D++ + + L + ++Y
Sbjct: 61 IIAYYN--HFMDDNTL--LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPE 255
+H+ +++RD KT N+ L KL DFG+++ G ++ VVGT Y +PE
Sbjct: 117 IHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPE 171
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVLE-RNRPTMEQKLLEWVKQFPADGKKFSMMI 314
+ +SDIW+ G VLYE+LT +R + N + K+++ ++ ++
Sbjct: 172 LCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ---------GNYTPVV 222
Query: 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357
YS + L + L+++PE+RPT ++V++ L
Sbjct: 223 SV-----YS----SELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 4e-21
Identities = 66/218 (30%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
++GEG FG V+ L + ++VAVK L + L K + E + L + H ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRA-----------QP-----TLPWKTR 182
G C D ++V+EYM + L F RA QP L
Sbjct: 72 FYGVCGDGDPL----IMVFEYMKHGDLNK--FLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 183 LEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS 242
L I A G+ YL ++RD T N L+ N K+ DFG++R+ + D+ V
Sbjct: 126 LHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG 182
Query: 243 TAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT 280
+ + PE I ++SD+WSFGV+L+EI T
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 78/285 (27%), Positives = 114/285 (40%), Gaps = 54/285 (18%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVS 132
F + IG+G FG VYK + + VVA+K ++ + E+QFL
Sbjct: 3 FTLLECIGKGSFGEVYKAIDK---RTNQ--VVAIKVIDLEEAEDEIEDIQQEIQFLSQCR 57
Query: 133 HPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAE 191
P + K G + +L ++ EY S D L + L I+
Sbjct: 58 SPYITKYYG-SFLKG----SKLWIIMEYCGGGSCLDLL--KPGK-LDETYIAFILREVLL 109
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST---AVVGT 248
GL YLHE I+RD K +N+LL KL+DFG++ G T + VGT
Sbjct: 110 GLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGT 161
Query: 249 YGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK-----LLEWVKQF 303
+ APE I+ ++DIWS G+ E+ G P + L K
Sbjct: 162 PFWMAPEVIKQSGYDEKADIWSLGITAIELAKG-------EPPLSDLHPMRVLFLIPKNN 214
Query: 304 PADGKKFSMMIDPRL-RNQYSINAARRVAKLADNCLKKNPEERPT 347
P P L N++S V+ CL K+P+ERP+
Sbjct: 215 P-----------PSLEGNKFSKPFKDFVSL----CLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 4e-21
Identities = 64/210 (30%), Positives = 110/210 (52%), Gaps = 17/210 (8%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLVK 138
IG G FG V +G ++ G+ E + VA+K L + + + +L+E +G HPN++
Sbjct: 12 IGAGEFGEVCRGRLKL-PGKRE-IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L G + + +++ E+M N +L D + + ++ G A G+ YL E
Sbjct: 70 LEGVVT----KSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR--EGPTGDHTHVSTAVVGTYG--YAAP 254
+ ++RD N+L++ N K+SDFGL+R E T D T+ S ++ G + AP
Sbjct: 125 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS-SLGGKIPIRWTAP 180
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILT-GRR 283
E I S SD+WS+G+V++E+++ G R
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 5e-21
Identities = 83/311 (26%), Positives = 136/311 (43%), Gaps = 55/311 (17%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-HKQWLAEVQFLGVVS-HPNLV 137
IGEG FG V K I+ G + A+K++ + + H+ + E++ L + HPN++
Sbjct: 15 IGEGNFGQVLKARIKK---DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRL--------------FSRAQPTLPWKTRL 183
LLG C + RG L + EY P+ +L D L + TL + L
Sbjct: 72 NLLGAC---EHRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST 243
A G+ YL + Q I+RD N+L+ N+ K++DFGL+R G +V
Sbjct: 128 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK 180
Query: 244 AVVGTYG-----YAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLE 298
T G + A E + + SD+WS+GV+L+EI++ P E
Sbjct: 181 ----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-----LGGTPYCGMTCAE 231
Query: 299 WVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358
++ P R + +N V L C ++ P ERP+ Q++ SL
Sbjct: 232 LYEKLPQG-----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280
Query: 359 VQESEQGSSST 369
++E + ++T
Sbjct: 281 LEERKTYVNTT 291
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 7e-21
Identities = 69/224 (30%), Positives = 101/224 (45%), Gaps = 30/224 (13%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH-KQWLAEVQFLGVVSHPNLVK 138
+GEG FG V K T L GR VAVK L + + L+E L V+HP+++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSL-----EDR-----------------LFSRAQPT 176
L G CS + LL+ EY SL E R L + +
Sbjct: 68 LYGACSQDGPL----LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 177 LPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236
L + + G+ YL E +++++RD NVL+ K K+SDFGL+R+
Sbjct: 124 LTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 237 DHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT 280
D + + A E + +QSD+WSFGV+L+EI+T
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 8e-21
Identities = 85/280 (30%), Positives = 126/280 (45%), Gaps = 42/280 (15%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQFLGV 130
F + +IG G FG+VY T + VVAVKK++ G Q +++W + EV+FL
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNE-----VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQ 77
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA 190
+ HPN ++ G C ++ LV EY S D L +P L I GA
Sbjct: 78 LKHPNTIEYKG-CYLKEHTA---WLVMEYCLG-SASDLLEVHKKP-LQEVEIAAITHGAL 131
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
+GLAYLH +I+RD K N+LL + KL+DFG A + + + VGT
Sbjct: 132 QGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN------SFVGTPY 182
Query: 251 YAAPEYI---ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307
+ APE I + G + D+WS G+ E+ ER P + + +
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMSALYHIAQND 236
Query: 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT 347
P L++ ++ R D CL+K P+ERP
Sbjct: 237 S-------PTLQSNEWTDSFRG---FVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-20
Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 21/214 (9%)
Query: 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ---WLAEVQF 127
F KIG+G F VYK I LDGR VVA+KK+ + K L E+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKA-ICLLDGR----VVALKKVQIFEMMDAKARQDCLKEIDL 55
Query: 128 LGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRL---FSRAQPTLPWKTRLE 184
L + HPN++K L +E I V E L R+ F + + +P +T +
Sbjct: 56 LKQLDHPNVIKYLASFIENNELNI----VLELADAGDLS-RMIKHFKKQKRLIPERTIWK 110
Query: 185 IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTA 244
+ L ++H ++++RD K +NV + KL D GL R T + +
Sbjct: 111 YFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHS 165
Query: 245 VVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEI 278
+VGT Y +PE I +SDIWS G +LYE+
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 87/285 (30%), Positives = 126/285 (44%), Gaps = 52/285 (18%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQFLGV 130
F + +IG G FG+VY D R VVA+KK++ G Q +++W + EV+FL
Sbjct: 17 FTDLREIGHGSFGAVYFAR----DVRTNE-VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ 71
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEI---IL 187
+ HPN ++ G C + LV EY S D L +P +EI
Sbjct: 72 LRHPNTIEYKG-CYLREHTA---WLVMEYCLG-SASDILEVHKKPL----QEVEIAAICH 122
Query: 188 GAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTA--V 245
GA +GLAYLH + I+RD K N+LL KL+DFG A + VS A
Sbjct: 123 GALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSA--------SLVSPANSF 171
Query: 246 VGTYGYAAPEYI---ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ 302
VGT + APE I + G + D+WS G+ E+ ER P + +
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMSALYH 225
Query: 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT 347
+ P L S + + D+CL+K P++RP+
Sbjct: 226 IAQNDS-------PTLS---SNDWSDYFRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 79/271 (29%), Positives = 118/271 (43%), Gaps = 31/271 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
K+G G FG V+ G VAVK L G + +L E + + H LV+
Sbjct: 13 KLGAGQFGEVWMGYYN------NSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVR 65
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L + E+ I + EYM SL D L S + ++ AEG+AY+
Sbjct: 66 LYAVVTKEEPIYI----ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 121
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE 258
I+RD + +NVL+ + K++DFGLAR ++T A + APE I
Sbjct: 122 K---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAIN 177
Query: 259 TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRL 318
G +SD+WSFG++LYEI+T ++ P M A + + M PR+
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKI---PYPGMSNS-----DVMSALQRGYRM---PRM 226
Query: 319 RNQYSINAARRVAKLADNCLKKNPEERPTMN 349
N + + C K+ EERPT +
Sbjct: 227 E-----NCPDELYDIMKTCWKEKAEERPTFD 252
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 2e-20
Identities = 79/277 (28%), Positives = 126/277 (45%), Gaps = 48/277 (17%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNL 136
+G+GGFG V ++ G+ + A KKL+ L +G + L E + L VS +
Sbjct: 1 LGKGGFGEVCACQVKA-TGK----MYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFI 55
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAE---GL 193
V L T+D+ LV M L+ +++ +P P I AA+ GL
Sbjct: 56 VSLAYAFETKDDL----CLVMTLMNGGDLKYHIYNVGEPGFP---EARAIFYAAQIICGL 108
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAA 253
+LH+ +++YRD K NVLLD + ++SD GLA E G GT GY A
Sbjct: 109 EHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK---GRAGTPGYMA 162
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEILTGR-----RVLERNRPTMEQKLLEWVKQFPADGK 308
PE ++ D ++ G LYE++ GR R + + ++++ LE ++P
Sbjct: 163 PEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYP---D 219
Query: 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
KFS P ++ L + L+K+PE+R
Sbjct: 220 KFS----PEAKD------------LCEALLQKDPEKR 240
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
++GEG FG V+ L + ++VAVK L + + E + L V+ H ++V+
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 139 LLGYCSTEDERGIQRLLVYEYMP----NRSL-----------EDRLFSRAQPTLPWKTRL 183
G C+ G L+V+EYM NR L + Q TL L
Sbjct: 72 FYGVCT----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG--QML 125
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST 243
I A G+ YL + ++RD T N L+ K+ DFG++R+ + D+ V
Sbjct: 126 AIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG 182
Query: 244 AVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT 280
+ + PE I ++SDIWSFGVVL+EI T
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 3e-20
Identities = 77/287 (26%), Positives = 118/287 (41%), Gaps = 34/287 (11%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL-NNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+G G FG VY+G R DG L VAVK L + Q +L E + +H N+V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRL-FSRAQPTLPWKTR----LEIILGAAEGL 193
L+G + R ++ E M L+ L +R +P P L A+G
Sbjct: 74 LIGVSF----ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKP----KLSDFGLAREGPTGDHTHVSTAVVGTY 249
YL E I+RD N LL P K++DFG+AR+ + +
Sbjct: 130 KYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 250 GYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309
+ PE G S++D+WSFGV+L+EI + + R E V +F G
Sbjct: 186 KWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VMEFVTGGG- 238
Query: 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
R V ++ +C + PE+RP ++E ++
Sbjct: 239 ---------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 72/240 (30%), Positives = 108/240 (45%), Gaps = 40/240 (16%)
Query: 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH----GLQGHKQWLAEV 125
+ + K+GEG FG VYK + GR VVA+KK+ H G L E+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKA-RQIKTGR----VVALKKILMHNEKDGF--PITALREI 58
Query: 126 QFLGVVSHPNLVKLLGYC-STEDERGIQRLLVYEYMP------NRSLEDRLFSRAQPTLP 178
+ L + HPN+V L+ D+ +R VY P + LE+ + +
Sbjct: 59 KILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQI- 117
Query: 179 WKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR------- 231
K + +L EG+ YLHE +++RD K +N+L+D K++DFGLAR
Sbjct: 118 -KCYMLQLL---EGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 232 --EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQS---DIWSFGVVLYEILTGRRVLE 286
+G G T T +V T Y PE + + + DIW G V E+ T R +L+
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLL--GERRYTTAVDIWGIGCVFAEMFTRRPILQ 228
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 5e-20
Identities = 76/280 (27%), Positives = 130/280 (46%), Gaps = 32/280 (11%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLVK 138
IG G FG V G ++ L G+ E + VA+K L + + + +L+E +G HPN++
Sbjct: 12 IGAGEFGEVCSGRLK-LPGKRE-IPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L G + + ++V EYM N SL D + + ++ G A G+ YL +
Sbjct: 70 LEGVVT----KSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD 124
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR---EGPTGDHTHVSTAVVGTYGYAAPE 255
+ ++RD N+L++ N K+SDFGL+R + P +T + + APE
Sbjct: 125 ---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI--PIRWTAPE 179
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMID 315
I S SD+WS+G+V++E+++ RP E + +K I+
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMS-----YGERPYWEMSNQDVIKA-----------IE 223
Query: 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
R ++ + +L +C +K+ ERP Q+V L
Sbjct: 224 EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 8e-20
Identities = 85/296 (28%), Positives = 137/296 (46%), Gaps = 40/296 (13%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA-EVQFLGVVS 132
F ++ +IG+G FG V+KG +D R + VVA+K ++ + + + E+ L
Sbjct: 6 FTKLERIGKGSFGEVFKG----IDNRTQQ-VVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 133 HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWK--TRLEIILGAA 190
P + K G +G + ++ EY+ S D L RA P ++ T L+ IL
Sbjct: 61 SPYVTKYYG----SYLKGTKLWIIMEYLGGGSALDLL--RAGPFDEFQIATMLKEIL--- 111
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
+GL YLH + I+RD K +NVLL KL+DFG+A G D VGT
Sbjct: 112 KGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPF 166
Query: 251 YAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310
+ APE I+ S++DIWS G+ E+ G N ++L + +
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGE---PPNSDMHPMRVLFLIPKNNP----- 218
Query: 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGS 366
P L ++S + + D CL K+P RPT ++++ K V+ +++ S
Sbjct: 219 -----PTLTGEFS----KPFKEFIDACLNKDPSFRPTAKELLKH-KFIVKNAKKTS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 9e-20
Identities = 86/297 (28%), Positives = 129/297 (43%), Gaps = 55/297 (18%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-HKQWLAEVQFLGVVS-HPNLV 137
IGEG FG V + I+ G + A+K L + H+ + E++ L + HPN++
Sbjct: 10 IGEGNFGQVIRAMIKK---DGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 138 KLLGYCSTEDERGIQRLLVYEYMP----------NRSLE-DRLFSRAQ---PTLPWKTRL 183
LLG C + RG + + EY P +R LE D F++ TL + L
Sbjct: 67 NLLGAC---ENRGYLYIAI-EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST 243
+ A G+ YL E Q I+RD NVL+ N K++DFGL+R G+ +V
Sbjct: 123 QFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKK 175
Query: 244 AVVGTYG-----YAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLE 298
T G + A E + ++SD+WSFGV+L+EI++ P E
Sbjct: 176 ----TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS-----LGGTPYCGMTCAE 226
Query: 299 WVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
++ P + M PR N V +L C + P ERP Q+ L
Sbjct: 227 LYEKLPQGYR----MEKPR-------NCDDEVYELMRQCWRDRPYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 9e-20
Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 24/220 (10%)
Query: 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH-KQWLAEVQFLGVVSHPN 135
M ++GE FG +YKG + L G +VA+K L + ++ E + + HPN
Sbjct: 10 MEELGECAFGKIYKGHLY-LPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRA---------------QPTLPWK 180
+V LLG + E +++EY+ L + L R+ + +L
Sbjct: 69 IVCLLGVVTQEQPV----CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 181 TRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTH 240
L I + A G+ YL +++D N+L+ K+SD GL+RE + D+
Sbjct: 125 DFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR 181
Query: 241 VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT 280
V + + PE I G S SDIWSFGVVL+EI +
Sbjct: 182 VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 18/223 (8%)
Query: 59 LRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL-NNHGLQG 117
+R+ EL+ ++ +G G FG+VYKG P DG + VA+K L N +
Sbjct: 1 MRILKETELK-------KVKVLGSGAFGTVYKGIWIP-DGENVKIPVAIKVLRENTSPKA 52
Query: 118 HKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTL 177
+K+ L E + V P + +LLG C T + + +L+ Y + + E++ +Q L
Sbjct: 53 NKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLL 112
Query: 178 PWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGD 237
W ++ A+G++YL E +++++RD NVL+ K++DFGLAR +
Sbjct: 113 NWCVQI------AKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE 163
Query: 238 HTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT 280
+ + + A E I QSD+WS+GV ++E++T
Sbjct: 164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 84/297 (28%), Positives = 131/297 (44%), Gaps = 55/297 (18%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-HKQWLAEVQFLGVVSH-PNLV 137
IGEG FG V K I+ G + A+K++ + + H+ + E++ L + H PN++
Sbjct: 3 IGEGNFGQVLKARIKK---DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 138 KLLGYCSTEDERGIQRLLVYEYMP----------NRSLE-DRLFSRAQ---PTLPWKTRL 183
LLG C + RG L + EY P +R LE D F+ A TL + L
Sbjct: 60 NLLGAC---EHRGYLYLAI-EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST 243
A G+ YL + Q I+RD N+L+ N+ K++DFGL+R G +V
Sbjct: 116 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK 168
Query: 244 AVVGTYG-----YAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLE 298
T G + A E + + SD+WS+GV+L+EI++ P E
Sbjct: 169 ----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-----LGGTPYCGMTCAE 219
Query: 299 WVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
++ P + + P N V L C ++ P ERP+ Q++ SL
Sbjct: 220 LYEKLPQGYR----LEKPL-------NCDDEVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 83/272 (30%), Positives = 121/272 (44%), Gaps = 38/272 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
K+G G FG V+ GT +G + VAVK L G + +L E Q + + H LV+
Sbjct: 13 KLGNGQFGEVWMGT---WNGNTK---VAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQ 65
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L S E I +V EYM SL D L L +++ A G+AY+
Sbjct: 66 LYAVVS---EEPI--YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 120
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE 258
+ I+RD +++N+L+ K++DFGLAR ++T A + APE
Sbjct: 121 ---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 176
Query: 259 TGHLKSQSDIWSFGVVLYEILTGRRVL---ERNRPTMEQKLLEWVKQFPADGKKFSMMID 315
G +SD+WSFG++L E++T RV NR +EQ + P D
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQD--------- 227
Query: 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPT 347
+ +L C KK+PEERPT
Sbjct: 228 ----------CPISLHELMLQCWKKDPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 75/300 (25%), Positives = 115/300 (38%), Gaps = 54/300 (18%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL-----NNHGLQGHKQWLAEVQFLGVVSH 133
+GEG +G V K + +VA+KK + K L EV+ L + H
Sbjct: 8 VVGEGAYGVVLKCR-----NKATGEIVAIKKFKESEDDEDV---KKTALREVKVLRQLRH 59
Query: 134 PNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEG 192
N+V L + RL LV+EY+ LE L + LP I +
Sbjct: 60 ENIVNLKEAFRRKG-----RLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQA 112
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA 252
+AY H +I+RD K N+L+ + KL DFG AR + + T V T Y
Sbjct: 113 IAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVATRWYR 168
Query: 253 APEYIETGHLKSQS-----DIWSFGVVLYEILTGR----------------RVLERNRPT 291
APE + + + D+W+ G ++ E+L G + L P
Sbjct: 169 APELL----VGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLG-PLPP 223
Query: 292 MEQKLLEWVKQFPADGKKFSMMIDPRLRNQ-YSINAARRVAKLADNCLKKNPEERPTMNQ 350
Q+L +F G F P + Y + CL+ +P+ER T ++
Sbjct: 224 SHQELFSSNPRF--AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 2e-19
Identities = 74/283 (26%), Positives = 126/283 (44%), Gaps = 40/283 (14%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ-WLAEVQFLGVVSHPNLVK 138
+G G FG + +G ++ L + E L VA+ L ++ +LAE LG H N+V+
Sbjct: 13 LGTGRFGELCRGCLK-LPSKRE-LPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L G + RG ++V EYM N +L D + + L + ++ G A G+ YL E
Sbjct: 71 LEGVIT----RGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE 125
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG------YA 252
+ +++ VL++ + K+S F +E S A+ T +A
Sbjct: 126 ---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK-------SEAIYTTMSGKSPVLWA 175
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSM 312
APE I+ H S SD+WSFG+V++E+++ RP + + +K
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMS-----YGERPYWDMSGQDVIKA---------- 220
Query: 313 MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
++ R N + +L +C +K ERP +Q+ L
Sbjct: 221 -VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-19
Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 25/206 (12%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
IGEG FG+V +G + G+ + V K + + +L E + + H NLV+
Sbjct: 13 IIGEGEFGAVLQG-----EYTGQKVAVKNIKCDVTA----QAFLEETAVMTKLHHKNLVR 63
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
LLG G+ +V E M +L + L +R + + L+ L AEG+ YL
Sbjct: 64 LLGVIL---HNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES 118
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG-DHTHVSTAVVGTYGYAAPEYI 257
++++RD N+L+ + K+SDFGLAR G G D++ + + APE +
Sbjct: 119 K---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEAL 169
Query: 258 ETGHLKSQSDIWSFGVVLYEILT-GR 282
+ S+SD+WS+GV+L+E+ + GR
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 2e-19
Identities = 91/324 (28%), Positives = 141/324 (43%), Gaps = 42/324 (12%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQFLGV 130
F + +IG G FG+VY D R VVA+KK++ G Q +++W + EV+FL
Sbjct: 27 FTDLREIGHGSFGAVYFAR----DVRTNE-VVAIKKMSYSGKQSNEKWQDIIKEVKFLQR 81
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA 190
+ HPN ++ G C + LV EY S D L +P L I GA
Sbjct: 82 IKHPNSIEYKG-CYLREHTA---WLVMEYCLG-SASDLLEVHKKP-LQEVEIAAITHGAL 135
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
+GLAYLH +I+RD K N+LL + KL+DFG A + + VGT
Sbjct: 136 QGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPY 186
Query: 251 YAAPEYI---ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307
+ APE I + G + D+WS G+ E+ ER P + + +
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMSALYHIAQNE 240
Query: 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSS 367
P L++ + R D+CL+K P++RPT ++++ + + + E
Sbjct: 241 S-------PTLQSNEWSDYFR---NFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLI 290
Query: 368 STTTAAKTPVTSSSRLVDRRSKRV 391
K V L R+ K++
Sbjct: 291 DLIQRTKDAVRELDNLQYRKMKKL 314
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 5e-19
Identities = 61/227 (26%), Positives = 106/227 (46%), Gaps = 28/227 (12%)
Query: 60 RVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQGH 118
R+ ELR ++ +G G FG+V+KG P +G + VA+K + + G Q
Sbjct: 2 RILKETELR-------KLKLLGSGVFGTVHKGIWIP-EGDSIKIPVAIKTIQDRSGRQTF 53
Query: 119 KQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR-----A 173
++ + +G + H +V+LLG C G LV + P SL D +
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGICP-----GASLQLVTQLSPLGSLLDHVRQHRDSLDP 108
Query: 174 QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233
Q L W ++ A+G+ YL E ++++R+ N+LL + +++DFG+A
Sbjct: 109 QRLLNWCVQI------AKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159
Query: 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT 280
D + + + A E I G QSD+WS+GV ++E+++
Sbjct: 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 6e-19
Identities = 64/215 (29%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
++GEG FG V+ L + ++VAVK L + K + E + L + H ++VK
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQ------------PT-LPWKTRLEI 185
G C D ++V+EYM + L F RA P L L I
Sbjct: 72 FYGVCVEGDPL----IMVFEYMKHGDLNK--FLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 186 ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAV 245
A G+ YL ++RD T N L+ N K+ DFG++R+ + D+ V
Sbjct: 126 AQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 246 VGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT 280
+ + PE I ++SD+WS GVVL+EI T
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 6e-19
Identities = 79/280 (28%), Positives = 124/280 (44%), Gaps = 34/280 (12%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK-QWLAEVQFLGVVSHPNLV 137
+IG G FG V+ G +R + VAVK K ++L E + L SHPN+V
Sbjct: 2 RIGRGNFGEVFSGRLR-----ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 56
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRL-FSRAQ-PTLPWKTRLEIILGAAEGLAY 195
+L+G C+ Q+ +Y M D L F R + P L K ++++ AA G+ Y
Sbjct: 57 RLIGVCT-------QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEY 109
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPE 255
L I+RD N L+ K+SDFG++RE G + + APE
Sbjct: 110 LESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE 166
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMID 315
+ G S+SD+WSFG++L+E + V N Q+ E ++Q
Sbjct: 167 ALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN--LSNQQTREAIEQ------------- 211
Query: 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
+R V +L + C + +P +RP+ + V + L
Sbjct: 212 -GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 7e-19
Identities = 65/303 (21%), Positives = 127/303 (41%), Gaps = 63/303 (20%)
Query: 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN----NHGLQGHKQWLAEVQFLGVVS 132
+ +G G FG V+ + ++ G +V VK L + ++ E+ +S
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRR---ELDMFRKLS 66
Query: 133 HPNLVKLLGYCSTEDERGIQRLLVYEY----------MPNRSLEDRLFSRAQPTLPWKTR 182
H N+V+LLG C + ++ EY +S +++L P L K +
Sbjct: 67 HKNVVRLLGLCREAEPH----YMILEYTDLGDLKQFLRATKSKDEKLKP---PPLSTKQK 119
Query: 183 LEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS 242
+ + A G+ +L + ++RD N L+ + K+S L+++ ++ +
Sbjct: 120 VALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR 176
Query: 243 TAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEI----------LTGRRVLERNRPTM 292
A++ + APE ++ ++SD+WSFGV+++E+ L+ VL R +
Sbjct: 177 NALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR----L 231
Query: 293 EQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVV 352
+ LE +G R+ KL C NP++RP+ +++V
Sbjct: 232 QAGKLELP---VPEG------------------CPSRLYKLMTRCWAVNPKDRPSFSELV 270
Query: 353 ESL 355
+L
Sbjct: 271 SAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 8e-19
Identities = 80/271 (29%), Positives = 123/271 (45%), Gaps = 34/271 (12%)
Query: 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLV 137
+K+G+G FG V+ GT +G VA+K L G + +L E Q + + H LV
Sbjct: 12 VKLGQGCFGEVWMGT---WNGTTR---VAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 64
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
+L S E +V EYM SL D L L +++ A G+AY+
Sbjct: 65 QLYAVVSEE-----PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 119
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYI 257
+ ++RD + +N+L+ N K++DFGLAR ++T A + APE
Sbjct: 120 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAA 175
Query: 258 ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM-EQKLLEWVKQFPADGKKFSMMIDP 316
G +SD+WSFG++L E+ T RV P M +++L+ V+ + + M P
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRV---PYPGMVNREVLDQVE------RGYRMPCPP 226
Query: 317 RLRNQYSINAARRVAKLADNCLKKNPEERPT 347
+ L C +K PEERPT
Sbjct: 227 E--------CPESLHDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 8e-19
Identities = 86/304 (28%), Positives = 132/304 (43%), Gaps = 58/304 (19%)
Query: 63 DMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQW 121
D++ + E +G G +G V K P ++AVK++ Q K+
Sbjct: 2 DLEVIEE----------LGRGAYGVVDKMRHVPTG-----TIMAVKRIRATVNSQEQKRL 46
Query: 122 LAEVQF-LGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRA---QPTL 177
L ++ + V P V G E + I E M + SL D+ + + T+
Sbjct: 47 LMDLDISMRSVDCPYTVTFYGALFREGDVWI----CMEVM-DTSL-DKFYKKVYDKGLTI 100
Query: 178 PWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGD 237
P +I + + L YLH L VI+RD K SNVL++ N + KL DFG++ G D
Sbjct: 101 PEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVD 156
Query: 238 HTHVSTAVVGTYGYAAPEYI----ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTME 293
+ T G Y APE I +SD+WS G+ + E+ TGR + + T
Sbjct: 157 -SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK-TPF 214
Query: 294 QKLLEWVK----QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMN 349
Q+L + V+ Q PA+ KFS Q +N CLKKN +ERP
Sbjct: 215 QQLKQVVEEPSPQLPAE--KFSPEF------QDFVN----------KCLKKNYKERPNYP 256
Query: 350 QVVE 353
++++
Sbjct: 257 ELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 8e-19
Identities = 85/316 (26%), Positives = 125/316 (39%), Gaps = 80/316 (25%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA-----EVQFLGVVSH 133
K+GEG + VYK + GR +VA+KK+ + K + E++ L + H
Sbjct: 7 KLGEGTYAVVYKARDK-ETGR----IVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE-------II 186
PN++ LL + I LV+E+M T LE I+
Sbjct: 62 PNIIGLLDVFGHKSN--IN--LVFEFME-------------------TDLEKVIKDKSIV 98
Query: 187 LGAAE----------GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236
L A+ GL YLH +++RD K +N+L+ + KL+DFGLAR +
Sbjct: 99 LTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS- 154
Query: 237 DHTHVSTAVVGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGR---------RVLE 286
+ ++ VV T Y APE + H D+WS G + E+L L
Sbjct: 155 PNRKMTHQVV-TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG 213
Query: 287 R-----NRPTMEQKLLEW--VKQFPADGKKFSMMIDPRLRNQYSINAARRVA-KLADNCL 338
+ PT E W V P D +F L+ + AA A L L
Sbjct: 214 KIFEALGTPTEEN----WPGVTSLP-DYVEFKPFPPTPLKQIFP--AASDDALDLLQRLL 266
Query: 339 KKNPEERPTMNQVVES 354
NP +R T Q +E
Sbjct: 267 TLNPNKRITARQALEH 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 9e-19
Identities = 70/242 (28%), Positives = 111/242 (45%), Gaps = 33/242 (13%)
Query: 119 KQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLP 178
KQ L E+Q + P +V G + +E I + E+M SL DR++ + P +P
Sbjct: 48 KQILRELQIMHECRSPYIVSFYG--AFLNENNI--CMCMEFMDCGSL-DRIYKKGGP-IP 101
Query: 179 WKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDH 238
+ +I + EGL YL+ I ++RD K SN+L++ + KL DFG++ E
Sbjct: 102 VEILGKIAVAVVEGLTYLYNVHRI--MHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157
Query: 239 THVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK--- 295
++ VGT Y +PE I+ G +SD+WS G+ + E+ G+ + + +
Sbjct: 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP 215
Query: 296 -----LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQ 350
LL+ + Q P PRL + R D CL K+P ERPT Q
Sbjct: 216 MGILDLLQQIVQEPP----------PRLPSSDFPEDLRD---FVDACLLKDPTERPTPQQ 262
Query: 351 VV 352
+
Sbjct: 263 LC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 70/228 (30%), Positives = 113/228 (49%), Gaps = 28/228 (12%)
Query: 59 LRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQG 117
LR+ EL+ R+ +G G FG+VYKG P +G + VA+K LN G +
Sbjct: 1 LRILKETELK-------RVKVLGSGAFGTVYKGIWVP-EGETVKIPVAIKILNETTGPKA 52
Query: 118 HKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR----- 172
+ +++ E + + HP+LV+LLG C + IQ LV + MP+ L D +
Sbjct: 53 NVEFMDEALIMASMDHPHLVRLLGVCLSPT---IQ--LVTQLMPHGCLLDYVHEHKDNIG 107
Query: 173 AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232
+Q L W ++ A+G+ YL E ++++RD NVL+ K++DFGLAR
Sbjct: 108 SQLLLNWCVQI------AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158
Query: 233 GPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT 280
+ + + + A E I QSD+WS+GV ++E++T
Sbjct: 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 69/221 (31%), Positives = 108/221 (48%), Gaps = 19/221 (8%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQGHKQ-WLAEVQFLGVV---SHP 134
IGEG +G+VYK GR VA+KK+ +G L E+ L + HP
Sbjct: 7 IGEGAYGTVYKAR-DLNTGR----FVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHP 61
Query: 135 NLVKLLGYCST-EDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGL 193
N+V+LL C +R ++ LV+E++ ++ L L +P LP +T +++ G+
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAA 253
+LH +++RD K N+L+ + + K++DFGLAR T+VV T Y A
Sbjct: 121 DFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVTLWYRA 174
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ 294
PE + + D+WS G + E L RR L R +Q
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAE-LFRRRPLFRGTSEADQ 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-18
Identities = 84/292 (28%), Positives = 131/292 (44%), Gaps = 29/292 (9%)
Query: 76 RMLKIGEGGFGSVYKGTIRPL-DGRGEPLVVAVKKLNNHGLQGHKQWL-AEVQFLGVVSH 133
R+ +GEG FG V P D GE VAVK L H L E++ L + H
Sbjct: 8 RIRDLGEGHFGKVELCRYDPEGDNTGE--QVAVKSLKPESGGNHIADLKKEIEILRNLYH 65
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGL 193
N+VK G C+ + GI+ L+ E++P+ SL++ L R + + K +L+ + +G+
Sbjct: 66 ENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGM 122
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTH-VSTAVVGTYGYA 252
YL Q ++RD NVL++ + K+ DFGL + T + V + +
Sbjct: 123 DYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILT--------GRRVLERNRPTMEQKLLEWVKQFP 304
APE + SD+WSFGV LYE+LT L+ PT Q + + +
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239
Query: 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
+GK+ PR N V +L C + P +R T ++E +
Sbjct: 240 EEGKRL-----PR-----PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-18
Identities = 79/277 (28%), Positives = 123/277 (44%), Gaps = 38/277 (13%)
Query: 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLV 137
+K+G+G FG V+ GT +G + VA+K L G + +L E Q + + H LV
Sbjct: 12 VKLGQGCFGEVWMGT---WNGTTK---VAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLV 64
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
L S E +V E+M SL D L L +++ A+G+AY+
Sbjct: 65 PLYAVVSEE-----PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE 119
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYI 257
+ I+RD + +N+L+ N K++DFGLAR ++T A + APE
Sbjct: 120 R---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF-PIKWTAPEAA 175
Query: 258 ETGHLKSQSDIWSFGVVLYEILTGRRVLER---NRPTMEQKLLEWVKQFPADGKKFSMMI 314
G +SD+WSFG++L E++T RV NR +EQ +
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ-------------------V 216
Query: 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQV 351
+ R + +L C KK+P+ERPT +
Sbjct: 217 ERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 3e-18
Identities = 69/258 (26%), Positives = 114/258 (44%), Gaps = 44/258 (17%)
Query: 119 KQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLP 178
Q + E++ L + P +V G ++ E I E+M SL D++ +A +P
Sbjct: 44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKAG-RIP 97
Query: 179 WKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDH 238
+I + GL YL E + ++++RD K SN+L++ + KL DFG++ +
Sbjct: 98 ENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ----LI 151
Query: 239 THVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLE 298
++ + VGT Y +PE ++ H QSDIWS G+ L E+ GR + P + K LE
Sbjct: 152 DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI----PPPDAKELE 207
Query: 299 WVKQFPADGKKFSMMIDPRLRNQYSINAARRVA--------------KL----------- 333
F + R + + ++ R +A KL
Sbjct: 208 --AMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQD 265
Query: 334 -ADNCLKKNPEERPTMNQ 350
D CLKKNP+ER + +
Sbjct: 266 FVDKCLKKNPKERADLKE 283
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 5e-18
Identities = 75/222 (33%), Positives = 115/222 (51%), Gaps = 33/222 (14%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL----NNHGLQGHKQWLAEVQFLG 129
F ++ KIGEG +G VYK + L G VVA+KK+ G+ + E+ L
Sbjct: 2 FQKVEKIGEGTYGVVYKARNK-LTGE----VVALKKIRLDTETEGVPSTA--IREISLLK 54
Query: 130 VVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPW---KTRLEII 186
++HPN+VKLL TE+ + LV+E++ ++ L+ + + +P K+ L +
Sbjct: 55 ELNHPNIVKLLDVIHTEN----KLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL 109
Query: 187 LGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG--PTGDHTHVSTA 244
L +GLA+ H +V++RD K N+L++ KL+DFGLAR P +TH
Sbjct: 110 L---QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---- 159
Query: 245 VVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGRRVL 285
V T Y APE + S + DIWS G + E++T RR L
Sbjct: 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-18
Identities = 77/279 (27%), Positives = 126/279 (45%), Gaps = 32/279 (11%)
Query: 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNL 136
M ++G G FG V+ G R + VA+K +N G + ++ E + + +SHP L
Sbjct: 9 MKELGSGQFGVVHLGKWR------AQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKL 61
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
V+L G C+ + I V E+M N L + L R Q L L + EG+ YL
Sbjct: 62 VQLYGVCTQQKPLYI----VTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYL 116
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
I+RD N L+ K+SDFG+ R ++T S A ++ PE
Sbjct: 117 ERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKWSPPEV 172
Query: 257 IETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDP 316
S+SD+WSFGV+++E+ T E P ++ E V+ + + P
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFT-----EGKMPFEKKSNYEVVEMISRGFRLYR----P 223
Query: 317 RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
+L A+ V ++ +C + PE RPT +++ ++
Sbjct: 224 KL-------ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 5e-18
Identities = 84/286 (29%), Positives = 126/286 (44%), Gaps = 42/286 (14%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQFLGV 130
F+ + +IG G FG+VY D R VVA+KK++ G Q +++W + EV+FL
Sbjct: 17 FSDLREIGHGSFGAVYFAR----DVRNSE-VVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA 190
+ HPN ++ G C + LV EY S D L +P L + GA
Sbjct: 72 LRHPNTIQYRG-CYLREHTA---WLVMEYCLG-SASDLLEVHKKP-LQEVEIAAVTHGAL 125
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
+GLAYLH +I+RD K N+LL KL DFG A + VGT
Sbjct: 126 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPY 176
Query: 251 YAAPEYI---ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307
+ APE I + G + D+WS G+ E+ ER P + + +
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAMSALYHIAQNE 230
Query: 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
P L++ + R D+CL+K P++RPT +++
Sbjct: 231 S-------PALQSGHWSEYFR---NFVDSCLQKIPQDRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 6e-18
Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 15/213 (7%)
Query: 76 RMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPN 135
RML G+G FGSV + ++ DG + + V + K + +++L E + HPN
Sbjct: 5 RML--GKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPN 62
Query: 136 LVKLLGYCSTEDERGIQRL----LVYEYMPNRSLEDRLF-SR--AQP-TLPWKTRLEIIL 187
++KL+G + R RL ++ +M + L L SR +P TLP +T + ++
Sbjct: 63 VIKLIGV--SLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 188 GAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVG 247
A G+ YL I+RD N +L+ N ++DFGL+++ +GD+ A
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 248 TYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT 280
+ A E + + SD+W+FGV ++EI+T
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 86/287 (29%), Positives = 127/287 (44%), Gaps = 46/287 (16%)
Query: 76 RMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL-NNHGLQGHKQWLAEVQFLGVVSHP 134
R+ +IG G G+VYK RP GR + A+K + NH +Q E++ L V+HP
Sbjct: 78 RVNRIGSGAGGTVYKVIHRP-TGR----LYALKVIYGNHEDTVRRQICREIEILRDVNHP 132
Query: 135 NLVKLLGYCSTEDERG--IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEG 192
N+VK C + IQ LL E+M SLE + + L R +I+ G
Sbjct: 133 NVVK----CHDMFDHNGEIQVLL--EFMDGGSLEGTHIAD-EQFLADVAR-QIL----SG 180
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR-EGPTGDHTHVSTAVVGTYGY 251
+AYLH +++RD K SN+L++ K++DFG++R T D + S VGT Y
Sbjct: 181 IAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAY 234
Query: 252 AAPEYIETGHLKSQ-----SDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306
+PE I T DIWS GV + E GR R +W A
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------DWASLMCA- 287
Query: 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
M P + A+R CL++ P +R + Q+++
Sbjct: 288 ----ICMSQP---PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 6e-18
Identities = 82/288 (28%), Positives = 125/288 (43%), Gaps = 47/288 (16%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKK--LNNHGLQGHKQWLAEVQFLGVVSH-PNL 136
IG G FG+V K +P ++AVK+ + K+ L ++ + S P +
Sbjct: 12 IGRGAFGTVNKMLHKPSG-----TIMAVKRIRSTVDEKE-QKRLLMDLDVVMRSSDCPYI 65
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLED---RLFSRAQPTLPWKTRLEIILGA---- 189
VK G E + I E M + SL+ ++ + +P E ILG
Sbjct: 66 VKFYGALFREGDCWI----CMELM-DISLDKFYKYVYEVLKSVIP-----EEILGKIAVA 115
Query: 190 -AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT 248
+ L YL E E+++I+RD K SN+LLD N KL DFG++ G D + T G
Sbjct: 116 TVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVD-SIAKTRDAGC 170
Query: 249 YGYAAPEYIETGHLKS---QSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305
Y APE I+ +SD+WS G+ LYE+ TG+ + +Q L + VK P
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ-LTQVVKGDP- 228
Query: 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
P L N + + CL K+ +RP +++E
Sbjct: 229 ----------PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 19/212 (8%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQGHKQWLAEVQFLGVVS 132
F ++ +G G FG+VYKG P +G + VA+K+L + +K+ L E + V
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 133 HPNLVKLLGYCSTEDERGIQRLLVY----EYMPNRSLEDRLFSRAQPTLPWKTRLEIILG 188
+P++ +LLG C T + I +L+ + +Y+ R +D + S Q L W ++
Sbjct: 68 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGS--QYLLNWCVQI----- 118
Query: 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT 248
A+G+ YL E ++++RD NVL+ K++DFGLA+ + + +
Sbjct: 119 -AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174
Query: 249 YGYAAPEYIETGHLKSQSDIWSFGVVLYEILT 280
+ A E I QSD+WS+GV ++E++T
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-17
Identities = 72/284 (25%), Positives = 130/284 (45%), Gaps = 37/284 (13%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVV---AVKKLNNHGLQGHKQWLAEVQFLGV 130
+ ++ KIGEG FG K + G+ V+ + K++ + ++ EV L
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSN 55
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA 190
+ HPN+V+ Y + +E G +V +Y L ++ ++ P L+ +
Sbjct: 56 MKHPNIVQ---YQESFEENG-NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQIC 111
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
L ++H+ ++++RD K+ N+ L + KL DFG+AR ++ +GT
Sbjct: 112 LALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVELARTCIGTPY 166
Query: 251 YAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK-QFPADGKK 309
Y +PE E ++SDIW+ G VLYE+ T + E M+ +L+ ++ +P
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG--NMKNLVLKIIRGSYPPVSSH 224
Query: 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
+S LRN L K+NP +RP++N ++E
Sbjct: 225 YS----YDLRN------------LVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 74/241 (30%), Positives = 107/241 (44%), Gaps = 54/241 (22%)
Query: 66 ELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL----NNHGLQGHKQW 121
R T F ++ +IGEG +G VY+ R GE +VA+KK+ G+
Sbjct: 2 RCRSVTE-FEKLNRIGEGTYGIVYRA--RDTTS-GE--IVALKKVRMDNERDGIPISS-- 53
Query: 122 LAEVQFLGVVSHPNLVKLL---------------GYCSTEDERGIQRLLVYEYMPNRSLE 166
L E+ L + HPN+V+L YC E+ + LL + MP
Sbjct: 54 LREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYC----EQDLASLL--DNMPTP--- 104
Query: 167 DRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226
FS +Q ++L GL YLHE +I+RD K SN+LL K++D
Sbjct: 105 ---FSESQVKC-------LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIAD 151
Query: 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYI--ETGHLKSQSDIWSFGVVLYEILTGRRV 284
FGLAR G T V T Y APE + T + + D+W+ G +L E+L + +
Sbjct: 152 FGLAR--TYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTA-IDMWAVGCILAELLAHKPL 208
Query: 285 L 285
L
Sbjct: 209 L 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 65/215 (30%), Positives = 91/215 (42%), Gaps = 36/215 (16%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH---GLQGHKQWLAEVQFLGVVSHPNL 136
IG+G FG V + R + A+K +N + L E + L ++HP L
Sbjct: 8 IGKGAFGKVCI-----VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFL 62
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRL-----FSRAQPTLPWKTRL---EIILG 188
V L + S +DE + LV + + L L FS Q + EI+L
Sbjct: 63 VNL--WYSFQDEENM--YLVVDLLLGGDLRYHLSQKVKFSEEQ------VKFWICEIVLA 112
Query: 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT 248
L YLH +I+RD K N+LLD ++DF +A + T T+ GT
Sbjct: 113 ----LEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGT 162
Query: 249 YGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRR 283
GY APE + D WS GV YE L G+R
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 77/288 (26%), Positives = 129/288 (44%), Gaps = 44/288 (15%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH 133
+ + KIGEG FG +Y + E V+ L ++ + EV L + H
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAK---SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKH 58
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDR-------LFSRAQPTLPWKTRLEII 186
PN+V + S ++ + +V EY L R LFS Q L W ++ +
Sbjct: 59 PNIVTF--FASFQENGRL--FIVMEYCDGGDLMKRINRQRGVLFSEDQ-ILSWFVQISL- 112
Query: 187 LGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK-PKLSDFGLAREGPTGDHTHVSTAV 245
GL ++H+ ++++RD K+ N+ L N KL DFG+AR+ D ++
Sbjct: 113 -----GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTC 162
Query: 246 VGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305
VGT Y +PE + +++DIWS G VLYE+ T + E N + Q +L+ + + A
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN--NLHQLVLKICQGYFA 220
Query: 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
I P N +R + L K +P +RP++ +++
Sbjct: 221 P-------ISP--------NFSRDLRSLISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 75/283 (26%), Positives = 129/283 (45%), Gaps = 33/283 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPN 135
KIG G F VY+ T LDG + VA+KK+ L + + E+ L ++HPN
Sbjct: 9 KIGRGQFSEVYRATCL-LDG----VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAY 195
++K Y S ++ + +L + S + F + + +P KT + + L +
Sbjct: 64 VIKY--YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPE 255
+H +V++RD K +NV + KL D GL R + T + ++VGT Y +PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPE 176
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ--FPADGKKFSMM 313
I +SDIWS G +LYE+ + ++ + L + ++Q +P
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEQCDYP--------- 226
Query: 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
P + YS + +L + C+ +PE+RP + V + K
Sbjct: 227 --PLPSDHYS----EELRQLVNMCINPDPEKRPDITYVYDVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 3e-17
Identities = 77/284 (27%), Positives = 113/284 (39%), Gaps = 29/284 (10%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ-WLAEVQFLGVVSHPNLV 137
IGEG FG VY+G + E + VAVK N ++ +L E + HP++V
Sbjct: 13 CIGEGQFGDVYQGVY--MSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
KL+G TE+ I V E P L L + +L + + + LAYL
Sbjct: 71 KLIGVI-TENPVWI----VMELAPLGELRSYL-QVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYI 257
+ ++RD NVL+ KL DFGL+R + S + + APE I
Sbjct: 125 S---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWMAPESI 180
Query: 258 ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPR 317
S SD+W FGV ++EIL + K + VK I+
Sbjct: 181 NFRRFTSASDVWMFGVCMWEIL-----------MLGVKPFQGVKN-----NDVIGRIENG 224
Query: 318 LRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361
R N + L C +P +RP ++ L +QE
Sbjct: 225 ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 75/289 (25%), Positives = 137/289 (47%), Gaps = 36/289 (12%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLV 137
++G+G FG VY+G + + VA+K +N ++ ++L E + + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFS----------RAQPTLPWKTRLEIIL 187
+LLG S +G L++ E M L+ L S +A P+L K +++
Sbjct: 73 RLLGVVS----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL--KKMIQMAG 126
Query: 188 GAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVG 247
A+G+AYL+ + ++RD N ++ +F K+ DFG+ R+ D+ +
Sbjct: 127 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 248 TYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307
+ +PE ++ G + SD+WSFGVVL+EI T + E+ M E V +F +G
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT---LAEQPYQGMSN---EQVLRFVMEG 237
Query: 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
++ P N + +L C + NP+ RP+ +++ S+K
Sbjct: 238 ---GLLDKPD-------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 87/315 (27%), Positives = 128/315 (40%), Gaps = 72/315 (22%)
Query: 67 LREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQ 126
L + T F + IGEG +G VYK + G+ +VA+K ++ ++ E
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKK-TGQ----LVAIKIMDIIE-DEEEEIKEEYN 54
Query: 127 FLGVVS-HPNLVKLLGYCSTEDERGI--QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRL 183
L S HPN+ G ++ G Q LV E S+ D + RL
Sbjct: 55 ILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDL----VKGLRKKGKRL 110
Query: 184 E------IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGD 237
+ I+ GLAYLHE +VI+RD K N+LL N + KL DFG++ + D
Sbjct: 111 KEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ---LD 164
Query: 238 HT-HVSTAVVGTYGYAAPEYI-----ETGHLKSQSDIWSFGVVLYEILTGR--------- 282
T +GT + APE I ++SD+WS G+ E+ G+
Sbjct: 165 STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM 224
Query: 283 RVL---ERNR-PTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCL 338
R L RN PT++ W K+F N + CL
Sbjct: 225 RALFKIPRNPPPTLKSPEN-WSKKF----------------NDF-----------ISECL 256
Query: 339 KKNPEERPTMNQVVE 353
KN E+RP M +++E
Sbjct: 257 IKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 3e-17
Identities = 83/252 (32%), Positives = 119/252 (47%), Gaps = 69/252 (27%)
Query: 56 EHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGR-GEPLVVAVKKL---- 110
+H LR +++ + K+G+G +G V+K +D R E VVA+KK+
Sbjct: 3 KHILRKYEILQ------------KLGKGAYGIVWKA----IDRRTKE--VVALKKIFDAF 44
Query: 111 -NNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDERGIQRLLVYEYMPN------ 162
N Q + E+ FL + HPN+VKLL E+++ I LV+EYM
Sbjct: 45 RNATDAQ---RTFREIMFLQELGDHPNIVKLLNVIKAENDKDI--YLVFEYMETDLHAVI 99
Query: 163 RS--LED--RLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG 218
R+ LED + + Q +L A L Y+H G VI+RD K SN+LL+
Sbjct: 100 RANILEDVHKRYIMYQ-----------LLKA---LKYIHSG---NVIHRDLKPSNILLNS 142
Query: 219 NFKPKLSDFGLAR---EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQS-----DIWS 270
+ + KL+DFGLAR E V T V T Y APE + L S D+WS
Sbjct: 143 DCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEIL----LGSTRYTKGVDMWS 198
Query: 271 FGVVLYEILTGR 282
G +L E+L G+
Sbjct: 199 VGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 74/290 (25%), Positives = 131/290 (45%), Gaps = 52/290 (17%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW----------LAEVQFLG 129
+G G FG VYK +R + L A+K++N H K ++EV +
Sbjct: 8 LGSGAFGCVYK--VRKKNNGQNLL--ALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIK 63
Query: 130 -VVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFS------RAQPTLPWKTR 182
+ HPN+V+ Y T E + +V + + L + S R W
Sbjct: 64 EQLRHPNIVR---YYKTFLE-NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119
Query: 183 LEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS 242
++++L L YLH+ E ++++RD +N++L + K ++DFGLA++ + +
Sbjct: 120 VQMVL----ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKL- 170
Query: 243 TAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVL-ERNRPTMEQKLLEWVK 301
T+VVGT Y+ PE ++ ++D+W+FG +LY++ T + N ++ K++E V
Sbjct: 171 TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV- 229
Query: 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQV 351
+P YS V + +CL + E RP + QV
Sbjct: 230 ------------YEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-17
Identities = 66/225 (29%), Positives = 113/225 (50%), Gaps = 24/225 (10%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWL--------AEVQFLGV 130
+IGEG +G V+K R L G VA+K++ +Q ++ + A ++ L
Sbjct: 8 EIGEGAYGKVFKA--RDLKNGGR--FVALKRVR---VQTGEEGMPLSTIREVAVLRHLET 60
Query: 131 VSHPNLVKLLGYCS-TEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGA 189
HPN+V+L C+ + +R + LV+E++ ++ L L +P +P +T +++
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQL 119
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
GL +LH +V++RD K N+L+ + + KL+DFGLAR T+VV T
Sbjct: 120 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTL 173
Query: 250 GYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ 294
Y APE + + D+WS G + E+ R+ L R ++Q
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 4e-17
Identities = 74/285 (25%), Positives = 124/285 (43%), Gaps = 42/285 (14%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH 133
+ +KIGEG G V T + GR VAVKK++ Q + EV + H
Sbjct: 21 LDNFVKIGEGSTGIVCIATDKS-TGR----QVAVKKMDLRKQQRRELLFNEVVIMRDYQH 75
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLED-----RLFSRAQPTLPWKTRLEIILG 188
PN+V++ DE +V E++ +L D R+ T+ +L
Sbjct: 76 PNIVEMYSSYLVGDEL----WVVMEFLEGGALTDIVTHTRMNEEQIATV-----CLAVLK 126
Query: 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT 248
A L++LH VI+RD K+ ++LL + + KLSDFG ++VGT
Sbjct: 127 A---LSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGT 178
Query: 249 YGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308
+ APE I ++ DIWS G+++ E++ G P + L+ +K+ +
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE------PPYFNEPPLQAMKRIRDNLP 232
Query: 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
P+L+N + R+ D L ++P +R T +++
Sbjct: 233 -------PKLKN--LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 87/306 (28%), Positives = 128/306 (41%), Gaps = 72/306 (23%)
Query: 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL-NNHGLQGHKQWLAEVQFLGV 130
N + +IG G G VYK + V+AVK++ + +K+ L ++ V
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTG-----HVMAVKQMRRTGNKEENKRILMDLD---V 66
Query: 131 V--SH--PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEII 186
V SH P +VK GY T+ + I E M + D+L R Q +P E I
Sbjct: 67 VLKSHDCPYIVKCYGYFITDSDVFI----CMELMS--TCLDKLLKRIQGPIP-----EDI 115
Query: 187 LG-----AAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHV 241
LG + L YL E + VI+RD K SN+LLD + KL DFG++ G D +
Sbjct: 116 LGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS--GRLVD-SKA 170
Query: 242 STAVVGTYGYAAPEYIETGHLKS----QSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL 297
T G Y APE I+ ++D+WS G+ L E+ TG
Sbjct: 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATG---------------- 214
Query: 298 EWVKQFPADGKK--FSMMID------PRL--RNQYSINAARRVAKLADNCLKKNPEERPT 347
QFP K F ++ P L +S + V D CL K+ +RP
Sbjct: 215 ----QFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFV----DLCLTKDHRKRPK 266
Query: 348 MNQVVE 353
++++
Sbjct: 267 YRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 5e-17
Identities = 83/290 (28%), Positives = 125/290 (43%), Gaps = 38/290 (13%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWL-AEVQFLGVV- 131
F + L G G FG V + T L + VAVK L ++ L +E++ + +
Sbjct: 39 FGKTL--GAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLG 96
Query: 132 SHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAE 191
+H N+V LLG C+ G L++ EY L + L + + L + L A+
Sbjct: 97 NHENIVNLLGACT----IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVG---- 247
G+A+L I+RD NVLL K+ DFGLAR D + S VV
Sbjct: 153 GMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLAR-----DIMNDSNYVVKGNAR 204
Query: 248 -TYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERN-RPTMEQKLLEWVKQFPA 305
+ APE I +SD+WS+G++L+EI + L N P M P
Sbjct: 205 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS----LGSNPYPGM-----------PV 249
Query: 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
D KF +I R +A + + C +P +RPT Q+V+ +
Sbjct: 250 D-SKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 7e-17
Identities = 84/296 (28%), Positives = 134/296 (45%), Gaps = 39/296 (13%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH-KQWLAEVQFLGVVS 132
F ++ K+GEG + +VYKG R GE +VA+K+++ +G + E+ + +
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRT---TGE--IVALKEIHLDAEEGTPSTAIREISLMKELK 56
Query: 133 HPNLVKLLGYCSTEDERGIQRLLVYEYMPN---RSLEDRLFSRAQPTLPWKTRLEIILGA 189
H N+V+L TE+ + +LV+EYM + ++ A K+ +L
Sbjct: 57 HENIVRLHDVIHTEN----KLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLL-- 110
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
+G+A+ HE +V++RD K N+L++ + KL+DFGLAR +T S VV T
Sbjct: 111 -KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVV-TL 164
Query: 250 GYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGRRVLERNRPTMEQKL-----------L 297
Y AP+ + S S DIWS G ++ E++TG R L +Q L
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLLKIFRIMGTPTES 223
Query: 298 EW--VKQFPADGKKFSMMIDPRLRNQYSINAARRVA-KLADNCLKKNPEERPTMNQ 350
W + Q P F P Q A + L L+ NPE R + +
Sbjct: 224 TWPGISQLPEYKPTFP--RYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHD 277
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 9e-17
Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL--NNHGLQGHKQWLAEVQFLGVV 131
+ ++ KIGEG +G V+K R + +VA+KK + K L E++ L +
Sbjct: 3 YEKLSKIGEGSYGVVFK--CRNRETGQ---IVAIKKFVESEDDPVIKKIALREIRMLKQL 57
Query: 132 SHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA 190
HPNLV L+ E R ++L LV+EY + L + + +P +II
Sbjct: 58 KHPNLVNLI-----EVFRRKRKLHLVFEYCDHTVLNE--LEKNPRGVPEHLIKKIIWQTL 110
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR--EGPTGDHTHVSTAVVGT 248
+ + + H+ I+RD K N+L+ + KL DFG AR GP D+T V T
Sbjct: 111 QAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD----YVAT 163
Query: 249 YGYAAPEYIETGHLK--SQSDIWSFGVVLYEILTG 281
Y APE + G + D+W+ G V E+LTG
Sbjct: 164 RWYRAPELL-VGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 75/234 (32%), Positives = 105/234 (44%), Gaps = 33/234 (14%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ---WLAEVQFLGVVSHPNL 136
+G G FG V I G GE A+K L + KQ E L +SHP +
Sbjct: 26 LGTGSFGRV---RIAKHKGTGE--YYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKT----RLEIILGAAEG 192
V + CS +DE + LL E++ L L R P E++L
Sbjct: 81 VNM--MCSFQDENRVYFLL--EFVVGGELFTHL--RKAGRFPNDVAKFYHAELVLA---- 130
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA 252
YLH +IYRD K N+LLD K++DFG A++ P T + GT Y
Sbjct: 131 FEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT-----LCGTPEYL 182
Query: 253 APEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRP-TMEQKLLEWVKQFP 304
APE I++ GH K+ D W+ GV+LYE + G + P + +K+L +FP
Sbjct: 183 APEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP 235
|
Length = 329 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 54/156 (34%), Positives = 72/156 (46%), Gaps = 23/156 (14%)
Query: 133 HPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSL-----EDRLFSRAQPTLPWKTRLEII 186
HP L +L T+D RL V EY+ L F + EI+
Sbjct: 55 HPFLTQLHSCFQTKD-----RLFFVMEYVNGGDLMFHIQRSGRFDEPRARF---YAAEIV 106
Query: 187 LGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVV 246
LG L +LHE +IYRD K NVLLD K++DFG+ +EG G T ++
Sbjct: 107 LG----LQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFC 157
Query: 247 GTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR 282
GT Y APE + D W+ GV+LYE+L G+
Sbjct: 158 GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 2e-16
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL----NNHGLQGHKQWL-AEVQFLGVVSHP 134
+G+G FG VY +D E +AVK++ ++ + L E+Q L + H
Sbjct: 10 LGQGAFGRVY--LCYDVDTGRE---LAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64
Query: 135 NLVKLLGYCSTEDERGIQRLLVY-EYMPNRSLED--RLFSRAQPTLPWKTRLEIILGAAE 191
+V+ G C +DE L ++ EYMP S++D + + T+ K +I+ E
Sbjct: 65 RIVQYYG-CLRDDET----LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----E 115
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPT-GDHTHVSTAVVGTYG 250
G+ YLH +++RD K +N+L D KL DFG ++ T +V GT
Sbjct: 116 GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172
Query: 251 YAAPEYIETGHLKSQSDIWSFGVVLYEILT 280
+ +PE I ++D+WS G + E+LT
Sbjct: 173 WMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 67/256 (26%), Positives = 101/256 (39%), Gaps = 36/256 (14%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVV-AVKKLNNHGLQGHKQWLAEVQFLGVVSH-PNLV 137
I +G FGSVY R G+ + +KK + AE + + P +
Sbjct: 4 ISKGAFGSVYLAKKR---STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPW--KTRLEIILGAAEGLAY 195
KL ++D LV EY+ + + W + E++LG +
Sbjct: 61 KLYYSFQSKD----YLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLG----VED 112
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPE 255
LH+ +I+RD K N+L+D KL+DFGL+R G + VGT Y APE
Sbjct: 113 LHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPE 163
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRP-TMEQKLLEWVKQFPADGKKFS--- 311
I SD WS G V++E L G P + +L +P + K+F
Sbjct: 164 TILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPE 223
Query: 312 --------MMIDPRLR 319
+ +DP R
Sbjct: 224 AVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 81/282 (28%), Positives = 129/282 (45%), Gaps = 37/282 (13%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA-EVQFLGVVS 132
F ++ KIG+G FG V+KG +D R + VVA+K ++ + + + E+ L
Sbjct: 6 FTKLEKIGKGSFGEVFKG----IDNRTQK-VVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 133 HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA-E 191
P + K G + + I + EY+ S D L +P +T++ IL +
Sbjct: 61 SPYVTKYYGSYLKDTKLWI----IMEYLGGGSALDLL----EPGPLDETQIATILREILK 112
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGY 251
GL YLH + I+RD K +NVLL + + KL+DFG+A G D VGT +
Sbjct: 113 GLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFW 167
Query: 252 AAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311
APE I+ S++DIWS G+ E+ G P E ++ + P +
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGE------PPHSELHPMKVLFLIPKNNP--- 218
Query: 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
P L YS + + + + CL K P RPT ++++
Sbjct: 219 ----PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 73/229 (31%), Positives = 110/229 (48%), Gaps = 52/229 (22%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW-----LAEVQFL 128
+ ++ KIGEG +G VYK + L G +VA+KK+ L+ + + E+ L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDK-LTGE----IVALKKIR---LETEDEGVPSTAIREISLL 52
Query: 129 GVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYM-----------PNRSLEDRLFSRAQPT 176
++HPN+V+LL +E +L LV+E++ P L+ L
Sbjct: 53 KELNHPNIVRLLDVVHSE-----NKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI------ 101
Query: 177 LPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE-G-P 234
K+ L +L +G+AY H +V++RD K N+L+D KL+DFGLAR G P
Sbjct: 102 ---KSYLYQLL---QGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVP 152
Query: 235 TGDHTHVSTAVVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGR 282
+TH VV T Y APE + S DIWS G + E++ R
Sbjct: 153 VRTYTH---EVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 4e-16
Identities = 88/353 (24%), Positives = 156/353 (44%), Gaps = 62/353 (17%)
Query: 66 ELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--HKQWLA 123
EL++ + F ++ ++G G G V+K + +P ++ +KL + ++ Q +
Sbjct: 1 ELKD--DDFEKISELGAGNGGVVFKVSHKPSG------LIMARKLIHLEIKPAIRNQIIR 52
Query: 124 EVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRL 183
E+Q L + P +V G ++ E I E+M SL D++ +A +P +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKKAG-RIPEQILG 106
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST 243
++ + +GL YL E + ++++RD K SN+L++ + KL DFG++ G D ++
Sbjct: 107 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MAN 160
Query: 244 AVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303
+ VGT Y +PE ++ H QSDIWS G+ L E+ GR + P + K LE +
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI----PPPDAKELELMFGC 216
Query: 304 PADGKKFSMMIDPRLR------NQYSINAARRVA-------------------------- 331
P +G PR R + Y ++ +A
Sbjct: 217 PVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQ 276
Query: 332 KLADNCLKKNPEERPTMNQVVESLKLAVQESEQ----GSSSTTTAAKTPVTSS 380
+ CL KNP ER + Q++ + E+E+ G +T P T +
Sbjct: 277 DFVNKCLIKNPAERADLKQLMVHAFIKRSEAEEVDFAGWLCSTIGLNQPSTPT 329
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 4e-16
Identities = 88/322 (27%), Positives = 135/322 (41%), Gaps = 58/322 (18%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA----EVQFLG 129
+ R+ IG G +G+VY+G GR VVA+K +N L ++ EV L
Sbjct: 3 YQRLELIGRGAYGAVYRG-KHVPTGR----VVALKIIN---LDTPDDDVSDIQREVALLS 54
Query: 130 VVSH---PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEII 186
+ PN+ K G + R ++ EY S+ R +A P + II
Sbjct: 55 QLRQSQPPNITKYYG-SYLKGPR---LWIIMEYAEGGSV--RTLMKAGPIAEKYISV-II 107
Query: 187 LGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVV 246
L Y+H+ + VI+RD K +N+L+ KL DFG+A + + V
Sbjct: 108 REVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN--SSKRSTFV 162
Query: 247 GTYGYAAPEYIETGHL-KSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305
GT + APE I G +++DIWS G+ +YE+ TG N P + + P
Sbjct: 163 GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG------NPPYSDVDAFRAMMLIPK 216
Query: 306 DGKKFSMMIDPRLR-NQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364
PRL N YS VA CL + P+ER + ++++S +
Sbjct: 217 SKP-------PRLEDNGYSKLLREFVA----ACLDEEPKERLSAEELLKSKWIKAH---- 261
Query: 365 GSSSTTTAAKTPVTSSSRLVDR 386
+KTPV+ L+ R
Sbjct: 262 --------SKTPVSILKELISR 275
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-16
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 24/220 (10%)
Query: 77 MLKIGEGGFGSVYKGTIRPLDGRGEPL-VVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHP 134
M ++GE FG VYKG + GE VA+K L + +++ E + HP
Sbjct: 10 MEELGEDRFGKVYKGHLFG-TAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHP 68
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRA--------------QPTLPWK 180
N+V LLG + E +++ Y + L + L R+ + TL
Sbjct: 69 NIVCLLGVVTKEQPLS----MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124
Query: 181 TRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTH 240
+ I+ A G+ +L V+++D T NVL+ K+SD GL RE D+
Sbjct: 125 DFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181
Query: 241 VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT 280
+ + + +PE I G SDIWS+GVVL+E+ +
Sbjct: 182 LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-16
Identities = 76/286 (26%), Positives = 131/286 (45%), Gaps = 32/286 (11%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVK--KLNNHGLQGHKQWLAEVQFLGVVSHPNLV 137
+GEG FGSV +G + D L VAVK K+ + +L+E + HPN++
Sbjct: 7 LGEGEFGSVMEGQLNQDD---SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 138 KLLGYC--STEDERGIQRLLVYEYMPNRSLED-RLFSRA--QPT-LPWKTRLEIILGAAE 191
+L+G C + E E +++ +M + L L+SR P LP + ++ + A
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGY 251
G+ YL I+RD N +L+ N ++DFGL+++ GD+ +
Sbjct: 124 GMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 252 AAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ-KLLEWVKQFPADGKKF 310
A E + ++SD+WSFGV ++EI T + P +E ++ ++++Q G +
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQT---PYPGVENSEIYDYLRQ----GNRL 233
Query: 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
D L YS L +C NP++RP+ + L+
Sbjct: 234 KQPPDC-LDGLYS---------LMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 6e-16
Identities = 69/213 (32%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 80 IGEGGFGSVYKGTIRPLDGR-GEPLVVAVKKLNN--HGLQGHKQWLAEVQFLGVVSHPNL 136
IG G +G V D R G VA+KK++N L K+ L E++ L + H N+
Sbjct: 8 IGSGAYGVVCSAV----DKRTGRK--VAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 137 VKL---LGYCSTEDERGIQRLLVYEYMPNRSLED--RLFSRAQPTLPWKTRLEIILGAAE 191
+ L L S ED + +V E M D ++ QP + +
Sbjct: 62 IGLLDILRPPSPEDFNDV--YIVTELMET----DLHKVIKSPQPLTDDHIQY-FLYQILR 114
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE-GPTGDHTHVSTAVVGTYG 250
GL YLH VI+RD K SN+L++ N K+ DFGLAR P D T V T
Sbjct: 115 GLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171
Query: 251 YAAPEYIETGHLKSQS-DIWSFGVVLYEILTGR 282
Y APE + + +++ DIWS G + E+LT +
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 6e-16
Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 18/206 (8%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ---GHKQWLAEVQFLGVVSHPNL 136
+G+GGFG V ++ G+ + A KKL+ L+ G K L E + L V+ P +
Sbjct: 1 LGKGGFGEVCAVQVK---NTGK--MYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFI 55
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
V L + E LV M L+ +++ + L + + G+ +L
Sbjct: 56 VNL----AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHL 111
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
H + ++YRD K NVLLD +LSD GLA E G T GT GY APE
Sbjct: 112 HS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEI 165
Query: 257 IETGHLKSQSDIWSFGVVLYEILTGR 282
++ D ++ G +YE++ GR
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 7e-16
Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-HKQWLAEVQFLGVVSHPNL 136
+++G G FG V KG + R + + VA+K L N + + + E + + + +P +
Sbjct: 1 VELGSGNFGCVKKGVYKM---RKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI 57
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
V+++G C E +LV E L ++ S + + +E++ + G+ YL
Sbjct: 58 VRMIGVCEAEA-----LMLVMEMASGGPL-NKFLSGKKDEITVSNVVELMHQVSMGMKYL 111
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE-GPTGDHTHVSTAVVGTYGYAAPE 255
++RD NVLL K+SDFGL++ G + +A + APE
Sbjct: 112 EGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE 168
Query: 256 YIETGHLKSQSDIWSFGVVLYEILT 280
I S+SD+WS+G+ ++E +
Sbjct: 169 CINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 8e-16
Identities = 83/295 (28%), Positives = 126/295 (42%), Gaps = 43/295 (14%)
Query: 80 IGEGGFGSVYKGTIRPLDGR--GEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVV-SHPN 135
+GEG FG V +D +P+ VAVK L + + ++E++ + ++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQP--------------TLPWKT 181
++ LLG C+ + G +LV EY +L + L +R P L +K
Sbjct: 80 IINLLGACTQD---GPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 182 RLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHV 241
+ A G+ YL + I+RD NVL+ + K++DFGLAR+ D+
Sbjct: 136 LVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKK 192
Query: 242 STAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ-KLLEWV 300
+T + APE + QSD+WSFGV+L+EI T P E KLL
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL--- 249
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
K+ M P N + + C P +RPT Q+VE L
Sbjct: 250 -------KEGHRMDKP-------ANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 8e-16
Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 36/221 (16%)
Query: 75 NRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHP 134
+ +G+G +G VY R L + + +A+K++ + + E+ + H
Sbjct: 11 GERVVLGKGTYGIVYAA--RDLSTQ---VRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQP------TLPWKTRLEIILG 188
N+V+ LG S I E +P SL L S+ P T+ + T+ +I+
Sbjct: 66 NIVQYLGSDSENGFFKI----FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QIL-- 118
Query: 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLLDG-NFKPKLSDFG----LAREGPTGDHTHVST 243
EGL YLH+ Q+++RD K NVL++ + K+SDFG LA P +
Sbjct: 119 --EGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTE 167
Query: 244 AVVGTYGYAAPEYIETGH--LKSQSDIWSFGVVLYEILTGR 282
GT Y APE I+ G + +DIWS G + E+ TG+
Sbjct: 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 9e-16
Identities = 72/218 (33%), Positives = 102/218 (46%), Gaps = 36/218 (16%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWL---AEVQFLGV 130
R+ +G G FG V+ D E A+K + + KQ E + L
Sbjct: 3 LERIKTVGTGTFGRVHLVR----DRISEHYY-ALKVMAIPEVIRLKQEQHVHNEKRVLKE 57
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRL----E 184
VSHP +++L + + D+R + L+ EY+P LFS R T L E
Sbjct: 58 VSHPFIIRL--FWTEHDQRFLYMLM--EYVPG----GELFSYLRNSGRFSNSTGLFYASE 109
Query: 185 IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTA 244
I+ L YLH EI +YRD K N+LLD KL+DFG A++ D T
Sbjct: 110 IVCA----LEYLH-SKEI--VYRDLKPENILLDKEGHIKLTDFGFAKK--LRDRTW---T 157
Query: 245 VVGTYGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTG 281
+ GT Y APE I+ GH K+ D W+ G+++YE+L G
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKA-VDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 69/220 (31%), Positives = 103/220 (46%), Gaps = 40/220 (18%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN--NHGLQGHKQWLAEVQFLGVVSHPNL 136
IGEG +G V T +P + VA+KK++ H + L E++ L H N+
Sbjct: 12 YIGEGAYGMVCSATHKPTGVK-----VAIKKISPFEHQTFCQRT-LREIKILRRFKHENI 65
Query: 137 VKLL------GYCSTEDERGIQRLL---VYEYMPNRSLED---RLFSRAQPTLPWKTRLE 184
+ +L + S D +Q L+ +Y+ + + L + + F L
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYF------------LY 113
Query: 185 IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR-EGPTGDHTHVST 243
IL GL Y+H V++RD K SN+LL+ N K+ DFGLAR P DHT T
Sbjct: 114 QIL---RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT 167
Query: 244 AVVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGR 282
V T Y APE + +++ DIWS G +L E+L+ R
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 9e-16
Identities = 53/193 (27%), Positives = 86/193 (44%), Gaps = 19/193 (9%)
Query: 105 VAVKKLNNHGLQGHKQ---WLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMP 161
VA+K L + Q + E + HPN+V LL V+EY+P
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL---LFAVFEYVP 62
Query: 162 NRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL---DG 218
R+L + L A LP ++L + LA H +++RD K N+++
Sbjct: 63 GRTLREVL--AADGALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGV 117
Query: 219 NFKPKLSDFGLAREGPTGDHTHVSTA-----VVGTYGYAAPEYIETGHLKSQSDIWSFGV 273
K+ DFG+ P V+T V+GT Y APE + + SD++++G+
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGL 177
Query: 274 VLYEILTGRRVLE 286
+ E LTG+RV++
Sbjct: 178 IFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 77/278 (27%), Positives = 121/278 (43%), Gaps = 35/278 (12%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
K+G G FG V+ T + VAVK + G + +LAE + + H LVK
Sbjct: 13 KLGAGQFGEVWMATY------NKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVK 65
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L + E ++ E+M SL D L S P ++ AEG+A++ +
Sbjct: 66 LHAVVTKE-----PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE 258
I+RD + +N+L+ + K++DFGLAR ++T A + APE I
Sbjct: 121 R---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAIN 176
Query: 259 TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRL 318
G +SD+WSFG++L EI+T R+ P M E ++ ++
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRI---PYPGMSNP--EVIRA-----------LERGY 220
Query: 319 RNQYSINAARRVAKLADNCLKKNPEERPT---MNQVVE 353
R N + + C K PEERPT + V++
Sbjct: 221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 90/293 (30%), Positives = 131/293 (44%), Gaps = 53/293 (18%)
Query: 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK--QWLAEVQFLGVVSHP 134
+ ++G+G +GSVYK RP + +A+K++ L K Q + E+ L P
Sbjct: 6 LDELGKGNYGSVYKVLHRPTG-----VTMAMKEIRLE-LDESKFNQIIMELDILHKAVSP 59
Query: 135 NLVKLLGYCSTEDERGIQRLLVY---EYMPNRSLEDRLF--SRAQPTLPWKTRLEIILGA 189
+V G E VY EYM SL D+L+ A +P I
Sbjct: 60 YIVDFYGAFFIEGA-------VYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAV 111
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGD-HTHVSTAVVGT 248
+GL +L E E +I+RD K +NVL++GN + KL DFG+ +G+ ++ +G
Sbjct: 112 VKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGV-----SGNLVASLAKTNIGC 164
Query: 249 YGYAAPEYIETGHLKS------QSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ 302
Y APE I++G QSD+WS G+ + E+ GR P + Q
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR------YPYPPETYANIFAQ 218
Query: 303 FPA--DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
A DG P L + YS +A VAK CL K P RPT Q++E
Sbjct: 219 LSAIVDGDP------PTLPSGYSDDAQDFVAK----CLNKIPNRRPTYAQLLE 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 75/250 (30%), Positives = 124/250 (49%), Gaps = 28/250 (11%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--HKQWLAEVQFLGVV 131
F R+ ++G G G V K +P L++A +KL + ++ Q + E+Q L
Sbjct: 7 FERISELGAGNGGVVTKVQHKP-----SGLIMA-RKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 132 SHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAE 191
+ P +V G ++ E I E+M SL D++ A+ +P + ++ +
Sbjct: 61 NSPYIVGFYGAFYSDGEISI----CMEHMDGGSL-DQVLKEAK-RIPEEILGKVSIAVLR 114
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGY 251
GLAYL E + Q+++RD K SN+L++ + KL DFG++ G D ++ + VGT Y
Sbjct: 115 GLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSY 168
Query: 252 AAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA----DG 307
+PE ++ H QSDIWS G+ L E+ GR + P + K LE + P +G
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI----PPPDAKELEAIFGRPVVDGEEG 224
Query: 308 KKFSMMIDPR 317
+ S+ PR
Sbjct: 225 EPHSISPRPR 234
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVV----AVKKLN-NHGLQGHKQWLAEVQFLGVVSH 133
++G+G FG+VY + E L V V +LN N +Q ++ E Q L + H
Sbjct: 7 RLGKGSFGTVYLVKDKKAV-AEERLKVLKEIPVGELNPNETVQANQ----EAQLLSKLDH 61
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRL--FSRAQPTLPWKTRLEIILGAAE 191
P +VK D I + EY R L+ +L TL E +
Sbjct: 62 PAIVKFHASFLERDAFCI----ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL 117
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGY 251
G+ Y+H+ ++++RD K N+ L N K+ DFG++R ++T GT Y
Sbjct: 118 GVHYMHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRL--LMGSCDLATTFTGTPYY 171
Query: 252 AAPEYIETGHLKSQSDIWSFGVVLYEI 278
+PE ++ S+SDIWS G +LYE+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 71/212 (33%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN--HGLQGHKQWLAEVQFLGVVSHPNLV 137
IG G FG V+ T P DG+ VA+KK+ N L K+ E++ L H N++
Sbjct: 8 IGYGAFGVVWSVT-DPRDGKR----VALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVL 62
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLP--WKTRLEIILGAAEGLAY 195
L + + V + L ++ QP K L IL GL Y
Sbjct: 63 SALDILQPPHIDPFEEIYVVTELMQSDLH-KIIVSPQPLSSDHVKVFLYQIL---RGLKY 118
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPE 255
LH +++RD K N+L++ N K+ DFGLAR + H++ VV Y Y APE
Sbjct: 119 LHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPE 174
Query: 256 YIETG--HLKSQSDIWSFGVVLYEILTGRRVL 285
I G H S DIWS G + E+L GRR+L
Sbjct: 175 -ILMGSRHYTSAVDIWSVGCIFAELL-GRRIL 204
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL----NNHGLQ-GHKQWLAEVQFLGVVSH 133
+IG G +G+VYK R G VA+K + N GL + +A ++ L H
Sbjct: 7 EIGVGAYGTVYKA--RDPHS-GH--FVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 134 PNLVKLLGYCST-EDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEG 192
PN+V+L+ C+T +R + LV+E++ ++ L L P LP +T +++ G
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA 252
L +LH +++RD K N+L+ + KL+DFGLAR T VV T Y
Sbjct: 121 LDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLWYR 174
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEIL 279
APE + + D+WS G + E+
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 42/100 (42%), Positives = 60/100 (60%), Gaps = 11/100 (11%)
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST 243
EII G L +LH+ +IYRD K NVLLD + K++DFG+ +E G+ ++
Sbjct: 104 EIICG----LQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--AS 154
Query: 244 AVVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGR 282
GT Y APE ++ G ++S D WSFGV+LYE+L G+
Sbjct: 155 TFCGTPDYIAPEILK-GQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 68/206 (33%), Positives = 104/206 (50%), Gaps = 19/206 (9%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ--GHKQWLAEVQFLGVVSHPNLV 137
+G+G FG V+ +R + G + A+K L L+ + E L V+HP +V
Sbjct: 4 LGQGSFGKVF--LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGA-AEGLAYL 196
KL TE + L+ +++ L RL T + ++ L A L +L
Sbjct: 62 KLHYAFQTEG----KLYLILDFLRGGDLFTRLSKEVMFT---EEDVKFYLAELALALDHL 114
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
H + +IYRD K N+LLD KL+DFGL++E + DH + + GT Y APE
Sbjct: 115 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEYMAPEV 169
Query: 257 I-ETGHLKSQSDIWSFGVVLYEILTG 281
+ GH +S +D WSFGV+++E+LTG
Sbjct: 170 VNRRGHTQS-ADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 82/278 (29%), Positives = 121/278 (43%), Gaps = 51/278 (18%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN------NHGLQGHKQWLAEVQFLGVVSH 133
+G+GG+G V++ +R + G + A+K L N H + AE L V H
Sbjct: 4 LGKGGYGKVFQ--VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--AERNILEAVKH 59
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRL---EIILGAA 190
P +V L+ T G + L+ EY+ L L R + EI L
Sbjct: 60 PFIVDLIYAFQT----GGKLYLILEYLSGGELFMHL-EREGIFMEDTACFYLSEISLA-- 112
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
L +LH+ +IYRD K N+LLD KL+DFGL +E V+ GT
Sbjct: 113 --LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIE 165
Query: 251 YAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGRRVL--ERNRPTMEQKLLEWVKQFPADG 307
Y APE + +GH K+ D WS G ++Y++LTG E + T+++ L
Sbjct: 166 YMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL----------- 213
Query: 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
K + + P L + A + KL LK+NP R
Sbjct: 214 -KGKLNLPPYLTPE----ARDLLKKL----LKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 5e-15
Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 23/217 (10%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL----NNHGLQGHKQWLAEVQFLG 129
+ ++ KIGEG +G+V+K R E +VA+K++ ++ G+ L E+ L
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRE---THE--IVALKRVRLDDDDEGVPSSA--LREICLLK 54
Query: 130 VVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGA 189
+ H N+V+L ++ + LV+EY ++ L+ + F + + +
Sbjct: 55 ELKHKNIVRLYDVLHSDKKL----TLVFEYC-DQDLK-KYFDSCNGDIDPEIVKSFMFQL 108
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
+GLA+ H V++RD K N+L++ N + KL+DFGLAR G +A V T
Sbjct: 109 LKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVTL 163
Query: 250 GYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGRRVL 285
Y P+ + L S S D+WS G + E+ R L
Sbjct: 164 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 5e-15
Identities = 70/222 (31%), Positives = 109/222 (49%), Gaps = 37/222 (16%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGR-GEPLVVAVKKLNNHGLQGHKQ-----WLAEVQF 127
+ ++ +I EG +G VY R D + GE +VA+KKL K+ L E+
Sbjct: 7 YEKLNRIEEGTYGVVY----RARDKKTGE--IVALKKLKMEK---EKEGFPITSLREINI 57
Query: 128 LGVVSHPNLVKL----LGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLP--WKT 181
L + HPN+V + +G S D + +V EY+ + L+ + + QP L K
Sbjct: 58 LLKLQHPNIVTVKEVVVG--SNLD----KIYMVMEYVEH-DLKSLMETMKQPFLQSEVKC 110
Query: 182 RLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHV 241
+ +L G+A+LH+ +++RD KTSN+LL+ K+ DFGLARE G
Sbjct: 111 LMLQLL---SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLARE--YGSPLKP 162
Query: 242 STAVVGTYGYAAPE-YIETGHLKSQSDIWSFGVVLYEILTGR 282
T +V T Y APE + + D+WS G + E+LT +
Sbjct: 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 81/282 (28%), Positives = 125/282 (44%), Gaps = 37/282 (13%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA-EVQFLGVVS 132
F ++ +IG+G FG VYKG +D R + VVA+K ++ + + + E+ L
Sbjct: 6 FTKLERIGKGSFGEVYKG----IDNRTKE-VVAIKIIDLEEAEDEIEDIQQEITVLSQCD 60
Query: 133 HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA-E 191
P + + G +G + ++ EY+ S D L +P +T + IL +
Sbjct: 61 SPYITRYYG----SYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILK 112
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGY 251
GL YLH + I+RD K +NVLL KL+DFG+A G D VGT +
Sbjct: 113 GLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFW 167
Query: 252 AAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311
APE I+ ++DIWS G+ E+ G P L+ K P
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP--KNSP------- 218
Query: 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
P L QYS + + + CL K+P RPT ++++
Sbjct: 219 ----PTLEGQYS----KPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 8e-15
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 21/214 (9%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN--HGLQGHKQWLAEVQFLGVVSHPNL 136
IG G +G V I G+ VA+KK+ + K+ L E++ L H N+
Sbjct: 12 NIGSGAYGVVCSA-IDTRSGKK----VAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI 66
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTR--LEIILGAAEGLA 194
+ + +V + M + L + S QP R L +L GL
Sbjct: 67 IAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSD-QPLTEEHIRYFLYQLL---RGLK 121
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG--DHTHVSTAVVGTYGYA 252
Y+H VI+RD K SN+L++ + + ++ DFG+AR + +H + T V T Y
Sbjct: 122 YIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178
Query: 253 APEYIETGHLKSQS-DIWSFGVVLYEILTGRRVL 285
APE + + + + D+WS G + E+L GRR L
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 8e-15
Identities = 79/295 (26%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 80 IGEGGFGSVYKGTIRPLDGR--GEPLVVAVKKLNNHGLQGH-KQWLAEVQFLGVVS-HPN 135
+GEG FG V +D E + VAVK L + + ++E++ + ++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQP--------------TLPWKT 181
++ LLG C+ + ++ EY +L + L +R P + +K
Sbjct: 83 IINLLGACT----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 182 RLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHV 241
+ A G+ YL + I+RD NVL+ N K++DFGLAR+ D+
Sbjct: 139 LVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 242 STAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ-KLLEWV 300
+T + APE + QSD+WSFGV+++EI T P E KLL
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL--- 252
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
K+ M P N + + +C P RPT Q+VE L
Sbjct: 253 -------KEGHRMDKP-------ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 9e-15
Identities = 72/281 (25%), Positives = 123/281 (43%), Gaps = 44/281 (15%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+G G G+VYK L R ++AVK + + ++ KQ ++E++ L P ++
Sbjct: 9 LGHGNGGTVYK-AYHLLTRR----ILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIG 63
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
G E+ I E+M SL D + L I + +GL YL
Sbjct: 64 FYGAFFVENRISI----CTEFMDGGSL-DVYRKIPEHVLG-----RIAVAVVKGLTYL-- 111
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE 258
+++++RD K SN+L++ + KL DFG++ + ++ VGT Y APE I
Sbjct: 112 -WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERIS 166
Query: 259 TGHLKSQSDIWSFGVVLYEILTGR----RVLERNRPTMEQKLLEW-VKQFPADGKKFSMM 313
SD+WS G+ E+ GR ++ + M +LL+ V + P
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--------- 217
Query: 314 IDPRLR-NQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
P L Q+S + + C++K P+ERP +++
Sbjct: 218 --PVLPVGQFSEKFVHFITQ----CMRKQPKERPAPENLMD 252
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 82/305 (26%), Positives = 132/305 (43%), Gaps = 44/305 (14%)
Query: 80 IGEGGFGSVYKGTIRPLDGR--GEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVS-HPN 135
+GEG FG V + +D + + VAVK L ++ + ++E++ + ++ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPT--------------LPWKT 181
++ LLG C+ E G ++V EY +L + L +R P L +K
Sbjct: 80 IINLLGVCTQE---GPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 182 RLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHV 241
+ A G+ YL + I+RD NVL+ + K++DFGLAR D+
Sbjct: 136 LVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK 192
Query: 242 STAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ-KLLEWV 300
++ + APE + QSD+WSFG++++EI T P E KLL
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL--- 249
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL-KLAV 359
++ M P N + L C P +RPT Q+VE+L K+
Sbjct: 250 -------REGHRMDKPS-------NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295
Query: 360 QESEQ 364
SE+
Sbjct: 296 AVSEE 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 63/234 (26%), Positives = 103/234 (44%), Gaps = 26/234 (11%)
Query: 123 AEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTR 182
+E+ L H +VK ++D + LL+ EY L ++ R + LP++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDD----KLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-E 168
Query: 183 LEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS 242
E+ L + + L E ++++RD K++N+ L KL DFG +++ V+
Sbjct: 169 YEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228
Query: 243 TAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLE--RNRPTMEQKLLEWV 300
++ GT Y APE E ++D+WS GV+LYE+LT R + R M+Q L
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY 288
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354
FP + + L D L KNP RPT Q++ +
Sbjct: 289 DPFPC-------------------PVSSGMKALLDPLLSKNPALRPTTQQLLHT 323
|
Length = 478 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 80/295 (27%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLV--VAVKKLNNHGLQGH-KQWLAEVQFLGVV-SHPN 135
+GEG FG V LD V VAVK L + + ++E++ + ++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPW--------------KT 181
++ LLG C+ + ++ EY +L + L +R P + + K
Sbjct: 86 IINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 182 RLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHV 241
+ A G+ YL + I+RD NVL+ + K++DFGLAR+ D+
Sbjct: 142 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 242 STAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ-KLLEWV 300
+T + APE + QSD+WSFGV+L+EI T P E KLL
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 255
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
K+ M P N + + +C P +RPT Q+VE L
Sbjct: 256 -------KEGHRMDKPS-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-14
Identities = 61/217 (28%), Positives = 90/217 (41%), Gaps = 29/217 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLV 137
+IG G FG V G + V VK+L +L EVQ ++HPN++
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKAR---VVVKELRASATPDEQLLFLQEVQPYRELNHPNVL 58
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR-------AQPTLPWKTRLEIILGAA 190
+ LG C I LLV E+ P L++ L S AQ + + E+ A
Sbjct: 59 QCLGQCI----ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV----A 110
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
GL +LH + I+ D N L + K+ D+GLA E D+
Sbjct: 111 SGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR 167
Query: 251 YAAPEYIETGH-------LKSQSDIWSFGVVLYEILT 280
+ APE +E +S+IWS GV ++E+ T
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-14
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 31/218 (14%)
Query: 80 IGEGGFGSVYKGTIRPLDG-RGEPLVVAVKKLNNHGLQG---HKQWLA----EVQFLGVV 131
IG G FGSVY G ++ GE + V +L + + L E+ L +
Sbjct: 8 IGSGSFGSVYLG----MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 132 SHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRL--FSRAQPTLPWKTRLEIILGA 189
H N+V+ LG D I EY+P S+ L + + TL + + IL
Sbjct: 64 QHENIVQYLGSSLDADHLNI----FLEYVPGGSVAALLNNYGAFEETLV-RNFVRQIL-- 116
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE-----GPTGDHTHVSTA 244
+GL YLH +I+RD K +N+L+D K+SDFG++++ T + +
Sbjct: 117 -KGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA-RPS 171
Query: 245 VVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR 282
+ G+ + APE ++ ++DIWS G ++ E+LTG+
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 26/220 (11%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKK----LNNHGLQGHKQWLAEVQFLG 129
+ ++ KIGEG +G VYK + G+ +VA+KK ++ G+ L E+ L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKN-TGK----LVALKKTRLEMDEEGIPPTA--LREISLLQ 55
Query: 130 VVSH-PNLVKLLGYCSTEDERG-IQRLLVYEYMPN--RSLEDRLFSRAQPTLPWKTRLEI 185
++S +V+LL E++ G LV+EY+ + + D LP KT
Sbjct: 56 MLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 186 ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD-GNFKPKLSDFGLAREG--PTGDHTHVS 242
+ +G+A+ H + V++RD K N+L+D K++D GL R P +TH
Sbjct: 116 MYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH-- 170
Query: 243 TAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTG 281
+V T Y APE + H + DIWS G + E+
Sbjct: 171 -EIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 72/290 (24%), Positives = 110/290 (37%), Gaps = 67/290 (23%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+IG G +G VYK GE +VA+K + + E+ L HPN+V
Sbjct: 10 RIGSGTYGDVYKARDIA---TGE--LVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
G D+ I V EY SL+D ++ + L + +GLAYLHE
Sbjct: 65 YFGSYLRRDKLWI----VMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS---TAVVGTYGYAAPE 255
I+RD K +N+LL + KL+DFG++ + T + +GT + APE
Sbjct: 120 ---TGKIHRDIKGANILLTEDGDVKLADFGVSAQ-----LTATIAKRKSFIGTPYWMAPE 171
Query: 256 YIE---TGHLKSQSDIWSFGVVLYEILTG---------RRVL------ERNRPTMEQKLL 297
G + DIW+ G+ E+ R L P ++ K
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK 231
Query: 298 EWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT 347
W F + ++ CL K+P++RPT
Sbjct: 232 -WSPVF--------------------HDFIKK-------CLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 69/205 (33%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKK--LNNHGLQGHKQWLAEVQ-FLGVVSHPNL 136
IG+G FG V R LDG+ + V KK LN + K +AE L V HP L
Sbjct: 3 IGKGSFGKVLLAK-RKLDGKCYAVKVLQKKIVLNR---KEQKHIMAERNVLLKNVKHPFL 58
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
V L T + + V +++ L L + + + P A L YL
Sbjct: 59 VGLHYSFQTTE----KLYFVLDFVNGGELFFHL--QRERSFPEPRARFYAAEIASALGYL 112
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
H I ++YRD K N+LLD L+DFGL +EG T +T GT Y APE
Sbjct: 113 HS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYLAPEV 167
Query: 257 IETGHLKSQSDIWSFGVVLYEILTG 281
I + D W G VLYE+L G
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 55/183 (30%), Positives = 79/183 (43%), Gaps = 46/183 (25%)
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE--GPTGDHTHV 241
EI+L L +LH+ + +IYRD K N+LLD L+DFGL++E + +
Sbjct: 113 EIVLA----LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY- 164
Query: 242 STAVVGTYGYAAPEYI---ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLE 298
+ GT Y APE I GH K+ D WS GV+ +E+LTG
Sbjct: 165 --SFCGTIEYMAPEVIRGGSGGHDKA-VDWWSLGVLTFELLTG----------------- 204
Query: 299 WVKQFPADGKKFS--------MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQ 350
F DG++ S + P S A + KL L+K+P++R N
Sbjct: 205 -ASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKL----LEKDPKKRLGANG 259
Query: 351 VVE 353
E
Sbjct: 260 ADE 262
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 73/264 (27%), Positives = 114/264 (43%), Gaps = 36/264 (13%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ---GHKQWLAEVQFLGV 130
F + +G+GGFG V +R G+ + A K+L ++ G L E Q L
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRA-TGK----MYACKRLEKKRIKKRKGESMALNEKQILEK 56
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA 190
V+ +V L T+D LV M L+ +++ P + + AA
Sbjct: 57 VNSQFVVNLAYAYETKD----ALCLVLTIMNGGDLKFHIYNMGNPGFEEE---RALFYAA 109
Query: 191 E---GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVG 247
E GL LH +YRD K N+LLD ++SD GLA + P G+ VG
Sbjct: 110 EILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR---GRVG 163
Query: 248 TYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR-----RVLERNRPTMEQKLLE---- 298
T GY APE + D W G ++YE++ G+ R + R +++++LE
Sbjct: 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEV 223
Query: 299 WVKQFPADGKKFSMMI---DPRLR 319
+ +F + K M+ DP+ R
Sbjct: 224 YSAKFSEEAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-14
Identities = 71/277 (25%), Positives = 111/277 (40%), Gaps = 34/277 (12%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--HKQWLAEVQFLGVVSHPNL 136
++G G FG+V KG + VAVK L N + L E + + +P +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEK---TVAVKILKNDNNDPALKDELLREANVMQQLDNPYI 58
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
V+++G C E +LV E L L T K E++ + G+ YL
Sbjct: 59 VRMIGICEAES-----WMLVMELAELGPLNKFLQKNKHVTE--KNITELVHQVSMGMKYL 111
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY--GYAAP 254
E ++RD NVLL K+SDFGL++ D + G + + AP
Sbjct: 112 EET---NFVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAP 167
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMI 314
E + S+SD+WSFGV+++E + QK + +K G + + MI
Sbjct: 168 ECMNYYKFSSKSDVWSFGVLMWEAF-----------SYGQKPYKGMK-----GNEVTQMI 211
Query: 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQV 351
+ R + + L C +ERP V
Sbjct: 212 ESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 38/93 (40%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
A GL +LH +IYRD K NV+LD K++DFG+ +E G T + GT
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTP 165
Query: 250 GYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR 282
Y APE I D W+FGV+LYE+L G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 74/237 (31%), Positives = 113/237 (47%), Gaps = 26/237 (10%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQFLGV 130
FN + +G G FG V T + + P VA+K+ + KQ +E + L
Sbjct: 32 FNFIRTLGTGSFGRVILATYK--NEDFPP--VAIKRFEKSKIIKQKQVDHVFSERKILNY 87
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA 190
++HP V L G S +DE + LV E++ E F R P ++ A
Sbjct: 88 INHPFCVNLYG--SFKDESYL--YLVLEFVIGG--EFFTFLRRNKRFP----NDVGCFYA 137
Query: 191 EGLAYLHEGLE-IQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
+ + E L+ + ++YRD K N+LLD + K++DFG A+ T +T + GT
Sbjct: 138 AQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT-----LCGTP 192
Query: 250 GYAAPE-YIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM-EQKLLEWVKQFP 304
Y APE + GH K+ +D W+ G+ +YEIL G N P + QK+LE + FP
Sbjct: 193 EYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP 248
|
Length = 340 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 4e-14
Identities = 78/310 (25%), Positives = 137/310 (44%), Gaps = 34/310 (10%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLD-GRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS 132
+ R KIG+G G+VY +D G+ VA+K++N + + E+ +
Sbjct: 21 YTRFEKIGQGASGTVYTA----IDIATGQE--VAIKQMNLQQQPKKELIINEILVMRENK 74
Query: 133 HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEG 192
+PN+V L DE + V EY+ SL D + + + + +
Sbjct: 75 NPNIVNYLDSYLVGDELWV----VMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQA 127
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA 252
L +LH QVI+RD K+ N+LL + KL+DFG + T + + ST +VGT +
Sbjct: 128 LDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRST-MVGTPYWM 182
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSM 312
APE + + DIWS G++ E++ G P + + L + +G
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGE------PPYLNENPLRALYLIATNGT---- 232
Query: 313 MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSSSTTTA 372
P L+N ++A R + CL+ + + R + ++++ L + + + A
Sbjct: 233 ---PELQNPERLSAVFR--DFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTPLIIA 287
Query: 373 AKTPVTSSSR 382
AK + +SSR
Sbjct: 288 AKEAIKNSSR 297
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-14
Identities = 71/273 (26%), Positives = 114/273 (41%), Gaps = 28/273 (10%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKL 139
+G+G +G V R G+ V+ L N + K E Q L + HPN+V
Sbjct: 8 VGKGSYGEVSLVRHRTD---GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 140 LGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEG 199
S E E G +V + L +L + LP +E + A L YLHE
Sbjct: 65 RE--SWEGEDG-LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 200 LEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET 259
+++RD KT NV L K+ D G+AR + +++ ++GT Y +PE
Sbjct: 122 ---HILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMASTLIGTPYYMSPELFSN 176
Query: 260 GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLR 319
+SD+W+ G +YE+ T + N M + + +GK P +
Sbjct: 177 KPYNYKSDVWALGCCVYEMATLKHAF--NAKDMNSLVYRII-----EGKL------PPMP 223
Query: 320 NQYSINAARRVAKLADNCLKKNPEERPTMNQVV 352
YS + +L L K PE+RP++ ++
Sbjct: 224 KDYS----PELGELIATMLSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-14
Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 40/279 (14%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ---GHKQWLAEVQFLGV 130
F + +G+GGFG V +R G+ + A KKL ++ G L E Q L
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRA-TGK----MYACKKLEKKRIKKRKGESMALNEKQILEK 56
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA 190
V+ +V L T+D LV M L+ ++ + + AA
Sbjct: 57 VNSRFVVSLAYAYETKD----ALCLVLTLMNGGDLKFHIYHMGEAGFEEG---RAVFYAA 109
Query: 191 E---GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVG 247
E GL LH+ +++YRD K N+LLD + ++SD GLA P G VG
Sbjct: 110 EICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVG 163
Query: 248 TYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLE-WVKQFPAD 306
T GY APE ++ D W+ G +LYE++ G+ ++ + ++++ +E VK+
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-- 221
Query: 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
+YS + L L K+P+ER
Sbjct: 222 -------------EEYSEKFSPDARSLCKMLLCKDPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-14
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPN 135
KIG G F VY+ T LD + VA+KK+ + + + + E+ L ++HPN
Sbjct: 9 KIGRGQFSEVYRATCL-LDRK----PVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRL--FSRAQPTLPWKTRLEIILGAAEGL 193
++K L ++E I V E L + F + + +P +T + + +
Sbjct: 64 VIKYLDSFIEDNELNI----VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAA 253
++H +V++RD K +NV + KL D GL R + T + ++VGT Y +
Sbjct: 120 EHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMS 174
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEI 278
PE I +SDIWS G +LYE+
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 6e-14
Identities = 53/152 (34%), Positives = 75/152 (49%), Gaps = 15/152 (9%)
Query: 133 HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKT--RLEIILGAA 190
HP L L YC+ + + + V EY+ L + S + LP T EII G
Sbjct: 55 HPFLTHL--YCTFQTKENL--FFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG-- 108
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
L +LH ++YRD K N+LLD + K++DFG+ +E GD + GT
Sbjct: 109 --LQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPD 161
Query: 251 YAAPEYIETGHLKSQSDIWSFGVVLYEILTGR 282
Y APE + + D WSFGV+LYE+L G+
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 63/225 (28%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 74 FNRMLKIGEGGFGSVY----KGTIRPLDGRGEPLVVAVKKLNN---HGLQGHKQWLAEVQ 126
F + ++G+GG+G V+ K T GE +VA+K++ L + L E
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDT-------GE--IVALKRMKKSLLFKLNEVRHVLTERD 53
Query: 127 FLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMP----------NRSLEDRLFSRAQPT 176
L LVKLL Y + +D+ + L EY+P L +
Sbjct: 54 ILTTTKSEWLVKLL-Y-AFQDDEYL--YLAMEYVPGGDFRTLLNNLGVLSED-------- 101
Query: 177 LPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236
R + AE + E+ I+RD K N L+D + KL+DFGL++ T
Sbjct: 102 ---HARFYM----AEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY 154
Query: 237 DHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTG 281
++ VVG+ Y APE + D WS G +LYE L G
Sbjct: 155 ANS-----VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 7e-14
Identities = 37/91 (40%), Positives = 53/91 (58%), Gaps = 5/91 (5%)
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGY 251
GL +LH +IYRD K NV+LD + K++DFG+ +E GD+ ++ GT Y
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDY 162
Query: 252 AAPEYIETGHLKSQSDIWSFGVVLYEILTGR 282
APE ++ D WSFGV+LYE+L G+
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 8e-14
Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 32/282 (11%)
Query: 82 EGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKL 139
EG FG ++ G + E V VK + +H +Q L E L +SH N++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVF-VKTVKDHASEIQVTL-LLQESCLLYGLSHQNILPI 73
Query: 140 LGYCSTEDERGIQRLLVYEYMPNRSLEDRL----FSRAQPTLPWKTR--LEIILGAAEGL 193
L C E G ++Y YM +L+ L A T+ + + + A G+
Sbjct: 74 LHVCI---EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAA 253
+YLH+ VI++D N ++D + K++D L+R+ D+ + + A
Sbjct: 131 SYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMA 187
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313
E + S SD+WSFGV+L+E++T + P +E E + + DG
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMTLGQT-----PYVEIDPFE-MAAYLKDGY----- 236
Query: 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
R IN + + C +PEERP+ +Q+V+ L
Sbjct: 237 -----RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 8e-14
Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 31/219 (14%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA-----EVQFL 128
+ ++ KIGEG +G VYKG + +VA+KK+ L+ ++ + E+ L
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQ-----IVAMKKIR---LESEEEGVPSTAIREISLL 53
Query: 129 GVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMP---NRSLEDRLFSRAQPTLPWKTRLE 184
+ HPN+V L E RL L++E++ + L+ + K+ L
Sbjct: 54 KELQHPNIVCLQDVLMQES-----RLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLY 108
Query: 185 IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTA 244
IL +G+ + H +V++RD K N+L+D KL+DFGLAR G V T
Sbjct: 109 QIL---QGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARA--FGIPVRVYTH 160
Query: 245 VVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGR 282
V T Y APE + S DIWS G + E+ T +
Sbjct: 161 EVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 8e-14
Identities = 69/244 (28%), Positives = 99/244 (40%), Gaps = 52/244 (21%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH---KQWLAEVQFLGV 130
F ++ +G+G G V+ + L G G+ A+K L+ + K+ L E + L
Sbjct: 3 FKKIKLLGKGDVGRVF---LVRLKGTGKLF--ALKVLDKKEMIKRNKVKRVLTEQEILAT 57
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA 190
+ HP L L Y S + E + LV +Y P L L + L + AA
Sbjct: 58 LDHPFLPTL--YASFQTETYL--CLVMDYCPGGELFRLLQRQPGKCLSEEV---ARFYAA 110
Query: 191 E---GLAYLH-EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHV----- 241
E L YLH G ++YRD K N+LL + LSDF L+++
Sbjct: 111 EVLLALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK 166
Query: 242 ----------------------STAVVGTYGYAAPEYIE-TGHLKSQSDIWSFGVVLYEI 278
S + VGT Y APE I GH S D W+ G++LYE+
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEM 225
Query: 279 LTGR 282
L G
Sbjct: 226 LYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 69/209 (33%), Positives = 88/209 (42%), Gaps = 26/209 (12%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQ-FLGVVSHPN 135
IG+G FG V DG+ AVK L + K+ +AE L V HP
Sbjct: 3 IGKGSFGKVLLAK-HKADGK----FYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPF 57
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRL---EIILGAAEG 192
LV L T D + V +Y+ L L R + + R EI A
Sbjct: 58 LVGLHYSFQTAD----KLYFVLDYVNGGELFFHL-QRERSFPEPRARFYAAEI----ASA 108
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA 252
L YLH + +IYRD K N+LLD L+DFGL +EG T ++ GT Y
Sbjct: 109 LGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYL 163
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILTG 281
APE + D W G VLYE+L G
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 74/307 (24%), Positives = 132/307 (42%), Gaps = 32/307 (10%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH 133
+ R KIG+G G+V+ VA+K++N + + E+ + + +
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQE-----VAIKQINLQKQPKKELIINEILVMKELKN 75
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGL 193
PN+V L DE +V EY+ SL D + + + + + L
Sbjct: 76 PNIVNFLDSFLVGDEL----FVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQAL 128
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAA 253
+LH QVI+RD K+ NVLL + KL+DFG + T + + ST +VGT + A
Sbjct: 129 EFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ-ITPEQSKRST-MVGTPYWMA 183
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313
PE + + DIWS G++ E++ G P + + L + +G
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGE------PPYLNENPLRALYLIATNGT----- 232
Query: 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSSSTTTAA 373
P L+N ++ R + CL+ + E+R + ++++ L + + + AA
Sbjct: 233 --PELQNPEKLSPIFR--DFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLILAA 288
Query: 374 KTPVTSS 380
K + S+
Sbjct: 289 KEAMKSN 295
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 83/322 (25%), Positives = 133/322 (41%), Gaps = 79/322 (24%)
Query: 56 EHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL 115
EH R D E+ E ++G+G FG VYK + + A K +
Sbjct: 2 EHVRRDLDPNEVWEIIG------ELGDGAFGKVYKA-----KNKETGALAAAKVIETKSE 50
Query: 116 QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLE------DRL 169
+ + ++ E++ L +HP +VKLLG + + I + E+ P +++ DR
Sbjct: 51 EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI----MIEFCPGGAVDAIMLELDRG 106
Query: 170 FSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229
+ Q + + LE L YLH +++I+RD K NVLL + KL+DFG+
Sbjct: 107 LTEPQIQVICRQMLE-------ALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGV 156
Query: 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKS-----QSDIWSFGVVLYEI------ 278
+ + S +GT + APE + +K ++DIWS G+ L E+
Sbjct: 157 SAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
Query: 279 ---LTGRRVL----ERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVA 331
L RVL + PT+ Q +W +F R
Sbjct: 215 HHELNPMRVLLKIAKSEPPTLSQP-SKWSMEF------------------------RDFL 249
Query: 332 KLADNCLKKNPEERPTMNQVVE 353
K A L K+PE RP+ Q++E
Sbjct: 250 KTA---LDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 57/169 (33%), Positives = 78/169 (46%), Gaps = 27/169 (15%)
Query: 122 LAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSL-----EDRLFSRAQPT 176
L E + L HP L L T+D + V EY+ L +R+FS
Sbjct: 43 LTESRVLKNTRHPFLTSLKYSFQTKD----RLCFVMEYVNGGELFFHLSRERVFSED--- 95
Query: 177 LPWKTRL---EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233
+TR EI+ L YLH G +++YRD K N++LD + K++DFGL +EG
Sbjct: 96 ---RTRFYGAEIV----SALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEG 145
Query: 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR 282
T T GT Y APE +E D W GVV+YE++ GR
Sbjct: 146 ITDAAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 68/294 (23%), Positives = 117/294 (39%), Gaps = 65/294 (22%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKL 139
+G+G FG VYK + L A K + + + ++ E+ L HPN+V L
Sbjct: 13 LGDGAFGKVYKAQ-----HKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGL 67
Query: 140 LGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEG 199
E++ I + E+ +L+ + + + R + E L +LH
Sbjct: 68 YEAYFYENKLWI----LIEFCDGGALDSIMLELERGLTEPQIRY-VCRQMLEALNFLHSH 122
Query: 200 LEIQVIYRDFKTSNVLL--DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYI 257
VI+RD K N+LL DG+ KL+DFG++ + + + +GT + APE +
Sbjct: 123 K---VIHRDLKAGNILLTLDGDV--KLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVV 175
Query: 258 ETGHLKSQ-----SDIWSFGVVLYEILTGR-------------RVLERNRPTMEQKLLEW 299
K +DIWS G+ L E+ ++L+ PT++Q W
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSK-W 234
Query: 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
F F + CL K+P++RPT ++++
Sbjct: 235 SSSF----NDF-------------------LKS----CLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 47/151 (31%), Positives = 78/151 (51%), Gaps = 24/151 (15%)
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST 243
EI+L L +LH+ + +IYRD K N+LLD N L+DFGL++E D +
Sbjct: 113 EIVLA----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAY 164
Query: 244 AVVGTYGYAAPEYI---ETGHLKSQSDIWSFGVVLYEILTGRRVL-----ERNRPTMEQK 295
+ GT Y AP+ + + GH K+ D WS GV++YE+LTG + ++ + ++
Sbjct: 165 SFCGTIEYMAPDIVRGGDGGHDKA-VDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR 223
Query: 296 LLEWVKQFPADGKKFS-------MMIDPRLR 319
+L+ +P + + +M DP+ R
Sbjct: 224 ILKSEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 79/315 (25%), Positives = 130/315 (41%), Gaps = 78/315 (24%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA--EVQFLGVVSHPNL 136
+GEG +G V K + G+ +VA+KK + +A E++ L + H NL
Sbjct: 8 LVGEGSYGMVMKCKHKE-TGQ----IVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62
Query: 137 VKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAY 195
V L+ R +RL LV+E++ + L+D + L + + G+ +
Sbjct: 63 VNLIEVF-----RRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRKYLFQILRGIEF 115
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR--EGPTGDHTHVSTAVVGTYGYAA 253
H +I+RD K N+L+ + KL DFG AR P G+ V T V T Y A
Sbjct: 116 CHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GE---VYTDYVATRWYRA 168
Query: 254 PEYI--ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG---- 307
PE + +T + ++ DIW+ G ++ E+LTG + FP D
Sbjct: 169 PELLVGDTKYGRA-VDIWAVGCLVTEMLTGEPL------------------FPGDSDIDQ 209
Query: 308 -----KKFSMMIDPRLRNQYS----------------INAARRVAKL-------ADNCLK 339
K +I PR + + +R KL A CL+
Sbjct: 210 LYHIIKCLGNLI-PRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLR 268
Query: 340 KNPEERPTMNQVVES 354
+P++RP+ +Q++
Sbjct: 269 IDPDDRPSSSQLLHH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 57/170 (33%), Positives = 74/170 (43%), Gaps = 29/170 (17%)
Query: 122 LAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSL-----EDRLFSRAQP 175
L E + L HP L L T D RL V EY L +R+FS
Sbjct: 43 LTESRVLQNTRHPFLTALKYSFQTHD-----RLCFVMEYANGGELFFHLSRERVFSED-- 95
Query: 176 TLPWKTRL---EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232
+ R EI+ L YLH V+YRD K N++LD + K++DFGL +E
Sbjct: 96 ----RARFYGAEIVSA----LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKE 144
Query: 233 GPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR 282
G + T GT Y APE +E D W GVV+YE++ GR
Sbjct: 145 GISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 38/223 (17%)
Query: 132 SHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFS-RAQPTLPWK-TRL---EI 185
+HP LV L TE RL V E++ D +F + Q LP + R EI
Sbjct: 54 NHPFLVGLHSCFQTE-----SRLFFVIEFVSG---GDLMFHMQRQRKLPEEHARFYSAEI 105
Query: 186 ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG-PTGDHTHVSTA 244
L L +LHE +IYRD K NVLLD KL+D+G+ +EG GD T +
Sbjct: 106 SLA----LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---ST 155
Query: 245 VVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLE--RNRPTMEQKLLEWVKQ 302
GT Y APE + D W+ GV+++E++ GR + +Q +++
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL-- 213
Query: 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
F ++++ ++R S++ + + + L K+P+ER
Sbjct: 214 -------FQVILEKQIRIPRSLSV--KASSVLKGFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 50/160 (31%), Positives = 73/160 (45%), Gaps = 26/160 (16%)
Query: 189 AAE---GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAV 245
AAE L +LH VIYRD K N+LLD KL+DFG+ +EG T +T
Sbjct: 102 AAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTF 156
Query: 246 VGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305
GT Y APE ++ D W+ GV++YE++ G+ E + E L E
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFE------- 206
Query: 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
S++ D L Y + ++ + + KNP +R
Sbjct: 207 -----SILHDDVL---YPVWLSKEAVSILKAFMTKNPNKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 68/280 (24%), Positives = 123/280 (43%), Gaps = 32/280 (11%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH 133
+ +KIGEG G V T++ G+ +VAVKK++ Q + EV + H
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKS-SGK----LVAVKKMDLRKQQRRELLFNEVVIMRDYQH 76
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGL 193
N+V++ DE + V E++ +L D + + + + L + L
Sbjct: 77 ENVVEMYNSYLVGDELWV----VMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKAL 129
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAA 253
+ LH VI+RD K+ ++LL + + KLSDFG + ++VGT + A
Sbjct: 130 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKSLVGTPYWMA 184
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313
PE I + DIWS G+++ E++ G P K++ P
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR--DNLP--------- 233
Query: 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
P+L+N + ++ + + D L ++P +R T ++++
Sbjct: 234 --PKLKNLHKVSPS--LKGFLDRLLVRDPAQRATAAELLK 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 72/255 (28%), Positives = 113/255 (44%), Gaps = 30/255 (11%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ---GHKQWLAEVQFLGVVSHPNL 136
+G+GGFG V +R G+ + A KKL ++ G L E + L V+ +
Sbjct: 8 LGKGGFGEVCACQVRA-TGK----MYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFV 62
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
V L T+D LV M L+ +++ P + I AAE L
Sbjct: 63 VSLAYAYETKD----ALCLVLTIMNGGDLKFHIYNMGNPGFDEQ---RAIFYAAELCCGL 115
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
+ +++YRD K N+LLD ++SD GLA + P G+ VGT GY APE
Sbjct: 116 EDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR---GRVGTVGYMAPEV 172
Query: 257 IETGHLKSQSDIWSFGVVLYEILTG----RRVLER-NRPTMEQKLL----EWVKQFPADG 307
I D W G ++YE++ G R+ ER R +++++ E+ ++F D
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDA 232
Query: 308 KKFSMMI---DPRLR 319
K M+ +P+ R
Sbjct: 233 KSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 9e-13
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA---EVQFLGVVSHPNL 136
+G+G FG VY D G L V + + + K+ A E+Q L + H +
Sbjct: 10 LGQGAFGRVY--LCYDAD-TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
V+ G ER + + E+MP S++D+L ++ L + EG++YL
Sbjct: 67 VQYYGCLRDPMERTLS--IFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQILEGVSYL 122
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS-TAVVGTYGYAAPE 255
H + +++RD K +N+L D KL DFG ++ T + +V GT + +PE
Sbjct: 123 HSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGR 282
I ++DIWS G + E+LT +
Sbjct: 180 VISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 89/348 (25%), Positives = 142/348 (40%), Gaps = 91/348 (26%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-HKQWLAEVQFL-GVVSHPNLV 137
+G G FG V + + +D + VAVK L HK ++E++ L + +H N+V
Sbjct: 15 LGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVV 74
Query: 138 KLLGYCS-----------------------------------TEDERGIQRLLVYEYMPN 162
LLG C+ + +RG R +V + +
Sbjct: 75 NLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVD 134
Query: 163 RSLE----DRLFSRAQPTLP------------WKTRLEI------ILGAAEGLAYLHEGL 200
R +E LFSR QP+ WK+ L + A G+ +L
Sbjct: 135 RRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR- 193
Query: 201 EIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE---GPTGDHTHVSTAVVGTYGYAAPEYI 257
+ I+RD N+LL N K+ DFGLAR+ P D+ +A + + APE I
Sbjct: 194 --KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP--DYVRKGSARL-PLKWMAPESI 248
Query: 258 ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPR 317
+QSD+WSFGV+L+EI + + P G + + R
Sbjct: 249 FDKVYTTQSDVWSFGVLLWEIFS-------------------LGASPYPGVQINEEFCQR 289
Query: 318 LRNQYSI----NAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361
L++ + NA + ++ C + +P+ERPT + +VE L +QE
Sbjct: 290 LKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 64/209 (30%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ---GHKQWLAEVQFLGVVSHPNL 136
+G+GGFG V +R G+ + A KKL ++ G L E Q L V+ +
Sbjct: 8 LGKGGFGEVCACQVR-ATGK----MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV 62
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAE---GL 193
V L T+D LV M L+ +++ P + + AAE GL
Sbjct: 63 VSLAYAYETKD----ALCLVLTLMNGGDLKFHIYNMGNPGFDEE---RAVFYAAEITCGL 115
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAA 253
LH +++YRD K N+LLD ++SD GLA E P G+ VGT GY A
Sbjct: 116 EDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR---GRVGTVGYMA 169
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEILTGR 282
PE ++ D W G ++YE++ G+
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 85/311 (27%), Positives = 138/311 (44%), Gaps = 50/311 (16%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW-----LAEVQFL 128
F+ + +IGEG +G VYK R D GE +VA+KK+ L K+ + E++ L
Sbjct: 9 FDIIGQIGEGTYGQVYKA--RDKD-TGE--LVALKKVR---LDNEKEGFPITAIREIKIL 60
Query: 129 GVVSHPNLVKLLGYCSTE----DERGIQR--LLVYEYMPNR---SLEDRL--FSRAQPTL 177
++H N+V L + + D + + LV+EYM + LE L FS
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 178 PWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGD 237
K LE GL Y H+ ++RD K SN+LL+ + KL+DFGLAR + +
Sbjct: 121 FMKQLLE-------GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170
Query: 238 HTHVSTAVVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGRRVLERNRPTMEQKL 296
+ V+ T Y PE + + D+WS G +L E+ T + + + N+ + +L
Sbjct: 171 SRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229
Query: 297 LEWVKQFPA-------------DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPE 343
+ + P + K RLR ++S + L D+ L +P
Sbjct: 230 ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPAL-DLLDHMLTLDPS 288
Query: 344 ERPTMNQVVES 354
+R T + + S
Sbjct: 289 KRCTAEEALNS 299
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 76 RMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK-QWLAEVQFLGVVSHP 134
++ K+GEG + +VYKG + D +VA+K++ +G + EV L + H
Sbjct: 10 KLDKLGEGTYATVYKGRSKLTDN-----LVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLA 194
N+V L TE LV+EY+ ++ L+ L +L + GL
Sbjct: 65 NIVTLHDIIHTEK----SLTLVFEYL-DKDLKQYLDDCGNSINMHNVKL-FLFQLLRGLN 118
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP 254
Y H +V++RD K N+L++ + KL+DFGLAR T+ + V T Y P
Sbjct: 119 YCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPP 173
Query: 255 E-YIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKL 296
+ + + +Q D+W G + YE+ TGR + + T+E++L
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS--TVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 64/229 (27%), Positives = 92/229 (40%), Gaps = 51/229 (22%)
Query: 79 KIGEGGFGSVYKG-TIRPLDGRGEPLVVAVKKL--NNHGLQGHKQ-WLAEVQFLGVVSHP 134
IG G +G VYK DG+ A+KK + G Q E+ L + H
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGK----EYAIKKFKGDKEQYTGISQSACREIALLRELKHE 62
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLF----------SRAQPTLPWKTRLE 184
N+V L+ ++ + L+++Y E L+ + P K+ L
Sbjct: 63 NVVSLVEVFLEHADKSVY--LLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 185 IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP----KLSDFGLAR--EGP---- 234
IL G+ YLH V++RD K +N+L+ G K+ D GLAR P
Sbjct: 116 QIL---NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 235 -TGDHTHVSTAVVGTYGYAAPEYIETG--HLKSQSDIWSFGVVLYEILT 280
D VV T Y APE + G H DIW+ G + E+LT
Sbjct: 170 ADLD------PVVVTIWYRAPELL-LGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 68/223 (30%), Positives = 97/223 (43%), Gaps = 46/223 (20%)
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSL----EDRLFSRAQPTLPWKTRLEII 186
HP LV L TED V EY L +FS + ++
Sbjct: 59 ERHPFLVNLFACFQTED----HVCFVMEYAAGGDLMMHIHTDVFSEPRAVF---YAACVV 111
Query: 187 LGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGP-TGDHTHVSTAV 245
LG L YLHE +++YRD K N+LLD K++DFGL +EG GD T ST
Sbjct: 112 LG----LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST-F 161
Query: 246 VGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP 304
GT + APE + ET + ++ D W GV++YE+L G FP
Sbjct: 162 CGTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGE------------------SPFP 202
Query: 305 ADGKK--FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
D ++ F +++ +R Y +R + L++NPE R
Sbjct: 203 GDDEEEVFDSIVNDEVR--YPRFLSREAISIMRRLLRRNPERR 243
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 55/220 (25%), Positives = 101/220 (45%), Gaps = 39/220 (17%)
Query: 80 IGEGGFGSVYK------GTIRPLDGRGEPLVVAVKKL----NNHGLQGH--KQWLAEVQF 127
+G G F S Y+ GT+ +AVK++ N Q + E++
Sbjct: 8 LGTGAFSSCYQARDVKTGTL-----------MAVKQVTYVRNTSSEQEEVVEALRKEIRL 56
Query: 128 LGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRL--FSRAQPTLPWKTRLEI 185
+ ++HP+++++LG +T ++ L E+M S+ L + + + ++
Sbjct: 57 MARLNHPHIIRMLG--ATCEDSHFN--LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL 112
Query: 186 ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP-KLSDFGLA-REGPTGDHT-HVS 242
+ G L+YLHE Q+I+RD K +N+L+D + +++DFG A R G
Sbjct: 113 LRG----LSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ 165
Query: 243 TAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR 282
++GT + APE + D+WS G V+ E+ T +
Sbjct: 166 GQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 77/293 (26%), Positives = 129/293 (44%), Gaps = 46/293 (15%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH 133
+ R KIG+G G+VY VA+K++N + + E+ + H
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQE-----VAIKQMNLQQQPKKELIINEILVMRENKH 75
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA--- 190
PN+V L DE + V EY+ SL D + +T ++ AA
Sbjct: 76 PNIVNYLDSYLVGDELWV----VMEYLAGGSLTDVVT---------ETCMDEGQIAAVCR 122
Query: 191 ---EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVG 247
+ L +LH QVI+RD K+ N+LL + KL+DFG + T + + ST +VG
Sbjct: 123 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRST-MVG 177
Query: 248 TYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307
T + APE + + DIWS G++ E++ G P + + L + +G
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE------PPYLNENPLRALYLIATNG 231
Query: 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES--LKLA 358
P L+N ++A R + CL+ + E+R + ++++ LK+A
Sbjct: 232 T-------PELQNPEKLSAIFR--DFLNRCLEMDVEKRGSAKELLQHPFLKIA 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 73/292 (25%), Positives = 131/292 (44%), Gaps = 42/292 (14%)
Query: 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS 132
+ +KIGEG G V T + + VAVKK++ Q + EV +
Sbjct: 23 YLDSFIKIGEGSTGIVCIATEKHTGKQ-----VAVKKMDLRKQQRRELLFNEVVIMRDYH 77
Query: 133 HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEG 192
H N+V + DE + V E++ +L D + + + + L
Sbjct: 78 HENVVDMYNSYLVGDELWV----VMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRA 130
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG----LAREGPTGDHTHVSTAVVGT 248
L+YLH VI+RD K+ ++LL + + KLSDFG +++E P ++VGT
Sbjct: 131 LSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK------RKSLVGT 181
Query: 249 YGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308
+ APE I ++ DIWS G+++ E++ G P + L+ +++ +
Sbjct: 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE------PPYFNEPPLQAMRRIRDN-- 233
Query: 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES--LKLA 358
+ PR+++ + +++ R D L + P +R T ++++ LKLA
Sbjct: 234 -----LPPRVKDSHKVSSVLR--GFLDLMLVREPSQRATAQELLQHPFLKLA 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 69/294 (23%), Positives = 122/294 (41%), Gaps = 56/294 (19%)
Query: 80 IGEGGFGSVYKGTIRP-----LDGRGEPLVVAVKKLNNHGLQGHKQWLA---EVQFLGVV 131
+G+G F ++YKG +R + G G+ + V +K L H+ LA + +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG----SDHRDSLAFFETASLMSQL 58
Query: 132 SHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFS-RAQPTLPWKTRLEIILGAA 190
SH +LVKL G C + + ++V EY+ L+ L + +L WK L++ A
Sbjct: 59 SHKHLVKLYGVCVRD-----ENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLA 111
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLL-----DGNFKP--KLSDFGLAREGPTGDHTHVST 243
L YL + ++++ + N+L+ + + P KLSD G+ + +
Sbjct: 112 SALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER---- 164
Query: 244 AVVGTYGYAAPEYIETGH--LKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK 301
V + APE I G L +D WSFG L EI + + E+ +
Sbjct: 165 --VERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK------E 216
Query: 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
+F D ++ + +A L + C +P +RP+ ++ L
Sbjct: 217 RFYQDQ------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 3e-12
Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 23/207 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW--LAEVQFLGVVS-HPN 135
KIGEG F V K R G+ A+K + H + +Q L E+Q L +S HPN
Sbjct: 6 KIGEGTFSEVLKAQSRK-TGK----YYAIKCMKKH-FKSLEQVNNLREIQALRRLSPHPN 59
Query: 136 LVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLA 194
+++L +R RL LV+E M + +L + + R +P LP K + + L
Sbjct: 60 ILRL---IEVLFDRKTGRLALVFELM-DMNLYELIKGRKRP-LPEKRVKSYMYQLLKSLD 114
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP 254
++H + +RD K N+L+ + KL+DFG R T + T Y AP
Sbjct: 115 HMHR---NGIFHRDIKPENILIKDDIL-KLADFGSCR---GIYSKPPYTEYISTRWYRAP 167
Query: 255 EYIET-GHLKSQSDIWSFGVVLYEILT 280
E + T G+ + DIW+ G V +EIL+
Sbjct: 168 ECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 3e-12
Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
++G+G FG VYK + ++ A K ++ + + ++ E+ L HPN+VK
Sbjct: 12 ELGDGAFGKVYKA-----QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
LL E+ I + E+ +++ + +P + R+ + E L YLHE
Sbjct: 67 LLDAFYYENNLWI----LIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTLEALNYLHE 121
Query: 199 GLEIQVIYRDFKTSNVL--LDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
++I+RD K N+L LDG+ KL+DFG++ + S +GT + APE
Sbjct: 122 N---KIIHRDLKAGNILFTLDGDI--KLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEV 174
Query: 257 I--ETGHLKS---QSDIWSFGVVLYEI 278
+ ET + ++D+WS G+ L E+
Sbjct: 175 VMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 36/90 (40%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA 252
L YLH V+YRD K N++LD + K++DFGL +EG + T GT Y
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYL 162
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILTGR 282
APE +E D W GVV+YE++ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 4e-12
Identities = 50/146 (34%), Positives = 66/146 (45%), Gaps = 24/146 (16%)
Query: 189 AAE---GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAV 245
AAE L +LH+ +IYRD K NVLLD KL+DFG+ +EG +T+
Sbjct: 102 AAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI---FNGKTTST 155
Query: 246 -VGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLE------ 298
GT Y APE ++ D W+ GV+LYE+L G E E L E
Sbjct: 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILNDE 212
Query: 299 -----WVKQFPADGKKFSMMIDPRLR 319
W+ Q D K M +P +R
Sbjct: 213 VVYPTWLSQDAVDILKAFMTKNPTMR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 68/268 (25%), Positives = 115/268 (42%), Gaps = 33/268 (12%)
Query: 65 QELREATNGFN-RMLK-IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWL 122
Q+ RE ++K + G G V+ T G+ +P+V+ + G +G L
Sbjct: 57 QKAREVVASLGYTVIKTLTPGSEGRVFVAT---KPGQPDPVVLKI------GQKGTT--L 105
Query: 123 AEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTR 182
E L V+HP+++++ T I +++ Y + L L R++P LP
Sbjct: 106 IEAMLLQNVNHPSVIRMK---DTLVSGAITCMVLPHY--SSDLYTYLTKRSRP-LPIDQA 159
Query: 183 LEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS 242
L I EGL YLH ++I+RD KT N+ ++ + + D G A+ P +
Sbjct: 160 LIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFLG 215
Query: 243 TAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM--------EQ 294
A GT APE + S++DIWS G+VL+E+L + + P+
Sbjct: 216 LA--GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHS 273
Query: 295 KLLEWVKQFPADGKKFSMMIDPRLRNQY 322
LL+ + ++F RL +
Sbjct: 274 HLLKIISTLKVHPEEFPRDPGSRLVRGF 301
|
Length = 357 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 6e-12
Identities = 74/265 (27%), Positives = 117/265 (44%), Gaps = 44/265 (16%)
Query: 38 TARSLPSPRSIPELYKEK--EHHLR-----VFDMQELREATNGFNRMLKIGEGGFGSVYK 90
T +L IP L K K ++ L + +LR F+ + IG G FG V
Sbjct: 2 TVTALVYDCDIPALRKNKNIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQ- 60
Query: 91 GTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFL----GVVSHPN---LVKLLGYC 143
+R + V A+K L+ + ++ F +++H N +V+L +
Sbjct: 61 -LVRHKSSKQ---VYAMKLLSKFEMIKR----SDSAFFWEERDIMAHANSEWIVQL--HY 110
Query: 144 STEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKT--RLEIILGAAEGLAYLHEGLE 201
+ +D++ + +V EYMP L + L S W E++L L +H
Sbjct: 111 AFQDDKYL--YMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLA----LDAIHS--- 160
Query: 202 IQVIYRDFKTSNVLLDGNFKPKLSDFGLA-REGPTGDHTHVSTAVVGTYGYAAPEYIET- 259
+ I+RD K N+LLD + KL+DFG + G TA VGT Y +PE +++
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTA-VGTPDYISPEVLKSQ 218
Query: 260 ---GHLKSQSDIWSFGVVLYEILTG 281
G+ + D WS GV LYE+L G
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 8e-12
Identities = 69/223 (30%), Positives = 108/223 (48%), Gaps = 39/223 (17%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL----NNHGLQGHKQWLAEVQFLG 129
+ ++ KIGEG +G VYK R + +A+KK+ + G+ + E+ L
Sbjct: 4 YEKVEKIGEGTYGVVYKARDRVTNE-----TIALKKIRLEQEDEGVPSTA--IREISLLK 56
Query: 130 VVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRL-----FSRAQPTLPWKTRL 183
+ H N+V+L +E +RL LV+EY+ + L+ + F++ + KT L
Sbjct: 57 EMQHGNIVRLQDVVHSE-----KRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLI--KTYL 108
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD-GNFKPKLSDFGLAREG--PTGDHTH 240
IL G+AY H +V++RD K N+L+D KL+DFGLAR P TH
Sbjct: 109 YQIL---RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162
Query: 241 VSTAVVGTYGYAAPE-YIETGHLKSQSDIWSFGVVLYEILTGR 282
V T Y APE + + H + DIWS G + E++ +
Sbjct: 163 ----EVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 8e-12
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 23/220 (10%)
Query: 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKK--LNNHGLQGHKQWLAEVQFLG 129
+ + ++ KIG+G FG V+K + + +VA+KK + N L E++ L
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHK-KTKQ----IVALKKVLMENEKEGFPITALREIKILQ 66
Query: 130 VVSHPNLVKLLGYCSTEDERG----IQRLLVYEYMPNRSLED--RLFSRAQPTLPWKTRL 183
++ H N+V L+ C T+ LV+E+ + D L S
Sbjct: 67 LLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH----DLAGLLSNKNVKFTLSEIK 122
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR--EGPTGDHTHV 241
+++ GL Y+H ++++RD K +N+L+ + KL+DFGLAR +
Sbjct: 123 KVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNR 179
Query: 242 STAVVGTYGYAAPE-YIETGHLKSQSDIWSFGVVLYEILT 280
T V T Y PE + D+W G ++ E+ T
Sbjct: 180 YTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 9e-12
Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 13/167 (7%)
Query: 124 EVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRL 183
E L + HPN+V + + + G +V EY L ++ + P T L
Sbjct: 48 EAVLLAKMKHPNIV---AFKESFEADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTIL 103
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR--EGPTGDHTHV 241
+ + G+ ++HE +V++RD K+ N+ L N K KL DFG AR P
Sbjct: 104 QWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA----Y 156
Query: 242 STAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERN 288
+ VGT Y PE E ++SDIWS G +LYE+ T + + N
Sbjct: 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 9e-12
Identities = 74/302 (24%), Positives = 131/302 (43%), Gaps = 34/302 (11%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLD-GRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS 132
+ R KIG+G G+VY +D G+ VA++++N + + E+ +
Sbjct: 22 YTRFEKIGQGASGTVYTA----MDVATGQE--VAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 133 HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEG 192
+PN+V L DE + V EY+ SL D + + + + +
Sbjct: 76 NPNIVNYLDSYLVGDELWV----VMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQA 128
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA 252
L +LH QVI+RD K+ N+LL + KL+DFG + T + + S +VGT +
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRS-TMVGTPYWM 183
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSM 312
APE + + DIWS G++ E++ G P + + L + +G
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGE------PPYLNENPLRALYLIATNGT---- 233
Query: 313 MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSSSTTTA 372
P L+N ++A R + CL + E+R + ++++ L + + + A
Sbjct: 234 ---PELQNPEKLSAIFR--DFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAA 288
Query: 373 AK 374
AK
Sbjct: 289 AK 290
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 9e-12
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA---EVQFLGVVSHPNL 136
+G+G FG VY +D G L + + + K+ A E+Q L + H +
Sbjct: 10 LGQGAFGRVY--LCYDVD-TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
V+ G E+ + + EYMP S++D+L +A L + EG++YL
Sbjct: 67 VQYYGCLRDRAEKTLT--IFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEGMSYL 122
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST-AVVGTYGYAAPE 255
H + +++RD K +N+L D KL DFG ++ T + +V GT + +PE
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPE 179
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGR 282
I ++D+WS G + E+LT +
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 37/91 (40%), Positives = 48/91 (52%), Gaps = 4/91 (4%)
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGY 251
L YLH E V+YRD K N++LD + K++DFGL +EG T GT Y
Sbjct: 107 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEY 162
Query: 252 AAPEYIETGHLKSQSDIWSFGVVLYEILTGR 282
APE +E D W GVV+YE++ GR
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 72/242 (29%), Positives = 95/242 (39%), Gaps = 48/242 (19%)
Query: 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ---WLAEVQFL 128
+ F + IG G FG V+ G+ V A+K L + Q AE L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVR-DKDTGQ----VYAMKVLRKSDMIKRNQIAHVRAERDIL 55
Query: 129 GVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKT-RLEIIL 187
P +VKL Y S +DE + LV EYMP L L R P +T R I
Sbjct: 56 ADADSPWIVKL--YYSFQDEEHL--YLVMEYMPGGDLM-NLLIRKD-VFPEETARFYI-- 107
Query: 188 GAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA----------------- 230
AE + L ++ I+RD K N+L+D + KL+DFGL
Sbjct: 108 --AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSH 165
Query: 231 ----------REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEIL 279
R + + VGT Y APE + G D WS GV+LYE+L
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEML 224
Query: 280 TG 281
G
Sbjct: 225 YG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 38/216 (17%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN------HGLQGHKQWLAEVQFLGVVSH 133
+G G +G V + VA+KKL+ H K+ E++ L + H
Sbjct: 23 VGSGAYGQVCSAFDTKTGRK-----VAIKKLSRPFQSAIHA----KRTYRELRLLKHMDH 73
Query: 134 PNLVKLLG-YCSTEDERGIQRL-LVYEYMP---NRSLEDRLFSRAQPTLPWKTRLEIILG 188
N++ LL + Q + LV M N ++ + S ++
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-------LVYQ 126
Query: 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHT-HVSTAVVG 247
GL Y+H +I+RD K SN+ ++ + + K+ DFGLAR HT T V
Sbjct: 127 ILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR------HTDDEMTGYVA 177
Query: 248 TYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGR 282
T Y APE + H DIWS G ++ E+LTG+
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 49/159 (30%), Positives = 80/159 (50%), Gaps = 24/159 (15%)
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG-PTGDHTHVSTAVVGTYG 250
L YLHE +IYRD K NVLLD KL+D+G+ +EG GD T + GT
Sbjct: 108 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPN 161
Query: 251 YAAPEYIETGHLKSQSDIWSFGVVLYEILTGRR----VLERNRPTMEQKLLEWVKQFPAD 306
Y APE + D W+ GV+++E++ GR V + P +Q +++
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP--DQNTEDYL------ 213
Query: 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
F ++++ ++R S++ + A + + L K+P+ER
Sbjct: 214 ---FQVILEKQIRIPRSLSV--KAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 64/223 (28%), Positives = 99/223 (44%), Gaps = 18/223 (8%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK-QWLAEVQFLGVVSHPNLV 137
K+GEG + +VYKG R ++G+ +VA+K ++ +G + E L + H N+V
Sbjct: 12 KLGEGSYATVYKGISR-INGQ----LVALKVISMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
L T++ V+EYM + L + P+ RL + GLAY+H
Sbjct: 67 LLHDIIHTKE----TLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIH 120
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPE-Y 256
+++RD K N+L+ + KL+DFGLAR T+ S V T Y P+
Sbjct: 121 GQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVL 175
Query: 257 IETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW 299
+ S DIW G + E+L G+ EQ W
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 39/100 (39%), Positives = 59/100 (59%), Gaps = 11/100 (11%)
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST 243
EIIL L +LH+ + ++YRD K N+LLD L+DFGL++E + + +
Sbjct: 113 EIILA----LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS-EEKERTY 164
Query: 244 AVVGTYGYAAPEYI--ETGHLKSQSDIWSFGVVLYEILTG 281
+ GT Y APE I + GH K+ D WS G++++E+LTG
Sbjct: 165 SFCGTIEYMAPEIIRGKGGHGKA-VDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 26/159 (16%)
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG-PTGDHTHVSTAVVGTYG 250
L +LHE +IYRD K NVLLD + KL+D+G+ +EG GD T + GT
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPN 161
Query: 251 YAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLE--RNRPTM--EQKLLEWVKQFPAD 306
Y APE + D W+ GV+++E++ GR + + P M E L + + + P
Sbjct: 162 YIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI- 220
Query: 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
R+ S+ A+ + L K+P+ER
Sbjct: 221 ----------RIPRFLSVKASHVLKGF----LNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 3e-11
Identities = 81/296 (27%), Positives = 130/296 (43%), Gaps = 37/296 (12%)
Query: 67 LREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQ 126
LR+ F + +G G +G VYKG R + G+ + V + + KQ E+
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKG--RHVK-TGQLAAIKVMDVTGDEEEEIKQ---EIN 54
Query: 127 FLGVVSH-PNLVKLLGYCSTEDERGI--QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRL 183
L SH N+ G ++ G+ Q LV E+ S+ D + + TL +
Sbjct: 55 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 114
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHT-HVS 242
I GL++LH+ +VI+RD K NVLL N + KL DFG++ + D T
Sbjct: 115 YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ---LDRTVGRR 168
Query: 243 TAVVGTYGYAAPEYIETGH-----LKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL 297
+GT + APE I +SD+WS G+ E+ G L P + L
Sbjct: 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRAL 225
Query: 298 EWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
+ + PA PRL+++ +++ ++CL KN +RPT Q+++
Sbjct: 226 FLIPRNPA----------PRLKSK---KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN---HGLQGHKQWLAEVQFLGVVSHPNL 136
IG+G +G V + VA+KK+N+ H + L E++ L ++ HP++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEK-----VAIKKINDVFEHVSDATR-ILREIKLLRLLRHPDI 61
Query: 137 VKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEGL 193
V++ R + + +V+E M E L +A L + + L
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLRAL 116
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR----EGPTGDHTHVSTAVVGTY 249
Y+H V +RD K N+L + + K K+ DFGLAR + PT T V T
Sbjct: 117 KYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT---AIFWTDYVATR 170
Query: 250 GYAAPEYIETGHLKSQS--DIWSFGVVLYEILTGR 282
Y APE + K DIWS G + E+LTG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 87/319 (27%), Positives = 135/319 (42%), Gaps = 49/319 (15%)
Query: 51 LYKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL 110
LY ++ + ++ L + T+ + + IG+G +G VYK T + DG + AVK L
Sbjct: 1 LYGLFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKK-DGS----LAAVKIL 55
Query: 111 NNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDE-RGIQRLLVYEYMPNRSLEDR 168
+ ++ AE L + HPN+VK G D+ G Q LV E S+ +
Sbjct: 56 DPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTEL 114
Query: 169 ---LFSRAQPTLPWKTRLE------IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN 219
L Q RL+ I+ GA GL +LH ++I+RD K +N+LL
Sbjct: 115 VKGLLICGQ-------RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTE 164
Query: 220 FKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGH-----LKSQSDIWSFGVV 274
KL DFG++ + T +T+ VGT + APE I ++ D+WS G+
Sbjct: 165 GGVKLVDFGVSAQ-LTSTRLRRNTS-VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGIT 222
Query: 275 LYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLA 334
E+ G L P K L + + P P L + R
Sbjct: 223 AIELGDGDPPLFDMHPV---KTLFKIPRNPP----------PTLLHPE--KWCRSFNHFI 267
Query: 335 DNCLKKNPEERPTMNQVVE 353
CL K+ E RP++ ++E
Sbjct: 268 SQCLIKDFEARPSVTHLLE 286
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 36/92 (39%), Positives = 47/92 (51%), Gaps = 5/92 (5%)
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
A + YLH + +IYRD K N+LLD L+DFGL +EG + T ++ GT
Sbjct: 106 ASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTP 160
Query: 250 GYAAPEYIETGHLKSQSDIWSFGVVLYEILTG 281
Y APE + D W G VLYE+L G
Sbjct: 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 45/130 (34%), Positives = 64/130 (49%), Gaps = 9/130 (6%)
Query: 189 AAE---GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAV 245
AAE GL +LH +IYRD K NV+LD K++DFG+ +E T +
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTF 161
Query: 246 VGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLE-RNRPTMEQKLLEWVKQFP 304
GT Y APE I D W+FGV+LYE+L G+ E + + Q ++E +P
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP 221
Query: 305 ADGKKFSMMI 314
K ++ I
Sbjct: 222 KSMSKEAVAI 231
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 40/103 (38%), Positives = 59/103 (57%), Gaps = 20/103 (19%)
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA----REGPTGDHT 239
EIILG L ++H V+YRD K +N+LLD + ++SD GLA ++ P
Sbjct: 105 EIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----- 152
Query: 240 HVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTG 281
H S VGT+GY APE ++ G S +D +S G +L+++L G
Sbjct: 153 HAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 27/230 (11%)
Query: 61 VFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ 120
V +++L+ ++ + IG G FG V + + + V A+K L+ +
Sbjct: 32 VRKIRKLQMKAEDYDVVKVIGRGAFGEV-----QLVRHKSSQKVYAMKLLSKFEMIKRSD 86
Query: 121 ---WLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTL 177
+ E + + P +V+L +C+ +D++ + +V EYMP L + L S
Sbjct: 87 SAFFWEERDIMAFANSPWVVQL--FCAFQDDKYL--YMVMEYMPGGDLVN-LMSNYDVPE 141
Query: 178 PWKT--RLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPT 235
W E++L L +H + +I+RD K N+LLD + KL+DFG +
Sbjct: 142 KWAKFYTAEVVLA----LDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194
Query: 236 GDHTHVSTAVVGTYGYAAPEYIET----GHLKSQSDIWSFGVVLYEILTG 281
TA VGT Y +PE +++ G+ + D WS GV L+E+L G
Sbjct: 195 TGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 76 RMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK-QWLAEVQFLGVVSHP 134
++ K+GEG + +V+KG + + +VA+K++ +G + EV L + H
Sbjct: 10 KLEKLGEGTYATVFKGRSKLTEN-----LVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLA 194
N+V L T+ LV+EY+ ++ L+ + ++ + GLA
Sbjct: 65 NIVTLHDIVHTDK----SLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKI-FLYQILRGLA 118
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP 254
Y H +V++RD K N+L++ + KL+DFGLAR T+ + V T Y P
Sbjct: 119 YCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPP 173
Query: 255 E-YIETGHLKSQSDIWSFGVVLYEILTGR 282
+ + + +Q D+W G + +E+ +GR
Sbjct: 174 DVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-11
Identities = 64/224 (28%), Positives = 96/224 (42%), Gaps = 19/224 (8%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNL 136
+G+GGFG V +R G+ + A KKLN L +G++ + E + L V H
Sbjct: 1 LGKGGFGEVSACQMRA-TGK----LYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRF 54
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEGLA 194
+ L Y + LV M L +++ P P GL
Sbjct: 55 IVSLAYAF---QTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLE 111
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP 254
+LH+ ++IYRD K NVLLD + ++SD GLA E G + GT G+ AP
Sbjct: 112 HLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAP 166
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLE 298
E ++ D ++ GV LYE++ R +E K L+
Sbjct: 167 ELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 210
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 66/209 (31%), Positives = 88/209 (42%), Gaps = 26/209 (12%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQ-FLGVVSHPN 135
IG+G FG V + E AVK L + + K ++E L V HP
Sbjct: 3 IGKGSFGKVLLAR-----HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 57
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRL---EIILGAAEG 192
LV L T D + V +Y+ L L R + L + R EI A
Sbjct: 58 LVGLHFSFQTAD----KLYFVLDYINGGELFYHL-QRERCFLEPRARFYAAEI----ASA 108
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA 252
L YLH + ++YRD K N+LLD L+DFGL +E +H ++ GT Y
Sbjct: 109 LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI--EHNGTTSTFCGTPEYL 163
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILTG 281
APE + D W G VLYE+L G
Sbjct: 164 APEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 81/334 (24%), Positives = 123/334 (36%), Gaps = 80/334 (23%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL-----NNHGLQGHKQWLAEVQFLGVVSH 133
IG+GG G VY P+ R VA+KK+ N L K++L E + + H
Sbjct: 9 LIGKGGMGEVYLAY-DPVCSRR----VALKKIREDLSENPLL--KKRFLREAKIAADLIH 61
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMP---NRSLEDRLFS-RAQPTLP--------WKT 181
P +V + CS D VY MP +L+ L S + +L
Sbjct: 62 PGIVPVYSICSDGD-------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114
Query: 182 RLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKL-SDFGLA---------- 230
L I + Y+H V++RD K N+LL G F + D+G A
Sbjct: 115 FLSIFHKICATIEYVHSK---GVLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDL 170
Query: 231 ------REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRV 284
+ +VGT Y APE + +DI++ GV+LY++LT
Sbjct: 171 LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLS-- 228
Query: 285 LERNRPTMEQKLLEWVKQFPADGKKF-SMMIDPRLRNQYSINAARRV----AKLADNCLK 339
FP KK + + + + R + +++A L
Sbjct: 229 ------------------FPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALA 270
Query: 340 KNPEERPTMNQVVESLKLAVQESEQGSSSTTTAA 373
+P ER V+ LK ++ QGS T A
Sbjct: 271 VDPAER---YSSVQELKQDLEPHLQGSPEWTVKA 301
|
Length = 932 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 80 IGEGGFGSVY----KGTIRPLDGRGEPLVVAVKKLNN--HGLQGHKQWLAEVQFLGVVSH 133
+G G FG VY T R L + P ++ + + L+ E+Q L + H
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALE------CEIQLLKNLRH 63
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGL 193
+V+ G +E+ + + EYMP S++D+L +A L +G+
Sbjct: 64 DRIVQYYGCLRDPEEKKLS--IFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQGV 119
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS-TAVVGTYGYA 252
+YLH + +++RD K +N+L D KL DFG ++ T + +V GT +
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILT 280
+PE I ++D+WS + E+LT
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 49/139 (35%), Positives = 67/139 (48%), Gaps = 12/139 (8%)
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
AE L L + VIYRD K N+LLD L DFGL + D + GT
Sbjct: 100 AELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTP 157
Query: 250 GYAAPEYIETGHLKSQS-DIWSFGVVLYEILTG-RRVLERNRPTMEQKLLEWVKQFP--A 305
Y APE + GH +++ D W+ GV+LYE+LTG + N M +K+L+ +FP
Sbjct: 158 EYLAPELL-LGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGF 216
Query: 306 DGKKFSMMI-----DPRLR 319
D ++I DP R
Sbjct: 217 DRDAKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 57/222 (25%), Positives = 92/222 (41%), Gaps = 40/222 (18%)
Query: 124 EVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFS---RAQPTLPWK 180
E+ L +SH ++ L+ + V MP + LF+ R+ P LP +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKS-------TVCMVMPKYKCD--LFTYVDRSGP-LPLE 185
Query: 181 TRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTH 240
+ I E LAYLH +I+RD KT N+ LD L DFG A + H
Sbjct: 186 QAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACK--LDAHPD 240
Query: 241 VSTAV--VGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVL-ERNRPTMEQKLL 297
GT +PE + +++DIWS G+VL+E+ L + + +L
Sbjct: 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLR 300
Query: 298 EWVK-------QFPADG--------KKFSMMIDPRLRNQYSI 324
++ +FP +G K++++ LR Y+I
Sbjct: 301 SIIRCMQVHPLEFPQNGSTNLCKHFKQYAI----VLRPPYTI 338
|
Length = 392 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 38/97 (39%), Positives = 51/97 (52%), Gaps = 8/97 (8%)
Query: 189 AAE---GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAV 245
AAE GL +LH +IYRD K NV+LD K++DFG+ +E T +
Sbjct: 107 AAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTF 161
Query: 246 VGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR 282
GT Y APE I D W++GV+LYE+L G+
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 36/100 (36%), Positives = 53/100 (53%), Gaps = 12/100 (12%)
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST 243
E++L L +LH+ ++YRD K N+LLD L DFGL++ T + T +
Sbjct: 104 ELVLA----LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TN 154
Query: 244 AVVGTYGYAAPEYI--ETGHLKSQSDIWSFGVVLYEILTG 281
GT Y APE + E G+ K D WS GV+++E+ G
Sbjct: 155 TFCGTTEYLAPEVLLDEKGYTK-HVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 2e-10
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 24/220 (10%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
K+G G +G VYK + DG+ E A+K++ G+ E+ L + HPN++
Sbjct: 8 KVGRGTYGHVYKA--KRKDGKDEK-EYALKQIEGTGIS--MSACREIALLRELKHPNVIA 62
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPT------LPWKTRLEIILGAAEG 192
L + +R + L+++Y + F RA LP ++ +G
Sbjct: 63 LQKVFLSHSDRKV--WLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNF----KPKLSDFGLAR--EGPTGDHTHVSTAVV 246
+ YLH V++RD K +N+L+ G + K++D G AR P + VV
Sbjct: 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 247 GTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVL 285
T+ Y APE + H DIW+ G + E+LT +
Sbjct: 178 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 21/212 (9%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
+IG G FG V G + + P V VK+L + +Q ++L E Q + H NL+
Sbjct: 2 EIGNGWFGKVILGEV---NSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRLE-IILGAAEGLA 194
+ LG C+ LLV E+ P L+ L S +A+ P T L+ + A GL
Sbjct: 59 QCLGQCT----EVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLL 114
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP 254
+LH+ I+ D N LL + K+ D+GL+ D+ + + AP
Sbjct: 115 HLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAP 171
Query: 255 EYIETGH-------LKSQSDIWSFGVVLYEIL 279
E ++ H +S++WS GV ++E+
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 33/220 (15%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKL 139
+G G G V+ D R VAVKK+ Q K L E++ + + H N+VK+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKR-----VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV 67
Query: 140 ---LGYCSTEDERGIQRL-------LVYEYMPN---RSLEDRLFSRAQPTLPWKTRLEII 186
LG ++ + L +V EYM LE S L L
Sbjct: 68 YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLL--- 124
Query: 187 LGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG-NFKPKLSDFGLAR-EGPTGDHT-HVST 243
GL Y+H V++RD K +NV ++ + K+ DFGLAR P H ++S
Sbjct: 125 ----RGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 244 AVVGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGR 282
+V + Y +P + + D+W+ G + E+LTG+
Sbjct: 178 GLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK-QWLAEVQFLGVVSHPNLV 137
K+GEG + +V+KG + + +VA+K++ +G + EV L + H N+V
Sbjct: 12 KLGEGTYATVFKGRSKLTEN-----LVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
L TE R + LV+EY+ + L+ L + ++ + GL+Y H
Sbjct: 67 TLHDIIHTE--RCLT--LVFEYLDS-DLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCH 120
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPE-Y 256
+ ++++RD K N+L++ + KL+DFGLAR T+ + V T Y P+
Sbjct: 121 KR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVL 175
Query: 257 IETGHLKSQSDIWSFGVVLYEILTGR 282
+ + + D+W G +LYE+ TGR
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 70/243 (28%), Positives = 101/243 (41%), Gaps = 50/243 (20%)
Query: 61 VFDMQELR----EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN--HG 114
F QEL E + + +G G +GSV D + L VAVKKL+
Sbjct: 2 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAA----FDTK-TGLRVAVKKLSRPFQS 56
Query: 115 LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLED------- 167
+ K+ E++ L + H N++ LL + P RSLE+
Sbjct: 57 IIHAKRTYRELRLLKHMKHENVIGLLDV----------------FTPARSLEEFNDVYLV 100
Query: 168 -RLFSRAQPTLPWKTRLE------IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF 220
L + +L +I GL Y+H +I+RD K SN+ ++ +
Sbjct: 101 THLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157
Query: 221 KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPE-YIETGHLKSQSDIWSFGVVLYEIL 279
+ K+ DFGLAR T D T V T Y APE + H DIWS G ++ E+L
Sbjct: 158 ELKILDFGLARH--TDDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 212
Query: 280 TGR 282
TGR
Sbjct: 213 TGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 33/222 (14%)
Query: 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN--HGLQGHKQWLAEVQ 126
E TN + + +G G FG V + L G+ VA+KK+ K+ E++
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQ-LTGQN----VAIKKIMKPFSTPVLAKRTYRELK 61
Query: 127 FLGVVSHPNLVKL--LGYCSTEDERGIQRLL---VYEYMPNRSLEDRLFSRAQPTLPWKT 181
L + H N++ L + ED + LL ++ + +R LE + Q L
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQF---IQYFLYQIL 118
Query: 182 RLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHV 241
R GL Y+H V++RD K SN+L++ N K+ DFGLAR
Sbjct: 119 R---------GLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQ 161
Query: 242 STAVVGTYGYAAPEYIETGH-LKSQSDIWSFGVVLYEILTGR 282
T V T Y APE + T + DIWS G + E+L G+
Sbjct: 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 70/276 (25%), Positives = 120/276 (43%), Gaps = 32/276 (11%)
Query: 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLV 137
+KIGEG G V + GR VAVK ++ Q + EV + H N+V
Sbjct: 27 IKIGEGSTGIVCIAREKH-SGRQ----VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVV 81
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
++ +E + + E++ +L D + +Q L + + + L YLH
Sbjct: 82 EMYKSYLVGEELWV----LMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLH 134
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYI 257
VI+RD K+ ++LL + + KLSDFG + ++VGT + APE I
Sbjct: 135 SQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQ--ISKDVPKRKSLVGTPYWMAPEVI 189
Query: 258 ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPR 317
++ DIWS G+++ E++ G + P K L + P P+
Sbjct: 190 SRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL---RDSPP----------PK 236
Query: 318 LRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
L+N + I+ R + L + P+ER T ++++
Sbjct: 237 LKNAHKISPVLR--DFLERMLTREPQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 85/313 (27%), Positives = 124/313 (39%), Gaps = 74/313 (23%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN-----HGLQGHKQWLAEVQFLGVVSHP 134
IG G FG V R + + + A+KKL H + AE L +P
Sbjct: 9 IGRGAFGEV-----RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVR--AERDILAEADNP 61
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWK-TRLEIILGAAEGL 193
+VKL Y S +DE + L+ EY+P + L + T + TR I AE +
Sbjct: 62 WVVKL--YYSFQDENYL--YLIMEYLPGGDMMTLLMKK--DTFTEEETRFYI----AETI 111
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDH-THVST--------- 243
+ ++ I+RD K N+LLD KLSDFGL TG +H +
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLC----TGLKKSHRTEFYRILSHAL 167
Query: 244 ------------------------------AVVGTYGYAAPE-YIETGHLKSQSDIWSFG 272
+ VGT Y APE +++TG+ K D WS G
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLG 226
Query: 273 VVLYEILTGRRVLERNRPTME-QKLLEWVK--QFPADGKKFSMMIDPRLRNQYSINAARR 329
V++YE+L G + P +K++ W + QFP + D R A RR
Sbjct: 227 VIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKR--LCCEAERR 284
Query: 330 VAKLADNCLKKNP 342
+ N +K +P
Sbjct: 285 LGNNGVNEIKSHP 297
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 39/107 (36%), Positives = 61/107 (57%), Gaps = 12/107 (11%)
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST 243
EIILG L ++H V+YRD K +N+LLD + ++SD GLA + + H S
Sbjct: 105 EIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS- 155
Query: 244 AVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNR 289
VGT+GY APE ++ G S +D +S G +L+++L G +++
Sbjct: 156 --VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 8e-10
Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK-QWLAEVQFLGV 130
+ + ++ K+GEG + +VYKG + ++G+ +VA+K + +G + E L
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSK-VNGK----LVALKVIRLQEEEGTPFTAIREASLLKG 59
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA 190
+ H N+V L T++ LV+EY+ + L + P +L +
Sbjct: 60 LKHANIVLLHDIIHTKE----TLTLVFEYV-HTDLCQYMDKHPGGLHPENVKL-FLFQLL 113
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
GL+Y+H+ +++RD K N+L+ + KL+DFGLAR HT+ + V T
Sbjct: 114 RGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLW 168
Query: 251 YAAPE-YIETGHLKSQSDIWSFGVVLYEILTG 281
Y P+ + + + D+W G + E++ G
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 39/111 (35%), Positives = 60/111 (54%), Gaps = 17/111 (15%)
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR---EGPTGDHTHVSTAVVGT 248
GL Y+H V++RD K N+L++ + + K+ DFGLAR E P + + T V T
Sbjct: 117 GLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172
Query: 249 YGYAAPEYIETGHLKSQS-----DIWSFGVVLYEILTGRRVLERNRPTMEQ 294
Y APE + L QS D+WS G +L E+L GR+ + + + ++Q
Sbjct: 173 RWYRAPEIM----LSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQ 218
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 62/222 (27%), Positives = 94/222 (42%), Gaps = 42/222 (18%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN--HGLQGHKQWLAEVQFLGVVSHPNLV 137
IG G +G V + + VA+KK+ N K+ L E++ L + H N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEK-----VAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVI 67
Query: 138 KLLGYCSTEDERGIQRL-LVYEYM---------PNRSLED---RLFSRAQPTLPWKTRLE 184
+ + +VYE M +++L D + F L
Sbjct: 68 AIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYF------------LY 115
Query: 185 IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTA 244
+L GL Y+H V++RD K SN+LL+ N K+ DFGLAR T + T
Sbjct: 116 QLL---RGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTE 167
Query: 245 VVGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGRRVL 285
V T Y APE + + D+WS G + E+L GR+ L
Sbjct: 168 YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 64/230 (27%), Positives = 96/230 (41%), Gaps = 38/230 (16%)
Query: 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFL 128
F + I G +G+VY +R + R A+KK+N L +Q E L
Sbjct: 1 EDFETIKLISNGAYGAVY--LVRHKETRQR---FAMKKINKQNLILRNQIQQVFVERDIL 55
Query: 129 GVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKT-RL---E 184
+P +V + +CS E +R + +V EY+ L + LP R+ E
Sbjct: 56 TFAENPFVVSM--FCSFETKRHL--CMVMEYVEGGDCATLL--KNIGALPVDMARMYFAE 109
Query: 185 IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHV--- 241
+L L YLH +++RD K N+L+ KL+DFGL++ G T++
Sbjct: 110 TVLA----LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEG 162
Query: 242 ----------STAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTG 281
V GT Y APE I D W+ G++LYE L G
Sbjct: 163 HIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 85/318 (26%), Positives = 138/318 (43%), Gaps = 49/318 (15%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGR-GEPLVVAVKKLNNHGLQGH---KQWLAEVQFLG 129
+ + ++G G +GSV +D R GE VA+KKL+ Q K+ E+ L
Sbjct: 17 YTSLKQVGSGAYGSVCSA----IDKRTGEK--VAIKKLS-RPFQSEIFAKRAYRELTLLK 69
Query: 130 VVSHPNLVKLLG-YCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIIL 187
+ H N++ LL + S Q LV YM D P K + ++
Sbjct: 70 HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM----QTDLQKIMGHPLSEDKVQY-LVY 124
Query: 188 GAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVG 247
GL Y+H +I+RD K N+ ++ + + K+ DFGLAR T V
Sbjct: 125 QMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVV 176
Query: 248 TYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306
T Y APE I H DIWS G ++ E+LTG + L + + ++Q L + +K
Sbjct: 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG-KTLFKGKDYLDQ-LTQILKVTGVP 234
Query: 307 GKKFSMMID-----------PRL-RNQYSI---NAARRVAKLADNCLKKNPEERPTMNQV 351
G +F ++ P+ R +S A+ + L + L+ + ++R T +
Sbjct: 235 GPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA 294
Query: 352 VE-----SLKLAVQESEQ 364
+E S + A +E+EQ
Sbjct: 295 LEHPYFDSFRDADEETEQ 312
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 52/188 (27%), Positives = 80/188 (42%), Gaps = 5/188 (2%)
Query: 100 GEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKL---LGYCSTEDERGIQRL-L 155
GEP V V + + AEV L ++VK + + + L
Sbjct: 57 GEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIAL 116
Query: 156 VYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVL 215
V +Y L + SRA+ ++ E L + L +H +I+RD K++N+L
Sbjct: 117 VLDYANAGDLRQEIKSRAKTNRTFREH-EAGLLFIQVLLAVHHVHSKHMIHRDIKSANIL 175
Query: 216 LDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVL 275
L N KL DFG ++ V GT Y APE ++D++S GV+L
Sbjct: 176 LCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLL 235
Query: 276 YEILTGRR 283
YE+LT +R
Sbjct: 236 YELLTLKR 243
|
Length = 496 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
K+GEG + +VYKG + L G+ +VA+K++ H + E L + H N+V
Sbjct: 12 KLGEGSYATVYKGRSK-LTGQ----LVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV 66
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
L T+ LV+EY+ + L+ + RL + GLAY H
Sbjct: 67 TLHDIIHTKK----TLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRL-FLFQLLRGLAYCH 120
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP--- 254
+ +V++RD K N+L+ + KL+DFGLAR T+ S VV T Y P
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-SNEVV-TLWYRPPDVL 175
Query: 255 ----EYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ 294
EY + D+W G + YE+ TGR + + +Q
Sbjct: 176 LGSTEY------STSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 24/220 (10%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
K+G G +G VYK + DG+ + A+K++ G+ E+ L + HPN++
Sbjct: 8 KVGRGTYGHVYKAKRK--DGKDDR-DYALKQIEGTGIS--MSACREIALLRELKHPNVIS 62
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPT------LPWKTRLEIILGAAEG 192
L + +R + L+++Y + F RA LP ++ +G
Sbjct: 63 LQKVFLSHADRKV--WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNF----KPKLSDFGLAR--EGPTGDHTHVSTAVV 246
+ YLH V++RD K +N+L+ G + K++D G AR P + VV
Sbjct: 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 247 GTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVL 285
T+ Y APE + H DIW+ G + E+LT +
Sbjct: 178 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 4e-09
Identities = 59/237 (24%), Positives = 96/237 (40%), Gaps = 56/237 (23%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN----HGLQGHKQW----------LAEV 125
+GEG +G V K L G+ +VA+KK+ + + +Q L E+
Sbjct: 17 LGEGTYGKVEKA-YDTLTGK----IVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 126 QFLGVVSHPNLVKLLG-YCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE 184
+ + + H N++ L+ Y I LV + M S ++ R K RL
Sbjct: 72 KIMNEIKHENIMGLVDVYVE---GDFIN--LVMDIM--ASDLKKVVDR-------KIRLT 117
Query: 185 ------IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE------ 232
I+L GL LH+ ++RD +N+ ++ K++DFGLAR
Sbjct: 118 ESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPY 174
Query: 233 -GPTGDHTHVS-----TAVVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGR 282
+ T+ V T Y APE + + D+WS G + E+LTG+
Sbjct: 175 SDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 71/288 (24%), Positives = 123/288 (42%), Gaps = 28/288 (9%)
Query: 1 MKCFYIFKDKFKPKKGSNSAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHLR 60
MK + I +D ++ ++ A + + N+ L+ RS + E E +
Sbjct: 1 MKDWPIDEDINIYEEKNHKANKGGSGKFEMNDKKLDEEERSHNNNAG------EDEDEEK 54
Query: 61 VFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ 120
+ D R + IG G FG VY+ +D + VA+KK+ LQ +
Sbjct: 55 MIDNDINRSPNKSYKLGNIIGNGSFGVVYEAIC--IDTSEK---VAIKKV----LQDPQY 105
Query: 121 WLAEVQFLGVVSHPNLVKLLGYCSTE----DERGIQRLLVYEYMPNRSLE-DRLFSRAQP 175
E+ + ++H N++ L Y TE +E+ I +V E++P + + ++R
Sbjct: 106 KNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNH 165
Query: 176 TLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP-KLSDFGLAREGP 234
LP LAY+H + +RD K N+L+D N KL DFG A+
Sbjct: 166 ALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL 222
Query: 235 TGDHTHVSTAVVGTYGYAAPE-YIETGHLKSQSDIWSFGVVLYEILTG 281
G S + + + Y APE + + + D+WS G ++ E++ G
Sbjct: 223 AGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 77/290 (26%), Positives = 125/290 (43%), Gaps = 31/290 (10%)
Query: 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN--HGLQGHKQWLAEVQFLG 129
N F + +GEG +G V K + +VA+KK + + + L E++ L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKE-----IVAIKKFKDSEENEEVKETTLRELKMLR 55
Query: 130 VVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGA 189
+ N+V+L R + LV+EY+ LE L P K R I
Sbjct: 56 TLKQENIVEL----KEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKVR-SYIYQL 109
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
+ + + H+ +++RD K N+L+ N KL DFG AR G + + T V T
Sbjct: 110 IKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATR 165
Query: 250 GYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVL----ERNRPTMEQKLL-----EWV 300
Y +PE + D+WS G +L E+ G+ + E ++ QK+L E +
Sbjct: 166 WYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225
Query: 301 KQFPAD----GKKFSMMIDPR-LRNQYSINAARRVAKLADNCLKKNPEER 345
K F ++ G +F + P+ L +Y + + L N LK NP +R
Sbjct: 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDR 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 79/300 (26%), Positives = 125/300 (41%), Gaps = 37/300 (12%)
Query: 63 DMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWL 122
D+ LR+ F + +G G +G VYKG R + G+ +A K+ + ++
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKG--RHVK-TGQ---LAAIKVMDVTEDEEEEIK 60
Query: 123 AEVQFLGVVSH-PNLVKLLGYCSTEDERGI--QRLLVYEYMPNRSLEDRLFSRAQPTLPW 179
E+ L SH N+ G + G Q LV E+ S+ D + + L
Sbjct: 61 LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120
Query: 180 KTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHT 239
I GLA+LH +VI+RD K NVLL N + KL DFG++ + D T
Sbjct: 121 DWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ---LDRT 174
Query: 240 -HVSTAVVGTYGYAAPEYIETGH-----LKSQSDIWSFGVVLYEILTGRRVLERNRPTME 293
+GT + APE I +SDIWS G+ E+ G L P
Sbjct: 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP--- 231
Query: 294 QKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
+ L + + P P+L+++ +++ + CL KN RP+ Q+++
Sbjct: 232 MRALFLIPRNPP----------PKLKSK---KWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 70/254 (27%), Positives = 110/254 (43%), Gaps = 28/254 (11%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN-HGLQGH-KQWLAEVQFLGVV 131
+ + IG G G V LD VA+KKL+ Q H K+ E+ + V
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 132 SHPNLVKLLGYCSTED--ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGA 189
+H N++ LL + + E LV E M + L Q L + ++
Sbjct: 74 NHKNIISLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQM 128
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
G+ +LH +I+RD K SN+++ + K+ DFGLAR T + + T V T
Sbjct: 129 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTR 182
Query: 250 GYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW---VKQFPAD 306
Y APE I K DIWS G ++ E++ ++L R ++Q W ++Q
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVR-HKILFPGRDYIDQ----WNKVIEQLGTP 237
Query: 307 GKKFSMMIDPRLRN 320
+F + P +RN
Sbjct: 238 CPEFMKKLQPTVRN 251
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 5e-09
Identities = 52/168 (30%), Positives = 81/168 (48%), Gaps = 35/168 (20%)
Query: 205 IYRDFKTSNVLLDGNFKPKLSDFGLARE---GPTGDHTHVSTAVVGTYGYAAPEYIETGH 261
I+RD N+LL N K+ DFGLAR+ P D+ A + + APE I
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDP--DYVRKGDARL-PLKWMAPESIFDKV 251
Query: 262 LKSQSDIWSFGVVLYEILT-------GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMI 314
+QSD+WSFGV+L+EI + G ++ E E+ ++ K+ + M
Sbjct: 252 YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-----------EFCRRL----KEGTRMR 296
Query: 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362
P +Y A + + +C NPE+RPT +++VE L +QE+
Sbjct: 297 AP----EY---ATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQEN 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 77/288 (26%), Positives = 122/288 (42%), Gaps = 45/288 (15%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN-HGLQGHKQWLAEVQFLGVVS-HPNLV 137
IG+G +G V+K + +G AVK L+ H + ++ AE L +S HPN+V
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSK----AAVKILDPIHDID--EEIEAEYNILKALSDHPNVV 78
Query: 138 KLLG-YCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE------IILGAA 190
K G Y + + G Q LV E S+ D + L R+E I+ A
Sbjct: 79 KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDL----VKGFLKRGERMEEPIIAYILHEAL 134
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
GL +LH + I+RD K +N+LL KL DFG++ + + ++ VGT
Sbjct: 135 MGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPF 189
Query: 251 YAAPEYIETGH-----LKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305
+ APE I ++ D+WS G+ E+ G L P + L + + P
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM--RALFKIPRNPP- 246
Query: 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
P L + CL K+ E+RPT++ +++
Sbjct: 247 ----------PTLHQPELWSN--EFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 68/243 (27%), Positives = 107/243 (44%), Gaps = 40/243 (16%)
Query: 52 YKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSV----YKGTIRPLDGRGEPLVVAV 107
YK+ + +R +LR + + IG G FG V +K T + V A+
Sbjct: 28 YKDTINKIR-----DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK---------VYAM 73
Query: 108 KKLNNHGLQGHKQ---WLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRS 164
K L+ + + E + + P +V+L + + +D+R + +V EYMP
Sbjct: 74 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FYAFQDDRYL--YMVMEYMPGGD 129
Query: 165 LEDRLFSRAQPTLPWKT--RLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP 222
L + L S W E++L L +H + I+RD K N+LLD +
Sbjct: 130 LVN-LMSNYDVPEKWARFYTAEVVLA----LDAIHS---MGFIHRDVKPDNMLLDKSGHL 181
Query: 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET----GHLKSQSDIWSFGVVLYEI 278
KL+DFG + TA VGT Y +PE +++ G+ + D WS GV LYE+
Sbjct: 182 KLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
Query: 279 LTG 281
L G
Sbjct: 241 LVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-09
Identities = 53/215 (24%), Positives = 85/215 (39%), Gaps = 28/215 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
+IG G FG V I G VV VK+L N + ++L + ++ HPN++
Sbjct: 2 EIGNGWFGKVLLSEI--YTDTGVARVV-VKELKANASSKEQNEFLQQGDPYRILQHPNIL 58
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSL------EDRLFSRAQPTLPWKTRLEIILGAAE 191
+ LG C I LLV+EY L E +Q L + EI A
Sbjct: 59 QCLGQCV----EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI----AA 110
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGY 251
G+ ++H+ ++ D N L + K+ D+G+ D+ +
Sbjct: 111 GVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167
Query: 252 AAPEYIETGHLK-------SQSDIWSFGVVLYEIL 279
APE + H S++W+ GV L+E+
Sbjct: 168 LAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 6/97 (6%)
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
AE + +H ++ ++RD K NVLLD N +L+DFG + D T S+ VGT
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLK-MNQDGTVQSSVAVGTP 167
Query: 250 GYAAPEYIET-----GHLKSQSDIWSFGVVLYEILTG 281
Y +PE ++ G + D WS GV +YE+L G
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 56/186 (30%), Positives = 84/186 (45%), Gaps = 15/186 (8%)
Query: 105 VAVKKLNN-HGLQGH-KQWLAEVQFLGVVSHPNLVKLLGYCSTED--ERGIQRLLVYEYM 160
VAVKKL+ Q H K+ E+ L V+H N++ LL + + E LV E M
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108
Query: 161 PNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF 220
+ L L + ++ G+ +LH +I+RD K SN+++ +
Sbjct: 109 -----DANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 160
Query: 221 KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT 280
K+ DFGLAR T + T V T Y APE I K DIWS G ++ E++
Sbjct: 161 TLKILDFGLARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVK 217
Query: 281 GRRVLE 286
G + +
Sbjct: 218 GSVIFQ 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 46/134 (34%), Positives = 64/134 (47%), Gaps = 11/134 (8%)
Query: 155 LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNV 214
LV EY P L L +R + + + L AE + +H ++ ++RD K NV
Sbjct: 78 LVMEYQPGGDLLS-LLNRYEDQFD-EDMAQFYL--AELVLAIHSVHQMGYVHRDIKPENV 133
Query: 215 LLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET--GHLKS----QSDI 268
L+D KL+DFG A T + S VGT Y APE + T G K + D
Sbjct: 134 LIDRTGHIKLADFGSAAR-LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDW 192
Query: 269 WSFGVVLYEILTGR 282
WS GV+ YE++ GR
Sbjct: 193 WSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 22/171 (12%)
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
+GL Y+H +I+RD K N+ ++ + + K+ DFGLAR+ + T V T
Sbjct: 129 KGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRW 180
Query: 251 YAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL---------EWV 300
Y APE I H DIWS G ++ E+LTG+ + + + + + E+V
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV 240
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKK----NPEERPT 347
++ ++ K + PR R + + LA N L+K + E R T
Sbjct: 241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT 291
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 66/233 (28%), Positives = 100/233 (42%), Gaps = 32/233 (13%)
Query: 62 FDMQELR----EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN--HGL 115
F QEL E + + +G G +GSV L + VAVKKL+ L
Sbjct: 1 FYRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQK-----VAVKKLSRPFQSL 55
Query: 116 QGHKQWLAEVQFLGVVSHPNLVKLLGYC--STEDERGIQRLLVYEYMP---NRSLEDRLF 170
++ E++ L + H N++ LL +T E + LV M N ++ +
Sbjct: 56 IHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKL 115
Query: 171 SRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230
S +I GL Y+H +I+RD K SNV ++ + + ++ DFGLA
Sbjct: 116 SDEHVQF-------LIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA 165
Query: 231 REGPTGDHTHVSTAVVGTYGYAAPE-YIETGHLKSQSDIWSFGVVLYEILTGR 282
R+ D T V T Y APE + H DIWS G ++ E+L G+
Sbjct: 166 RQ--ADDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 32/86 (37%), Positives = 44/86 (51%), Gaps = 6/86 (6%)
Query: 201 EIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE-- 258
++ ++RD K NVLLD N +L+DFG D T S VGT Y +PE ++
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA-DGTVQSNVAVGTPDYISPEILQAM 178
Query: 259 ---TGHLKSQSDIWSFGVVLYEILTG 281
G + D WS GV +YE+L G
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 18/164 (10%)
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
A+G+++L I+RD N+LL K+ DFGLAR+ + V
Sbjct: 224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 250 GYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309
+ APE I +SD+WS+G++L+EI + + P M P D K
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS---LGSSPYPGM-----------PVDS-K 325
Query: 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
F MI R A + + +C +P +RPT Q+V+
Sbjct: 326 FYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 78/303 (25%), Positives = 117/303 (38%), Gaps = 88/303 (29%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-----NHGLQGHKQWLAEVQFL 128
F ++ IG G FG V +R +D + A+K L H + AE L
Sbjct: 3 FVKIKTIGIGAFGEVC--LVRKVDTN---ALYAMKTLRKADVLMRNQAAHVK--AERDIL 55
Query: 129 GVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILG 188
+ +VKL Y S +D+ + V +Y+P + L RL I
Sbjct: 56 AEADNEWVVKL--YYSFQDKDNL--YFVMDYIPGGDMMSLLI-----------RLGIF-- 98
Query: 189 AAEGLA--YLHE-GLEIQ------VIYRDFKTSNVLLDGNFKPKLSDFGL---------A 230
E LA Y+ E I+ I+RD K N+L+D + KL+DFGL +
Sbjct: 99 -EEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 231 REGPTGDHTHVST--------------------------------AVVGTYGYAAPEYIE 258
+ GDH + ++VGT Y APE +
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217
Query: 259 -TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ-KLLEWVK--QFPADGK---KFS 311
TG+ + D WS GV+LYE+L G+ + P Q K++ W P+ K + S
Sbjct: 218 RTGYTQL-CDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREAS 276
Query: 312 MMI 314
+I
Sbjct: 277 DLI 279
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGY 251
G+ +LH +I+RD K SN+++ + K+ DFGLAR G ++ VV Y Y
Sbjct: 130 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-Y 183
Query: 252 AAPEYIETGHLKSQSDIWSFGVVLYEILTGR 282
APE I K DIWS G ++ E++ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 7e-08
Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 32/158 (20%)
Query: 133 HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSL------EDRLFSRAQPTLPWKTRLEII 186
+PN +KL Y S +G +L+ +Y+ + L E +L + + II
Sbjct: 68 NPNFIKL--YYSVTTLKGH--VLIMDYIKDGDLFDLLKKEGKLSEA-------EVKK-II 115
Query: 187 LGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPK--LSDFGLAREGPTGDHTHVSTA 244
E L LH+ +I+ D K NVL D K + L D+GL + +
Sbjct: 116 RQLVEALNDLHK---HNIIHNDIKLENVLYDR-AKDRIYLCDYGLCK------IIGTPSC 165
Query: 245 VVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTG 281
GT Y +PE I+ GH S D W+ GV+ YE+LTG
Sbjct: 166 YDGTLDYFSPEKIK-GHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 62/222 (27%), Positives = 99/222 (44%), Gaps = 23/222 (10%)
Query: 105 VAVKKLNN-HGLQGH-KQWLAEVQFLGVVSHPNLVKLLGYCSTED--ERGIQRLLVYEYM 160
VA+KKL+ Q H K+ E+ + V+H N++ LL + + E +V E M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 161 PNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF 220
+ L Q L + ++ G+ +LH +I+RD K SN+++ +
Sbjct: 112 -----DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC 163
Query: 221 KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT 280
K+ DFGLAR T + + T V T Y APE I K DIWS G ++ E++
Sbjct: 164 TLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIK 220
Query: 281 GRRVLERNRPTMEQKLLEW---VKQFPADGKKFSMMIDPRLR 319
G VL ++Q W ++Q +F + P +R
Sbjct: 221 G-GVLFPGTDHIDQ----WNKVIEQLGTPCPEFMKKLQPTVR 257
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 9e-08
Identities = 52/170 (30%), Positives = 72/170 (42%), Gaps = 34/170 (20%)
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
A+G+ +L I+RD NVLL K+ DFGLAR D + S VV
Sbjct: 222 AQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVKGN 273
Query: 250 G-----YAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERN-RPTM--EQKLLEWVK 301
+ APE I QSD+WS+G++L+EI + L ++ P + K + VK
Sbjct: 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS----LGKSPYPGILVNSKFYKMVK 329
Query: 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQV 351
G + S D YSI C P ERPT +Q+
Sbjct: 330 ----RGYQMSRP-DFAPPEIYSIMKM---------CWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 30/86 (34%), Positives = 46/86 (53%), Gaps = 6/86 (6%)
Query: 201 EIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET- 259
++ ++RD K N+L+D N +L+DFG + D T S+ VGT Y +PE ++
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLK-LMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 260 ----GHLKSQSDIWSFGVVLYEILTG 281
G + D WS GV +YE+L G
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 49/178 (27%), Positives = 76/178 (42%), Gaps = 28/178 (15%)
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE-GPTGDHTHVSTAVVGT 248
A+G+ +L + I+RD N+LL N K+ DFGLAR+ D+ A +
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-P 244
Query: 249 YGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308
+ APE I QSD+WSFGV+L+EI + + P G
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------------------LGASPYPGV 285
Query: 309 KFSMMIDPRLRNQYSINA----ARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362
K RL+ + A + + +C P +RPT +++VE L +Q +
Sbjct: 286 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 343
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 67/223 (30%), Positives = 95/223 (42%), Gaps = 40/223 (17%)
Query: 124 EVQFLGVVSHPNLVKLLGYCSTEDER---GIQRLLV-------YEYMPNRSLEDRLFSRA 173
E + L +SHP ++ LL D R G+ L++ Y Y+ R R A
Sbjct: 210 EARLLRRLSHPAVLALL------DVRVVGGLTCLVLPKYRSDLYTYLGARL---RPLGLA 260
Query: 174 QPTLPWKTRLEIILGAAEGLAYLH-EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232
Q T + +L A + Y+H EG +I+RD KT NVL++G L DFG A
Sbjct: 261 QVTAVARQ----LLSAID---YIHGEG----IIHRDIKTENVLVNGPEDICLGDFGAACF 309
Query: 233 GPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYE-------ILTGRRVL 285
T + GT APE + DIWS G+V++E + + R
Sbjct: 310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGD 369
Query: 286 ERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAAR 328
ER RP Q +L ++Q +F RL +QY AAR
Sbjct: 370 ER-RPYDAQ-ILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAAR 410
|
Length = 461 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 60/241 (24%), Positives = 106/241 (43%), Gaps = 56/241 (23%)
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTL---PWKTRLEIIL 187
VSH ++V L G C R ++ ++V E++ L+ LF + + PWK ++ L
Sbjct: 61 VSHKHIVLLYGVCV----RDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQL 114
Query: 188 GAAEGLAYLHEGLEIQVIYRDFKTSNVLL-----DGNFKP--KLSDFG-----LAREGPT 235
+A L+YL + +++ + T N+LL DG P KLSD G L+R+
Sbjct: 115 ASA--LSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ--- 166
Query: 236 GDHTHVSTAVVGTYGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ 294
V + APE +E + +L +D WSFG L+EI + P ++
Sbjct: 167 --------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEI-----PLKDK 213
Query: 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354
L E + + M++ P + + +A L +C+ +P +RP ++
Sbjct: 214 TLAEKERFYEGQ----CMLVTP---------SCKELADLMTHCMNYDPNQRPFFRAIMRD 260
Query: 355 L 355
+
Sbjct: 261 I 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 73/293 (24%), Positives = 121/293 (41%), Gaps = 40/293 (13%)
Query: 68 REATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQF 127
R F + +IG G +G VYK R ++ GE + V KL + E+
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKA--RNVN-TGELAAIKVIKLEPG--EDFAVVQQEIIM 59
Query: 128 LGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIIL 187
+ H N+V G D+ I E+ SL+D ++ P + +I
Sbjct: 60 MKDCKHSNIVAYFGSYLRRDKLWIC----MEFCGGGSLQD-IYHVTGPL----SESQIAY 110
Query: 188 GAAE---GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTA 244
+ E GL YLH ++ +RD K +N+LL N KL+DFG++ + +
Sbjct: 111 VSRETLQGLYYLHSKGKM---HRDIKGANILLTDNGHVKLADFGVSAQ--ITATIAKRKS 165
Query: 245 VVGTYGYAAPEYI---ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK 301
+GT + APE G DIW+ G+ E+ E P + + +
Sbjct: 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELA------ELQPPMFDLHPMRAL- 218
Query: 302 QFPADGKKFSMMIDPRLRNQYS-INAARRVAKLADNCLKKNPEERPTMNQVVE 353
F F P+L+++ N+ K+A L KNP++RPT ++++
Sbjct: 219 -FLMTKSNFQ---PPKLKDKMKWSNSFHHFVKMA---LTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 78/295 (26%), Positives = 125/295 (42%), Gaps = 46/295 (15%)
Query: 68 REATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQF 127
R + + + ++G G +G VYK R L GE V + KL G L + +
Sbjct: 5 RNPQHDYELIQRVGSGTYGDVYKA--RNLH-TGELAAVKIIKLE----PGDDFSLIQQEI 57
Query: 128 LGV--VSHPNLVKLLG-YCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE 184
V H N+V G Y S E + + EY SL+D ++ P + L+
Sbjct: 58 FMVKECKHCNIVAYFGSYLSRE-----KLWICMEYCGGGSLQD-IYHVTGPL----SELQ 107
Query: 185 IILGAAE---GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHV 241
I E GLAYLH ++ +RD K +N+LL N KL+DFG+A +
Sbjct: 108 IAYVCRETLQGLAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164
Query: 242 STAVVGTYGYAAPEYI---ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLE 298
S +GT + APE + G DIW+ G+ E+ E P + +
Sbjct: 165 S--FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELA------ELQPPMFDLHPMR 216
Query: 299 WVKQFPADGKKFSMMIDPRLRNQYSINAA-RRVAKLADNCLKKNPEERPTMNQVV 352
+ F F P+L+++ ++ K++ L KNP++RPT +++
Sbjct: 217 AL--FLMSKSNFQ---PPKLKDKTKWSSTFHNFVKIS---LTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 9e-07
Identities = 43/160 (26%), Positives = 72/160 (45%), Gaps = 22/160 (13%)
Query: 135 NLVKLLGYCSTEDERGIQRLLVYE---YMPNRSLEDRLFS---------RAQPTLPWKTR 182
N + LG + E+ I+ +L E YM + + L+S + +P L +TR
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL-KQTR 270
Query: 183 LEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR--EGPTGDHTH 240
I+ + Y+H+ +I+RD K N+ L+ + K L DFG A E +
Sbjct: 271 -AIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326
Query: 241 VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT 280
VGT +PE + +DIWS G++L ++L+
Sbjct: 327 ---GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 70/294 (23%), Positives = 114/294 (38%), Gaps = 57/294 (19%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLV--VAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLV 137
+G+G F ++KG R + GE V +K L+ + + + +SH +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
G C DE ++V EY+ SL D + + + +LE+ A L +L
Sbjct: 63 LNYGVCVCGDES----IMVQEYVKFGSL-DTYLKKNKNLINISWKLEVAKQLAWALHFLE 117
Query: 198 EGLEIQVIYRDFKTSNVLL--DGNFKP------KLSDFG-----LAREGPTGDHTHVSTA 244
+ + + + NVLL + + K KLSD G L +E
Sbjct: 118 DK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE-----------I 163
Query: 245 VVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK-- 301
++ + PE IE +L +D WSFG L+EI +G L+ K
Sbjct: 164 LLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG--------GDKPLSALDSQKKL 215
Query: 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
QF D R+Q +A L + C+ P+ RP+ ++ L
Sbjct: 216 QFYED------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 46/165 (27%), Positives = 72/165 (43%), Gaps = 40/165 (24%)
Query: 205 IYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST-AVVGTYGYAAPEYIETGHLK 263
++RD NVLL K+ DFGLAR+ D +VS + + APE I
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARD-IMHDSNYVSKGSTFLPVKWMAPESIFDNLYT 317
Query: 264 SQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYS 323
+ SD+WS+G++L+EI + + P G M++D N+
Sbjct: 318 TLSDVWSYGILLWEIFS-------------------LGGTPYPG----MIVDSTFYNK-- 352
Query: 324 INAARRVAK----------LADNCLKKNPEERPT---MNQVVESL 355
I + R+AK + C PE+RP+ ++ +VESL
Sbjct: 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-06
Identities = 64/245 (26%), Positives = 100/245 (40%), Gaps = 52/245 (21%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWL---AEVQFLGV 130
F + IG G FG V R + + + A+K L + +Q AE L
Sbjct: 3 FESLKVIGRGAFGEV-----RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE 57
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA 190
+VK+ + S +D+R + L+ E++P + L + TL + A
Sbjct: 58 ADGAWVVKM--FYSFQDKRNL--YLIMEFLPGGDMMTLLMKK--DTL---SEEATQFYIA 108
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR---------------EGPT 235
E + + ++ I+RD K N+LLD KLSDFGL P
Sbjct: 109 ETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP 168
Query: 236 GDHT------------------HVSTAVVGTYGYAAPE-YIETGHLKSQSDIWSFGVVLY 276
D + ++ + VGT Y APE +++TG+ K D WS GV++Y
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK-LCDWWSLGVIMY 227
Query: 277 EILTG 281
E+L G
Sbjct: 228 EMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 59/288 (20%), Positives = 121/288 (42%), Gaps = 41/288 (14%)
Query: 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK----QWLAEVQFLGVVS 132
+ I E S+YKG + +++ + +GHK E++ L +
Sbjct: 25 SVLIKENDQNSIYKGIFN-----NKEVII---RTFKKFHKGHKVLIDITENEIKNLRRID 76
Query: 133 HPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAE 191
N++K+ G+ + + RL L+ EY L R + L +KT+L++ + +
Sbjct: 77 SNNILKIYGFI-IDIVDDLPRLSLILEYCTRGYL--REVLDKEKDLSFKTKLDMAIDCCK 133
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGY 251
GL L++ Y++ + + L+ N+K K+ GL + + +V+ V Y
Sbjct: 134 GLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV-----Y 186
Query: 252 AAPEYIET--GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309
+ + + + DI+S GVVL+EI TG+ E N T E
Sbjct: 187 FSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE-NLTTKE---------------I 230
Query: 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357
+ ++I+ + ++ + + + C + +RP + +++ +L L
Sbjct: 231 YDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278
|
Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 52/194 (26%), Positives = 84/194 (43%), Gaps = 34/194 (17%)
Query: 175 PTLPWKTRLEIILGAAEGLAYLH-EGLEIQV------------IYRDFKTSNVLLDGNFK 221
P+ P +TR + ++ + L+Y+ G QV ++RD NVL+
Sbjct: 218 PSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKL 277
Query: 222 PKLSDFGLAREGPTGDHTHVSTAVVGTY---GYAAPEYIETGHLKSQSDIWSFGVVLYEI 278
K+ DFGLAR+ D ++S T+ + APE I + SD+WSFG++L+EI
Sbjct: 278 VKICDFGLARD-IMRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
Query: 279 LTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCL 338
T P E QF K+ M P +A+ + ++ C
Sbjct: 335 FTLGGTPYPELPMNE--------QFYNAIKRGYRMAKP-------AHASDEIYEIMQKCW 379
Query: 339 KKNPEERPTMNQVV 352
++ E RP +Q+V
Sbjct: 380 EEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 40/155 (25%), Positives = 60/155 (38%), Gaps = 18/155 (11%)
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEII-LGAAEG 192
PN+V L Y +ED LV ++ L + E + AAE
Sbjct: 45 PNMVCLHKYIVSED----SVFLVLQHAEGGKLWSHISKFL------NIPEECVKRWAAEM 94
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE-GPTGDHTHVSTAVVGTYGY 251
+ L ++ RD +N+LLD +L+ F E + D V Y
Sbjct: 95 VVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------Y 148
Query: 252 AAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLE 286
APE D WS G +L+E+LTG+ ++E
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 40/162 (24%), Positives = 65/162 (40%), Gaps = 11/162 (6%)
Query: 124 EVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRL 183
E L ++HP++++L G + +P + + A+ + L
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNK-------FTCLILPRYKTDLYCYLAAKRNIAICDIL 185
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST 243
I + YLHE ++I+RD K N+ ++ L DFG A P + +
Sbjct: 186 AIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYY 241
Query: 244 AVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVL 285
GT APE + DIWS G+VL+E+ T L
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 67/303 (22%), Positives = 118/303 (38%), Gaps = 56/303 (18%)
Query: 71 TNGFNRMLKIGEGGFG----SVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQ 126
TN ++ L++ GG + + + G L V +K L+ +
Sbjct: 9 TNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETAS 68
Query: 127 FLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEII 186
+ VSH +L + G C RG + ++V E++ + L D + + +P ++ +
Sbjct: 69 LMSQVSHIHLAFVHGVCV----RGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAWKITVA 123
Query: 187 LGAAEGLAYLHEGLEIQVIYRDFKTSNVLL-----DGNFKP--KLSDFG-----LAREGP 234
A L+YL + +++ + N+LL P KLSD G L+RE
Sbjct: 124 QQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE-- 178
Query: 235 TGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEI-LTGRRVLERNRPTM 292
V + APE + G L + +D WSFG L EI G L+ P+
Sbjct: 179 ---------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229
Query: 293 EQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVV 352
+++ E + P +P + + +A L CL P +RP+ ++
Sbjct: 230 KERFYEKKHRLP----------EP---------SCKELATLISQCLTYEPTQRPSFRTIL 270
Query: 353 ESL 355
L
Sbjct: 271 RDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 36/115 (31%), Positives = 52/115 (45%), Gaps = 35/115 (30%)
Query: 201 EIQVIYRDFKTSNVLLDGNFKPKLSDFGLA------------------------------ 230
++ I+RD K N+LLD KLSDFGL
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 231 -REGPT--GDHTHVSTAVVGTYGYAAPE-YIETGHLKSQSDIWSFGVVLYEILTG 281
R+ T + ++ + VGT Y APE +++TG+ K D WS GV++YE+L G
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNK-LCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 68/302 (22%), Positives = 116/302 (38%), Gaps = 49/302 (16%)
Query: 14 KKGSNSAPEPRNQNRLDNNSALNRTA---------RSLPSPRSIPELY-----KEKEHHL 59
K+ +A + + A P P+ Y +E H
Sbjct: 57 KRDRETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPPPKKKKVTYALPNQSREEGHF 116
Query: 60 RVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK 119
V +++ +T F + +GEG FG V + R R E AVK + N + +
Sbjct: 117 YVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRK---RKE--YCAVKIVRNVP-KYTR 170
Query: 120 QWLAEVQFLGVVSHPN------LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRA 173
E+QF+ V + L+K+ Y ++E G +++ +Y P L D +
Sbjct: 171 DAKIEIQFMEKVRQADPADRFPLMKIQRY--FQNETGHMCIVMPKYGP--CLLDWIMKHG 226
Query: 174 QPTLPWKTR--LEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN-----------F 220
P+ R +II L Y H E+ +++ D K N+L++ +
Sbjct: 227 ----PFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRAL 280
Query: 221 KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT 280
P + G D H TA+V T Y +PE + +D+WS G ++YE+ T
Sbjct: 281 PPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYT 340
Query: 281 GR 282
G+
Sbjct: 341 GK 342
|
Length = 467 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 37/141 (26%), Positives = 55/141 (39%), Gaps = 46/141 (32%)
Query: 205 IYRDFKTSNVLLDGNFKPKLSDFGL---------AREGPTGDHTH--------------- 240
I+RD K N+L+D + KL+DFGL ++ +GDH
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 241 ---------------------VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEIL 279
++ ++VGT Y APE + D WS GV+LYE+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 280 TGRRVLERNRPTMEQ-KLLEW 299
G+ P Q K++ W
Sbjct: 243 VGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 64/277 (23%), Positives = 106/277 (38%), Gaps = 42/277 (15%)
Query: 104 VVAVKK--LNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMP 161
+VAVKK L++ + K E+ + HPN++ + D + +V M
Sbjct: 27 LVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-TSFIVDS---ELYVVSPLMA 82
Query: 162 NRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK 221
S ED L + LP I+ L Y+H I+R K S++LL G+ K
Sbjct: 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGK 139
Query: 222 PKLSDFGLA--------REGPTGDHTHVSTAVVGTYGYAAPEYIETGHL--KSQSDIWSF 271
LS + R+ D S + + +PE ++ +SDI+S
Sbjct: 140 VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP---WLSPEVLQQNLQGYNEKSDIYSV 196
Query: 272 GVVLYEILTGRRVLERNRPTMEQKLLEWVK----------QFPAD----GKKFSMMIDPR 317
G+ E+ G + T Q LLE V+ +P + S P
Sbjct: 197 GITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPN 254
Query: 318 LRNQYSINAARRVA----KLADNCLKKNPEERPTMNQ 350
R+ R + + + CL+++PE RP+ +Q
Sbjct: 255 NRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQ 291
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 7e-05
Identities = 46/201 (22%), Positives = 72/201 (35%), Gaps = 31/201 (15%)
Query: 164 SLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLE-IQVIYRDFKTSNVLLDGNFKP 222
SL D L R +P L E A + L ++ ++R K+ N+LL +
Sbjct: 2 SLADILEVRGRP-----------LNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLL 50
Query: 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR 282
KL + + APE I+ ++DI+S G+ LYE L
Sbjct: 51 KLDGSVAFKTPEQSR---PDPYFM------APEVIQGQSYTEKADIYSLGITLYEAL-DY 100
Query: 283 RVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLR-NQYSINAARRVAKLADNCLKKN 341
+ + L + PAD DPR R N ++AAR C +
Sbjct: 101 ELPYNEERELSAILEILLNGMPAD--------DPRDRSNLEGVSAARSFEDFMRLCASRL 152
Query: 342 PEERPTMNQVVESLKLAVQES 362
P+ R N + + E+
Sbjct: 153 PQRREAANHYLAHCRALFAET 173
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 57/222 (25%), Positives = 90/222 (40%), Gaps = 46/222 (20%)
Query: 185 IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD----FGLAREGPTG---- 236
I+ GA GL YLH+ I+R+ K S++L+ G+ LS + L R G
Sbjct: 106 ILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 237 DHTHVSTAVVGTYGYAAPEYI--ETGHLKSQSDIWSFGVVLYEILTGR-RVLERNRPTME 293
D ST+V+ + +PE + + +SDI+S G+ E+ TGR + R M
Sbjct: 163 DFPQFSTSVLP---WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML 219
Query: 294 QKLLEWVKQFPADGKKFS----------------------------MMIDPRLRNQYSIN 325
+ L+ P D F M RLR S
Sbjct: 220 LQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKT 279
Query: 326 AARRVAKLADNCLKKNPEERPTMNQVVESLKL-AVQESEQGS 366
+ L + CL+++PE+RP+ + ++ V+E QGS
Sbjct: 280 FSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQGS 321
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 40/151 (26%), Positives = 53/151 (35%), Gaps = 50/151 (33%)
Query: 205 IYRDFKTSNVLLDGNFKPKLSDFGLA---------------REGPT---GDHTHVSTAV- 245
I+RD K N+L+D KLSDFGL+ +G + S AV
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182
Query: 246 --------------------------VGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEI 278
VGT Y APE I Q D WS G +++E
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWSLGAIMFEC 241
Query: 279 LTG-RRVLERNRPTMEQKLLEWVK--QFPAD 306
L G N +K++ W + FP D
Sbjct: 242 LIGWPPFCSENSHETYRKIINWRETLYFPDD 272
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 36/141 (25%), Positives = 54/141 (38%), Gaps = 46/141 (32%)
Query: 205 IYRDFKTSNVLLDGNFKPKLSDFGL---------AREGPTGDHTH--------------- 240
I+RD K N+L+D + KL+DFGL ++ G H
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182
Query: 241 ---------------------VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEIL 279
++ ++VGT Y APE + D WS GV+L+E+L
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242
Query: 280 TGRRVLERNRPTMEQ-KLLEW 299
G+ PT Q K++ W
Sbjct: 243 VGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (96), Expect = 8e-04
Identities = 39/151 (25%), Positives = 69/151 (45%), Gaps = 25/151 (16%)
Query: 203 QVIYRDFKTSNVLLDG---------------NFKP--KLSDFGLAREGPTGDHTHVSTAV 245
+V++RD K N+ L N +P K+ DFGL++ H +
Sbjct: 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH---SC 201
Query: 246 VGTYGYAAPEYI--ETGHLKSQSDIWSFGVVLYEILTGRRVLER-NRPTMEQKLLEWVKQ 302
VGT Y +PE + ET +SD+W+ G ++YE+ +G+ + N + L+
Sbjct: 202 VGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPD 261
Query: 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKL 333
P GK S ++ ++N +++A R + L
Sbjct: 262 LPIKGK--SKELNILIKNLLNLSAKERPSAL 290
|
Length = 1021 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.001
Identities = 34/158 (21%), Positives = 58/158 (36%), Gaps = 24/158 (15%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV-SHPNLV 137
+ G VY L + E V+ K+N +G EV L ++ V
Sbjct: 5 LLKGGLTNRVYL-----LGTKDEDYVL---KINPSREKG-ADREREVAILQLLARKGLPV 55
Query: 138 -KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
K+L E L+ E++ +L++ + E + AE LA L
Sbjct: 56 PKVLAS----GESDGWSYLLMEWIEGETLDEV------SEEEKEDIAEQL---AELLAKL 102
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGP 234
H+ + + + D N+L+D + D+ A GP
Sbjct: 103 HQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 17/64 (26%), Positives = 23/64 (35%), Gaps = 12/64 (18%)
Query: 61 VFDMQELREATNGFNRML---------KIGEGGFGSVYKGT-IRPLDGRGEPLVVAVKKL 110
DM L F K+GEG FG VYK + + + V +KK
Sbjct: 112 FVDMFVLAPLEGLFRPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV--LKKA 169
Query: 111 NNHG 114
+G
Sbjct: 170 TEYG 173
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 393 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.58 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.44 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.4 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.31 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.31 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.3 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.26 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.26 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.19 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.04 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.01 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.99 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.98 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.97 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.89 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.69 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.65 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.5 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.5 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.45 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.44 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.43 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.42 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.39 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.37 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.32 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.18 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.11 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.08 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.91 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.89 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.86 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.83 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.82 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.73 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.62 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.5 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.45 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.34 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.33 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.26 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.18 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.18 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.17 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.13 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.12 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.12 | |
| PLN02236 | 344 | choline kinase | 97.03 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.92 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.7 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.27 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.96 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.8 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.55 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.33 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.98 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.95 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.75 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.42 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.99 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.94 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-54 Score=377.88 Aligned_cols=261 Identities=28% Similarity=0.416 Sum_probs=216.8
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++.+.++.||+|..|+||++.++.+ ++.+|+|++.-. .....+++.+|+++++.++|||||.+||.|..+..
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t-----~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~-- 151 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPT-----GKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE-- 151 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCC-----CeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc--
Confidence 3566778999999999999997644 457999999533 44567889999999999999999999999988874
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..+++||||++|+|++++.. .+.+++.....++.++++||.|||.. .+||||||||.||||+..|+|||||||.+
T Consensus 152 -~isI~mEYMDgGSLd~~~k~--~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 152 -EISICMEYMDGGSLDDILKR--VGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred -eEEeehhhcCCCCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEecccccc
Confidence 35999999999999999843 36799999999999999999999962 29999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCch---hhhHHHHHHhhcCcCC
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPT---MEQKLLEWVKQFPADG 307 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~---~~~~~~~~~~~~~~~~ 307 (393)
..+... ...+.+||..|||||.+.+..|+.++||||||++++|+.+|+.||....+. .-..+.......
T Consensus 227 ~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p---- 298 (364)
T KOG0581|consen 227 GILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP---- 298 (364)
T ss_pred HHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC----
Confidence 876544 567889999999999999999999999999999999999999999875221 111222211111
Q ss_pred cccccccCcccccccCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 308 KKFSMMIDPRLRNQYSI-NAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
....+. .+++++.+|+..||++||.+||+++++++|.|.......
T Consensus 299 -----------pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 299 -----------PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP 344 (364)
T ss_pred -----------CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence 111222 378999999999999999999999999999998765443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-53 Score=375.73 Aligned_cols=259 Identities=24% Similarity=0.362 Sum_probs=209.2
Q ss_pred HHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-------cHHHHHHHHHHhhcCCCCccceeee
Q 035862 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-------GHKQWLAEVQFLGVVSHPNLVKLLG 141 (393)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~ 141 (393)
...+.|.+.+.||+|+||.|-+|..+.+. +.||||++.+.... ......+|+++|+.++|||||++++
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tg-----k~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d 243 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTG-----KQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKD 243 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccC-----cEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEee
Confidence 34577999999999999999999966554 45999999864222 2233568999999999999999999
Q ss_pred eeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC--
Q 035862 142 YCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN-- 219 (393)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-- 219 (393)
+|..++. .|+||||++||+|.+++ ..++.+.+.....+++|++.|+.|||++ ||+||||||+|||++.+
T Consensus 244 ~f~~~ds----~YmVlE~v~GGeLfd~v--v~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e 314 (475)
T KOG0615|consen 244 FFEVPDS----SYMVLEYVEGGELFDKV--VANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAE 314 (475)
T ss_pred eeecCCc----eEEEEEEecCccHHHHH--HhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCc
Confidence 9999884 49999999999999999 4455678888899999999999999999 99999999999999776
Q ss_pred -CceEEeeccCCccCCCCCCccccccccccCCccCccccccCCC---CchhhHHHHHHHHHHHHhCCCccCCCCchh-hh
Q 035862 220 -FKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHL---KSQSDIWSFGVVLYEILTGRRVLERNRPTM-EQ 294 (393)
Q Consensus 220 -~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslGvil~elltg~~pf~~~~~~~-~~ 294 (393)
..+||+|||+|+..... ..+.+.|||+.|.|||++.+..+ ..++||||+||+||-+|+|.+||....... ..
T Consensus 315 ~~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~ 391 (475)
T KOG0615|consen 315 DCLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLK 391 (475)
T ss_pred ceEEEecccchhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHH
Confidence 67999999999976533 34567899999999999976543 347899999999999999999998654432 11
Q ss_pred HHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
..+... .+.+ ....-..++++..+||.+||..||++|||+.|+|+|.|.-
T Consensus 392 eQI~~G-~y~f-------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 392 EQILKG-RYAF-------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred HHHhcC-cccc-------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 111000 0100 1111225789999999999999999999999999999975
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-52 Score=369.03 Aligned_cols=254 Identities=28% Similarity=0.443 Sum_probs=208.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|...+.||.|+||+||+|+++.+. ..||||.+... .....+.+..|+.+|+.++|||||.+++++..++
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~-----~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~- 82 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSG-----TEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD- 82 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCC-----ceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-
Confidence 567999999999999999999987554 46999999876 3445566789999999999999999999999888
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC------Cce
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN------FKP 222 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~------~~~ 222 (393)
++|+|||||+||+|.+||.. .+.+++.+++.++.||+.||++||++ +||||||||.||||+.. -.+
T Consensus 83 ---~i~lVMEyC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~L 154 (429)
T KOG0595|consen 83 ---FIYLVMEYCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVL 154 (429)
T ss_pred ---eEEEEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceE
Confidence 67999999999999999954 45799999999999999999999999 99999999999999765 458
Q ss_pred EEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhh
Q 035862 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ 302 (393)
Q Consensus 223 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (393)
||+|||+|+.+.... .....+|++.|||||++..++|+.|+|+||+|+|+|++++|++||.......-....+..
T Consensus 155 KIADFGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~-- 229 (429)
T KOG0595|consen 155 KIADFGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKG-- 229 (429)
T ss_pred EecccchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcc--
Confidence 999999999876543 456789999999999999999999999999999999999999999866543322211111
Q ss_pred cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.......+...+..+.+++...|+.+|.+|-+..+...+..
T Consensus 230 -------------~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~ 270 (429)
T KOG0595|consen 230 -------------NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPF 270 (429)
T ss_pred -------------ccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhh
Confidence 11122223334455667888888888888888777766644
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-51 Score=378.08 Aligned_cols=291 Identities=52% Similarity=0.902 Sum_probs=245.6
Q ss_pred ccccccHHHHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccc
Q 035862 58 HLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLV 137 (393)
Q Consensus 58 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv 137 (393)
..+.|+..++..++++|.....||+|+||.||+|...+. ..||||.+.........+|.+|+.++.+++|||+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~------~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv 134 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG------TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLV 134 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC------CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcc
Confidence 567799999999999999999999999999999997543 46999988765433145599999999999999999
Q ss_pred eeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC
Q 035862 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD 217 (393)
Q Consensus 138 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~ 217 (393)
+++|||.+.+. .++|||||+.+|+|.++|+......++|..+.+|+.++|.||+|||..+...|+||||||.|||+|
T Consensus 135 ~LlGyC~e~~~---~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD 211 (361)
T KOG1187|consen 135 KLLGYCLEGGE---HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD 211 (361)
T ss_pred cEEEEEecCCc---eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence 99999998874 359999999999999999765543789999999999999999999998766899999999999999
Q ss_pred CCCceEEeeccCCccCCCCCCccccccc-cccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHH
Q 035862 218 GNFKPKLSDFGLAREGPTGDHTHVSTAV-VGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKL 296 (393)
Q Consensus 218 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~ 296 (393)
+++++||+|||+|+..+.. .. ..... .||.+|+|||++..+..+.|+|||||||++.||+||+.+.+...+..+..+
T Consensus 212 ~~~~aKlsDFGLa~~~~~~-~~-~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l 289 (361)
T KOG1187|consen 212 EDFNAKLSDFGLAKLGPEG-DT-SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSL 289 (361)
T ss_pred CCCCEEccCccCcccCCcc-cc-ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccH
Confidence 9999999999999765431 11 11122 899999999999999999999999999999999999998887665555557
Q ss_pred HHHHhhcCcCCcccccccCcccc-cccCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 297 LEWVKQFPADGKKFSMMIDPRLR-NQYSI-NAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
..|......++ .+.+++|+.+. ..+.. ..-..+..+...|++.+|.+||+|.++++.|..+..
T Consensus 290 ~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 290 VEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 77765554544 78888999876 66654 456678999999999999999999999998855543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-51 Score=380.26 Aligned_cols=252 Identities=27% Similarity=0.431 Sum_probs=213.8
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC---CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH---GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.+|...+.||+|||+.||.+++..+++ .||+|++.+. .......+.+|++|.++++|||||+++++|++.+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge-----~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~- 91 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGE-----VVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN- 91 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCc-----EEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC-
Confidence 359999999999999999999765554 5999999874 2234567889999999999999999999999888
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
+.|+|.|+|..++|.+++. ..+.+++.+++.+++||+.||.|||++ +|+|||||.+|+|++++.+|||+|||
T Consensus 92 ---nVYivLELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 92 ---NVYIVLELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred ---ceEEEEEecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence 5699999999999999985 456799999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+|......+. ...+.||||.|.|||++....++..+||||+||+||-||.|++||+...-... ...+...
T Consensus 164 LAt~le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vket------y~~Ik~~-- 233 (592)
T KOG0575|consen 164 LATQLEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKET------YNKIKLN-- 233 (592)
T ss_pred eeeeecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHH------HHHHHhc--
Confidence 9998765433 23568999999999999999999999999999999999999999985422111 1111110
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.-..|..++.++.+||.++|++||.+|||+++|+.|-+.
T Consensus 234 ----------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 234 ----------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred ----------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 011233567899999999999999999999999999877
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-52 Score=352.32 Aligned_cols=261 Identities=26% Similarity=0.368 Sum_probs=208.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.+|+++++||.|.||+||++....++ ..+|.|.++.... ........|+.+|++++|||||+++++...++..
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g-----~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDG-----KLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCc-----chhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 35888999999999999999876544 4699999985533 3345578999999999999999999954444332
Q ss_pred cceEEEEEeecCCCChHHHHh--hcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC-CeEeccCCCCCeEeCCCCceEEee
Q 035862 150 GIQRLLVYEYMPNRSLEDRLF--SRAQPTLPWKTRLEIILGAAEGLAYLHEGLEI-QVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~-~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
.+++|||+|.+|+|..++. ......+++..+|.++.|++.||..+|+..+. -|+||||||.||+++.+|.+||+|
T Consensus 94 --vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGD 171 (375)
T KOG0591|consen 94 --VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGD 171 (375)
T ss_pred --hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeecc
Confidence 3589999999999999884 34567899999999999999999999994221 399999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
||+++.+... .....+.+|||.||+||.+.+..|+.++||||+||++|||+...+||.+..-..- .....+.
T Consensus 172 fGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L---~~KI~qg--- 243 (375)
T KOG0591|consen 172 FGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSL---CKKIEQG--- 243 (375)
T ss_pred chhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHH---HHHHHcC---
Confidence 9999986543 3345678999999999999999999999999999999999999999987632111 1111111
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.........++.++..+|..|+..||+.||+...++..+..
T Consensus 244 ----------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 244 ----------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ----------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11111124678999999999999999999996665555543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-51 Score=350.50 Aligned_cols=267 Identities=26% Similarity=0.378 Sum_probs=210.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
+.|+.+.++|+|+||.||+++++. ++.+||||++..+.. ...+-.++|+++|++++|+|+|.++++|....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~-----TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkr-- 74 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKD-----TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKR-- 74 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCC-----cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcc--
Confidence 468899999999999999999654 456899999876543 23355789999999999999999999998777
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
.+++|+|||+. ++.+-|... ..+++...+..+++|++.|+.|+|++ +++||||||+||||+.+|.+||||||+
T Consensus 75 --klhLVFE~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGF 147 (396)
T KOG0593|consen 75 --KLHLVFEYCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGF 147 (396)
T ss_pred --eeEEEeeecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchh
Confidence 56999999977 444445433 34589999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHH-h------
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV-K------ 301 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~-~------ 301 (393)
|+.+..... ..+.++.|.||+|||++.+ .+|...+||||+||++.||++|.+.|++.++-.+.-.+... .
T Consensus 148 AR~L~~pgd--~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prh 225 (396)
T KOG0593|consen 148 ARTLSAPGD--NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRH 225 (396)
T ss_pred hHhhcCCcc--hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHH
Confidence 998764222 3467899999999999987 68999999999999999999999999887665443222211 1
Q ss_pred ------hcCcCCcccccccCcc-cccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 302 ------QFPADGKKFSMMIDPR-LRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 302 ------~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
...+.|-.+.+.-++. +...+ +..+.-+.+|+++||..||.+|++.++++.|.
T Consensus 226 q~iF~~N~~F~Gv~lP~~~~~epLe~k~-p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~ 285 (396)
T KOG0593|consen 226 QSIFSSNPFFHGVRLPEPEHPEPLERKY-PKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP 285 (396)
T ss_pred HHHhccCCceeeeecCCCCCccchhhhc-ccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence 1111112222211111 11112 24566789999999999999999999999985
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=366.79 Aligned_cols=262 Identities=34% Similarity=0.566 Sum_probs=215.4
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc--HHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--HKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
......||.|+||+||+|.++... .||+|.+....... ...+.+|+.+|+.++|||||+++|++.....
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~------~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~--- 113 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTD------VVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG--- 113 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCce------eEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC---
Confidence 344455999999999999987544 39999998653222 4589999999999999999999999988763
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-eEeccCCCCCeEeCCCC-ceEEeeccC
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQ-VIYRDFKTSNVLLDGNF-KPKLSDFGL 229 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~-ivH~Dikp~NIll~~~~-~~kl~Dfg~ 229 (393)
.+++||||+.+|+|.+++.......+++..++.++.||+.||.|||++ + ||||||||+|||++.++ ++||+|||+
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCcc
Confidence 358999999999999999765567899999999999999999999998 8 99999999999999998 999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccc--cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIE--TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
++...... ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||....+ .+ ......
T Consensus 191 sr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~-~~~~v~------- 259 (362)
T KOG0192|consen 191 SREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQ-VASAVV------- 259 (362)
T ss_pred ceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HH-HHHHHH-------
Confidence 98754332 2234478999999999999 56999999999999999999999999987655 11 111111
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCC
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQG 365 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 365 (393)
....+...+..++..+..++..||..||..||++.+++..|..+.......
T Consensus 260 -------~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 260 -------VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred -------hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 112233333446788999999999999999999999999999887755443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-50 Score=353.29 Aligned_cols=251 Identities=27% Similarity=0.388 Sum_probs=209.6
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc---cHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ---GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|+++++||+|+||+||.++.+ +.++.+|+|++++.... ..+....|..+|..++||.||+++-.|.+.+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~-----dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~- 98 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKK-----DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEE- 98 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEc-----ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCC-
Confidence 56999999999999999999865 45568999999876433 3456788999999999999999999888877
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
.+|+|+||+.||.|...| ..++.+++..++-++..|+.||.|||+. |||||||||+|||++.+|+++|+|||
T Consensus 99 ---kLylVld~~~GGeLf~hL--~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFg 170 (357)
T KOG0598|consen 99 ---KLYLVLDYLNGGELFYHL--QREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFG 170 (357)
T ss_pred ---eEEEEEeccCCccHHHHH--HhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccc
Confidence 679999999999999988 5567799999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+++.....+. ...+.+||+.|||||++.+..|+..+|.||||+++|||++|.+||...+.....+.+...+
T Consensus 171 L~k~~~~~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k------- 241 (357)
T KOG0598|consen 171 LCKEDLKDGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK------- 241 (357)
T ss_pred cchhcccCCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-------
Confidence 9986443322 3456899999999999999999999999999999999999999998765432221111000
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC----CHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP----TMNQVVESL 355 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp----s~~~~l~~l 355 (393)
....+...+.++.+++.++|..||++|. .+.++-+|.
T Consensus 242 ----------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~Hp 282 (357)
T KOG0598|consen 242 ----------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHP 282 (357)
T ss_pred ----------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCc
Confidence 1112223568899999999999999995 577777774
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=362.95 Aligned_cols=274 Identities=27% Similarity=0.382 Sum_probs=219.6
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHH-HHHHHHHHhhcCC-CCccceeeeeeecCC
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK-QWLAEVQFLGVVS-HPNLVKLLGYCSTED 147 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 147 (393)
..++|.++++||.|+||.||+|+...+. ..||||.+++......+ .-++|++.|++++ ||||+++.+++.+.+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~-----~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETG-----ELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCC-----ceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 3567999999999999999999965443 35999999876433222 2368999999999 999999999998877
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
. .+++|||||+ .+|.+++..+ ...+++..++.|+.||+.||+|+|.+ |++|||+||+|||+..+..+||+||
T Consensus 83 ~---~L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDF 154 (538)
T KOG0661|consen 83 R---ILYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADF 154 (538)
T ss_pred c---eEeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccc
Confidence 5 6799999994 5999999877 78899999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
|+|+...... ..+.++.|.||+|||++ ....|+.+.|||++|||++|+.+-++.|++.++..+...+..+..-|..
T Consensus 155 GLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~ 231 (538)
T KOG0661|consen 155 GLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDK 231 (538)
T ss_pred ccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcc
Confidence 9999765443 45788999999999977 5678999999999999999999999999988766554332222222222
Q ss_pred Cccc-------------ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 307 GKKF-------------SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 307 ~~~~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
.... .....-.+..-.+ .++.++.++|.+|+.+||.+|||++++++|......
T Consensus 232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred ccchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 1110 0111111111122 378899999999999999999999999999876554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=362.86 Aligned_cols=256 Identities=32% Similarity=0.499 Sum_probs=218.1
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceE
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 153 (393)
+..++.||+|.||.||.|.+....+ ||+|.+.... .....|.+|+++|+.++|+|||+++++|..++. +
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~------vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p----i 276 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTK------VAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP----I 276 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCc------ccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCc----e
Confidence 4567789999999999999986643 8999987753 345678899999999999999999999998773 4
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
+|||||+..|+|.++|.......+...+.+.++.|||+||+||+++ ++|||||.+.||||++++.+||+|||+|+..
T Consensus 277 yIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 277 YIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccccc
Confidence 9999999999999999876778899999999999999999999999 9999999999999999999999999999943
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSM 312 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (393)
. .+.........-+..|.|||.+....++.|||||||||+||||+| |+.||....... .-.
T Consensus 354 ~-d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-----------------v~~ 415 (468)
T KOG0197|consen 354 G-DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-----------------VLE 415 (468)
T ss_pred C-CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-----------------HHH
Confidence 3 333333344455668999999999999999999999999999999 777776543211 122
Q ss_pred ccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 313 MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
.++++.+.+.|..||+++.+++..||..+|++|||++.+...+..+...
T Consensus 416 ~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 416 LLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred HHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 3456677778888999999999999999999999999999999887653
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=328.14 Aligned_cols=271 Identities=25% Similarity=0.346 Sum_probs=214.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|...++||+|+||.||+|++..++ +.||||++.... ........+|++.|+.++|+||+.++++|...+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~-----~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-- 74 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETG-----KRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-- 74 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCC-----cEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC--
Confidence 46888899999999999999976544 459999987542 223456789999999999999999999998877
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
.+.+|+||++. +|+..+++.. ..++...+..++.++++|++|||++ .|+||||||+|+|++++|.+||+|||+
T Consensus 75 --~l~lVfEfm~t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGL 147 (318)
T KOG0659|consen 75 --NLSLVFEFMPT-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGL 147 (318)
T ss_pred --ceEEEEEeccc-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccc
Confidence 45899999965 9999886544 4588899999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC-
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG- 307 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~- 307 (393)
|+........ ....+-|.+|+|||++.| ..|+..+||||.|||+.||+.|.+.|.+.++-.+-..+-.....|...
T Consensus 148 Ar~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~ 225 (318)
T KOG0659|consen 148 ARFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQ 225 (318)
T ss_pred hhccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCccc
Confidence 9987665443 334488999999998866 689999999999999999999999998776654443333332222221
Q ss_pred -ccccccc--------CcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 308 -KKFSMMI--------DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 308 -~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.....+- ........-..++.++.+|+.+||.+||.+|+++.|+++|-+.-
T Consensus 226 WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~ 285 (318)
T KOG0659|consen 226 WPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFK 285 (318)
T ss_pred CccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhh
Confidence 1111111 11111112224567789999999999999999999999998765
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=354.52 Aligned_cols=273 Identities=27% Similarity=0.382 Sum_probs=218.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.+.|+.+.+||+|+||.||+|++..+ +.+||+|++.... ........+|+.||++++||||+++.+.......
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~t-----gkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLET-----GKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS 190 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeeccc-----CcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence 45688999999999999999996544 4579999997654 4455667899999999999999999999988744
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
. .+|||+|||+. +|..++.. ..-.+++.++..++.||+.||+|||.+ ||+|||||..|||||.+|.+||+|||
T Consensus 191 ~--siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFG 263 (560)
T KOG0600|consen 191 G--SIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFG 263 (560)
T ss_pred c--eEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEecccc
Confidence 4 56999999977 88887743 344689999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
+|++....... ..+..+-|.||+|||++.|. .|+.++|+||.||||.||++|+++|.+..+..+...+..+-..|.+.
T Consensus 264 LAr~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~ 342 (560)
T KOG0600|consen 264 LARFYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTED 342 (560)
T ss_pred ceeeccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChh
Confidence 99976544433 35678899999999999874 79999999999999999999999999887766555444333333222
Q ss_pred c-c---cc--cccCc------ccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 308 K-K---FS--MMIDP------RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 308 ~-~---~~--~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
. . +. ..+.+ .+++ .-...+....+|+..||..||.+|.|+.+++++-+.
T Consensus 343 ~W~~~kLP~~~~~kp~~~y~r~l~E-~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 343 YWPVSKLPHATIFKPQQPYKRRLRE-TFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred ccccccCCcccccCCCCcccchHHH-HhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 1 1 00 00100 0111 112456788999999999999999999999998665
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=347.68 Aligned_cols=264 Identities=30% Similarity=0.441 Sum_probs=210.3
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccce
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQ 152 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 152 (393)
++...+.||+|+||+||++.+..+ +...|+|.+........+.+.+|+.+|++++|||||+++|....... ..
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~-----g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~--~~ 90 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKT-----GELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN--DE 90 (313)
T ss_pred hhhhhccccCccceEEEEEEecCC-----CcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC--ee
Confidence 477788999999999999997643 34599999876533335668899999999999999999997544443 35
Q ss_pred EEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC-CCceEEeeccCCc
Q 035862 153 RLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG-NFKPKLSDFGLAR 231 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~ 231 (393)
++++|||+.+|+|.+++..... .+++..++.+.+|+++||.|||++ |+||+||||+|||++. ++.+||+|||++.
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~ 166 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAK 166 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccc
Confidence 6899999999999999976555 799999999999999999999999 9999999999999999 7999999999998
Q ss_pred cCCC-CCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 232 EGPT-GDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 232 ~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
.... ...........||+.|||||++..+ ....++|||||||++.||+||++||.......+..+ ....
T Consensus 167 ~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~-~ig~-------- 237 (313)
T KOG0198|consen 167 KLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALL-LIGR-------- 237 (313)
T ss_pred ccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHH-HHhc--------
Confidence 6553 1111223457899999999999853 334599999999999999999999986411111111 1110
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
....+..+..++.++.+|+.+|+..||++|||+.++++|++......
T Consensus 238 ------~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 238 ------EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred ------cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 01112445567899999999999999999999999999998876544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=356.18 Aligned_cols=249 Identities=32% Similarity=0.469 Sum_probs=213.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|.+.+.||+|+||.||+|+ .+++..+||+|.+.+... ...+.+.+|++|++.++||||+.++++|....
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgr-----rK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~-- 74 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGR-----RKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSA-- 74 (808)
T ss_pred cchhHHHHhcCCccceeeecc-----cccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccc--
Confidence 468888999999999999998 455667899999987643 34566889999999999999999999998887
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
++++|.||+.| +|..+| ...+.++++.+..++.+++.||.|||++ +|.|||+||.|||++.+|.+|+||||+
T Consensus 75 --~~~vVte~a~g-~L~~il--~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 75 --HLWVVTEYAVG-DLFTIL--EQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGL 146 (808)
T ss_pred --eEEEEehhhhh-hHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhh
Confidence 66999999977 999999 5566799999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
|+.... .....+...|||.|||||++.++.|+..+|+||||||+||+++|++||...+ +.+..+.+..+.
T Consensus 147 Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d~-- 216 (808)
T KOG0597|consen 147 ARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKDP-- 216 (808)
T ss_pred hhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcCC--
Confidence 997543 3445677899999999999999999999999999999999999999997432 222222221111
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
..++..++..+.+|++.+|.+||.+|.++.+++.|.
T Consensus 217 ----------v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 217 ----------VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred ----------CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 112346789999999999999999999999999996
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=354.18 Aligned_cols=256 Identities=25% Similarity=0.389 Sum_probs=212.3
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC----Cc-ccHHHHHHHHHHhhcCC-CCccceeeeee
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH----GL-QGHKQWLAEVQFLGVVS-HPNLVKLLGYC 143 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 143 (393)
..++|.+.+.||+|+||+|+.|.+..++ ..||+|++.+. .. .....+.+|+.+++.+. ||||+++++++
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~-----~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~ 89 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTG-----EKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVF 89 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCC-----CeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEE
Confidence 3568999999999999999999976555 45999987664 11 23445668999999999 99999999999
Q ss_pred ecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC-Cce
Q 035862 144 STEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN-FKP 222 (393)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~ 222 (393)
.... ..++||||+.||+|.+++.+ .+.+.+..+..+++||+.|++|||+. ||+||||||+|||++.+ +++
T Consensus 90 ~t~~----~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~ 160 (370)
T KOG0583|consen 90 ATPT----KIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNL 160 (370)
T ss_pred ecCC----eEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCE
Confidence 9888 45999999999999999965 56789999999999999999999999 99999999999999999 999
Q ss_pred EEeeccCCccCCCCCCccccccccccCCccCccccccCC-CC-chhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHH
Q 035862 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGH-LK-SQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300 (393)
Q Consensus 223 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~ 300 (393)
||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+......... .
T Consensus 161 Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k---i 235 (370)
T KOG0583|consen 161 KLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK---I 235 (370)
T ss_pred EEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH---H
Confidence 999999998763 1222456789999999999999877 86 689999999999999999999987432211111 1
Q ss_pred hhcCcCCcccccccCcccccccCHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 301 KQFPADGKKFSMMIDPRLRNQYSINA-ARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
. .. .-.++..+ +.++..|+.+||..||.+|+++.+++.|.|...
T Consensus 236 ~---~~------------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 236 R---KG------------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred h---cC------------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 0 00 01122233 788999999999999999999999999999886
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=352.32 Aligned_cols=258 Identities=25% Similarity=0.371 Sum_probs=215.0
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc---HHHHHHHHHHhhcCCCCccceeeeeeecC
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG---HKQWLAEVQFLGVVSHPNLVKLLGYCSTE 146 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 146 (393)
..++|+.+..||+|+||.||+|+-+. ++.++|+|++++..... ...++.|-.+|....+|+||+++..|.+.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~-----Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKD-----TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEcc-----CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence 35789999999999999999999554 45579999999875443 34567899999999999999999999888
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
+ ++||||||++||++..+| .....+++..++.++.+++.|++.||+. |+|||||||+|+|||..|++||+|
T Consensus 214 ~----~LYLiMEylPGGD~mTLL--~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSD 284 (550)
T KOG0605|consen 214 E----YLYLIMEYLPGGDMMTLL--MRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSD 284 (550)
T ss_pred C----eeEEEEEecCCccHHHHH--HhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeecc
Confidence 7 779999999999999999 5567899999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCC----------------------CCCc-----------------------cccccccccCCccCccccccCC
Q 035862 227 FGLAREGPT----------------------GDHT-----------------------HVSTAVVGTYGYAAPEYIETGH 261 (393)
Q Consensus 227 fg~a~~~~~----------------------~~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~ 261 (393)
||++..... .+.. ....+.+|||.|+|||++.+..
T Consensus 285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg 364 (550)
T KOG0605|consen 285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG 364 (550)
T ss_pred ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence 999853211 0000 0112569999999999999999
Q ss_pred CCchhhHHHHHHHHHHHHhCCCccCCCCchhh-hHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhccc
Q 035862 262 LKSQSDIWSFGVVLYEILTGRRVLERNRPTME-QKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKK 340 (393)
Q Consensus 262 ~~~~~DiwslGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 340 (393)
|+..+|+||||||+||||.|.+||....+... ..+..|...+.+... ..++.++.+||.+||+
T Consensus 365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~---------------~~~s~eA~DLI~rll~- 428 (550)
T KOG0605|consen 365 YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE---------------VDLSDEAKDLITRLLC- 428 (550)
T ss_pred CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc---------------CcccHHHHHHHHHHhc-
Confidence 99999999999999999999999988776543 455566544433221 1245889999999999
Q ss_pred CCCCCC---CHHHHHHHHHH
Q 035862 341 NPEERP---TMNQVVESLKL 357 (393)
Q Consensus 341 dp~~Rp---s~~~~l~~l~~ 357 (393)
||++|. +++||-+|++.
T Consensus 429 d~~~RLG~~G~~EIK~HPfF 448 (550)
T KOG0605|consen 429 DPENRLGSKGAEEIKKHPFF 448 (550)
T ss_pred CHHHhcCcccHHHHhcCCcc
Confidence 999997 48999998764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-48 Score=355.39 Aligned_cols=258 Identities=25% Similarity=0.398 Sum_probs=218.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
...|....+||+|+.|.||.|....+. ..||+|.+........+-+++|+.+|+..+|+|||.+++.|...+
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~-----~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~d--- 343 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTK-----QEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGD--- 343 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCC-----ceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccc---
Confidence 457888899999999999999865444 459999998877666777899999999999999999999988876
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
.++.||||++||+|.+.+. ...+++.++..+++.++.||+|||.+ ||+|||||.+|||++.+|.+||+|||++
T Consensus 344 -eLWVVMEym~ggsLTDvVt---~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFc 416 (550)
T KOG0578|consen 344 -ELWVVMEYMEGGSLTDVVT---KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFC 416 (550)
T ss_pred -eeEEEEeecCCCchhhhhh---cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeee
Confidence 5699999999999999883 34489999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ .....+|||.|||||++....|+.++||||||++++||+-|.+||-...+.....++. .++
T Consensus 417 aqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa------~ng--- 485 (550)
T KOG0578|consen 417 AQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TNG--- 485 (550)
T ss_pred eccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh------hcC---
Confidence 87655433 4567899999999999999999999999999999999999999998655433222221 111
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
......+..++..+.+|+.+||+.|+++|+++.++|+|.....+
T Consensus 486 ------~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 486 ------TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred ------CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 11223344678999999999999999999999999999877443
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-48 Score=352.47 Aligned_cols=255 Identities=24% Similarity=0.362 Sum_probs=211.6
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc---cHHHHHHHHHHhhcC-CCCccceeeeeeec
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ---GHKQWLAEVQFLGVV-SHPNLVKLLGYCST 145 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 145 (393)
.-++|.+++.||+|+|++|++|+.+.++ +.||||++.+.... ..+.+..|-.+|.+| .||.|++|+-.|.+
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~-----keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD 145 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATG-----KEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD 145 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCC-----ceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec
Confidence 3568999999999999999999976544 46999999875332 233456788899999 69999999988887
Q ss_pred CCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 146 EDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
+. .+|+|+||+++|+|.++| .+.+.+++..++.++.+|+.||+|||++ |||||||||+|||++.||+++|+
T Consensus 146 ~~----sLYFvLe~A~nGdll~~i--~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikIT 216 (604)
T KOG0592|consen 146 EE----SLYFVLEYAPNGDLLDLI--KKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKIT 216 (604)
T ss_pred cc----ceEEEEEecCCCcHHHHH--HHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEe
Confidence 77 569999999999999999 4557899999999999999999999999 99999999999999999999999
Q ss_pred eccCCccCCCCCCc---------c--ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhh
Q 035862 226 DFGLAREGPTGDHT---------H--VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ 294 (393)
Q Consensus 226 Dfg~a~~~~~~~~~---------~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~ 294 (393)
|||.|..+...... . ....++||..|.+||++.....+..+|||+||||+|+|+.|.+||...++-...
T Consensus 217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF 296 (604)
T KOG0592|consen 217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF 296 (604)
T ss_pred eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH
Confidence 99999876543222 1 125689999999999999999999999999999999999999999876554332
Q ss_pred HHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
..+..+ .-.++.+.++.+.+|++++|..||.+|+++.+|.+|+.
T Consensus 297 qkI~~l------------------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 297 QKIQAL------------------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPF 340 (604)
T ss_pred HHHHHh------------------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcc
Confidence 221111 11123345588999999999999999999999999853
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-47 Score=328.24 Aligned_cols=274 Identities=24% Similarity=0.314 Sum_probs=218.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
+.|+.++.|++|+||.||+|++..+ +.+||+|+++-.. ....-..++|+.+|.+++|||||.+-.+....+-.
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t-----~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKT-----DEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCc-----ceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 4589999999999999999996544 4579999987543 22334567999999999999999999998876655
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..|+|||||+. +|..++.... .++...++..++.|+++|++|||.+ .|+||||||+|+|++..|.+||+|||+
T Consensus 151 --~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGL 223 (419)
T KOG0663|consen 151 --KIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGL 223 (419)
T ss_pred --eeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccch
Confidence 46999999976 9999986655 4688999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
|+..... ....+..+-|.+|+|||++.+ ..|+..+|+||+|||+.||+++++.|.+.++-.+.+.+......|.+..
T Consensus 224 AR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i 301 (419)
T KOG0663|consen 224 AREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI 301 (419)
T ss_pred hhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence 9987654 234567789999999999877 5799999999999999999999999998877655544443333333210
Q ss_pred -----ccc--------cccCcccccccCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 309 -----KFS--------MMIDPRLRNQYSIN-AARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 309 -----~~~--------~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.+. ...-..++..+... .++...+|+..+|.+||.+|.|+.+.|+|-|..-
T Consensus 302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 000 00001111112111 5688899999999999999999999999987764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=335.46 Aligned_cols=266 Identities=25% Similarity=0.359 Sum_probs=214.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-cHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+.|++...||.|..++||+|+....+. +||||++.-+... ..+.+.+|+..++.++||||++++..|..+.
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e-----~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~--- 97 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNE-----VVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS--- 97 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCC-----EEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc---
Confidence 569999999999999999999876554 6999999865433 3577899999999999999999999999887
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
.+++||.||.+|++.+.+...-...+++..+..|++++++||.|||++ |.||||||+.||||+++|.|||+|||.+
T Consensus 98 -~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvs 173 (516)
T KOG0582|consen 98 -ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVS 173 (516)
T ss_pred -eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceee
Confidence 569999999999999999877777899999999999999999999999 9999999999999999999999999988
Q ss_pred ccCCCCCCc-ccc-ccccccCCccCccccc--cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 231 REGPTGDHT-HVS-TAVVGTYGYAAPEYIE--TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 231 ~~~~~~~~~-~~~-~~~~gt~~y~aPE~~~--~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
..+...+.. ... ...+||+.|||||++. ...|+.|+||||||++..||.+|..||....+.. -+...+.+.|..
T Consensus 174 a~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl~tLqn~pp~ 251 (516)
T KOG0582|consen 174 ASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLLLTLQNDPPT 251 (516)
T ss_pred eeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHHHHhcCCCCC
Confidence 765443322 122 5679999999999953 3579999999999999999999999998664421 111112111110
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.. . ..+........+..+..++..||.+||.+|||++++++|-+.
T Consensus 252 ~~--t----~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FF 296 (516)
T KOG0582|consen 252 LL--T----SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFF 296 (516)
T ss_pred cc--c----ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHH
Confidence 00 0 011111122355689999999999999999999999998664
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=351.28 Aligned_cols=269 Identities=28% Similarity=0.428 Sum_probs=210.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcC-CCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||.||+|.+...........||+|++..... .....+.+|+.++..+ +||||+++++++...+.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 357999999999999999999875444445566799999875432 2345688999999999 79999999998875443
Q ss_pred ccceEEEEEeecCCCChHHHHhhcC-------------------------------------------------------
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRA------------------------------------------------------- 173 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------- 173 (393)
..++||||+++|+|.+++....
T Consensus 86 ---~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 86 ---PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred ---ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4589999999999999986421
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCcccccccccc
Q 035862 174 -----QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT 248 (393)
Q Consensus 174 -----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 248 (393)
...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...............++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 12477788899999999999999998 9999999999999999999999999999764332222222334566
Q ss_pred CCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHH
Q 035862 249 YGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAA 327 (393)
Q Consensus 249 ~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (393)
..|+|||++.+..++.++|||||||++|||++ |..||........ +...... +. ....+..++
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~~~~~----~~----------~~~~~~~~~ 303 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQRLKD----GT----------RMRAPENAT 303 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHHHHhc----CC----------CCCCCCCCC
Confidence 78999999999999999999999999999997 9999976443211 1111110 00 001122345
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 328 RRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 328 ~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
.++.+++.+||+.||.+|||+.++++.|+.++++
T Consensus 304 ~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 304 PEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 7899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=343.28 Aligned_cols=278 Identities=26% Similarity=0.375 Sum_probs=215.6
Q ss_pred ccHHHHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc--------------cHHHHHHHHHH
Q 035862 62 FDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ--------------GHKQWLAEVQF 127 (393)
Q Consensus 62 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~E~~~ 127 (393)
++..+-....|+|+++..||+|.||.|-+|++. ..+..||+|++.+.... ..+...+|+.+
T Consensus 87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~-----~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIai 161 (576)
T KOG0585|consen 87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDE-----VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAI 161 (576)
T ss_pred ecCcccceehhheehhhhhcCCccceEEEEeec-----CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHH
Confidence 333344556789999999999999999999954 44567999999764321 12467899999
Q ss_pred hhcCCCCccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 035862 128 LGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPT-LPWKTRLEIILGAAEGLAYLHEGLEIQVIY 206 (393)
Q Consensus 128 l~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH 206 (393)
|+++.|||||+|+++..+.... .+|||+|||..|.+... ..... +.+.+++.++++++.||+|||.+ ||+|
T Consensus 162 lKkl~H~nVV~LiEvLDDP~s~--~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiH 233 (576)
T KOG0585|consen 162 LKKLHHPNVVKLIEVLDDPESD--KLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIH 233 (576)
T ss_pred HHhcCCcCeeEEEEeecCcccC--ceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhc---Ceec
Confidence 9999999999999998776665 67999999998887643 33344 89999999999999999999999 9999
Q ss_pred ccCCCCCeEeCCCCceEEeeccCCccCCCCCC---ccccccccccCCccCccccccCC----CCchhhHHHHHHHHHHHH
Q 035862 207 RDFKTSNVLLDGNFKPKLSDFGLAREGPTGDH---THVSTAVVGTYGYAAPEYIETGH----LKSQSDIWSFGVVLYEIL 279 (393)
Q Consensus 207 ~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslGvil~ell 279 (393)
|||||.|+||+++|++||+|||.+.....+.. .......+|||.|+|||++.++. .+.+.||||+||+||.|+
T Consensus 234 RDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCll 313 (576)
T KOG0585|consen 234 RDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLL 313 (576)
T ss_pred cccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhh
Confidence 99999999999999999999999986533211 11223479999999999987632 356789999999999999
Q ss_pred hCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 280 TGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 280 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.|+.||-++... .+.. .+++..+.-.-..+..+++.+||.+||++||++|.++.+|..|+|-..
T Consensus 314 fG~~PF~~~~~~---~l~~-------------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 314 FGQLPFFDDFEL---ELFD-------------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred hccCCcccchHH---HHHH-------------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 999999765321 1111 112222211112245688999999999999999999999999999876
Q ss_pred hhhcCCCCC
Q 035862 360 QESEQGSSS 368 (393)
Q Consensus 360 ~~~~~~~~~ 368 (393)
.......+.
T Consensus 378 ~g~~~~~s~ 386 (576)
T KOG0585|consen 378 DGDSPQSSE 386 (576)
T ss_pred CCCCCccCC
Confidence 544443333
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=335.24 Aligned_cols=276 Identities=26% Similarity=0.372 Sum_probs=216.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecC--CCcccHHHHHHHHHHhhcCCCCccceeeeeeec-CC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN--HGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCST-ED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~ 147 (393)
...|..++.||.|+||.|+.|.+..++. .||+|++.. ......++..+|+++|+.++|+||+.+++++.. ..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~-----~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGE-----KVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCC-----EeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 3456668899999999999999876554 599999983 344556778899999999999999999999876 22
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
....-.|+|+|+| +.+|...+ +.+..++...+..+++||+.||.|+|+. +++||||||.|+|++.+..+||+||
T Consensus 96 ~~f~DvYiV~elM-etDL~~ii--k~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQII--KSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred cccceeEEehhHH-hhHHHHHH--HcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence 2233569999999 56999988 4555699999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
|+|+...........+.++.|.+|.|||++. ...|+...||||+|||+.||++|++.|.+.+...+-.++......|.+
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 9999875543333457889999999999775 478999999999999999999999999887655443333222222211
Q ss_pred Cccccccc---------------CcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 307 GKKFSMMI---------------DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 307 ~~~~~~~~---------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
..+..+. ...+...++ ++++.+.+|+.+||..||.+|+|++|++.|+....
T Consensus 250 -e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 250 -EDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred -HHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 0010000 001111111 56788999999999999999999999999986543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=322.92 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=209.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccH---HHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH---KQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|++++.||.|+||.|.+++.+.+ +..+|+|++.+...... +...+|..+|+.+.||.++++++.+.+.+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~-----g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHS-----GNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccC-----CceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence 45699999999999999999997644 44699999987644333 34578999999999999999998888776
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
++++||||++||.|..++ ++.+.+++..++.++.||+.||+|||+. +|++|||||+|||+|.+|.+||+||
T Consensus 118 ----~lymvmeyv~GGElFS~L--rk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 118 ----NLYMVMEYVPGGELFSYL--RKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred ----eEEEEEeccCCccHHHHH--HhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence 679999999999999999 5556799999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|+|...... ..+.||||.|+|||.++...|..++|.|||||++|||+.|.+||....+... ....+..
T Consensus 189 GFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i--Y~KI~~~----- 256 (355)
T KOG0616|consen 189 GFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI--YEKILEG----- 256 (355)
T ss_pred cceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH--HHHHHhC-----
Confidence 999875432 3567999999999999999999999999999999999999999987766221 1111110
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCC-----CCHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER-----PTMNQVVESLKL 357 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R-----ps~~~~l~~l~~ 357 (393)
.-.+|...+.++.+|++++|+.|-.+| ....+|..|.|.
T Consensus 257 -----------~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF 300 (355)
T KOG0616|consen 257 -----------KVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWF 300 (355)
T ss_pred -----------cccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccc
Confidence 112334567889999999999999999 456688888664
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=314.54 Aligned_cols=254 Identities=28% Similarity=0.427 Sum_probs=217.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|++.+.||+|.||.||+|+.+ .+..+||+|++.++.. ....++.+|++|-+.++||||+++|++|.++.
T Consensus 21 l~dfeigr~LgkgkFG~vYlarek-----ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ 95 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREK-----KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK 95 (281)
T ss_pred hhhccccccccCCccccEeEeeec-----cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence 356999999999999999999954 3456899999977532 33467889999999999999999999999887
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..|+++||..+|.|...|.......+++...+.++.|++.||.|+|.. +++||||||+|+|++.+|.+||+||
T Consensus 96 ----riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 96 ----RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred ----eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCC
Confidence 459999999999999999877788899999999999999999999998 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|.+...+.. .....+||..|.|||...+..++..+|+|++|++.||++.|.+||+..........+..+
T Consensus 169 GwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~------- 237 (281)
T KOG0580|consen 169 GWSVHAPSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV------- 237 (281)
T ss_pred CceeecCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc-------
Confidence 999875422 345689999999999999999999999999999999999999999876533222211111
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.-.++..++.++.++|.+||.++|.+|.+..++++|+|-.
T Consensus 238 -----------~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 238 -----------DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred -----------cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 1112345678899999999999999999999999999865
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=341.77 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=210.3
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
.|....+||+|.||.||+|.+..+.+ .||+|++.-.. ......+.+|+.+|.+++++||.++|+.+....
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k-----~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~---- 84 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKK-----VVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT---- 84 (467)
T ss_pred ccccchhccccccceeeeeeeccccc-----eEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc----
Confidence 47777899999999999999765554 69999997653 234567788999999999999999999998777
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.++++||||.||++.+.+ .....+.+..+..++++++.|+.|||.+ +.+|||||+.|||+..+|.+||+|||.+.
T Consensus 85 ~LwiiMey~~gGsv~~lL--~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 85 KLWIIMEYCGGGSVLDLL--KSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred cHHHHHHHhcCcchhhhh--ccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceee
Confidence 559999999999999998 4445558888889999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (393)
........ ...++||+.|||||++.+..|+.|+||||||++.+||++|.+|+....+. ..-
T Consensus 160 ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-----------------rvl 220 (467)
T KOG0201|consen 160 QLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-----------------RVL 220 (467)
T ss_pred eeechhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-----------------eEE
Confidence 76554332 36789999999999999889999999999999999999999999765431 111
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 354 (393)
..+.+...+.....+++.+++|+..||++||+.||++.++++|
T Consensus 221 flIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 221 FLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred EeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1233333333444678899999999999999999999999998
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=359.23 Aligned_cols=272 Identities=31% Similarity=0.490 Sum_probs=231.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-cHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.+-+..+.||+|+||.||+|....-........||||.++..... .+.+|.+|++++..++|||||+|+|+|...+..
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~- 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL- 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee-
Confidence 345667789999999999999776666678899999999987655 778899999999999999999999999999854
Q ss_pred ceEEEEEeecCCCChHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRA------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG 218 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~ 218 (393)
|+|+|||..|+|.+||.... ...++..+.+.|+.||+.||.||-++ .+|||||..+|+||.+
T Consensus 565 ---~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 565 ---CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred ---EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 99999999999999996432 12378889999999999999999998 9999999999999999
Q ss_pred CCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHH
Q 035862 219 NFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLL 297 (393)
Q Consensus 219 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~ 297 (393)
+..|||+|||+++.....+.++......-..+|||||.+..+.|+.++||||+||+|||+++ |.-||.+.... .++
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~---EVI 715 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ---EVI 715 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH---HHH
Confidence 99999999999998777777665555566789999999999999999999999999999999 88888765433 233
Q ss_pred HHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCCCC
Q 035862 298 EWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSS 367 (393)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~~ 367 (393)
+..+. .. ....+.+++.+++.|+..||+..|.+||+++||-..|....+..+.-++
T Consensus 716 e~i~~-------------g~-lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~~~ 771 (774)
T KOG1026|consen 716 ECIRA-------------GQ-LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKYSS 771 (774)
T ss_pred HHHHc-------------CC-cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccccc
Confidence 32221 12 2456678899999999999999999999999999999998876655443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=320.65 Aligned_cols=275 Identities=24% Similarity=0.325 Sum_probs=212.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCc-cceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPN-LVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~ 148 (393)
..|..+++||+|+||+||+|+...++ ..||+|++.-... .......+|+.+|+.++|+| |+.+++++.....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g-----~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTG-----KFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCC-----CEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence 34777788999999999999976554 4699999976543 24456789999999999999 9999999977662
Q ss_pred --ccceEEEEEeecCCCChHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEE
Q 035862 149 --RGIQRLLVYEYMPNRSLEDRLFSRAQ--PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKL 224 (393)
Q Consensus 149 --~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 224 (393)
....+++|+||++ .+|..++..... ..++...++.++.||+.||+|||++ +|+||||||.||||+++|.+||
T Consensus 86 ~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKl 161 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKL 161 (323)
T ss_pred ccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEee
Confidence 2235689999995 499999965543 3678889999999999999999999 9999999999999999999999
Q ss_pred eeccCCccCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 225 SDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
+|||+|+....... ..+..++|.+|+|||++.+. .|+..+||||+|||++||+++++.|.+..+..+...+......
T Consensus 162 aDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt 239 (323)
T KOG0594|consen 162 ADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT 239 (323)
T ss_pred eccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence 99999996543332 34677899999999999876 7999999999999999999999999987775444333333333
Q ss_pred CcCCccccccc-----Ccccccc-----cCH---HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 304 PADGKKFSMMI-----DPRLRNQ-----YSI---NAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 304 ~~~~~~~~~~~-----~~~~~~~-----~~~---~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
|... .+.... ....... ... ....+..+++.+||+++|.+|.|++.++.|....
T Consensus 240 P~e~-~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~ 306 (323)
T KOG0594|consen 240 PNEK-DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFS 306 (323)
T ss_pred CCcc-CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhc
Confidence 3221 000000 0001000 111 1224789999999999999999999999996654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=331.46 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=206.2
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.|+..+.||+|+||.||+|.+..++ ..||+|.+..... .....+.+|+.+++.++|+||+++++++...+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-- 73 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCC-----ceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC--
Confidence 3778899999999999999976444 4699998865422 22345678999999999999999999988766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+.+++|.+++.......+++..+..++.|++.||+|||+. +|+||||||+|||+++++.++|+|||+
T Consensus 74 --~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~ 148 (285)
T cd05631 74 --ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGL 148 (285)
T ss_pred --eEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 569999999999999888655555789999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhh-HHHHHHhhcCcCCc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ-KLLEWVKQFPADGK 308 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~ 308 (393)
+....... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||......... ........
T Consensus 149 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~------ 219 (285)
T cd05631 149 AVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE------ 219 (285)
T ss_pred cEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc------
Confidence 97643322 123457899999999999999999999999999999999999999865432211 11111100
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT-----MNQVVESLKLA 358 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~~l~~l~~~ 358 (393)
....++...+.++.+|+.+||+.||.+||+ ++++++|.|..
T Consensus 220 ---------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~ 265 (285)
T cd05631 220 ---------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265 (285)
T ss_pred ---------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhc
Confidence 011122345678999999999999999997 89999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=331.28 Aligned_cols=254 Identities=22% Similarity=0.379 Sum_probs=211.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc---HHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG---HKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
..+|++.+.||.|+||.|-+|+.. ..+..||||.+++..... .-.+.+|++|++.++||||+.+|++|...+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~-----~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd 126 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEH-----KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD 126 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhc-----cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc
Confidence 457999999999999999999843 345679999998764433 344679999999999999999999999888
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
.+++||||..+|.|.+|+ ...+.+++..++.+++||++|+.|+|.+ +++|||||.+|||+|+++++||+||
T Consensus 127 ----KIvivMEYaS~GeLYDYi--Ser~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADF 197 (668)
T KOG0611|consen 127 ----KIVIVMEYASGGELYDYI--SERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADF 197 (668)
T ss_pred ----eEEEEEEecCCccHHHHH--HHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeecc
Confidence 459999999999999999 4556799999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCC-chhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLK-SQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
|++..+.... ....+||++-|.+||.+.+..|. +.+|-|||||+||-|..|..||++.+.. ..++++..
T Consensus 198 GLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------~lvrQIs~- 267 (668)
T KOG0611|consen 198 GLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------RLVRQISR- 267 (668)
T ss_pred chhhhhcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------HHHHHhhc-
Confidence 9998765433 34678999999999999998884 6899999999999999999999876432 12222111
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
..++. +.-+.++.-||+.||..+|++|.|+.+|..|.|.-+.
T Consensus 268 ---------GaYrE---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwg 309 (668)
T KOG0611|consen 268 ---------GAYRE---PETPSDASGLIRWMLMVNPERRATIEDIASHWWVNWG 309 (668)
T ss_pred ---------ccccC---CCCCchHHHHHHHHHhcCcccchhHHHHhhhheeecc
Confidence 01110 1123567789999999999999999999999997554
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=327.52 Aligned_cols=268 Identities=27% Similarity=0.368 Sum_probs=209.6
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc-cc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER-GI 151 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~ 151 (393)
.|...+++|.|+||.||+|....+. ..||||+.-.+.. .-.+|+++|+.+.|||||++.-+|...... ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~-----~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETE-----EEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCC-----ceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 4777889999999999999987654 3599998765432 223699999999999999999888766555 45
Q ss_pred eEEEEEeecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC-CceEEeecc
Q 035862 152 QRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN-FKPKLSDFG 228 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg 228 (393)
++.+||||++. +|.++++. ..+..++...++-+..||++||.|||+. ||+||||||.|+|+|.+ |.+||||||
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCC
Confidence 77899999955 99998853 2356688888999999999999999998 99999999999999876 999999999
Q ss_pred CCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
.|+....++.. .++.+|..|+|||++.+ ..|+.+.||||.||++.||+-|++.|.+.+...+...+-.+...|...
T Consensus 172 SAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 172 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred cceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence 99987665533 56789999999998876 579999999999999999999999999865544433222222222211
Q ss_pred -----------cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 308 -----------KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 308 -----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
..+..+....+........++++.+|+.++|.++|.+|.++.+++.|..
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f 308 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF 308 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence 0111111111111233356789999999999999999999999999853
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=346.41 Aligned_cols=260 Identities=25% Similarity=0.369 Sum_probs=215.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
+-|..++.||.|+-|.|-+|++..+++ .+|||++.+... .....+.+|+-||+.+.|||++.+|+++....
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGq-----laaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~- 85 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQ-----LAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ- 85 (786)
T ss_pred cceeccccccCCCCceehhhhcccccc-----eeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc-
Confidence 348888999999999999999765554 599999976521 22344678999999999999999999998777
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
++|+|.||++||-|.+++ ...+++++..+..++.||+.|+.|||.. +|+|||+||+|+|++..++|||+|||
T Consensus 86 ---~lylvlEyv~gGELFdyl--v~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFG 157 (786)
T KOG0588|consen 86 ---HLYLVLEYVPGGELFDYL--VRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFG 157 (786)
T ss_pred ---eEEEEEEecCCchhHHHH--HhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccc
Confidence 679999999999999999 5567899999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCC-chhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLK-SQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
+|..-..+. .-.+.||+|.|.|||++.|..|+ .++||||.|||||.||||+.||++.+-. .+...++.-.+
T Consensus 158 MAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---~LLlKV~~G~f-- 229 (786)
T KOG0588|consen 158 MASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---VLLLKVQRGVF-- 229 (786)
T ss_pred eeecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---HHHHHHHcCcc--
Confidence 997643332 34567999999999999999885 5899999999999999999999854321 11111111111
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCCC
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGS 366 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~ 366 (393)
+.+..++.++++||.+||..||..|.|+++|++|+|...-.....+
T Consensus 230 -------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 230 -------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred -------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 1234678999999999999999999999999999998876554444
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-45 Score=342.11 Aligned_cols=251 Identities=25% Similarity=0.422 Sum_probs=210.7
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCC-CCccceeeeeeec
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVS-HPNLVKLLGYCST 145 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 145 (393)
..++|.++++||+|+||+|+++..+.+++ .+|||++++... ......+.|.+|+...+ ||.++.++..|.+
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e-----~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNE-----YYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCc-----EEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc
Confidence 45789999999999999999999765554 699999998643 34556788999988886 9999999999999
Q ss_pred CCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 146 EDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
.+ ++|+||||+.||++..+ .....+++..+.-++..++.||.|||++ ||||||||.+|||+|.+|.+||+
T Consensus 441 ~~----~l~fvmey~~Ggdm~~~---~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiA 510 (694)
T KOG0694|consen 441 KE----HLFFVMEYVAGGDLMHH---IHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIA 510 (694)
T ss_pred CC----eEEEEEEecCCCcEEEE---EecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEec
Confidence 88 77999999999995443 3445699999999999999999999999 99999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
|||+++.....+ ...++.+|||.|+|||++.+..|+..+|.|||||+|||||.|..||.+.++....+-+-
T Consensus 511 DFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~------- 581 (694)
T KOG0694|consen 511 DFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV------- 581 (694)
T ss_pred ccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-------
Confidence 999998754332 25678999999999999999999999999999999999999999999765543322111
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM-----NQVVESL 355 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~~l~~l 355 (393)
.. ...||..++.+..++++++|.++|++|..+ .+|..|.
T Consensus 582 ---------~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hp 625 (694)
T KOG0694|consen 582 ---------ND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHP 625 (694)
T ss_pred ---------cC--CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCC
Confidence 00 123556788999999999999999999865 6666663
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-45 Score=332.80 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=203.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++.+.||+|+||.||+|.+..+ +..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 74 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRIS-----EHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR- 74 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCC-----CCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC-
Confidence 4689999999999999999996543 34699999865321 23345778999999999999999998887665
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+.+++|.+++.. ...+++..++.++.|++.||+|||++ |++||||||+|||++.+|.+||+|||
T Consensus 75 ---~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg 146 (291)
T cd05612 75 ---FLYMLMEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG 146 (291)
T ss_pred ---eEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecC
Confidence 56999999999999999853 45689999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
++...... .....|++.|+|||++.+..++.++|||||||++|+|++|..||.......... ..... .
T Consensus 147 ~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~--~i~~~----~- 214 (291)
T cd05612 147 FAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE--KILAG----K- 214 (291)
T ss_pred cchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhC----C-
Confidence 98764322 123578999999999999999999999999999999999999997654322111 11100 0
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT-----MNQVVESLKLA 358 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~~l~~l~~~ 358 (393)
...+...+..+.+|+.+||+.||.+||+ +.++++|.|..
T Consensus 215 -----------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~ 258 (291)
T cd05612 215 -----------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258 (291)
T ss_pred -----------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence 0112233577899999999999999995 99999998864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=342.05 Aligned_cols=265 Identities=28% Similarity=0.389 Sum_probs=208.8
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcC-CCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 149 (393)
++|++.+.||+|+||.||+|.+...+.......||+|.+.... ......+.+|+.+++.+ +|+||+++++.+...+
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~-- 115 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG-- 115 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC--
Confidence 4699999999999999999997665555566789999997543 23345678899999999 7999999999998776
Q ss_pred cceEEEEEeecCCCChHHHHhhcC--------------------------------------------------------
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRA-------------------------------------------------------- 173 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~-------------------------------------------------------- 173 (393)
..++||||+.+|+|.+++....
T Consensus 116 --~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 116 --PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred --CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 4599999999999999885321
Q ss_pred ------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCccc
Q 035862 174 ------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHV 241 (393)
Q Consensus 174 ------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 241 (393)
...+++..++.++.|++.||.|||++ ||+||||||+|||+++++.+||+|||++...........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 12467888999999999999999998 999999999999999999999999999976543322222
Q ss_pred cccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcccccccCccccc
Q 035862 242 STAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRN 320 (393)
Q Consensus 242 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (393)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||....... ......... ...
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~~~~~--------------~~~ 334 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKMVKRG--------------YQM 334 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHHHHcc--------------cCc
Confidence 223345668999999988899999999999999999997 999997643321 111111110 000
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 321 QYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 321 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
..+...+.++.+++.+||+.||.+||++.++++.|..++
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 111123578999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=329.24 Aligned_cols=270 Identities=25% Similarity=0.360 Sum_probs=204.1
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|++.+.||+|+||.||+|++..+ +..||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKET-----KEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG-- 73 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCC-----CcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC--
Confidence 4799999999999999999997543 3469999887542 223456778999999999999999999987766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+.++.+..+. .....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 74 --~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~ 146 (287)
T cd07848 74 --KLYLVFEYVEKNMLELLE--EMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGF 146 (287)
T ss_pred --EEEEEEecCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccC
Confidence 569999999887776544 2335689999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHH-HhhcCcC--
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW-VKQFPAD-- 306 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~-~~~~~~~-- 306 (393)
+......... ......|++.|+|||++.+..++.++|||||||++|+|++|++||.............. ....+..
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07848 147 ARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQM 225 (287)
T ss_pred cccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHH
Confidence 9865432211 22345789999999999988999999999999999999999999986544322111111 0000000
Q ss_pred -----CcccccccCc------ccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 307 -----GKKFSMMIDP------RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 307 -----~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
...+.....+ .........++.++.+|+.+||++||++|||++++++|.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~ 286 (287)
T cd07848 226 KLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA 286 (287)
T ss_pred HhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 0000000000 0011112235678999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=332.60 Aligned_cols=269 Identities=26% Similarity=0.377 Sum_probs=207.4
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|++.+.||+|+||.||++.+..+ +..+|+|.+.... ......+.+|+++++.++||||+++++++...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 76 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPS-----GLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-- 76 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCC-----CcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--
Confidence 36799999999999999999996543 3468999887542 233456889999999999999999999998766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+
T Consensus 77 --~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 150 (331)
T cd06649 77 --EISICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGV 150 (331)
T ss_pred --EEEEEeecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcc
Confidence 56999999999999999843 34689999999999999999999974 2699999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+...... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||........... ......++..
T Consensus 151 ~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~---~~~~~~~~~~ 223 (331)
T cd06649 151 SGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI---FGRPVVDGEE 223 (331)
T ss_pred ccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---hccccccccc
Confidence 8754322 12345789999999999999999999999999999999999999975443211111 1100000000
Q ss_pred --cc-------------------------------cccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 310 --FS-------------------------------MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 310 --~~-------------------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.. .+............++.++.+|+.+||+.||++|||+.++++|.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 224 GEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred CCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 00 000000000011135678999999999999999999999999998
Q ss_pred HHH
Q 035862 357 LAV 359 (393)
Q Consensus 357 ~~~ 359 (393)
...
T Consensus 304 ~~~ 306 (331)
T cd06649 304 IKR 306 (331)
T ss_pred Hhh
Confidence 754
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=334.05 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=217.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|..++.+|+|+||.+++++.+..+ ..+++|.+.-.. ...+....+|+.+++++.|||||.+.+.|..++.
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~-----~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~ 77 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDD-----KLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ 77 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCC-----ceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc
Confidence 357999999999999999998865433 468999886543 2334567899999999999999999999988774
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
++++||+||+||+|.+.|...+...++++.++.|+.|++.|+.|||++ .|+|||||+.|||++.++.|||+|||
T Consensus 78 ---~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfG 151 (426)
T KOG0589|consen 78 ---LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFG 151 (426)
T ss_pred ---eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchh
Confidence 479999999999999999877778899999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+|+...... ....+.+||+.|+.||++.+.+|..|+|||||||++|||++-+++|...+...-. ....
T Consensus 152 laK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li--~ki~-------- 219 (426)
T KOG0589|consen 152 LAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELI--LKIN-------- 219 (426)
T ss_pred hhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHH--HHHh--------
Confidence 999865543 2456789999999999999999999999999999999999999999866432211 1111
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
+......+...+.++..++..||..+|..||++.+++.++-..
T Consensus 220 -------~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~ 262 (426)
T KOG0589|consen 220 -------RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLL 262 (426)
T ss_pred -------hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhh
Confidence 1112334456789999999999999999999999999986444
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=327.48 Aligned_cols=269 Identities=24% Similarity=0.368 Sum_probs=202.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|++.+.||.|+||.||+|....++ ..||+|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 76 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTE-----NLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER--- 76 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCC-----CEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC---
Confidence 56999999999999999999865443 4699998865432 23346778999999999999999999987765
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+ +|.+++... ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 77 -~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~ 150 (288)
T cd07871 77 -CLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLA 150 (288)
T ss_pred -eEEEEEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcce
Confidence 56999999965 999888543 34578899999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC--
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG-- 307 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-- 307 (393)
........ ......+++.|+|||++.+ ..++.++||||+||++|+|++|++||..................+...
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07871 151 RAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228 (288)
T ss_pred eeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHh
Confidence 75432221 2234578999999998865 568999999999999999999999997655433222111111111100
Q ss_pred ------cccccccCcccccc----cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 308 ------KKFSMMIDPRLRNQ----YSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 308 ------~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
..+.....+..... .....+.++.+|+.+||++||.+|||++++++|.|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~ 287 (288)
T cd07871 229 PGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287 (288)
T ss_pred hccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence 00000111110000 01124577899999999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=340.93 Aligned_cols=264 Identities=27% Similarity=0.417 Sum_probs=206.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcC-CCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 149 (393)
++|++.+.||+|+||.||+|.+...........||+|++.... ......+.+|+.++..+ +||||+++++++...+
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~-- 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG-- 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC--
Confidence 4688999999999999999986544444566789999987543 23345678899999999 7999999999998776
Q ss_pred cceEEEEEeecCCCChHHHHhhcC--------------------------------------------------------
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRA-------------------------------------------------------- 173 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~-------------------------------------------------------- 173 (393)
..++||||+++|+|.+++....
T Consensus 113 --~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 113 --PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred --cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 4499999999999999885422
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCC
Q 035862 174 -----------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236 (393)
Q Consensus 174 -----------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 236 (393)
...+++..++.++.||+.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 12467888999999999999999998 9999999999999999999999999999765433
Q ss_pred CCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcccccccC
Q 035862 237 DHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMID 315 (393)
Q Consensus 237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (393)
..........++..|+|||++.+..++.++|||||||++|||++ |..||....... ........ +
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~----~-------- 333 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKE----G-------- 333 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHh----C--------
Confidence 22222223345667999999999999999999999999999998 888886543221 11111111 0
Q ss_pred cccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.....+...+.++.+|+.+||+.||++||++.++++.|+..
T Consensus 334 --~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 334 --YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00011112356899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=339.07 Aligned_cols=269 Identities=23% Similarity=0.307 Sum_probs=213.1
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-C-----Cccceeeeeeec
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-H-----PNLVKLLGYCST 145 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~ 145 (393)
.+|.+++.||+|+||.|-+|++..+++ .||||+++... ....+...|+.+|..++ | -|+|+++++|..
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e-----~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGE-----IVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCc-----EEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 378999999999999999999876654 59999998764 34556678999999998 4 389999999998
Q ss_pred CCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC--ceE
Q 035862 146 EDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF--KPK 223 (393)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~--~~k 223 (393)
.+ ++|||+|.+ ..+|.++|..+...+++...++.++.||+.||.+||.. +|||+||||+||||.+-+ .||
T Consensus 260 r~----HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vK 331 (586)
T KOG0667|consen 260 RN----HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIK 331 (586)
T ss_pred cc----ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCcee
Confidence 88 679999999 56999999988888999999999999999999999998 999999999999997554 699
Q ss_pred EeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 224 LSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 224 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
|+|||.|+...... ..++.+..|+|||++.|..|+.+.||||||||++||++|.+.|.+.++..+...+......
T Consensus 332 VIDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~ 406 (586)
T KOG0667|consen 332 VIDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGL 406 (586)
T ss_pred EEecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCC
Confidence 99999998754432 2678899999999999999999999999999999999999999887665443222211111
Q ss_pred CcCC-----ccccccc--------------------------------Cc--------ccccccCHHHHHHHHHHHHHhc
Q 035862 304 PADG-----KKFSMMI--------------------------------DP--------RLRNQYSINAARRVAKLADNCL 338 (393)
Q Consensus 304 ~~~~-----~~~~~~~--------------------------------~~--------~~~~~~~~~~~~~l~~li~~~l 338 (393)
|... ......+ +. .+...........+.+|+.+||
T Consensus 407 Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L 486 (586)
T KOG0667|consen 407 PPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCL 486 (586)
T ss_pred CCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHh
Confidence 1110 0000000 00 0000111123456799999999
Q ss_pred ccCCCCCCCHHHHHHHHHHHH
Q 035862 339 KKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 339 ~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.+||.+|+|..++++|.|.-.
T Consensus 487 ~~dP~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 487 EWDPAERITPAQALNHPFLTG 507 (586)
T ss_pred ccCchhcCCHHHHhcCccccc
Confidence 999999999999999998753
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=337.34 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=203.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++.+.||+|+||.||+|.+..++ ..||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 91 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTG-----EYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN- 91 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC-
Confidence 56999999999999999999975443 469999986532 123456788999999999999999999998776
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+.+++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 92 ---~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg 163 (329)
T PTZ00263 92 ---RVYFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFG 163 (329)
T ss_pred ---EEEEEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeecc
Confidence 56999999999999999853 45688999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
++....... ....|++.|+|||++.+..++.++|||||||++|+|++|..||......... ..... ..
T Consensus 164 ~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~i~~---~~- 231 (329)
T PTZ00263 164 FAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY---EKILA---GR- 231 (329)
T ss_pred CceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH---HHHhc---CC-
Confidence 997653321 2357899999999999999999999999999999999999999765432111 11100 00
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT-----MNQVVESLKL 357 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~~l~~l~~ 357 (393)
...+..++..+.+|+.+||+.||.+||+ +.+++.|.|.
T Consensus 232 -----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f 274 (329)
T PTZ00263 232 -----------LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274 (329)
T ss_pred -----------cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCcc
Confidence 0111124567899999999999999986 7999999764
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=333.41 Aligned_cols=268 Identities=28% Similarity=0.405 Sum_probs=211.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcC-CCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 149 (393)
++|++.+.||+|+||.||+|.............||+|++..... .....+.+|+.++..+ +|+||+++++++...+.
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~- 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG- 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC-
Confidence 47999999999999999999876555555667899999875422 2345677899999999 79999999998875543
Q ss_pred cceEEEEEeecCCCChHHHHhhcCC-------------------------------------------------------
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQ------------------------------------------------------- 174 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------- 174 (393)
..+++|||+.+++|.+++.....
T Consensus 86 --~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 86 --PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred --CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 46899999999999999854221
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCC
Q 035862 175 ----PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250 (393)
Q Consensus 175 ----~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~ 250 (393)
..+++..+..++.|++.||.|||++ +|+||||||+|||+++++.++|+|||++................++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 2578899999999999999999998 999999999999999999999999999986543332222334456778
Q ss_pred ccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHH
Q 035862 251 YAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARR 329 (393)
Q Consensus 251 y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (393)
|+|||++.+..++.++|||||||++|||++ |..||....... .+...... ......+...+.+
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~~~~~--------------~~~~~~~~~~~~~ 304 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRRLKE--------------GTRMRAPEYATPE 304 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHHHHhc--------------cCCCCCCccCCHH
Confidence 999999999999999999999999999998 999997543221 11111110 0001111234577
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 330 VAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 330 l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
+.+++.+||+.+|++||++.+++++|..+++.
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=324.96 Aligned_cols=268 Identities=29% Similarity=0.465 Sum_probs=203.6
Q ss_pred cCCcccceecccCCceEEEEEEcCCC-----------CCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCcccee
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLD-----------GRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKL 139 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----------~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~ 139 (393)
++|.+.++||+|+||.||+|.+.... ..+....||+|.+..... .....+.+|+.++..++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 57999999999999999999865332 233556799999876432 234568899999999999999999
Q ss_pred eeeeecCCcccceEEEEEeecCCCChHHHHhhcC-----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 035862 140 LGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRA-----------------QPTLPWKTRLEIILGAAEGLAYLHEGLEI 202 (393)
Q Consensus 140 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~ 202 (393)
++++...+ ..++||||+.+++|.+++.... ...+++..++.++.||+.||.|||+.
T Consensus 85 ~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~--- 157 (304)
T cd05096 85 LGVCVDED----PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL--- 157 (304)
T ss_pred EEEEecCC----ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---
Confidence 99998766 4599999999999999885422 12467788999999999999999998
Q ss_pred CeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh--
Q 035862 203 QVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-- 280 (393)
Q Consensus 203 ~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-- 280 (393)
+|+||||||+|||++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 999999999999999999999999999976544333223334456788999999988899999999999999999997
Q ss_pred CCCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 281 GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 281 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
+..||....... .............. ......+..++..+.+|+.+||+.||++|||+.++.+.|.
T Consensus 238 ~~~p~~~~~~~~---~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 238 KEQPYGELTDEQ---VIENAGEFFRDQGR-------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCCCcCCHHH---HHHHHHHHhhhccc-------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 456665433221 11111110000000 0000011234578999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=334.97 Aligned_cols=257 Identities=24% Similarity=0.351 Sum_probs=206.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++.+.||+|+||.||+|.+..++ ..||+|++.... ......+.+|+.++..++||||+++++++...+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~- 74 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTG-----EIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE- 74 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC-
Confidence 46999999999999999999976443 369999987542 123456778999999999999999999988766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+++++|.+++. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~e~~~g~~L~~~l~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg 146 (333)
T cd05600 75 ---YLYLAMEYVPGGDFRTLLN--NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFG 146 (333)
T ss_pred ---EEEEEEeCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCc
Confidence 5699999999999999984 345688999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHH-HHHHhhcCcCC
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKL-LEWVKQFPADG 307 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~~ 307 (393)
++..... ......|++.|+|||++.+..++.++|||||||++|||++|..||........... ..+....
T Consensus 147 ~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---- 217 (333)
T cd05600 147 LSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL---- 217 (333)
T ss_pred CCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc----
Confidence 9976433 22446799999999999999999999999999999999999999976544322111 1111000
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
...........++.++.+|+.+||..+|.+||++.++++|.|..
T Consensus 218 -------~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~ 261 (333)
T cd05600 218 -------QRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFK 261 (333)
T ss_pred -------cCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccC
Confidence 00000000123568899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=322.11 Aligned_cols=262 Identities=29% Similarity=0.506 Sum_probs=210.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|++.+.||+|+||.||+|.+...........|++|.+..... .....+.+|+.++..++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--- 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ--- 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC---
Confidence 46889999999999999999876554444557799999875432 23456789999999999999999999987665
Q ss_pred ceEEEEEeecCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQ--------------PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL 216 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll 216 (393)
..+++|||+++++|.+++..... ..+++..++.++.|++.||.|||+. +++|+||||+||++
T Consensus 82 -~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~ 157 (283)
T cd05048 82 -PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLV 157 (283)
T ss_pred -ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEE
Confidence 45999999999999999864321 4578889999999999999999998 99999999999999
Q ss_pred CCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhH
Q 035862 217 DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQK 295 (393)
Q Consensus 217 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~ 295 (393)
++++.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--- 234 (283)
T cd05048 158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--- 234 (283)
T ss_pred cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999976543333223344567889999999988899999999999999999998 999997654321
Q ss_pred HHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
....... ......+..++.++.+|+.+||+.||.+||++.+++++|..
T Consensus 235 ~~~~i~~--------------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 235 VIEMIRS--------------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHc--------------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 2221111 01111233567889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=300.69 Aligned_cols=268 Identities=25% Similarity=0.344 Sum_probs=212.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc-c
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE-R 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~ 149 (393)
.++|++.+.||+|||+.||++....++ ..||+|++.-......+..++|++..+.++|||+++++++...+.. .
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~-----~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTG-----HLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcc-----cchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 468999999999999999999854444 4699999987776778889999999999999999999988755443 3
Q ss_pred cceEEEEEeecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSR--AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
....|++++|...|+|.+.+... ++..+++.+++.|+.++++||.+||.. ...+.||||||.|||+++++.++|.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence 34679999999999999998643 345689999999999999999999997 224999999999999999999999999
Q ss_pred cCCccCCCCCCcc-------ccccccccCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHH
Q 035862 228 GLAREGPTGDHTH-------VSTAVVGTYGYAAPEYIE---TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL 297 (393)
Q Consensus 228 g~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~ 297 (393)
|.+......-... .-....+|..|+|||++. +...+.++|||||||++|.|+.|..||+..-.
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~------- 246 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ------- 246 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-------
Confidence 9997654322111 112456789999999985 45678999999999999999999999973211
Q ss_pred HHHhhcCcCCcccccc-cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 298 EWVKQFPADGKKFSMM-IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 298 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.|..+... .+..+.-+....+++.+.++++.||+.||.+||++.+++.++..+.
T Consensus 247 --------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 --------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 12222211 1222222222237899999999999999999999999999998764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=334.45 Aligned_cols=246 Identities=26% Similarity=0.349 Sum_probs=198.3
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRL 154 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 154 (393)
+.||+|+||.||+|.+..+ +..||+|++.... ......+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~----~~~ 71 (323)
T cd05571 1 KLLGKGTFGKVILVREKAT-----GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD----RLC 71 (323)
T ss_pred CeeeeCCCeEEEEEEECCC-----CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC----EEE
Confidence 3699999999999986543 3469999987532 223345678999999999999999999988776 569
Q ss_pred EEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCC
Q 035862 155 LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGP 234 (393)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 234 (393)
+||||+.+++|.+++. ....+++..+..++.||+.||+|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus 72 lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 72 FVMEYANGGELFFHLS--RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred EEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence 9999999999999884 345689999999999999999999998 99999999999999999999999999987532
Q ss_pred CCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccccccc
Q 035862 235 TGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMI 314 (393)
Q Consensus 235 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (393)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......... .... ..
T Consensus 147 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~---~~~~---~~------- 211 (323)
T cd05571 147 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE---LILM---EE------- 211 (323)
T ss_pred cCCC--cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHH---HHHc---CC-------
Confidence 2211 2234679999999999999999999999999999999999999997654321111 1100 00
Q ss_pred CcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHH
Q 035862 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKL 357 (393)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~ 357 (393)
...+..++.++.+|+.+||+.||++|| ++.++++|.|.
T Consensus 212 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f 254 (323)
T cd05571 212 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF 254 (323)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCc
Confidence 011223567899999999999999999 89999998664
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=345.71 Aligned_cols=266 Identities=25% Similarity=0.321 Sum_probs=214.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCccceeee-eeecC-C
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLG-YCSTE-D 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~-~~~~~-~ 147 (393)
..++++.+.|.+|||+.||+|.+...+ ..||+|++--......+.+.+|+++|+.|+ |+|||.+++ ..... .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~-----~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGG-----KKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCC-----ceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 346888899999999999999976543 459999987766677788899999999998 999999999 33222 1
Q ss_pred cc-cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 148 ER-GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 148 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
.. ....+|+||||.||.|-+++..+....|++.++++|++|+++|+++||.. ..+|||||||-+||||+.+|+.||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 22 24567889999999999999877777899999999999999999999996 44699999999999999999999999
Q ss_pred ccCCccCCCCCCcc-------ccccccccCCccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHH
Q 035862 227 FGLAREGPTGDHTH-------VSTAVVGTYGYAAPEYI---ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKL 296 (393)
Q Consensus 227 fg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~ 296 (393)
||.+.-........ ..-...-|+.|+|||++ .+...+.|+|||+|||+||-||....||+.....
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----- 264 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----- 264 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-----
Confidence 99986432221110 01123568999999977 5678999999999999999999999999854221
Q ss_pred HHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 297 LEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
.+++..+.-+....++..+.+||..||+.||++||++-+++.++..+....
T Consensus 265 ---------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 ---------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 123333332233468899999999999999999999999999999887544
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=317.14 Aligned_cols=258 Identities=26% Similarity=0.364 Sum_probs=212.4
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc---HHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG---HKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.+.|+.++.||+|.-|+||++..+.+. ..+|+|++.+..... ..++..|-+||+.+.||.+..+|+.|..+.
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~-----~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTN-----CLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCC-----ceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 356888899999999999999976544 579999998875443 345667999999999999999999999887
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
+.|++||||.||+|..+++.+....+++..++.++..++.||+|||-. |||+|||||+||||-++|+|-|+||
T Consensus 151 ----~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDF 223 (459)
T KOG0610|consen 151 ----YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDF 223 (459)
T ss_pred ----eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeec
Confidence 669999999999999999888889999999999999999999999998 9999999999999999999999999
Q ss_pred cCCccCCC---------------------------------CCC---------------------ccccccccccCCccC
Q 035862 228 GLAREGPT---------------------------------GDH---------------------THVSTAVVGTYGYAA 253 (393)
Q Consensus 228 g~a~~~~~---------------------------------~~~---------------------~~~~~~~~gt~~y~a 253 (393)
.++..... ... .......+||-.|+|
T Consensus 224 DLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlA 303 (459)
T KOG0610|consen 224 DLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLA 303 (459)
T ss_pred cccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccc
Confidence 98753211 000 002235799999999
Q ss_pred ccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHH
Q 035862 254 PEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKL 333 (393)
Q Consensus 254 PE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 333 (393)
||++.|...+.++|+|+|||++|||+.|..||.+..... .+...+.+ .+.-.-...++..+.+|
T Consensus 304 PEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~--Tl~NIv~~--------------~l~Fp~~~~vs~~akDL 367 (459)
T KOG0610|consen 304 PEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--TLRNIVGQ--------------PLKFPEEPEVSSAAKDL 367 (459)
T ss_pred ceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchh--hHHHHhcC--------------CCcCCCCCcchhHHHHH
Confidence 999999999999999999999999999999997654322 22222211 11111112567889999
Q ss_pred HHHhcccCCCCCCC----HHHHHHHHH
Q 035862 334 ADNCLKKNPEERPT----MNQVVESLK 356 (393)
Q Consensus 334 i~~~l~~dp~~Rps----~~~~l~~l~ 356 (393)
|+++|.+||.+|.. +.||-+|..
T Consensus 368 Ir~LLvKdP~kRlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 368 IRKLLVKDPSKRLGSKRGAAEIKRHPF 394 (459)
T ss_pred HHHHhccChhhhhccccchHHhhcCcc
Confidence 99999999999998 999998853
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=335.42 Aligned_cols=251 Identities=25% Similarity=0.334 Sum_probs=204.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|.+.+.||+|+||.||+|.+.... ...||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNED----FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCC----CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 356999999999999999999865322 2469999886432 223456778999999999999999999998776
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..++||||+.+|+|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 105 ----~~~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DF 175 (340)
T PTZ00426 105 ----YLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDF 175 (340)
T ss_pred ----EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecC
Confidence 56999999999999999853 45689999999999999999999998 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||....+...... .....
T Consensus 176 G~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~--i~~~~---- 244 (340)
T PTZ00426 176 GFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK--ILEGI---- 244 (340)
T ss_pred CCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH--HhcCC----
Confidence 999764321 2345799999999999998899999999999999999999999986544321111 11000
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKL 357 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~ 357 (393)
...+...+..+.+++++||+.||.+|+ +++++++|.|.
T Consensus 245 ------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f 287 (340)
T PTZ00426 245 ------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287 (340)
T ss_pred ------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCc
Confidence 011223456789999999999999995 89999999764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=323.34 Aligned_cols=251 Identities=20% Similarity=0.293 Sum_probs=199.2
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc---HHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG---HKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRL 154 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 154 (393)
..||+|++|.||+|.+. +..||+|.+....... .+.+.+|+.+|+.++||||+++++++..........+
T Consensus 26 ~~i~~g~~~~v~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~ 98 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLS 98 (283)
T ss_pred eEEeeCCceEEEEEEEC-------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceE
Confidence 57999999999999863 2359999987653322 4567799999999999999999999876222223568
Q ss_pred EEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCC
Q 035862 155 LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGP 234 (393)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 234 (393)
+||||+.+|+|.+++.. ...+++.....++.|++.||.|||+. .+++||||||+|||+++++.+||+|||++....
T Consensus 99 lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~ 174 (283)
T PHA02988 99 LILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174 (283)
T ss_pred EEEEeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence 99999999999999954 45688999999999999999999973 278899999999999999999999999987543
Q ss_pred CCCCccccccccccCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccccc
Q 035862 235 TGDHTHVSTAVVGTYGYAAPEYIET--GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSM 312 (393)
Q Consensus 235 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (393)
... ....|+..|+|||++.+ ..++.++|||||||++|||++|..||......... ......
T Consensus 175 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~--~~i~~~---------- 237 (283)
T PHA02988 175 SPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY--DLIINK---------- 237 (283)
T ss_pred ccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHhc----------
Confidence 321 23468899999999976 68999999999999999999999999865432111 111100
Q ss_pred ccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 313 MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
..+...+..++..+.+|+.+||+.||++|||+.++++.|.+...
T Consensus 238 ----~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 238 ----NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ----CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 00111122356789999999999999999999999999988653
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=335.57 Aligned_cols=246 Identities=27% Similarity=0.448 Sum_probs=206.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
+....++-||.|+.|.||+|+.... .||||+++.-. ..+++-|++++||||+.|.|+|....
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~ne-------tVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsP---- 185 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLHNE-------TVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSP---- 185 (904)
T ss_pred HHhhhhhhhccCcccceeeeeccCc-------eehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCc----
Confidence 3344456799999999999987533 39999885432 14788999999999999999998776
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..|||||||..|.|.+.| +....+.......|..+|+.|+.|||.+ .|||||||.-||||+.+..|||+|||-++
T Consensus 186 cyCIiMEfCa~GqL~~VL--ka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~ 260 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVL--KAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSK 260 (904)
T ss_pred eeEEeeeccccccHHHHH--hccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchH
Confidence 559999999999999999 5566788889999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (393)
...... ..-.++||..|||||++.+.+.+.|+|||||||+|||||||..||.+-.... .+.
T Consensus 261 e~~~~S---TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----------------IIw 321 (904)
T KOG4721|consen 261 ELSDKS---TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----------------IIW 321 (904)
T ss_pred hhhhhh---hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----------------eEE
Confidence 755442 3346799999999999999999999999999999999999999997543221 111
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.+-...+....+..+++.+.-|++.||+-.|.+||++.+++.||+..-
T Consensus 322 GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 322 GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 222334555667788899999999999999999999999999987543
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=323.12 Aligned_cols=273 Identities=25% Similarity=0.392 Sum_probs=201.6
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcC---CCCccceeeeeeecC
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVV---SHPNLVKLLGYCSTE 146 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~ 146 (393)
++|++.+.||+|+||.||+|.+... .+..||+|.+..... .....+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~ 76 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKN----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 76 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCC----CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence 3699999999999999999986422 235689998864322 2233455677766655 699999999988643
Q ss_pred Cc-ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 147 DE-RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 147 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
.. ....+++||||+. ++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 77 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred cCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEc
Confidence 21 2235799999995 5999998766566789999999999999999999998 99999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhh-HHHHHHhhcC
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ-KLLEWVKQFP 304 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~ 304 (393)
|||++...... .......|++.|+|||++.+..++.++|||||||++|||++|.+||......... .+.... ..+
T Consensus 153 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~-~~~ 228 (290)
T cd07862 153 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI-GLP 228 (290)
T ss_pred cccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh-CCC
Confidence 99999764332 1234457899999999998889999999999999999999999999876543221 111111 111
Q ss_pred cCCcc-----c-ccccCccc---ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 305 ADGKK-----F-SMMIDPRL---RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 305 ~~~~~-----~-~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
..... . ........ .......++..+.+|+.+||+.||++|||+.++++|.|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~ 289 (290)
T cd07862 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289 (290)
T ss_pred ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCC
Confidence 11000 0 00000000 00111235677899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=330.24 Aligned_cols=275 Identities=24% Similarity=0.369 Sum_probs=202.4
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc-
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER- 149 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~- 149 (393)
+|++.+.||+|+||.||+|.+..++ ..||+|.+... .......+.+|+.+++.++||||+++++++...+..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTG-----EKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCC-----CEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCC
Confidence 5889999999999999999965433 46999988643 222345678899999999999999999988654321
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
....|+||||+ +++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~~lv~e~~-~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~ 149 (338)
T cd07859 76 FKDIYVVFELM-ESDLHQVIK--ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGL 149 (338)
T ss_pred CceEEEEEecC-CCCHHHHHH--hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcc
Confidence 22569999999 469999884 344689999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCC-ccccccccccCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 230 AREGPTGDH-THVSTAVVGTYGYAAPEYIET--GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 230 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
+........ ........|++.|+|||++.+ ..++.++|||||||++|+|++|++||..................+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 229 (338)
T cd07859 150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP 229 (338)
T ss_pred ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 975432221 112234679999999999865 67899999999999999999999999765432211111100000000
Q ss_pred C----------cccccccCccccccc---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 307 G----------KKFSMMIDPRLRNQY---SINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 307 ~----------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
. ......+.+...... -...+..+.+++.+||+.||++|||+.++++|.|..
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~ 294 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhh
Confidence 0 000000000000000 012356788999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=323.58 Aligned_cols=272 Identities=23% Similarity=0.369 Sum_probs=202.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|++.+.||+|+||.||+|.+..+ +..||+|++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVN-----GKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE-- 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCC-----CCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC--
Confidence 36799999999999999999997543 34699999875432 22345678999999999999999999998766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+. ++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 77 --~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 149 (303)
T cd07869 77 --TLTLVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGL 149 (303)
T ss_pred --eEEEEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCc
Confidence 5699999995 6888877543 34588899999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHH-HHHHhhcCcCC
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKL-LEWVKQFPADG 307 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~~ 307 (393)
+........ ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.......+... .......+...
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 227 (303)
T cd07869 150 ARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNED 227 (303)
T ss_pred ceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChh
Confidence 875432211 2234578999999998865 4688999999999999999999999986543222111 11110111000
Q ss_pred -------------cccccccCcccccccC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 308 -------------KKFSMMIDPRLRNQYS-INAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 308 -------------~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
..+.......+..... ...+.++.+|+.+||+.||++|||+.++++|.|..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~ 292 (303)
T cd07869 228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS 292 (303)
T ss_pred hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence 0000000000000000 01236788999999999999999999999998763
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=334.31 Aligned_cols=266 Identities=20% Similarity=0.268 Sum_probs=200.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.+.||+|+||.||+|.+..++. .||+|.... ..+.+|+.+++.++||||+++++++....
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~-----~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~--- 156 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCE-----HVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNK--- 156 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCC-----EEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECC---
Confidence 3679999999999999999999765443 599997532 34678999999999999999999998765
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++|||++ +++|..++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 157 -~~~lv~e~~-~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a 229 (391)
T PHA03212 157 -FTCLILPRY-KTDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229 (391)
T ss_pred -eeEEEEecC-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcc
Confidence 559999999 4689888843 34688999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCch-----hhh---HHHHHHhh
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPT-----MEQ---KLLEWVKQ 302 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~-----~~~---~~~~~~~~ 302 (393)
........ .......||+.|+|||++.+..++.++|||||||++|||++|..||...... ... .+......
T Consensus 230 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~ 308 (391)
T PHA03212 230 CFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308 (391)
T ss_pred cccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence 75322211 1223457999999999999999999999999999999999999887543211 011 11111110
Q ss_pred cC----cCCc-ccccc---------cCccccc--ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 303 FP----ADGK-KFSMM---------IDPRLRN--QYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 303 ~~----~~~~-~~~~~---------~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.+ .... ..... ..+..+. ......+.++.+|+.+||+.||.+|||+.++++|.|..
T Consensus 309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~ 380 (391)
T PHA03212 309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQ 380 (391)
T ss_pred ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhc
Confidence 00 0000 00000 0000000 01113567899999999999999999999999999874
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=319.59 Aligned_cols=267 Identities=27% Similarity=0.433 Sum_probs=213.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|.+.+.||+|+||.||++.............+++|.+..........+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD---- 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC----
Confidence 4688999999999999999986544344566779999987665555667889999999999999999999998765
Q ss_pred eEEEEEeecCCCChHHHHhhcC-----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRA-----------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF 220 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~ 220 (393)
..++||||+.+++|.+++.... ...+++..++.++.|++.||+|||+. |++||||||+||++++++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 4599999999999999985432 23489999999999999999999998 999999999999999999
Q ss_pred ceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHH
Q 035862 221 KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEW 299 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~ 299 (393)
.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ....
T Consensus 158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~ 234 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIEC 234 (288)
T ss_pred cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence 999999999976533322222233456778999999998999999999999999999998 899986554321 1111
Q ss_pred HhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
...... ...+...+.++.+|+.+||+.||.+|||+.++++.|+.+....
T Consensus 235 i~~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 235 ITQGRV--------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred HHcCCc--------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 111000 0001123567999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=322.31 Aligned_cols=264 Identities=25% Similarity=0.399 Sum_probs=208.1
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.+|+..+.||+|+||.||+|.+...+ ......||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~--- 82 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEG-EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--- 82 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCC-CccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC---
Confidence 46999999999999999999875433 2334568999987543 234566888999999999999999999987643
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
.++++||+.+|+|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 83 --~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 83 --VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred --ceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccc
Confidence 378999999999999986433 4578889999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
................++..|+|||++.+..++.++|||||||++|||++ |..||........ ...... +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~---~~~~~~----~~- 228 (316)
T cd05108 157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSILEK----GE- 228 (316)
T ss_pred ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHhC----CC-
Confidence 87544332222223345678999999999999999999999999999998 9999976433221 111111 00
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
....+..++.++.+++.+||..+|.+||++.+++..+..+..+.
T Consensus 229 ---------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 229 ---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 00111123467899999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=334.73 Aligned_cols=267 Identities=25% Similarity=0.375 Sum_probs=210.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCC-CCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||.||+|.+...........||+|++..... .....+.+|+.+++.+. ||||+++++++...+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~- 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG- 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC-
Confidence 467999999999999999999976555445566799999975432 23456889999999996 999999999997766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcC-------------------------------------------------------
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRA------------------------------------------------------- 173 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------- 173 (393)
..++||||+++|+|.+++....
T Consensus 115 ---~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 115 ---PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred ---ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 4599999999999999885421
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCe
Q 035862 174 ---------------------------------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNV 214 (393)
Q Consensus 174 ---------------------------------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NI 214 (393)
...+++..++.++.|++.||.|||+. +++||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhE
Confidence 12477888899999999999999998 999999999999
Q ss_pred EeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhh
Q 035862 215 LLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME 293 (393)
Q Consensus 215 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~ 293 (393)
|+++++.+||+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~- 347 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS- 347 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-
Confidence 999999999999999976533322222233456788999999998899999999999999999997 889987542211
Q ss_pred hHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 294 QKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
.+...... ......+..++.++.+++.+||+.||++||++.++.+.|..+..
T Consensus 348 -~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 348 -TFYNKIKS--------------GYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred -HHHHHHhc--------------CCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11111110 00111122456789999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=339.04 Aligned_cols=271 Identities=23% Similarity=0.343 Sum_probs=201.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCC---
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED--- 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 147 (393)
..+|.+.+.||+|+||.||+|.+..++ ..||+|++.... ....+|+.+++.++||||+++++++....
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~-----~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTS-----EKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCC-----CEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 457999999999999999999975443 359999886532 22347999999999999999998775432
Q ss_pred -cccceEEEEEeecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC-ceE
Q 035862 148 -ERGIQRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF-KPK 223 (393)
Q Consensus 148 -~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-~~k 223 (393)
....++++||||+.+ +|.+++.. .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vk 211 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLK 211 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCcee
Confidence 222356899999965 78777642 3446789999999999999999999998 999999999999998665 799
Q ss_pred EeeccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH-HHHHHh
Q 035862 224 LSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK-LLEWVK 301 (393)
Q Consensus 224 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~-~~~~~~ 301 (393)
|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.......... ......
T Consensus 212 L~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 288 (440)
T PTZ00036 212 LCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG 288 (440)
T ss_pred eeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 99999998654322 1234578999999998866 468999999999999999999999997654432211 111110
Q ss_pred hcCcC-----------CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 302 QFPAD-----------GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 302 ~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.+.. ...+.......+...++...+.++.+||.+||++||.+|||+.+++.|.|..
T Consensus 289 -~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~ 355 (440)
T PTZ00036 289 -TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355 (440)
T ss_pred -CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHH
Confidence 0000 0000111111122222334567899999999999999999999999998864
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=329.70 Aligned_cols=256 Identities=27% Similarity=0.371 Sum_probs=198.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|+.++.||+|+||.||+|.+..++ ..||+|.+..... .....+.+|+++++.++|+||+++++++...+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 145 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTG-----RLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG-- 145 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCC-----CEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC--
Confidence 345778889999999999999865433 4699999865432 33456789999999999999999999987766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+++++|.+.. ...+..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 146 --~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~ 214 (353)
T PLN00034 146 --EIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGV 214 (353)
T ss_pred --eEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccccc
Confidence 569999999999986532 346778889999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcC
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIET-----GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP 304 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (393)
+........ ......|+..|+|||++.. ...+.++|||||||++|||++|+.||.................
T Consensus 215 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-- 290 (353)
T PLN00034 215 SRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM-- 290 (353)
T ss_pred ceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc--
Confidence 976432211 1234579999999998743 2345689999999999999999999974332211111111100
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
......+..++.++.+||.+||+.||++||++.++++|.|....
T Consensus 291 ------------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 291 ------------SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred ------------cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 00011122456789999999999999999999999999987754
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=318.75 Aligned_cols=265 Identities=27% Similarity=0.450 Sum_probs=213.8
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
.+|.+.+.||+|+||.||+|.+...........+++|.+..........+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD---- 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC----
Confidence 4588889999999999999987655445566779999987665555567889999999999999999999998766
Q ss_pred eEEEEEeecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRA--------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD 217 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~ 217 (393)
..++||||+++++|.+++.... ...+++..++.++.||+.||+|||++ +++||||||+||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVG 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEc
Confidence 4599999999999999996432 23478999999999999999999998 999999999999999
Q ss_pred CCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHH
Q 035862 218 GNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKL 296 (393)
Q Consensus 218 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~ 296 (393)
.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||....... .
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~ 234 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---V 234 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 999999999999976544332223344567789999999999999999999999999999999 999986654322 1
Q ss_pred HHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 297 LEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
........ ....+..++..+.+++.+||+.+|++||++.++++.|..+..
T Consensus 235 ~~~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECITQGR--------------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHhCCC--------------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11111100 000111245779999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=318.33 Aligned_cols=261 Identities=30% Similarity=0.473 Sum_probs=208.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-cHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|.+.+.||+|+||.||+|.+...........|++|.+...... ....+.+|+++++.++||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 81 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD--- 81 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC---
Confidence 458888999999999999998765544455678999998765433 3467889999999999999999999998775
Q ss_pred ceEEEEEeecCCCChHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRA------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG 218 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~ 218 (393)
..++||||+++++|.+++.... ...+++..+..++.|++.|+.|||++ +++||||||+||+++.
T Consensus 82 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~ 157 (280)
T cd05049 82 -PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGY 157 (280)
T ss_pred -CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcC
Confidence 5699999999999999996432 24578889999999999999999998 9999999999999999
Q ss_pred CCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHH
Q 035862 219 NFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLL 297 (393)
Q Consensus 219 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~ 297 (393)
++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~--- 234 (280)
T cd05049 158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI--- 234 (280)
T ss_pred CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---
Confidence 99999999999875433222222234456788999999999999999999999999999998 99998765432211
Q ss_pred HHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 298 EWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
..... + .....+..++..+.+++.+||+.||++||++.++++.|.
T Consensus 235 ~~~~~----~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 ECITQ----G----------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHc----C----------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11111 0 000111234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=328.72 Aligned_cols=263 Identities=28% Similarity=0.448 Sum_probs=212.1
Q ss_pred HHHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeee
Q 035862 65 QELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGY 142 (393)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~ 142 (393)
++.+...+...+...||+|.||+||+|.+-. -||||+++-.. ....+.|.+|+..+++-+|.||+-|.|+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~ 456 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGA 456 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehh
Confidence 4444555667888999999999999999752 19999987543 3455778999999999999999999999
Q ss_pred eecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCce
Q 035862 143 CSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP 222 (393)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 222 (393)
|..+.. .+|+.||+|-+|..+++..+ ..+...+.+.|++|++.|+.|||.+ +|||||||..|||+.++++|
T Consensus 457 ~~~p~~-----AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kV 527 (678)
T KOG0193|consen 457 CMNPPL-----AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKV 527 (678)
T ss_pred hcCCce-----eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcE
Confidence 987762 89999999999999997655 4588899999999999999999999 99999999999999999999
Q ss_pred EEeeccCCccCCCCCCccccccccccCCccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHH
Q 035862 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET---GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW 299 (393)
Q Consensus 223 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~ 299 (393)
||+|||++................|...|||||++.. .+|+..+||||||+++|||+||..||..+.. ++.+.
T Consensus 528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--dqIif-- 603 (678)
T KOG0193|consen 528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--DQIIF-- 603 (678)
T ss_pred EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--hheEE--
Confidence 9999999976444333333344567789999999953 4789999999999999999999999984322 11111
Q ss_pred HhhcCcCCcccccccCccc----ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 300 VKQFPADGKKFSMMIDPRL----RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
++.+++ ......+++.++.+|+..||.+++++||.+.+|+..|..++..
T Consensus 604 -------------mVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 604 -------------MVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred -------------EecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 111111 1112235678999999999999999999999999988888763
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=303.53 Aligned_cols=260 Identities=25% Similarity=0.378 Sum_probs=209.1
Q ss_pred HHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc----c----cHHHHHHHHHHhhcCC-CCccce
Q 035862 68 REATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL----Q----GHKQWLAEVQFLGVVS-HPNLVK 138 (393)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~E~~~l~~l~-h~niv~ 138 (393)
+...+.|.-.+.||.|..++|-++..+.++.+ +|+|++..... . ..+.-.+|+.||+++. ||||++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e-----~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~ 87 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKE-----FAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIID 87 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccc-----eeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEE
Confidence 44566788888999999999988886655544 88888753211 1 1233467999999986 999999
Q ss_pred eeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC
Q 035862 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG 218 (393)
Q Consensus 139 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~ 218 (393)
+.+++..+. .+++|+|.|..|.|.|+| .+.-++++...+.|++|+.+|++|||.. +||||||||+|||+++
T Consensus 88 l~D~yes~s----F~FlVFdl~prGELFDyL--ts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILldd 158 (411)
T KOG0599|consen 88 LQDVYESDA----FVFLVFDLMPRGELFDYL--TSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDD 158 (411)
T ss_pred eeeeccCcc----hhhhhhhhcccchHHHHh--hhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeecc
Confidence 999998776 569999999999999999 5556799999999999999999999999 9999999999999999
Q ss_pred CCceEEeeccCCccCCCCCCccccccccccCCccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCccCCCCchh
Q 035862 219 NFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET------GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM 292 (393)
Q Consensus 219 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslGvil~elltg~~pf~~~~~~~ 292 (393)
+-++||+|||++.....++. ....||||+|+|||.+.. ..|+..+|+|++|||+|.|+.|++||.....-.
T Consensus 159 n~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml 235 (411)
T KOG0599|consen 159 NMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML 235 (411)
T ss_pred ccceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH
Confidence 99999999999998876653 357899999999998853 468889999999999999999999998653322
Q ss_pred hhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 293 EQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
....+... .+.+ ..+-=.+.+.+..+||.+||+.||.+|.|++|++.|.+.+
T Consensus 236 MLR~ImeG-kyqF-------------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~ 287 (411)
T KOG0599|consen 236 MLRMIMEG-KYQF-------------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFI 287 (411)
T ss_pred HHHHHHhc-cccc-------------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence 21111100 1111 1111125678899999999999999999999999998764
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=327.41 Aligned_cols=254 Identities=26% Similarity=0.337 Sum_probs=213.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc---cHHHHHHHHHHhhcCC-CCccceeeeeeecC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ---GHKQWLAEVQFLGVVS-HPNLVKLLGYCSTE 146 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 146 (393)
...|++.+.||.|.||.||++..+.++ ..+|+|.+.+.... ....+.+|+.+|+++. ||||+.++++|.+.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg-----~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTG-----KEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCC-----ceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 456889999999999999999976554 45999999876543 3357889999999999 99999999999988
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC----Cce
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN----FKP 222 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~----~~~ 222 (393)
+ ..++|||++.||.|.+.+... .+++..+..++.|++.++.|||+. |++||||||+|+|+... +.+
T Consensus 109 ~----~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 109 D----SVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred C----eEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcE
Confidence 8 559999999999999999665 389999999999999999999998 99999999999999543 579
Q ss_pred EEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhh
Q 035862 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ 302 (393)
Q Consensus 223 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (393)
|++|||++..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||...........+ ...
T Consensus 179 k~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i--~~~ 253 (382)
T KOG0032|consen 179 KLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI--LRG 253 (382)
T ss_pred EEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH--HcC
Confidence 9999999998655 22456789999999999999999999999999999999999999999877654333211 111
Q ss_pred cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
-. ......-..++..+.+|+..||..||..|+|+.++++|+|
T Consensus 254 ~~------------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 254 DF------------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred CC------------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 00 1111222246789999999999999999999999999998
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=352.01 Aligned_cols=268 Identities=29% Similarity=0.468 Sum_probs=222.9
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
.-...+.||+|+||.||.|.+.+.........||+|.+.+. +.+....|++|..+|+.++|||||+++|++......
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~-- 770 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP-- 770 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc--
Confidence 35567789999999999999887665555788999999875 445667899999999999999999999999986644
Q ss_pred eEEEEEeecCCCChHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRA-----QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
++++|||+||+|..||+... ...++....+.++.||++|+.||+++ ++|||||..+|+|++....+||+|
T Consensus 771 --~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 771 --LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred --EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 89999999999999996541 34578889999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCc
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
||+|+.....+.+.......-...|||||.+..+.++.|+|||||||++||++| |..||...+....-. .+.
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~--~~~----- 918 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL--DVL----- 918 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH--HHH-----
Confidence 999996655555544444344568999999999999999999999999999999 888887654432111 111
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcC
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 364 (393)
..+ +...+..|++.++++|..||+.+|++||++..|++.+..+.+....
T Consensus 919 ---------~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 919 ---------EGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred ---------hCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 111 4445667889999999999999999999999999999888876543
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=340.42 Aligned_cols=255 Identities=22% Similarity=0.284 Sum_probs=203.8
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccce
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQ 152 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 152 (393)
.|.+.+.||+|+||.||+|....+ ....|++|.+..........+.+|+.+++.++||||+++++++...+ .
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~----~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~----~ 139 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSD----PKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD----K 139 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCC----CCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC----E
Confidence 489999999999999999985433 13457888776554444456778999999999999999999998776 5
Q ss_pred EEEEEeecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 153 RLLVYEYMPNRSLEDRLFSR--AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
.++||||+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla 216 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFS 216 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCc
Confidence 69999999999999988542 344688999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
...............+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... .+.......
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~--~~~~~~~~~------- 287 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE--IMQQVLYGK------- 287 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCC-------
Confidence 86543322223345679999999999999999999999999999999999999997543321 111111000
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
....+..++.++.+||.+||..||++||++.+++.+.
T Consensus 288 --------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~ 324 (478)
T PTZ00267 288 --------YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTE 324 (478)
T ss_pred --------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCH
Confidence 0011223457899999999999999999999998763
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=327.60 Aligned_cols=245 Identities=25% Similarity=0.319 Sum_probs=196.7
Q ss_pred ecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEE
Q 035862 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLV 156 (393)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv 156 (393)
||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.++..++||||+++++++...+ ..++|
T Consensus 1 lg~G~~g~Vy~~~~~~~-----~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv 71 (312)
T cd05585 1 IGKGSFGKVMQVRKRDT-----QRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE----KLYLV 71 (312)
T ss_pred CCcCCCeEEEEEEECCC-----CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC----eEEEE
Confidence 79999999999997543 3469999986532 233456778999999999999999999988766 56999
Q ss_pred EeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCC
Q 035862 157 YEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236 (393)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 236 (393)
|||+.+++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 72 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 72 LAFINGGELFHHLQR--EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred EcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence 999999999999853 45689999999999999999999998 9999999999999999999999999998753222
Q ss_pred CCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCc
Q 035862 237 DHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDP 316 (393)
Q Consensus 237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (393)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ........ .
T Consensus 147 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~--~~~~~~~~----~--------- 209 (312)
T cd05585 147 D--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE--MYRKILQE----P--------- 209 (312)
T ss_pred C--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH--HHHHHHcC----C---------
Confidence 2 12334679999999999999999999999999999999999999997653321 11111110 0
Q ss_pred ccccccCHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHHHHHH
Q 035862 317 RLRNQYSINAARRVAKLADNCLKKNPEERP---TMNQVVESLKLA 358 (393)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~~l~~l~~~ 358 (393)
...+..++.++.+|+.+||+.||.+|| ++.+++.|.|..
T Consensus 210 ---~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~ 251 (312)
T cd05585 210 ---LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFS 251 (312)
T ss_pred ---CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcC
Confidence 011223567889999999999999997 578999987643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=325.98 Aligned_cols=269 Identities=25% Similarity=0.394 Sum_probs=205.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|++.++||+|+||.||+|.+..+ +..+++|.+.... ......+.+|+++++.++||||+++++++...+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~-----~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 76 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPS-----GLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-- 76 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCC-----CcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC--
Confidence 36799999999999999999986533 3468889876542 233456889999999999999999999998766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+. .+++||||||+|||+++++.+||+|||+
T Consensus 77 --~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 77 --EISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred --EEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCc
Confidence 56999999999999999853 34588999999999999999999973 2799999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||............. .+..+..
T Consensus 151 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~ 222 (333)
T cd06650 151 SGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFG----CPVEGDP 222 (333)
T ss_pred chhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhc----CcccCCc
Confidence 8754322 1234578999999999998899999999999999999999999997544322111110 0000000
Q ss_pred ccc--------------------------------ccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 310 FSM--------------------------------MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 310 ~~~--------------------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
... ..............+.++.+|+.+||++||++|||+.+++.|.+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~ 302 (333)
T cd06650 223 AESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302 (333)
T ss_pred cccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence 000 000000000001245778999999999999999999999999887
Q ss_pred HHh
Q 035862 358 AVQ 360 (393)
Q Consensus 358 ~~~ 360 (393)
...
T Consensus 303 ~~~ 305 (333)
T cd06650 303 KRS 305 (333)
T ss_pred hcC
Confidence 544
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=329.05 Aligned_cols=246 Identities=26% Similarity=0.358 Sum_probs=197.5
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRL 154 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 154 (393)
+.||+|+||.||++.+..+ +..||+|++.... ......+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----~~~ 71 (328)
T cd05593 1 KLLGKGTFGKVILVREKAS-----GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD----RLC 71 (328)
T ss_pred CeeeeCCCEEEEEEEECCC-----CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC----EEE
Confidence 3699999999999986543 3469999987542 223456778999999999999999999988776 569
Q ss_pred EEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCC
Q 035862 155 LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGP 234 (393)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 234 (393)
+||||+++++|.+++. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 72 lv~Ey~~~g~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 72 FVMEYVNGGELFFHLS--RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred EEEeCCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 9999999999998884 345689999999999999999999998 99999999999999999999999999987532
Q ss_pred CCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccccccc
Q 035862 235 TGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMI 314 (393)
Q Consensus 235 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (393)
... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .... ...
T Consensus 147 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~---~~~~---~~~------- 211 (328)
T cd05593 147 TDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---ELIL---MED------- 211 (328)
T ss_pred Ccc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH---HHhc---cCC-------
Confidence 211 1223457999999999999999999999999999999999999999765432111 1110 000
Q ss_pred CcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHH
Q 035862 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKL 357 (393)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~ 357 (393)
...+..++.++.+|+.+||+.||++|+ ++.++++|.|.
T Consensus 212 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~ 254 (328)
T cd05593 212 -----IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254 (328)
T ss_pred -----ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCc
Confidence 011223467889999999999999997 89999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=328.17 Aligned_cols=246 Identities=26% Similarity=0.348 Sum_probs=197.2
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRL 154 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 154 (393)
+.||+|+||.||++.+..+ +..||+|.+.... ......+.+|+.+++.++||||+++++++...+ ..|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~----~~~ 71 (323)
T cd05595 1 KLLGKGTFGKVILVREKAT-----GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD----RLC 71 (323)
T ss_pred CeeeeCCCEEEEEEEECCC-----CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC----EEE
Confidence 3699999999999986543 3469999987542 123345678999999999999999999988776 569
Q ss_pred EEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCC
Q 035862 155 LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGP 234 (393)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 234 (393)
+||||+++++|..++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 72 lv~E~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 72 FVMEYANGGELFFHLS--RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred EEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence 9999999999998884 344689999999999999999999998 99999999999999999999999999987532
Q ss_pred CCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccccccc
Q 035862 235 TGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMI 314 (393)
Q Consensus 235 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (393)
.... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||........... .... .
T Consensus 147 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~--~~~~----~------- 211 (323)
T cd05595 147 SDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL--ILME----E------- 211 (323)
T ss_pred CCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH--HhcC----C-------
Confidence 2211 22345799999999999999999999999999999999999999976543221111 1000 0
Q ss_pred CcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHH
Q 035862 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKL 357 (393)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~ 357 (393)
...+..++.++.+|+.+||+.||++|| ++.++++|.|.
T Consensus 212 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~ 254 (323)
T cd05595 212 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 254 (323)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCc
Confidence 011223467889999999999999998 89999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=313.58 Aligned_cols=259 Identities=26% Similarity=0.410 Sum_probs=204.8
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|++.+.||+|+||.||+|.+... ......||+|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~--~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~--- 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLP--SKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN--- 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecC--CCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC---
Confidence 4689999999999999999986532 23556899999876532 23456789999999999999999999988765
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+|||++.++.++++|||.+
T Consensus 80 -~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 80 -TMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred -CcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccc
Confidence 459999999999999998643 34689999999999999999999998 9999999999999999999999999987
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
........ .......++..|+|||.+.+..++.++|||||||++||+++ |..||........ ...... +
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~~----~-- 224 (266)
T cd05064 155 QEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKAVED----G-- 224 (266)
T ss_pred ccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHHHC----C--
Confidence 65322111 11112345678999999999999999999999999999875 9999976543321 111111 0
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.....+..++..+.+++.+||+.+|.+||++.++++.|..+
T Consensus 225 --------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 --------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00111234567899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=330.47 Aligned_cols=271 Identities=30% Similarity=0.481 Sum_probs=217.2
Q ss_pred HHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC---CcccHHHHHHHHHHhhcCCCCccceeeeee
Q 035862 67 LREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH---GLQGHKQWLAEVQFLGVVSHPNLVKLLGYC 143 (393)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 143 (393)
++-..++-...++||+|+||.||+|.+...+.... ..||+|..... .......+++|++++++++|||||++||+.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~-~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKV-VPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCcee-eeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 33344566677899999999999999875443212 22899998753 245567789999999999999999999999
Q ss_pred ecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceE
Q 035862 144 STEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPK 223 (393)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~k 223 (393)
..+.+. ++|||+|.||+|.++|..... .++..+...++.+.+.||+|||++ +++||||-.+|+|++.++.+|
T Consensus 231 ~~~~Pl----~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 231 VLEEPL----MLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred cCCCcc----EEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEE
Confidence 888754 999999999999999965443 589999999999999999999999 999999999999999999999
Q ss_pred EeeccCCccCCCCCCccccc-cccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHh
Q 035862 224 LSDFGLAREGPTGDHTHVST-AVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVK 301 (393)
Q Consensus 224 l~Dfg~a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~ 301 (393)
|+|||+++... ...... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+....... .+.
T Consensus 303 ISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~---~kI- 375 (474)
T KOG0194|consen 303 ISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK---AKI- 375 (474)
T ss_pred eCccccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH---HHH-
Confidence 99999998643 111111 2245678999999999999999999999999999999 78898765443211 111
Q ss_pred hcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCC
Q 035862 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQG 365 (393)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 365 (393)
.....+...+...+.++..++.+||..+|++||++.++.+.+..+....+..
T Consensus 376 ------------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 376 ------------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred ------------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 0112223333356788999999999999999999999999999998876653
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=315.04 Aligned_cols=255 Identities=35% Similarity=0.587 Sum_probs=199.5
Q ss_pred ccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEE
Q 035862 76 RMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRL 154 (393)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 154 (393)
+.+.||.|+||.||+|.+.. ........|+||.+..... .....+.+|++.++.++||||++++|++...+. .+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~-~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~----~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQ-KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP----LF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEES-TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS----EE
T ss_pred EeeEEccCCCcEEEEEEEEc-ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc----cc
Confidence 45689999999999999874 3445678899999965432 336788999999999999999999999995553 59
Q ss_pred EEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCC
Q 035862 155 LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGP 234 (393)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 234 (393)
+||||+.+|+|.+++.......+++..++.++.|++.||.|||++ +++|+||+++||++++++.+||+|||++....
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence 999999999999999877567799999999999999999999998 99999999999999999999999999998763
Q ss_pred CCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 235 TGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 235 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
............+...|+|||.+.+..++.++||||||+++|||++ |..||....... +......
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~~~~~----------- 220 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIEKLKQ----------- 220 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHHHHHT-----------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccc-----------
Confidence 3333333344567789999999999999999999999999999999 678886653321 1111111
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
..+...+..++..+.+++..||..||++||++.++++.|
T Consensus 221 ---~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 221 ---GQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---TEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---cccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 011112223467899999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=333.41 Aligned_cols=256 Identities=23% Similarity=0.305 Sum_probs=200.0
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.|+.++.||+|+||+||+|.+..+ +..||+|++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~-----~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-- 74 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDT-----HALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD-- 74 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCC-----CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC--
Confidence 588999999999999999986544 34699999875422 23345788999999999999999999998766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
.+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 75 --~~~lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 75 --NLYFVMDYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred --EEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence 56999999999999999853 34689999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCC---------------------------------------------ccccccccccCCccCccccccCCCCc
Q 035862 230 AREGPTGDH---------------------------------------------THVSTAVVGTYGYAAPEYIETGHLKS 264 (393)
Q Consensus 230 a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 264 (393)
+........ .......+||+.|+|||++.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 753211000 00112357999999999999889999
Q ss_pred hhhHHHHHHHHHHHHhCCCccCCCCchhhhHH-HHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhc--ccC
Q 035862 265 QSDIWSFGVVLYEILTGRRVLERNRPTMEQKL-LEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCL--KKN 341 (393)
Q Consensus 265 ~~DiwslGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l--~~d 341 (393)
++|||||||++|||++|..||........... ..+.... .......++.++.+|+.+|+ ..+
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------~~~~~~~~s~~~~dli~~ll~~~~~ 292 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL---------------HIPPQVKLSPEAVDLITKLCCSAEE 292 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---------------CCCCCCCCCHHHHHHHHHHccCccc
Confidence 99999999999999999999987654322211 1110000 00011124678889999855 455
Q ss_pred CCCCCCHHHHHHHHHH
Q 035862 342 PEERPTMNQVVESLKL 357 (393)
Q Consensus 342 p~~Rps~~~~l~~l~~ 357 (393)
+..||++.+++.|.+.
T Consensus 293 ~~~R~~~~~~l~hp~f 308 (381)
T cd05626 293 RLGRNGADDIKAHPFF 308 (381)
T ss_pred ccCCCCHHHHhcCccc
Confidence 6669999999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=340.79 Aligned_cols=264 Identities=22% Similarity=0.273 Sum_probs=208.4
Q ss_pred HHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeec
Q 035862 68 REATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCST 145 (393)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 145 (393)
+...++|.+.+.||+|+||+||+|.+..++ ..||+|.+.... ......+.+|+.++..++|+||+++++.+..
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~ 102 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDG-----EPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK 102 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCC-----CEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence 344578999999999999999999865443 469999987543 2334567789999999999999999887755
Q ss_pred CCcc----cceEEEEEeecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC
Q 035862 146 EDER----GIQRLLVYEYMPNRSLEDRLFSR--AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN 219 (393)
Q Consensus 146 ~~~~----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~ 219 (393)
.+.. ...+++||||+.+|+|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+|||++.+
T Consensus 103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~ 179 (496)
T PTZ00283 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSN 179 (496)
T ss_pred ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCC
Confidence 4321 12468999999999999998643 235689999999999999999999998 99999999999999999
Q ss_pred CceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHH
Q 035862 220 FKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW 299 (393)
Q Consensus 220 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~ 299 (393)
+.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||........ +...
T Consensus 180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~--~~~~ 257 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV--MHKT 257 (496)
T ss_pred CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHH
Confidence 99999999999765433222233456799999999999999999999999999999999999999976533211 1111
Q ss_pred HhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
... .....+..++.++.+++.+||+.||.+||++.+++++.+
T Consensus 258 ~~~---------------~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~ 299 (496)
T PTZ00283 258 LAG---------------RYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPI 299 (496)
T ss_pred hcC---------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHH
Confidence 100 001122245678999999999999999999999998854
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=330.38 Aligned_cols=256 Identities=25% Similarity=0.330 Sum_probs=198.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++.+.||+|+||+||+|....+ +..||+|++.... ......+.+|+.++..++||||+++++.+.+.+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~- 74 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDT-----GHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL- 74 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCC-----CCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-
Confidence 4689999999999999999986543 3469999987532 122345678999999999999999999998766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
.+++||||+++|+|.+++.. ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG 146 (363)
T cd05628 75 ---NLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG 146 (363)
T ss_pred ---eEEEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence 56999999999999999853 45689999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCc---------------------------------cccccccccCCccCccccccCCCCchhhHHHHHHHH
Q 035862 229 LAREGPTGDHT---------------------------------HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVL 275 (393)
Q Consensus 229 ~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 275 (393)
++......... ......+||+.|+|||++.+..++.++|||||||++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil 226 (363)
T cd05628 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (363)
T ss_pred CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHH
Confidence 98754321100 011235799999999999999999999999999999
Q ss_pred HHHHhCCCccCCCCchhhhHH-HHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCC---CCCCHHHH
Q 035862 276 YEILTGRRVLERNRPTMEQKL-LEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPE---ERPTMNQV 351 (393)
Q Consensus 276 ~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~---~Rps~~~~ 351 (393)
|||++|..||........... ..+..... +.+ ...++.++.+++.+|+. +|. .||++.++
T Consensus 227 ~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~---------~p~------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei 290 (363)
T cd05628 227 YEMLIGYPPFCSETPQETYKKVMNWKETLI---------FPP------EVPISEKAKDLILRFCC-EWEHRIGAPGVEEI 290 (363)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHcCcCccc---------CCC------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH
Confidence 999999999976543321111 11000000 000 01245778889988665 444 56899999
Q ss_pred HHHHHH
Q 035862 352 VESLKL 357 (393)
Q Consensus 352 l~~l~~ 357 (393)
++|.|.
T Consensus 291 ~~hp~f 296 (363)
T cd05628 291 KTNPFF 296 (363)
T ss_pred hCCCCC
Confidence 999653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=315.16 Aligned_cols=265 Identities=31% Similarity=0.439 Sum_probs=208.6
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
+|++.+.||+|+||.||+|.............+++|.+..... .....+.+|+.+++.++||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--- 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP--- 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC---
Confidence 4788899999999999999876544444556789998875432 234567889999999999999999999887663
Q ss_pred eEEEEEeecCCCChHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRA----------------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDF 209 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Di 209 (393)
.+++|||+.+++|.+++.... ...+++..++.++.|++.||.|||+. +++||||
T Consensus 78 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~di 153 (290)
T cd05045 78 -LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDL 153 (290)
T ss_pred -cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhh
Confidence 499999999999999885321 13478889999999999999999998 9999999
Q ss_pred CCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCC
Q 035862 210 KTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERN 288 (393)
Q Consensus 210 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~ 288 (393)
||+|||+++++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999976433222212223345678999999988899999999999999999998 99999755
Q ss_pred CchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 289 RPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
.+.. +....... .....+..++.++.+++.+||+.+|++||++.++++.|+.++..
T Consensus 234 ~~~~---~~~~~~~~--------------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 234 APER---LFNLLKTG--------------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CHHH---HHHHHhCC--------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 4322 11111110 01111223457899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=333.32 Aligned_cols=256 Identities=25% Similarity=0.364 Sum_probs=202.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++.+.||.|+||+||+|.+..++ ..||+|++.... ......+.+|+.++..++||||+++++++...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTG-----HIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN- 74 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-
Confidence 47999999999999999999975443 469999987532 123345678999999999999999999998776
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
+.++||||+.+|+|.+++.. ...+++..++.++.|++.||+|||+. +|+||||||+|||++.+|.+||+|||
T Consensus 75 ---~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 146 (364)
T cd05599 75 ---YLYLIMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG 146 (364)
T ss_pred ---eEEEEECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence 56999999999999999854 34689999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCcc------------------------------------ccccccccCCccCccccccCCCCchhhHHHHH
Q 035862 229 LAREGPTGDHTH------------------------------------VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFG 272 (393)
Q Consensus 229 ~a~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 272 (393)
++.......... .....+||+.|+|||++.+..++.++||||||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 226 (364)
T cd05599 147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226 (364)
T ss_pred cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecch
Confidence 986532211000 01124699999999999999999999999999
Q ss_pred HHHHHHHhCCCccCCCCchhhhH-HHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC---H
Q 035862 273 VVLYEILTGRRVLERNRPTMEQK-LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT---M 348 (393)
Q Consensus 273 vil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~ 348 (393)
|++|||++|..||.......... ...+...... .....+++++.+||.+||. +|.+|++ +
T Consensus 227 ~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~---------------~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~ 290 (364)
T cd05599 227 VIMYEMLVGYPPFCSDNPQETYRKIINWKETLQF---------------PDEVPLSPEAKDLIKRLCC-EAERRLGNNGV 290 (364)
T ss_pred hHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCC---------------CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCH
Confidence 99999999999998665432111 1111000000 0011245788999999996 9999998 9
Q ss_pred HHHHHHHHH
Q 035862 349 NQVVESLKL 357 (393)
Q Consensus 349 ~~~l~~l~~ 357 (393)
.+++.|.|.
T Consensus 291 ~~ll~h~~~ 299 (364)
T cd05599 291 NEIKSHPFF 299 (364)
T ss_pred HHHhcCCCc
Confidence 999999764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=312.95 Aligned_cols=263 Identities=26% Similarity=0.417 Sum_probs=204.4
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
..++|++.+.||+|+||.||+|.+...........||+|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ- 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 3567999999999999999999876443344567799999865322 23455788999999999999999999987665
Q ss_pred ccceEEEEEeecCCCChHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRA--------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF 220 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~ 220 (393)
..++||||+.+++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++
T Consensus 83 ---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~ 156 (277)
T cd05062 83 ---PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDF 156 (277)
T ss_pred ---CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCC
Confidence 4599999999999999985422 12356788899999999999999998 999999999999999999
Q ss_pred ceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHH
Q 035862 221 KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEW 299 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~ 299 (393)
.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||....... ....
T Consensus 157 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~ 233 (277)
T cd05062 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRF 233 (277)
T ss_pred CEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence 999999999875443332222223455778999999998899999999999999999999 788886543321 1111
Q ss_pred HhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
...... ...+..++..+.+++.+||+.||++|||+.++++.+.
T Consensus 234 ~~~~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VMEGGL--------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcCCc--------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111000 0011124567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=317.96 Aligned_cols=257 Identities=27% Similarity=0.427 Sum_probs=206.3
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.|++.+.||+|+||.||++.+..+ +..||+|.+..... .....+.+|+.+++.++||||+++++.+...+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRAT-----GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCC-----CceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC--
Confidence 488899999999999999986533 34699999865322 12344678999999999999999999987766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
.+++||||+.+++|.+++.......+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+
T Consensus 74 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 74 --ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred --eEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence 569999999999999988665556789999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhh-HHHHHHhhcCcCCc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ-KLLEWVKQFPADGK 308 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~ 308 (393)
+....... ......|+..|+|||++.+..++.++||||+||++|+|++|..||......... .+......
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~------ 219 (285)
T cd05605 149 AVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE------ 219 (285)
T ss_pred ceecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh------
Confidence 87643222 123457899999999999889999999999999999999999999764332111 11111110
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKLAV 359 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~~~ 359 (393)
....++..++..+.+|+.+||..||.+|| ++.++++|.|...
T Consensus 220 ---------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 220 ---------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred ---------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 01112234567889999999999999999 8999999977653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=318.95 Aligned_cols=265 Identities=26% Similarity=0.397 Sum_probs=209.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcC-CCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 148 (393)
.++|.+.+.||+|+||.||+|.+...........+|+|.+.... ......+.+|+.+++.+ +||||+++++++...+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~- 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG- 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC-
Confidence 35699999999999999999986544444566789999887543 23345678899999999 7999999999987766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+.+++|.+++.......+++..+..++.|++.||.|||++ +++|+||||+|||++.++.++|+|||
T Consensus 113 ---~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 113 ---PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred ---ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCc
Confidence 459999999999999999655545589999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
++................++..|+|||.+.+..++.++||||+||++|+|++ |..||........ +.......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~~~---- 260 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIKEG---- 260 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHHcC----
Confidence 9976543322212223356778999999998999999999999999999998 9999875543221 11111110
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.....+...+.++.+++.+||+.+|++||++.++++.|.++
T Consensus 261 ----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 ----------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00011112357899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=313.24 Aligned_cols=261 Identities=28% Similarity=0.462 Sum_probs=207.1
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
.+|....+||+|+||.||++.............+++|.+..........+.+|+++++.++|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR---- 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC----
Confidence 4688889999999999999976544444566789999987665555667889999999999999999999988766
Q ss_pred eEEEEEeecCCCChHHHHhhcCC-------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQ-------------PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG 218 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~ 218 (393)
..+++|||+.+++|.+++..... ..+++..++.++.|++.|++|||+. +++||||||+|||+++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcC
Confidence 45999999999999999864321 3578899999999999999999998 9999999999999999
Q ss_pred CCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHH
Q 035862 219 NFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLL 297 (393)
Q Consensus 219 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~ 297 (393)
++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |.+||.........
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--- 234 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI--- 234 (280)
T ss_pred CCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH---
Confidence 99999999999875433222222233445678999999999999999999999999999998 89998654332111
Q ss_pred HHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 298 EWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
..... +. ....+..++..+.+++.+||+.||.+||++.++++.|.
T Consensus 235 ~~~~~----~~----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ECITQ----GR----------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHc----Cc----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 11100 00 00111234577899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=326.28 Aligned_cols=258 Identities=24% Similarity=0.344 Sum_probs=201.4
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC----cccHHHHHHHHHHhhcCC-CCccceeeeeeecCC
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG----LQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTED 147 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 147 (393)
+|++.+.||+|+||.||+++... ....+..||+|++.+.. ......+..|+.++..++ ||||+++++++...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVT--GHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcc--cCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence 48899999999999999998642 22355679999986532 122345678999999995 999999999887766
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..++||||+.+++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 79 ----~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Df 149 (332)
T cd05614 79 ----KLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDF 149 (332)
T ss_pred ----EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeC
Confidence 56999999999999999854 34689999999999999999999998 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhh-hHHHHHHhhcCc
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTME-QKLLEWVKQFPA 305 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~~~ 305 (393)
|++......... ......||+.|+|||++.+. .++.++|||||||++|||++|..||........ ..+.......
T Consensus 150 G~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-- 226 (332)
T cd05614 150 GLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC-- 226 (332)
T ss_pred cCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC--
Confidence 999764332221 22345799999999999765 478899999999999999999999964332211 1111111100
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKL 357 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~ 357 (393)
++ ..+..++..+.+++.+||+.||++|| +++++++|.|.
T Consensus 227 ---------~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 270 (332)
T cd05614 227 ---------DP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270 (332)
T ss_pred ---------CC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCc
Confidence 01 11223457789999999999999999 88999999763
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=324.06 Aligned_cols=248 Identities=26% Similarity=0.404 Sum_probs=196.1
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHh---hcCCCCccceeeeeeecCC
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFL---GVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~ 147 (393)
|++.+.||+|+||.||+|.+..++ ..||+|.+.+.. ......+.+|+.++ +.++||||+++++++...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTG-----ELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 678899999999999999875443 469999987532 12234455665554 5678999999999998766
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..|+||||+++++|..++. ...+++..++.++.||+.||.|||+. |++||||||+||+++.++.+||+||
T Consensus 76 ----~~~lv~E~~~~~~L~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 76 ----HVCFVMEYAAGGDLMMHIH---TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred ----EEEEEEcCCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence 5699999999999998873 24589999999999999999999998 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|++....... .......|++.|+|||.+.+..++.++|||||||++|+|++|..||.......... ......
T Consensus 146 g~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~--~i~~~~---- 217 (324)
T cd05589 146 GLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD--SIVNDE---- 217 (324)
T ss_pred cCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhCC----
Confidence 9987532221 12345679999999999999999999999999999999999999997654322111 111100
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLK 356 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~ 356 (393)
...+..++..+.+++.+||+.||.+|| ++.++++|.+
T Consensus 218 ------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~ 259 (324)
T cd05589 218 ------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259 (324)
T ss_pred ------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCC
Confidence 011223467789999999999999999 6899999865
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=302.91 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=204.4
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.+.|++...||+|.|+.||++....++.+ +++|.+... .....+.+.+|++|-+.++||||+++.+...++.
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~-----fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~- 83 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLE-----FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES- 83 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHH-----HHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccc-
Confidence 45688888999999999999987655554 666665432 1124566788999999999999999999887766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC---CceEEe
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN---FKPKLS 225 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~ 225 (393)
+.|+|+|++.|++|..-|..+ ..+++..+...++||++||.|+|.+ +|||||+||+|+++... .-+||+
T Consensus 84 ---~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~ 155 (355)
T KOG0033|consen 84 ---FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLA 155 (355)
T ss_pred ---eeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeec
Confidence 669999999999998777444 4568888999999999999999999 99999999999999543 349999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhh-cC
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ-FP 304 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~-~~ 304 (393)
|||+|.....+ ......+|||.|||||++...+|+-.+|||+.||+||-|+.|++||.+.+... .+...... +.
T Consensus 156 ~FGvAi~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--lye~I~~g~yd 230 (355)
T KOG0033|consen 156 DFGLAIEVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYEQIKAGAYD 230 (355)
T ss_pred ccceEEEeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--HHHHHhccccC
Confidence 99999877622 24456799999999999999999999999999999999999999998743321 11111111 11
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.++ ..=..+++++.+|+++||..||.+|.|+.|.++|.|..
T Consensus 231 ~~~-------------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 231 YPS-------------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred CCC-------------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 111 11124678899999999999999999999999999854
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=324.18 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=198.2
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCC-ccceeeeeeecCCc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHP-NLVKLLGYCSTEDE 148 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~ 148 (393)
+|++++.||+|+||.||+|.+..+ +..||+|++.+.. ......+..|..++..++|+ +|+.+++++...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGT-----DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD- 74 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCC-----CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-
Confidence 488999999999999999986543 3469999987532 23345677899999999765 5788888887766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
.+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05587 75 ---RLYFVMEYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG 146 (324)
T ss_pred ---EEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence 56999999999999998843 34688999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
++........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .......
T Consensus 147 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~~~i~~~----- 216 (324)
T cd05587 147 MCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQSIMEH----- 216 (324)
T ss_pred cceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHHHcC-----
Confidence 9865322211 22345799999999999999999999999999999999999999976543211 1111110
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM-----NQVVESLK 356 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~~l~~l~ 356 (393)
....+..++.++.+++.+||..||.+|++. .++++|.+
T Consensus 217 ----------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~ 259 (324)
T cd05587 217 ----------NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAF 259 (324)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCC
Confidence 001122345788999999999999999976 78888754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=318.89 Aligned_cols=256 Identities=23% Similarity=0.382 Sum_probs=215.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc--HHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--HKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
+-|...+.||+|.|+.|-+|++.-++.+ ||||++.+..... ...+++|++-|+.++|||||++|++..+..
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGek-----VAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT-- 90 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEK-----VAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT-- 90 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccce-----eEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc--
Confidence 3477778899999999999987766654 9999998875443 356889999999999999999999887666
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC-CCCceEEeecc
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD-GNFKPKLSDFG 228 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg 228 (393)
.+|||+|.-++|+|.+||.... .++.+..+.+++.||+.|+.|+|+. .+|||||||+|+.+- .-|-|||+|||
T Consensus 91 --KlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFG 164 (864)
T KOG4717|consen 91 --KLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFG 164 (864)
T ss_pred --eEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecc
Confidence 6799999999999999997655 4589999999999999999999998 999999999999875 45899999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCC-chhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLK-SQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
++..+..+.. .+..+|+..|-|||++.+..|+ +++||||||||||.|.+|++||+...+.....++
T Consensus 165 FSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---------- 231 (864)
T KOG4717|consen 165 FSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---------- 231 (864)
T ss_pred ccccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh----------
Confidence 9987665543 3567999999999999999997 5799999999999999999999876654332221
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
+| ..-..+..++.++.+||..||..||++|.+.++|..+.|..-.+
T Consensus 232 ------mD--CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 232 ------MD--CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred ------hc--ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 11 12234567899999999999999999999999999998876443
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=316.19 Aligned_cols=265 Identities=31% Similarity=0.450 Sum_probs=209.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcC-CCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||.||++.............+++|.+.... ......+.+|+.++..+ +|+||+++++++...+
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~- 89 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG- 89 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC-
Confidence 35689999999999999999988755544566789999987542 22335578899999999 7999999999987765
Q ss_pred ccceEEEEEeecCCCChHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCe
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSR--------------AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNV 214 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NI 214 (393)
..+++|||+.+++|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+||
T Consensus 90 ---~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni 163 (293)
T cd05053 90 ---PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV 163 (293)
T ss_pred ---CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence 459999999999999998542 234688999999999999999999998 999999999999
Q ss_pred EeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhh
Q 035862 215 LLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME 293 (393)
Q Consensus 215 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~ 293 (393)
++++++.+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 999999999999999986544332222223345678999999988899999999999999999997 9999875433221
Q ss_pred hHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 294 QKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.. ..... .....+..++..+.+|+.+||..||++|||+.++++.|..+.
T Consensus 244 ~~---~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FK---LLKEG--------------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH---HHHcC--------------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 11110 000112234577899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=332.59 Aligned_cols=256 Identities=22% Similarity=0.299 Sum_probs=199.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|.+++.||.|+||.||+|....+ +..||+|++.... ......+.+|+++++.++||||+++++++...+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~- 74 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDT-----GKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ- 74 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCC-----CCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence 4689999999999999999986543 3469999986532 123455778999999999999999999998766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
+.|+||||+++++|.+++.. ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG 146 (377)
T cd05629 75 ---YLYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG 146 (377)
T ss_pred ---eeEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence 56999999999999999853 45688999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCc---------------------------------------------cccccccccCCccCccccccCCCC
Q 035862 229 LAREGPTGDHT---------------------------------------------HVSTAVVGTYGYAAPEYIETGHLK 263 (393)
Q Consensus 229 ~a~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~ 263 (393)
++......... ......+||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 226 (377)
T cd05629 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence 98632110000 000124699999999999999999
Q ss_pred chhhHHHHHHHHHHHHhCCCccCCCCchhhhH-HHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCC
Q 035862 264 SQSDIWSFGVVLYEILTGRRVLERNRPTMEQK-LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNP 342 (393)
Q Consensus 264 ~~~DiwslGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 342 (393)
.++|||||||++|||++|..||.......... ...+...... .....++.++.+|+.+||. +|
T Consensus 227 ~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---------------p~~~~~s~~~~dli~~lL~-~~ 290 (377)
T cd05629 227 QECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYF---------------PDDIHLSVEAEDLIRRLIT-NA 290 (377)
T ss_pred CceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCC---------------CCCCCCCHHHHHHHHHHhc-CH
Confidence 99999999999999999999997654422111 1111000000 0011245788999999997 77
Q ss_pred CCC---CCHHHHHHHHHH
Q 035862 343 EER---PTMNQVVESLKL 357 (393)
Q Consensus 343 ~~R---ps~~~~l~~l~~ 357 (393)
.+| +++.+++.|.|.
T Consensus 291 ~~r~~r~~~~~~l~hp~~ 308 (377)
T cd05629 291 ENRLGRGGAHEIKSHPFF 308 (377)
T ss_pred hhcCCCCCHHHHhcCCCc
Confidence 765 599999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=324.03 Aligned_cols=249 Identities=26% Similarity=0.357 Sum_probs=198.0
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC----cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG----LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 153 (393)
+.||+|+||.||+++.... ...+..||+|.+.... ......+.+|+.+++.++||||+++++++...+ ..
T Consensus 2 ~~lg~G~~g~V~~~~~~~~--~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~----~~ 75 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTG--ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG----KL 75 (323)
T ss_pred ceeeecCCeEEEEEEEccc--CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC----eE
Confidence 5799999999999986422 2355679999987532 122345678999999999999999999998766 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+.+++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 76 YLILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred EEEEeCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 999999999999998843 45678889999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
..... ......|++.|+|||++.+..++.++|||||||++|||++|..||........ ....... .
T Consensus 151 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~--~~~~~~~----~------ 216 (323)
T cd05584 151 IHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT--IDKILKG----K------ 216 (323)
T ss_pred ccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH--HHHHHcC----C------
Confidence 22211 22345799999999999988899999999999999999999999976543211 1111100 0
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKL 357 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~ 357 (393)
...+..++..+.+|+.+||+.||++|| ++.++++|.|.
T Consensus 217 ------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~ 259 (323)
T cd05584 217 ------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF 259 (323)
T ss_pred ------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCc
Confidence 011223457789999999999999999 89999998763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=309.43 Aligned_cols=256 Identities=27% Similarity=0.439 Sum_probs=205.1
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
.+|.+.+.||+|+||.||+|.+...+ ..|++|.+.... .....+.+|+.+++.++||||+++++++...+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 75 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP---- 75 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCC-----ceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCC----
Confidence 35888899999999999999976433 359999887543 34567889999999999999999999988766
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..+++|||+.+++|.+++.......+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 76 PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccc
Confidence 458999999999999999765556789999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||........ .......
T Consensus 153 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~~~~~~------- 221 (263)
T cd05052 153 LMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELLEKG------- 221 (263)
T ss_pred ccccceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHCC-------
Confidence 65432211 1112234567999999998999999999999999999998 9999876433211 1111110
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.....+..++.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 222 -------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 -------YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 01111223457899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=314.93 Aligned_cols=262 Identities=26% Similarity=0.420 Sum_probs=207.1
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-cHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.+|++.+.||+|+||.||+|.+..+........||+|.+...... ....+.+|+.++..++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--- 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ--- 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC---
Confidence 357788899999999999998765544455678999999755322 2355778999999999999999999998776
Q ss_pred ceEEEEEeecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRA--------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL 216 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll 216 (393)
..++++||+.+++|.+++.... ...+++..++.++.|++.||.|||+. |++||||||+||++
T Consensus 82 -~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~ 157 (283)
T cd05091 82 -PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLV 157 (283)
T ss_pred -ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEe
Confidence 4589999999999999984321 23478888999999999999999998 99999999999999
Q ss_pred CCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhH
Q 035862 217 DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQK 295 (393)
Q Consensus 217 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~ 295 (393)
++++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~ 234 (283)
T cd05091 158 FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---D 234 (283)
T ss_pred cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 9999999999999886543332222334456788999999988889999999999999999998 88888654332 1
Q ss_pred HHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.......... ...+..++..+.+|+.+||+.+|.+||++.+++..|..
T Consensus 235 ~~~~i~~~~~--------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNRQV--------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcCCc--------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 2222211110 11222456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=323.81 Aligned_cols=268 Identities=27% Similarity=0.398 Sum_probs=207.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcC-CCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 149 (393)
++|++.+.||+|+||.||+|.+...+.......||+|.+..... .....+.+|+.++..+ +||||+++++++...+.
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~- 85 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG- 85 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC-
Confidence 57999999999999999999876555555677899999975432 2345678899999999 68999999998865543
Q ss_pred cceEEEEEeecCCCChHHHHhhcC--------------------------------------------------------
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRA-------------------------------------------------------- 173 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~-------------------------------------------------------- 173 (393)
..++||||+.+|+|.+++....
T Consensus 86 --~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 86 --PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred --ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4589999999999999985421
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCcccccc
Q 035862 174 ---------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTA 244 (393)
Q Consensus 174 ---------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 244 (393)
...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..............
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12367788889999999999999998 999999999999999999999999999876433222212223
Q ss_pred ccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccC
Q 035862 245 VVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYS 323 (393)
Q Consensus 245 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (393)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ....... +. ....+
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~~~~----~~----------~~~~~ 304 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLKE----GT----------RMRAP 304 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHHHHhc----cC----------CCCCC
Confidence 345678999999988899999999999999999997 8899865432211 1111110 00 00011
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 324 INAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 324 ~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
...+.++.+++..||+.||++||++.+++++|..+++.
T Consensus 305 ~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 305 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 12346789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=327.48 Aligned_cols=246 Identities=26% Similarity=0.340 Sum_probs=196.3
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRL 154 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 154 (393)
+.||+|+||.||++.+..+ +..||+|.+.... ......+.+|++++..++||||+++++++...+ ..+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~-----~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~----~~~ 71 (325)
T cd05594 1 KLLGKGTFGKVILVKEKAT-----GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD----RLC 71 (325)
T ss_pred CeeeeCCCEEEEEEEECCC-----CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC----EEE
Confidence 3699999999999986543 3469999987532 123345678999999999999999999988776 569
Q ss_pred EEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 155 LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE-GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
+||||+++++|..++. ....+++..++.++.||+.||.|||+ . ||+||||||+|||++.++.+||+|||++...
T Consensus 72 lv~E~~~~~~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 72 FVMEYANGGELFFHLS--RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred EEEeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 9999999999998884 34568999999999999999999997 6 9999999999999999999999999998753
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............ ... .
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i---~~~---~------ 212 (325)
T cd05594 147 IKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---LME---E------ 212 (325)
T ss_pred CCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH---hcC---C------
Confidence 22211 123457999999999999999999999999999999999999999765432111111 000 0
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKL 357 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~ 357 (393)
...+...+.++.+|+.+||+.||++|+ ++.++++|.|.
T Consensus 213 ------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~ 255 (325)
T cd05594 213 ------IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255 (325)
T ss_pred ------CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCc
Confidence 001123457889999999999999996 99999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=330.78 Aligned_cols=256 Identities=27% Similarity=0.365 Sum_probs=205.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|.+.+.||+|+||+||+|.+..+ +..||+|++.... ......+.+|+.++..++||||+++++++...+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDT-----GQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE- 74 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCC-----CCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC-
Confidence 4799999999999999999997543 3469999987532 133456788999999999999999999988766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
+.++||||+.+++|.+++... ..+++..++.++.|++.||+|||+. ||+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg 146 (350)
T cd05573 75 ---HLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFG 146 (350)
T ss_pred ---eEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCC
Confidence 569999999999999998544 5689999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCC---------------------------CccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhC
Q 035862 229 LAREGPTGD---------------------------HTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTG 281 (393)
Q Consensus 229 ~a~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg 281 (393)
++....... .........||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 226 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccC
Confidence 997654332 00122345799999999999999999999999999999999999
Q ss_pred CCccCCCCchhhhHH-HHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHH
Q 035862 282 RRVLERNRPTMEQKL-LEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT-MNQVVESLKL 357 (393)
Q Consensus 282 ~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~~l~~l~~ 357 (393)
+.||........... ..+.... .......++.++.+||.+||. ||.+||+ +.++++|.|.
T Consensus 227 ~~Pf~~~~~~~~~~~i~~~~~~~---------------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~ 288 (350)
T cd05573 227 FPPFYSDTLQETYNKIINWKESL---------------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFF 288 (350)
T ss_pred CCCCCCCCHHHHHHHHhccCCcc---------------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCc
Confidence 999987653221111 1100000 000011146789999999997 9999999 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=334.00 Aligned_cols=256 Identities=24% Similarity=0.309 Sum_probs=200.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++++.||+|+||.||+|.+..+ +..||+|.+..... .....+.+|+.+++.++||||+++++.+...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~-----~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~- 74 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDT-----NALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD- 74 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCC-----CCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-
Confidence 3699999999999999999997544 44699999865321 22345778999999999999999999998766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
.+++||||+++++|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG 146 (376)
T cd05598 75 ---NLYFVMDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG 146 (376)
T ss_pred ---EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCC
Confidence 56999999999999999843 45688999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCC-----------------------------------------ccccccccccCCccCccccccCCCCchhh
Q 035862 229 LAREGPTGDH-----------------------------------------THVSTAVVGTYGYAAPEYIETGHLKSQSD 267 (393)
Q Consensus 229 ~a~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 267 (393)
++........ .......+||+.|+|||++.+..++.++|
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 226 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence 9743210000 00012357999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCccCCCCchhhhHHH-HHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC
Q 035862 268 IWSFGVVLYEILTGRRVLERNRPTMEQKLL-EWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP 346 (393)
Q Consensus 268 iwslGvil~elltg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 346 (393)
||||||++|+|++|+.||....+....... .+... ........++.++.++|.+|+ .+|.+|+
T Consensus 227 iwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~~~~~s~~~~~li~~l~-~~p~~R~ 290 (376)
T cd05598 227 WWSVGVILYEMLVGQPPFLADTPAETQLKVINWETT---------------LHIPSQAKLSREASDLILRLC-CGAEDRL 290 (376)
T ss_pred eeeccceeeehhhCCCCCCCCCHHHHHHHHhccCcc---------------ccCCCCCCCCHHHHHHHHHHh-cCHhhcC
Confidence 999999999999999999876543222111 11000 000111134577888999976 5999999
Q ss_pred ---CHHHHHHHHHH
Q 035862 347 ---TMNQVVESLKL 357 (393)
Q Consensus 347 ---s~~~~l~~l~~ 357 (393)
++.++++|.|.
T Consensus 291 ~~~t~~ell~h~~~ 304 (376)
T cd05598 291 GKNGADEIKAHPFF 304 (376)
T ss_pred CCCCHHHHhCCCCc
Confidence 99999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=332.84 Aligned_cols=255 Identities=24% Similarity=0.330 Sum_probs=199.7
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.|++++.||+|+||+||+|.+..+ +..||+|++..... .....+.+|+.+++.++||||+++++.+...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~-----~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-- 74 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDT-----KALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-- 74 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCC-----CCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC--
Confidence 588999999999999999986543 34699999875421 23345778999999999999999999998766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
.+++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.+|.+||+|||+
T Consensus 75 --~~~lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 75 --NLYFVMDYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred --EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence 56999999999999999854 34688999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCC---------------------------------------------ccccccccccCCccCccccccCCCCc
Q 035862 230 AREGPTGDH---------------------------------------------THVSTAVVGTYGYAAPEYIETGHLKS 264 (393)
Q Consensus 230 a~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 264 (393)
+........ .......+||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 753210000 00112357999999999999999999
Q ss_pred hhhHHHHHHHHHHHHhCCCccCCCCchhhhHH-HHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCC
Q 035862 265 QSDIWSFGVVLYEILTGRRVLERNRPTMEQKL-LEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPE 343 (393)
Q Consensus 265 ~~DiwslGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~ 343 (393)
++|||||||++|||++|+.||....+...... ..+... .........++++.+++.+|+ .+|.
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~~~~~s~~~~~li~~l~-~~p~ 291 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS---------------LHIPPQAKLSPEASDLIIKLC-RGPE 291 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC---------------cCCCCcccCCHHHHHHHHHHc-cCHh
Confidence 99999999999999999999986554322211 111000 000111234677888998876 5999
Q ss_pred CCCC---HHHHHHHHHH
Q 035862 344 ERPT---MNQVVESLKL 357 (393)
Q Consensus 344 ~Rps---~~~~l~~l~~ 357 (393)
+|++ +.++++|.+.
T Consensus 292 ~R~~~~~~~ei~~hp~f 308 (382)
T cd05625 292 DRLGKNGADEIKAHPFF 308 (382)
T ss_pred HcCCCCCHHHHhcCCCc
Confidence 9997 9999998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=323.63 Aligned_cols=246 Identities=25% Similarity=0.367 Sum_probs=195.9
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcC-CCCccceeeeeeecCCcccceE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 153 (393)
+.||+|+||.||+|.+..+ +..||+|.+.+.. ......+..|..++..+ +||||+++++++...+ .+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~----~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLKES-----GRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD----RL 71 (320)
T ss_pred CeeeeCCCeEEEEEEEcCC-----CCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC----EE
Confidence 3699999999999986543 3469999987532 22344566788888776 6999999999998776 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...
T Consensus 72 ~iv~Ey~~~g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred EEEEcCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 999999999999998843 35689999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ....... .
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~---~~~i~~~---~------ 212 (320)
T cd05590 147 IFNGK--TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL---FEAILND---E------ 212 (320)
T ss_pred CcCCC--cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH---HHHHhcC---C------
Confidence 22211 22345799999999999999999999999999999999999999976543211 1111110 0
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM------NQVVESLKL 357 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~~l~~l~~ 357 (393)
...+..++.++.+|+.+||+.||.+||++ +++++|.|.
T Consensus 213 ------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f 256 (320)
T cd05590 213 ------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256 (320)
T ss_pred ------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCc
Confidence 01112345788999999999999999998 889988764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=314.39 Aligned_cols=277 Identities=30% Similarity=0.434 Sum_probs=207.6
Q ss_pred cCC-cccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGF-NRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y-~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++| ++.+.||+|+||+||++.+... ....+..||+|.+..... .....+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccc-cCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 345 8899999999999999875422 234556799999875432 2345678899999999999999999988765433
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+++++|.+++.. ..+++..++.++.|++.||.|||++ +++||||||+||++++++.++|+|||+
T Consensus 82 --~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~ 153 (283)
T cd05080 82 --GLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGL 153 (283)
T ss_pred --eEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccc
Confidence 56899999999999999843 3489999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCcc-ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 230 AREGPTGDHTH-VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 230 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+.......... ......++..|+|||.+.+..++.++||||||+++|+|++|..||............. ... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~-~~~~~ 231 (283)
T cd05080 154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP-KQG-QMTVV 231 (283)
T ss_pred ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcc-ccc-ccchh
Confidence 98654332211 1122345667999999988889999999999999999999999986543322111100 000 00000
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
......+.......+..++..+.+++.+||+.+|++|||++++++.|+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 011111111122223345688999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=321.91 Aligned_cols=245 Identities=24% Similarity=0.398 Sum_probs=192.2
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhc-CCCCccceeeeeeecCCcccceE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGV-VSHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~ 153 (393)
+.||+|+||.||+|.+..++ ..||+|.+.... .........|..++.. .+||||+++++++...+ ..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~----~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTN-----EFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE----HL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC----EE
Confidence 36999999999999975443 469999987532 1223445566777665 47999999999987766 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~e~~~gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred EEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 999999999999998843 34689999999999999999999998 9999999999999999999999999999754
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .......
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~--~~~i~~~----------- 211 (316)
T cd05592 147 MNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL--FDSILND----------- 211 (316)
T ss_pred CCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHcC-----------
Confidence 3222 123456799999999999999999999999999999999999999976543211 1111100
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMN-QVVESLK 356 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~~l~~l~ 356 (393)
....+..++.++.+|+.+||+.||.+||++. ++++|.+
T Consensus 212 -----~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~ 250 (316)
T cd05592 212 -----RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPF 250 (316)
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcc
Confidence 0111223457789999999999999999865 7777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=308.46 Aligned_cols=260 Identities=28% Similarity=0.457 Sum_probs=206.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|.+.+.||+|+||.||+|.+...+ .....|++|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPG--KKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR--- 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCC--CCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC---
Confidence 46899999999999999999875431 2345799998875432 23456788999999999999999999987765
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..+++|||+.+++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||++++++.++|+|||++
T Consensus 79 -~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~ 153 (266)
T cd05033 79 -PVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLS 153 (266)
T ss_pred -ceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchh
Confidence 4599999999999999986433 3689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
................++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~------ 224 (266)
T cd05033 154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAVEDG------ 224 (266)
T ss_pred hcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHHHcC------
Confidence 87642222212223345678999999998899999999999999999998 999986543221 11111110
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.....+..++..+.+++.+||+.+|++||++.+++++|..+
T Consensus 225 --------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 --------YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00011123457789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=314.45 Aligned_cols=272 Identities=26% Similarity=0.363 Sum_probs=200.2
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcC---CCCccceeeeeeecCC
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVV---SHPNLVKLLGYCSTED 147 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~ 147 (393)
+|++.+.||+|+||+||+|.+..++ ..||+|.+..... .....+.+|+.+++.+ +||||+++++++....
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~ 75 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSG-----HFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSR 75 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCC-----cEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecccc
Confidence 4889999999999999999976443 4699998865321 1223455677766654 7999999999886532
Q ss_pred c-ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 148 E-RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 148 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
. .....++||||+.+ +|.+++.......+++..++.++.|++.||.|||+. |++||||||+|||++.++.+||+|
T Consensus 76 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~d 151 (288)
T cd07863 76 TDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLAD 151 (288)
T ss_pred CCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECc
Confidence 2 22357899999964 899988665556689999999999999999999998 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhh-HHHHHHhhcCc
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ-KLLEWVKQFPA 305 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~ 305 (393)
||++....... ......|+..|+|||++.+..++.++|||||||++|+|++|.+||......... ...........
T Consensus 152 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 152 FGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 228 (288)
T ss_pred cCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence 99997653322 123456889999999999889999999999999999999999999765443221 11111110000
Q ss_pred CCccc-----ccccCccc---ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 306 DGKKF-----SMMIDPRL---RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 306 ~~~~~-----~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
..... .....+.. .......++..+.+++.+||+.||++|||+.+++.|.|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~ 287 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 00000 00000000 01111235677899999999999999999999998865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=321.92 Aligned_cols=267 Identities=28% Similarity=0.430 Sum_probs=225.7
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
.....++||.|.||.||+|.+..-. ++....||||..+.. .....+.|+.|+.+++.+.||||++++|+|.+..
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~-kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P---- 464 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPE-KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP---- 464 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccc-cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc----
Confidence 4556678999999999999986543 677888999999874 4455778999999999999999999999998765
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.++|||.+.-|.|.+||..++ ..++......++.||+.||+|||+. .+|||||...|||+.....+||+|||+++
T Consensus 465 -~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 -MWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred -eeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhh
Confidence 499999999999999997554 4589999999999999999999998 99999999999999999999999999999
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
.......+.. +...-+..|||||.+....++.++|||-|||++||++. |..||..-.. ++.
T Consensus 540 ~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN-----------------sDV 601 (974)
T KOG4257|consen 540 YLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN-----------------SDV 601 (974)
T ss_pred hccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc-----------------cce
Confidence 8876655432 34445668999999999999999999999999999876 8899975322 222
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCCCC
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSS 367 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~~ 367 (393)
-..+..+-+.+.+.+|++.++.|+.+||.++|.+||.+.++...|..++++....++
T Consensus 602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~~ 658 (974)
T KOG4257|consen 602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINSS 658 (974)
T ss_pred EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhhH
Confidence 333445556677888999999999999999999999999999999998885544433
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=334.90 Aligned_cols=274 Identities=22% Similarity=0.336 Sum_probs=198.4
Q ss_pred HHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC------CCcccee
Q 035862 66 ELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS------HPNLVKL 139 (393)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~ 139 (393)
++....++|++.++||+|+||+||+|.+... +..||+|++.... ........|+.+++.+. |.+++.+
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~-----~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i 196 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKR-----KEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKI 196 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCC-----CeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence 3344567899999999999999999987543 3469999986532 22233455666666654 4568888
Q ss_pred eeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCCeEeCC
Q 035862 140 LGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE-GLEIQVIYRDFKTSNVLLDG 218 (393)
Q Consensus 140 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dikp~NIll~~ 218 (393)
++++..... +.|+|||++ +++|.+++.. ...+++..++.++.||+.||.|||+ . ||+||||||+|||++.
T Consensus 197 ~~~~~~~~~---~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~ 267 (467)
T PTZ00284 197 QRYFQNETG---HMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMET 267 (467)
T ss_pred EEEEEcCCc---eEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEec
Confidence 888875443 568999998 7789988843 3568999999999999999999997 5 9999999999999987
Q ss_pred CC----------------ceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCC
Q 035862 219 NF----------------KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR 282 (393)
Q Consensus 219 ~~----------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~ 282 (393)
++ .+||+|||.+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~ 342 (467)
T PTZ00284 268 SDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342 (467)
T ss_pred CCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCC
Confidence 65 499999998754221 223568999999999999999999999999999999999999
Q ss_pred CccCCCCchhhhHHHH-HHhhcCcCC----------------cccccccCcc-c----c--cccCHHHHHHHHHHHHHhc
Q 035862 283 RVLERNRPTMEQKLLE-WVKQFPADG----------------KKFSMMIDPR-L----R--NQYSINAARRVAKLADNCL 338 (393)
Q Consensus 283 ~pf~~~~~~~~~~~~~-~~~~~~~~~----------------~~~~~~~~~~-~----~--~~~~~~~~~~l~~li~~~l 338 (393)
.||...........+. ....++..- .......++. + . ..........+.+||.+||
T Consensus 343 ~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 422 (467)
T PTZ00284 343 LLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLL 422 (467)
T ss_pred CCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhC
Confidence 9998665432222111 111111000 0000000000 0 0 0000012456789999999
Q ss_pred ccCCCCCCCHHHHHHHHHHHH
Q 035862 339 KKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 339 ~~dp~~Rps~~~~l~~l~~~~ 359 (393)
++||++|||+.|+++|.|...
T Consensus 423 ~~dP~~R~ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 423 HYDRQKRLNARQMTTHPYVLK 443 (467)
T ss_pred CcChhhCCCHHHHhcCccccc
Confidence 999999999999999998764
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=322.99 Aligned_cols=246 Identities=26% Similarity=0.388 Sum_probs=196.0
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcC-CCCccceeeeeeecCCcccceE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 153 (393)
+.||+|+||.||+|.+..++ ..||+|.+.... ......+..|.+++..+ +||||+++++++...+ ..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~----~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTD-----EVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD----RL 71 (321)
T ss_pred CccccCCCeEEEEEEECCCC-----CEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC----eE
Confidence 36999999999999865433 469999987532 22334566788888865 6999999999998776 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+++++|..++. ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~E~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQ--RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred EEEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 99999999999999884 345688999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
..... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||........ ....... .
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~---~~~i~~~---~------ 212 (321)
T cd05591 147 ILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL---FESILHD---D------ 212 (321)
T ss_pred ccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH---HHHHHcC---C------
Confidence 22221 22345789999999999999999999999999999999999999986543221 1111110 0
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERP-------TMNQVVESLKL 357 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-------s~~~~l~~l~~ 357 (393)
...+..++.++.+++.+||+.||++|| ++.++++|.+.
T Consensus 213 ------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~ 257 (321)
T cd05591 213 ------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF 257 (321)
T ss_pred ------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence 001112457889999999999999999 89999999754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=326.20 Aligned_cols=275 Identities=26% Similarity=0.319 Sum_probs=203.8
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc-
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER- 149 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~- 149 (393)
+|++.+.||+|+||.||+|.+..+ +..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRD-----GKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCC-----CCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccc
Confidence 478889999999999999986533 3469999886532 22345678999999999999999999998766521
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
....++||||+. ++|.+++. ....+++..++.++.||+.||.|||+. +++||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~ 149 (372)
T cd07853 76 FEEIYVVTELMQ-SDLHKIIV--SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGL 149 (372)
T ss_pred cceEEEEeeccc-cCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccc
Confidence 125699999995 58888773 345689999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+........ .......+++.|+|||++.+. .++.++|||||||++|||++|+.||....+......+......+....
T Consensus 150 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 150 ARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred eeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 976433221 122345688999999998774 579999999999999999999999987654432221111100000000
Q ss_pred ------cccc-cc----Cc-cc--ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 309 ------KFSM-MI----DP-RL--RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 309 ------~~~~-~~----~~-~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.... +. .+ .. ........++++.+|+.+||+.||++|||+.++++|.|...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 293 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence 0000 00 00 00 00011123678899999999999999999999999988643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=310.94 Aligned_cols=261 Identities=28% Similarity=0.475 Sum_probs=204.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|++.+.||+|+||.||+|.+...+ ......+++|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 80 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPG-MDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ--- 80 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCC-CCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC---
Confidence 46888999999999999999864332 23456799999875432 23356788999999999999999999987766
Q ss_pred ceEEEEEeecCCCChHHHHhhcC---------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeE
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRA---------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVL 215 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIl 215 (393)
..++||||+.+++|.+++.... ...+++..+..++.|++.||.|||++ +++||||||+|||
T Consensus 81 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil 156 (283)
T cd05090 81 -PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL 156 (283)
T ss_pred -ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence 4599999999999999985322 23478888999999999999999998 9999999999999
Q ss_pred eCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhh
Q 035862 216 LDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQ 294 (393)
Q Consensus 216 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~ 294 (393)
+++++.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~-- 234 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE-- 234 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 99999999999999976543332223334456778999999988889999999999999999998 988987654321
Q ss_pred HHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.......... ...+..++..+.+++.+||+.||.+||++.+++++|..
T Consensus 235 -~~~~~~~~~~--------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 -VIEMVRKRQL--------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHHcCCc--------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111000 01112345778999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=309.58 Aligned_cols=262 Identities=28% Similarity=0.434 Sum_probs=203.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|.+.+.||+|++|.||+|.+...........|++|....... .....+.+|+.+++.++|+||+++++++...+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~- 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP- 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC-
Confidence 457999999999999999999986533333566799998865432 234567889999999999999999998877663
Q ss_pred cceEEEEEeecCCCChHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC---c
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQ-----PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF---K 221 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~---~ 221 (393)
.++||||+.+++|.+++..... ..+++..++.++.||+.||+|||+. +++||||||+||+++.++ .
T Consensus 84 ---~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~ 157 (277)
T cd05036 84 ---RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRV 157 (277)
T ss_pred ---cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcc
Confidence 4899999999999999854321 3588999999999999999999998 999999999999998765 5
Q ss_pred eEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHH
Q 035862 222 PKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWV 300 (393)
Q Consensus 222 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~ 300 (393)
+||+|||++.................+..|+|||++.+..++.++|||||||++|+|++ |..||......... ...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~---~~~ 234 (277)
T cd05036 158 AKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM---EFV 234 (277)
T ss_pred eEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHH
Confidence 99999999986532222111122234568999999998999999999999999999997 99999765432211 111
Q ss_pred hhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
... .....+..++..+.+++.+||+.+|++||++.+++++|.
T Consensus 235 ~~~--------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGG--------------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcC--------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 110 001112234578899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=314.37 Aligned_cols=268 Identities=28% Similarity=0.421 Sum_probs=208.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCC--CCceEEEEEEecCCC-cccHHHHHHHHHHhhcC-CCCccceeeeeeecCC
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGR--GEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTED 147 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 147 (393)
++|.+.+.||+|+||.||+|.+...+.. .....+|+|.+.... ......+.+|+.+++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 5699999999999999999987543321 234569999987542 23345677899999999 6999999999998776
Q ss_pred cccceEEEEEeecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCC
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRA--------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSN 213 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~N 213 (393)
..++||||+.+++|.+++.... ...+++..++.++.|++.||+|||+. |++||||||+|
T Consensus 98 ----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 98 ----PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 4599999999999999996532 13478899999999999999999998 99999999999
Q ss_pred eEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchh
Q 035862 214 VLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTM 292 (393)
Q Consensus 214 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~ 292 (393)
|+++.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 9999999999999999876533222111222234568999999988899999999999999999998 888886543221
Q ss_pred hhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 293 EQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
+....... .....+..++.++.+|+.+||..+|.+||++.++++.|+.+.....
T Consensus 251 ---~~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 251 ---LFKLLKEG--------------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred ---HHHHHHcC--------------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 11111110 0111122345789999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=327.55 Aligned_cols=258 Identities=22% Similarity=0.281 Sum_probs=202.5
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecC
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTE 146 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 146 (393)
..++|++.+.||+|+||.||+|.+..++ ..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSK-----QVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3567999999999999999999875443 469999986431 12234467899999999999999999988876
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
+ ..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 116 ~----~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 116 K----YLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred C----EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEe
Confidence 6 56999999999999998843 3478889999999999999999998 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccC----CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhh
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG----HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ 302 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (393)
||++........ .......||+.|+|||++.+. .++.++|||||||++|||++|..||........ .......
T Consensus 186 fG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~~i~~~ 262 (370)
T cd05596 186 FGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--YSKIMDH 262 (370)
T ss_pred ccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH--HHHHHcC
Confidence 999876433221 122346799999999998653 478999999999999999999999986543211 1111110
Q ss_pred cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHH
Q 035862 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEE--RPTMNQVVESLKL 357 (393)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~~l~~l~~ 357 (393)
... +.......++.++.+|+.+||+.+|.+ |+++.++++|.|.
T Consensus 263 ----~~~--------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~ 307 (370)
T cd05596 263 ----KNS--------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307 (370)
T ss_pred ----CCc--------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCccc
Confidence 000 000001124678999999999999987 9999999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=312.67 Aligned_cols=250 Identities=28% Similarity=0.416 Sum_probs=198.0
Q ss_pred ecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc---cHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEE
Q 035862 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ---GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLV 156 (393)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv 156 (393)
||+|+||+||++.+..++ ..||+|.+...... ....+..|+.+++.++||||+++.+++.... ..++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~----~~~lv 71 (280)
T cd05608 1 LGKGGFGEVSACQMRATG-----KLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT----DLCLV 71 (280)
T ss_pred CCCCCceeEEEEEEccCC-----cEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC----eEEEE
Confidence 699999999999875443 46999998654222 2245678999999999999999999887765 56999
Q ss_pred EeecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCC
Q 035862 157 YEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGP 234 (393)
Q Consensus 157 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 234 (393)
|||+++++|..++.. .....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++....
T Consensus 72 ~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 148 (280)
T cd05608 72 MTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELK 148 (280)
T ss_pred EeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecC
Confidence 999999999988753 2345689999999999999999999998 99999999999999999999999999987643
Q ss_pred CCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhh-HHHHHHhhcCcCCcccccc
Q 035862 235 TGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ-KLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 235 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 313 (393)
.... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||......... .... .....
T Consensus 149 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~---~~~~~------- 216 (280)
T cd05608 149 DGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---RILND------- 216 (280)
T ss_pred CCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH---hhccc-------
Confidence 3221 123457899999999999999999999999999999999999999764332111 1111 00000
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKLA 358 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~~ 358 (393)
....+..++..+.+++.+||+.||++|| +++++++|.|.-
T Consensus 217 -----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~ 261 (280)
T cd05608 217 -----SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFR 261 (280)
T ss_pred -----CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhh
Confidence 0012223567899999999999999999 889999998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=320.15 Aligned_cols=274 Identities=25% Similarity=0.347 Sum_probs=203.1
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 93 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVL-----GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQK 93 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCC-----CceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 457899999999999999999986543 346999998653 2233456778999999999999999999986554
Q ss_pred cc--cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 148 ER--GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 148 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
.. ....|+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||++ ||+||||||+|||++.+|.+||+
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~ 165 (359)
T cd07876 94 SLEEFQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 165 (359)
T ss_pred CccccceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEe
Confidence 21 1246999999965 6766652 2478889999999999999999999 99999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH-HH-------
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK-LL------- 297 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~-~~------- 297 (393)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...... ..
T Consensus 166 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 166 DFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred cCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 999997543221 2234578999999999999999999999999999999999999997654321100 00
Q ss_pred ------------HHHhhcCc-CCcccccccCccc---ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 298 ------------EWVKQFPA-DGKKFSMMIDPRL---RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 298 ------------~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.+....+. .+..+........ ........+.++.+|+.+||+.||++|||+.++++|.|...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 00000000 0000000000000 00011123567899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=308.07 Aligned_cols=254 Identities=29% Similarity=0.433 Sum_probs=203.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.++||+|+||.||+|.+... ..|++|.+.... .....+.+|+.+++.++|+||+++++.+...+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~------~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 74 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNS------TKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE---- 74 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCC------ceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----
Confidence 5699999999999999999985422 248999876543 23567889999999999999999999887665
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..+++|||+.+++|.+++.......+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~ 151 (261)
T cd05072 75 PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLAR 151 (261)
T ss_pred CcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccce
Confidence 459999999999999999766666788999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||........ ........
T Consensus 152 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~~~~~------ 221 (261)
T cd05072 152 VIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSALQRGY------ 221 (261)
T ss_pred ecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHHHHcCC------
Confidence 65432211 1223345678999999988889999999999999999998 9999975433221 11111100
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.......++.++.+++.+||..+|++||++.++++.|+.
T Consensus 222 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 222 --------RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 000111245778999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=316.44 Aligned_cols=272 Identities=22% Similarity=0.363 Sum_probs=203.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|.+.+.||+|+||.||+|++..++ ..||+|.+..... .....+.+|+.+++.++||||+++++++..++
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 77 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTE-----NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK--- 77 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCC-----CeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC---
Confidence 56999999999999999999865433 4699998875432 22345678999999999999999999998766
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+ +|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 78 -~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 151 (309)
T cd07872 78 -SLTLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA 151 (309)
T ss_pred -eEEEEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccc
Confidence 56999999965 888887543 34578899999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC--
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG-- 307 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-- 307 (393)
........ ......+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..................+...
T Consensus 152 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
T cd07872 152 RAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229 (309)
T ss_pred eecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 75432221 1233467899999998865 568999999999999999999999997665433222111111111000
Q ss_pred ------cccccccCccccc----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 308 ------KKFSMMIDPRLRN----QYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 308 ------~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
..+.....+.... .....++.++.+|+.+||+.||.+|||+.++++|.|...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 230 PGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred hhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 0000000000000 011135678899999999999999999999999988753
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=320.83 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=193.6
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhc-CCCCccceeeeeeecCCcccceE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGV-VSHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~ 153 (393)
+.||+|+||.||+|.+..++ ..||+|.+.... .........|..++.. .+||||+++++++...+ +.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~----~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKG-----EYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE----HL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC----EE
Confidence 36999999999999975443 469999987532 1233455677777765 47999999999998766 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+.+++|..++.. ...+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred EEEECCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 999999999999998843 35688999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ........ .
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~~~~~~---~------ 212 (316)
T cd05620 147 VFGDN--RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFESIRVD---T------ 212 (316)
T ss_pred ccCCC--ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHhC---C------
Confidence 22211 2345679999999999999999999999999999999999999997654321 11111100 0
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCH-HHHHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM-NQVVESLKL 357 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-~~~l~~l~~ 357 (393)
...+..++.++.+++.+||+.||++||++ .++++|.+.
T Consensus 213 ------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f 251 (316)
T cd05620 213 ------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFF 251 (316)
T ss_pred ------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCc
Confidence 01111245778999999999999999997 577777554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=320.69 Aligned_cols=246 Identities=27% Similarity=0.406 Sum_probs=196.1
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcC-CCCccceeeeeeecCCcccceE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 153 (393)
+.||+|+||+||+|.+..++ ..||+|.+.+.. ......+..|..++..+ +||||+++++++...+ ..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~----~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTD-----ELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD----RL 71 (318)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC----EE
Confidence 36999999999999875443 459999987532 22344567788888877 6999999999988766 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+++++|..++.. ...+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred EEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 999999999999988843 34689999999999999999999998 9999999999999999999999999998653
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
..... .....+|++.|+|||++.+..++.++|||||||++|+|++|..||........ ....... .
T Consensus 147 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~---~~~i~~~---~------ 212 (318)
T cd05570 147 ILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL---FQSILED---E------ 212 (318)
T ss_pred CcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH---HHHHHcC---C------
Confidence 22211 12345789999999999999999999999999999999999999976543211 1111100 0
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM-----NQVVESLKL 357 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~~l~~l~~ 357 (393)
...+..++..+.+|+.+||..||.+||++ .+++++.|.
T Consensus 213 ------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~ 255 (318)
T cd05570 213 ------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFF 255 (318)
T ss_pred ------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCc
Confidence 01122345788999999999999999999 999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=308.64 Aligned_cols=255 Identities=29% Similarity=0.468 Sum_probs=207.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
..+|++.+.||.|+||.||+|.+.. ...+++|.+..........+..|+.+++.++||||+++++++...+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~------~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 75 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN------RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE--- 75 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC------CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC---
Confidence 3468899999999999999999754 2359999988766555677889999999999999999999988776
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+++|.+++.......+++..++.++.|++.||.|||++ |++|+||+|+||++++++.+||+|||.+
T Consensus 76 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~ 151 (261)
T cd05148 76 -PVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLA 151 (261)
T ss_pred -CeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccch
Confidence 459999999999999999766666789999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......... .....
T Consensus 152 ~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~--~~~~~------- 220 (261)
T cd05148 152 RLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD--QITAG------- 220 (261)
T ss_pred hhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH--HHHhC-------
Confidence 76533221 1223345678999999988899999999999999999998 899997654321111 11111
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.....+..++..+.+++.+||+.||.+|||+.++++.|+.
T Consensus 221 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 221 --------YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0111122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=325.37 Aligned_cols=266 Identities=25% Similarity=0.395 Sum_probs=207.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCC-CCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 148 (393)
.++|.+.+.||+|+||.||+|++...........||+|++..... .....+.+|+.+|..+. ||||+++++++...+
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~- 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG- 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC-
Confidence 345888899999999999999986544444566799999975432 22346788999999998 999999999998766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcC-------------------------------------------------------
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRA------------------------------------------------------- 173 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------- 173 (393)
..++||||+.+|+|.+++....
T Consensus 115 ---~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 115 ---PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred ---CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 4599999999999999985421
Q ss_pred -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 035862 174 -----------------------------------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTS 212 (393)
Q Consensus 174 -----------------------------------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~ 212 (393)
...+++..++.++.|++.||.|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 12356777889999999999999998 9999999999
Q ss_pred CeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCch
Q 035862 213 NVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPT 291 (393)
Q Consensus 213 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~ 291 (393)
|||+++++.+||+|||++................++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 99999999999999999975433222112223456788999999998889999999999999999998 88898654322
Q ss_pred hhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 292 MEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.. ....... ..+...+..++.++.+|+.+||..+|.+||++.++++.|..++
T Consensus 349 ~~--~~~~~~~--------------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 EQ--FYNAIKR--------------GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HH--HHHHHHc--------------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11 1111100 0011112234678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=321.67 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=195.9
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcC-CCCccceeeeeeecCCcccceE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 153 (393)
+.||+|+||.||+|.+..++ ..||+|.+.... ......+..|..++..+ +||||+++++++...+ .+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~----~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTR-----RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES----RL 71 (329)
T ss_pred CeEeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC----EE
Confidence 36999999999999975443 469999987532 22334567899999888 6999999999998776 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+++++|.+++. ....+++..++.++.||+.||.|||++ |++||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~e~~~~g~L~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQ--RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred EEEEeCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 99999999999998884 345689999999999999999999998 9999999999999999999999999998743
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCch------hhhHHHHHHhhcCcCC
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPT------MEQKLLEWVKQFPADG 307 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~------~~~~~~~~~~~~~~~~ 307 (393)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...........
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~----- 219 (329)
T cd05588 147 IRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE----- 219 (329)
T ss_pred ccCCC--ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc-----
Confidence 22111 223467999999999999999999999999999999999999999632111 01111111110
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT------MNQVVESLKL 357 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps------~~~~l~~l~~ 357 (393)
.. ...+..++.++.+++.+||+.||.+|++ +.++++|.|.
T Consensus 220 --------~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~ 265 (329)
T cd05588 220 --------KQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265 (329)
T ss_pred --------CC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCC
Confidence 00 0112234577899999999999999987 7899998765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=321.12 Aligned_cols=250 Identities=26% Similarity=0.393 Sum_probs=197.6
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCC-CCccceeeeeeecCCc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDE 148 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 148 (393)
+|.+.+.||+|+||.||+|.+..++ ..||+|.+.+... ........|..++..+. |++|+++++++...+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTD-----ELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD- 74 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC-
Confidence 4888999999999999999865433 4699999875421 22334566788887774 899999999887766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
.+++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||
T Consensus 75 ---~~~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG 146 (323)
T cd05616 75 ---RLYFVMEYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred ---EEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence 56999999999999998843 34688999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
++........ ......||+.|+|||++.+..++.++|||||||++|||++|..||........ .......
T Consensus 147 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~--~~~i~~~------ 216 (323)
T cd05616 147 MCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQSIMEH------ 216 (323)
T ss_pred CceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH--HHHHHhC------
Confidence 9875322211 22346799999999999999999999999999999999999999976543211 1111110
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM-----NQVVESLK 356 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~~l~~l~ 356 (393)
...++...+.++.+++.+||+.||.+|++. .++++|.+
T Consensus 217 ----------~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~ 259 (323)
T cd05616 217 ----------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 259 (323)
T ss_pred ----------CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCC
Confidence 001122356788999999999999999984 78887744
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=318.64 Aligned_cols=245 Identities=25% Similarity=0.405 Sum_probs=193.2
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhc-CCCCccceeeeeeecCCcccceE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGV-VSHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~ 153 (393)
+.||+|+||.||+|.+..++ ..||+|.+.... .........|..++.. ++||||+++++++.+.+ ..
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~----~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTN-----QFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE----NL 71 (316)
T ss_pred CeeeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC----EE
Confidence 36999999999999975443 469999987542 1233445667777776 48999999999998776 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 999999999999998843 34688999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...... ..
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~---~~~i~~---~~------ 212 (316)
T cd05619 147 MLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL---FQSIRM---DN------ 212 (316)
T ss_pred CCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh---CC------
Confidence 22221 22345789999999999999999999999999999999999999976543211 111110 00
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMN-QVVESLK 356 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~~l~~l~ 356 (393)
...+..++.++.+|+.+||+.||++||++. ++++|.+
T Consensus 213 ------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~ 250 (316)
T cd05619 213 ------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPF 250 (316)
T ss_pred ------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcc
Confidence 011123457789999999999999999996 7877755
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=326.36 Aligned_cols=262 Identities=22% Similarity=0.290 Sum_probs=203.0
Q ss_pred HHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeee
Q 035862 67 LREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYC 143 (393)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 143 (393)
+....++|++.+.||+|+||.||+|.+..++ ..+|+|.+.+.. ......+.+|+.+++.++||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQ-----KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF 112 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 3344578999999999999999999975443 469999986421 12234567899999999999999999999
Q ss_pred ecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceE
Q 035862 144 STEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPK 223 (393)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~k 223 (393)
...+ ..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|
T Consensus 113 ~~~~----~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~k 182 (370)
T cd05621 113 QDDK----YLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLK 182 (370)
T ss_pred EcCC----EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEE
Confidence 8766 56999999999999998843 2478999999999999999999998 999999999999999999999
Q ss_pred EeeccCCccCCCCCCccccccccccCCccCccccccC----CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHH
Q 035862 224 LSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG----HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW 299 (393)
Q Consensus 224 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~ 299 (393)
|+|||++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ....
T Consensus 183 L~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~--~~~i 259 (370)
T cd05621 183 LADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT--YSKI 259 (370)
T ss_pred EEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH--HHHH
Confidence 999999976533221 122456799999999998654 378899999999999999999999976543221 1111
Q ss_pred HhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHHH
Q 035862 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEE--RPTMNQVVESLKLA 358 (393)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~~l~~l~~~ 358 (393)
... .. .+.......++..+.+++..||..++.+ |+++.++++|.|..
T Consensus 260 ~~~----~~--------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~ 308 (370)
T cd05621 260 MDH----KN--------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK 308 (370)
T ss_pred HhC----Cc--------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccC
Confidence 110 00 0000111234678899999999855543 89999999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=325.05 Aligned_cols=257 Identities=23% Similarity=0.272 Sum_probs=202.6
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|.+.+.||+|+||+||+|.+..++ ..||+|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~- 74 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATG-----DIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD- 74 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCC-----CEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-
Confidence 46999999999999999999865433 4699999875422 23455778999999999999999999887765
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+++++|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg 147 (330)
T cd05601 75 ---NLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG 147 (330)
T ss_pred ---eEEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCC
Confidence 569999999999999998543 24689999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhh
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIE------TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ 302 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (393)
++......... ......||+.|+|||++. ...++.++|||||||++|+|++|..||........ +......
T Consensus 148 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~--~~~i~~~ 224 (330)
T cd05601 148 SAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT--YNNIMNF 224 (330)
T ss_pred CCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH--HHHHHcC
Confidence 99765433221 223457899999999986 45678999999999999999999999976543221 1111100
Q ss_pred cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.. .........++.++.+|+.+||+ +|.+||++.+++.|.|.
T Consensus 225 ----~~--------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~ 266 (330)
T cd05601 225 ----QR--------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFF 266 (330)
T ss_pred ----CC--------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCc
Confidence 00 00000111245778999999998 99999999999999764
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=322.92 Aligned_cols=274 Identities=24% Similarity=0.312 Sum_probs=203.5
Q ss_pred HHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecC
Q 035862 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTE 146 (393)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 146 (393)
...++|++.+.||+|+||.||+|.+... +..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 88 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVL-----DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ 88 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCC-----CceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecc
Confidence 3467899999999999999999986533 3459999987542 23345677899999999999999999988654
Q ss_pred Cc--ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEE
Q 035862 147 DE--RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKL 224 (393)
Q Consensus 147 ~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 224 (393)
.. .....++||||+++ +|.+.+. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl 160 (355)
T cd07874 89 KSLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_pred ccccccceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEE
Confidence 42 11246999999965 7777663 2478889999999999999999998 9999999999999999999999
Q ss_pred eeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH-HHH-----
Q 035862 225 SDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK-LLE----- 298 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~-~~~----- 298 (393)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ...
T Consensus 161 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (355)
T cd07874 161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_pred eeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999997643321 2234578999999999999999999999999999999999999997654321110 000
Q ss_pred ----------HHhhcCcCCcc-----cccccCccc---ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 299 ----------WVKQFPADGKK-----FSMMIDPRL---RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 299 ----------~~~~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
....+...... +........ ........+.++.+||.+||+.||++|||+.++++|.|..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~ 315 (355)
T cd07874 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYIN 315 (355)
T ss_pred CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchh
Confidence 00000000000 000000000 0011112356789999999999999999999999998775
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=308.05 Aligned_cols=264 Identities=25% Similarity=0.387 Sum_probs=205.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|++.+.||+|+||+||+|.+..++. .....||+|.+..... .....+.+|+.++..++||||+++++++....
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~-~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--- 82 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGE-NVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTST--- 82 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCC-ccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC---
Confidence 568999999999999999998764432 2334589999875432 33456788999999999999999999886543
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
.+++|||+++|+|.+++... ...+++..++.++.|++.||.|||++ +++||||||+|||+++++.+||+|||++
T Consensus 83 --~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 83 --VQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred --cEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCce
Confidence 37899999999999998543 34589999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
................++..|+|||.+.+..++.++|||||||++|||++ |..||........ ....... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~----~- 228 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---PDLLEKG----E- 228 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHCC----C-
Confidence 86543322211222345678999999998899999999999999999998 8899865433221 1111110 0
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
....+..++.++.+++.+||+.||++||++.++++.+..+.+..
T Consensus 229 ---------~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 229 ---------RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ---------cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 00111234577899999999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=306.67 Aligned_cols=262 Identities=26% Similarity=0.427 Sum_probs=200.5
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc--c
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE--R 149 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~ 149 (393)
|.+.+.||+|+||.||+|.+.... ....+|+|.+.... ......+.+|+.+++.++||||+++++++..... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~---~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDD---SILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCC---CeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccC
Confidence 346678999999999999875332 33468999876542 2334567889999999999999999998754321 1
Q ss_pred cceEEEEEeecCCCChHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSR----AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
....+++|||+.+++|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 154 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVA 154 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEEC
Confidence 12458999999999999987422 234578999999999999999999998 99999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcC
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFP 304 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 304 (393)
|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... .......
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~-- 229 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDYLRQ-- 229 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHc--
Confidence 9999986543332222223346678999999999999999999999999999999 788987543321 1111111
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
+.. ...+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 230 --~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 --GNR----------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred --CCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 001113456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=309.23 Aligned_cols=262 Identities=27% Similarity=0.438 Sum_probs=207.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|.+.+.||+|+||.||+|.+...........|++|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ-- 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC--
Confidence 357999999999999999999987555445567899999865432 33456788999999999999999999988765
Q ss_pred cceEEEEEeecCCCChHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRA--------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK 221 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~ 221 (393)
..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.
T Consensus 83 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~ 157 (277)
T cd05032 83 --PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLT 157 (277)
T ss_pred --CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCC
Confidence 4599999999999999986432 23467889999999999999999998 9999999999999999999
Q ss_pred eEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHH
Q 035862 222 PKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWV 300 (393)
Q Consensus 222 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~ 300 (393)
+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......... ..
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~---~~ 234 (277)
T cd05032 158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK---FV 234 (277)
T ss_pred EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH---HH
Confidence 99999999876543332222233456788999999988889999999999999999998 999987554322111 11
Q ss_pred hhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.. +. ....+..++..+.+++.+||+.+|++|||+.+++..|+
T Consensus 235 ~~----~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 ID----GG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hc----CC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 10 00 00111123578999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=311.67 Aligned_cols=268 Identities=28% Similarity=0.434 Sum_probs=209.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCC--CCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcC-CCCccceeeeeeecC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLD--GRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTE 146 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 146 (393)
.++|.+.+.||+|+||.||+|.+...+ .......+++|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 356889999999999999999864322 22345679999887542 23346688999999999 799999999998876
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRA--------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTS 212 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~ 212 (393)
. ..++||||+.+++|.+++.... ...+++..+..++.|++.||.|||++ |++||||||+
T Consensus 94 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 166 (304)
T cd05101 94 G----PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAAR 166 (304)
T ss_pred C----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccccc
Confidence 5 4599999999999999996532 23477888999999999999999998 9999999999
Q ss_pred CeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCch
Q 035862 213 NVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPT 291 (393)
Q Consensus 213 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~ 291 (393)
||++++++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999999986544332222233456678999999988889999999999999999998 77888654322
Q ss_pred hhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 292 MEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
. ........ . ....+..++..+.+|+.+||..+|.+||++.++++.|..+....
T Consensus 247 ~---~~~~~~~~----~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~ 300 (304)
T cd05101 247 E---LFKLLKEG----H----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT 300 (304)
T ss_pred H---HHHHHHcC----C----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence 1 11111110 0 00111235678999999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=307.35 Aligned_cols=264 Identities=25% Similarity=0.396 Sum_probs=204.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|++.+.||+|+||.||+|.+..++. .....+++|.+..... .....+..|+.+++.++||||+++++++...
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~---- 81 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGD-SIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA---- 81 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCC-ceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC----
Confidence 468889999999999999998754332 2233578888764322 2335567788889999999999999987533
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++++||+.+|+|.+++.... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+|||++
T Consensus 82 -~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 82 -SLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred -ccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccc
Confidence 3478999999999999986433 4589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+...............++..|+|||.+.+..++.++|||||||++|||++ |..||............. . +..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~---~----~~~ 229 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE---K----GER 229 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---C----CCc
Confidence 76543332222334556778999999988899999999999999999998 999997654332222211 1 000
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
. ..+..++.++.+++.+||..||++|||+.++++.|..+.++.
T Consensus 230 ~----------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 230 L----------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred C----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 0 001113456788999999999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=311.33 Aligned_cols=256 Identities=28% Similarity=0.445 Sum_probs=204.8
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc---cHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ---GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.|+..+.||+|+||.||++.+..++ ..||+|.+...... ....+.+|+.+++.++|+||+.+++.+...+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATG-----KMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD-- 73 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCC-----ceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC--
Confidence 3778889999999999999976444 46999988654222 2244678999999999999999999987766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+.+++|.+++.......+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||+
T Consensus 74 --~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05630 74 --ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGL 148 (285)
T ss_pred --EEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccc
Confidence 569999999999999998665556689999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH-HHHHHhhcCcCCc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK-LLEWVKQFPADGK 308 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~ 308 (393)
+........ .....|+..|+|||++.+..++.++||||+||++|+|++|..||.......... .......
T Consensus 149 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~------ 219 (285)
T cd05630 149 AVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------ 219 (285)
T ss_pred eeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh------
Confidence 875432221 123478999999999999999999999999999999999999997643321111 1110000
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT-----MNQVVESLKLA 358 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~~l~~l~~~ 358 (393)
.....+..++.++.+|+.+||+.||++||| +.++++|.|..
T Consensus 220 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~ 265 (285)
T cd05630 220 ---------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK 265 (285)
T ss_pred ---------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence 001112234577899999999999999999 99999998864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=320.56 Aligned_cols=253 Identities=25% Similarity=0.385 Sum_probs=194.5
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcC-CCCccceeeeeeecCCcccceE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 153 (393)
+.||+|+||.||+|.+..++ ..||+|.+.+.. ......+.+|+.++..+ +||||+++++++...+ ..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~----~~ 71 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTE-----RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES----RL 71 (329)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC----EE
Confidence 36999999999999975443 469999987542 22334567788888776 7999999999988776 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+++++|..++. ....+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 72 ~lv~E~~~~~~L~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 72 FFVIEYVNGGDLMFHMQ--RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred EEEEeCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 99999999999998874 345689999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCch--hhhHHHHHHhhcCcCCcccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPT--MEQKLLEWVKQFPADGKKFS 311 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~ 311 (393)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .......+....
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------- 216 (329)
T cd05618 147 LRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV-------- 216 (329)
T ss_pred cCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH--------
Confidence 22211 223457899999999999999999999999999999999999999532111 000000000000
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHHHHH
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT------MNQVVESLKL 357 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps------~~~~l~~l~~ 357 (393)
.... ....+...+..+.+++.+||+.||++||+ +.++++|.+.
T Consensus 217 -i~~~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f 265 (329)
T cd05618 217 -ILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 265 (329)
T ss_pred -HhcC--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCC
Confidence 0000 01122234677899999999999999998 5799998653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=325.12 Aligned_cols=272 Identities=23% Similarity=0.275 Sum_probs=205.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
..+|.+++.||+|+||.||++.... ......|++|.+... ....+|+.+++.++||||+++++++....
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~---~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~--- 159 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHG---DEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKS--- 159 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcC---CccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCC---
Confidence 4579999999999999999997542 234567899987653 23457999999999999999999987765
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++|||++. ++|.+++ .....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.++|+|||++
T Consensus 160 -~~~lv~e~~~-~~l~~~l--~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a 232 (392)
T PHA03207 160 -TVCMVMPKYK-CDLFTYV--DRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAA 232 (392)
T ss_pred -EEEEEehhcC-CCHHHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccc
Confidence 5699999995 6898888 3445689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchh-hhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM-EQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 309 (393)
................||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+.............
T Consensus 233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~ 312 (392)
T PHA03207 233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312 (392)
T ss_pred cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence 76544333323345679999999999999999999999999999999999999996543321 11111111111000000
Q ss_pred cccc-----------cCccccccc-------CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 310 FSMM-----------IDPRLRNQY-------SINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 310 ~~~~-----------~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
+... .....+..+ ....+.++.+||.+||..||++|||+.+++.|.+....
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0000 000000000 01235678899999999999999999999999987543
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=327.90 Aligned_cols=267 Identities=22% Similarity=0.259 Sum_probs=198.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
..+|.+.+.||+|+||.||+|.+.... ..|++|.... ..+.+|+.+|+.++|+||+++++++...+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~-----~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~--- 233 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYP-----QRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGG--- 233 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCC-----CEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECC---
Confidence 457999999999999999999976443 4589986432 23568999999999999999999987766
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++|||++. ++|.+++.... ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 234 -~~~lv~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla 307 (461)
T PHA03211 234 -LTCLVLPKYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAA 307 (461)
T ss_pred -EEEEEEEccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCc
Confidence 5599999994 68988885432 3689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCch-----hhhHHHHHHhhcCc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPT-----MEQKLLEWVKQFPA 305 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~-----~~~~~~~~~~~~~~ 305 (393)
+...............||..|+|||++.+..++.++|||||||++|||++|..++...... ....+.........
T Consensus 308 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~ 387 (461)
T PHA03211 308 CFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQV 387 (461)
T ss_pred eecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcc
Confidence 7653322222223457999999999999999999999999999999999988665332111 11122222211111
Q ss_pred CCcccccccC------------ccccc-----ccC--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 306 DGKKFSMMID------------PRLRN-----QYS--INAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 306 ~~~~~~~~~~------------~~~~~-----~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
....+..... ..... .+. ...+.++.+||.+||+.||.+|||+.|+++|.|.
T Consensus 388 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f 458 (461)
T PHA03211 388 HVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF 458 (461)
T ss_pred ccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence 0000000000 00000 000 1234578999999999999999999999999775
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=305.56 Aligned_cols=255 Identities=23% Similarity=0.324 Sum_probs=202.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-----ccHHHHHHHHHHhhcCCCCccceeeeeeecC
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-----QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTE 146 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 146 (393)
++|.+.+.||+|++|.||.|....++ ..+++|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~-----~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTG-----RELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCC-----cEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC
Confidence 46889999999999999999865333 4599998764321 1234577899999999999999999999877
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
+ ..++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|
T Consensus 77 ~----~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~d 147 (263)
T cd06625 77 E----TLSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGD 147 (263)
T ss_pred C----eEEEEEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 6 56999999999999998854 34588899999999999999999998 999999999999999999999999
Q ss_pred ccCCccCCCCCCcc-ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 227 FGLAREGPTGDHTH-VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 227 fg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
||++.......... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||......... .... .
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~-~--- 221 (263)
T cd06625 148 FGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI--FKIA-T--- 221 (263)
T ss_pred cccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH--HHHh-c---
Confidence 99987543321111 112346788999999999988999999999999999999999999754332111 1100 0
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.......+..++..+.+++.+||..+|.+||++.+++++.|
T Consensus 222 ----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 222 ----------QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred ----------cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 00111222345678899999999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=327.09 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=209.1
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccce
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQ 152 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 152 (393)
-|.++..||.|+||.||+|..+. .+...|-|++...+......++-|++||..+.||+||++++.|..++ .
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nke-----t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en----k 103 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKE-----TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN----K 103 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhccc-----chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC----c
Confidence 46778899999999999998543 44457888888877778888999999999999999999999888777 5
Q ss_pred EEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 153 RLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
++++.|||.||-.+..+..- ...+.+.++.-+++|++.||.|||++ +|||||||.+|||++-+|.++|+|||.+..
T Consensus 104 LwiliEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAK 179 (1187)
T ss_pred eEEEEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeeccccccc
Confidence 69999999999998877543 45689999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCCccccccccccCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 233 GPTGDHTHVSTAVVGTYGYAAPEYIE-----TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 233 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
... .......+.|||+|||||+.. ..+|+.++||||||++|.||..+.+|-..-++-.. ++.....-
T Consensus 180 n~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV--llKiaKSe---- 251 (1187)
T KOG0579|consen 180 NKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSE---- 251 (1187)
T ss_pred chh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH--HHHHhhcC----
Confidence 332 233456789999999999874 56899999999999999999999998765443211 11111111
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
......+...+..+.+|+.+||.+||..||++.++++|.|.
T Consensus 252 ---------PPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv 292 (1187)
T KOG0579|consen 252 ---------PPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFV 292 (1187)
T ss_pred ---------CCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccc
Confidence 11111234567889999999999999999999999999764
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=303.58 Aligned_cols=255 Identities=29% Similarity=0.405 Sum_probs=202.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.++||+|+||.||+|.+... ..|++|.+.... .....+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~------~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~----- 73 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE----- 73 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC------ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECCC-----
Confidence 5699999999999999999986432 248999987543 2345688999999999999999999887432
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+.+++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.+.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~ 150 (262)
T cd05071 74 PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 150 (262)
T ss_pred CcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCcee
Confidence 348999999999999999765555688999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ ......++..|+|||+..+..++.++||||||+++|+|++ |..||............ ...
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~--~~~-------- 219 (262)
T cd05071 151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--ERG-------- 219 (262)
T ss_pred eccccccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH--hcC--------
Confidence 65433221 1123346678999999988899999999999999999999 88888755432111110 000
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.....+..++..+.+++.+||+.||++||++.++++.|+..+
T Consensus 220 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 220 -------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred -------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 001112245678899999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=312.76 Aligned_cols=268 Identities=26% Similarity=0.388 Sum_probs=205.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|++.+.||+|+||.||++.+..+ +..+++|.+.... ......+.+|+++++.++||||+++++.+...+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~-----~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 72 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPS-----GLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG--- 72 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCC-----CeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC---
Confidence 4699999999999999999986533 3468888886542 223456788999999999999999999998776
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE-GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+ . +++|+||||+|||++.++.+||+|||+
T Consensus 73 -~~~lv~ey~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (308)
T cd06615 73 -EISICMEHMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGV 146 (308)
T ss_pred -EEEEEeeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCC
Confidence 56999999999999999854 3568999999999999999999997 5 899999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+...... ......|+..|+|||++.+..++.++|+|||||++|+|++|..||............ .........
T Consensus 147 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~ 219 (308)
T cd06615 147 SGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF---GRPVSEGEA 219 (308)
T ss_pred ccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhh---cCccccccc
Confidence 8754322 123457889999999998888999999999999999999999999654322111111 100000000
Q ss_pred c-----------------------ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 310 F-----------------------SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 310 ~-----------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
. ...............++.++.+|+.+||..+|++||++.+++++.|....
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 220 KESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 0 00000000000011256779999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=308.09 Aligned_cols=266 Identities=28% Similarity=0.458 Sum_probs=205.7
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
..++|++.+.||+|+||.||+|..+..........||+|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ- 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 3567999999999999999999876433334456799998865432 22345778999999999999999999987766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRA--------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF 220 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~ 220 (393)
..++||||+.+|+|.+++.... ........+..++.|++.||.|||++ +++||||||+||++++++
T Consensus 83 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~ 156 (288)
T cd05061 83 ---PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDF 156 (288)
T ss_pred ---CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCC
Confidence 4599999999999999996422 13346677889999999999999998 999999999999999999
Q ss_pred ceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHH
Q 035862 221 KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEW 299 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~ 299 (393)
.++|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ....
T Consensus 157 ~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~ 233 (288)
T cd05061 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKF 233 (288)
T ss_pred cEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence 999999999875433322222223345678999999998899999999999999999998 788886543321 1111
Q ss_pred HhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
... +... ..+..++..+.+++.+||+.||++|||+.++++.+....
T Consensus 234 ~~~----~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMD----GGYL----------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHc----CCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 110 0000 011123578999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=303.39 Aligned_cols=251 Identities=28% Similarity=0.470 Sum_probs=198.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.+.||+|+||.||+|.+... ..+++|.+.... .....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~------~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 72 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQ------IKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK---- 72 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccC------ceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCC----
Confidence 4588899999999999999986432 258999876543 33467888999999999999999999987766
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||++++++.+||+|||.+.
T Consensus 73 ~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~ 148 (256)
T cd05114 73 PLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTR 148 (256)
T ss_pred CEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcc
Confidence 4599999999999999885433 3588999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||........ ....... ..
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i~~~----~~- 219 (256)
T cd05114 149 YVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMISRG----FR- 219 (256)
T ss_pred ccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHCC----CC-
Confidence 64332211 1122345568999999988899999999999999999999 8999975543211 1111110 00
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
. ..+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 220 --~-------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 220 --L-------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --C-------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0 01112346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=319.98 Aligned_cols=273 Identities=24% Similarity=0.314 Sum_probs=203.0
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
..++|++.+.||+|+||.||+|.+...+ ..||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~ 96 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILE-----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK 96 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCC-----cEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccc
Confidence 3568999999999999999999865443 359999987532 233456778999999999999999999876543
Q ss_pred c--ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 148 E--RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 148 ~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
. .....|+||||+.+ +|.+++. ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~ 168 (364)
T cd07875 97 SLEEFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 168 (364)
T ss_pred cccccCeEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEE
Confidence 2 12256999999965 7877763 2478889999999999999999998 99999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHH-HH------
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKL-LE------ 298 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~-~~------ 298 (393)
|||++....... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+....... ..
T Consensus 169 DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 169 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred eCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999997643321 22345789999999999999999999999999999999999999976543221110 00
Q ss_pred -------------HHhhcCcC-CcccccccCccc---ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 299 -------------WVKQFPAD-GKKFSMMIDPRL---RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 299 -------------~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.....+.. +..+........ ........+.++.+||.+||+.||.+|||+.++++|.|..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~ 322 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 322 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 00000000 000000000000 0001112346789999999999999999999999998864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=313.67 Aligned_cols=269 Identities=22% Similarity=0.349 Sum_probs=192.0
Q ss_pred cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEE
Q 035862 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLV 156 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv 156 (393)
..+||+|+||.||+|.... ......+|+|.+.... ....+.+|+.+++.++||||+++++++...... ..+++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~---~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKD---GKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADR--KVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEcc---CCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCc--EEEEE
Confidence 3579999999999998642 1234579999987543 234567899999999999999999988765443 56899
Q ss_pred EeecCCCChHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe----CCCCceEEe
Q 035862 157 YEYMPNRSLEDRLFSR-------AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL----DGNFKPKLS 225 (393)
Q Consensus 157 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~ 225 (393)
|||+. ++|.+++... ....+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+
T Consensus 79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07868 79 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence 99995 5888877422 123588999999999999999999998 99999999999999 456789999
Q ss_pred eccCCccCCCCCCc-cccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhh-------hHH
Q 035862 226 DFGLAREGPTGDHT-HVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTME-------QKL 296 (393)
Q Consensus 226 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~-------~~~ 296 (393)
|||++......... .......||+.|+|||++.+ ..++.++||||+||++|+|++|.+||........ ..+
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~ 234 (317)
T cd07868 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 234 (317)
T ss_pred ecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHH
Confidence 99999765332211 12234678999999999876 4689999999999999999999999965432210 001
Q ss_pred HHHHhh--------------cCcCCcccccccCccc--------ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 035862 297 LEWVKQ--------------FPADGKKFSMMIDPRL--------RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354 (393)
Q Consensus 297 ~~~~~~--------------~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 354 (393)
...... .+.............. ........+..+.+|+.+||++||.+|||++++++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 235 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 110000 0000000000000000 000000123568899999999999999999999998
Q ss_pred HH
Q 035862 355 LK 356 (393)
Q Consensus 355 l~ 356 (393)
.|
T Consensus 315 p~ 316 (317)
T cd07868 315 PY 316 (317)
T ss_pred CC
Confidence 65
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=308.03 Aligned_cols=249 Identities=27% Similarity=0.385 Sum_probs=193.9
Q ss_pred ecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEE
Q 035862 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLV 156 (393)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv 156 (393)
||+|+||.||++....+ +..||+|.+..... .....+..|+++++.++||||+++++++.... +.++|
T Consensus 1 lg~G~~g~Vy~~~~~~~-----~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~----~~~lv 71 (277)
T cd05607 1 LGKGGFGEVCAVQVKNT-----GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT----HLCLV 71 (277)
T ss_pred CCCCCceEEEEEEEccC-----CcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC----eEEEE
Confidence 79999999999986543 44699999864321 12334567999999999999999999987665 56999
Q ss_pred EeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCC
Q 035862 157 YEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236 (393)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 236 (393)
|||+++++|.+++.......+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 72 ~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 72 MSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred EecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 9999999999988665556688999999999999999999998 9999999999999999999999999998765332
Q ss_pred CCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhh-hHHHHHHhhcCcCCcccccccC
Q 035862 237 DHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTME-QKLLEWVKQFPADGKKFSMMID 315 (393)
Q Consensus 237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 315 (393)
. ......|+..|+|||++.+..++.++|||||||++|+|++|..||........ ........ .
T Consensus 149 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~---------- 212 (277)
T cd05607 149 K---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL---E---------- 212 (277)
T ss_pred c---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh---c----------
Confidence 2 12345689999999999988899999999999999999999999975433211 11111000 0
Q ss_pred cccccccCHHHHHHHHHHHHHhcccCCCCCCCHH----HHHHHHHH
Q 035862 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPTMN----QVVESLKL 357 (393)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~----~~l~~l~~ 357 (393)
.... .....++.++.+|+.+||++||++||++. +++.|.|.
T Consensus 213 ~~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f 257 (277)
T cd05607 213 DEVK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFF 257 (277)
T ss_pred cccc-cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhh
Confidence 0000 00113467899999999999999999994 45566544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=303.77 Aligned_cols=259 Identities=24% Similarity=0.375 Sum_probs=205.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++.+.||+|+||.||+|+...++ ..|++|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 75 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDR-----KPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN- 75 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCC-----CEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-
Confidence 57999999999999999999975443 359999875422 223345788999999999999999999988765
Q ss_pred ccceEEEEEeecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
..+++|||+.+++|.+++.. .....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|
T Consensus 76 ---~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d 149 (267)
T cd08228 76 ---ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred ---eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECc
Confidence 55999999999999988853 2334578899999999999999999998 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
||++........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||......... .........
T Consensus 150 ~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~-- 224 (267)
T cd08228 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS-LCQKIEQCD-- 224 (267)
T ss_pred cccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHH-HHHHHhcCC--
Confidence 999876533221 123456888999999998888999999999999999999999999654332211 111111100
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.........+..+.+++.+||..+|++||++.++++.+..+
T Consensus 225 -----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 -----------YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -----------CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 01111224567899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=311.61 Aligned_cols=263 Identities=30% Similarity=0.462 Sum_probs=204.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcC-CCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||.||+|.+..+ +....+++|.+.... ......+.+|+.++..+ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~- 81 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG- 81 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccC---CceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC-
Confidence 35789999999999999999987532 233457888766432 23345677899999999 7999999999987766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCe
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRA--------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNV 214 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NI 214 (393)
..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+. |++||||||+||
T Consensus 82 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Ni 155 (303)
T cd05088 82 ---YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNI 155 (303)
T ss_pred ---CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheE
Confidence 4599999999999999986432 23578999999999999999999998 999999999999
Q ss_pred EeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhh
Q 035862 215 LLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME 293 (393)
Q Consensus 215 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~ 293 (393)
|++.++.+||+|||++....... ......++..|+|||.+.+..++.++|||||||++|+|+| |..||.......
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 231 (303)
T cd05088 156 LVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE- 231 (303)
T ss_pred EecCCCcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH-
Confidence 99999999999999986321111 1112234567999999988889999999999999999998 999996543321
Q ss_pred hHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 294 QKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
...... .. .....+...+..+.+|+.+||+.+|++||++.+++..+..+++...
T Consensus 232 --~~~~~~---~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 232 --LYEKLP---QG-----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred --HHHHHh---cC-----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 111111 00 0001112245678999999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=307.96 Aligned_cols=261 Identities=27% Similarity=0.359 Sum_probs=204.8
Q ss_pred HHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcC-CCCccceeeeeeecCC
Q 035862 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTED 147 (393)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 147 (393)
.+.+.|++.+.||+|+||.||+|.+... +..|++|.+.... .....+.+|+.+++.+ +||||+++++++...+
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~-----~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKT-----GQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 76 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCC-----CcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence 3456789999999999999999986543 3469999986543 3445678899999998 6999999999987654
Q ss_pred cc--cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 148 ER--GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 148 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
.. ....+++|||+.+++|.+++.......+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+
T Consensus 77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEc
Confidence 32 13578999999999999998765556789999999999999999999998 99999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHH
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE-----TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~ 300 (393)
|||++........ ......|+..|+|||++. +..++.++||||+||++|+|++|..||....+.......
T Consensus 154 Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~--- 228 (272)
T cd06637 154 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--- 228 (272)
T ss_pred cCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH---
Confidence 9999875432211 223457899999999886 346888999999999999999999999754332211110
Q ss_pred hhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
...+ ........++.++.+|+.+||..+|.+|||+.++++|.|
T Consensus 229 ~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (272)
T cd06637 229 PRNP-------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271 (272)
T ss_pred hcCC-------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence 0000 000111134577899999999999999999999998865
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=303.77 Aligned_cols=255 Identities=29% Similarity=0.418 Sum_probs=203.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.+.||+|++|.||+|.+.. ...|++|.+.... .....+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~------~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 74 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN------TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE--- 74 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC------CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCC---
Confidence 3569999999999999999998542 2358999987644 33566889999999999999999999987766
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..+++|||+.+++|.+++.......+++..+..++.|++.||.+||+. +++||||||+||++++++.++|+|||++
T Consensus 75 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~ 150 (261)
T cd05068 75 -PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLA 150 (261)
T ss_pred -CeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceE
Confidence 459999999999999999665555789999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
......... .......+..|+|||.+.+..++.++||||||+++|+|++ |+.||......... .......
T Consensus 151 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~--~~~~~~~------ 221 (261)
T cd05068 151 RVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL--QQVDQGY------ 221 (261)
T ss_pred EEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH--HHHHcCC------
Confidence 765422111 1111223457999999998899999999999999999999 99999754332111 1111110
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
....+..++..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 222 ---------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 222 ---------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 001122345789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=319.56 Aligned_cols=245 Identities=28% Similarity=0.392 Sum_probs=191.4
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHH-HhhcCCCCccceeeeeeecCCcccceE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQ-FLGVVSHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~ 153 (393)
+.||+|+||+||+|.+..++ ..||+|.+..... .....+..|.. +++.++||||+++++.+...+ ..
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~----~~ 71 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADG-----KFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD----KL 71 (323)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC----EE
Confidence 36999999999999975443 4699999875321 12233445544 567899999999999987766 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 72 YFVLDYVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred EEEEcCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 999999999999998843 45689999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ....... +.
T Consensus 147 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~-~~-------- 213 (323)
T cd05575 147 IEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM--YDNILNK-PL-------- 213 (323)
T ss_pred ccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH--HHHHHcC-CC--------
Confidence 2221 123345799999999999999999999999999999999999999976543211 1111100 00
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM----NQVVESLK 356 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~~~l~~l~ 356 (393)
......+..+.+++.+||+.||.+||++ .++++|.|
T Consensus 214 -------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~ 253 (323)
T cd05575 214 -------RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVF 253 (323)
T ss_pred -------CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCC
Confidence 0111235788999999999999999987 58887765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=309.05 Aligned_cols=276 Identities=25% Similarity=0.402 Sum_probs=204.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
..|++.+.||+|+||.||+|.....+ ...+..|++|.+..........+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-- 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQ-DNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR-- 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCc-CCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC--
Confidence 46889999999999999999864322 234557999998776555566788999999999999999999987655433
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||++ |++||||||+||++++++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence 458999999999999998543 24588999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCcc-ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC---
Q 035862 232 EGPTGDHTH-VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG--- 307 (393)
Q Consensus 232 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--- 307 (393)
......... ......++..|+|||++.+..++.++|||||||++|||++|..++........ ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 232 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFM----RMMGNDKQGQMIV 232 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhh----hhcccccccccch
Confidence 654332211 11122334569999999988999999999999999999998876643221110 0000000000
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
..+...+........+..++.++.+|+.+||..+|++|||+.++++.|+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000000011111111223567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=308.61 Aligned_cols=257 Identities=24% Similarity=0.338 Sum_probs=200.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.+.||+|+||.||+|.+..+ +..|++|++..........+.+|+.+++.++||||+++++.+...+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~-----~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~--- 79 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHT-----GELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE--- 79 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCC-----CeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC---
Confidence 35799999999999999999986433 3469999987654444556778999999999999999999998766
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||++
T Consensus 80 -~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~ 153 (267)
T cd06646 80 -KLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVA 153 (267)
T ss_pred -EEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccc
Confidence 56999999999999998843 34688999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIE---TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
........ ......|+..|+|||.+. ...++.++|+||+||++|+|++|..||....+...... . ..
T Consensus 154 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~------~--~~ 223 (267)
T cd06646 154 AKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL------M--SK 223 (267)
T ss_pred eeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee------e--ec
Confidence 76432211 123356888999999874 34578899999999999999999999864432211100 0 00
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.. ...+... ....++..+.+|+.+||+.+|++||++++++++++
T Consensus 224 ~~---~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 224 SN---FQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CC---CCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00 0000000 11134578999999999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=301.50 Aligned_cols=248 Identities=29% Similarity=0.491 Sum_probs=193.3
Q ss_pred eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEEE
Q 035862 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVY 157 (393)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 157 (393)
.||+|+||.||+|.+..+ +..+++|.+.... ......+.+|+++++.++||||+++++++.... ..++||
T Consensus 2 ~lg~g~~g~vy~~~~~~~-----~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~ 72 (252)
T cd05084 2 RIGRGNFGEVFSGRLRAD-----NTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ----PIYIVM 72 (252)
T ss_pred ccCcccCccEEEEEEecC-----CceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC----CeEEEE
Confidence 699999999999987543 3469999876542 233456889999999999999999999988766 459999
Q ss_pred eecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCC
Q 035862 158 EYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGD 237 (393)
Q Consensus 158 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 237 (393)
||+.+++|.+++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 73 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 148 (252)
T cd05084 73 ELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV 148 (252)
T ss_pred eeccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccc
Confidence 999999999998543 34588999999999999999999998 99999999999999999999999999987543221
Q ss_pred CccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcccccccCc
Q 035862 238 HTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDP 316 (393)
Q Consensus 238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (393)
.........++..|+|||.+.+..++.++||||||+++|+|++ |..||............. .
T Consensus 149 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~---~-------------- 211 (252)
T cd05084 149 YASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE---Q-------------- 211 (252)
T ss_pred ccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH---c--------------
Confidence 1111111223456999999998899999999999999999998 888886543322111111 0
Q ss_pred ccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 317 RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
......+..++..+.+|+.+||+.+|++|||+.++++.|.
T Consensus 212 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 212 GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 0011112234578999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=307.91 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=204.1
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.|+..+.||.|+||+||+|.+..+ +..+|+|.+..... .....+.+|+.+++.++|+||+.+++.+...+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-- 73 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRAT-----GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD-- 73 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCC-----CcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC--
Confidence 377788999999999999987543 34699999865422 22344678999999999999999999888766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+.+++|.+++.......+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+
T Consensus 74 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~ 148 (285)
T cd05632 74 --ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred --EEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCc
Confidence 569999999999999988765556799999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+....... ......|+..|+|||++.+..++.++|+|||||++|+|++|..||............. ......
T Consensus 149 ~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~~~~~~--- 220 (285)
T cd05632 149 AVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RRVLET--- 220 (285)
T ss_pred ceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhhhcc---
Confidence 86543221 1234578999999999998899999999999999999999999997654332211111 110000
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT-----MNQVVESLKLA 358 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~~l~~l~~~ 358 (393)
...++..++..+.+|+..||+.||++||+ +.+++.|.+..
T Consensus 221 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~ 265 (285)
T cd05632 221 ---------EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFR 265 (285)
T ss_pred ---------ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhh
Confidence 00112234577899999999999999999 88999986653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=302.89 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=204.8
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+|.+.+.||+|++|.||+|.+..++ ..|++|.+... .......+.+|+++++.++||||+++++.+...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 72 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADK-----RVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG--- 72 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCC-----cEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC---
Confidence 4788899999999999999875443 45999987643 2334566788999999999999999999988765
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+++++|.+++.......+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++
T Consensus 73 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 73 -KLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred -EEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence 569999999999999999765556789999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ ......|++.|+|||++.+..++.++|+||||+++|+|++|..||....... .......
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~-------- 215 (256)
T cd08529 149 KLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILKIIR-------- 215 (256)
T ss_pred eeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHc--------
Confidence 76543322 2234568899999999999899999999999999999999999997654221 1111100
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
......+..++..+.+++.+||+.+|++||++.+++++.+
T Consensus 216 ------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 255 (256)
T cd08529 216 ------GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPS 255 (256)
T ss_pred ------CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCC
Confidence 0011112235678999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=301.54 Aligned_cols=249 Identities=26% Similarity=0.408 Sum_probs=195.6
Q ss_pred eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEE
Q 035862 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLV 156 (393)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv 156 (393)
.||+|+||.||+|.+.. ......+++|++..... .....+.+|+.+++.+.||||+++++++..+ ..++|
T Consensus 2 ~lg~G~~g~v~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~lv 73 (257)
T cd05116 2 ELGSGNFGTVKKGMYKM---KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE-----SWMLV 73 (257)
T ss_pred cCCCcCCcceEEeEEec---CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CcEEE
Confidence 58999999999997642 23456799999865432 2345678899999999999999999987543 34899
Q ss_pred EeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCC
Q 035862 157 YEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236 (393)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 236 (393)
|||+.+++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||.||+++.++.+||+|||++......
T Consensus 74 ~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 74 MELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred EecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 999999999999843 34688999999999999999999998 9999999999999999999999999999765433
Q ss_pred CCcc-ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccccccc
Q 035862 237 DHTH-VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMI 314 (393)
Q Consensus 237 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (393)
.... ......++..|+|||.+....++.++|||||||++|||++ |..||........ ......
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~i~~------------ 213 (257)
T cd05116 149 ENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---TQMIES------------ 213 (257)
T ss_pred CCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHC------------
Confidence 2211 1122334578999999988889999999999999999998 9999976543221 111111
Q ss_pred CcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
......+..++.++.++|.+||+.||++||++.+|.+.|..
T Consensus 214 --~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 214 --GERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred --CCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 00111222356789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=316.95 Aligned_cols=264 Identities=24% Similarity=0.336 Sum_probs=195.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
..+|.+.+.||+|+||.||+|..... +..||+|..... ....|+.+++.++||||+++++++...+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 130 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQ-----PDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGA--- 130 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCC-----CceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCC---
Confidence 45799999999999999999996543 345899975432 2346899999999999999999998776
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++|||++. ++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 131 -~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 204 (357)
T PHA03209 131 -ITCMVLPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA 204 (357)
T ss_pred -eeEEEEEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccc
Confidence 4599999994 5888888543 34689999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchh--------hhHHHHHHhh
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM--------EQKLLEWVKQ 302 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~--------~~~~~~~~~~ 302 (393)
....... ......||..|+|||++.+..++.++|||||||++|||+++..++....+.. ...+......
T Consensus 205 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~ 281 (357)
T PHA03209 205 QFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIST 281 (357)
T ss_pred cccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHH
Confidence 7532221 1234578999999999999999999999999999999998655543222211 1111111111
Q ss_pred cCcCCcccc---------cccC--ccccc-------ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 303 FPADGKKFS---------MMID--PRLRN-------QYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 303 ~~~~~~~~~---------~~~~--~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.......+. .+++ ...+. ......+.++.+||.+||+.||.+|||+.++++|.|.
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f 354 (357)
T PHA03209 282 LKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF 354 (357)
T ss_pred hccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchh
Confidence 111110000 0000 00000 0011345677889999999999999999999999875
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=316.28 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=196.8
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCC-CCccceeeeeeecCCc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDE 148 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 148 (393)
+|+..+.||+|+||.||+|.+..+ +..||+|++.... ......+..|..++..+. |++|+++++++...+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~- 74 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGT-----DELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD- 74 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCC-----CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC-
Confidence 477889999999999999986543 3469999987532 223345677888888876 577888988887766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+++++|.+++. ....+++..++.++.|++.||.|||+. |++||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~Ey~~~g~L~~~i~--~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg 146 (323)
T cd05615 75 ---RLYFVMEYVNGGDLMYHIQ--QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred ---EEEEEEcCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence 5699999999999999884 335689999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...... ..
T Consensus 147 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--~~~i~~-~~---- 217 (323)
T cd05615 147 MCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL--FQSIME-HN---- 217 (323)
T ss_pred cccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHHHh-CC----
Confidence 9875322211 22345689999999999999999999999999999999999999976543211 111111 00
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT-----MNQVVESLK 356 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~~l~~l~ 356 (393)
..++..++.++.+++.+||+.+|.+|++ ..++.+|.+
T Consensus 218 -----------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~ 259 (323)
T cd05615 218 -----------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAF 259 (323)
T ss_pred -----------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcc
Confidence 0112234577899999999999999997 467777744
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=309.87 Aligned_cols=267 Identities=27% Similarity=0.423 Sum_probs=206.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCC--CCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcC-CCCccceeeeeeecCC
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLD--GRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTED 147 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 147 (393)
++|.+.+.||+|+||.||+|...... .......+++|.+.... ......+..|+.+++.+ +||||+++++++...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46889999999999999999864322 12345678999887542 23345678899999999 5999999999987665
Q ss_pred cccceEEEEEeecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCC
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRA--------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSN 213 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~N 213 (393)
..+++|||+.+++|.+++.... ...+++..+..++.|++.||.|||++ |++||||||+|
T Consensus 92 ----~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 92 ----PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ----ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 4599999999999999996432 23578889999999999999999998 99999999999
Q ss_pred eEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchh
Q 035862 214 VLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTM 292 (393)
Q Consensus 214 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~ 292 (393)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999976543222211222234567999999988899999999999999999999 888886544322
Q ss_pred hhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 293 EQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
.. ...... . ....+..++.++.+++.+||..+|++||++.++++.|+.+....
T Consensus 245 ~~---~~~~~~----~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 245 LF---KLLREG----H----------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HH---HHHHcC----C----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 11 111110 0 00112234567889999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=302.05 Aligned_cols=253 Identities=31% Similarity=0.451 Sum_probs=200.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.+.||+|+||.||+|.+... ..+++|.+..... ....+.+|+.+++.++|+|++++++++...
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~------~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~----- 73 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGN------TKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEE----- 73 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCC------ceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCC-----
Confidence 4689999999999999999976422 2489998876432 345688999999999999999999987432
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..+++|||+.+++|.+++.......+++..++.++.|++.||.|||++ +++||||||+||++++++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 74 PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeee
Confidence 348999999999999999765556689999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .......
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~-------- 218 (260)
T cd05070 151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQVER-------- 218 (260)
T ss_pred eccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHc--------
Confidence 64332211 1122345668999999988889999999999999999999 889997543321 1111111
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
......+...+..+.+|+.+||..+|++|||+.++.+.|+.
T Consensus 219 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 219 ------GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ------CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00111222345789999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=307.29 Aligned_cols=261 Identities=28% Similarity=0.417 Sum_probs=202.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-CcccHHHHHHHHHHhhcC-CCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 149 (393)
++|++.+.||+|+||.||+|.+...+ ....+++|.+... .......+.+|+.++.++ +||||+++++++...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-- 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDG---LKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG-- 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCC---CcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC--
Confidence 57899999999999999999875432 2234677777642 223345678899999999 6999999999987765
Q ss_pred cceEEEEEeecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeE
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRA--------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVL 215 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIl 215 (393)
..+++|||+++++|.+++.... ...+++..++.++.|++.||+|||+. |++||||||+|||
T Consensus 77 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil 151 (297)
T cd05089 77 --YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVL 151 (297)
T ss_pred --cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEE
Confidence 4599999999999999985422 13578899999999999999999998 9999999999999
Q ss_pred eCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhh
Q 035862 216 LDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQ 294 (393)
Q Consensus 216 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~ 294 (393)
+++++.+||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~- 227 (297)
T cd05089 152 VGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL- 227 (297)
T ss_pred ECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-
Confidence 9999999999999986422110 1111233457999999988899999999999999999997 9999975433211
Q ss_pred HHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
....... .....+..++..+.+|+.+||+.+|.+||++.++++.|..+.+..
T Consensus 228 -~~~~~~~---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 228 -YEKLPQG---------------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred -HHHHhcC---------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111100 011112235578899999999999999999999999999888655
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=322.42 Aligned_cols=262 Identities=23% Similarity=0.291 Sum_probs=202.0
Q ss_pred HHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeee
Q 035862 66 ELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGY 142 (393)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~ 142 (393)
++....++|++.+.||+|+||.||+|.+..++ ..+|+|.+.... ......+.+|+.+++.++||||+++++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~-----~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR-----KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 111 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCC-----cEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34445688999999999999999999875443 469999986422 1223446789999999999999999999
Q ss_pred eecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCce
Q 035862 143 CSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP 222 (393)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 222 (393)
+...+ +.++||||+++++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+
T Consensus 112 ~~~~~----~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~i 181 (371)
T cd05622 112 FQDDR----YLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHL 181 (371)
T ss_pred EEcCC----EEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCE
Confidence 87765 66999999999999998843 3478889999999999999999998 99999999999999999999
Q ss_pred EEeeccCCccCCCCCCccccccccccCCccCccccccC----CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHH
Q 035862 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG----HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLE 298 (393)
Q Consensus 223 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~ 298 (393)
||+|||++........ .......||+.|+|||++.+. .++.++|||||||++|||++|..||........ ...
T Consensus 182 kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~~~ 258 (371)
T cd05622 182 KLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--YSK 258 (371)
T ss_pred EEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH--HHH
Confidence 9999999976533221 123456799999999998654 378999999999999999999999986543211 111
Q ss_pred HHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHH
Q 035862 299 WVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEE--RPTMNQVVESLKL 357 (393)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~~l~~l~~ 357 (393)
..... .. +.......++..+.++|.+||..++.+ |+++.++++|+|.
T Consensus 259 i~~~~----~~--------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 259 IMNHK----NS--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred HHcCC----Cc--------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 11100 00 000011135678899999999844433 7899999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=324.20 Aligned_cols=256 Identities=24% Similarity=0.348 Sum_probs=200.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|+..+.||+|+||.||+|....++ ..||+|++.... ......+.+|+.++..++||||+++++.+...+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 74 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTG-----HIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR- 74 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 46899999999999999999875443 469999986432 223456778999999999999999999988766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.+|.+||+|||
T Consensus 75 ---~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG 146 (360)
T cd05627 75 ---NLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFG 146 (360)
T ss_pred ---EEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeecc
Confidence 56999999999999999843 45689999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCc---------------------------------cccccccccCCccCccccccCCCCchhhHHHHHHHH
Q 035862 229 LAREGPTGDHT---------------------------------HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVL 275 (393)
Q Consensus 229 ~a~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 275 (393)
++......... ......+||+.|+|||++.+..++.++|||||||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 226 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccccee
Confidence 98754221100 011235799999999999999999999999999999
Q ss_pred HHHHhCCCccCCCCchhhhHHH-HHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC---CHHHH
Q 035862 276 YEILTGRRVLERNRPTMEQKLL-EWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP---TMNQV 351 (393)
Q Consensus 276 ~elltg~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~~ 351 (393)
|||++|+.||....+......+ .+..... +.+ ....+.++.+||.+|+ .||.+|+ ++.++
T Consensus 227 yel~tG~~Pf~~~~~~~~~~~i~~~~~~~~---------~p~------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 290 (360)
T cd05627 227 YEMLIGYPPFCSETPQETYRKVMNWKETLV---------FPP------EVPISEKAKDLILRFC-TDSENRIGSNGVEEI 290 (360)
T ss_pred eecccCCCCCCCCCHHHHHHHHHcCCCcee---------cCC------CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHH
Confidence 9999999999765543221111 1000000 000 0124577889999976 5999998 58999
Q ss_pred HHHHHH
Q 035862 352 VESLKL 357 (393)
Q Consensus 352 l~~l~~ 357 (393)
++|.|.
T Consensus 291 ~~hp~f 296 (360)
T cd05627 291 KSHPFF 296 (360)
T ss_pred hcCCCC
Confidence 999763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=317.41 Aligned_cols=273 Identities=24% Similarity=0.331 Sum_probs=202.7
Q ss_pred HHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeec
Q 035862 68 REATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCST 145 (393)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 145 (393)
.+..++|++++.||.|+||.||+|.+..++ ..||+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLR-----QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTP 85 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCC-----CEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcc
Confidence 345678999999999999999999865433 4699999875422 233456789999999999999999998764
Q ss_pred CCc--ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceE
Q 035862 146 EDE--RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPK 223 (393)
Q Consensus 146 ~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~k 223 (393)
... .....+++++++ +++|.+++. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~~~~~~~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~k 158 (343)
T cd07878 86 ATSIENFNEVYLVTNLM-GADLNNIVK---CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELR 158 (343)
T ss_pred cccccccCcEEEEeecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEE
Confidence 332 122458999998 779988773 34589999999999999999999998 999999999999999999999
Q ss_pred EeeccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhh
Q 035862 224 LSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ 302 (393)
Q Consensus 224 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (393)
|+|||++...... .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||......... ......
T Consensus 159 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~ 231 (343)
T cd07878 159 ILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL--KRIMEV 231 (343)
T ss_pred EcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHH
Confidence 9999999764332 234578999999999876 57899999999999999999999999765432111 111100
Q ss_pred cCcCCccc---------ccccC--ccccc----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 303 FPADGKKF---------SMMID--PRLRN----QYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 303 ~~~~~~~~---------~~~~~--~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
........ ..... +.... ......++.+.+|+.+||+.||.+|||+.+++.|.|...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 232 VGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred hCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 00000000 00000 00000 000012456789999999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=308.94 Aligned_cols=258 Identities=24% Similarity=0.363 Sum_probs=207.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
..+|++.+.||+|+||.||+|.+...+ ..|++|.+..........+.+|+.+++.+.||||+++++.+....
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~--- 90 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATG-----QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--- 90 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCC-----cEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC---
Confidence 457999999999999999999865333 469999887655555567889999999999999999999988665
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+++|.+++.. ..+++..+..++.|++.||.|||+. |++||||||+||+++.++.++|+|||++
T Consensus 91 -~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~ 163 (296)
T cd06654 91 -ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (296)
T ss_pred -EEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccc
Confidence 56999999999999998843 3478899999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+.... ...... +
T Consensus 164 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~~~~----~--- 232 (296)
T cd06654 164 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIATN----G--- 232 (296)
T ss_pred hhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHHhcC----C---
Confidence 75432221 123357889999999998888999999999999999999999999765432111 111100 0
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
......+..++..+.+++.+||..||++||++.+++++.+....
T Consensus 233 ------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 233 ------TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred ------CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 00011122455778999999999999999999999999886643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=310.12 Aligned_cols=271 Identities=24% Similarity=0.375 Sum_probs=203.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|.+.+.||.|+||.||+|.+..++ ..||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-- 77 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTD-----NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-- 77 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCC-----cEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC--
Confidence 357999999999999999999865433 469999886442 223345678999999999999999999998766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+. ++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||++++++.++|+|||+
T Consensus 78 --~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 150 (301)
T cd07873 78 --SLTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGL 150 (301)
T ss_pred --eEEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcc
Confidence 5699999996 5998888543 34588999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+........ ......+++.|+|||.+.+ ..++.++|||||||++|+|++|++||..................+...
T Consensus 151 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~- 227 (301)
T cd07873 151 ARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEE- 227 (301)
T ss_pred hhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChh-
Confidence 875432221 1233467889999998865 457889999999999999999999997654432211111111111110
Q ss_pred cccccc---------Cccccc----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 309 KFSMMI---------DPRLRN----QYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 309 ~~~~~~---------~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
....++ .+.... .....++..+.+||.+||+.||.+|||+.++++|.|..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~ 290 (301)
T cd07873 228 TWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFH 290 (301)
T ss_pred hchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 000000 000000 11123467889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=300.79 Aligned_cols=251 Identities=29% Similarity=0.447 Sum_probs=198.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
.+|.+.+.||+|+||.||+|.+... ..+|+|.+.... .....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~------~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 72 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQ------YDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR---- 72 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCC------CcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC----
Confidence 3588899999999999999976432 249999887543 33467889999999999999999999987666
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||+|||.+.
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~ 148 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR 148 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccce
Confidence 3499999999999999986533 3689999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ....... ..
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~~~~----~~- 219 (256)
T cd05113 149 YVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VEKVSQG----LR- 219 (256)
T ss_pred ecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHHhcC----CC-
Confidence 54332211 1122345668999999988889999999999999999998 9999875443211 1111110 00
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
...+...+..+.+++.+||+.+|.+||++.++++.+
T Consensus 220 ---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 220 ---------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred ---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 001112357889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=307.01 Aligned_cols=256 Identities=32% Similarity=0.523 Sum_probs=202.2
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHH--HHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK--QWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
|++.+.||+|+||+||++..... +..+|+|.+......... ...+|+.+++.++||||+++++++....
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~---- 71 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKN-----GQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN---- 71 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTT-----TEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS----
T ss_pred CEEeEEEEeCCCEEEEEEEECCC-----CeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc----
Confidence 67889999999999999996543 346999999877543332 2346999999999999999999998866
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+.+++|.+++. ....+++..++.++.|++.||.+||+. +++|+||||+||+++.++.++|+|||.+.
T Consensus 72 ~~~~v~~~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 72 YLYIVMEYCPGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEEEEEETTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred ccccccccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 5689999999999999995 345689999999999999999999999 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccccCCccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
.. ...........++..|+|||++. +..++.++||||||+++|+|++|..||.......................
T Consensus 147 ~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 222 (260)
T PF00069_consen 147 KL--SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS-- 222 (260)
T ss_dssp ES--TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH--
T ss_pred cc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc--
Confidence 53 11122344567899999999998 88999999999999999999999999986622222222111111000000
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
..........+.+++.+||+.||++||++.++++|.|
T Consensus 223 ---------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~ 259 (260)
T PF00069_consen 223 ---------SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPW 259 (260)
T ss_dssp ---------TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred ---------ccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence 0000011378999999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=318.74 Aligned_cols=245 Identities=27% Similarity=0.375 Sum_probs=189.9
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHH-HHhhcCCCCccceeeeeeecCCcccceE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEV-QFLGVVSHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~~~ 153 (393)
+.||+|+||+||+|.+..++ ..||+|++..... .....+..|. .+++.++||||+++++++...+ ..
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~----~~ 71 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEE-----KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD----KL 71 (325)
T ss_pred CeeeeCCCeEEEEEEECCCC-----CEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC----eE
Confidence 36999999999999875433 4699999875321 1222334443 4567899999999999988776 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+.+++|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 72 YFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 999999999999998843 45678889999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .......+.
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~-------- 213 (325)
T cd05602 147 IEHNG--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YDNILNKPL-------- 213 (325)
T ss_pred ccCCC--CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HHHHHhCCc--------
Confidence 22211 23356799999999999999999999999999999999999999976543221 111111000
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHH----HHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMN----QVVESLK 356 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~----~~l~~l~ 356 (393)
.....++..+.+++.+||+.||.+||++. ++++|++
T Consensus 214 -------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~ 253 (325)
T cd05602 214 -------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIF 253 (325)
T ss_pred -------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcc
Confidence 01123457889999999999999999876 6666553
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=306.09 Aligned_cols=268 Identities=28% Similarity=0.461 Sum_probs=202.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCC---------CCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeee
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDG---------RGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLG 141 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---------~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~ 141 (393)
++|++.+.||+|+||.||++....... .+....||+|.+..... .....+.+|+++++.++|||++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 579999999999999999998643221 23445689999876432 23456889999999999999999999
Q ss_pred eeecCCcccceEEEEEeecCCCChHHHHhhcC----------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 035862 142 YCSTEDERGIQRLLVYEYMPNRSLEDRLFSRA----------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKT 211 (393)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp 211 (393)
++...+ ..++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||
T Consensus 85 ~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp 157 (295)
T cd05097 85 VCVSDD----PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLAT 157 (295)
T ss_pred EEcCCC----ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccCh
Confidence 997766 4599999999999999985432 12467888999999999999999998 999999999
Q ss_pred CCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh--CCCccCCCC
Q 035862 212 SNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT--GRRVLERNR 289 (393)
Q Consensus 212 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt--g~~pf~~~~ 289 (393)
+||++++++.+||+|||++................++..|+|||.+.+..++.++|||||||++|+|++ +..||....
T Consensus 158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999999999999976543322222233455778999999988899999999999999999998 556776433
Q ss_pred chhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 290 PTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
... .............. ......+...+..+.+|+.+||+.||++||++.++++.|.
T Consensus 238 ~~~--~~~~~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 238 DEQ--VIENTGEFFRNQGR--------QIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred hHH--HHHHHHHhhhhccc--------cccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 221 11111110000000 0000011124578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=301.02 Aligned_cols=251 Identities=26% Similarity=0.367 Sum_probs=202.2
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
+|++.+.||.|+||.||++.+..++ ..+++|.+... .......+.+|+.+++.++||||+++++.+...+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 71 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSD-----QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG---- 71 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCC-----ceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC----
Confidence 4888999999999999999865443 45899987543 2234456778999999999999999999998776
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.++++|||+++++|.+++.......+++..++.++.|++.||.|||++ +++|+||||+||++++++.++|+|||.+.
T Consensus 72 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 72 HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcce
Confidence 569999999999999988665556689999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (393)
....... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||........ .......
T Consensus 149 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~~--------- 215 (255)
T cd08219 149 LLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL--ILKVCQG--------- 215 (255)
T ss_pred eeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH--HHHHhcC---------
Confidence 6533221 22345788999999999988899999999999999999999999975433211 1111100
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 354 (393)
.....+..++..+.+|+.+||+.||++||++.+++..
T Consensus 216 ------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 ------SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------CCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0011122345778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=318.30 Aligned_cols=248 Identities=24% Similarity=0.358 Sum_probs=194.5
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcC-CCCccceeeeeeecCCcccceE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 153 (393)
+.||+|+||.||+|.+... +..||+|++..... .....+.+|+.++..+ +||||+++++++...+ .+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKN-----DQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS----RL 71 (327)
T ss_pred CeeeeCCCeEEEEEEECCC-----CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC----EE
Confidence 3699999999999987543 34699999976421 2334567899998888 5999999999987766 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+++++|..++. ....+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~e~~~~~~L~~~~~--~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQ--RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred EEEEeCCCCCcHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 99999999999998884 335689999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhh----hHHHHHHhhcCcCCcc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTME----QKLLEWVKQFPADGKK 309 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~----~~~~~~~~~~~~~~~~ 309 (393)
..... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..........
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------ 218 (327)
T cd05617 147 LGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK------ 218 (327)
T ss_pred cCCCC--ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC------
Confidence 22111 22346799999999999999999999999999999999999999964322111 1111111110
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT------MNQVVESLK 356 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps------~~~~l~~l~ 356 (393)
....+...+..+.+++.+||+.||.+|++ +.++++|.+
T Consensus 219 ---------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~ 262 (327)
T cd05617 219 ---------PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTF 262 (327)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCC
Confidence 00112234577899999999999999998 568888864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=301.10 Aligned_cols=250 Identities=30% Similarity=0.457 Sum_probs=197.4
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccce
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQ 152 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 152 (393)
+|++.+.||+|+||.||+|.+... ..+++|.+.... .....+.+|+.+++.++||||+++++++...+ .
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~------~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~ 73 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGK------IDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR----P 73 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCC------ccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC----c
Confidence 588889999999999999986422 248999886543 23456788999999999999999999987665 4
Q ss_pred EEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 153 RLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~ 149 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARY 149 (256)
T ss_pred eEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCccccee
Confidence 599999999999999986543 3689999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcccc
Q 035862 233 GPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311 (393)
Q Consensus 233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (393)
....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......... ......
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~~-------- 217 (256)
T cd05059 150 VLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---ESVSAG-------- 217 (256)
T ss_pred ccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---HHHHcC--------
Confidence 4322111 1111223457999999998999999999999999999999 89998765432211 111100
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
.....+..++.++.+++.+||..+|++|||+.++++.|
T Consensus 218 ------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 218 ------YRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 00111123467899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=299.50 Aligned_cols=253 Identities=30% Similarity=0.422 Sum_probs=200.6
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|.+...||+|++|.||+|.+.... .+++|.+.... .....+.+|+.+++.++|||++++++++.. +
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~------~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~---- 73 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT------KVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-E---- 73 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc------eEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-C----
Confidence 46889999999999999999864322 38899876543 334567889999999999999999988743 2
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..+++|||+.+++|.+++.......+++..+..++.|++.||.|||+. |++|+||||+||++++++.++|+|||++.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~ 150 (260)
T cd05069 74 PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLAR 150 (260)
T ss_pred CcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccce
Confidence 348999999999999999765555688999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ ......++..|+|||...+..++.++||||||+++|+|++ |..||....+... .......
T Consensus 151 ~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~------- 219 (260)
T cd05069 151 LIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQVERG------- 219 (260)
T ss_pred EccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcC-------
Confidence 65332211 1223345678999999988889999999999999999999 8999976433211 1111110
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.....+...+..+.+++.+||.+||++||++.++++.|+.
T Consensus 220 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 -------YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0011122356789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=300.13 Aligned_cols=249 Identities=30% Similarity=0.460 Sum_probs=199.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|.+.+.||+|+||.||++.... ..+++|...... ..+.+.+|+.+++.++|+|++++++++...+.
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--- 73 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG--- 73 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcC-------CcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC---
Confidence 468999999999999999997542 248999886543 34568899999999999999999997654432
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..+++|||+.+++|.+++.......+++..++.++.|++.||+|||++ |++||||||+||++++++.+||+|||++.
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~ 150 (256)
T cd05082 74 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 150 (256)
T ss_pred ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccce
Confidence 459999999999999999766555688999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
...... ....++..|+|||++.+..++.++|||||||++|+|++ |+.||....... .......
T Consensus 151 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~~-------- 214 (256)
T cd05082 151 EASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEK-------- 214 (256)
T ss_pred eccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhc--------
Confidence 543221 22344568999999998899999999999999999998 999986543211 1111110
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
......+..++..+.+++.+||+.+|++|||+.++++.|..
T Consensus 215 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 215 ------GYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ------CCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 00111122346789999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=306.86 Aligned_cols=268 Identities=29% Similarity=0.471 Sum_probs=206.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCC-----------CCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCcccee
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDG-----------RGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKL 139 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----------~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~ 139 (393)
.+|++.+.||+|+||.||+|.+..... ......|++|.+..... .....+.+|+.+++.++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 579999999999999999998764332 22446789999876532 335567889999999999999999
Q ss_pred eeeeecCCcccceEEEEEeecCCCChHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 035862 140 LGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRA---------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFK 210 (393)
Q Consensus 140 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dik 210 (393)
++++...+ ..+++|||+.+++|.+++.... ...+++..++.++.|++.||.|||+. +++|+|||
T Consensus 85 ~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlk 157 (296)
T cd05051 85 LGVCTVDP----PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLA 157 (296)
T ss_pred EEEEecCC----CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccc
Confidence 99998765 4599999999999999985433 12689999999999999999999998 99999999
Q ss_pred CCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh--CCCccCCC
Q 035862 211 TSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT--GRRVLERN 288 (393)
Q Consensus 211 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt--g~~pf~~~ 288 (393)
|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|||++ +..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999999876544333333344566788999999988889999999999999999998 66777543
Q ss_pred CchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 289 RPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
... .............. .......+..++.++.+++.+||+.||.+|||+.++++.|.
T Consensus 238 ~~~---~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 238 TDQ---QVIENAGHFFRDDG-------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ChH---HHHHHHHhcccccc-------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 321 11111111100000 00001112234578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=306.44 Aligned_cols=255 Identities=24% Similarity=0.348 Sum_probs=200.1
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|.+.+.||+|+||.||+|.+..+ +..|++|.+..........+.+|+.+++.++||||+++++.+...+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~---- 79 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNT-----GELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD---- 79 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCC-----CcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC----
Confidence 4688889999999999999986533 3469999987654444556778999999999999999999988766
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++.
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSA 154 (267)
T ss_pred EEEEEEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeee
Confidence 56999999999999998843 44689999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCCCccccccccccCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIE---TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
...... .......|+..|+|||++. ...++.++|+|||||++|+|++|..||....+......... .. ..
T Consensus 155 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~-~~--~~-- 227 (267)
T cd06645 155 QITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK-SN--FQ-- 227 (267)
T ss_pred EccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc-cC--CC--
Confidence 543221 1223457899999999874 45688999999999999999999999865443221111000 00 00
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
.+.... ...++..+.+++.+||..+|++||++.++++|.
T Consensus 228 ------~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~ 266 (267)
T cd06645 228 ------PPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHP 266 (267)
T ss_pred ------CCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCC
Confidence 000000 012456789999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=301.70 Aligned_cols=251 Identities=28% Similarity=0.402 Sum_probs=207.5
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceE
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 153 (393)
|.++.+||+|+||.||+|.++. .+.++|+|.+.-. ....++..|+.|++++..|++|++||.+.... -+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~E-----sG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s----DL 103 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRE-----SGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS----DL 103 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhc-----cCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCC----ce
Confidence 6667789999999999998653 4568999998654 44677889999999999999999999876655 35
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++|||||..|++.+.++.+ ++++.+..+..+++..++||+|||.. .-+|||||..|||++.+|.+||+|||.+..+
T Consensus 104 WIVMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 104 WIVMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQL 179 (502)
T ss_pred EeehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchh
Confidence 9999999999999988654 46799999999999999999999998 8899999999999999999999999999875
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
.... ...+...|||.|||||++..-.|+.++||||||++..||..|++||.+-.+-... .-+|.
T Consensus 180 TDTM--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI------FMIPT-------- 243 (502)
T KOG0574|consen 180 TDTM--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI------FMIPT-------- 243 (502)
T ss_pred hhhH--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee------EeccC--------
Confidence 4332 2346679999999999999999999999999999999999999999764331110 00111
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.+...-..+...+.++.+|+++||-+.|++|.|+.++++|..
T Consensus 244 -~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~F 285 (502)
T KOG0574|consen 244 -KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTF 285 (502)
T ss_pred -CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhh
Confidence 111112234567899999999999999999999999999843
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=300.68 Aligned_cols=254 Identities=29% Similarity=0.442 Sum_probs=202.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.++||+|+||.||+|.... +..|++|.+.... .....+.+|+.+++.++||||+++++++.. +
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~------~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~--- 73 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNG------HTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ-E--- 73 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCC------CceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc-C---
Confidence 4579999999999999999998542 2359999987654 334678899999999999999999988643 2
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..+++|||+.+++|.+++.......+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++
T Consensus 74 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 149 (260)
T cd05067 74 -PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLA 149 (260)
T ss_pred -CcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcce
Confidence 359999999999999998766666789999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
......... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||......... ......
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~~------ 219 (260)
T cd05067 150 RLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI---QNLERG------ 219 (260)
T ss_pred eecCCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH---HHHHcC------
Confidence 765422211 1223345678999999988889999999999999999999 99999755432111 111110
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.....+...+.++.+++.+||+.+|++||++++++..|+.
T Consensus 220 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 --------YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0001112345789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=299.14 Aligned_cols=251 Identities=25% Similarity=0.441 Sum_probs=196.1
Q ss_pred eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEEE
Q 035862 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVY 157 (393)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 157 (393)
.||+|+||.||+|.+... ..+..||+|.+..... .....+.+|+.+++.++||||+++++++... ..++||
T Consensus 2 ~ig~G~~g~v~~~~~~~~---~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~-----~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMR---KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-----ALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEecC---CCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC-----CeEEEE
Confidence 389999999999986522 2344689998876532 2345688999999999999999999987533 358999
Q ss_pred eecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCC
Q 035862 158 EYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGD 237 (393)
Q Consensus 158 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 237 (393)
||+.+++|.+++... ...+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++.......
T Consensus 74 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 149 (257)
T cd05115 74 EMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD 149 (257)
T ss_pred EeCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence 999999999988543 34689999999999999999999998 99999999999999999999999999997543332
Q ss_pred Ccc-ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcccccccC
Q 035862 238 HTH-VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMID 315 (393)
Q Consensus 238 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (393)
... ......++..|+|||.+.+..++.++|||||||++|++++ |..||......... .....
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~------------- 213 (257)
T cd05115 150 SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM---SFIEQ------------- 213 (257)
T ss_pred cceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH---HHHHC-------------
Confidence 211 1122234578999999988889999999999999999996 99999765432211 11111
Q ss_pred cccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
......+..++.++.+++.+||..+|++||++.++++.|...
T Consensus 214 -~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 214 -GKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 011112223568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=300.26 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=203.4
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+|++.+.||.|++|.||++.+...+ ..+++|.+.... ......+.+|+.+++.++|+|++++++.+...+.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 73 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDG-----KQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDG-- 73 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCC-----cEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCC--
Confidence 5889999999999999999865433 359999886432 2334567889999999999999999987754332
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
.++++|||+.+++|.+++.......+++.+++.++.|++.|+.+||+. +++||||||+||+++.++.++|+|||++
T Consensus 74 -~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 74 -LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred -EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccce
Confidence 568999999999999999765556689999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ ......+++.|+|||++.+..++.++||||||+++|+|++|..||........ ........
T Consensus 150 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~------- 218 (257)
T cd08223 150 RVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL--VYRIIEGK------- 218 (257)
T ss_pred EEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHhcC-------
Confidence 76533221 22345688999999999999999999999999999999999999975432211 11111100
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
....+...+..+.+++.+||+.+|++||++.+++++.|
T Consensus 219 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 256 (257)
T cd08223 219 --------LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256 (257)
T ss_pred --------CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 01122345678999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=337.95 Aligned_cols=262 Identities=23% Similarity=0.355 Sum_probs=202.6
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
..++|.+++.||.|+||+||+|.+... ...+++|.+.... ......+..|+.+++.++||||++++++|....
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~t-----g~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRT-----QEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCC-----CeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 457899999999999999999997543 3468999886542 223456788999999999999999999887654
Q ss_pred cccceEEEEEeecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCC----CCCeEeccCCCCCeEeCC---
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSR--AQPTLPWKTRLEIILGAAEGLAYLHEGL----EIQVIYRDFKTSNVLLDG--- 218 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~ql~~~l~~LH~~~----~~~ivH~Dikp~NIll~~--- 218 (393)
.. .+|+||||+.+++|.++|... ....+++..++.|+.||+.||.|||+.. ..+||||||||+||||+.
T Consensus 86 ~~--~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 86 NQ--KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred CC--EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 33 569999999999999998542 2356899999999999999999999841 025999999999999964
Q ss_pred --------------CCceEEeeccCCccCCCCCCccccccccccCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCC
Q 035862 219 --------------NFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET--GHLKSQSDIWSFGVVLYEILTGR 282 (393)
Q Consensus 219 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltg~ 282 (393)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++||||||||+|+|++|.
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 2358999999997643322 2234579999999999854 45889999999999999999999
Q ss_pred CccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 283 RVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 283 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.||....... . +...+...+. + .....+.++.+||..||..+|.+||++.+++.+.+..
T Consensus 241 ~PF~~~~~~~-q-li~~lk~~p~------------l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik 299 (1021)
T PTZ00266 241 TPFHKANNFS-Q-LISELKRGPD------------L---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK 299 (1021)
T ss_pred CCCCcCCcHH-H-HHHHHhcCCC------------C---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence 9997543321 1 1111111110 0 0012357799999999999999999999999886654
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=301.67 Aligned_cols=263 Identities=26% Similarity=0.441 Sum_probs=203.6
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc--c
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE--R 149 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~ 149 (393)
|.+.+.||+|+||.||+|...... .....||+|.+..... .....+.+|+..++.++||||+++++++..... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDD--GSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCC--CCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 567789999999999999875322 2345699998875422 234567899999999999999999998866543 1
Q ss_pred cceEEEEEeecCCCChHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSR----AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
....+++|||+.+++|..++... ....+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEEC
Confidence 12458999999999999988542 234689999999999999999999998 99999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcC
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFP 304 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 304 (393)
|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||....... ........
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~~~~- 231 (273)
T cd05035 156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLRHG- 231 (273)
T ss_pred CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcC-
Confidence 9999986543332222222345678999999988899999999999999999999 888886543321 11111110
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
. ....+..++..+.+++.+||+.||++||++.+++++|..+
T Consensus 232 ---~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 ---N----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---C----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0011223467899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=305.36 Aligned_cols=262 Identities=29% Similarity=0.456 Sum_probs=203.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|++.+.||+|+||.||+|.+...........|++|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~-- 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK-- 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--
Confidence 467999999999999999999865322233456799999875432 23456888999999999999999999988766
Q ss_pred cceEEEEEeecCCCChHHHHhhcC--------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRA--------------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDF 209 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Di 209 (393)
..++||||+.+++|.+++.... ...+++..++.++.|++.||.|||++ +++||||
T Consensus 82 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl 156 (288)
T cd05050 82 --PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDL 156 (288)
T ss_pred --ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceecccc
Confidence 4599999999999999996422 13477888999999999999999998 9999999
Q ss_pred CCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCC
Q 035862 210 KTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERN 288 (393)
Q Consensus 210 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~ 288 (393)
||+||++++++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999875433322222223345667999999998899999999999999999998 88888654
Q ss_pred CchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 289 RPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.... ....... +.. ...+..++.++.+|+.+||+.||.+|||+.++++.|+
T Consensus 237 ~~~~---~~~~~~~----~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 237 AHEE---VIYYVRD----GNV----------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CHHH---HHHHHhc----CCC----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 3321 1111111 000 0011234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=314.37 Aligned_cols=259 Identities=22% Similarity=0.284 Sum_probs=198.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++.+.||+|+||.||++....++ ..||+|++.+.. ......+.+|+.++..++|+||+++++++...+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTG-----QVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCC-----CEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC-
Confidence 47999999999999999999875443 469999986421 123345778999999999999999999998776
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
+.++||||+.+++|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg 147 (331)
T cd05597 75 ---NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG 147 (331)
T ss_pred ---eEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence 569999999999999998542 34689999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIET-----GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
++......... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.......... .....
T Consensus 148 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~--~i~~~- 223 (331)
T cd05597 148 SCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG--KIMNH- 223 (331)
T ss_pred ceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH--HHHcC-
Confidence 98754332211 1223469999999999863 457889999999999999999999997654321111 11100
Q ss_pred CcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHH
Q 035862 304 PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEE--RPTMNQVVESLKL 357 (393)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~~l~~l~~ 357 (393)
..... +.. ....++.++.+|+.+||+.+++. |+++.++++|.|.
T Consensus 224 ---~~~~~--~~~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~ 269 (331)
T cd05597 224 ---KEHFQ--FPP-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFF 269 (331)
T ss_pred ---CCccc--CCC-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCC
Confidence 00000 000 01125678899999988764443 7899999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=316.32 Aligned_cols=245 Identities=26% Similarity=0.353 Sum_probs=189.9
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHH-HHhhcCCCCccceeeeeeecCCcccceE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEV-QFLGVVSHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~~~ 153 (393)
+.||+|+||.||+|++..+ +..||+|.+.+... .....+.+|. .+++.++||||+++++++...+ ..
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~----~~ 71 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSD-----GSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE----KL 71 (321)
T ss_pred CeeeeCCCEEEEEEEECCC-----CCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC----EE
Confidence 3699999999999997543 34699999865321 1223344454 4678899999999999987766 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+++++|..++.. ...+++..+..++.||+.||.|||+. +|+||||||+||+++.+|.+||+|||++...
T Consensus 72 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 72 YFVLDYVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred EEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 999999999999988843 45688899999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
..... ......|++.|+|||++.+..++.++|||||||++|||++|..||....... ........+
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~--------- 212 (321)
T cd05603 147 VEPEE--TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYDNILHKP--------- 212 (321)
T ss_pred CCCCC--ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHHHHhcCC---------
Confidence 22221 2344578999999999998899999999999999999999999997654221 111111100
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM----NQVVESLK 356 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~~~l~~l~ 356 (393)
...+...+..+.+++.+||+.||.+||++ .++++|.+
T Consensus 213 ------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05603 213 ------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVF 253 (321)
T ss_pred ------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCC
Confidence 01112235678999999999999999875 47766654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=306.54 Aligned_cols=258 Identities=24% Similarity=0.364 Sum_probs=208.6
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
.+|++.+.||.|++|.||+|.+... +..|++|.+..........+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 89 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVAT-----GQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD---- 89 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCC-----CcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc----
Confidence 4699999999999999999986433 3469999887655555667889999999999999999999998766
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++|+||+.+++|.+++.. ..+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccch
Confidence 56999999999999998843 3589999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (393)
....... ......++..|+|||.+.+..++.++|||||||++|+|++|..||....+....... .... .
T Consensus 164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~--~~~~-~------ 232 (296)
T cd06655 164 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI--ATNG-T------ 232 (296)
T ss_pred hcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhcC-C------
Confidence 6433221 123456888999999999888999999999999999999999999766543222111 1000 0
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
.....+..++..+.+||.+||..||.+||++.+++++.|.....
T Consensus 233 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 233 ------PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred ------cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 00011223457789999999999999999999999999886543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=305.91 Aligned_cols=257 Identities=24% Similarity=0.358 Sum_probs=200.1
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|++.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+++.++||||+++++.+...+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 72 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLT-----RRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN--- 72 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCC-----CcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC---
Confidence 3688889999999999999986533 3469999886542 233456788999999999999999999998776
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+++++|..+. .+++..+..++.|++.||.|||+. |++|+||||+||+++.++.++|+|||++
T Consensus 73 -~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~ 142 (279)
T cd06619 73 -RISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVS 142 (279)
T ss_pred -EEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence 458999999999997542 468888999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH-HHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK-LLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~ 309 (393)
...... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.......... ........
T Consensus 143 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------ 212 (279)
T cd06619 143 TQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI------ 212 (279)
T ss_pred eecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH------
Confidence 754322 1234578999999999999899999999999999999999999996532211100 00000000
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
.+...........+.++.+++.+||+.+|++||++++++++.|....
T Consensus 213 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 213 ----VDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred ----hccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 00000000011245678999999999999999999999999887543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=301.94 Aligned_cols=266 Identities=26% Similarity=0.385 Sum_probs=208.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|.+.+.||+|+||.||+|.+.... ......|++|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~-~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~- 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEK-PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE- 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCC-CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC-
Confidence 467999999999999999999976422 2335678999886542 2334567889999999999999999998876432
Q ss_pred cceEEEEEeecCCCChHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceE
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQ------PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPK 223 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~k 223 (393)
..+++++|+.+++|.+++..... ..+++..++.++.|++.||.|||+. +++|+||||+||++++++.+|
T Consensus 83 --~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~k 157 (280)
T cd05043 83 --PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVK 157 (280)
T ss_pred --CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEE
Confidence 45899999999999999865322 4588999999999999999999998 999999999999999999999
Q ss_pred EeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhh
Q 035862 224 LSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQ 302 (393)
Q Consensus 224 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~ 302 (393)
|+|||+++...............++..|+|||++.+..++.++|||||||++|++++ |..||....+.. .......
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~ 234 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLKD 234 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHHc
Confidence 999999976543332222223455678999999988889999999999999999999 999997654322 1111111
Q ss_pred cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
+. .......++.++.+++.+||..||++|||+.++++.|..+.+
T Consensus 235 ----~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 ----GY----------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred ----CC----------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00 001112345788999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=317.49 Aligned_cols=248 Identities=27% Similarity=0.360 Sum_probs=196.9
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLL 155 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~l 155 (393)
+.||+|+||.||+++... ....+..||+|++..... .....+.+|+++++.++||||+++++++...+ ..|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKIT--GPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG----KLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEec--cCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC----EEEE
Confidence 579999999999987532 123456799999875422 22345678999999999999999999998766 5699
Q ss_pred EEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCC
Q 035862 156 VYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPT 235 (393)
Q Consensus 156 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 235 (393)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 76 v~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 76 ILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 150 (318)
T ss_pred EEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence 9999999999998843 45689999999999999999999998 999999999999999999999999999876433
Q ss_pred CCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccC
Q 035862 236 GDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMID 315 (393)
Q Consensus 236 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (393)
... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||......... ...... .
T Consensus 151 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~--~~i~~~----~-------- 214 (318)
T cd05582 151 HEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM--TMILKA----K-------- 214 (318)
T ss_pred CCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH--HHHHcC----C--------
Confidence 211 223457899999999999888999999999999999999999999765432111 111100 0
Q ss_pred cccccccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHH
Q 035862 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPT-----MNQVVESLK 356 (393)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~~l~~l~ 356 (393)
...+..++.++.+|+.+||+.||++||+ +.+++.|.|
T Consensus 215 ----~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~ 256 (318)
T cd05582 215 ----LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF 256 (318)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCC
Confidence 0112234578899999999999999999 677887754
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=305.44 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=203.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
+.|++++.||.|+||.||+|.+..++ ..+++|.+..........+.+|+.+++.++||||+++++.+..+.
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 82 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETG-----ALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG---- 82 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCC-----ceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC----
Confidence 56999999999999999999865433 469999987765555677888999999999999999999987765
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+++++|..++.... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred eEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccce
Confidence 5699999999999988775433 4589999999999999999999998 99999999999999999999999999886
Q ss_pred cCCCCCCccccccccccCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIE-----TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
..... ........++..|+|||++. ...++.++|||||||++|+|++|..||....... .........+
T Consensus 159 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~~~~~-- 232 (292)
T cd06644 159 KNVKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIAKSEP-- 232 (292)
T ss_pred ecccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HHHHHhcCCC--
Confidence 53222 11223456888999999884 3457889999999999999999999997654321 1111111000
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
+ ....+..++.++.+++.+||..+|++||++.+++++.+.
T Consensus 233 ---------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 272 (292)
T cd06644 233 ---------P--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV 272 (292)
T ss_pred ---------c--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 0 001112345678999999999999999999999998763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=310.35 Aligned_cols=267 Identities=28% Similarity=0.432 Sum_probs=207.1
Q ss_pred cCCcccceecccCCceEEEEEEcCCCC--CCCceEEEEEEecCCC-cccHHHHHHHHHHhhcC-CCCccceeeeeeecCC
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDG--RGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTED 147 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 147 (393)
.+|++.+.||+|+||.||+|.+...+. ......|++|.+.... ......+.+|+.+++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468999999999999999998653322 2234568999887542 23346788999999999 7999999999998765
Q ss_pred cccceEEEEEeecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCC
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRA--------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSN 213 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~N 213 (393)
..+++|||+.+++|.+++.... ...+++..+..++.|++.||.|||++ |++||||||+|
T Consensus 92 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 92 ----PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 4599999999999999986432 23477888899999999999999998 99999999999
Q ss_pred eEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchh
Q 035862 214 VLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTM 292 (393)
Q Consensus 214 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~ 292 (393)
||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.......
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999976543322222222344567999999999999999999999999999998 888886543222
Q ss_pred hhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 293 EQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
. ....... .....+..++.++.+++.+||+.+|++||++.++++.|..+....
T Consensus 245 ~---~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 245 L---FKLLKEG--------------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred H---HHHHHcC--------------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 1 1111110 000111234567899999999999999999999999999888544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=334.77 Aligned_cols=264 Identities=24% Similarity=0.325 Sum_probs=203.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++.++||+|+||.||+|.+..++ ..||+|++..... ....++.+|+++++.++||||+++++++...+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg-----~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~- 75 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCS-----RRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD- 75 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCC-----cEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC-
Confidence 57999999999999999999975443 4599999875422 23456889999999999999999999988766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRA---------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN 219 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~ 219 (393)
..++||||++|++|.+++.... ...+++..++.++.||+.||+|||++ ||+||||||+|||++.+
T Consensus 76 ---~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~d 149 (932)
T PRK13184 76 ---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLF 149 (932)
T ss_pred ---EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCC
Confidence 5699999999999999885321 12355677889999999999999998 99999999999999999
Q ss_pred CceEEeeccCCccCCCCCC----------------ccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 035862 220 FKPKLSDFGLAREGPTGDH----------------THVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRR 283 (393)
Q Consensus 220 ~~~kl~Dfg~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~ 283 (393)
|.++|+|||++........ .......+||+.|+|||++.+..++.++|||||||++|||+||..
T Consensus 150 g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~ 229 (932)
T PRK13184 150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229 (932)
T ss_pred CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence 9999999999976521110 001123579999999999999999999999999999999999999
Q ss_pred ccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHhhh
Q 035862 284 VLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-TMNQVVESLKLAVQES 362 (393)
Q Consensus 284 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~~l~~l~~~~~~~ 362 (393)
||......... ... .. ..+ ........++..+.+++.+||..||++|| +++++++.|...++..
T Consensus 230 PF~~~~~~ki~-~~~---~i----------~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 230 PYRRKKGRKIS-YRD---VI----------LSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred CCCCcchhhhh-hhh---hc----------cCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 99753221100 000 00 000 00000113557789999999999999996 5777778888777643
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=317.64 Aligned_cols=245 Identities=28% Similarity=0.360 Sum_probs=190.5
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHH-HhhcCCCCccceeeeeeecCCcccceE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQ-FLGVVSHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~ 153 (393)
+.||+|+||+||+|.+..+ +..+|+|++.... ......+..|.. +++.++||||+++++++...+ ..
T Consensus 1 ~~lG~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~----~~ 71 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLD-----GKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE----KL 71 (325)
T ss_pred CceeeCCCeEEEEEEECCC-----CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC----EE
Confidence 3699999999999986543 3469999986532 122234445544 567799999999999988776 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+.+++|..++. ....+++..+..++.||+.||.|||+. ||+||||||+|||+++++.+||+|||++...
T Consensus 72 ~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 72 YFVLDFVNGGELFFHLQ--RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred EEEEcCCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 99999999999998884 345689999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
..... ......|++.|+|||++.+..++.++|||||||++|+|++|..||........ ....... .
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~--~~~~~~~-~--------- 212 (325)
T cd05604 147 IAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM--YDNILHK-P--------- 212 (325)
T ss_pred CCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH--HHHHHcC-C---------
Confidence 22211 22346799999999999999999999999999999999999999976543221 1111100 0
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM----NQVVESLK 356 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~~~l~~l~ 356 (393)
. ......+..+.+++.+||+.+|.+||++ .++++|.|
T Consensus 213 ----~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~ 253 (325)
T cd05604 213 ----L--VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPF 253 (325)
T ss_pred ----c--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCC
Confidence 0 0111245678899999999999999977 47777644
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=298.34 Aligned_cols=249 Identities=33% Similarity=0.535 Sum_probs=202.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.+.||.|+||.||+|... +..|++|.+..... ..+++.+|+.+++.++|+||+++++++...+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 73 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN---- 73 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC----
Confidence 56899999999999999999853 23599999976643 4567889999999999999999999988755
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+.+++|.+++.......+++..++.++.|++.||.|||+. +++|+||||+||++++++.++|+|||.+.
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~ 150 (256)
T cd05039 74 PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK 150 (256)
T ss_pred CeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccc
Confidence 459999999999999999765555789999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
...... .....+..|+|||.+.+..++.++||||||+++|+|++ |..||....... +.......
T Consensus 151 ~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~------- 215 (256)
T cd05039 151 EASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHVEKG------- 215 (256)
T ss_pred cccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhcC-------
Confidence 653221 12334567999999988889999999999999999997 999987553321 11111110
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.....+...+..+.+++.+||..+|++||++.++++.|..
T Consensus 216 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 216 -------YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -------CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0011112345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=301.45 Aligned_cols=259 Identities=25% Similarity=0.379 Sum_probs=204.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++.+.||+|+||.||+|.+..++ ..+++|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~-----~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~- 75 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDG-----VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN- 75 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCC-----ceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-
Confidence 46888999999999999999865433 458999876432 223356788999999999999999999998766
Q ss_pred ccceEEEEEeecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
..+++|||+.+++|.+++.. .....+++..++.++.|++.||.|||+. |++|+||||+||+++.++.++|+|
T Consensus 76 ---~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~d 149 (267)
T cd08229 76 ---ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred ---eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECc
Confidence 56999999999999998853 2345689999999999999999999998 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......... .......
T Consensus 150 fg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~--- 223 (267)
T cd08229 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-CKKIEQC--- 223 (267)
T ss_pred chhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHH-hhhhhcC---
Confidence 999876433221 1234568899999999988889999999999999999999999996543321111 1111100
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
..........+..+.+++.+||..||++|||+.++++.+..+
T Consensus 224 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 224 ----------DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ----------CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 000111123567899999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=310.56 Aligned_cols=269 Identities=19% Similarity=0.287 Sum_probs=198.2
Q ss_pred ccceeccc--CCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 76 RMLKIGEG--GFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 76 ~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++.+||+| +|++||++..+.++ ..||+|.+..... .....+.+|+.+++.++||||+++++++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~---- 72 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTG-----EYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN---- 72 (327)
T ss_pred hhhhccccccceEEEEEEeecccC-----cEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC----
Confidence 45689999 67899999865444 4699999875432 23345678999999999999999999998776
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+++++|.+++.......+++..++.++.|++.||.|||++ +|+||||||+|||++.++.++++||+...
T Consensus 73 ~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 73 ELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence 569999999999999998655555689999999999999999999998 99999999999999999999999998654
Q ss_pred cCCCCCCc-----cccccccccCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHh-hc
Q 035862 232 EGPTGDHT-----HVSTAVVGTYGYAAPEYIET--GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK-QF 303 (393)
Q Consensus 232 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~-~~ 303 (393)
........ .......++..|+|||++.+ ..++.++|||||||++|+|++|..||........ ...... ..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~ 227 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTV 227 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCc
Confidence 32211110 01122356778999999876 4689999999999999999999999975432211 111000 00
Q ss_pred CcC-------Cccc---------cc-c------------cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 035862 304 PAD-------GKKF---------SM-M------------IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354 (393)
Q Consensus 304 ~~~-------~~~~---------~~-~------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 354 (393)
+.. .... .. . ............++..+.+|+.+||+.||++|||+.++++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000 0000 00 0 00000111222456789999999999999999999999999
Q ss_pred HHHH
Q 035862 355 LKLA 358 (393)
Q Consensus 355 l~~~ 358 (393)
.|..
T Consensus 308 p~f~ 311 (327)
T cd08227 308 SFFK 311 (327)
T ss_pred hhhh
Confidence 8864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=302.42 Aligned_cols=244 Identities=24% Similarity=0.407 Sum_probs=190.2
Q ss_pred eecccCCceEEEEEEcCCC-------------------CCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCcccee
Q 035862 79 KIGEGGFGSVYKGTIRPLD-------------------GRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKL 139 (393)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~-------------------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 139 (393)
.||+|+||.||+|.....+ .......|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999854221 223446789999876554445667889999999999999999
Q ss_pred eeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC
Q 035862 140 LGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN 219 (393)
Q Consensus 140 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~ 219 (393)
++++...+ ..++||||+++++|..++... ...+++..+..++.|++.||+|||+. +|+||||||+|||++..
T Consensus 82 ~~~~~~~~----~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 82 HGVCVRGS----ENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL 153 (274)
T ss_pred EEEEEeCC----ceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence 99998776 459999999999999988543 34688999999999999999999998 99999999999999765
Q ss_pred C-------ceEEeeccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHH-hCCCccCCCCc
Q 035862 220 F-------KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEIL-TGRRVLERNRP 290 (393)
Q Consensus 220 ~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell-tg~~pf~~~~~ 290 (393)
+ .+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred CcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 4 3899999987643221 22357788999998865 56899999999999999985 69999976544
Q ss_pred hhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 291 TMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
............ .+...+..+.+++.+||+.+|++||++.+++++|
T Consensus 228 ~~~~~~~~~~~~-------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 SEKERFYEKKHR-------------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHHHhccC-------------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 322211110000 0011235689999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=299.07 Aligned_cols=260 Identities=25% Similarity=0.444 Sum_probs=203.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|+..+.||+|+||.||+|.+.... .....+++|.+.... ......+.+|+++++.++|||++++.+++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPG--RKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK--- 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCC--CCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC---
Confidence 46888899999999999999875432 234578999887542 233456788999999999999999999998766
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++
T Consensus 80 -~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~ 154 (268)
T cd05063 80 -PAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLS 154 (268)
T ss_pred -CcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccc
Confidence 459999999999999998543 35689999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccc-cccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 231 REGPTGDHTHV-STAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 231 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
........... ......+..|+|||++.+..++.++|||||||++|||++ |..||....... ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~i~~~----- 226 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKAINDG----- 226 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHhcC-----
Confidence 76543222111 111223457999999988889999999999999999997 999997554321 11111110
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.....+..++..+.+++.+||..+|++||++.++++.|..+
T Consensus 227 ---------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ---------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111123457789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=298.23 Aligned_cols=259 Identities=25% Similarity=0.369 Sum_probs=205.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC---CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH---GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++.+.||+|+||.||+|....++ ..|++|.+... .......+.+|+++++.++|+|++++++.+...+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~- 75 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDG-----RVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN- 75 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCC-----CEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-
Confidence 57999999999999999999975333 45899987642 2223456889999999999999999999998765
Q ss_pred ccceEEEEEeecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSR--AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
..++||||+++++|.+++... ....+++..++.++.|++.||.|||+. |++||||+|+||+++.++.++|+|
T Consensus 76 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d 149 (267)
T cd08224 76 ---ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGD 149 (267)
T ss_pred ---eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEec
Confidence 559999999999999988542 235588999999999999999999998 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
||++........ ......++..|+|||.+.+..++.++|+|||||++|+|++|..||.......... ......
T Consensus 150 ~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~---- 222 (267)
T cd08224 150 LGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL-CKKIEK---- 222 (267)
T ss_pred cceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHH-Hhhhhc----
Confidence 999876433221 1233468889999999998899999999999999999999999996543221111 111000
Q ss_pred CcccccccCcccccccC-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYS-INAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
......+ ...+..+.+++.+||..+|++||++.++++.+..+.
T Consensus 223 ----------~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 ----------CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ----------CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0001111 145678999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=305.15 Aligned_cols=268 Identities=25% Similarity=0.337 Sum_probs=199.3
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+|++.+.||+|++|.||+|.+..+ +..|++|.+.... ......+.+|+.+++.++||||+++++++..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 72 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKT-----GQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES--- 72 (285)
T ss_pred CceEeeEecccCceEEEEEEECCC-----CcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC---
Confidence 488899999999999999986533 3469999886432 223456788999999999999999999998765
Q ss_pred ceEEEEEeecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRA-QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+. ++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 73 -~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 147 (285)
T cd07861 73 -RLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGL 147 (285)
T ss_pred -eEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccc
Confidence 5699999996 58988885433 35689999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHH-HHHHhhcCcC-
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKL-LEWVKQFPAD- 306 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~- 306 (393)
+....... .......+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||........... ..........
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (285)
T cd07861 148 ARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDV 225 (285)
T ss_pred eeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 87543221 12233467889999998865 4578999999999999999999999976543221111 0000000000
Q ss_pred ----------CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 307 ----------GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 307 ----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
............ ......++.++.++|.+||+.||.+|||+.++++|.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~ 284 (285)
T cd07861 226 WPGVTSLPDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284 (285)
T ss_pred hhcchhhHHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence 000000000000 0011135678899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=303.82 Aligned_cols=268 Identities=27% Similarity=0.444 Sum_probs=201.8
Q ss_pred cCCcccceecccCCceEEEEEEcCC-----------CCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCcccee
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPL-----------DGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKL 139 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----------~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~ 139 (393)
++|++.+.||+|+||.||++.+... ........+|+|.+.... ......+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 5699999999999999999864321 122345679999987543 2334578899999999999999999
Q ss_pred eeeeecCCcccceEEEEEeecCCCChHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 035862 140 LGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQ---------PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFK 210 (393)
Q Consensus 140 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dik 210 (393)
++++...+ ..++||||+.+++|.+++..... ..+++..++.++.|++.||+|||+. +++|+|||
T Consensus 85 ~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlk 157 (296)
T cd05095 85 LAVCITSD----PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLA 157 (296)
T ss_pred EEEEecCC----ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCC
Confidence 99998776 35999999999999999864321 2467788999999999999999998 99999999
Q ss_pred CCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh--CCCccCCC
Q 035862 211 TSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT--GRRVLERN 288 (393)
Q Consensus 211 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt--g~~pf~~~ 288 (393)
|+|||++.++.++|+|||++................++..|+|||...+..++.++|||||||++|||++ |..||...
T Consensus 158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999876433322222223345678999999888889999999999999999998 66787644
Q ss_pred CchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 289 RPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
..... .......+..... ......+..++..+.+|+.+||+.||++||++.++++.|.
T Consensus 238 ~~~~~--~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 238 SDEQV--IENTGEFFRDQGR--------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred ChHHH--HHHHHHHHhhccc--------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 32211 1110000000000 0000111234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=291.91 Aligned_cols=260 Identities=23% Similarity=0.315 Sum_probs=208.6
Q ss_pred hcCCccc-ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCccceeeeeeecCCc
Q 035862 71 TNGFNRM-LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 148 (393)
+++|.+. ++||-|-.|.|-.+..+.++++ +|+|++... ....+|+++.-..+ |||||.++++|...-.
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ek-----fALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEK-----FALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhh-----hHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 4566653 5699999999999998777765 999998654 34567888766665 9999999999987766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC---CceEEe
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN---FKPKLS 225 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~ 225 (393)
....+.+|||.++||.|...+.++....+++.++..|+.||+.|+.|||+. +|.||||||+|+|.+.+ ..+||+
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence 666788999999999999999888888899999999999999999999998 99999999999999654 469999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchh-hhHHHHHHh--h
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM-EQKLLEWVK--Q 302 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~-~~~~~~~~~--~ 302 (393)
|||+|+..... ....+.+.||.|.|||++....|+...|+||+||++|-|++|.+||..+.... ...+..... +
T Consensus 207 DfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq 283 (400)
T KOG0604|consen 207 DFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ 283 (400)
T ss_pred ccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC
Confidence 99999864322 23345788999999999999999999999999999999999999997653211 001111000 0
Q ss_pred cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
+.+ ..+-=..+|++..++|+.+|..+|.+|.|+.++++|.|..-
T Consensus 284 y~F-------------P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 284 YEF-------------PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred ccC-------------CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 000 00001257899999999999999999999999999998653
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=306.24 Aligned_cols=275 Identities=25% Similarity=0.390 Sum_probs=203.7
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
-|++++.||+|+||.||++.+... ....+..|++|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~-- 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPE-GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN-- 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccC-CCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC--
Confidence 478899999999999999986422 23455679999987543 23345688999999999999999999988775433
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ |++||||||+||+++.++.++|+|||++.
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 4589999999999999985432 3589999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCc-cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC--c
Q 035862 232 EGPTGDHT-HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG--K 308 (393)
Q Consensus 232 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~ 308 (393)
........ .......++..|+|||.+.+..++.++|||||||++|+|++++.|+.......... ........ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~----~~~~~~~~~~~ 233 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKM----IGPTHGQMTVT 233 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhh----cccccccccHH
Confidence 65433221 11223456778999999988889999999999999999999877653221100000 00000000 0
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.....+........+..++..+.+|+.+||+.+|++||++.++++.++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 234 RLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000000001111223567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=299.34 Aligned_cols=263 Identities=25% Similarity=0.416 Sum_probs=207.1
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.+|++.+.||+|+||.||+|.+..++ ......+++|.+..... .....+.+|+.+++.++||||+++++++.. .
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~--- 81 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEG-EKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-S--- 81 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCC-CCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C---
Confidence 46889999999999999999876443 33455789998876543 234567889999999999999999999876 2
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++
T Consensus 82 -~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~ 156 (279)
T cd05057 82 -QVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLA 156 (279)
T ss_pred -ceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccc
Confidence 4589999999999999986543 3489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
................++..|+|||.+....++.++|+||||+++||+++ |..||........ ...... +..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~----~~~ 229 (279)
T cd05057 157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI---PDLLEK----GER 229 (279)
T ss_pred ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHHhC----CCC
Confidence 86543322212222234568999999988899999999999999999998 9999976543221 111111 000
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
...+..++..+.+++.+||..+|.+||++.++++.+..+.++
T Consensus 230 ----------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 230 ----------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred ----------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 001112346788999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=304.18 Aligned_cols=264 Identities=25% Similarity=0.415 Sum_probs=205.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|+..+.||+|+||.||+|.+..++. .....+++|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--- 82 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGE-TVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT--- 82 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCC-cceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC---
Confidence 468889999999999999998764432 2234678898875432 22345788999999999999999999886543
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
.++++||+.+|+|.+++... ...+++..++.++.|++.||.|||++ +++|+||||+||++++++.+||+|||++
T Consensus 83 --~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 83 --IQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred --ceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccc
Confidence 37899999999999998543 33578899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
................++..|+|||.+.+..++.++|||||||++|||++ |..||.......... ..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~---~~~~~----~~ 229 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD---LLEKG----ER 229 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHCC----CC
Confidence 86543322222223455678999999998999999999999999999997 889987543322211 11110 00
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
. ..+..++..+.+++.+||..+|++||++.++++.+..+..+.
T Consensus 230 ~----------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 230 L----------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred C----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0 001123467899999999999999999999999999876554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=297.84 Aligned_cols=253 Identities=35% Similarity=0.578 Sum_probs=203.5
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc-HHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-HKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLV 156 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv 156 (393)
+.||+|+||.||+|.+.... .....+++|.+....... ...+.+|+.+++.++|+||+++++++.... ..++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~----~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD--GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEE----PLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCC--CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCC----ceEEE
Confidence 36999999999999876431 234569999988664333 567889999999999999999999988754 56999
Q ss_pred EeecCCCChHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 157 YEYMPNRSLEDRLFSRA-------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 157 ~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
|||+.+++|.+++.... ...+++..++.++.|++.||+|||++ +++|+||+|+||++++++.++|+|||.
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~ 151 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGL 151 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccc
Confidence 99999999999986542 36689999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+................++..|+|||.+....++.++||||||+++|+|++ |..||....... .......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~------ 222 (262)
T cd00192 152 SRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYLRK------ 222 (262)
T ss_pred ccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHc------
Confidence 987654432223344567889999999988899999999999999999999 699997653321 1111111
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
......+..++.++.+++.+||+.+|.+|||+.+++++|+
T Consensus 223 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 --------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --------CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0011122344688999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=299.62 Aligned_cols=261 Identities=27% Similarity=0.394 Sum_probs=205.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|.+.+.||+|+||.||+|.+.... +....|++|...... ....+.+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~---- 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPE--NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN---- 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCC--CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC----
Confidence 46888999999999999999875331 334568999887654 33456788999999999999999999988653
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 80 -~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 80 -PVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred -CcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCcee
Confidence 2489999999999999985433 3589999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
......... ......++..|+|||.+....++.++||||||+++|+|++ |..||......... ..... +.
T Consensus 155 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~~~----~~- 225 (270)
T cd05056 155 RYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRIEN----GE- 225 (270)
T ss_pred eecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHc----CC-
Confidence 765433211 1222334568999999988889999999999999999996 99999765432211 11111 00
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
....+..++..+.+++.+||..+|.+|||+.++++.|..+..+
T Consensus 226 ---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 ---------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0011223457899999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=298.26 Aligned_cols=255 Identities=32% Similarity=0.449 Sum_probs=203.4
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|.+.+.||.|+||.||+|.+... ..+++|.+.... .....+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~------~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 74 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGT------TKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE--- 74 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCC------ceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCC---
Confidence 46799999999999999999986422 348999887644 34567889999999999999999999987655
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+++++|.+++.......+++..+..++.|++.|+.|||++ +++|+||||+||++++++.++|+|||++
T Consensus 75 -~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~ 150 (261)
T cd05034 75 -PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLA 150 (261)
T ss_pred -ceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccc
Confidence 459999999999999999766556789999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
........ .......++..|+|||.+.+..++.++||||||+++|+|++ |+.||....... .........
T Consensus 151 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~~~~~------ 221 (261)
T cd05034 151 RLIEDDEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE--VLEQVERGY------ 221 (261)
T ss_pred eeccchhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCC------
Confidence 76543211 11122234568999999998889999999999999999998 999997543321 111111110
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
....+...+.++.+++.+||+.+|.+||+++++.+.|+.
T Consensus 222 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 ---------RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001111235779999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=306.44 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=206.8
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
...+|.+.+.||.|+||.||+|.....+ ..|++|.+..........+.+|+.+++.++||||+++++++...+
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 89 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATG-----QEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-- 89 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCC-----CEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--
Confidence 3468999999999999999999865333 369999987655455566788999999999999999999998766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||+
T Consensus 90 --~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~ 161 (297)
T cd06656 90 --ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGF 161 (297)
T ss_pred --EEEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCcc
Confidence 56999999999999998843 3478899999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+........ ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||....+...... ..
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~--~~--------- 228 (297)
T cd06656 162 CAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--IA--------- 228 (297)
T ss_pred ceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee--ec---------
Confidence 875433221 12345688899999999988899999999999999999999999975433211000 00
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.........+...+..+.+|+.+||..+|++||++.+++++.|...
T Consensus 229 ----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 274 (297)
T cd06656 229 ----TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKL 274 (297)
T ss_pred ----cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcc
Confidence 0000011112235577899999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=297.61 Aligned_cols=256 Identities=25% Similarity=0.374 Sum_probs=204.6
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.+.||.|+||.||+|.+..++ ..+++|.+..........+.+|+.+++.++||||+++++.+...+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~---- 73 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATG-----ELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD---- 73 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCC-----CEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC----
Confidence 57999999999999999999875433 359999987655455677889999999999999999999987766
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.++++|||+.+++|.+++... ...+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++.
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccch
Confidence 569999999999999988543 24689999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccccCCccCccccccC---CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETG---HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
....... ......++..|+|||.+.+. .++.++|+||||+++|+|++|..||....+........ ...+..
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~-~~~~~~--- 223 (262)
T cd06613 150 QLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS-KSNFPP--- 223 (262)
T ss_pred hhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hccCCC---
Confidence 6433211 12345688899999999776 88999999999999999999999997654332211111 000000
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
.........+.++.+|+.+||..+|.+|||+.+++.+-
T Consensus 224 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~ 261 (262)
T cd06613 224 ---------PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261 (262)
T ss_pred ---------ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 00111234567899999999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=307.91 Aligned_cols=268 Identities=23% Similarity=0.363 Sum_probs=191.7
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEEE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVY 157 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 157 (393)
.+||+|+||.||+|..... .....||+|.+.... ....+.+|+.+++.++||||+++++++...... ..++||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~---~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--~~~lv~ 79 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDG---KDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDR--KVWLLF 79 (317)
T ss_pred eEeccCCCeeEEEEEecCC---CccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCC--eEEEEE
Confidence 5799999999999986432 244579999887543 234567899999999999999999998765443 569999
Q ss_pred eecCCCChHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe----CCCCceEEee
Q 035862 158 EYMPNRSLEDRLFSR-------AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL----DGNFKPKLSD 226 (393)
Q Consensus 158 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~D 226 (393)
||+. ++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+|||+ +.++.+||+|
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~D 155 (317)
T cd07867 80 DYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIAD 155 (317)
T ss_pred eeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEee
Confidence 9995 4887776421 123578899999999999999999998 99999999999999 5667899999
Q ss_pred ccCCccCCCCCCc-cccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhh-------hHHH
Q 035862 227 FGLAREGPTGDHT-HVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTME-------QKLL 297 (393)
Q Consensus 227 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~-------~~~~ 297 (393)
||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+||.+||........ ....
T Consensus 156 fG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 235 (317)
T cd07867 156 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLD 235 (317)
T ss_pred ccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHH
Confidence 9999865432211 12234578999999999876 4589999999999999999999999965432211 1111
Q ss_pred HHHhhcCcCC-ccccc---------c---c-C-----ccc---ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 298 EWVKQFPADG-KKFSM---------M---I-D-----PRL---RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 298 ~~~~~~~~~~-~~~~~---------~---~-~-----~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
.......... ..... . . . ..+ ........+..+.+|+.+||+.||.+|||+.|+++|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp 315 (317)
T cd07867 236 RIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP 315 (317)
T ss_pred HHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence 1111000000 00000 0 0 0 000 0000011245688999999999999999999999986
Q ss_pred H
Q 035862 356 K 356 (393)
Q Consensus 356 ~ 356 (393)
|
T Consensus 316 ~ 316 (317)
T cd07867 316 Y 316 (317)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=298.54 Aligned_cols=260 Identities=26% Similarity=0.428 Sum_probs=203.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.+|++.+.||+|+||.||+|.+...+ .....+++|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPG--KREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK--- 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCC--CCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC---
Confidence 46889999999999999999865332 2345689998865432 23456788999999999999999999987665
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++
T Consensus 79 -~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd05066 79 -PVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLS 153 (267)
T ss_pred -ccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcc
Confidence 4599999999999999986443 4578999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCcc-ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 231 REGPTGDHTH-VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 231 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
.......... ......++..|+|||.+.+..++.++|+||||+++|++++ |..||......... ...... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~---~~~~~~----~ 226 (267)
T cd05066 154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI---KAIEEG----Y 226 (267)
T ss_pred cccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH---HHHhCC----C
Confidence 8654322211 1122233567999999998899999999999999999886 99999765432211 111110 0
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
....+..++..+.+++.+||+.+|.+||++.++++.|..+
T Consensus 227 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ----------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011123457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=299.49 Aligned_cols=260 Identities=26% Similarity=0.446 Sum_probs=203.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|++.+.||+|+||.||+|.+...+. ....|++|.+.... ......+..|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~--- 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGK--REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR--- 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCC--CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC---
Confidence 358889999999999999998764332 34579999987542 234567889999999999999999999987665
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+|||++
T Consensus 79 -~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~ 153 (269)
T cd05065 79 -PVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLS 153 (269)
T ss_pred -ceEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccc
Confidence 459999999999999988543 34588999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCcccccc-c--cccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 231 REGPTGDHTHVSTA-V--VGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 231 ~~~~~~~~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
.............. . ..+..|+|||.+.+..++.++|||||||++||+++ |..||....... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i~~~--- 227 (269)
T cd05065 154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAIEQD--- 227 (269)
T ss_pred cccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHHHcC---
Confidence 76433222111111 1 12357999999998999999999999999999886 999997654321 11211110
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.....+..++..+.+++.+||..+|.+||++.+++..|+.+
T Consensus 228 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 -----------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00011123457789999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=316.82 Aligned_cols=247 Identities=33% Similarity=0.456 Sum_probs=201.1
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc---HHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG---HKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
|.-++.||.|+||.||-|++..+. .+||||++...+.+. ...++.|+.+|++++|||++.+.|+|..+.
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~-----evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~--- 99 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNS-----EVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH--- 99 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCcc-----ceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc---
Confidence 666678999999999999976544 479999998765544 355788999999999999999999998766
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..+|||||| -|+-.|++.- ..+++.+..+..|..+.+.||+|||+. +.||||||.+|||+++.|.|||+|||.|
T Consensus 100 -TaWLVMEYC-lGSAsDlleV-hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSA 173 (948)
T KOG0577|consen 100 -TAWLVMEYC-LGSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSA 173 (948)
T ss_pred -hHHHHHHHH-hccHHHHHHH-HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccch
Confidence 449999999 4588887643 345689999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIE---TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
..... .++++|||.|||||++. .+.|+.++||||||++..||...++|+..-+. ...+.....+ .
T Consensus 174 si~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--MSALYHIAQN----e 241 (948)
T KOG0577|consen 174 SIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQN----E 241 (948)
T ss_pred hhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--HHHHHHHHhc----C
Confidence 76543 35689999999999885 57899999999999999999999999864321 1111111111 0
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.+.+ ...+.+..+.+|+..||++-|.+|||.+++++|..
T Consensus 242 -------sPtL---qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~f 280 (948)
T KOG0577|consen 242 -------SPTL---QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRF 280 (948)
T ss_pred -------CCCC---CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcch
Confidence 0111 13467899999999999999999999999999743
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=304.34 Aligned_cols=266 Identities=26% Similarity=0.334 Sum_probs=205.6
Q ss_pred HHHHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcC-CCCccceeeee
Q 035862 64 MQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV-SHPNLVKLLGY 142 (393)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 142 (393)
..++....+.|++.+.||.|+||.||+|.+...+ ..+++|...... .....+..|+.+++.+ +|+||++++++
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~ 81 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTG-----QLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGA 81 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCC-----cEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeee
Confidence 3344455678999999999999999999975433 469999886543 2345677899999988 69999999998
Q ss_pred eecCCc--ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC
Q 035862 143 CSTEDE--RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF 220 (393)
Q Consensus 143 ~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~ 220 (393)
+..... .....+++|||+.+++|.+++.......+++..++.++.|++.||.|||+. +++|+||+|+||++++++
T Consensus 82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA 158 (282)
T ss_pred hhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence 864321 223679999999999999999765556688999999999999999999998 999999999999999999
Q ss_pred ceEEeeccCCccCCCCCCccccccccccCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH
Q 035862 221 KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE-----TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK 295 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~ 295 (393)
.++|+|||++........ ......|+..|+|||.+. ...++.++|||||||++|+|++|..||....+.....
T Consensus 159 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~ 236 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF 236 (282)
T ss_pred CEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh
Confidence 999999999875432211 123456889999999875 3568889999999999999999999997544322111
Q ss_pred HHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
. .... .........++.++.+||.+||+.||.+||++.+++++.|
T Consensus 237 ~--~~~~--------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~ 281 (282)
T cd06636 237 L--IPRN--------------PPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281 (282)
T ss_pred h--HhhC--------------CCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence 1 0000 0000111135678999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=298.45 Aligned_cols=245 Identities=23% Similarity=0.393 Sum_probs=189.8
Q ss_pred eecccCCceEEEEEEcCCCC-------CCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 79 KIGEGGFGSVYKGTIRPLDG-------RGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~-------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
.||+|+||.||+|....... ......+++|.+..........+.+|+.+++.++||||+++++++.....
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~--- 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE--- 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC---
Confidence 58999999999998643221 12345688998876554555567889999999999999999999887663
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc-------eEE
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK-------PKL 224 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~-------~kl 224 (393)
.++||||+.+++|..++... ...+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +++
T Consensus 79 -~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 79 -NIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred -CEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence 48999999999999887543 34589999999999999999999998 9999999999999987664 899
Q ss_pred eeccCCccCCCCCCccccccccccCCccCccccc-cCCCCchhhHHHHHHHHHHHH-hCCCccCCCCchhhhHHHHHHhh
Q 035862 225 SDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE-TGHLKSQSDIWSFGVVLYEIL-TGRRVLERNRPTMEQKLLEWVKQ 302 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~ell-tg~~pf~~~~~~~~~~~~~~~~~ 302 (393)
+|||++...... ....++..|+|||++. +..++.++|||||||++|+|+ +|..||..........+.. ..
T Consensus 154 ~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~--~~ 225 (262)
T cd05077 154 SDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE--GQ 225 (262)
T ss_pred CCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHh--cC
Confidence 999998654221 2346788899999886 467899999999999999998 5888876543221111100 00
Q ss_pred cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
. . .....+.++.+|+.+||+.||.+||++.+++++++
T Consensus 226 ~---------------~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 226 C---------------M--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred c---------------c--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 0 00112467899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=308.51 Aligned_cols=265 Identities=31% Similarity=0.475 Sum_probs=217.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc-HHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-HKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.....+.++||+|-||.|.++.... ...||+|.++...... +..|.+|+++|.+++||||+.++|+|..++..
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEG------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecC------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 4567888999999999999997532 5679999999875544 47899999999999999999999999999865
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
++|+||++.|+|..+|.....+.+.-.....|+.||++||+||.+- ++|||||.+.|+|++.++++||+|||+
T Consensus 611 ----cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgm 683 (807)
T KOG1094|consen 611 ----CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGM 683 (807)
T ss_pred ----HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccc
Confidence 9999999999999999776656556666778999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh--CCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT--GRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
++.+..++........+-...|||+|.+..++++.++|+|+||+++||+++ ...||..... ++.......-++..+
T Consensus 684 sR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~--e~vven~~~~~~~~~ 761 (807)
T KOG1094|consen 684 SRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD--EQVVENAGEFFRDQG 761 (807)
T ss_pred ccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH--HHHHHhhhhhcCCCC
Confidence 998888888877777888899999999999999999999999999999776 5677764332 221111111111111
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
. ......+..++..+++++..||+.+-++||+++++-.+|...
T Consensus 762 ~--------~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 R--------QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred c--------ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1 111223345778999999999999999999999999988764
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=297.14 Aligned_cols=253 Identities=24% Similarity=0.377 Sum_probs=204.3
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+|+..+.||.|+||.||.+....+ +..+++|.+.... ......+.+|+.+++.++|+||+++++++...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-----~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--- 72 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTED-----DSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN--- 72 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCC-----CcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC---
Confidence 488999999999999999986533 3458999876432 234456789999999999999999999998765
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
.++++|||+++++|.+++.......+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++
T Consensus 73 -~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 73 -TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred -eEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence 569999999999999999765556789999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.......... .....
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~--~~~~~-------- 216 (256)
T cd08221 149 KILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV--KIVQG-------- 216 (256)
T ss_pred EEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHcC--------
Confidence 76533221 2234578999999999988889999999999999999999999997644321111 11100
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.. ...+..++.++.+++.+||+.+|.+||++.+++++++
T Consensus 217 ------~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~ 255 (256)
T cd08221 217 ------NY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255 (256)
T ss_pred ------CC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence 00 0111235678999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=300.23 Aligned_cols=261 Identities=23% Similarity=0.431 Sum_probs=206.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-cHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.+|++...||.|+||.||+|+............+++|.+...... ....+.+|+.+++.++|+||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE--- 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC---
Confidence 468899999999999999999876655666778999998765433 3567889999999999999999999987765
Q ss_pred ceEEEEEeecCCCChHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceE
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQ-------PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPK 223 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~k 223 (393)
..++||||+++++|.+++..... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.++
T Consensus 82 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~ 157 (275)
T cd05046 82 -PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVK 157 (275)
T ss_pred -cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEE
Confidence 45999999999999999864431 2589999999999999999999998 999999999999999999999
Q ss_pred EeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhh
Q 035862 224 LSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQ 302 (393)
Q Consensus 224 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~ 302 (393)
++|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ........
T Consensus 158 l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~~~~ 233 (275)
T cd05046 158 VSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNRLQA 233 (275)
T ss_pred EcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHHHHc
Confidence 9999998654322111 2223456778999999988889999999999999999999 78888643321 11111111
Q ss_pred cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.. .....+..++..+.+++.+||+.+|.+||++.+++..|+
T Consensus 234 ~~-------------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GK-------------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CC-------------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 000111234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=302.67 Aligned_cols=256 Identities=24% Similarity=0.395 Sum_probs=202.8
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceE
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 153 (393)
|++.+.||.|+||.||+|.+.. .+..+++|.+..........+.+|+.+++.++||||+++++++...+ ..
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~----~~ 77 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKE-----TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN----NL 77 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECC-----CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC----EE
Confidence 6778899999999999998653 33468999887655455667888999999999999999999988765 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+.+++|..++... ...+++..+..++.|++.||.|||+. |++||||||+||+++.++.+||+|||++...
T Consensus 78 ~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 78 WILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred EEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccc
Confidence 9999999999999887542 34689999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCCccccccccccCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIE-----TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
.... .......++..|+|||++. +..++.++|||||||++|+|++|.+||....+.. .........+.
T Consensus 154 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~~~~~~--- 226 (282)
T cd06643 154 TRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKIAKSEPP--- 226 (282)
T ss_pred cccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHHhhcCCC---
Confidence 3221 1223457889999999884 4567889999999999999999999997654321 11111111000
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
....+..++.++.+|+.+||+.||.+||++.+++++.+...
T Consensus 227 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 227 ----------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred ----------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 00111234578999999999999999999999999987544
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=299.73 Aligned_cols=253 Identities=23% Similarity=0.379 Sum_probs=199.6
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc---------HHHHHHHHHHhhcCCCCccceeeeee
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG---------HKQWLAEVQFLGVVSHPNLVKLLGYC 143 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~ 143 (393)
+|.+...||.|++|.||+|.+... +..+++|.+....... ...+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~-----~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASS-----GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCC-----CcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 477888999999999999986533 3459999886543221 24567899999999999999999998
Q ss_pred ecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceE
Q 035862 144 STEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPK 223 (393)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~k 223 (393)
...+ ..++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++
T Consensus 76 ~~~~----~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~ 146 (267)
T cd06628 76 LDAD----HLNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIK 146 (267)
T ss_pred EeCC----ccEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEE
Confidence 8766 45999999999999999943 35688899999999999999999998 999999999999999999999
Q ss_pred EeeccCCccCCCCCCc----cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHH
Q 035862 224 LSDFGLAREGPTGDHT----HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW 299 (393)
Q Consensus 224 l~Dfg~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~ 299 (393)
|+|||++......... .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||....... .....
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~ 224 (267)
T cd06628 147 ISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AIFKI 224 (267)
T ss_pred ecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HHHHH
Confidence 9999998765421111 11123457889999999998889999999999999999999999997543211 11111
Q ss_pred HhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.. ......+...+..+.+++.+||+.||.+||++.+++++.+
T Consensus 225 ~~---------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 266 (267)
T cd06628 225 GE---------------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266 (267)
T ss_pred hc---------------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence 00 0011122245678999999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=295.41 Aligned_cols=253 Identities=29% Similarity=0.473 Sum_probs=201.2
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLV 156 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv 156 (393)
+.||+|++|.||+|.+... .+....|++|.+..... ...+.+.+|+.+++.++||||+++++++.. . ..++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~----~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTS--GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H----PLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecC--CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-C----eEEEE
Confidence 3689999999999987532 33445699999987665 456678899999999999999999999876 3 56999
Q ss_pred EeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCC
Q 035862 157 YEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236 (393)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 236 (393)
|||+++++|.+++.......+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++......
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~ 150 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccc
Confidence 9999999999999665435689999999999999999999998 9999999999999999999999999999865442
Q ss_pred CCc-cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccccccc
Q 035862 237 DHT-HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMI 314 (393)
Q Consensus 237 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (393)
... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......... . ... ....
T Consensus 151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~--~-~~~---~~~~----- 219 (257)
T cd05040 151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK--K-IDK---EGER----- 219 (257)
T ss_pred ccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH--H-HHh---cCCc-----
Confidence 221 11223456788999999998899999999999999999998 999996543322111 1 110 0000
Q ss_pred CcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
...+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 220 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 -----LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -----CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0011134578999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=299.79 Aligned_cols=253 Identities=30% Similarity=0.512 Sum_probs=198.0
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLV 156 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv 156 (393)
++||+|+||.||+|.+...+ +....+++|.+..... .....+.+|+.+++.+.||||+++++++... ..++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~--~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKS--GKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE-----PLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccC--CCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCC-----ceEEE
Confidence 36999999999999865433 2345799999876543 2445688899999999999999999987533 34899
Q ss_pred EeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCC
Q 035862 157 YEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236 (393)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 236 (393)
|||+.+++|.+++... ..+++..++.++.|++.||.|||.. +++|+||||+|||++.++.+||+|||++......
T Consensus 74 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~ 148 (257)
T cd05060 74 MELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAG 148 (257)
T ss_pred EEeCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecC
Confidence 9999999999999544 3689999999999999999999998 9999999999999999999999999999865433
Q ss_pred CCcc-ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccccccc
Q 035862 237 DHTH-VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMI 314 (393)
Q Consensus 237 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (393)
.... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .+........
T Consensus 149 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~~~---------- 215 (257)
T cd05060 149 SDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLESGE---------- 215 (257)
T ss_pred CcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHcCC----------
Confidence 2211 1111223467999999998899999999999999999998 99999754332 1222111110
Q ss_pred CcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 315 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
....+..++..+.+++.+||..+|++||++.++++.|....
T Consensus 216 ----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 ----RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred ----cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01112234578899999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=303.56 Aligned_cols=258 Identities=24% Similarity=0.391 Sum_probs=205.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.+.||.|+||.||+|.+..+ +..+++|.+..........+.+|+++++.++||||+++++.+....
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 75 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKET-----GLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN--- 75 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCC-----CcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC---
Confidence 35699999999999999999987533 3469999987665555667889999999999999999999998765
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 76 -~~~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~ 150 (280)
T cd06611 76 -KLWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS 150 (280)
T ss_pred -eEEEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccc
Confidence 569999999999999988543 34589999999999999999999999 9999999999999999999999999988
Q ss_pred ccCCCCCCccccccccccCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIE-----TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
........ ......+++.|+|||.+. ...++.++|+||||+++|+|++|..||....... ......... .
T Consensus 151 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~-~ 225 (280)
T cd06611 151 AKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLKILKSE-P 225 (280)
T ss_pred hhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHHHhcCC-C
Confidence 65432211 223456889999999874 3457789999999999999999999997653321 111111100 0
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
+ ....+..++.++.+++.+||+.+|.+||++.+++++.|..
T Consensus 226 ----------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 266 (280)
T cd06611 226 ----------P--TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVS 266 (280)
T ss_pred ----------C--CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhc
Confidence 0 0011223457889999999999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=308.41 Aligned_cols=259 Identities=25% Similarity=0.349 Sum_probs=206.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc---cHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ---GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|+..+.||+|++|.||+|....+ +..+++|.+...... ....+.+|+++++.++||||+++++.+....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 74 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGT-----GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET- 74 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCC-----CcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-
Confidence 3688999999999999999987543 346999998765332 3456788999999999999999999987665
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+.+++|.+++.......+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||
T Consensus 75 ---~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 75 ---YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred ---EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecc
Confidence 569999999999999998765556789999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCc---------------------------cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhC
Q 035862 229 LAREGPTGDHT---------------------------HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTG 281 (393)
Q Consensus 229 ~a~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg 281 (393)
++......... .......|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 98754322110 011234688899999999988899999999999999999999
Q ss_pred CCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHHHHHH
Q 035862 282 RRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT----MNQVVESLKL 357 (393)
Q Consensus 282 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~~l~~l~~ 357 (393)
..||........ +...... ..........+..+.+++.+||..||++||+ +.+++.|.|.
T Consensus 229 ~~pf~~~~~~~~--~~~~~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~ 292 (316)
T cd05574 229 TTPFKGSNRDET--FSNILKK--------------EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292 (316)
T ss_pred CCCCCCCchHHH--HHHHhcC--------------CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence 999975543211 1111100 0000011125688999999999999999999 9999998766
Q ss_pred H
Q 035862 358 A 358 (393)
Q Consensus 358 ~ 358 (393)
.
T Consensus 293 ~ 293 (316)
T cd05574 293 R 293 (316)
T ss_pred h
Confidence 4
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=295.62 Aligned_cols=257 Identities=29% Similarity=0.460 Sum_probs=194.8
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLV 156 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv 156 (393)
+.||+|+||.||+|.+... ......+|+|.+... .......+.+|+.+++.++||||+++++++...+. ..+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDS--DGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEG---SPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecC--CCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCC---CcEEE
Confidence 3689999999999986532 234567999988543 22345677889999999999999999997764432 34899
Q ss_pred EeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCC
Q 035862 157 YEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236 (393)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 236 (393)
|||+.+++|.+++.... ...++..+..++.|++.||.|||+. +++||||||+|||+++++.+||+|||++......
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 76 LPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred EecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 99999999999985433 3456777888999999999999998 9999999999999999999999999998754322
Q ss_pred CCcc--ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhC-CCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 237 DHTH--VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTG-RRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 237 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
.... ......++..|+|||.+.+..++.++|||||||++|||++| .+||....... ....... +..
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~~~----~~~---- 220 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYLLQ----GRR---- 220 (262)
T ss_pred cceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHhc----CCC----
Confidence 1111 11233456789999999888999999999999999999995 55665432211 1111110 000
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
...+...+..+.+++.+||..+|++||++.++++.++.+..
T Consensus 221 ------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 221 ------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00111235678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=295.89 Aligned_cols=255 Identities=27% Similarity=0.389 Sum_probs=190.1
Q ss_pred eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEEE
Q 035862 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVY 157 (393)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 157 (393)
.||+|+||.||+|.+.. ......+++|.+..... .....+.+|+.+++.++||||+++++++.... ..++||
T Consensus 2 ~lg~G~~g~Vy~~~~~~---~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~ 74 (269)
T cd05087 2 EIGNGWFGKVILGEVNS---GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT----PYLLVM 74 (269)
T ss_pred cccccCCceEEEEEEcC---CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC----CcEEEE
Confidence 59999999999998642 22345689998875432 23346788999999999999999999987765 348999
Q ss_pred eecCCCChHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCC
Q 035862 158 EYMPNRSLEDRLFSRA---QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGP 234 (393)
Q Consensus 158 e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 234 (393)
||+++++|.+++.... ....++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999999999996432 22456777888999999999999998 99999999999999999999999999987543
Q ss_pred CCCCccccccccccCCccCccccccC-------CCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 235 TGDHTHVSTAVVGTYGYAAPEYIETG-------HLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 235 ~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
............++..|+|||++.+. .++.++||||||+++|||++ |..||........... .....
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~--~~~~~--- 226 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY--TVREQ--- 226 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH--Hhhcc---
Confidence 32222222334677889999988542 35789999999999999996 9999976543221111 01000
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.. ....+.. ....+..+.+++..|| .+|++|||+.+|...|.
T Consensus 227 ~~---~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 227 QL---KLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cC---CCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00 0011111 1123466888999999 68999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=300.77 Aligned_cols=254 Identities=28% Similarity=0.364 Sum_probs=204.8
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|++.+.||.|++|.||+|.+..+ +..+++|.+.... ......+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 72 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRT-----NQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS--- 72 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCC-----CeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC---
Confidence 4688899999999999999987543 3469999987543 233456778999999999999999999988765
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
.+++|+||+.+++|.+++... .+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++
T Consensus 73 -~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 145 (274)
T cd06609 73 -KLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS 145 (274)
T ss_pred -eEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 669999999999999998532 689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
....... .......++..|+|||.+.+..++.++||||||+++|+|++|..||....+..... .....
T Consensus 146 ~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~--~~~~~-------- 213 (274)
T cd06609 146 GQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF--LIPKN-------- 213 (274)
T ss_pred eeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH--Hhhhc--------
Confidence 7654332 12234568889999999998889999999999999999999999997544221110 00000
Q ss_pred ccccCcccccccCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSIN-AARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
........ ++.++.+++.+||..+|++||++++++++.+...
T Consensus 214 -------~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~ 256 (274)
T cd06609 214 -------NPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256 (274)
T ss_pred -------CCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence 00011111 4577899999999999999999999999987754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=301.65 Aligned_cols=269 Identities=26% Similarity=0.385 Sum_probs=201.1
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|++...||+|+||.||+|.+... +..|++|.+.... ....+.+.+|+.+++.++|||++++++++....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-- 73 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRET-----GQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR-- 73 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCC-----CcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC--
Confidence 4689999999999999999987533 3469999876432 223355778999999999999999999998765
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+++++|..++. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||+
T Consensus 74 --~~~~v~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 74 --KLHLVFEYCDHTVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGF 146 (286)
T ss_pred --EEEEEEeccCccHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcccc
Confidence 5699999999988887763 334689999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHH-Hhhc-C--
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW-VKQF-P-- 304 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~-~~~~-~-- 304 (393)
+........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.............. .... +
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07847 147 ARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH 224 (286)
T ss_pred ceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 986544321 1223457889999999876 5678999999999999999999999986554322111110 0000 0
Q ss_pred ----cCCcccccccCccccc-----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 305 ----ADGKKFSMMIDPRLRN-----QYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 305 ----~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
...........+.... ......+..+.+|+.+||+.+|++||++.+++.|.+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~ 285 (286)
T cd07847 225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285 (286)
T ss_pred hhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence 0000000000000000 001134678899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=297.74 Aligned_cols=253 Identities=28% Similarity=0.405 Sum_probs=204.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|+..+.||.|+||.||+|..... +..+++|.+..... ...+.+|+++++.++||||+++++++....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~-----~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~---- 71 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKET-----GQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT---- 71 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCC-----CcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC----
Confidence 5799999999999999999997543 34689998875432 567889999999999999999999998775
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++++||+.+++|.+++... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~ 147 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSG 147 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccch
Confidence 569999999999999998543 35689999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (393)
....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||....+....... . ..
T Consensus 148 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~--~-~~-------- 214 (256)
T cd06612 148 QLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI--P-NK-------- 214 (256)
T ss_pred hcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh--c-cC--------
Confidence 6543321 223345788999999999889999999999999999999999999754332211100 0 00
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.......+..++.++.+++.+||+.||++|||+.+++.+.|
T Consensus 215 ----~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~ 255 (256)
T cd06612 215 ----PPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255 (256)
T ss_pred ----CCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence 00001112245678999999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=310.54 Aligned_cols=259 Identities=21% Similarity=0.275 Sum_probs=198.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++.+.||+|+||.||++.+...+ ..+|+|.+.+.. ......+.+|+.++..++|+||+++++++...+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNAD-----KVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN- 74 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCC-----CEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-
Confidence 46899999999999999999875443 469999986421 122334678899999999999999999988766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+.+|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG 147 (332)
T cd05623 75 ---NLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 147 (332)
T ss_pred ---EEEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecc
Confidence 569999999999999999543 34589999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIE-----TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
++........ .......||+.|+|||++. ...++.++|||||||++|||++|+.||......... ......
T Consensus 148 ~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~--~~i~~~- 223 (332)
T cd05623 148 SCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY--GKIMNH- 223 (332)
T ss_pred hheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH--HHHhCC-
Confidence 9875432221 1223457999999999986 346889999999999999999999999765432211 111100
Q ss_pred CcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHH
Q 035862 304 PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEE--RPTMNQVVESLKL 357 (393)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~~l~~l~~ 357 (393)
.... .. ......++.++.+|+.+||..++.. |+++.++++|.|.
T Consensus 224 ---~~~~------~~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f 269 (332)
T cd05623 224 ---KERF------QF-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF 269 (332)
T ss_pred ---Cccc------cC-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCc
Confidence 0000 00 0011235678999999999665444 6899999999654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=325.28 Aligned_cols=280 Identities=20% Similarity=0.275 Sum_probs=194.8
Q ss_pred HHhcCCcccceecccCCceEEEEEEcCCCCCCC----------ceE----EEEEEecCCCcccHHHHHHHHHHhhcCCCC
Q 035862 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGE----------PLV----VAVKKLNNHGLQGHKQWLAEVQFLGVVSHP 134 (393)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~----------~~~----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 134 (393)
...++|++++.||+|+||+||++.++....... +.. ++.|.+.. .......+.+|+.+|+.++||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCCCC
Confidence 346789999999999999999987643221100 000 01111111 112334577899999999999
Q ss_pred ccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 035862 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRA---QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKT 211 (393)
Q Consensus 135 niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp 211 (393)
||+++++++...+ ..++|++++ +++|.+++.... ........++.++.||+.||.|||++ +|+||||||
T Consensus 224 nIv~l~~~~~~~~----~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP 295 (501)
T PHA03210 224 NILKIEEILRSEA----NTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKL 295 (501)
T ss_pred CcCcEeEEEEECC----eeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 9999999998776 458999999 457887774322 12234566788999999999999998 999999999
Q ss_pred CCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCc-cCCCCc
Q 035862 212 SNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRV-LERNRP 290 (393)
Q Consensus 212 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~p-f~~~~~ 290 (393)
+|||++.++.+||+|||++......... ......||..|+|||++.+..++.++|||||||++|||++|..+ +.....
T Consensus 296 ~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~ 374 (501)
T PHA03210 296 ENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG 374 (501)
T ss_pred HHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence 9999999999999999999765432211 22346799999999999999999999999999999999998754 443332
Q ss_pred hhhhHHHHHHhhcCcCCccc-------ccccCc--------ccccc-cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 035862 291 TMEQKLLEWVKQFPADGKKF-------SMMIDP--------RLRNQ-YSINAARRVAKLADNCLKKNPEERPTMNQVVES 354 (393)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~--------~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 354 (393)
.....+.............+ ...++. .+... .....+.++.+++.+||+.||.+|||+.|++.|
T Consensus 375 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 375 KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 22222222222111111100 000000 00000 001234567889999999999999999999999
Q ss_pred HHHH
Q 035862 355 LKLA 358 (393)
Q Consensus 355 l~~~ 358 (393)
.|..
T Consensus 455 p~f~ 458 (501)
T PHA03210 455 PLFS 458 (501)
T ss_pred hhhh
Confidence 8864
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=298.31 Aligned_cols=258 Identities=23% Similarity=0.346 Sum_probs=201.1
Q ss_pred HHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
..++.+.....||+|+||.||+|.+..+ +..|++|.+..........+.+|+.+++.++|+||+++++++...+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 78 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLST-----QVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG- 78 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCC-----CcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC-
Confidence 3455666667899999999999986533 3469999887765555667889999999999999999999988766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC-CCceEEe
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTL--PWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG-NFKPKLS 225 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~--~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~ 225 (393)
..++|+||+.+++|.+++.... ..+ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.++|+
T Consensus 79 ---~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~ 151 (268)
T cd06624 79 ---FFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKIS 151 (268)
T ss_pred ---EEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEe
Confidence 5699999999999999986432 234 7788889999999999999998 9999999999999976 6799999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccC--CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG--HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
|||++........ ......++..|+|||.+.+. .++.++||||||+++|+|++|..||............. ..
T Consensus 152 dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~---~~ 226 (268)
T cd06624 152 DFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV---GM 226 (268)
T ss_pred cchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhh---hh
Confidence 9999875432211 12234678999999998654 37889999999999999999999996543221111000 00
Q ss_pred CcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 304 PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.......+..+++++.+|+.+||+.+|.+|||+.+++.|.|
T Consensus 227 ------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 267 (268)
T cd06624 227 ------------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267 (268)
T ss_pred ------------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence 00111223345678999999999999999999999999865
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=299.17 Aligned_cols=257 Identities=23% Similarity=0.321 Sum_probs=198.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-----ccHHHHHHHHHHhhcCCCCccceeeeeeecC
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-----QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTE 146 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 146 (393)
.+|+..+.||+|+||.||+|....++ ..|++|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 76 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTG-----RELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR 76 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCC-----cEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC
Confidence 36889999999999999999865433 4699998764321 2234577899999999999999999988754
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
... ..+++|||+.+++|.+++.. ...+++..++.++.|++.||+|||+. +++||||+|+||+++.++.++|+|
T Consensus 77 ~~~--~~~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~d 149 (266)
T cd06651 77 AEK--TLTIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (266)
T ss_pred CCC--EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence 333 56899999999999999854 34578899999999999999999998 999999999999999999999999
Q ss_pred ccCCccCCCCCCc-cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 227 FGLAREGPTGDHT-HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 227 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
||++......... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||......... .... ..
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~--~~~~-~~-- 224 (266)
T cd06651 150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI--FKIA-TQ-- 224 (266)
T ss_pred CCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH--HHHh-cC--
Confidence 9998754321111 1112345788999999999888999999999999999999999999754322111 1100 00
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
......+..++..+.+++ +||..+|++||+++++++|.+.
T Consensus 225 -----------~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~ 264 (266)
T cd06651 225 -----------PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFA 264 (266)
T ss_pred -----------CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCccc
Confidence 001122334557788888 6778999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=311.87 Aligned_cols=259 Identities=22% Similarity=0.273 Sum_probs=198.6
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|.+.+.||+|+||.||++++..+ +..||+|.+.+.. ......+.+|..++..++|+||+++++++...+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~- 74 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHT-----ERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN- 74 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCC-----CCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 4799999999999999999986543 3469999986531 122344678899999999999999999998776
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..|+||||+.||+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 75 ---~~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG 147 (331)
T cd05624 75 ---YLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG 147 (331)
T ss_pred ---EEEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence 569999999999999999543 34688999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIET-----GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
++......... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... ....
T Consensus 148 ~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~--~i~~-- 222 (331)
T cd05624 148 SCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG--KIMN-- 222 (331)
T ss_pred ceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH--HHHc--
Confidence 98764332211 1233579999999999875 467889999999999999999999997654322111 1110
Q ss_pred CcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHH
Q 035862 304 PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEE--RPTMNQVVESLKL 357 (393)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~~l~~l~~ 357 (393)
...... +. .....++.++.+++.+||+.++++ |++++++++|.|.
T Consensus 223 --~~~~~~--~p-----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f 269 (331)
T cd05624 223 --HEERFQ--FP-----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFF 269 (331)
T ss_pred --CCCccc--CC-----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCc
Confidence 000000 00 001134678999999999876554 4689999998653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=300.44 Aligned_cols=260 Identities=27% Similarity=0.408 Sum_probs=203.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|++++.||+|+||.||+|.+... +..|++|.+... .......+.+|+.+++.++||||+++++.+...+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~-----~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--- 72 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPT-----GVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG--- 72 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCC-----CcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC---
Confidence 3688999999999999999986533 346999988653 2233456889999999999999999999888765
Q ss_pred ceEEEEEeecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRA-QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+++++|..++.... ...+++..+..++.|++.||.|||+. .+++|+||||+||+++.++.++|+|||+
T Consensus 73 -~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~ 149 (286)
T cd06622 73 -AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGV 149 (286)
T ss_pred -eEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCC
Confidence 5699999999999998885431 23689999999999999999999962 2899999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccC------CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETG------HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
+...... ......++..|+|||.+.+. .++.++|||||||++|+|++|..||.................
T Consensus 150 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~- 224 (286)
T cd06622 150 SGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD- 224 (286)
T ss_pred cccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhh-
Confidence 8754322 12334678899999998554 357899999999999999999999975433221111111100
Q ss_pred CcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 304 PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
......+..++.++.+|+.+||+.+|++||++.+++.+.|....
T Consensus 225 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 225 -------------GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred -------------cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 00111223467889999999999999999999999999887654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=282.59 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=200.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCC-CCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 149 (393)
++.+.+..||.|+.|.|++++++.+ +.++|||.+.+.. ....++++..+.++...+ .|+||+.+|+|..+...
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~-----~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRST-----GHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEccc-----ceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 4456677899999999999998654 3579999998764 344567778888877665 89999999999887754
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
++-||.| +.-++.++ .+...++|+..+-.+...+++||.||..+ ++|+|||+||.|||+|+.|++||||||+
T Consensus 167 ----~IcMelM-s~C~ekLl-krik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGI 238 (391)
T KOG0983|consen 167 ----FICMELM-STCAEKLL-KRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGI 238 (391)
T ss_pred ----HHHHHHH-HHHHHHHH-HHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccc
Confidence 6678888 33444444 34456699999999999999999999876 5999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIE---TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
+..+.... ..+...|-+.|||||.+. ...|+.++||||||++++||.||..||.......+-...-. ...|
T Consensus 239 sGrlvdSk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl-n~eP-- 312 (391)
T KOG0983|consen 239 SGRLVDSK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL-NEEP-- 312 (391)
T ss_pred cceeeccc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH-hcCC--
Confidence 98765433 345567899999999985 35799999999999999999999999988765433221111 1110
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
+.++ ....+++++.+|+..||++|+.+||...++++|..
T Consensus 313 ---------P~L~--~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~F 351 (391)
T KOG0983|consen 313 ---------PLLP--GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPF 351 (391)
T ss_pred ---------CCCC--cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcc
Confidence 1111 12237889999999999999999999999999853
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=302.88 Aligned_cols=266 Identities=26% Similarity=0.355 Sum_probs=202.8
Q ss_pred HHHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcC-CCCccceeeeee
Q 035862 65 QELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV-SHPNLVKLLGYC 143 (393)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 143 (393)
..+....++|++.+.||+|+||.||+|.+...+ ..+++|...... .....+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~-----~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNG-----SKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCC-----ceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 334456788999999999999999999865433 458999876532 2235577899999998 699999999987
Q ss_pred ecCC-cccceEEEEEeecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC
Q 035862 144 STED-ERGIQRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF 220 (393)
Q Consensus 144 ~~~~-~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~ 220 (393)
.... ..+...++||||+++++|.+++.. .....+++..++.++.|++.||.|||+. +++||||||+||++++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 5432 222367999999999999998753 2335688999999999999999999998 999999999999999999
Q ss_pred ceEEeeccCCccCCCCCCccccccccccCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH
Q 035862 221 KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-----GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK 295 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~ 295 (393)
.++|+|||++........ ......|++.|+|||++.. ..++.++|||||||++|+|++|..||....+...
T Consensus 162 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-- 237 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-- 237 (286)
T ss_pred CEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--
Confidence 999999999876433221 2234568999999998753 4578899999999999999999999975433211
Q ss_pred HHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
........ ... ...+..++.++.+++.+||+.||++|||+.+++++++
T Consensus 238 ~~~~~~~~-----------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 238 LFKIPRNP-----------PPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred HhhccccC-----------CCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 11100000 000 0011123467999999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=299.78 Aligned_cols=267 Identities=24% Similarity=0.341 Sum_probs=202.0
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+|++.+.||.|++|.||+|.+... +..|++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~-----~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--- 72 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRET-----GETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS--- 72 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCC-----CceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC---
Confidence 588999999999999999997543 3459999887543 233466889999999999999999999988755
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||++++++.++|+|||++
T Consensus 73 -~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~ 146 (286)
T cd07832 73 -GFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLA 146 (286)
T ss_pred -eeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence 569999999 999999886443 5689999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc-
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK- 308 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~- 308 (393)
........ .......++..|+|||.+.+. .++.++||||+|+++|+|++|.++|....+..... ...........
T Consensus 147 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~--~~~~~~~~~~~~ 223 (286)
T cd07832 147 RLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA--IVFRTLGTPNEE 223 (286)
T ss_pred ccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH--HHHHHcCCCChH
Confidence 86544321 122345788999999988654 46899999999999999999988886554322111 11111000000
Q ss_pred ------cc---ccc-c--Cccc-ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 309 ------KF---SMM-I--DPRL-RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 309 ------~~---~~~-~--~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.. ... . .... ......+.+..+.+++.+||+.+|++||++++++.|.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~ 284 (286)
T cd07832 224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284 (286)
T ss_pred HHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence 00 000 0 0000 00011134588999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=301.12 Aligned_cols=263 Identities=27% Similarity=0.371 Sum_probs=205.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|++.+.||+|+||+||++.+... +..|++|++.... ......+.+|+++++.++||||+++++.+...+
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~-----~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 76 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPT-----GTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN-- 76 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCC-----CcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC--
Confidence 35688999999999999999986533 3468999876543 234567889999999999999999999998775
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
.+++||||+++++|.+++.. ...+++..+..++.+++.||.|||+. .+++||||+|+||++++++.++|+|||+
T Consensus 77 --~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl 150 (284)
T cd06620 77 --NICMCMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGV 150 (284)
T ss_pred --EEEEEEecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCc
Confidence 56999999999999998843 35689999999999999999999963 2899999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchh-----hhHHHHHHhhcC
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM-----EQKLLEWVKQFP 304 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~-----~~~~~~~~~~~~ 304 (393)
+....... .....|+..|+|||++.+..++.++|||||||++|+|++|..||....... ............
T Consensus 151 ~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (284)
T cd06620 151 SGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226 (284)
T ss_pred ccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh
Confidence 86532211 123578999999999988899999999999999999999999997654321 011111111110
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
. ..........++.++.+|+.+||+.||.+|||+.+++++++.+..
T Consensus 227 ~----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 227 Q----------EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred h----------ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 0 000000111256789999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=294.40 Aligned_cols=254 Identities=28% Similarity=0.400 Sum_probs=188.0
Q ss_pred eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEEE
Q 035862 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVY 157 (393)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 157 (393)
.||+|+||.||+|..... .....+++|.+..... .....+.+|+.+++.++||||+++++.+...+ ..++||
T Consensus 2 ~lg~G~fg~v~~~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~----~~~lv~ 74 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRG---MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI----PYLLVL 74 (269)
T ss_pred cCCccCCceEEEEEEecC---CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC----ceEEEE
Confidence 599999999999975422 2345688887764432 23456788999999999999999999988766 459999
Q ss_pred eecCCCChHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCC
Q 035862 158 EYMPNRSLEDRLFSRAQ---PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGP 234 (393)
Q Consensus 158 e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 234 (393)
||+.+++|.+++..... ...++..++.++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccc
Confidence 99999999999965432 2346778889999999999999998 99999999999999999999999999986533
Q ss_pred CCCCccccccccccCCccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 235 TGDHTHVSTAVVGTYGYAAPEYIET-------GHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 235 ~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
............++..|+|||++.. ..++.++|||||||++|||++ |..||....+... ..........
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~~~~~~~- 228 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LKQVVREQDI- 228 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HHHHhhccCc-
Confidence 2221111223345678999998743 456889999999999999999 7788865433211 1111111000
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
. ...+ .....++..+.+++..|| .||++|||++++++.+
T Consensus 229 --~---~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 229 --K---LPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred --c---CCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 0 0011 112234577788999998 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=312.17 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=220.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
..+.....+||-|.||.||.|.|+..+- .||||.++.+. -...+|+.|+.+|+.++|||+|+++|+|..+...
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkysl-----TvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF- 338 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSL-----TVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF- 338 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccce-----eeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe-
Confidence 3456667889999999999999876554 49999998764 4567899999999999999999999999988854
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
|||+|||..|+|.+||+.-....++....+.++.||.+|++||..+ ++|||||...|+|+.++..||++|||++
T Consensus 339 ---YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 339 ---YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred ---EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 9999999999999999877777788888899999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+..... .+.......-...|.|||-+....++.|+|||+|||+|||+.| |..||.+-+-...
T Consensus 413 RlMtgD-TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV---------------- 475 (1157)
T KOG4278|consen 413 RLMTGD-TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---------------- 475 (1157)
T ss_pred hhhcCC-ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH----------------
Confidence 976433 2323333344568999999999999999999999999999998 7788875433221
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
-.++.+.++...+..|++.+++|++.||+++|.+||++.++-+.++.++..+
T Consensus 476 -Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 476 -YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred -HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 1234455666677789999999999999999999999999999999887644
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=295.30 Aligned_cols=251 Identities=31% Similarity=0.495 Sum_probs=194.1
Q ss_pred eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcC-CCCccceeeeeeecCCcccceEEEE
Q 035862 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDERGIQRLLV 156 (393)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~lv 156 (393)
.||+|+||.||+|.+..+ +....+++|.+.... ......+.+|+.++..+ +||||+++++++...+ ..+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~---~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~----~~~lv 74 (270)
T cd05047 2 VIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----YLYLA 74 (270)
T ss_pred cCCCCCCceEEEEEEcCC---CCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC----CceEE
Confidence 589999999999987532 233457888876432 23345678899999999 7999999999998766 45999
Q ss_pred EeecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCce
Q 035862 157 YEYMPNRSLEDRLFSRA--------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP 222 (393)
Q Consensus 157 ~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 222 (393)
|||+.+++|.+++.... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~ 151 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 151 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeE
Confidence 99999999999985432 13478899999999999999999998 99999999999999999999
Q ss_pred EEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHh
Q 035862 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVK 301 (393)
Q Consensus 223 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~ 301 (393)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||....... .....
T Consensus 152 kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~- 224 (270)
T cd05047 152 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL- 224 (270)
T ss_pred EECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHH-
Confidence 99999998632211 11112233567999999988899999999999999999997 999996543211 11111
Q ss_pred hcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
+.. .....+..++.++.+++.+||..+|.+|||+.+++..|..++
T Consensus 225 --~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 --PQG-----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --hCC-----------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 110 000111234567899999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=314.72 Aligned_cols=245 Identities=24% Similarity=0.326 Sum_probs=189.2
Q ss_pred ecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcC---CCCccceeeeeeecCCcccceE
Q 035862 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVV---SHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~ 153 (393)
||+|+||+||+|++..++ ..||+|++..... ........|..++... .||||+++++++...+ ..
T Consensus 1 lG~G~~g~Vy~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~----~~ 71 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTR-----RIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS----DL 71 (330)
T ss_pred CCCCCceEEEEEEECCCC-----CEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC----eE
Confidence 799999999999865433 4699999864321 1223345566666654 6999999999988776 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+.+++|.+++. ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 72 ~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 72 YLVTDYMSGGELFWHLQ--KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred EEEEcCCCCChHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 99999999999999884 345689999999999999999999998 9999999999999999999999999998753
Q ss_pred CCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSM 312 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (393)
..... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||........ ..... .....
T Consensus 147 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~--~~~i~----~~~~~--- 215 (330)
T cd05586 147 LTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM--YRNIA----FGKVR--- 215 (330)
T ss_pred CCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH--HHHHH----cCCCC---
Confidence 22221 22346799999999998754 589999999999999999999999976533211 11110 00000
Q ss_pred ccCcccccccCHHHHHHHHHHHHHhcccCCCCCC----CHHHHHHHHHH
Q 035862 313 MIDPRLRNQYSINAARRVAKLADNCLKKNPEERP----TMNQVVESLKL 357 (393)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp----s~~~~l~~l~~ 357 (393)
+. ...++.++.+|+.+||+.||.+|| ++.++++|.|.
T Consensus 216 -----~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~ 256 (330)
T cd05586 216 -----FP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256 (330)
T ss_pred -----CC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccc
Confidence 00 012457789999999999999998 68999998764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=299.58 Aligned_cols=261 Identities=29% Similarity=0.397 Sum_probs=204.5
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcC-CCCccceeeeeeecCCc
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 148 (393)
..++|++.+.||+|++|.||+|.+... +..+++|.+..... ....+.+|+.+++.+ .|+||+++++++.....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKT-----GQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCC-----CcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 457899999999999999999987533 34699998876542 346688999999998 69999999999976552
Q ss_pred --ccceEEEEEeecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEE
Q 035862 149 --RGIQRLLVYEYMPNRSLEDRLFSRA--QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKL 224 (393)
Q Consensus 149 --~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 224 (393)
.+...++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l 154 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKL 154 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEE
Confidence 2346799999999999999885433 46789999999999999999999998 9999999999999999999999
Q ss_pred eeccCCccCCCCCCccccccccccCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHH
Q 035862 225 SDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-----GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW 299 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~ 299 (393)
+|||++....... .......|+..|+|||.+.. ..++.++|||||||++|+|++|..||........ ....
T Consensus 155 ~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~ 230 (275)
T cd06608 155 VDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LFKI 230 (275)
T ss_pred CCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HHHh
Confidence 9999987543322 12234568899999998753 3567899999999999999999999975432211 1111
Q ss_pred HhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
....+ + ....+...+.++.+|+.+||..||++|||+.+++++.|
T Consensus 231 ~~~~~-----------~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~ 274 (275)
T cd06608 231 PRNPP-----------P--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274 (275)
T ss_pred hccCC-----------C--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence 11100 0 01112235678999999999999999999999998765
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=295.46 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=203.5
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+|++.+.||+|+||.+|++..... +..|++|.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 72 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKED-----GKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENG--- 72 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCC-----CCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCC---
Confidence 588999999999999999986533 346999988643 2233456888999999999999999999987765
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+++|.+++.......+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++
T Consensus 73 -~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 73 -NLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred -eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence 569999999999999988655555688999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ ......|++.|+|||++.+..++.++|+|||||++|+|++|..||........ ........
T Consensus 149 ~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~--~~~~~~~~------- 217 (256)
T cd08218 149 RVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL--VLKIIRGS------- 217 (256)
T ss_pred eecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH--HHHHhcCC-------
Confidence 76433221 12334688899999999988999999999999999999999999975433211 11111110
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
....+...+.++.+++.+||+.+|.+||++.++++|.|
T Consensus 218 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~ 255 (256)
T cd08218 218 --------YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255 (256)
T ss_pred --------CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence 01112234678999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=312.81 Aligned_cols=256 Identities=26% Similarity=0.358 Sum_probs=214.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc--cHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ--GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.+.|.+...||+|.|+.|.+|++..++.+ ||+|.+.+.... ....+.+|+++++.++|||||+++.+...+.
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~-----VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~- 128 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTE-----VAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA- 128 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCce-----EEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc-
Confidence 56799999999999999999998766554 999999886433 3345789999999999999999999998887
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
.+|+||||+.+|.+++++ .....+.+..+..++.|+++|++|||++ .|||||||++|||++.+.++||+|||
T Consensus 129 ---~lylV~eya~~ge~~~yl--~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfg 200 (596)
T KOG0586|consen 129 ---TLYLVMEYASGGELFDYL--VKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFG 200 (596)
T ss_pred ---eeEEEEEeccCchhHHHH--HhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccc
Confidence 569999999999999999 4555677789999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHL-KSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
++..+.... .....+|++.|.|||++.+..| .+.+|+||+|+++|.|+.|..||++..-
T Consensus 201 fS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l----------------- 260 (596)
T KOG0586|consen 201 FSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL----------------- 260 (596)
T ss_pred cceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-----------------
Confidence 998876433 4467899999999999999877 4689999999999999999999985432
Q ss_pred cccccccCccccc--ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 308 KKFSMMIDPRLRN--QYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 308 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
..+-++-++. ..+.-++.++.++|+++|..+|.+|++++++.++-|.-....+
T Consensus 261 ---k~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 261 ---KELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred ---ccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 1111111111 1222467889999999999999999999999999886554444
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=301.30 Aligned_cols=266 Identities=29% Similarity=0.442 Sum_probs=206.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-cHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
..|++.+.||+|+||.||+|.+...+ ...+..+|+|.+...... ....+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~- 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLG-DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR- 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCC-CCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC-
Confidence 35788899999999999999875432 335668999999866443 456788999999999999999999988764433
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..+++|||+++++|.+++.... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 82 -~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 82 -SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred -ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 5699999999999999986433 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCcc-ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhh------------hHHH
Q 035862 231 REGPTGDHTH-VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTME------------QKLL 297 (393)
Q Consensus 231 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~------------~~~~ 297 (393)
.......... ......++..|+|||.+.+..++.++||||||+++|+|++|..|+........ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 8764322211 11123445679999999888999999999999999999999998864322110 0111
Q ss_pred HHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 298 EWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.... .......+..++.++.+++.+||+.+|++||++.++++.|..+
T Consensus 237 ~~~~--------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 237 ELLK--------------EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHH--------------cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111 1111111223457899999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=301.25 Aligned_cols=270 Identities=28% Similarity=0.384 Sum_probs=207.5
Q ss_pred ccHHHHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcC-CCCccceee
Q 035862 62 FDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV-SHPNLVKLL 140 (393)
Q Consensus 62 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 140 (393)
+.+.++..+.++|.+...||+|+||.||+|....+ +..+++|.+.... .....+.+|+.++..+ +|||+++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~-----~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~ 85 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKD-----GSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFY 85 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCC-----CCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 44556667788999999999999999999986533 3469999886543 2345567899999988 799999999
Q ss_pred eeeecCCc-ccceEEEEEeecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC
Q 035862 141 GYCSTEDE-RGIQRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD 217 (393)
Q Consensus 141 ~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~ 217 (393)
+++...+. .....++||||+++++|.+++.. .....+++..++.++.|++.||.|||+. +++||||||+||+++
T Consensus 86 ~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~ 162 (291)
T cd06639 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLT 162 (291)
T ss_pred EEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEc
Confidence 99876542 22356999999999999998853 2345689999999999999999999998 999999999999999
Q ss_pred CCCceEEeeccCCccCCCCCCccccccccccCCccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCccCCCCchh
Q 035862 218 GNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG-----HLKSQSDIWSFGVVLYEILTGRRVLERNRPTM 292 (393)
Q Consensus 218 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslGvil~elltg~~pf~~~~~~~ 292 (393)
.++.+||+|||++........ ......|+..|+|||.+... .++.++|||||||++|+|++|+.||....+..
T Consensus 163 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~ 240 (291)
T cd06639 163 TEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240 (291)
T ss_pred CCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence 999999999999876433221 12334688899999988543 36889999999999999999999997543321
Q ss_pred hhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 293 EQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.........+. .. ..+...+..+.+++.+||+.+|++||++.++++|.|.
T Consensus 241 --~~~~~~~~~~~-----------~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~ 290 (291)
T cd06639 241 --TLFKIPRNPPP-----------TL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290 (291)
T ss_pred --HHHHHhcCCCC-----------CC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCccc
Confidence 11111111000 00 0112344679999999999999999999999998653
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=297.47 Aligned_cols=256 Identities=23% Similarity=0.300 Sum_probs=199.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-----cccHHHHHHHHHHhhcCCCCccceeeeeeecC
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-----LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTE 146 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 146 (393)
.+|.+.+.||+|+||.||.|.+..+ +..|++|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~-----~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 76 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADT-----GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP 76 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCC-----CcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC
Confidence 3688999999999999999986543 3469999875321 12235677899999999999999999987665
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
... .++++|||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|
T Consensus 77 ~~~--~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 77 MER--TLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred CCc--eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECc
Confidence 433 568999999999999998543 4578888999999999999999998 999999999999999999999999
Q ss_pred ccCCccCCCCCCc-cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 227 FGLAREGPTGDHT-HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 227 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
||++......... .......++..|+|||++.+..++.++|||||||++|+|++|+.||........ ..... ..+
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~-~~~- 225 (265)
T cd06652 150 FGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IFKIA-TQP- 225 (265)
T ss_pred CccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HHHHh-cCC-
Confidence 9998754321111 012234688899999999888899999999999999999999999975432211 11111 000
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.....+...+..+.+++.+|| .+|++||++++++++.+
T Consensus 226 ------------~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~~~~ 263 (265)
T cd06652 226 ------------TNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLRHTF 263 (265)
T ss_pred ------------CCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhcCcc
Confidence 011223355678899999999 49999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=296.69 Aligned_cols=254 Identities=26% Similarity=0.385 Sum_probs=199.4
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc------ccHHHHHHHHHHhhcCCCCccceeeeeeecC
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL------QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTE 146 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 146 (393)
+|.+.+.||.|+||.||+|... .+..+|+|.+..... .....+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEEc------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC
Confidence 4788899999999999999753 233589998764321 1224577899999999999999999999876
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
+ ..+++|||+.+++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|
T Consensus 75 ~----~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 145 (265)
T cd06631 75 N----TISIFMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLID 145 (265)
T ss_pred C----eEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEecc
Confidence 5 56999999999999999843 34578999999999999999999998 999999999999999999999999
Q ss_pred ccCCccCCCCCC----ccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhh
Q 035862 227 FGLAREGPTGDH----THVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ 302 (393)
Q Consensus 227 fg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (393)
||++........ ........++..|+|||++.+..++.++|+|||||++|+|++|..||............. ..
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~--~~ 223 (265)
T cd06631 146 FGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG--AH 223 (265)
T ss_pred chhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh--hc
Confidence 999875422111 111234568899999999998889999999999999999999999997544322211111 00
Q ss_pred cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
. ......+..++.++.+++.+||..+|.+||++.+++.+.|
T Consensus 224 ~-------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 264 (265)
T cd06631 224 R-------------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264 (265)
T ss_pred c-------------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 0 0001112234678899999999999999999999998754
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=293.83 Aligned_cols=246 Identities=29% Similarity=0.471 Sum_probs=197.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.+.||+|+||.||++... +..+++|...... ....+.+|+.+++.++|||++++++++....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-------~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---- 72 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYT-------GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG---- 72 (254)
T ss_pred HHceeeeeeccCCCCceEecccC-------CCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC----
Confidence 46899999999999999998632 2348999886542 3456788999999999999999999886543
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.++||||+.+++|.+++.......+++..++.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++.
T Consensus 73 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 73 -LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred -cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccce
Confidence 48999999999999999766555689999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
...... .....+..|+|||.+.+..++.++|+|||||++|+|++ |..||.......... ....
T Consensus 149 ~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~~-------- 212 (254)
T cd05083 149 VGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE---CVEK-------- 212 (254)
T ss_pred eccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH---HHhC--------
Confidence 543211 12234567999999988899999999999999999998 999997654322111 1110
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
......+..++..+.+++.+||+.+|++||++.++++.+.
T Consensus 213 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 213 ------GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred ------CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 0011111234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=304.11 Aligned_cols=255 Identities=29% Similarity=0.438 Sum_probs=212.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc---cHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ---GHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.+.|..-++||+|+||.||-+..+.++ +.+|.|++.+.... .....++|-.||..++.+.||.+-..|.+.+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTG-----KMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATG-----KMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecch-----hhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence 467899999999999999999876544 46999988765322 2345678999999999999999998898888
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
.+|+||..|+||+|.-.|++..++.+++..++.++.+|+.||++||+. +||+||+||+|||+|+.|+++|+|+
T Consensus 259 ----~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 259 ----ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred ----ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeecc
Confidence 569999999999999999888888999999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhh-HHHHHHhhcCcC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ-KLLEWVKQFPAD 306 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~ 306 (393)
|+|.....+. .....+||.+|||||++.+..|+...|.|||||++|||+.|+.||....+.... .+-....
T Consensus 332 GLAvei~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~----- 403 (591)
T KOG0986|consen 332 GLAVEIPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL----- 403 (591)
T ss_pred ceEEecCCCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh-----
Confidence 9998766544 334569999999999999999999999999999999999999999765433221 1111111
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT-----MNQVVESL 355 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~~l~~l 355 (393)
.-..+++...++++.+|.+.+|.+||.+|.. +.++-+|+
T Consensus 404 ----------~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hp 447 (591)
T KOG0986|consen 404 ----------EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHP 447 (591)
T ss_pred ----------cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCc
Confidence 1123456678899999999999999999975 44666664
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=298.28 Aligned_cols=244 Identities=25% Similarity=0.394 Sum_probs=189.8
Q ss_pred eecccCCceEEEEEEcCCCC--CCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEE
Q 035862 79 KIGEGGFGSVYKGTIRPLDG--RGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLV 156 (393)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv 156 (393)
.||.|+||.||+|....... ......+++|.+..........+.+|+.+++.++||||+++++++...+. .++|
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~----~~lv 77 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE----SIMV 77 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCC----cEEE
Confidence 69999999999998754322 12345688888766544445677889999999999999999999987663 4899
Q ss_pred EeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc--------eEEeecc
Q 035862 157 YEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK--------PKLSDFG 228 (393)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~--------~kl~Dfg 228 (393)
|||+.+++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++. ++++|||
T Consensus 78 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccc
Confidence 99999999999986443 3588999999999999999999998 9999999999999987765 6999999
Q ss_pred CCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCC-CccCCCCchhhhHHHHHHhhcCcC
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGR-RVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
++...... ....++..|+|||++.+ ..++.++|||||||++|+|++|. .||....+........ .
T Consensus 154 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~---~---- 220 (258)
T cd05078 154 ISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE---D---- 220 (258)
T ss_pred cccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH---c----
Confidence 88654321 23467889999999976 45799999999999999999995 5554433322111111 0
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
. ...+...+.++.+++.+||+.||++|||++++++.|
T Consensus 221 ~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 221 R------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred c------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 011112346789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=296.24 Aligned_cols=255 Identities=26% Similarity=0.378 Sum_probs=206.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
..|+..+.||.|+||.||+|.+... +..|++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 75 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRT-----QQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT--- 75 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccC-----CEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC---
Confidence 3578888999999999999986533 3469999887543 233456788999999999999999999998766
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 76 -~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 76 -KLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred -EEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccc
Confidence 56999999999999998843 3578889999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+.......
T Consensus 149 ~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------------- 213 (277)
T cd06640 149 GQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI------------- 213 (277)
T ss_pred eeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-------------
Confidence 76533221 123346788999999998888999999999999999999999999754432111100
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
...........++..+.+++.+||+.+|++||++.+++.+.+....
T Consensus 214 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 214 ----PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ----hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 0011122334567889999999999999999999999999887544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=302.95 Aligned_cols=255 Identities=26% Similarity=0.387 Sum_probs=202.0
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceE
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 153 (393)
|.....||+|+||.||++....+ +..|++|.+..........+.+|+.+++.++||||+++++.+...+ ..
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~----~~ 94 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHT-----GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD----EL 94 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCC-----CCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC----eE
Confidence 44456799999999999986433 3469999987655455567889999999999999999999988766 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+++++|.+++.. ..+++..++.++.||+.||.|||++ +++||||||+||++++++.++|+|||++...
T Consensus 95 ~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 95 WVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168 (292)
T ss_pred EEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence 999999999999998732 3578999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
..... ......|+..|+|||.+.+..++.++||||||+++|||++|..||......... .......+
T Consensus 169 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~~~~~~--------- 235 (292)
T cd06658 169 SKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM--RRIRDNLP--------- 235 (292)
T ss_pred ccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhcCC---------
Confidence 32211 123456889999999998888999999999999999999999999765432211 11111110
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
.... .....+..+.+++.+||..||.+|||+.+++++.+....
T Consensus 236 --~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 236 --PRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred --Cccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence 0000 011245678899999999999999999999999877653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=292.08 Aligned_cols=256 Identities=36% Similarity=0.571 Sum_probs=202.1
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-cHHHHHHHHHHhhcCCCCccceeeeeeecCCcccce
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQ 152 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 152 (393)
+++.+.||.|+||.||++.+...+. .....|++|.+...... ....+..|+.++..++|+||+++++++...+ .
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSG-EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE----P 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCC-CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC----e
Confidence 3567889999999999999764331 23467999999765433 4567889999999999999999999998775 4
Q ss_pred EEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 153 RLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
.+++|||+.+++|.+++.......+++..+..++.|++.||++||+. +++|+||+|+||++++++.++|+|||++..
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~ 152 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRD 152 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCcee
Confidence 59999999999999998654433389999999999999999999998 999999999999999999999999999976
Q ss_pred CCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcccc
Q 035862 233 GPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311 (393)
Q Consensus 233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (393)
......... ....++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..........
T Consensus 153 ~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~~~~------- 221 (258)
T smart00219 153 LYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEYLKKGY------- 221 (258)
T ss_pred ccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhcCC-------
Confidence 544322211 12336789999999988889999999999999999998 78888653221 1111111100
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
....+...+.++.+++.+||+.||++|||+.++++.|
T Consensus 222 -------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 -------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0011112567899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=293.55 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=201.4
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|.+.+.||+|+||.||+|.+... ..+++|.+.... .....+.+|+.+++.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~------~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~--- 73 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKH------TKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E--- 73 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCC------ccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-C---
Confidence 45799999999999999999975422 248899877543 234668889999999999999999998876 3
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..+++|||+.+++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||.+
T Consensus 74 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 149 (260)
T cd05073 74 -PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA 149 (260)
T ss_pred -CeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcce
Confidence 458999999999999999765556688889999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
......... ......++..|+|||++....++.++|+|||||++|++++ |..||........ ....... .
T Consensus 150 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~~~~----~- 220 (260)
T cd05073 150 RVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV---IRALERG----Y- 220 (260)
T ss_pred eeccCCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHhCC----C-
Confidence 764332211 1222345677999999988889999999999999999999 8999975433211 1111110 0
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
........+.++.+++.+||+.+|++||++.++++.|+.
T Consensus 221 ---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 ---------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 001112345779999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=301.14 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=202.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++.+.||+|+||.||++.+... +..+++|.+..... .....+.+|+++++.++||||+++++++...+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 74 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGS-----GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS- 74 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCC-----CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-
Confidence 4689999999999999999997543 34699998865321 23456788999999999999999999987766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||+. |++|+||+|+||++++++.+||+|||
T Consensus 75 ---~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg 146 (290)
T cd05580 75 ---NLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG 146 (290)
T ss_pred ---eEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence 569999999999999998543 5689999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
++...... .....+++.|+|||.+.+..++.++||||||+++|+|++|..||........ .......
T Consensus 147 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~------ 213 (290)
T cd05580 147 FAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI--YEKILEG------ 213 (290)
T ss_pred CccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHhcC------
Confidence 98765432 2345688999999999888899999999999999999999999976542211 1111100
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLK 356 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~ 356 (393)
....+...+..+.+++.+||..||.+|+ +++++++|.+
T Consensus 214 ----------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 214 ----------KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred ----------CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence 0011122357889999999999999999 8999999876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=296.45 Aligned_cols=254 Identities=34% Similarity=0.543 Sum_probs=197.9
Q ss_pred eecccCCceEEEEEEcCCCC-CCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEE
Q 035862 79 KIGEGGFGSVYKGTIRPLDG-RGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLV 156 (393)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv 156 (393)
.||+|+||.||+|.+..... ......+++|.+.... ......+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v 77 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE----PQYII 77 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC----CeEEE
Confidence 59999999999998754331 2234578999876542 234567889999999999999999999987665 45999
Q ss_pred EeecCCCChHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC-----ceEEee
Q 035862 157 YEYMPNRSLEDRLFSRA-----QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF-----KPKLSD 226 (393)
Q Consensus 157 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-----~~kl~D 226 (393)
|||+.+++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++ .++|+|
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 78 MELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999999999996432 23478899999999999999999998 999999999999999887 899999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCc
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......... .....
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~---~~~~~--- 228 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL---QHVTA--- 228 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH---HHHhc---
Confidence 999876533322222223355678999999999999999999999999999998 99999754332111 11100
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
+ .....+...+..+.+++.+||..+|.+||++.++++.|.
T Consensus 229 -~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 -G----------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -C----------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 011112245678999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=300.69 Aligned_cols=267 Identities=25% Similarity=0.328 Sum_probs=197.4
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+|++.+.||+|+||.||+|.+..++ ..+++|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g-----~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--- 72 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDK--- 72 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCC-----cEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCC---
Confidence 4888899999999999999975443 3589998864321 22345678999999999999999999987665
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++|+||+. ++|.+++... ...+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 73 -~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 146 (284)
T cd07839 73 -KLTLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA 146 (284)
T ss_pred -ceEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchh
Confidence 5699999996 5888877543 34589999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc-CC-
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA-DG- 307 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~- 307 (393)
........ ......++..|+|||++.+. .++.++|||||||++|+|++|..||.......+. +......... +.
T Consensus 147 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 223 (284)
T cd07839 147 RAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEE 223 (284)
T ss_pred hccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH-HHHHHHHhCCCChH
Confidence 75433221 12345678899999988764 4789999999999999999999886543332211 1111100000 00
Q ss_pred -----------cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 308 -----------KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 308 -----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.............+....++.++.+|+.+||+.||.+|||+.++++|.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~ 283 (284)
T cd07839 224 SWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283 (284)
T ss_pred HhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence 0000000000001112235688999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=300.02 Aligned_cols=253 Identities=26% Similarity=0.372 Sum_probs=201.8
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
.|+..+.||.|+||.||+|.+.. .+..|++|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 75 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNR-----TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGT---- 75 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcC-----CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCC----
Confidence 46777889999999999998643 33469999887543 233456788999999999999999999988765
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+.+++|.+++.. ..+++..++.++.|++.|+.|||++ +++|+||+|+||++++++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06642 76 KLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred ceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccc
Confidence 45999999999999998842 4588999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (393)
....... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+.... ...
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~----------- 213 (277)
T cd06642 150 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FLI----------- 213 (277)
T ss_pred cccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hhh-----------
Confidence 6443221 123346788999999999889999999999999999999999998644322111 000
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
...........++.++.+++.+||+.+|++||++.+++.|.+...
T Consensus 214 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 214 ---PKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258 (277)
T ss_pred ---hcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHH
Confidence 000111122235677899999999999999999999999987543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=293.63 Aligned_cols=254 Identities=23% Similarity=0.354 Sum_probs=203.6
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+|++.+.||.|+||.||+|.+..++ ..+++|.+.... ......+..|+.+++.++||||+++++++......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~- 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDG-----KILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ- 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCC-----CEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC-
Confidence 4888999999999999999865433 468999886542 23345677899999999999999999987654433
Q ss_pred ceEEEEEeecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhh-----cCCCCCeEeccCCCCCeEeCCCCceE
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSR--AQPTLPWKTRLEIILGAAEGLAYLH-----EGLEIQVIYRDFKTSNVLLDGNFKPK 223 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~ql~~~l~~LH-----~~~~~~ivH~Dikp~NIll~~~~~~k 223 (393)
..+++|||+.+++|.+++... ....+++..++.++.|++.||.||| +. +++|+||+|+||++++++.+|
T Consensus 75 -~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~k 150 (265)
T cd08217 75 -TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVK 150 (265)
T ss_pred -EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEE
Confidence 568999999999999998543 2456899999999999999999999 76 999999999999999999999
Q ss_pred EeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 224 LSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 224 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
|+|||++........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...... .........
T Consensus 151 l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~ 225 (265)
T cd08217 151 LGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKIKEG 225 (265)
T ss_pred EecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHHhcC
Confidence 999999987544322 123457899999999999888999999999999999999999999865421 122211111
Q ss_pred CcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 304 PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
.....+...+..+.+++.+||+.+|++||++.+++++.
T Consensus 226 --------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~ 263 (265)
T cd08217 226 --------------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263 (265)
T ss_pred --------------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCC
Confidence 01112234567899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=296.37 Aligned_cols=264 Identities=27% Similarity=0.377 Sum_probs=205.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|+..+.||.|++|.||+|.+.. .+..+++|.+..... .....+.+|+++++.++||||+++++++...+..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~- 74 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN-----TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS- 74 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC-----CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCC-
Confidence 468899999999999999999753 345699998875432 3456688999999999999999999998765543
Q ss_pred ceEEEEEeecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 151 IQRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
.+++||||+++++|.+++.. .....+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||
T Consensus 75 -~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg 150 (287)
T cd06621 75 -SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFG 150 (287)
T ss_pred -eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecc
Confidence 56999999999999988743 2345688999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCch--hhhHHHHHHhhcCcC
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPT--MEQKLLEWVKQFPAD 306 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~ 306 (393)
++....... .....++..|+|||.+.+..++.++|||||||++|+|++|..||...... .......+.......
T Consensus 151 ~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (287)
T cd06621 151 VSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP 226 (287)
T ss_pred ccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch
Confidence 986543221 12345788999999999999999999999999999999999999765321 111222222211100
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
. +... .......++.+.+|+.+||..+|.+|||+.+++++.|.
T Consensus 227 --~----~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 227 --E----LKDE--PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred --h----hccC--CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 0 0000 00001246789999999999999999999999999886
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=290.52 Aligned_cols=248 Identities=31% Similarity=0.494 Sum_probs=195.2
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-cHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLV 156 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv 156 (393)
++||.|+||.||+|.+.. + ..|++|.+...... ....+.+|+.+++.++||||+++++++.... ..++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~-----~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~~v 70 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-N-----TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ----PIYIV 70 (251)
T ss_pred CccccCCCceEEEEEEeC-C-----CcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC----CeEEE
Confidence 369999999999998654 2 35999988765433 4456889999999999999999999988776 45999
Q ss_pred EeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCC
Q 035862 157 YEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236 (393)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 236 (393)
|||+.+++|.+++.... ..+++..+..++.+++.||.|||++ +++||||+|+||+++.++.++|+|||++......
T Consensus 71 ~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 71 MELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 99999999999986443 3578899999999999999999999 9999999999999999999999999998754322
Q ss_pred CCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcccccccC
Q 035862 237 DHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMID 315 (393)
Q Consensus 237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (393)
..........++..|+|||.+.+..++.++|+|||||++|+|++ |..||............. ..
T Consensus 147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~---~~------------ 211 (251)
T cd05041 147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE---SG------------ 211 (251)
T ss_pred cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh---cC------------
Confidence 11111112234567999999988899999999999999999999 888886554322211111 10
Q ss_pred cccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.....+..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 212 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 212 --YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred --CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 000112234578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=291.74 Aligned_cols=243 Identities=26% Similarity=0.450 Sum_probs=190.0
Q ss_pred ceecccCCceEEEEEEcCCCC-----CCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccce
Q 035862 78 LKIGEGGFGSVYKGTIRPLDG-----RGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQ 152 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 152 (393)
+.||+|+||.||+|.+..... ......+++|.+...... ...+.+|+.+++.++||||+++++++.. + .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~----~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-D----E 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-C----C
Confidence 369999999999999865441 223346788877654433 5678899999999999999999999877 3 3
Q ss_pred EEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC-------ceEEe
Q 035862 153 RLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF-------KPKLS 225 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-------~~kl~ 225 (393)
.++||||+.+++|.+++..... .+++..+..++.||+.||.|||++ +++||||||+|||++.++ .+||+
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence 4899999999999999864432 688999999999999999999998 999999999999999888 79999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccC--CCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhh
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG--HLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQ 302 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~ 302 (393)
|||++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||............. .
T Consensus 151 Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~ 221 (259)
T cd05037 151 DPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---D 221 (259)
T ss_pred CCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---c
Confidence 9999876433 1234567789999999776 78999999999999999999 577776543221111111 0
Q ss_pred cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
... ... .....+.+++.+||..+|.+||++.++++.|
T Consensus 222 ----~~~--------~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 222 ----QHR--------LPM----PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ----CCC--------CCC----CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000 000 0116789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=314.73 Aligned_cols=279 Identities=28% Similarity=0.406 Sum_probs=211.0
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc--cc
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE--RG 150 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~ 150 (393)
+...+.||+|+||.||+|+++.++. .||||.++... ....+...+|+++|++++|||||+++++-.+... ..
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~-----~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGR-----LVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred eeehhhhcCCccceeeeeccccccc-----chhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 4455679999999999999765554 59999998753 3445678899999999999999999987655441 12
Q ss_pred ceEEEEEeecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC--CCCc--eEEe
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRA-QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD--GNFK--PKLS 225 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~--~~~~--~kl~ 225 (393)
....+|||||.||+|...+.+.+ ..++++...+.++.+++.||.|||.+ ||+||||||+||++- .+|+ .||+
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeee
Confidence 35689999999999999996543 46799999999999999999999999 999999999999993 3344 7999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhh-hHHHHHHhhc
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTME-QKLLEWVKQF 303 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~ 303 (393)
|||.|+...... ...+.+||..|++||++. .+.|+..+|.|||||++|++.||..||.++..... ..+.......
T Consensus 167 DfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tk 243 (732)
T KOG4250|consen 167 DFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITK 243 (732)
T ss_pred cccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhcc
Confidence 999999876554 567899999999999998 48899999999999999999999999977644321 1111111111
Q ss_pred CcCCc----------ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHHHHhhhc
Q 035862 304 PADGK----------KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP--TMNQVVESLKLAVQESE 363 (393)
Q Consensus 304 ~~~~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp--s~~~~l~~l~~~~~~~~ 363 (393)
+.++. .+..-..=+............+..++..+|..+|++|. ...+....+..++....
T Consensus 244 kp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~v 315 (732)
T KOG4250|consen 244 KPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKV 315 (732)
T ss_pred CCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhhe
Confidence 11110 00000000012222234456677899999999999999 88888888888876543
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=292.35 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=201.7
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+|+..+.||+|+||.||++..... +..+++|.+.... ......+.+|+.+++.++|||++++++.+...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--- 72 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKAD-----QKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK--- 72 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCC-----CcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCC---
Confidence 588899999999999999986543 3469999887543 233566788999999999999999999887665
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC-CceEEeeccC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN-FKPKLSDFGL 229 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~ 229 (393)
..++||||+.+++|.+++.......+++..+..++.|++.||.|||++ +++|+||+|+||+++++ +.+||+|||+
T Consensus 73 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 73 -ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred -EEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 569999999999999999765556689999999999999999999998 99999999999999865 4589999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+....... ......++..|+|||.+.+..++.++||||||+++|+|++|..||........ ........
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~------ 217 (256)
T cd08220 149 SKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL--VLKIMSGT------ 217 (256)
T ss_pred ceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH--HHHHHhcC------
Confidence 97654322 12235688899999999988899999999999999999999999976543211 11111100
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
....+..++.++.+++.+||..+|.+|||+.+++.+.
T Consensus 218 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p 254 (256)
T cd08220 218 ---------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254 (256)
T ss_pred ---------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCC
Confidence 0011123467899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=296.21 Aligned_cols=258 Identities=26% Similarity=0.394 Sum_probs=198.0
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc----------cHHHHHHHHHHhhcCCCCccceeeee
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ----------GHKQWLAEVQFLGVVSHPNLVKLLGY 142 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~ 142 (393)
+|...+.||.|+||.||+|....+ +..+++|.+...... ..+.+.+|+.+++.++|||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~-----~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 76 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTT-----GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF 76 (272)
T ss_pred ceeecceecccCceEEEEEeecCC-----CceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 477888999999999999986433 346999987532110 12356789999999999999999999
Q ss_pred eecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCce
Q 035862 143 CSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP 222 (393)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 222 (393)
+...+ ..++||||+.+++|.+++... ..+++..+..++.|++.||.|||++ +++||||+|+||+++.++.+
T Consensus 77 ~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~ 147 (272)
T cd06629 77 ETTEE----YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGIC 147 (272)
T ss_pred eccCC----ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeE
Confidence 87765 459999999999999998543 5688999999999999999999998 99999999999999999999
Q ss_pred EEeeccCCccCCCCCCccccccccccCCccCccccccCC--CCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHH
Q 035862 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGH--LKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300 (393)
Q Consensus 223 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~ 300 (393)
+|+|||++................|+..|+|||.+.... ++.++|+||||+++|++++|..||........ .....
T Consensus 148 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~ 225 (272)
T cd06629 148 KISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFKLG 225 (272)
T ss_pred EEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHHhh
Confidence 999999997643322221223456888999999987654 78999999999999999999999964332211 11100
Q ss_pred hhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
. .. ............++..+.+++.+||..+|.+||++.+++.|.|
T Consensus 226 ~----~~------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (272)
T cd06629 226 N----KR------SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271 (272)
T ss_pred c----cc------cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence 0 00 0001111112235688999999999999999999999998854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=299.72 Aligned_cols=270 Identities=26% Similarity=0.387 Sum_probs=203.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|++.+.||+|+||.||+|.+..++ ..|++|.+.... ......+.+|+++++.++|+||+++++++...+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~-----~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 73 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATG-----EIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG-- 73 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCC-----cEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC--
Confidence 36899999999999999999875433 469999886532 233467889999999999999999999998765
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+.++.+..+. .....+++..++.++.|++.||.|||++ +++|+||+|+||++++++.+||+|||+
T Consensus 74 --~~~iv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~ 146 (288)
T cd07833 74 --RLYLVFEYVERTLLELLE--ASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGF 146 (288)
T ss_pred --EEEEEEecCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeec
Confidence 569999999886666555 2334589999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHH-HHHhhcCcC-
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL-EWVKQFPAD- 306 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~-~~~~~~~~~- 306 (393)
+........ .......++..|+|||++.+. .++.++||||||+++|+|++|..||............ ......+..
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T cd07833 147 ARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSH 225 (288)
T ss_pred ccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 876544332 122345678899999999887 8899999999999999999999999765432211111 101000000
Q ss_pred ------Ccccc-----cccC-cccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 307 ------GKKFS-----MMID-PRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 307 ------~~~~~-----~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
..... .... ......++..++.++.+|+.+||..+|++||++++++++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 287 (288)
T cd07833 226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287 (288)
T ss_pred hhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence 00000 0000 00111122234788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=294.80 Aligned_cols=260 Identities=27% Similarity=0.391 Sum_probs=205.1
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|++.+.||.|+||+||+|.... .+..+++|++.... ......+.+|+.+++.++|+||+++++.+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 72 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP-----NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD--- 72 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC-----CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC---
Confidence 479999999999999999998653 33468999986543 234567889999999999999999999887765
Q ss_pred ceEEEEEeecCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQ-PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++|||++.+++|.+++..... ..+++..+..++.|++.||.|||+. |++||||+|+||++++++.++|+|||+
T Consensus 73 -~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~ 148 (267)
T cd06610 73 -ELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGV 148 (267)
T ss_pred -EEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccch
Confidence 56999999999999999865433 5689999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCcc--ccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 230 AREGPTGDHTH--VSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 230 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
+.......... ......|+..|+|||.+... .++.++|+|||||++|+|++|+.||....... .........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~--- 223 (267)
T cd06610 149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQND--- 223 (267)
T ss_pred HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhcCC---
Confidence 87654433221 22345688999999998776 78999999999999999999999997543321 111111110
Q ss_pred CcccccccCcccccc-cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQ-YSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.. .+... ....++..+.+++.+||..||++||++.++++|.+
T Consensus 224 ~~--------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~ 266 (267)
T cd06610 224 PP--------SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266 (267)
T ss_pred CC--------CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence 00 00000 01245678899999999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=320.05 Aligned_cols=265 Identities=26% Similarity=0.454 Sum_probs=221.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
....+.++||.|.||.|++|+++..+ .....||||.++.... ..+..|+.|+.||-++.||||++|.|+......
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pg--kre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P-- 704 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPG--KREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP-- 704 (996)
T ss_pred hheEEEEEEecccccceecccccCCC--CcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce--
Confidence 34667889999999999999987544 3567899999987543 345669999999999999999999999987764
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..+|.|||++|+|+.||+.+.. .+...+...+++.|+.|+.||.+. ++|||||...||||+.+..+|++|||++
T Consensus 705 --vMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 705 --VMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred --eEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccce
Confidence 3789999999999999987664 488899999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCc-cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 231 REGPTGDHT-HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 231 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+...+.... .......-...|.|||.+...+++.++||||+|++|||.++ |..||.+-+. ++++..
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN---QdVIka--------- 846 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVIKA--------- 846 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch---HHHHHH---------
Confidence 976544321 12222334568999999999999999999999999999776 9999976543 222222
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
+...++.+.+.+|+..|.+|+..||++|-.+||.+.+|+..|.+++.+..
T Consensus 847 -----Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 847 -----IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred -----HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 23455666677899999999999999999999999999999999987654
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=304.76 Aligned_cols=273 Identities=25% Similarity=0.339 Sum_probs=203.9
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
..++|+..+.||+|+||.||+|.+..++ ..||+|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 88 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTG-----QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK 88 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCC-----CEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC
Confidence 4578999999999999999999875443 45999998643 2233456778999999999999999999886543
Q ss_pred c--ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 148 E--RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 148 ~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
. .....++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~ 160 (353)
T cd07850 89 SLEEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 160 (353)
T ss_pred CccccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence 2 1124699999995 588887732 278889999999999999999998 99999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH-HHH------
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK-LLE------ 298 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~-~~~------ 298 (393)
|||++....... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+...... ...
T Consensus 161 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 161 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred cCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999997653322 1233467889999999999999999999999999999999999997654321110 000
Q ss_pred -------------HHhhcC-cCCcccccccCccc----ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 299 -------------WVKQFP-ADGKKFSMMIDPRL----RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 299 -------------~~~~~~-~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
+....+ .....+........ ........+..+.+|+.+||+.||++|||+.++++|.|..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~ 315 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYIN 315 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHh
Confidence 000000 00001111111110 0111223467789999999999999999999999998875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=289.49 Aligned_cols=246 Identities=30% Similarity=0.485 Sum_probs=192.8
Q ss_pred eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-cHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEEE
Q 035862 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVY 157 (393)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 157 (393)
+||+|+||.||+|.... ...+++|.+...... ....+.+|+.+++.++||||+++++++...+ ..++||
T Consensus 2 ~ig~g~~g~vy~~~~~~------~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~ 71 (250)
T cd05085 2 LLGKGNFGEVFKGTLKD------KTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ----PIYIVM 71 (250)
T ss_pred ccCCCCCceEEEEEecC------CcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC----ccEEEE
Confidence 69999999999998532 235899988765332 2345788999999999999999999998776 459999
Q ss_pred eecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCC
Q 035862 158 EYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGD 237 (393)
Q Consensus 158 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 237 (393)
||+.+++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||++++++.+||+|||++.......
T Consensus 72 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 72 ELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI 147 (250)
T ss_pred ECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccc
Confidence 9999999999885433 4578999999999999999999998 99999999999999999999999999987533221
Q ss_pred CccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcccccccCc
Q 035862 238 HTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDP 316 (393)
Q Consensus 238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (393)
.. ......++..|+|||++.+..++.++||||||+++|++++ |..||.......... .....
T Consensus 148 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~---~~~~~------------- 210 (250)
T cd05085 148 YS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE---QVEKG------------- 210 (250)
T ss_pred cc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH---HHHcC-------------
Confidence 11 1112234567999999998899999999999999999998 999997553322111 11110
Q ss_pred ccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 317 RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.....+..++..+.+++.+||..+|++||++.++++.|.
T Consensus 211 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 211 -YRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 001111234578999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=298.69 Aligned_cols=269 Identities=27% Similarity=0.358 Sum_probs=201.4
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-----cHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-----GHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
+|++.+.||+|++|.||+|.+... +..|++|.+...... ....+..|+.+++.++|+||+++++++...+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKET-----GRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCC-----CcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC
Confidence 478889999999999999996543 346999998765322 2344678999999999999999999998755
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
.+++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++ +++|+||+|+||+++.++.++|+||
T Consensus 76 ----~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df 146 (298)
T cd07841 76 ----NINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF 146 (298)
T ss_pred ----EEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence 569999999 889999985433 3689999999999999999999998 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHH-HHHhhcCc
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL-EWVKQFPA 305 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~-~~~~~~~~ 305 (393)
|++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|.++|....+....... .... .+.
T Consensus 147 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~-~~~ 223 (298)
T cd07841 147 GLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALG-TPT 223 (298)
T ss_pred eeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcC-CCc
Confidence 99976543321 1223356788999998854 46789999999999999999998888765432211111 1100 000
Q ss_pred CCc-----ccccccCcccc-----cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 306 DGK-----KFSMMIDPRLR-----NQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 306 ~~~-----~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
... ........... .......+..+.+|+.+||++||++|||+.+++++.|..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~ 286 (298)
T cd07841 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286 (298)
T ss_pred hhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcccc
Confidence 000 00000000000 001123467899999999999999999999999987765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=308.86 Aligned_cols=257 Identities=21% Similarity=0.328 Sum_probs=200.1
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCC-CCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 148 (393)
..|+++++||+||.+.||++...+ ...||+|++... ......-+.+|+.+|.+++ |.+|++++++-..++
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~------~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~- 433 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSD------KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG- 433 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCC------CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc-
Confidence 459999999999999999997432 235777765432 3344567899999999997 999999999988866
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
++|+||||- ..+|..+|...... ++...++.+..|++.|+.++|++ ||||.||||.|+|+- .|.+||+|||
T Consensus 434 ---~lYmvmE~G-d~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFG 504 (677)
T KOG0596|consen 434 ---YLYMVMECG-DIDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFG 504 (677)
T ss_pred ---eEEEEeecc-cccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeec
Confidence 789999997 45999999655443 33347888999999999999999 999999999999997 5789999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCC-----------CCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHH
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGH-----------LKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL 297 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~ 297 (393)
+|...............+||+.||+||.+.... .+.++||||||||||+|+.|++||...... .
T Consensus 505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~-----~ 579 (677)
T KOG0596|consen 505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ-----I 579 (677)
T ss_pred hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-----H
Confidence 998876665555667789999999999985432 457899999999999999999999743221 1
Q ss_pred HHHhhcCcCCcccccccCcccccccCHHH-HHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 298 EWVKQFPADGKKFSMMIDPRLRNQYSINA-ARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.. +..+.++...-+++..- ..++.++++.||..||++||++.++|+|.....
T Consensus 580 aK----------l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 580 AK----------LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred HH----------HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 11 12223332222222111 133899999999999999999999999976544
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=298.59 Aligned_cols=266 Identities=26% Similarity=0.377 Sum_probs=200.0
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+|+..+.||.|++|.||+|.+..+ +..|++|.+.... ......+.+|+++++.++||||+++++++...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 72 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLT-----GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN--- 72 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCC-----CCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCC---
Confidence 488899999999999999986533 3469999886432 223356788999999999999999999987665
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+. ++|.+++.......+++..++.++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++
T Consensus 73 -~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 73 -KLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred -cEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccch
Confidence 4599999995 6899988666566789999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC--
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG-- 307 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-- 307 (393)
........ ......++..|+|||++.+. .++.++||||||+++|+|+||+.||........ ............
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~ 223 (284)
T cd07860 148 RAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEV 223 (284)
T ss_pred hhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChh
Confidence 75432211 12334568899999988664 468899999999999999999999976543221 111111100000
Q ss_pred ------------cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 308 ------------KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 308 ------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
..+......... .....++.++.++|.+||+.||.+||+++++++|.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 283 (284)
T cd07860 224 VWPGVTSLPDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283 (284)
T ss_pred hhhhhhHHHHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCC
Confidence 000000000000 011134577889999999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=314.01 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=205.4
Q ss_pred eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEEEe
Q 035862 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYE 158 (393)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 158 (393)
+||+|+||+||.|++..+.- .+|||-+.........-+.+|+.+.++++|.|||+++|.+...+ +.-+.||
T Consensus 582 VLGKGTYG~VYA~RD~~tqv-----rIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG----f~kIFME 652 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQV-----RIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG----FFKIFME 652 (1226)
T ss_pred EeecCceeEEEeecccccee-----EEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC----eEEEEee
Confidence 59999999999999765554 49999988766666667889999999999999999999987766 5678999
Q ss_pred ecCCCChHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC-CCCceEEeeccCCccCCC
Q 035862 159 YMPNRSLEDRLFSRAQPTL--PWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD-GNFKPKLSDFGLAREGPT 235 (393)
Q Consensus 159 ~~~~~~L~~~l~~~~~~~~--~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~ 235 (393)
.++||+|.+++...= +++ .+.++-.+.+||++||.|||.+ .|||||||-+|+||+ -.|.+||+|||-++.+..
T Consensus 653 qVPGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg 728 (1226)
T KOG4279|consen 653 QVPGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG 728 (1226)
T ss_pred cCCCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc
Confidence 999999999996543 334 6788889999999999999999 999999999999995 569999999999887543
Q ss_pred CCCccccccccccCCccCccccccC--CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 236 GDHTHVSTAVVGTYGYAAPEYIETG--HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 236 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
. +.....+-||..|||||++..+ .|..++|||||||++.||.||++||..-.......+.. .-
T Consensus 729 i--nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV--Gm----------- 793 (1226)
T KOG4279|consen 729 I--NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV--GM----------- 793 (1226)
T ss_pred C--CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh--cc-----------
Confidence 2 2234567899999999999654 68899999999999999999999996543221111100 00
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
=...++.+..++.++..||.+|+.+||..||++.+++........
T Consensus 794 --yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 794 --YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred --eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 012455677899999999999999999999999999998765443
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=300.95 Aligned_cols=269 Identities=24% Similarity=0.373 Sum_probs=200.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc--cHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ--GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|++.+.||+|+||.||+|.+... +..|++|.+...... ..+.+.+|+++++.++||||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 73 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKET-----GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKK-- 73 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCC-----CCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCC--
Confidence 4688999999999999999986533 346999987654322 3456778999999999999999999997665
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+++++|.++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+
T Consensus 74 --~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~ 146 (286)
T cd07846 74 --RLYLVFEFVDHTVLDDLEK--YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF 146 (286)
T ss_pred --eEEEEEecCCccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeee
Confidence 5699999999988888763 334589999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhh-HHHHHHhhcCcC-
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ-KLLEWVKQFPAD- 306 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~- 306 (393)
+........ ......++..|+|||++.+ ..++.++||||||+++|+|++|.+||......... ............
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (286)
T cd07846 147 ARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRH 224 (286)
T ss_pred eeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhh
Confidence 876433221 2234567889999998865 45788999999999999999999999755432211 111111110000
Q ss_pred -----------CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 307 -----------GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 307 -----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
+..................++..+.+|+.+||+.+|++||++.+++++.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 285 (286)
T cd07846 225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285 (286)
T ss_pred HHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence 00000000000000011235678999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=297.68 Aligned_cols=269 Identities=25% Similarity=0.369 Sum_probs=197.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|++.+.||+|++|.||+|..... +..|++|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 76 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLT-----GQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK-- 76 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCC-----CcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC--
Confidence 36799999999999999999986533 34699999865422 22345678999999999999999999988766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 77 --~~~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 149 (291)
T cd07844 77 --TLTLVFEYLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGL 149 (291)
T ss_pred --eEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcccc
Confidence 56999999975 9999885443 3688999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHH-HHHHhhcCcCC
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKL-LEWVKQFPADG 307 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~~ 307 (393)
+........ ......++..|+|||++.+ ..++.++||||+|+++|+|++|..||.......+... .......+...
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07844 150 ARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE 227 (291)
T ss_pred ccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChh
Confidence 875432211 1123356788999998865 5588999999999999999999999975542222111 10000000000
Q ss_pred c-------------ccccccCcccccccCHHHH--HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 308 K-------------KFSMMIDPRLRNQYSINAA--RRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 308 ~-------------~~~~~~~~~~~~~~~~~~~--~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
. .........+... ....+ .++.+++.+||+.+|++|||+.+++.+.|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~ 290 (291)
T cd07844 228 TWPGVSSNPEFKPYSFPFYPPRPLINH-APRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290 (291)
T ss_pred hhhhhhhccccccccccccCChhHHHh-CcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 0 0000000000000 00122 67889999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=300.87 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=201.7
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceE
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 153 (393)
|.....||.|+||.||+|.+...+ ..|++|.+..........+.+|+.++..++|||++++++++...+ ..
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~----~~ 93 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSG-----RQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE----EL 93 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCC-----CEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC----eE
Confidence 445567999999999999865333 369999987654455567889999999999999999999988766 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+++++|.+++.. ..+++..++.++.|++.||.|||++ +++||||+|+||+++.++.+||+|||++...
T Consensus 94 ~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred EEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 999999999999987733 4578999999999999999999998 9999999999999999999999999998654
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
..... ......|+..|+|||++.+..++.++|||||||++|+|++|..||....+..... .....+...
T Consensus 168 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~~~~------ 236 (297)
T cd06659 168 SKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLRDSPPPK------ 236 (297)
T ss_pred ccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHhccCCCC------
Confidence 32211 1234578899999999998889999999999999999999999997554322111 111110000
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.......+..+.+++.+||+.+|++||++.+++++.+...
T Consensus 237 ------~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~ 276 (297)
T cd06659 237 ------LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQ 276 (297)
T ss_pred ------ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhcc
Confidence 0001124567899999999999999999999999987664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=296.07 Aligned_cols=258 Identities=28% Similarity=0.406 Sum_probs=204.1
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|+..+.||.|++|.||+|.+...+ ..+++|.+..... .....+.+|+.+++.++||||+++++.+....
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--- 72 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTG-----KIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG--- 72 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCC-----cEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC---
Confidence 36888889999999999999875433 4599998876532 34466789999999999999999999988775
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE-GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++++||+.+++|.+++.... ..+++..+..++.|++.||+|||+ . +++|+||||+||++++++.++|+|||.
T Consensus 73 -~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~ 147 (265)
T cd06605 73 -DISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGV 147 (265)
T ss_pred -EEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 5699999999999999986543 568899999999999999999999 7 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+....... .....++..|+|||.+.+..++.++||||||+++|+|++|..||.......... .........
T Consensus 148 ~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~---- 218 (265)
T cd06605 148 SGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI-FELLQYIVN---- 218 (265)
T ss_pred chhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH-HHHHHHHhc----
Confidence 86542211 112578889999999999999999999999999999999999997543211110 011110000
Q ss_pred cccccCcccccccCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSI-NAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.. ....+. .++.++.++|.+||..||++|||+.+++.+.|..
T Consensus 219 ------~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~ 261 (265)
T cd06605 219 ------EP-PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261 (265)
T ss_pred ------CC-CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhh
Confidence 00 001111 1567899999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=299.40 Aligned_cols=257 Identities=25% Similarity=0.336 Sum_probs=199.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++.+.||+|+||.||++.+.... ..|++|.+..... .....+.+|+.+++.++||||+++++.+...+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~-----~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~- 74 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETR-----QRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR- 74 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCC-----cEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC-
Confidence 46899999999999999999875443 4599998875432 22345778999999999999999999987765
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
+.++||||++|++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||
T Consensus 75 ---~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg 146 (305)
T cd05609 75 ---HLCMVMEYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFG 146 (305)
T ss_pred ---EEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCC
Confidence 56999999999999999944 35689999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCc-------------cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH
Q 035862 229 LAREGPTGDHT-------------HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK 295 (393)
Q Consensus 229 ~a~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~ 295 (393)
+++........ .......++..|+|||.+.+..++.++|+|||||++|+|++|..||....... .
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~--~ 224 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--L 224 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--H
Confidence 98642111100 01112457889999999988889999999999999999999999997543321 1
Q ss_pred HHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHHHH
Q 035862 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT---MNQVVESLKL 357 (393)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~~l~~l~~ 357 (393)
.......... .+. ....++.++.+++.+||+.||++||+ +.+++++.+.
T Consensus 225 ~~~~~~~~~~---------~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 225 FGQVISDDIE---------WPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred HHHHHhcccC---------CCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 1111110000 000 01134577899999999999999998 6777777654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=298.44 Aligned_cols=259 Identities=24% Similarity=0.365 Sum_probs=206.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|.+.+.||+|+||.||+|....+ +..|++|.+..........+.+|+.+++.++||||+++++.+...+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~--- 89 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVAT-----GQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD--- 89 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCC-----CCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC---
Confidence 36799999999999999999986433 3359999986554444567888999999999999999999988766
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++|+||+++++|.+++.. ..+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||++
T Consensus 90 -~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~ 162 (293)
T cd06647 90 -ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (293)
T ss_pred -cEEEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcce
Confidence 45999999999999998843 3478889999999999999999998 9999999999999999999999999988
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ ......+++.|+|||.+.+..++.++|+||||+++|++++|..||........... .. ..
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~--~~----~~---- 230 (293)
T cd06647 163 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--IA----TN---- 230 (293)
T ss_pred eccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee--hh----cC----
Confidence 75433222 12334688899999999888899999999999999999999999976543211100 00 00
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
.......+..++..+.+++.+||..+|++||++.+++.|.+.....
T Consensus 231 -----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 231 -----GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred -----CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 0000111223457789999999999999999999999998775443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=290.84 Aligned_cols=251 Identities=27% Similarity=0.374 Sum_probs=199.5
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-----cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-----LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
+|+..+.||+|++|.||+|....++ ..|++|.+.... ......+.+|+.+++.++|+||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDG-----DFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCC-----cEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC
Confidence 4778889999999999999865333 359999876532 123456788999999999999999999987665
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+||
T Consensus 76 ----~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~ 146 (258)
T cd06632 76 ----NLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADF 146 (258)
T ss_pred ----eEEEEEEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence 56999999999999999853 34588999999999999999999998 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGH-LKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
|++....... ......++..|+|||.+.... ++.++|+||||+++|+|++|..||....+.. ..........
T Consensus 147 ~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~-- 219 (258)
T cd06632 147 GMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVFKIGRSKE-- 219 (258)
T ss_pred ccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHHHHHhccc--
Confidence 9987643322 123456889999999987766 8999999999999999999999997654211 1111111000
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
....+..++..+.+++.+||+.+|.+||++.+++.+.+
T Consensus 220 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 257 (258)
T cd06632 220 ------------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257 (258)
T ss_pred ------------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence 01112234678899999999999999999999998753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=293.82 Aligned_cols=257 Identities=21% Similarity=0.367 Sum_probs=201.2
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc------ccHHHHHHHHHHhhcCCCCccceeeeeeecC
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL------QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTE 146 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 146 (393)
+|+..+.||+|++|.||+|.+..++ ..+++|.+..... .....+.+|+.+++.++|+||+++++++...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTG-----TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCC-----cEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC
Confidence 4788899999999999999865443 3599998865331 1245678899999999999999999999876
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC-ceEEe
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF-KPKLS 225 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~ 225 (393)
+ ..++||||+.+++|.+++.. ...+++..++.++.|++.||.|||++ |++|+||+|+||+++.++ .++|+
T Consensus 76 ~----~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~ 146 (268)
T cd06630 76 S----HFNLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIA 146 (268)
T ss_pred C----eEEEEEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence 6 55999999999999999853 34688999999999999999999998 999999999999998776 59999
Q ss_pred eccCCccCCCCCCc--cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 226 DFGLAREGPTGDHT--HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 226 Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
|||.+......... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.................
T Consensus 147 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~- 225 (268)
T cd06630 147 DFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS- 225 (268)
T ss_pred ccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc-
Confidence 99998765432111 112234678899999999888899999999999999999999999964432211111110000
Q ss_pred CcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 304 PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.......+...+.++.+++.+||..+|.+||++.++++|.+
T Consensus 226 ------------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~ 266 (268)
T cd06630 226 ------------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPV 266 (268)
T ss_pred ------------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcc
Confidence 00112233356688999999999999999999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=312.66 Aligned_cols=258 Identities=28% Similarity=0.442 Sum_probs=214.9
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-cHHHHHHHHHHhhcCCCCccceeeeeeecCCcccce
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQ 152 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 152 (393)
....++||+|.||.|++|.|.. ..++...||||++...... ....|++|+.+|..++|+|++++||+..+..
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~--psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp----- 184 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQ--PSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP----- 184 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccC--CCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch-----
Confidence 3445689999999999999865 4567788999999877554 6678999999999999999999999998743
Q ss_pred EEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 153 RLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
+.+|||.+..|+|.+.|+......+.......++.||+.||.||.++ ++|||||...|+|+.....|||+|||+.+.
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRa 261 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRA 261 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceec
Confidence 37899999999999999886677788899999999999999999999 999999999999999999999999999998
Q ss_pred CCCCCCcc-ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 233 GPTGDHTH-VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 233 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
+...+... +.....-...|+|||.+....++.++|||++||++||||| |..||.+.......
T Consensus 262 Lg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL---------------- 325 (1039)
T KOG0199|consen 262 LGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL---------------- 325 (1039)
T ss_pred cCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH----------------
Confidence 77655443 2233445568999999999999999999999999999999 77888765432211
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
+.+|.+-+...+..|++++++++..||..+|.+||++..|.+.+-..
T Consensus 326 -~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 326 -KNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred -HhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 12233333445557899999999999999999999999998655433
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=290.26 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=206.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHH---HHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK---QWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|..+++||+|+||.|-+++ ++..++.+|+|++++....... .-+.|-++|+..+||.+..+...|...+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~r-----EKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCR-----EKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEe-----ecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 4679999999999999999998 4556668999999887544333 3467889999999999999988888887
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
.+|+||||++||.|.-.| .....+++...+.+...|+.||.|||++ +||+||||.+|+|++.+|++||+||
T Consensus 242 ----rlCFVMeyanGGeLf~HL--srer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDF 312 (516)
T KOG0690|consen 242 ----RLCFVMEYANGGELFFHL--SRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDF 312 (516)
T ss_pred ----eEEEEEEEccCceEeeeh--hhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeec
Confidence 679999999999998777 4456789999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|+++..... .......+|||.|+|||++....|...+|.|.+||++|||++|+.||...+...-..++-..
T Consensus 313 GLCKE~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e------- 383 (516)
T KOG0690|consen 313 GLCKEEIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME------- 383 (516)
T ss_pred ccchhcccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-------
Confidence 999753322 22456789999999999999999999999999999999999999999865443222221100
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESL 355 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l 355 (393)
...++..+++++..|+..+|.+||.+|. .+.+|..|-
T Consensus 384 -----------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~ 425 (516)
T KOG0690|consen 384 -----------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHR 425 (516)
T ss_pred -----------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhh
Confidence 0123335678899999999999999995 367777763
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=288.82 Aligned_cols=255 Identities=22% Similarity=0.358 Sum_probs=187.6
Q ss_pred eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEEE
Q 035862 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVY 157 (393)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv~ 157 (393)
.||+|+||.||+|...... ....+++|.+.... ......+.+|+.+++.++||||+++++.+.... ..++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~---~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~----~~~lv~ 74 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDT---GVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI----PYLLVF 74 (268)
T ss_pred cCCCCcCceEEEEEEEcCC---CcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC----ccEEEE
Confidence 5999999999999754222 23346677765432 234567889999999999999999999998765 459999
Q ss_pred eecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCC
Q 035862 158 EYMPNRSLEDRLFSRA--QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPT 235 (393)
Q Consensus 158 e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 235 (393)
||+++++|.+++.... ....++..++.++.|++.||.|||+. +++||||||+|||++.++.++|+|||++.....
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~ 151 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK 151 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCc
Confidence 9999999999996532 23467777889999999999999998 999999999999999999999999999864322
Q ss_pred CCCccccccccccCCccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 236 GDHTHVSTAVVGTYGYAAPEYIET-------GHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 236 ~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
...........++..|+|||++.. ..++.++|||||||++|||++ |..||....+.. ..........
T Consensus 152 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~~~~~--- 226 (268)
T cd05086 152 EDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE--VLNHVIKDQQ--- 226 (268)
T ss_pred chhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhhcc---
Confidence 221112234567889999998743 245789999999999999997 566776543321 1111111100
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
....++... ...++.+.+++..|| .+|++||+++++++.|.
T Consensus 227 ---~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 227 ---VKLFKPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ---cccCCCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 011112211 124567888999999 78999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=296.06 Aligned_cols=270 Identities=24% Similarity=0.355 Sum_probs=198.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
+++|.+.+.||+|+||.||+|.....+ ..|++|.+..... .....+.+|+.+++.++|+||+++++++...+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-- 76 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRING-----QLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE-- 76 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCC-----cEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC--
Confidence 467999999999999999999865443 3599999865432 22345678999999999999999999988665
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 77 --~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 149 (291)
T cd07870 77 --TLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGL 149 (291)
T ss_pred --eEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccc
Confidence 5699999995 68877764333 4578888899999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHh-hcCcCC
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK-QFPADG 307 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~-~~~~~~ 307 (393)
+........ ......++..|+|||.+.+. .++.++|||||||++|+|++|..||....+..+.....+.. ..+.+.
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 227 (291)
T cd07870 150 ARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED 227 (291)
T ss_pred ccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChh
Confidence 875432221 12334678899999998764 57889999999999999999999997655432221111100 001000
Q ss_pred ---------ccccccc----Cccccccc-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 308 ---------KKFSMMI----DPRLRNQY-SINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 308 ---------~~~~~~~----~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
....... ...+.... ....+..+.+++.+||..||.+|||+.+++.|.|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~ 290 (291)
T cd07870 228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290 (291)
T ss_pred hhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence 0000000 00000000 0012467889999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=304.61 Aligned_cols=279 Identities=24% Similarity=0.323 Sum_probs=207.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||.|+||.||+|....++ ..|++|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 78 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSG-----KKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGA 78 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCC-----CEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCC
Confidence 367999999999999999999865443 469999987542 2334567789999999999999999998876554
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
....+++||||+. ++|.+++. ....+++..++.++.|++.||.|||++ +++||||||+||++++++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg 152 (334)
T cd07855 79 DFKDVYVVMDLME-SDLHHIIH--SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFG 152 (334)
T ss_pred CCceEEEEEehhh-hhHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccc
Confidence 4457799999995 58998884 344589999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCc--cccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 229 LAREGPTGDHT--HVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 229 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
++......... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..................+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~ 232 (334)
T cd07855 153 MARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS 232 (334)
T ss_pred cceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCCh
Confidence 98754332211 12234578899999998865 5688999999999999999999999976544322211111111110
Q ss_pred CC-------cccccccCc-cccc-----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 306 DG-------KKFSMMIDP-RLRN-----QYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 306 ~~-------~~~~~~~~~-~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
.. ......... .... ......+.++.+++.+||+.+|.+||++.+++.+.|....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 00 000000000 0000 0112346889999999999999999999999999988643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=288.91 Aligned_cols=251 Identities=30% Similarity=0.507 Sum_probs=197.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
.+|++.+.||.|+||.||+|.+.. +..+++|.+.... .....+.+|+++++.++|||++++++++....
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~------~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 72 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE------KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERS---- 72 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC------CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCC----
Confidence 368888999999999999998642 2248999886543 23456888999999999999999999987665
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+.+++|.+++.... ..+++..++.++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 148 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTR 148 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCccee
Confidence 4599999999999999885433 3578999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...... ....
T Consensus 149 ~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~---~~~~-- 219 (256)
T cd05112 149 FVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVETIN---AGFR-- 219 (256)
T ss_pred ecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHh---CCCC--
Confidence 5432211 11122335678999999998899999999999999999998 999987543221 111110 0000
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
... +...+..+.+|+.+||+.+|++||++.++++.|
T Consensus 220 --~~~-------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 220 --LYK-------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred --CCC-------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 000 111347799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=287.74 Aligned_cols=282 Identities=23% Similarity=0.335 Sum_probs=208.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
...|+.+..||+|+||.||+|.-..+..+ ..+.+|+|+++... ........+|+.+++.++|||++.+..++...+.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~k-r~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDK-RTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcc-cchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 45699999999999999999965433322 24579999987652 2333567899999999999999999999987533
Q ss_pred ccceEEEEEeecCCCChHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC----Cc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFS---RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN----FK 221 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~----~~ 221 (393)
..++++||.+. +|...|+. .....++...+..|+.||+.|+.|||++ =|+||||||.||||..+ |.
T Consensus 102 ---~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 102 ---KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred ---eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCe
Confidence 56999999977 88887742 2335689999999999999999999999 89999999999999887 89
Q ss_pred eEEeeccCCccCCCCCCcc-ccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhh-----
Q 035862 222 PKLSDFGLAREGPTGDHTH-VSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ----- 294 (393)
Q Consensus 222 ~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~----- 294 (393)
|||+|||+++.....-... .....+-|.+|+|||++.| ..|+.+.|||++|||+.||+|..+.|.........
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq 254 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQ 254 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCch
Confidence 9999999999765443222 2345678999999999987 57999999999999999999999999654332221
Q ss_pred --H--HHHHHhhcCcCCcc-----cccc---c---CcccccccCH--------HHHHHHHHHHHHhcccCCCCCCCHHHH
Q 035862 295 --K--LLEWVKQFPADGKK-----FSMM---I---DPRLRNQYSI--------NAARRVAKLADNCLKKNPEERPTMNQV 351 (393)
Q Consensus 295 --~--~~~~~~~~~~~~~~-----~~~~---~---~~~~~~~~~~--------~~~~~l~~li~~~l~~dp~~Rps~~~~ 351 (393)
. .+..+...|.+..- ..+. + ........+. .-++...+|+.+||++||.+|.|++++
T Consensus 255 ~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 255 HDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 1 11111122222100 0000 0 0000000000 013448899999999999999999999
Q ss_pred HHHHHHHHh
Q 035862 352 VESLKLAVQ 360 (393)
Q Consensus 352 l~~l~~~~~ 360 (393)
++|...-..
T Consensus 335 leh~yF~~d 343 (438)
T KOG0666|consen 335 LEHPYFTED 343 (438)
T ss_pred hcccccccC
Confidence 999876544
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=295.08 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=203.5
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
+|++.+.||.|+||.||+|.+..++ ..|++|.+..... ...+.+.+|++++++++||||+++++.+...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 73 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTK-----KMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEE-- 73 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCC-----cEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCC--
Confidence 4889999999999999999865333 4599999875432 23567888999999999999999999887665
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++|+||+.+++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||+
T Consensus 74 --~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 74 --NMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI 146 (258)
T ss_pred --eEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccc
Confidence 569999999999999998543 5789999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||..........+......
T Consensus 147 ~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------- 216 (258)
T cd05578 147 ATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------- 216 (258)
T ss_pred ccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-------
Confidence 87654332 12345688899999999888899999999999999999999999986654322222211110
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCH--HHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM--NQVVESLK 356 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~--~~~l~~l~ 356 (393)
.....+...+..+.+++.+||+.||.+||++ +++++|.+
T Consensus 217 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~ 257 (258)
T cd05578 217 --------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPY 257 (258)
T ss_pred --------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCC
Confidence 1111222355889999999999999999999 88876643
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=298.01 Aligned_cols=274 Identities=27% Similarity=0.338 Sum_probs=202.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+..... .....+.+|+.+++.++|+||+++++++.....
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSG-----EIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHL 80 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCC-----cEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCC
Confidence 467999999999999999999975433 4699998864322 222345679999999999999999999876543
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
. ..++||||+.+ +|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+|||
T Consensus 81 ~--~~~lv~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg 153 (309)
T cd07845 81 D--SIFLVMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG 153 (309)
T ss_pred C--eEEEEEecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence 3 46999999964 898887543 25689999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
++........ ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||....+.............+...
T Consensus 154 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07845 154 LARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNES 231 (309)
T ss_pred eeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 9976543221 1223355788999998865 567899999999999999999999998655433222111111111000
Q ss_pred c--cc------ccc-cCccccc---ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 308 K--KF------SMM-IDPRLRN---QYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 308 ~--~~------~~~-~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
. .+ ... ....... ......+..+.+||.+||+.||++|||+.+++.|.|..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 0 00 000 0000000 00012467889999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=296.96 Aligned_cols=271 Identities=24% Similarity=0.355 Sum_probs=200.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|++.+.||.|+||.||+|.+..+ +..+++|.+..... .....+.+|+.++..++||||+++++++...+..
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKT-----GEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCC-----CcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCC
Confidence 5689999999999999999986533 34689998865432 2233567899999999999999999998766322
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 80 --~~~lv~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~ 152 (293)
T cd07843 80 --KIYMVMEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGL 152 (293)
T ss_pred --cEEEEehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCc
Confidence 66999999964 9998885433 3689999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH-HHHHHh------
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK-LLEWVK------ 301 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~-~~~~~~------ 301 (393)
+........ ......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||.......... ......
T Consensus 153 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (293)
T cd07843 153 AREYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI 230 (293)
T ss_pred eeeccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHH
Confidence 886543321 22334678899999988654 46889999999999999999999997654322111 111000
Q ss_pred -----hcCcCC-cccccccCcccccccCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 302 -----QFPADG-KKFSMMIDPRLRNQYSIN-AARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 302 -----~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.++... ..........+...++.. ++..+.++|.+||+.+|++|||+.+++.+.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~ 292 (293)
T cd07843 231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292 (293)
T ss_pred HHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence 000000 000000011111112222 4678899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=289.95 Aligned_cols=257 Identities=27% Similarity=0.395 Sum_probs=207.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|++.+.||.|++|.||+|.+..+ +..|++|.+..... .....+.+|+..+..++|+|++++++++...+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~-----~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 72 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPT-----GKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG--- 72 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCC-----CcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC---
Confidence 3688999999999999999987643 34699999876543 34567889999999999999999999988775
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE-GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
.+++||||+++++|.+++... ..+++..++.++.|++.|+.|||+ . +++|+||+|+||+++.++.++|+|||+
T Consensus 73 -~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~ 146 (264)
T cd06623 73 -EISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGI 146 (264)
T ss_pred -eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCcc
Confidence 569999999999999999543 568999999999999999999999 8 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..................
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~------ 218 (264)
T cd06623 147 SKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG------ 218 (264)
T ss_pred ceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC------
Confidence 8765432221 12456788999999999889999999999999999999999999766421111111111110
Q ss_pred cccccCcccccccCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSIN-AARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.....+.. ++..+.+++.+||..+|++||++.+++++.+..
T Consensus 219 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~ 260 (264)
T cd06623 219 --------PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIK 260 (264)
T ss_pred --------CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHH
Confidence 00111122 567899999999999999999999999997753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=294.14 Aligned_cols=255 Identities=27% Similarity=0.396 Sum_probs=201.7
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccce
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQ 152 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 152 (393)
.|...+.||+|++|.||++..... +..+++|.+..........+.+|+.+++.++||||+++++++...+ +
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~----~ 90 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKST-----GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD----E 90 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCC-----CCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC----e
Confidence 355567999999999999986533 3469999886554444566789999999999999999999988766 5
Q ss_pred EEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 153 RLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
.++++||+.+++|.+++.. ..+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||.+..
T Consensus 91 ~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred EEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 5999999999999998854 4588999999999999999999998 999999999999999999999999998865
Q ss_pred CCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccccc
Q 035862 233 GPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSM 312 (393)
Q Consensus 233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (393)
...... ......|+..|+|||.+.+..++.++|||||||++|+|++|..||....+...... ......
T Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~---~~~~~~------- 232 (285)
T cd06648 165 VSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR---IRDNLP------- 232 (285)
T ss_pred hccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH---HHhcCC-------
Confidence 432211 12335688999999999888899999999999999999999999976543221111 111000
Q ss_pred ccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 313 MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
+... ....++..+.+|+.+||+.+|++||++.+++++.+...
T Consensus 233 ---~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 274 (285)
T cd06648 233 ---PKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAK 274 (285)
T ss_pred ---CCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccCccccc
Confidence 0000 01124578999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=289.44 Aligned_cols=263 Identities=25% Similarity=0.432 Sum_probs=201.5
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc-
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG- 150 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~- 150 (393)
|.+.+.||+|+||.||+|.+... .+.+..+|+|.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~--~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSE--DGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeecc--CCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 56778899999999999986532 2345679999886542 233456788999999999999999999886644322
Q ss_pred -ceEEEEEeecCCCChHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 151 -IQRLLVYEYMPNRSLEDRLFSR----AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 151 -~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
...+++++|+.+++|.+++... ....+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEEC
Confidence 2347889999999999887432 123578889999999999999999998 99999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcC
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFP 304 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 304 (393)
|||++................+++.|++||.+.+..++.++|||||||++|+|++ |.+||....... ........
T Consensus 156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~~- 231 (273)
T cd05074 156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYLIKG- 231 (273)
T ss_pred cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHHHcC-
Confidence 9999886543322222233345678999999988889999999999999999999 888886543321 11111110
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
... ..+...+..+.+++.+||+.+|++|||+.+++..|+.+
T Consensus 232 ---~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 ---NRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ---CcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 01112457899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=293.53 Aligned_cols=250 Identities=29% Similarity=0.439 Sum_probs=197.7
Q ss_pred ecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEE
Q 035862 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLV 156 (393)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv 156 (393)
||+|+||+||+|.+..+ +..|++|.+..... .....+.+|+++++.++||||+++++.+...+ ..|+|
T Consensus 1 lg~g~~g~vy~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~~lv 71 (277)
T cd05577 1 LGKGGFGEVCACQVKAT-----GKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD----DLCLV 71 (277)
T ss_pred CCCCCceeEEEEEEcCC-----CcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC----eEEEE
Confidence 68999999999986543 34699998865321 22345678999999999999999999987765 56999
Q ss_pred EeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCC
Q 035862 157 YEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236 (393)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 236 (393)
|||+++++|.+++.......+++..++.++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+......
T Consensus 72 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 72 MTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred EecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence 9999999999999765555789999999999999999999998 9999999999999999999999999998754321
Q ss_pred CCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCc
Q 035862 237 DHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDP 316 (393)
Q Consensus 237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (393)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.............. ....
T Consensus 149 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~----------- 212 (277)
T cd05577 149 K---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--RTLE----------- 212 (277)
T ss_pred C---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh--cccc-----------
Confidence 1 12344678899999999888899999999999999999999999976543211111110 0000
Q ss_pred ccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHH
Q 035862 317 RLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKLA 358 (393)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~~ 358 (393)
.....+...+..+.+++.+||+.||.+|| ++.+++.|.|..
T Consensus 213 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~ 258 (277)
T cd05577 213 -MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFK 258 (277)
T ss_pred -ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhh
Confidence 01112223467899999999999999999 888899988763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=288.96 Aligned_cols=256 Identities=30% Similarity=0.439 Sum_probs=201.2
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc--cHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ--GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+|.+.+.||+|+||.||+|..... +..|++|.+...... ....+.+|+.+++.++|+||+++++++...+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--- 72 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDT-----GELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE--- 72 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCC-----CcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC---
Confidence 588899999999999999986433 346999998765432 4567889999999999999999999987665
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++|+||+.+++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++
T Consensus 73 -~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~ 146 (264)
T cd06626 73 -KVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA 146 (264)
T ss_pred -EEEEEEecCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 56999999999999999853 34578899999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccc--cccccccCCccCccccccCC---CCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 231 REGPTGDHTHV--STAVVGTYGYAAPEYIETGH---LKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 231 ~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
........... .....++..|+|||.+.+.. ++.++||||||+++|++++|..||............ ... .
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~--~~~--~ 222 (264)
T cd06626 147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH--VGA--G 222 (264)
T ss_pred cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH--Hhc--C
Confidence 76543322110 12356788999999998766 889999999999999999999999754322221111 000 0
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
. .+.+. ....++..+.+++.+||+.+|.+||++.+++.+.|
T Consensus 223 ~--------~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~ 263 (264)
T cd06626 223 H--------KPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263 (264)
T ss_pred C--------CCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 0 00000 01123677889999999999999999999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=298.51 Aligned_cols=275 Identities=22% Similarity=0.300 Sum_probs=200.5
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
+|++.+.||+|+||.||+|.+... +.+..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~---~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG---KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC---CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCc
Confidence 488899999999999999997541 245579999988632 33345677899999999999999999999876333
Q ss_pred cceEEEEEeecCCCChHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC----CCce
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSR---AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG----NFKP 222 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~----~~~~ 222 (393)
..++||||+.+ +|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++. ++.+
T Consensus 78 --~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~ 151 (316)
T cd07842 78 --SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVV 151 (316)
T ss_pred --eEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceE
Confidence 67999999965 777766422 223689999999999999999999998 9999999999999999 8999
Q ss_pred EEeeccCCccCCCCCC-ccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchh-------h
Q 035862 223 KLSDFGLAREGPTGDH-THVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM-------E 293 (393)
Q Consensus 223 kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~-------~ 293 (393)
||+|||++........ ........++..|+|||++.+ ..++.++|||||||++|+|++|.+||....... .
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 231 (316)
T cd07842 152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231 (316)
T ss_pred EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence 9999999886543322 112234567889999998866 457899999999999999999999997554322 0
Q ss_pred hHHHHHHhhcCcCCc----------cccc----ccC-----cccccccCH--HHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 035862 294 QKLLEWVKQFPADGK----------KFSM----MID-----PRLRNQYSI--NAARRVAKLADNCLKKNPEERPTMNQVV 352 (393)
Q Consensus 294 ~~~~~~~~~~~~~~~----------~~~~----~~~-----~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~~l 352 (393)
..+......+..... .... ... ..+...... ..+.++.+++.+||+.||++|||+.+++
T Consensus 232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil 311 (316)
T cd07842 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEAL 311 (316)
T ss_pred HHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 111111111000000 0000 000 000000111 2446789999999999999999999999
Q ss_pred HHHH
Q 035862 353 ESLK 356 (393)
Q Consensus 353 ~~l~ 356 (393)
+|.|
T Consensus 312 ~~~~ 315 (316)
T cd07842 312 EHPY 315 (316)
T ss_pred cCCC
Confidence 8854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=290.12 Aligned_cols=254 Identities=27% Similarity=0.389 Sum_probs=202.3
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
-|+..+.||.|+||.||+|.+... +..+|+|...... ......+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 75 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRT-----QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT---- 75 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCC-----CcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC----
Confidence 377888999999999999986433 3469999876443 233456778999999999999999999998766
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+.+++|.+++.. ..+++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 76 ~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 76 KLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred eEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccce
Confidence 56999999999999998842 3578999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (393)
....... ......++..|+|||.+.+..++.++|+|||||++|+|++|..||.......... .... .
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~---~----- 216 (277)
T cd06641 150 QLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF---LIPK---N----- 216 (277)
T ss_pred ecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH---HHhc---C-----
Confidence 5433211 1233467889999999988889999999999999999999999997543221111 1100 0
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
........++.++.+++.+||+.+|.+||++.+++.|.+....
T Consensus 217 ------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 217 ------NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ------CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 0011122345778999999999999999999999999776543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=292.04 Aligned_cols=259 Identities=28% Similarity=0.405 Sum_probs=197.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHH-hhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQF-LGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|++.+.||+|+||.||+|.+..+ +..||+|.+..... .....+..|+.+ ++..+||||+++++++...+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~-- 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPT-----GTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG-- 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCC-----CcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC--
Confidence 4689999999999999999986543 45699999876432 223445556665 56678999999999998766
Q ss_pred cceEEEEEeecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSR--AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..+++|||++ ++|.+++... ....+++..++.++.|++.||.|||++ .+++||||||+||+++.++.+||+||
T Consensus 74 --~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~df 148 (283)
T cd06617 74 --DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDF 148 (283)
T ss_pred --cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeec
Confidence 4599999996 5888877542 335689999999999999999999974 38999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIET----GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
|++....... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.......+. ........
T Consensus 149 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~ 224 (283)
T cd06617 149 GISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ-LKQVVEEP 224 (283)
T ss_pred cccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH-HHHHHhcC
Confidence 9987643221 1233467889999998865 45688999999999999999999999653322111 11111100
Q ss_pred CcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 304 PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
. ... ....++.++.+|+.+||..+|.+||++.+++++.|....
T Consensus 225 ~-----------~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 225 S-----------PQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred C-----------CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 0 000 011246789999999999999999999999999887764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=292.36 Aligned_cols=263 Identities=18% Similarity=0.177 Sum_probs=189.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHH-----------HHHHHHHHhhcCCCCccceee
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK-----------QWLAEVQFLGVVSHPNLVKLL 140 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-----------~~~~E~~~l~~l~h~niv~~~ 140 (393)
++|.+.++||+|+||.||+|.+..+.. ....+++|........... ....+...+..+.|+|+++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~--~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHC--INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcc--cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 579999999999999999998754421 1234666654332211111 112334455667899999999
Q ss_pred eeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC
Q 035862 141 GYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF 220 (393)
Q Consensus 141 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~ 220 (393)
+.+........+.+++++++ ..++.+.+.. ....++..++.++.|++.||.|||+. +++||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKR--IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred EeeeEecCCceEEEEEEehh-ccCHHHHHHh--hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 97766554444557888887 4477766632 23357888999999999999999998 999999999999999999
Q ss_pred ceEEeeccCCccCCCCCCc-----cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH
Q 035862 221 KPKLSDFGLAREGPTGDHT-----HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK 295 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~ 295 (393)
.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999999765322111 11223469999999999999999999999999999999999999997653322111
Q ss_pred ---HHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 296 ---LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 296 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
........... .. ....++..+.+++..||..+|++||++.++.+.+
T Consensus 244 ~~~~~~~~~~~~~~----------~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRLHEG----------KI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHHHHHhhhh----------hh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 11111111110 00 0112457899999999999999999999999865
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=293.02 Aligned_cols=266 Identities=26% Similarity=0.360 Sum_probs=198.8
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
|++.+.||.|++|.||+|.+..+ +..|++|.+..... .....+.+|+.+++.++|||++++++++...+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~---- 71 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLT-----GEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSEN---- 71 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCC-----CCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCC----
Confidence 67788999999999999986543 34699998865431 22356778999999999999999999988765
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..+++|||++ ++|.+++.......+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.
T Consensus 72 ~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 72 KLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred eEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 5699999995 6999988655545689999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH-HHHHHhhcCcCC--
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK-LLEWVKQFPADG-- 307 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~-- 307 (393)
....... ......++..|+|||++.+. .++.++||||||+++|+|++|..||.......+.. ..... ..+...
T Consensus 148 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~ 224 (283)
T cd07835 148 AFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTL-GTPDEDVW 224 (283)
T ss_pred ccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-CCCChHHh
Confidence 5432211 12234568899999988654 57899999999999999999999997654432211 11110 000000
Q ss_pred ----------cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 308 ----------KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 308 ----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
..+....... ........+..+.+++.+||+.||.+||++++++++.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 282 (283)
T cd07835 225 PGVTSLPDYKPTFPKWARQD-LSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282 (283)
T ss_pred hhhhhchhhhhhcccccccc-hhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence 0000000000 01111234578899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=293.01 Aligned_cols=272 Identities=25% Similarity=0.330 Sum_probs=199.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|++.+.||.|++|.||+|.+..+ +..|++|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 74 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVT-----NETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-- 74 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCC-----CcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC--
Confidence 5799999999999999999986533 34699998865422 23356778999999999999999999998765
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC-CCceEEeecc
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG-NFKPKLSDFG 228 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg 228 (393)
..++||||++ ++|.+++.......+++..++.++.||+.||+|||++ +++|+||+|+||+++. ++.+||+|||
T Consensus 75 --~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 75 --RLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred --eEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence 5699999995 5888887555545568888999999999999999998 9999999999999985 5679999999
Q ss_pred CCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
++....... .......+++.|+|||++.+ ..++.++|||||||++|+|+||..||.......+..........+...
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 226 (294)
T PLN00009 149 LARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEE 226 (294)
T ss_pred cccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 997543221 11233467889999998866 457899999999999999999999997654332211110000111000
Q ss_pred c-----cccccc--Cccccc----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 308 K-----KFSMMI--DPRLRN----QYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 308 ~-----~~~~~~--~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
. ...... .+.... ......+..+.+++.+||+.+|++||++.+++++.|..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~ 288 (294)
T PLN00009 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288 (294)
T ss_pred hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHh
Confidence 0 000000 000000 01123457789999999999999999999999987654
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=287.04 Aligned_cols=254 Identities=23% Similarity=0.397 Sum_probs=198.0
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC----------cccHHHHHHHHHHhhc-CCCCccceeee
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG----------LQGHKQWLAEVQFLGV-VSHPNLVKLLG 141 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~~~~ 141 (393)
+|++.+.||+|+||.||+|.+... ....+++|.+.... ......+.+|+.++.. ++||||+++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~----~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~ 76 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN----GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK 76 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC----CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEe
Confidence 478889999999999999997541 23468999875321 1223446678887765 78999999999
Q ss_pred eeecCCcccceEEEEEeecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCCeEeCC
Q 035862 142 YCSTEDERGIQRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEGLAYLHE-GLEIQVIYRDFKTSNVLLDG 218 (393)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dikp~NIll~~ 218 (393)
++...+ ..+++|||+++++|.+++.. .....+++..++.++.|++.||.|||+ . +++|+||+|+||+++.
T Consensus 77 ~~~~~~----~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~ 149 (269)
T cd08528 77 TFLEND----RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGE 149 (269)
T ss_pred eEccCC----eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECC
Confidence 998766 56999999999999998743 234568999999999999999999996 5 8999999999999999
Q ss_pred CCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHH
Q 035862 219 NFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLE 298 (393)
Q Consensus 219 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~ 298 (393)
++.++|+|||++....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...........
T Consensus 150 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~-- 224 (269)
T cd08528 150 DDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK-- 224 (269)
T ss_pred CCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHH--
Confidence 9999999999997644332 22345788899999999988899999999999999999999999965433211111
Q ss_pred HHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 299 WVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.... ..........+..+.+++.+||+.||++||++.++..++.
T Consensus 225 -~~~~-------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 -IVEA-------------VYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -Hhhc-------------cCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1000 0000011124577899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=302.17 Aligned_cols=275 Identities=27% Similarity=0.356 Sum_probs=200.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc-
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE- 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 148 (393)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTG-----VKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE 78 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCC-----CeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence 468999999999999999999875433 469999986432 2234557789999999999999999998765442
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
.....++|+||+. ++|.+++. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||
T Consensus 79 ~~~~~~lv~e~~~-~~l~~~~~---~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg 151 (336)
T cd07849 79 SFNDVYIVQELME-TDLYKLIK---TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFG 151 (336)
T ss_pred ccceEEEEehhcc-cCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccc
Confidence 2235699999995 48887773 24589999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCcc-ccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 229 LAREGPTGDHTH-VSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 229 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
++.......... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||..................+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~ 231 (336)
T cd07849 152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ 231 (336)
T ss_pred ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 987643322111 1233578899999998754 56899999999999999999999999765432211111000000000
Q ss_pred CcccccccC-----------cccccc---cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 307 GKKFSMMID-----------PRLRNQ---YSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 307 ~~~~~~~~~-----------~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.....+.+ ...... .....+.++.+++.+||+.||++|||+.++++|.+..
T Consensus 232 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~ 296 (336)
T cd07849 232 -EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE 296 (336)
T ss_pred -HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence 00000000 000000 0112357799999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=291.86 Aligned_cols=260 Identities=28% Similarity=0.398 Sum_probs=208.3
Q ss_pred HHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
...+.|+....||+|++|.||+|.+... +..+++|++..... ....+.+|+++++.++|+|++++++.+...+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~-----~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 88 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRAT-----GKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGD- 88 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccC-----CcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC-
Confidence 3466799999999999999999987533 34599999876543 4566788999999999999999999998776
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++|+||+++++|.+++.... ..+++..++.++.|++.||.|||+. |++|+||+|+||+++.++.++|+|||
T Consensus 89 ---~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~ 161 (286)
T cd06614 89 ---ELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFG 161 (286)
T ss_pred ---EEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccc
Confidence 5699999999999999996543 3689999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
++........ ......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+....... ......
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~--~~~~~~--- 234 (286)
T cd06614 162 FAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI--TTKGIP--- 234 (286)
T ss_pred hhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhcCCC---
Confidence 8865433221 122345788999999998888999999999999999999999999765443221111 110000
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.......++..+.+++.+||+.+|.+||++.+++.+.+...
T Consensus 235 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 235 ----------PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred ----------CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 00011124578999999999999999999999999887654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=289.19 Aligned_cols=248 Identities=27% Similarity=0.385 Sum_probs=198.8
Q ss_pred ecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEE
Q 035862 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLV 156 (393)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv 156 (393)
||.|++|.||+|.+... +..+++|.+..... .....+.+|+.+++.++||||+++++.+.... ..+++
T Consensus 1 lg~g~~~~v~~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~lv 71 (262)
T cd05572 1 LGVGGFGRVELVKVKSK-----NRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK----YIYML 71 (262)
T ss_pred CCCCCceEEEEEEECCC-----CcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC----ccEEE
Confidence 69999999999997543 34699999875432 23456888999999999999999999987665 45999
Q ss_pred EeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCC
Q 035862 157 YEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236 (393)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 236 (393)
|||+++++|.+++.. ...+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 72 MEYCLGGELWTILRD--RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred EecCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 999999999999954 34588999999999999999999998 9999999999999999999999999999865443
Q ss_pred CCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCc
Q 035862 237 DHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDP 316 (393)
Q Consensus 237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (393)
. ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||................ .
T Consensus 147 ~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------------~ 209 (262)
T cd05572 147 Q---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILK--------------G 209 (262)
T ss_pred c---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhc--------------c
Confidence 2 1233568899999999988889999999999999999999999997654311111111110 0
Q ss_pred ccccccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHHH
Q 035862 317 RLRNQYSINAARRVAKLADNCLKKNPEERPT-----MNQVVESLKLA 358 (393)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~~l~~l~~~ 358 (393)
......+...+.++.+++.+||+.+|++||+ ++++++|.|.-
T Consensus 210 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~ 256 (262)
T cd05572 210 NGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256 (262)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhh
Confidence 0111122233678999999999999999999 99999998853
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=302.41 Aligned_cols=274 Identities=25% Similarity=0.344 Sum_probs=203.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|.+.+.||+|+||+||+|.+..+ +..|++|.+... .......+.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSET-----NEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHR 78 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCC-----CCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccc
Confidence 45799999999999999999986543 346999988653 22234566789999999999999999998765432
Q ss_pred -ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 149 -RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 149 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
.....++||||+. ++|.+++. ....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Df 152 (337)
T cd07858 79 EAFNDVYIVYELMD-TDLHQIIR--SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDF 152 (337)
T ss_pred cccCcEEEEEeCCC-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcC
Confidence 1124699999995 68988884 345689999999999999999999998 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
|++....... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||..................+.+
T Consensus 153 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 153 GLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred ccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 9998654332 12234567889999998764 46899999999999999999999999765332211111111000000
Q ss_pred C-c------cccccc-------CcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 307 G-K------KFSMMI-------DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 307 ~-~------~~~~~~-------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
. . ...... ..... .....++.++.+++.+||+.+|++|||+.++++|.|..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~ 295 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence 0 0 000000 00000 01124567899999999999999999999999997764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=290.57 Aligned_cols=253 Identities=27% Similarity=0.403 Sum_probs=199.4
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCC---CCccceeeeeeecCCc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVS---HPNLVKLLGYCSTEDE 148 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~ 148 (393)
.|+..+.||.|+||.||+|.+..++ ..+++|.+.... ......+.+|+.+++.++ |||++++++++....
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~- 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTG-----RVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP- 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCC-----cEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC-
Confidence 4778889999999999999975433 469999886542 233456778999999986 999999999987655
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+.+++|.+++.. ..+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||
T Consensus 76 ---~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 76 ---RLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred ---EEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence 56999999999999998843 3688999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
++........ ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||......... ......
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~---~~~~~~---- 217 (277)
T cd06917 147 VAALLNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM---MLIPKS---- 217 (277)
T ss_pred ceeecCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh---hccccC----
Confidence 9876544321 2234568899999998865 45789999999999999999999999754322111 000000
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
..+.+.. ...+.++.+++.+||+.||++||++.+++++.|..
T Consensus 218 ------~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~ 259 (277)
T cd06917 218 ------KPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKSKWIK 259 (277)
T ss_pred ------CCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhh
Confidence 0001100 01457899999999999999999999999987763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=293.25 Aligned_cols=272 Identities=24% Similarity=0.325 Sum_probs=199.6
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCC-CCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 148 (393)
++|++.+.||+|+||.||+|.+..+ +..|++|.+..... .....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~-----~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 75 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNT-----GKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEK 75 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCC-----CcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCC
Confidence 4689999999999999999997543 34699998765422 23356778999999996 6999999998876654
Q ss_pred -ccceEEEEEeecCCCChHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC-CCceE
Q 035862 149 -RGIQRLLVYEYMPNRSLEDRLFSRA---QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG-NFKPK 223 (393)
Q Consensus 149 -~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~-~~~~k 223 (393)
.....++||||+++ +|.+++.... ...+++..++.++.||+.||.|||+. +++||||+|+||+++. ++.+|
T Consensus 76 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~k 151 (295)
T cd07837 76 NGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLK 151 (295)
T ss_pred CCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEE
Confidence 22246999999975 8988885432 34689999999999999999999998 9999999999999998 89999
Q ss_pred EeeccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH-HHHHHh
Q 035862 224 LSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK-LLEWVK 301 (393)
Q Consensus 224 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~-~~~~~~ 301 (393)
|+|||++........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....+..+.. +.....
T Consensus 152 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~ 229 (295)
T cd07837 152 IADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229 (295)
T ss_pred EeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 999999875432211 1223456889999998865 467899999999999999999999997654332211 111110
Q ss_pred hcCcCCcccccccC-------cc----cccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 302 QFPADGKKFSMMID-------PR----LRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 302 ~~~~~~~~~~~~~~-------~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.+.. ..+..... +. .........+..+.+||.+||..||.+||++.+++.|.|
T Consensus 230 -~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~ 293 (295)
T cd07837 230 -TPTE-QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293 (295)
T ss_pred -CCCh-hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence 0000 00000000 00 000011235678999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=289.00 Aligned_cols=253 Identities=26% Similarity=0.430 Sum_probs=201.3
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+|.+.+.||.|+||.||+|.....+ ..+++|.+.... ......+.+|+.+++.++|+||+++++.+...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~--- 72 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDS-----EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG--- 72 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCC-----ceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC---
Confidence 4788899999999999999975433 358999886532 123456778999999999999999999887665
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc-eEEeeccC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK-PKLSDFGL 229 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~-~kl~Dfg~ 229 (393)
..++|+||+.+++|.+++.......+++..+..++.|++.||.|||+. +++|+||||+||++++++. +||+|||.
T Consensus 73 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 73 -RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred -eEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccccc
Confidence 569999999999999999665555689999999999999999999998 9999999999999998864 69999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||....... .........
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~------ 218 (257)
T cd08225 149 ARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ--LVLKICQGY------ 218 (257)
T ss_pred chhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHhccc------
Confidence 876543221 2233468889999999988889999999999999999999999997543221 111111100
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
. .......+.++.+++.+||..+|++|||+.+++++.|
T Consensus 219 ----~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~ 256 (257)
T cd08225 219 ----F-----APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPF 256 (257)
T ss_pred ----C-----CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence 0 0011134567999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=284.85 Aligned_cols=253 Identities=30% Similarity=0.434 Sum_probs=203.8
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccce
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQ 152 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 152 (393)
+|...+.||+|++|.||++.+... +..+++|.+..........+.+|+.+++.++|+|++++++++.... .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~-----~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~ 71 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRT-----GKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD----E 71 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCC-----CcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC----e
Confidence 477889999999999999997533 3469999987765445677889999999999999999999988775 4
Q ss_pred EEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 153 RLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
.++++||+.+++|.+++.... ..+++..+..++.|++.||.+||.. +++||||+|+||++++++.++|+|||.+..
T Consensus 72 ~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 147 (253)
T cd05122 72 LWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ 147 (253)
T ss_pred EEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccc
Confidence 599999999999999885433 5689999999999999999999998 999999999999999999999999999876
Q ss_pred CCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccccc
Q 035862 233 GPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSM 312 (393)
Q Consensus 233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (393)
...... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||............. .... ..
T Consensus 148 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~-----~~ 216 (253)
T cd05122 148 LSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA---TNGP-----PG 216 (253)
T ss_pred cccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---hcCC-----CC
Confidence 544321 234568889999999988889999999999999999999999997653322111111 0000 00
Q ss_pred ccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 313 MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.. ....++..+.+++.+||+.||++|||+.++++|.|
T Consensus 217 ~~-------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 217 LR-------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred cC-------cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00 01113577999999999999999999999998753
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=298.02 Aligned_cols=275 Identities=29% Similarity=0.414 Sum_probs=201.9
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcC-CCCccceeeeeeecC
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTE 146 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 146 (393)
..++|++.+.||+|+||.||+|.+..+ +..+++|++... .......+.+|+.+++.+ +||||+++++++...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~-----~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~ 79 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRT-----KEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE 79 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCC-----CeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC
Confidence 356799999999999999999986533 346999987542 223344567899999999 999999999988765
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
+.. ..++||||+. ++|.+++... .+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|
T Consensus 80 ~~~--~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d 150 (337)
T cd07852 80 NDK--DIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLAD 150 (337)
T ss_pred CCc--eEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEee
Confidence 433 5699999996 5999888432 678889999999999999999998 999999999999999999999999
Q ss_pred ccCCccCCCCCCc---cccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhh
Q 035862 227 FGLAREGPTGDHT---HVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ 302 (393)
Q Consensus 227 fg~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (393)
||++......... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....+............
T Consensus 151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 230 (337)
T cd07852 151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG 230 (337)
T ss_pred ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999765433221 12234568899999998755 5678899999999999999999999976544322111100000
Q ss_pred cCcC-----------CcccccccCccc--ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 303 FPAD-----------GKKFSMMIDPRL--RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 303 ~~~~-----------~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.+.. ...+........ .......++.++.+++.+||+.||.+|||+.+++++.+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~ 299 (337)
T cd07852 231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299 (337)
T ss_pred CCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhh
Confidence 0000 000000000000 0011112467899999999999999999999999996554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=290.68 Aligned_cols=268 Identities=26% Similarity=0.383 Sum_probs=200.1
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
+|++.+.||.|++|.||+|.+..+ +..|++|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---- 71 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTT-----GEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN---- 71 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCC-----CeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC----
Confidence 488899999999999999996533 34699999875432 23456678999999999999999999998776
Q ss_pred eEEEEEeecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRA-QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+ +|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++
T Consensus 72 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~ 147 (284)
T cd07836 72 KLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLA 147 (284)
T ss_pred cEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchh
Confidence 45999999975 8888875433 34689999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH-HHHHHh-------
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK-LLEWVK------- 301 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~-~~~~~~------- 301 (393)
........ ......++..|++||++.+ ..++.++|||||||++|+|++|..||.......... ......
T Consensus 148 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 148 RAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTW 225 (284)
T ss_pred hhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhH
Confidence 75433211 1233467889999998865 457889999999999999999999997654322111 111100
Q ss_pred ----hcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 302 ----QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 302 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
..+.....+....... ........+..+.+++.+||+.||.+||++.+++++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~ 283 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQD-LQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283 (284)
T ss_pred HHHhcCchhcccccCCChHH-HHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 0000000000000000 01111234678899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=290.04 Aligned_cols=266 Identities=27% Similarity=0.340 Sum_probs=194.7
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCC-CCccceeeeeeecCCcccc
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 151 (393)
|++.+.||+|+||.||+|....+ +..|++|.+.... ........+|+.++..+. |+|++++++++.+....
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~-----~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~-- 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKT-----GKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTG-- 73 (282)
T ss_pred CceEeeccccccceEEEEEEcCC-----CcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCC--
Confidence 67788999999999999986533 3469999887542 222234457888888886 99999999999876322
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.+++||||+. ++|.+++.... ..+++..++.++.|++.||.|||+. +++||||+|+||+++. +.+||+|||++.
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 74 RLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred cEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccc
Confidence 5699999996 58888875433 4689999999999999999999998 9999999999999999 999999999997
Q ss_pred cCCCCCCccccccccccCCccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHH-HHH--------h
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL-EWV--------K 301 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~-~~~--------~ 301 (393)
....... .....++..|+|||.+. +..++.++|||||||++|||++|..||............ ... .
T Consensus 148 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
T cd07831 148 GIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLK 224 (282)
T ss_pred ccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 6533221 12346788999999764 456788999999999999999999999765432211111 100 0
Q ss_pred hcCcCCc---ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 302 QFPADGK---KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 302 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
....... .+.......+ ......++..+.+++.+||+++|++||++.+++++.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~ 281 (282)
T cd07831 225 KFRKSRHMNYNFPSKKGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281 (282)
T ss_pred hhcccccccccCcccccccH-HHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence 0000000 0000000000 0011245788999999999999999999999998864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=296.06 Aligned_cols=269 Identities=23% Similarity=0.307 Sum_probs=197.2
Q ss_pred eeccc--CCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEE
Q 035862 79 KIGEG--GFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRL 154 (393)
Q Consensus 79 ~lg~G--~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 154 (393)
.||.| +||+||++.+...+ ..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~----~~~ 75 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTG-----TLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS----WLW 75 (328)
T ss_pred HhCCcccCceeEEEEEEcCCC-----cEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC----ceE
Confidence 46666 89999999865443 469999987542 223456788999999999999999999998776 459
Q ss_pred EEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCC
Q 035862 155 LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGP 234 (393)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 234 (393)
+||||+.+++|.+++.......+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+....
T Consensus 76 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~ 152 (328)
T cd08226 76 VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLV 152 (328)
T ss_pred EEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhh
Confidence 999999999999998765555689999999999999999999998 99999999999999999999999998654321
Q ss_pred CCCCcc-----ccccccccCCccCccccccC--CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 235 TGDHTH-----VSTAVVGTYGYAAPEYIETG--HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 235 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
...... ......++..|+|||++.+. .++.++|||||||++|+|++|..||........ ........+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~ 230 (328)
T cd08226 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSP 230 (328)
T ss_pred ccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCC
Confidence 111100 01112345679999998763 478999999999999999999999976543211 111111000000
Q ss_pred c--------------------------c-----cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 308 K--------------------------K-----FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 308 ~--------------------------~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
. . ........+.......++..+.+|+.+||+.||++|||+.++++|.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 0 0 00011111222223456788999999999999999999999999988
Q ss_pred HHHhh
Q 035862 357 LAVQE 361 (393)
Q Consensus 357 ~~~~~ 361 (393)
.....
T Consensus 311 ~~~~~ 315 (328)
T cd08226 311 FKQVK 315 (328)
T ss_pred HHHHH
Confidence 65443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=290.13 Aligned_cols=270 Identities=23% Similarity=0.311 Sum_probs=208.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC--CCc----cceeeeeee
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS--HPN----LVKLLGYCS 144 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~n----iv~~~~~~~ 144 (393)
.++|.+..++|+|+||.|-.++++.. +..||+|+++.-. ...+..+-|+.+|.+++ .|+ ++++.+||.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~-----~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRET-----KEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCC-----CceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 78999999999999999999997654 4569999987643 33455667999999985 232 677778887
Q ss_pred cCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC------
Q 035862 145 TEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG------ 218 (393)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~------ 218 (393)
..+ +.|+|+|.+ |-++.+++..+...+++...++.+++||+++++|||+. +++|.||||+|||+.+
T Consensus 162 yrg----hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 162 YRG----HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred ccC----ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence 666 569999999 77999999888888899999999999999999999999 9999999999999932
Q ss_pred --------------CCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCc
Q 035862 219 --------------NFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRV 284 (393)
Q Consensus 219 --------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~p 284 (393)
+..|+|+|||.|....... +..+.|..|.|||++.+..|+..+||||+||||+|+.||...
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 3358999999998744322 567889999999999999999999999999999999999999
Q ss_pred cCCCCchhhhHHHHHHhh-cCcCC------------cccc-----------cccCc--cc--ccccCHHHHHHHHHHHHH
Q 035862 285 LERNRPTMEQKLLEWVKQ-FPADG------------KKFS-----------MMIDP--RL--RNQYSINAARRVAKLADN 336 (393)
Q Consensus 285 f~~~~~~~~~~~~~~~~~-~~~~~------------~~~~-----------~~~~~--~~--~~~~~~~~~~~l~~li~~ 336 (393)
|..++...+-.+.+...+ +|... ..++ ...+. .+ ..........+|.+|+++
T Consensus 309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 988875554433332221 11110 0000 00000 00 001112344679999999
Q ss_pred hcccCCCCCCCHHHHHHHHHHHH
Q 035862 337 CLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 337 ~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
||..||.+|+|+.|++.|.+...
T Consensus 389 mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred HHccCccccccHHHHhcCHHhhc
Confidence 99999999999999999987643
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=285.67 Aligned_cols=257 Identities=27% Similarity=0.396 Sum_probs=205.7
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+|...+.||+|++|.||+|....+ +..+++|.+..... .....+.+|+.+++.++||||+++++.+......
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~- 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDT-----GELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKN- 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCC-----CcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC-
Confidence 477889999999999999987543 34699998876542 3456788999999999999999999998876211
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++++||+.+++|.+++.... .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 75 -~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 75 -TLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred -eEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccE
Confidence 5699999999999999985443 789999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
................++..|+|||.+.+..++.++||||||+++|+|++|..||......... .....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~---------- 217 (260)
T cd06606 149 KRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA-LYKIG---------- 217 (260)
T ss_pred EecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-HHhcc----------
Confidence 8755443211123457888999999998888999999999999999999999999766521111 11100
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
........+...+..+.+|+.+||..+|++||++.++++|.|
T Consensus 218 ----~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~ 259 (260)
T cd06606 218 ----SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPF 259 (260)
T ss_pred ----ccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence 001111223344688999999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=293.96 Aligned_cols=276 Identities=23% Similarity=0.358 Sum_probs=199.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||.||+|.... .+..||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKK-----TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 85 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECC-----CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence 4579999999999999999998654 34569999886432 1223345689999999999999999998876542
Q ss_pred c----cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEE
Q 035862 149 R----GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKL 224 (393)
Q Consensus 149 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 224 (393)
. ....++||||+. ++|.+++... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl 160 (310)
T cd07865 86 PYNRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKL 160 (310)
T ss_pred cccCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEE
Confidence 1 235699999995 5888877433 24689999999999999999999998 9999999999999999999999
Q ss_pred eeccCCccCCCCCCc--cccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHh
Q 035862 225 SDFGLAREGPTGDHT--HVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK 301 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~ 301 (393)
+|||++......... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||................
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~ 240 (310)
T cd07865 161 ADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLC 240 (310)
T ss_pred CcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999999765332211 112234678899999988664 47889999999999999999999997665433322222211
Q ss_pred h-cCcCC----ccccc---c-cCccccccc-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 302 Q-FPADG----KKFSM---M-IDPRLRNQY-----SINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 302 ~-~~~~~----~~~~~---~-~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
. .+... ..... . ......... ....+..+.+||.+||..||.+|||+.++++|.|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~ 309 (310)
T cd07865 241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309 (310)
T ss_pred CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence 1 11000 00000 0 000000000 0012356789999999999999999999998865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=290.70 Aligned_cols=247 Identities=25% Similarity=0.347 Sum_probs=189.0
Q ss_pred eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc---cHHHHHHHHHHhh---cCCCCccceeeeeeecCCcccce
Q 035862 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ---GHKQWLAEVQFLG---VVSHPNLVKLLGYCSTEDERGIQ 152 (393)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~~~ 152 (393)
.||+|+||.||++.+..+ +..+|+|.+...... ....+.+|..+++ ..+||||+.+++.+...+ .
T Consensus 1 ~lg~G~~g~Vy~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~ 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKADT-----GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD----K 71 (279)
T ss_pred CcccCCCeEEEEEEECCC-----CcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC----e
Confidence 489999999999986533 346999988654221 1222344444333 347999999999988766 4
Q ss_pred EEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 153 RLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
.++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+|||+++++.++|+|||++..
T Consensus 72 ~~lv~e~~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred EEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 5999999999999998843 35689999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCCccccccccccCCccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccc
Q 035862 233 GPTGDHTHVSTAVVGTYGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311 (393)
Q Consensus 233 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (393)
..... .....|+..|+|||.+. +..++.++||||+||++|+|++|..||.................
T Consensus 147 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--------- 213 (279)
T cd05633 147 FSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--------- 213 (279)
T ss_pred ccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc---------
Confidence 43221 12346899999999886 45689999999999999999999999975433221111111100
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHH
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKLA 358 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~~ 358 (393)
.....+..++.++.+++.+||+.||.+|| +++++++|.+..
T Consensus 214 ------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~ 259 (279)
T cd05633 214 ------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFK 259 (279)
T ss_pred ------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcccc
Confidence 01112234567899999999999999999 699999997663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=292.68 Aligned_cols=252 Identities=30% Similarity=0.413 Sum_probs=198.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
..|+..+.||+|+||.||+|..... +..|++|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~- 88 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRT-----NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH- 88 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCC-----CcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-
Confidence 4588999999999999999986533 34699998864322 23346788999999999999999999998766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+. ++|.+++... ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||
T Consensus 89 ---~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg 160 (307)
T cd06607 89 ---TAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFG 160 (307)
T ss_pred ---eEEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecC
Confidence 4599999996 5777776433 34589999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIE---TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
++...... ....++..|+|||++. ...++.++||||||+++|+|++|..||............ ...
T Consensus 161 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~--~~~--- 229 (307)
T cd06607 161 SASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQN--- 229 (307)
T ss_pred cceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH--hcC---
Confidence 98754322 2346788999999874 456889999999999999999999999754332211100 000
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
. ........++..+.+++.+||+.+|++||++.+++.+.|...
T Consensus 230 -~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 230 -D----------SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred -C----------CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 0 000111235678999999999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=291.37 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=201.2
Q ss_pred ccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEE
Q 035862 76 RMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLL 155 (393)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~l 155 (393)
...+||+|+||.||++....+ +..|++|.+..........+.+|+.+++.++|+||+++++.+...+ ..++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~l 94 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSS-----GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD----ELWV 94 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCC-----CeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC----EEEE
Confidence 345799999999999986533 3469999886554445566888999999999999999999998776 5699
Q ss_pred EEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCC
Q 035862 156 VYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPT 235 (393)
Q Consensus 156 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 235 (393)
||||+++++|.+++.. ..+++..++.++.|++.||+|||+. |++||||+|+||+++.++.++|+|||++.....
T Consensus 95 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 95 VMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred EEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 9999999999997732 3578999999999999999999998 999999999999999999999999998865433
Q ss_pred CCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccC
Q 035862 236 GDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMID 315 (393)
Q Consensus 236 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (393)
... ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||............. ...+.
T Consensus 169 ~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~--~~~~~---------- 234 (292)
T cd06657 169 EVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR--DNLPP---------- 234 (292)
T ss_pred ccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hhCCc----------
Confidence 221 1233568899999999988888999999999999999999999997543322111111 11110
Q ss_pred cccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
... ....++..+.+++.+||+.+|.+||++.+++.|.+.....
T Consensus 235 -~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 235 -KLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred -ccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 000 0112456788999999999999999999999998877654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=288.30 Aligned_cols=255 Identities=22% Similarity=0.295 Sum_probs=199.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-----CcccHHHHHHHHHHhhcCCCCccceeeeeeecC
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-----GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTE 146 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 146 (393)
.+|++.+.||+|+||.||+|.+..+ +..|++|.+... .......+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 76 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADT-----GRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP 76 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCC-----CCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC
Confidence 3688999999999999999986533 346999987532 122345678899999999999999999988665
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
... ..+++|||+.+++|.+++.. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|
T Consensus 77 ~~~--~~~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 77 EEK--KLSIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred CCC--EEEEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence 433 56899999999999998853 34578899999999999999999998 999999999999999999999999
Q ss_pred ccCCccCCCCCCc-cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 227 FGLAREGPTGDHT-HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 227 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
||++......... .......++..|+|||++.+..++.++|+|||||++|+|++|..||....... ....... .
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~-~-- 224 (264)
T cd06653 150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFKIAT-Q-- 224 (264)
T ss_pred cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHHHHc-C--
Confidence 9999764321111 11123568899999999988889999999999999999999999997543221 1111110 0
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
......+..+++.+.+++.+||. +|..||++.+++.|+
T Consensus 225 -----------~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~ 262 (264)
T cd06653 225 -----------PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP 262 (264)
T ss_pred -----------CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence 01112233566889999999998 579999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=296.96 Aligned_cols=279 Identities=26% Similarity=0.339 Sum_probs=207.5
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCC-cc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED-ER 149 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~ 149 (393)
+|++.+.||.|++|.||+|..... +..|++|.+.... ....+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRT-----GRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCC-----CcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccc
Confidence 588899999999999999996533 3469999887643 334567889999999999999999999987765 12
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
...+|++|||+. ++|.+++.. ...+++..++.++.|++.||.|||+. |++||||||+|||++.++.++|+|||+
T Consensus 76 ~~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~ 149 (330)
T cd07834 76 FNDVYIVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGL 149 (330)
T ss_pred ccceEEEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCc
Confidence 225699999996 589888843 34789999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCc-cccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHH-HHHHhhcCcC
Q 035862 230 AREGPTGDHT-HVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKL-LEWVKQFPAD 306 (393)
Q Consensus 230 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~ 306 (393)
+......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||........... .......+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 229 (330)
T cd07834 150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE 229 (330)
T ss_pred eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence 9865443210 112345678899999999887 889999999999999999999999976654322111 1111000000
Q ss_pred C------cccccccC---c---ccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 307 G------KKFSMMID---P---RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 307 ~------~~~~~~~~---~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
. ......+. . .-........+..+.+|+.+||+.+|.+||++.+++.|.|......
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0 00000000 0 0000011125678999999999999999999999999987754333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=290.98 Aligned_cols=256 Identities=30% Similarity=0.427 Sum_probs=200.4
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.|...+.||+|+||.||+|++... +..+++|.+..... .....+.+|+.+++.++|||++++++++...+
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~-----~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-- 98 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRT-----NEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-- 98 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCC-----CcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC--
Confidence 377788999999999999986543 34699998865422 23346788999999999999999999998766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+.+ +|.+.+... ...+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+
T Consensus 99 --~~~lv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~ 171 (317)
T cd06635 99 --TAWLVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGS 171 (317)
T ss_pred --eEEEEEeCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCC
Confidence 45999999965 787776433 34589999999999999999999998 999999999999999999999999998
Q ss_pred CccCCCCCCccccccccccCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIE---TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
+...... ....|+..|+|||.+. ...++.++|||||||++|+|++|..||......... .......
T Consensus 172 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~~~~~--- 240 (317)
T cd06635 172 ASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQNE--- 240 (317)
T ss_pred ccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH--HHHHhcc---
Confidence 8654321 2346888999999874 456889999999999999999999998754322111 1111100
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcC
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 364 (393)
.........+..+.+++.+||+.+|.+||++.+++++++......+.
T Consensus 241 -----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~ 287 (317)
T cd06635 241 -----------SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPET 287 (317)
T ss_pred -----------CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCccc
Confidence 00011123457789999999999999999999999999987655444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=284.29 Aligned_cols=253 Identities=27% Similarity=0.430 Sum_probs=204.9
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+|.+.+.||.|+||.||++.+..+ +..+++|.+..... .....+.+|+++++.++|||++++++.+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~--- 72 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSD-----GKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKG--- 72 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCC-----CcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCC---
Confidence 488889999999999999997543 34699999876533 44566888999999999999999999987764
Q ss_pred ceEEEEEeecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRA--QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++|+||+++++|.+++.... ...+++..+..++.|++.||.+||+. |++|+||+|+||++++++.++|+|||
T Consensus 73 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~ 148 (258)
T cd08215 73 -KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFG 148 (258)
T ss_pred -EEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCcc
Confidence 5699999999999999986543 46789999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
.+....... .......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||....... .........
T Consensus 149 ~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~~~~~~----- 219 (258)
T cd08215 149 ISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE--LALKILKGQ----- 219 (258)
T ss_pred ceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH--HHHHHhcCC-----
Confidence 997654432 12334578899999999988889999999999999999999999997554221 111111100
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
....+...+..+.+++.+||..+|++||++.+++++.+
T Consensus 220 ----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 257 (258)
T cd08215 220 ----------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPF 257 (258)
T ss_pred ----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence 01112234578999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=294.79 Aligned_cols=277 Identities=24% Similarity=0.301 Sum_probs=199.7
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCC-CCccceeeeeeecCCcc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDER 149 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 149 (393)
+|.+.+.||+|+||.||++.+... ..+..||+|.+.... ......+.+|+.+++.+. ||||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~---~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAET---SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCC---CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 478889999999999999997543 124569999886532 122456778999999984 99999999876543222
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
....+++++|+. ++|.+++. ....+++..++.++.||+.||.|||+. |++||||||+|||+++++.+||+|||+
T Consensus 78 ~~~~~~~~e~~~-~~L~~~l~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 78 FNELYLYEELME-ADLHQIIR--SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred CCcEEEEEeccc-CCHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 235688899985 69999884 345689999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCc--cccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhh-HHHHHHhhcCc
Q 035862 230 AREGPTGDHT--HVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ-KLLEWVKQFPA 305 (393)
Q Consensus 230 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~ 305 (393)
+......... .......|+..|+|||.+.+ ..++.++||||+||++|+|++|.+||......... ....... .+.
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~ 230 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLG-TPD 230 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhC-CCC
Confidence 9764432211 11233578999999998765 56899999999999999999999999765422110 0111000 000
Q ss_pred CC-------cc-------cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 306 DG-------KK-------FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 306 ~~-------~~-------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
.. .. ........+. ......+..+.+|+.+||+.||.+|||+.+++.+.|...-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 00 00 0000000000 0001235678999999999999999999999999886443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=331.05 Aligned_cols=258 Identities=28% Similarity=0.342 Sum_probs=206.0
Q ss_pred HHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeec
Q 035862 68 REATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCST 145 (393)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 145 (393)
...+-+++...+||.|.||.||.|.+..++ ...|+|-+.-.. ......+.+|+.++..++|||+|+++|+-..
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tG-----ellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTG-----ELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH 1305 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCcc-----chhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec
Confidence 334457888889999999999999966544 358888765432 2233556789999999999999999999887
Q ss_pred CCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 146 EDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
.+. .+|.||||++|+|.+.+ ....-.++.....+..|++.|++|||++ |||||||||+||+++.+|.+|++
T Consensus 1306 Rek----v~IFMEyC~~GsLa~ll--~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~ 1376 (1509)
T KOG4645|consen 1306 REK----VYIFMEYCEGGSLASLL--EHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYG 1376 (1509)
T ss_pred HHH----HHHHHHHhccCcHHHHH--HhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEee
Confidence 774 48899999999999988 3444467777788999999999999999 99999999999999999999999
Q ss_pred eccCCccCCCCCCc--cccccccccCCccCccccccC---CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHH
Q 035862 226 DFGLAREGPTGDHT--HVSTAVVGTYGYAAPEYIETG---HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300 (393)
Q Consensus 226 Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~ 300 (393)
|||.|........+ ......+||+.|||||++.+. ....+.|||||||++.||+||+.||...+......+...+
T Consensus 1377 DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~ 1456 (1509)
T KOG4645|consen 1377 DFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA 1456 (1509)
T ss_pred cccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc
Confidence 99999875443211 123467999999999999764 4567899999999999999999999876655443332222
Q ss_pred hhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
. -.++.|..++.+..+||..||..||+.|+++.|+++|-
T Consensus 1457 g----------------h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1457 G----------------HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred c----------------CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 1 12334555889999999999999999999999888774
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=292.48 Aligned_cols=259 Identities=29% Similarity=0.440 Sum_probs=196.3
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCC-CCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 150 (393)
+|...+.||+|+||.||++.+..+ +..+|+|.+..... .....+.+|+.++..+. ||||+++++++..++
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~--- 76 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPS-----GTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG--- 76 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCC-----CCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC---
Confidence 466677899999999999987543 34699999875432 33456788999999986 999999999887765
Q ss_pred ceEEEEEeecCCCChHHHH---hhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 151 IQRLLVYEYMPNRSLEDRL---FSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..+++|||+. ++|.++. .......+++..+..++.|++.||+|||+. .+++||||||+||+++.++.++|+||
T Consensus 77 -~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 77 -DCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred -cEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeec
Confidence 4489999985 4665543 223346789999999999999999999963 28999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccC---CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG---HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP 304 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (393)
|++....... ......|+..|+|||++.+. .++.++|||||||++|+|++|+.||.......+. .......
T Consensus 153 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~-- 226 (288)
T cd06616 153 GISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQ-LTQVVKG-- 226 (288)
T ss_pred chhHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHH-HhhhcCC--
Confidence 9987543322 11234678899999998766 6899999999999999999999999754321111 1111100
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.. +.+.......++.++.+|+.+||+.+|++|||+.+++.+.+..
T Consensus 227 -~~--------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 271 (288)
T cd06616 227 -DP--------PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK 271 (288)
T ss_pred -CC--------CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 00 0111111123567899999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=289.08 Aligned_cols=267 Identities=28% Similarity=0.355 Sum_probs=201.0
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc--cHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ--GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
|++.+.||.|++|.||+|.... .+..+++|.+...... ....+.+|+.+++.++|+||+++++++...+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 71 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL-----TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKG---- 71 (283)
T ss_pred CccceeeecCCCceEEEEEcCC-----CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCC----
Confidence 6677899999999999998643 3446999988754322 3456778999999999999999999987765
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.
T Consensus 72 ~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 72 DLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred CEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 56999999965 8888875433 5689999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHH-HHHh-hcCcCCc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL-EWVK-QFPADGK 308 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~-~~~~-~~~~~~~ 308 (393)
...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+........ .... ..+....
T Consensus 147 ~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd05118 147 SFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWP 224 (283)
T ss_pred ecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcc
Confidence 654432 112334678899999998776 7899999999999999999999999765543221111 1000 0000000
Q ss_pred cccc-------ccCc---ccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 309 KFSM-------MIDP---RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 309 ~~~~-------~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.+.. .... .........++.++.+||.+||++||.+||++.+++.+.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~ 282 (283)
T cd05118 225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282 (283)
T ss_pred cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence 0000 0000 0001112346788999999999999999999999998865
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=278.69 Aligned_cols=263 Identities=21% Similarity=0.314 Sum_probs=207.3
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCccceeeeeeecCCcccceEEEE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDERGIQRLLV 156 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~lv 156 (393)
..||+|+++.|-.+....++. .||||++.+.....+.+.++|++++.+++ |+||+++++||.++. ..|||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~-----EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~----~FYLV 154 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGK-----EYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT----RFYLV 154 (463)
T ss_pred HHhcCccceeeeeeeeeccch-----hhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc----eEEEE
Confidence 469999999999988765554 49999999987778889999999999998 999999999999887 45999
Q ss_pred EeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc---eEEeeccCCccC
Q 035862 157 YEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK---PKLSDFGLAREG 233 (393)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~a~~~ 233 (393)
||-+.||+|...|. +...+++.++..+..+|+.||.|||.+ ||.|||+||+|||-.+... +|||||.+....
T Consensus 155 fEKm~GGplLshI~--~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQ--KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred EecccCchHHHHHH--HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeecccccccc
Confidence 99999999999994 445689999999999999999999999 9999999999999976554 899999887542
Q ss_pred CCCCCc-----cccccccccCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchh-----------
Q 035862 234 PTGDHT-----HVSTAVVGTYGYAAPEYIE-----TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM----------- 292 (393)
Q Consensus 234 ~~~~~~-----~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~----------- 292 (393)
...... ....+.+|+..|||||+.. ...|+.+.|.||||||+|-||+|++||.++....
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~ 309 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRV 309 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHH
Confidence 221111 1223568999999999773 3468999999999999999999999997654421
Q ss_pred -hhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCC
Q 035862 293 -EQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQG 365 (393)
Q Consensus 293 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 365 (393)
++++.+....-.. ++ ...-=..++.+..++++.+|..|+.+|.++.++++|+|.-....+.-
T Consensus 310 CQ~~LFesIQEGkY------eF-----PdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~eka 372 (463)
T KOG0607|consen 310 CQNKLFESIQEGKY------EF-----PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKA 372 (463)
T ss_pred HHHHHHHHHhccCC------cC-----ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhcc
Confidence 1222222211000 00 00001257899999999999999999999999999998766555433
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=255.37 Aligned_cols=269 Identities=25% Similarity=0.349 Sum_probs=207.4
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+|...++||+|+||+||+|+.+.+ ...||+|.++-. ........++|+.+|+.++|.|||+++++...+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t-----~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdk--- 74 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRET-----HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK--- 74 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCc-----cceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc---
Confidence 466677899999999999986544 457999988654 3334567889999999999999999999887766
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
.+.+|+||| ..+|..+.. .-++.++.+.++.++.|+++||.|+|++ ++.|||+||.|+||+.+|++||+|||++
T Consensus 75 -kltlvfe~c-dqdlkkyfd-slng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgla 148 (292)
T KOG0662|consen 75 -KLTLVFEFC-DQDLKKYFD-SLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLA 148 (292)
T ss_pred -eeEEeHHHh-hHHHHHHHH-hcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchh
Confidence 568999999 559988874 4456789999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+.+...-. -.+..+-|.+|.+|.++.+. -|+...|+||.|||+.|+.. |++.|++++-..+...+.+....|....
T Consensus 149 rafgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~ 226 (292)
T KOG0662|consen 149 RAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQ 226 (292)
T ss_pred hhcCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcccc
Confidence 97654332 23456789999999999775 58999999999999999987 6666766655444444444444333221
Q ss_pred c--cccccCcccccccC---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 309 K--FSMMIDPRLRNQYS---------INAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 309 ~--~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
- ...+-|-.....++ +.....-.++++++|.-+|.+|.++++.++|...
T Consensus 227 wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf 286 (292)
T KOG0662|consen 227 WPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYF 286 (292)
T ss_pred CCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccc
Confidence 1 11111111111122 2344566899999999999999999999998754
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=282.56 Aligned_cols=278 Identities=24% Similarity=0.352 Sum_probs=206.8
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecC--CCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN--HGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
+.|....+||+|.||.||+|+...++. .||+|++-- .........++|+++|..++|+|++.+++.|......
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~k-----kvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGK-----KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccc-----hhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 468888899999999999998654443 377776532 2233345678999999999999999999988654433
Q ss_pred c----ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 150 G----IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 150 ~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
. ..+|+||++|+. +|..++.+.. ..++..++..++.+++.||.|+|++ .|+|||+||+|+||+.+|.+||+
T Consensus 92 ~~r~r~t~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklA 166 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLA 166 (376)
T ss_pred cccccceeeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEee
Confidence 2 347999999976 9988885443 4589999999999999999999999 99999999999999999999999
Q ss_pred eccCCccCCCCCCc--cccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHH-h
Q 035862 226 DFGLAREGPTGDHT--HVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV-K 301 (393)
Q Consensus 226 Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~-~ 301 (393)
|||+++.+...... ...+..+-|.+|++||.+.+ ..|+.+.|||..|||+.||+|+.+.+.++.+.....++..+ .
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 99999765443322 23445677999999998876 57999999999999999999999999887665443333222 1
Q ss_pred hcCcCCc------cccccc-----Cccccccc-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 302 QFPADGK------KFSMMI-----DPRLRNQY-----SINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 302 ~~~~~~~------~~~~~~-----~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.+..+-. .+...+ .+...... +-.-.++..+|+.++|..||.+|+.+.++++|.+...
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 1111100 000000 00000000 0011357889999999999999999999999987654
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=299.69 Aligned_cols=274 Identities=22% Similarity=0.295 Sum_probs=201.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
..+|.+.+.||.|+||.||+|....+ +..|++|.+........+.+.+|+.+++.++||||+++++++.......
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~-----~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDC-----DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCC-----CcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 36799999999999999999986543 3469999987665555677889999999999999999998776543221
Q ss_pred ----------ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC-CC
Q 035862 151 ----------IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD-GN 219 (393)
Q Consensus 151 ----------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~-~~ 219 (393)
...++||||+. ++|.+++. ...+++..++.++.||+.||.|||+. |++||||||+||+++ ++
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~ 151 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLE---QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTED 151 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCC
Confidence 14689999996 58988773 23588999999999999999999998 999999999999997 45
Q ss_pred CceEEeeccCCccCCCCCCc-cccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHH
Q 035862 220 FKPKLSDFGLAREGPTGDHT-HVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL 297 (393)
Q Consensus 220 ~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~ 297 (393)
+.++|+|||++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....+......
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~- 230 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL- 230 (342)
T ss_pred ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-
Confidence 67899999998754322111 11123467889999997654 5688899999999999999999999976554322211
Q ss_pred HHHhhcCcCCcc--------cccccC-ccc-----ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 298 EWVKQFPADGKK--------FSMMID-PRL-----RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 298 ~~~~~~~~~~~~--------~~~~~~-~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.....+..... ...... ... ........+.++.+|+.+||+.||.+|||+.+++.|.|..
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~ 304 (342)
T cd07854 231 -ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304 (342)
T ss_pred -HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence 11111111000 000000 000 0001113457889999999999999999999999998774
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=288.79 Aligned_cols=270 Identities=26% Similarity=0.382 Sum_probs=200.2
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
|++.+.||.|++|.||+|.+... +..+++|.+.... ......+.+|+.+++.++|||++++++++......
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~-- 73 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKT-----GELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKG-- 73 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCC-----CeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCC--
Confidence 67788999999999999986543 3469999998653 23345677899999999999999999999876211
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+.+ +|.+++.... ..+++..++.++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++.
T Consensus 74 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 74 SIYMVFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred cEEEEeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccccee
Confidence 56999999965 8988875432 4689999999999999999999998 99999999999999999999999999997
Q ss_pred cCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHH-HHHHhhcCcCC-c
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKL-LEWVKQFPADG-K 308 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~~-~ 308 (393)
....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||........... ........... .
T Consensus 149 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07840 149 PYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227 (287)
T ss_pred eccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcc
Confidence 6544321 11233456788999997765 4678999999999999999999999976554322111 11111100000 0
Q ss_pred ccccc-----------cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 309 KFSMM-----------IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 309 ~~~~~-----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
....+ ....+.......++..+.+++.+||+.+|.+||++.+++++.|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~ 286 (287)
T cd07840 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286 (287)
T ss_pred ccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcC
Confidence 00000 0000111111113678999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=283.33 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=193.3
Q ss_pred HHHHhcCCccccee--cccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcC-CCCccceeeeee
Q 035862 67 LREATNGFNRMLKI--GEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV-SHPNLVKLLGYC 143 (393)
Q Consensus 67 ~~~~~~~y~~~~~l--g~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 143 (393)
.....++|.+.+.+ |.|+||.||++....+ +..+++|.......... |+.....+ +||||+++++.+
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~ 78 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPT-----QKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSV 78 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCC-----CcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEE
Confidence 34445677777777 9999999999986543 34689998865432211 22222222 699999999999
Q ss_pred ecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC-ce
Q 035862 144 STEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF-KP 222 (393)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-~~ 222 (393)
...+ ..++||||+++++|.+++... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++ .+
T Consensus 79 ~~~~----~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~ 149 (267)
T PHA03390 79 TTLK----GHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRI 149 (267)
T ss_pred ecCC----eeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeE
Confidence 8876 569999999999999998543 3789999999999999999999998 999999999999999998 99
Q ss_pred EEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhh
Q 035862 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ 302 (393)
Q Consensus 223 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (393)
+|+|||++...... ....++..|+|||++.+..++.++||||+|+++|+|++|..||....... .....+...
T Consensus 150 ~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~ 222 (267)
T PHA03390 150 YLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKR 222 (267)
T ss_pred EEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHh
Confidence 99999998754322 22467889999999998899999999999999999999999997443221 111111111
Q ss_pred cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHH
Q 035862 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT-MNQVVESLKL 357 (393)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~~l~~l~~ 357 (393)
... ........+..+.+||.+||+.+|.+||+ ++++++|.|.
T Consensus 223 ~~~-------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~ 265 (267)
T PHA03390 223 QQK-------------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL 265 (267)
T ss_pred hcc-------------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcc
Confidence 100 00111245688999999999999999996 6999988764
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=282.28 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=202.0
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+|++.+.||.|+||.||++....+ +..+++|.+.... ......+.+|+++++.++|+||+++++++....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 72 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSD-----NQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGN--- 72 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCC-----CCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCC---
Confidence 488899999999999999986533 3458999887542 233456678999999999999999999887765
Q ss_pred ceEEEEEeecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSR--AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+++++|.+++... ....+++..++.++.|++.||.|||+. |++|+||+|+||++++++.+||+|||
T Consensus 73 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g 148 (256)
T cd08530 73 -KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLG 148 (256)
T ss_pred -EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeecc
Confidence 569999999999999988542 235688999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
++...... ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......... .....
T Consensus 149 ~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~---~~~~~------ 215 (256)
T cd08530 149 ISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR---YKVQR------ 215 (256)
T ss_pred chhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHhc------
Confidence 99765443 122356788999999999999999999999999999999999999765432111 11100
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
......+...+.++.+++.+||+.+|++||++.++++++
T Consensus 216 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p 254 (256)
T cd08530 216 --------GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254 (256)
T ss_pred --------CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence 011112234668899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=319.92 Aligned_cols=285 Identities=24% Similarity=0.280 Sum_probs=218.6
Q ss_pred HHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeee
Q 035862 66 ELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGY 142 (393)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~ 142 (393)
+++-..++|.++++||+|+||.|.+++.+.++ .+||+|++.+... ....-|..|-.+|..-+.+.|++++-.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~-----~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA 143 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTE-----KVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA 143 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccc-----cchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH
Confidence 34444679999999999999999999975444 5799999987432 233457788899999999999999988
Q ss_pred eecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCce
Q 035862 143 CSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP 222 (393)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 222 (393)
|.++. ++|+||||+.||+|-.++.+. ..+|+..++.++..|+.||..||+. |+|||||||+|||++..|++
T Consensus 144 FQD~~----~LYlVMdY~pGGDlltLlSk~--~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHi 214 (1317)
T KOG0612|consen 144 FQDER----YLYLVMDYMPGGDLLTLLSKF--DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHI 214 (1317)
T ss_pred hcCcc----ceEEEEecccCchHHHHHhhc--CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcE
Confidence 88777 789999999999999998443 3799999999999999999999998 99999999999999999999
Q ss_pred EEeeccCCccCCCCCCccccccccccCCccCccccc----c-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhh-HH
Q 035862 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE----T-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ-KL 296 (393)
Q Consensus 223 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~-~~ 296 (393)
||+|||.+-..... ........+|||.|.+||++. + +.|+..+|.||+||++|||+.|..||...+-.... .+
T Consensus 215 kLADFGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KI 293 (1317)
T KOG0612|consen 215 KLADFGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKI 293 (1317)
T ss_pred eeccchhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHH
Confidence 99999988766433 334567789999999999995 3 57899999999999999999999999754321111 11
Q ss_pred HHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHHHHHH--hhhcCCCCCCCC
Q 035862 297 LEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT---MNQVVESLKLAV--QESEQGSSSTTT 371 (393)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~~l~~l~~~~--~~~~~~~~~~~~ 371 (393)
......+.+ + ....+|.++.+||.+.+ -+|+.|.. ++++-.|++..- .++--++.+|..
T Consensus 294 m~hk~~l~F-------------P--~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~v 357 (1317)
T KOG0612|consen 294 MNHKESLSF-------------P--DETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVV 357 (1317)
T ss_pred hchhhhcCC-------------C--cccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCC
Confidence 111000100 0 11247899999999988 67889998 999999976532 122223444544
Q ss_pred CCCCCCCCCc
Q 035862 372 AAKTPVTSSS 381 (393)
Q Consensus 372 ~~~~~~~~~~ 381 (393)
+..++..-+|
T Consensus 358 Pevssd~DTs 367 (1317)
T KOG0612|consen 358 PEVSSDDDTS 367 (1317)
T ss_pred CcCCCCCccc
Confidence 4444443333
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=280.26 Aligned_cols=250 Identities=32% Similarity=0.459 Sum_probs=202.0
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+|++.+.||+|++|.||+|.+...+ ..|++|.+..... .....+.+|+++++.++|||++++++++....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 72 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETG-----DFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD--- 72 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCC-----cEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC---
Confidence 4788899999999999999865333 3599999877643 34567889999999999999999999987765
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..+++|||+.+++|.+++... ..+++..++.++.|++.||.+||+. |++||||+|+||+++.++.++|+|||++
T Consensus 73 -~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 73 -SLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred -EEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccc
Confidence 569999999999999998543 5689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
......... .....++..|+|||.+.+..++.++||||+|+++|+|++|..||........ ..... . .
T Consensus 147 ~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--~~~~~-~--~----- 214 (254)
T cd06627 147 TKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--LFRIV-Q--D----- 214 (254)
T ss_pred eecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHh-c--c-----
Confidence 865443221 2345678899999999888889999999999999999999999975442211 11110 0 0
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
.....+..++..+.+++.+||..+|++||++.+++.+-
T Consensus 215 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~ 252 (254)
T cd06627 215 -------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHP 252 (254)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCC
Confidence 00111223467889999999999999999999998763
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=288.41 Aligned_cols=265 Identities=23% Similarity=0.286 Sum_probs=194.8
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLL 155 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~l 155 (393)
+.+|.| |.||.+.... .+..||+|++... .......+.+|+.+++.++||||+++++++...+ ..++
T Consensus 8 ~~~~~~--~~v~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~----~~~~ 76 (314)
T cd08216 8 KCFEDL--MIVHLAKHKP-----TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS----ELYV 76 (314)
T ss_pred HhhcCC--ceEEEEEecC-----CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC----eEEE
Confidence 334444 4455555332 3446999998754 2334567889999999999999999999988766 4599
Q ss_pred EEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCC
Q 035862 156 VYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPT 235 (393)
Q Consensus 156 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 235 (393)
+|||+.+++|.+++.......+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||.+.....
T Consensus 77 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~ 153 (314)
T cd08216 77 VSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIK 153 (314)
T ss_pred EEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecc
Confidence 99999999999999765556789999999999999999999998 999999999999999999999999998865432
Q ss_pred CCCc-----cccccccccCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHh-hc----
Q 035862 236 GDHT-----HVSTAVVGTYGYAAPEYIET--GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK-QF---- 303 (393)
Q Consensus 236 ~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~-~~---- 303 (393)
.... .......++..|+|||++.+ ..++.++||||+||++|+|++|..||........ ..+... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 231 (314)
T cd08216 154 HGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLL 231 (314)
T ss_pred ccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCcccc
Confidence 2211 11233457778999999865 4588999999999999999999999976543221 111111 00
Q ss_pred -----CcCCccccc--------ccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 304 -----PADGKKFSM--------MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 304 -----~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
+........ ..............+.++.+|+.+||+.||++|||+.++++|.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~ 299 (314)
T cd08216 232 DKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299 (314)
T ss_pred ccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHh
Confidence 000000000 0001112223335678899999999999999999999999998865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=293.38 Aligned_cols=269 Identities=24% Similarity=0.319 Sum_probs=198.5
Q ss_pred cCCcc-cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc--------------HHHHHHHHHHhhcCCCCcc
Q 035862 72 NGFNR-MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--------------HKQWLAEVQFLGVVSHPNL 136 (393)
Q Consensus 72 ~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~ni 136 (393)
++|.. .+.||.|+||.||+|.+... +..||+|.+....... ...+.+|+++++.++||||
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 82 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLT-----GKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI 82 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCC-----CCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce
Confidence 45654 46799999999999986533 3469999886542221 1246789999999999999
Q ss_pred ceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe
Q 035862 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL 216 (393)
Q Consensus 137 v~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll 216 (393)
+++++++...+ ..++||||+. ++|.+++. ....+++..+..++.|++.||.|||+. |++|+||+|+||++
T Consensus 83 v~~~~~~~~~~----~~~lv~e~~~-~~l~~~l~--~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill 152 (335)
T PTZ00024 83 MGLVDVYVEGD----FINLVMDIMA-SDLKKVVD--RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFI 152 (335)
T ss_pred eeeeEEEecCC----cEEEEEeccc-cCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEE
Confidence 99999998766 5699999996 59999884 344689999999999999999999998 99999999999999
Q ss_pred CCCCceEEeeccCCccCCCCCC------------ccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCC
Q 035862 217 DGNFKPKLSDFGLAREGPTGDH------------THVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRR 283 (393)
Q Consensus 217 ~~~~~~kl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~ 283 (393)
+.++.++|+|||++........ ........++..|+|||.+.+. .++.++|||||||++|+|++|..
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 232 (335)
T PTZ00024 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKP 232 (335)
T ss_pred CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 9999999999999876441110 1111234567889999998764 46899999999999999999999
Q ss_pred ccCCCCchhhhH-HHHHHhhcCcCCccccc------------ccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 035862 284 VLERNRPTMEQK-LLEWVKQFPADGKKFSM------------MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQ 350 (393)
Q Consensus 284 pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 350 (393)
||....+..... +...... +... .+.. ....... ......+.++.+++.+||+.+|++||++.+
T Consensus 233 p~~~~~~~~~~~~i~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~ 309 (335)
T PTZ00024 233 LFPGENEIDQLGRIFELLGT-PNED-NWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKE 309 (335)
T ss_pred CCCCCCHHHHHHHHHHHhCC-Cchh-hCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHH
Confidence 997665432211 1111111 1100 0000 0000000 011124577899999999999999999999
Q ss_pred HHHHHHHH
Q 035862 351 VVESLKLA 358 (393)
Q Consensus 351 ~l~~l~~~ 358 (393)
++.|.|..
T Consensus 310 ~l~~~~~~ 317 (335)
T PTZ00024 310 ALKHEYFK 317 (335)
T ss_pred HhcCcccC
Confidence 99998875
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=291.40 Aligned_cols=275 Identities=26% Similarity=0.331 Sum_probs=199.4
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||.|+||.||+|.+..++ ..+++|.+..... .....+.+|+++++.++||||+++++++.....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTG-----RVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD 81 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCC-----cEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence 468999999999999999999965443 3589998764322 123456789999999999999999998765442
Q ss_pred c----cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEE
Q 035862 149 R----GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKL 224 (393)
Q Consensus 149 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 224 (393)
. ...+++||||+.+ +|...+.. ....+++..+..++.|++.||.|||+. |++|+||||+||++++++.++|
T Consensus 82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l 156 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDH-DLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKI 156 (311)
T ss_pred cccccCceEEEEEecCCc-CHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence 2 2356899999955 77776643 234689999999999999999999998 9999999999999999999999
Q ss_pred eeccCCccCCCCCCc---------cccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhh
Q 035862 225 SDFGLAREGPTGDHT---------HVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ 294 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~ 294 (393)
+|||++......... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.........
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~ 236 (311)
T cd07866 157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL 236 (311)
T ss_pred CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999754332211 11223467888999998765 45889999999999999999999999765543222
Q ss_pred HH-HHHHhhcCcCCcc----ccc--------ccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 295 KL-LEWVKQFPADGKK----FSM--------MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 295 ~~-~~~~~~~~~~~~~----~~~--------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.. ............. ... ...+.+... -......+.+|+.+||+.||.+|||+.+++.|.|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~ 310 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhcCCC
Confidence 11 1111111000000 000 000000000 0123367889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=288.08 Aligned_cols=275 Identities=27% Similarity=0.345 Sum_probs=200.8
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
..++|++.+.||+|+||.||+|.+..+ +..|++|.+.... ......+.+|+++++.++||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~ 79 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDT-----GELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQ 79 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCC-----CcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcc
Confidence 457899999999999999999997543 3468999886542 222345678999999999999999999887654
Q ss_pred c------ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc
Q 035862 148 E------RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK 221 (393)
Q Consensus 148 ~------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~ 221 (393)
. .....++|+||+++ +|...+... ...+++..++.++.|++.||+|||+. +|+|+||||+||++++++.
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred hhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCc
Confidence 1 11256999999976 777776443 34689999999999999999999998 9999999999999999999
Q ss_pred eEEeeccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHH
Q 035862 222 PKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300 (393)
Q Consensus 222 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~ 300 (393)
+||+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|++||...............
T Consensus 155 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~ 233 (302)
T cd07864 155 IKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRL 233 (302)
T ss_pred EEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999999998765433221 1122356778999998864 45788999999999999999999999765443222221111
Q ss_pred hhcCcCC--ccccc---c--------cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 301 KQFPADG--KKFSM---M--------IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 301 ~~~~~~~--~~~~~---~--------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
...+... ..+.. . ........ ...++..+.+++.+||+.||.+||++.+++.+.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 301 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 1111100 00000 0 00000000 1124678999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=284.02 Aligned_cols=269 Identities=25% Similarity=0.366 Sum_probs=198.9
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcC---CCCccceeeeeeecCCc
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVV---SHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~ 148 (393)
|++.+.||+|+||.||+|.+..+ +..|++|.+..... .....+.+|+.+++.+ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 75 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNT-----GRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRT 75 (287)
T ss_pred CeEEEEecccCceEEEEEEECCC-----CCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccC
Confidence 67788999999999999997542 34699999874322 1223455677766655 69999999999987653
Q ss_pred -ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 149 -RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 149 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
.....+++|||+.+ +|.+++.......+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+||
T Consensus 76 ~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~df 151 (287)
T cd07838 76 DRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADF 151 (287)
T ss_pred CCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEecc
Confidence 22246999999964 899988655555689999999999999999999998 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|++........ .....++..|+|||.+.+..++.++|+|||||++|+|++|.+||........ ............
T Consensus 152 g~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 226 (287)
T cd07838 152 GLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPS 226 (287)
T ss_pred CcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCC
Confidence 99876533321 1234578899999999988999999999999999999999999976543221 111111110000
Q ss_pred cc-c-------ccccCccc---ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 308 KK-F-------SMMIDPRL---RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 308 ~~-~-------~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.. + ........ ........+..+.+++.+||+.||.+||++.+++.|.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~ 286 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcC
Confidence 00 0 00000000 01112245678899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=288.50 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=202.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCC-CCccceeeeeeecCC
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTED 147 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 147 (393)
++|.+.+.||.|+||.||+|.... .+..|++|++..... .....+.+|+.+++.++ ||||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE-----TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC-----CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 468999999999999999998754 334699998875321 22356778999999999 999999999887665
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..++||||+.+++|.+++.. ...+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+||
T Consensus 76 ----~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df 146 (280)
T cd05581 76 ----NLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDF 146 (280)
T ss_pred ----eEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCC
Confidence 55999999999999999954 34689999999999999999999998 9999999999999999999999999
Q ss_pred cCCccCCCCCCc------------------cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCC
Q 035862 228 GLAREGPTGDHT------------------HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNR 289 (393)
Q Consensus 228 g~a~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~ 289 (393)
|++......... .......++..|+|||.+.+..++.++|+||||++++++++|..||....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 998765432211 12234467889999999988889999999999999999999999998654
Q ss_pred chhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHHHH
Q 035862 290 PTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM----NQVVESLK 356 (393)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~~~l~~l~ 356 (393)
.... +.. ... .....+...+..+.+|+.+||+.+|.+||++ +++++|.+
T Consensus 227 ~~~~--~~~-~~~---------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 227 EYLT--FQK-ILK---------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred HHHH--HHH-HHh---------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence 2211 111 100 0111122346778999999999999999999 99988754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=301.60 Aligned_cols=252 Identities=21% Similarity=0.353 Sum_probs=195.9
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecC----CCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN----HGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 153 (393)
.+||+|+|-+||+|.+..++ ..||--.++. .......++..|+.+|+.|+||||+++|..+.+.... ..
T Consensus 46 evLGrGafKtVYka~De~~g-----iEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~--~i 118 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEG-----IEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK--TI 118 (632)
T ss_pred hhcccccceeeeeccccccc-----hhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc--ee
Confidence 46999999999999964333 3354332221 1223457789999999999999999999998877764 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC-CceEEeeccCCcc
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN-FKPKLSDFGLARE 232 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg~a~~ 232 (393)
.+|+|.+..|+|..|+ .+.+.+....+..|++||++||.|||++ ..+|+|||||-+||||+.+ |.|||+|+|+|..
T Consensus 119 n~iTEL~TSGtLr~Y~--kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 119 NFITELFTSGTLREYR--KKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeeecccCCcHHHHH--HHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHH
Confidence 8999999999999998 4455678889999999999999999997 4599999999999999765 8999999999986
Q ss_pred CCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccccc
Q 035862 233 GPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSM 312 (393)
Q Consensus 233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (393)
..... ....+|||.|||||+.. ..|+..+||||||++++||.|+..||..-... .+.+......... ..+..
T Consensus 196 ~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-AQIYKKV~SGiKP--~sl~k 267 (632)
T KOG0584|consen 196 LRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-AQIYKKVTSGIKP--AALSK 267 (632)
T ss_pred hhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-HHHHHHHHcCCCH--HHhhc
Confidence 54332 33479999999999886 88999999999999999999999999643222 2222222111111 11111
Q ss_pred ccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 313 MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 313 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
+- .+++++||.+||.. ..+|||+.|+|++......
T Consensus 268 V~------------dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 268 VK------------DPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred cC------------CHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 11 36789999999999 9999999999999876654
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=284.51 Aligned_cols=247 Identities=24% Similarity=0.333 Sum_probs=189.3
Q ss_pred eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc---HHHHHHHH---HHhhcCCCCccceeeeeeecCCcccce
Q 035862 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG---HKQWLAEV---QFLGVVSHPNLVKLLGYCSTEDERGIQ 152 (393)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~---~~l~~l~h~niv~~~~~~~~~~~~~~~ 152 (393)
.||+|+||.||+|.+..+ +..||+|.+....... ...+..|. ..++...||||+.+++.+...+ .
T Consensus 1 ~ig~g~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKADT-----GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD----K 71 (278)
T ss_pred CcccCCCeEEEEEEEecC-----CCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC----E
Confidence 489999999999986533 3469999887543221 11233343 3444567999999999888776 5
Q ss_pred EEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 153 RLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
.++||||+.|++|.+++. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 72 ~~~v~e~~~g~~L~~~l~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 72 LSFILDLMNGGDLHYHLS--QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred EEEEEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 699999999999999884 345689999999999999999999998 999999999999999999999999999875
Q ss_pred CCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccc
Q 035862 233 GPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311 (393)
Q Consensus 233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (393)
..... .....|+..|+|||++.+. .++.++||||+||++|+|++|..||.................
T Consensus 147 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------- 213 (278)
T cd05606 147 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--------- 213 (278)
T ss_pred cCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc---------
Confidence 43221 2234789999999998754 689999999999999999999999976532211111110000
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHH
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKLA 358 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~~ 358 (393)
.....+...+.++.+++.+||..+|.+|| ++.+++++.|..
T Consensus 214 ------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~ 259 (278)
T cd05606 214 ------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFR 259 (278)
T ss_pred ------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcccc
Confidence 01112223467899999999999999999 999999987663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=281.45 Aligned_cols=246 Identities=26% Similarity=0.325 Sum_probs=188.9
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc---HHHHHHHHHH-hhcCCCCccceeeeeeecCCcccceE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG---HKQWLAEVQF-LGVVSHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~ 153 (393)
+.||.|+||.||+|.+...+ ..||+|.+....... ...+..|..+ ....+|+|++++++++...+ ..
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~----~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTG-----DYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD----YL 72 (260)
T ss_pred ccCCcCCCeeEEEEEecCCC-----CeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC----eE
Confidence 46999999999999865433 469999987543221 1223444444 44568999999999998766 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++...
T Consensus 73 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 73 YLVMEYLNGGDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred EEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 999999999999999843 34689999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ........ .
T Consensus 148 ~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~-~-------- 210 (260)
T cd05611 148 LE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV--FDNILSRR-I-------- 210 (260)
T ss_pred cc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHhcc-c--------
Confidence 32 2234678899999999888899999999999999999999999976543221 11111100 0
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPT---MNQVVESLKL 357 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~~l~~l~~ 357 (393)
.........++..+.+++.+||+.+|++||+ +.+++.|.|.
T Consensus 211 ---~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~ 254 (260)
T cd05611 211 ---NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254 (260)
T ss_pred ---CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence 0011111135678999999999999999995 4788888765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=283.71 Aligned_cols=273 Identities=25% Similarity=0.330 Sum_probs=211.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-----C---Cccceeeeee
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-----H---PNLVKLLGYC 143 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~ 143 (393)
++|.+.++||.|.|++||+|++...+ +.||+|+.+... ...+..+.|+++|++++ | .+||+|++.|
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~-----r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNK-----RYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCC-----eEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 58999999999999999999976544 469999987542 33456788999999975 2 3699999999
Q ss_pred ecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC----
Q 035862 144 STEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN---- 219 (393)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~---- 219 (393)
...+..+.+.|+|+|++ |.+|..+|.......++...+++|++|++.||.|||.. +||||.||||+|||+..+
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~~~e~~~ 228 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLCSTEIDP 228 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeeeccccch
Confidence 99999999999999999 88999999888888999999999999999999999987 699999999999999310
Q ss_pred --------------------------------------------------------------------------------
Q 035862 220 -------------------------------------------------------------------------------- 219 (393)
Q Consensus 220 -------------------------------------------------------------------------------- 219 (393)
T Consensus 229 ~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~ 308 (590)
T KOG1290|consen 229 AKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPR 308 (590)
T ss_pred hhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccC
Confidence
Q ss_pred --------------------------------------------------------------------------------
Q 035862 220 -------------------------------------------------------------------------------- 219 (393)
Q Consensus 220 -------------------------------------------------------------------------------- 219 (393)
T Consensus 309 ~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~ 388 (590)
T KOG1290|consen 309 INGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPE 388 (590)
T ss_pred CCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCc
Confidence
Q ss_pred --CceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCch----hh
Q 035862 220 --FKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPT----ME 293 (393)
Q Consensus 220 --~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~----~~ 293 (393)
-.+||+|||-|+... ...+....|..|+|||++.+..|+..+||||++|++|||+||...|++.+.. .+
T Consensus 389 ~di~vKIaDlGNACW~~-----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDE 463 (590)
T KOG1290|consen 389 CDIRVKIADLGNACWVH-----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDE 463 (590)
T ss_pred cceeEEEeeccchhhhh-----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccH
Confidence 012333333333211 1234557789999999999999999999999999999999999999765332 12
Q ss_pred ---hHHHHHHhhcCc----CCcccccccCccc-------------------ccccCHHHHHHHHHHHHHhcccCCCCCCC
Q 035862 294 ---QKLLEWVKQFPA----DGKKFSMMIDPRL-------------------RNQYSINAARRVAKLADNCLKKNPEERPT 347 (393)
Q Consensus 294 ---~~~~~~~~~~~~----~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps 347 (393)
+.+++++..+|. .|.--..++++.- .-.++.+...++.+|+.-||+.+|++|||
T Consensus 464 DHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~t 543 (590)
T KOG1290|consen 464 DHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPT 543 (590)
T ss_pred HHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcccccc
Confidence 233444433332 2222222332210 11234466788999999999999999999
Q ss_pred HHHHHHHHHHH
Q 035862 348 MNQVVESLKLA 358 (393)
Q Consensus 348 ~~~~l~~l~~~ 358 (393)
+.++++|+|..
T Consensus 544 A~~cl~hPwLn 554 (590)
T KOG1290|consen 544 AAQCLKHPWLN 554 (590)
T ss_pred HHHHhcCcccc
Confidence 99999999986
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=285.05 Aligned_cols=267 Identities=28% Similarity=0.376 Sum_probs=197.7
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCC-CCccceeeeeeecCCcccc
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 151 (393)
|++.+.||.|++|+||+|.....+ ..|++|.+..... .......+|+..++.++ |||++++++++...+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~-----~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~---- 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETG-----ELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREND---- 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCC-----cEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCC----
Confidence 677889999999999999975433 4599998865432 12233457899999999 999999999988755
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+ +++|.+++.......+++..+..++.|++.+|.|||++ +++|+||+|+||++++++.++|+|||++.
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccce
Confidence 569999999 78999988655545789999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccccCCccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH-HHHHHhhcCcCC--
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK-LLEWVKQFPADG-- 307 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~-- 307 (393)
...... ......++..|+|||.+. +..++.++|+||||+++|+|++|++||.......... ............
T Consensus 148 ~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd07830 148 EIRSRP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWP 224 (283)
T ss_pred eccCCC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhh
Confidence 643322 123456788999999874 4567899999999999999999999997654432211 111111000000
Q ss_pred --c----ccccccCcccc---cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 308 --K----KFSMMIDPRLR---NQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 308 --~----~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
. .....+..... .......+.++.+++.+||+.+|++||++.+++.+.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~ 282 (283)
T cd07830 225 EGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282 (283)
T ss_pred hHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence 0 00000000000 0000112477999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=294.98 Aligned_cols=249 Identities=27% Similarity=0.385 Sum_probs=206.8
Q ss_pred cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEE
Q 035862 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRL 154 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 154 (393)
.+.||.|.||+||-|.++.++.. ||||++.+.. .....++.+|+.||..+.||.||.+.-.|.+.+ ..+
T Consensus 569 devLGSGQFG~VYgg~hRktGrd-----VAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~e----rvF 639 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRD-----VAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPE----RVF 639 (888)
T ss_pred HhhccCCcceeeecceecccCce-----eeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCc----eEE
Confidence 46799999999999998766654 9999997642 233467889999999999999999999998888 459
Q ss_pred EEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC---CceEEeeccCCc
Q 035862 155 LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN---FKPKLSDFGLAR 231 (393)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~Dfg~a~ 231 (393)
.|||-+ .|++.++|-+.+.+.+++.....++.||+.||.|||.+ +|+|.||||+|||+.+. -++||||||+|+
T Consensus 640 VVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 640 VVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred EEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccccee
Confidence 999999 55888888788888999999999999999999999998 99999999999999655 469999999999
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (393)
...... .....+|||.|+|||++..+.|...-|+||+|||+|.-++|..||....+-.++ +.....-+|.+..
T Consensus 716 iIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ-IQNAaFMyPp~PW--- 788 (888)
T KOG4236|consen 716 IIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ-IQNAAFMYPPNPW--- 788 (888)
T ss_pred ecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH-hhccccccCCCch---
Confidence 876544 346789999999999999999999999999999999999999999754332222 1111111222211
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.+++..+.+||..+|+..-++|-|+...+.|.|.
T Consensus 789 ------------~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wl 822 (888)
T KOG4236|consen 789 ------------SEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWL 822 (888)
T ss_pred ------------hhcCHHHHHHHHHHHHHHHHHhcchHhhccchhh
Confidence 1567889999999999999999999999999875
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=282.44 Aligned_cols=248 Identities=26% Similarity=0.372 Sum_probs=195.0
Q ss_pred ecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEE
Q 035862 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLV 156 (393)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv 156 (393)
||.|+||.||++.+..++ ..+++|.+..... .....+.+|+.+++.++||||+++++.+.... ..+++
T Consensus 1 lg~g~~~~vy~~~~~~~~-----~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~lv 71 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTG-----DIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKK----NLYLV 71 (265)
T ss_pred CCCCCceEEEEEEECCCC-----CEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCc----EEEEE
Confidence 689999999999975433 4699999876533 33456788999999999999999999887655 56999
Q ss_pred EeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCC
Q 035862 157 YEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236 (393)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 236 (393)
|||+.+++|.+++... ..+++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 72 MEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred EecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 9999999999998543 3689999999999999999999998 9999999999999999999999999998754332
Q ss_pred CC------ccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 237 DH------THVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 237 ~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
.. ........++..|+|||.+....++.++||||||+++|+|++|..||......... .. ......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--~~-~~~~~~----- 218 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF--QN-ILNGKI----- 218 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-HhcCCc-----
Confidence 21 11223456788999999998888999999999999999999999999765432211 11 110000
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCH---HHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM---NQVVESLKL 357 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~---~~~l~~l~~ 357 (393)
........+..+.+|+.+||+.+|.+|||+ .+++++.|.
T Consensus 219 --------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~ 260 (265)
T cd05579 219 --------EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260 (265)
T ss_pred --------CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence 000000136788999999999999999999 887877654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=292.32 Aligned_cols=277 Identities=26% Similarity=0.344 Sum_probs=203.6
Q ss_pred HHHHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeee
Q 035862 64 MQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLG 141 (393)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~ 141 (393)
..++....++|.+.+.||+|+||.||+|.+..+ +..||+|++.... ......+.+|+.+++.++||||+++++
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~ 83 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKT-----GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCC-----CeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence 345666779999999999999999999986433 3469999987532 122355778999999999999999999
Q ss_pred eeecCCc--ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC
Q 035862 142 YCSTEDE--RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN 219 (393)
Q Consensus 142 ~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~ 219 (393)
++..... .....+++++++ +++|.+++.. ..+++..++.++.|++.||.|||+. +++||||||+||+++++
T Consensus 84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~ 156 (345)
T cd07877 84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNED 156 (345)
T ss_pred eeeecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCC
Confidence 8864332 112357888887 7899887732 3589999999999999999999998 99999999999999999
Q ss_pred CceEEeeccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHH
Q 035862 220 FKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLE 298 (393)
Q Consensus 220 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~ 298 (393)
+.+||+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.............
T Consensus 157 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (345)
T cd07877 157 CELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231 (345)
T ss_pred CCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999998754221 233567889999998866 568899999999999999999999997654322111110
Q ss_pred HHhhcCcCCccccccc-----------Ccccc---cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 299 WVKQFPADGKKFSMMI-----------DPRLR---NQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 299 ~~~~~~~~~~~~~~~~-----------~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.....+.. .....+. ..... .......+.++.+||.+||+.||.+||++.+++.|.+..
T Consensus 232 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~ 304 (345)
T cd07877 232 RLVGTPGA-ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 304 (345)
T ss_pred HHhCCCCH-HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhh
Confidence 00000000 0000000 00000 000012356789999999999999999999999998755
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=289.36 Aligned_cols=270 Identities=26% Similarity=0.358 Sum_probs=208.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-------cccHHHHHHHHHHhhcCCCCccceeeeee
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-------LQGHKQWLAEVQFLGVVSHPNLVKLLGYC 143 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 143 (393)
.++|-.+.+||+|||+.||+|.+.... +.||+|+-.-.. ....+...+|..|.+.+.||-||++|++|
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~Eq-----RYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQ-----RYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchh-----heeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 457888999999999999999865433 458888754221 11234578999999999999999999999
Q ss_pred ecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC---CCC
Q 035862 144 STEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD---GNF 220 (393)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~---~~~ 220 (393)
..+... .|-|+|||+|.+|+-|| .....+++..++.|+.||+.||.||... ..+|+|-||||.|||+. ..|
T Consensus 537 slDtds---FCTVLEYceGNDLDFYL--KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 537 SLDTDS---FCTVLEYCEGNDLDFYL--KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred eecccc---ceeeeeecCCCchhHHH--HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccc
Confidence 876653 48899999999999999 4556789999999999999999999985 55899999999999994 458
Q ss_pred ceEEeeccCCccCCCCCCc-----cccccccccCCccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCccCCCCch
Q 035862 221 KPKLSDFGLAREGPTGDHT-----HVSTAVVGTYGYAAPEYIET----GHLKSQSDIWSFGVVLYEILTGRRVLERNRPT 291 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~elltg~~pf~~~~~~ 291 (393)
.+||+|||++......... .......||.||++||++.- ...+.++||||+|||+|..+.|+.||..+...
T Consensus 611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ 690 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ 690 (775)
T ss_pred eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence 8999999999986554333 23456789999999998853 35688999999999999999999999876432
Q ss_pred hhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 292 MEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
+++.....-+... .+.-+.-+.++.++.+||++||.+--++|..+.++..+...+.....
T Consensus 691 --QdILqeNTIlkAt----------EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~rr 750 (775)
T KOG1151|consen 691 --QDILQENTILKAT----------EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIRR 750 (775)
T ss_pred --HHHHhhhchhcce----------eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhhh
Confidence 2222211111000 00001112456889999999999999999999999998777654433
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=288.87 Aligned_cols=270 Identities=26% Similarity=0.340 Sum_probs=200.9
Q ss_pred HHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecC
Q 035862 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTE 146 (393)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 146 (393)
...++|++.+.||.|+||.||+|.+..++ ..|++|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 81 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTG-----QNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP 81 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCC-----CEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence 45788999999999999999999865433 469999876432 22345677899999999999999999988654
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
.. ..+++|||+ +++|.+++. ...+++..+..++.|++.||.|||+. +++||||+|.||++++++.++|+|
T Consensus 82 ~~---~~~lv~e~~-~~~L~~~~~---~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~d 151 (328)
T cd07856 82 LE---DIYFVTELL-GTDLHRLLT---SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICD 151 (328)
T ss_pred CC---cEEEEeehh-ccCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCc
Confidence 33 458999999 668988773 23578888899999999999999998 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHH-HHHhhcC
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL-EWVKQFP 304 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~-~~~~~~~ 304 (393)
||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||............ ......+
T Consensus 152 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 226 (328)
T cd07856 152 FGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226 (328)
T ss_pred cccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9998753221 123467889999998765 57899999999999999999999999765442221111 1110000
Q ss_pred c-------CCcccccccCcccccccC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 305 A-------DGKKFSMMIDPRLRNQYS-----INAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 305 ~-------~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
. ..........-......+ ..++..+.++|.+||+.+|++||++.+++.+.|..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~ 292 (328)
T cd07856 227 DDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLA 292 (328)
T ss_pred HHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccc
Confidence 0 000000000000000111 12457899999999999999999999999997764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=292.04 Aligned_cols=274 Identities=25% Similarity=0.329 Sum_probs=202.9
Q ss_pred HHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeee
Q 035862 67 LREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCS 144 (393)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 144 (393)
+....++|++.+.||+|+||.||+|....+ +..||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRT-----GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFT 84 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCC-----CcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeec
Confidence 344567899999999999999999986533 3469999886432 122345778999999999999999999887
Q ss_pred cCCccc--ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCce
Q 035862 145 TEDERG--IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP 222 (393)
Q Consensus 145 ~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 222 (393)
...... ...++||||+ +++|.+++. ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~---~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07880 85 PDLSLDRFHDFYLVMPFM-GTDLGKLMK---HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCEL 157 (343)
T ss_pred CCccccccceEEEEEecC-CCCHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCE
Confidence 654321 2458999999 779988874 24589999999999999999999998 99999999999999999999
Q ss_pred EEeeccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHh
Q 035862 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK 301 (393)
Q Consensus 223 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~ 301 (393)
+|+|||++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||........ ......
T Consensus 158 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~~~~ 230 (343)
T cd07880 158 KILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--LMEIMK 230 (343)
T ss_pred EEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH
Confidence 99999998754322 123467889999998876 4588999999999999999999999976543211 111111
Q ss_pred hcCcCCcccccccC------------cc---cccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 302 QFPADGKKFSMMID------------PR---LRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 302 ~~~~~~~~~~~~~~------------~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
........+...+. .. ........++..+.+++.+||+.||.+|||+.+++.|.+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~ 303 (343)
T cd07880 231 VTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303 (343)
T ss_pred hcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence 00000000000000 00 000011134567899999999999999999999999877653
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=285.90 Aligned_cols=253 Identities=29% Similarity=0.386 Sum_probs=197.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC---CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH---GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
+.|...+.||+|+||.||+|.+... +..+++|.+... .......+.+|+.+++.++|+|++++++++....
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~-----~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 88 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRN-----SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH- 88 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCC-----CcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-
Confidence 3477788999999999999997533 346899987643 2223346778999999999999999999988765
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||
T Consensus 89 ---~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg 160 (308)
T cd06634 89 ---TAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (308)
T ss_pred ---eeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcc
Confidence 4599999996 58887765433 4578999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIE---TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
++...... ....++..|+|||.+. ...++.++|||||||++|+|++|..||......... .......
T Consensus 161 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~~-- 230 (308)
T cd06634 161 SASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIAQNE-- 230 (308)
T ss_pred cceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH--HHHhhcC--
Confidence 98754322 2346788999999874 356788999999999999999999998654322111 1111100
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
.........+..+.+||.+||..+|++||++.+++++.+....
T Consensus 231 ------------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 231 ------------SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ------------CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 0001112356778999999999999999999999999887763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=290.58 Aligned_cols=267 Identities=26% Similarity=0.373 Sum_probs=197.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|.+...||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~ 88 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRT-----GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS 88 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCC-----CcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccccc
Confidence 47899999999999999999986533 3469999886532 2223457789999999999999999998865432
Q ss_pred c--cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 149 R--GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 149 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
. ....++|+||+. .+|..++ ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~d 160 (342)
T cd07879 89 GDEFQDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILD 160 (342)
T ss_pred CCCCceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEee
Confidence 1 124589999995 4777655 23588999999999999999999998 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
||++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ +.........
T Consensus 161 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~ 233 (342)
T cd07879 161 FGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQILKVTGV 233 (342)
T ss_pred CCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCC
Confidence 9998754321 123467889999998866 4688999999999999999999999986543221 1111111111
Q ss_pred CCcccccccC-----------cc-ccccc---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 306 DGKKFSMMID-----------PR-LRNQY---SINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 306 ~~~~~~~~~~-----------~~-~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.+..+..... +. .+... ....+..+.+|+.+||+.||.+||++.+++.|.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f 300 (342)
T cd07879 234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300 (342)
T ss_pred CCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcch
Confidence 1000000000 00 00000 01245678899999999999999999999998554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=283.68 Aligned_cols=258 Identities=27% Similarity=0.420 Sum_probs=195.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCC-CCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||.|+||.||+|.+..+ +..||+|.+..... .....+..|+.++.... ||||+++++++....
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~- 87 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKT-----GHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS- 87 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCC-----CeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC-
Confidence 35789999999999999999997533 34699999875432 23345566777666665 999999999998766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE-GLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..+++|||+. ++|.+++... ...+++..+..++.|++.||+|||+ . +++||||+|+||++++++.+||+||
T Consensus 88 ---~~~~v~e~~~-~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 88 ---DVFICMELMS-TCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred ---eEEEEeeccC-cCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECcc
Confidence 5699999984 5777766443 3468999999999999999999996 5 8999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCC----CCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGH----LKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
|++........ .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||.......+ .+......
T Consensus 160 g~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~- 234 (296)
T cd06618 160 GISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-VLTKILQE- 234 (296)
T ss_pred ccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-HHHHHhcC-
Confidence 99876433221 12335778999999987553 78899999999999999999999975332211 11111111
Q ss_pred CcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 304 PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.... . .....++.++.+|+.+||..||.+||++.+++.+.|...
T Consensus 235 --~~~~--------~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 278 (296)
T cd06618 235 --EPPS--------L--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR 278 (296)
T ss_pred --CCCC--------C--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence 0000 0 000124577899999999999999999999999987553
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=279.19 Aligned_cols=252 Identities=25% Similarity=0.368 Sum_probs=194.3
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecC---C--CcccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN---H--GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~---~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
+|.+.+.||+|+||.||++.+..... .+++|.+.. . .......+..|+.+++.++||||+++++++....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVA-----EERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCC-----cceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC
Confidence 48888999999999999998754322 144444332 1 1122345667899999999999999999987665
Q ss_pred cccceEEEEEeecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
..++||||+.+++|.+++.. .....+++..++.++.|++.||.|||+. |++|+||+|+||++++ +.++|+
T Consensus 76 ----~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~ 147 (260)
T cd08222 76 ----AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIG 147 (260)
T ss_pred ----ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeec
Confidence 45999999999999998854 2345689999999999999999999998 9999999999999975 669999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
|||++........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........ .......
T Consensus 148 d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~--~~~~~~~--- 220 (260)
T cd08222 148 DFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV--VLRIVEG--- 220 (260)
T ss_pred ccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHHcC---
Confidence 9999876433221 22345678899999999888899999999999999999999999965432111 1111100
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.....+..++.++.+++.+||+.+|++||++.++++|.|
T Consensus 221 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 259 (260)
T cd08222 221 ------------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259 (260)
T ss_pred ------------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence 011122345678999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=281.31 Aligned_cols=266 Identities=28% Similarity=0.395 Sum_probs=199.2
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
|+....||+|++|.||+|....+ +..+++|.+.... ......+..|+.+++.++|+|++++++++...+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~-----~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~---- 71 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKT-----GEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTER---- 71 (282)
T ss_pred CeeehcccccCcceEEEeeecCC-----CcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCC----
Confidence 56678899999999999986543 3469999987653 233456778999999999999999999988765
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+. ++|.+++.... ..+++..++.++.|++.||.|||+. +++||||+|+||++++++.++|+|||++.
T Consensus 72 ~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 72 KLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred ceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccc
Confidence 5699999997 59999986443 4689999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH-HHHHHhh-------
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK-LLEWVKQ------- 302 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~-~~~~~~~------- 302 (393)
....... ......++..|+|||.+.+. .++.++|||||||++|||++|..||.......... .......
T Consensus 147 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (282)
T cd07829 147 AFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWP 224 (282)
T ss_pred ccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHH
Confidence 6543221 12234567789999998766 78999999999999999999999997654322111 1111000
Q ss_pred ----cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 303 ----FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 303 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.+.....+.......... .....+..+.+++.+||..||++||++.+++.+.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~ 281 (282)
T cd07829 225 GVTKLPDYKPTFPKFPPKDLEK-VLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281 (282)
T ss_pred hhcccccccccccccCccchHH-hcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence 000000000000000000 11123678999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=283.18 Aligned_cols=280 Identities=26% Similarity=0.390 Sum_probs=206.1
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhc--CCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGV--VSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~ 149 (393)
...+.+.+||+|.||.||+|.+.. ..||||++.. .....+.+|-.|.+. ++|+||++|++.-...+..
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~-------~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDN-------RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred CchhhHHHhhcCccceeehhhccC-------ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 345566789999999999998753 3599999965 344567778777776 5799999999887666644
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC------CCCeEeccCCCCCeEeCCCCceE
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGL------EIQVIYRDFKTSNVLLDGNFKPK 223 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~------~~~ivH~Dikp~NIll~~~~~~k 223 (393)
....+||++|.+.|+|.+||.. ..++|.....++..+++||+|||... ..+|+|||||..||||..|++..
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 5577999999999999999943 46899999999999999999999763 35799999999999999999999
Q ss_pred EeeccCCccCCCCCCccccccccccCCccCccccccCC-CC-----chhhHHHHHHHHHHHHhCCCccCC-CCchhhhHH
Q 035862 224 LSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGH-LK-----SQSDIWSFGVVLYEILTGRRVLER-NRPTMEQKL 296 (393)
Q Consensus 224 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwslGvil~elltg~~pf~~-~~~~~~~~~ 296 (393)
|+|||+|..+..+......-..+||.+|||||++.+.. +. .+.||||+|.+||||++...-+.. ..+..+.-+
T Consensus 357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 99999998876554443444579999999999997642 22 368999999999999998766642 112111111
Q ss_pred HHHHhhcCcCCcccccccCcccccccCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcC
Q 035862 297 LEWVKQFPADGKKFSMMIDPRLRNQYSI-----NAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364 (393)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 364 (393)
...+..-|.-+.--...+.+..++..+. ....-+.+.+..||+.||+.|.|+.=+.+.++.+..-.+.
T Consensus 437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 1111111111110011112222222222 2345688999999999999999999999999888765543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=322.72 Aligned_cols=266 Identities=29% Similarity=0.493 Sum_probs=203.0
Q ss_pred HHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 68 REATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
+.....|.....||+|+||.||+|.+... +..||+|.+...... ...|++++++++||||+++++++...+
T Consensus 686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~ 756 (968)
T PLN00113 686 NDILSSLKEENVISRGKKGASYKGKSIKN-----GMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEK 756 (968)
T ss_pred HHHHhhCCcccEEccCCCeeEEEEEECCC-----CcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCC
Confidence 34456688889999999999999986433 346999988654321 234688999999999999999998776
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
. .++||||+++|+|.+++. .+++..+..++.|++.||+|||..+..+|+||||||+||+++.++..++. |
T Consensus 757 ~----~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~ 826 (968)
T PLN00113 757 G----AYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-L 826 (968)
T ss_pred C----CEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-e
Confidence 3 499999999999999983 37899999999999999999995444499999999999999999888875 6
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|....... .....+++.|+|||++.+..++.++|||||||++|||+||+.||...... ......|..... ..
T Consensus 827 ~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~-~~ 898 (968)
T PLN00113 827 SLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCY-SD 898 (968)
T ss_pred cccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhc-Cc
Confidence 65543211 12336789999999999999999999999999999999999999543221 122333333221 11
Q ss_pred cccccccCccccc--ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 308 KKFSMMIDPRLRN--QYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 308 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
.....++++.+.. ........++.+++.+||+.||++||++.++++.|+.+.+
T Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 2223334443322 2233455678899999999999999999999999998865
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=282.02 Aligned_cols=249 Identities=31% Similarity=0.440 Sum_probs=194.4
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
|.....||+|+||.||+|++..+ +..|++|.+..... .....+.+|+.+++.++|||++++++++...+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~-----~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 94 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHT-----NEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH--- 94 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCC-----CcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC---
Confidence 67778899999999999986433 34699998865422 22345778999999999999999999998776
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+. ++|.+++... ...+++..++.++.|++.||.|||+. |++|+||+|+||++++++.+||+|||++
T Consensus 95 -~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~ 168 (313)
T cd06633 95 -TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA 168 (313)
T ss_pred -EEEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCC
Confidence 5599999995 5787777543 34588999999999999999999998 9999999999999999999999999988
Q ss_pred ccCCCCCCccccccccccCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIE---TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
..... .....|+..|+|||++. ...++.++|||||||++|+|++|..||............ ... ..
T Consensus 169 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~--~~~-~~-- 237 (313)
T cd06633 169 SKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQN-DS-- 237 (313)
T ss_pred cccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--Hhc-CC--
Confidence 64322 12356888999999984 456888999999999999999999998765432211111 000 00
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
........+..+.+|+.+||+.+|.+||++.+++.+.+..
T Consensus 238 -----------~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~ 277 (313)
T cd06633 238 -----------PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR 277 (313)
T ss_pred -----------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence 0001112346789999999999999999999999986643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=293.49 Aligned_cols=245 Identities=25% Similarity=0.350 Sum_probs=198.8
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcC-CCCccceeeeeeecCCc
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 148 (393)
++..|.....+|.|+|+.|-.+.+..++. ..++|++.+...+ ..+|+.++... +||||+++.+++....
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~-----~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~- 389 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQ-----EPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGK- 389 (612)
T ss_pred cchhhccccccCCCCccceeeeecccccc-----chhheeccccccc----cccccchhhhhcCCCcceeecceecCCc-
Confidence 46789999999999999999988665554 4899998776222 23466565554 5999999999987766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe-CCCCceEEeec
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL-DGNFKPKLSDF 227 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll-~~~~~~kl~Df 227 (393)
+.++|||.+.|+-|.+.+.... .+. ..+..|+.+|+.|+.|||.+ |+|||||||+|||+ ++.|+++|+||
T Consensus 390 ---~~~~v~e~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyF 460 (612)
T KOG0603|consen 390 ---EIYLVMELLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYF 460 (612)
T ss_pred ---eeeeeehhccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEe
Confidence 5699999999999988884333 233 67788999999999999998 99999999999999 68999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|.++..... ....+-|..|.|||++....|+.++||||||++||+||+|+.||..+....+ +...+
T Consensus 461 G~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e--i~~~i------- 526 (612)
T KOG0603|consen 461 GFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE--IHTRI------- 526 (612)
T ss_pred chhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH--HHHhh-------
Confidence 999875443 2344678899999999999999999999999999999999999987654411 11111
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
........+|.++++|+.+||+.||.+||++.++..|.|.
T Consensus 527 ----------~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 527 ----------QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ----------cCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 1112224678999999999999999999999999999999
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=281.53 Aligned_cols=260 Identities=23% Similarity=0.328 Sum_probs=198.9
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc----ccHHHHHHHHHHhhcC-CCCccceeeeeeecCC
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL----QGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTED 147 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 147 (393)
.|++.+.||.|+||.||.|..... ...+..||+|.+..... .....+.+|+.++..+ +|+||+++++++....
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~--~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSG--HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccC--CCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC
Confidence 478889999999999999986422 12445799999865321 2235567899999999 5999999999887665
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+|||++.++.+||+||
T Consensus 79 ----~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 149 (290)
T cd05613 79 ----KLHLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDF 149 (290)
T ss_pred ----eEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeC
Confidence 56899999999999999854 34688999999999999999999998 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccC--CCCchhhHHHHHHHHHHHHhCCCccCCCCchh-hhHHHHHHhhcC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG--HLKSQSDIWSFGVVLYEILTGRRVLERNRPTM-EQKLLEWVKQFP 304 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltg~~pf~~~~~~~-~~~~~~~~~~~~ 304 (393)
|++......... ......|+..|+|||.+.+. .++.++||||||+++|+|++|..||....... ...........
T Consensus 150 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~- 227 (290)
T cd05613 150 GLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS- 227 (290)
T ss_pred ccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-
Confidence 998764332211 12245688999999998653 46789999999999999999999996432211 11111111000
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHHH
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKLAV 359 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~~~ 359 (393)
...++..++..+.+++.+||+.||++|| ++.+++.+.+...
T Consensus 228 --------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 273 (290)
T cd05613 228 --------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273 (290)
T ss_pred --------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccccc
Confidence 0011223457789999999999999997 8999999866543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=280.33 Aligned_cols=257 Identities=24% Similarity=0.347 Sum_probs=195.0
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc----ccHHHHHHHHHHhhcC-CCCccceeeeeeecCC
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL----QGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTED 147 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 147 (393)
+|++.+.||+|++|.||++...... ..+..|++|.+..... .....+.+|+.++..+ +||||+++++.+....
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~--~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGH--DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccc--cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC
Confidence 4788899999999999999864322 2345699998864321 2234567899999999 5999999999887665
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+||
T Consensus 79 ----~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df 149 (288)
T cd05583 79 ----KLHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDF 149 (288)
T ss_pred ----EEEEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEEC
Confidence 56899999999999998843 34688999999999999999999998 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCC--CCchhhHHHHHHHHHHHHhCCCccCCCCchh-hhHHHHHHhhcC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGH--LKSQSDIWSFGVVLYEILTGRRVLERNRPTM-EQKLLEWVKQFP 304 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltg~~pf~~~~~~~-~~~~~~~~~~~~ 304 (393)
|++......... ......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||....... ...........
T Consensus 150 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~- 227 (288)
T cd05583 150 GLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS- 227 (288)
T ss_pred cccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-
Confidence 998765433211 122346889999999987654 7889999999999999999999996432211 11111111000
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHH---HHHHHHH
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMN---QVVESLK 356 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~---~~l~~l~ 356 (393)
....+..++..+.+++.+||+.||++|||+. +++++++
T Consensus 228 --------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 228 --------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred --------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 0011223457789999999999999999965 4455554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=291.44 Aligned_cols=272 Identities=24% Similarity=0.329 Sum_probs=202.5
Q ss_pred HHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecC
Q 035862 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTE 146 (393)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 146 (393)
+..++|++...||+|++|.||+|.+..+ +..|++|.+.... ......+.+|+.+++.++|||++++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKT-----GRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPA 86 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCC-----CcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcc
Confidence 3467899999999999999999997543 3469999886532 22335567899999999999999999877654
Q ss_pred Cc--ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEE
Q 035862 147 DE--RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKL 224 (393)
Q Consensus 147 ~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 224 (393)
+. .....++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+. |++||||||+||++++++.++|
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL 159 (343)
T cd07851 87 SSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKI 159 (343)
T ss_pred ccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEE
Confidence 42 122469999999 6799998843 4589999999999999999999998 9999999999999999999999
Q ss_pred eeccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 225 SDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......... .......
T Consensus 160 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~--~~i~~~~ 232 (343)
T cd07851 160 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL--KRIMNLV 232 (343)
T ss_pred cccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHhc
Confidence 999999764322 233467889999998865 46789999999999999999999999765432211 1111110
Q ss_pred CcCCccc---------ccc---cCccccccc---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 304 PADGKKF---------SMM---IDPRLRNQY---SINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 304 ~~~~~~~---------~~~---~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
......+ ... +....+..+ ....+..+.+|+.+||+.||++|||+.+++.|.|...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~ 303 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccc
Confidence 0000000 000 000000000 0123678999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=306.81 Aligned_cols=258 Identities=29% Similarity=0.424 Sum_probs=190.1
Q ss_pred HHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
...++|+.+..||+||||.||+++++-++ ..||||++.-.. ........+|+..|++++|||||+++..+.+..
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDG-----r~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~ 550 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDG-----REYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVEST 550 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccc-----hhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccC
Confidence 45678999999999999999999965544 459999987653 233456789999999999999999986432100
Q ss_pred -----------------------------------------------------c--------------------------
Q 035862 148 -----------------------------------------------------E-------------------------- 148 (393)
Q Consensus 148 -----------------------------------------------------~-------------------------- 148 (393)
.
T Consensus 551 ~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~ 630 (1351)
T KOG1035|consen 551 AELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL 630 (1351)
T ss_pred CccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc
Confidence 0
Q ss_pred ------------------------------------ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHH
Q 035862 149 ------------------------------------RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEG 192 (393)
Q Consensus 149 ------------------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~ 192 (393)
....+||=||||+..+|.+++..+... -.....|.++++|++|
T Consensus 631 S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 631 SNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEG 709 (1351)
T ss_pred ccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHH
Confidence 003567889999887777776433322 1467889999999999
Q ss_pred HHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCC----------------CCCCccccccccccCCccCccc
Q 035862 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGP----------------TGDHTHVSTAVVGTYGYAAPEY 256 (393)
Q Consensus 193 l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~ 256 (393)
|.|+|+. |||||||||.||++++++.|||+|||+|.... .+......+..+||.-|+|||+
T Consensus 710 LaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 9999999 99999999999999999999999999998621 0111113457899999999999
Q ss_pred cccC---CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHH-HHHHhh--cCcCCcccccccCcccccccCHHHHHHH
Q 035862 257 IETG---HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKL-LEWVKQ--FPADGKKFSMMIDPRLRNQYSINAARRV 330 (393)
Q Consensus 257 ~~~~---~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l 330 (393)
+.+. .|+.|+|+|||||+++||+. ||. +.++... ..-++. +|.+ ..+.+ +..+.-
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~---TsMERa~iL~~LR~g~iP~~----~~f~~---------~~~~~e 847 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFG---TSMERASILTNLRKGSIPEP----ADFFD---------PEHPEE 847 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCC---chHHHHHHHHhcccCCCCCC----ccccc---------ccchHH
Confidence 9765 49999999999999999986 354 3333211 111111 1111 00111 122345
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 035862 331 AKLADNCLKKNPEERPTMNQVVES 354 (393)
Q Consensus 331 ~~li~~~l~~dp~~Rps~~~~l~~ 354 (393)
..+|+.||+.||.+|||+.++|+.
T Consensus 848 ~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHHHHHhcCCCccCCCHHHHhhc
Confidence 679999999999999999999975
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=270.26 Aligned_cols=256 Identities=27% Similarity=0.428 Sum_probs=197.7
Q ss_pred cccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhc-CCCCccceeeeeeecCCcccce
Q 035862 75 NRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGV-VSHPNLVKLLGYCSTEDERGIQ 152 (393)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~ 152 (393)
+-+..||.|+||+|++..++ ..++.+|||.++.... ...++++.|.+.... -+.||||++||.+..++.
T Consensus 67 qdlg~iG~G~fG~V~KM~hk-----~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd---- 137 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHK-----PSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD---- 137 (361)
T ss_pred HHHHHhcCCcchhhhhhhcC-----ccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc----
Confidence 33457999999999998865 3456799999987654 456678888876554 469999999998877764
Q ss_pred EEEEEeecCCCChHHH---HhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 153 RLLVYEYMPNRSLEDR---LFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~~---l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
+++-||.| ..+|+.+ .+......+++..+-.|....+.||.||-.. ..|+|||+||+|||++..|.+||||||+
T Consensus 138 cWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGI 214 (361)
T KOG1006|consen 138 CWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGI 214 (361)
T ss_pred eeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccc
Confidence 48899999 4476553 3455667899999999999999999999876 6899999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIET--GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
+..+...- ..+...|-..|||||.+.. ..|+.++|+||||++|||+.||..|+.......++.-.-.....|.
T Consensus 215 cGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~-- 289 (361)
T KOG1006|consen 215 CGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPI-- 289 (361)
T ss_pred hHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCe--
Confidence 97654322 3455678889999999853 4699999999999999999999999987655444322211111110
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
+. ...-..+.+..+..||.-||.+|-..||...++.++..
T Consensus 290 -----l~----~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~f 329 (361)
T KOG1006|consen 290 -----LL----FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPF 329 (361)
T ss_pred -----ec----CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCch
Confidence 00 11111246788999999999999999999999999854
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=305.65 Aligned_cols=147 Identities=28% Similarity=0.368 Sum_probs=127.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|.++++||+|+||.||+|.+... +..||+|++..... .....+..|+.++..++||||+++++++...+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNN-----SKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCC-----CcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence 46799999999999999999997643 34699999875432 22356778999999999999999998887666
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
+.|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||.. +|+||||||+|||++.++.+||+||
T Consensus 78 ----~~~lVmEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DF 148 (669)
T cd05610 78 ----NVYLVMEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDF 148 (669)
T ss_pred ----EEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeC
Confidence 56999999999999999843 34578899999999999999999998 9999999999999999999999999
Q ss_pred cCCc
Q 035862 228 GLAR 231 (393)
Q Consensus 228 g~a~ 231 (393)
|+++
T Consensus 149 Gls~ 152 (669)
T cd05610 149 GLSK 152 (669)
T ss_pred CCCc
Confidence 9885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=295.95 Aligned_cols=261 Identities=27% Similarity=0.389 Sum_probs=213.0
Q ss_pred HHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCccceeeeeeecCC
Q 035862 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTED 147 (393)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 147 (393)
...+.|++...||.|.+|.||+++.+.++ ...|+|++.... ....+...|..+|+... |||++.++|++...+
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~-----~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTG-----QLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecC-----ceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 34567999999999999999999966444 347788776654 23455667888998875 999999999886543
Q ss_pred c-ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 148 E-RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 148 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
. .+-+++||||||.||+..|++.+.....+.|..+..|++.++.|+.+||.+ .++|||||-.|||++.+|.|||+|
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvD 166 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVD 166 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEee
Confidence 3 345889999999999999999877788899999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHh
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-----GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK 301 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~ 301 (393)
||++..+...-. .....+|||.|||||++.. ..|+..+|+||||++..||.-|.+|+-+--+. ..+.
T Consensus 167 FGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------raLF 238 (953)
T KOG0587|consen 167 FGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------RALF 238 (953)
T ss_pred eeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh------hhhc
Confidence 999987654432 3467899999999999964 35788999999999999999999999754332 1111
Q ss_pred hcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
.+| .++......+...+.++.+||..||.+|..+||++.++++|.
T Consensus 239 ~Ip---------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hp 283 (953)
T KOG0587|consen 239 LIP---------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHP 283 (953)
T ss_pred cCC---------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence 121 223333444567889999999999999999999999999874
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=273.05 Aligned_cols=266 Identities=29% Similarity=0.393 Sum_probs=207.2
Q ss_pred HHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhc--CCCCccceeeeeeec
Q 035862 68 REATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGV--VSHPNLVKLLGYCST 145 (393)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~ 145 (393)
+-...+..+.+.||+|.||.||+|.++... ||||++.... ...+.+|.+|.+. ++|+||+.|++.-..
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wrGe~-------VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~ 276 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWRGED-------VAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNK 276 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccccCCc-------eEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhcccc
Confidence 344567888999999999999999998655 9999997643 3567788888876 689999999998887
Q ss_pred CCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeEeccCCCCCeEeCCCC
Q 035862 146 EDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEG-----LEIQVIYRDFKTSNVLLDGNF 220 (393)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-----~~~~ivH~Dikp~NIll~~~~ 220 (393)
+...-.+++||.+|.+.|+|.|||.. .+++....+.++..++.||++||.. ....|.|||||..||||..+|
T Consensus 277 ~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 277 DNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred CCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 77777899999999999999999943 5688999999999999999999964 345799999999999999999
Q ss_pred ceEEeeccCCccCCCCCCc--cccccccccCCccCccccccCC----C--CchhhHHHHHHHHHHHHhCC----------
Q 035862 221 KPKLSDFGLAREGPTGDHT--HVSTAVVGTYGYAAPEYIETGH----L--KSQSDIWSFGVVLYEILTGR---------- 282 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DiwslGvil~elltg~---------- 282 (393)
..-|+|+|+|......... ...+..+||.+|||||++...- + -..+||||||.++||++-..
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 9999999999876544221 2446679999999999995421 1 23589999999999998743
Q ss_pred CccCCC---CchhhhHHHHHHhhcCcCCcccccccCcccccccC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 035862 283 RVLERN---RPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYS-----INAARRVAKLADNCLKKNPEERPTMNQVVES 354 (393)
Q Consensus 283 ~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 354 (393)
.||.+- +++.++.. ..+..+.+++..+ ..+-..+.++++.||..+|.-|.|+-.+-+.
T Consensus 434 ~Pyyd~Vp~DPs~eeMr--------------kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKt 499 (513)
T KOG2052|consen 434 LPYYDVVPSDPSFEEMR--------------KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKT 499 (513)
T ss_pred CCcccCCCCCCCHHHHh--------------cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHH
Confidence 455332 22222110 1111122222222 2455778899999999999999999999999
Q ss_pred HHHHHh
Q 035862 355 LKLAVQ 360 (393)
Q Consensus 355 l~~~~~ 360 (393)
+.++.+
T Consensus 500 l~~l~~ 505 (513)
T KOG2052|consen 500 LAKLSN 505 (513)
T ss_pred HHHHhc
Confidence 988875
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=272.40 Aligned_cols=243 Identities=29% Similarity=0.399 Sum_probs=193.5
Q ss_pred ecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc---cHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEE
Q 035862 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ---GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLV 156 (393)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv 156 (393)
||.|+||.||++..... +..+++|.+...... ....+..|+.+++.++||||+++++.+...+ ..++|
T Consensus 1 lg~G~~~~v~~~~~~~~-----~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~v 71 (250)
T cd05123 1 LGKGSFGKVLLVRKKDT-----GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEE----KLYLV 71 (250)
T ss_pred CCCCCceEEEEEEECCC-----CcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCC----eeEEE
Confidence 69999999999986532 346999988764322 3446788999999999999999999887665 56999
Q ss_pred EeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCC
Q 035862 157 YEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236 (393)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 236 (393)
|||+.+++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 72 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 72 LEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 9999999999998433 4689999999999999999999998 9999999999999999999999999998765432
Q ss_pred CCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCc
Q 035862 237 DHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDP 316 (393)
Q Consensus 237 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (393)
. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... . ....... ..
T Consensus 147 ~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~--~-~~~~~~~---~~--------- 209 (250)
T cd05123 147 G--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK--E-IYEKILK---DP--------- 209 (250)
T ss_pred C--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--H-HHHHHhc---CC---------
Confidence 1 1223456788999999998888899999999999999999999999765431 1 1111110 00
Q ss_pred ccccccCHHHHHHHHHHHHHhcccCCCCCCCH---HHHHHHHH
Q 035862 317 RLRNQYSINAARRVAKLADNCLKKNPEERPTM---NQVVESLK 356 (393)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~---~~~l~~l~ 356 (393)
...+...+..+.+++.+||..||++||++ .++++|.|
T Consensus 210 ---~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~ 249 (250)
T cd05123 210 ---LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249 (250)
T ss_pred ---CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCC
Confidence 01112235788999999999999999999 77777653
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=292.92 Aligned_cols=263 Identities=27% Similarity=0.410 Sum_probs=220.5
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccce
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQ 152 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 152 (393)
....++||+|+||+||+|.+... .+.-+.+||+|++... ......++++|+.+|..+.|||++++++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pe-ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~----- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPE-GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST----- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecC-CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence 44567899999999999998766 4567788999998754 3445677899999999999999999999998775
Q ss_pred EEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 153 RLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
+-||++|+++|.|.++++... ..+-.+..+.|..||++||.|||.+ ++|||||-.+||||..-..+||.|||+++.
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~l 847 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKL 847 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhc
Confidence 368999999999999997644 4578888999999999999999998 999999999999999999999999999998
Q ss_pred CCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcccc
Q 035862 233 GPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311 (393)
Q Consensus 233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (393)
....+...........+.|||-|.+....|+.++|||||||++||++| |..|+..-......++.
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-------------- 913 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-------------- 913 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH--------------
Confidence 766655544445566778999999999999999999999999999998 88888765443333322
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
..+-+...+..++.+++.++.+||..|+..||+++++...+.....+..
T Consensus 914 ---e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 914 ---EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred ---hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 2333344566788999999999999999999999999999988766553
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=274.42 Aligned_cols=242 Identities=26% Similarity=0.416 Sum_probs=198.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc---cHHHHHHHHHHhhcCC-CCccceeeeeeecCC
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ---GHKQWLAEVQFLGVVS-HPNLVKLLGYCSTED 147 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 147 (393)
.+|..+.+||.|+||.|-+|.- ++....+|||++++.... ..+--+.|-++|.... -|.+++++.+|.+-+
T Consensus 349 tDFnFl~VlGKGSFGKVlLaer-----kgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAER-----KGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cccceEEEeccCccceeeeecc-----cCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 4699999999999999999974 445557999999876332 2222356777887765 678899999998888
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
.+|+||||+.||+|--.| ..-+.+.+..+..++..|+-||-+||++ ||++||||.+|||++.+|.+||+||
T Consensus 424 ----RLyFVMEyvnGGDLMyhi--QQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DF 494 (683)
T KOG0696|consen 424 ----RLYFVMEYVNGGDLMYHI--QQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADF 494 (683)
T ss_pred ----heeeEEEEecCchhhhHH--HHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeec
Confidence 569999999999998777 3445688889999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|++........ .....+|||.|+|||.+..++|+..+|.||+||+||||+.|++||++.++..... ..+..
T Consensus 495 GmcKEni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~--aI~eh----- 565 (683)
T KOG0696|consen 495 GMCKENIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ--AIMEH----- 565 (683)
T ss_pred ccccccccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH--HHHHc-----
Confidence 99986544433 3467899999999999999999999999999999999999999998765443221 11111
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT 347 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 347 (393)
.-.++..++.++..+.+..|.+.|.+|..
T Consensus 566 -----------nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 566 -----------NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -----------cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 12345567889999999999999999964
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=300.68 Aligned_cols=266 Identities=30% Similarity=0.471 Sum_probs=212.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCC--CceEEEEEEecCCCc-ccHHHHHHHHHHhhcCC-CCccceeeeeeecCC
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRG--EPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTED 147 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 147 (393)
++..+.+.||+|+||.|++|......... ....||+|.+..... ...+.+..|+++++.+. |+||+.++|+|...+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~ 375 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG 375 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence 34456669999999999999866444332 367899999876533 34567889999999986 999999999998854
Q ss_pred cccceEEEEEeecCCCChHHHHhhcC------------C--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCC
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRA------------Q--PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSN 213 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~N 213 (393)
.+++|+||+..|+|.++++... . ..++....+.++.||+.|++||++. ++|||||..+|
T Consensus 376 ----~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN 448 (609)
T KOG0200|consen 376 ----PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN 448 (609)
T ss_pred ----ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence 4599999999999999996544 0 1388889999999999999999998 99999999999
Q ss_pred eEeCCCCceEEeeccCCccCCCCCCcccccccc--ccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCc
Q 035862 214 VLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVV--GTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRP 290 (393)
Q Consensus 214 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~ 290 (393)
||++.+..+||+|||+++.....+..... ... -...|||||.+....|+.++||||+||+|||++| |..||.+-..
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 99999999999999999965554443211 112 2346999999999999999999999999999999 7788865221
Q ss_pred hhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 291 TMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
. ..+.+ .+.++.+...|..++.+++++++.||+.+|++||++.++.+.+...+++
T Consensus 528 ~--~~l~~--------------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 528 T--EELLE--------------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred H--HHHHH--------------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 1 11121 2233445556667889999999999999999999999999999997654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=270.42 Aligned_cols=228 Identities=21% Similarity=0.233 Sum_probs=179.1
Q ss_pred cCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEEEeecCC
Q 035862 83 GGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPN 162 (393)
Q Consensus 83 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~ 162 (393)
|.+|.||++.+..++. .|++|.+.... ...+|...+....||||+++++++...+ ..++||||+.+
T Consensus 4 g~~~~v~~~~~~~~~~-----~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~----~~~lv~e~~~~ 69 (237)
T cd05576 4 GVIDKVLLVMDTRTQQ-----TFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSED----SVFLVLQHAEG 69 (237)
T ss_pred cccceEEEEEEccCCc-----EEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCC----eEEEEEecCCC
Confidence 8899999999765443 59999987643 2233445555567999999999988765 56999999999
Q ss_pred CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCcccc
Q 035862 163 RSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS 242 (393)
Q Consensus 163 ~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 242 (393)
++|.+++... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++++|||.+...... .
T Consensus 70 ~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~ 139 (237)
T cd05576 70 GKLWSHISKF--LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----C 139 (237)
T ss_pred CCHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-----c
Confidence 9999998543 4589999999999999999999998 9999999999999999999999999987654322 1
Q ss_pred ccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCccccccc
Q 035862 243 TAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQY 322 (393)
Q Consensus 243 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (393)
....++..|+|||.+.+..++.++|+||+|+++|+|++|..|+........ .......
T Consensus 140 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------------------~~~~~~~ 197 (237)
T cd05576 140 DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------------------THTTLNI 197 (237)
T ss_pred ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------------------cccccCC
Confidence 233556789999999888899999999999999999999988753321100 0000012
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHHH
Q 035862 323 SINAARRVAKLADNCLKKNPEERPTM-----NQVVESLK 356 (393)
Q Consensus 323 ~~~~~~~l~~li~~~l~~dp~~Rps~-----~~~l~~l~ 356 (393)
+..++..+.+++.+||+.||++||++ .++++|.|
T Consensus 198 ~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~ 236 (237)
T cd05576 198 PEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236 (237)
T ss_pred cccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCC
Confidence 22356789999999999999999986 77776643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=269.09 Aligned_cols=271 Identities=26% Similarity=0.350 Sum_probs=226.0
Q ss_pred HHHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-cHHHHHHHHHHhhcCCCCccceeeeee
Q 035862 65 QELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-GHKQWLAEVQFLGVVSHPNLVKLLGYC 143 (393)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~ 143 (393)
.++.....+++...++-+|+||.||.|.++..+...+.+.|.+|.++....+ ....++.|...+..+.|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3444445678888899999999999999988777777778888888765333 345678899999999999999999999
Q ss_pred ecCCcccceEEEEEeecCCCChHHHHhh------cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC
Q 035862 144 STEDERGIQRLLVYEYMPNRSLEDRLFS------RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD 217 (393)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~ 217 (393)
.++.. .++.++.++.-|+|..++.. .....+...+...++.|++.|++|||+. ++||.||..+|.+|+
T Consensus 357 ie~~~---~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 357 IEDYA---TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID 430 (563)
T ss_pred eeccC---cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence 87654 56889999999999999962 1234567778889999999999999998 999999999999999
Q ss_pred CCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHH
Q 035862 218 GNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKL 296 (393)
Q Consensus 218 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~ 296 (393)
+...+||+|=.+++.+-..+..........+..||+||.+.+..|+.++|+|||||++|||+| |+.|+..-++.+....
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y 510 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY 510 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH
Confidence 999999999999998777766666666677889999999999999999999999999999999 8888876665443322
Q ss_pred HHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 297 LEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
+.++.+...|.+|+++++.++..||..+|++||+++++..-|..-
T Consensus 511 -----------------lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 511 -----------------LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred -----------------HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 223445555668999999999999999999999999998887543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=251.79 Aligned_cols=268 Identities=21% Similarity=0.350 Sum_probs=207.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 149 (393)
.++|++.+++|+|.++.||.|....+.+ .++||.+++- ..+.+.+|++||..+. ||||++++++..++...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~e-----K~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNE-----KCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK 108 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCc-----eEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence 4689999999999999999998654444 3899998763 3467889999999998 99999999998877665
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC-CceEEeecc
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN-FKPKLSDFG 228 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~Dfg 228 (393)
.+.+|+||+++.+...+. ++++...++.++.+++.||.|||+. ||+|||+||.|++|+.. -.++|+|+|
T Consensus 109 --tpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWG 178 (338)
T KOG0668|consen 109 --TPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWG 178 (338)
T ss_pred --CchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecc
Confidence 568999999887776654 5678888999999999999999999 99999999999999865 569999999
Q ss_pred CCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHH-----------
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKL----------- 296 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~----------- 296 (393)
+|.+...+... +..+.+..|..||++.. ..|+..-|+|||||++..|+..+.||-......++..
T Consensus 179 LAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el 255 (338)
T KOG0668|consen 179 LAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL 255 (338)
T ss_pred hHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence 99887665543 34577889999998865 6789999999999999999999999976655544422
Q ss_pred HHHHhhcCcC-CcccccccCccc--------ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 297 LEWVKQFPAD-GKKFSMMIDPRL--------RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 297 ~~~~~~~~~~-~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
...+..+... ...+..++.... ......-.++++.+|+.++|.+|-.+|+|++|++.|.....
T Consensus 256 ~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 256 YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 1122111111 011111111111 11111234688999999999999999999999999987654
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=278.08 Aligned_cols=255 Identities=25% Similarity=0.372 Sum_probs=211.4
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc---HHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG---HKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
..+++++..||.|+||.|-++...... ..+|+|++++..... ......|-.||..++.|.||++|..|.++.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~-----~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k 493 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQK-----ATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK 493 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccc-----hHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence 456778889999999999998865332 248899888764432 345678999999999999999999998777
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
+.|++||-|-||.|-..| +..+.+...+++.++..+++|++|||++ |||+|||||+|++++.+|-+||.||
T Consensus 494 ----yvYmLmEaClGGElWTiL--rdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDF 564 (732)
T KOG0614|consen 494 ----YVYMLMEACLGGELWTIL--RDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDF 564 (732)
T ss_pred ----hhhhhHHhhcCchhhhhh--hhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeeh
Confidence 669999999999999988 5556789999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|+|+....+..+ .+++|||.|.|||++.+...+.++|.||||+++|||++|.+||...++-....++ ++.+.
T Consensus 565 GFAKki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I--LkGid--- 636 (732)
T KOG0614|consen 565 GFAKKIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI--LKGID--- 636 (732)
T ss_pred hhHHHhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH--Hhhhh---
Confidence 999987666544 5679999999999999999999999999999999999999999987664332221 11110
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT-----MNQVVESLKLA 358 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~~l~~l~~~ 358 (393)
...+|..+.....+||+++-..+|.+|.. +.+|-+|-|..
T Consensus 637 -----------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 637 -----------KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred -----------hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 11233345677889999998999999986 88999998864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=279.58 Aligned_cols=254 Identities=26% Similarity=0.347 Sum_probs=199.0
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccH---HHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH---KQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
-|..++.||-|+||.|.++.-.++ ..+||+|.+.+.....+ .....|-.||.....+.||+||-.|.+.+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT-----~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd-- 702 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDT-----RALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-- 702 (1034)
T ss_pred ceEEEeeecccccceeEEEeecch-----hhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC--
Confidence 477788899999999999985443 45799999987643333 33567999999999999999999998888
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
.+|+||+|+.||++-.+|.. .+-+++..++.++..+..|+++.|.. |+|||||||+|||||.+|.|||+|||+
T Consensus 703 --nLYFVMdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGL 775 (1034)
T KOG0608|consen 703 --NLYFVMDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 775 (1034)
T ss_pred --ceEEEEeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccc
Confidence 56999999999999998854 45688999999999999999999998 999999999999999999999999999
Q ss_pred CccCC---------CCCCc-------------------------------cccccccccCCccCccccccCCCCchhhHH
Q 035862 230 AREGP---------TGDHT-------------------------------HVSTAVVGTYGYAAPEYIETGHLKSQSDIW 269 (393)
Q Consensus 230 a~~~~---------~~~~~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 269 (393)
+.-+. .++.. ...-..+||+.|+|||++....|+..+|.|
T Consensus 776 CTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdww 855 (1034)
T KOG0608|consen 776 CTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWW 855 (1034)
T ss_pred cccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhh
Confidence 86221 11000 011256999999999999999999999999
Q ss_pred HHHHHHHHHHhCCCccCCCCchhhh-HHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-
Q 035862 270 SFGVVLYEILTGRRVLERNRPTMEQ-KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT- 347 (393)
Q Consensus 270 slGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps- 347 (393)
|.|||||||+.|++||....+...+ .++.|-..+. -.+..+++.++.++|.++ +-+++.|..
T Consensus 856 s~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~---------------~~~~~~ls~e~~~li~kL-c~sad~RLGk 919 (1034)
T KOG0608|consen 856 SVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLH---------------IPYQGNLSKEALDLIQKL-CCSADSRLGK 919 (1034)
T ss_pred HhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccc---------------cccccccCHHHHHHHHHH-hcChhhhhcc
Confidence 9999999999999999887765433 3333332221 122235677888888774 467778863
Q ss_pred --HHHHHHHHH
Q 035862 348 --MNQVVESLK 356 (393)
Q Consensus 348 --~~~~l~~l~ 356 (393)
+++|-.|.+
T Consensus 920 ng~d~vKaHpf 930 (1034)
T KOG0608|consen 920 NGADQVKAHPF 930 (1034)
T ss_pred cchhhhhcCcc
Confidence 455666544
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=293.35 Aligned_cols=277 Identities=19% Similarity=0.220 Sum_probs=174.2
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecC--C
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTE--D 147 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~ 147 (393)
..++|++.+.||+|+||.||+|++..+.. ..+..||+|++...... .....+ .+....+.++..+...+... .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~-~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQS-KKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCcc-ccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 45789999999999999999999865421 23456999987653221 111111 12222233333322221110 0
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCC------------------CCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQP------------------TLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDF 209 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------------~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Di 209 (393)
......++||||+.+++|.+++...... ......+..++.||+.||.|||+. +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 1122569999999999999988543211 112344667999999999999998 9999999
Q ss_pred CCCCeEeCC-CCceEEeeccCCccCCCCCCccccccccccCCccCccccccC----------------------CCCchh
Q 035862 210 KTSNVLLDG-NFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG----------------------HLKSQS 266 (393)
Q Consensus 210 kp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~ 266 (393)
||+|||+++ ++.+||+|||++........ .......+++.|+|||.+... .++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999985 58999999999976533222 123456889999999966322 234567
Q ss_pred hHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccc----c--CHHHHHHHHHHHHHhccc
Q 035862 267 DIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQ----Y--SINAARRVAKLADNCLKK 340 (393)
Q Consensus 267 DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~--~~~~~~~l~~li~~~l~~ 340 (393)
|||||||++|||+++..++...... +.........+-..+.....+..... + .........+|+.+||++
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~----~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQ----FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHH----HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 9999999999999976654322111 11111100000000000001100000 0 001123456899999999
Q ss_pred CCCCCCCHHHHHHHHHHHH
Q 035862 341 NPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 341 dp~~Rps~~~~l~~l~~~~ 359 (393)
||++|||+.++++|.|...
T Consensus 437 dP~kR~ta~e~L~Hpff~~ 455 (566)
T PLN03225 437 KGRQRISAKAALAHPYFDR 455 (566)
T ss_pred CcccCCCHHHHhCCcCcCC
Confidence 9999999999999988754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=277.32 Aligned_cols=273 Identities=19% Similarity=0.224 Sum_probs=185.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCC-----------CCCCceEEEEEEecCCCcccHHH--------------HHHHH
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLD-----------GRGEPLVVAVKKLNNHGLQGHKQ--------------WLAEV 125 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----------~~~~~~~vavK~~~~~~~~~~~~--------------~~~E~ 125 (393)
.++|.+.++||+|+||.||+|.+...+ ....+..||||.+.......... ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999999753322 12344579999986543222222 23466
Q ss_pred HHhhcCCCCc-----cceeeeeeecCCc----ccceEEEEEeecCCCChHHHHhhcC----------------------C
Q 035862 126 QFLGVVSHPN-----LVKLLGYCSTEDE----RGIQRLLVYEYMPNRSLEDRLFSRA----------------------Q 174 (393)
Q Consensus 126 ~~l~~l~h~n-----iv~~~~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~ 174 (393)
.++..++|.+ +++++++|..... .....++||||+.+++|.+++.... .
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 6666676554 4677777654211 1124599999999999999885421 1
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCc
Q 035862 175 PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP 254 (393)
Q Consensus 175 ~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 254 (393)
..+++..++.++.|++.+|.|||+. +|+||||||+|||++.++.+||+|||++......... ......+++.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence 1245677889999999999999998 9999999999999999999999999999754332211 11223457899999
Q ss_pred cccccCC--------------------C--CchhhHHHHHHHHHHHHhCCC-ccCCCCchhh------hHHHHHHhhcCc
Q 035862 255 EYIETGH--------------------L--KSQSDIWSFGVVLYEILTGRR-VLERNRPTME------QKLLEWVKQFPA 305 (393)
Q Consensus 255 E~~~~~~--------------------~--~~~~DiwslGvil~elltg~~-pf~~~~~~~~------~~~~~~~~~~~~ 305 (393)
|.+.... | ..+.||||+||++|+|++|.. ||........ .....|.. ...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~-~~~ 458 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM-YKG 458 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh-hcc
Confidence 9875332 1 124799999999999999875 6643211100 01111110 000
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNP---EERPTMNQVVESLKLA 358 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp---~~Rps~~~~l~~l~~~ 358 (393)
....-......++...+|+.+||..+| .+|+|++++++|.|..
T Consensus 459 ----------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~ 504 (507)
T PLN03224 459 ----------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL 504 (507)
T ss_pred ----------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence 000001112346889999999999866 6899999999998864
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=254.50 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=198.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC---CcccHHHHHHHHHHhhcC-CCCccceeeeeeecC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH---GLQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTE 146 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 146 (393)
.++|..+++||+|+|+.|-++++..++ +.+|+|++++. ......-...|-.+..+. +||.+|.+..+|.++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~-----qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTD-----QIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccc-----eeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 578999999999999999999876555 47999998764 223333445566666665 599999999999888
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
. .+++|.||++||+|--.+ ..+..+|++.++.+...|+.||.|||+. ||++||||.+|+|++..|.+||+|
T Consensus 324 s----rlffvieyv~ggdlmfhm--qrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltd 394 (593)
T KOG0695|consen 324 S----RLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTD 394 (593)
T ss_pred c----eEEEEEEEecCcceeeeh--hhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecc
Confidence 7 669999999999997655 4566799999999999999999999998 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCC-----chhhhHHHHHHh
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNR-----PTMEQKLLEWVK 301 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~-----~~~~~~~~~~~~ 301 (393)
+|+++....... ..+..+|||.|.|||.+.+..|...+|.|+|||+++||+.|+.||+--. ...+.-+...
T Consensus 395 ygmcke~l~~gd--~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv-- 470 (593)
T KOG0695|consen 395 YGMCKEGLGPGD--TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV-- 470 (593)
T ss_pred cchhhcCCCCCc--ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--
Confidence 999986443332 3567899999999999999999999999999999999999999995321 1111111111
Q ss_pred hcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC------HHHHHHH
Q 035862 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT------MNQVVES 354 (393)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps------~~~~l~~ 354 (393)
++.+.++ .+..++-.+..+++..|++||.+|.. +.++-.|
T Consensus 471 -----------ilekqir--iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h 516 (593)
T KOG0695|consen 471 -----------ILEKQIR--IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSH 516 (593)
T ss_pred -----------Hhhhccc--ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcc
Confidence 1122221 22234556778999999999999964 4555554
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=255.94 Aligned_cols=273 Identities=25% Similarity=0.345 Sum_probs=202.8
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc-c
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER-G 150 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~ 150 (393)
.+-.+.||-|+||.||.+.+.. +++.|++|++..- ....-+.+.+|+++|..++|.|++..+++..-.... .
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPR-----dgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPR-----SGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFF 129 (449)
T ss_pred CCCCCcccccceeEEEeccCCC-----CccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHH
Confidence 3445679999999999998654 3445999988643 333456788999999999999999998876543321 1
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..+|.++|.+.. +|...| .....++...+.-+++||++||.|||+. +|.||||||+|+|++.|..+||||||++
T Consensus 130 qEiYV~TELmQS-DLHKII--VSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 130 QELYVLTELMQS-DLHKII--VSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred HHHHHHHHHHHh-hhhhee--ccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccc
Confidence 234778888844 888877 4556688889999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC---
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD--- 306 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--- 306 (393)
+.....+. ...+..+-|..|+|||++.| ..|+.++||||+|||+.||+..+..|....+-.+..++..+...|..
T Consensus 204 Rvee~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 204 RTWDQRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred cccchhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence 97644433 34556678999999999977 57999999999999999999999999887775554443322222211
Q ss_pred -----CcccccccC----cccc----cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 307 -----GKKFSMMID----PRLR----NQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 307 -----~~~~~~~~~----~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
|-+...+.. +.+. ...+.....+...++..++..||+.|.+..+.+.++..-
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 111111100 0000 001112335677889999999999999999999987653
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=250.55 Aligned_cols=242 Identities=31% Similarity=0.435 Sum_probs=191.4
Q ss_pred CCceEEEEEEcCCCCCCCceEEEEEEecCCCccc-HHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEEEeecCC
Q 035862 84 GFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-HKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPN 162 (393)
Q Consensus 84 ~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~ 162 (393)
+||.||+|.... .+..+++|.+....... ...+.+|++.++.++|+|++++++++.... ..++++||+.+
T Consensus 1 ~~g~v~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~l~~e~~~~ 71 (244)
T smart00220 1 SFGKVYLARDKK-----TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDED----KLYLVMEYCDG 71 (244)
T ss_pred CceEEEEEEECC-----CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC----EEEEEEeCCCC
Confidence 589999999754 23469999987665444 677889999999999999999999988765 55999999999
Q ss_pred CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCcccc
Q 035862 163 RSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS 242 (393)
Q Consensus 163 ~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 242 (393)
++|.+++.... .+++..++.++.+++.++.+||+. +++|+||+|.||++++++.++|+|||.+....... ..
T Consensus 72 ~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~ 143 (244)
T smart00220 72 GDLFDLLKKRG--RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LL 143 (244)
T ss_pred CCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc---cc
Confidence 99999985433 388999999999999999999998 99999999999999999999999999998754432 22
Q ss_pred ccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCccccccc
Q 035862 243 TAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQY 322 (393)
Q Consensus 243 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (393)
....++..|++||.+.+..++.++||||||+++|+|++|..||...... .............. ...
T Consensus 144 ~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~~~~~~~------------~~~ 209 (244)
T smart00220 144 TTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIGKPKPPF------------PPP 209 (244)
T ss_pred ccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhccCCCC------------ccc
Confidence 3456788999999998888999999999999999999999999753211 11111111110000 000
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 323 SINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 323 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
...++.++.+++.+||..+|++||++.+++++.+
T Consensus 210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~ 243 (244)
T smart00220 210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPF 243 (244)
T ss_pred cccCCHHHHHHHHHHccCCchhccCHHHHhhCCC
Confidence 0004578999999999999999999999998643
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=236.26 Aligned_cols=210 Identities=25% Similarity=0.353 Sum_probs=169.0
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-CcccHHHHHHHHHHhhcC-CCCccceeeeeeecCC
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTED 147 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 147 (393)
..+....+..||+|++|.|-+.++. .++.+.|+|.+... ..+..++.++|+.+.... ..|.+|.+||.+..+.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~-----~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHI-----QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeec-----cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 3445666678999999999877754 35568999998764 334566778888876664 5999999999877666
Q ss_pred cccceEEEEEeecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
. .++.||.|+ .+|..+-.. .....+++..+-+|+..+++||.|||++ ..++|||+||+||||+.+|++|+|
T Consensus 119 d----vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiC 191 (282)
T KOG0984|consen 119 D----VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKIC 191 (282)
T ss_pred c----EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEc
Confidence 4 388999994 488776532 3567799999999999999999999997 689999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCcccccc----CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhh
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET----GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ 294 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~ 294 (393)
|||.+..+.+.- ..+...|-..|||||.+.. ..|+.++||||||+++.||.+++.||+......++
T Consensus 192 DFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~q 261 (282)
T KOG0984|consen 192 DFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQ 261 (282)
T ss_pred ccccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHH
Confidence 999998764432 2233567889999998843 47999999999999999999999999876554443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=264.07 Aligned_cols=278 Identities=23% Similarity=0.300 Sum_probs=208.0
Q ss_pred ccHHHHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCC------Cc
Q 035862 62 FDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH------PN 135 (393)
Q Consensus 62 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~n 135 (393)
|...--+..-++|.+....|+|-|++|..|.+...+. .||||++.... ...+.=+.|++||+.|+. -|
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~-----~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQ-----EVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCC-----eeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhH
Confidence 3333334455789999999999999999998654333 69999998754 334455689999999862 47
Q ss_pred cceeeeeeecCCcccceEEEEEeecCCCChHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCe
Q 035862 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR-AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNV 214 (393)
Q Consensus 136 iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NI 214 (393)
++.++..|...+ ++|||+|-+ ..+|.+.|... .+-++....+..++.|+..||..|-.. ||+|.||||+||
T Consensus 496 clrl~r~F~hkn----HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNi 567 (752)
T KOG0670|consen 496 CLRLFRHFKHKN----HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNI 567 (752)
T ss_pred HHHHHHHhhhcc----eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccce
Confidence 899988887776 789999999 66999998543 345688899999999999999999987 999999999999
Q ss_pred EeCCCC-ceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhh
Q 035862 215 LLDGNF-KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTME 293 (393)
Q Consensus 215 ll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~ 293 (393)
||++.. .+||||||.|......+. +.+.-+..|.|||++.|..|+...|+||+||+||||.||+..|++......
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M 643 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM 643 (752)
T ss_pred EeccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH
Confidence 998774 589999999987655443 345567799999999999999999999999999999999999987655433
Q ss_pred hHH-HHHHhhcCcC---------------------------Ccc-cccc--cCc------cccc--ccC---HHHHHHHH
Q 035862 294 QKL-LEWVKQFPAD---------------------------GKK-FSMM--IDP------RLRN--QYS---INAARRVA 331 (393)
Q Consensus 294 ~~~-~~~~~~~~~~---------------------------~~~-~~~~--~~~------~~~~--~~~---~~~~~~l~ 331 (393)
..+ .+....+|-. +.. ...+ +.+ .+.. .++ ...-.++.
T Consensus 644 Lrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~r 723 (752)
T KOG0670|consen 644 LRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLR 723 (752)
T ss_pred HHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHH
Confidence 222 2211111110 000 0000 000 0000 011 23456789
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 332 KLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 332 ~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
+|+.+||..||++|.|+.++|.|+..
T Consensus 724 dLLdkml~LdP~KRit~nqAL~HpFi 749 (752)
T KOG0670|consen 724 DLLDKMLILDPEKRITVNQALKHPFI 749 (752)
T ss_pred HHHHHHhccChhhcCCHHHHhcCCcc
Confidence 99999999999999999999998754
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=243.13 Aligned_cols=269 Identities=25% Similarity=0.318 Sum_probs=197.8
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.+|..++.+|.|.- .|..|.+.- ....|++|++... .....++..+|...+..++|+||++++.+|.-....
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v-----~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQV-----LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhh-----ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 46888888999987 666665433 3345999987654 223456678999999999999999999998643321
Q ss_pred --cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 150 --GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 150 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
....|+|||++ ..+|...+. -.++-..+..++.|++.|+.|||+. ||+||||||+||++..++.+||.||
T Consensus 91 ~~~~e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~df 162 (369)
T KOG0665|consen 91 EEFQEVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDF 162 (369)
T ss_pred HHHHhHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccc
Confidence 12348999999 559988874 3466778899999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhh--------------
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTME-------------- 293 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~-------------- 293 (393)
|+|+..... ...+..+.+..|.|||++.+..|...+||||+||++.||++|...|.+...-.+
T Consensus 163 g~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 163 GLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred hhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence 999864332 355678999999999999998899999999999999999999999975422111
Q ss_pred --hHHHHHHhhcCcC-----CcccccccCcc-cccc--cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 294 --QKLLEWVKQFPAD-----GKKFSMMIDPR-LRNQ--YSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 294 --~~~~~~~~~~~~~-----~~~~~~~~~~~-~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
..+....+.+..+ +..+.+.+... .+.. .+.--+..+.+++.+||..||++|.|++++|.|+..
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~ 313 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI 313 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence 1111111111110 01112211111 1111 111224567899999999999999999999999754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=273.17 Aligned_cols=245 Identities=25% Similarity=0.352 Sum_probs=182.4
Q ss_pred ccceecccCCce-EEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCccceeeeeeecCCcccceE
Q 035862 76 RMLKIGEGGFGS-VYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 76 ~~~~lg~G~~g~-Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 153 (393)
-.+.+|.|+-|+ ||+|.+.. +.||||.+-... ...+.+|+..|+.-. |||||++++.-.+.. ++
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~ye~-------R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~q----F~ 578 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVYEG-------REVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQ----FL 578 (903)
T ss_pred cHHHcccCCCCcEEEEEeeCC-------ceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCc----eE
Confidence 334688998875 79998642 359999886533 345678999999886 999999975544333 77
Q ss_pred EEEEeecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC---C--CceEEee
Q 035862 154 LLVYEYMPNRSLEDRLFSR--AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG---N--FKPKLSD 226 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~--~~~kl~D 226 (393)
|+..|.| ..+|.+++... ..........+....|+++||++||+. +||||||||.||||+. + ..++|+|
T Consensus 579 YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSD 654 (903)
T KOG1027|consen 579 YIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISD 654 (903)
T ss_pred EEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecc
Confidence 9999999 55999999653 111111134578899999999999998 9999999999999965 3 4689999
Q ss_pred ccCCccCCCCCCc-cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhC-CCccCCCCchhhhHHHHHHhhcC
Q 035862 227 FGLAREGPTGDHT-HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTG-RRVLERNRPTMEQKLLEWVKQFP 304 (393)
Q Consensus 227 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~ 304 (393)
||+++....+... .......||.+|+|||++....-+.++|||||||++|+.++| .+||.+........+
T Consensus 655 fglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl-------- 726 (903)
T KOG1027|consen 655 FGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL-------- 726 (903)
T ss_pred cccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh--------
Confidence 9999987654332 234567899999999999988888899999999999998886 899986532211110
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
.....+.. .....++ ++.+||.+|++++|..||++.+++.|+
T Consensus 727 ~~~~~L~~-------L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 727 TGNYTLVH-------LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred cCccceee-------eccCchH--HHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 00000000 0001111 789999999999999999999999984
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=258.53 Aligned_cols=255 Identities=24% Similarity=0.324 Sum_probs=203.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|..+..+|.|++|.||++++..++ ...|+|+++-.......-..+|+-+++..+||||+.+++.+...+.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~-----elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk-- 86 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSG-----ELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-- 86 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccC-----chhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC--
Confidence 467999999999999999999975444 4689998887666666777889999999999999999999988874
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
+++.||||.||+|++.- ...+.+++.++....+..+.||+|||+. |=+|||||-.|||+++.|.+|++|||.+
T Consensus 87 --lwicMEycgggslQdiy--~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 87 --LWICMEYCGGGSLQDIY--HVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred --cEEEEEecCCCccccee--eecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCch
Confidence 49999999999999865 4456789999999999999999999998 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYI---ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
......-. ....+.||+.|||||+. ..+.|.+.+|||++|++..|+-..++|..+.-+-... ..+..--++.
T Consensus 160 aqitati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l---~LmTkS~~qp 234 (829)
T KOG0576|consen 160 AQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL---FLMTKSGFQP 234 (829)
T ss_pred hhhhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH---HHhhccCCCC
Confidence 75433221 33567999999999976 4578999999999999999999888876543221111 1111100000
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 354 (393)
....-....++.+.+|++.+|.++|++||+++.++.|
T Consensus 235 ----------p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 235 ----------PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred ----------CcccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 0111122356789999999999999999999999886
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=251.57 Aligned_cols=198 Identities=27% Similarity=0.403 Sum_probs=168.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc--------cHHHHHHHHHHhhcCC---CCcccee
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ--------GHKQWLAEVQFLGVVS---HPNLVKL 139 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---h~niv~~ 139 (393)
..+|..++.+|.|+||.|++|.++.. ...|++|.+.+...- .....-.|++||..++ |+||+++
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n-----~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl 634 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKEN-----NYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL 634 (772)
T ss_pred cccceeeeeccccccceEEEeeeccc-----ceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence 45699999999999999999997533 457999998775321 1112346999999998 9999999
Q ss_pred eeeeecCCcccceEEEEEeec-CCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC
Q 035862 140 LGYCSTEDERGIQRLLVYEYM-PNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG 218 (393)
Q Consensus 140 ~~~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~ 218 (393)
+++|.+++ +.||+||-- +|-+|.++| .-.+.+.+..+..|+.|++.|+++||++ ||||||||-+|+.++.
T Consensus 635 LdfFEddd----~yyl~te~hg~gIDLFd~I--E~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~ 705 (772)
T KOG1152|consen 635 LDFFEDDD----YYYLETEVHGEGIDLFDFI--EFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDS 705 (772)
T ss_pred hheeecCC----eeEEEecCCCCCcchhhhh--hccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEec
Confidence 99999888 458999865 566899998 4556799999999999999999999999 9999999999999999
Q ss_pred CCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCC-chhhHHHHHHHHHHHHhCCCccC
Q 035862 219 NFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLK-SQSDIWSFGVVLYEILTGRRVLE 286 (393)
Q Consensus 219 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltg~~pf~ 286 (393)
+|-+||+|||.+.....+. ...++||..|.|||++.|..|- ..-|||+||++||.++....||.
T Consensus 706 ~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 706 NGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999999999997654443 4568999999999999998774 55899999999999999988875
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=223.47 Aligned_cols=212 Identities=39% Similarity=0.618 Sum_probs=179.3
Q ss_pred ecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-cHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEEEe
Q 035862 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYE 158 (393)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv~e 158 (393)
||+|++|.||++.... .+..+++|........ ....+.+|+..++.+.|++++++++++.... ..+++||
T Consensus 1 l~~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~~~~e 71 (215)
T cd00180 1 LGEGGFGTVYLARDKK-----TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN----HLYLVME 71 (215)
T ss_pred CCcCCceEEEEEEecC-----CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC----eEEEEEe
Confidence 6899999999998653 2345999998765432 3467889999999999999999999998764 5599999
Q ss_pred ecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC-CCceEEeeccCCccCCCCC
Q 035862 159 YMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG-NFKPKLSDFGLAREGPTGD 237 (393)
Q Consensus 159 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~~~~~~ 237 (393)
|+.+++|.+++.... ..++...++.++.+++.++.+||+. +++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 72 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 72 YCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred cCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence 999899999985432 4588999999999999999999998 9999999999999999 8999999999997654332
Q ss_pred CccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCc
Q 035862 238 HTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDP 316 (393)
Q Consensus 238 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (393)
. ......+...|++||.+... .++.++|+|++|+++++|
T Consensus 148 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------- 187 (215)
T cd00180 148 S--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------- 187 (215)
T ss_pred c--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------
Confidence 1 12335678899999999877 888999999999999999
Q ss_pred ccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 317 RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
..+.+++..|++.+|.+||++.++++++
T Consensus 188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -----------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -----------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 3467899999999999999999998764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=226.84 Aligned_cols=257 Identities=20% Similarity=0.362 Sum_probs=187.8
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCccceeeee-eecCC
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGY-CSTED 147 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~~~ 147 (393)
..+.|.+.+.||+|.||.+-++.++... ..+++|-+...- .....|.+|...--.+. |.||+.-|++ |...+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~-----t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSK-----TRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCc-----eEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 3567999999999999999999976544 458999887653 45677889988776676 8999988765 44444
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC--CCCceEEe
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD--GNFKPKLS 225 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~--~~~~~kl~ 225 (393)
..++++||++.|+|.+-+ ...++-+.....++.|+++|+.|+|++ ++||||||.+||||- +...+|||
T Consensus 96 ----~YvF~qE~aP~gdL~snv---~~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlc 165 (378)
T KOG1345|consen 96 ----AYVFVQEFAPRGDLRSNV---EAAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLC 165 (378)
T ss_pred ----eEEEeeccCccchhhhhc---CcccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEee
Confidence 448899999999998766 345688889999999999999999999 999999999999993 34579999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccC-----CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHH
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG-----HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~ 300 (393)
|||+++..+..- .....+..|.+||+.... ...+.+|||.||+++|.++||+.||.... ..++-..+|.
T Consensus 166 DFG~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~ 239 (378)
T KOG1345|consen 166 DFGLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWE 239 (378)
T ss_pred ecccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHH
Confidence 999997643321 223446679999977432 34678999999999999999999998432 2233333333
Q ss_pred hhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHHHHH
Q 035862 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER---PTMNQVVESLKL 357 (393)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~~~l~~l~~ 357 (393)
.-...-..... +.. ...++.+..+.++-|..++++| .+++...+.+|.
T Consensus 240 ~w~~rk~~~~P----~~F-----~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 240 QWLKRKNPALP----KKF-----NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred HHhcccCccCc----hhh-----cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 21111000000 000 1245778889999999999999 555555555554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=240.16 Aligned_cols=274 Identities=26% Similarity=0.349 Sum_probs=201.3
Q ss_pred HHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCccceeeeeeec
Q 035862 67 LREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCST 145 (393)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 145 (393)
+....+.|..+.+||+|+|++||++.+... ......||+|.+...+. ..+..+|+++|..+. +.||+++.+++..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~--~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQ--DTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhh--ccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 445567799999999999999999987652 33556799999987643 456889999999987 9999999999988
Q ss_pred CCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC-CceEE
Q 035862 146 EDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN-FKPKL 224 (393)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl 224 (393)
.+ +.++|+||++.....++. ..++...+..+++.++.||.++|.+ |||||||||.|+|.+.. +.-.|
T Consensus 107 nd----~v~ivlp~~~H~~f~~l~-----~~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~L 174 (418)
T KOG1167|consen 107 ND----QVAIVLPYFEHDRFRDLY-----RSLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVL 174 (418)
T ss_pred CC----eeEEEecccCccCHHHHH-----hcCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceE
Confidence 88 459999999999988887 3466888999999999999999999 99999999999999754 67899
Q ss_pred eeccCCccC-----------------CC-CCC------------------------ccccccccccCCccCcccccc-CC
Q 035862 225 SDFGLAREG-----------------PT-GDH------------------------THVSTAVVGTYGYAAPEYIET-GH 261 (393)
Q Consensus 225 ~Dfg~a~~~-----------------~~-~~~------------------------~~~~~~~~gt~~y~aPE~~~~-~~ 261 (393)
+|||+|... .. ... ........||++|.|||++.. ..
T Consensus 175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~ 254 (418)
T KOG1167|consen 175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR 254 (418)
T ss_pred EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence 999998610 00 000 001124589999999998854 66
Q ss_pred CCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHH----------HHHhhcCc-----CCc----------ccccc---
Q 035862 262 LKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL----------EWVKQFPA-----DGK----------KFSMM--- 313 (393)
Q Consensus 262 ~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~----------~~~~~~~~-----~~~----------~~~~~--- 313 (393)
.+.++||||.|||+..+++++.||-........... ......+. +.. .+..+
T Consensus 255 QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~ 334 (418)
T KOG1167|consen 255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIE 334 (418)
T ss_pred cCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChh
Confidence 789999999999999999999999654433221100 00000000 000 00000
Q ss_pred -cCc--c--c-ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 314 -IDP--R--L-RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 314 -~~~--~--~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
+.+ . . ........+..+.+|+++||+.||.+|.|++++|+|..
T Consensus 335 ~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF 383 (418)
T KOG1167|consen 335 SIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF 383 (418)
T ss_pred hcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence 000 0 0 11111234457899999999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-29 Score=218.33 Aligned_cols=200 Identities=34% Similarity=0.464 Sum_probs=168.4
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-cHHHHHHHHHHhhcCCCCccceeeeeeecCCcccce
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQ 152 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 152 (393)
|.+.+.||.|++|.||++.....+ ..+++|........ ....+.+|++.++.++|+|++++++++...+ .
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~-----~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~----~ 71 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTG-----ELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPE----P 71 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCC-----cEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCC----c
Confidence 566788999999999999875433 35999999876544 5677888999999999999999999987765 4
Q ss_pred EEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 153 RLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
.++++|++.+++|.+++...... +++..++.++.+++.++.+||+. +++|+||+|.||+++.++.++|+|||.+..
T Consensus 72 ~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~ 147 (225)
T smart00221 72 LYLVMEYCEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARF 147 (225)
T ss_pred eEEEEeccCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence 59999999999999998543321 78899999999999999999998 999999999999999999999999999887
Q ss_pred CCCCCCccccccccccCCccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCccCC
Q 035862 233 GPTGDHTHVSTAVVGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGRRVLER 287 (393)
Q Consensus 233 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~elltg~~pf~~ 287 (393)
....... ......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 148 ~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 148 IHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 5443200 12345678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=262.58 Aligned_cols=205 Identities=17% Similarity=0.203 Sum_probs=142.9
Q ss_pred cCCC-CccceeeeeeecCC---cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeE
Q 035862 130 VVSH-PNLVKLLGYCSTED---ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVI 205 (393)
Q Consensus 130 ~l~h-~niv~~~~~~~~~~---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~iv 205 (393)
.++| +||+.++++|.... .....+++++||+ +++|.++|... ...+++..++.++.||+.||.|||++ ||+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 3455 57888888763222 1112346778887 66999999543 34589999999999999999999998 999
Q ss_pred eccCCCCCeEeCCCC-------------------ceEEeeccCCccCCCCCC--------------ccccccccccCCcc
Q 035862 206 YRDFKTSNVLLDGNF-------------------KPKLSDFGLAREGPTGDH--------------THVSTAVVGTYGYA 252 (393)
Q Consensus 206 H~Dikp~NIll~~~~-------------------~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y~ 252 (393)
||||||+||||+..| .+|++|||+++....... .......+||+.|+
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 999999999996544 455666666543211000 00011246889999
Q ss_pred CccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHH
Q 035862 253 APEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAK 332 (393)
Q Consensus 253 aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 332 (393)
|||++.+..|+.++|||||||+||||++|.+|+....... ....... ..+.. ........+
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~----~~~~~~~----------~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTM----SSLRHRV----------LPPQI-----LLNWPKEAS 243 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHH----HHHHHhh----------cChhh-----hhcCHHHHH
Confidence 9999999999999999999999999999988765321111 1110000 00000 011234568
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 333 LADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 333 li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
++..||+++|.+||++.++++|.+..
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h~~~~ 269 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQSEFIN 269 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhchhhh
Confidence 89999999999999999999998754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-28 Score=205.35 Aligned_cols=170 Identities=25% Similarity=0.268 Sum_probs=129.9
Q ss_pred CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCcccc
Q 035862 163 RSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS 242 (393)
Q Consensus 163 ~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 242 (393)
|+|.+++... ...+++..++.++.|++.||.|||++ + ||+|||++.++.+|+ ||++......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~------ 62 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE------ 62 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc------
Confidence 6899988643 34699999999999999999999997 6 999999999999999 9998764332
Q ss_pred ccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCccccccc
Q 035862 243 TAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQY 322 (393)
Q Consensus 243 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (393)
...|++.|+|||++.+..++.++|||||||++|||++|+.||....... ..+........... +. ....
T Consensus 63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~--------~~-~~~~ 131 (176)
T smart00750 63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMPADD--------PR-DRSN 131 (176)
T ss_pred -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhccCC--------cc-cccc
Confidence 2268899999999999999999999999999999999999996543211 11111111111100 00 0011
Q ss_pred CHHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 323 SINAAR--RVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 323 ~~~~~~--~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
....+. ++.+++.+||..+|.+||++.+++++++.....
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 123333 699999999999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.9e-26 Score=210.89 Aligned_cols=264 Identities=25% Similarity=0.227 Sum_probs=200.4
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCC----Cccceeeeeee-cCC
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH----PNLVKLLGYCS-TED 147 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~~-~~~ 147 (393)
+|.+.++||+|+||.||.+.+.... ...+|+|............+..|..++..+.. +++..+++... ...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~----~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK----NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC----CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence 7999999999999999999865432 44688888776533332356678888888863 58888888774 333
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC-----Cce
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN-----FKP 222 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-----~~~ 222 (393)
+.++||+.+ |.+|.++........++..++..++.|++.+|.+||+. |++||||||+|+++... -.+
T Consensus 95 ----~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 95 ----FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred ----eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceE
Confidence 559999999 88999987656667899999999999999999999998 99999999999999765 359
Q ss_pred EEeeccCCc--cCCCCCCc---cc---cccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhh-
Q 035862 223 KLSDFGLAR--EGPTGDHT---HV---STAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTME- 293 (393)
Q Consensus 223 kl~Dfg~a~--~~~~~~~~---~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~- 293 (393)
.|.|||+++ ........ .. .....||..|+++.+..+...+.+.|+||++.++.+++.|..||........
T Consensus 167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~ 246 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK 246 (322)
T ss_pred EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH
Confidence 999999998 32222211 11 1245699999999999999999999999999999999999999966543322
Q ss_pred hHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 294 QKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
..+........... .....+..+..+...+-..+..++|....+...+.......
T Consensus 247 ~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 247 SKFEKDPRKLLTDR--------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHHHhhhhcccc--------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 12211111111100 11123466777777777799999999999999998888766
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=193.03 Aligned_cols=264 Identities=19% Similarity=0.207 Sum_probs=201.2
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCccceeeeeeecCCcccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 151 (393)
.|.+.++||+|+||.++.|...-.. ..||||.-...+. ..++..|.+..+.+. .++|...+-+..+.-
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nn-----e~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~---- 97 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNN-----EPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGK---- 97 (449)
T ss_pred cceeccccccCcceeeecccccccC-----ceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccc----
Confidence 5999999999999999999865443 4699998765432 356777888888886 788888876654433
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC-----ceEEee
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF-----KPKLSD 226 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-----~~kl~D 226 (393)
+-.||+|.+ |.+|+|++ .-+...++..++..++.|++.-++|+|.+ .+|.|||||+|+||...+ .|.++|
T Consensus 98 ~NiLVidLL-GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred hhhhhhhhh-CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEe
Confidence 458999999 88999954 56778899999999999999999999999 999999999999996544 489999
Q ss_pred ccCCccCCCCCCcc-----ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHh
Q 035862 227 FGLAREGPTGDHTH-----VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK 301 (393)
Q Consensus 227 fg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~ 301 (393)
||+|+...+..... ...+..||..||+.....+.+.+.+.|+-|||-++++.|-|..||.+-.........+...
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG 252 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG 252 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc
Confidence 99998766554332 2346789999999999999999999999999999999999999997654322221111110
Q ss_pred hcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
. ... ..-....-.+++.++...+.-.=+.+-.+-|..+-+...+..++...
T Consensus 253 e---~Kr-------~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 253 E---TKR-------STPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred c---ccc-------cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 0 000 00001111245678888888888888899999988888887777543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-27 Score=229.34 Aligned_cols=264 Identities=22% Similarity=0.226 Sum_probs=192.0
Q ss_pred cccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-c-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccce
Q 035862 75 NRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-L-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQ 152 (393)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 152 (393)
.....+|.|++|.|+.+.............+.++ ..... . .....+..|+.+-..++|||++..+..+......
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~--- 396 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI--- 396 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc---
Confidence 4566799999998888776544444333334433 21111 0 1111245677788889999998887777665543
Q ss_pred EEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 153 RLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
.-+||||++ +|..++.. ...+....+..++.||+.|+.|+|.. ||.|||+|++|++++.+|.+||+|||.+..
T Consensus 397 -~~~mE~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~v 469 (601)
T KOG0590|consen 397 -LQSMEYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASV 469 (601)
T ss_pred -hhhhhcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCccee
Confidence 334999999 99998843 34577888899999999999999998 999999999999999999999999999976
Q ss_pred CCCCCCc--cccccccccCCccCccccccCCCCc-hhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 233 GPTGDHT--HVSTAVVGTYGYAAPEYIETGHLKS-QSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 233 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+...... ......+|+..|+|||++.+..|++ ..||||.|++++.|.+|+.||........+.. . ......
T Consensus 470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-~--~~~~~~--- 543 (601)
T KOG0590|consen 470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-T--NNYSDQ--- 543 (601)
T ss_pred eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-h--hccccc---
Confidence 5544443 4556789999999999999999986 58999999999999999999976543322110 0 000000
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.-...-.......++.....+|.+||+.||.+|.|+++|++.-|..
T Consensus 544 ---~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~ 589 (601)
T KOG0590|consen 544 ---RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIR 589 (601)
T ss_pred ---cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhh
Confidence 0000011112235677889999999999999999999999987754
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=185.65 Aligned_cols=261 Identities=22% Similarity=0.261 Sum_probs=192.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCC-CccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH-PNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~ 149 (393)
.+.|.++++||+|+||.+|.|.....+. .||+|+-.... ...++..|.++.+.+++ ..|..+..+..+..
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge-----~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~-- 84 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGE-----EVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKD-- 84 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCc-----eEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccc--
Confidence 4679999999999999999999765554 49999987653 33557779999998884 45555555565555
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC---CceEEee
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN---FKPKLSD 226 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~D 226 (393)
+-.+||+.+ |.+|++++ +-....++..+++.++.|++.-++|+|.. +.+||||||+|+|..-+ ..+.|+|
T Consensus 85 --ynvlVMdLL-GPsLEdLf-nfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LID 157 (341)
T KOG1163|consen 85 --YNVLVMDLL-GPSLEDLF-NFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLID 157 (341)
T ss_pred --cceeeeecc-CccHHHHH-HHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEe
Confidence 348999999 88999965 44566789999999999999999999998 99999999999999644 4699999
Q ss_pred ccCCccCCCCCCcc-----ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHh
Q 035862 227 FGLAREGPTGDHTH-----VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK 301 (393)
Q Consensus 227 fg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~ 301 (393)
||+|+..-+..... ......||..|.+-....+...+.+.|+-|+|.+|..+.-|..||.+-.....+...+...
T Consensus 158 FGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~ 237 (341)
T KOG1163|consen 158 FGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS 237 (341)
T ss_pred ccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH
Confidence 99998654432221 2345689999999988888889999999999999999999999998766554433222221
Q ss_pred hcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
..... ..+ ...-...|.++.-.+.-|=..--++-|...-+-+.+.-
T Consensus 238 EkK~s-----~~i-----e~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 238 EKKMS-----TPI-----EVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred HhhcC-----CCH-----HHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 11110 000 00111235667777777777777777776655554443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=204.52 Aligned_cols=168 Identities=18% Similarity=0.121 Sum_probs=127.2
Q ss_pred HHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-----CcccHHHHHHHHHHhhcCCCCccce-eeee
Q 035862 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-----GLQGHKQWLAEVQFLGVVSHPNLVK-LLGY 142 (393)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-~~~~ 142 (393)
...++|.+.+.||+|+||+||+|.+... .+..+|+|++... .......+.+|+++|+.++|+|++. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~----~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGD----PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCC----CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 3456899999999999999999986532 2335799986533 1123456889999999999999985 4432
Q ss_pred eecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC-CCCCeEeCCCCc
Q 035862 143 CSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDF-KTSNVLLDGNFK 221 (393)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Di-kp~NIll~~~~~ 221 (393)
+ ..++||||++|++|.. + ... . ...++.|++.||.|||+. ||+|||| ||+|||++.++.
T Consensus 91 ----~----~~~LVmE~~~G~~L~~-~--~~~---~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ 150 (365)
T PRK09188 91 ----G----KDGLVRGWTEGVPLHL-A--RPH---G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGE 150 (365)
T ss_pred ----C----CcEEEEEccCCCCHHH-h--Ccc---c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCC
Confidence 2 2499999999999963 2 111 1 146789999999999998 9999999 999999999999
Q ss_pred eEEeeccCCccCCCCCCccc------cccccccCCccCccccccC
Q 035862 222 PKLSDFGLAREGPTGDHTHV------STAVVGTYGYAAPEYIETG 260 (393)
Q Consensus 222 ~kl~Dfg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 260 (393)
+||+|||+++.......... .....++..|+|||.+...
T Consensus 151 ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 151 AAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999999986544321111 1356788889999988643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-23 Score=193.81 Aligned_cols=260 Identities=33% Similarity=0.506 Sum_probs=196.6
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc---cHHHHHHHHHHhhcCCCC-ccceeeeeeecCCcc
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ---GHKQWLAEVQFLGVVSHP-NLVKLLGYCSTEDER 149 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~ 149 (393)
|.....||.|+||.||++.+. ..+++|.+...... ....+.+|+.++..+.|+ +++++++++....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-- 71 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG-- 71 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC--
Confidence 677889999999999999865 35888888765433 356788999999999988 7999999995554
Q ss_pred cceEEEEEeecCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC-ceEEeec
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQ-PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF-KPKLSDF 227 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Df 227 (393)
..+++++++.++++.+++..... ..++......++.|++.++.|+|+. +++|||+||+||+++..+ .++++||
T Consensus 72 --~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~df 146 (384)
T COG0515 72 --SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDF 146 (384)
T ss_pred --EEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEecc
Confidence 35899999999999976643321 2688999999999999999999998 999999999999999998 7999999
Q ss_pred cCCccCCCCCCcc----ccccccccCCccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCccCCCCch-hhhHHHHH
Q 035862 228 GLAREGPTGDHTH----VSTAVVGTYGYAAPEYIET---GHLKSQSDIWSFGVVLYEILTGRRVLERNRPT-MEQKLLEW 299 (393)
Q Consensus 228 g~a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltg~~pf~~~~~~-~~~~~~~~ 299 (393)
|.+.......... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||...... ........
T Consensus 147 g~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 226 (384)
T COG0515 147 GLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI 226 (384)
T ss_pred CcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHH
Confidence 9997544433221 2356789999999999987 57889999999999999999999997665431 01111111
Q ss_pred HhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 035862 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354 (393)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 354 (393)
....... ......... ........+.+++..|+..+|..|.+..+...+
T Consensus 227 ~~~~~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 227 ILELPTP--SLASPLSPS----NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHhcCCc--ccccccCcc----ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 1111111 000000000 002234678899999999999999999988887
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=188.28 Aligned_cols=250 Identities=22% Similarity=0.399 Sum_probs=193.9
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+.....+|.+...|..|+|++...+ ++.|++.-. .....+.|..|.-.|+.+.||||+.+++.|..+.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwqgnd-------ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp--- 260 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQGND-------IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP--- 260 (448)
T ss_pred hhhhhhhhccCCCcccccccccCcc-------hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC---
Confidence 3455667999999999999987555 555655432 2233356788999999999999999999998876
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe--ecc
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS--DFG 228 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~--Dfg 228 (393)
.+.+|..|++.|+|...++.......+-.++..++.++++|++|||+. +.-|.---|....++|+++.+.+|+ |-.
T Consensus 261 -nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~k 338 (448)
T KOG0195|consen 261 -NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTK 338 (448)
T ss_pred -CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccce
Confidence 569999999999999999877777778889999999999999999986 3234444688999999999987765 322
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCC---chhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLK---SQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
++.. .......|.|++||.++..+.+ ..+|+|||++++|||-|...||.+-++-.....
T Consensus 339 fsfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk--------- 400 (448)
T KOG0195|consen 339 FSFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK--------- 400 (448)
T ss_pred eeee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh---------
Confidence 2211 1223457899999999776544 478999999999999999999987655322211
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
+--.+++...++..+..+..|+.-|++.||.+||.+..++-.|++..
T Consensus 401 -------ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 401 -------IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -------hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 11234556667778899999999999999999999999998888753
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-24 Score=183.34 Aligned_cols=176 Identities=12% Similarity=0.085 Sum_probs=132.3
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHH---------HHHHHHHhhcCCCCccceee
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ---------WLAEVQFLGVVSHPNLVKLL 140 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~~~ 140 (393)
..++|+.++.||.|+||.||++... .. .+++|.+.......... +.+|+..+.++.|++|..+.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~--~~-----~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~ 101 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTD--YG-----KYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLN 101 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecC--CC-----cEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcce
Confidence 4578999999999999999996532 11 39999997654332222 56899999999999999998
Q ss_pred eeeecCCcc----cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe
Q 035862 141 GYCSTEDER----GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL 216 (393)
Q Consensus 141 ~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll 216 (393)
+++...... ....+++|||++|.+|.++. .+++ ....+++.++..+|+. |++|||++|+||++
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili 168 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIV 168 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEE
Confidence 886644311 12458999999999998864 1222 3456899999999999 99999999999999
Q ss_pred CCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh
Q 035862 217 DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT 280 (393)
Q Consensus 217 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt 280 (393)
+.+| ++|+|||........... ..++....|+.++|+||||+++..+..
T Consensus 169 ~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred eCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 9999 999999988654221110 003344557789999999999876543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-23 Score=207.19 Aligned_cols=247 Identities=21% Similarity=0.268 Sum_probs=173.8
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-c---cHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-Q---GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.|...+.||.+.|-.|.+|+++.. .|++|++-+..+ . ...+.+.|++ ...+++||.+++.-+......
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG-------~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG-------LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc-------eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHH
Confidence 466777899999999999985421 288888765432 2 2334445555 556789999998877555543
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
.|||-+|+.+ +|.|.+ ...+-+..-+.+.|+.||+.||..+|.. ||+|||||.+||||+.-.-+.|+||.
T Consensus 96 ----AylvRqyvkh-nLyDRl--STRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFA 165 (1431)
T KOG1240|consen 96 ----AYLVRQYVKH-NLYDRL--STRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFA 165 (1431)
T ss_pred ----HHHHHHHHhh-hhhhhh--ccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhccc
Confidence 3788889855 999988 4445567778889999999999999998 99999999999999999999999997
Q ss_pred CCccCCCCCCc-----cccccccccCCccCccccccC----------C-CCchhhHHHHHHHHHHHHh-CCCccCCCCch
Q 035862 229 LAREGPTGDHT-----HVSTAVVGTYGYAAPEYIETG----------H-LKSQSDIWSFGVVLYEILT-GRRVLERNRPT 291 (393)
Q Consensus 229 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslGvil~ellt-g~~pf~~~~~~ 291 (393)
.-+..-..+.. -...+...-..|+|||.+... . .+++.||||+||+++||++ |++||.-.
T Consensus 166 sFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS--- 242 (1431)
T KOG1240|consen 166 SFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS--- 242 (1431)
T ss_pred ccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---
Confidence 65432222111 122333444579999988431 1 5678999999999999988 68888521
Q ss_pred hhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 035862 292 MEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354 (393)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 354 (393)
+.+ .+-..-..++ +..-..+ .+..+++++..|++.||.+|.++++.|+.
T Consensus 243 --QL~-aYr~~~~~~~----e~~Le~I-------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 243 --QLL-AYRSGNADDP----EQLLEKI-------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred --HHH-hHhccCccCH----HHHHHhC-------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111 1110000000 0000000 12357889999999999999999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=172.61 Aligned_cols=139 Identities=17% Similarity=0.110 Sum_probs=105.0
Q ss_pred cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc--c------------------------HHHHHHHHHHhhc
Q 035862 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ--G------------------------HKQWLAEVQFLGV 130 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~ 130 (393)
...||+|+||.||+|.+. ++..||+|+++..... . ......|++++..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 75 (190)
T cd05147 2 NGCISTGKEANVYHATTA------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKR 75 (190)
T ss_pred CCccccccceEEEEEECC------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 457999999999999853 3346999998754211 0 0122359999999
Q ss_pred CCCCccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEeccC
Q 035862 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL-HEGLEIQVIYRDF 209 (393)
Q Consensus 131 l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~L-H~~~~~~ivH~Di 209 (393)
+.++++.....+.... .++||||++|+++...+. ....++...+..++.|++.+|.++ |+. ||+||||
T Consensus 76 l~~~~v~~p~~~~~~~------~~iVmE~i~g~~l~~~~~--~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl 144 (190)
T cd05147 76 LVTAGIPCPEPILLKS------HVLVMEFIGDDGWAAPRL--KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADL 144 (190)
T ss_pred HHHCCCCCCcEEEecC------CEEEEEEeCCCCCcchhh--hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 9887764433222211 189999998877765432 234688899999999999999999 687 9999999
Q ss_pred CCCCeEeCCCCceEEeeccCCccC
Q 035862 210 KTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 210 kp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
||+|||++ ++.++|+|||+|...
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CHHHEEEE-CCcEEEEEccccccC
Confidence 99999998 578999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=166.54 Aligned_cols=140 Identities=18% Similarity=0.105 Sum_probs=107.2
Q ss_pred cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc--------------------------HHHHHHHHHHhhc
Q 035862 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--------------------------HKQWLAEVQFLGV 130 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~ 130 (393)
...||+|++|.||+|.+. ++..||+|++....... ...+..|...+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 75 (190)
T cd05145 2 NGCISTGKEANVYHARTG------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKR 75 (190)
T ss_pred CceeecCCCcEEEEEEcC------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 467999999999999854 34469999987652110 1123478899999
Q ss_pred CCCCccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccC
Q 035862 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE-GLEIQVIYRDF 209 (393)
Q Consensus 131 l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Di 209 (393)
+.|+++.....+.... .++||||++|+++..... ....++...+..++.|++.++.++|+ . ||+||||
T Consensus 76 l~~~~i~~p~~~~~~~------~~lVmE~~~g~~~~~~~l--~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDl 144 (190)
T cd05145 76 LYEAGVPVPEPILLKK------NVLVMEFIGDDGSPAPRL--KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDL 144 (190)
T ss_pred HHhCCCCCceEEEecC------CEEEEEEecCCCchhhhh--hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCC
Confidence 9998875444433322 289999998876544321 22457788899999999999999999 8 9999999
Q ss_pred CCCCeEeCCCCceEEeeccCCccCC
Q 035862 210 KTSNVLLDGNFKPKLSDFGLAREGP 234 (393)
Q Consensus 210 kp~NIll~~~~~~kl~Dfg~a~~~~ 234 (393)
||+|||++ ++.++|+|||++....
T Consensus 145 kP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 145 SEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred ChhhEEEE-CCCEEEEEcccceecC
Confidence 99999999 8999999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=195.54 Aligned_cols=253 Identities=21% Similarity=0.211 Sum_probs=185.7
Q ss_pred HHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC---CCccceeeeee
Q 035862 67 LREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS---HPNLVKLLGYC 143 (393)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~ 143 (393)
++.....|.+-+.||+|+||+||+|...+ +..||+|+-.+..... |.--.+++.+|+ -+.|+.+...+
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~------~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN------GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAH 763 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC------CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHH
Confidence 33445679999999999999999998543 5679999988765431 111222333333 34556665555
Q ss_pred ecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC------
Q 035862 144 STEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD------ 217 (393)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~------ 217 (393)
...+.. ++|+||.+.|+|.+++ +..+.+++..+..++.|++..++.||.. +||||||||+|.||.
T Consensus 764 ~~~~~S----~lv~ey~~~Gtlld~~--N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~ 834 (974)
T KOG1166|consen 764 VFQNAS----VLVSEYSPYGTLLDLI--NTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICAD 834 (974)
T ss_pred ccCCcc----eeeeeccccccHHHhh--ccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCC
Confidence 555543 8999999999999999 4677899999999999999999999998 999999999999993
Q ss_pred -CCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHH
Q 035862 218 -GNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKL 296 (393)
Q Consensus 218 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~ 296 (393)
+..-++|+|||.+..+..-.........++|..+-.+|+..|..|++.+|.|.|+.+++.||.|++.-
T Consensus 835 ~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q----------- 903 (974)
T KOG1166|consen 835 SDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME----------- 903 (974)
T ss_pred CcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------
Confidence 23359999999997654444344566788999999999999999999999999999999999996421
Q ss_pred HHHHhhcCcCCcccccccCcccccccCHHHHHHH-HHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 297 LEWVKQFPADGKKFSMMIDPRLRNQYSINAARRV-AKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
..++.. ..++..++. ....++ .+|+..+|+.|-..=|...++...++.++..
T Consensus 904 -------~~~g~~--~~~~~~~~R----y~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 904 -------VKNGSS--WMVKTNFPR----YWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred -------hcCCcc--eeccccchh----hhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 111111 111221221 122333 4677778886666668888888888777654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-21 Score=172.40 Aligned_cols=236 Identities=23% Similarity=0.273 Sum_probs=145.0
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCC----------Cccceee
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSH----------PNLVKLL 140 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------~niv~~~ 140 (393)
+.....||.|+++.||.+++..++ ..+++|+...... ...+.+.+|.-....+.+ -.++-.+
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~-----~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~ 88 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETG-----EEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL 88 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTT-----EEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred EEEccccccCCceEEEEEEEccCC-----ceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence 456678999999999999976544 4599988753322 234555555544444322 1222222
Q ss_pred eeeecC---------Cccc----ceEEEEEeecCCCChHHHHh---hcCCC--CCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 035862 141 GYCSTE---------DERG----IQRLLVYEYMPNRSLEDRLF---SRAQP--TLPWKTRLEIILGAAEGLAYLHEGLEI 202 (393)
Q Consensus 141 ~~~~~~---------~~~~----~~~~lv~e~~~~~~L~~~l~---~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~~~ 202 (393)
+..... .... ...+++|+-+ .++|.+++. ..... .+.......+..|++..+++||+.
T Consensus 89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~--- 164 (288)
T PF14531_consen 89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY--- 164 (288)
T ss_dssp EEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred EEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---
Confidence 222211 1000 0236778877 558887752 22222 233444566778999999999999
Q ss_pred CeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCcccccc--------CCCCchhhHHHHHHH
Q 035862 203 QVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET--------GHLKSQSDIWSFGVV 274 (393)
Q Consensus 203 ~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvi 274 (393)
|+||+||+|+|++++.+|.++|+||+......... .....+..|.+||.... ..++.+.|.|+||++
T Consensus 165 GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 165 GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred ceEecccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 99999999999999999999999998876533211 11344578999997743 257889999999999
Q ss_pred HHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCC
Q 035862 275 LYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345 (393)
Q Consensus 275 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 345 (393)
+|.|++|..||....+.... ...-..+. ++++.+..||..+|+++|.+|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~---------------------~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADP---------------------EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTS---------------------GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccc---------------------cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999754322110 00112334 688999999999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-23 Score=194.82 Aligned_cols=229 Identities=29% Similarity=0.393 Sum_probs=181.9
Q ss_pred eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc--HHHHHHHHHHhhcCC-CCccceeeeeeecCCcccceEEE
Q 035862 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--HKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDERGIQRLL 155 (393)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~l 155 (393)
.+|+|+||.|++++- ......+..+++|++.+..... ......|..++..++ ||.++++...+..+. .+++
T Consensus 1 vlg~g~~gkvfLvrk--~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~----kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRK--AGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDG----KLYL 74 (612)
T ss_pred CCCcCCCcchHHHHH--hccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecccc----chhH
Confidence 379999999998642 3345567789999887653221 123456888888887 999999999888877 4599
Q ss_pred EEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCC
Q 035862 156 VYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPT 235 (393)
Q Consensus 156 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 235 (393)
++++..||.|...+ .....+.+.....+...++-+++++|+. +++|||+|++||+++.+|.+++.|||+++....
T Consensus 75 ~ld~~rgg~lft~l--~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~ 149 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRL--SKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK 149 (612)
T ss_pred hhhhcccchhhhcc--ccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHh
Confidence 99999999998877 4445677778888889999999999998 999999999999999999999999999986543
Q ss_pred CCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccC
Q 035862 236 GDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMID 315 (393)
Q Consensus 236 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (393)
.. ..+||..|||||++. .....+|.||+|++++||+||..||.. .. +..++
T Consensus 150 ~~------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~----~~~Il----------- 200 (612)
T KOG0603|consen 150 EK------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DT----MKRIL----------- 200 (612)
T ss_pred hh------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HH----HHHHh-----------
Confidence 32 128999999999998 567889999999999999999999975 11 11111
Q ss_pred cccccccCHHHHHHHHHHHHHhcccCCCCCCCH
Q 035862 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPTM 348 (393)
Q Consensus 316 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 348 (393)
......+...+..+.+++..++..+|.+|...
T Consensus 201 -~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 201 -KAELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred -hhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 11223455678889999999999999999765
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7e-22 Score=176.30 Aligned_cols=205 Identities=21% Similarity=0.304 Sum_probs=144.7
Q ss_pred CCCccceeeeeeecCC-----------------------cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHH
Q 035862 132 SHPNLVKLLGYCSTED-----------------------ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILG 188 (393)
Q Consensus 132 ~h~niv~~~~~~~~~~-----------------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~q 188 (393)
.|||||.+.++|.++- .....+|+||.-+. .+|.+++..+ ..+.....-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~---~~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR---HRSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC---CCchHHHHHHHHH
Confidence 5999999998875432 12346689998884 4999998443 3566778889999
Q ss_pred HHHHHHHhhcCCCCCeEeccCCCCCeEe--CCCC--ceEEeeccCCccCCCCCCc----cccccccccCCccCccccccC
Q 035862 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLL--DGNF--KPKLSDFGLAREGPTGDHT----HVSTAVVGTYGYAAPEYIETG 260 (393)
Q Consensus 189 l~~~l~~LH~~~~~~ivH~Dikp~NIll--~~~~--~~kl~Dfg~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~ 260 (393)
+++|+.|||++ ||.|||+|.+|||+ ++|+ .+.|+|||++-......-. ......-|...-||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999 99999999999999 4444 4789999987532221110 111234567788999988543
Q ss_pred C------CCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHH
Q 035862 261 H------LKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLA 334 (393)
Q Consensus 261 ~------~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 334 (393)
+ --.++|.|+.|.+.||+++...||....+..-.. ... ........+..++..+.+++
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~------------r~Y----qe~qLPalp~~vpp~~rqlV 490 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT------------RTY----QESQLPALPSRVPPVARQLV 490 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech------------hhh----hhhhCCCCcccCChHHHHHH
Confidence 2 1248999999999999999999997632211000 000 00111223345678899999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 335 DNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 335 ~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
..+|+.||++|++..-..+-+...+
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~LsL 515 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLNLSL 515 (598)
T ss_pred HHHhcCCccccCCccHHHhHHHHHH
Confidence 9999999999999877777665544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-21 Score=164.17 Aligned_cols=141 Identities=15% Similarity=0.211 Sum_probs=106.6
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcC-----CCCccceeeeeeecCCc
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV-----SHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~ 148 (393)
+.-...||+|+||.||. +..+. . .+||++........+.+.+|+.+++.+ .||||+++++++.++..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~-----~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g 75 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDA-----Q-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG 75 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCc-----C-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC
Confidence 34456899999999995 33222 1 368887765444567789999999999 57999999999988754
Q ss_pred ccceEEEEEee--cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHH-HHhhcCCCCCeEeccCCCCCeEeCC----CCc
Q 035862 149 RGIQRLLVYEY--MPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGL-AYLHEGLEIQVIYRDFKTSNVLLDG----NFK 221 (393)
Q Consensus 149 ~~~~~~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l-~~LH~~~~~~ivH~Dikp~NIll~~----~~~ 221 (393)
.+....+|+|| +.+++|.+++.+ ..+++. ..++.|++.++ +|||++ +|+||||||+|||++. ++.
T Consensus 76 ~g~v~~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~ 147 (210)
T PRK10345 76 TGYVYDVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVI 147 (210)
T ss_pred CeEEEEEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCc
Confidence 43334478999 457999999943 235555 35677888777 999999 9999999999999974 347
Q ss_pred eEEeeccCC
Q 035862 222 PKLSDFGLA 230 (393)
Q Consensus 222 ~kl~Dfg~a 230 (393)
++|+||+.+
T Consensus 148 ~~LiDg~G~ 156 (210)
T PRK10345 148 PVVCDNIGE 156 (210)
T ss_pred EEEEECCCC
Confidence 999995443
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=158.64 Aligned_cols=186 Identities=18% Similarity=0.124 Sum_probs=135.1
Q ss_pred ccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc----cHHHHHHHHHHhhcCC-CCccceeeeeeecCCccc
Q 035862 76 RMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ----GHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 150 (393)
+...|++|+||+||.+.. .+..++.+.+...... ....+.+|+++|+++. |+++.+++++ +
T Consensus 6 ~~~~l~~~~f~~v~~~~~-------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~--- 71 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----D--- 71 (218)
T ss_pred cceeecCCCcceEEEeec-------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----c---
Confidence 456899999999997652 2234666666544321 1124678999999996 5889999886 1
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC-CCCCeEeCCCCceEEeeccC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDF-KTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Di-kp~NIll~~~~~~kl~Dfg~ 229 (393)
..+++|||+.|.+|...+. . ....++.|++.+|.++|++ ||+|||| ||+|||++.+|.++|+|||+
T Consensus 72 -~~~lvmeyI~G~~L~~~~~--------~-~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~ 138 (218)
T PRK12274 72 -GRHLDRSYLAGAAMYQRPP--------R-GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQL 138 (218)
T ss_pred -CEEEEEeeecCccHHhhhh--------h-hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCC
Confidence 2389999999999875431 1 1135788999999999999 9999999 79999999999999999999
Q ss_pred CccCCCCCCc----c-------ccccccccCCccCccccccC-CCC-chhhHHHHHHHHHHHHhCCCccCCC
Q 035862 230 AREGPTGDHT----H-------VSTAVVGTYGYAAPEYIETG-HLK-SQSDIWSFGVVLYEILTGRRVLERN 288 (393)
Q Consensus 230 a~~~~~~~~~----~-------~~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslGvil~elltg~~pf~~~ 288 (393)
+......... . .......++.|++|+...-. ..+ ...+.++.|+-+|.++|+..++...
T Consensus 139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 9865433210 0 00112367778888754322 233 5679999999999999999887544
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=177.30 Aligned_cols=219 Identities=26% Similarity=0.422 Sum_probs=163.6
Q ss_pred hhcCCCCccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe-Ee
Q 035862 128 LGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQV-IY 206 (393)
Q Consensus 128 l~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i-vH 206 (393)
|+.+.|.|+.+++|.+.... ..+.|.+||..|+|.|.+... ...+++.....++++++.||.|||.. .| +|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~----~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~h 72 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP----EMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS---PIGYH 72 (484)
T ss_pred CcccchhhhhhheeeEecCC----ceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC---cceee
Confidence 46789999999999999885 458999999999999999653 45588889999999999999999987 44 99
Q ss_pred ccCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccC-------CCCchhhHHHHHHHHHHHH
Q 035862 207 RDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG-------HLKSQSDIWSFGVVLYEIL 279 (393)
Q Consensus 207 ~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslGvil~ell 279 (393)
+.+++.|.+++..-.+||+|||+.................-..-|.|||.+.+. ..+.+.||||+|++++|++
T Consensus 73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 999999999999999999999998776431111111222334579999999763 1467799999999999999
Q ss_pred hCCCccCCCCchhh-hHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 280 TGRRVLERNRPTME-QKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 280 tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
+...||........ ..++..+.. .+. ..+.+.+.... ...+++..++..||..+|.+||+++++-..+..+
T Consensus 153 ~r~~~~~~~~~~~~~~eii~~~~~---~~~---~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPDEIILRVKK---GGS---NPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred hccCccccccccCChHHHHHHHHh---cCC---CCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 99999976433322 222222222 011 11112111111 3445789999999999999999999999988877
Q ss_pred Hhhh
Q 035862 359 VQES 362 (393)
Q Consensus 359 ~~~~ 362 (393)
....
T Consensus 225 ~~~~ 228 (484)
T KOG1023|consen 225 NKGG 228 (484)
T ss_pred cccc
Confidence 6543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-21 Score=179.92 Aligned_cols=178 Identities=26% Similarity=0.360 Sum_probs=132.4
Q ss_pred eEEEEEeecCCCChHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 152 QRLLVYEYMPNRSLEDRLFS-RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
++|+.|++|...+|.+||.. ......++...+.++.|++.|+.| + +.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 57899999999999999963 334556788899999999999999 5 9999999999999999999999999998
Q ss_pred ccCCCCC----CccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhC-CCccCCCCchhhhHHHHHHhhcCc
Q 035862 231 REGPTGD----HTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTG-RRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 231 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
....... .....+..+||.+||+||.+.+..|+.++||||||++|+||+.- ...|+. ....
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------~~t~-------- 469 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------IATL-------- 469 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------HHhh--------
Confidence 7655444 12244567999999999999999999999999999999999982 111110 0000
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
..+.+..+....-.+. ++-..|+.++|.+.|.+||++.+..-+.
T Consensus 470 -----~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~ 513 (516)
T KOG1033|consen 470 -----TDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHE 513 (516)
T ss_pred -----hhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhh
Confidence 0011111110111111 3345799999999999999666655444
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=186.34 Aligned_cols=211 Identities=27% Similarity=0.377 Sum_probs=146.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|..++.|..|++|.||.++++.+.. .+|+ ++++.... .+- ++.....|.+
T Consensus 82 e~df~~IklisngAygavylvrh~~trq-----rfa~-kiNkq~li-----lRn--ilt~a~npfv-------------- 134 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQ-----RFAM-KINKQNLI-----LRN--ILTFAGNPFV-------------- 134 (1205)
T ss_pred ccccceeEeeccCCCCceeeeecccccc-----chhh-cccccchh-----hhc--cccccCCcce--------------
Confidence 4689999999999999999998765544 3787 44443221 110 2222233322
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
| |+-...+ ...+.++... +.+++|||+- ||+|||+||+|.+|+.-|.+|++|||++
T Consensus 135 -----v------gDc~tll--k~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLs 190 (1205)
T KOG0606|consen 135 -----V------GDCATLL--KNIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLS 190 (1205)
T ss_pred -----e------chhhhhc--ccCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhh
Confidence 2 3444444 2234455443 7789999998 9999999999999999999999999998
Q ss_pred ccCCCCCCcc-------------ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHH
Q 035862 231 REGPTGDHTH-------------VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL 297 (393)
Q Consensus 231 ~~~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~ 297 (393)
.......... .....+||+.|+|||++.-+.|...+|+|++|+|+||.+-|+.||.+..++. .+.
T Consensus 191 k~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee--lfg 268 (1205)
T KOG0606|consen 191 KKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--LFG 268 (1205)
T ss_pred hhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH--HHh
Confidence 7532111100 1124599999999999999999999999999999999999999998765542 222
Q ss_pred HHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC
Q 035862 298 EWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT 347 (393)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 347 (393)
..+........ -....+.++++++.++|+.+|..|.-
T Consensus 269 ~visd~i~wpE-------------~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 269 QVISDDIEWPE-------------EDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred hhhhhhccccc-------------cCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 22211111000 01124578999999999999999954
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.8e-19 Score=157.51 Aligned_cols=141 Identities=17% Similarity=0.103 Sum_probs=106.9
Q ss_pred CCcccceecccCCceEEEEE-EcCCCCCCCceEEEEEEecCCCcc------------------------cHHHHHHHHHH
Q 035862 73 GFNRMLKIGEGGFGSVYKGT-IRPLDGRGEPLVVAVKKLNNHGLQ------------------------GHKQWLAEVQF 127 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~ 127 (393)
.|.+.+.||+|+||.||+|. +.. .+..||+|.+...... ....+..|+.+
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~-----~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 103 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDG-----SGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN 103 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCC-----CCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence 48899999999999999998 322 2346999988753210 01234579999
Q ss_pred hhcCCCCc--cceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-e
Q 035862 128 LGVVSHPN--LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQ-V 204 (393)
Q Consensus 128 l~~l~h~n--iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~-i 204 (393)
+..+.+.+ +.+++++ .. .++||||+.|.+|..+.. ....+....+..++.|++.++.+||+. | +
T Consensus 104 L~~L~~~~i~~p~~~~~---~~-----~~lV~E~~~g~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~i 170 (237)
T smart00090 104 LQRLYEAGVPVPKPIAW---RR-----NVLVMEFIGGDGLPAPRL--KDVEPEEEEEFELYDDILEEMRKLYKE---GEL 170 (237)
T ss_pred HHHHHhcCCCCCeeeEe---cC-----ceEEEEEecCCccccccc--ccCCcchHHHHHHHHHHHHHHHHHHhc---CCE
Confidence 99997532 3344432 11 289999999988876542 223456666789999999999999998 9 9
Q ss_pred EeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 205 IYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 205 vH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
+||||||+||+++ ++.++|+|||.+..
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 9999999999999 88999999998864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.8e-18 Score=150.77 Aligned_cols=134 Identities=22% Similarity=0.265 Sum_probs=106.2
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc--------cHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ--------GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
+.||+|++|.||+|.+... .+++|........ ....+.+|+.++..+.|+++.....++...+.
T Consensus 2 ~~l~~G~~~~vy~~~~~~~-------~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~- 73 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGI-------KAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN- 73 (211)
T ss_pred cccccCceEEEEEEeeCCC-------ceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC-
Confidence 5799999999999986321 2778875543211 12346789999999999988776666554443
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
.+++|||++|++|.+++.... . .+..++.+++.+|.++|+. +++|+|++|+|||++ ++.++|+|||.
T Consensus 74 ---~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~ 140 (211)
T PRK14879 74 ---FIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGL 140 (211)
T ss_pred ---CEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCc
Confidence 389999999999999884321 2 7788999999999999998 999999999999999 78999999998
Q ss_pred Ccc
Q 035862 230 ARE 232 (393)
Q Consensus 230 a~~ 232 (393)
+..
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-18 Score=148.64 Aligned_cols=130 Identities=22% Similarity=0.317 Sum_probs=99.6
Q ss_pred eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc--------cHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ--------GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.||+|+||.||+|.+.. ..+++|........ ...++.+|++++..+.|+++.....++...+.
T Consensus 1 ~ig~G~~~~vy~~~~~~-------~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-- 71 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLG-------LKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN-- 71 (199)
T ss_pred CCCCCceEEEEEeecCC-------ccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC--
Confidence 48999999999998432 23788875432211 12456689999999988765544444443332
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
.++||||++|++|.+++.... ..++.+++.+|.+||+. |++|+|++|+||+++ ++.++++|||++
T Consensus 72 --~~lv~e~~~g~~l~~~~~~~~---------~~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a 136 (199)
T TIGR03724 72 --KTIVMEYIEGKPLKDVIEEGN---------DELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLG 136 (199)
T ss_pred --CEEEEEEECCccHHHHHhhcH---------HHHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCC
Confidence 389999999999998873211 07899999999999998 999999999999999 899999999998
Q ss_pred cc
Q 035862 231 RE 232 (393)
Q Consensus 231 ~~ 232 (393)
..
T Consensus 137 ~~ 138 (199)
T TIGR03724 137 KY 138 (199)
T ss_pred cC
Confidence 75
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=5e-18 Score=167.83 Aligned_cols=136 Identities=24% Similarity=0.275 Sum_probs=106.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEec-CC-Cc------ccHHHHHHHHHHhhcCCCCccceeeeee
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NH-GL------QGHKQWLAEVQFLGVVSHPNLVKLLGYC 143 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~-~~-~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~ 143 (393)
..|...+.||+|+||+||+|.+.... +++|+.. +. .. .....+.+|+++++.++|++++....++
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-------~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~ 405 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-------AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYD 405 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-------ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEE
Confidence 44567889999999999999864322 2233221 11 10 1124577899999999999998877666
Q ss_pred ecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceE
Q 035862 144 STEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPK 223 (393)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~k 223 (393)
..... .++||||++|++|.+++. ....++.+++.+|.+||+. +++||||||+|||+ +++.++
T Consensus 406 ~~~~~----~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~ 467 (535)
T PRK09605 406 VDPEE----KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLY 467 (535)
T ss_pred EeCCC----CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEE
Confidence 65443 389999999999999883 3567899999999999998 99999999999999 678999
Q ss_pred EeeccCCcc
Q 035862 224 LSDFGLARE 232 (393)
Q Consensus 224 l~Dfg~a~~ 232 (393)
|+|||+++.
T Consensus 468 liDFGla~~ 476 (535)
T PRK09605 468 LIDFGLGKY 476 (535)
T ss_pred EEeCccccc
Confidence 999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.9e-17 Score=141.54 Aligned_cols=137 Identities=18% Similarity=0.103 Sum_probs=104.3
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc----------------------cHHHHHHHHHHhhc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ----------------------GHKQWLAEVQFLGV 130 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~ 130 (393)
.|.+.+.||+|+||.||++... ++..|++|++...... ....+..|+.++..
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 4888899999999999999753 2346999986543210 01125678888888
Q ss_pred CCCCc--cceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 035862 131 VSHPN--LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRD 208 (393)
Q Consensus 131 l~h~n--iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~D 208 (393)
+.|++ +...++. . ..++||||++|++|.+... ......++.+++.++.++|+. |++|||
T Consensus 90 l~~~~i~v~~~~~~----~----~~~lv~e~~~g~~L~~~~~--------~~~~~~~~~~i~~~l~~lh~~---gi~H~D 150 (198)
T cd05144 90 LYEEGFPVPKPIDW----N----RHAVVMEYIDGVELYRVRV--------LEDPEEVLDEILEEIVKAYKH---GIIHGD 150 (198)
T ss_pred HHHcCCCCCceeec----C----CceEEEEEeCCcchhhccc--------cccHHHHHHHHHHHHHHHHHC---CCCcCC
Confidence 87774 4444432 1 2389999999999876541 024567889999999999998 999999
Q ss_pred CCCCCeEeCCCCceEEeeccCCccCC
Q 035862 209 FKTSNVLLDGNFKPKLSDFGLAREGP 234 (393)
Q Consensus 209 ikp~NIll~~~~~~kl~Dfg~a~~~~ 234 (393)
|||+||++++++.++|+|||.+....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.4e-19 Score=175.78 Aligned_cols=263 Identities=24% Similarity=0.291 Sum_probs=195.4
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCC-CCccceeeeeeecCCcc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDER 149 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 149 (393)
.|...+.||+|+|+.|-..... ......++.|.+.... .........|..+-..++ |+|++.+++.....+.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~----~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~- 95 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNS----RDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS- 95 (601)
T ss_pred cccccccccccccchhhhhhhc----CCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcc-
Confidence 4777778999999999776542 2233456766665442 222334445777777787 9999999998877764
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh-cCCCCCeEeccCCCCCeEeCCCC-ceEEeec
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH-EGLEIQVIYRDFKTSNVLLDGNF-KPKLSDF 227 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH-~~~~~~ivH~Dikp~NIll~~~~-~~kl~Df 227 (393)
.+++++|..|+++.+.+........+...+..++.|+..++.|+| .. ++.|+||||+|.+++..+ .++++||
T Consensus 96 ---~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df 169 (601)
T KOG0590|consen 96 ---YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADF 169 (601)
T ss_pred ---cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCc
Confidence 488999999999998773222224566777889999999999999 77 999999999999999999 9999999
Q ss_pred cCCccCCC-CCCccccccccc-cCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcC
Q 035862 228 GLAREGPT-GDHTHVSTAVVG-TYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP 304 (393)
Q Consensus 228 g~a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (393)
|+|..... .+........+| ++.|+|||...+. ......|+||.|+++.-+++|..|+........ ....|....
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~- 247 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK- 247 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc-
Confidence 99987666 444445566788 9999999999884 556789999999999999999999875443221 111111100
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.......-...+....+++.+++..+|..|.+.+++-...|...
T Consensus 248 -----------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 248 -----------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -----------cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 00001111234567888999999999999999999999988776
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.8e-16 Score=139.98 Aligned_cols=138 Identities=18% Similarity=0.161 Sum_probs=102.3
Q ss_pred ceec-ccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-------------cccHHHHHHHHHHhhcCCCCcc--ceeee
Q 035862 78 LKIG-EGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-------------LQGHKQWLAEVQFLGVVSHPNL--VKLLG 141 (393)
Q Consensus 78 ~~lg-~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~ 141 (393)
..|| .|+.|+||.+.... ..+++|...... ......+.+|+.++..+.|++| +..++
T Consensus 37 ~~lg~~~g~gtv~~v~~~~-------~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~ 109 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTPG-------VNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIA 109 (239)
T ss_pred ceeecCCCCccEEEEEeCC-------ceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEe
Confidence 4687 88889999887531 237888764321 1223457789999999998775 66776
Q ss_pred eeecCCcccceEEEEEeecCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC
Q 035862 142 YCSTEDERGIQRLLVYEYMPN-RSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF 220 (393)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~ 220 (393)
+...........++|||+++| .+|.+++.. ..++.. .+.+++.+|.+||++ ||+||||||+|||++.++
T Consensus 110 ~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 110 ARVVRHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDG 179 (239)
T ss_pred eeeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCC
Confidence 654433222234699999997 689888743 234443 367899999999999 999999999999999999
Q ss_pred ceEEeeccCCcc
Q 035862 221 KPKLSDFGLARE 232 (393)
Q Consensus 221 ~~kl~Dfg~a~~ 232 (393)
.++|+|||.+..
T Consensus 180 ~v~LIDfg~~~~ 191 (239)
T PRK01723 180 KFWLIDFDRGEL 191 (239)
T ss_pred CEEEEECCCccc
Confidence 999999998865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=3e-16 Score=134.01 Aligned_cols=135 Identities=21% Similarity=0.134 Sum_probs=92.5
Q ss_pred cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc--HHH----------------------HHHHHHHhhcCC
Q 035862 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--HKQ----------------------WLAEVQFLGVVS 132 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~ 132 (393)
.+.||+|+||+||+|.+. .+..||+|++....... ... ...|...+..+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 75 (187)
T cd05119 2 GGPIGTGKEADVYLALDG------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY 75 (187)
T ss_pred CcccccccceeEEEEECC------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH
Confidence 467999999999999854 23469999876532111 011 124555555554
Q ss_pred CCc--cceeeeeeecCCcccceEEEEEeecCCCChHHH-HhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEecc
Q 035862 133 HPN--LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDR-LFSRAQPTLPWKTRLEIILGAAEGLAYLHE-GLEIQVIYRD 208 (393)
Q Consensus 133 h~n--iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~D 208 (393)
+.. +.+.++.. ..++||||+.++++... +.... .. ..+..++.+++.++.++|. . +++|+|
T Consensus 76 ~~~~~~~~~~~~~--------~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~D 140 (187)
T cd05119 76 EAGVPVPKPIDLN--------RHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGD 140 (187)
T ss_pred HcCCCCCceEecC--------CCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCC
Confidence 332 33443321 23899999998543211 11100 11 5678899999999999999 7 999999
Q ss_pred CCCCCeEeCCCCceEEeeccCCccC
Q 035862 209 FKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 209 ikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
|||+||+++ ++.++|+|||.+...
T Consensus 141 l~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 141 LSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CChhhEEEE-CCcEEEEECcccccc
Confidence 999999999 899999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=7.2e-16 Score=126.49 Aligned_cols=135 Identities=19% Similarity=0.158 Sum_probs=108.8
Q ss_pred ccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCC--CccceeeeeeecCCcccceE
Q 035862 76 RMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH--PNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~ 153 (393)
+.+.||.|.++.||++.... ..+++|....... ...+..|+.++..+.| .++.+++.++...+ ..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-------~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~----~~ 68 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-------EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDG----WS 68 (155)
T ss_pred cceecccccccceEEEEecC-------CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC----cc
Confidence 35679999999999998643 2489998866432 4567889999999976 58888888776553 44
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
+++|||+.++.+..+ +......++.+++.++.++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 69 ~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 69 YLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999999988777643 4556678899999999999985334799999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=9.8e-15 Score=138.22 Aligned_cols=253 Identities=23% Similarity=0.274 Sum_probs=182.4
Q ss_pred cCCcccceecc--cCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCC-CCccceeeeeeecC
Q 035862 72 NGFNRMLKIGE--GGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTE 146 (393)
Q Consensus 72 ~~y~~~~~lg~--G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 146 (393)
..+.+...+|. |.+|.||.+... .......+|+|.-... .......-++|+.....++ |+|.++.+..+...
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~---~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCT---NSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhcccccccccCCCCCceeecccCC---cccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 45788889999 999999998752 1334456888874332 2233334456777777776 99999987777766
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHH----HHHHhhcCCCCCeEeccCCCCCeEeCCC-Cc
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAE----GLAYLHEGLEIQVIYRDFKTSNVLLDGN-FK 221 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~----~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~ 221 (393)
+ .+++-+|.+ +.+|..+..... ..++...++..+.+... |+.++|.. +++|-|+||.||+...+ ..
T Consensus 191 ~----~lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s 261 (524)
T KOG0601|consen 191 G----ILFIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTS 261 (524)
T ss_pred C----cceeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccce
Confidence 6 458888998 568888774333 34788889999999999 99999999 99999999999999999 88
Q ss_pred eEEeeccCCccCCCCCCcc---ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHH
Q 035862 222 PKLSDFGLAREGPTGDHTH---VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLE 298 (393)
Q Consensus 222 ~kl~Dfg~a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~ 298 (393)
.+++|||+........... ......|...|++||+.+ .-++...|||++|.++.+..++..+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-------- 332 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN-------- 332 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC--------
Confidence 9999999988765544221 112236788999999775 5678899999999999999998776543200
Q ss_pred HHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 035862 299 WVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354 (393)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~ 354 (393)
..+...-...++.++-...+.++...+..|++.+|..|++.+.+..+
T Consensus 333 ---------~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 333 ---------SSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ---------CCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 00000001112222222334566669999999999999998888775
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.4e-15 Score=130.20 Aligned_cols=208 Identities=20% Similarity=0.261 Sum_probs=141.5
Q ss_pred HhhcCCCCccceeeeeeecCCc-ccceEEEEEeecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC
Q 035862 127 FLGVVSHPNLVKLLGYCSTEDE-RGIQRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQ 203 (393)
Q Consensus 127 ~l~~l~h~niv~~~~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ 203 (393)
-|-++-|.|||+++.++.+... ......++.||++.|+|..+|+. .....+......+|+.||+.||.|||+ +...
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCc
Confidence 3445669999999998866543 23355889999999999999964 345567788888999999999999999 5679
Q ss_pred eEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCcc--ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhC
Q 035862 204 VIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTH--VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTG 281 (393)
Q Consensus 204 ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg 281 (393)
|+|+++..+.|++..+|-+|+.--.-........... ......+.++|.+||.=.....+..+|||++|+...+|.-+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999999988875211111110000000 11123467889999976666777899999999999999887
Q ss_pred CCccCCCCchhh-hHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 282 RRVLERNRPTME-QKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 282 ~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
..--.......+ +..+. .....+.. ..-+.++.+|++..|..||++.+++-|+-
T Consensus 279 Eiq~tnseS~~~~ee~ia----------~~i~~len-----------~lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIA----------NVIIGLEN-----------GLQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred eeccCCCcceeehhhhhh----------hheeeccC-----------ccccCcCcccccCCCCCCcchhhhhcCce
Confidence 643211111100 00000 00000000 11245899999999999999999998753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.1e-13 Score=130.80 Aligned_cols=146 Identities=16% Similarity=0.097 Sum_probs=95.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHH--------------------------------
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK-------------------------------- 119 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-------------------------------- 119 (393)
..|. .+.||.|++|.||+|+... +..||||+..+.......
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~------G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~ 190 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVD------GKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEF 190 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecC------CCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHH
Confidence 3444 3579999999999999752 235999998654211000
Q ss_pred --------HHHHHHHHhhcC----CCCccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHH
Q 035862 120 --------QWLAEVQFLGVV----SHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIIL 187 (393)
Q Consensus 120 --------~~~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ 187 (393)
.+.+|+..+..+ +|.+-+.+-.++..... ..++||||++|++|.++...... .. ....++.
T Consensus 191 ~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~---~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~ 263 (437)
T TIGR01982 191 EKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTS---ERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAE 263 (437)
T ss_pred HHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcC---CceEEEEeECCcccccHHHHHhc-CC---CHHHHHH
Confidence 123344444443 23333343333322111 23899999999999887643211 12 2344566
Q ss_pred HHHH-HHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCC
Q 035862 188 GAAE-GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGP 234 (393)
Q Consensus 188 ql~~-~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 234 (393)
+++. .+..+|.. |++|+|++|+||+++++|.++++|||++....
T Consensus 264 ~~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 264 NLARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 6655 46788887 99999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.3e-13 Score=111.49 Aligned_cols=130 Identities=18% Similarity=0.117 Sum_probs=92.2
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccc-eeeeeeecCCcccceEEEE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLV-KLLGYCSTEDERGIQRLLV 156 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~lv 156 (393)
+.|+.|.++.||++... +..|++|....... ....+..|+.+++.+.+.+++ +++.+.... .++|
T Consensus 4 ~~l~~G~~~~vy~~~~~-------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~------~~lv 69 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPET------GVLI 69 (170)
T ss_pred eecCCcccCceEEEEEC-------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCC------CeEE
Confidence 56899999999998753 23489998765432 123356788888888655544 454443211 2799
Q ss_pred EeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 157 YEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGL--EIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 157 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
|||++|.++.+.- . ....++.+++.+|..||+.. +.+++|+|++|.||+++ ++.++++|||.+..
T Consensus 70 ~e~i~G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 70 TEFIEGSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred EEecCCCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9999998876420 1 11345678999999999871 12359999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.3e-13 Score=128.60 Aligned_cols=149 Identities=15% Similarity=0.084 Sum_probs=94.2
Q ss_pred HHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc------------------------------
Q 035862 68 REATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG------------------------------ 117 (393)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~------------------------------ 117 (393)
.+.+..|.. ..||+|++|.||+|+...+ +..||||+..+.-...
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~-----G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~ 189 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKDN-----GREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREV 189 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECCC-----CCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHH
Confidence 444567877 7899999999999998643 3459999997642110
Q ss_pred ----HHH------HHHHHHHhhcC----CCCccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCC----CCCH
Q 035862 118 ----HKQ------WLAEVQFLGVV----SHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQP----TLPW 179 (393)
Q Consensus 118 ----~~~------~~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~ 179 (393)
.+. +.+|+..+.++ .+.+.+.+-.++.+-. ...++||||+.|++|.++-.-...+ .+..
T Consensus 190 v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~s---t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~ 266 (537)
T PRK04750 190 VAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYC---SETVMVMERMYGIPVSDVAALRAAGTDMKLLAE 266 (537)
T ss_pred HHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccC---CCceEEEeeecCccHHhHHHHHhcCCCHHHHHH
Confidence 011 23344333333 2333344333332211 1338999999999998743211111 2333
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC----ceEEeeccCCccCCC
Q 035862 180 KTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF----KPKLSDFGLAREGPT 235 (393)
Q Consensus 180 ~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~----~~kl~Dfg~a~~~~~ 235 (393)
..+..++.|++ .. |++|+|+||+||+++.+| .++++|||++.....
T Consensus 267 ~~v~~~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 267 RGVEVFFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33444444443 34 999999999999999988 999999999986644
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.2e-12 Score=122.61 Aligned_cols=163 Identities=18% Similarity=0.216 Sum_probs=121.2
Q ss_pred ceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHH
Q 035862 102 PLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKT 181 (393)
Q Consensus 102 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 181 (393)
+..|.+...............+-++.|+.++||||+++++.+..++ .+|+|+|-+ ..|..++... ....
T Consensus 37 ~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~----~~ylvTErV--~Pl~~~lk~l-----~~~~ 105 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG----TLYLVTERV--RPLETVLKEL-----GKEE 105 (690)
T ss_pred CCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC----ceEEEeecc--ccHHHHHHHh-----HHHH
Confidence 3346666666544333455677889999999999999999888777 569999998 5888888432 3566
Q ss_pred HHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCC
Q 035862 182 RLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGH 261 (393)
Q Consensus 182 ~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 261 (393)
+..-+.||+.||.|||.. ++++|++|.-+.|+|+..|..||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 777899999999999854 4999999999999999999999999998865433221 011112223456666443222
Q ss_pred CCchhhHHHHHHHHHHHHhC
Q 035862 262 LKSQSDIWSFGVVLYEILTG 281 (393)
Q Consensus 262 ~~~~~DiwslGvil~elltg 281 (393)
-..|.|-|||+++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 357999999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.3e-12 Score=123.88 Aligned_cols=250 Identities=21% Similarity=0.197 Sum_probs=173.3
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHH--HHHHHHHhhcCC-CCccceeeeeeecC
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ--WLAEVQFLGVVS-HPNLVKLLGYCSTE 146 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-h~niv~~~~~~~~~ 146 (393)
...+|..+..||.|.|+.|+....+ ...+..|++|-+.+.-.....+ -+.|+.+...+. |.+++.++..+...
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r----~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKR----PEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ecCCcceeEEccCCccccceeeeec----CCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence 3568999999999999999987743 1234468888776543222222 245666666665 77777766555444
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC-CceEEe
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN-FKPKLS 225 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~ 225 (393)
.. .++=-|||+++++...+ .....+.+...+.+..|++.++.++|+. .++|+|+||.||++..+ +..++.
T Consensus 339 r~----~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~ 409 (524)
T KOG0601|consen 339 RQ----GYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLG 409 (524)
T ss_pred cc----ccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcc
Confidence 42 36788999999988665 3334567788899999999999999998 99999999999999886 778999
Q ss_pred eccCCccCCCCCCccccccccccCCcc--CccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYA--APEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
|||....+.... ....+..++. ++.......+..+.|++|||..+.+.+++...-+....
T Consensus 410 ~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------------- 471 (524)
T KOG0601|consen 410 DFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------------- 471 (524)
T ss_pred ccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc-------------
Confidence 999886432211 1122233344 55555667788899999999999999998754332211
Q ss_pred CcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 304 PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
...+..... ...+ ....++..+.+.+...++..||.+.++..+....
T Consensus 472 ------~~~i~~~~~-p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 472 ------SLTIRSGDT-PNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ------ceeeecccc-cCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 111111111 1111 2237788899999999999999999887776544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=2e-11 Score=103.25 Aligned_cols=141 Identities=15% Similarity=0.083 Sum_probs=95.5
Q ss_pred ceecccCCceEEEEEEcCCC-CCCCceEEEEEEecCCCc----------------------ccHHHH----HHHHHHhhc
Q 035862 78 LKIGEGGFGSVYKGTIRPLD-GRGEPLVVAVKKLNNHGL----------------------QGHKQW----LAEVQFLGV 130 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~-~~~~~~~vavK~~~~~~~----------------------~~~~~~----~~E~~~l~~ 130 (393)
..||.|--+.||.|...... ....+..+|+|+.+.... .....+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999743210 011345689997643210 001122 379999988
Q ss_pred CCC--CccceeeeeeecCCcccceEEEEEeecCCCChHH-HHhhcCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEe
Q 035862 131 VSH--PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLED-RLFSRAQPTLPWKTRLEIILGAAEGLAYL-HEGLEIQVIY 206 (393)
Q Consensus 131 l~h--~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~i~~ql~~~l~~L-H~~~~~~ivH 206 (393)
+.. -++..++++ ... ++||||+.+..+.. .+. ...++......+..+++.+|..| |.. |+||
T Consensus 83 l~~~Gv~vP~pi~~--~~~------~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVH 148 (197)
T cd05146 83 MQKAGIPCPEVVVL--KKH------VLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVH 148 (197)
T ss_pred HHHcCCCCCeEEEe--cCC------EEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 763 455566554 222 89999997643321 121 12345556677889999999998 887 9999
Q ss_pred ccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 207 RDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 207 ~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
+||++.|||+. ++.+.|+|||.+...
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 99999999997 578999999988653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.5e-11 Score=97.30 Aligned_cols=144 Identities=19% Similarity=0.209 Sum_probs=101.6
Q ss_pred ccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--------ccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 76 RMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--------QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.+..+-+|+-+.|+++.+.. ..+.||.-..... -...+..+|++.|.++.--.|.-..-++.+..
T Consensus 11 ~l~likQGAEArv~~~~~~G-------e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSG-------EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY 83 (229)
T ss_pred cceeeeccceeeEeeeccCC-------ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC
Confidence 56689999999999987642 2355554322211 12345678999999876433332222343333
Q ss_pred cccceEEEEEeecCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc---eE
Q 035862 148 ERGIQRLLVYEYMPN-RSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK---PK 223 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~---~k 223 (393)
.. .++|||++| .++.+++...............++.+|-+.+.-||.+ +|+|+||..+||++..+|. +.
T Consensus 84 ~~----~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 84 GG----QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred CC----eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceE
Confidence 33 889999976 4788888765555444444578999999999999999 9999999999999976653 58
Q ss_pred EeeccCCccC
Q 035862 224 LSDFGLAREG 233 (393)
Q Consensus 224 l~Dfg~a~~~ 233 (393)
++|||++...
T Consensus 157 lIdfgls~~s 166 (229)
T KOG3087|consen 157 LIDFGLSSVS 166 (229)
T ss_pred EEeecchhcc
Confidence 9999998653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.9e-10 Score=107.44 Aligned_cols=220 Identities=17% Similarity=0.234 Sum_probs=153.0
Q ss_pred CceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEEEeecCC-C
Q 035862 85 FGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPN-R 163 (393)
Q Consensus 85 ~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~-~ 163 (393)
-.+.|+++...++ ..|++|.+.............-+++++++.|+|+|++.+++........-+++|++|.++ +
T Consensus 289 ~~Ttyk~~s~~DG-----~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~ 363 (655)
T KOG3741|consen 289 SITTYKATSNVDG-----NAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSP 363 (655)
T ss_pred cceeEeeeeccCC-----ceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCc
Confidence 3678888854433 459999984433332222334578889999999999999998655555678999999876 6
Q ss_pred ChHHHHhhc-------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 164 SLEDRLFSR-------------AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 164 ~L~~~l~~~-------------~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
+|.++.+.. .+...++..+|.++.||..||.++|+. |+..+-|.|.+||++.+..++|+..|..
T Consensus 364 TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 364 TLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred hHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccce
Confidence 787766422 134578899999999999999999999 9999999999999999888999877766
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
....... . +-+ +--.+-|.=.||.+++.|.||..--...+...+..
T Consensus 441 Dvl~~d~--------------~--~~l---e~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~--------------- 486 (655)
T KOG3741|consen 441 DVLQEDP--------------T--EPL---ESQQQNDLRDLGLLLLALATGTENSNRTDSTQSSH--------------- 486 (655)
T ss_pred eeecCCC--------------C--cch---hHHhhhhHHHHHHHHHHHhhcccccccccchHHHH---------------
Confidence 5432221 0 111 11246799999999999999964211111100000
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
.......++.++++++.-....++++ -++.+++.++
T Consensus 487 --------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 487 --------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred --------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 01112246677888888888888876 6777777654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.7e-11 Score=97.66 Aligned_cols=130 Identities=23% Similarity=0.303 Sum_probs=90.8
Q ss_pred eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---c-----cHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---Q-----GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 79 ~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.+++|+-+.+|.+.+.+. .+.+|.--++.. . ...+..+|++++..+.--.|.-..-+..+.+..
T Consensus 3 ~i~~GAEa~i~~~~~~g~-------~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~- 74 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGL-------PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG- 74 (204)
T ss_pred hhhCCcceeEEeeeccCc-------ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC-
Confidence 578999999999854321 145554322211 1 123456899999987643333222233344432
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
.++|||++|..|.+.+... ...++..+-.-+.-||.+ ||+|+||.++||++..++ +.++|||++
T Consensus 75 ---~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg 138 (204)
T COG3642 75 ---LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLG 138 (204)
T ss_pred ---EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcc
Confidence 7999999999999888433 245677777888899999 999999999999998766 999999999
Q ss_pred cc
Q 035862 231 RE 232 (393)
Q Consensus 231 ~~ 232 (393)
..
T Consensus 139 ~~ 140 (204)
T COG3642 139 EF 140 (204)
T ss_pred cc
Confidence 75
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.9e-12 Score=129.33 Aligned_cols=248 Identities=22% Similarity=0.256 Sum_probs=164.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
+++.+.+-+-+|.++.++.+.-...+ ...+.|+...... ...+....+-.++-...+|-++....-+.-..
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sg-----h~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs- 877 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSG-----HTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS- 877 (1205)
T ss_pred ccceecccccCCCCcccccCCccccc-----cccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCC-
Confidence 45667777889999999887633222 2234443322111 11112222222222234565554433322222
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
.++++++|+.+++|...+++. +..+....+..+..+..++++||.. .+.|+|++|.|+++..+|..+++|||
T Consensus 878 ---P~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~ 949 (1205)
T KOG0606|consen 878 ---PLPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFG 949 (1205)
T ss_pred ---CcchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccc
Confidence 458999999999999988543 3456666677778889999999997 79999999999999999999999998
Q ss_pred CCccCCCC-----------------------------CCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHH
Q 035862 229 LAREGPTG-----------------------------DHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEIL 279 (393)
Q Consensus 229 ~a~~~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell 279 (393)
........ +.........||+.|.+||...+......+|+|++|++++|.+
T Consensus 950 t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 950 TLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred cccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence 43221100 0001123467999999999999999999999999999999999
Q ss_pred hCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccc-cccCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 035862 280 TGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLR-NQYSINAARRVAKLADNCLKKNPEERPTMN 349 (393)
Q Consensus 280 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 349 (393)
+|.+||....+. +.+.. +...... ...+...+..+.+++...+..+|.+|..+.
T Consensus 1030 ~g~pp~na~tpq--~~f~n--------------i~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQ--QIFEN--------------ILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred cCCCCCCCcchh--hhhhc--------------cccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 999999765442 11111 1111110 112234567889999999999999998876
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.6e-10 Score=101.02 Aligned_cols=272 Identities=17% Similarity=0.184 Sum_probs=161.5
Q ss_pred ccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeee---ecCCcccce
Q 035862 76 RMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYC---STEDERGIQ 152 (393)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~---~~~~~~~~~ 152 (393)
..+.||+|+-+.+|-.--. .+ .+-|+..........+...| +.+.-.||-+-.-+.|- ......+..
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d------~VAKIYh~Pppa~~aqk~a~--la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RD------QVAKIYHAPPPAAQAQKVAE--LAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCccccCCccceeeecchh--hc------hhheeecCCCchHHHHHHHH--hccCCCCcchhhhhcccHHHhhCCCccce
Confidence 3456999999999964211 11 23355544433322222222 22223465433211111 111111222
Q ss_pred EEEEEeecCCC-ChHHHH----hhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 153 RLLVYEYMPNR-SLEDRL----FSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 153 ~~lv~e~~~~~-~L~~~l----~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
.-++|..+.|. .+.+++ +.+..+...|...+..++.|+.+.+.||.. |.+-+|+.++|+|+++++.+.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcc
Confidence 45677777664 222222 123445678999999999999999999998 9999999999999999999999975
Q ss_pred cCCccCCCCCCccccccccccCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhC-CCccCCCCc------hhhhH
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIE-----TGHLKSQSDIWSFGVVLYEILTG-RRVLERNRP------TMEQK 295 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~elltg-~~pf~~~~~------~~~~~ 295 (393)
..-... .+.......+|.+.|.+||... +..-+...|.|.||+++++++.| ++||.+-.. ..+..
T Consensus 162 Dsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 162 DSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred cceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 432221 1122334568999999999764 34567789999999999998887 999964211 11111
Q ss_pred HHHHHhhcCcCCcccccccCcccccccC-HHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHHHHHhhhcCCCC
Q 035862 296 LLEWVKQFPADGKKFSMMIDPRLRNQYS-INAARRVAKLADNCLKK--NPEERPTMNQVVESLKLAVQESEQGSS 367 (393)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~--dp~~Rps~~~~l~~l~~~~~~~~~~~~ 367 (393)
+..-...+..+. ..-..+ -....+ ...++++..|..+|+.. ++.-|||++..+..|..+.+....=..
T Consensus 239 Ia~g~f~ya~~~---~~g~~p-~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v 309 (637)
T COG4248 239 IAHGRFAYASDQ---RRGLKP-PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTV 309 (637)
T ss_pred hhcceeeechhc---cCCCCC-CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhh
Confidence 111000000000 000000 011111 24567788888888864 367899999999888877765544333
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.7e-10 Score=98.91 Aligned_cols=145 Identities=21% Similarity=0.228 Sum_probs=104.3
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCC--CccceeeeeeecCCcccceEE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSH--PNLVKLLGYCSTEDERGIQRL 154 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~ 154 (393)
+.|+.|..+.||++.... +..+++|....... .....+..|+++++.+.+ .++.+++.+....... ...+
T Consensus 4 ~~l~~G~~n~~~~v~~~~------g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~-~~~~ 76 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG------GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVL-GTPF 76 (223)
T ss_pred eecCCCccceEEEEEecC------CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCcc-CCce
Confidence 468999999999987532 23488998765432 134567789999999875 3456677665543211 1238
Q ss_pred EEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 035862 155 LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEG----------------------------------- 199 (393)
Q Consensus 155 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~----------------------------------- 199 (393)
+||||++|.++.+.+.. ..++......++.+++.+|..||+.
T Consensus 77 ~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 77 YVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred EEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 99999999888765421 3466667777888888888888852
Q ss_pred ------------------CCCCeEeccCCCCCeEeCC--CCceEEeeccCCcc
Q 035862 200 ------------------LEIQVIYRDFKTSNVLLDG--NFKPKLSDFGLARE 232 (393)
Q Consensus 200 ------------------~~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~a~~ 232 (393)
....++|+|++|+||+++. ++.+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 0246899999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=4.3e-09 Score=94.12 Aligned_cols=110 Identities=15% Similarity=0.083 Sum_probs=79.7
Q ss_pred HHHHHHHHhhcCCCCc--cceeeeeeecCCcc-cceEEEEEeecCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 035862 120 QWLAEVQFLGVVSHPN--LVKLLGYCSTEDER-GIQRLLVYEYMPNR-SLEDRLFSRAQPTLPWKTRLEIILGAAEGLAY 195 (393)
Q Consensus 120 ~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~-~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~ 195 (393)
.+.+|...+..+..-+ ...++++....... ...-++|||++++. +|.+++........+......++.+++..+.-
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 3668888887764322 23344444322111 12348999999885 89998743323445666778899999999999
Q ss_pred hhcCCCCCeEeccCCCCCeEeCC-------CCceEEeeccCCcc
Q 035862 196 LHEGLEIQVIYRDFKTSNVLLDG-------NFKPKLSDFGLARE 232 (393)
Q Consensus 196 LH~~~~~~ivH~Dikp~NIll~~-------~~~~kl~Dfg~a~~ 232 (393)
||.+ ||+|+|+++.|||++. ++.+.|+||+.+..
T Consensus 154 LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 154 MHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 9999 9999999999999975 46799999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=5.2e-09 Score=88.30 Aligned_cols=97 Identities=23% Similarity=0.286 Sum_probs=64.1
Q ss_pred HHHHHHHhhcCCCC--ccceeeeeeecCCcccceEEEEEeecC--CCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH-
Q 035862 121 WLAEVQFLGVVSHP--NLVKLLGYCSTEDERGIQRLLVYEYMP--NRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAY- 195 (393)
Q Consensus 121 ~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~- 195 (393)
..+|.+.|..+..- ++.+++++. .. ++||||++ |..+..+. ... +.......++.+++..+..
T Consensus 55 ~~~E~~~L~~l~~~Gv~vP~p~~~~--~~------~ivME~I~~~G~~~~~l~-~~~---~~~~~~~~~~~~il~~~~~~ 122 (188)
T PF01163_consen 55 AKKEFRNLKRLYEAGVPVPKPYDYN--RN------VIVMEYIGEDGVPLPRLK-DVD---LSPEEPKELLEEILEEIIKM 122 (188)
T ss_dssp HHHHHHHHHHCCCTT-SS--EEEEE--TT------EEEEE--EETTEEGGCHH-HCG---GGGSTHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCccCCcEEEEe--CC------EEEEEecCCCccchhhHH-hcc---ccchhHHHHHHHHHHHHHHH
Confidence 56799999999855 456665442 22 89999998 65554433 111 1134456677788885555
Q ss_pred hhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 196 LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
+|.. |++|+|+.+.|||++++ .+.|+|||.+...
T Consensus 123 ~~~~---givHGDLs~~NIlv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 123 LHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp HHCT---TEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred HHhc---CceecCCChhhEEeecc-eEEEEecCcceec
Confidence 5787 99999999999999987 8999999988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.2e-08 Score=86.58 Aligned_cols=143 Identities=17% Similarity=0.105 Sum_probs=103.5
Q ss_pred ecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC------cccHHHHHHHHHHhhcCCCC--ccceeeeeeecCCcccc
Q 035862 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG------LQGHKQWLAEVQFLGVVSHP--NLVKLLGYCSTEDERGI 151 (393)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~ 151 (393)
-|+||.+.|+.....+. .+-+|.....- +.....+.+|+..|..+..- .+.++............
T Consensus 26 ~~rgG~SgV~r~~~~g~-------~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~ 98 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-------KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEW 98 (216)
T ss_pred cCCCCcceEEEEEeCCc-------EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCce
Confidence 56789999998764321 47888765211 22456788999999887632 24444422222233334
Q ss_pred eEEEEEeecCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc--eEEeecc
Q 035862 152 QRLLVYEYMPN-RSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK--PKLSDFG 228 (393)
Q Consensus 152 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~--~kl~Dfg 228 (393)
.-+||+|-+.| .+|.+++.+......+......++.+++.++.-||+. |+.|+|+.+.||+++.+|. ++++||.
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlE 175 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLE 175 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhh
Confidence 56899998753 6899988554444567777889999999999999999 9999999999999987777 9999998
Q ss_pred CCcc
Q 035862 229 LARE 232 (393)
Q Consensus 229 ~a~~ 232 (393)
-++.
T Consensus 176 k~r~ 179 (216)
T PRK09902 176 KSRR 179 (216)
T ss_pred ccch
Confidence 7764
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.2e-08 Score=88.10 Aligned_cols=109 Identities=24% Similarity=0.257 Sum_probs=82.9
Q ss_pred HHHHHHHHHhhcCCCC--ccceeeeeeecCCcccceEEEEEeecCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH
Q 035862 119 KQWLAEVQFLGVVSHP--NLVKLLGYCSTEDERGIQRLLVYEYMPN-RSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAY 195 (393)
Q Consensus 119 ~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~ 195 (393)
....+|...+..+..- .+...+++..........-++|+|++++ .+|.+++..... .+......++.+++..+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence 4567788877776522 2445555555433333455899999988 489998854322 5566778999999999999
Q ss_pred hhcCCCCCeEeccCCCCCeEeCCCC---ceEEeeccCCcc
Q 035862 196 LHEGLEIQVIYRDFKTSNVLLDGNF---KPKLSDFGLARE 232 (393)
Q Consensus 196 LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~a~~ 232 (393)
||.+ ||+|+|+++.|||++.++ .+.++||+-++.
T Consensus 134 lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999 999999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.3e-10 Score=112.19 Aligned_cols=150 Identities=21% Similarity=0.346 Sum_probs=107.6
Q ss_pred HHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCcc-------ccccccccCCccCccccccCC
Q 035862 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTH-------VSTAVVGTYGYAAPEYIETGH 261 (393)
Q Consensus 189 l~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~ 261 (393)
.+.|+.|+|+. .++||++|.|++|.++.+|..||+.|+++.......... ...-..-...|.|||++.+..
T Consensus 108 v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 108 VADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred ccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 33899999986 699999999999999999999999999886544321111 111223456899999999988
Q ss_pred CCchhhHHHHHHHHHHHH-hCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhccc
Q 035862 262 LKSQSDIWSFGVVLYEIL-TGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKK 340 (393)
Q Consensus 262 ~~~~~DiwslGvil~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 340 (393)
.+.++|+||+||++|.+. .|+..+..+.......... ..+..-...++.+++.++.+-+.+++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~--------------~~~~~~~~~~s~~~p~el~~~l~k~l~~ 251 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR--------------NLLNAGAFGYSNNLPSELRESLKKLLNG 251 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh--------------cccccccccccccCcHHHHHHHHHHhcC
Confidence 899999999999999999 5555554443222211111 1111112223356778999999999999
Q ss_pred CCCCCCCHHHHHHH
Q 035862 341 NPEERPTMNQVVES 354 (393)
Q Consensus 341 dp~~Rps~~~~l~~ 354 (393)
++.-||++..+...
T Consensus 252 ~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 252 DSAVRPTLDLLLSI 265 (700)
T ss_pred CcccCcchhhhhcc
Confidence 99999987777654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.4e-08 Score=88.34 Aligned_cols=134 Identities=19% Similarity=0.086 Sum_probs=92.1
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc----------------------ccHHHHHHHHHHhhcC
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL----------------------QGHKQWLAEVQFLGVV 131 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l 131 (393)
+.+...||-|--+.||.|... .+..+++|.-+-... ..+..+.+|.++|..+
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L 166 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRL 166 (304)
T ss_pred HhhccccccCccceEEEEECC------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHh
Confidence 566788999999999999854 233588885432110 1123457899999998
Q ss_pred CCC--ccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 035862 132 SHP--NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDF 209 (393)
Q Consensus 132 ~h~--niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Di 209 (393)
.-. .+.+.+++- .-++|||+++|..|...- +.....-.++..|+.-+..+-.. |+||+|+
T Consensus 167 ~~~G~~VP~P~~~n--------RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHGDl 228 (304)
T COG0478 167 YPEGVKVPKPIAWN--------RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHGDL 228 (304)
T ss_pred hhcCCCCCCccccc--------cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---CccccCC
Confidence 744 666666542 228899999997765422 12233334444555545444455 9999999
Q ss_pred CCCCeEeCCCCceEEeeccCCc
Q 035862 210 KTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 210 kp~NIll~~~~~~kl~Dfg~a~ 231 (393)
++-||+++++|.+.++||--+.
T Consensus 229 SefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 229 SEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred chheEEEecCCCEEEEeCcccc
Confidence 9999999999999999997554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=1e-07 Score=92.44 Aligned_cols=152 Identities=16% Similarity=0.122 Sum_probs=92.7
Q ss_pred HHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccH-----------------------------
Q 035862 68 REATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH----------------------------- 118 (393)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~----------------------------- 118 (393)
++.+..|+. .-|+.++-|.||+|++.. +..||||+.++.-....
T Consensus 122 ee~F~eF~~-~PiAsASIaQVH~A~L~s------G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~v 194 (517)
T COG0661 122 EELFSEFEP-EPIASASIAQVHRAVLKS------GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEV 194 (517)
T ss_pred HHHHHHcCC-CchhhhhHhhheeEEecC------CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHH
Confidence 334444543 569999999999999864 34599999876422100
Q ss_pred -----H------HHHHHHHHhhcC----CCCccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHH
Q 035862 119 -----K------QWLAEVQFLGVV----SHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRL 183 (393)
Q Consensus 119 -----~------~~~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 183 (393)
+ .+.+|+..+.++ +...-+.+-.++.+-.. ..+++|||++|..+.+...-.. .+++...+.
T Consensus 195 v~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~---~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia 270 (517)
T COG0661 195 VDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTT---RRVLTMEWIDGIKISDIAALKS-AGIDRKELA 270 (517)
T ss_pred HHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccC---CcEEEEEeeCCEecccHHHHHh-cCCCHHHHH
Confidence 0 123344444443 22222333333332111 2289999999999988753233 334433333
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCC
Q 035862 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPT 235 (393)
Q Consensus 184 ~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 235 (393)
....++.--.-+ + . |++|.|.+|+||+++.+|.+.+.|||+......
T Consensus 271 ~~~~~~f~~q~~-~-d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 271 ELLVRAFLRQLL-R-D---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHHHHH-h-c---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 322222211111 2 3 999999999999999999999999999886544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.1e-07 Score=77.05 Aligned_cols=140 Identities=13% Similarity=0.057 Sum_probs=86.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHH---------HHHHHHhhcCCC---Cccce
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---------LAEVQFLGVVSH---PNLVK 138 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h---~niv~ 138 (393)
.++|...+.+-......|.+-.... ..+.+|..........+.+ .+.+..+..+.. -....
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~-------~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~ 102 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDG-------KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPAD 102 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECC-------cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccc
Confidence 4678888888888877777655322 2488898876543222221 223333333321 22222
Q ss_pred eeeeeecCCc-ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC
Q 035862 139 LLGYCSTEDE-RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD 217 (393)
Q Consensus 139 ~~~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~ 217 (393)
++.+..-... .....+++|||++|..|.+.. .+++ .+...+..++.-||.. |++|+|..|+|++++
T Consensus 103 ~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~------~i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~ 169 (229)
T PF06176_consen 103 PYLAAEKKIFRYTSSYVLLMEYIEGVELNDIE------DIDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVS 169 (229)
T ss_pred ceeeeeeeeccceeEEEEEEEEecCeecccch------hcCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEE
Confidence 2222211111 111236899999998887653 1232 2445677889999998 999999999999998
Q ss_pred CCCceEEeeccCCc
Q 035862 218 GNFKPKLSDFGLAR 231 (393)
Q Consensus 218 ~~~~~kl~Dfg~a~ 231 (393)
+++ ++++||+..+
T Consensus 170 ~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 170 NNG-IRIIDTQGKR 182 (229)
T ss_pred CCc-EEEEECcccc
Confidence 655 9999998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.50 E-value=2e-06 Score=74.24 Aligned_cols=149 Identities=19% Similarity=0.188 Sum_probs=93.7
Q ss_pred HHHHHHHhcCCcccceecc---cCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc-------------------HHH-
Q 035862 64 MQELREATNGFNRMLKIGE---GGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-------------------HKQ- 120 (393)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~---G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------~~~- 120 (393)
...+....++..+....|. |--+.||+|.. +....+|+|+........ .++
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~l 110 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAET------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKL 110 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeecc------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHH
Confidence 3445566666666666654 55567999863 234469999876432211 111
Q ss_pred ----HHHHHHHhhcCC--CCccceeeeeeecCCcccceEEEEEeecCCCCh-HHHHhhcCCCCCCHHHHHHHHHHHHHHH
Q 035862 121 ----WLAEVQFLGVVS--HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSL-EDRLFSRAQPTLPWKTRLEIILGAAEGL 193 (393)
Q Consensus 121 ----~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~~~~~i~~ql~~~l 193 (393)
...|..-|+++. +-.+.+.+++. .-.|||||+....+ .-.| +..++.......+..+++..+
T Consensus 111 v~~W~~kEf~NL~R~~eAGVrvP~Pi~~~--------~nVLvMEfIg~~g~pAP~L---kDv~~e~~e~~~~~~~~v~~~ 179 (268)
T COG1718 111 VFAWARKEFRNLKRAYEAGVRVPEPIAFR--------NNVLVMEFIGDDGLPAPRL---KDVPLELEEAEGLYEDVVEYM 179 (268)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCCceeec--------CCeEEEEeccCCCCCCCCc---ccCCcCchhHHHHHHHHHHHH
Confidence 245777777764 33334444432 12899999954311 0011 111223335667778888888
Q ss_pred HHhhc-CCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 194 AYLHE-GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 194 ~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
.-|-. . ++||+||+.-|||+. ++.+.++|||-|...
T Consensus 180 ~~l~~~a---~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 180 RRLYKEA---GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred HHHHHhc---CcccccchhhheEEE-CCeEEEEECcccccc
Confidence 87776 5 999999999999999 889999999988653
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.50 E-value=4e-06 Score=71.03 Aligned_cols=102 Identities=26% Similarity=0.270 Sum_probs=80.3
Q ss_pred HHHHHhhcCCC-CccceeeeeeecCCcccceEEEEEeecCCCChHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 035862 123 AEVQFLGVVSH-PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFS-RAQPTLPWKTRLEIILGAAEGLAYLHEGL 200 (393)
Q Consensus 123 ~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ 200 (393)
.|.-+++.+++ +++.+++|.|- .++|.||...+++...-.. ..-...+|..+..++.+++..+.+|+...
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG--------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG--------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC--------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 57788888875 69999999982 1789999976655321000 11124689999999999999999999865
Q ss_pred CCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 201 EIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 201 ~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
...+.-.|++|+|+-++++|++|++|...+..
T Consensus 80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 55688899999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.8e-06 Score=70.55 Aligned_cols=130 Identities=19% Similarity=0.189 Sum_probs=89.3
Q ss_pred cccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccc-eeeeeeecCCcccceE
Q 035862 75 NRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLV-KLLGYCSTEDERGIQR 153 (393)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~ 153 (393)
+..+.||+|++|.||+|.++.. .+++|+-..++ .+..+..|+++|..++--++- +++.+ ..+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~-------~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y--g~~------ 87 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGG-------EVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY--GED------ 87 (201)
T ss_pred hhhhhhhcccccEEEEeeccCc-------eEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe--chh------
Confidence 4456799999999999987643 38888877653 456788899999998865554 33332 222
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC-CCCeEeCCCCceEEeeccCCcc
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFK-TSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dik-p~NIll~~~~~~kl~Dfg~a~~ 232 (393)
++.|||+.|.+|.++.... +.. ....++++-.-|-.. ||-|+.|. |...+|..++.+.|+||..|..
T Consensus 88 ~i~me~i~G~~L~~~~~~~-----~rk----~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG-----DRK----HLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhhcCcchhhhhhcc-----cHH----HHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 5679999998998765211 222 233355554445555 99999887 5555555566999999998874
Q ss_pred C
Q 035862 233 G 233 (393)
Q Consensus 233 ~ 233 (393)
.
T Consensus 156 k 156 (201)
T COG2112 156 K 156 (201)
T ss_pred c
Confidence 3
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.44 E-value=6.1e-06 Score=72.29 Aligned_cols=139 Identities=19% Similarity=0.162 Sum_probs=78.7
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCc--cceeeeeeecCCcccceEEE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPN--LVKLLGYCSTEDERGIQRLL 155 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~l 155 (393)
..||.|..+.||+.. +. .+++|...... ......+|.++++.+..-. +.+.+++....+. ..+
T Consensus 7 ~~i~~G~t~~~y~~~----~~-----~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~----~gl 71 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TG-----KWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGR----LGL 71 (226)
T ss_pred eeecCCCCcceeEec----CC-----CEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe----eee
Confidence 469999999999831 11 26777765432 2345678999998876333 3555655544442 367
Q ss_pred EEeecCCCC-hHHHH---------------------hhcCCCCCCHHHHHH-HHHH----------HHH-HHHHhhcC-C
Q 035862 156 VYEYMPNRS-LEDRL---------------------FSRAQPTLPWKTRLE-IILG----------AAE-GLAYLHEG-L 200 (393)
Q Consensus 156 v~e~~~~~~-L~~~l---------------------~~~~~~~~~~~~~~~-i~~q----------l~~-~l~~LH~~-~ 200 (393)
|||+++|.+ +...+ +.......+...... +..+ +.. ...+|... .
T Consensus 72 v~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~ 151 (226)
T TIGR02172 72 IYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPD 151 (226)
T ss_pred eeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCC
Confidence 999998864 21111 110001111111000 0000 000 11122111 1
Q ss_pred CCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 201 EIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 201 ~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
...++|+|+.|.||++++++ +.++||+.+..
T Consensus 152 ~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 152 TSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 23578999999999999988 99999997753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.7e-06 Score=83.71 Aligned_cols=139 Identities=18% Similarity=0.090 Sum_probs=85.2
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc-------------------------------HHH------
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-------------------------------HKQ------ 120 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~~------ 120 (393)
+.||..+.|.||+|+.+. +..||||+-++.-... .+.
T Consensus 167 ~piaaASlaQVhrA~L~~------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD 240 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD 240 (538)
T ss_pred chhhhcchhheEEEEecC------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence 469999999999999875 3459999987642110 001
Q ss_pred HHHHHHHhhc----CCCCc------cceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHH
Q 035862 121 WLAEVQFLGV----VSHPN------LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA 190 (393)
Q Consensus 121 ~~~E~~~l~~----l~h~n------iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~ 190 (393)
|.+|++-..+ +.|-+ |.+++-.+.. ..+|+|||++|..+.|.-.-.+ ..++...+..-+.+..
T Consensus 241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st------~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~ 313 (538)
T KOG1235|consen 241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLST------KRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAY 313 (538)
T ss_pred hHHHHHhHHHHHHHHHhcccccceeCCeehhhcCc------ceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHH
Confidence 2233332222 33444 3333322222 3389999999988876543222 2355444433333322
Q ss_pred HHHHHhhcCCCCCeEeccCCCCCeEeCC----CCceEEeeccCCccCC
Q 035862 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDG----NFKPKLSDFGLAREGP 234 (393)
Q Consensus 191 ~~l~~LH~~~~~~ivH~Dikp~NIll~~----~~~~kl~Dfg~a~~~~ 234 (393)
.-+-+. .|++|+|=.|+||++.. ++.+.+.|||+.....
T Consensus 314 ~~qIf~-----~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 314 LEQIFK-----TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHHHh-----cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 222222 29999999999999984 6789999999987643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.42 E-value=1.5e-06 Score=76.60 Aligned_cols=145 Identities=19% Similarity=0.205 Sum_probs=81.4
Q ss_pred cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCC--ccceeeeeeecCCcccceEE
Q 035862 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHP--NLVKLLGYCSTEDERGIQRL 154 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~ 154 (393)
++.|+.|..+.||+..... + .+++|..... .....+.+|..+++.+... .+..++.+....... ...+
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~------~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~-~~~~ 71 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G------RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFN-GFPY 71 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S------EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEET-SEEE
T ss_pred CccCCCCCeeeEEEEEECC-c------EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccc-ccce
Confidence 3578999999999988543 1 4889987654 3445667888888887532 355666544333222 2468
Q ss_pred EEEeecCCCChHH----------------HH---hhc--CCCCCCHHH---------HHHH------------HHHHHH-
Q 035862 155 LVYEYMPNRSLED----------------RL---FSR--AQPTLPWKT---------RLEI------------ILGAAE- 191 (393)
Q Consensus 155 lv~e~~~~~~L~~----------------~l---~~~--~~~~~~~~~---------~~~i------------~~ql~~- 191 (393)
++|++++|.++.. .+ +.. ......... .... ...+..
T Consensus 72 ~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (239)
T PF01636_consen 72 LLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEER 151 (239)
T ss_dssp EEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred EEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHH
Confidence 9999999988777 11 111 111111100 0000 011111
Q ss_pred HHHHhhc----CCCCCeEeccCCCCCeEeC-CCCceEEeeccCCc
Q 035862 192 GLAYLHE----GLEIQVIYRDFKTSNVLLD-GNFKPKLSDFGLAR 231 (393)
Q Consensus 192 ~l~~LH~----~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~ 231 (393)
.+..++. .....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 152 LLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2233332 1234799999999999999 66767899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.8e-08 Score=96.64 Aligned_cols=190 Identities=18% Similarity=0.139 Sum_probs=130.3
Q ss_pred HHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCc-cceeeeeeecCC
Q 035862 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPN-LVKLLGYCSTED 147 (393)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~ 147 (393)
+-+.-|....-+++|+++.+++.+...+. ....+.+... ....-++++|.+++||| .+..++-+..++
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaek------lL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~ 307 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEK------LLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGED 307 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhh------heeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCccc
Confidence 33445556667899999999998743221 1224444332 23445889999999999 555554444444
Q ss_pred cccceEEEEEeecCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 148 ERGIQRLLVYEYMPNR-SLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
+..++++++.++ +-...+ ......+...+...+.+.-.++++++|+. .=+|+| ||+.++ +..+..|
T Consensus 308 ----~~~i~~~i~s~~rs~~~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~ 374 (829)
T KOG0576|consen 308 ----YLWIPMRICSTGRSSALEM-TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLD 374 (829)
T ss_pred ----ccchhhhhhcCCccccccC-ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-ccccccc
Confidence 668899999876 222111 11112233334455666677889999986 568888 777665 7789999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCcc
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVL 285 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf 285 (393)
|+....+.... ......+++.++|||+.....+....|.|++|+-..++--|-+|-
T Consensus 375 ~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 375 FAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 99987765543 345678999999999999999999999999998777777777665
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.1e-06 Score=90.04 Aligned_cols=202 Identities=22% Similarity=0.292 Sum_probs=141.3
Q ss_pred HHHHHhhcCCCCccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 035862 123 AEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEI 202 (393)
Q Consensus 123 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~ 202 (393)
-|...+..+.|+|++.++.+.......+..+.+..+++...++...+ ..-..++..+.+.+..++.+||.|+|+.
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~--q~v~~i~~~~~r~~~~~~~~GL~~~h~~--- 305 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL--QSVGSIPLETLRILHQKLLEGLAYLHSL--- 305 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH--hhccccCHHHHHHHHHHHhhhHHHHHHh---
Confidence 35666777889999999988876665543344557888888888877 4445688899999999999999999997
Q ss_pred CeEeccCCCC---CeEeCCCCceEEe--eccCCccCCCCCCccccccccccCCccCccccccCCCCch--hhHHHHHHHH
Q 035862 203 QVIYRDFKTS---NVLLDGNFKPKLS--DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQ--SDIWSFGVVL 275 (393)
Q Consensus 203 ~ivH~Dikp~---NIll~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DiwslGvil 275 (393)
...|.-+... +-..+..+.+.++ ||+.+......... .....+..+.++|......++.+ .|+|.+|...
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 5555555544 4445566667766 88888765544322 23345566788887776665544 7999999999
Q ss_pred HHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 035862 276 YEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355 (393)
Q Consensus 276 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l 355 (393)
..+..|..+-..... . ..+++ ......+.++..+|+.-++++|+++.+++.+.
T Consensus 383 ~~~~~~~~i~~~~~~-----~--------------~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSAV-----P--------------VSLLD--------VLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhhcCcccccccc-----h--------------hhhhc--------cccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 999988654321100 0 00000 00112577889999999999999999999997
Q ss_pred HHHH
Q 035862 356 KLAV 359 (393)
Q Consensus 356 ~~~~ 359 (393)
..-.
T Consensus 436 f~~~ 439 (1351)
T KOG1035|consen 436 FLRF 439 (1351)
T ss_pred hccc
Confidence 6543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.1e-05 Score=71.76 Aligned_cols=138 Identities=17% Similarity=0.135 Sum_probs=78.5
Q ss_pred ecccCC-ceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCccceeeeeeecCCcccceEEEEE
Q 035862 80 IGEGGF-GSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDERGIQRLLVY 157 (393)
Q Consensus 80 lg~G~~-g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~lv~ 157 (393)
|..|.. ..||+..... ..+.+|...... ...+.+|+++++.+. +--+.+++++....+ ..++||
T Consensus 6 ~~~g~~~~~v~~~~~~~-------~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~----~~~lv~ 71 (244)
T cd05150 6 VTEGQSGATVYRLDGKN-------PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDG----RAWLLT 71 (244)
T ss_pred cCCCCCcCeEEEEcCCC-------CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCC----ccEEEE
Confidence 445555 7889876321 137778775432 234567888888775 333556666665443 238999
Q ss_pred eecCCCChHHHH-------------------hhcCCC--CCCHH--HHHHHHH--------------------HHHHHHH
Q 035862 158 EYMPNRSLEDRL-------------------FSRAQP--TLPWK--TRLEIIL--------------------GAAEGLA 194 (393)
Q Consensus 158 e~~~~~~L~~~l-------------------~~~~~~--~~~~~--~~~~i~~--------------------ql~~~l~ 194 (393)
|+++|.+|.... +..... .+... ....... .+...+.
T Consensus 72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T cd05150 72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA 151 (244)
T ss_pred EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence 999998776432 111000 11100 0000000 0111112
Q ss_pred HhhcC----CCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 195 YLHEG----LEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 195 ~LH~~----~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.|-.. ....++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 22111 12369999999999999998878899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.18 E-value=4.7e-05 Score=79.54 Aligned_cols=153 Identities=19% Similarity=0.255 Sum_probs=89.0
Q ss_pred cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCC-CCcc--ceeeeeeecCCcccce
Q 035862 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVS-HPNL--VKLLGYCSTEDERGIQ 152 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~~~~~~~ 152 (393)
+..++.|.+..+|+...... +....+++|+..... ......+.+|+++++.+. |+++ .+++.++.+....+ .
T Consensus 43 v~~l~gG~sn~ty~l~~~~~---~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G-~ 118 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNG---GSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIG-T 118 (822)
T ss_pred EEEeCCCCcCceEEEEECCC---CcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCC-C
Confidence 56789999999998765321 111236666654322 123346778999999986 6664 67777765542211 3
Q ss_pred EEEEEeecCCCChHH--------------------HH---hhcCCC--CC-----C----HHHHHHHHH-----------
Q 035862 153 RLLVYEYMPNRSLED--------------------RL---FSRAQP--TL-----P----WKTRLEIIL----------- 187 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~--------------------~l---~~~~~~--~~-----~----~~~~~~i~~----------- 187 (393)
.|+||||++|..+.+ .+ +..... .+ + ..++..+..
T Consensus 119 ~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~ 198 (822)
T PLN02876 119 AFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKP 198 (822)
T ss_pred ceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCC
Confidence 589999998865321 01 110000 00 0 112211111
Q ss_pred ----HHHHHHHHhhcCCC--------CCeEeccCCCCCeEeCCC-Cc-eEEeeccCCccC
Q 035862 188 ----GAAEGLAYLHEGLE--------IQVIYRDFKTSNVLLDGN-FK-PKLSDFGLAREG 233 (393)
Q Consensus 188 ----ql~~~l~~LH~~~~--------~~ivH~Dikp~NIll~~~-~~-~kl~Dfg~a~~~ 233 (393)
.+...+.+|..+.+ ..+||+|++++||+++.+ +. +-|.||+++...
T Consensus 199 ~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 199 PRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred CCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 12234556644322 359999999999999853 33 579999988753
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.11 E-value=0.0001 Score=62.80 Aligned_cols=128 Identities=20% Similarity=0.227 Sum_probs=84.3
Q ss_pred cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC----------------cccHHHHHHHHHHhhcCC------CC
Q 035862 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG----------------LQGHKQWLAEVQFLGVVS------HP 134 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~ 134 (393)
...||+|+.=.||.- ..+. -..||+..... ....++..+|+.....+. +.
T Consensus 6 ~~~i~~G~~R~cy~H--P~dp------~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~ 77 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDDP------NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWS 77 (199)
T ss_pred CcccccCCCceEEEC--CCCC------CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccc
Confidence 457999999999862 2222 26888887655 122345566666555544 88
Q ss_pred ccceeeeeeecCCcccceEEEEEeecC------CCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 035862 135 NLVKLLGYCSTEDERGIQRLLVYEYMP------NRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRD 208 (393)
Q Consensus 135 niv~~~~~~~~~~~~~~~~~lv~e~~~------~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~D 208 (393)
+|.+++|+..++-.. -+|+|.+. ..+|.+++.. ..++. ..... +-.-..||-++ .|+.+|
T Consensus 78 ~i~r~~G~veT~~G~----Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~~---L~~f~~~l~~~---~Iv~~d 143 (199)
T PF10707_consen 78 HIPRFYGFVETNLGL----GLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQA---LDEFKRYLLDH---HIVIRD 143 (199)
T ss_pred ccccEeEEEecCCce----EEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHHH---HHHHHHHHHHc---CCeecC
Confidence 999999999888755 55666642 2478888832 23444 33333 33445566666 899999
Q ss_pred CCCCCeEeCCC--C--ceEEee
Q 035862 209 FKTSNVLLDGN--F--KPKLSD 226 (393)
Q Consensus 209 ikp~NIll~~~--~--~~kl~D 226 (393)
++|.||++... + .+.|+|
T Consensus 144 l~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 144 LNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred CCcccEEEEecCCCceEEEEEe
Confidence 99999999533 2 477776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.08 E-value=4.1e-05 Score=67.67 Aligned_cols=31 Identities=19% Similarity=0.197 Sum_probs=26.1
Q ss_pred CCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 202 IQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 202 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
..++|+|+.++||++++++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 4699999999999998766567999997753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.91 E-value=9.5e-05 Score=66.25 Aligned_cols=137 Identities=16% Similarity=0.092 Sum_probs=73.9
Q ss_pred ecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCcc-ceeeeeeecCCcccceEEEEEe
Q 035862 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNL-VKLLGYCSTEDERGIQRLLVYE 158 (393)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~lv~e 158 (393)
+..|-...+|+.... +..+++|..........-...+|..+++.+....+ .+++... .+ ++|||
T Consensus 4 ~~~G~tn~~y~~~~~-------~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~~------~~v~e 68 (256)
T TIGR02721 4 LSGGLTNRSWRIEHP-------GISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--EH------WLLVE 68 (256)
T ss_pred CCCcCcCCeEEEEeC-------CccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--CC------EEEEE
Confidence 556777889987521 12377787554322211124568888888864333 3333332 22 78999
Q ss_pred ecCCCChHHH--------------H---hhcC--CCCCCHH-HHHHHHHHH---------HHHHHHhhcC-----CCCCe
Q 035862 159 YMPNRSLEDR--------------L---FSRA--QPTLPWK-TRLEIILGA---------AEGLAYLHEG-----LEIQV 204 (393)
Q Consensus 159 ~~~~~~L~~~--------------l---~~~~--~~~~~~~-~~~~i~~ql---------~~~l~~LH~~-----~~~~i 204 (393)
|++|..+... + +... ...+... .+..+..++ ...+..+-.. .+..+
T Consensus 69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 148 (256)
T TIGR02721 69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP 148 (256)
T ss_pred eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence 9998765421 1 1111 1111111 111111111 1111112111 12368
Q ss_pred EeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 205 IYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 205 vH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
+|+|+.|.||++++++ +.|+||+.+..
T Consensus 149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 149 LHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred ecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 9999999999999887 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00024 Score=67.18 Aligned_cols=77 Identities=17% Similarity=0.116 Sum_probs=49.8
Q ss_pred cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC------C-cccHHHHHHHHHHhhcCC---CCccceeeeeeecC
Q 035862 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH------G-LQGHKQWLAEVQFLGVVS---HPNLVKLLGYCSTE 146 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 146 (393)
.+.||.|.+..||++..... ...+.||.-.+. . .....+...|.+.|..+. -.++.+++.+..+.
T Consensus 31 ~~elggGn~N~VyrV~~~~g-----~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~ 105 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEG-----GKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEEL 105 (401)
T ss_pred eeEcCCCceEEEEEEEeCCC-----CeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCC
Confidence 35799999999999986421 124888875421 1 123456667888888763 34567777663322
Q ss_pred CcccceEEEEEeecCCCC
Q 035862 147 DERGIQRLLVYEYMPNRS 164 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~ 164 (393)
.++||||+++..
T Consensus 106 ------~~lVME~L~~~~ 117 (401)
T PRK09550 106 ------AVTVMEDLSDHK 117 (401)
T ss_pred ------CEEEEecCCCcc
Confidence 289999997643
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00039 Score=63.67 Aligned_cols=81 Identities=14% Similarity=0.094 Sum_probs=52.5
Q ss_pred cccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCC---CccceeeeeeecCCcccc
Q 035862 75 NRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH---PNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~~ 151 (393)
...+.||.|..+.||.....+. .+.+|..+.. .....+..|...|+.+.. -.+.++++++......+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-------~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g- 86 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-------NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPG- 86 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-------CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCC-
Confidence 3455799999999999753211 1566664321 123467789998888753 35777887765432111
Q ss_pred eEEEEEeecCCCCh
Q 035862 152 QRLLVYEYMPNRSL 165 (393)
Q Consensus 152 ~~~lv~e~~~~~~L 165 (393)
..++|||+++|.++
T Consensus 87 ~~~LVmE~i~G~~~ 100 (297)
T PRK10593 87 PDVLLLERLRGVSV 100 (297)
T ss_pred CeEEEEeccCCEec
Confidence 34999999998765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00027 Score=59.88 Aligned_cols=129 Identities=24% Similarity=0.313 Sum_probs=86.4
Q ss_pred cCCcccceecccCC-ceEEEEEEcCCCCCCCceEEEEEEecC---CCc------------------ccHHHHHHHHHHhh
Q 035862 72 NGFNRMLKIGEGGF-GSVYKGTIRPLDGRGEPLVVAVKKLNN---HGL------------------QGHKQWLAEVQFLG 129 (393)
Q Consensus 72 ~~y~~~~~lg~G~~-g~Vy~~~~~~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~ 129 (393)
..++.++.||.|.- |.||++..... .+|+|.... ... ....-|..|.+...
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~-------~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfg 109 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGR-------IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFG 109 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCe-------EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhH
Confidence 57888999999999 99999986532 599999321 111 01122455666555
Q ss_pred cC---CCCcc--ceeeeeeecCC--------------cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHH
Q 035862 130 VV---SHPNL--VKLLGYCSTED--------------ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA 190 (393)
Q Consensus 130 ~l---~h~ni--v~~~~~~~~~~--------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~ 190 (393)
++ .+.++ ++.+||..-.. .......||.||+.... .+. ..-+.++.
T Consensus 110 RLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~~ 174 (207)
T PF13095_consen 110 RLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQML 174 (207)
T ss_pred HHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHHH
Confidence 54 45566 89999884441 11123356778775533 122 23456677
Q ss_pred HHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 191 ~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
+-+..+|.. ||+-+|+++.|.. + -+|+|||.+
T Consensus 175 ~dl~~~~k~---gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 175 RDLKILHKL---GIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHHHHHHHC---CeeeccCcccccc---C--CEEEecccC
Confidence 788899998 9999999999987 2 388999865
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00032 Score=61.88 Aligned_cols=31 Identities=19% Similarity=0.263 Sum_probs=27.3
Q ss_pred CCeEeccCCCCCeEeCC-CCceEEeeccCCcc
Q 035862 202 IQVIYRDFKTSNVLLDG-NFKPKLSDFGLARE 232 (393)
Q Consensus 202 ~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~ 232 (393)
..++|+|+.+.|||+++ ++.+.|+||..|..
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 47999999999999998 57899999987753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00056 Score=62.68 Aligned_cols=146 Identities=20% Similarity=0.161 Sum_probs=78.8
Q ss_pred cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCc--cceeeeeeecCC--cccce
Q 035862 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPN--LVKLLGYCSTED--ERGIQ 152 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~--~~~~~ 152 (393)
+..|..|....+|+..... . .+++|..... .......|+.++..+.+.+ +.+++....... .....
T Consensus 19 i~~i~~G~~n~~y~v~~~~--~-----~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~ 88 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS--G-----RYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK 88 (296)
T ss_pred eecccCccccceEEEEeCC--C-----cEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence 4567777778899875321 1 3788887642 2344556777777764322 334432110000 00113
Q ss_pred EEEEEeecCCCChHH----HH----------hhcC-C--C------CCCHHHH----------HHHHHHHHHHHHHhhc-
Q 035862 153 RLLVYEYMPNRSLED----RL----------FSRA-Q--P------TLPWKTR----------LEIILGAAEGLAYLHE- 198 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~----~l----------~~~~-~--~------~~~~~~~----------~~i~~ql~~~l~~LH~- 198 (393)
.++|++|++|..+.. .+ +... . . ...+... ......+..++.++..
T Consensus 89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~ 168 (296)
T cd05153 89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF 168 (296)
T ss_pred eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence 478999999876532 01 1000 0 0 0011000 0011112333444442
Q ss_pred ---CCCCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 199 ---GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 199 ---~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
..+.+++|+|+.|.||++++++.+.|+||+.+..
T Consensus 169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 1235799999999999999987788999987753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.0027 Score=58.82 Aligned_cols=32 Identities=31% Similarity=0.356 Sum_probs=27.1
Q ss_pred CCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 201 EIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 201 ~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
+.+++|+|+.|+||+++++...-|+||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 45899999999999998666568999998753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0043 Score=57.14 Aligned_cols=31 Identities=35% Similarity=0.379 Sum_probs=27.6
Q ss_pred CCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 201 EIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 201 ~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
+.+++|+|+.+.||++++++.+.|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 4589999999999999988877899999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.45 E-value=3.5e-05 Score=81.42 Aligned_cols=159 Identities=13% Similarity=0.012 Sum_probs=112.3
Q ss_pred HHHHHhhcCCCCccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhcCC
Q 035862 123 AEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQ--PTLPWKTRLEIILGAAEGLAYLHEGL 200 (393)
Q Consensus 123 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ 200 (393)
.|..-++...|+++...+.-..... ....+.+++|+.+|.+.+.|.+... ..+....+.....+.+.+..-+|+..
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~--s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSE--STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCC--ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3444555567888776544332222 2244789999999999998865332 23333334333344366666666542
Q ss_pred CC--CeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHH
Q 035862 201 EI--QVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEI 278 (393)
Q Consensus 201 ~~--~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el 278 (393)
.. -.+|+++|+.|.+|..+..+|+.++|+.+.... .........+++.|+.|+....-.++.++|+|..|+-+|++
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence 22 368999999999999999999999999983211 12234556788899999999888999999999999999999
Q ss_pred HhCCCcc
Q 035862 279 LTGRRVL 285 (393)
Q Consensus 279 ltg~~pf 285 (393)
.-|..+|
T Consensus 1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred hcccHHH
Confidence 9988776
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0006 Score=64.99 Aligned_cols=167 Identities=24% Similarity=0.360 Sum_probs=93.2
Q ss_pred HHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh
Q 035862 118 HKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197 (393)
Q Consensus 118 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH 197 (393)
..+++-...+++.+.|+|...++++-..... ...+|||++ +.+|++.+..+... ... ++
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~---r~IVV~e~~-~~Sled~~~~~~l~---~~s-------------~~- 84 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHE---RVIVVMEHY-TMSLEDILKTGNLK---DES-------------LL- 84 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccc---eEEEEehhh-ccchHHHHHhcccc---hhh-------------hc-
Confidence 3456667889999999999999987765554 357899999 66999988543311 100 00
Q ss_pred cCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHH
Q 035862 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYE 277 (393)
Q Consensus 198 ~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~e 277 (393)
.+ ++.|- |+ ++.+| -++.. | |-. ..+|+||||+|.++.+
T Consensus 85 ~~---~~~~~-----~~-------~~~td-~~~t~------------------~--~~~-----~~pKsdVwsl~~i~~e 123 (725)
T KOG1093|consen 85 AH---GVLHL-----NI-------IYITD-HFLTK------------------Y--PSP-----IGPKSDVWSLGFIILE 123 (725)
T ss_pred cc---cccee-----hh-------hhccc-ccccc------------------C--CCC-----CCcchhhhhHHHHHHH
Confidence 11 44332 22 23333 11100 0 100 1149999999999999
Q ss_pred HHhCCCccCCCCchhhhHHHHHHhhcC-cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 035862 278 ILTGRRVLERNRPTMEQKLLEWVKQFP-ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353 (393)
Q Consensus 278 lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~ 353 (393)
+..|...+........ ......+. .+.......... .....++..+.++..+|+-..|..||...++.+
T Consensus 124 l~L~~~l~~~~~~s~~---l~~i~k~~~~d~~~~~~a~e~----~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k 193 (725)
T KOG1093|consen 124 LYLGISLEAELTESEY---LEILLKYYTDDQELLSTAMEH----LIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK 193 (725)
T ss_pred HHHhhHHHHHHHHHHH---HHHHHHhccCchhHHHHHHHH----HHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence 9999766543222111 11111111 111111100000 122245667778888888888888886655554
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00019 Score=64.61 Aligned_cols=134 Identities=15% Similarity=0.063 Sum_probs=86.9
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEec--CCCc--------------------ccHHHHHHHHHHhhc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN--NHGL--------------------QGHKQWLAEVQFLGV 130 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~--~~~~--------------------~~~~~~~~E~~~l~~ 130 (393)
-+.+++.||-|--+.+|.+.+. .+...++|.-+ ..+. -.+-...+|...|+.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~------~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmka 166 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE------EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKA 166 (465)
T ss_pred hhhhccccccccccceEEEecC------CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHH
Confidence 4778899999999999998753 22235655321 1100 011234568888877
Q ss_pred CC-CCc-cceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 035862 131 VS-HPN-LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRD 208 (393)
Q Consensus 131 l~-h~n-iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~D 208 (393)
+. |.. +.+.+++. .-++|||++.|-+|...-. . .. .-.+...+..-+--|..+ |+||+|
T Consensus 167 L~e~gfpVPkpiD~~--------RH~Vvmelv~g~Pl~~v~~-v----~d---~~~ly~~lm~~Iv~la~~---GlIHgD 227 (465)
T KOG2268|consen 167 LYERGFPVPKPIDHN--------RHCVVMELVDGYPLRQVRH-V----ED---PPTLYDDLMGLIVRLANH---GLIHGD 227 (465)
T ss_pred HHHcCCCCCCccccc--------ceeeHHHhhcccceeeeee-c----CC---hHHHHHHHHHHHHHHHHc---Cceecc
Confidence 75 322 33444332 2388999999988865321 1 11 223444455555667777 999999
Q ss_pred CCCCCeEeCCCCceEEeeccCCc
Q 035862 209 FKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 209 ikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..-=||++++++.++++||--..
T Consensus 228 FNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 228 FNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred cchheeEEecCCCEEEeechHhh
Confidence 99999999999999999996443
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0064 Score=57.51 Aligned_cols=74 Identities=14% Similarity=0.129 Sum_probs=47.7
Q ss_pred ccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-------ccHHHHHHHHHHhhcCC---CCccceeeeeeec
Q 035862 76 RMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-------QGHKQWLAEVQFLGVVS---HPNLVKLLGYCST 145 (393)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~ 145 (393)
..+.||.|....||+.... + ..++||.-..... ....+...|+..|+.+. ..++.+++.++.+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~-----~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded 108 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--S-----GSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT 108 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--C-----ccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC
Confidence 3567899999999997742 1 1388887652110 12334445677776654 2477788887764
Q ss_pred CCcccceEEEEEeecCC
Q 035862 146 EDERGIQRLLVYEYMPN 162 (393)
Q Consensus 146 ~~~~~~~~~lv~e~~~~ 162 (393)
.. +++|||+++
T Consensus 109 ~~------vlvME~L~~ 119 (418)
T PLN02756 109 MA------LIGMRYLEP 119 (418)
T ss_pred CC------EEEEeecCC
Confidence 43 889999976
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0052 Score=57.04 Aligned_cols=31 Identities=16% Similarity=0.230 Sum_probs=26.1
Q ss_pred CCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 202 IQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 202 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
..++|||+.++||++++++ ++++||.++...
T Consensus 192 ~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~G 222 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEHE-TKVIDPEFAFYG 222 (370)
T ss_pred ceeeeccCCcccEEEcCCC-CEEEcCcccccC
Confidence 3789999999999998765 779999877653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0015 Score=59.88 Aligned_cols=113 Identities=17% Similarity=0.229 Sum_probs=76.0
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
.+.+.|++|++- |++|.- + ....+.++..++.+.+..++-+..+ ...-|||+.-+||||+ +|+|.|+||.
T Consensus 297 e~~y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred CceEEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEee
Confidence 344778888887 666642 1 2245778899999999988888876 5788999999999999 9999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCC
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR 282 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~ 282 (393)
+++....... +-....-.|-.+.|.. +..-|||-+ |--|+.|+
T Consensus 367 lsRl~~~q~~-------isy~rldhp~lF~G~d-d~QFeIYrl---Mr~l~~g~ 409 (488)
T COG5072 367 LSRLSYSQGI-------ISYNRLDHPDLFNGVD-DYQFEIYRL---MRRLLKGR 409 (488)
T ss_pred eeecccCCce-------eeccccCchhhhcCcc-ceeeeHHHH---HHHHhcCc
Confidence 9984322211 1111223344454333 666677764 34444443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0068 Score=55.65 Aligned_cols=33 Identities=27% Similarity=0.239 Sum_probs=28.5
Q ss_pred CCCCeEeccCCCCCeEeCCC----CceEEeeccCCcc
Q 035862 200 LEIQVIYRDFKTSNVLLDGN----FKPKLSDFGLARE 232 (393)
Q Consensus 200 ~~~~ivH~Dikp~NIll~~~----~~~kl~Dfg~a~~ 232 (393)
.+..++|+|+.|.|||++++ +.+.++||..+..
T Consensus 177 ~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 177 SPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred CCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 34589999999999999985 8899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0071 Score=54.74 Aligned_cols=30 Identities=20% Similarity=0.383 Sum_probs=25.4
Q ss_pred CeEeccCCCCCeEeCCCCc-eEEeeccCCcc
Q 035862 203 QVIYRDFKTSNVLLDGNFK-PKLSDFGLARE 232 (393)
Q Consensus 203 ~ivH~Dikp~NIll~~~~~-~kl~Dfg~a~~ 232 (393)
.++|+|++|+|||+++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 5899999999999997565 46999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0077 Score=55.11 Aligned_cols=107 Identities=18% Similarity=0.186 Sum_probs=67.4
Q ss_pred HHHHHHHHHhhcCCC--CccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHH-HHHHHHHHH
Q 035862 119 KQWLAEVQFLGVVSH--PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEII-LGAAEGLAY 195 (393)
Q Consensus 119 ~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~-~ql~~~l~~ 195 (393)
....+|+.+++.+.- --+...++.|.++. . ..++.||+|++|..+.+.+. +......++ ..++..|..
T Consensus 66 ~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~-~-g~pf~v~~~veGe~~~~~~~-------~~~~~~~~~~~~l~~~La~ 136 (321)
T COG3173 66 HDEKREYRVIAALLDVDVPVPRAFGLCGEGY-L-GTPFYVMEWVEGEVVWSALP-------PESLGRQFALDALADFLAE 136 (321)
T ss_pred hHHHhHHHHHHHhcCCCCCCcccccccccCC-C-CCceEEEEEecceeccCcCC-------cccchHHHHHHHHHHHHHH
Confidence 444567777776642 23345556666555 1 24599999998854433221 111111222 255566666
Q ss_pred hhcC-------------------------------------------------------CCCCeEeccCCCCCeEeCCCC
Q 035862 196 LHEG-------------------------------------------------------LEIQVIYRDFKTSNVLLDGNF 220 (393)
Q Consensus 196 LH~~-------------------------------------------------------~~~~ivH~Dikp~NIll~~~~ 220 (393)
||+- ....++|+|+.+.|+++++++
T Consensus 137 LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~ 216 (321)
T COG3173 137 LHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGR 216 (321)
T ss_pred HhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCC
Confidence 6642 125799999999999999998
Q ss_pred ceEEeeccCCccCC
Q 035862 221 KPKLSDFGLAREGP 234 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~ 234 (393)
-+=+.||+++....
T Consensus 217 ~~gVlDwe~~~lGD 230 (321)
T COG3173 217 PTGVLDWELATLGD 230 (321)
T ss_pred eeEEEeccccccCC
Confidence 89999999987543
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0035 Score=57.61 Aligned_cols=140 Identities=16% Similarity=0.099 Sum_probs=88.8
Q ss_pred ccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc----------------------cHHH----HHHHHHHhh
Q 035862 76 RMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ----------------------GHKQ----WLAEVQFLG 129 (393)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~----~~~E~~~l~ 129 (393)
+-..|..|--+.||.|.-. ++..+|||+.+.+-.. .++. +..|++-|.
T Consensus 148 inGCiSTGKEANVYHat~~------dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLk 221 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE------DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLK 221 (520)
T ss_pred cccccccCccceeEeeecC------CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHH
Confidence 3345777888899998733 2334899977542110 0111 245777788
Q ss_pred cCCCCccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccC
Q 035862 130 VVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDF 209 (393)
Q Consensus 130 ~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Di 209 (393)
+++...|.-.--+..-.. +|||+|+.+.....= .-....++...+..+-.|++.-+.-|-+. +++||.||
T Consensus 222 Rl~~aGIP~PePIlLk~h------VLVM~FlGrdgw~aP--kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADL 291 (520)
T KOG2270|consen 222 RLNNAGIPCPEPILLKNH------VLVMEFLGRDGWAAP--KLKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADL 291 (520)
T ss_pred HHHhcCCCCCCceeeecc------eEeeeeccCCCCcCc--ccccccCChHHHHHHHHHHHHHHHHHHHH--hceeccch
Confidence 776544332211121111 799999954222110 01233466667788888888888888766 59999999
Q ss_pred CCCCeEeCCCCceEEeeccCCcc
Q 035862 210 KTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 210 kp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
+--|+|+- +|.+.++|-+-+..
T Consensus 292 SEfN~Lyh-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 292 SEFNLLYH-DGKLYIIDVSQSVE 313 (520)
T ss_pred hhhhheEE-CCEEEEEEcccccc
Confidence 99999986 57899999987764
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.011 Score=55.26 Aligned_cols=146 Identities=17% Similarity=0.182 Sum_probs=79.5
Q ss_pred cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCcc-ceeeeeeecCCcccceEEE
Q 035862 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNL-VKLLGYCSTEDERGIQRLL 155 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~l 155 (393)
+..|..|-.-.+|++...... ......|++|........... ..+|..+++.+..-++ .++++.+. + ..
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~-~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~--~------g~ 110 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKE-GNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFP--N------GR 110 (344)
T ss_pred EEEcCCcccceeEEEEeCCCC-CCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEEC--C------ce
Confidence 344555777789987643211 122346888887654332222 2568888888763333 34555442 2 24
Q ss_pred EEeecCCCChHHH-----------------HhhcC--CC--CCCHHHHHHHHHHH-----------------HHHHHHh-
Q 035862 156 VYEYMPNRSLEDR-----------------LFSRA--QP--TLPWKTRLEIILGA-----------------AEGLAYL- 196 (393)
Q Consensus 156 v~e~~~~~~L~~~-----------------l~~~~--~~--~~~~~~~~~i~~ql-----------------~~~l~~L- 196 (393)
|++|+++.+|... ++... .. ...+..+..+..++ ...+..|
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 7899887776421 01111 00 11122222222111 1111122
Q ss_pred ---hc-CCCCCeEeccCCCCCeEeCC-CCceEEeeccCCcc
Q 035862 197 ---HE-GLEIQVIYRDFKTSNVLLDG-NFKPKLSDFGLARE 232 (393)
Q Consensus 197 ---H~-~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~ 232 (393)
.. ..+..++|+|+++.|||+++ ++.+.++||..+..
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11 12347899999999999986 47899999988753
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.007 Score=54.89 Aligned_cols=75 Identities=15% Similarity=0.252 Sum_probs=42.1
Q ss_pred cccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC---CCccceeeeeeecCCcccc
Q 035862 75 NRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS---HPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~ 151 (393)
+..+.++.|....+|+... .+..+.+|.-... ....+..|+.-|+.+. --.+.+++++....+..
T Consensus 20 ~~~~~v~GG~i~~a~~~~~-------~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~-- 87 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDT-------DGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDA-- 87 (288)
T ss_dssp -EEEEE--SSSSEEEEEET-------TS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCC--
T ss_pred eeeEecCCCChhheEEEEC-------CCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCc--
Confidence 4455688888899998761 2235888887632 2345666777666663 44577888877666543
Q ss_pred eEEEEEeecCCC
Q 035862 152 QRLLVYEYMPNR 163 (393)
Q Consensus 152 ~~~lv~e~~~~~ 163 (393)
+|||||++.+
T Consensus 88 --fLlle~l~~~ 97 (288)
T PF03881_consen 88 --FLLLEFLEMG 97 (288)
T ss_dssp --EEEEE-----
T ss_pred --eEEEEeecCC
Confidence 8999999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.01 Score=55.85 Aligned_cols=75 Identities=19% Similarity=0.215 Sum_probs=46.5
Q ss_pred cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC---C---cccHHHHHHHHHHhhcCC--CC-ccceeeeeeecCC
Q 035862 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH---G---LQGHKQWLAEVQFLGVVS--HP-NLVKLLGYCSTED 147 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~ 147 (393)
...||.|.-..||++.+.. .+..|.||.-.+. . .-...+..-|.++|+... -| ++.+++.+-.+.
T Consensus 34 ~~eigdGnlN~VfrV~~~~-----~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~- 107 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ-----KNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVM- 107 (409)
T ss_pred eeEcCCCceEEEEEEeeCC-----CCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHH-
Confidence 4579999999999998631 1123888865321 1 223455666888888764 34 455565543222
Q ss_pred cccceEEEEEeecCC
Q 035862 148 ERGIQRLLVYEYMPN 162 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~ 162 (393)
..+|||+++.
T Consensus 108 -----~~~vMEdL~~ 117 (409)
T PRK12396 108 -----NCCVMEDLSD 117 (409)
T ss_pred -----hhHHHHhCcc
Confidence 2789999854
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.045 Score=50.93 Aligned_cols=30 Identities=20% Similarity=0.217 Sum_probs=26.1
Q ss_pred CeEeccCCCCCeEeCC-CCceEEeeccCCcc
Q 035862 203 QVIYRDFKTSNVLLDG-NFKPKLSDFGLARE 232 (393)
Q Consensus 203 ~ivH~Dikp~NIll~~-~~~~kl~Dfg~a~~ 232 (393)
-++|+|+.+.|||+++ ++.++++||..|..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 4799999999999975 57899999998864
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.13 Score=48.73 Aligned_cols=30 Identities=20% Similarity=0.082 Sum_probs=24.8
Q ss_pred CCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 202 IQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 202 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
...+|.|+-+.||+.++ +.+.++||..|..
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccccC
Confidence 47899999999999765 4599999987753
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.064 Score=46.08 Aligned_cols=102 Identities=13% Similarity=0.107 Sum_probs=65.3
Q ss_pred EEEEEecCCCcc-cHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHH
Q 035862 105 VAVKKLNNHGLQ-GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRL 183 (393)
Q Consensus 105 vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 183 (393)
..+|++...... ....+..+.+++.++. .|+++.. + .+...-+|.|+|..... .+ .
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N---D---n~~~yGvIlE~Cy~~~i-----------~~----~ 144 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN---D---NNYKYGVILERCYKIKI-----------NF----S 144 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec---C---CCceeEEEEeeccCccc-----------ch----h
Confidence 556666544333 3445677888887765 4566652 1 22234678898843111 11 1
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 184 ~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
.++..=+.+|...|+. ..+.+|||-.|+||+-+..|.+||.|-+..
T Consensus 145 N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 145 NFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 1222224567788864 358999999999999999999999998754
|
The function of this family is unknown. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.064 Score=50.28 Aligned_cols=60 Identities=18% Similarity=0.125 Sum_probs=40.0
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHh-hcCCCCCeEeccCCCCCeEeCCC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL-HEGLEIQVIYRDFKTSNVLLDGN 219 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~L-H~~~~~~ivH~Dikp~NIll~~~ 219 (393)
.++-+|..|.++..++... ..++.....++.--+.|+--+ --. +.+|.|+.|+||++--+
T Consensus 321 vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vD---NFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVD---NFVHADLHPGNVLIRFN 381 (565)
T ss_pred eeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhh---cceecccCCCcEEEEec
Confidence 6677888888998888433 345555555555445554432 222 89999999999999533
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.21 Score=53.65 Aligned_cols=33 Identities=39% Similarity=0.459 Sum_probs=27.5
Q ss_pred CCCCeEeccCCCCCeEeCCCC--ceE-EeeccCCcc
Q 035862 200 LEIQVIYRDFKTSNVLLDGNF--KPK-LSDFGLARE 232 (393)
Q Consensus 200 ~~~~ivH~Dikp~NIll~~~~--~~k-l~Dfg~a~~ 232 (393)
.+.++||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 201 Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 201 LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 355899999999999999875 555 999998764
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.022 Score=47.85 Aligned_cols=30 Identities=17% Similarity=0.252 Sum_probs=26.4
Q ss_pred CCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 202 IQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 202 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
.-.+|+|+.|+|++++++| ++|+||+.+..
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 3579999999999998888 99999998864
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.95 E-value=0.058 Score=48.53 Aligned_cols=47 Identities=17% Similarity=0.132 Sum_probs=34.1
Q ss_pred HHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 185 IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 185 i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
.+..+-.++.-.+.. ..-++|+|+.|+|++.++.+.++|+||..|..
T Consensus 137 ~~~~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 137 KLKELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 333444444444431 02489999999999999999999999998864
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.75 E-value=0.7 Score=40.17 Aligned_cols=56 Identities=23% Similarity=0.321 Sum_probs=35.5
Q ss_pred EEEEEEecCCCcccHHHHHHHHHHhhcCC---CCccceeeeeeecCCcccceEEEEEeecCCCChH
Q 035862 104 VVAVKKLNNHGLQGHKQWLAEVQFLGVVS---HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLE 166 (393)
Q Consensus 104 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 166 (393)
.+.+|+-... ....|..|+.-|..+. .-.+.+++.+-...+ +.|+||||++-+.+.
T Consensus 41 ~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~----~sylVle~L~~~~~d 99 (286)
T COG3001 41 PFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRD----HSYLVLEYLPTGPLD 99 (286)
T ss_pred ceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCC----eeEEEEeeccCCCCC
Confidence 4888875443 2345666766666554 344556665555444 559999999887665
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.087 Score=48.51 Aligned_cols=29 Identities=21% Similarity=0.277 Sum_probs=25.6
Q ss_pred CCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 202 IQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 202 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 48999999999999987 678999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.99 E-value=0.13 Score=47.59 Aligned_cols=29 Identities=31% Similarity=0.418 Sum_probs=25.9
Q ss_pred eEeccCCCCCeEeCCCCc-eEEeeccCCcc
Q 035862 204 VIYRDFKTSNVLLDGNFK-PKLSDFGLARE 232 (393)
Q Consensus 204 ivH~Dikp~NIll~~~~~-~kl~Dfg~a~~ 232 (393)
+||+|+.|+||+++.+.. +-++||+-+..
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 999999999999999885 89999997753
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.94 E-value=1.1 Score=43.45 Aligned_cols=30 Identities=20% Similarity=0.297 Sum_probs=25.2
Q ss_pred CCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 202 IQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 202 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
..++|.|+-+.|||.++++ ++|+||..|..
T Consensus 284 ~VfCHNDl~~~NiL~~~~~-l~LIDfEYAg~ 313 (442)
T PTZ00296 284 IVFCHNDLQENNIINTNKC-LRLIDFEYSGY 313 (442)
T ss_pred eeEEeCCCCccceeecCCC-EEEEeeccccc
Confidence 4689999999999987555 99999987753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 393 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-53 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-52 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-50 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-49 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-39 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-36 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-22 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-21 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-21 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-21 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-21 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-20 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-20 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-20 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-20 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-20 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-20 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-19 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-19 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-19 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-19 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-19 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-18 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-17 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-17 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-17 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-17 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-17 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-17 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-16 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-16 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-16 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-16 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-16 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-16 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-16 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-16 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-16 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-15 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-15 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-14 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-14 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-14 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-14 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-14 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-14 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-14 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-12 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-12 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-12 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-12 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-12 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 8e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-11 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 9e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-10 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-10 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-10 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-10 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 8e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-10 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 4e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-08 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 9e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 9e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 6e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 458 bits (1180), Expect = e-163
Identities = 112/310 (36%), Positives = 160/310 (51%), Gaps = 29/310 (9%)
Query: 58 HLRVFDMQELREATNGFNRML------KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN 111
F EL+ TN F+ K+GEGGFG VYKG ++ VAVKKL
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGY---VNNT----TVAVKKLA 63
Query: 112 NH----GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLED 167
+ +Q+ E++ + H NLV+LLG+ S D LVY YMPN SL D
Sbjct: 64 AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD----DLCLVYVYMPNGSLLD 119
Query: 168 RLFSR-AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226
RL P L W R +I GAA G+ +LHE I+RD K++N+LLD F K+SD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISD 176
Query: 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLE 286
FGLAR T +++ +VGT Y APE + G + +SDI+SFGVVL EI+TG ++
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 287 RNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP 346
+R Q LL+ ++ + K ID ++ N + + +A CL + +RP
Sbjct: 236 EHRE--PQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 347 TMNQVVESLK 356
+ +V + L+
Sbjct: 293 DIKKVQQLLQ 302
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 431 bits (1111), Expect = e-152
Identities = 119/331 (35%), Positives = 183/331 (55%), Gaps = 18/331 (5%)
Query: 36 NRTARSLPSPRSIPELYKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRP 95
++ +++ S + +L EATN F+ IG G FG VYKG +R
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR- 61
Query: 96 LDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLL 155
DG VA+K+ QG +++ E++ L HP+LV L+G+C + + +L
Sbjct: 62 -DGA----KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN----EMIL 112
Query: 156 VYEYMPNRSLEDRLFSRAQPT--LPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSN 213
+Y+YM N +L+ L+ PT + W+ RLEI +GAA GL YLH +I+RD K+ N
Sbjct: 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSIN 169
Query: 214 VLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGV 273
+LLD NF PK++DFG++++G D TH+ST V GT GY PEY G L +SD++SFGV
Sbjct: 170 ILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229
Query: 274 VLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKL 333
VL+E+L R + ++ P L EW + +G + ++DP L ++ + R+
Sbjct: 230 VLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG-QLEQIVDPNLADKIRPESLRKFGDT 288
Query: 334 ADNCLKKNPEERPTMNQVVESLK--LAVQES 362
A CL + E+RP+M V+ L+ L +QES
Sbjct: 289 AVKCLALSSEDRPSMGDVLWKLEYALRLQES 319
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 396 bits (1020), Expect = e-138
Identities = 117/304 (38%), Positives = 178/304 (58%), Gaps = 17/304 (5%)
Query: 58 HLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG 117
L+ F ++EL+ A++ F+ +G GGFG VYKG + DG +VAVK+L QG
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA--DGT----LVAVKRLKEERTQG 69
Query: 118 HK-QWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLF--SRAQ 174
+ Q+ EV+ + + H NL++L G+C T +RLLVY YM N S+ L +Q
Sbjct: 70 GELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERLLVYPYMANGSVASCLRERPESQ 125
Query: 175 PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGP 234
P L W R I LG+A GLAYLH+ + ++I+RD K +N+LLD F+ + DFGLA+
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 235 TGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ 294
D THV+TAV GT G+ APEY+ TG ++D++ +GV+L E++TG+R + R +
Sbjct: 186 YKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 295 K--LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVV 352
LL+WVK + K ++D L+ Y ++ ++A C + +P ERP M++VV
Sbjct: 245 DVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 353 ESLK 356
L+
Sbjct: 304 RMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 270 bits (691), Expect = 1e-88
Identities = 73/312 (23%), Positives = 118/312 (37%), Gaps = 28/312 (8%)
Query: 62 FDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW 121
+ L + + G FG V+K + E VAVK Q +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-----NEY--VAVKIFPIQDKQSWQN- 65
Query: 122 LAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKT 181
EV L + H N+++ +G + L+ + SL D L + + W
Sbjct: 66 EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNE 122
Query: 182 RLEIILGAAEGLAYLHE-------GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGP 234
I A GLAYLHE G + + +RD K+ NVLL N ++DFGLA +
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 235 TGDHTHVSTAVVGTYGYAAPEYIETGHLKS-----QSDIWSFGVVLYEILTGRRVLERNR 289
G + VGT Y APE +E + D+++ G+VL+E+ + +
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 290 PTMEQKLLEWVKQFPADGKKFS----MMIDPRLRNQYSINAA-RRVAKLADNCLKKNPEE 344
E + Q P+ P LR+ + +A + + + C + E
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 345 RPTMNQVVESLK 356
R + V E +
Sbjct: 303 RLSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 2e-68
Identities = 74/341 (21%), Positives = 131/341 (38%), Gaps = 47/341 (13%)
Query: 62 FDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW 121
E + + IG G +G+VYKG++ P VAVK + + +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-----ERP--VAVKVFSF---ANRQNF 52
Query: 122 LAE--VQFLGVVSHPNLVKLLGYCSTEDERG-IQRLLVYEYMPNRSLEDRLFSRAQPTLP 178
+ E + + ++ H N+ + + G ++ LLV EY PN SL L T
Sbjct: 53 INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS---LHTSD 109
Query: 179 WKTRLEIILGAAEGLAYLHE------GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR- 231
W + + GLAYLH + + +RD + NVL+ + +SDFGL+
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 232 -----EGPTGDHTHVSTAVVGTYGYAAPEYIE-------TGHLKSQSDIWSFGVVLYEIL 279
G+ + + + VGT Y APE +E Q D+++ G++ +EI
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 280 TGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM-------IDPRLRNQYSIN--AARRV 330
L + + + + + M P+ + N A R +
Sbjct: 230 MRCTDLFPGES-VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL 288
Query: 331 AKLADNCLKKNPEERPTMNQVVESLK--LAVQESEQGSSST 369
+ ++C ++ E R T E + + + E + S T
Sbjct: 289 KETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPT 329
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-61
Identities = 75/298 (25%), Positives = 133/298 (44%), Gaps = 34/298 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAE--VQFLGVVSHPNL 136
IG+G FG V++G R GE VAVK ++ + + W E + ++ H N+
Sbjct: 49 SIGKGRFGEVWRGKWR-----GEE--VAVKIFSS---REERSWFREAEIYQTVMLRHENI 98
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
+ + + ++ Q LV +Y + SL D L + T+ + +++ L A GLA+L
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHL 155
Query: 197 HEGLEIQ-----VIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTH--VSTAVVGTY 249
H + + +RD K+ N+L+ N ++D GLA + T VGT
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 250 GYAAPEYIE----TGHLKS--QSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303
Y APE ++ H +S ++DI++ G+V +EI R + + + V
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSD 274
Query: 304 PADGKKFSMMIDPRLR-----NQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
P+ + ++ + +LR S A R +AK+ C N R T ++ ++L
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 2e-61
Identities = 73/301 (24%), Positives = 130/301 (43%), Gaps = 61/301 (20%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH--KQWLAEVQFLGVVSHPNL 136
KIG G FG+V++ G VAVK L ++L EV + + HPN+
Sbjct: 44 KIGAGSFGTVHRAEWH-----GSD--VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR-AQPTLPWKTRLEIILGAAEGLAY 195
V +G + I V EY+ SL L A+ L + RL + A+G+ Y
Sbjct: 97 VLFMGAVTQPPNLSI----VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPE 255
LH +++R+ K+ N+L+D + K+ DFGL+R + + S + GT + APE
Sbjct: 153 LH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPE 209
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRR-------------VLERN-RPTMEQKLLEWVK 301
+ +SD++SFGV+L+E+ T ++ V + R +
Sbjct: 210 VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI--------- 260
Query: 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361
P + ++P++ A + + C P +RP+ +++ L+ ++
Sbjct: 261 --PRN-------LNPQV------------AAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299
Query: 362 S 362
+
Sbjct: 300 A 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 2e-61
Identities = 75/298 (25%), Positives = 122/298 (40%), Gaps = 34/298 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWL--AEVQFLGVVSHPNL 136
+IG+G +G V+ G R GE VAVK W E+ ++ H N+
Sbjct: 44 QIGKGRYGEVWMGKWR-----GEK--VAVKVFFT---TEEASWFRETEIYQTVLMRHENI 93
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
+ + Q L+ +Y N SL D L TL K+ L++ + GL +L
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHL 150
Query: 197 HEGLEIQ-----VIYRDFKTSNVLLDGNFKPKLSDFGLAR--EGPTGDHTHVSTAVVGTY 249
H + + +RD K+ N+L+ N ++D GLA T + VGT
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 250 GYAAPEYIE----TGHLKS--QSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303
Y PE ++ H +S +D++SFG++L+E+ R V + + V
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSD 269
Query: 304 PADGKKFSMMIDPRLR-----NQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
P+ ++ +LR S R++ KL C NP R T +V ++L
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 5e-61
Identities = 77/308 (25%), Positives = 128/308 (41%), Gaps = 78/308 (25%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA-------EVQFLGVV 131
+IG+GGFG V+KG L VA+K L +G + + EV + +
Sbjct: 26 QIGKGGFGLVHKGR---LVKDKSV--VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 132 SHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAE 191
+HPN+VKL G +V E++P L RL +A P + W +L ++L A
Sbjct: 81 NHPNIVKLYGLMHN------PPRMVMEFVPCGDLYHRLLDKAHP-IKWSVKLRLMLDIAL 133
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLD-----GNFKPKLSDFGLAREGPTGDHTHVSTAVV 246
G+ Y+ +++RD ++ N+ L K++DFGL+++ H + ++
Sbjct: 134 GIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLL 187
Query: 247 GTYGYAAPEYIETGHLKS--QSDIWSFGVVLYEILTGRR---------------VLERN- 288
G + + APE I ++D +SF ++LY ILTG + E
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247
Query: 289 RPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM 348
RPT P D PRL + + C +P++RP
Sbjct: 248 RPT-----------IPED-------CPPRL------------RNVIELCWSGDPKKRPHF 277
Query: 349 NQVVESLK 356
+ +V+ L
Sbjct: 278 SYIVKELS 285
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 6e-61
Identities = 73/280 (26%), Positives = 120/280 (42%), Gaps = 37/280 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+G G FG V K R + VA+K++ + + K ++ E++ L V+HPN+VK
Sbjct: 15 VVGRGAFGVVCKAKWR-----AKD--VAIKQIESESER--KAFIVELRQLSRVNHPNIVK 65
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFS-RAQPTLPWKTRLEIILGAAEGLAYLH 197
L G C LV EY SL + L P + L ++G+AYLH
Sbjct: 66 LYGACL------NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFK-PKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
+I+RD K N+LL K+ DFG A + T G+ + APE
Sbjct: 120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAWMAPEV 174
Query: 257 IETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDP 316
E + + D++S+G++L+E++T R+ P E + +
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRK------PFDEIGGPAFR---------IMWAVHN 219
Query: 317 RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
R N + + L C K+P +RP+M ++V+ +
Sbjct: 220 GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-60
Identities = 70/290 (24%), Positives = 114/290 (39%), Gaps = 40/290 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+G+G FG K T R GE V+ +K+L + + +L EV+ + + HPN++K
Sbjct: 17 VLGKGCFGQAIKVTHR---ETGE--VMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
+G + + + EY+ +L + S PW R+ A G+AYLH
Sbjct: 72 FIGVLYKDK----RLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAKDIASGMAYLHS 126
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR------------EGPTGDHTHVSTAVV 246
+ +I+RD + N L+ N ++DFGLAR VV
Sbjct: 127 ---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183
Query: 247 GTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306
G + APE I + D++SFG+VL EI+ F +
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--DPDYLPRT------MDFGLN 235
Query: 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
+ F P N + C +PE+RP+ ++ L+
Sbjct: 236 VRGFLDRYCPP-------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 5e-60
Identities = 78/302 (25%), Positives = 129/302 (42%), Gaps = 42/302 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAE--VQFLGVVSHPNL 136
+G+G +G V++G+ + GE VAVK ++ + K W E + ++ H N+
Sbjct: 15 CVGKGRYGEVWRGSWQ-----GEN--VAVKIFSS---RDEKSWFRETELYNTVMLRHENI 64
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
+ + T Q L+ Y SL D L TL + L I+L A GLA+L
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHL 121
Query: 197 HEGLEIQ-----VIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHV--STAVVGTY 249
H + + +RD K+ N+L+ N + ++D GLA + + VGT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 250 GYAAPEYIE----TGHLKS--QSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303
Y APE ++ S + DIW+FG+VL+E+ R V + + V
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVVPND 240
Query: 304 PADGKKFSMMID--------PRLRNQYSINAA-RRVAKLADNCLKKNPEERPTMNQVVES 354
P+ F M P + N++ + +AKL C +NP R T ++ ++
Sbjct: 241 PS----FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296
Query: 355 LK 356
L
Sbjct: 297 LT 298
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 3e-59
Identities = 63/297 (21%), Positives = 113/297 (38%), Gaps = 66/297 (22%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH--KQWLAEVQFLGVVSHPNL 136
K+ E G ++KG + G + VK L + + E L + SHPN+
Sbjct: 17 KLNENHSGELWKGRWQ-----GND--IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
+ +LG C + L+ +MP SL + L + ++ L A G+A+L
Sbjct: 70 LPVLGACQSPPAPHP--TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
H LE + + +V++D + ++S + S + + APE
Sbjct: 128 H-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFS-------FQSPGRMYAPAWVAPEA 179
Query: 257 IE---TGHLKSQSDIWSFGVVLYEILTGRR--------------VLERNRPTMEQKLLEW 299
++ + +D+WSF V+L+E++T LE RPT+
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI------- 232
Query: 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
P I P + +KL C+ ++P +RP + +V L+
Sbjct: 233 ----PPG-------ISPHV------------SKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 5e-59
Identities = 75/304 (24%), Positives = 118/304 (38%), Gaps = 74/304 (24%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA----EVQFLGVVSHP 134
IG GGFG VY+ G+ VAVK + + Q + E + ++ HP
Sbjct: 14 IIGIGGFGKVYRAFWI-----GDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP 66
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLA 194
N++ L G C E + V E+ L L + +P + + A G+
Sbjct: 67 NIIALRGVCLKEPNLCL----VMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMN 119
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKP--------KLSDFGLAREGPTGDHTHVSTAVV 246
YLH+ + +I+RD K+SN+L+ + K++DFGLARE H +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAA 175
Query: 247 GTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRR-------------VLERN-RPTM 292
G Y + APE I SD+WS+GV+L+E+LTG V +
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235
Query: 293 EQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVV 352
P+ AKL ++C +P RP+ ++
Sbjct: 236 -----------PST-------CPEPF------------AKLMEDCWNPDPHSRPSFTNIL 265
Query: 353 ESLK 356
+ L
Sbjct: 266 DQLT 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 9e-59
Identities = 80/287 (27%), Positives = 134/287 (46%), Gaps = 42/287 (14%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH--KQWLAEVQFLGVVSHPNL 136
+IG G FG+VYKG G+ VAVK LN + + EV L H N+
Sbjct: 31 RIGSGSFGTVYKGKWH-----GD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
+ +GY + Q +V ++ SL L + + K ++I A G+ YL
Sbjct: 83 LLFMGYSTAP-----QLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYL 136
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
H +I+RD K++N+ L + K+ DFGLA E +H + G+ + APE
Sbjct: 137 HA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV 193
Query: 257 I---ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRP----TMEQKLLEWVKQFPADGKK 309
I ++ QSD+++FG+VLYE++TG+ P +++E V G+
Sbjct: 194 IRMQDSNPYSFQSDVYAFGIVLYELMTGQL------PYSNINNRDQIIEMV------GRG 241
Query: 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
++R+ N +R+ +L CLKK +ERP+ +++ ++
Sbjct: 242 SLSPDLSKVRS----NCPKRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 6e-54
Identities = 72/334 (21%), Positives = 120/334 (35%), Gaps = 60/334 (17%)
Query: 41 SLPSPRSIPELYKEKEHHLRVF--DMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDG 98
SL S RS P + L+ + ++L IG+G FG VY G
Sbjct: 7 SLLSARSFPRKASQTSIFLQEWDIPFEQLEIGE-------LIGKGRFGQVYHGRWH---- 55
Query: 99 RGEPLVVAVKKLNNHGLQGH--KQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLV 156
GE VA++ ++ K + EV H N+V +G C + I +
Sbjct: 56 -GE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI----I 107
Query: 157 YEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL 216
R+L + A+ L +I +G+ YLH ++++D K+ NV
Sbjct: 108 TSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFY 163
Query: 217 DGNFKPKLSDFGLARE---GPTGDHTHVSTAVVGTYGYAAPEYIETGHLKS--------- 264
D N K ++DFGL G G + APE I +
Sbjct: 164 D-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSK 222
Query: 265 QSDIWSFGVVLYEILTGRRVLERNRP--TMEQKLLEWVKQFPADGKKFSMMIDPRLRNQY 322
SD+++ G + YE+ P T + + W G K ++
Sbjct: 223 HSDVFALGTIWYELHARE------WPFKTQPAEAIIWQMGT---GMK---PNLSQI---- 266
Query: 323 SINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
+ ++ + C EERPT ++++ L+
Sbjct: 267 --GMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-47
Identities = 86/302 (28%), Positives = 117/302 (38%), Gaps = 32/302 (10%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL-NNHGLQGHKQWLAEVQFLGVVSHPNLV 137
+GEG FG V P G +VAVK L + G Q W E+ L + H +++
Sbjct: 38 DLGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
K G C +Q LV EY+P SL D L ++ L EG+AYLH
Sbjct: 97 KYKGCCEDAGAASLQ--LVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH 151
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG-----YA 252
I+RD NVLLD + K+ DFGLA+ P G V G +
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH----EYYRVREDGDSPVFWY 204
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311
APE ++ SD+WSFGV LYE+LT +
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCD------SSQSPPTKFLELIGIAQGQMTVL 258
Query: 312 MMIDPRLRNQYSI----NAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSS 367
+ + L + V L NC + RPT ++ LK V E QG +
Sbjct: 259 RLTE-LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILK-TVHEKYQGQA 316
Query: 368 ST 369
+
Sbjct: 317 PS 318
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-46
Identities = 73/280 (26%), Positives = 120/280 (42%), Gaps = 32/280 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
+IG G FG V+ G +R + +VAVK ++L E + L SHPN+V
Sbjct: 121 QIGRGNFGEVFSGRLR-----ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
+L+G C+ + +V E + L + L KT L+++ AA G+ YL
Sbjct: 176 RLIGVCTQKQPI----YIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE 230
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYI 257
I+RD N L+ K+SDFG++RE G + + APE +
Sbjct: 231 S---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEAL 287
Query: 258 ETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDP 316
G S+SD+WSFG++L+E + G P + ++F G + + P
Sbjct: 288 NYGRYSSESDVWSFGILLWETFSLGA------SPYPNLSNQQ-TREFVEKGGR---LPCP 337
Query: 317 RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
V +L + C P +RP+ + + + L+
Sbjct: 338 E-------LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-46
Identities = 72/294 (24%), Positives = 120/294 (40%), Gaps = 25/294 (8%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
++G+G FGSV PL VVAVKKL + + + + E++ L + H N+VK
Sbjct: 48 QLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
G C + R ++ L+ EY+P SL D L + + L+ +G+ YL
Sbjct: 107 YKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG- 162
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG-----YAA 253
+ I+RD T N+L++ + K+ DFGL + P V G + A
Sbjct: 163 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK----EYYKVKEPGESPIFWYA 216
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313
PE + SD+WSFGVVLYE+ T + + + + +
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272
Query: 314 IDPRLRNQYSI----NAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363
I+ L+N + + + C N +RP+ + + +
Sbjct: 273 IE-LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-46
Identities = 71/286 (24%), Positives = 118/286 (41%), Gaps = 25/286 (8%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
++G+G FGSV PL VVAVKKL + + + + E++ L + H N+VK
Sbjct: 17 QLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
G C + R ++ L+ EY+P SL D L + + L+ +G+ YL
Sbjct: 76 YKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG- 131
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG-----YAA 253
+ I+RD T N+L++ + K+ DFGL + P G + A
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWYA 185
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313
PE + SD+WSFGVVLYE+ T + + + + +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGNDKQGQMIVFHL 241
Query: 314 IDPRLRNQYSI----NAARRVAKLADNCLKKNPEERPTMNQVVESL 355
I+ L+N + + + C N +RP+ + +
Sbjct: 242 IE-LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 9e-46
Identities = 69/303 (22%), Positives = 121/303 (39%), Gaps = 36/303 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
K+GEGGF V DG A+K++ H Q ++ E + +HPN+++
Sbjct: 36 KLGEGGFSYVDLVE-GLHDGH----FYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTR--LEIILGAAEGLAYL 196
L+ YC E + L+ + +L + + L ++LG GL +
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE---GPTGDHTHVST----AVVGTY 249
H +RD K +N+LL +P L D G + G ++ A T
Sbjct: 151 H---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 250 GYAAPEYIET---GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306
Y APE + ++D+WS G VLY ++ G + + L A
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL-------AV 260
Query: 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGS 366
+ S+ PR +S + +L ++ + +P +RP + ++ L+ A+Q G
Sbjct: 261 QNQLSIPQSPR----HS----SALWQLLNSMMTVDPHQRPHIPLLLSQLE-ALQPPAPGQ 311
Query: 367 SST 369
+T
Sbjct: 312 HTT 314
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-45
Identities = 74/294 (25%), Positives = 116/294 (39%), Gaps = 41/294 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL-NNHGLQGHKQWLAEVQFLGVVSHPNLV 137
+GEG FG V P G VAVK L G E++ L + H N+V
Sbjct: 28 DLGEGHFGKVELCRYDPE-GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
K G C+ + GI+ L+ E++P+ SL++ L + + K +L+ + +G+ YL
Sbjct: 87 KYKGICTEDGGNGIK--LIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLG 143
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG-----YA 252
Q ++RD NVL++ + K+ DFGL + T V +
Sbjct: 144 S---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK----EYYTVKDDRDSPVFWY 196
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311
APE + SD+WSFGV L+E+LT + L +
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCD------SDSSPMALFLKMIGPTHGQ---- 246
Query: 312 MMIDPRLRNQYSINAARR----------VAKLADNCLKKNPEERPTMNQVVESL 355
M RL N + +R V +L C + P R + ++E
Sbjct: 247 -MTVTRLVNT--LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-45
Identities = 77/304 (25%), Positives = 124/304 (40%), Gaps = 28/304 (9%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
++G+G FGSV PL G +VAVK+L + G + + E+Q L + +VK
Sbjct: 30 QLGKGNFGSVELCRYDPL-GDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
G + ++ LV EY+P+ L D L + L L +G+ YL
Sbjct: 89 YRGVSYGPGRQSLR--LVMEYLPSGCLRDFLQRH-RARLDASRLLLYSSQICKGMEYLG- 144
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG-----YAA 253
+ ++RD N+L++ K++DFGLA+ P VV G + A
Sbjct: 145 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK----DYYVVREPGQSPIFWYA 198
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSM 312
PE + QSD+WSFGVVLYE+ T + + D S
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCD------KSCSPSAEFLRMMGCERDVPALSR 252
Query: 313 MIDPRLRNQYSI----NAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSSS 368
+++ L + V +L C +P++RP+ + + L + S +
Sbjct: 253 LLE-LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETH 311
Query: 369 TTTA 372
TA
Sbjct: 312 AFTA 315
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 9e-43
Identities = 66/303 (21%), Positives = 119/303 (39%), Gaps = 49/303 (16%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH 133
F + IG GGFG V+K +DG+ +K++ +++ EV+ L + H
Sbjct: 13 FKEIELIGSGGFGQVFKAK-HRIDGK----TYVIKRVK----YNNEKAEREVKALAKLDH 63
Query: 134 PNLVKLLGYCSTEDERGIQRL------------LVYEYMPNRSLEDRLFSRAQPTLPWKT 181
N+V G D + E+ +LE + R L
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 182 RLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHV 241
LE+ +G+ Y+H ++I RD K SN+ L + K+ DFGL + +
Sbjct: 124 ALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGK 177
Query: 242 STAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK 301
T GT Y +PE I + + D+++ G++L E+L E
Sbjct: 178 RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC------DTAFETSKF---- 227
Query: 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361
F+ + D + + + ++ L L K PE+RP ++++ +L + +
Sbjct: 228 --------FTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275
Query: 362 SEQ 364
E+
Sbjct: 276 PEK 278
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-42
Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 30/285 (10%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
K+G G +G VY+G + L VAVK L +++L E + + HPNLV+
Sbjct: 227 KLGGGQYGEVYEGVWK-----KYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQ 280
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
LLG C+ E ++ E+M +L D L + + L + + + YL +
Sbjct: 281 LLGVCTREP----PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE 258
I+R+ N L+ N K++DFGL+R TGD + APE +
Sbjct: 337 ---KNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLA 392
Query: 259 TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRL 318
+SD+W+FGV+L+EI T + V + + M P
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDYR---MERPE- 442
Query: 319 RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363
+V +L C + NP +RP+ ++ ++ + QES
Sbjct: 443 ------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 481
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 80/285 (28%), Positives = 118/285 (41%), Gaps = 32/285 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
K+G+G FG V+ GT VA+K L G + +L E Q + + H LV+
Sbjct: 191 KLGQGCFGEVWMGTWNG------TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQ 243
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L S E +V EYM SL D L L +++ A G+AY+
Sbjct: 244 LYAVVSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE 258
+ ++RD + +N+L+ N K++DFGLAR ++T A + APE
Sbjct: 299 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 354
Query: 259 TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRL 318
G +SD+WSFG++L E+ T RV E V G + M P
Sbjct: 355 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYR---MPCPP- 404
Query: 319 RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363
+ L C +K PEERPT + L+ +E
Sbjct: 405 ------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-42
Identities = 64/299 (21%), Positives = 116/299 (38%), Gaps = 69/299 (23%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
+G G FG+VYKG P + + + VA+K+L + +K+ L E + V +P++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
+LLG C T L+ + MP L D + + + + L + A+G+ YL
Sbjct: 81 RLLGICLTS-----TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG-----YA 252
+ ++++RD NVL+ K++DFGLA+ + + + G +
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWM 186
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILT----------GRRVLER----NRPTMEQKLLE 298
A E I QSD+WS+GV ++E++T + R + Q
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER--LPQ---- 240
Query: 299 WVKQFPAD--GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
P + +M C + + RP +++
Sbjct: 241 -----PPICTIDVYMIMRK---------------------CWMIDADSRPKFRELIIEF 273
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-42
Identities = 81/317 (25%), Positives = 135/317 (42%), Gaps = 47/317 (14%)
Query: 49 PELYKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVK 108
PEL + +H + + FN IG G FG VY GT+ DG + + AVK
Sbjct: 9 PELVQAVQHVVIGPSSLIVH-----FNE--VIGRGHFGCVYHGTLLDNDG--KKIHCAVK 59
Query: 109 KLN-NHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLED 167
LN + Q+L E + SHPN++ LLG C + L+V YM + L +
Sbjct: 60 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRN 116
Query: 168 RLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227
+ + K + L A+G+ YL + ++RD N +LD F K++DF
Sbjct: 117 FIRNE-THNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADF 172
Query: 228 GLAREGPTGDHTHVSTAVVG------TYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT- 280
GLAR+ ++ V A E ++T ++SD+WSFGV+L+E++T
Sbjct: 173 GLARDMYDKEYYSVHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMTR 228
Query: 281 GRRVLERNRPTME-QKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLK 339
G P + + ++ Q G+ ++ P + ++ C
Sbjct: 229 G----APPYPDVNTFDITVYLLQ----GR---RLLQPE-------YCPDPLYEVMLKCWH 270
Query: 340 KNPEERPTMNQVVESLK 356
E RP+ +++V +
Sbjct: 271 PKAEMRPSFSELVSRIS 287
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-41
Identities = 76/284 (26%), Positives = 116/284 (40%), Gaps = 36/284 (12%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQFLGVVSHPN 135
K+G+G FG V +G G+ VAVK L L + + EV + + H N
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAY 195
L++L G T +V E P SL DRL Q T + AEG+ Y
Sbjct: 83 LIRLYGVVLTP-----PMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGY 136
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT---YGYA 252
L + I+RD N+LL K+ DFGL R P D +V + +
Sbjct: 137 LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWC 191
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311
APE ++T SD W FGV L+E+ T G+ P + + + + +G++
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ------EPWIGLNGSQILHKIDKEGER-- 243
Query: 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
+ P + + + + C PE+RPT + + L
Sbjct: 244 -LPRPE-------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 71/318 (22%), Positives = 126/318 (39%), Gaps = 60/318 (18%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH 133
F + +G+G FG V K LD R A+KK+ + + L+EV L ++H
Sbjct: 8 FEEIAVLGQGAFGQVVKARNA-LDSR----YYAIKKIRHTEEK-LSTILSEVMLLASLNH 61
Query: 134 PNLVKLLGYCSTEDERGIQRL-----------LVYEYMPNRSLEDRLFSRAQPTLP---W 179
+V+ Y + + R + + EY N +L D + S W
Sbjct: 62 QYVVRY--YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW 119
Query: 180 KTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR-------- 231
+ +I+ E L+Y+H +I+RD K N+ +D + K+ DFGLA+
Sbjct: 120 RLFRQIL----EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 232 ----EGPTGDHTHVSTAVVGTYGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVLE 286
+ T+ +GT Y A E ++ TGH + D++S G++ +E++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST-G 231
Query: 287 RNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP 346
R + +KL +FP P + K+ + +P +RP
Sbjct: 232 MERVNILKKLRSVSIEFP-----------PDFDDNKMKVE----KKIIRLLIDHDPNKRP 276
Query: 347 TMNQVVES--LKLAVQES 362
++ S L + Q+
Sbjct: 277 GARTLLNSGWLPVKHQDE 294
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-41
Identities = 74/308 (24%), Positives = 126/308 (40%), Gaps = 56/308 (18%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
++GEG FG V+ L + ++VAVK L + + E + L ++ H ++V+
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR-------------AQPTLPWKTRLEI 185
G C+ L+V+EYM + L L S A L L +
Sbjct: 108 FFGVCTEGR----PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 186 ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAV 245
A G+ YL + ++RD T N L+ K+ DFG++R+ + D+
Sbjct: 164 ASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR----- 215
Query: 246 VGTYG-----YAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRP----TMEQK 295
VG + PE I ++SD+WSFGVVL+EI T G+ +P + +
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK------QPWYQLSNTE- 268
Query: 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
++ + Q G+ + PR V + C ++ P++R ++ V L
Sbjct: 269 AIDCITQ----GR---ELERPR-------ACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314
Query: 356 KLAVQESE 363
+ Q
Sbjct: 315 QALAQAPP 322
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-41
Identities = 68/287 (23%), Positives = 114/287 (39%), Gaps = 34/287 (11%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVV 131
+ + IG G +G K + DG+ ++ K+L+ + + ++EV L +
Sbjct: 8 YEVLYTIGTGSYGRCQKIRRKS-DGK----ILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 132 SHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRL--FSRAQPTLPWKTRLEIILGA 189
HPN+V+ Y D +V EY L + ++ + L + L ++
Sbjct: 63 KHPNIVRY--YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 190 AEGLAYLHE--GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVG 247
L H V++RD K +NV LDG KL DFGLAR T + VG
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVG 178
Query: 248 TYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLE-RNRPTMEQKLLEWVKQFPAD 306
T Y +PE + +SDIWS G +LYE+ ++ + K+ E +F
Sbjct: 179 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKFRRI 236
Query: 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
++S L + L RP++ +++E
Sbjct: 237 PYRYS----DELNE------------IITRMLNLKDYHRPSVEEILE 267
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 80/285 (28%), Positives = 118/285 (41%), Gaps = 32/285 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
K+G+G FG V+ GT VA+K L G + +L E Q + + H LV+
Sbjct: 274 KLGQGCFGEVWMGTWNG------TTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQ 326
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L S E +V EYM SL D L L +++ A G+AY+
Sbjct: 327 LYAVVSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE 258
+ ++RD + +N+L+ N K++DFGLAR ++T A + APE
Sbjct: 382 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAAL 437
Query: 259 TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRL 318
G +SD+WSFG++L E+ T RV E V G + M P
Sbjct: 438 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYR---MPCPP- 487
Query: 319 RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363
+ L C +K PEERPT + L+ +E
Sbjct: 488 ------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-41
Identities = 83/281 (29%), Positives = 122/281 (43%), Gaps = 42/281 (14%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
IG+G FG V G R VAVK + N + +LAE + + H NLV+
Sbjct: 200 TIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 250
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
LLG E++ G+ +V EYM SL D L SR + L L+ L E + YL
Sbjct: 251 LLGVI-VEEKGGL--YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT---YGYAAPE 255
++RD NVL+ + K+SDFGL +E S+ + APE
Sbjct: 308 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--------ASSTQDTGKLPVKWTAPE 356
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMID 315
+ ++SD+WSFG++L+EI + RV P + ++ V++ G K M
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEK----GYK---MDA 407
Query: 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
P V + NC + RPT Q+ E L+
Sbjct: 408 PD-------GCPPAVYDVMKNCWHLDAATRPTFLQLREQLE 441
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-41
Identities = 77/321 (23%), Positives = 130/321 (40%), Gaps = 42/321 (13%)
Query: 36 NRTARSLPSPRSIPELYKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRP 95
++ + P P+ P+ + F KIG G F VY+
Sbjct: 5 SQGMQGPPVPQFQPQKALRPDMGYNTLA---------NFRIEKKIGRGQFSEVYRA-ACL 54
Query: 96 LDGRGEPLVVAVKKLNNHGLQGHK---QWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQ 152
LDG VA+KK+ L K + E+ L ++HPN++K ++E I
Sbjct: 55 LDGV----PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI- 109
Query: 153 RLLVYEYMPNRSLEDRL--FSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFK 210
V E L + F + + +P +T + + L ++H +V++RD K
Sbjct: 110 ---VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIK 163
Query: 211 TSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWS 270
+NV + KL D GL R T + ++VGT Y +PE I +SDIWS
Sbjct: 164 PANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWS 221
Query: 271 FGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRV 330
G +LYE+ + ++ + L + ++Q P + YS +
Sbjct: 222 LGCLLYEMAALQSPFYGDKMNLYS-LCKKIEQ----CD-----YPPLPSDHYS----EEL 267
Query: 331 AKLADNCLKKNPEERPTMNQV 351
+L + C+ +PE+RP + V
Sbjct: 268 RQLVNMCINPDPEKRPDVTYV 288
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-41
Identities = 81/344 (23%), Positives = 139/344 (40%), Gaps = 48/344 (13%)
Query: 23 PRNQNRLDNNSALNRTARSLPSPRSI-PELYKEKEHHLRVFDMQELREATNGFNRMLKIG 81
+ N ++ PEL + +H + + FN IG
Sbjct: 46 SLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVH-----FNE--VIG 98
Query: 82 EGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLVKLL 140
G FG VY GT+ DG + + AVK LN + Q+L E + SHPN++ LL
Sbjct: 99 RGHFGCVYHGTLLDNDG--KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 141 GYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGL 200
G C + L+V YM + L + + + K + L A+G+ +L
Sbjct: 157 GICLRSEG---SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS-- 210
Query: 201 EIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVG------TYGYAAP 254
+ ++RD N +LD F K++DFGLAR+ + V A
Sbjct: 211 -KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----AL 265
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME-QKLLEWVKQFPADGKKFSM 312
E ++T ++SD+WSFGV+L+E++T G P + + ++ Q G++
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRG----APPYPDVNTFDITVYLLQ----GRR--- 314
Query: 313 MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
++ P + ++ C E RP+ +++V +
Sbjct: 315 LLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-40
Identities = 74/307 (24%), Positives = 125/307 (40%), Gaps = 38/307 (12%)
Query: 54 EKEHHLRVFDMQELREAT---NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL 110
HH D+ + R+ KIGEG FG DGR +K++
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVK-STEDGR----QYVIKEI 57
Query: 111 NNHGLQGH--KQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDR 168
N + ++ EV L + HPN+V+ I V +Y L R
Sbjct: 58 NISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI----VMDYCEGGDLFKR 113
Query: 169 LFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228
+ ++ L+ + L ++H+ ++++RD K+ N+ L + +L DFG
Sbjct: 114 INAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFG 170
Query: 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLE-R 287
+AR ++ A +GT Y +PE E ++SDIW+ G VLYE+ T + E
Sbjct: 171 IARV--LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228
Query: 288 NRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT 347
+ + K++ FP +S LR+ L K+NP +RP+
Sbjct: 229 SMKNLVLKIIS--GSFPPVSLHYS----YDLRS------------LVSQLFKRNPRDRPS 270
Query: 348 MNQVVES 354
+N ++E
Sbjct: 271 VNSILEK 277
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-40
Identities = 69/324 (21%), Positives = 133/324 (41%), Gaps = 43/324 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
+G G FG+V+KG P +G + V +K + G Q + + +G + H ++V
Sbjct: 20 VLGSGVFGTVHKGVWIP-EGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
+LLG C LV +Y+P SL D + + L + L + A+G+ YL
Sbjct: 79 RLLGLCPGS-----SLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLE 132
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG-----YA 252
E +++R+ NVLL + +++DFG+A P D + + +
Sbjct: 133 E---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWM 184
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME-QKLLEWVKQFPADGKKF 310
A E I G QSD+WS+GV ++E++T G + ++ + +++ G++
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY----AGLRLAEVPDLLEK----GER- 235
Query: 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ--GSSS 368
+ P+ V + C + RPT ++ ++ +
Sbjct: 236 --LAQPQ-------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKR 286
Query: 369 TTTAAKTPVTSSSRLVDRRSKRVQ 392
+ P L +++ + V+
Sbjct: 287 ESGPGIAPGPEPHGLTNKKLEEVE 310
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 66/300 (22%), Positives = 115/300 (38%), Gaps = 42/300 (14%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-HKQWLAEVQFLGVVSHPNLV 137
+G+G +V++G + G+ + A+K NN + E + L ++H N+V
Sbjct: 16 ILGQGATANVFRGRHKK---TGD--LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPT-LPWKTRLEIILGAAEGLAYL 196
KL + E+ ++L+ E+ P SL L + LP L ++ G+ +L
Sbjct: 71 KL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 197 HEGLEIQVIYRDFKTSNVLL----DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA 252
E +++R+ K N++ DG KL+DFG ARE D + GT Y
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYL 182
Query: 253 APEYIETGHLKSQS--------DIWSFGVVLYEILTGRR-------------VLERNRPT 291
P+ E L+ D+WS GV Y TG V+ +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 292 MEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQV 351
+ V++ +S D + S + + N L+ + E+ +Q
Sbjct: 243 KPSGAISGVQKAENGPIDWSG--DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-40
Identities = 76/304 (25%), Positives = 130/304 (42%), Gaps = 61/304 (20%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
++GEG FG V+ L + ++VAVK L + L K + E + L + H ++VK
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR--------------AQPTLPWKTRLE 184
G C D ++V+EYM + L L + A+ L L
Sbjct: 82 FYGVCGDGD----PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137
Query: 185 IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTA 244
I A G+ YL ++RD T N L+ N K+ DFG++R+ + D+ V
Sbjct: 138 IASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVG-- 192
Query: 245 VVGTYGYA-------APEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRP----TM 292
G+ PE I ++SD+WSFGV+L+EI T G+ +P +
Sbjct: 193 -----GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------QPWFQLSN 241
Query: 293 EQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVV 352
+ ++E + Q G+ ++ PR + V + C ++ P++R + ++
Sbjct: 242 TE-VIECITQ----GR---VLERPR-------VCPKEVYDVMLGCWQREPQQRLNIKEIY 286
Query: 353 ESLK 356
+ L
Sbjct: 287 KILH 290
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-40
Identities = 73/333 (21%), Positives = 132/333 (39%), Gaps = 74/333 (22%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
++G+G FG VY+G + + VA+K +N ++ ++L E + + ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLED-----RLFSRAQPTLPWKTRLEIILGA--- 189
+LLG S L++ E M L+ R P L + ++I A
Sbjct: 92 RLLGVVSQGQ----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
A+G+AYL+ + ++RD N ++ +F K+ DFG+ R+ D+ G
Sbjct: 148 ADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-----RKGGK 199
Query: 250 GY-----AAPEYIETGHLKSQSDIWSFGVVLYEILT--------------GRRVLERNRP 290
G +PE ++ G + SD+WSFGVVL+EI T R V+E
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL- 258
Query: 291 TMEQKLLEWVKQFPAD--GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM 348
+++ P + F +M C + NP+ RP+
Sbjct: 259 -LDK---------PDNCPDMLFELMRM---------------------CWQYNPKMRPSF 287
Query: 349 NQVVESLKLAVQESEQGSSSTTTAAKTPVTSSS 381
+++ S+K ++ + S +
Sbjct: 288 LEIISSIKEEMEPGFREVSFYYSEENKLPEPEE 320
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-40
Identities = 65/301 (21%), Positives = 114/301 (37%), Gaps = 47/301 (15%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ-WLAEVQFLGVVS 132
F + +G GGFG V++ +D A+K++ + ++ + EV+ L +
Sbjct: 7 FEPIQCLGRGGFGVVFEAK-NKVDDC----NYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 133 HPNLVKLLGYCSTEDERGIQ-----RLLVY---EYMPNRSLEDRLFSR-AQPTLPWKTRL 183
HP +V+ ++ ++ +Y + +L+D + R L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE----------G 233
I L AE + +LH +++RD K SN+ + K+ DFGL
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTME 293
T VGT Y +PE I + DI+S G++L+E+L +
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-----FSTQMER 233
Query: 294 QKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
+ L V+ KF P L Q + + L +P ERP ++E
Sbjct: 234 VRTLTDVRN-----LKF-----PPLFTQKYPCE----YVMVQDMLSPSPMERPEAINIIE 279
Query: 354 S 354
+
Sbjct: 280 N 280
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 6e-40
Identities = 68/289 (23%), Positives = 119/289 (41%), Gaps = 46/289 (15%)
Query: 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL-NNHGLQGHKQWLAEVQFLGVVSHPNL 136
+++G G FGSV +G R R + + VA+K L ++ + E Q + + +P +
Sbjct: 16 IELGCGNFGSVRQGVYRM---RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
V+L+G C E +LV E L L + + +P E++ + G+ YL
Sbjct: 73 VRLIGVCQAE-----ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYL 126
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG------ 250
E ++RD NVLL K+SDFGL++ D + + +
Sbjct: 127 EE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLK 178
Query: 251 YAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLER--NRPTMEQKLLEWVKQFPADG 307
+ APE I S+SD+WS+GV ++E L+ G++ ++ M
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF------------- 225
Query: 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
I+ R + + L +C E+RP V + ++
Sbjct: 226 ------IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 8e-40
Identities = 72/308 (23%), Positives = 115/308 (37%), Gaps = 48/308 (15%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-HKQWLAEVQFLGVVSHPNLV 137
I GG G +Y R ++GR V +K L + G +AE QFL V HP++V
Sbjct: 87 CIAHGGLGWIYLALDRNVNGR----PVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIV 142
Query: 138 KLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
++ + D G +V EY+ +SL+ + LP + +L L+YL
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYL 198
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE-GPTGDHTHVSTAVVGTYGYAAPE 255
H I ++Y D K N++L + KL D G G + GT G+ APE
Sbjct: 199 HS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG-------YLYGTPGFQAPE 247
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMID 315
I +DI++ G L + +V P D D
Sbjct: 248 -IVRTGPTVATDIYTVGRTLAALTLDLPTRNG----------RYVDGLPED--------D 288
Query: 316 PRLRNQYSINAARRVAKLADNCLKKNPEERP-TMNQVVESLKLAVQESEQGSSSTTTAAK 374
P L+ +L + +P +R T ++ L ++E +
Sbjct: 289 PVLK------TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGL 342
Query: 375 TPVTSSSR 382
+ + S SR
Sbjct: 343 STIFSPSR 350
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-40
Identities = 73/295 (24%), Positives = 126/295 (42%), Gaps = 40/295 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
IG+G FG VY G D + A+K L+ +Q + +L E + ++HPN++
Sbjct: 28 VIGKGHFGVVYHGEYI--DQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
L+G + ++ YM + L + S Q K + L A G+ YL
Sbjct: 86 ALIGIMLPPEGL---PHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLA 141
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVG------TYGY 251
E + ++RD N +LD +F K++DFGLAR+ ++ V T
Sbjct: 142 E---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT--- 195
Query: 252 AAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME-QKLLEWVKQFPADGKK 309
A E ++T ++SD+WSFGV+L+E+LT G ++ L ++ Q G++
Sbjct: 196 -ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY----RHIDPFDLTHFLAQ----GRR 246
Query: 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364
+ P + ++ C + +P RPT +V ++ V
Sbjct: 247 ---LPQPE-------YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-40
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
+G G FG+VYKG P + + + VA+K+L + +K+ L E + V +P++
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
+LLG C T L+ + MP L D + + + + L + A+G+ YL
Sbjct: 81 RLLGICLTS-----TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG-----YA 252
+ ++++RD NVL+ K++DFGLA+ + + + G +
Sbjct: 135 D---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWM 186
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILT-GRR 283
A E I QSD+WS+GV ++E++T G +
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 67/288 (23%), Positives = 110/288 (38%), Gaps = 50/288 (17%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN--NHGLQGHKQWLAEVQFL-GV 130
F R+ ++G G +G V+K DGR + AVK+ G + + LAEV V
Sbjct: 59 FQRLSRLGHGSYGEVFKV-RSKEDGR----LYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 131 VSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGA 189
HP V+L + E+ L L E SL+ +LP +
Sbjct: 114 GQHPCCVRL--EQAWEEG---GILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDT 166
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
LA+LH +++ D K +N+ L + KL DFGL E T V G
Sbjct: 167 LLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDP 220
Query: 250 GYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309
Y APE ++ + + +D++S G+ + E+ + P G+
Sbjct: 221 RYMAPELLQGSYGTA-ADVFSLGLTILEVACNMEL-------------------PHGGEG 260
Query: 310 FSMMID----PRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
+ + P S + R V + L+ +P+ R T ++
Sbjct: 261 WQQLRQGYLPPEFTAGLS-SELRSVLVM---MLEPDPKLRATAEALLA 304
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 82/283 (28%), Positives = 124/283 (43%), Gaps = 46/283 (16%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
IG+G FG V G R VAVK + N + +LAE + + H NLV+
Sbjct: 28 TIGKGEFGDVMLGDYRGNK-------VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 78
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
LLG E++ G+ +V EYM SL D L SR + L L+ L E + YL
Sbjct: 79 LLGVI-VEEKGGL--YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 135
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT---YGYAAPE 255
++RD NVL+ + K+SDFGL +E S+ + APE
Sbjct: 136 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--------ASSTQDTGKLPVKWTAPE 184
Query: 256 YIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME-QKLLEWVKQFPADGKKFSMM 313
+ ++SD+WSFG++L+EI + GR P + + ++ V++ G K M
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPY----PRIPLKDVVPRVEK----GYK---M 233
Query: 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
P V ++ NC + RP+ Q+ E L+
Sbjct: 234 DAPD-------GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-39
Identities = 76/290 (26%), Positives = 128/290 (44%), Gaps = 40/290 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
K+G G +G VY+G + L VAVK L +++L E + + HPNLV+
Sbjct: 20 KLGGGQYGEVYEGVWK-----KYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
LLG C+ E ++ E+M +L D L + + L + + + YL +
Sbjct: 74 LLGVCTREP----PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT---YGYAAPE 255
I+RD N L+ N K++DFGL+R +T A G + APE
Sbjct: 130 ---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT----AHAGAKFPIKWTAPE 182
Query: 256 YIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME-QKLLEWVKQFPADGKKFSMM 313
+ +SD+W+FGV+L+EI T G P ++ ++ E +++ + M
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY----PGIDLSQVYELLEK----DYR---M 231
Query: 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363
P +V +L C + NP +RP+ ++ ++ + QES
Sbjct: 232 ERPE-------GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-39
Identities = 67/305 (21%), Positives = 117/305 (38%), Gaps = 42/305 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-HKQWLAEVQFLGVVSHPNLV 137
+G+G +V++G + G+ + A+K NN + E + L ++H N+V
Sbjct: 16 ILGQGATANVFRGRHKK---TGD--LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPT-LPWKTRLEIILGAAEGLAYL 196
KL + E+ ++L+ E+ P SL L + LP L ++ G+ +L
Sbjct: 71 KL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 197 HEGLEIQVIYRDFKTSNVLL----DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA 252
E +++R+ K N++ DG KL+DFG ARE D + GT Y
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEYL 182
Query: 253 APEYIETGHLKSQS--------DIWSFGVVLYEILTGR------RVLERNRPTMEQKL-- 296
P+ E L+ D+WS GV Y TG RN+ M + +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242
Query: 297 -----LEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQV 351
+ V++ +S + S + + N L+ + E+ +Q
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPV--SCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 352 VESLK 356
Sbjct: 301 FAETS 305
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-39
Identities = 71/292 (24%), Positives = 116/292 (39%), Gaps = 38/292 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ-WLAEVQFLGVVSHPNLV 137
+GEG FG VY+G G VAVK +K+ +++E + + HP++V
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKIN--VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
KL+G E ++ E P L L + +L T + L + +AYL
Sbjct: 77 KLIGIIEEE-----PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLE 130
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTA---VVGTYGYAAP 254
I ++RD N+L+ KL DFGL+R D+ S + +P
Sbjct: 131 S---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SP 183
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313
E I + SD+W F V ++EIL+ G+ +P + + V G + +
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILSFGK------QPFFWLENKD-VIGVLEKGDR---L 233
Query: 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL-KLAVQESEQ 364
P + L C +P +RP ++V SL + E +
Sbjct: 234 PKPD-------LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKDI 278
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-39
Identities = 76/304 (25%), Positives = 119/304 (39%), Gaps = 52/304 (17%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
+G G FG VY+G + + PL VAVK L Q +L E + +H N+V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLED-----RLFSRAQPTLPWKTRLEIILGAAEG 192
+ +G + + R ++ E M L+ R +L L + A G
Sbjct: 97 RCIGVSL----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDG---NFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
YL E I+RD N LL K+ DFG+AR+ + G
Sbjct: 153 CQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY-----RKGGC 204
Query: 250 GY-----AAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRP----TMEQKLLEW 299
PE G S++D WSFGV+L+EI + G P + ++ +LE+
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY------MPYPSKSNQE-VLEF 257
Query: 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359
V G M P+ N V ++ C + PE+RP ++E ++
Sbjct: 258 VTS----GG---RMDPPK-------NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303
Query: 360 QESE 363
Q+ +
Sbjct: 304 QDPD 307
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-39
Identities = 79/280 (28%), Positives = 118/280 (42%), Gaps = 38/280 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
K+G G FG V+ T VAVK + G + +LAE + + H LVK
Sbjct: 195 KLGAGQFGEVWMATYNK------HTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVK 247
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L + E ++ E+M SL D L S P ++ AEG+A++ +
Sbjct: 248 LHAVVTKE-----PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT---YGYAAPE 255
I+RD + +N+L+ + K++DFGLAR ++T A G + APE
Sbjct: 303 ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT----AREGAKFPIKWTAPE 355
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMID 315
I G +SD+WSFG++L EI+T R+ E V + G + M
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------VIRALERGYR---MPR 406
Query: 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
P N + + C K PEERPT + L
Sbjct: 407 PE-------NCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-39
Identities = 73/287 (25%), Positives = 118/287 (41%), Gaps = 44/287 (15%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVK--KLNNHGLQGHKQWLAEVQFLGVVSHPNL 136
++G G FG+V KG + VAVK K + + LAE + + +P +
Sbjct: 24 ELGSGNFGTVKKGY---YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
V+++G C E +LV E L L + + K +E++ + G+ YL
Sbjct: 81 VRMIGICEAE-----SWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL 133
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG------ 250
E E ++RD NVLL K+SDFGL++ ++ + +
Sbjct: 134 -E--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVK 185
Query: 251 YAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309
+ APE I S+SD+WSFGV+++E + G+ +P K E V G++
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ------KPYRGMKGSE-VTAMLEKGER 238
Query: 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
M P R + L + C + E RP V L+
Sbjct: 239 ---MGCPA-------GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 275
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 8e-39
Identities = 77/301 (25%), Positives = 119/301 (39%), Gaps = 46/301 (15%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
+G G FG VY+G + + PL VAVK L Q +L E + +H N+V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLED-----RLFSRAQPTLPWKTRLEIILGAAEG 192
+ +G + + R ++ E M L+ R +L L + A G
Sbjct: 138 RCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDG---NFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
YL E I+RD N LL K+ DFG+AR+ + G
Sbjct: 194 CQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY-----RKGGC 245
Query: 250 GY-----AAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME-QKLLEWVKQ 302
PE G S++D WSFGV+L+EI + G P+ Q++LE+V
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLG----YMPYPSKSNQEVLEFVTS 301
Query: 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362
G M P+ N V ++ C + PE+RP ++E ++ Q+
Sbjct: 302 ----GG---RMDPPK-------NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347
Query: 363 E 363
+
Sbjct: 348 D 348
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 74/290 (25%), Positives = 133/290 (45%), Gaps = 40/290 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVK--KLNNHGLQGHKQWLAEVQFLGVVSHPNL 136
+GEG FGSV +G ++ G L VAVK KL+N + +++L+E + SHPN+
Sbjct: 41 ILGEGEFGSVMEGNLK--QEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 137 VKLLGYCSTEDERGIQRLLV-YEYMPNRSLEDRLFSRAQPT----LPWKTRLEIILGAAE 191
++LLG C +GI + +V +M L L T +P +T L+ ++ A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTA----VVG 247
G+ YL ++RD N +L + ++DFGL+++ +GD+ V
Sbjct: 159 GMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215
Query: 248 TYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME-QKLLEWVKQFPA 305
A E + S+SD+W+FGV ++EI T G P ++ ++ +++
Sbjct: 216 I----AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY----PGVQNHEMYDYLLH--- 264
Query: 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
G + P + + ++ +C + +P +RPT + + L
Sbjct: 265 -GH---RLKQPE-------DCLDELYEIMYSCWRTDPLDRPTFSVLRLQL 303
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 73/291 (25%), Positives = 128/291 (43%), Gaps = 35/291 (12%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
IG G FG VYKG ++ G+ E + VA+K L + + +L E +G SH N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKE-VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
+L G S +++ EYM N +L+ L + + ++ G A G+ YL
Sbjct: 110 RLEGVISKYKPM----MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA 164
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT---YGYAAP 254
+ ++RD N+L++ N K+SDFGL+R D + G + AP
Sbjct: 165 N---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAP 219
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME-QKLLEWVKQFPADGKKFSM 312
E I S SD+WSFG+V++E++T G R + ++++ + G +
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGERPY----WELSNHEVMKAIND----GFR--- 268
Query: 313 MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363
+ P + + +L C ++ RP +V L ++ +
Sbjct: 269 LPTPM-------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-38
Identities = 86/355 (24%), Positives = 142/355 (40%), Gaps = 42/355 (11%)
Query: 13 PKKGSNSAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHLRVFDMQELREATN 72
P S R + L+++ AR + P D +EL++
Sbjct: 271 PAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKL 330
Query: 73 GFNR------MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL-NNHGLQGHKQWLAEV 125
R +++G G FGSV +G R R + + VA+K L ++ + E
Sbjct: 331 FLKRDNLLIADIELGCGNFGSVRQGVYRM---RKKQIDVAIKVLKQGTEKADTEEMMREA 387
Query: 126 QFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEI 185
Q + + +P +V+L+G C E +LV E L L + + +P E+
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAE-----ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAEL 441
Query: 186 ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAV 245
+ + G+ YL E ++R+ NVLL K+SDFGL++ D + TA
Sbjct: 442 LHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY--TAR 496
Query: 246 VGT---YGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVK 301
+ APE I S+SD+WS+GV ++E L+ G+ +P + K E V
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ------KPYKKMKGPE-VM 549
Query: 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
F GK+ M P + L +C E+RP V + ++
Sbjct: 550 AFIEQGKR---MECPP-------ECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 594
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-38
Identities = 62/302 (20%), Positives = 113/302 (37%), Gaps = 69/302 (22%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGE--PLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNL 136
+G+G F ++KG R + G+ V +K L+ + + + +SH +L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
V G C DE +LV E++ SL+ L + + +LE+ A + +L
Sbjct: 75 VLNYGVCVCGDE----NILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFL 129
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKP--------KLSDFGLAREGPTGDHTHVSTAVVGT 248
E +I+ + N+LL KLSD G++ V+
Sbjct: 130 E---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPK 174
Query: 249 YGY------AAPEYIETG-HLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME-QKLLEW 299
PE IE +L +D WSFG L+EI + G + L ++ Q+ L++
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL----SALDSQRKLQF 230
Query: 300 VKQ-----FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354
+ P + +++ + C+ P+ RP+ ++
Sbjct: 231 YEDRHQLPAPKAAELANLINN---------------------CMDYEPDHRPSFRAIIRD 269
Query: 355 LK 356
L
Sbjct: 270 LN 271
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-38
Identities = 82/287 (28%), Positives = 131/287 (45%), Gaps = 36/287 (12%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
++G G FG V+ G VAVK L G +LAE + + H LV+
Sbjct: 20 RLGAGQFGEVWMGYYNG------HTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L + E ++ EYM N SL D L + + L L++ AEG+A++ E
Sbjct: 73 LYAVVTQE-----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE 258
I+RD + +N+L+ K++DFGLAR ++T A + APE I
Sbjct: 128 ---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAIN 183
Query: 259 TGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME-QKLLEWVKQFPADGKKFSMMIDP 316
G +SD+WSFG++L EI+T GR P M ++++ +++ G + M+ P
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPY----PGMTNPEVIQNLER----GYR---MVRP 232
Query: 317 RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363
N + +L C K+ PE+RPT + + L+ +E
Sbjct: 233 D-------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-38
Identities = 68/293 (23%), Positives = 114/293 (38%), Gaps = 40/293 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
IGEG FG V++G + VA+K +++L E + HP++V
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALA--VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
KL+G + ++ E L L R + +L + + + LAYL
Sbjct: 80 KLIGVITEN-----PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE 133
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTA---VVGTYGYAAP 254
+ ++RD NVL+ N KL DFGL+R + S + AP
Sbjct: 134 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----AP 186
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME-QKLLEWVKQFPADGKKFSM 312
E I S SD+W FGV ++EIL G + ++ ++ ++ +G++
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILMHGVKPF----QGVKNNDVIGRIE----NGER--- 235
Query: 313 MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL-KLAVQESEQ 364
+ P N + L C +P RP ++ L + +E Q
Sbjct: 236 LPMPP-------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 281
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-38
Identities = 80/300 (26%), Positives = 132/300 (44%), Gaps = 36/300 (12%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
IG G G V G +R R P VA+K L + + + +L+E +G HPN++
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVP--VAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
+L G + ++V EYM N SL+ L + + ++ G G+ YL
Sbjct: 114 RLEGVVTRGR----LAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT---YGYAAP 254
+ + ++RD NVL+D N K+SDFGL+R D + G + AP
Sbjct: 169 D---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPIRWTAP 223
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME-QKLLEWVKQFPADGKKFSM 312
E I S SD+WSFGVV++E+L G R M + ++ V++ G +
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERPY----WNMTNRDVISSVEE----GYR--- 272
Query: 313 MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSSSTTTA 372
+ P + +L +C K+ +RP +Q+V L ++ E ++ T +
Sbjct: 273 LPAPM-------GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATATVS 325
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-38
Identities = 69/304 (22%), Positives = 126/304 (41%), Gaps = 41/304 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVK--KLNNHGLQGHKQWLAEVQFLGVVSHPNL 136
+G+G FGSV + ++ DG + VAVK K + +++L E + HP++
Sbjct: 30 MLGKGEFGSVREAQLKQEDG--SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 137 VKLLGYCSTEDERGIQR--LLVYEYMPNRSLEDRLFSRAQP----TLPWKTRLEIILGAA 190
KL+G +G +++ +M + L L + LP +T + ++ A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTA----VV 246
G+ YL I+RD N +L + ++DFGL+R+ +GD+ A V
Sbjct: 148 CGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204
Query: 247 GTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME-QKLLEWVKQFP 304
A E + SD+W+FGV ++EI+T G+ +E ++ ++
Sbjct: 205 WL----ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY----AGIENAEIYNYLIG-- 254
Query: 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364
G + + P V L C +P++RP+ + L+ +
Sbjct: 255 --GNR---LKQPP-------ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSV 302
Query: 365 GSSS 368
S+S
Sbjct: 303 LSTS 306
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 9e-38
Identities = 71/304 (23%), Positives = 118/304 (38%), Gaps = 60/304 (19%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
++GE FG VYKG + + VA+K L +++ E + HPN+V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR--------------AQPTLPWKTRL 183
LLG + + +++ Y + L + L R + L +
Sbjct: 76 CLLGVVTKDQ----PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST 243
++ A G+ YL V+++D T NVL+ K+SD GL RE D+ +
Sbjct: 132 HLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL- 187
Query: 244 AVVGTYGYA-------APEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRP--TME 293
G + APE I G SDIWS+GVVL+E+ + G +P
Sbjct: 188 ------GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL------QPYCGYS 235
Query: 294 -QKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVV 352
Q ++E ++ + + ++ P + V L C + P RP +
Sbjct: 236 NQDVVEMIR----NRQ---VLPCPD-------DCPAWVYALMIECWNEFPSRRPRFKDIH 281
Query: 353 ESLK 356
L+
Sbjct: 282 SRLR 285
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-37
Identities = 68/293 (23%), Positives = 113/293 (38%), Gaps = 40/293 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
IGEG FG V++G + VA+K +++L E + HP++V
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMA--VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
KL+G + ++ E L L R + +L + + + LAYL
Sbjct: 455 KLIGVITEN-----PVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLE 508
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTA---VVGTYGYAAP 254
+ ++RD NVL+ N KL DFGL+R + S + AP
Sbjct: 509 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----AP 561
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME-QKLLEWVKQFPADGKKFSM 312
E I S SD+W FGV ++EIL G + ++ ++ ++ G++
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKPF----QGVKNNDVIGRIEN----GER--- 610
Query: 313 MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL-KLAVQESEQ 364
+ P N + L C +P RP ++ L + +E Q
Sbjct: 611 LPMPP-------NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKLQ 656
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-37
Identities = 75/311 (24%), Positives = 124/311 (39%), Gaps = 55/311 (17%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFL-GVVSHPNL 136
+G G FG V + +D VAVK L H+ ++E++ L + H N+
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGA------- 189
V LLG C+ +++ E+ +L L S+ +P+K E +
Sbjct: 94 VNLLGACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 190 -------AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS 242
A+G+ +L + I+RD N+LL K+ DFGLAR+
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 243 TA----VVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRP----TME 293
+ APE I QSD+WSFGV+L+EI + G P ++
Sbjct: 208 GDARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGA------SPYPGVKID 257
Query: 294 QKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
++ +K +G + M P + + +C P +RPT +++VE
Sbjct: 258 EEFCRRLK----EGTR---MRAPD-------YTTPEMYQTMLDCWHGEPSQRPTFSELVE 303
Query: 354 SLKLAVQESEQ 364
L +Q + Q
Sbjct: 304 HLGNLLQANAQ 314
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 78/282 (27%), Positives = 130/282 (46%), Gaps = 40/282 (14%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+IG G FG V+ G VA+K + G + ++ E + + +SHP LV+
Sbjct: 15 EIGSGQFGLVHLGYWLN------KDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L G C + LV E+M + L D L ++ + +T L + L EG+AYL E
Sbjct: 68 LYGVCLEQAPI----CLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT---YGYAAPE 255
VI+RD N L+ N K+SDFG+ R +T + GT +A+PE
Sbjct: 123 ---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT----SSTGTKFPVKWASPE 175
Query: 256 YIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMI 314
S+SD+WSFGV+++E+ + G+ P + E V+ + +
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFSEGK------IPYENRSNSEVVEDISTGFR----LY 225
Query: 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
PR A+ V ++ ++C ++ PE+RP ++++ L
Sbjct: 226 KPR-------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 77/283 (27%), Positives = 126/283 (44%), Gaps = 42/283 (14%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
++G G FG V G + VAVK + G ++ E Q + +SHP LVK
Sbjct: 15 ELGSGQFGVVKLGKWK------GQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVK 67
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
G CS E +V EY+ N L + L S L LE+ EG+A+L
Sbjct: 68 FYGVCSKEY----PIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT---YGYAAPE 255
Q I+RD N L+D + K+SDFG+ R + + VGT ++APE
Sbjct: 123 ---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV----SSVGTKFPVKWSAPE 175
Query: 256 YIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME-QKLLEWVKQFPADGKKFSMM 313
S+SD+W+FG++++E+ + G+ +++ V Q G + +
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFSLGKMPY----DLYTNSEVVLKVSQ----GHR---L 224
Query: 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
P A+ + ++ +C + PE+RPT Q++ S++
Sbjct: 225 YRPH-------LASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 71/290 (24%), Positives = 127/290 (43%), Gaps = 43/290 (14%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
++G G FG V G R VA+K + G +++ E + + +SH LV+
Sbjct: 31 ELGTGQFGVVKYGKWR------GQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L G C+ + ++ EYM N L + L + + LE+ E + YL
Sbjct: 84 LYGVCTKQRPI----FIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT---YGYAAPE 255
Q ++RD N L++ K+SDFGL+R ++T + VG+ ++ PE
Sbjct: 139 ---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT----SSVGSKFPVRWSPPE 191
Query: 256 YIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME-QKLLEWVKQFPADGKKFSMM 313
+ S+SDIW+FGV+++EI + G+ + E + Q G + +
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY----ERFTNSETAEHIAQ----GLR---L 240
Query: 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL-KLAVQES 362
P A+ +V + +C + +ERPT ++ ++ + +ES
Sbjct: 241 YRPH-------LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 283
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 77/313 (24%), Positives = 128/313 (40%), Gaps = 58/313 (18%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFL-GVVSHPNL 136
+G G FG V + T L + VAVK L + L + ++E++ L + +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGA------- 189
V LLG C+ L++ EY L + L + + KT I+
Sbjct: 90 VNLLGACTIGGP----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 190 ---------AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTH 240
A+G+A+L I+RD N+LL K+ DFGLAR+ +
Sbjct: 146 DLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 241 VSTA----VVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRP----T 291
V V APE I +SD+WS+G+ L+E+ + G P
Sbjct: 203 VKGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGS------SPYPGMP 252
Query: 292 MEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQV 351
++ K + +K +G + M+ P +A + + C +P +RPT Q+
Sbjct: 253 VDSKFYKMIK----EGFR---MLSPE-------HAPAEMYDIMKTCWDADPLKRPTFKQI 298
Query: 352 VESLKLAVQESEQ 364
V+ ++ + ES
Sbjct: 299 VQLIEKQISESTN 311
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 81/318 (25%), Positives = 124/318 (38%), Gaps = 66/318 (20%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
IGEG FG V++ L +VAVK L + E + +PN+V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR----------------------AQP 175
KLLG C+ G L++EYM L + L S P
Sbjct: 114 KLLGVCA----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 176 TLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPT 235
L +L I A G+AYL E + ++RD T N L+ N K++DFGL+R +
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 236 GDHTHVSTAVVGTYGY-----AAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNR 289
D PE I ++SD+W++GVVL+EI + G +
Sbjct: 227 AD-----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL------Q 275
Query: 290 P----TMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
P E+ ++ +V+ DG ++ P N + L C K P +R
Sbjct: 276 PYYGMAHEE-VIYYVR----DGN---ILACPE-------NCPLELYNLMRLCWSKLPADR 320
Query: 346 PTMNQVVESLKLAVQESE 363
P+ + L+ + +E
Sbjct: 321 PSFCSIHRILQRMCERAE 338
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-36
Identities = 74/317 (23%), Positives = 131/317 (41%), Gaps = 42/317 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
+G G FG V G ++ + VA+K L + + + +L E +G HPN++
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEIS--VAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
+L G + ++V EYM N SL+ L + ++ G A G+ YL
Sbjct: 110 RLEGVVTKSKPV----MIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS 164
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT---YGYAAP 254
+ + ++RD N+L++ N K+SDFGL R D + G + +P
Sbjct: 165 D---MGYVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSP 219
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILT-GRRVLER--NRPTMEQKLLEWVKQFPADGKKFS 311
E I S SD+WS+G+VL+E+++ G R N+ ++
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA----------------- 262
Query: 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSSSTTT 371
+D R ++ + +L +C +K+ RP Q+V L + + S
Sbjct: 263 --VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL----DKLIRNPGSLKI 316
Query: 372 AAKTPVTSSSRLVDRRS 388
S+ L+D+ +
Sbjct: 317 ITSAAARPSNLLLDQSN 333
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-36
Identities = 82/308 (26%), Positives = 128/308 (41%), Gaps = 59/308 (19%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLG-VVSHPNL 136
IGEG FG V K I+ G + A+K++ H+ + E++ L + HPN+
Sbjct: 32 VIGEGNFGQVLKARIK---KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRL--------------FSRAQPTLPWKTR 182
+ LLG C L EY P+ +L D L + TL +
Sbjct: 89 INLLGACEHRG----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 183 LEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS 242
L A G+ YL + Q I+RD N+L+ N+ K++DFGL+R
Sbjct: 145 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------E 193
Query: 243 TAVVGTYG-----YAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME-QK 295
V T G + A E + + SD+WS+GV+L+EI++ G M +
Sbjct: 194 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY----CGMTCAE 249
Query: 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
L E + Q G + + P N V L C ++ P ERP+ Q++ SL
Sbjct: 250 LYEKLPQ----GYR---LEKPL-------NCDDEVYDLMRQCWREKPYERPSFAQILVSL 295
Query: 356 KLAVQESE 363
++E +
Sbjct: 296 NRMLEERK 303
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-36
Identities = 71/301 (23%), Positives = 112/301 (37%), Gaps = 56/301 (18%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFL-GVVSHPNLV 137
+ EGGF VY+ GR A+K+L ++ + ++ + EV F+ + HPN+V
Sbjct: 35 VLAEGGFAFVYEAQ-DVGSGR----EYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 138 KLLGYCSTEDERGIQR----LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGL 193
+ S E LL+ E + +E ++ L T L+I +
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE---GPTGDHTHVSTAVV---- 246
++H + +I+RD K N+LL KL DFG A P + A+V
Sbjct: 150 QHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 247 ---GTYGYAAPEYIETGHLK---SQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300
T Y PE I+ + DIW+ G +LY + + P
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ------HP---------- 252
Query: 301 KQFPADGK------KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354
F K K+S+ L L+ NPEER ++ +VV
Sbjct: 253 --FEDGAKLRIVNGKYSIPPHDT----QY----TVFHSLIRAMLQVNPEERLSIAEVVHQ 302
Query: 355 L 355
L
Sbjct: 303 L 303
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-35
Identities = 83/312 (26%), Positives = 120/312 (38%), Gaps = 60/312 (19%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFL-GVVSHPNL 136
+G G FG V + T L L VAVK L + ++E++ + + H N+
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSL------------EDRLFSRAQPTLPWKTRLE 184
V LLG C+ L++ EY L D F+ A T + L
Sbjct: 113 VNLLGACTHGGP----VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 185 IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTA 244
A+G+A+L I+RD NVLL K+ DFGLAR D + S
Sbjct: 169 FSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLAR-----DIMNDSNY 220
Query: 245 VVGTYG-----YAAPEYIETGHLKSQSDIWSFGVVLYEILT-------GRRVLERNRPTM 292
+V + APE I QSD+WS+G++L+EI + G V
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV-------- 272
Query: 293 EQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVV 352
K + VK DG + M P A + + + C P RPT Q+
Sbjct: 273 NSKFYKLVK----DGYQ---MAQPA-------FAPKNIYSIMQACWALEPTHRPTFQQIC 318
Query: 353 ESLKLAVQESEQ 364
L+ QE +
Sbjct: 319 SFLQEQAQEDRR 330
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 56/312 (17%), Positives = 104/312 (33%), Gaps = 64/312 (20%)
Query: 79 KIGEGGFGSVY----KGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA----------- 123
+ +G F + A+KK L+ + +
Sbjct: 38 TLNQGKFNKIILCEKDNKF-----------YALKKYEKSLLEKKRDFTKSNNDKISIKSK 86
Query: 124 ------EVQFLGVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPT 176
E+Q + + + + G + D + ++YEYM N S+
Sbjct: 87 YDDFKNELQIITDIKNEYCLTCEGIITNYD-----EVYIIYEYMENDSILKFDEYFFVLD 141
Query: 177 LPWKTRL----------EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226
+ + ++ +Y+H I +RD K SN+L+D N + KLSD
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNS----FSYIHNEKNI--CHRDVKPSNILMDKNGRVKLSD 195
Query: 227 FGLAREGPTGD-HTHVSTAVVGTYGYAAPEYIET--GHLKSQSDIWSFGVVLYEILTGRR 283
FG + GTY + PE+ + ++ DIWS G+ LY +
Sbjct: 196 FGESEYMVDKKIKG-----SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV 250
Query: 284 --VLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKN 341
L+ + + + ++P D F + + + + L+KN
Sbjct: 251 PFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKN 310
Query: 342 PEERPTMNQVVE 353
P ER T ++
Sbjct: 311 PAERITSEDALK 322
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 67/321 (20%), Positives = 127/321 (39%), Gaps = 56/321 (17%)
Query: 44 SPRSIPELYKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPL 103
SP + E+ + V + F +G G G++ + D R
Sbjct: 4 SPSLEQDDGDEETSVVIVGKIS--------FCPKDVLGHGAEGTIVYRGMF--DNR---- 49
Query: 104 VVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDERGIQRLLVYEYMPN 162
VAVK++ + EVQ L HPN+++ +C+ +D + + E
Sbjct: 50 DVAVKRILPECFSFADR---EVQLLRESDEHPNVIRY--FCTEKDRQFQ--YIAIELCAA 102
Query: 163 RSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL-----D 217
+L++ + + L + ++ GLA+LH + +++RD K N+L+
Sbjct: 103 -TLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAH 157
Query: 218 GNFKPKLSDFGLAREGPTGDHT-HVSTAVVGTYGYAAPEYIETGHLKSQS---DIWSFGV 273
G K +SDFGL ++ G H+ + V GT G+ APE + ++ + DI+S G
Sbjct: 158 GKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGC 217
Query: 274 VLYEILTGRRVLERNRP---TMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRV 330
V Y +++ P +++++ + D D R
Sbjct: 218 VFYYVISEGS-----HPFGKSLQRQANILLGACSLDCLHPEKHEDVIARE---------- 262
Query: 331 AKLADNCLKKNPEERPTMNQV 351
L + + +P++RP+ V
Sbjct: 263 --LIEKMIAMDPQKRPSAKHV 281
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 4e-35
Identities = 79/371 (21%), Positives = 129/371 (34%), Gaps = 43/371 (11%)
Query: 16 GSNSAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHLRVFDMQELREATNGFN 75
GS S+ + + L + P + L+ D E RE +
Sbjct: 3 GSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVD-YEYREEVHWMT 61
Query: 76 RMLKIGEGGFGSVYKGTIRPLDGR-GEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHP 134
++G G FG V++ D + G AVKK+ L+ + E+ +S P
Sbjct: 62 HQPRVGRGSFGEVHRM----KDKQTGF--QCAVKKVR---LEVFRV--EELVACAGLSSP 110
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLA 194
+V L G I E + SL + + LP L + A EGL
Sbjct: 111 RIVPLYGAVREGPWVNI----FMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLE 164
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGN-FKPKLSDFGLAR---EGPTGDHTHVSTAVVGTYG 250
YLH ++++ D K NVLL + + L DFG A G + GT
Sbjct: 165 YLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 251 YAAPEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309
+ APE + ++ DIWS ++ +L G L+ + P
Sbjct: 222 HMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHPW-TQYFRG-PLCLKIASEPP----- 273
Query: 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSSST 369
+ + A+ + + L+K P R + ++ + A+QE S
Sbjct: 274 ----PIREIPPSCAPLTAQAIQE----GLRKEPVHRASAMELRRKVGKALQEVGGLKSPW 325
Query: 370 TTAAKTPVTSS 380
K P +S
Sbjct: 326 KGEYKEPRGNS 336
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 72/291 (24%), Positives = 113/291 (38%), Gaps = 34/291 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ-WLAEVQFLGVVSHPNLV 137
++G GGFG V + + GE VA+K+ +++ W E+Q + ++HPN+V
Sbjct: 21 RLGTGGFGYVLRWIHQD---TGE--QVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 138 KLLGYCSTEDERGIQR----LLVYEYMPNRSLEDRLFSRAQPT-LPWKTRLEIILGAAEG 192
+ + + LL EY L L L ++ +
Sbjct: 76 SA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKP---KLSDFGLAREGPTGDHTHVSTAVVGTY 249
L YLHE ++I+RD K N++L + K+ D G A+E G + T VGT
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG---ELCTEFVGTL 187
Query: 250 GYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRR-VLERNRPTMEQKLLE-------WVK 301
Y APE +E D WSFG + +E +TG R L +P + V
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 302 QFPADGKKFSMMI-DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQV 351
KFS ++ P + R + L + +R T Q
Sbjct: 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM---LMWHQRQRGTDPQN 295
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-35
Identities = 84/316 (26%), Positives = 133/316 (42%), Gaps = 64/316 (20%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
+GEG FG V K T L GR VAVK L N + L+E L V+HP+++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR----------------------AQP 175
KL G CS + LL+ EY SL L +
Sbjct: 90 KLYGACSQDGP----LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 176 TLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPT 235
L + ++G+ YL E+++++RD N+L+ K K+SDFGL+R+
Sbjct: 146 ALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 236 GDHTHVSTAVVGTYG-----YAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNR 289
D + V + G + A E + +QSD+WSFGV+L+EI+T G
Sbjct: 203 ED-----SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG------N 251
Query: 290 P--TME-QKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP 346
P + ++L +K G + M P N + + +L C K+ P++RP
Sbjct: 252 PYPGIPPERLFNLLK----TGHR---MERPD-------NCSEEMYRLMLQCWKQEPDKRP 297
Query: 347 TMNQVVESLKLAVQES 362
+ + L+ + +
Sbjct: 298 VFADISKDLEKMMVKR 313
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-35
Identities = 69/318 (21%), Positives = 122/318 (38%), Gaps = 63/318 (19%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFL-GVVSHPNL 136
+G G FG V T + G + VAVK L + ++E++ + + SH N+
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGA------- 189
V LLG C+ L++EY L + L S+ + + E
Sbjct: 112 VNLLGACTLSGP----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 190 --------------AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPT 235
A+G+ +L ++RD NVL+ K+ DFGLAR+ +
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 236 GDHTHVSTA----VVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRP 290
+ V V APE + G +SD+WS+G++L+EI + G P
Sbjct: 225 DSNYVVRGNARLPVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGV------NP 274
Query: 291 ----TMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP 346
++ + ++ +G K M P A + + +C + +RP
Sbjct: 275 YPGIPVDANFYKLIQ----NGFK---MDQPF-------YATEEIYIIMQSCWAFDSRKRP 320
Query: 347 TMNQVVESLKLAVQESEQ 364
+ + L + ++E+
Sbjct: 321 SFPNLTSFLGCQLADAEE 338
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 2e-34
Identities = 48/351 (13%), Positives = 106/351 (30%), Gaps = 25/351 (7%)
Query: 11 FKPKKGSNSAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHLRVFDMQELREA 70
G+ AP N D+ + S P ++ + + E +
Sbjct: 4 QMSSLGTVDAPNFIVGNPWDDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLG 63
Query: 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGV 130
+ +GEG F VY+ T L+ +K ++ L
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPT---LPWKTRLEIIL 187
+K ++ +LV E +L + + +P + +
Sbjct: 124 SMQHMFMKFYSAHLFQNGS----VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 188 GAAEGLAYLHEGLEIQVIYRDFKTSNVLL-----------DGNFKPKLSDFGLAREGPTG 236
+ +H+ ++I+ D K N +L D + L D G + +
Sbjct: 180 RMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236
Query: 237 DHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR--RVLERNRPTMEQ 294
+ TA T G+ E + Q D + +Y +L G +V +
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE 296
Query: 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
L + + F +M++ + + + + + + +++ +
Sbjct: 297 GLFRRLPHLDMWNEFFHVMLNI--PDCHHLPSLDLLRQKLKKVFQQHYTNK 345
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 88/367 (23%), Positives = 149/367 (40%), Gaps = 55/367 (14%)
Query: 22 EPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHLRVFDMQELREATNGFNRMLKIG 81
+ + +++N+ L R L S P L E+ L E + +G
Sbjct: 33 SAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGK--PLG 90
Query: 82 EGGFGSVYKGTIRPLDG--RGEPLVVAVKKLN-NHGLQGHKQWLAEVQFL-GVVSHPNLV 137
EG FG V +D E + VAVK L + + ++E++ + + H N++
Sbjct: 91 EGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 150
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR--------------AQPTLPWKTRL 183
LLG C+ + ++ EY +L + L +R + + +K +
Sbjct: 151 NLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST 243
A G+ YL + I+RD NVL+ N K++DFGLAR+ D+ +T
Sbjct: 207 SCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 244 A----VVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERN-RPTME-QKLL 297
V APE + QSD+WSFGV+++EI T L + P + ++L
Sbjct: 264 NGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFT----LGGSPYPGIPVEELF 315
Query: 298 EWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357
+ +K+ G + M P N + + +C P +RPT Q+VE L
Sbjct: 316 KLLKE----GHR---MDKPA-------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361
Query: 358 AVQESEQ 364
+ +
Sbjct: 362 ILTLTTN 368
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 2e-34
Identities = 45/319 (14%), Positives = 86/319 (26%), Gaps = 83/319 (26%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKL----------------------------N 111
+G+ + + T G V N
Sbjct: 81 LGQEDPYAYLEAT-DQETGE----SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135
Query: 112 NHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLE--DRL 169
+ H +++ + ++++ D + R +Y M + + L
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD--ERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 170 FS--RAQPTLPWKTRLEIILGAAEGLAYLHE-GLEIQVIYRDFKTSNVLLDGNFKPKLSD 226
S +L RL++ L LA LH G +++ + +++LD L+
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTG 249
Query: 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQ-----------SDIWSFGVVL 275
F + G+ PE S D W+ G+V+
Sbjct: 250 FEHLVRD------GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303
Query: 276 YEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLAD 335
Y I P + R+ +I V L +
Sbjct: 304 YWIWCAD--------------------LPITKDAALGGSEWIFRSCKNIPQP--VRALLE 341
Query: 336 NCLKKNPEERPTMNQVVES 354
L+ E+R Q +E+
Sbjct: 342 GFLRYPKEDRLLPLQAMET 360
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-34
Identities = 74/286 (25%), Positives = 119/286 (41%), Gaps = 50/286 (17%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQF-LGVVSHPNL 136
++G G +G V K P ++AVK++ Q K+ L ++ + V P
Sbjct: 14 ELGRGAYGVVEKMRHVPSG-----QIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLED--RLFSRAQPTLPWKTRLEIILGA----- 189
V G E + I E M + SL+ + T+P E ILG
Sbjct: 69 VTFYGALFREGDVWI----CMELM-DTSLDKFYKQVIDKGQTIP-----EDILGKIAVSI 118
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
+ L +LH ++ VI+RD K SNVL++ + K+ DFG++ G
Sbjct: 119 VKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGY---LVDDVAKDIDAGCK 173
Query: 250 GYAAPEYIETGHLKS----QSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305
Y APE I + +SDIWS G+ + E+ R + +Q L+ V + P+
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--LKQVVEEPS 231
Query: 306 DGKKFSMMIDPRL-RNQYSINAARRVAKLADNCLKKNPEERPTMNQ 350
P+L +++S ++ CLKKN +ERPT +
Sbjct: 232 ----------PQLPADKFSAEFVDFTSQ----CLKKNSKERPTYPE 263
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-34
Identities = 78/301 (25%), Positives = 128/301 (42%), Gaps = 53/301 (17%)
Query: 79 KIGEGGFGSVYKGTIRPLDG--RGEPLVVAVKKLN-NHGLQGHKQWLAEVQFL-GVVSHP 134
+GEG FG V +D E + VAVK L + + ++E++ + + H
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR--------------AQPTLPWK 180
N++ LLG C+ + ++ EY +L + L +R + + +K
Sbjct: 102 NIINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 181 TRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTH 240
+ A G+ YL + I+RD NVL+ N K++DFGLAR+ D+
Sbjct: 158 DLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214
Query: 241 VSTA----VVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTME-Q 294
+T V APE + QSD+WSFGV+++EI T G P + +
Sbjct: 215 KTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY----PGIPVE 266
Query: 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354
+L + +K +G + M P N + + +C P +RPT Q+VE
Sbjct: 267 ELFKLLK----EGHR---MDKPA-------NCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
Query: 355 L 355
L
Sbjct: 313 L 313
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-34
Identities = 60/313 (19%), Positives = 123/313 (39%), Gaps = 57/313 (18%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH--KQWLAEVQFLGVVSHPNL 136
+IG GG V++ L+ + + + A+K +N + E+ +L + +
Sbjct: 35 QIGSGGSSKVFQV----LNEKKQ--IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 137 --VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLA 194
++L Y T+ I +V E N L L + + ++ R E +
Sbjct: 89 KIIRLYDYEITDQY--I--YMVMECG-NIDLNSWL--KKKKSIDPWERKSYWKNMLEAVH 141
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP 254
+H+ +++ D K +N L+ KL DFG+A + + V + VGT Y P
Sbjct: 142 TIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 255 EYIETGHLKSQ-----------SDIWSFGVVLYEILTGR---RVLERNRPTMEQKLLEWV 300
E I+ + SD+WS G +LY + G+ + + + +
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257
Query: 301 K-QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES--LKL 357
+ +FP + L++ + CLK++P++R ++ +++ +++
Sbjct: 258 EIEFPDI-------PEKDLQD------------VLKCCLKRDPKQRISIPELLAHPYVQI 298
Query: 358 AVQESEQGSSSTT 370
Q + TT
Sbjct: 299 QTHPVNQMAKGTT 311
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-34
Identities = 79/315 (25%), Positives = 129/315 (40%), Gaps = 54/315 (17%)
Query: 54 EKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-N 112
E L++ Q + +IG G +GSV K +P ++AVK++
Sbjct: 4 ESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSG-----QIMAVKRIRST 58
Query: 113 HGLQGHKQWLAEVQF-LGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLED---R 168
+ KQ L ++ + P +V+ G E + I E M + S +
Sbjct: 59 VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI----CMELM-STSFDKFYKY 113
Query: 169 LFSRAQPTLPWKTRLEIILGA-----AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPK 223
++S +P E ILG + L +L E +++I+RD K SN+LLD + K
Sbjct: 114 VYSVLDDVIP-----EEILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIK 166
Query: 224 LSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKS----QSDIWSFGVVLYEIL 279
L DFG++ + + T G Y APE I+ + +SD+WS G+ LYE+
Sbjct: 167 LCDFGISGQ---LVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223
Query: 280 TGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRN----QYSINAARRVAKLAD 335
TGR + +Q L V + P+L N ++S + V
Sbjct: 224 TGRFPYPKWNSVFDQ--LTQVVKGDP----------PQLSNSEEREFSPSFINFVNL--- 268
Query: 336 NCLKKNPEERPTMNQ 350
CL K+ +RP +
Sbjct: 269 -CLTKDESKRPKYKE 282
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 8e-34
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA----EVQFLGVVSHP 134
+G GG V+ R VAVK L L + E Q ++HP
Sbjct: 19 ILGFGGMSEVHLARDLRDH-R----DVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHP 72
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLA 194
+V + E G +V EY+ +L D + + + K +E+I A + L
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALN 130
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST-AVVGTYGYAA 253
+ H+ +I+RD K +N+++ K+ DFG+AR ++ T AV+GT Y +
Sbjct: 131 FSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEILTGRR 283
PE + ++SD++S G VLYE+LTG
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 9e-34
Identities = 72/297 (24%), Positives = 118/297 (39%), Gaps = 41/297 (13%)
Query: 63 DMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQW 121
Q + N + ++G G G V+K R V+AVK++ + + +K+
Sbjct: 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTG-----HVIAVKQMRRSGNKEENKRI 70
Query: 122 LAEVQFL-GVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWK 180
L ++ + P +V+ G T + I E M ++L R Q +P +
Sbjct: 71 LMDLDVVLKSHDCPYIVQCFGTFITNTDVFI----AMELM-GTCA-EKLKKRMQGPIPER 124
Query: 181 TRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTH 240
++ + + L YL E + VI+RD K SN+LLD + KL DFG++
Sbjct: 125 ILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGR---LVDDK 179
Query: 241 VSTAVVGTYGYAAPEYIETGHLK-----SQSDIWSFGVVLYEILTGRRVLERNRPTMEQK 295
G Y APE I+ ++D+WS G+ L E+ TG+ + + E
Sbjct: 180 AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV- 238
Query: 296 LLEWVKQFPADGKKFSMMIDPRLRN--QYSINAARRVAKLADNCLKKNPEERPTMNQ 350
L V Q P L +S + V CL K+ +RP N+
Sbjct: 239 -LTKVLQEEP----------PLLPGHMGFSGDFQSFVKD----CLTKDHRKRPKYNK 280
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 69/343 (20%), Positives = 117/343 (34%), Gaps = 63/343 (18%)
Query: 21 PEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHLRVFDMQELREATNGFNRMLKI 80
P P + + A + P R + +
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRF------------L 49
Query: 81 GEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK---QWLAEVQFLGVVSHPNLV 137
G+GGF ++ + V A K + L + E+ ++H ++V
Sbjct: 50 GKGGFAKCFEIS-DADTKE----VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104
Query: 138 KLLGYCSTEDERGIQRLLVY---EYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLA 194
G+ D V+ E RSL + R T P + R + G
Sbjct: 105 GFHGFFEDNDF-------VFVVLELCRRRSLLELHKRRKALTEP-EAR-YYLRQIVLGCQ 155
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP 254
YLH +VI+RD K N+ L+ + + K+ DFGLA + GT Y AP
Sbjct: 156 YLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIAP 210
Query: 255 EYIE-TGHLKSQSDIWSFGVVLYEILTGRRVL---ERNRPTMEQKLLEWVKQFPADGKKF 310
E + GH + D+WS G ++Y +L G+ ++ + P
Sbjct: 211 EVLSKKGH-SFEVDVWSIGCIMYTLLVGK--PPFETSCLKETYLRIKKNEYSIPKH---- 263
Query: 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
+ AA + K+ L+ +P RPT+N+++
Sbjct: 264 -----------INPVAASLIQKM----LQTDPTARPTINELLN 291
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-33
Identities = 65/347 (18%), Positives = 116/347 (33%), Gaps = 94/347 (27%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVS 132
F + +G GGFG V++ +D A+K++ + ++ + EV+ L +
Sbjct: 8 FEPIQCMGRGGFGVVFEAK-NKVDDC----NYAIKRIRLPNRELAREKVMREVKALAKLE 62
Query: 133 HPNLVKLLGYCSTEDERGIQRLLVYEYM-------------------------------- 160
HP +V+ Q + ++
Sbjct: 63 HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKN 122
Query: 161 ---------------------PNRSLEDRLFSRAQPTLP-WKTRLEIILGAAEGLAYLHE 198
+L+D + R L I + AE + +LH
Sbjct: 123 TVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH- 181
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE----------GPTGDHTHVSTAVVGT 248
+++RD K SN+ + K+ DFGL T VGT
Sbjct: 182 --SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 249 YGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ-KLLEWVKQFPADG 307
Y +PE I + + DI+S G++L+E+L ME+ +++ V+
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF------STQMERVRIITDVRN----- 288
Query: 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354
KF P L Q + + + L +P ERP ++E+
Sbjct: 289 LKF-----PLLFTQKY----PQEHMMVQDMLSPSPTERPEATDIIEN 326
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-33
Identities = 63/272 (23%), Positives = 116/272 (42%), Gaps = 31/272 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNL 136
+IG G F +VYKG LD + VA +L + L +++ E + L + HPN+
Sbjct: 33 EIGRGSFKTVYKG----LD-TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
V+ + + +LV E M + +L+ L + + K +GL +L
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFL 145
Query: 197 HEGLEIQVIYRDFKTSNVLLDG-NFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPE 255
H +I+RD K N+ + G K+ D GLA + AV+GT + APE
Sbjct: 146 HTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPE 200
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMID 315
E + D+++FG+ + E+ T P E + ++ + +
Sbjct: 201 MYEEKY-DESVDVYAFGMCMLEMATSE------YPYSE------CQNAAQIYRRVTSGVK 247
Query: 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPT 347
P ++ +I + + + C+++N +ER +
Sbjct: 248 PASFDKVAIPEVKE---IIEGCIRQNKDERYS 276
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 70/283 (24%), Positives = 119/283 (42%), Gaps = 48/283 (16%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVK-----KLNNHGLQGHKQWLAEVQFLGVVSHP 134
+G+G F VY+ G VA+K + G+ ++ EV+ + HP
Sbjct: 19 LGKGSFAGVYRAESIH-TGL----EVAIKMIDKKAMYKAGMV--QRVQNEVKIHCQLKHP 71
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLA 194
++++L Y ED + LV E N + L +R +P + R + G+
Sbjct: 72 SILELYNY--FEDSNYV--YLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGML 126
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP 254
YLH +++RD SN+LL N K++DFGLA + H + GT Y +P
Sbjct: 127 YLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISP 181
Query: 255 EYIE-TGHLKSQSDIWSFGVVLYEILTGRRVL---ERNRPTMEQKLLEWVKQFPADGKKF 310
E + H +SD+WS G + Y +L GR K++ + P+
Sbjct: 182 EIATRSAH-GLESDVWSLGCMFYTLLIGR--PPFDTDTVKNTLNKVVLADYEMPSF---- 234
Query: 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
SI A + +L L++NP +R +++ V++
Sbjct: 235 -----------LSIEAKDLIHQL----LRRNPADRLSLSSVLD 262
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-33
Identities = 63/310 (20%), Positives = 110/310 (35%), Gaps = 73/310 (23%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKK--LNNHGLQGHKQWLAEVQFLGVV 131
F+ + KIG G FGSV+K ++ LDG + A+K+ G + L EV V+
Sbjct: 13 FHELEKIGSGEFGSVFKC-VKRLDGC----IYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 132 S-HPNLVKLLGYCSTEDERGIQRLLVY-EYMPNRSLEDRL--FSRAQPTLPWKTRLEIIL 187
H ++V+ Y S E +L+ EY SL D + R +++L
Sbjct: 68 GQHSHVVR---YFSAWAEDD--HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 188 GAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP-------------------KLSDFG 228
GL Y+H + +++ D K SN+ + P K+ D G
Sbjct: 123 QVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYI--ETGHLKSQSDIWSFGVVLYEILTGRRVLE 286
G + A E + HL +DI++ + +
Sbjct: 180 HVT------RISSPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGA----- 227
Query: 287 RNRPTMEQKLLEWVKQFPADGKKFSMMID---PRLRNQYSINAARRVAKLADNCLKKNPE 343
+ P +G ++ + PR+ S + K+ + +PE
Sbjct: 228 --------------EPLPRNGDQWHEIRQGRLPRIPQVLS-QEFTELLKV---MIHPDPE 269
Query: 344 ERPTMNQVVE 353
RP+ +V+
Sbjct: 270 RRPSAMALVK 279
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 63/327 (19%), Positives = 127/327 (38%), Gaps = 49/327 (14%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH--KQWLAEVQFLGVVSHPNL 136
+IG GG V++ L+ + + + A+K +N + E+ +L + +
Sbjct: 16 QIGSGGSSKVFQV----LNEKKQ--IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 137 --VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLA 194
++L Y T+ +V E N L L + + ++ R E +
Sbjct: 70 KIIRLYDYEITDQYI----YMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNMLEAVH 122
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP 254
+H+ +++ D K +N L+ + KL DFG+A + + V + VGT Y P
Sbjct: 123 TIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 255 EYIETGHLKSQ-----------SDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303
E I+ + SD+WS G +LY + G+ ++ +
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---------- 228
Query: 304 PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES--LKLAVQE 361
K +IDP ++ + + + CLK++P++R ++ +++ +++
Sbjct: 229 -----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283
Query: 362 SEQGSSSTTTAAKTPVTSSSRLVDRRS 388
Q + TT K + L S
Sbjct: 284 VNQMAKGTTEEMKYVLGQLVGLNSPNS 310
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-33
Identities = 45/371 (12%), Positives = 90/371 (24%), Gaps = 82/371 (22%)
Query: 33 SALNRTARSLPSPRSIPELYKEKEHHLRVFDMQELREAT--------NGFNRMLK----I 80
+ +P + + R L +
Sbjct: 27 VVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVL 86
Query: 81 GEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH----------------------GLQGH 118
G+ + + T G V G++
Sbjct: 87 GQEDPYAYLEAT-DQETGE----SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQ 141
Query: 119 KQWLAEVQFLG---VVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRL-----F 170
KQ ++F+ +V P K++ E + + +L+
Sbjct: 142 KQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH 201
Query: 171 SRAQPTLPWKTRLEIILGAAEGLAYLHE-GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229
S +L RL++ L LA LH G +++ + +++LD L+ F
Sbjct: 202 SSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEH 257
Query: 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIE-----TGHLKSQSDIWSFGVVLYEILTGRR- 283
+ A + + D W+ G+ +Y I
Sbjct: 258 LVRDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 284 VLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPE 343
+ + + K P V L + L+ E
Sbjct: 317 NTDDAALGGSEWIFRSCKNIPQP-----------------------VRALLEGFLRYPKE 353
Query: 344 ERPTMNQVVES 354
+R Q +E+
Sbjct: 354 DRLLPLQAMET 364
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-33
Identities = 80/310 (25%), Positives = 127/310 (40%), Gaps = 53/310 (17%)
Query: 79 KIGEGGFGSVYKGTIRPLDGR--GEPLVVAVKKLN-NHGLQGHKQWLAEVQFL-GVVSHP 134
+GEG FG V LD VAVK L + + ++E++ + + H
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGA----- 189
N++ LLG C+ + ++ EY +L + L +R P L +
Sbjct: 136 NIINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 190 ---------AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTH 240
A G+ YL + I+RD NVL+ + K++DFGLAR+ D+
Sbjct: 192 DLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 241 VSTA----VVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERN-RPTME-Q 294
+T V APE + QSD+WSFGV+L+EI T L + P + +
Sbjct: 249 KTTNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFT----LGGSPYPGVPVE 300
Query: 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES 354
+L + +K+ G + M P N + + +C P +RPT Q+VE
Sbjct: 301 ELFKLLKE----GHR---MDKPS-------NCTNELYMMMRDCWHAVPSQRPTFKQLVED 346
Query: 355 LKLAVQESEQ 364
L V +
Sbjct: 347 LDRIVALTSN 356
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-33
Identities = 64/284 (22%), Positives = 108/284 (38%), Gaps = 51/284 (17%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK---QWLAEVQFLGVVSHPNL 136
+G+GGF ++ + V A K + L + E+ ++H ++
Sbjct: 23 LGKGGFAKCFEIS-DADTKE----VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV 77
Query: 137 VKLLGYCSTEDERGIQRLLVY---EYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGL 193
V G+ D V+ E RSL + R T P + R + G
Sbjct: 78 VGFHGFFEDNDF-------VFVVLELCRRRSLLELHKRRKALTEP-EAR-YYLRQIVLGC 128
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAA 253
YLH +VI+RD K N+ L+ + + K+ DFGLA + GT Y A
Sbjct: 129 QYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--GTPNYIA 183
Query: 254 PEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVL---ERNRPTMEQKLLEWVKQFPADGKK 309
PE + GH + D+WS G ++Y +L G+ ++ + P
Sbjct: 184 PEVLSKKGH-SFEVDVWSIGCIMYTLLVGK--PPFETSCLKETYLRIKKNEYSIPKH--- 237
Query: 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
+ AA + K+ L+ +P RPT+N+++
Sbjct: 238 ------------INPVAASLIQKM----LQTDPTARPTINELLN 265
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-33
Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA----EVQFLGVVSHP 134
K+G GG +VY L+ VA+K + + ++ L EV +SH
Sbjct: 18 KLGGGGMSTVYLAEDTILN-I----KVAIKAIFIP-PREKEETLKRFEREVHNSSQLSHQ 71
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLA 194
N+V + E++ LV EY+ +L + + + L T + +G+
Sbjct: 72 NIVSM--IDVDEEDD--CYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIK 125
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST-AVVGTYGYAA 253
+ H+ +++++RD K N+L+D N K+ DFG+A+ + + T V+GT Y +
Sbjct: 126 HAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFS 180
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEILTGRR 283
PE + +DI+S G+VLYE+L G
Sbjct: 181 PEQAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 35/372 (9%), Positives = 80/372 (21%), Gaps = 67/372 (18%)
Query: 14 KKGSNSAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHLRVFDMQELREATNG 73
K+ R + + + + ++ + + R + E
Sbjct: 16 KREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEP------ 69
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG---HKQWLAEVQFLGV 130
+ G V+ E A+K ++
Sbjct: 70 ------LRVGDRSVVFLVRDVER---LED--FALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 131 VSHPNLVKLLGYC----------------------STEDERGIQRLLVYEYMPNRSLED- 167
+ + + +D LL+ + LE
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELL 177
Query: 168 ----RLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPK 223
+ + A L +++ F N+ + + +
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLM 234
Query: 224 LSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLK--SQSDIWSFGVVLYEILTG 281
L D + T A YA E++ + W G+ +Y +
Sbjct: 235 LGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289
Query: 282 RRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKN 341
P ++ + P + + V L L +
Sbjct: 290 FLPFGLVTPGIKGSWKRPSLRVPGTD-------SLAFGSCTPLPDF--VKTLIGRFLNFD 340
Query: 342 PEERPTMNQVVE 353
R + +E
Sbjct: 341 RRRRLLPLEAME 352
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 69/393 (17%), Positives = 145/393 (36%), Gaps = 62/393 (15%)
Query: 17 SNSAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHLRVFDMQELREATNGFNR 76
+S PR + + +A + + SP + + + R ++
Sbjct: 6 HSSGLVPRG-SGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRI----YSI 60
Query: 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHP 134
+ +IG GG V++ L+ + + + A+K +N Q + E+ +L +
Sbjct: 61 LKQIGSGGSSKVFQV----LNEKKQ--IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 135 NL--VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEG 192
+ ++L Y T+ +V E N L L + + ++ R E
Sbjct: 115 SDKIIRLYDYEITDQYI----YMVMEC-GNIDLNSWL--KKKKSIDPWERKSYWKNMLEA 167
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA 252
+ +H+ +++ D K +N L+ KL DFG+A + + V + VG Y
Sbjct: 168 VHTIHQ---HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 253 APEYIETGHLKSQ-----------SDIWSFGVVLYEILTGR---RVLERNRPTMEQKLLE 298
PE I+ + SD+WS G +LY + G+ + + + +
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 283
Query: 299 WVK-QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVES--L 355
+ +FP + L++ + CLK++P++R ++ +++ +
Sbjct: 284 NHEIEFPDI-------PEKDLQD------------VLKCCLKRDPKQRISIPELLAHPYV 324
Query: 356 KLAVQESEQGSSSTTTAAKTPVTSSSRLVDRRS 388
++ Q + TT K + L S
Sbjct: 325 QIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNS 357
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-32
Identities = 73/281 (25%), Positives = 118/281 (41%), Gaps = 47/281 (16%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK---QWLAEVQFLGVVSHPNL 136
+G+G FG+VY + ++A+K L L+ Q EV+ + HPN+
Sbjct: 17 LGKGKFGNVYLAREKQ-SKF----ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
++L GY D + L+ EY P ++ L + + I A L+Y
Sbjct: 72 LRLYGYF--HDATRV--YLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSYC 125
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
H +VI+RD K N+LL + K++DFG + P+ T + GT Y PE
Sbjct: 126 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---D-LCGTLDYLPPEM 178
Query: 257 IET-GHLKSQSDIWSFGVVLYEILTGRRVL---ERNRPTMEQKLLEWVKQFPADGKKFSM 312
IE H + D+WS GV+ YE L G+ +++ FP
Sbjct: 179 IEGRMHDEK-VDLWSLGVLCYEFLVGK--PPFEANTYQETYKRISRVEFTFP-------- 227
Query: 313 MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
+ + A +++L LK NP +RP + +V+E
Sbjct: 228 -------DFVTEGARDLISRL----LKHNPSQRPMLREVLE 257
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-32
Identities = 53/209 (25%), Positives = 81/209 (38%), Gaps = 20/209 (9%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA----EVQFLGVVSHP 134
+G GG G VY+ + R +VA+K ++ L + E + G + P
Sbjct: 41 LVGRGGMGDVYEAEDTVRE-R----IVALKLMSET-LSSDPVFRTRMQREARTAGRLQEP 94
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLA 194
++V + + E Q + + L L R Q L + I+ L
Sbjct: 95 HVVPIHDF----GEIDGQLYVDMRLINGVDLAAML--RRQGPLAPPRAVAIVRQIGSALD 148
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP 254
H +RD K N+L+ + L DFG+A T + VGT Y AP
Sbjct: 149 AAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAP 204
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILTGRR 283
E H ++DI++ VLYE LTG
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-31
Identities = 72/277 (25%), Positives = 115/277 (41%), Gaps = 43/277 (15%)
Query: 80 IGEGGFGSVYKGTIRPLDGR-GEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+G+G +G VY G D +A+K++ + + E+ + H N+V+
Sbjct: 30 LGKGTYGIVYAG----RDLSNQV--RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEI----ILGAAEGLA 194
LG S I E +P SL L S+ P + + IL EGL
Sbjct: 84 YLGSFSENGFIKI----FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL---EGLK 136
Query: 195 YLHEGLEIQVIYRDFKTSNVLLD-GNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAA 253
YLH+ Q+++RD K NVL++ + K+SDFG ++ + GT Y A
Sbjct: 137 YLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGTLQYMA 191
Query: 254 PEYIE---TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310
PE I+ G+ K+ +DIWS G + E+ TG+ P E + A K
Sbjct: 192 PEIIDKGPRGYGKA-ADIWSLGCTIIEMATGK------PP-----FYELGEPQAAMFKVG 239
Query: 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT 347
+ P + S A + K C + +P++R
Sbjct: 240 MFKVHPEIPESMSAEAKAFILK----CFEPDPDKRAC 272
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-31
Identities = 80/298 (26%), Positives = 117/298 (39%), Gaps = 57/298 (19%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA-EVQFLGVVS 132
+ IG G V P + E VA+K++N Q L E+Q +
Sbjct: 17 YELQEVIGSGATAVVQAAYCAP---KKE--KVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 133 HPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRLE------I 185
HPN+V Y S + L LV + + S+ D + L+ I
Sbjct: 72 HPNIVSY--YTSFVVK---DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 186 ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA---REGPTGDHTHVS 242
+ EGL YLH+ I+RD K N+LL + +++DFG++ G V
Sbjct: 127 LREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183
Query: 243 TAVVGTYGYAAPEYIETGHL-KSQSDIWSFGVVLYEILTGR---------RVL---ERNR 289
VGT + APE +E ++DIWSFG+ E+ TG +VL +N
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND 243
Query: 290 PTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT 347
P LE Q KK+ R K+ CL+K+PE+RPT
Sbjct: 244 PPS----LETGVQDKEMLKKYG----KSFR------------KMISLCLQKDPEKRPT 281
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-30
Identities = 75/325 (23%), Positives = 134/325 (41%), Gaps = 54/325 (16%)
Query: 53 KEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN- 111
K+K L+ D +++ E +G G G V+K + +P G V+A K ++
Sbjct: 24 KQKVGELKDDDFEKISE----------LGAGNGGVVFKVSHKP-SGL----VMARKLIHL 68
Query: 112 NHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFS 171
Q + E+Q L + P +V G ++ E I E+M SL+
Sbjct: 69 EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI----CMEHMDGGSLDQ--VL 122
Query: 172 RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231
+ +P + ++ + +GL YL E + ++++RD K SN+L++ + KL DFG++
Sbjct: 123 KKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 180
Query: 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPT 291
+ + ++ VGT Y +PE ++ H QSDIWS G+ L E+ GR +
Sbjct: 181 QL---IDSMANS-FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236
Query: 292 MEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLA----------------- 334
+ + + A R N++ +++ +A
Sbjct: 237 ELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGV 296
Query: 335 ---------DNCLKKNPEERPTMNQ 350
+ CL KNP ER + Q
Sbjct: 297 FSLEFQDFVNKCLIKNPAERADLKQ 321
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 63/301 (20%), Positives = 115/301 (38%), Gaps = 57/301 (18%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLG-VVSHPNLV 137
+G G G+V GR VAVK++ + L E++ L HPN++
Sbjct: 22 ILGYGSSGTVVFQGSF--QGR----PVAVKRML---IDFCDIALMEIKLLTESDDHPNVI 72
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRL-----FSRAQPTLPWKTRLEIILGAAEG 192
+ YCS +R + + E +L+D + + ++ A G
Sbjct: 73 RY--YCSETTDRFL--YIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLD-------------GNFKPKLSDFGLAREGPTGDHT 239
+A+LH +++I+RD K N+L+ N + +SDFGL ++ +G +
Sbjct: 128 VAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 240 HVSTA--VVGTYGYAAPEYIETGHLKSQS-------DIWSFGVVLYEILTGRRVLERNRP 290
+ GT G+ APE +E + DI+S G V Y IL+ + ++
Sbjct: 185 FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244
Query: 291 TMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQ 350
+ E ++ + + + L + +P +RPT +
Sbjct: 245 SRESNIIRGIFSLDEMKCLHDRSLIAEATD------------LISQMIDHDPLKRPTAMK 292
Query: 351 V 351
V
Sbjct: 293 V 293
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 66/283 (23%), Positives = 116/283 (40%), Gaps = 51/283 (18%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK---QWLAEVQFLGVVSHPNL 136
+G+G FG+VY + + ++A+K L L+ Q E++ + HPN+
Sbjct: 22 LGKGKFGNVYLAREKQ-NKF----IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNI 76
Query: 137 VKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAY 195
+++ Y R+ L+ E+ P L L + + + A+ L Y
Sbjct: 77 LRMYNYFHDRK-----RIYLMLEFAPRGELYKEL--QKHGRFDEQRSATFMEELADALHY 129
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGD-HTHVSTAVVGTYGYAAP 254
HE +VI+RD K N+L+ + K++DFG + P+ T + GT Y P
Sbjct: 130 CHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT-----MCGTLDYLPP 181
Query: 255 EYIET-GHLKSQSDIWSFGVVLYEILTGRRVL---ERNRPTMEQKLLEWVKQFPADGKKF 310
E IE H + D+W GV+ YE L G + ++++ +FP
Sbjct: 182 EMIEGKTHDEK-VDLWCAGVLCYEFLVGM--PPFDSPSHTETHRRIVNVDLKFP------ 232
Query: 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
S + ++KL L+ +P +R + V+E
Sbjct: 233 ---------PFLSDGSKDLISKL----LRYHPPQRLPLKGVME 262
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 65/292 (22%), Positives = 108/292 (36%), Gaps = 59/292 (20%)
Query: 74 FNRMLKIGEGGFGSVY----KGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQ 126
F +GEG F +V T R A+K L + + E
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSR---------EYAIKILEKRHIIKENKVPYVTRERD 82
Query: 127 FLGVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRL-- 183
+ + HP VKL ++ +L Y N L + + TR
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDE-----KLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYT 136
Query: 184 -EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS 242
EI+ L YLH +I+RD K N+LL+ + +++DFG A+ +
Sbjct: 137 AEIVSA----LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189
Query: 243 TAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGR---RVLERNRPTMEQKLLE 298
+ VGT Y +PE + KS SD+W+ G ++Y+++ G R N + QK+++
Sbjct: 190 NSFVGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFR--AGNEYLIFQKIIK 246
Query: 299 WVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQ 350
FP P+ R+ L + L + +R +
Sbjct: 247 LEYDFPEK-------FFPKARD------------LVEKLLVLDATKRLGCEE 279
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 65/278 (23%), Positives = 113/278 (40%), Gaps = 37/278 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--HKQWLAEVQFLGVVSHPNL 136
K+G G +G V + + A+K + + + + L EV L ++ HPN+
Sbjct: 44 KLGSGAYGEVLLCR-----DKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
+KL + ED+R LV E L D + R + II G+ YL
Sbjct: 99 MKLYDFF--EDKRNYY--LVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLSGVTYL 152
Query: 197 HEGLEIQVIYRDFKTSNVLL---DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAA 253
H+ +++RD K N+LL + + K+ DFGL+ +GT Y A
Sbjct: 153 HK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIA 206
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313
PE + + D+WS GV+L+ +L G +Q++L V++ K++
Sbjct: 207 PEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT---DQEILRKVEK-----GKYTFD 257
Query: 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQV 351
S A + ++ L+ + + R + Q
Sbjct: 258 SPE--WKNVSEGAKDLIKQM----LQFDSQRRISAQQA 289
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 70/282 (24%), Positives = 117/282 (41%), Gaps = 44/282 (15%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG---HKQWLAEVQFLGVVSHPN 135
+G+G FG V + G+ AVK ++ ++ + L EVQ L + HPN
Sbjct: 33 VLGKGSFGEVILCKDKI-TGQ----ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAY 195
++KL + ED+ LV E L D + SR + II G+ Y
Sbjct: 88 IMKLYEFF--EDKGYFY--LVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVLSGITY 141
Query: 196 LHEGLEIQVIYRDFKTSNVLL---DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA 252
+H+ ++++RD K N+LL + ++ DFGL+ +GT Y
Sbjct: 142 MHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYI 195
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRP---TMEQKLLEWVKQFPADGKK 309
APE + G + D+WS GV+LY +L+G P E +L+ V++ K
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLSGC------PPFNGANEYDILKKVEK-----GK 243
Query: 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQV 351
++ + + S +A + K+ L P R +
Sbjct: 244 YTFELPQ--WKKVSESAKDLIRKM----LTYVPSMRISARDA 279
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 79/288 (27%), Positives = 114/288 (39%), Gaps = 61/288 (21%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWL-AEVQFLGVVS 132
F ++ KIG+G FG V+KG + VVA+K ++ + + + E+ L
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNR---TQK--VVAIKIIDLEEAEDEIEDIQQEITVLSQCD 78
Query: 133 HPNLVKLLG-YCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAE 191
P + K G Y + + ++ EY+ S D L L I+ +
Sbjct: 79 SPYVTKYYGSYL-----KDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILK 130
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGY 251
GL YLH + I+RD K +NVLL + + KL+DFG+A G D VGT +
Sbjct: 131 GLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFW 185
Query: 252 AAPEYIETGHLKSQSDIWSFGVVLYEILTGR---------RVL---ERNRPTMEQKLLEW 299
APE I+ S++DIWS G+ E+ G +VL +N P
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP--------- 236
Query: 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT 347
P L YS V CL K P RPT
Sbjct: 237 ----------------PTLEGNYSKPLKEFVEA----CLNKEPSFRPT 264
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-28
Identities = 79/318 (24%), Positives = 123/318 (38%), Gaps = 61/318 (19%)
Query: 54 EKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH 113
L D+ LR+ F + +G G +G VYKG G+ + A+K ++
Sbjct: 6 SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVK-TGQ----LAAIKVMDVT 60
Query: 114 GLQGHKQWLAEVQFLGVVS-HPNLVKLLG-YCSTEDERGIQRL-LVYEYMPNRSLEDRLF 170
G ++ E+ L S H N+ G + +L LV E+ S+ D +
Sbjct: 61 G-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119
Query: 171 SRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230
+ TL + I GL++LH+ +VI+RD K NVLL N + KL DFG++
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 176
Query: 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLK-----SQSDIWSFGVVLYEILTGR--- 282
+ +T +GT + APE I +SD+WS G+ E+ G
Sbjct: 177 AQ-LDRTVGRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234
Query: 283 ------RVL----ERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAK 332
R L P ++ K +W K+F + F +
Sbjct: 235 CDMHPMRALFLIPRNPAPRLKSK--KWSKKF----QSF-------------------IES 269
Query: 333 LADNCLKKNPEERPTMNQ 350
CL KN +RP Q
Sbjct: 270 ----CLVKNHSQRPATEQ 283
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 56/337 (16%), Positives = 113/337 (33%), Gaps = 53/337 (15%)
Query: 51 LYKEKEHHLRVFDMQELREATNGFNRMLKIGEG--GFGSVYKGTIRPLDGRGEPLVVAVK 108
+ +L M + + IG+G +V +P GE V V+
Sbjct: 4 HHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKP---TGE--YVTVR 58
Query: 109 KLN--NHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSL 165
++N + E+ + +HPN+V ++E L +V +M S
Sbjct: 59 RINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE-----LWVVTSFMAYGSA 113
Query: 166 EDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225
+D + + + I+ G + L Y+H + ++R K S++L+ + K LS
Sbjct: 114 KDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLS 170
Query: 226 DFGLARE-GPTGD----HTHVSTAVVGTYGYAAPEYIETGHL--KSQSDIWSFGVVLYEI 278
G V + +PE ++ ++SDI+S G+ E+
Sbjct: 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 230
Query: 279 LTGR---------RVL-----------ERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRL 318
G ++L ++L + A+ +
Sbjct: 231 ANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTP 290
Query: 319 RNQYSINAARRVAK--------LADNCLKKNPEERPT 347
R + + + + CL++NP+ RP+
Sbjct: 291 RPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS 327
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 72/281 (25%), Positives = 111/281 (39%), Gaps = 43/281 (15%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--HKQWLAEVQFLGVVSHPNL 136
+G+G FG V K R AVK +N + L EV+ L + HPN+
Sbjct: 29 MLGKGSFGEVLKCK-----DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
+KL ED +V E L D + R + II G+ Y+
Sbjct: 84 MKLFEIL--EDSSSFY--IVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYM 137
Query: 197 HEGLEIQVIYRDFKTSNVLL---DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAA 253
H+ +++RD K N+LL + + K+ DFGL+ +GT Y A
Sbjct: 138 HK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIA 191
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRP---TMEQKLLEWVKQFPADGKKF 310
PE + G + D+WS GV+LY +L+G P E +L+ V+ K+
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVILYILLSGT------PPFYGKNEYDILKRVET-----GKY 239
Query: 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQV 351
+ + S +A + K+ L +P R T Q
Sbjct: 240 AFDLPQ--WRTISDDAKDLIRKM----LTFHPSLRITATQC 274
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 61/292 (20%), Positives = 110/292 (37%), Gaps = 54/292 (18%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA-------------EV 125
K+G G +G V + A+K + + E+
Sbjct: 43 KLGSGAYGEVLLCK-----EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 126 QFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEI 185
L + HPN++KL ED++ LV E+ L +++ +R + I
Sbjct: 98 SLLKSLDHPNIIKLFDVF--EDKKYFY--LVTEFYEGGELFEQIINRHK--FDECDAANI 151
Query: 186 ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL---DGNFKPKLSDFGLAREGPTGDHTHVS 242
+ G+ YLH+ +++RD K N+LL + K+ DFGL+
Sbjct: 152 MKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KL 205
Query: 243 TAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRP---TMEQKLLEW 299
+GT Y APE ++ + + + D+WS GV++Y +L G P +Q +++
Sbjct: 206 RDRLGTAYYIAPEVLKKKYNE-KCDVWSCGVIMYILLCGY------PPFGGQNDQDIIKK 258
Query: 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQV 351
V++ F D S A + + L + +R T +
Sbjct: 259 VEKGKYY---F----DFNDWKNISDEAKELIKLM----LTYDYNKRCTAEEA 299
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 68/326 (20%), Positives = 106/326 (32%), Gaps = 83/326 (25%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVK-----KLNNHGLQGHKQWLAEVQFLGVVSH 133
IG+G +G V + A+K K+ + ++ EV+ + + H
Sbjct: 33 AIGQGSYGVVRVAIENQ-TRA----IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA--- 190
PN+ +L EDE+ I LV E L D+L + +
Sbjct: 88 PNIARLYEVY--EDEQYI--CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 191 -----------------------------------EGLAYLHEGLEIQVIYRDFKTSNVL 215
L YLH + +RD K N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200
Query: 216 L--DGNFKPKLSDFGLAR--EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLK--SQSDIW 269
+ +F+ KL DFGL++ + T GT + APE + T + + D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 270 SFGVVLYEILTGRRVLERNRP---TMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINA 326
S GV+L+ +L G P + + V KK N S
Sbjct: 261 SAGVLLHLLLMGA------VPFPGVNDADTISQVLN-----KKLCFENPN--YNVLSPL- 306
Query: 327 ARRVAK-LADNCLKKNPEERPTMNQV 351
A+ L N L +N +ER +
Sbjct: 307 ----ARDLLSNLLNRNVDERFDAMRA 328
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 73/298 (24%), Positives = 122/298 (40%), Gaps = 65/298 (21%)
Query: 73 GFNRMLK-IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH--KQWLAEVQFLG 129
G R+LK IG+G F V G VA+K ++ L ++ EV+ +
Sbjct: 15 GNYRLLKTIGKGNFAKVKLARHILT---GRE--VAIKIIDKTQLNPTSLQKLFREVRIMK 69
Query: 130 VVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE----- 184
+++HPN+VKL TE L+ EY + D L + R++
Sbjct: 70 ILNHPNIVKLFEVIETEK----TLYLIMEYASGGEVFDYLVA--------HGRMKEKEAR 117
Query: 185 -----IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHT 239
I+ + Y H+ ++++RD K N+LLD + K++DFG + E G
Sbjct: 118 SKFRQIV----SAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL 170
Query: 240 HVSTAVVGTYGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVL---ERNRPTMEQK 295
G YAAPE + + + D+WS GV+LY +++G L +N + ++
Sbjct: 171 DAF---CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS--LPFDGQNLKELRER 225
Query: 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
+L + P S N L L NP +R T+ Q+++
Sbjct: 226 VLRGKYRIP---FYMS----TDCEN------------LLKRFLVLNPIKRGTLEQIMK 264
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 65/282 (23%), Positives = 107/282 (37%), Gaps = 47/282 (16%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
IG G +G V +G + A KK+ + ++ ++ E++ + + HPN+++
Sbjct: 16 TIGRGSWGEVKIAV-----QKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L ED I LV E L +R+ + I+ +AY H
Sbjct: 71 LYETF--EDNTDIY--LVMELCTGGELFERVVHKRV--FRESDAARIMKDVLSAVAYCH- 123
Query: 199 GLEIQVIYRDFKTSNVLL---DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPE 255
++ V +RD K N L + KL DFGLA G + VGT Y +P+
Sbjct: 124 --KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKVGTPYYVSPQ 178
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMID 315
+E + + D WS GV++Y +L G P S ++
Sbjct: 179 VLEGLYGP-ECDEWSAGVMMYVLLCGYP--------------------PFSAPTDSEVML 217
Query: 316 PRLRNQYSINAA--RRV---AK-LADNCLKKNPEERPTMNQV 351
++ V A+ L L K+P++R T Q
Sbjct: 218 KIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 62/293 (21%), Positives = 111/293 (37%), Gaps = 53/293 (18%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVK-----KLNNHGLQGHKQWLA---EVQFLGV 130
+G G G V R + VA++ K + L E++ L
Sbjct: 142 TLGSGACGEVKLAFER-KTCK----KVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA 190
++HP ++K+ + ED +V E M L D++ + L T
Sbjct: 197 LNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQML 249
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLL---DGNFKPKLSDFGLAREGPTGDHTHVSTAVVG 247
+ YLHE +I+RD K NVLL + + K++DFG ++ G+ + + T + G
Sbjct: 250 LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCG 303
Query: 248 TYGYAAPEYIETGHLKSQS---DIWSFGVVLYEILTGRRVL----ERNRPTMEQKLLEWV 300
T Y APE + + + D WS GV+L+ L+G R + +++ ++
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--YPPFSEHRTQVSLKDQITSGK 361
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
F + + + L L +P+ R T + +
Sbjct: 362 YNFIPE---------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-26
Identities = 78/298 (26%), Positives = 118/298 (39%), Gaps = 78/298 (26%)
Query: 76 RMLK-IGEGGFGSVY----KGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQF 127
+ +G GGFG V+ K T + + A KKLN L+ K + + E +
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGK---------LYACKKLNKKRLKKRKGYQGAMVEKKI 238
Query: 128 LGVVSHPNLVKLLGYC-STEDERGIQRL-LVYEYMP---------NRSLEDRLFSRAQPT 176
L V +V L Y T+ L LV M N ++ F +
Sbjct: 239 LAKVHSRFIVSLA-YAFETKT-----DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPR-- 290
Query: 177 LPWKTRL---EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233
+I+ G L +LH+ +IYRD K NVLLD + ++SD GLA E
Sbjct: 291 ----AIFYTAQIVSG----LEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339
Query: 234 PTGDHTHVSTAVVGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGR-----RVLER 287
G + GT G+ APE + + S D ++ GV LYE++ R R +
Sbjct: 340 KAGQTK--TKGYAGTPGFMAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKV 396
Query: 288 NRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
++Q++LE +P KFS + L L+K+PE+R
Sbjct: 397 ENKELKQRVLEQAVTYP---DKFSP------------ASKDFCEAL----LQKDPEKR 435
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 66/293 (22%), Positives = 115/293 (39%), Gaps = 63/293 (21%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH 133
+ + ++G+G FG VYK + G + A K + + + ++ E++ L H
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKE-TGA----LAAAKVIETKSEEELEDYIVEIEILATCDH 75
Query: 134 PNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEG 192
P +VKLLG + + L ++ E+ P +++ + L + E
Sbjct: 76 PYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEA 129
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA 252
L +LH ++I+RD K NVL+ +L+DFG++ + +GT +
Sbjct: 130 LNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIGTPYWM 184
Query: 253 APEYIETGHLKSQS-----DIWSFGVVLYEILTGR---------RVL----ERNRPTMEQ 294
APE + +K DIWS G+ L E+ RVL + + PT+
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLT 244
Query: 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT 347
+W +F + F + L KNPE RP+
Sbjct: 245 P-SKWSVEF----RDF-------------------LKI----ALDKNPETRPS 269
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 72/310 (23%), Positives = 124/310 (40%), Gaps = 78/310 (25%)
Query: 64 MQELREATNG------FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG 117
+++LR + + R KIG+G G+VY G+ VA++++N
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDV---ATGQ--EVAIRQMNLQQQPK 60
Query: 118 HKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPT 176
+ + E+ + +PN+V L DE L +V EY+ SL D
Sbjct: 61 KELIINEILVMRENKNPNIVNYLDSYLVGDE-----LWVVMEYLAGGSLTD--------- 106
Query: 177 LPWKTRLE------IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230
+ +T ++ + + L +LH QVI+RD K+ N+LL + KL+DFG
Sbjct: 107 VVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163
Query: 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR-------- 282
+ T + + ST +VGT + APE + + DIWS G++ E++ G
Sbjct: 164 AQ-ITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221
Query: 283 -RVL----ERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNC 337
R L P ++ +K S R+ + C
Sbjct: 222 LRALYLIATNGTPELQNP------------EKLS----AIFRD------------FLNRC 253
Query: 338 LKKNPEERPT 347
L+ + E+R +
Sbjct: 254 LEMDVEKRGS 263
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 71/287 (24%), Positives = 112/287 (39%), Gaps = 53/287 (18%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA-EVQFLGVVSHPNLV 137
K+G G FG V+ R L +K +N Q + + E++ L + HPN++
Sbjct: 29 KLGSGAFGDVHLVE-----ERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTR--LEIILGAAEGLAY 195
K+ ED + +V E L +R+ S E++ LAY
Sbjct: 84 KIFEVF--EDYHNMY--IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 196 LHEGLEIQVIYRDFKTSNVLL---DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA 252
H V+++D K N+L + K+ DFGLA + + ST GT Y
Sbjct: 140 FHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYM 193
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRP---TMEQKLLEWVKQ----FPA 305
APE + + + DIWS GVV+Y +LTG P T +++ + +
Sbjct: 194 APEVFK-RDVTFKCDIWSAGVVMYFLLTGC------LPFTGTSLEEVQQKATYKEPNYAV 246
Query: 306 DGKKFSMMIDPRLRNQYSINAARRVAK-LADNCLKKNPEERPTMNQV 351
+ + + A L L K+PE RP+ QV
Sbjct: 247 ECRPLTPQ-----------------AVDLLKQMLTKDPERRPSAAQV 276
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 71/345 (20%), Positives = 122/345 (35%), Gaps = 76/345 (22%)
Query: 32 NSALNRTARSLPSPRSIPELYKEKEHHLRVFDMQELREATNGFNRMLK-IGEGGFGSVYK 90
S+ + S + + H + +E ++ +G GGFGSVY
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYS 61
Query: 91 GTIRPLDGRGEPLVVAVK-----KLNNHGLQGHKQWLA-EVQFLGVVSH--PNLVKLLGY 142
G R D VA+K ++++ G + + EV L VS +++LL +
Sbjct: 62 GI-RVSDNL----PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116
Query: 143 CSTEDERGIQRLLVYEY-MPNRSLEDRLFSRAQPTLPWKTRLE----------IILGAAE 191
D +L+ E P + L D + + L+ ++ E
Sbjct: 117 FERPDSF----VLILERPEPVQDLFDFITE--------RGALQEELARSFFWQVL----E 160
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGN-FKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
+ + H V++RD K N+L+D N + KL DFG GT
Sbjct: 161 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVYTDF---DGTRV 213
Query: 251 YAAPEYIETGHL--KSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308
Y+ PE+I H + +WS G++LY+++ G P +
Sbjct: 214 YSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGD--------------------IPFEHD 252
Query: 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
+ + R + S L CL P +RPT ++
Sbjct: 253 EEIIRGQVFFRQRVSSECQH----LIRWCLALRPSDRPTFEEIQN 293
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-26
Identities = 74/344 (21%), Positives = 129/344 (37%), Gaps = 79/344 (22%)
Query: 25 NQNRLDNNSALNRTARSLPSPR-SIPELYKEKEHHLRVFDMQELREATNGFNRMLKIGEG 83
+ + + L S + + + D + L + +KIGEG
Sbjct: 3 HHHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLL------LDSYVKIGEG 56
Query: 84 GFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYC 143
G V + GR VAVK ++ Q + EV + H N+V++
Sbjct: 57 STGIVCLAREKH-SGR----QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 144 STEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRLE------IILGAAEGLAYL 196
+E L ++ E++ +L D + + RL + + LAYL
Sbjct: 112 LVGEE-----LWVLMEFLQGGALTD---------IVSQVRLNEEQIATVCEAVLQALAYL 157
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
H VI+RD K+ ++LL + + KLSDFG + + D + +VGT + APE
Sbjct: 158 HAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQ-ISKDVPKRKS-LVGTPYWMAPEV 212
Query: 257 IETGHLKSQSDIWSFGVVLYEILTGR---------RVL----ERNRPTMEQKLLEWVKQF 303
I ++ DIWS G+++ E++ G + + + P ++
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS-------- 264
Query: 304 PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT 347
K S P LR+ + L ++P+ER T
Sbjct: 265 ----HKVS----PVLRD------------FLERMLVRDPQERAT 288
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 79/288 (27%), Positives = 120/288 (41%), Gaps = 61/288 (21%)
Query: 76 RMLK-IGEGGFGSVY----KGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQF 127
R + +G+GGFG V + T + + A KKL ++ K L E Q
Sbjct: 187 RQYRVLGKGGFGEVCACQVRATGK---------MYACKKLEKKRIKKRKGEAMALNEKQI 237
Query: 128 LGVVSHPNLVKLLGYC-STEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLP-WKTRL- 183
L V+ +V L Y T+D L LV M L+ ++ Q P +
Sbjct: 238 LEKVNSRFVVSL-AYAYETKD-----ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 184 --EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHV 241
EI G L LH +++YRD K N+LLD + ++SD GLA P G
Sbjct: 292 AAEICCG----LEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK- 343
Query: 242 STAVVGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGR---RVLERNRPTMEQKLL 297
VGT GY APE + + S D W+ G +LYE++ G+ + +R + +++
Sbjct: 344 --GRVGTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQ--QRKKKIKREEVE 398
Query: 298 EWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
VK+ P ++S A ++L L K+P ER
Sbjct: 399 RLVKEVP-----------EEYSERFSPQARSLCSQL----LCKDPAER 431
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 66/292 (22%), Positives = 105/292 (35%), Gaps = 63/292 (21%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+G G F V+ R G+ + A+K + E+ L + H N+V
Sbjct: 16 VLGSGAFSEVFLVKQRL-TGK----LFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE-----IILGAAEGL 193
L E LV + + L DR+ R T E +I +
Sbjct: 71 LEDIY--ESTTHYY--LVMQLVSGGELFDRILERGVYT-------EKDASLVIQQVLSAV 119
Query: 194 AYLHEGLEIQVIYRDFKTSNVLL---DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
YLHE +++RD K N+L + N K ++DFGL++ + + + GT G
Sbjct: 120 KYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPG 172
Query: 251 YAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310
Y APE + D WS GV+ Y +L G P +
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCGYP--------------------PFYEETE 212
Query: 311 SMMIDPRLRNQY--------SINAARRVAK-LADNCLKKNPEERPTMNQVVE 353
S + + Y I+ + AK + L+K+P ER T + +
Sbjct: 213 SKLFEKIKEGYYEFESPFWDDISES---AKDFICHLLEKDPNERYTCEKALS 261
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 68/335 (20%), Positives = 117/335 (34%), Gaps = 89/335 (26%)
Query: 43 PSPRSIPELYKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEP 102
P + P K++E + + L +G+GGFG+V+ G R D
Sbjct: 14 PGTPTPPPGGKDREAFEAEYRLGPL------------LGKGGFGTVFAGH-RLTDR---- 56
Query: 103 LVVAVK-----KLNNHGLQGHKQWLA-EVQFLGVVS----HPNLVKLLGYCSTEDERGIQ 152
L VA+K ++ EV L V HP +++LL + T++
Sbjct: 57 LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEG--F- 113
Query: 153 RLLVYEY-MPNRSLEDRLFSRAQPTLPWKTRLE----------IILGAAEGLAYLHEGLE 201
+LV E +P + L D + K L ++ + + H
Sbjct: 114 -MLVLERPLPAQDLFDYITE--------KGPLGEGPSRCFFGQVV----AAIQHCHS--- 157
Query: 202 IQVIYRDFKTSNVLLDG-NFKPKLSDFGLAREGPTGD-HTHVSTAVVGTYGYAAPEYIET 259
V++RD K N+L+D KL DFG GT Y+ PE+I
Sbjct: 158 RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-----GTRVYSPPEWISR 212
Query: 260 GH-LKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRL 318
+ +WS G++LY+++ G P + + + +
Sbjct: 213 HQYHALPATVWSLGILLYDMVCGD--------------------IPFERDQEILEAELHF 252
Query: 319 RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
S + L CL P RP++ +++
Sbjct: 253 PAHVSPDCCA----LIRRCLAPKPSSRPSLEEILL 283
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 88/353 (24%), Positives = 132/353 (37%), Gaps = 77/353 (21%)
Query: 17 SNSAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHLRVFDMQELREATN---G 73
S + + L P P + L+ D+ EL +
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMDPMPA------GGRAGSLKDPDVAELFFKDDPEKL 55
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQFLGV 130
F+ + +IG G FG+VY E VVA+KK++ G Q +++W + EV+FL
Sbjct: 56 FSDLREIGHGSFGAVYFARDV---RNSE--VVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 110
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA 190
+ HPN ++ G E + V EY S D L +P L + GA
Sbjct: 111 LRHPNTIQYRGCYLREHTAWL----VMEYCLG-SASDLLEVHKKP-LQEVEIAAVTHGAL 164
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
+GLAYLH +I+RD K N+LL KL DFG A ++ VGT
Sbjct: 165 QGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANS-FVGTPY 215
Query: 251 YAAPEYIETGHLK---SQSDIWSFGVVLYEILTGR---------RVL----ERNRPTMEQ 294
+ APE I + D+WS G+ E+ + L + P ++
Sbjct: 216 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS 275
Query: 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT 347
W + F + F V CL+K P++RPT
Sbjct: 276 G--HWSEYF----RNF-------------------VDS----CLQKIPQDRPT 299
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 62/293 (21%), Positives = 102/293 (34%), Gaps = 61/293 (20%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA----EVQFLGVVSHPN 135
+GEG +G V + AVK L L+ A E+Q L + H N
Sbjct: 13 LGEGSYGKVKEVL-DSETLCR----RAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKN 67
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE----------I 185
+++L+ E+++ + +V EY E + + R +
Sbjct: 68 VIQLVDVLYNEEKQKM--YMVMEYCVCGMQE--MLDSVP-----EKRFPVCQAHGYFCQL 118
Query: 186 ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAV 245
I +GL YLH ++++D K N+LL K+S G+A
Sbjct: 119 I----DGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 246 VGTYGYAAPEYI--ETGHLKSQSDIWSFGVVLYEILTGRRVL---ERNRPTMEQKLLEWV 300
G+ + PE + DIWS GV LY I TG N + + + +
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL--YPFEGDNIYKLFENIGKGS 229
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
P D P L + L L+ P +R ++ Q+ +
Sbjct: 230 YAIPGD-------CGPPLSD------------LLKGMLEYEPAKRFSIRQIRQ 263
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 78/304 (25%), Positives = 125/304 (41%), Gaps = 66/304 (21%)
Query: 64 MQELREATNG------FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG 117
+++L E + F+ + K+GEG +GSVYK + G+ +VA+K++
Sbjct: 15 LKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKE-TGQ----IVAIKQVPVE--SD 67
Query: 118 HKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPT 176
++ + E+ + P++VK G + L +V EY S+ D + T
Sbjct: 68 LQEIIKEISIMQQCDSPHVVKYYGSYFKNTD-----LWIVMEYCGAGSVSD-IIRLRNKT 121
Query: 177 LPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236
L I+ +GL YLH + I+RD K N+LL+ KL+DFG+A + T
Sbjct: 122 LTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQ-LTD 177
Query: 237 DHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR---------RVL-- 285
+T V+GT + APE I+ +DIWS G+ E+ G+ R +
Sbjct: 178 TMAKRNT-VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM 236
Query: 286 --ERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPE 343
PT + W F F V + CL K+PE
Sbjct: 237 IPTNPPPTFRKP-ELWSDNF----TDF-------------------VKQ----CLVKSPE 268
Query: 344 ERPT 347
+R T
Sbjct: 269 QRAT 272
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 72/286 (25%), Positives = 111/286 (38%), Gaps = 49/286 (17%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--HKQWLAEVQFLGVVSHPNL 136
+G+G FG V K R AVK +N + L EV+ L + HPN+
Sbjct: 29 MLGKGSFGEVLKCK-----DRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
+KL ED +V E L D + R + II G+ Y+
Sbjct: 84 MKLFEIL--EDSSSFY--IVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFSGITYM 137
Query: 197 HEGLEIQVIYRDFKTSNVLL---DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAA 253
H+ +++RD K N+LL + + K+ DFGL+ +GT Y A
Sbjct: 138 HK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIA 191
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313
PE + + + + D+WS GV+LY +L+G P GK +
Sbjct: 192 PEVLRGTYDE-KCDVWSAGVILYILLSGTP--------------------PFYGKNEYDI 230
Query: 314 IDPRLRNQYSINAA--RRV---AK-LADNCLKKNPEERPTMNQVVE 353
+ +Y+ + R + AK L L +P R T Q +E
Sbjct: 231 LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 72/291 (24%), Positives = 120/291 (41%), Gaps = 51/291 (17%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVK-----KLNNHGLQGHKQWLAEVQFLGVVSH 133
IG+G F V + R G+ AVK K + + E ++ H
Sbjct: 31 VIGKGPFSVVRRCINRE-TGQ----QFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTR-----LEIILG 188
P++V+LL + + +V+E+M L + RA + + IL
Sbjct: 86 PHIVELLETY--SSDGML--YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLL---DGNFKPKLSDFGLAREGPTGDHTHVSTAV 245
A L Y H + +I+RD K VLL + + KL FG+A + G+ V+
Sbjct: 142 A---LRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGR 193
Query: 246 VGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM--EQKLLEWVKQF 303
VGT + APE ++ D+W GV+L+ +L+G P +++L E + +
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGC------LPFYGTKERLFEGIIK- 246
Query: 304 PADGKKFSMMIDPRLRNQYSINAARRVAK-LADNCLKKNPEERPTMNQVVE 353
K+ M +PR + S + AK L L +P ER T+ + +
Sbjct: 247 ----GKYKM--NPRQWSHISES-----AKDLVRRMLMLDPAERITVYEALN 286
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 67/316 (21%), Positives = 112/316 (35%), Gaps = 86/316 (27%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA---------------- 123
IG+G +G V D A+K L+ L +
Sbjct: 21 IGKGSYGVVKLAY-NENDNT----YYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 124 ----------EVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRA 173
E+ L + HPN+VKL+ +E + +V+E + + +
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL--YMVFELVNQGPVME------ 127
Query: 174 QPTLPWKTRLE----------IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPK 223
+P L +I G + YLH ++I+RD K SN+L+ + K
Sbjct: 128 ---VPTLKPLSEDQARFYFQDLIKG----IEYLHY---QKIIHRDIKPSNLLVGEDGHIK 177
Query: 224 LSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLK---SQSDIWSFGVVLYEILT 280
++DFG++ E G +S VGT + APE + D+W+ GV LY +
Sbjct: 178 IADFGVSNE-FKGSDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
Query: 281 GRRVL---ERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNC 337
G+ + + K+ +FP I L++ L
Sbjct: 236 GQ--CPFMDERIMCLHSKIKSQALEFPDQPD-----IAEDLKD------------LITRM 276
Query: 338 LKKNPEERPTMNQVVE 353
L KNPE R + ++
Sbjct: 277 LDKNPESRIVVPEIKL 292
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 71/264 (26%), Positives = 113/264 (42%), Gaps = 41/264 (15%)
Query: 34 ALNRTARSLPSPRSIPELYKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTI 93
+ + L + P K + D + + + IG G FG V++ +
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKL 61
Query: 94 RPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGY-CSTEDERGIQ 152
E VA+KK+ LQ + E+Q + +V HPN+V L + S D++
Sbjct: 62 VE---SDE---VAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111
Query: 153 RL-LVYEYMPNRSLED-----RLFSRAQPTLPWKTRLEI------ILGAAEGLAYLHEGL 200
L LV EY+P E R +++ + T+P L I +L LAY+H
Sbjct: 112 FLNLVLEYVP----ETVYRASRHYAKLKQTMP---MLLIKLYMYQLL---RSLAYIH--- 158
Query: 201 EIQVIYRDFKTSNVLLDGNFKP-KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET 259
I + +RD K N+LLD KL DFG A+ + + + + Y APE I
Sbjct: 159 SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK---ILIAGEPNVSYICSRYYRAPELIFG 215
Query: 260 GHLKSQS-DIWSFGVVLYEILTGR 282
+ + DIWS G V+ E++ G+
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 68/219 (31%), Positives = 107/219 (48%), Gaps = 40/219 (18%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
IG G FG VY+ + GE +VA+KK+ LQ + E+Q + + H N+V+
Sbjct: 61 VIGNGSFGVVYQAKLCD---SGE--LVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 111
Query: 139 LLGY-CSTEDERGIQRL-LVYEYMPNRSLED-----RLFSRAQPTLPWKTRLEI------ 185
L + S+ +++ L LV +Y+P E R +SRA+ TLP + +
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLP---VIYVKLYMYQ 164
Query: 186 ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP-KLSDFGLAREGPTGDHTHVSTA 244
+ LAY+H + +RD K N+LLD + KL DFG A++ G+ + +
Sbjct: 165 LF---RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 215
Query: 245 VVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGR 282
+ + Y APE I + S D+WS G VL E+L G+
Sbjct: 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 77/293 (26%), Positives = 121/293 (41%), Gaps = 69/293 (23%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVK-----KLNNHGLQGHKQWLAEVQFLGVVSHP 134
+G G FG V G + G VAVK K+ + + G + E+Q L + HP
Sbjct: 19 LGVGTFGKVKIGEHQLT---GHK--VAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHP 71
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE---------- 184
+++KL ST + +V EY+ L D + R+E
Sbjct: 72 HIIKLYQVISTPTD--F--FMVMEYVSGGELFDYICK--------HGRVEEMEARRLFQQ 119
Query: 185 IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTA 244
I+ + Y H V++RD K NVLLD + K++DFGL+ G+ S
Sbjct: 120 IL----SAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-- 170
Query: 245 VVGTYGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVL---ERNRPTMEQKLLEWV 300
G+ YAAPE I + + DIWS GV+LY +L G L + + PT+ +K+ V
Sbjct: 171 -CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT--LPFDDEHVPTLFKKIRGGV 227
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
P + + A + + L+ +P +R T+ + E
Sbjct: 228 FYIP---------------EYLNRSVATLLMHM----LQVDPLKRATIKDIRE 261
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 78/361 (21%), Positives = 135/361 (37%), Gaps = 71/361 (19%)
Query: 12 KPKKGSNSAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHLRVFDMQELREAT 71
P + +N E + N N +S+ +P+ KE + + ++
Sbjct: 47 DPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKE----FYQKYDPKD-- 100
Query: 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA-------- 123
IG G V + R G AVK + + + L
Sbjct: 101 -------VIGRGVSSVVRRCVHR---ATGHE--FAVKIMEVTAERLSPEQLEEVREATRR 148
Query: 124 EVQFLGVVS-HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTR 182
E L V+ HP+++ L+ E + LV++ M L D L + + +TR
Sbjct: 149 ETHILRQVAGHPHIITLIDSY--ESSSFM--FLVFDLMRKGELFDYLTEKVALSEK-ETR 203
Query: 183 LEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS 242
I+ E +++LH +++RD K N+LLD N + +LSDFG + G+
Sbjct: 204 -SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL--- 256
Query: 243 TAVVGTYGYAAPEYIETGHLKSQS------DIWSFGVVLYEILTGRRVLERNRPTMEQKL 296
+ GT GY APE ++ ++ D+W+ GV+L+ +L G
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP------------- 303
Query: 297 LEWVKQFPADGKKFSMMIDPRLRNQYSINAA--RRV---AK-LADNCLKKNPEERPTMNQ 350
P ++ +M+ + QY ++ K L L+ +PE R T Q
Sbjct: 304 -------PFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQ 356
Query: 351 V 351
Sbjct: 357 A 357
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 67/287 (23%), Positives = 101/287 (35%), Gaps = 47/287 (16%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLV 137
+G G G V + R G+ A+K L + EV S P++V
Sbjct: 36 VLGLGVNGKVLECFHRR-TGQ----KCALKLLYDSPKARQ-----EVDHHWQASGGPHIV 85
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
+L L++ E M L R+ R + EI+ + +LH
Sbjct: 86 CILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 198 EGLEIQVIYRDFKTSNVLL---DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP 254
+ +RD K N+L + + KL+DFG A+E + T T Y AP
Sbjct: 146 S---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQT-PCYTPYYVAP 198
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK--FSM 312
E + D+WS GV++Y +L G P F ++ +
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCGF------PP------------FYSNTGQAISPG 240
Query: 313 MIDPRLRNQYSINAA--RRV---AK-LADNCLKKNPEERPTMNQVVE 353
M QY V AK L LK +P ER T+ Q +
Sbjct: 241 MKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 78/355 (21%), Positives = 138/355 (38%), Gaps = 65/355 (18%)
Query: 13 PKKGSNSAPEPRNQNRLDNNSALNRTARSLPSPRSI-PELYKEKEHHLRVFDMQELREAT 71
+S+ L S + TA + P S+ P+ + + + + D E+
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVES-- 59
Query: 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV 131
++G G VY+ + + L V K ++ ++ E+ L +
Sbjct: 60 -------ELGRGATSIVYRCKQKG-TQKPYALKVLKKTVDKKIVR------TEIGVLLRL 105
Query: 132 SHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE-----II 186
SHPN++KL E I LV E + L DR+ + + E +
Sbjct: 106 SHPNIIKLKEIF--ETPTEIS--LVLELVTGGELFDRIVEKGYYS-------ERDAADAV 154
Query: 187 LGAAEGLAYLHEGLEIQVIYRDFKTSNVLL---DGNFKPKLSDFGLAREGPTGDHTHVST 243
E +AYLH E +++RD K N+L + K++DFGL++ +H +
Sbjct: 155 KQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLMK 208
Query: 244 AVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRR--VLERNRPTMEQKLLEWVK 301
V GT GY APE + + D+WS G++ Y +L G ER M +++L
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY 268
Query: 302 QFPADGKKFSMMIDPRLRNQY--SINAARRVAK-LADNCLKKNPEERPTMNQVVE 353
F + + ++ AK L + +P++R T Q ++
Sbjct: 269 YFISP---------------WWDEVSLN---AKDLVRKLIVLDPKKRLTTFQALQ 305
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 75/285 (26%), Positives = 126/285 (44%), Gaps = 60/285 (21%)
Query: 77 MLK-IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW--LAEVQFLGVVSH 133
+LK +G+G FG V+ ++ + G + A+K L L+ + E L V+H
Sbjct: 28 LLKVLGQGSFGKVFL--VKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 134 PNLVKLLGYCS--TEDERGIQRL-LVYEYMPNRSL-----EDRLFSRAQPTLPWKTRL-- 183
P +VKL + + TE +L L+ +++ L ++ +F+ +
Sbjct: 86 PFIVKL--HYAFQTEG-----KLYLILDFLRGGDLFTRLSKEVMFTEED------VKFYL 132
Query: 184 -EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS 242
E+ L L +LH + +IYRD K N+LLD KL+DFGL++E + +
Sbjct: 133 AELALA----LDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--A 183
Query: 243 TAVVGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGRRVLE-RNRPTMEQKLLEWV 300
+ GT Y APE + GH +S +D WSFGV+++E+LTG + ++R +L+
Sbjct: 184 YSFCGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK-- 240
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
+ S A + L K+NP R
Sbjct: 241 -------------AKLGMPQFLSPEAQSLLRML----FKRNPANR 268
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 6e-24
Identities = 73/308 (23%), Positives = 117/308 (37%), Gaps = 68/308 (22%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW-----LAEVQFL 128
+ ++ KIGEG +G V+K R G+ +VA+KK L E++ L
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNR-DTGQ----IVAIKKFL---ESEDDPVIKKIALREIRML 56
Query: 129 GVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIIL 187
+ HPNLV LL + RL LV+EY + ++ L + + I
Sbjct: 57 KQLKHPNLVNLLEVFRRKR-----RLHLVFEYC-DHTVLHELDRYQRGVPEHLVK-SITW 109
Query: 188 GAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE--GPTGDHTHVSTAV 245
+ + + H+ I+RD K N+L+ + KL DFG AR GP+ +
Sbjct: 110 QTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD----E 162
Query: 246 VGTYGYAAPEYIETGHLKSQS-----DIWSFGVVLYEILTGR----------------RV 284
V T Y +PE + + D+W+ G V E+L+G +
Sbjct: 163 VATRWYRSPELL----VGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKT 218
Query: 285 L----ERNRPTMEQKLLEWVKQFPADGKKFSMMIDPR-LRNQYSINAARRVAKLADNCLK 339
L R++ ++ K D L ++ N + L CL
Sbjct: 219 LGDLIPRHQQVFST--NQYFSGV-----KIPDPEDMEPLELKFP-NISYPALGLLKGCLH 270
Query: 340 KNPEERPT 347
+P ER T
Sbjct: 271 MDPTERLT 278
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 9e-24
Identities = 66/286 (23%), Positives = 111/286 (38%), Gaps = 51/286 (17%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA-EVQFLGVVSHPNLVK 138
+GEG +G V R E VAVK ++ + + E+ +++H N+VK
Sbjct: 15 LGEGAYGEVQLAVNRVT---EEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE----------IILG 188
G+ + L EY L DR+ + ++
Sbjct: 70 FYGHRREGNI--Q--YLFLEYCSGGELFDRIEP--------DIGMPEPDAQRFFHQLM-- 115
Query: 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT 248
G+ YLH I + +RD K N+LLD K+SDFGLA + + + GT
Sbjct: 116 --AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 249 YGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307
Y APE ++ D+WS G+VL +L G ++ + Q+ +W +
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKE------ 223
Query: 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
KK + ++ + K+ L +NP R T+ + +
Sbjct: 224 KKTYLNPWKKI----DSAPLALLHKI----LVENPSARITIPDIKK 261
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 72/291 (24%), Positives = 118/291 (40%), Gaps = 67/291 (23%)
Query: 76 RMLK-IGEGGFGSVY----KGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQF 127
+ + IG GGFG VY T + + A+K L+ ++ + L E
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGK---------MYAMKCLDKKRIKMKQGETLALNERIM 242
Query: 128 LGVVS---HPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRL 183
L +VS P +V + T D +L + + M L L + R
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPD-----KLSFILDLMNGGDLHYHLSQHGVFSEA-DMRF 296
Query: 184 ---EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTH 240
EIILG L ++H V+YRD K +N+LLD + ++SD GLA +
Sbjct: 297 YAAEIILG----LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 346
Query: 241 VSTAVVGTYGYAAPEYI--ETGHLKSQSDIWSFGVVLYEILTG----RRVLERNRPTMEQ 294
A VGT+GY APE + + S +D +S G +L+++L G R+ +++ +++
Sbjct: 347 -PHASVGTHGYMAPEVLQKGVAYDSS-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 404
Query: 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
L + P FS R L + L+++ R
Sbjct: 405 MTLTMAVELP---DSFS-------------PELR---SLLEGLLQRDVNRR 436
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 69/296 (23%), Positives = 113/296 (38%), Gaps = 74/296 (25%)
Query: 74 FNRMLKIGEGGFGSVY----KGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQ 126
F + IG+G FG V T + + A+K +N + E+Q
Sbjct: 17 FEILRAIGKGSFGKVCIVQKNDTKK---------MYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 127 FLGVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSL-----EDRLFSRAQPTLPWK 180
+ + HP LV L + S +DE + + +V + + L ++ F
Sbjct: 68 IMQGLEHPFLVNL--WYSFQDE---EDMFMVVDLLLGGDLRYHLQQNVHFKEET------ 116
Query: 181 TRL---EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGD 237
+L E+++ L YL ++I+RD K N+LLD + ++DF +A P
Sbjct: 117 VKLFICELVMA----LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169
Query: 238 HTHVSTAVVGTYGYAAPEYIE----TGHLKSQSDIWSFGVVLYEILTGRR----VLERNR 289
T + GT Y APE G+ + D WS GV YE+L GRR +
Sbjct: 170 QI---TTMAGTKPYMAPEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRRPYHIRSSTSS 225
Query: 290 PTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
+ V +P+ +S + KL L+ NP++R
Sbjct: 226 KEIVHTFETTVVTYPSA---------------WSQEMVSLLKKL----LEPNPDQR 262
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 68/308 (22%), Positives = 115/308 (37%), Gaps = 68/308 (22%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW-----LAEVQFL 128
+ + +GEG +G V K + GR +VA+KK + + E++ L
Sbjct: 27 YENLGLVGEGSYGMVMKCRNK-DTGR----IVAIKKFL---ESDDDKMVKKIAMREIKLL 78
Query: 129 GVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIIL 187
+ H NLV LL C + R LV+E++ + ++ D L + +
Sbjct: 79 KQLRHENLVNLLEVCKKKK-----RWYLVFEFV-DHTILDDLELFPNGLDYQVVQK-YLF 131
Query: 188 GAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE--GPTGDHTHVSTAV 245
G+ + H +I+RD K N+L+ + KL DFG AR P +
Sbjct: 132 QIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD----E 184
Query: 246 VGTYGYAAPEYIETGHLKSQS-----DIWSFGVVLYEILTGR----------------RV 284
V T Y APE + + D+W+ G ++ E+ G
Sbjct: 185 VATRWYRAPELL----VGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMC 240
Query: 285 L----ERNRPTMEQKLLEWVK-QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLK 339
L R++ K + + P ++ L +Y + V LA CL
Sbjct: 241 LGNLIPRHQELFN-KNPVFAGVRLPEIKEREP------LERRYP-KLSEVVIDLAKKCLH 292
Query: 340 KNPEERPT 347
+P++RP
Sbjct: 293 IDPDKRPF 300
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 76/314 (24%), Positives = 121/314 (38%), Gaps = 71/314 (22%)
Query: 51 LYKEKEHHLRVFDMQELREAT-NGFNRMLKIGEGGFGSVY----KGTIRPLDGRGEPLVV 105
L K KE L+ ++ A + F+R+ +G G FG V K +
Sbjct: 19 LAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGN---------HY 69
Query: 106 AVKKLNNHGLQGHKQW---LAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMP 161
A+K L+ + KQ L E + L V+ P LVKL L +V EY+
Sbjct: 70 AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-----NLYMVMEYVA 124
Query: 162 NRSL-----EDRLFSRAQPTLPWKTRL---EIILGAAEGLAYLHEGLEIQVIYRDFKTSN 213
+ FS R +I+L YLH + +IYRD K N
Sbjct: 125 GGEMFSHLRRIGRFSEPH------ARFYAAQIVLT----FEYLHS---LDLIYRDLKPEN 171
Query: 214 VLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFG 272
+L+D +++DFG A+ T + GT APE I + G+ K+ D W+ G
Sbjct: 172 LLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKA-VDWWALG 225
Query: 273 VVLYEILTGRR-VLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVA 331
V++YE+ G + +K++ +FP+ L++
Sbjct: 226 VLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH-------FSSDLKD----------- 267
Query: 332 KLADNCLKKNPEER 345
L N L+ + +R
Sbjct: 268 -LLRNLLQVDLTKR 280
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 65/295 (22%), Positives = 110/295 (37%), Gaps = 69/295 (23%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLVK 138
IG G FG + E VAVK + + + Q E+ + HPN+V+
Sbjct: 28 IGSGNFGVARLMRDKLT---KEL--VAVKYIERGAAIDENVQ--REIINHRSLRHPNIVR 80
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE----------IILG 188
T I + EY L +R+ + R ++ G
Sbjct: 81 FKEVILTPTHLAI----IMEYASGGELYERICN--------AGRFSEDEARFFFQQLLSG 128
Query: 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP--KLSDFGLAREGPTGDHTHVSTAVV 246
++Y H +Q+ +RD K N LLDG+ P K+ DFG ++ + V
Sbjct: 129 ----VSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---V 178
Query: 247 GTYGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVL---ERNRPTMEQKLLEWVKQ 302
GT Y APE + + +D+WS GV LY +L G + P +K ++ +
Sbjct: 179 GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEEPRDYRKTIQRI-- 234
Query: 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKK----NPEERPTMNQVVE 353
L +YSI R++ + + + +P R ++ ++
Sbjct: 235 ---------------LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-23
Identities = 69/290 (23%), Positives = 116/290 (40%), Gaps = 70/290 (24%)
Query: 74 FNRMLKIGEGGFGSVY----KGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQ 126
F + +G G FG V+ + R A+K L + KQ E
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGR---------YYAMKVLKKEIVVRLKQVEHTNDERL 58
Query: 127 FLGVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSL-----EDRLFSRAQPTLPWK 180
L +V+HP ++++ G ++ ++ +Y+ L + + F
Sbjct: 59 MLSIVTHPFIIRMWGTFQDAQ-----QIFMIMDYIEGGELFSLLRKSQRFPNPV------ 107
Query: 181 TRL---EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGD 237
+ E+ L L YLH +IYRD K N+LLD N K++DFG A+ P
Sbjct: 108 AKFYAAEVCLA----LEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160
Query: 238 HTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRR-VLERNRPTMEQK 295
+T + GT Y APE + T + KS D WSFG+++YE+L G + N +K
Sbjct: 161 YT-----LCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEK 214
Query: 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
+L +FP + +++ L + ++ +R
Sbjct: 215 ILNAELRFPPF-------FNEDVKD------------LLSRLITRDLSQR 245
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 3e-23
Identities = 68/354 (19%), Positives = 114/354 (32%), Gaps = 91/354 (25%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAE------------- 124
+G G FG V + +D VAVK L H+ ++E
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 125 VQFLGVVS--------------HPNLVKLL------------------------------ 140
V LG + NL L
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148
Query: 141 -----GYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAY 195
++ + + + + E+ + L + + A+G+ +
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPE 255
L + I+RD N+LL K+ DFGLAR+ + APE
Sbjct: 209 LAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265
Query: 256 YIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRP----TMEQKLLEWVKQFPADGKKF 310
I QSD+WSFGV+L+EI + G P ++++ +K +G +
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGA------SPYPGVKIDEEFCRRLK----EGTR- 314
Query: 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364
M P + + +C P +RPT +++VE L +Q + Q
Sbjct: 315 --MRAPD-------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANAQ 359
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-23
Identities = 70/297 (23%), Positives = 114/297 (38%), Gaps = 59/297 (19%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVK--------KLNNHGLQGHKQWLA-EVQFLG 129
+G G V + +P + AVK + +Q ++ EV L
Sbjct: 24 ILGRGVSSVVRRCIHKP-TCK----EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78
Query: 130 VVS-HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILG 188
VS HPN+++L E LV++ M L D L + + +TR +I+
Sbjct: 79 KVSGHPNIIQLKDTY--ETNTFF--FLVFDLMKKGELFDYLTEKVTLSEK-ETR-KIMRA 132
Query: 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT 248
E + LH+ + +++RD K N+LLD + KL+DFG + + G+ V GT
Sbjct: 133 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGT 186
Query: 249 YGYAAPEYIETGHLKSQS------DIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ 302
Y APE IE + D+WS GV++Y +L G
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP------------------- 227
Query: 303 FPADGKKFSMMIDPRLRNQYSINAA--RRV---AK-LADNCLKKNPEERPTMNQVVE 353
P +K +M+ + Y + K L L P++R T + +
Sbjct: 228 -PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 4e-23
Identities = 60/298 (20%), Positives = 99/298 (33%), Gaps = 79/298 (26%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVK-----KLNNHGL---QGHKQWLAEVQFLGVV 131
+G G FG V+ + V VK K+ + E+ L V
Sbjct: 32 LGSGAFGFVWTAV-DKEKNK----EVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 132 SHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE------- 184
H N++K+L + Q LV E + L+ LF+ + RL+
Sbjct: 87 EHANIIKVLDIFENQGF--FQ--LVMEKHGS-GLD--LFAF----IDRHPRLDEPLASYI 135
Query: 185 ---IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHV 241
++ + YL +I+RD K N+++ +F KL DFG A G +
Sbjct: 136 FRQLVSA----VGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188
Query: 242 STAVVGTYGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300
GT Y APE + + + ++WS GV LY ++
Sbjct: 189 F---CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE------------------ 227
Query: 301 KQFPADGKKFSMMIDPRLRNQYSI-----NAARRVAKLADNCLKKNPEERPTMNQVVE 353
P ++ + L L+ PE R T+ ++V
Sbjct: 228 --NPFCE------LEETVEAAIHPPYLVSKELMS---LVSGLLQPVPERRTTLEKLVT 274
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 4e-23
Identities = 74/288 (25%), Positives = 117/288 (40%), Gaps = 62/288 (21%)
Query: 76 RMLK-IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQW---LAEVQFLGV 130
+L+ +G+GG+G V++ +R + G + A+K L ++ K AE L
Sbjct: 20 ELLRVLGKGGYGKVFQ--VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 131 VSHPNLVKLLGYCS--TEDERGIQRL-LVYEYMPNRSL-----EDRLFSRAQPTLPWKTR 182
V HP +V L + T +L L+ EY+ L + +F
Sbjct: 78 VKHPFIVDL--IYAFQTGG-----KLYLILEYLSGGELFMQLEREGIFMEDT------AC 124
Query: 183 L---EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHT 239
EI + L +LH+ +IYRD K N++L+ KL+DFGL +E
Sbjct: 125 FYLAEISMA----LGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV 177
Query: 240 HVSTAVVGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGRRVLE-RNRPTMEQKLL 297
+ GT Y APE + +GH ++ D WS G ++Y++LTG NR K+L
Sbjct: 178 --THTFCGTIEYMAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL 234
Query: 298 EWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
+ L + A + KL LK+N R
Sbjct: 235 K---------------CKLNLPPYLTQEARDLLKKL----LKRNAASR 263
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 5e-23
Identities = 67/237 (28%), Positives = 104/237 (43%), Gaps = 48/237 (20%)
Query: 68 REATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW----LA 123
R+ + F G+G FG+V G + G VA+KK+ +Q ++ L
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKS---TGM--SVAIKKV----IQ-DPRFRNRELQ 68
Query: 124 EVQFLGVVSHPNLVKLLGYCSTEDERGIQRL---LVYEYMPNRSLED-----RLFSRAQP 175
+Q L V+ HPN+V+L Y T ER + + +V EY+P + R + R Q
Sbjct: 69 IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQV 124
Query: 176 TLPW---KTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG-NFKPKLSDFGLAR 231
P K L ++ + LH + V +RD K NVL++ + KL DFG A+
Sbjct: 125 APPPILIKVFLFQLI---RSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180
Query: 232 E-GPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQS-----DIWSFGVVLYEILTGR 282
+ P+ + + Y Y APE I +Q DIWS G + E++ G
Sbjct: 181 KLSPSEPNVAY---ICSRY-YRAPELI----FGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-23
Identities = 59/270 (21%), Positives = 102/270 (37%), Gaps = 45/270 (16%)
Query: 64 MQELREATNGFNRMLKIGEGGFGSVY----KGTIRPLDGRGEPLVVAVKKLNNHGLQGHK 119
++E+R + F + IG G F V K T + V A+K +N +
Sbjct: 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQ---------VYAMKIMNKWDMLKRG 103
Query: 120 Q---WLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQP 175
+ + E L + +L + + +DE L LV EY L L S+
Sbjct: 104 EVSCFREERDVLVNGDRRWITQL--HFAFQDEN---YLYLVMEYYVGGDLLTLL-SKFGE 157
Query: 176 TLPWK-TRL---EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231
+P + R EI++ + +H + ++RD K N+LLD +L+DFG
Sbjct: 158 RIPAEMARFYLAEIVMA----IDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCL 210
Query: 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQS-------DIWSFGVVLYEILTGRR- 283
+ A VGT Y +PE ++ + D W+ GV YE+ G+
Sbjct: 211 KLRADGTVRSLVA-VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
Query: 284 VLERNRPTMEQKLLEWVK--QFPADGKKFS 311
+ K++ + + P +
Sbjct: 270 FYADSTAETYGKIVHYKEHLSLPLVDEGVP 299
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 6e-23
Identities = 66/286 (23%), Positives = 111/286 (38%), Gaps = 51/286 (17%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA-EVQFLGVVSHPNLVK 138
+GEG +G V R E VAVK ++ + + E+ +++H N+VK
Sbjct: 15 LGEGAYGEVQLAVNRVT---EEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 69
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE----------IILG 188
G+ + L EY L DR+ + ++
Sbjct: 70 FYGHRREGNI--Q--YLFLEYCSGGELFDRIEP--------DIGMPEPDAQRFFHQLM-- 115
Query: 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT 248
G+ YLH I + +RD K N+LLD K+SDFGLA + + + GT
Sbjct: 116 --AGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 249 YGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307
Y APE ++ D+WS G+VL +L G ++ + Q+ +W +
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKE------ 223
Query: 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
KK + ++ + K+ L +NP R T+ + +
Sbjct: 224 KKTYLNPWKKI----DSAPLALLHKI----LVENPSARITIPDIKK 261
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-23
Identities = 72/306 (23%), Positives = 129/306 (42%), Gaps = 57/306 (18%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH-KQWLAEVQFLGVVS 132
F ++ K+G G + +VYKG + G VA+K++ +G + E+ + +
Sbjct: 7 FKQLEKLGNGTYATVYKGLNK-TTGV----YVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 133 HPNLVKLLGYCSTEDERGIQRL-LVYEYMPN---RSLEDRLFSRAQPTLPWKTRLEIILG 188
H N+V+L TE+ +L LV+E+M N + ++ R L
Sbjct: 62 HENIVRLYDVIHTEN-----KLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE--GPTGDHTHVSTAVV 246
+GLA+ HE ++++RD K N+L++ + KL DFGLAR P + VV
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE---VV 170
Query: 247 GTYGYAAPEYIETGHLKSQS-----DIWSFGVVLYEILTGR----------------RVL 285
T Y AP+ + + S++ DIWS G +L E++TG+ ++
Sbjct: 171 -TLWYRAPDVL----MGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225
Query: 286 ----ERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKN 341
E P++ KL ++ ++ + L+ + L+ N
Sbjct: 226 GTPNESLWPSVT-KLPKYNPNIQ---QRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN 281
Query: 342 PEERPT 347
P+ R +
Sbjct: 282 PDMRLS 287
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 62/258 (24%), Positives = 100/258 (38%), Gaps = 43/258 (16%)
Query: 74 FNRMLKIGEGGFGSVY----KGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ---WLAEVQ 126
F + IG G FG V K + V A+K LN + + + E
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADK---------VFAMKILNKWEMLKRAETACFREERD 126
Query: 127 FLGVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWK-TRL- 183
L + L + + +D+ L LV +Y L L S+ + LP + R
Sbjct: 127 VLVNGDSKWITTL--HYAFQDDN---NLYLVMDYYVGGDLLTLL-SKFEDRLPEEMARFY 180
Query: 184 --EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHV 241
E+++ + +H+ + ++RD K N+L+D N +L+DFG +
Sbjct: 181 LAEMVIA----IDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233
Query: 242 STAVVGTYGYAAPEYIETGHLKSQS-----DIWSFGVVLYEILTGRR-VLERNRPTMEQK 295
S A VGT Y +PE ++ D WS GV +YE+L G + K
Sbjct: 234 SVA-VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292
Query: 296 LLEWVK--QFPADGKKFS 311
++ + QFP S
Sbjct: 293 IMNHKERFQFPTQVTDVS 310
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 7e-23
Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 43/229 (18%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEV-------- 125
+ + +IG G +G+VYK G VA+K + + +
Sbjct: 11 YEPVAEIGVGAYGTVYKARDP-HSGH----FVALKSVR---VPNGGGGGGGLPISTVREV 62
Query: 126 ---QFLGVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKT 181
+ L HPN+V+L+ C+T ++ LV+E++ ++ L L P LP +T
Sbjct: 63 ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAET 121
Query: 182 RLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE-GPTGDHTH 240
+++ GL +LH +++RD K N+L+ KL+DFGLAR T
Sbjct: 122 IKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178
Query: 241 VSTAVVGTYGYAAPE------YIETGHLKSQS-DIWSFGVVLYEILTGR 282
V VV T Y APE Y + D+WS G + E+ +
Sbjct: 179 V---VV-TLWYRAPEVLLQSTY-------ATPVDMWSVGCIFAEMFRRK 216
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-22
Identities = 75/300 (25%), Positives = 124/300 (41%), Gaps = 53/300 (17%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ-----WLAEVQFL 128
+ ++ KIGEG +G+V+K R +VA+K++ L + L E+ L
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNR-ETHE----IVALKRVR---LDDDDEGVPSSALREICLL 55
Query: 129 GVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPW--KTRLEI 185
+ H N+V+L ++ +L LV+E+ L+ S P K+ L
Sbjct: 56 KELKHKNIVRLHDVLHSDK-----KLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 186 ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAV 245
+L +GL + H V++RD K N+L++ N + KL++FGLAR G +A
Sbjct: 110 LL---KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARA--FGIPVRCYSAE 161
Query: 246 VGTYGYAAPEYIETGHLKSQS-----DIWSFGVVLYEILTGRRVLERNRPTMEQ-----K 295
V T Y P+ + ++ D+WS G + E+ R L +Q +
Sbjct: 162 VVTLWYRPPDVL----FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217
Query: 296 LL------EW--VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT 347
LL +W + + P D K + M L N LK NP +R +
Sbjct: 218 LLGTPTEEQWPSMTKLP-DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 63/294 (21%), Positives = 111/294 (37%), Gaps = 55/294 (18%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA--------EVQFLGV 130
+G G G V R + VA+K ++ A E++ L
Sbjct: 17 TLGSGACGEVKLAFER-KTCK----KVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA 190
++HP ++K+ + ED +V E M L D++ + L T
Sbjct: 72 LNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQML 124
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP---KLSDFGLAREGPTGDHTHVSTAVVG 247
+ YLHE +I+RD K NVLL + K++DFG ++ G+ + + T + G
Sbjct: 125 LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT-LCG 178
Query: 248 TYGYAAPEYIETGHLKSQS---DIWSFGVVLYEILTGRRVL----ERNRPTMEQKLLEWV 300
T Y APE + + + D WS GV+L+ L+G R + +++ ++
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG--YPPFSEHRTQVSLKDQITSGK 236
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAK-LADNCLKKNPEERPTMNQVVE 353
F + ++ A L L +P+ R T + +
Sbjct: 237 YNFIPEVWA-------------EVSEK---ALDLVKKLLVVDPKARFTTEEALR 274
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 64/295 (21%), Positives = 113/295 (38%), Gaps = 65/295 (22%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--HKQWLAEVQFLGVVSHPNL 136
++G+G F V + G+ A +N L H++ E + ++ HPN+
Sbjct: 18 ELGKGAFSVVRRCVKVL-AGQ----EYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE-----IILGAAE 191
V+L +E L+++ + L + + +R + E I E
Sbjct: 73 VRLHDSI--SEEGHHY--LIFDLVTGGELFEDIVAREYYS-------EADASHCIQQILE 121
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLL---DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT 248
+ + H ++ V++R+ K N+LL KL+DFGLA E GT
Sbjct: 122 AVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAGT 176
Query: 249 YGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM---EQKLLEWVKQ--- 302
GY +PE + D+W+ GV+LY +L G P + +L + +K
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGY------PPFWDEDQHRLYQQIKAGAY 230
Query: 303 -FPADGKKFSMMIDPRLRNQY--SINAARRVAK-LADNCLKKNPEERPTMNQVVE 353
FP+ ++ AK L + L NP +R T + ++
Sbjct: 231 DFPSP---------------EWDTVTPE---AKDLINKMLTINPSKRITAAEALK 267
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 81/346 (23%), Positives = 140/346 (40%), Gaps = 70/346 (20%)
Query: 26 QNRLDNNSALNRTARSLPSPRSIPELYKEKEHHLRVFDMQELREAT-NGFNRMLK-IGEG 83
+ + S+ S +L K + F +LK +G G
Sbjct: 7 HHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFE-LLKVLGTG 65
Query: 84 GFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQW---LAEVQFLGVVSH-PNLVK 138
+G V+ +R + G + A+K L +Q K E Q L + P LV
Sbjct: 66 AYGKVFL--VRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVT 123
Query: 139 LLGYCS--TEDERGIQRL-LVYEYMPNRSL-----EDRLFSRAQPTLPWKTRL---EIIL 187
L + + TE +L L+ +Y+ L + F+ + ++ EI+L
Sbjct: 124 L--HYAFQTET-----KLHLILDYINGGELFTHLSQRERFTEHE------VQIYVGEIVL 170
Query: 188 GAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVG 247
L +LH+ + +IYRD K N+LLD N L+DFGL++E + G
Sbjct: 171 A----LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCG 222
Query: 248 TYGYAAPEYI---ETGHLKSQSDIWSFGVVLYEILTGR-----RVLERNRPTMEQKLLEW 299
T Y AP+ + ++GH K+ D WS GV++YE+LTG + ++ + +++L+
Sbjct: 223 TIEYMAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 281
Query: 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
+P + S A + +L L K+P++R
Sbjct: 282 EPPYPQE---------------MSALAKDLIQRL----LMKDPKKR 308
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 61/251 (24%), Positives = 96/251 (38%), Gaps = 48/251 (19%)
Query: 74 FNRMLKIGEGGFGSVY----KGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ---WLAEVQ 126
+ + IG G FG V K T + V A+K L+ + + E
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRK---------VYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 127 FLGVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPN----RSLEDRLFSRAQPTLPWKT 181
+ + P +V+L + + +D+R L +V EYMP + +
Sbjct: 122 IMAFANSPWVVQL--FYAFQDDR---YLYMVMEYMPGGDLVNLMSNYDVPEKW------A 170
Query: 182 RL---EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDH 238
R E++L L +H + I+RD K N+LLD + KL+DFG +
Sbjct: 171 RFYTAEVVLA----LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223
Query: 239 THVSTAVVGTYGYAAPEYIETGHLKSQ----SDIWSFGVVLYEILTGRR-VLERNRPTME 293
TA VGT Y +PE +++ D WS GV LYE+L G +
Sbjct: 224 VRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY 282
Query: 294 QKLLEWVKQFP 304
K++
Sbjct: 283 SKIMNHKNSLT 293
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-22
Identities = 66/224 (29%), Positives = 106/224 (47%), Gaps = 44/224 (19%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ-----WLAEVQFL 128
++ + KIGEG +G VYK + GE A+KK+ L+ + + E+ L
Sbjct: 4 YHGLEKIGEGTYGVVYKAQ----NNYGE--TFALKKIR---LEKEDEGIPSTTIREISIL 54
Query: 129 GVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPW--KTRLEI 185
+ H N+VKL T+ RL LV+E++ L+ L K+ L
Sbjct: 55 KELKHSNIVKLYDVIHTKK-----RLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 186 ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE--GPTGDHTHVST 243
+L G+AY H+ +V++RD K N+L++ + K++DFGLAR P +TH
Sbjct: 109 LL---NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE-- 160
Query: 244 AVVGTYGYAAPEYIETGHLKSQS-----DIWSFGVVLYEILTGR 282
+V T Y AP+ + + S+ DIWS G + E++ G
Sbjct: 161 -IV-TLWYRAPDVL----MGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 64/226 (28%), Positives = 105/226 (46%), Gaps = 39/226 (17%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ-----WLAEVQFL 128
+ + +IGEG +G V+K GR VA+K++ +Q ++ + EV L
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGR----FVALKRVR---VQTGEEGMPLSTIREVAVL 65
Query: 129 ---GVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRLE 184
HPN+V+L C+ +L LV+E++ ++ L L +P +P +T +
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD 124
Query: 185 IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE-GPTGDHTHVST 243
++ GL +LH +V++RD K N+L+ + + KL+DFGLAR T V
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-- 179
Query: 244 AVVGTYGYAAPE------YIETGHLKSQS-DIWSFGVVLYEILTGR 282
VV T Y APE Y + D+WS G + E+ +
Sbjct: 180 -VV-TLWYRAPEVLLQSSY-------ATPVDLWSVGCIFAEMFRRK 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-22
Identities = 65/296 (21%), Positives = 116/296 (39%), Gaps = 64/296 (21%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLV 137
+GEG F K + + AVK ++ ++ E+ L + HPN+V
Sbjct: 18 PLGEGSFSICRKCVHKK-SNQ----AFAVKIISKRMEANTQK---EITALKLCEGHPNIV 69
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE-----IILGAAEG 192
KL D+ LV E + L +R+ + + E I+
Sbjct: 70 KLHEVF--HDQLHT--FLVMELLNGGELFERIKKKKHFS-------ETEASYIMRKLVSA 118
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLL---DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
++++H+ + V++RD K N+L + N + K+ DFG AR T
Sbjct: 119 VSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQPLKTPCFTL 173
Query: 250 GYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTG----RRVLERNRPTMEQKLLEWVKQ-- 302
YAAPE + G+ +S D+WS GV+LY +L+G + T ++++ +K+
Sbjct: 174 HYAAPELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
Query: 303 --FPADGKKFSMMIDPRLRNQY--SINAARRVAK-LADNCLKKNPEERPTMNQVVE 353
F + +++ AK L L +P +R M+ +
Sbjct: 233 FSFEGE---------------AWKNVSQE---AKDLIQGLLTVDPNKRLKMSGLRY 270
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 79/293 (26%), Positives = 122/293 (41%), Gaps = 69/293 (23%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVK-----KLNNHGLQGHKQWLAEVQFLGVVSHP 134
+G G FG V G G VAVK K+ + + G + E+Q L + HP
Sbjct: 24 LGVGTFGKVKVGKHELT---GHK--VAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHP 76
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE---------- 184
+++KL ST + I +V EY+ L D + RL+
Sbjct: 77 HIIKLYQVISTPSD--I--FMVMEYVSGGELFDYICK--------NGRLDEKESRRLFQQ 124
Query: 185 IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTA 244
I+ G+ Y H V++RD K NVLLD + K++DFGL+ G+ S
Sbjct: 125 IL----SGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-- 175
Query: 245 VVGTYGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVL---ERNRPTMEQKLLEWV 300
G+ YAAPE I + + DIWS GV+LY +L G L + + PT+ +K+ + +
Sbjct: 176 -CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT--LPFDDDHVPTLFKKICDGI 232
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
P + V L + L+ +P +R T+ + E
Sbjct: 233 FYTPQY---LN----------------PSVISLLKHMLQVDPMKRATIKDIRE 266
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 63/274 (22%), Positives = 112/274 (40%), Gaps = 24/274 (8%)
Query: 12 KPKKGSNSAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHLRVFDMQELREAT 71
+ G N A E + L + ++ R+ IP +H + +
Sbjct: 31 DSRSGHNEAKEVWSNADLTERMPV-KSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFY 89
Query: 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV 131
++ +G G FG V+K L +A K + G++ ++ E+ + +
Sbjct: 90 T-VSKTEILGGGRFGQVHKCE-----ETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 132 SHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEI--ILGA 189
H NL++L E + I +LV EY+ L DR+ + T L + I
Sbjct: 144 DHANLIQLYDAF--ESKNDI--VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC-- 197
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLL--DGNFKPKLSDFGLAREGPTGDHTHVSTAVVG 247
EG+ ++H+ + +++ D K N+L + K+ DFGLAR G
Sbjct: 198 -EGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRY---KPREKLKVNFG 250
Query: 248 TYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTG 281
T + APE + + +D+WS GV+ Y +L+G
Sbjct: 251 TPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 34/223 (15%)
Query: 78 LKIGEGGFGSVYKGTIR-PLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNL 136
K+G G +G VYK + D + A+K++ G+ E+ L + HPN+
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDK----DYALKQIEGTGI--SMSACREIALLRELKHPNV 80
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPN------RSLEDRLFSRAQPTLPWKTRLEIILGAA 190
+ L + +R + L+++Y + + ++ LP ++
Sbjct: 81 ISLQKVFLSHADRKV--WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 138
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP----KLSDFGLARE--GPTGDHTHVSTA 244
+G+ YLH V++RD K +N+L+ G K++D G AR P +
Sbjct: 139 DGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 245 VVGTYGYAAPEYIETGHLKSQS-----DIWSFGVVLYEILTGR 282
VV T+ Y APE + L ++ DIW+ G + E+LT
Sbjct: 196 VV-TFWYRAPELL----LGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 4e-22
Identities = 69/293 (23%), Positives = 114/293 (38%), Gaps = 66/293 (22%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--HKQWLAEVQFLGVVSHPNL 136
++G+G F V + + G A K +N L ++ E + + HPN+
Sbjct: 13 ELGKGAFSVVRRCVHK-TTGL----EFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE-----IILGAAE 191
V+L ++E LV++ + L + + +R + E I E
Sbjct: 68 VRLHDSI--QEESFHY--LVFDLVTGGELFEDIVAREFYS-------EADASHCIQQILE 116
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP---KLSDFGLAREGPTGDHTHVSTAVVGT 248
+AY H +++R+ K N+LL K KL+DFGLA E GT
Sbjct: 117 SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGT 170
Query: 249 YGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRP---TMEQKLLEWVKQ--- 302
GY +PE ++ DIW+ GV+LY +L G P + +L +K
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY------PPFWDEDQHRLYAQIKAGAY 224
Query: 303 -FPADGKKFSMMIDPRLRNQY--SINAARRVAK-LADNCLKKNPEERPTMNQV 351
+P+ ++ AK L D+ L NP++R T +Q
Sbjct: 225 DYPSP---------------EWDTVTPE---AKSLIDSMLTVNPKKRITADQA 259
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 4e-22
Identities = 76/352 (21%), Positives = 131/352 (37%), Gaps = 57/352 (16%)
Query: 9 DKFKPKKGSNSAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHLR-VFDMQEL 67
D+ K ++G + + + S+ + P+ + K H+ +D+ E
Sbjct: 105 DERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHE- 163
Query: 68 REATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQF 127
++G G FG V++ T R A K + + E+Q
Sbjct: 164 -----------ELGTGAFGVVHRVT-----ERATGNNFAAKFVMTPHESDKETVRKEIQT 207
Query: 128 LGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIIL 187
+ V+ HP LV L ED+ + +++YE+M L +++ + +E +
Sbjct: 208 MSVLRHPTLVNLHDAF--EDDNEM--VMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMR 262
Query: 188 GAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP--KLSDFGLAREGPTGDHTHVSTAV 245
+GL ++HE ++ D K N++ KL DFGL V
Sbjct: 263 QVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---T 316
Query: 246 VGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM---EQKLLEWVKQ 302
GT +AAPE E + +D+WS GV+ Y +L+G P + + L VK
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVKS 370
Query: 303 --FPADGKKFSMMIDPRLRNQYSINAARRVAK-LADNCLKKNPEERPTMNQV 351
+ D FS I+ K L +P R T++Q
Sbjct: 371 CDWNMDDSAFS-----------GISED---GKDFIRKLLLADPNTRMTIHQA 408
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-22
Identities = 64/222 (28%), Positives = 105/222 (47%), Gaps = 40/222 (18%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ-----WLAEVQFL 128
+ ++ K+GEG +G VYK D +G +VA+K++ L + + E+ L
Sbjct: 23 YQKLEKVGEGTYGVVYKAK----DSQGR--IVALKRIR---LDAEDEGIPSTAIREISLL 73
Query: 129 GVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPW--KTRLEI 185
+ HPN+V L+ +E L LV+E+M L+ L K L
Sbjct: 74 KELHHPNIVSLIDVIHSER-----CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 186 ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAV 245
+L G+A+ H+ ++++RD K N+L++ + KL+DFGLAR G T
Sbjct: 128 LL---RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARA--FGIPVRSYTHE 179
Query: 246 VGTYGYAAPEYIETGHLKSQS-----DIWSFGVVLYEILTGR 282
V T Y AP+ + + S+ DIWS G + E++TG+
Sbjct: 180 VVTLWYRAPDVL----MGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-22
Identities = 72/293 (24%), Positives = 120/293 (40%), Gaps = 70/293 (23%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVK-----KLNNHGLQGHKQWLAEVQFLGVVSHP 134
+GEG FG V T + VA+K L + + E+ +L ++ HP
Sbjct: 17 LGEGSFGKVKLATHYKT---QQK--VALKFISRQLLKKSDMHMRVE--REISYLKLLRHP 69
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE---------- 184
+++KL +T + I ++V EY L D + K R+
Sbjct: 70 HIIKLYDVITTPTD--I--VMVIEYA-GGELFDYIVE--------KKRMTEDEGRRFFQQ 116
Query: 185 IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTA 244
II + Y H ++++RD K N+LLD N K++DFGL+ G+ S
Sbjct: 117 II----CAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS-- 167
Query: 245 VVGTYGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVL---ERNRPTMEQKLLEWV 300
G+ YAAPE I + + D+WS G+VLY +L GR L + P + +K+ V
Sbjct: 168 -CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR--LPFDDEFIPNLFKKVNSCV 224
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
P + S A + ++ + +P +R T+ ++
Sbjct: 225 YVMP---------------DFLSPGAQSLIRRM----IVADPMQRITIQEIRR 258
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 7e-22
Identities = 62/293 (21%), Positives = 109/293 (37%), Gaps = 62/293 (21%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLG-VVSHPNLV 137
IG G + + + AVK ++ + E++ L HPN++
Sbjct: 29 DIGVGSYSVCKRCIHK-ATNM----EFAVKIIDKSKRDPTE----EIEILLRYGQHPNII 79
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE-----IILGAAEG 192
L +D + + +V E M L D++ + + E ++ +
Sbjct: 80 TLKDVY--DDGKYV--YVVTELMKGGELLDKILRQKFFS-------EREASAVLFTITKT 128
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLL---DGNFKP-KLSDFGLAREGPTGDHTHVSTAVVGT 248
+ YLH V++RD K SN+L GN + ++ DFG A++ + + T
Sbjct: 129 VEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYT 183
Query: 249 YGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTG----RRVLERNRPTMEQKLLEWVKQF 303
+ APE +E G+ + DIWS GV+LY +LTG + + ++
Sbjct: 184 ANFVAPEVLERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL 242
Query: 304 PADGKKFSMMIDPRLRNQY--SINAARRVAK-LADNCLKKNPEERPTMNQVVE 353
Y S++ AK L L +P +R T V+
Sbjct: 243 SGG---------------YWNSVSDT---AKDLVSKMLHVDPHQRLTAALVLR 277
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 9e-22
Identities = 68/291 (23%), Positives = 111/291 (38%), Gaps = 58/291 (19%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--HKQWLAEVQFLGVVSHPNL 136
++G+G F V + + G A K +N L ++ E + + HPN+
Sbjct: 36 ELGKGAFSVVRRCVHKT-TGL----EFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE-----IILGAAE 191
V+L ++E LV++ + L + + +R + E I E
Sbjct: 91 VRLHDSI--QEESFHY--LVFDLVTGGELFEDIVAREFYS-------EADASHCIQQILE 139
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP---KLSDFGLAREGPTGDHTHVSTAVVGT 248
+AY H +++R+ K N+LL K KL+DFGLA E GT
Sbjct: 140 SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGT 193
Query: 249 YGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308
GY +PE ++ DIW+ GV+LY +L G P +
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP--------------------PFWDE 233
Query: 309 KFSMMIDPRLRNQYSINAA--RRV---AK-LADNCLKKNPEERPTMNQVVE 353
+ Y + V AK L D+ L NP++R T +Q ++
Sbjct: 234 DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-21
Identities = 80/290 (27%), Positives = 118/290 (40%), Gaps = 70/290 (24%)
Query: 76 RMLK-IGEGGFGSV----YKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQF 127
LK +G+G FG V K T R A+K L + + + E +
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGR---------YYAMKILRKEVIIAKDEVAHTVTESRV 58
Query: 128 LGVVSHPNLVKLLGYC-STEDERGIQRL-LVYEYMPNRSL-----EDRLFSRAQPTLPWK 180
L HP L L Y T D RL V EY L +R+F+ +
Sbjct: 59 LQNTRHPFLTALK-YAFQTHD-----RLCFVMEYANGGELFFHLSRERVFTEER------ 106
Query: 181 TRL---EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGD 237
R EI+ L YLH V+YRD K N++LD + K++DFGL +EG +
Sbjct: 107 ARFYGAEIVSA----LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 238 HTHVSTAVVGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGRR-VLERNRPTMEQK 295
T GT Y APE + + + ++ D W GVV+YE++ GR ++ + +
Sbjct: 160 AT--MKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216
Query: 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
+L +FP S A +A L LKK+P++R
Sbjct: 217 ILMEEIRFPRT---------------LSPEAKSLLAGL----LKKDPKQR 247
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 2e-21
Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 40/224 (17%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ-----WLAEVQFL 128
+ ++ +GEG F +VYK + + +VA+KK+ K L E++ L
Sbjct: 12 YEKLDFLGEGQFATVYKARDK-NTNQ----IVAIKKIKLGHRSEAKDGINRTALREIKLL 66
Query: 129 GVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPW--KTRLEI 185
+SHPN++ LL + + LV+++M LE + + P K + +
Sbjct: 67 QELSHPNIIGLLDAFGHKS-----NISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 186 ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE--GPTGDHTHVST 243
L +GL YLH+ +++RD K +N+LLD N KL+DFGLA+ P +TH
Sbjct: 121 TL---QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ-- 172
Query: 244 AVVGTYGYAAPEYIETGHLKSQS-----DIWSFGVVLYEILTGR 282
VV T Y APE + ++ D+W+ G +L E+L
Sbjct: 173 -VV-TRWYRAPELL----FGARMYGVGVDMWAVGCILAELLLRV 210
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 54/284 (19%), Positives = 112/284 (39%), Gaps = 41/284 (14%)
Query: 1 MKCFYIFKDKFKPKKGSNSAPEPRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHLR 60
M+ + +G P+ + ++ + + +P+ + K+ +
Sbjct: 1 MRGSHHHHHHGSKVRGKYDGPKINDYDKFYEDI----------WKKYVPQPVEVKQGSVY 50
Query: 61 -VFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK 119
+D+ E ++G G FG V++ + V K +N
Sbjct: 51 DYYDILE------------ELGSGAFGVVHRCV-----EKATGRVFVAKFINTPYPLDKY 93
Query: 120 QWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPW 179
E+ + + HP L+ L ED+ + +L+ E++ L DR+ + +
Sbjct: 94 TVKNEISIMNQLHHPKLINLHDAF--EDKYEM--VLILEFLSGGELFDRIAAEDY-KMSE 148
Query: 180 KTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL--DGNFKPKLSDFGLAREGPTGD 237
+ + A EGL ++HE +++ D K N++ K+ DFGLA + +
Sbjct: 149 AEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL---N 202
Query: 238 HTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTG 281
+ T +AAPE ++ + +D+W+ GV+ Y +L+G
Sbjct: 203 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 33/216 (15%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPL---VVAVKKLNNHGLQGHKQWL-AEVQFLGVVSHP 134
++G G F V K + G + ++ ++ + EV L V HP
Sbjct: 19 ELGSGQFAIVKKCREK---STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE-----IILGA 189
N++ L E+ + L+ E + L D L + + E I
Sbjct: 76 NIITLHDVY--ENRTDVV--LILELVSGGELFDFLAQKESLS-------EEEATSFIKQI 124
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP----KLSDFGLAREGPTGDHTHVSTAV 245
+G+ YLH ++ + D K N++L P KL DFGLA E + +
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI---EDGVEFKNI 178
Query: 246 VGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTG 281
GT + APE + L ++D+WS GV+ Y +L+G
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 36/220 (16%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH-KQWLAEVQFLGVVS 132
+ ++ K+GEG + +VYKG + L +VA+K++ +G + EV L +
Sbjct: 4 YIKLDKLGEGTYATVYKGKSK-LTDN----LVALKEIRLEHEEGAPCTAIREVSLLKDLK 58
Query: 133 HPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPW--KTRLEIILGA 189
H N+V L TE L LV+EY+ ++ L+ L K L +L
Sbjct: 59 HANIVTLHDIIHTEK-----SLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLL-- 110
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE--GPTGDHTHVSTAVVG 247
GLAY H +V++RD K N+L++ + KL+DFGLAR PT + + VV
Sbjct: 111 -RGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE---VV- 162
Query: 248 TYGYAAPEYIETGHLKSQS-----DIWSFGVVLYEILTGR 282
T Y P+ + L S D+W G + YE+ TGR
Sbjct: 163 TLWYRPPDIL----LGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 64/310 (20%), Positives = 107/310 (34%), Gaps = 71/310 (22%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVK 138
+GEG V + AVK + + EV+ L H N+++
Sbjct: 21 LGEGAHARVQTCINL---ITSQE--YAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLE 75
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE-----IILGAAEGL 193
L+ + E+E LV+E M S+ + R E ++ A L
Sbjct: 76 LIEFF--EEEDRF--YLVFEKMRGGSILSHIHKRRHFN-------ELEASVVVQDVASAL 124
Query: 194 AYLHEGLEIQVIYRDFKTSNVLL---DGNFKPKLSDFGLAREGPTGDHTHVSTA-----V 245
+LH + +RD K N+L + K+ DF L +
Sbjct: 125 DFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 246 VGTYGYAAPEYIETGHLKSQS-----DIWSFGVVLYEILTG------------RRVLERN 288
G+ Y APE +E ++ D+WS GV+LY +L+G
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241
Query: 289 RPTMEQKLLEWVKQ----FPADGKKFSMMIDPRLRNQYSINAARRVAK-LADNCLKKNPE 343
P + L E +++ FP I+ A AK L L ++ +
Sbjct: 242 CPACQNMLFESIQEGKYEFPDKDWA-------------HISCA---AKDLISKLLVRDAK 285
Query: 344 ERPTMNQVVE 353
+R + QV++
Sbjct: 286 QRLSAAQVLQ 295
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 79/290 (27%), Positives = 116/290 (40%), Gaps = 69/290 (23%)
Query: 76 RMLK-IGEGGFGSVY----KGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQF 127
LK +G+G FG V K T R A+K L + + L E +
Sbjct: 151 EYLKLLGKGTFGKVILVKEKATGR---------YYAMKILKKEVIVAKDEVAHTLTENRV 201
Query: 128 LGVVSHPNLVKLLGYC-STEDERGIQRL-LVYEYMPNRSL-----EDRLFSRAQPTLPWK 180
L HP L L Y T D RL V EY L +R+FS +
Sbjct: 202 LQNSRHPFLTALK-YSFQTHD-----RLCFVMEYANGGELFFHLSRERVFSEDR------ 249
Query: 181 TRL---EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGD 237
R EI+ L YLH + +YRD K N++LD + K++DFGL +EG
Sbjct: 250 ARFYGAEIVSA----LDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303
Query: 238 HTHVSTAVVGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGRRVLE-RNRPTMEQK 295
T GT Y APE + + + ++ D W GVV+YE++ GR ++ + +
Sbjct: 304 AT--MKTFCGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 360
Query: 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
+L +FP A ++ L LKK+P++R
Sbjct: 361 ILMEEIRFPRT---------------LGPEAKSLLSGL----LKKDPKQR 391
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-21
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 43/221 (19%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA------EVQFLGVVS 132
++G G F V K + G+ A K + L ++ ++ EV L +
Sbjct: 12 ELGSGQFAIVRKCRQKG-TGK----EYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 133 HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE-------- 184
HPN++ L E++ + L+ E + L D L + T E
Sbjct: 67 HPNIITLHDIF--ENKTDVV--LILELVSGGELFDFLAEKESLT-------EDEATQFLK 115
Query: 185 IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP----KLSDFGLAREGPTGDHTH 240
IL +G+ YLH ++ + D K N++L P KL DFG+A + G+
Sbjct: 116 QIL---DGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK 169
Query: 241 VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTG 281
+ GT + APE + L ++D+WS GV+ Y +L+G
Sbjct: 170 N---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-21
Identities = 53/216 (24%), Positives = 86/216 (39%), Gaps = 33/216 (15%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPL---VVAVKKLNNHGLQGHKQWLA-EVQFLGVVSHP 134
++G G F V K + G + ++ ++ + EV L V H
Sbjct: 19 ELGSGQFAIVKKCREK---STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE-----IILGA 189
N++ L E+ + L+ E + L D L + + E I
Sbjct: 76 NVITLHDVY--ENRTDVV--LILELVSGGELFDFLAQKESLS-------EEEATSFIKQI 124
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP----KLSDFGLAREGPTGDHTHVSTAV 245
+G+ YLH ++ + D K N++L P KL DFGLA E G +
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---I 178
Query: 246 VGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTG 281
GT + APE + L ++D+WS GV+ Y +L+G
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 4e-21
Identities = 74/347 (21%), Positives = 123/347 (35%), Gaps = 74/347 (21%)
Query: 39 ARSLPSPRSIPELYKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDG 98
A E + + V + R+ K+GEG +G VYK +
Sbjct: 2 AHHHHHHMGTLEAQTQGPGSMSVSAAPSATSIDR-YRRITKLGEGTYGEVYKAIDT-VTN 59
Query: 99 RGEPLVVAVKKLNNHGLQGHKQ-----WLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQR 153
VA+K++ L+ ++ + EV L + H N+++L R
Sbjct: 60 E----TVAIKRIR---LEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH-----R 107
Query: 154 L-LVYEYMPN--RSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFK 210
L L++EY N + D+ + + K+ L ++ G+ + H + ++RD K
Sbjct: 108 LHLIFEYAENDLKKYMDKNPDVSMRVI--KSFLYQLI---NGVNFCHSR---RCLHRDLK 159
Query: 211 TSNVLLDGNFKP-----KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQ 265
N+LL + K+ DFGLAR G T + T Y PE + L S+
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEIITLWYRPPEIL----LGSR 213
Query: 266 S-----DIWSFGVVLYEILTGR----------------RVL----ERNRPTMEQKLLEWV 300
DIWS + E+L VL + P + L +W
Sbjct: 214 HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT-ALPDWK 272
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT 347
+ FP KF L+ L L+ +P +R +
Sbjct: 273 QSFP----KFRG---KTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS 312
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 5e-21
Identities = 79/300 (26%), Positives = 112/300 (37%), Gaps = 80/300 (26%)
Query: 76 RMLK-IGEGGFGSVY----KGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQ- 126
+L+ IG G + V K T R + A+K + + + E
Sbjct: 12 DLLRVIGRGSYAKVLLVRLKKTDR---------IYAMKVVKKELVNDDEDIDWVQTEKHV 62
Query: 127 FLGVVSHPNLVKLLGYC-STEDERGIQRL-LVYEYMPNRSL-----EDRLFSRAQPTLPW 179
F +HP LV L C TE RL V EY+ L R
Sbjct: 63 FEQASNHPFLVGLH-SCFQTES-----RLFFVIEYVNGGDLMFHMQRQRKLPEEH----- 111
Query: 180 KTRL---EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236
R EI L L YLHE +IYRD K NVLLD KL+D+G+ +EG
Sbjct: 112 -ARFYSAEISLA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163
Query: 237 DHTHVSTAVVGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGR----------RVL 285
T ++ GT Y APE + + S D W+ GV+++E++ GR
Sbjct: 164 GDT--TSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPD 220
Query: 286 ERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
+ + Q +LE + P S+ AA + L K+P+ER
Sbjct: 221 QNTEDYLFQVILEKQIRIPRS---------------LSVKAASVLKSF----LNKDPKER 261
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 70/351 (19%), Positives = 128/351 (36%), Gaps = 44/351 (12%)
Query: 12 KPKKGSNSAPEPRNQNRLDNNSALNRTARSLP-SPRSIPELYKEKEHHLRVFDMQELREA 70
+ + P P + + + A+ P P+ P+ + + ++ + + +
Sbjct: 6 QGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKV 65
Query: 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGV 130
T+ +G G G V + + E A+K L + + EV+
Sbjct: 66 TSQ-----VLGLGINGKVLQIFNK---RTQEK--FALKMLQDC-----PKARREVELHWR 110
Query: 131 VS-HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGA 189
S P++V+++ L+V E + L R+ R + EI+
Sbjct: 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 170
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLL---DGNFKPKLSDFGLAREGPTGDHTHVSTAVV 246
E + YLH I + +RD K N+L N KL+DFG A+E + + T
Sbjct: 171 GEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPC 224
Query: 247 GTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRR-VLERNRPTMEQKLLEWVKQFPA 305
T Y APE + D+WS GV++Y +L G + + + ++
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM--- 281
Query: 306 DGKKFSMMIDPRLRNQY--SINAARRVAK-LADNCLKKNPEERPTMNQVVE 353
G+ N ++ K L N LK P +R T+ + +
Sbjct: 282 -GQ-------YEFPNPEWSEVSEE---VKMLIRNLLKTEPTQRMTITEFMN 321
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 6e-21
Identities = 85/335 (25%), Positives = 124/335 (37%), Gaps = 84/335 (25%)
Query: 33 SALNRTARSLPSPRSIPELYKEKEHHLRVFDMQELREATNGFNRMLK-IGEGGFGSVY-- 89
+N P+P L H + D F+ LK IG+G FG V
Sbjct: 9 ELMNANPAPPPAPSQQINLGPSSNPHAKPSD----------FH-FLKVIGKGSFGKVLLA 57
Query: 90 --KGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQ-FLGVVSHPNLVKLLGYC 143
K AVK L + K+ ++E L V HP LV L +
Sbjct: 58 RHKAEEV---------FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL--HF 106
Query: 144 S--TEDERGIQRL-LVYEYMPNRSL-----EDRLFSRAQPTLPWKTRL---EIILGAAEG 192
S T D +L V +Y+ L +R F + R EI
Sbjct: 107 SFQTAD-----KLYFVLDYINGGELFYHLQRERCFLEPR------ARFYAAEIASA---- 151
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA 252
L YLH + ++YRD K N+LLD L+DFGL +E + T ++ GT Y
Sbjct: 152 LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYL 206
Query: 253 APEYI-ETGHLKSQSDIWSFGVVLYEILTGRR-VLERNRPTMEQKLLEWVKQFPADGKKF 310
APE + + + ++ D W G VLYE+L G RN M +L
Sbjct: 207 APEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN------------ 253
Query: 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
+L+ + +A + L L+K+ +R
Sbjct: 254 ---KPLQLKPNITNSARHLLEGL----LQKDRTKR 281
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 7e-21
Identities = 43/307 (14%), Positives = 88/307 (28%), Gaps = 61/307 (19%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQFLGVVSHPN 135
G ++ LD R VA+ ++ G+ L+ L + P
Sbjct: 38 FHGGVPPLQFWQALDTALD-R----QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAY 195
+ ++L T L+V E++ SL++ + P + + A
Sbjct: 93 VARVLDVVHTRA----GGLVVAEWIRGGSLQEVADTSPSP----VGAIRAMQSLAAAADA 144
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPE 255
H V S V + G V+
Sbjct: 145 AHR---AGVALSIDHPSRVRV----------------SIDG------DVVLAYPATMPDA 179
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMID 315
Q DI G LY +L R L + L + I+
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLP--EAGVRSGLAPAERDTAGQ------PIE 224
Query: 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSSSTTTAAKT 375
P ++ + +++ +A ++ + R ++ ++ A +++
Sbjct: 225 PADIDR---DIPFQISAVAARSVQGDGGIRSAS-TLLNLMQQATAVADRTEVLGPIDE-A 279
Query: 376 PVTSSSR 382
PV+++ R
Sbjct: 280 PVSAAPR 286
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 7e-21
Identities = 68/314 (21%), Positives = 127/314 (40%), Gaps = 67/314 (21%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ-----WLAEVQFL 128
+ ++ KIG+G FG V+K R G+ VA+KK+ ++ K+ L E++ L
Sbjct: 19 YEKLAKIGQGTFGEVFKARHR-KTGQ----KVALKKVL---MENEKEGFPITALREIKIL 70
Query: 129 GVVSHPNLVKLLGYCSTEDERGIQRL----LVYEYMPN---RSLEDRLFSRAQPTLPWKT 181
++ H N+V L+ C T+ + LV+++ + L + L + K
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KR 128
Query: 182 RLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE--GPTGDHT 239
++++L GL Y+H ++++RD K +NVL+ + KL+DFGLAR
Sbjct: 129 VMQMLL---NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 240 HVSTAVVGTYGYAAPEYIETGHLKSQS-----DIWSFGVVLYEILTGR------------ 282
+ T V T Y PE + L + D+W G ++ E+ T
Sbjct: 183 NRYTNRVVTLWYRPPELL----LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238
Query: 283 ----RVL----ERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVA-KL 333
++ P ++ E ++ + +++++ A L
Sbjct: 239 ALISQLCGSITPEVWPNVDN--YELYEKL-----ELVKGQKRKVKDRLKAYVRDPYALDL 291
Query: 334 ADNCLKKNPEERPT 347
D L +P +R
Sbjct: 292 IDKLLVLDPAQRID 305
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 68/292 (23%), Positives = 119/292 (40%), Gaps = 55/292 (18%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPL---VVAVKKLNNHGLQGHKQWLA-EVQFLGVVSHP 134
++G G F V K + G + ++ + ++ + EV L + HP
Sbjct: 18 ELGSGQFAVVKKCREK---STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRL-EIILGAAEGL 193
N++ L E++ + L+ E + L D L + T T + IL G+
Sbjct: 75 NVITLHEVY--ENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQIL---NGV 127
Query: 194 AYLHEGLEIQVIYRDFKTSNVLL----DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
YLH +Q+ + D K N++L + K+ DFGLA + D + + GT
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTP 181
Query: 250 GYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM---EQKLLEWVKQ---- 302
+ APE + L ++D+WS GV+ Y +L+G P + +Q+ L V
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------SPFLGDTKQETLANVSAVNYE 235
Query: 303 FPADGKKFSMMIDPRLRNQYSINAARRVAK-LADNCLKKNPEERPTMNQVVE 353
F + FS + +A AK L K+P++R T+ ++
Sbjct: 236 FEDE--YFS-----------NTSAL---AKDFIRRLLVKDPKKRMTIQDSLQ 271
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 75/324 (23%), Positives = 121/324 (37%), Gaps = 63/324 (19%)
Query: 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN--HGLQGHKQWLAEVQ 126
+ + IG G G V L+ VA+KKL+ K+ E+
Sbjct: 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAYRELV 76
Query: 127 FLGVVSHPNLVKLLG-YCSTEDERGIQRL-LVYEYMP-------NRSLEDRLFSRAQPTL 177
+ V+H N++ LL + + Q + +V E M L+ R L
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH---ERMSYLL 133
Query: 178 PWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGD 237
G+ +LH +I+RD K SN+++ + K+ DFGLAR T
Sbjct: 134 YQMLC---------GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAG 178
Query: 238 HTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR-------------RV 284
+ + T V T Y APE I K DIWS G ++ E++ G +V
Sbjct: 179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 238
Query: 285 LER-NRPTME------QKLLEWVKQFPA-DGKKFSMMIDPRLRNQYSINAARRVAKLADN 336
+E+ P E + +V+ P G F + P + + A A +
Sbjct: 239 IEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLF-PDVLFPADSEHNKLKASQARD 297
Query: 337 CLKK----NPEERPTMNQVVESLK 356
L K + +R + V E+L+
Sbjct: 298 LLSKMLVIDASKRIS---VDEALQ 318
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 76/291 (26%), Positives = 110/291 (37%), Gaps = 71/291 (24%)
Query: 76 RMLK-IGEGGFGSVY----KGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQ- 126
++ +G+G FG V K T + AVK L + + E +
Sbjct: 26 EFIRVLGKGSFGKVMLARVKETGD---------LYAVKVLKKDVILQDDDVECTMTEKRI 76
Query: 127 FLGVVSHPNLVKLLGYC-STEDERGIQRL-LVYEYMPNRSL-----EDRLFSRAQPTLPW 179
+HP L +L C T D RL V E++ L + R F A+
Sbjct: 77 LSLARNHPFLTQLF-CCFQTPD-----RLFFVMEFVNGGDLMFHIQKSRRFDEAR----- 125
Query: 180 KTRL---EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236
R EII L +LH+ +IYRD K NVLLD KL+DFG+ +EG
Sbjct: 126 -ARFYAAEIISA----LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177
Query: 237 DHTHVSTAVVGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGRR-VLERNRPTMEQ 294
T + GT Y APE + E + + D W+ GV+LYE+L G N + +
Sbjct: 178 GVT--TATFCGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENEDDLFE 234
Query: 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
+L +P +A + + KNP R
Sbjct: 235 AILNDEVVYPTW---------------LHEDATGILKSF----MTKNPTMR 266
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 78/300 (26%), Positives = 112/300 (37%), Gaps = 80/300 (26%)
Query: 76 RMLK-IGEGGFGSVY----KGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQ- 126
+L+ IG G + V K T R + A++ + + + E
Sbjct: 55 DLLRVIGRGSYAKVLLVRLKKTDR---------IYAMRVVKKELVNDDEDIDWVQTEKHV 105
Query: 127 FLGVVSHPNLVKLLGYC-STEDERGIQRL-LVYEYMPNRSL-----EDRLFSRAQPTLPW 179
F +HP LV L C TE RL V EY+ L R
Sbjct: 106 FEQASNHPFLVGLH-SCFQTES-----RLFFVIEYVNGGDLMFHMQRQRKLPEEH----- 154
Query: 180 KTRL---EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236
R EI L L YLHE +IYRD K NVLLD KL+D+G+ +EG
Sbjct: 155 -ARFYSAEISLA----LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206
Query: 237 DHTHVSTAVVGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGR----------RVL 285
T ++ GT Y APE + + S D W+ GV+++E++ GR
Sbjct: 207 GDT--TSTFCGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPD 263
Query: 286 ERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
+ + Q +LE + P S+ AA + L K+P+ER
Sbjct: 264 QNTEDYLFQVILEKQIRIPRS---------------LSVKAASVLKSF----LNKDPKER 304
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 4e-20
Identities = 52/285 (18%), Positives = 106/285 (37%), Gaps = 49/285 (17%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+G G FG V++ K + G E+ L + H N++
Sbjct: 12 DLGRGEFGIVHRCV-----ETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILH 65
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L E + ++++E++ + +R+ + L + + + E L +LH
Sbjct: 66 LHESF--ESMEEL--VMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS 120
Query: 199 GLEIQVIYRDFKTSNVLL--DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
+ + D + N++ + K+ +FG AR+ GD + Y APE
Sbjct: 121 ---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEV 174
Query: 257 IETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM---EQKLLEWVKQ----FPADGKK 309
+ + + +D+WS G ++Y +L+G P + Q+++E + F +
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGI------NPFLAETNQQIIENIMNAEYTFDEE--A 226
Query: 310 FSMMIDPRLRNQYSINAARRVAK-LADNCLKKNPEERPTMNQVVE 353
F I+ A D L K + R T ++ ++
Sbjct: 227 FK-----------EISIE---AMDFVDRLLVKERKSRMTASEALQ 257
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 60/287 (20%), Positives = 106/287 (36%), Gaps = 51/287 (17%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--HKQWLAEVQFLGVVSH-PN 135
++G G F V + + A K L + L E+ L + P
Sbjct: 36 ELGRGKFAVVRQCI-----SKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR 90
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAY 195
++ L E+ I +L+ EY + + + +I EG+ Y
Sbjct: 91 VINLHEVY--ENTSEI--ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 196 LHEGLEIQVIYRDFKTSNVLL---DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA 252
LH+ +++ D K N+LL K+ DFG++R+ ++GT Y
Sbjct: 147 LHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYL 200
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM---EQKLLEWVKQ----FPA 305
APE + + + +D+W+ G++ Y +LT P + Q+ + Q +
Sbjct: 201 APEILNYDPITTATDMWNIGIIAYMLLTHT------SPFVGEDNQETYLNISQVNVDYSE 254
Query: 306 DGKKFSMMIDPRLRNQYSINAARRVAK-LADNCLKKNPEERPTMNQV 351
+ FS S++ A + L KNPE+RPT
Sbjct: 255 E--TFS-----------SVSQL---ATDFIQSLLVKNPEKRPTAEIC 285
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 6e-20
Identities = 75/291 (25%), Positives = 106/291 (36%), Gaps = 71/291 (24%)
Query: 76 RMLK-IGEGGFGSV----YKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQ- 126
L +G+G FG V KGT + AVK L + + E +
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGTDE---------LYAVKILKKDVVIQDDDVECTMVEKRV 73
Query: 127 FLGVVSHPNLVKLLGYC-STEDERGIQRL-LVYEYMPNRSL-----EDRLFSRAQPTLPW 179
P L +L C T D RL V EY+ L + F
Sbjct: 74 LALPGKPPFLTQLH-SCFQTMD-----RLYFVMEYVNGGDLMYHIQQVGRFKEPH----- 122
Query: 180 KTRL---EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236
EI +G L +L +IYRD K NV+LD K++DFG+ +E
Sbjct: 123 -AVFYAAEIAIG----LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174
Query: 237 DHTHVSTAVVGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGRR-VLERNRPTMEQ 294
T + GT Y APE I + KS D W+FGV+LYE+L G+ + + Q
Sbjct: 175 GVT--TKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 231
Query: 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
++E +P S A L + K+P +R
Sbjct: 232 SIMEHNVAYPKS---------------MSKEAVAICKGL----MTKHPGKR 263
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-20
Identities = 61/219 (27%), Positives = 91/219 (41%), Gaps = 31/219 (14%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH-----------KQWLAEVQF 127
I G +G+V G +D G P VA+K++ N G K+ L E++
Sbjct: 29 FISSGSYGAVCAG----VDSEGIP--VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 128 LGVVSHPNLVKLLGYCSTEDERGIQRL-LVYEYMPNRSLEDRLFSRAQPTLPWKTRLEI- 185
L HPN++ L +E + +L LV E M L + + P + +
Sbjct: 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMY 141
Query: 186 -ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTA 244
IL GL LHE V++RD N+LL N + DF LARE + T
Sbjct: 142 HIL---LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTH 192
Query: 245 VVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGR 282
V Y APE + ++ D+WS G V+ E+ +
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 76/311 (24%), Positives = 125/311 (40%), Gaps = 59/311 (18%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN--HGLQGHKQWLAEVQFLGVVSHPNLV 137
IG G G V LD VA+KKL+ K+ E+ + V+H N++
Sbjct: 70 IGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 124
Query: 138 KLL----GYCSTEDERGIQRLLVYEYMP---NRSLEDRLFSRAQPTLPWKTRLEIILGAA 190
LL + E+ + + LV E M + ++ L L ++ +L
Sbjct: 125 SLLNVFTPQKTLEEFQDV--YLVMELMDANLCQVIQMELDHERMSYLLYQ-----ML--- 174
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
G+ +LH +I+RD K SN+++ + K+ DFGLAR T + + T V T
Sbjct: 175 CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRY 228
Query: 251 YAAPEYIETGHLKSQSDIWSFGVVLYEILTGR-------------RVLER-NRPTME--- 293
Y APE I K DIWS G ++ E++ + +V+E+ P E
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288
Query: 294 ---QKLLEWVKQFPA-DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKK----NPEER 345
+ +V+ P G F + P + A A + L K +P +R
Sbjct: 289 KLQPTVRNYVENRPKYAGLTFPKLF-PDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 347
Query: 346 PTMNQVVESLK 356
+ V ++L+
Sbjct: 348 IS---VDDALQ 355
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 70/291 (24%), Positives = 108/291 (37%), Gaps = 71/291 (24%)
Query: 76 RMLK-IGEGGFGSV----YKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQ- 126
+ K +G+G FG V +K T + A+K L + + E +
Sbjct: 20 ILHKMLGKGSFGKVFLAEFKKTNQ---------FFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 127 FLGVVSHPNLVKLLGYCS-TEDERGIQRL-LVYEYMPNRSL-----EDRLFSRAQPTLPW 179
HP L + T++ L V EY+ L F ++
Sbjct: 71 LSLAWEHPFLTHMF-CTFQTKE-----NLFFVMEYLNGGDLMYHIQSCHKFDLSR----- 119
Query: 180 KTRL---EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236
EIILG L +LH ++YRD K N+LLD + K++DFG+ +E G
Sbjct: 120 -ATFYAAEIILG----LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171
Query: 237 DHTHVSTAVVGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGRRVLE-RNRPTMEQ 294
D + GT Y APE + + S D WSFGV+LYE+L G+ ++ +
Sbjct: 172 DAK--TNTFCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228
Query: 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
+ +P A + KL + PE+R
Sbjct: 229 SIRMDNPFYPRW---------------LEKEAKDLLVKL----FVREPEKR 260
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH-KQWLAEVQFLGVVSHPNLVK 138
IGEG +G V R VA+KK++ Q + ++ L E++ L H N++
Sbjct: 35 IGEGAYGMVCSAYDNLNKVR-----VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIG 89
Query: 139 LLGYCSTEDERGIQRL-LVYEYMP---NRSLEDRLFSRAQPTLPWKTRLEI--ILGAAEG 192
+ ++ + +V + M + L + Q + IL G
Sbjct: 90 INDIIRAPTIEQMKDVYIVQDLMETDLYKLL------KTQHLSNDHICYFLYQIL---RG 140
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE-GPTGDHTHVSTAVVGTYGY 251
L Y+H V++RD K SN+LL+ K+ DFGLAR P DHT T V T Y
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 252 AAPEYIETGHLKSQS-DIWSFGVVLYEILTGR 282
APE + ++S DIWS G +L E+L+ R
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 76/291 (26%), Positives = 107/291 (36%), Gaps = 71/291 (24%)
Query: 76 RMLK-IGEGGFGSV----YKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQ- 126
L +G+G FG V KGT + AVK L + + E +
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDE---------LYAVKILKKDVVIQDDDVECTMVEKRV 394
Query: 127 FLGVVSHPNLVKLLGYCS-TEDERGIQRL-LVYEYMPNRSL-----EDRLFSRAQPTLPW 179
P L +L C T D RL V EY+ L + F
Sbjct: 395 LALPGKPPFLTQLH-SCFQTMD-----RLYFVMEYVNGGDLMYHIQQVGRFKEPH----- 443
Query: 180 KTRL---EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG 236
EI +G L +L +IYRD K NV+LD K++DFG+ +E
Sbjct: 444 -AVFYAAEIAIG----LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495
Query: 237 DHTHVSTAVVGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGRRVLE-RNRPTMEQ 294
T + GT Y APE I + KS D W+FGV+LYE+L G+ E + + Q
Sbjct: 496 GVT--TKTFCGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQ 552
Query: 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
++E +P S A L + K+P +R
Sbjct: 553 SIMEHNVAYPKS---------------MSKEAVAICKGL----MTKHPGKR 584
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 9e-19
Identities = 50/251 (19%), Positives = 93/251 (37%), Gaps = 72/251 (28%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+G G FG V + G+ A+KK+ + E+ + V+ H N++K
Sbjct: 14 TLGTGSFGIVCEVFDIE---SGKR--FALKKVLQDP----RYKNRELDIMKVLDHVNIIK 64
Query: 139 LLGYCSTEDERGIQRL----------------------------------LVYEYMPNRS 164
L+ Y T + + ++ EY+P
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP--- 121
Query: 165 LED-----RLFSRAQPTLPWKTRLEI------ILGAAEGLAYLHEGLEIQVIYRDFKTSN 213
+ + F R+ ++P I + + ++H + + +RD K N
Sbjct: 122 -DTLHKVLKSFIRSGRSIP---MNLISIYIYQLF---RAVGFIHS---LGICHRDIKPQN 171
Query: 214 VLLDGN-FKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQS-DIWSF 271
+L++ KL DFG A++ + S A + + Y APE + + S D+WS
Sbjct: 172 LLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSI 228
Query: 272 GVVLYEILTGR 282
G V E++ G+
Sbjct: 229 GCVFGELILGK 239
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 57/222 (25%), Positives = 95/222 (42%), Gaps = 35/222 (15%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+G GG G V+ D R VA+KK+ Q K L E++ + + H N+VK
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKR-----VAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 139 LLGYCSTEDERGIQRL----------LVYEYMP---NRSLEDRLFSRAQPTLPWKTRLEI 185
+ + + +V EYM L P L RL +
Sbjct: 73 VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL------EQGPLLEEHARLFM 126
Query: 186 --ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD-GNFKPKLSDFGLAR-EGPTGDHTHV 241
+L GL Y+H V++RD K +N+ ++ + K+ DFGLAR P H
Sbjct: 127 YQLL---RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 242 STAVVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGR 282
+ + T Y +P + + + +++ D+W+ G + E+LTG+
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 9e-18
Identities = 57/284 (20%), Positives = 97/284 (34%), Gaps = 61/284 (21%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLG-VVSHPNLV 137
+G G G V + + A+K L + + EV+ P++V
Sbjct: 25 VLGLGINGKVLQIFNKR-TQE----KFALKMLQDC-----PKARREVELHWRASQCPHIV 74
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
+++ L+V E + L R+ R + EI+ E + YLH
Sbjct: 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 198 EGLEIQVIYRDFKTSNVLL---DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT-YGYAA 253
I + +RD K N+L N KL+DFG A+E G Y +
Sbjct: 135 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------------TTGEKYDKSC 179
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEILTGRR-VLERNRPTMEQKLLEWVKQFPADGKKFSM 312
D+WS GV++Y +L G + + + ++ G+
Sbjct: 180 -------------DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQ---- 218
Query: 313 MIDPRLRNQY--SINAARRVAK-LADNCLKKNPEERPTMNQVVE 353
N ++ K L N LK P +R T+ + +
Sbjct: 219 ---YEFPNPEWSEVSEE---VKMLIRNLLKTEPTQRMTITEFMN 256
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 51/217 (23%), Positives = 87/217 (40%), Gaps = 38/217 (17%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFL-GVVSHPNLV 137
K+G G + V++ E V VK L K+ E++ L + PN++
Sbjct: 43 KLGRGKYSEVFEAINIT---NNEK--VVVKILKPVK---KKKIKREIKILENLRGGPNII 94
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEI------ILGAAE 191
L R LV+E+ + + F + TL T +I IL +
Sbjct: 95 TLADIVKDPVSR--TPALVFEH-----VNNTDFKQLYQTL---TDYDIRFYMYEIL---K 141
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDG-NFKPKLSDFGLAREG-PTGDHTHVSTAVVGTY 249
L Y H +++RD K NV++D + K +L D+GLA P ++ V +
Sbjct: 142 ALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR----VASR 194
Query: 250 GYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGRRVL 285
+ PE + + S D+WS G +L ++ +
Sbjct: 195 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 3e-17
Identities = 55/220 (25%), Positives = 85/220 (38%), Gaps = 33/220 (15%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH-KQWLAEVQFLGVVSHPNLV 137
+GEG +G V T +P VA+KK+ + L E++ L H N++
Sbjct: 18 LLGEGAYGVVCSATHKPTGEI-----VAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 138 KLLGYCSTEDERGIQRL-LVYEYMP---NRSLEDRLFSRAQPTLPWKTRLEI--ILGAAE 191
+ + + ++ E M +R + Q + I L
Sbjct: 73 TIFNIQRPDSFENFNEVYIIQELMQTDLHRVI------STQMLSDDHIQYFIYQTL---R 123
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR--------EGPTGDHTHVST 243
+ LH VI+RD K SN+L++ N K+ DFGLAR
Sbjct: 124 AVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 244 AVVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGR 282
V T Y APE + T S++ D+WS G +L E+ R
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 61/248 (24%), Positives = 101/248 (40%), Gaps = 39/248 (15%)
Query: 47 SIPELYKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVA 106
S+ + K+ + V E + +G G +GSV + + VA
Sbjct: 1 SLSLIRKKGFYKQDVNK--TAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEK-----VA 53
Query: 107 VKKLNN--HGLQGHKQWLAEVQFLGVVSHPNLVKLLG----YCSTEDERGIQRLLVYEYM 160
+KKL+ K+ E+ L + H N++ LL S + LV +M
Sbjct: 54 IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF--YLVMPFM 111
Query: 161 P---NRSLEDRLFSRAQPTLPWKTRLEI--ILGAAEGLAYLHEGLEIQVIYRDFKTSNVL 215
+ + K + + +L +GL Y+H V++RD K N+
Sbjct: 112 QTDLQKIMG-------LKFSEEKIQYLVYQML---KGLKYIHSA---GVVHRDLKPGNLA 158
Query: 216 LDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQS-DIWSFGVV 274
++ + + K+ DFGLAR T V T Y APE I + +Q+ DIWS G +
Sbjct: 159 VNEDCELKILDFGLARH-----ADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCI 213
Query: 275 LYEILTGR 282
+ E+LTG+
Sbjct: 214 MAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 55/224 (24%), Positives = 97/224 (43%), Gaps = 32/224 (14%)
Query: 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN--HGLQGHKQWLAEVQ 126
E + + +G G +G+V + VA+KKL K+ E++
Sbjct: 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAK-----VAIKKLYRPFQSELFAKRAYRELR 76
Query: 127 FLGVVSHPNLVKLLG-YCSTEDERGIQRL-LVYEYMP---NRSLEDRLFSRAQPTLPWKT 181
L + H N++ LL + E LV +M + + + + +
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM------KHEKLGEDRI 130
Query: 182 RLEI--ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHT 239
+ + +L +GL Y+H +I+RD K N+ ++ + + K+ DFGLAR+ +
Sbjct: 131 QFLVYQML---KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--- 181
Query: 240 HVSTAVVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGR 282
T V T Y APE I +Q+ DIWS G ++ E++TG+
Sbjct: 182 --MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 64/215 (29%), Positives = 94/215 (43%), Gaps = 36/215 (16%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN--HGLQGHKQWLAEVQFLGVVSHPNLV 137
+G G +GSV R VAVKKL+ + K+ E++ L + H N++
Sbjct: 37 VGSGAYGSVCAAFDTKTGLR-----VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI 91
Query: 138 KLLG----YCSTEDERGIQRLLVYEYMP---NRSLEDRLFSRAQPTLPWKTRLEI--ILG 188
LL S E+ + LV M N + + Q + I IL
Sbjct: 92 GLLDVFTPARSLEEFNDV--YLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQIL- 142
Query: 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT 248
GL Y+H +I+RD K SN+ ++ + + K+ DFGLAR T V T
Sbjct: 143 --RGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH-----TADEMTGYVAT 192
Query: 249 YGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGR 282
Y APE + +Q+ DIWS G ++ E+LTGR
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 9e-16
Identities = 57/296 (19%), Positives = 101/296 (34%), Gaps = 58/296 (19%)
Query: 23 PRNQNRLDNNSALNRTARSLPSPRSIPELYKEKEHHLRVFDMQELREATNGFNRMLKIGE 82
+NS T + + + + + + + IG
Sbjct: 4 HEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGT 63
Query: 83 GGFGSVYKGTIRPLDGRGEPLVVAVKKLNN--HGLQGHKQWLAEVQFLGVVSHPNLVKLL 140
G +G V + + VVA+KK+ L K+ L E+ L ++H ++VK+L
Sbjct: 64 GSYGHVCEAYDKL---EKR--VVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 141 GYCSTEDERGIQRL-LVYEYMP---------NRSLEDRLFSRAQPTLPWKTRLEIILGAA 190
+D L +V E L + KT L +L
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHI---------KTLLYNLL--- 166
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
G+ Y+H +++RD K +N L++ + K+ DFGLAR ++ + +
Sbjct: 167 VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 251 -------------------------YAAPEYIETGHLKSQS-DIWSFGVVLYEILT 280
Y APE I +++ D+WS G + E+L
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 58/241 (24%), Positives = 91/241 (37%), Gaps = 43/241 (17%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN--HGLQGHKQWLAEVQFLGVVSHPNL 136
IG G +G VY + + VA+KK+N L K+ L E+ L + +
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKN-----VAIKKVNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 137 VKLLGYCSTEDERGIQRL-LVYEYMPNRSLED--RLFSRAQPTLPWKTRLEI--ILGAAE 191
++L +D L +V E D +LF + + +L
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIAD----SDLKKLFKTPIFLTEEHIKTILYNLL---L 140
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR-------------------- 231
G ++HE +I+RD K +N LL+ + K+ DFGLAR
Sbjct: 141 GENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGRRVLERNRP 290
+ T+ V T Y APE I ++S DIWS G + E+L + +
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
Query: 291 T 291
Sbjct: 258 N 258
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 66/237 (27%), Positives = 105/237 (44%), Gaps = 57/237 (24%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNN---HGLQGHKQWLAEVQFLG-VVSHP 134
K+G+G +G V+K R GE VVAVKK+ + + ++ E+ L + H
Sbjct: 16 KLGKGAYGIVWKSIDRR---TGE--VVAVKKIFDAFQNSTDA-QRTFREIMILTELSGHE 69
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMP---NRSLEDRLFSRAQPTLPWKTRLEI--ILGA 189
N+V LL +++R + LV++YM + + RA P + + ++
Sbjct: 70 NIVNLLNVLRADNDRDV--YLVFDYMETDLHAVI------RANILEPVHKQYVVYQLI-- 119
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR------------------ 231
+ + YLH G +++RD K SN+LL+ K++DFGL+R
Sbjct: 120 -KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 232 -EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQS-----DIWSFGVVLYEILTGR 282
D + T V T Y APE + L S D+WS G +L EIL G+
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEIL----LGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 49/231 (21%), Positives = 83/231 (35%), Gaps = 41/231 (17%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
IG+GGFG +Y + + G VK + E++F + P ++
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEP----SDNGPLFTELKFYQRAAKPEQIQ 97
Query: 139 LLGYCSTEDERGI---------------QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRL 183
G+ R ++ + L+ ++ KT L
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAKRFSRKTVL 155
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPK---LSDFGLARE-GPTGDHT 239
++ L + L Y+H E + ++ D K SN+LL P L D+GLA P G H
Sbjct: 156 QLSLRILDILEYIH---EHEYVHGDIKASNLLL-NYKNPDQVYLVDYGLAYRYCPEGVHK 211
Query: 240 HVS----TAVVGTYGYAAPEYIETGHL-KSQS---DIWSFGVVLYEILTGR 282
+ GT + + I+ H + S D+ G + + LTG
Sbjct: 212 AYAADPKRCHDGTIEFTS---IDA-HNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 49/222 (22%), Positives = 90/222 (40%), Gaps = 33/222 (14%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS------ 132
K+G G F +V+ D V A+K + + E++ L V+
Sbjct: 26 KLGWGHFSTVWLA----KDMVNNTHV-AMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTK 79
Query: 133 -----HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIIL 187
+++KLL + + + G+ ++V+E + +L + +P +I
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISK 138
Query: 188 GAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP------KLSDFGLAREGPTGDHTHV 241
GL Y+H +I+ D K NVL++ P K++D G A H
Sbjct: 139 QLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHY 192
Query: 242 STAVVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGR 282
+ ++ T Y +PE + G DIWS +++E++TG
Sbjct: 193 TNSIQ-TREYRSPEVL-LGAPWGCGADIWSTACLIFELITGD 232
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 61/217 (28%), Positives = 83/217 (38%), Gaps = 33/217 (15%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH-PNLV 137
KIG G FG +Y GT G VA+K H Q E + ++ +
Sbjct: 16 KIGSGSFGDIYLGT-DIAAGE----EVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
+ + D ++V E + SLED LF+ KT L + + Y+H
Sbjct: 69 TIRWCGAEGD----YNVMVMELL-GPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPK---LSDFGLA---REGPTGDHTHVSTA--VVGTY 249
I+RD K N L+ K + DFGLA R+ T H + GT
Sbjct: 123 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 250 GYAAPEYIETGHL-KSQS---DIWSFGVVLYEILTGR 282
YA+ I T HL QS D+ S G VL G
Sbjct: 180 RYAS---INT-HLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 38/229 (16%), Positives = 77/229 (33%), Gaps = 37/229 (16%)
Query: 79 KIGEGGFGSVYKGT---IRPLDGRGEPLVVAVKKLNNHG-----------LQGHKQWLAE 124
G +Y+ D + ++K G Q
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 125 VQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLE 184
+ L + +G+ +D+ R LV + RSL+ L + L ++ L+
Sbjct: 109 KK-LYSTPLLAIPTCMGFGVHQDK---YRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQ 163
Query: 185 IILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPK--LSDFGLARE-GPTGDHTH- 240
+ + L +LH E + ++ + N+ +D + + L+ +G A P+G H
Sbjct: 164 VACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220
Query: 241 ---VSTAVVGTYGYAAPEYIETGHL-KSQS---DIWSFGVVLYEILTGR 282
+ G + + ++ H S D+ S G + + L G
Sbjct: 221 VEGSRSPHEGDLEFIS---MDL-HKGCGPSRRSDLQSLGYCMLKWLYGF 265
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 50/247 (20%), Positives = 90/247 (36%), Gaps = 46/247 (18%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLV- 137
KIG GGFG +Y + E V K+ + +E++F V+ + +
Sbjct: 44 KIGSGGFGLIYLAF---PTNKPEKDARHVVKVEYQ---ENGPLFSELKFYQRVAKKDCIK 97
Query: 138 --------------KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRL 183
G TE + R +V E + L+ + T T L
Sbjct: 98 KWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-IS-GQNGTFKKSTVL 154
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPK--LSDFGLARE-GPTGDHTH 240
++ + + L Y+H E + ++ D K +N+LL + L+D+GL+ P G+H
Sbjct: 155 QLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 241 VS----TAVVGTYGYAAPEYIETGHL-KSQS---DIWSFGVVLYEILTGR----RVLERN 288
GT + + ++ H + S D+ G + L G+ + L+
Sbjct: 212 YQENPRKGHNGTIEFTS---LDA-HKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267
Query: 289 RPTMEQK 295
K
Sbjct: 268 VAVQTAK 274
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 51/219 (23%), Positives = 81/219 (36%), Gaps = 35/219 (15%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH-PNLV 137
+IGEG FG +++GT L+ + VA+K Q E + +++ +
Sbjct: 17 RIGEGSFGVIFEGT-NLLNNQ----QVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
+ + +LV + + SLED L KT + +H
Sbjct: 70 NVYYFGQEGL----HNVLVIDLLG-PSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPK-----LSDFGLA---REGPTGDHTHVST--AVVG 247
E ++YRD K N L+ + DFG+ R+ T H + G
Sbjct: 124 ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 248 TYGYAAPEYIETGHL-KSQS---DIWSFGVVLYEILTGR 282
T Y + I T HL + QS D+ + G V L G
Sbjct: 181 TARYMS---INT-HLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 2e-10
Identities = 42/269 (15%), Positives = 64/269 (23%), Gaps = 66/269 (24%)
Query: 57 HHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ 116
T R KIGEG FG V++ D VA+K + G
Sbjct: 6 SQKGPVPFSHCL-PTEKLQRCEKIGEGVFGEVFQTI---ADHTP----VAIKIIAIEGPD 57
Query: 117 GHK-----------------QWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEY 159
+ L+ + + L + L +++
Sbjct: 58 LVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDH 117
Query: 160 M----------PNRSLEDRLF-------------SRAQPTLPWKTRLEIILGAAEGLAYL 196
P+ +D+LF T I+ LA
Sbjct: 118 YNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVA 177
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA---- 252
L +RD NVLL KL + + Y +
Sbjct: 178 EASLRF--EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGL--QVSIIDYTLSRLER 233
Query: 253 ----------APEYIETGHLKSQSDIWSF 271
E + TG Q DI+
Sbjct: 234 DGIVVFCDVSMDEDLFTGDGDYQFDIYRL 262
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 61/222 (27%), Positives = 84/222 (37%), Gaps = 41/222 (18%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVK--KLNNHGLQGHKQWLAEVQFLGVVSHPNL 136
KIG G FG + G VA+K + + Q H ++ Q P +
Sbjct: 16 KIGCGNFGELRLGK-NLYTNE----YVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
Y + +V E + SLED LF T KT L I + + Y+
Sbjct: 71 Y----YFGPCGK---YNAMVLELL-GPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYV 121
Query: 197 HEGLEIQVIYRDFKTSNVLL--DGNFKPK---LSDFGLA---REGPTGDH----THVSTA 244
H +IYRD K N L+ GN + + DF LA + T H H S
Sbjct: 122 H---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKS-- 176
Query: 245 VVGTYGYAAPEYIETGHL-KSQS---DIWSFGVVLYEILTGR 282
+ GT Y + I T HL K QS D+ + G + L G
Sbjct: 177 LTGTARYMS---INT-HLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 5e-10
Identities = 46/281 (16%), Positives = 83/281 (29%), Gaps = 91/281 (32%)
Query: 155 LVYEYM-PN-RSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTS 212
+V+E + + + + LP +II +GL YLH + ++I+ D K
Sbjct: 122 MVFEVLGHHLLKWIIKSNYQG---LPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPE 176
Query: 213 NVLL-------------------------------------------------DGNFKPK 223
N+LL K K
Sbjct: 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK 236
Query: 224 LSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRR 283
++D G A T + T Y + E + + +DIWS + +E+ TG
Sbjct: 237 IADLGNAC---WVHKHF--TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDY 291
Query: 284 VLERNRPT-----------MEQKL----LEWVKQ-------FPADG--KKFSMMIDPRLR 319
+ E + + + L + + F G K + + L
Sbjct: 292 LFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLF 351
Query: 320 N----QYSINA--ARRVAKLADNCLKKNPEERPTMNQVVES 354
+Y + A L+ PE+R T + +
Sbjct: 352 EVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 55/245 (22%), Positives = 93/245 (37%), Gaps = 40/245 (16%)
Query: 52 YKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN 111
Y + + V + ++ + + IG+G FG V K R E VA+K +
Sbjct: 37 YDDDNYDYIVKNGEKW---MDRYEIDSLIGKGSFGQVVKAYDR---VEQE--WVAIKIIK 88
Query: 112 NHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRL-----------LVYEYM 160
N Q EV+ L +L+ TE + I L LV+E +
Sbjct: 89 NK-KAFLNQAQIEVRLL---------ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML 138
Query: 161 PNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF 220
+ +L D L + + + L +L E+ +I+ D K N+LL
Sbjct: 139 -SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPK 196
Query: 221 KP--KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYE 277
+ K+ DFG + + + + Y +PE + G + D+WS G +L E
Sbjct: 197 RSAIKIVDFGSS----CQLGQRIYQYIQSRF-YRSPEVL-LGMPYDLAIDMWSLGCILVE 250
Query: 278 ILTGR 282
+ TG
Sbjct: 251 MHTGE 255
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 59/216 (27%), Positives = 87/216 (40%), Gaps = 31/216 (14%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
KIG G FG +Y GT VA+K + H Q L E + ++ +
Sbjct: 14 KIGSGSFGEIYLGT-NIQTNE----EVAIKL--ENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
+ + E + +LV + + SLED LF+ L KT L + + ++H
Sbjct: 67 NVRWFGVEGD---YNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVH- 120
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPK---LSDFGLA---REGPTGDHTHVSTA--VVGTYG 250
++RD K N L+ + + DFGLA R+ T H + GT
Sbjct: 121 --SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 251 YAAPEYIETGHL-KSQS---DIWSFGVVLYEILTGR 282
YA+ + T HL QS D+ S G VL L G
Sbjct: 179 YAS---VNT-HLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 43/219 (19%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKL 139
IG+G FG V K + VA+K + N + H+Q E++ L +
Sbjct: 105 IGKGSFGQVVKAYDH---KVHQ--HVALKMVRNE-KRFHRQAAEEIRIL---------EH 149
Query: 140 LGYCSTEDERGIQRL-----------LVYEYMPNRSLEDRLFSRAQPTLPWKTRL--EII 186
L ++ + + + +E + + +L + + + L +
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYE--LIKKNKFQGFSLPLVRKFA 206
Query: 187 LGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP--KLSDFGLAREGPTGDHTHVSTA 244
+ L LH+ ++I+ D K N+LL + K+ DFG + +H V T
Sbjct: 207 HSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTY 259
Query: 245 VVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGR 282
+ + Y APE I G D+WS G +L E+LTG
Sbjct: 260 IQSRF-YRAPEVI-LGARYGMPIDMWSLGCILAELLTGY 296
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 67/332 (20%), Positives = 115/332 (34%), Gaps = 87/332 (26%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+GEG FG V + +D + VAVK + N + + +E+Q L +
Sbjct: 21 TLGEGAFGKVVEC----IDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVL---------E 66
Query: 139 LLGYCSTEDERGIQRL-----------LVYEYMPNRSLEDRLFSRAQPTLPWKTRL--EI 185
L ++ +V+E + S D F + LP++ ++
Sbjct: 67 HLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYD--FIKENGFLPFRLDHIRKM 123
Query: 186 ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP-------------------KLSD 226
+ + +LH ++ + D K N+L + K+ D
Sbjct: 124 AYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTG---- 281
FG A T D H ST +V T Y APE I SQ D+WS G +L E G
Sbjct: 181 FGSA----TYDDEHHST-LVSTRHYRAPEVI-LALGWSQPCDVWSIGCILIEYYLGFTVF 234
Query: 282 --------------------RRVLERNRPTM--EQKLLEWVKQFPADGKKFSMMIDPRLR 319
+ ++++ R L+W + + G+ S P
Sbjct: 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEH-SSAGRYVSRACKPLKE 293
Query: 320 NQYSINAARR-VAKLADNCLKKNPEERPTMNQ 350
S + + L L+ +P +R T+ +
Sbjct: 294 FMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 52/236 (22%), Positives = 85/236 (36%), Gaps = 59/236 (25%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+GEG FG V + LD VA+K + N G + E+ L K
Sbjct: 26 NLGEGTFGKVVEC----LDHARGKSQVALKIIRNVGKY-REAARLEINVL---------K 71
Query: 139 LLGYCSTEDERGIQRL-----------LVYEYMPNRSLEDRLFSRAQPTLPWKTRL--EI 185
+ E++ + + +E + ++ + F + P+ +
Sbjct: 72 KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFE--FLKENNFQPYPLPHVRHM 128
Query: 186 ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP-------------------KLSD 226
L +LHE Q+ + D K N+L + +++D
Sbjct: 129 AYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTG 281
FG A T DH H +T +V T Y PE I +Q D+WS G +L+E G
Sbjct: 186 FGSA----TFDHEHHTT-IVATRHYRPPEVI-LELGWAQPCDVWSIGCILFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 59/251 (23%), Positives = 87/251 (34%), Gaps = 85/251 (33%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH----- 133
K+G+G FG V + AVK + N + + E L + +
Sbjct: 42 KMGDGTFGRVLLCQHI---DNKK--YYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINN 95
Query: 134 PNLVKLLGY-------C-STEDERGIQRLL---VYEYMPNR-----SLED-RLFSRAQPT 176
N+VK G C E L +YE + +ED +L+ +
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFE-------PLGPSLYEIITRNNYNGFHIEDIKLYCI-E-- 145
Query: 177 LPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP-------------- 222
IL + L YL + + + + D K N+LLD +
Sbjct: 146 ---------IL---KALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190
Query: 223 -----------KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQS-DIWS 270
KL DFG A T + + ++ T Y APE I S D+WS
Sbjct: 191 IQIYRTKSTGIKLIDFGCA----TFKSDYHGS-IINTRQYRAPEVI-LNLGWDVSSDMWS 244
Query: 271 FGVVLYEILTG 281
FG VL E+ TG
Sbjct: 245 FGCVLAELYTG 255
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 393 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.14 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.12 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.78 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.56 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.51 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.49 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.41 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.31 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.27 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.91 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.85 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.66 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.65 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.63 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.41 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.24 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.19 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.14 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.13 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.91 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.9 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.21 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.2 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.2 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.2 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.15 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.83 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.38 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-60 Score=432.74 Aligned_cols=266 Identities=27% Similarity=0.425 Sum_probs=218.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|.+.+.||+|+||+||+|.+.......++..||||++........+.+.+|+++|++++|||||+++++|.+.+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~---- 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD---- 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC----
Confidence 4688899999999999999998765556677899999998776666778999999999999999999999998876
Q ss_pred eEEEEEeecCCCChHHHHhhc-----------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC
Q 035862 152 QRLLVYEYMPNRSLEDRLFSR-----------AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF 220 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~ 220 (393)
.+++|||||++|+|.++|... ....+++..++.++.|++.||+|||++ +|+||||||+|||+++++
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCC
Confidence 459999999999999999643 235699999999999999999999998 999999999999999999
Q ss_pred ceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHH
Q 035862 221 KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEW 299 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~ 299 (393)
.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||....... +...
T Consensus 166 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~ 242 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIEC 242 (299)
T ss_dssp CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHH
T ss_pred cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence 999999999986544433334445679999999999999999999999999999999999 899998654332 1111
Q ss_pred HhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
.... .+...+..+++++.+|+.+||+.||++|||+.++.+.|+.+.+.
T Consensus 243 i~~~--------------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 243 ITQG--------------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcC--------------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1110 01112334668899999999999999999999999999887654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-59 Score=433.42 Aligned_cols=266 Identities=26% Similarity=0.448 Sum_probs=212.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|.+.++||+|+||+||+|.++......++..||||++........+.|.+|+++|+.++|||||+++++|.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~---- 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR---- 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----
Confidence 3577888999999999999998765555677899999998776666788999999999999999999999998776
Q ss_pred eEEEEEeecCCCChHHHHhhcC-------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRA-------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG 218 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~ 218 (393)
.+++|||||++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||||++
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECC
Confidence 4599999999999999996532 24689999999999999999999998 9999999999999999
Q ss_pred CCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHH
Q 035862 219 NFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLL 297 (393)
Q Consensus 219 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~ 297 (393)
++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |+.||........ .
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~ 270 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---I 270 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---H
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---H
Confidence 99999999999987655444444556789999999999999999999999999999999999 8999986544321 1
Q ss_pred HHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 298 EWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
..... + .+...+..+++++.+|+.+||+.||++|||+.+|+++|+.+.+.
T Consensus 271 ~~i~~----g----------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 DCITQ----G----------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHH----T----------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHc----C----------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11111 0 01122334568899999999999999999999999999998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-60 Score=436.01 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=208.8
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|++++.||+|+||+||+|++..++ ..||+|++..... .....+.+|+.+|+.++|||||++++++.+.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-- 96 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDG-----RQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG-- 96 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTC-----CEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT--
T ss_pred cceEEeEEEecCCCeEEEEEEECCCC-----CEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC--
Confidence 57999999999999999999976544 4699999976532 33567889999999999999999999998776
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
.+|+|||||+||+|.++|.......+++..++.++.||+.||+|||++ ||+||||||+||||+.+|.+||+|||+
T Consensus 97 --~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 97 --SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp --EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred --EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEccccc
Confidence 569999999999999999776667789999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
|+..... .......+||+.|||||++.+..|+.++|||||||++|||+||+.||...+.... +....... .
T Consensus 172 a~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~--~~~i~~~~-~---- 242 (350)
T 4b9d_A 172 ARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL--VLKIISGS-F---- 242 (350)
T ss_dssp ESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHTC-C----
T ss_pred ceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--HHHHHcCC-C----
Confidence 9865321 1233457899999999999999999999999999999999999999986543221 11111110 0
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
...+..++.++.+||.+||++||++|||+.++++|.|..
T Consensus 243 ----------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 281 (350)
T 4b9d_A 243 ----------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA 281 (350)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred ----------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhh
Confidence 011223568899999999999999999999999998764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=433.86 Aligned_cols=256 Identities=26% Similarity=0.367 Sum_probs=214.6
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
..|+++++||+|+||+||+|+++.++ ..||+|++........+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~---- 144 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSG-----KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD---- 144 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCC-----CEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----
Confidence 56999999999999999999976544 469999997665555667889999999999999999999998877
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.+|+|||||+||+|.+++.. ..+++..++.++.||+.||+|||++ ||+||||||+||||+.+|.+||+|||+|+
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCce
Confidence 56999999999999999854 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (393)
....... .....+||+.|||||++.+..|+.++|||||||++|||++|++||.......... ......+..
T Consensus 219 ~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~--~i~~~~~~~----- 289 (346)
T 4fih_A 219 QVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK--MIRDNLPPR----- 289 (346)
T ss_dssp ECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHHSSCCC-----
T ss_pred ecCCCCC--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH--HHHcCCCCC-----
Confidence 7543322 3456799999999999999999999999999999999999999998654432211 111111110
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
......+++++.+||.+||++||++|||+.|+++|.|...
T Consensus 290 --------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 290 --------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329 (346)
T ss_dssp --------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred --------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcC
Confidence 0111235688999999999999999999999999998753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-59 Score=425.26 Aligned_cols=263 Identities=26% Similarity=0.403 Sum_probs=212.6
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++++.++||+|+||+||+|.+........+..||||++.... ....+.|.+|+.++++++|||||+++|+|...+.
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~-- 103 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP-- 103 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE--
Confidence 3467788999999999999998655555567889999997543 2345779999999999999999999999987764
Q ss_pred ceEEEEEeecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRA--------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL 216 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll 216 (393)
+++|||||++|+|.++|.... ...+++..++.++.||+.||+|||++ +||||||||+||||
T Consensus 104 --~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl 178 (308)
T 4gt4_A 104 --LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 178 (308)
T ss_dssp --CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred --EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence 499999999999999996432 24589999999999999999999999 99999999999999
Q ss_pred CCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhH
Q 035862 217 DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQK 295 (393)
Q Consensus 217 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~ 295 (393)
++++.+||+|||+++.....+........+||+.|||||++.+..|+.++|||||||++|||+| |..||.......
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--- 255 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--- 255 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999986544433334456789999999999999999999999999999999998 899998664322
Q ss_pred HHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
+....... .+.+.+..++.++.+|+.+||+.||++|||+.+|+++|+..
T Consensus 256 ~~~~i~~~--------------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 256 VVEMIRNR--------------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHcC--------------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 22222110 11122335678899999999999999999999999998753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-58 Score=426.26 Aligned_cols=259 Identities=23% Similarity=0.251 Sum_probs=210.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
+.|.+.++||+|+||+||+|+++.++ ..||+|++..... ..+|+.+++.++|||||++++++.+.+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g-----~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~---- 123 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTG-----FQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGP---- 123 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETT----
T ss_pred hheEeCcEeccCCCeEEEEEEECCCC-----CEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECC----
Confidence 46888899999999999999976544 4699999976432 246999999999999999999998776
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC-ceEEeeccCC
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF-KPKLSDFGLA 230 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a 230 (393)
.+|+|||||+||+|.++|... ..+++..++.++.||+.||+|||++ +|+||||||+||||+.+| .+||+|||+|
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla 198 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHA 198 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTC
T ss_pred EEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCC
Confidence 569999999999999999543 4699999999999999999999999 999999999999999998 5999999999
Q ss_pred ccCCCCCCcc---ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 231 REGPTGDHTH---VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 231 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
+......... .....+||+.|||||++.+..|+.++|||||||++|||+||++||.......... ...... .
T Consensus 199 ~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~i~~~~-~-- 273 (336)
T 4g3f_A 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL--KIASEP-P-- 273 (336)
T ss_dssp EEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH--HHHHSC-C--
T ss_pred eEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH--HHHcCC-C--
Confidence 8764332211 2234689999999999999999999999999999999999999997654332111 111110 0
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcC
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 364 (393)
.....+..+++++.+||.+||++||.+|||+.|+++++..+++....
T Consensus 274 ----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 274 ----------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp ----------GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred ----------CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 01122335678899999999999999999999999999998876544
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-59 Score=426.34 Aligned_cols=253 Identities=19% Similarity=0.275 Sum_probs=210.1
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++++.||+|+||+||+|+++.++ ..||+|++.+.. ......+.+|+++|+.++|||||++++++.+++
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~-----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~- 105 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATS-----REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE- 105 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred cccEEEEEEecccCeEEEEEEECCCC-----CEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-
Confidence 45999999999999999999976544 469999997532 234567889999999999999999999998876
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
.+|+|||||+||+|.+++.. .+.+++..++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||
T Consensus 106 ---~~yivmEy~~gG~L~~~i~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFG 177 (311)
T 4aw0_A 106 ---KLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 177 (311)
T ss_dssp ---EEEEEECCCTTEEHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred ---EEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcC
Confidence 66999999999999999954 35699999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+|+..............+||+.|||||++.+..|+.++|||||||++|+|++|+.||...+.... +...... ..
T Consensus 178 la~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--~~~i~~~-~~--- 251 (311)
T 4aw0_A 178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI--FAKIIKL-EY--- 251 (311)
T ss_dssp TCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHT-CC---
T ss_pred CceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHcC-CC---
Confidence 99876544444445677999999999999999999999999999999999999999976543221 1111111 00
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.++..+++++.+||.+||++||++|||++|++.+.|
T Consensus 252 ------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~ 287 (311)
T 4aw0_A 252 ------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 287 (311)
T ss_dssp ------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHH
T ss_pred ------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHH
Confidence 112234678999999999999999999998654433
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-59 Score=439.07 Aligned_cols=256 Identities=26% Similarity=0.367 Sum_probs=215.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
+.|+++++||+|+||.||+|+++.++ ..||||++..........+.+|+.+|+.++|||||+++++|...+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~---- 221 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSG-----KLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD---- 221 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCC-----CEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC----
Confidence 56999999999999999999976544 469999998766666677899999999999999999999998877
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.+|+|||||+||+|.+++.. ..+++..++.++.||+.||+|||++ ||+||||||+||||+.+|.+||+|||+|+
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccce
Confidence 56999999999999999853 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (393)
....... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.......... ......+..
T Consensus 296 ~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~--~i~~~~~~~----- 366 (423)
T 4fie_A 296 QVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK--MIRDNLPPR----- 366 (423)
T ss_dssp ECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHHHSCCCC-----
T ss_pred ECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH--HHHcCCCCC-----
Confidence 7543322 3456799999999999999999999999999999999999999998654432211 111111110
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
......++.++.+||.+||++||++|||+.|+++|.|...
T Consensus 367 --------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~ 406 (423)
T 4fie_A 367 --------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 406 (423)
T ss_dssp --------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred --------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcC
Confidence 0111235688999999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-58 Score=416.49 Aligned_cols=260 Identities=28% Similarity=0.440 Sum_probs=203.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
+++.+.++||+|+||+||+|++.. .||||+++... ....+.+.+|+.++++++|||||++++++..+
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~--- 104 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD--- 104 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS---
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC---
Confidence 568889999999999999998531 28999986432 33456789999999999999999999988543
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
.+++|||||++|+|.++|.... ..+++..+..++.|++.||+|||++ +||||||||+|||+++++.+||+|||+
T Consensus 105 --~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGl 178 (307)
T 3omv_A 105 --NLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGL 178 (307)
T ss_dssp --SCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred --eEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccC
Confidence 3489999999999999996443 4699999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIET---GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
|+..............+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.......... ........
T Consensus 179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~--~~~~~~~~- 255 (307)
T 3omv_A 179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII--FMVGRGYA- 255 (307)
T ss_dssp CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHHTTCC-
T ss_pred ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH--HHHhcCCC-
Confidence 987654433334456789999999999964 458999999999999999999999998654432211 11111000
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
.+. ....+..++.++.+|+.+||+.||++|||+.+++++|+.+..
T Consensus 256 --------~p~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 256 --------SPD-LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp --------CCC-STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred --------CCC-cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 000 111223466889999999999999999999999999988754
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-59 Score=431.21 Aligned_cols=278 Identities=26% Similarity=0.367 Sum_probs=227.6
Q ss_pred cHHHHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCC-Cccceee
Q 035862 63 DMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSH-PNLVKLL 140 (393)
Q Consensus 63 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~~~ 140 (393)
+..+++...++|++.+.||+|+||+||+|.+...+.....+.||+|.+..... ...+.+.+|+.+|.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 33444444678999999999999999999998777777788999999976543 334668899999999975 9999999
Q ss_pred eeeecCCcccceEEEEEeecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 035862 141 GYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRA--------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIY 206 (393)
Q Consensus 141 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH 206 (393)
++|...+. .+++|||||++|+|.++|.... ...+++..++.++.||+.||+|||++ +|||
T Consensus 135 g~~~~~~~---~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiH 208 (353)
T 4ase_A 135 GACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH 208 (353)
T ss_dssp EEECCTTS---CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred EEEEecCC---EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---Ceec
Confidence 99876543 3589999999999999996432 24589999999999999999999999 9999
Q ss_pred ccCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCcc
Q 035862 207 RDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVL 285 (393)
Q Consensus 207 ~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf 285 (393)
|||||+|||+++++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||+| |..||
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987655444444556789999999999999999999999999999999998 99999
Q ss_pred CCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 286 ERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
........ +...... ..+...+..+++++.+|+.+||+.||++|||+.+++++|..+++.+
T Consensus 289 ~~~~~~~~--~~~~i~~--------------g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 289 PGVKIDEE--FCRRLKE--------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp TTCCCSHH--HHHHHHH--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCHHHH--HHHHHHc--------------CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 86543221 1111111 1111223345688999999999999999999999999999988754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-58 Score=410.77 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=195.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|++.+.||+|+||+||+|.+..+ +..||+|++.+.. ......+.+|+.+++.++|||||++++++.+++
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTT-----GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTT-----CCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCC-----CCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 46899999999999999999996543 4569999997643 233567889999999999999999999998876
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
.+|+||||+ +|+|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+||
T Consensus 87 ----~~~ivmEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DF 156 (275)
T 3hyh_A 87 ----EIIMVIEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADF 156 (275)
T ss_dssp ----EEEEEEECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCS
T ss_pred ----EEEEEEeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeec
Confidence 569999999 6799999854 45699999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHL-KSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
|+|+...... .....+||+.|+|||++.+..| +.++|||||||++|+|+||+.||...+... .+....... .
T Consensus 157 Gla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~--~~~~i~~~~-~- 229 (275)
T 3hyh_A 157 GLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV--LFKNISNGV-Y- 229 (275)
T ss_dssp SCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHTC-C-
T ss_pred CCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHcCC-C-
Confidence 9998654322 2345789999999999998876 579999999999999999999997654321 111111111 0
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
..+..+++++.+||.+||++||++|||+.|+++|.|.-
T Consensus 230 --------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k 267 (275)
T 3hyh_A 230 --------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFK 267 (275)
T ss_dssp --------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHH
T ss_pred --------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccc
Confidence 11123467899999999999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-58 Score=416.46 Aligned_cols=254 Identities=23% Similarity=0.368 Sum_probs=202.5
Q ss_pred cccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccce
Q 035862 75 NRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQ 152 (393)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 152 (393)
++..+||+|+||+||+|.+..++ ..||+|++.... ......+.+|+.+|+.++|||||++++++.........
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETT-----VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCC-----eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 56678999999999999976544 469999986542 23456688999999999999999999998764333336
Q ss_pred EEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCCeEeCC-CCceEEeeccC
Q 035862 153 RLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQ--VIYRDFKTSNVLLDG-NFKPKLSDFGL 229 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~--ivH~Dikp~NIll~~-~~~~kl~Dfg~ 229 (393)
+|+|||||+||+|.+++.. ...+++..++.++.||+.||+|||++ + |+||||||+|||++. +|.+||+|||+
T Consensus 104 ~~lvmEy~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGl 178 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcC
Confidence 7999999999999999954 35689999999999999999999998 7 999999999999974 79999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
|+..... .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||........ +.........
T Consensus 179 a~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~~i~~~~~---- 247 (290)
T 3fpq_A 179 ATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVK---- 247 (290)
T ss_dssp GGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHTTTCC----
T ss_pred CEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHHHHHcCCC----
Confidence 9764322 2345789999999998865 699999999999999999999999975433221 1111111000
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
....+..+++++.+||.+||++||++|||+.++++|.|.-
T Consensus 248 ---------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~ 287 (290)
T 3fpq_A 248 ---------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287 (290)
T ss_dssp ---------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ---------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 0111122346799999999999999999999999998753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-58 Score=417.07 Aligned_cols=255 Identities=26% Similarity=0.350 Sum_probs=203.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|++++.||+|+||+||+|+.... ...+..||+|++.+... .....+.+|+.+|+.++|||||++++++.+++
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-- 99 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISG--SDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG-- 99 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSS--TTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT--
T ss_pred cccEEEEEEecCCCeEEEEEEEccC--CCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC--
Confidence 4699999999999999999986432 23456899999976422 23346788999999999999999999998876
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
.+|+|||||+||+|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+
T Consensus 100 --~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl 172 (304)
T 3ubd_A 100 --KLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGL 172 (304)
T ss_dssp --EEEEEECCCTTCEEHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred --EEEEEEEcCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEeccccc
Confidence 56999999999999999954 35699999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
|+...... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||...+.... +....... .
T Consensus 173 a~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~--~~~i~~~~-~---- 243 (304)
T 3ubd_A 173 SKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET--MTMILKAK-L---- 243 (304)
T ss_dssp EEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCC-C----
T ss_pred ceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH--HHHHHcCC-C----
Confidence 98643322 233467899999999999999999999999999999999999999986544321 11111110 0
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT-----MNQVVESLKL 357 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~~l~~l~~ 357 (393)
..+..+++++.+||.+||++||++||| ++|+++|.|.
T Consensus 244 -----------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f 285 (304)
T 3ubd_A 244 -----------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285 (304)
T ss_dssp -----------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred -----------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence 112235688999999999999999998 5899999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-55 Score=399.48 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=193.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|++++.||+|+||+||+|+++.++ ..||+|++..... ...+.+.+|+.+|+.++|||||++++++...+..
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 78 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDD-----CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTC-----CEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCC-----CEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence 356999999999999999999976444 4699999875433 3346788999999999999999999998765431
Q ss_pred --------cceEEEEEeecCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC
Q 035862 150 --------GIQRLLVYEYMPNRSLEDRLFSRAQ-PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF 220 (393)
Q Consensus 150 --------~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~ 220 (393)
..++|+|||||++|+|.+++..... ...++..++.++.||+.||+|||++ ||+||||||+|||++.+|
T Consensus 79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~ 155 (299)
T 4g31_A 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDD 155 (299)
T ss_dssp --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCC
Confidence 2357999999999999999964432 2345567889999999999999999 999999999999999999
Q ss_pred ceEEeeccCCccCCCCCCc----------cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCc
Q 035862 221 KPKLSDFGLAREGPTGDHT----------HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRP 290 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~ 290 (393)
.+||+|||+|+........ ...+..+||+.|||||++.+..|+.++|||||||++|||++ ||.....
T Consensus 156 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~ 232 (299)
T 4g31_A 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME 232 (299)
T ss_dssp CEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH
Confidence 9999999999875433221 12234689999999999999999999999999999999996 6653211
Q ss_pred hhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 291 TMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
............. .......++.+.+||.+||++||++|||+.++++|.|.
T Consensus 233 --~~~~~~~~~~~~~--------------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~ 283 (299)
T 4g31_A 233 --RVRTLTDVRNLKF--------------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283 (299)
T ss_dssp --HHHHHHHHHTTCC--------------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred --HHHHHHHHhcCCC--------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 1111111111100 01112345667889999999999999999999998764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-55 Score=401.24 Aligned_cols=274 Identities=26% Similarity=0.302 Sum_probs=201.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
.+|.+.++||+|+||+||+|++. +..||||++..... .......|+..+..++|||||++++++..++....
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-------g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-------GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-------TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-------CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 35788899999999999999863 34699999975432 11222346666678899999999999987765545
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEG-----LEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-----~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
.+++|||||++|+|.+++.. ..+++..+..++.|++.||+|||++ ...+|+||||||+||||+.++.+||+|
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 67999999999999999954 3589999999999999999999974 134899999999999999999999999
Q ss_pred ccCCccCCCCCCcc--ccccccccCCccCccccccC------CCCchhhHHHHHHHHHHHHhCCCccCCCCchhh-----
Q 035862 227 FGLAREGPTGDHTH--VSTAVVGTYGYAAPEYIETG------HLKSQSDIWSFGVVLYEILTGRRVLERNRPTME----- 293 (393)
Q Consensus 227 fg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslGvil~elltg~~pf~~~~~~~~----- 293 (393)
||+|+......... .....+||+.|||||++.+. .++.++|||||||++|||+||.+||........
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~ 231 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence 99998654332221 22346899999999999754 467899999999999999999888754322100
Q ss_pred ----hHHHHHHhhcCcCCcccccccCcccccc-cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 294 ----QKLLEWVKQFPADGKKFSMMIDPRLRNQ-YSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 294 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
........... ....++.+... ....++..+.+|+.+||+.||++|||+.++++.|+.+.+..
T Consensus 232 ~~~~~~~~~~~~~~~------~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 232 VPSDPSVEEMRKVVC------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SCSSCCHHHHHHHHT------TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccccchHHHHHHHHh------cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 00000000000 00111111111 12356778999999999999999999999999999887643
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=410.65 Aligned_cols=276 Identities=25% Similarity=0.342 Sum_probs=210.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc-
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE- 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 148 (393)
++|++++.||+|+||+||+|+++.++ ..||||++..... ...+.+.+|+++|+.++|||||++++++.....
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 128 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTG-----QQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY 128 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCT
T ss_pred CCeEEEEEEecccCeEEEEEEECCCC-----CEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccc
Confidence 57999999999999999999976544 4699999976432 334567899999999999999999999865432
Q ss_pred -ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 149 -RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 149 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
....+|+|||||+ |+|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+||
T Consensus 129 ~~~~~~~ivmE~~~-g~L~~~i~--~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DF 202 (398)
T 4b99_A 129 GEFKSVYVVLDLME-SDLHQIIH--SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDF 202 (398)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHT--SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCEEEEEEeCCC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeec
Confidence 1236799999995 68999984 456799999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCC--CccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcC
Q 035862 228 GLAREGPTGD--HTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP 304 (393)
Q Consensus 228 g~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (393)
|+|+...... ........+||+.|+|||++.+. .|+.++||||+||++|||++|++||.+.+.......+......+
T Consensus 203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p 282 (398)
T 4b99_A 203 GMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 282 (398)
T ss_dssp TTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9998654322 12234567999999999998775 56999999999999999999999998765543332222221111
Q ss_pred cCCcccccc-----------cCcccc---cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 305 ADGKKFSMM-----------IDPRLR---NQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 305 ~~~~~~~~~-----------~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
... ..... +.+... ......++.++.+||.+||.+||++|||+.|+++|.|...
T Consensus 283 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 350 (398)
T 4b99_A 283 SPA-VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350 (398)
T ss_dssp CGG-GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTT
T ss_pred ChH-HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCc
Confidence 110 00000 000000 0001134678999999999999999999999999998753
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=396.56 Aligned_cols=273 Identities=25% Similarity=0.323 Sum_probs=205.5
Q ss_pred HHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcC-CCCccceeeeeeecCC
Q 035862 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTED 147 (393)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 147 (393)
...++|++.++||+|+||+||+|+++.. ...+..||+|.+.... ...++.+|+++|+.+ +||||+++++++...+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~--~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQ--VGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBT--TSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred CccCcEEEEEEEecccCcEEEEEEEccc--CCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 3457899999999999999999986521 2355789999987653 345678899999988 5999999999998876
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC-CceEEee
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN-FKPKLSD 226 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~D 226 (393)
++|+||||++|++|.+++ ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+ +.+||+|
T Consensus 94 ----~~~lvmE~~~g~~L~~~~-----~~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~D 161 (361)
T 4f9c_A 94 ----HVVIAMPYLEHESFLDIL-----NSLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVD 161 (361)
T ss_dssp ----EEEEEEECCCCCCHHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred ----EEEEEEeCCCcccHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECc
Confidence 669999999999999988 2489999999999999999999999 99999999999999876 8999999
Q ss_pred ccCCccCCCCCCc--------------------------cccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHH
Q 035862 227 FGLAREGPTGDHT--------------------------HVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEIL 279 (393)
Q Consensus 227 fg~a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~ell 279 (393)
||+|+........ ......+||+.|+|||++.+. .|+.++||||+||++|||+
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell 241 (361)
T 4f9c_A 162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLL 241 (361)
T ss_dssp CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHH
Confidence 9999754332110 112346899999999999775 5899999999999999999
Q ss_pred hCCCccCCCCchhhhHH--HHH---------HhhcCc--------CCccccc--------------cc----Cccccccc
Q 035862 280 TGRRVLERNRPTMEQKL--LEW---------VKQFPA--------DGKKFSM--------------MI----DPRLRNQY 322 (393)
Q Consensus 280 tg~~pf~~~~~~~~~~~--~~~---------~~~~~~--------~~~~~~~--------------~~----~~~~~~~~ 322 (393)
+|+.||.......++.. ... ...... ....... .. ........
T Consensus 242 ~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 321 (361)
T 4f9c_A 242 SGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEG 321 (361)
T ss_dssp HTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------
T ss_pred HCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccc
Confidence 99999976554433211 110 000000 0000000 00 00000011
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 323 SINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 323 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
...+++++.+||.+||++||++|||++|+++|.|.
T Consensus 322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f 356 (361)
T 4f9c_A 322 WNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFF 356 (361)
T ss_dssp CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred cccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence 12346789999999999999999999999999875
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-52 Score=411.79 Aligned_cols=257 Identities=23% Similarity=0.333 Sum_probs=213.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++++.||+|+||.||+|.++.++ ..||+|.+..........+.+|+.+|+.++|||||++++++...+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg-----~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~--- 227 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATG-----NNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN--- 227 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS---
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCC-----CEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC---
Confidence 468999999999999999999976544 469999998776666677889999999999999999999998776
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC--CceEEeecc
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN--FKPKLSDFG 228 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~--~~~kl~Dfg 228 (393)
.+|+|||||+||+|.++|... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 228 -~~~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG 302 (573)
T 3uto_A 228 -EMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 302 (573)
T ss_dssp -EEEEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred -EEEEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeecc
Confidence 669999999999999998533 34689999999999999999999999 99999999999999854 899999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+|+...... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||......... ........
T Consensus 303 ~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~---~~i~~~~~--- 373 (573)
T 3uto_A 303 LTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL---RNVKSCDW--- 373 (573)
T ss_dssp SCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHTTCC---
T ss_pred ceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HHHHhCCC---
Confidence 998765433 234568999999999999999999999999999999999999999865443221 11111100
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.........++.++.+||.+||+.||.+|||+.|+++|.|.
T Consensus 374 --------~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~ 414 (573)
T 3uto_A 374 --------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWL 414 (573)
T ss_dssp --------CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred --------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCc
Confidence 00111112356889999999999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=409.92 Aligned_cols=254 Identities=24% Similarity=0.328 Sum_probs=205.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHH---HHHHHHhhcCCCCccceeeeeee
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQW---LAEVQFLGVVSHPNLVKLLGYCS 144 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~h~niv~~~~~~~ 144 (393)
.++|+++++||+|+||.||+|+++.++ ..||+|++.+... ...... ..++.+++.++|||||+++++|.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg-----~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~ 262 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTG-----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 262 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCC-----CEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence 468999999999999999999976544 4799999965321 112223 34467778889999999999998
Q ss_pred cCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEE
Q 035862 145 TEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKL 224 (393)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 224 (393)
+.+ .+|+|||||+||+|.++|.. ...+++..++.++.||+.||+|||++ |||||||||+||||+.+|.+||
T Consensus 263 ~~~----~lylVmEy~~GGdL~~~l~~--~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL 333 (689)
T 3v5w_A 263 TPD----KLSFILDLMNGGDLHYHLSQ--HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI 333 (689)
T ss_dssp CSS----EEEEEECCCCSCBHHHHHHH--HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEE
T ss_pred ECC----EEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEe
Confidence 877 67999999999999999954 35699999999999999999999999 9999999999999999999999
Q ss_pred eeccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 225 SDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
+|||+|....... ....+||+.|||||++.. ..|+.++|||||||++|||++|.+||..........+.......
T Consensus 334 ~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~ 409 (689)
T 3v5w_A 334 SDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409 (689)
T ss_dssp CCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHC
T ss_pred cccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCC
Confidence 9999998754332 345689999999999964 57999999999999999999999999754332222222211111
Q ss_pred CcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHH
Q 035862 304 PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT-----MNQVVESLKL 357 (393)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~~l~~l~~ 357 (393)
+ ..++..++.++.+||.+||++||.+|++ ++++++|.|.
T Consensus 410 ~---------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF 453 (689)
T 3v5w_A 410 A---------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453 (689)
T ss_dssp C---------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGG
T ss_pred C---------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccc
Confidence 1 1122245688999999999999999998 7999999764
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=368.29 Aligned_cols=283 Identities=39% Similarity=0.731 Sum_probs=231.6
Q ss_pred HHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecC
Q 035862 67 LREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTE 146 (393)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 146 (393)
+...+++|++.+.||+|+||.||+|.+. .+..||+|.+..........+.+|+.+++.++||||+++++++...
T Consensus 34 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 34 LEEATNNFDHKFLIGHGVFGKVYKGVLR------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp CCCCCCCCSCCCCSCBCSSSEEEEEECT------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred HHHHHhccCccceeecCCCeeEEEEEEC------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 3445789999999999999999999853 2346999998877666677889999999999999999999999876
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEE
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQ--PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKL 224 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 224 (393)
+ ..++||||+++++|.+++..... ..+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||
T Consensus 108 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl 180 (321)
T 2qkw_B 108 N----EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKI 180 (321)
T ss_dssp T----CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEE
T ss_pred C----eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEE
Confidence 6 44999999999999999854432 3589999999999999999999998 9999999999999999999999
Q ss_pred eeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcC
Q 035862 225 SDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP 304 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (393)
+|||++................||+.|+|||++.+..++.++|||||||++|+|++|+.||....+........+.....
T Consensus 181 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 260 (321)
T 2qkw_B 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260 (321)
T ss_dssp CCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH
T ss_pred eecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc
Confidence 99999986543333333445678999999999999999999999999999999999999997655443333333322111
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
....+...+++.........++..+.+++.+||+.||++|||+.+++++|+.+++..+
T Consensus 261 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 261 -NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp -TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred -ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 1222344455566666777889999999999999999999999999999999886543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=357.24 Aligned_cols=257 Identities=24% Similarity=0.367 Sum_probs=212.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.+.||+|+||+||+|.+..+ +..||+|.+..........+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--- 90 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVAT-----GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD--- 90 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTT-----CCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---
T ss_pred hhceeeeeeeccCCCeEEEEEEECCC-----CcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC---
Confidence 56899999999999999999986543 3469999987665556677889999999999999999999998776
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+++++|.+++... .+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 91 -~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 91 -ELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (297)
T ss_dssp -EEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred -EEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 569999999999999998543 489999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||............... ..+
T Consensus 164 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~------ 234 (297)
T 3fxz_A 164 AQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP------ 234 (297)
T ss_dssp EECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH-CSC------
T ss_pred eecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCC------
Confidence 76543322 234568999999999999999999999999999999999999999866543222211111 000
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
....+..++..+.+|+.+||+.||++|||+.++++|.|...
T Consensus 235 --------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 235 --------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp --------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred --------CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 00112234678999999999999999999999999987654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=363.38 Aligned_cols=269 Identities=27% Similarity=0.423 Sum_probs=218.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCC--CCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcC-CCCccceeeeeeecC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLD--GRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTE 146 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 146 (393)
.++|.+.+.||+|+||.||+|.+...+ ....+..||+|.+..... .....+.+|+.+++.+ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467999999999999999999876432 234567899999976532 3345688999999999 899999999999876
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRA--------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTS 212 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~ 212 (393)
+ .+++||||+.+|+|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+
T Consensus 160 ~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~ 232 (370)
T 2psq_A 160 G----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 232 (370)
T ss_dssp S----SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGG
T ss_pred C----CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchh
Confidence 6 3599999999999999996543 23578999999999999999999999 9999999999
Q ss_pred CeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCch
Q 035862 213 NVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPT 291 (393)
Q Consensus 213 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~ 291 (393)
|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999986554433333445567889999999999999999999999999999999 99999765432
Q ss_pred hhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 292 MEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
.. ....... .....+..++.++.+++.+||+.||.+||++.+++++|+.++....
T Consensus 313 ~~---~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~ 367 (370)
T 2psq_A 313 EL---FKLLKEG--------------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 367 (370)
T ss_dssp GH---HHHHHTT--------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HH---HHHHhcC--------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 21 1111110 0111222456789999999999999999999999999999886543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=361.26 Aligned_cols=254 Identities=24% Similarity=0.403 Sum_probs=209.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||.||+|.+..++ ..||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~- 87 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTG-----REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK- 87 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCC-----CEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence 467999999999999999999975444 469999987542 234556789999999999999999999998766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 88 ---~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG 159 (328)
T 3fe3_A 88 ---TLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFG 159 (328)
T ss_dssp ---EEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred ---EEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeecc
Confidence 569999999999999999544 4589999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCC-chhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLK-SQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
++....... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||............ ....
T Consensus 160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i--~~~~---- 230 (328)
T 3fe3_A 160 FSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV--LRGK---- 230 (328)
T ss_dssp CCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHCC----
T ss_pred CceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--HhCC----
Confidence 997654332 23556899999999999888775 7999999999999999999999865433221111 1110
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
...+..++.++.+|+.+||+.||.+|||+.++++|.|...
T Consensus 231 ------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 270 (328)
T 3fe3_A 231 ------------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINA 270 (328)
T ss_dssp ------------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred ------------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcC
Confidence 0111234578899999999999999999999999988754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=354.54 Aligned_cols=264 Identities=25% Similarity=0.386 Sum_probs=212.8
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|.+.+.||+|+||+||+|.+..++ ..||+|.+..........+.+|+.+++.++||||+++++++...+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~-----~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~---- 80 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETG-----EVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK---- 80 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTC-----CEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT----
T ss_pred hHeeccceecCCCCEEEEEEEECCCC-----cEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC----
Confidence 56999999999999999999976443 469999987766666778899999999999999999999998776
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+++++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 156 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLAR 156 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCE
T ss_pred eeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccce
Confidence 569999999999999999653 35689999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCCcc------------ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHH
Q 035862 232 EGPTGDHTH------------VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW 299 (393)
Q Consensus 232 ~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~ 299 (393)
......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~---- 232 (310)
T 3s95_A 157 LMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF---- 232 (310)
T ss_dssp ECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS----
T ss_pred ecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH----
Confidence 654332211 1124579999999999999999999999999999999999999987543221100
Q ss_pred HhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
............+..++..+.+++.+||+.||++|||+.++++.|+.+.....
T Consensus 233 -----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 233 -----------GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp -----------SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -----------hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00000001111122345678999999999999999999999999998876543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=360.21 Aligned_cols=260 Identities=24% Similarity=0.350 Sum_probs=208.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|++.+.||+|+||+||+|.+..++ ..||+|++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-- 78 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTE-----EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-- 78 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCC-----cEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--
Confidence 468999999999999999999976443 4699999865432 22355788999999999999999999998776
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+++++|.+++ .....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+
T Consensus 79 --~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~ 151 (323)
T 3tki_A 79 --IQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 151 (323)
T ss_dssp --EEEEEEECCTTEEGGGGS--BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred --eEEEEEEcCCCCcHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeec
Confidence 569999999999999988 4455689999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHL-KSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+................||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... ...+......
T Consensus 152 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~~--- 227 (323)
T 3tki_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEKKTY--- 227 (323)
T ss_dssp CEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTTCTT---
T ss_pred cceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhccccc---
Confidence 976543333333446789999999999987765 77999999999999999999999765443221 1111111000
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
......++..+.+|+.+||+.||.+|||+.++++|.|...
T Consensus 228 -----------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~ 267 (323)
T 3tki_A 228 -----------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 267 (323)
T ss_dssp -----------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred -----------CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcc
Confidence 0001134577899999999999999999999999988753
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=356.34 Aligned_cols=289 Identities=40% Similarity=0.698 Sum_probs=231.4
Q ss_pred ccccccHHHHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCcc
Q 035862 58 HLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNL 136 (393)
Q Consensus 58 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~ni 136 (393)
....++..++....++|++.+.||+|+||.||+|.+. ++..||+|++..... .....+.+|+.+++.++||||
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i 89 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA------DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL 89 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS------SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTB
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec------CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCc
Confidence 3456788889999999999999999999999999743 234599999876432 223467899999999999999
Q ss_pred ceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCe
Q 035862 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRA--QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNV 214 (393)
Q Consensus 137 v~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NI 214 (393)
+++++++...+. .++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+....||+||||||+||
T Consensus 90 v~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Ni 165 (326)
T 3uim_A 90 LRLRGFCMTPTE----RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165 (326)
T ss_dssp CCCCEEECCSSC----CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGE
T ss_pred cceEEEEecCCc----eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhE
Confidence 999999987764 489999999999999996543 34589999999999999999999996555899999999999
Q ss_pred EeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCc--hh
Q 035862 215 LLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRP--TM 292 (393)
Q Consensus 215 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~--~~ 292 (393)
|++.++.+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ..
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 244 (326)
T 3uim_A 166 LLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244 (326)
T ss_dssp EECTTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTS
T ss_pred EECCCCCEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccccc
Confidence 9999999999999999865433222 33445699999999999999999999999999999999999999952111 01
Q ss_pred hhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 293 EQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
......+..... .........+...........+..+.+++.+||+.||.+|||+.+++++|+..
T Consensus 245 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 245 DVMLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp CSBHHHHHTTTT-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred chhHHHHHHHHh-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 112223333222 22334455566666677788899999999999999999999999999999853
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=360.22 Aligned_cols=256 Identities=23% Similarity=0.331 Sum_probs=208.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc------cHHHHHHHHHHhhcCCCCccceeeeeee
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ------GHKQWLAEVQFLGVVSHPNLVKLLGYCS 144 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~ 144 (393)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+...... ....+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-----~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTG-----LEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCC-----CEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE
Confidence 467999999999999999999976443 46999998765322 3467889999999999999999999998
Q ss_pred cCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC----
Q 035862 145 TEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF---- 220 (393)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~---- 220 (393)
..+ ..++||||+.|++|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||+++++
T Consensus 86 ~~~----~~~lv~e~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 86 NRT----DVVLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp CSS----EEEEEEECCCSCBHHHHHT--TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred eCC----EEEEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCcc
Confidence 766 5699999999999999994 445789999999999999999999999 999999999999998877
Q ss_pred ceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHH
Q 035862 221 KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~ 300 (393)
.+||+|||++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ +....
T Consensus 157 ~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~--~~~i~ 231 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LANIT 231 (361)
T ss_dssp CEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHHHH
T ss_pred CEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH
Confidence 79999999998754432 22456799999999999999999999999999999999999999976543221 11111
Q ss_pred hhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.... . ++. .....++..+.+||.+||..||.+|||+.++++|.|.
T Consensus 232 -~~~~---~----~~~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 276 (361)
T 2yab_A 232 -AVSY---D----FDE----EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (361)
T ss_dssp -TTCC---C----CCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred -hcCC---C----CCc----hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCc
Confidence 1100 0 000 1111345789999999999999999999999999775
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=361.50 Aligned_cols=277 Identities=25% Similarity=0.351 Sum_probs=222.5
Q ss_pred HHHHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcC-CCCccceeee
Q 035862 64 MQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVV-SHPNLVKLLG 141 (393)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~ 141 (393)
........++|++.+.||+|+||.||+|.+........+..||+|.+..... .....+.+|++++..+ +||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 3444445678999999999999999999987666667788999999976533 3345688999999999 6999999999
Q ss_pred eeecCCcccceEEEEEeecCCCChHHHHhhcCC-----------------------------------------------
Q 035862 142 YCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQ----------------------------------------------- 174 (393)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------- 174 (393)
++...+. ..++||||+.+|+|.+++.....
T Consensus 94 ~~~~~~~---~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 94 ACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EECSTTS---CCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeecCCC---ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9877553 35899999999999999965432
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCC
Q 035862 175 -----------------PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGD 237 (393)
Q Consensus 175 -----------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 237 (393)
..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1288999999999999999999999 99999999999999999999999999998664444
Q ss_pred CccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcccccccCc
Q 035862 238 HTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDP 316 (393)
Q Consensus 238 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (393)
.........||+.|+|||++.+..++.++|||||||++|+|++ |..||......... .......
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~~~~~------------- 312 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKEG------------- 312 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHHHHHT-------------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHHHHcC-------------
Confidence 4334456678999999999999999999999999999999998 99999765432211 1111110
Q ss_pred ccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 317 RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
.....+..++.++.+++.+||+.||.+|||+.+++++|..+++..
T Consensus 313 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 313 -TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 001112234578999999999999999999999999999988653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=366.17 Aligned_cols=274 Identities=26% Similarity=0.408 Sum_probs=216.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|.+.+.||+|+||.||+|.+........+..||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~- 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP- 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC-
Confidence 35799999999999999999997755555667789999997542 3344567899999999999999999999987664
Q ss_pred cceEEEEEeecCCCChHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC---c
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRA-----QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF---K 221 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~---~ 221 (393)
.++||||+.+++|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+| .
T Consensus 149 ---~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 149 ---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp ---CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred ---CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCce
Confidence 499999999999999996543 24589999999999999999999999 999999999999999655 4
Q ss_pred eEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHH
Q 035862 222 PKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWV 300 (393)
Q Consensus 222 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~ 300 (393)
+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||......... ...
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~---~~i 299 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---EFV 299 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHH
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHH
Confidence 99999999974322222222344578899999999999999999999999999999998 99999865433221 111
Q ss_pred hhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCCCCC
Q 035862 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSSS 368 (393)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~~~ 368 (393)
.... ....+..++..+.+|+.+||+.||.+|||+.+++++|+.+.+..+.....
T Consensus 300 ~~~~--------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~~~~~~ 353 (367)
T 3l9p_A 300 TSGG--------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTA 353 (367)
T ss_dssp HTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHHTCC
T ss_pred HcCC--------------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChhhccCC
Confidence 1100 01112234577999999999999999999999999999998877654443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=359.56 Aligned_cols=280 Identities=25% Similarity=0.314 Sum_probs=211.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.+.||+|+||+||+|.+. +..||+|++.... .......+|+.+++.++||||+++++++........
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL-------NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDV 95 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET-------TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred hhchhhheecccCceEEEEEEEC-------CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCc
Confidence 57999999999999999999864 2469999986543 233445668999999999999999999987665444
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-------CCCeEeccCCCCCeEeCCCCceEE
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGL-------EIQVIYRDFKTSNVLLDGNFKPKL 224 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~-------~~~ivH~Dikp~NIll~~~~~~kl 224 (393)
.+++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||
T Consensus 96 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 96 DLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred eEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 67999999999999999954 34899999999999999999999741 228999999999999999999999
Q ss_pred eeccCCccCCCCCCccccccccccCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHH
Q 035862 225 SDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-----GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW 299 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~ 299 (393)
+|||++................||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........+...
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 99999976544333323344689999999999976 3566789999999999999999999976533211111110
Q ss_pred HhhcCcCCccc----ccccCcccccc-cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 300 VKQFPADGKKF----SMMIDPRLRNQ-YSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 300 ~~~~~~~~~~~----~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
....+...... .....+.+... .....+.++.+|+.+||+.||++|||+.++++.|+.+.+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 00000000000 00001111111 12246678999999999999999999999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=356.88 Aligned_cols=253 Identities=26% Similarity=0.347 Sum_probs=208.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC---CcccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH---GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|++++.||+|+||.||+|....+ +..||+|++.+. .......+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKAT-----GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT-----CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCC-----CCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC
Confidence 36799999999999999999997543 346999998753 1234566789999999999999999999998776
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
.+++||||++||+|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+||
T Consensus 79 ----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF 149 (337)
T 1o6l_A 79 ----RLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp ----EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ----EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeec
Confidence 569999999999999988543 4689999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|++........ .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......... ......
T Consensus 150 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~i~~~~---- 221 (337)
T 1o6l_A 150 GLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE--LILMEE---- 221 (337)
T ss_dssp TTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHCC----
T ss_pred cchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHH--HHHcCC----
Confidence 99976432221 2345689999999999999999999999999999999999999997654322111 111100
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKL 357 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~ 357 (393)
...+..++.++.+||.+||+.||.+|| ++.++++|.|.
T Consensus 222 ------------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f 264 (337)
T 1o6l_A 222 ------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp ------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred ------------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCc
Confidence 011223467899999999999999999 99999999764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=352.46 Aligned_cols=266 Identities=27% Similarity=0.425 Sum_probs=212.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|++.+.||+|+||.||+|.+..++ .....||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 123 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPG--QRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR-- 123 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTT--SCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG--
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCC--CCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--
Confidence 357999999999999999999986433 245679999997653 334566889999999999999999999997665
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 124 --~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 124 --LAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp --CCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred --ccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCc
Confidence 459999999999999998543 34689999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCc-cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 230 AREGPTGDHT-HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 230 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
+......... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||............ ...
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~--~~~----- 270 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV--EEG----- 270 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH--HTT-----
T ss_pred ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH--HcC-----
Confidence 9875443221 12233456778999999999999999999999999999999 99999765443221111 111
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
.....+..++..+.+|+.+||..||.+|||+.++++.|+.+.+..+
T Consensus 271 ----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 271 ----------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp ----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred ----------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 0111222356789999999999999999999999999999987544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=350.96 Aligned_cols=267 Identities=29% Similarity=0.417 Sum_probs=218.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|.+.+.||+|+||.||+|.+........+..||+|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~- 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP- 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS-
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc-
Confidence 45799999999999999999998655545566889999997643 2344668899999999999999999999987663
Q ss_pred cceEEEEEeecCCCChHHHHhhcCC----------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQ----------------------PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYR 207 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~----------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~ 207 (393)
.++||||+.+++|.+++..... ..+++..++.++.|++.||.|||++ +|+||
T Consensus 101 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~ 174 (314)
T 2ivs_A 101 ---LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHR 174 (314)
T ss_dssp ---CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECC
T ss_pred ---eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCccc
Confidence 4999999999999999965432 3488999999999999999999999 99999
Q ss_pred cCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccC
Q 035862 208 DFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLE 286 (393)
Q Consensus 208 Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~ 286 (393)
||||+|||++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986654433333344567889999999999999999999999999999999 999997
Q ss_pred CCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 287 RNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
......... ...... ....+..++.++.+++.+||+.||.+||++.+++++|+.++..
T Consensus 255 ~~~~~~~~~---~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 255 GIPPERLFN---LLKTGH--------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp TCCGGGHHH---HHHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCHHHHHH---HhhcCC--------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 655432211 111110 1111223567899999999999999999999999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=349.47 Aligned_cols=254 Identities=25% Similarity=0.360 Sum_probs=209.2
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceE
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 153 (393)
|.....||+|+||.||+|.+..+ +..||+|++..........+.+|+.+++.++||||+++++++...+ ..
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~-----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~ 117 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHS-----GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE----EL 117 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTT-----CCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETT----EE
T ss_pred hhccEEeccCCCeEEEEEEECCC-----CcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECC----EE
Confidence 77788999999999999997543 3469999998766666778889999999999999999999998776 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
++||||+++++|.+++. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++...
T Consensus 118 ~lv~e~~~~~~L~~~l~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 191 (321)
T 2c30_A 118 WVLMEFLQGGALTDIVS---QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191 (321)
T ss_dssp EEEECCCCSCBHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEecCCCCCHHHHHH---hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeec
Confidence 99999999999999884 24589999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ......+...
T Consensus 192 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~~------ 260 (321)
T 2c30_A 192 SKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KRLRDSPPPK------ 260 (321)
T ss_dssp CSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHHSSCCC------
T ss_pred ccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHhcCCCCC------
Confidence 43221 234568999999999999999999999999999999999999999765433211 1111111100
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
. .....++..+.+|+.+||+.||++|||+.++++|.|...
T Consensus 261 ----~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 300 (321)
T 2c30_A 261 ----L--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ 300 (321)
T ss_dssp ----C--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGG
T ss_pred ----c--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcc
Confidence 0 011134577999999999999999999999999988753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=358.33 Aligned_cols=274 Identities=28% Similarity=0.407 Sum_probs=220.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCC--CCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcC-CCCccceeeeeeecC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDG--RGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTE 146 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 146 (393)
.++|.+.+.||+|+||.||+|.+...+. ......||+|++..... .....+.+|+++++.+ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4679999999999999999999765432 24556799999976532 3346688999999999 899999999999877
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRA--------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTS 212 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~ 212 (393)
+. .++||||+.+++|.+++.... ...+++..++.++.|++.||.|||+. +|+||||||+
T Consensus 148 ~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 220 (382)
T 3tt0_A 148 GP----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 220 (382)
T ss_dssp SS----CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred Cc----eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcc
Confidence 64 499999999999999997543 24589999999999999999999999 9999999999
Q ss_pred CeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCch
Q 035862 213 NVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPT 291 (393)
Q Consensus 213 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~ 291 (393)
|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987654443333445677889999999999999999999999999999999 99999765432
Q ss_pred hhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCCCCC
Q 035862 292 MEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSSS 368 (393)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~~~ 368 (393)
. ......... ....+..++.++.+|+.+||+.||++|||+.+++++|+.+.........+
T Consensus 301 ~---~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~ 360 (382)
T 3tt0_A 301 E---LFKLLKEGH--------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMG 360 (382)
T ss_dssp H---HHHHHHTTC--------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC--
T ss_pred H---HHHHHHcCC--------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCC
Confidence 2 111111110 01111234578999999999999999999999999999998766555443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=348.75 Aligned_cols=260 Identities=27% Similarity=0.451 Sum_probs=201.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||+||+|.+. +..||+|++..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH-------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred hhHceeeeEeecCCCeEEEEEEEC-------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 467999999999999999999753 23599999876532 334568899999999999999999999987763
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCCeEeCCCCceEEe
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQ-PTLPWKTRLEIILGAAEGLAYLHEGLEIQ--VIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~--ivH~Dikp~NIll~~~~~~kl~ 225 (393)
.++||||+++++|.+++..... ..+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+
T Consensus 109 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 109 ----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp ----CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred ----eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEEC
Confidence 4999999999999999954321 2389999999999999999999998 8 9999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.............. ..
T Consensus 182 Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~--~~-- 255 (309)
T 3p86_A 182 DFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF--KC-- 255 (309)
T ss_dssp CCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH--SC--
T ss_pred CCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--cC--
Confidence 999997543321 123456799999999999999999999999999999999999999986654322211110 00
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
.....+..++.++.+||.+||+.||.+|||+.++++.|+.+++..
T Consensus 256 ------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 256 ------------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 011122235678999999999999999999999999999988643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=345.49 Aligned_cols=275 Identities=23% Similarity=0.312 Sum_probs=215.6
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|.+.+.||+|+||+||+|.+..++ ..||+|++.... ......+.+|+.+++.++||||+++++++...+..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~- 82 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTG-----DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR- 82 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC-
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCC-----cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc-
Confidence 57999999999999999999976443 469999987543 23356678999999999999999999998876544
Q ss_pred ceEEEEEeecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe----CCCCceEEe
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRA-QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL----DGNFKPKLS 225 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl~ 225 (393)
..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. ||+||||||+|||+ +.++.+||+
T Consensus 83 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 83 -HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp -CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred -eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEc
Confidence 5699999999999999996533 23489999999999999999999999 99999999999999 788889999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccc--------cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchh--hhH
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE--------TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM--EQK 295 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~--~~~ 295 (393)
|||++........ .....||+.|+|||++. +..++.++|||||||++|||++|..||....... ...
T Consensus 159 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 235 (319)
T 4euu_A 159 DFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (319)
T ss_dssp CCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred cCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence 9999987544332 23467999999999886 5788999999999999999999999997543322 222
Q ss_pred HHHHHhhcCcCCcc-ccccc--------CcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 296 LLEWVKQFPADGKK-FSMMI--------DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 296 ~~~~~~~~~~~~~~-~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
+.......+..... ..... .-.........++..+.+|+.+||+.||++|||+.++++|+....
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 22333332221100 00000 111122445678899999999999999999999999999998653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=351.51 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=207.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc------cHHHHHHHHHHhhcCCCCccceeeeeee
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ------GHKQWLAEVQFLGVVSHPNLVKLLGYCS 144 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~ 144 (393)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+...... ....+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 84 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTG-----LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 84 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTC-----CEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCC-----cEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 356999999999999999999975443 46999998754321 3567889999999999999999999998
Q ss_pred cCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC----
Q 035862 145 TEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF---- 220 (393)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~---- 220 (393)
..+ ..++||||+++++|.+++. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++
T Consensus 85 ~~~----~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~ 155 (326)
T 2y0a_A 85 NKT----DVILILELVAGGELFDFLA--EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP 155 (326)
T ss_dssp CSS----EEEEEEECCCSCBHHHHHT--TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSC
T ss_pred eCC----EEEEEEEcCCCCCHHHHHH--hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCC
Confidence 766 5699999999999999994 445689999999999999999999998 999999999999999888
Q ss_pred ceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHH
Q 035862 221 KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~ 300 (393)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ....
T Consensus 156 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~~~ 230 (326)
T 2y0a_A 156 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL--ANVS 230 (326)
T ss_dssp CEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH--HHHH
T ss_pred CEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH--HHHH
Confidence 79999999998754332 223467999999999999999999999999999999999999999765432211 1111
Q ss_pred hhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.... .........++..+.+|+.+||+.||.+|||+.++++|.|.
T Consensus 231 -~~~~-----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 275 (326)
T 2y0a_A 231 -AVNY-----------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275 (326)
T ss_dssp -HTCC-----------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred -hcCC-----------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCc
Confidence 1000 00001111245778999999999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=360.57 Aligned_cols=253 Identities=25% Similarity=0.356 Sum_probs=203.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcC-CCCccceeeeeeecC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTE 146 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 146 (393)
.++|++.+.||+|+||.||+|++..++ ..||+|++.+.. ......+.+|..++..+ +||||+++++++...
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETG-----DLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCC-----CEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence 578999999999999999999976443 469999987531 22345677899999988 699999999999877
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
+ .+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|
T Consensus 97 ~----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~D 167 (353)
T 3txo_A 97 D----RLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLAD 167 (353)
T ss_dssp S----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred C----EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEcc
Confidence 6 569999999999999998543 4689999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
||++....... ......+||+.|+|||++.+..++.++|||||||++|||++|..||......... .......
T Consensus 168 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~--~~i~~~~--- 240 (353)
T 3txo_A 168 FGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF--EAILNDE--- 240 (353)
T ss_dssp CTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHCC---
T ss_pred ccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH--HHHHcCC---
Confidence 99997533222 2334568999999999999999999999999999999999999999865443221 1111110
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM------NQVVESLKL 357 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~~l~~l~~ 357 (393)
..++..++.++.+||.+||+.||.+||++ .++++|.|.
T Consensus 241 -------------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f 284 (353)
T 3txo_A 241 -------------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284 (353)
T ss_dssp -------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGG
T ss_pred -------------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcc
Confidence 01122345789999999999999999998 899998765
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=354.75 Aligned_cols=270 Identities=28% Similarity=0.424 Sum_probs=215.7
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
..++|++.+.||+|+||.||+|.+........+..||+|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 123 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK- 123 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC-
Confidence 3578999999999999999999987554445667899999986532 33466889999999999999999999998766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRA----------------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIY 206 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH 206 (393)
..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++ +|+|
T Consensus 124 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 124 ---PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred ---ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 3499999999999999996532 15689999999999999999999999 9999
Q ss_pred ccCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCcc
Q 035862 207 RDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVL 285 (393)
Q Consensus 207 ~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf 285 (393)
|||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999975433222223344578899999999999999999999999999999999 99999
Q ss_pred CCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 286 ERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
........ ........ ....+..++.++.+++.+||+.||.+||++.+++++|..+.+..+
T Consensus 278 ~~~~~~~~---~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 278 YGMAHEEV---IYYVRDGN--------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TTSCHHHH---HHHHHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCCChHHH---HHHHhCCC--------------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 76543221 11111100 001122345789999999999999999999999999999876443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=351.09 Aligned_cols=258 Identities=18% Similarity=0.272 Sum_probs=210.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|.+.+.||+|+||.||+|.+.. .+..||+|.+.... .....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 74 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETS-----SKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESME--- 74 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT---
T ss_pred hhceEeeeEEecCCCeEEEEEEECC-----CCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC---
Confidence 5689999999999999999999653 34579999987543 34456789999999999999999999998776
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC--CCceEEeecc
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG--NFKPKLSDFG 228 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~--~~~~kl~Dfg 228 (393)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++. ++.+||+|||
T Consensus 75 -~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg 149 (321)
T 1tki_A 75 -ELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp -EEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred -EEEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence 569999999999999998432 34689999999999999999999999 9999999999999987 7899999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ..........
T Consensus 150 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~i~~~~~~--- 221 (321)
T 1tki_A 150 QARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI--IENIMNAEYT--- 221 (321)
T ss_dssp TCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHHTCCC---
T ss_pred CCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH--HHHHHcCCCC---
Confidence 998764433 23456799999999999988899999999999999999999999976543221 1111111100
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.... ....++.++.+|+.+||..||.+|||+.++++|.|...
T Consensus 222 -----~~~~----~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 263 (321)
T 1tki_A 222 -----FDEE----AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp -----CCHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred -----CChh----hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence 0000 00124678999999999999999999999999999754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=357.16 Aligned_cols=270 Identities=24% Similarity=0.397 Sum_probs=214.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcC-CCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 148 (393)
.++|.+.+.||+|+||.||+|.+........+..||+|.+.... ......+.+|+.+++.+ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46799999999999999999998665556677889999997542 23456788999999999 89999999999987663
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQ---------------------PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYR 207 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~ 207 (393)
.++||||+++++|.+++..... ..+++..++.++.||+.||.|||++ ||+||
T Consensus 124 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~ 196 (344)
T 1rjb_A 124 ----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 196 (344)
T ss_dssp ----CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred ----cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence 4999999999999999965432 2378999999999999999999999 99999
Q ss_pred cCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccC
Q 035862 208 DFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLE 286 (393)
Q Consensus 208 Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~ 286 (393)
||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|+| |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999986544433333445677889999999999999999999999999999998 999997
Q ss_pred CCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 287 RNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
....... +....... .....+..++.++.+|+.+||+.||.+|||+.+++++|+.+.....
T Consensus 277 ~~~~~~~--~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 277 GIPVDAN--FYKLIQNG--------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp TCCCSHH--HHHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred cCCcHHH--HHHHHhcC--------------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 6543221 11111110 0111122345789999999999999999999999999999876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=357.96 Aligned_cols=255 Identities=25% Similarity=0.356 Sum_probs=208.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|++++.||+|+||.||+|.+..+ +..||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~-----~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDT-----KKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTT-----CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCC-----CCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 36799999999999999999997544 3469999986532 233467889999999999999999999998776
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..++||||+.||+|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+||
T Consensus 89 ----~~~lv~e~~~gg~L~~~l~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DF 159 (384)
T 4fr4_A 89 ----DMFMVVDLLLGGDLRYHLQ--QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDF 159 (384)
T ss_dssp ----EEEEEECCCTTEEHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred ----EEEEEEecCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEecc
Confidence 5699999999999999984 445699999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIET---GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP 304 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (393)
|++....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...................
T Consensus 160 G~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 236 (384)
T 4fr4_A 160 NIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTV 236 (384)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCC
T ss_pred ceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcc
Confidence 9998654332 2345789999999999864 458999999999999999999999997654433332222221111
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHH
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT-MNQVVESLKL 357 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~~l~~l~~ 357 (393)
..++..++.++.+||.+||+.||.+||+ +.++++|.|.
T Consensus 237 ---------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f 275 (384)
T 4fr4_A 237 ---------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275 (384)
T ss_dssp ---------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGG
T ss_pred ---------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhh
Confidence 1112234678999999999999999998 8999887654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=344.62 Aligned_cols=270 Identities=26% Similarity=0.400 Sum_probs=219.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcC-CCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 148 (393)
.++|.+.+.||+|+||.||+|.+........+..||+|.+..... .....+.+|+.+++.+ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 357999999999999999999976554556778899999986543 3346688999999999 89999999999987764
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCC----------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQ----------------PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTS 212 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~ 212 (393)
.++||||+++++|.+++..... ..+++..++.++.|++.||.|||++ |++||||||+
T Consensus 102 ----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~ 174 (313)
T 1t46_A 102 ----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (313)
T ss_dssp ----CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred ----cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccc
Confidence 4999999999999999965432 2489999999999999999999999 9999999999
Q ss_pred CeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCch
Q 035862 213 NVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPT 291 (393)
Q Consensus 213 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~ 291 (393)
||+++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999999987655443333445567889999999999999999999999999999999 99999765432
Q ss_pred hhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 292 MEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
.. ........ .....+..++..+.+++.+||+.||.+|||+.+++++|+.++.+..
T Consensus 255 ~~--~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 255 SK--FYKMIKEG--------------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp HH--HHHHHHHT--------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred hH--HHHHhccC--------------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 21 11111110 0011112345789999999999999999999999999999987543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=354.18 Aligned_cols=258 Identities=24% Similarity=0.346 Sum_probs=208.1
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
..++|++.+.||+|+||.||+|.+..++ ..||+|++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 101 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTG-----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES 101 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCC-----CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 3567999999999999999999975443 4699999976532 23456789999999999999999999998776
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC---ceEE
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF---KPKL 224 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl 224 (393)
..++||||+.+++|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||
T Consensus 102 ----~~~lv~e~~~gg~L~~~l~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl 172 (362)
T 2bdw_A 102 ----FHYLVFDLVTGGELFEDIV--AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL 172 (362)
T ss_dssp ----EEEEEECCCCSCBHHHHHT--TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred ----EEEEEEecCCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence 5699999999999999984 345689999999999999999999999 999999999999998654 5999
Q ss_pred eeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcC
Q 035862 225 SDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP 304 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (393)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ........
T Consensus 173 ~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~--~~i~~~~~ 247 (362)
T 2bdw_A 173 ADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY--AQIKAGAY 247 (362)
T ss_dssp CCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHTCC
T ss_pred eecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHhCCC
Confidence 9999998654332 223568999999999999999999999999999999999999999765432211 11111100
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
. + .......++.++.+||.+||+.||++||++.++++|.|..
T Consensus 248 ~----~--------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 289 (362)
T 2bdw_A 248 D----Y--------PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 289 (362)
T ss_dssp C----C--------CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHH
T ss_pred C----C--------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccC
Confidence 0 0 0000113457899999999999999999999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=343.94 Aligned_cols=269 Identities=24% Similarity=0.334 Sum_probs=204.6
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|++.+.||+|+||+||+|.+..++ ..||+|++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 74 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-- 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred CCceeeeEecCCCCeEEEEEEECCCC-----ceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC--
Confidence 57999999999999999999976443 4699999875432 23466789999999999999999999998766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+.+ +|.+++.. ....+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 75 --~~~lv~e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 75 --KLTLVFEFCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp --EEEEEEECCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred --EEEEEEecCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 56999999975 66666543 345699999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHh--hcCcC
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGH-LKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK--QFPAD 306 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~--~~~~~ 306 (393)
+........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.......+. ...... ..+..
T Consensus 148 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~-~~~i~~~~~~~~~ 224 (292)
T 3o0g_A 148 ARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTE 224 (292)
T ss_dssp CEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-HHHHHHHHCCCCT
T ss_pred ceecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHHhCCCCh
Confidence 986543221 234567899999999997765 899999999999999999988886544333221 111111 11111
Q ss_pred Cc--cccccc---------CcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 307 GK--KFSMMI---------DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 307 ~~--~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.. ...... ...........++.++.+|+.+||+.||++|||+.++++|.|.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 286 (292)
T 3o0g_A 225 EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp TTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCccc
Confidence 00 000000 0000111122456789999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=351.27 Aligned_cols=264 Identities=25% Similarity=0.391 Sum_probs=207.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|++.+.||+|+||+||+|.+..++. .....|++|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 90 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--- 90 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS---
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCc-eEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC---
Confidence 469999999999999999999764432 234457889886432 344567889999999999999999999998654
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
.++|+||+.+|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 91 --~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 91 --VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp --EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred --eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcce
Confidence 378999999999999986543 4689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
................+|+.|+|||++.+..++.++|||||||++|||++ |..||................
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-------- 236 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-------- 236 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC--------
Confidence 86544433333344567889999999999999999999999999999999 999998665433222211100
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
....+..++.++.+++.+||+.||.+||++.+++++|..+....
T Consensus 237 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 237 ---------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp ---------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred ---------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 11112234577999999999999999999999999999987654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=350.58 Aligned_cols=276 Identities=25% Similarity=0.383 Sum_probs=198.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||.||+|.+...+. ....||+|.+... .......+.+|+.+++.++||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDG--SFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC---------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCC--cceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 4579999999999999999998654331 2236999998764 23445678899999999999999999999977653
Q ss_pred cc--ceEEEEEeecCCCChHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCce
Q 035862 149 RG--IQRLLVYEYMPNRSLEDRLFSRA----QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP 222 (393)
Q Consensus 149 ~~--~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 222 (393)
.+ ...++||||+.+++|.+++.... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 21 12389999999999999985432 22589999999999999999999999 99999999999999999999
Q ss_pred EEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHh
Q 035862 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVK 301 (393)
Q Consensus 223 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~ 301 (393)
||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||............ ..
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~--~~ 254 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL--IG 254 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH--HT
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH--hc
Confidence 9999999987544443333344567889999999999999999999999999999999 99999865443221111 11
Q ss_pred hcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCCCCC
Q 035862 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSSS 368 (393)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~~~ 368 (393)
.. ....+..++.++.+|+.+||+.||.+|||+.++++.|+.++......+.+
T Consensus 255 ~~---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 255 GN---------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp TC---------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred CC---------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 00 01112234578999999999999999999999999999999877665544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=346.35 Aligned_cols=270 Identities=23% Similarity=0.330 Sum_probs=204.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++++.||+|+||+||+|.+.. +..||+|++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 92 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQ------GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER- 92 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETT------SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS-
T ss_pred HhhhHhhhhccCCCCeEEEEEEECC------CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC-
Confidence 4679999999999999999998632 34699999875432 23456789999999999999999999998766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+++ +|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 93 ---~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 164 (311)
T 3niz_A 93 ---CLTLVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFG 164 (311)
T ss_dssp ---CEEEEEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ---EEEEEEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCc
Confidence 56999999975 888877543 34589999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..................+...
T Consensus 165 ~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 242 (311)
T 3niz_A 165 LARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242 (311)
T ss_dssp TCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTT
T ss_pred CceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChH
Confidence 9986543221 2344578999999999876 568999999999999999999999997655443322211111111110
Q ss_pred ccccc-------------ccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 308 KKFSM-------------MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 308 ~~~~~-------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.... .............++.++.+||.+||+.||++|||+.++++|.|..
T Consensus 243 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 305 (311)
T 3niz_A 243 -EWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305 (311)
T ss_dssp -TSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred -HhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence 0000 0000000111123457889999999999999999999999998753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=341.16 Aligned_cols=283 Identities=39% Similarity=0.628 Sum_probs=223.8
Q ss_pred ccccccHHHHHHHhcCCccc------ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC----cccHHHHHHHHHH
Q 035862 58 HLRVFDMQELREATNGFNRM------LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG----LQGHKQWLAEVQF 127 (393)
Q Consensus 58 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~ 127 (393)
....|+..++..+++.|... +.||+|+||.||+|.+. +..||+|++.... ......+.+|+.+
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~E~~~ 83 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-------NTTVAVKKLAAMVDITTEELKQQFDQEIKV 83 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-------SCEEEEEEECCCTTSCTTTHHHHHHHHHHH
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-------CceEEEEEEecccCcchHHHHHHHHHHHHH
Confidence 34567888888888888877 89999999999999852 2359999986532 2335678899999
Q ss_pred hhcCCCCccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 035862 128 LGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR-AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIY 206 (393)
Q Consensus 128 l~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH 206 (393)
++.++||||+++++++...+. .++||||+++++|.+++... ....+++..++.++.|++.||.|||+. |++|
T Consensus 84 l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H 156 (307)
T 2nru_A 84 MAKCQHENLVELLGFSSDGDD----LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIH 156 (307)
T ss_dssp HHHCCCTTBCCEEEEECSSSS----CEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred HHhcCCCCeEEEEEEEecCCc----eEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---Ceec
Confidence 999999999999999987663 49999999999999998643 245689999999999999999999998 9999
Q ss_pred ccCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccC
Q 035862 207 RDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLE 286 (393)
Q Consensus 207 ~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~ 286 (393)
|||||+||+++.++.+||+|||++................|++.|+|||.+.+ .++.++||||||+++|+|++|..||.
T Consensus 157 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~ 235 (307)
T 2nru_A 157 RDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD 235 (307)
T ss_dssp SCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcc
Confidence 99999999999999999999999986554333333445679999999998865 58899999999999999999999997
Q ss_pred CCCchhh-hHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 287 RNRPTME-QKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 287 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
....... ....... ......+...+++.+ ...+...+..+.+++.+||+.||.+|||+.+++++|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 236 EHREPQLLLDIKEEI---EDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp TTBSSSBTTHHHHHH---HTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred cCcchHHHHHHHHHh---hhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 6543211 1111111 111122222233322 2345677889999999999999999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=345.69 Aligned_cols=264 Identities=24% Similarity=0.379 Sum_probs=206.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILN-----IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTC-----SEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCC-----CeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC
Confidence 357999999999999999999875443 4699999864322 33456789999999999999999999998766
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 85 ----~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Df 155 (294)
T 4eqm_A 85 ----CYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDF 155 (294)
T ss_dssp ----EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred ----eEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeC
Confidence 569999999999999999543 4689999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|++......... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......... .......
T Consensus 156 g~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~~~~~~---- 228 (294)
T 4eqm_A 156 GIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA--IKHIQDS---- 228 (294)
T ss_dssp SSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH--HHHHSSC----
T ss_pred CCcccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHhhcc----
Confidence 999865432211 234467999999999999999999999999999999999999999865432211 1111100
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHhhh
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-TMNQVVESLKLAVQES 362 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~~l~~l~~~~~~~ 362 (393)
.+.........++..+.+++.+||+.||.+|| +++++.+.|..++...
T Consensus 229 -------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 229 -------VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp -------CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred -------CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 00111112223567899999999999999998 8999998888776544
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=363.51 Aligned_cols=260 Identities=22% Similarity=0.302 Sum_probs=208.0
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
..++|++.+.||+|+||.||+|.+..+ +..+|+|++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~-----~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLA-----GQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTT-----TEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCC-----CcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC
Confidence 456799999999999999999986543 45699999876543 23456789999999999999999999998776
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC---CCCceEE
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD---GNFKPKL 224 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl 224 (393)
..++||||+.||+|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+|||++ .++.+||
T Consensus 84 ----~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL 154 (444)
T 3soa_A 84 ----HHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKL 154 (444)
T ss_dssp ----EEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEE
T ss_pred ----EEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEE
Confidence 569999999999999998543 4689999999999999999999999 999999999999998 5688999
Q ss_pred eeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcC
Q 035862 225 SDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP 304 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (393)
+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.......... .......
T Consensus 155 ~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~--~i~~~~~ 230 (444)
T 3soa_A 155 ADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ--QIKAGAY 230 (444)
T ss_dssp CCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHTCC
T ss_pred ccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHH--HHHhCCC
Confidence 99999976543322 2345689999999999999999999999999999999999999997654322111 1111100
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
. + .......+++++.+||.+||+.||.+|||+.++++|.|...
T Consensus 231 ~----~--------~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 231 D----F--------PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp C----C--------CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred C----C--------CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 0 0 00001134578999999999999999999999999987644
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=351.55 Aligned_cols=280 Identities=25% Similarity=0.386 Sum_probs=211.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.+.||+|+||+||+|++.... ...+..||+|++..........+.+|+.+++.++||||+++++++...+..
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~- 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQ-DNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR- 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTC-SSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT-
T ss_pred HHHhhhhheeeccCCEEEEEEEEeccc-CCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC-
Confidence 357999999999999999999864322 345678999999877666667788999999999999999999998665433
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 87 -~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 87 -NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp -SCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred -ceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 4589999999999999996543 3489999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCc-cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc-
Q 035862 231 REGPTGDHT-HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK- 308 (393)
Q Consensus 231 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~- 308 (393)
......... .......++..|+|||++.+..++.++||||||+++|+|++|..||........ ......+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~----~~~~~~~~~~~~ 237 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM----RMIGNDKQGQMI 237 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHH----HHHCTTCCTHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHH----hhhcCccccchh
Confidence 865433221 123344677789999999999999999999999999999999998864321110 00000000000
Q ss_pred --ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 309 --KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 309 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
.....+....+...+..++.++.+|+.+||+.||++|||+.++++.|+.+..+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 00000001111222334568899999999999999999999999999998764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=359.81 Aligned_cols=261 Identities=27% Similarity=0.436 Sum_probs=209.4
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|.+.+.||+|+||.||+|.+..+ +..||+|.+..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~- 186 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRAD-----NTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP- 186 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT-----CCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS-
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecC-----CeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC-
Confidence 45789999999999999999997543 34699999875432 233457889999999999999999999987663
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 187 ---~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~ 259 (377)
T 3cbl_A 187 ---IYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGM 259 (377)
T ss_dssp ---CEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGG
T ss_pred ---cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCC
Confidence 499999999999999996432 3588999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
++...............++..|+|||++.+..++.++|||||||++|||++ |..||........... ...
T Consensus 260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~---~~~------ 330 (377)
T 3cbl_A 260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF---VEK------ 330 (377)
T ss_dssp CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH---HHT------
T ss_pred ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHc------
Confidence 986433221111122345778999999998999999999999999999998 9999986544322211 111
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
..+...+..++.++.+|+.+||+.||++|||+.++++.|+.+...
T Consensus 331 --------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 331 --------GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp --------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 001112223567899999999999999999999999999988653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=353.13 Aligned_cols=253 Identities=25% Similarity=0.362 Sum_probs=206.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|.+.+.||+|+||.||+|.+..++ ..||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQ-----QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 468999999999999999999976444 469999986431 122356789999999999999999999998876
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..++||||+ +|+|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+|||+++++.+||+||
T Consensus 83 ----~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DF 152 (336)
T 3h4j_B 83 ----DIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADF 152 (336)
T ss_dssp ----EEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCS
T ss_pred ----EEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEe
Confidence 569999999 77999988543 4689999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHL-KSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
|++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........
T Consensus 153 G~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~------------- 216 (336)
T 3h4j_B 153 GLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL------------- 216 (336)
T ss_dssp SCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------------
T ss_pred ccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------------
Confidence 9998654332 2345689999999999988776 6899999999999999999999975422100
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
...... .....+..++.++.+|+.+||+.||.+|||+.++++|.|...
T Consensus 217 ---~~~i~~--~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 264 (336)
T 3h4j_B 217 ---FKKVNS--CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV 264 (336)
T ss_dssp ---BCCCCS--SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred ---HHHHHc--CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence 000000 011122345678999999999999999999999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=350.84 Aligned_cols=268 Identities=25% Similarity=0.356 Sum_probs=205.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|++.+.||+|+||.||+|.+.. .+..||+|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLR-----DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECC-----CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC
Confidence 4679999999999999999999753 345799999976532 23356789999999999999999999988776
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..+...++||||+++++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 160 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 160 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCC
T ss_pred CCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeec
Confidence 5555669999999999999999543 4689999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCc-cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 228 GLAREGPTGDHT-HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 228 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
|++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .......+..
T Consensus 161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~~~~~~~~~ 238 (311)
T 3ork_A 161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA--YQHVREDPIP 238 (311)
T ss_dssp SCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHCCCCC
T ss_pred cCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HHHhcCCCCC
Confidence 999765433221 1233457999999999999999999999999999999999999999765443211 1111111000
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
.......++.++.+|+.+||+.||.+||++.+++.+.+......
T Consensus 239 ------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 239 ------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp ------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred ------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 00011134678999999999999999998888887766555433
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=348.76 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=207.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|++.+.||+|+||.||+|+...+ +..||+|++.+.. ......+.+|..+++.++||||+++++++...+
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHN-----GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-----CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCC-----CCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC
Confidence 35799999999999999999997543 3469999987532 123456778999999999999999999998766
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
.+++||||++|++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+||
T Consensus 80 ----~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Df 150 (318)
T 1fot_A 80 ----QIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF 150 (318)
T ss_dssp ----EEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred ----EEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeec
Confidence 56999999999999999954 34689999999999999999999998 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|++...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||........ ........
T Consensus 151 g~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~---- 219 (318)
T 1fot_A 151 GFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT--YEKILNAE---- 219 (318)
T ss_dssp SSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHHCC----
T ss_pred CcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--HHHHHhCC----
Confidence 999864332 2346899999999999999999999999999999999999999976543221 11111110
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKL 357 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~ 357 (393)
...+..++.++.+|+.+||+.||.+|| +++++++|.|.
T Consensus 220 ------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f 262 (318)
T 1fot_A 220 ------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262 (318)
T ss_dssp ------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred ------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccc
Confidence 011223457899999999999999999 99999999775
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=342.74 Aligned_cols=256 Identities=25% Similarity=0.344 Sum_probs=201.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc--------------------------cHHHHHHH
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ--------------------------GHKQWLAE 124 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E 124 (393)
.++|++.+.||+|+||.||+|.+.. .+..||+|++...... ....+.+|
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 86 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEN-----DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE 86 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETT-----TTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECC-----CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence 4679999999999999999998653 3457999998754311 13457899
Q ss_pred HHHhhcCCCCccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCe
Q 035862 125 VQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQV 204 (393)
Q Consensus 125 ~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~i 204 (393)
+.+++.++||||+++++++...... ..++||||+++++|.+++ ....+++..++.++.|++.||.|||++ +|
T Consensus 87 ~~~l~~l~h~~iv~~~~~~~~~~~~--~~~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i 158 (298)
T 2zv2_A 87 IAILKKLDHPNVVKLVEVLDDPNED--HLYMVFELVNQGPVMEVP---TLKPLSEDQARFYFQDLIKGIEYLHYQ---KI 158 (298)
T ss_dssp HHHHHTCCCTTBCCEEEEEECSSSS--EEEEEEECCTTCBSCCSS---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred HHHHHhCCCCCCCeEEEEEEcCCCC--EEEEEEecCCCCcHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 9999999999999999999874433 669999999999998865 335689999999999999999999999 99
Q ss_pred EeccCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCC---CCchhhHHHHHHHHHHHHhC
Q 035862 205 IYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGH---LKSQSDIWSFGVVLYEILTG 281 (393)
Q Consensus 205 vH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslGvil~elltg 281 (393)
+||||||+|||++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g 236 (298)
T 2zv2_A 159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236 (298)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred eccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence 9999999999999999999999999986543322 234568999999999997655 47889999999999999999
Q ss_pred CCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 282 RRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 282 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
..||........ ......... .+ .....++.++.+||.+||+.||++|||+.++++|.|.
T Consensus 237 ~~pf~~~~~~~~---~~~~~~~~~---~~----------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~ 296 (298)
T 2zv2_A 237 QCPFMDERIMCL---HSKIKSQAL---EF----------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296 (298)
T ss_dssp SCSSCCSSHHHH---HHHHHHCCC---CC----------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred CCCCCCccHHHH---HHHHhcccC---CC----------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence 999976543211 111111000 00 0011245789999999999999999999999999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=345.77 Aligned_cols=278 Identities=27% Similarity=0.361 Sum_probs=207.9
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-----cccHHHHHHHHHHhhcCC---CCccceeee
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-----LQGHKQWLAEVQFLGVVS---HPNLVKLLG 141 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~~~~ 141 (393)
..++|++.+.||+|+||+||+|.+..+ +..||+|.+.... ......+.+|+.+++.++ ||||+++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHS-----GHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTT-----CCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCC-----CcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 357899999999999999999986433 4569999986322 122345667777777664 999999999
Q ss_pred eeecCCc-ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC
Q 035862 142 YCSTEDE-RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF 220 (393)
Q Consensus 142 ~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~ 220 (393)
++..... .....++||||+. ++|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGG 157 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTS
T ss_pred eeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCC
Confidence 9876543 2235689999996 5999999766666699999999999999999999999 999999999999999999
Q ss_pred ceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHH-HH
Q 035862 221 KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL-EW 299 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~-~~ 299 (393)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||............ ..
T Consensus 158 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (308)
T 3g33_A 158 TVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234 (308)
T ss_dssp CEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH
T ss_pred CEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999998654322 234568999999999999999999999999999999999999999876544332221 21
Q ss_pred HhhcCcCCcccccc-----cCc---ccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 300 VKQFPADGKKFSMM-----IDP---RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 300 ~~~~~~~~~~~~~~-----~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
....+......... +.+ .........++..+.+||.+||+.||++|||+.++++|.|...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~ 302 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC--
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccC
Confidence 11111111000000 000 0000111235678999999999999999999999999987654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=352.74 Aligned_cols=260 Identities=24% Similarity=0.308 Sum_probs=207.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-----CcccHHHHHHHHHHhhcCCCCccceeeeeeec
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-----GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCST 145 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 145 (393)
.++|++.+.||+|+||.||+|.+..++ ..||+|++... .......+.+|+.+++.++||||+++++++..
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 97 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETG-----QQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS 97 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCC-----CEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 356999999999999999999976443 46999998532 11245678899999999999999999999987
Q ss_pred CCcccceEEEEEeecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc--
Q 035862 146 EDERGIQRLLVYEYMPNRSLEDRLFSR--AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK-- 221 (393)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~-- 221 (393)
.+ ..++||||+++++|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.
T Consensus 98 ~~----~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~ 170 (351)
T 3c0i_A 98 DG----MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSA 170 (351)
T ss_dssp TT----EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTC
T ss_pred CC----EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCC
Confidence 66 569999999999999887543 334589999999999999999999999 9999999999999987655
Q ss_pred -eEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHH
Q 035862 222 -PKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300 (393)
Q Consensus 222 -~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~ 300 (393)
+||+|||++........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ......
T Consensus 171 ~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~i~ 245 (351)
T 3c0i_A 171 PVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER---LFEGII 245 (351)
T ss_dssp CEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH---HHHHHH
T ss_pred cEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH---HHHHHH
Confidence 99999999987544321 234568999999999999999999999999999999999999999764321 111111
Q ss_pred hhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
..... ..+.. ...++.++.+||.+||..||++|||+.++++|.|...
T Consensus 246 ~~~~~--------~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 246 KGKYK--------MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HTCCC--------CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred cCCCC--------CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 11000 00000 0124578999999999999999999999999988653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=357.57 Aligned_cols=256 Identities=24% Similarity=0.370 Sum_probs=204.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcC-CCCccceeeeeeecC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTE 146 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 146 (393)
.++|+++++||+|+||.||+|++.. .+..||+|++.+.. ......+.+|..++..+ +||||+++++++...
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKK-----TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC
Confidence 4579999999999999999999754 34579999997542 22334577899999876 799999999999877
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
+ .+++||||++||+|..++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|
T Consensus 126 ~----~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D 196 (396)
T 4dc2_A 126 S----RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 196 (396)
T ss_dssp S----EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred C----EEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEee
Confidence 6 569999999999999998543 4689999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchh------hhHHHHHH
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM------EQKLLEWV 300 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~------~~~~~~~~ 300 (393)
||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........
T Consensus 197 FGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i 274 (396)
T 4dc2_A 197 YGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 274 (396)
T ss_dssp CTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH
T ss_pred cceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH
Confidence 99998533222 13456789999999999999999999999999999999999999996432211 11111111
Q ss_pred hhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHHHH
Q 035862 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM------NQVVESLKL 357 (393)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~~l~~l~~ 357 (393)
... ....+..++.++.+||.+||+.||.+||++ .++++|.|.
T Consensus 275 ~~~---------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff 322 (396)
T 4dc2_A 275 LEK---------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322 (396)
T ss_dssp HHC---------------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred hcc---------------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence 110 011222356789999999999999999984 899999764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=345.57 Aligned_cols=278 Identities=25% Similarity=0.357 Sum_probs=222.2
Q ss_pred HHHHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcC-CCCccceeee
Q 035862 64 MQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVV-SHPNLVKLLG 141 (393)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~ 141 (393)
........++|++.+.||+|+||.||+|.+........+..||+|.+..... .....+.+|+.++..+ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 3344444678999999999999999999987655566778999999976533 2345688999999999 6999999999
Q ss_pred eeecCCcccceEEEEEeecCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEec
Q 035862 142 YCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQ--------------PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYR 207 (393)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~ 207 (393)
++...+. ..++||||+.+++|.+++..... ..+++..++.++.|++.||.|||++ ||+||
T Consensus 99 ~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~ 172 (316)
T 2xir_A 99 ACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 172 (316)
T ss_dssp EECCTTS---CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEecCCC---ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence 9876543 35999999999999999965432 1278999999999999999999999 99999
Q ss_pred cCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccC
Q 035862 208 DFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLE 286 (393)
Q Consensus 208 Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~ 286 (393)
||||+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999987654433333445678899999999999999999999999999999998 999997
Q ss_pred CCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 287 RNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
....... ......... ....+..++..+.+++.+||+.||.+|||+.+++++|..+++...
T Consensus 253 ~~~~~~~--~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 253 GVKIDEE--FCRRLKEGT--------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp TCCCSHH--HHHHHHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccchhHH--HHHHhccCc--------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 6543221 111111100 001112245779999999999999999999999999999987553
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=339.27 Aligned_cols=257 Identities=29% Similarity=0.460 Sum_probs=209.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.+.||+|+||.||+|.+.. +..||+|++.... .....+.+|+.+++.++||||+++++++...+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---- 78 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLN------KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA---- 78 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT------TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----
T ss_pred hhceeeheecCCCccEEEEEEecC------CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCC----
Confidence 569999999999999999998652 2359999998654 34567889999999999999999999998766
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred ceEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccc
Confidence 459999999999999998543 34589999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
...... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||......... .......
T Consensus 155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~--~~~~~~~------- 224 (269)
T 4hcu_A 155 FVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV--EDISTGF------- 224 (269)
T ss_dssp GBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--HHHHTTC-------
T ss_pred cccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHH--HHHhcCc-------
Confidence 643321 112234456778999999999999999999999999999999 99999865443211 1111110
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
....+...+..+.+++.+||+.||++|||+.+++++|..+.+.
T Consensus 225 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 225 --------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 0111122357799999999999999999999999999998763
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=355.40 Aligned_cols=258 Identities=22% Similarity=0.350 Sum_probs=209.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+..........+.+|+.+++.++||||+++++++...+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~--- 121 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATG-----RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY--- 121 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS---
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCC-----CEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC---
Confidence 467999999999999999999975433 469999998765555567889999999999999999999998766
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC--CCceEEeecc
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG--NFKPKLSDFG 228 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~--~~~~kl~Dfg 228 (393)
..++||||+.+++|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++. ++.+||+|||
T Consensus 122 -~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG 196 (387)
T 1kob_A 122 -EMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 196 (387)
T ss_dssp -EEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred -EEEEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecc
Confidence 569999999999999988533 34689999999999999999999999 9999999999999974 4779999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ... .......
T Consensus 197 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--~~~-i~~~~~~-- 268 (387)
T 1kob_A 197 LATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET--LQN-VKRCDWE-- 268 (387)
T ss_dssp TCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHH-HHHCCCC--
T ss_pred cceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH--HHH-HHhCCCC--
Confidence 998754432 22345799999999999999999999999999999999999999986543221 111 1111000
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.. ......++.++.+||.+||+.||.+|||+.++++|.|..
T Consensus 269 -----~~----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 309 (387)
T 1kob_A 269 -----FD----EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK 309 (387)
T ss_dssp -----CC----SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred -----CC----ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcccc
Confidence 00 111123467899999999999999999999999998753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=352.46 Aligned_cols=287 Identities=25% Similarity=0.373 Sum_probs=215.8
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.+.||+|+||.||+|.+...+ ...+..||+|.+..........+.+|+.+++.++||||+++++++...+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~-- 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLG-DNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ-- 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTS-SSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC--
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCC-CCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc--
Confidence 46999999999999999999864332 345678999999877666667789999999999999999999998765543
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++.
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred eEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 5699999999999999996533 3589999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCc-cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHT-HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ .......|++.|+|||++.+..++.++||||||+++|+|++|+.||........... ......+. ....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~-~~~~ 253 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERDVPA-LSRL 253 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C----CCH-HHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-cccccccc-HHHH
Confidence 75443322 123345688889999999999999999999999999999999999864322110000 00000000 0000
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCCCC
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSS 367 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~~ 367 (393)
...+........+..++..+.+|+.+||+.||.+|||+.+++++|+.+.........
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 310 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCET 310 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---------
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCccc
Confidence 000111112222334568899999999999999999999999999998876554443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=346.27 Aligned_cols=274 Identities=25% Similarity=0.360 Sum_probs=195.4
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|++++.||+|+||.||+|.+.. .+..||+|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 76 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT-----TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN-- 76 (317)
T ss_dssp ---------------CEEEEEECSS-----SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT--
T ss_pred ccceeEeeEECCCCCEEEEEEEECC-----CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC--
Confidence 4579999999999999999998643 345699999875432 33467889999999999999999999998766
Q ss_pred cceEEEEEeecCCCChHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRA----QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
..++||||++ ++|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+
T Consensus 77 --~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 150 (317)
T 2pmi_A 77 --KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLG 150 (317)
T ss_dssp --EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred --eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEEC
Confidence 5699999997 59999885432 24589999999999999999999999 99999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcC
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP 304 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (393)
|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..................+
T Consensus 151 Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 228 (317)
T 2pmi_A 151 DFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP 228 (317)
T ss_dssp CCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred cCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999986543221 2344578999999999976 468999999999999999999999998765443222211111111
Q ss_pred cCCc------------ccccccCc----ccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 305 ADGK------------KFSMMIDP----RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 305 ~~~~------------~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.... .+...... .+.......++.++.+|+.+||+.||++|||+.++++|.|...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 299 (317)
T 2pmi_A 229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAE 299 (317)
T ss_dssp CTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred ChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhc
Confidence 1000 00000000 0011111134578999999999999999999999999988653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=347.97 Aligned_cols=264 Identities=25% Similarity=0.392 Sum_probs=209.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|++.+.||+|+||+||+|.+..++ ......|++|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---- 87 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEG-ESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGS---- 87 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTT-CSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBS----
T ss_pred hHceeeeeeeecCCceEEEEEEcCCC-ceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC----
Confidence 57999999999999999999986543 2334568888876442 23334567899999999999999999988533
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 88 -~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 88 -SLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp -SEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred -ccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcc
Confidence 358999999999999998543 34688999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
................|+..|+|||++.+..++.++|||||||++|+|++ |..||................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-------- 234 (325)
T 3kex_A 163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE-------- 234 (325)
T ss_dssp GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC--------
T ss_pred cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC--------
Confidence 87655444434455678889999999999999999999999999999999 999998755433222221110
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
....+..++.++.+++.+||..||.+|||+.+++++|..+....
T Consensus 235 ---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 235 ---------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp ---------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred ---------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 00111123456888999999999999999999999999987654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=351.53 Aligned_cols=284 Identities=18% Similarity=0.211 Sum_probs=213.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccH-----------HHHHHHHHHhhcCCCCcccee
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH-----------KQWLAEVQFLGVVSHPNLVKL 139 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~ 139 (393)
.++|++.+.||+|+||.||+|.+........+..||+|++........ .....|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 357999999999999999999987655444566799999876542111 123456667778899999999
Q ss_pred eeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC--
Q 035862 140 LGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD-- 217 (393)
Q Consensus 140 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~-- 217 (393)
++++........+.++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 999987654444679999999 99999998653 35699999999999999999999999 999999999999998
Q ss_pred CCCceEEeeccCCccCCCCCCc-----cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchh
Q 035862 218 GNFKPKLSDFGLAREGPTGDHT-----HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM 292 (393)
Q Consensus 218 ~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~ 292 (393)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 8899999999999764332111 11234569999999999999999999999999999999999999998533222
Q ss_pred hhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCCC
Q 035862 293 EQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGS 366 (393)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~ 366 (393)
........ .... ....++++.+. ...++.++.+|+..||..||.+||++.++++.|..++.......
T Consensus 269 ~~~~~~~~-~~~~---~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~ 335 (364)
T 3op5_A 269 KYVRDSKI-RYRE---NIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD 335 (364)
T ss_dssp HHHHHHHH-HHHH---CHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHH-Hhhh---hHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence 11110000 0000 00011111100 01235789999999999999999999999999999988765443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=353.96 Aligned_cols=258 Identities=22% Similarity=0.325 Sum_probs=197.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.+.||+|+||+||+|++..++ ..||+|++.... .....+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~--- 89 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTK-----ELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPT--- 89 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTC-----CEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCC-----cEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC---
Confidence 357999999999999999999976443 469999997654 33456789999999999999999999998776
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc--eEEeecc
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK--PKLSDFG 228 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~--~kl~Dfg 228 (393)
..++||||+.+++|.+++... ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++. +||+|||
T Consensus 90 -~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg 163 (361)
T 3uc3_A 90 -HLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFG 163 (361)
T ss_dssp -EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred -EEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecC
Confidence 569999999999999998543 4589999999999999999999998 9999999999999987765 9999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCch-hhHHHHHHHHHHHHhCCCccCCCCchhh-hHHHHHHhhcCcC
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQ-SDIWSFGVVLYEILTGRRVLERNRPTME-QKLLEWVKQFPAD 306 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~ 306 (393)
++....... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ............
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~- 239 (361)
T 3uc3_A 164 YSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY- 239 (361)
T ss_dssp CC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC-
T ss_pred ccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC-
Confidence 997432222 2344679999999999988888766 8999999999999999999976433211 111111111100
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.......++.++.+||.+||+.||.+|||+.++++|.|...
T Consensus 240 ------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 240 ------------SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp ------------CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred ------------CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 00001123578899999999999999999999999999854
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=338.46 Aligned_cols=263 Identities=25% Similarity=0.360 Sum_probs=200.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|++.+.||+|+||.||+|.+...+ .....||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--- 88 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPE--NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN--- 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCC--CCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccC---
Confidence 357999999999999999999875432 345679999987643 23456688999999999999999999998432
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||++ |++||||||+|||++.++.+||+|||+
T Consensus 89 --~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 89 --PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp --SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---
T ss_pred --ccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccc
Confidence 348999999999999999644 34589999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......... ...... .
T Consensus 163 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~~i~~~----~ 234 (281)
T 1mp8_A 163 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIENG----E 234 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHTT----C
T ss_pred ccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---HHHHcC----C
Confidence 9865433221 2234456788999999999999999999999999999997 99999765443221 111110 0
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
....+..++..+.+++.+||+.||++|||+.+++++|+.+.+..
T Consensus 235 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 235 ----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 01112235678999999999999999999999999999987654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=354.45 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=207.0
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcC-CCCccceeeeeeec
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCST 145 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 145 (393)
..++|.+.+.||+|+||.||+|++.. .+..||+|++.+.. ......+..|..++..+ +||||+++++++..
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~ 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKK-----TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECC-----CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence 45789999999999999999999753 34579999997532 23345677899999876 89999999999987
Q ss_pred CCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 146 EDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
.+ .+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+
T Consensus 90 ~~----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~ 160 (345)
T 1xjd_A 90 KE----NLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIA 160 (345)
T ss_dssp SS----EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred CC----EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEe
Confidence 76 569999999999999999543 4589999999999999999999999 99999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
|||++........ .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......... ......
T Consensus 161 DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~i~~~~-- 234 (345)
T 1xjd_A 161 DFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH--SIRMDN-- 234 (345)
T ss_dssp CCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHCC--
T ss_pred EChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHHhCC--
Confidence 9999986433221 2345789999999999999999999999999999999999999997654322111 111110
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMN-QVVESLKL 357 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~~l~~l~~ 357 (393)
..++..++.++.+||.+||+.||.+||++. ++++|.|.
T Consensus 235 --------------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f 273 (345)
T 1xjd_A 235 --------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273 (345)
T ss_dssp --------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred --------------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccc
Confidence 011223457899999999999999999998 89888664
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=351.25 Aligned_cols=250 Identities=24% Similarity=0.307 Sum_probs=207.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|++++.||+|+||.||+|.+..++ ..||+|++.+.. ......+.+|+.+++.++||||+++++++...+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESG-----NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCC-----CEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 467999999999999999999976443 469999986532 133466788999999999999999999998766
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
.+++||||++|++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+||
T Consensus 115 ----~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF 185 (350)
T 1rdq_E 115 ----NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp ----EEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred ----EEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccc
Confidence 569999999999999999643 4589999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ ........
T Consensus 186 g~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~i~~~~---- 254 (350)
T 1rdq_E 186 GFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI--YEKIVSGK---- 254 (350)
T ss_dssp TTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCC----
T ss_pred ccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH--HHHHHcCC----
Confidence 999865332 2346899999999999999999999999999999999999999986543221 11111110
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT-----MNQVVESLKL 357 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~~l~~l~~ 357 (393)
...+..++.++.+||.+||+.||.+||+ +.++++|.|.
T Consensus 255 ------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f 297 (350)
T 1rdq_E 255 ------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp ------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred ------------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCc
Confidence 0112234678999999999999999998 9999999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=360.12 Aligned_cols=272 Identities=24% Similarity=0.291 Sum_probs=202.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++++.||+|+||+||+|.+..+ +..||+|++... .......+.+|+.+++.++||||+++++++.....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 135 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVL-----DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 135 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTT-----TEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCC-----CCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCc
Confidence 46899999999999999999997543 456999999764 22345667899999999999999999999976542
Q ss_pred --ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 149 --RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 149 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
.....|+||||+++ +|.+.+. ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|
T Consensus 136 ~~~~~~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~D 207 (464)
T 3ttj_A 136 LEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 207 (464)
T ss_dssp TTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred cccCCeEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEE
Confidence 22367999999966 5766662 2489999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcC--
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP-- 304 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~-- 304 (393)
||+++...... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.......+......+
T Consensus 208 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 208 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284 (464)
T ss_dssp CCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred EEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99998654322 2345789999999999999999999999999999999999999998765432211111100000
Q ss_pred ------------------c-CCcccccccCcccc---cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 305 ------------------A-DGKKFSMMIDPRLR---NQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 305 ------------------~-~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
. .+..+......... .......+.++.+||.+||+.||++|||+.++++|.|..
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~ 360 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 360 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence 0 00001111111110 011123467899999999999999999999999998753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=350.67 Aligned_cols=265 Identities=25% Similarity=0.439 Sum_probs=201.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|.+.+.||+|+||.||+|++.... ..+..||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 119 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPS--KKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK--- 119 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTT--SCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS---
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCC--CCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC---
Confidence 57999999999999999999865221 244569999997643 234467889999999999999999999998766
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 120 -~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 120 -PVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp -SCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred -ceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccc
Confidence 349999999999999999643 34689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCcc-ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 231 REGPTGDHTH-VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 231 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
.......... ......++..|+|||++.+..++.++|||||||++|||++ |..||........ ......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~---~~~i~~------ 265 (373)
T 2qol_A 195 RVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKAVDE------ 265 (373)
T ss_dssp -------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH---HHHHHT------
T ss_pred cccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHc------
Confidence 8654332111 1222345778999999999999999999999999999998 9999976543221 111111
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
..+...+..++..+.+++.+||+.||.+||++.++++.|+.++....
T Consensus 266 --------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 266 --------GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp --------TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred --------CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 01111122356789999999999999999999999999999987543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=350.77 Aligned_cols=253 Identities=25% Similarity=0.361 Sum_probs=207.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcC-CCCccceeeeeeecC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTE 146 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 146 (393)
.++|++++.||+|+||.||+|.+.. .+..||+|++.+.. ......+..|..++..+ +||||+++++++...
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKG-----TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETT-----EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence 5689999999999999999998643 45679999987532 23345678899999988 799999999999877
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
+ .+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|
T Consensus 94 ~----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~D 164 (353)
T 2i0e_A 94 D----RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIAD 164 (353)
T ss_dssp S----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred C----EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEe
Confidence 6 569999999999999999543 4589999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
||++........ .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........
T Consensus 165 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~~~i~~~~--- 237 (353)
T 2i0e_A 165 FGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQSIMEHN--- 237 (353)
T ss_dssp CTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCC---
T ss_pred CCcccccccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH--HHHHHhCC---
Confidence 999986432221 23456899999999999999999999999999999999999999976543221 11111110
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT-----MNQVVESLKL 357 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~~l~~l~~ 357 (393)
..++..++.++.+||.+||+.||.+||+ +.++++|.|.
T Consensus 238 -------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f 280 (353)
T 2i0e_A 238 -------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280 (353)
T ss_dssp -------------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred -------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence 0112235678999999999999999994 6999998764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=354.54 Aligned_cols=262 Identities=23% Similarity=0.293 Sum_probs=197.4
Q ss_pred hcCCccc-ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhh-cCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRM-LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLG-VVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~ 148 (393)
.++|.+. +.||+|+||+||+|.+..++ ..||+|++... ..+.+|+.++. ..+||||+++++++.....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~-----~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQ-----EKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cccceeccceeeeccCeEEEEEEECCCC-----CEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 4678776 68999999999999976444 46999998642 35667888874 4579999999999865222
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC---CCceEEe
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG---NFKPKLS 225 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~ 225 (393)
...++|+||||+.||+|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||++. ++.+||+
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEE
Confidence 223679999999999999999765556799999999999999999999998 9999999999999987 7899999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhh-hHHHHHHhhcC
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTME-QKLLEWVKQFP 304 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~~ 304 (393)
|||++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...........
T Consensus 207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~ 283 (400)
T 1nxk_A 207 DFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283 (400)
T ss_dssp CCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC
T ss_pred ecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc
Confidence 999998654322 23456889999999999999999999999999999999999999976543211 00111111000
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.. ........++.++.+||.+||+.||++|||+.++++|.|...
T Consensus 284 ~~-----------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 284 YE-----------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp CC-----------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cc-----------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 00 000001134678999999999999999999999999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=350.76 Aligned_cols=253 Identities=22% Similarity=0.338 Sum_probs=201.0
Q ss_pred ccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEE
Q 035862 76 RMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLL 155 (393)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~l 155 (393)
..+.||+|+||.||+|.+..++ ..||+|++..........+.+|+.+++.++||||+++++++...+ ..++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g-----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----~~~l 163 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATG-----LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN----DIVL 163 (373)
T ss_dssp EEEECC-----CEEEEEETTTC-----CEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----EEEE
T ss_pred cceEEecCcCEEEEEEEEcCCC-----cEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC----EEEE
Confidence 3668999999999999875433 469999998776566677899999999999999999999998776 5699
Q ss_pred EEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe--CCCCceEEeeccCCccC
Q 035862 156 VYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL--DGNFKPKLSDFGLAREG 233 (393)
Q Consensus 156 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll--~~~~~~kl~Dfg~a~~~ 233 (393)
||||+++++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++...
T Consensus 164 v~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp EEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred EEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 99999999999988643 34589999999999999999999999 99999999999999 66789999999999875
Q ss_pred CCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 234 PTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 234 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||........ +....... ..
T Consensus 240 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~i~~~~-~~------- 306 (373)
T 2x4f_A 240 KPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LNNILACR-WD------- 306 (373)
T ss_dssp CTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHHTC-CC-------
T ss_pred CCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhcc-CC-------
Confidence 44332 2345799999999999999999999999999999999999999976543321 11111110 00
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
. .......++.++.+||.+||+.||.+|||+.++++|.|..
T Consensus 307 ~----~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~ 347 (373)
T 2x4f_A 307 L----EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347 (373)
T ss_dssp S----CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred C----ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence 0 0011113457899999999999999999999999998854
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=337.16 Aligned_cols=258 Identities=28% Similarity=0.423 Sum_probs=209.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.+.||+|+||.||+|.+.. +..||+|.+.... .....+.+|+.+++.++||||+++++++...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 76 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG------QYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY--- 76 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT------TEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---
T ss_pred hhheeeeeeeccCCCceEEEEEecC------ceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCC---
Confidence 3579999999999999999998652 3359999997654 34567889999999999999999999997665
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++
T Consensus 77 -~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 151 (268)
T 3sxs_A 77 -PIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMT 151 (268)
T ss_dssp -SEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred -ceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccc
Confidence 4599999999999999996542 3589999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||............ ....
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~--~~~~------ 222 (268)
T 3sxs_A 152 RYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV--SQGH------ 222 (268)
T ss_dssp EECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--HTTC------
T ss_pred eecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH--HcCC------
Confidence 865443222 2234456778999999999899999999999999999999 99999765443221111 1110
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
....+...++.+.+++.+||+.||.+|||+.+++++|+.+.+.
T Consensus 223 ---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 223 ---------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ---------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 0011112357799999999999999999999999999887654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=339.72 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=202.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhc--CCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGV--VSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||+||+|.+. +..||+|++... ....+.+|.+++.. ++||||+++++++.....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQ-------GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEET-------TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred cCcEEEEEeeccCCCcEEEEEEEC-------CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 467999999999999999999862 346999998653 33455567776666 789999999998776544
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCCeEeccCCCCCeEeCCCC
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH--------EGLEIQVIYRDFKTSNVLLDGNF 220 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH--------~~~~~~ivH~Dikp~NIll~~~~ 220 (393)
.....++||||+++++|.+++. ...+++..++.++.|++.||.||| +. +|+||||||+|||++.++
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQ---LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHT---TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTS
T ss_pred CCceeEEehhhccCCCHHHHHh---hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCC
Confidence 4446799999999999999993 346899999999999999999999 77 999999999999999999
Q ss_pred ceEEeeccCCccCCCCCCcc--ccccccccCCccCccccccC------CCCchhhHHHHHHHHHHHHhC----------C
Q 035862 221 KPKLSDFGLAREGPTGDHTH--VSTAVVGTYGYAAPEYIETG------HLKSQSDIWSFGVVLYEILTG----------R 282 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslGvil~elltg----------~ 282 (393)
.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||++| .
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 99999999997543322211 12345799999999999876 456799999999999999999 7
Q ss_pred CccCCCCchhh--hHHHHHHhhcCcCCcccccccCccc-ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 283 RVLERNRPTME--QKLLEWVKQFPADGKKFSMMIDPRL-RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 283 ~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.||........ ......... .. ..+.. .......++.++.+|+.+||+.||++|||+.++++.|..+
T Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~---~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKVVCV---DQ------QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTT---SC------CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccCCCCcchhhhhHHHhc---cC------CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 88865322211 111111100 00 00011 1112335778999999999999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=339.52 Aligned_cols=269 Identities=25% Similarity=0.341 Sum_probs=201.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|++.+.||+|+||+||+|.+. .+..||+|++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 73 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-- 73 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--
T ss_pred ccchhhhhcccCCCEEEEEEEcC------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC--
Confidence 57999999999999999999863 234699999865432 23466789999999999999999999998766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+.+ +|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 74 --~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 146 (288)
T 1ob3_A 74 --RLVLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL 146 (288)
T ss_dssp --CEEEEEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred --eEEEEEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcc
Confidence 56999999975 999988543 35689999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC-
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG- 307 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~- 307 (393)
+....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..................+...
T Consensus 147 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 224 (288)
T 1ob3_A 147 ARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224 (288)
T ss_dssp HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhh
Confidence 87543221 12234578999999999876 468999999999999999999999998765432221111111110000
Q ss_pred c-cccc--ccCccc-------ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 308 K-KFSM--MIDPRL-------RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 308 ~-~~~~--~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
. .... ..++.. .......++.++.+|+.+||+.||++|||+.++++|.|.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 284 (288)
T 1ob3_A 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (288)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred chhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 0 0000 000000 011112356788999999999999999999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=349.69 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=205.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcC-CCCccceeeeeeecC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTE 146 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 146 (393)
.++|++.+.||+|+||.||+|++.. .+..||+|++.+... .....+.+|..++..+ +||||+++++++...
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKK-----TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hhheEEEEEEEecCCeEEEEEEECC-----CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence 3579999999999999999999754 345799999976432 2345577899999887 799999999999877
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
+ .+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|
T Consensus 83 ~----~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~D 153 (345)
T 3a8x_A 83 S----RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 153 (345)
T ss_dssp S----EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred C----EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEe
Confidence 6 569999999999999998543 4689999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchh------hhHHHHHH
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM------EQKLLEWV 300 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~------~~~~~~~~ 300 (393)
||++........ .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ........
T Consensus 154 FG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i 231 (345)
T 3a8x_A 154 YGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231 (345)
T ss_dssp GGGCBCSCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH
T ss_pred ccccccccCCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH
Confidence 999985332221 2345689999999999999999999999999999999999999996432110 11111111
Q ss_pred hhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHHHHHH
Q 035862 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM------NQVVESLKL 357 (393)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~~l~~l~~ 357 (393)
... ....+..++.++.+||.+||+.||.+||++ .++++|.|.
T Consensus 232 ~~~---------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f 279 (345)
T 3a8x_A 232 LEK---------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279 (345)
T ss_dssp HHC---------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred HcC---------------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCcc
Confidence 110 001122356789999999999999999995 899999765
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=339.67 Aligned_cols=261 Identities=28% Similarity=0.453 Sum_probs=216.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+.... .....+.+|+.+++.++||||+++++++...+
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 82 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKY-----SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP--- 82 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGG-----TEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---
T ss_pred ccceeEEeecCCCCceeEEEeEecCC-----CEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC---
Confidence 46799999999999999999997643 4569999997654 34567889999999999999999999997766
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+++|.+++.......+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++
T Consensus 83 -~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 158 (288)
T 3kfa_A 83 -PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLS 158 (288)
T ss_dssp -SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred -CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccc
Confidence 459999999999999999776667799999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||............. .
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~---~------- 227 (288)
T 3kfa_A 159 RLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---K------- 227 (288)
T ss_dssp GTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---T-------
T ss_pred eeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---c-------
Confidence 86543322 23344567889999999999999999999999999999999 999997655432221111 1
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
......+..++..+.+|+.+||..||.+|||+.++++.|..+.++.
T Consensus 228 -------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 228 -------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp -------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0111122234578999999999999999999999999999888754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=354.18 Aligned_cols=270 Identities=24% Similarity=0.292 Sum_probs=208.0
Q ss_pred HHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-----CCccceeeee
Q 035862 68 REATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-----HPNLVKLLGY 142 (393)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~~~~ 142 (393)
....++|.+.++||+|+||+||+|.+..++ ..||+|++.... .....+..|+.+++.+. ||||++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~ 104 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNK-----KYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHGK 104 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCC-----eEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence 344678999999999999999999975443 469999997532 33455677999999886 9999999999
Q ss_pred eecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC----
Q 035862 143 CSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG---- 218 (393)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~---- 218 (393)
+...+ ..++||||+ +++|.+++.......+++..++.++.||+.||.|||+. ||+||||||+|||++.
T Consensus 105 ~~~~~----~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 105 FMYYD----HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEETT----EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCC
T ss_pred eeECC----eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccc
Confidence 98876 569999999 89999999877666799999999999999999999999 9999999999999975
Q ss_pred ---------------------CCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHH
Q 035862 219 ---------------------NFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYE 277 (393)
Q Consensus 219 ---------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~e 277 (393)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 789999999999864332 234678999999999999999999999999999999
Q ss_pred HHhCCCccCCCCchhhhHHHHHH-hhcCcCC------ccccccc-Cccccc--------------------ccCHHHHHH
Q 035862 278 ILTGRRVLERNRPTMEQKLLEWV-KQFPADG------KKFSMMI-DPRLRN--------------------QYSINAARR 329 (393)
Q Consensus 278 lltg~~pf~~~~~~~~~~~~~~~-~~~~~~~------~~~~~~~-~~~~~~--------------------~~~~~~~~~ 329 (393)
|++|+.||............... ...+... ....... ...... ......++.
T Consensus 252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 99999999876543322221111 1111000 0000000 000000 000111267
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 330 VAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 330 l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
+.+||.+||+.||.+|||+.++++|.|
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~hp~ 358 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLKHKF 358 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred HHHHHHHHhcCChhhCCCHHHHhcCcc
Confidence 889999999999999999999999876
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=346.00 Aligned_cols=269 Identities=28% Similarity=0.390 Sum_probs=217.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcC-CCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 148 (393)
.++|.+.+.||+|+||.||+|.+...+.......||+|.+..... .....+.+|+.+++.+ +||||+++++++...+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 467999999999999999999987766656667899999976532 3456688999999999 89999999999987663
Q ss_pred ccceEEEEEeecCCCChHHHHhhcC------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRA------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL 216 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll 216 (393)
.++||||+++++|.+++.... ...+++..++.++.|++.||.|||++ ||+||||||+|||+
T Consensus 125 ----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 125 ----VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLL 197 (333)
T ss_dssp ----CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEE
T ss_pred ----eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEE
Confidence 499999999999999986432 34679999999999999999999999 99999999999999
Q ss_pred CCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhH
Q 035862 217 DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQK 295 (393)
Q Consensus 217 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~ 295 (393)
+.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~- 276 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF- 276 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH-
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH-
Confidence 9999999999999986543333333345567889999999999999999999999999999998 99999765432211
Q ss_pred HHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
....... .....+..++..+.+++.+||+.||.+|||+.+++++|+.+.+..
T Consensus 277 -~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 277 -YKLVKDG--------------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp -HHHHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -HHHHhcC--------------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 1111110 000111123578999999999999999999999999999887643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=356.01 Aligned_cols=275 Identities=26% Similarity=0.416 Sum_probs=199.5
Q ss_pred HHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCC-CCccceeeeeeec
Q 035862 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCST 145 (393)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 145 (393)
...++|++.+.||+|+||.||+|.+..++ ..||+|++... .......+.+|+.+++.+. ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 80 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTG-----EVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA 80 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTC-----CEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCC-----CEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec
Confidence 34678999999999999999999976444 46999998653 2234456788999999998 9999999999986
Q ss_pred CCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 146 EDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
.+.. .+|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+
T Consensus 81 ~~~~--~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~ 151 (388)
T 3oz6_A 81 DNDR--DVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVA 151 (388)
T ss_dssp TTSS--CEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred CCCC--EEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEec
Confidence 6543 5699999996 599998854 3588999999999999999999999 99999999999999999999999
Q ss_pred eccCCccCCCCC-------------------CccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCcc
Q 035862 226 DFGLAREGPTGD-------------------HTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVL 285 (393)
Q Consensus 226 Dfg~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf 285 (393)
|||+++...... ........+||+.|+|||++.+ ..++.++|||||||++|||++|++||
T Consensus 152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 231 (388)
T 3oz6_A 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231 (388)
T ss_dssp CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence 999997643211 1112345689999999999976 67999999999999999999999999
Q ss_pred CCCCchhhhHHHHHHhhcCcCCccccccc------------------Cccccccc------------CHHHHHHHHHHHH
Q 035862 286 ERNRPTMEQKLLEWVKQFPADGKKFSMMI------------------DPRLRNQY------------SINAARRVAKLAD 335 (393)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~------------~~~~~~~l~~li~ 335 (393)
...+.......+......|... ...... .......+ ...++.++.+|+.
T Consensus 232 ~~~~~~~~~~~i~~~~~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 310 (388)
T 3oz6_A 232 PGSSTMNQLERIIGVIDFPSNE-DVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD 310 (388)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHH-HHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHHhcCCCCHH-HHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence 8765433222211111111100 000000 00000000 0124578999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHH
Q 035862 336 NCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 336 ~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
+||+.||++|||+.++++|.|..
T Consensus 311 ~~L~~dP~~R~t~~e~l~Hp~~~ 333 (388)
T 3oz6_A 311 KLLQFNPNKRISANDALKHPFVS 333 (388)
T ss_dssp HHCCSSGGGSCCHHHHTTSTTTT
T ss_pred HhhccCcccCCCHHHHhCCHHHH
Confidence 99999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=357.93 Aligned_cols=254 Identities=30% Similarity=0.443 Sum_probs=209.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.+.||+|+||.||+|.+. +..||+|.+.... ....+.+|+.+++.++||||+++++++...+.
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-- 260 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG-- 260 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS--
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC--
Confidence 467999999999999999999864 2369999998654 45678899999999999999999999876543
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+|+|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 261 -~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 336 (450)
T 1k9a_A 261 -GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 336 (450)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred -ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence 359999999999999999776655689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+..... .....++..|+|||++.+..++.++|||||||++|||++ |..||.......... ....
T Consensus 337 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~---~i~~------- 401 (450)
T 1k9a_A 337 KEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---RVEK------- 401 (450)
T ss_dssp EECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH---HHHT-------
T ss_pred cccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHc-------
Confidence 854322 123367889999999999999999999999999999998 999997654322111 1110
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
..+...+..++.++.+||.+||+.||.+|||+.++++.|+.+...
T Consensus 402 -------~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 402 -------GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 111122334568899999999999999999999999999988653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=336.18 Aligned_cols=252 Identities=28% Similarity=0.520 Sum_probs=203.1
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc-------HHHHHHHHHHhhcCCCCccceeeeeee
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-------HKQWLAEVQFLGVVSHPNLVKLLGYCS 144 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~ 144 (393)
++|++.+.||+|+||.||+|.+..++ ..||+|.+....... ...+.+|+.+++.++||||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDK-----SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTC-----CEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred ccceehhccccCCceeEEEEEEcCCc-----eEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 57999999999999999999976443 469999986543221 156789999999999999999999986
Q ss_pred cCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCCeEeCCCCc-
Q 035862 145 TEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQ--VIYRDFKTSNVLLDGNFK- 221 (393)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~--ivH~Dikp~NIll~~~~~- 221 (393)
... ++||||+++++|.+++... ...+++..++.++.|++.||.|||++ + ++||||||+|||++.++.
T Consensus 94 ~~~------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~ 163 (287)
T 4f0f_A 94 NPP------RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDEN 163 (287)
T ss_dssp TTT------EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTT
T ss_pred CCC------eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCC
Confidence 654 7999999999999888543 34689999999999999999999998 8 999999999999988876
Q ss_pred ----eEEeeccCCccCCCCCCccccccccccCCccCcccc--ccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH
Q 035862 222 ----PKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYI--ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK 295 (393)
Q Consensus 222 ----~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~ 295 (393)
+||+|||++..... ......||+.|+|||++ ....++.++|||||||++|+|++|..||..........
T Consensus 164 ~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~ 238 (287)
T 4f0f_A 164 APVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF 238 (287)
T ss_dssp CSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH
T ss_pred CceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH
Confidence 99999999975332 23456799999999998 44567899999999999999999999997655433222
Q ss_pred HHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
....... ......+..++..+.+|+.+||+.||.+|||+.++++.|+.
T Consensus 239 ~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 239 INMIREE--------------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHHS--------------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHhcc--------------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 2111111 11111223456789999999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=344.06 Aligned_cols=264 Identities=25% Similarity=0.391 Sum_probs=206.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|++.+.||+|+||.||+|.+..++. .....|++|.+... .......+.+|+.+++.++||||+++++++....
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--- 90 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGE-KVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--- 90 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTC-SCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS---
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCc-eEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC---
Confidence 579999999999999999999865443 23445788887644 3345677889999999999999999999998654
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
.++|+||+.+++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 91 --~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 91 --VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp --EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred --ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 388999999999999986543 4589999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
................+|+.|+|||++.+..++.++|||||||++|+|++ |..||...............
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~--------- 235 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--------- 235 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT---------
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------
Confidence 87644433333444567889999999999999999999999999999999 99999876543322221110
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
.....+..++.++.+|+.+||..||.+||++.++++.|..+....
T Consensus 236 --------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 236 --------ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp --------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred --------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 011112234577999999999999999999999999999988644
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=338.69 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=206.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.+.||+|+||.||+|.+.. +..||+|++.... .....+.+|+.+++.++||||+++++++....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---- 92 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWRG------QYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR---- 92 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEETT------TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----
T ss_pred HHHHhHhhcCCCCCceEEEEEEcC------CCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCC----
Confidence 569999999999999999998652 3459999998654 34567889999999999999999999997766
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 168 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 168 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGG
T ss_pred CeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccc
Confidence 459999999999999999543 34589999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||............ ....
T Consensus 169 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~--~~~~------- 238 (283)
T 3gen_A 169 YVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI--AQGL------- 238 (283)
T ss_dssp GBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH--HTTC-------
T ss_pred cccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH--hccc-------
Confidence 643321 112233456788999999999999999999999999999998 99999865543222111 1110
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
....+...+..+.+++.+||+.||.+|||+.+++++|+.+..+
T Consensus 239 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 239 --------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp --------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 0111112357799999999999999999999999999998764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=343.91 Aligned_cols=270 Identities=27% Similarity=0.424 Sum_probs=214.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCC--CCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcC-CCCccceeeeeeecC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLD--GRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTE 146 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 146 (393)
.++|.+.+.||+|+||.||+|.+...+ ....+..||+|.+..... .....+.+|+.+++.+ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 357999999999999999999976433 224566899999976532 3346688999999999 899999999999876
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCC--------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCC
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQ--------------PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTS 212 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~ 212 (393)
+ ..++||||+.+++|.+++..... ..+++..++.++.||+.||.|||++ ||+||||||+
T Consensus 114 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~ 186 (334)
T 2pvf_A 114 G----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 186 (334)
T ss_dssp S----CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGG
T ss_pred C----ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccc
Confidence 6 44999999999999999965432 3488999999999999999999999 9999999999
Q ss_pred CeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCch
Q 035862 213 NVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPT 291 (393)
Q Consensus 213 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~ 291 (393)
|||++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 99999999999999999987654433333344567889999999998899999999999999999999 99999765432
Q ss_pred hhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcC
Q 035862 292 MEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364 (393)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 364 (393)
.. ........ ....+..++.++.+++.+||+.||.+|||+.+++++|..+......
T Consensus 267 ~~---~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 267 EL---FKLLKEGH--------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HH---HHHHHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HH---HHHHhcCC--------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 21 11111110 0111223457899999999999999999999999999999875543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=344.10 Aligned_cols=266 Identities=19% Similarity=0.188 Sum_probs=210.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcC-CCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 149 (393)
.++|++.+.||+|+||.||+|.+.. .+..||+|.+..... ...+.+|+.+++.+ +||||+++++++...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-- 78 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLY-----TNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGK-- 78 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETT-----TTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETT--
T ss_pred cCCeEEEEEeeccCCceEEEEEECC-----CCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCC--
Confidence 3579999999999999999999653 345799999875432 34577899999999 8999999999998766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc-----eEE
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK-----PKL 224 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~-----~kl 224 (393)
..++||||+ +++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++. +||
T Consensus 79 --~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl 151 (330)
T 2izr_A 79 --YNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHI 151 (330)
T ss_dssp --EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEE
T ss_pred --ccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEE
Confidence 569999999 99999998654 45699999999999999999999999 9999999999999999887 999
Q ss_pred eeccCCccCCCCCCcc-----ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHH
Q 035862 225 SDFGLAREGPTGDHTH-----VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW 299 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~ 299 (393)
+|||++.......... ......||+.|+|||++.+..++.++|||||||++|||++|..||..............
T Consensus 152 ~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~ 231 (330)
T 2izr_A 152 IDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK 231 (330)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH
T ss_pred EEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH
Confidence 9999998654332211 12456899999999999999999999999999999999999999987543322211111
Q ss_pred HhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
....... ... ......++ ++.+++..||+.||.+||++.++.+.|..+.+...
T Consensus 232 i~~~~~~-------~~~---~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 232 IGDTKRA-------TPI---EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp HHHHHHH-------SCH---HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHhhhcc-------CCH---HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 1100000 000 00000134 89999999999999999999999999998887653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=354.24 Aligned_cols=275 Identities=18% Similarity=0.261 Sum_probs=207.8
Q ss_pred hcCCcccceeccc--CCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecC
Q 035862 71 TNGFNRMLKIGEG--GFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTE 146 (393)
Q Consensus 71 ~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 146 (393)
.++|++.+.||+| +||+||+|.+..+ +..||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPT-----GEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTT-----CCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCC-----CCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 4579999999999 9999999997644 3469999987543 23345677899999999999999999999877
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
+ ..++||||+++++|.+++.......+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 99 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 99 N----ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp T----EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECC
T ss_pred C----EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcc
Confidence 6 569999999999999999776667799999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCCc-----cccccccccCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHH
Q 035862 227 FGLAREGPTGDHT-----HVSTAVVGTYGYAAPEYIET--GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW 299 (393)
Q Consensus 227 fg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~ 299 (393)
||.+......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... ..
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~-~~ 250 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE-KL 250 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHH-C-
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-Hh
Confidence 9988643221111 11233478999999999987 6799999999999999999999999976543321110 00
Q ss_pred HhhcCc-------CCcc-------------ccccc---------CcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 035862 300 VKQFPA-------DGKK-------------FSMMI---------DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQ 350 (393)
Q Consensus 300 ~~~~~~-------~~~~-------------~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 350 (393)
....+. .... ..... ...........++.++.+||.+||+.||++|||+.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e 330 (389)
T 3gni_B 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330 (389)
T ss_dssp -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence 000000 0000 00000 000011123345678999999999999999999999
Q ss_pred HHHHHHHH
Q 035862 351 VVESLKLA 358 (393)
Q Consensus 351 ~l~~l~~~ 358 (393)
+++|.|..
T Consensus 331 ll~hp~f~ 338 (389)
T 3gni_B 331 LLNHSFFK 338 (389)
T ss_dssp HTTSGGGG
T ss_pred HhcCHHHH
Confidence 99997754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=348.55 Aligned_cols=257 Identities=24% Similarity=0.314 Sum_probs=193.3
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
..++|++.+.||+|+||.||+|.+..++ ..||+|++.... ..+.+.+|+.+++.++||||+++++++...+
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 121 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQ-----KPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT-- 121 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSS--
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCC-----cEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCC--
Confidence 3568999999999999999999975433 469999997653 3456778999999999999999999998766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC---CCceEEee
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG---NFKPKLSD 226 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~D 226 (393)
..++||||+.+++|.+++. ....+++..++.++.|++.||.|||+. +|+||||||+|||++. ++.+||+|
T Consensus 122 --~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~D 194 (349)
T 2w4o_A 122 --EISLVLELVTGGELFDRIV--EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIAD 194 (349)
T ss_dssp --EEEEEECCCCSCBHHHHHT--TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred --eEEEEEEeCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEcc
Confidence 5699999999999999984 445689999999999999999999998 9999999999999975 88999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...........
T Consensus 195 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~i~~~~~~- 269 (349)
T 2w4o_A 195 FGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-MFRRILNCEYY- 269 (349)
T ss_dssp CC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-HHHHHHTTCCC-
T ss_pred CccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-HHHHHHhCCCc-
Confidence 99997643321 23456799999999999999999999999999999999999999976543321 11111111000
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
........++.++.+||.+||+.||++|||+.++++|.|..
T Consensus 270 -----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 310 (349)
T 2w4o_A 270 -----------FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVT 310 (349)
T ss_dssp -----------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred -----------cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence 00011123457899999999999999999999999998764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=357.69 Aligned_cols=262 Identities=23% Similarity=0.300 Sum_probs=209.5
Q ss_pred HHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeee
Q 035862 66 ELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGY 142 (393)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~ 142 (393)
++....++|++.+.||+|+||+||+|++..+ +..||+|++.+.. ......+.+|+.+++.++||||++++++
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~-----~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 137 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKST-----RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTT-----CCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCC-----CcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 3344467899999999999999999997644 3469999986521 1223347789999999999999999999
Q ss_pred eecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCce
Q 035862 143 CSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP 222 (393)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 222 (393)
+.+.+ .+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.+|.+
T Consensus 138 ~~~~~----~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~i 207 (410)
T 3v8s_A 138 FQDDR----YLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHL 207 (410)
T ss_dssp EECSS----EEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred EEECC----EEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCE
Confidence 98766 56999999999999999854 3589999999999999999999999 99999999999999999999
Q ss_pred EEeeccCCccCCCCCCccccccccccCCccCccccccCC----CCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH-HH
Q 035862 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGH----LKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK-LL 297 (393)
Q Consensus 223 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~-~~ 297 (393)
||+|||++....... .......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.......... +.
T Consensus 208 kL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 286 (410)
T 3v8s_A 208 KLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286 (410)
T ss_dssp EECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred EEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHH
Confidence 999999997654332 12234678999999999997655 8899999999999999999999998655432211 11
Q ss_pred HHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHHH
Q 035862 298 EWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEE--RPTMNQVVESLKLA 358 (393)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~~l~~l~~~ 358 (393)
.......... ...++.++.+||.+||+.+|.+ ||++.++++|.|..
T Consensus 287 ~~~~~~~~p~---------------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~ 334 (410)
T 3v8s_A 287 NHKNSLTFPD---------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK 334 (410)
T ss_dssp THHHHCCCCT---------------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGC
T ss_pred hccccccCCC---------------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcccc
Confidence 1111111110 0124578999999999999988 99999999998863
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=348.35 Aligned_cols=259 Identities=23% Similarity=0.345 Sum_probs=205.2
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcC-CCCccceeeeeeecCCc
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 148 (393)
..++|++.+.||+|+||.||+|.+.. .+..||+|.+...... ..+|++++..+ +||||+++++++...+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~- 89 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKA-----TNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGK- 89 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSS-
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECC-----CCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCC-
Confidence 35679999999999999999999754 3457999999765432 34678888877 6999999999998766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC----CceEE
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN----FKPKL 224 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~----~~~kl 224 (393)
..|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||+.++ +.+||
T Consensus 90 ---~~~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl 161 (342)
T 2qr7_A 90 ---YVYVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRI 161 (342)
T ss_dssp ---EEEEEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred ---EEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEE
Confidence 56999999999999999843 45689999999999999999999999 99999999999998543 35999
Q ss_pred eeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcC
Q 035862 225 SDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP 304 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (393)
+|||++........ .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..........+........
T Consensus 162 ~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~ 239 (342)
T 2qr7_A 162 CDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK 239 (342)
T ss_dssp CCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC
T ss_pred EECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC
Confidence 99999986543322 2345688999999999988889999999999999999999999997643322222222222111
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.. ........++.++.+||.+||..||++|||+.++++|.|...
T Consensus 240 ~~-----------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 240 FS-----------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp CC-----------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred cc-----------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 10 011111235678999999999999999999999999999743
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=358.74 Aligned_cols=254 Identities=28% Similarity=0.380 Sum_probs=208.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|.+.+.||+|+||.||+|.+..++ ..||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTG-----HKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTC-----CEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 357999999999999999999976443 469999986532 123456889999999999999999999998776
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..++||||+++++|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 90 ----~~~lv~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DF 160 (476)
T 2y94_A 90 ----DIFMVMEYVSGGELFDYIC--KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF 160 (476)
T ss_dssp ----EEEEEEECCSSEEHHHHTT--SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred ----EEEEEEeCCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEec
Confidence 5699999999999999984 445699999999999999999999998 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHL-KSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
|++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||........ .........
T Consensus 161 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~--~~~i~~~~~-- 233 (476)
T 2y94_A 161 GLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL--FKKICDGIF-- 233 (476)
T ss_dssp SSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH--HHHHHTTCC--
T ss_pred cchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH--HHHHhcCCc--
Confidence 9998754432 2345689999999999988765 6899999999999999999999986543221 111111100
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
..+..++.++.+||.+||+.||.+|||+.++++|.|...
T Consensus 234 --------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 234 --------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp --------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred --------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 011124577899999999999999999999999988753
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=364.80 Aligned_cols=259 Identities=26% Similarity=0.437 Sum_probs=214.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|.+.+.||+|+||.||+|.+... +..||+|.+.... .....+.+|+.+++.++||||+++++++...+.
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~-- 290 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKY-----SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-- 290 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGG-----TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCC-----CeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCc--
Confidence 45689999999999999999997643 3569999997654 346778999999999999999999999987763
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
.++||||+.+|+|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 291 --~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 291 --FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp --CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred --EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccc
Confidence 49999999999999999776666799999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+...... ........++..|+|||++.+..++.++|||||||++|||++ |..||......... .....
T Consensus 366 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~---~~~~~------- 434 (495)
T 1opk_A 366 RLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---ELLEK------- 434 (495)
T ss_dssp ECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HHHHT-------
T ss_pred eeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHc-------
Confidence 8754322 222334456788999999999999999999999999999999 99999765433221 11111
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
..+...+..++..+.+||.+||+.||.+|||+.++++.|+.+.+
T Consensus 435 -------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 435 -------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp -------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 11112233456889999999999999999999999999987754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=346.32 Aligned_cols=270 Identities=27% Similarity=0.420 Sum_probs=207.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|.+.+.||+|+||.||+|.+........+..||+|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 107 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP-- 107 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS--
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC--
Confidence 5699999999999999999986544344566789999997542 3344568899999999999999999999987764
Q ss_pred ceEEEEEeecCCCChHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC---Cce
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQ-----PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN---FKP 222 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~---~~~ 222 (393)
.++||||+++++|.+++..... ..+++..++.++.|++.||.|||+. ||+||||||+|||++.+ ..+
T Consensus 108 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 108 --RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp --CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred --cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceE
Confidence 4999999999999999965432 4588999999999999999999999 99999999999999844 469
Q ss_pred EEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHh
Q 035862 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVK 301 (393)
Q Consensus 223 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~ 301 (393)
||+|||++................|++.|+|||++.+..++.++||||||+++|+|++ |..||........ .....
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~~ 259 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---LEFVT 259 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---HHHHH
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH---HHHHh
Confidence 9999999875433222223344567899999999999999999999999999999998 9999976543221 11111
Q ss_pred hcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCC
Q 035862 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQG 365 (393)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 365 (393)
... ....+..++..+.+++.+||+.||.+||++.+++++|+.+....+..
T Consensus 260 ~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~~~ 309 (327)
T 2yfx_A 260 SGG--------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 309 (327)
T ss_dssp TTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHHHH
T ss_pred cCC--------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHHHh
Confidence 100 00111234578999999999999999999999999999998766543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=361.66 Aligned_cols=265 Identities=20% Similarity=0.272 Sum_probs=210.8
Q ss_pred HHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeee
Q 035862 66 ELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGY 142 (393)
Q Consensus 66 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~ 142 (393)
++....++|++.++||+|+||+||+|++.. .+..||+|++.+... .....+.+|..++..++||||++++++
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 142 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKN-----ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA 142 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcC-----CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 344456889999999999999999999754 345799999865311 122337789999999999999999999
Q ss_pred eecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCce
Q 035862 143 CSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP 222 (393)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 222 (393)
+...+ .+++||||+.||+|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.+|.+
T Consensus 143 ~~~~~----~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~v 214 (437)
T 4aw2_A 143 FQDDN----NLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHI 214 (437)
T ss_dssp EECSS----EEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred EeeCC----EEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCE
Confidence 98776 569999999999999999543 35689999999999999999999998 99999999999999999999
Q ss_pred EEeeccCCccCCCCCCccccccccccCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH-H
Q 035862 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE-----TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK-L 296 (393)
Q Consensus 223 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~-~ 296 (393)
||+|||++........ ......+||+.|+|||++. ...++.++|||||||++|||++|+.||.......... +
T Consensus 215 kL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i 293 (437)
T 4aw2_A 215 RLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293 (437)
T ss_dssp EECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred EEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhh
Confidence 9999999976543322 2234568999999999987 5678999999999999999999999998655432221 1
Q ss_pred HHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHHHHH
Q 035862 297 LEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEE--RPTMNQVVESLKLA 358 (393)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~~l~~l~~~ 358 (393)
......+.... ....++.++.+||.+||+.+|++ ||+++++++|.|..
T Consensus 294 ~~~~~~~~~p~--------------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~ 343 (437)
T 4aw2_A 294 MNHKERFQFPT--------------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS 343 (437)
T ss_dssp HTHHHHCCCCS--------------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred hhccccccCCc--------------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence 11111111110 00124578999999999988888 99999999998863
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=344.82 Aligned_cols=255 Identities=25% Similarity=0.353 Sum_probs=198.8
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc----ccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL----QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
++|++.+.||+|+||.||+|+... ....+..||+|++.+... .....+.+|+.+++.++||||+++++++...+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVT--GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG 94 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECS--STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred HHeEEEEEEEeCCCEEEEEEEEec--cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence 569999999999999999998642 123456799999976421 23345678999999999999999999998766
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+||
T Consensus 95 ----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Df 165 (327)
T 3a62_A 95 ----KLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDF 165 (327)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCC
T ss_pred ----EEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeC
Confidence 569999999999999998543 4588999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .......
T Consensus 166 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~i~~~~---- 237 (327)
T 3a62_A 166 GLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI--DKILKCK---- 237 (327)
T ss_dssp SCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHTC----
T ss_pred CcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHhCC----
Confidence 9987533221 1234567999999999999999999999999999999999999999865432211 1111110
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKL 357 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~ 357 (393)
...+..++.++.+|+.+||+.||.+|| ++.++++|.|.
T Consensus 238 ------------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f 280 (327)
T 3a62_A 238 ------------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280 (327)
T ss_dssp ------------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGG
T ss_pred ------------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcc
Confidence 011123457899999999999999999 89999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=362.93 Aligned_cols=253 Identities=26% Similarity=0.356 Sum_probs=198.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC---CcccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH---GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|++.+.||+|+||.||+|.+..+ +..||+|++... .......+.+|+.+++.++||||+++++++...+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKAT-----GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT-----CCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCC-----CCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 46799999999999999999997544 346999998753 2233455778999999999999999999998776
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE-GLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
.+++||||+++++|.+++... ..+++..++.++.||+.||+|||+ . ||+||||||+|||++.++.+||+|
T Consensus 222 ----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~D 292 (446)
T 4ejn_A 222 ----RLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITD 292 (446)
T ss_dssp ----EEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECC
T ss_pred ----EEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEcc
Confidence 569999999999999998543 468999999999999999999998 7 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
||++....... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ....
T Consensus 293 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i--~~~~--- 365 (446)
T 4ejn_A 293 FGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI--LMEE--- 365 (446)
T ss_dssp CCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHCC---
T ss_pred CCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH--HhCC---
Confidence 99997643322 1234578999999999999999999999999999999999999999765433221111 1100
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKL 357 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~ 357 (393)
...+..++.++.+||.+||+.||.+|| ++.++++|.|.
T Consensus 366 -------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f 408 (446)
T 4ejn_A 366 -------------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408 (446)
T ss_dssp -------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred -------------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence 011123457899999999999999999 99999999775
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=336.17 Aligned_cols=254 Identities=28% Similarity=0.441 Sum_probs=205.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|++.+.||+|+||.||+|.+..+ +..||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQS-----KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTT-----CCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccC-----CcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence 46799999999999999999997544 3469999986432 123456788999999999999999999998776
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+||
T Consensus 83 ----~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Df 153 (279)
T 3fdn_A 83 ----RVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADF 153 (279)
T ss_dssp ----EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSC
T ss_pred ----EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEec
Confidence 569999999999999998543 4589999999999999999999998 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|++...... ......|++.|+|||++.+..++.++||||||+++|+|++|..||............. ...
T Consensus 154 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~--- 223 (279)
T 3fdn_A 154 GWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS---RVE--- 223 (279)
T ss_dssp CEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---HTC---
T ss_pred cccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH---hCC---
Confidence 998654332 2234578999999999999999999999999999999999999998654332211111 110
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
...+..++..+.+|+.+||+.||.+|||+.++++|.|....
T Consensus 224 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 224 ------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp ------------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred ------------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 01112245778999999999999999999999999987654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=334.96 Aligned_cols=258 Identities=23% Similarity=0.307 Sum_probs=209.3
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
..++|++.+.||+|+||.||+|.+..+. ..+|+|++..........+.+|+.+++.++||||+++++++...+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 79 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTR-----IRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT-- 79 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCC-----cEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--
Confidence 4567999999999999999999975443 469999987765566778899999999999999999999998766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe---CCCCceEEee
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL---DGNFKPKLSD 226 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~D 226 (393)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ |++||||||+||++ +.++.+||+|
T Consensus 80 --~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~D 152 (277)
T 3f3z_A 80 --DIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLID 152 (277)
T ss_dssp --EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred --eEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEe
Confidence 569999999999999988543 4589999999999999999999999 99999999999999 7889999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
||++....... ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.......... ........
T Consensus 153 fg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~~~~~~- 225 (277)
T 3f3z_A 153 FGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML--KIREGTFT- 225 (277)
T ss_dssp CTTCEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHCCCC-
T ss_pred cccceeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHH--HHHhCCCC-
Confidence 99997654332 23456799999999988654 8999999999999999999999997654332211 11111000
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
........++..+.+|+.+||+.||.+|||+.++++|.|...
T Consensus 226 -----------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 226 -----------FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp -----------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred -----------CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 000000124578999999999999999999999999988654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=334.69 Aligned_cols=271 Identities=25% Similarity=0.405 Sum_probs=216.3
Q ss_pred cCCcccc-eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRML-KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|.+.. .||+|+||.||+|.+.. ...+..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--- 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRM---RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--- 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---
T ss_pred HHhhhhhccccccCceeEEEeEecc---CCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCC---
Confidence 4566766 89999999999998653 2345679999998653 23456688999999999999999999998432
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 83 --~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~ 156 (287)
T 1u59_A 83 --ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGL 156 (287)
T ss_dssp --SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred --CcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccc
Confidence 359999999999999998533 34589999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCcc-ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 230 AREGPTGDHTH-VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 230 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
+.......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~~i~~~---- 229 (287)
T 1u59_A 157 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFIEQG---- 229 (287)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---HHHHTT----
T ss_pred eeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH---HHHhcC----
Confidence 98754332221 2233456889999999998899999999999999999998 99999765443211 111110
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCCCCCCCC
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSSSTTT 371 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~~~~~~ 371 (393)
.....+..++.++.+++.+||+.||.+||++.+++++|+.+.............
T Consensus 230 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~~~~~ 283 (287)
T 1u59_A 230 ----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH 283 (287)
T ss_dssp ----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCSSCCC
T ss_pred ----------CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcccCCcc
Confidence 011122245688999999999999999999999999999999888777665544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=347.56 Aligned_cols=266 Identities=24% Similarity=0.388 Sum_probs=213.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|++.+.||+|+||.||+|.+........+..||+|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 101 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ-- 101 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS--
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCC--
Confidence 467999999999999999999876433334567799999976532 33456789999999999999999999997766
Q ss_pred cceEEEEEeecCCCChHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRA--------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK 221 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~ 221 (393)
..++||||+.+++|.+++.... ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++.
T Consensus 102 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 102 --PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred --ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCe
Confidence 3499999999999999985422 24578999999999999999999999 9999999999999999999
Q ss_pred eEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHH
Q 035862 222 PKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWV 300 (393)
Q Consensus 222 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~ 300 (393)
+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||......... ...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~ 253 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL---RFV 253 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH---HHH
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHH---HHH
Confidence 99999999976443332223344567889999999999999999999999999999999 89999765432211 111
Q ss_pred hhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
..... ...+..++..+.+|+.+||+.||.+|||+.+++++|.....
T Consensus 254 ~~~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 MEGGL--------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HTTCC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HcCCc--------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11000 01112345789999999999999999999999999988755
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=340.47 Aligned_cols=272 Identities=26% Similarity=0.340 Sum_probs=202.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc--cHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ--GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||+||+|.+..++ ..||+|++...... ....+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 75 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTG-----QIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR- 75 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCC-----cEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC-
Confidence 468999999999999999999975443 46999988655332 2456778999999999999999999998766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+.+++|.+++. ....+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||
T Consensus 76 ---~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 147 (311)
T 4agu_A 76 ---RLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFG 147 (311)
T ss_dssp ---EEEEEEECCSEEHHHHHHH--TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ---eEEEEEEeCCCchHHHHHh--hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCC
Confidence 5699999999999998873 345689999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc--
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA-- 305 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~-- 305 (393)
++........ ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||....................
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 225 (311)
T 4agu_A 148 FARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR 225 (311)
T ss_dssp TCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred CchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccc
Confidence 9986543222 2345578999999999876 6789999999999999999999999987655433222111100000
Q ss_pred ------CCcccccc--cCccc---ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 306 ------DGKKFSMM--IDPRL---RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 306 ------~~~~~~~~--~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
....+... .++.. .......++.++.+|+.+||+.||.+|||+.++++|.|..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 289 (311)
T 4agu_A 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289 (311)
T ss_dssp HHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGT
T ss_pred cccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHH
Confidence 00000000 00000 0000113567799999999999999999999999998764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=337.36 Aligned_cols=258 Identities=28% Similarity=0.435 Sum_probs=200.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.+.||+|+||.||+|.+. +..||+|.+... .....+.+|+.+++.++||||+++++++...
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----- 73 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-------AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNP----- 73 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-------TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTTT-----
T ss_pred hHeeeeeEeecCCCceEEEEEEC-------CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC-----
Confidence 56899999999999999999864 245999998754 3456788999999999999999999988633
Q ss_pred eEEEEEeecCCCChHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc-eEEeeccC
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQ-PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK-PKLSDFGL 229 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~-~kl~Dfg~ 229 (393)
.++||||+++++|.+++..... ..+++..++.++.|++.||.|||+....||+||||||+|||++.++. +||+|||+
T Consensus 74 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 74 -VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp -TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred -cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 3899999999999999964432 24788899999999999999999922129999999999999998887 79999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+...... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..................
T Consensus 153 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------ 221 (307)
T 2eva_A 153 ACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT------ 221 (307)
T ss_dssp -----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC------
T ss_pred ccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC------
Confidence 9754321 23346899999999999999999999999999999999999999754332221111111100
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcC
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 364 (393)
.......++..+.+++.+||+.||.+|||+.++++.|..+.+....
T Consensus 222 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 222 ---------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp ---------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred ---------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 0111123457799999999999999999999999999998765543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=341.95 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=207.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc------cHHHHHHHHHHhhcCCCCccceeeeeee
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ------GHKQWLAEVQFLGVVSHPNLVKLLGYCS 144 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~ 144 (393)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+...... ....+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTG-----LEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCC-----eEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 456999999999999999999975433 46999998764322 3567889999999999999999999998
Q ss_pred cCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC----
Q 035862 145 TEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF---- 220 (393)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~---- 220 (393)
..+ ..++||||+++++|.+++. ....+++..++.++.|++.||.|||+. ||+||||||+||+++.++
T Consensus 86 ~~~----~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~ 156 (321)
T 2a2a_A 86 NRT----DVVLILELVSGGELFDFLA--QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156 (321)
T ss_dssp CSS----EEEEEECCCCSCBHHHHHH--TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred cCC----EEEEEEEcCCCCcHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcC
Confidence 766 5699999999999999994 345689999999999999999999999 999999999999999888
Q ss_pred ceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHH
Q 035862 221 KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~ 300 (393)
.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||........ .....
T Consensus 157 ~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~i~ 231 (321)
T 2a2a_A 157 HIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LANIT 231 (321)
T ss_dssp CEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--HHHHH
T ss_pred CEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHH
Confidence 79999999998654432 22345799999999999999999999999999999999999999976543221 11111
Q ss_pred hhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
..... .+. ......+..+.+||.+||+.||++|||+.++++|.|.
T Consensus 232 -~~~~~-------~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~ 276 (321)
T 2a2a_A 232 -SVSYD-------FDE----EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276 (321)
T ss_dssp -TTCCC-------CCH----HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTT
T ss_pred -hcccc-------cCh----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 11000 000 0111245778999999999999999999999999774
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=356.65 Aligned_cols=277 Identities=22% Similarity=0.296 Sum_probs=192.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCC-
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED- 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~- 147 (393)
.++|++.+.||+|+||+||+|.+..++ ..||+|++.... ....+.+.+|+.+|+.++||||+++++++...+
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEK-----RVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC-------CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCC-----cEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 367999999999999999999976443 469999987542 234467889999999999999999999986543
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
.....+|+||||+ +++|.+++. ....+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+||
T Consensus 127 ~~~~~~~lv~e~~-~~~L~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DF 200 (458)
T 3rp9_A 127 EKFDELYVVLEIA-DSDFKKLFR--TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDF 200 (458)
T ss_dssp TTCCCEEEEECCC-SEEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCceEEEEEecc-ccchhhhcc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccc
Confidence 2223579999998 569999884 445699999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCc-------------------------cccccccccCCccCcccc-ccCCCCchhhHHHHHHHHHHHHh-
Q 035862 228 GLAREGPTGDHT-------------------------HVSTAVVGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILT- 280 (393)
Q Consensus 228 g~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~ellt- 280 (393)
|+++........ ......+||+.|+|||++ .+..|+.++|||||||++|||++
T Consensus 201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 999865422111 123456889999999976 56679999999999999999999
Q ss_pred ----------CCCccCCCCchh------------------hhH---HHHHHhhcCcCC-------------cccccccCc
Q 035862 281 ----------GRRVLERNRPTM------------------EQK---LLEWVKQFPADG-------------KKFSMMIDP 316 (393)
Q Consensus 281 ----------g~~pf~~~~~~~------------------~~~---~~~~~~~~~~~~-------------~~~~~~~~~ 316 (393)
|+++|.+..... ... +.......+... ..+......
T Consensus 281 ~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (458)
T 3rp9_A 281 IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGT 360 (458)
T ss_dssp STTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCC
T ss_pred ccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCC
Confidence 667775533100 000 000000000000 000000000
Q ss_pred ccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 317 RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 317 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.+. .....++.++.+||.+||..||++|||+.++++|.|...
T Consensus 361 ~~~-~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~ 402 (458)
T 3rp9_A 361 DLA-ERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE 402 (458)
T ss_dssp CGG-GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred CHH-HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhh
Confidence 000 111234678999999999999999999999999988643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=338.44 Aligned_cols=270 Identities=24% Similarity=0.415 Sum_probs=203.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|.+.+.||+|+||.||+|.+... ...+..||+|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQE--DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECT--TSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred HHHeeeccceeecCCeEEEEEEEecc--CCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 46799999999999999999987532 2345679999987543 2334668899999999999999999999877653
Q ss_pred cc-ceEEEEEeecCCCChHHHHhh----cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceE
Q 035862 149 RG-IQRLLVYEYMPNRSLEDRLFS----RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPK 223 (393)
Q Consensus 149 ~~-~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~k 223 (393)
.+ ...++||||+.+++|.+++.. .....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEE
Confidence 21 245899999999999999843 2345689999999999999999999998 999999999999999999999
Q ss_pred EeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhh
Q 035862 224 LSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQ 302 (393)
Q Consensus 224 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~ 302 (393)
|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||........... ....
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~--~~~~ 265 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY--LLHG 265 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH--HHTT
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH--HHcC
Confidence 999999986544433333344567889999999999999999999999999999999 8899976544322111 1111
Q ss_pred cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
. ....+..++..+.+++.+||..||.+|||+.+++++|..+.+..
T Consensus 266 ~---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 266 H---------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp C---------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred C---------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 0 01112234578999999999999999999999999999988654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=365.77 Aligned_cols=258 Identities=29% Similarity=0.461 Sum_probs=212.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|++.+.||+|+||.||+|.+..+ +..||+|++.+.. ......+.+|+.+|+.++||||+++++++...+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~t-----g~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRAT-----GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTT-----CCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCC-----CCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC
Confidence 46799999999999999999997644 3469999986532 123456788999999999999999999998776
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
.+|+||||++||+|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+||
T Consensus 258 ----~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DF 330 (576)
T 2acx_A 258 ----ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDL 330 (576)
T ss_dssp ----EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred ----EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEec
Confidence 569999999999999999766556699999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhh-hHHHHHHhhcCcC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTME-QKLLEWVKQFPAD 306 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~ 306 (393)
|++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||........ ..+.......+.
T Consensus 331 Gla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~- 406 (576)
T 2acx_A 331 GLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE- 406 (576)
T ss_dssp TTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC-
T ss_pred ccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc-
Confidence 9998754432 22345899999999999999999999999999999999999999986543211 112222211111
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKLA 358 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~~ 358 (393)
.++..++.++.+||.+||+.||.+|| ++.++++|.|..
T Consensus 407 --------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~ 449 (576)
T 2acx_A 407 --------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449 (576)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred --------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence 11223567899999999999999999 899999997653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=332.88 Aligned_cols=263 Identities=26% Similarity=0.363 Sum_probs=209.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|.+.+.||+|+||.||+|.+... ......||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 86 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNH--KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-- 86 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECT--TCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSS--
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCC--CCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC--
Confidence 45799999999999999999987533 2356679999987653 234567889999999999999999999986443
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
.++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||+
T Consensus 87 ---~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 87 ---TWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp ---CEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred ---CEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCC
Confidence 389999999999999996543 4589999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+......... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.................
T Consensus 160 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~------ 232 (281)
T 3cc6_A 160 SRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDR------ 232 (281)
T ss_dssp GGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCC------
T ss_pred Cccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCC------
Confidence 9865433221 2234467889999999999999999999999999999998 9999975544322211111100
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
...+..+++.+.+++.+||+.||.+|||+.+++++|..+.+..
T Consensus 233 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 233 -----------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp -----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 0111224577999999999999999999999999999887643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=343.59 Aligned_cols=277 Identities=29% Similarity=0.431 Sum_probs=213.0
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccce
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQ 152 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 152 (393)
|++++.||+|+||+||++.+.... ...+..||+|++..... .....+.+|+.+++.++||||+++++++...+.. .
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTN-DGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA--S 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC---CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT--E
T ss_pred HhhhheecCCCCeEEEEEEEccCC-CCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc--e
Confidence 488999999999999999765433 34677899999986532 3356688999999999999999999999876443 6
Q ss_pred EEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 153 RLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
.++||||+++++|.+++... .+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++..
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccc
Confidence 69999999999999998543 389999999999999999999999 999999999999999999999999999987
Q ss_pred CCCCCCc-cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC---Cc
Q 035862 233 GPTGDHT-HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD---GK 308 (393)
Q Consensus 233 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~ 308 (393)
....... .......++..|+|||++.+..++.++||||||+++|+|++|..||........... ..... ..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-----~~~~~~~~~~ 258 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELI-----GIAQGQMTVL 258 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHH-----CSCCHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhh-----cccccchhHH
Confidence 6543322 123445688889999999999999999999999999999999999965322110000 00000 00
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcC
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 364 (393)
.....+........+..++.++.+|+.+||+.||.+|||+.++++.|+.+.+....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 00000111111222334568899999999999999999999999999998876543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=335.51 Aligned_cols=268 Identities=16% Similarity=0.170 Sum_probs=211.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcC-CCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 149 (393)
.++|++.+.||+|+||.||+|.+.. .+..||+|++.... ....+.+|+.+++.+ +|+|++++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-- 79 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLL-----NNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-- 79 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETT-----TTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT--
T ss_pred ccceEEEEEEeecCCEEEEEEEECC-----CCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc--
Confidence 3579999999999999999999643 34579999986543 234577899999999 6999999999987666
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc-----eEE
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK-----PKL 224 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~-----~kl 224 (393)
..++||||+ +++|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++. +||
T Consensus 80 --~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 80 --HNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp --EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred --eeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEE
Confidence 569999999 99999999644 34589999999999999999999998 9999999999999987776 999
Q ss_pred eeccCCccCCCCCCc-----cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHH
Q 035862 225 SDFGLAREGPTGDHT-----HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW 299 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~ 299 (393)
+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............
T Consensus 153 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 232 (298)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred EECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHH
Confidence 999999865433221 123456799999999999999999999999999999999999999987543322221111
Q ss_pred HhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcC
Q 035862 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364 (393)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 364 (393)
....... .........++.++.+++.+||+.||++||++.++++.|..+......
T Consensus 233 ~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 233 IGEKKQS----------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HHHHHHH----------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHhhccC----------ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 1100000 000001113457899999999999999999999999999999876544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=361.71 Aligned_cols=259 Identities=28% Similarity=0.431 Sum_probs=210.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|.+.+.||+|+||.||+|.+.. ...||+|.+.... .....+.+|+.+++.++||||+++++++.. +
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~-~--- 255 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNK------HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-E--- 255 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETT------TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECS-S---
T ss_pred hHHeEEEEEcccCCceEEEEEEECC------ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC-C---
Confidence 4679999999999999999998742 3469999998654 456788999999999999999999999863 2
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+|+|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 256 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 256 -PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp -SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred -ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 349999999999999999654444688999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+...... ........++..|+|||++.+..++.++|||||||++|||++ |..||............ ....
T Consensus 332 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i--~~~~------ 402 (454)
T 1qcf_A 332 RVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL--ERGY------ 402 (454)
T ss_dssp GGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH--HHTC------
T ss_pred eEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH--HcCC------
Confidence 8653221 112233456778999999999999999999999999999999 99999865433221111 1111
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
+...+..++.++.+||.+||+.||++|||+.++++.|+.+....
T Consensus 403 ---------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 403 ---------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp ---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred ---------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 11112245688999999999999999999999999998876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=335.60 Aligned_cols=261 Identities=30% Similarity=0.480 Sum_probs=195.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||+||+|.+.. .+|+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 92 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-- 92 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--------EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--------ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCC--
Confidence 3579999999999999999998531 28999987543 23346688999999999999999999976433
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 93 ---~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg 165 (289)
T 3og7_A 93 ---QLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFG 165 (289)
T ss_dssp ---SCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred ---ccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccce
Confidence 348999999999999988543 35689999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIE---TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
++................||+.|+|||++. +..++.++||||||+++|+|++|..||........ ..........
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~~ 243 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGRGSL 243 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHHTSC
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhccccc
Confidence 997654333333344567999999999986 56788999999999999999999999976544322 1111111111
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
.. . .......++..+.+|+.+||+.||.+|||+.++++.|+.+.+
T Consensus 244 ~~---------~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 244 SP---------D-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CC---------C-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred Cc---------c-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 00 0 001112346789999999999999999999999999988754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=347.82 Aligned_cols=258 Identities=22% Similarity=0.374 Sum_probs=198.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCC--CccceeeeeeecC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSH--PNLVKLLGYCSTE 146 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~ 146 (393)
.++|++.+.||+|+||.||+|.+. .+..||+|++..... .....+.+|+.+++.++| |||+++++++...
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 81 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 81 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC
Confidence 356999999999999999999853 244699999875432 334667899999999986 9999999999876
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
+ ..++|||+ .+++|.+++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||++ ++.+||+|
T Consensus 82 ~----~~~lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~D 150 (343)
T 3dbq_A 82 Q----YIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID 150 (343)
T ss_dssp S----EEEEEECC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECC
T ss_pred C----EEEEEEeC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEee
Confidence 6 56999995 57899999954 35689999999999999999999999 999999999999997 68899999
Q ss_pred ccCCccCCCCCCccccccccccCCccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-----------GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK 295 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~ 295 (393)
||++................||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 151 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~ 230 (343)
T 3dbq_A 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 230 (343)
T ss_dssp CSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred cccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHH
Confidence 999987654433333445689999999999865 678999999999999999999999997643322211
Q ss_pred HHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
.... +.......+...+.++.+|+.+||+.||.+|||+.++++|.|...+
T Consensus 231 -~~~~--------------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 231 -HAII--------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp -HHHH--------------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred -HHHh--------------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 1111 1111111122234678999999999999999999999999987643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=330.45 Aligned_cols=255 Identities=22% Similarity=0.357 Sum_probs=206.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||.||+|.+. +..||+|++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 357999999999999999999874 3459999987653 2334568899999999999999999999987643
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCCeEeCCCCceEEee
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQ--VIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~--ivH~Dikp~NIll~~~~~~kl~D 226 (393)
. ..++||||+++++|.+++.......+++..++.++.|++.||.|||+. + ++||||||+||+++.++.++|+|
T Consensus 82 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~ 156 (271)
T 3kmu_A 82 P--HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISM 156 (271)
T ss_dssp S--SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred C--CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEe
Confidence 3 459999999999999999766555789999999999999999999998 8 99999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCc---hhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKS---QSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
||++..... ....||+.|+|||++.+..++. ++||||||+++|+|++|..||.......... .....
T Consensus 157 ~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--~~~~~- 226 (271)
T 3kmu_A 157 ADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM--KVALE- 226 (271)
T ss_dssp GGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH--HHHHS-
T ss_pred ccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH--HHHhc-
Confidence 988754322 2347899999999998765544 8999999999999999999997654432211 11111
Q ss_pred CcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 304 PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
......+..++.++.+++.+||+.||++|||+.++++.|..+.+
T Consensus 227 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 -------------GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 01111222356789999999999999999999999999988753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=343.46 Aligned_cols=260 Identities=22% Similarity=0.350 Sum_probs=201.1
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
..++|++.+.||+|+||.||+|++..++ ..||+|++..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDD-----CNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTC-----CEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCC-----cEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence 3567999999999999999999976443 4699999875432 345678899999999999999999999865432
Q ss_pred -----------------------------------------------------ccceEEEEEeecCCCChHHHHhhcCC-
Q 035862 149 -----------------------------------------------------RGIQRLLVYEYMPNRSLEDRLFSRAQ- 174 (393)
Q Consensus 149 -----------------------------------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~- 174 (393)
...+.++||||+++++|.+++.....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 11247999999999999999965432
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCc----------ccccc
Q 035862 175 PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHT----------HVSTA 244 (393)
Q Consensus 175 ~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~ 244 (393)
...++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++......... .....
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccc
Confidence 2345667899999999999999998 9999999999999999999999999999875543211 12234
Q ss_pred ccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCH
Q 035862 245 VVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSI 324 (393)
Q Consensus 245 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (393)
..||+.|+|||++.+..++.++|||||||++|+|++|..|+... ........... ......
T Consensus 236 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~~~~~~~--------------~~~~~~ 296 (332)
T 3qd2_B 236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIITDVRNLK--------------FPLLFT 296 (332)
T ss_dssp CC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHHHHHTTC--------------CCHHHH
T ss_pred cCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHHHhhccC--------------CCcccc
Confidence 57999999999999999999999999999999999987665311 11111111100 011122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 325 NAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 325 ~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
..+.++.+|+.+||+.||++|||+.++++|.|
T Consensus 297 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~ 328 (332)
T 3qd2_B 297 QKYPQEHMMVQDMLSPSPTERPEATDIIENAI 328 (332)
T ss_dssp HHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTT
T ss_pred cCChhHHHHHHHHccCCCCcCCCHHHHhhchh
Confidence 44577899999999999999999999999865
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=346.58 Aligned_cols=271 Identities=23% Similarity=0.324 Sum_probs=198.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc--cHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ--GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||+||+|.+.. .+..||+|++...... ....+.+|+.+++.++||||+++++++...+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 106 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTV-----TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH- 106 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETT-
T ss_pred hhhEEEEEEEEecCCeEEEEEEECC-----CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCC-
Confidence 4679999999999999999998653 3457999999754322 2345678999999999999999999998776
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe-----CCCCceE
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL-----DGNFKPK 223 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll-----~~~~~~k 223 (393)
..++||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+|
T Consensus 107 ---~~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~k 177 (329)
T 3gbz_A 107 ---RLHLIFEYAEN-DLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLK 177 (329)
T ss_dssp ---EEEEEEECCSE-EHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEE
T ss_pred ---EEEEEEecCCC-CHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEE
Confidence 56999999975 99999854 34589999999999999999999999 99999999999999 4555699
Q ss_pred EeeccCCccCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhh
Q 035862 224 LSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ 302 (393)
Q Consensus 224 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (393)
|+|||++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.................
T Consensus 178 l~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 255 (329)
T 3gbz_A 178 IGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLG 255 (329)
T ss_dssp ECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred ECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhC
Confidence 99999997643221 123445789999999999774 589999999999999999999999987654332221111111
Q ss_pred cCcCCc------------ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 303 FPADGK------------KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 303 ~~~~~~------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.+.... .+.......+.......++.++.+||.+||+.||.+|||+.++++|.|..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 323 (329)
T 3gbz_A 256 LPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323 (329)
T ss_dssp CCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred CCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccC
Confidence 111110 00111111111111222567889999999999999999999999998753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=344.89 Aligned_cols=266 Identities=24% Similarity=0.262 Sum_probs=204.4
Q ss_pred HHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-----CcccHHHHHHHHHHhhcCCCCccceeee
Q 035862 67 LREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-----GLQGHKQWLAEVQFLGVVSHPNLVKLLG 141 (393)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~ 141 (393)
+....++|++.+.||+|+||.||+|.+..+ +..||+|++... .......+.+|+.+++.++||||+++++
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 95 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQT-----RAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE 95 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTT-----CCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCC-----CceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeeh
Confidence 345667899999999999999999986544 346999988643 2244567889999999999999999999
Q ss_pred eeecCCcccceEEEEEeecCCCChHHHHhhcC--------------------------------------CCCCCHHHHH
Q 035862 142 YCSTEDERGIQRLLVYEYMPNRSLEDRLFSRA--------------------------------------QPTLPWKTRL 183 (393)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------~~~~~~~~~~ 183 (393)
++...+ ..++||||+++++|.+++.... ...+++..++
T Consensus 96 ~~~~~~----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (345)
T 3hko_A 96 VYEDEQ----YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLIS 171 (345)
T ss_dssp EEECSS----EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHH
T ss_pred hhccCC----eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHH
Confidence 998766 5699999999999999884110 1123577888
Q ss_pred HHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC--ceEEeeccCCccCCCCCC--ccccccccccCCccCcccccc
Q 035862 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF--KPKLSDFGLAREGPTGDH--THVSTAVVGTYGYAAPEYIET 259 (393)
Q Consensus 184 ~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~--~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~ 259 (393)
.++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||++........ ........||+.|+|||++.+
T Consensus 172 ~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 172 NIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHHHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 9999999999999999 999999999999998777 899999999975422111 112345679999999999975
Q ss_pred --CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHh
Q 035862 260 --GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNC 337 (393)
Q Consensus 260 --~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 337 (393)
..++.++|||||||++|+|++|+.||......... ......... ........++.++.+||.+|
T Consensus 249 ~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~------------~~~~~~~~~~~~~~~li~~~ 314 (345)
T 3hko_A 249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI--SQVLNKKLC------------FENPNYNVLSPLARDLLSNL 314 (345)
T ss_dssp SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHCCCC------------TTSGGGGGSCHHHHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHH--HHHHhcccc------------cCCcccccCCHHHHHHHHHH
Confidence 67899999999999999999999999765443221 111111100 00011112457899999999
Q ss_pred cccCCCCCCCHHHHHHHHHHH
Q 035862 338 LKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 338 l~~dp~~Rps~~~~l~~l~~~ 358 (393)
|+.||.+||++.++++|.|..
T Consensus 315 l~~~p~~Rps~~~~l~hp~~~ 335 (345)
T 3hko_A 315 LNRNVDERFDAMRALQHPWIS 335 (345)
T ss_dssp SCSCTTTSCCHHHHHHSHHHH
T ss_pred cCCChhHCCCHHHHhcChhhc
Confidence 999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=340.18 Aligned_cols=275 Identities=26% Similarity=0.401 Sum_probs=209.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+.|++.+.||+|+||.||+|.+... ....+..||+|.+.... ......+.+|+.+++.++||||+++++++...+..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~- 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPE-GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN- 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTT-SSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C-
T ss_pred hhhhhhhccCCCCceEEEEEEEccc-cCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc-
Confidence 3488999999999999999986432 23466789999987543 23456788999999999999999999999876433
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 99 -~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 99 -GIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred -eEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence 4689999999999999985543 4589999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCc-cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc-
Q 035862 231 REGPTGDHT-HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK- 308 (393)
Q Consensus 231 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~- 308 (393)
......... .......||..|+|||++.+..++.++||||||+++|+|++|..|+....... ..... +..+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~--~~~~~~ 247 (302)
T 4e5w_A 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF----LKMIG--PTHGQM 247 (302)
T ss_dssp EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH----HHHHC--SCCGGG
T ss_pred ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHH----hhccC--Cccccc
Confidence 876543322 22345578888999999999999999999999999999999999874321100 00000 00000
Q ss_pred c---cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 309 K---FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 309 ~---~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
. ....+........+..+++++.+|+.+||+.||.+|||+.++++.|+.++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0 00000011112223345688999999999999999999999999999876
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=339.24 Aligned_cols=267 Identities=26% Similarity=0.440 Sum_probs=206.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|.+.+.||+|+||.||+|.+...+ ......||+|.+..... .....+.+|+.+++.++||||+++++++...+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 119 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSS-GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK--- 119 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS---
T ss_pred HHhhcccEEecCCCeEEEEEEEecCC-CCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC---
Confidence 46888999999999999999876433 23456799999976532 33456789999999999999999999997765
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 120 -~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 120 -PMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp -SEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred -CcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcc
Confidence 459999999999999998643 35689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCcc-ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 231 REGPTGDHTH-VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 231 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
.......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||........ .......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~~~~~~~----- 266 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---MKAINDG----- 266 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHTT-----
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHHCC-----
Confidence 8654322111 1223456788999999999999999999999999999999 9999976543221 1111110
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcC
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 364 (393)
.....+..++..+.+++.+||+.||.+||++.+++++|+.++.....
T Consensus 267 ---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~ 313 (333)
T 1mqb_A 267 ---------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313 (333)
T ss_dssp ---------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred ---------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence 00111223457899999999999999999999999999998875543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=358.26 Aligned_cols=261 Identities=28% Similarity=0.406 Sum_probs=206.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.+.||+|+||.||+|.+.. ...||+|.+.... .....+.+|+.+++.++||||+++++++.. +
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~--- 251 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E--- 251 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT------TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S---
T ss_pred hhHceeeeeecCCCCeEEEEEEECC------CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C---
Confidence 4578999999999999999998753 2359999998654 345678999999999999999999999865 2
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+|+|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 252 -~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a 327 (452)
T 1fmk_A 252 -PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 327 (452)
T ss_dssp -SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred -ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccc
Confidence 348999999999999999654445689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+....... .......++..|+|||++.+..++.++|||||||++|||++ |..||......... .....
T Consensus 328 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~~i~~------- 396 (452)
T 1fmk_A 328 RLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL---DQVER------- 396 (452)
T ss_dssp C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHHT-------
T ss_pred eecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHc-------
Confidence 86543221 12234456788999999999999999999999999999999 99999765432211 11111
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcC
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 364 (393)
..+...+..++..+.+|+.+||+.||++|||+.++++.|..+....+.
T Consensus 397 -------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 397 -------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp -------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 011112234567899999999999999999999999999988754443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=345.36 Aligned_cols=272 Identities=24% Similarity=0.363 Sum_probs=201.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-cHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|.+.+.||+|+||+||+|.+..++ ..||+|++...... ....+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 73 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTD-----NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK--- 73 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS---
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCC-----cEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC---
Confidence 57999999999999999999975443 46999998754322 1123457999999999999999999998776
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+. ++|.+++... ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 74 -~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 147 (324)
T 3mtl_A 74 -SLTLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA 147 (324)
T ss_dssp -CEEEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred -EEEEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccc
Confidence 4599999996 5999988654 34589999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..................+... .
T Consensus 148 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~-~ 224 (324)
T 3mtl_A 148 RAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEE-T 224 (324)
T ss_dssp ECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT-T
T ss_pred ccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChH-h
Confidence 7643322 12344578999999999876 578999999999999999999999998765443322222211111111 0
Q ss_pred cccccC---------ccc----ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 310 FSMMID---------PRL----RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 310 ~~~~~~---------~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
+..... +.. .......++.++.+||.+||+.||.+|||+.++++|.|..-.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 000000 000 000112346788999999999999999999999999987643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=348.60 Aligned_cols=279 Identities=22% Similarity=0.304 Sum_probs=217.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|.+.+.||+|+||+||+|.+..++ ..||+|++.... ......+.+|+++++.++||||+++++++...+..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 82 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTG-----DLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR 82 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCC-----cEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence 357999999999999999999976443 469999987543 23356678999999999999999999998876543
Q ss_pred cceEEEEEeecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe----CCCCceEE
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRA-QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL----DGNFKPKL 224 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll----~~~~~~kl 224 (393)
..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. ||+||||||+|||+ +.++.+||
T Consensus 83 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (396)
T 4eut_A 83 --HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKL 157 (396)
T ss_dssp --CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEE
T ss_pred --eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEE
Confidence 5599999999999999995433 23489999999999999999999999 99999999999999 77788999
Q ss_pred eeccCCccCCCCCCccccccccccCCccCcccccc--------CCCCchhhHHHHHHHHHHHHhCCCccCCCCch--hhh
Q 035862 225 SDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET--------GHLKSQSDIWSFGVVLYEILTGRRVLERNRPT--MEQ 294 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~elltg~~pf~~~~~~--~~~ 294 (393)
+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...
T Consensus 158 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~ 234 (396)
T 4eut_A 158 TDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (396)
T ss_dssp CCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH
T ss_pred ecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHH
Confidence 9999998654322 2345679999999999865 56788999999999999999999999754322 122
Q ss_pred HHHHHHhhcCcCCcc-ccccc--------CcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 295 KLLEWVKQFPADGKK-FSMMI--------DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 295 ~~~~~~~~~~~~~~~-~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
.+.......+..... ..... .-.........++..+.+++.+||+.||++||++.++++.+..++...
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred HHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 222333322221100 00000 111122345678899999999999999999999999999999988643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=333.12 Aligned_cols=259 Identities=24% Similarity=0.362 Sum_probs=207.6
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
..++|++.+.||+|+||.||+|.+..++ ..||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 78 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTE-----EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN- 78 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCC-----cEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC-
Confidence 3567999999999999999999975433 469999986442 234467889999999999999999999998766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+++++|.+++ .....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||
T Consensus 79 ---~~~lv~e~~~~~~L~~~l--~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 150 (276)
T 2yex_A 79 ---IQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG 150 (276)
T ss_dssp ---EEEEEEECCTTEEGGGGS--BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ---EEEEEEEecCCCcHHHHH--hhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCC
Confidence 569999999999999988 3445689999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHL-KSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
++................|++.|+|||++.+..+ +.++||||||+++|+|++|..||........ ....+......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~-- 227 (276)
T 2yex_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKTY-- 227 (276)
T ss_dssp TCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTTCTT--
T ss_pred CccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhcccc--
Confidence 9976533322223345678999999999987665 7899999999999999999999976543221 11111111000
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
. .....++..+.+|+.+||+.||.+|||+.++++|.|.
T Consensus 228 ------~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (276)
T 2yex_A 228 ------L------NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265 (276)
T ss_dssp ------S------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred ------c------CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccc
Confidence 0 0011345778999999999999999999999998764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=355.02 Aligned_cols=264 Identities=21% Similarity=0.258 Sum_probs=208.9
Q ss_pred HHHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeee
Q 035862 65 QELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLG 141 (393)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~ 141 (393)
.+.....++|++.+.||+|+||.||+|++..+ +..||+|++.+... .....+.+|..++..++||||+++++
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~-----~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~ 128 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQT-----GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTT-----CCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCC-----CCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 34444568899999999999999999997543 34699999875321 22334778999999999999999999
Q ss_pred eeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc
Q 035862 142 YCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK 221 (393)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~ 221 (393)
++.+.+ .+|+||||+.||+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.+|.
T Consensus 129 ~~~~~~----~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~ 200 (412)
T 2vd5_A 129 AFQDEN----YLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGH 200 (412)
T ss_dssp EEECSS----EEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred EEeeCC----EEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCC
Confidence 998776 6699999999999999996532 3689999999999999999999998 9999999999999999999
Q ss_pred eEEeeccCCccCCCCCCccccccccccCCccCccccc-------cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhh
Q 035862 222 PKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE-------TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ 294 (393)
Q Consensus 222 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~ 294 (393)
+||+|||++........ ......+||+.|+|||++. ...++.++|||||||++|||++|+.||.........
T Consensus 201 vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~ 279 (412)
T 2vd5_A 201 IRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY 279 (412)
T ss_dssp EEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred EEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999986543322 1233468999999999997 357899999999999999999999999865543221
Q ss_pred H-HHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHHHHH
Q 035862 295 K-LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER---PTMNQVVESLKL 357 (393)
Q Consensus 295 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~~~l~~l~~ 357 (393)
. +.......... .....++.++.+||.+||+ +|.+| |+++++++|.|.
T Consensus 280 ~~i~~~~~~~~~p--------------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff 331 (412)
T 2vd5_A 280 GKIVHYKEHLSLP--------------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF 331 (412)
T ss_dssp HHHHTHHHHCCCC------------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred HHHHhcccCcCCC--------------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence 1 11111111100 0112346889999999999 99998 599999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=333.24 Aligned_cols=258 Identities=24% Similarity=0.351 Sum_probs=207.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||.||+|.+..++ ..||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 78 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTG-----LEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES- 78 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCC-----ceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC-
Confidence 578999999999999999999976443 469999986543 233456788999999999999999999998766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc---eEEe
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK---PKLS 225 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~ 225 (393)
..++||||+.+++|.+++... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++. +||+
T Consensus 79 ---~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 79 ---FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp ---EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred ---EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEe
Confidence 559999999999999988544 4589999999999999999999999 9999999999999987665 9999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||............ .... .
T Consensus 151 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~--~~~~-~ 224 (284)
T 3kk8_A 151 DFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGA-Y 224 (284)
T ss_dssp CCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHTC-C
T ss_pred eceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHH--Hhcc-c
Confidence 999997654332 223467999999999999999999999999999999999999999765433221111 1110 0
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
. ........++.++.+|+.+||+.||++|||+.++++|.|...
T Consensus 225 ~-----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (284)
T 3kk8_A 225 D-----------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267 (284)
T ss_dssp C-----------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred c-----------CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence 0 000001134577999999999999999999999999998754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=332.29 Aligned_cols=261 Identities=22% Similarity=0.271 Sum_probs=207.0
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC----cccHHHHHHHHHHhhcCCCCccceeeeeeec
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG----LQGHKQWLAEVQFLGVVSHPNLVKLLGYCST 145 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 145 (393)
..++|.+.+.||+|+||.||+|.+.. .+..||+|.+.... ......+.+|+.+++.++||||+++++++..
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~-----~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 77 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSE-----TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN 77 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTT-----TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccceeEeeEEecCCCeEEEEEEECC-----CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc
Confidence 35789999999999999999998643 33469999987532 2334678899999999999999999999865
Q ss_pred CCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 146 EDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
.+.. ..++||||+.++ |.+++.......+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+
T Consensus 78 ~~~~--~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~ 151 (305)
T 2wtk_C 78 EEKQ--KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKIS 151 (305)
T ss_dssp C-----CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred CCCC--eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEee
Confidence 4433 569999999775 88888766667799999999999999999999999 99999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCC--CCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGH--LKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
|||++................|++.|+|||++.+.. ++.++||||||+++|+|++|..||........ .......
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~i~~~ 228 (305)
T 2wtk_C 152 ALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL---FENIGKG 228 (305)
T ss_dssp CCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHC
T ss_pred ccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH---HHHHhcC
Confidence 999998754433333344567999999999997644 47899999999999999999999986543221 1111110
Q ss_pred CcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 304 PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.. ..+..++..+.+|+.+||+.||.+|||+.++++|.|...
T Consensus 229 ~~---------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 229 SY---------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp CC---------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred CC---------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 00 011124577899999999999999999999999988764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=333.33 Aligned_cols=261 Identities=29% Similarity=0.435 Sum_probs=209.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.+.||+|+||.||+|.+.. +..||+|.+.... .....+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 80 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNG------HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE---- 80 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred HHhhhheeeecCCCCeEEEEEEEcC------CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCC----
Confidence 4679999999999999999998642 3469999987654 3456788999999999999999999988643
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+++|.+++.......+++..++.++.|++.||.|||++ |++||||||+||++++++.+||+|||++
T Consensus 81 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 156 (279)
T 1qpc_A 81 -PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA 156 (279)
T ss_dssp -SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred -CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccc
Confidence 248999999999999999544334689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||........ .......
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~~~~------ 226 (279)
T 1qpc_A 157 RLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQNLERG------ 226 (279)
T ss_dssp EECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHTT------
T ss_pred ccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---HHHHhcc------
Confidence 87543321 12234467789999999998899999999999999999999 9999976543221 1111110
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcC
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 364 (393)
.....+..++.++.+++.+||+.||++|||+.++++.|+.+......
T Consensus 227 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 227 --------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred --------cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 00111223457899999999999999999999999999998875443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=346.15 Aligned_cols=255 Identities=24% Similarity=0.345 Sum_probs=181.8
Q ss_pred cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCccceeeeeeecCCcccceEEE
Q 035862 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDERGIQRLL 155 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~l 155 (393)
.+.||+|+||.||+|.+..++ ..||+|++... ....+.+|+.+++.+. ||||+++++++.... ..++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~----~~~l 83 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSN-----QAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQL----HTFL 83 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTC-----CEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----EEEE
T ss_pred CCccccCCCeEEEEEEECCCC-----CEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC----EEEE
Confidence 378999999999999976443 46999998653 3456778999999997 999999999998776 5699
Q ss_pred EEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC---ceEEeeccCCcc
Q 035862 156 VYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF---KPKLSDFGLARE 232 (393)
Q Consensus 156 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~---~~kl~Dfg~a~~ 232 (393)
||||+++++|.+++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||++..
T Consensus 84 v~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 84 VMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp EECCCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred EEEccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 9999999999999954 35689999999999999999999999 999999999999997766 799999999986
Q ss_pred CCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhh-HHHHHHhhcCcCCcccc
Q 035862 233 GPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ-KLLEWVKQFPADGKKFS 311 (393)
Q Consensus 233 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~ 311 (393)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... ........+.....
T Consensus 159 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~--- 233 (325)
T 3kn6_A 159 KPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF--- 233 (325)
T ss_dssp CCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC---
T ss_pred cCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC---
Confidence 443221 234567899999999999999999999999999999999999999765432110 00111111100000
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.........++.++.+||.+||+.||.+|||+.++++|.|..
T Consensus 234 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~ 275 (325)
T 3kn6_A 234 -----SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275 (325)
T ss_dssp -----CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred -----CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence 001111123568899999999999999999999999998864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=332.04 Aligned_cols=250 Identities=30% Similarity=0.469 Sum_probs=194.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc----ccHHHHHHHHHHhhcCCCCccceeeeeeecC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL----QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTE 146 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 146 (393)
.++|++.+.||+|+||.||+|.+. +..||+|++..... .....+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357999999999999999999864 23599999875432 2346688999999999999999999999876
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC---eEeccCCCCCeEeCC-----
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQ---VIYRDFKTSNVLLDG----- 218 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~---ivH~Dikp~NIll~~----- 218 (393)
+ ..++||||+++++|.+++. ...+++..++.++.|++.||.|||++ + ++||||||+|||++.
T Consensus 79 ~----~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~ 148 (271)
T 3dtc_A 79 P----NLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENG 148 (271)
T ss_dssp ------CEEEEECCTTEEHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSS
T ss_pred C----ceEEEEEcCCCCCHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccc
Confidence 6 4599999999999999883 34689999999999999999999998 7 999999999999986
Q ss_pred ---CCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH
Q 035862 219 ---NFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK 295 (393)
Q Consensus 219 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~ 295 (393)
++.+||+|||++....... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||..........
T Consensus 149 ~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 224 (271)
T 3dtc_A 149 DLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY 224 (271)
T ss_dssp CCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH
T ss_pred cccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 7789999999997643322 224578999999999999999999999999999999999999998654332211
Q ss_pred HHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.. ... ......+..++..+.+++.+||+.||.+|||+.+++++|..
T Consensus 225 ~~--~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 225 GV--AMN--------------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HH--HTS--------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred hh--hcC--------------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11 000 01111222345789999999999999999999999999974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=343.16 Aligned_cols=249 Identities=22% Similarity=0.277 Sum_probs=194.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcC-CCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 148 (393)
++|++.++||+|+||+||+|.+..+ +..||+|++..... ........|+..+..+ +||||+++++++...+
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~- 130 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKED-----GRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG- 130 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTT-----SCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred hheeeeheeccCCCeEEEEEEECCC-----CeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC-
Confidence 5799999999999999999997643 34699999865432 2233445555555554 8999999999998766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 131 ---~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 131 ---ILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp ---EEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred ---EEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence 569999999 679999886543 4689999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
++....... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+..... ......
T Consensus 203 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~~~~------- 266 (311)
T 3p1a_A 203 LLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-----WQQLRQ------- 266 (311)
T ss_dssp TCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-----HHHHTT-------
T ss_pred eeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHhc-------
Confidence 987654332 2344579999999999876 799999999999999999999776653211 111000
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
..........++.++.+|+.+||+.||++|||+.++++|.|.
T Consensus 267 -------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~ 308 (311)
T 3p1a_A 267 -------GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308 (311)
T ss_dssp -------TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred -------cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccc
Confidence 001111122346789999999999999999999999998764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=342.80 Aligned_cols=273 Identities=23% Similarity=0.370 Sum_probs=205.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc--cHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ--GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||.||+|.+..+ +..||+|++...... ....+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 97 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDT-----GRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK- 97 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTT-----CCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred hhhheeeeEEeecCCEEEEEEEECCC-----CceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC-
Confidence 35799999999999999999997543 346999998654332 2455778999999999999999999998766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+.+++|.+++. ....+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 98 ---~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 169 (331)
T 4aaa_A 98 ---RWYLVFEFVDHTILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG 169 (331)
T ss_dssp ---EEEEEEECCSEEHHHHHHH--STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred ---EEEEEEecCCcchHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCC
Confidence 5699999999999888763 345689999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHH-h-----
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV-K----- 301 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~-~----- 301 (393)
++........ ......|++.|+|||++.+. .++.++|||||||++|+|++|..||............... .
T Consensus 170 ~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (331)
T 4aaa_A 170 FARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPR 247 (331)
T ss_dssp TC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred CceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Confidence 9976433221 23456789999999999775 7899999999999999999999999876543222111100 0
Q ss_pred -------hcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 302 -------QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 302 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.....+..................++..+.+|+.+||+.||.+|||+.++++|.|...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 248 HQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 0000111111111111111111235688999999999999999999999999988754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=333.76 Aligned_cols=256 Identities=28% Similarity=0.376 Sum_probs=200.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|.+.+.||+|+||.||+|.+..++ ..+|+|.+.... ......+.+|+++++.++||||+++++++....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 93 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSG-----LERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH-- 93 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS--
T ss_pred hhheeecceeccCCCeEEEEEEEccCC-----ceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC--
Confidence 356999999999999999999975433 469999887543 234577889999999999999999999998766
Q ss_pred cceEEEEEeecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe---CCCCceEE
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSR--AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL---DGNFKPKL 224 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl 224 (393)
..++||||+++++|.+++... ....+++..++.++.|++.||.|||+. ||+||||||+||++ +.++.+||
T Consensus 94 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl 168 (285)
T 3is5_A 94 --NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKI 168 (285)
T ss_dssp --EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred --eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEE
Confidence 569999999999999988543 245689999999999999999999999 99999999999999 45688999
Q ss_pred eeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcC
Q 035862 225 SDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP 304 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (393)
+|||++....... ......|++.|+|||++. ..++.++||||||+++|+|++|+.||................ +
T Consensus 169 ~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~--~ 242 (285)
T 3is5_A 169 IDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE--P 242 (285)
T ss_dssp CCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C
T ss_pred EeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC--c
Confidence 9999997644322 234567899999999885 568999999999999999999999998654332221111110 0
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
. .. . ... ..++++.+|+.+||+.||++|||+.++++|.|.
T Consensus 243 ~----~~----~-~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f 282 (285)
T 3is5_A 243 N----YA----V-ECR----PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282 (285)
T ss_dssp C----CC----C---C----CCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred c----cc----c-ccC----cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHh
Confidence 0 00 0 000 134778899999999999999999999998764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=342.58 Aligned_cols=262 Identities=21% Similarity=0.312 Sum_probs=207.6
Q ss_pred HHHhcCCccc-ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCC-CCccceeeeee
Q 035862 68 REATNGFNRM-LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVS-HPNLVKLLGYC 143 (393)
Q Consensus 68 ~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 143 (393)
+...++|.+. +.||+|+||.||+|.+..++ ..||+|++.... ......+.+|+.++..+. ||||+++++++
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTG-----QEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCC-----CEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 3455678887 88999999999999976443 469999987542 234567889999999985 79999999999
Q ss_pred ecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC---CC
Q 035862 144 STEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG---NF 220 (393)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~~ 220 (393)
...+ ..++||||+.+++|.+++.......+++..++.++.|++.||+|||+. ||+||||||+|||++. ++
T Consensus 99 ~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 99 ENTS----EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp ECSS----EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBC
T ss_pred EeCC----eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCC
Confidence 8766 569999999999999998665567799999999999999999999999 9999999999999988 78
Q ss_pred ceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHH
Q 035862 221 KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~ 300 (393)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.............
T Consensus 172 ~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~-- 246 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS-- 246 (327)
T ss_dssp CEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--
T ss_pred cEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH--
Confidence 99999999998654322 2234679999999999999999999999999999999999999997654432211111
Q ss_pred hhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.... .........++..+.+||.+||+.||.+|||+.++++|.|..
T Consensus 247 -~~~~-----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~ 292 (327)
T 3lm5_A 247 -QVNV-----------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ 292 (327)
T ss_dssp -HTCC-----------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGC
T ss_pred -hccc-----------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhc
Confidence 1100 001111123457899999999999999999999999998864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=347.64 Aligned_cols=274 Identities=21% Similarity=0.295 Sum_probs=204.9
Q ss_pred HHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
...++|++.+.||+|+||+||+|.+..++ ..||+|++...... ..+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~-----~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~ 74 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESG-----KRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGD 74 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTC-----CEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCC-----CEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCc
Confidence 34678999999999999999999976444 46999998754322 2369999999999999999999865431
Q ss_pred ----------------------------------ccceEEEEEeecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHH
Q 035862 149 ----------------------------------RGIQRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEG 192 (393)
Q Consensus 149 ----------------------------------~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~ql~~~ 192 (393)
...++++||||+. ++|.+.+.. .....+++..++.++.||+.|
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a 153 (383)
T 3eb0_A 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRA 153 (383)
T ss_dssp -----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence 2235789999997 588877753 345679999999999999999
Q ss_pred HHHhhcCCCCCeEeccCCCCCeEeC-CCCceEEeeccCCccCCCCCCccccccccccCCccCccccccC-CCCchhhHHH
Q 035862 193 LAYLHEGLEIQVIYRDFKTSNVLLD-GNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWS 270 (393)
Q Consensus 193 l~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diws 270 (393)
|.|||+. ||+||||||+|||++ .++.+||+|||++....... ......||+.|+|||++.+. .++.++||||
T Consensus 154 L~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (383)
T 3eb0_A 154 VGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWS 227 (383)
T ss_dssp HHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHH
T ss_pred HHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhh
Confidence 9999998 999999999999997 68999999999998654332 22456789999999998764 5899999999
Q ss_pred HHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc-----------CCcccccccCcccccccCHHHHHHHHHHHHHhcc
Q 035862 271 FGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA-----------DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLK 339 (393)
Q Consensus 271 lGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 339 (393)
+||++|+|++|+.||...........+......+. ....+............+...+.++.+|+.+||+
T Consensus 228 lG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 99999999999999987654332211111100000 0001111111222222333456789999999999
Q ss_pred cCCCCCCCHHHHHHHHHHH
Q 035862 340 KNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 340 ~dp~~Rps~~~~l~~l~~~ 358 (393)
.||.+|||+.++++|.|..
T Consensus 308 ~dP~~R~t~~e~l~hp~f~ 326 (383)
T 3eb0_A 308 YEPDLRINPYEAMAHPFFD 326 (383)
T ss_dssp SSGGGSCCHHHHHTSGGGH
T ss_pred CChhhCCCHHHHhcCHHHH
Confidence 9999999999999997653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=345.47 Aligned_cols=267 Identities=27% Similarity=0.402 Sum_probs=201.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
..|.+.+.||+|+||+||+|.+... .+....||+|.+.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-- 164 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-- 164 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEET--TTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSS--
T ss_pred ceeecCcEeeeCCCeEEEEEEEECC--CCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCC--
Confidence 3477889999999999999987532 2345678999987543 2445678899999999999999999998765432
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+++++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 165 -~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a 239 (373)
T 3c1x_A 165 -SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 239 (373)
T ss_dssp -CCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred -CeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccc
Confidence 348999999999999999543 34578899999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCcc--ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 231 REGPTGDHTH--VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 231 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
+......... ......+++.|+|||++.+..++.++|||||||++|||++ |.+||........... ... +
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~---~~~----~ 312 (373)
T 3c1x_A 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQ----G 312 (373)
T ss_dssp ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH---HHT----T
T ss_pred ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH---HHc----C
Confidence 8653322111 1234567789999999999999999999999999999999 6777765433221111 111 0
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcC
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 364 (393)
. ....+..++..+.+++.+||+.||++|||+.+++++|..+......
T Consensus 313 ~----------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 313 R----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred C----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 0 0111223457899999999999999999999999999999876543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=333.61 Aligned_cols=267 Identities=27% Similarity=0.392 Sum_probs=207.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
..+|++.+.||+|+||+||+|.+... .+....+|+|.+..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 100 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDN--DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG- 100 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS-
T ss_pred ceehhhcceeeecCCceEEEEEEecC--CCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC-
Confidence 35699999999999999999987532 23456789999876432 344668899999999999999999998765443
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+
T Consensus 101 --~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 101 --SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGL 174 (298)
T ss_dssp --CCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred --ceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccc
Confidence 458999999999999999543 35588999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCc--cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 230 AREGPTGDHT--HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 230 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
+......... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||............ ....
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~--~~~~--- 249 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL--LQGR--- 249 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH--HTTC---
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH--hcCC---
Confidence 9865432211 12334567889999999999999999999999999999999 55666544332211111 1100
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
....+..++..+.+++.+||+.||.+|||+.++++.|..++....
T Consensus 250 ------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 250 ------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp ------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred ------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 011112245779999999999999999999999999999887543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=350.16 Aligned_cols=256 Identities=21% Similarity=0.370 Sum_probs=198.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCC--CCccceeeeeeecCC
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVS--HPNLVKLLGYCSTED 147 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 147 (393)
.+|++.+.||+|+||.||+|.+.. +..||+|++.... ......+.+|+.+++.++ ||||+++++++...+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT------CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC------CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 459999999999999999998532 4469999987543 234466889999999996 599999999998776
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
.+++||| +.+++|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+|||++ ++.+||+||
T Consensus 130 ----~~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DF 198 (390)
T 2zmd_A 130 ----YIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDF 198 (390)
T ss_dssp ----EEEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCC
T ss_pred ----EEEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEec
Confidence 5699999 5588999999643 4688999999999999999999998 999999999999995 589999999
Q ss_pred cCCccCCCCCCccccccccccCCccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHH
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-----------GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKL 296 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~ 296 (393)
|++...............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||......... +
T Consensus 199 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-~ 277 (390)
T 2zmd_A 199 GIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-L 277 (390)
T ss_dssp SSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-H
T ss_pred CccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH-H
Confidence 99987644333323445689999999999865 46899999999999999999999999765432221 1
Q ss_pred HHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 297 LEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
..... .......+...+.++.+||.+||+.||.+|||+.++++|.|...
T Consensus 278 ~~~~~--------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~ 326 (390)
T 2zmd_A 278 HAIID--------------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 326 (390)
T ss_dssp HHHHC--------------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred HHHhC--------------ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccc
Confidence 11111 00011111122467899999999999999999999999988753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=346.10 Aligned_cols=248 Identities=24% Similarity=0.340 Sum_probs=204.0
Q ss_pred HHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc--------cHHHHHHHHHHhhcCCCCccceee
Q 035862 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ--------GHKQWLAEVQFLGVVSHPNLVKLL 140 (393)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~ 140 (393)
...++|++.+.||+|+||.||+|.+..+ +..||+|.+...... ....+.+|+.+++.++||||++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~ 95 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEK-----NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVL 95 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTT-----TEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCC-----CcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 3457899999999999999999986543 457999998765321 233466799999999999999999
Q ss_pred eeeecCCcccceEEEEEeecCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC
Q 035862 141 GYCSTEDERGIQRLLVYEYMPNR-SLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN 219 (393)
Q Consensus 141 ~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~ 219 (393)
+++...+ ..++||||+.+| +|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.+
T Consensus 96 ~~~~~~~----~~~lv~e~~~~g~~l~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 166 (335)
T 3dls_A 96 DIFENQG----FFQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAED 166 (335)
T ss_dssp EEEECSS----EEEEEEECCTTSCBHHHHHH--TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred EEEeeCC----EEEEEEEeCCCCccHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCC
Confidence 9998766 569999998766 9999884 445689999999999999999999999 99999999999999999
Q ss_pred CceEEeeccCCccCCCCCCccccccccccCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHH
Q 035862 220 FKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHL-KSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLE 298 (393)
Q Consensus 220 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~ 298 (393)
+.+||+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......
T Consensus 167 ~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------ 237 (335)
T 3dls_A 167 FTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------ 237 (335)
T ss_dssp SCEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------
T ss_pred CcEEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------
Confidence 999999999998654432 2234679999999999988776 889999999999999999999996422110
Q ss_pred HHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 299 WVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.... ..+..++.++.+|+.+||+.||++|||+.++++|.|.
T Consensus 238 ----------------~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~ 278 (335)
T 3dls_A 238 ----------------EAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWV 278 (335)
T ss_dssp ----------------TTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred ----------------hhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccc
Confidence 0000 0111245789999999999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=349.83 Aligned_cols=251 Identities=27% Similarity=0.375 Sum_probs=195.6
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHH-hhcCCCCccceeeeeeecCC
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQF-LGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~ 147 (393)
++|++++.||+|+||.||+|++..+ +..||+|++.+... .....+.+|..+ ++.++||||+++++++...+
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAE-----EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTT-----CCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCC-----CCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 5699999999999999999997543 45699999976432 223445667766 57789999999999998776
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
.+|+||||+.||+|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+||
T Consensus 113 ----~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DF 183 (373)
T 2r5t_A 113 ----KLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDF 183 (373)
T ss_dssp ----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred ----EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeC
Confidence 569999999999999998543 4688999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|++....... ......+||+.|+|||++.+..++.++|||||||++|||++|..||........ ....... +.
T Consensus 184 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~--~~~i~~~-~~-- 256 (373)
T 2r5t_A 184 GLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--YDNILNK-PL-- 256 (373)
T ss_dssp CBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH--HHHHHHS-CC--
T ss_pred ccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHhc-cc--
Confidence 9997532221 123456899999999999999999999999999999999999999976543221 1111111 00
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM----NQVVESLK 356 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~~~l~~l~ 356 (393)
..+..++.++.+||.+||+.||.+||++ .++++|.+
T Consensus 257 -------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~ 296 (373)
T 2r5t_A 257 -------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296 (373)
T ss_dssp -------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGG
T ss_pred -------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcc
Confidence 0112345789999999999999999987 57777754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=338.92 Aligned_cols=258 Identities=23% Similarity=0.359 Sum_probs=205.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCC--CCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDG--RGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|.+.+.||+|+||+||+|.+..++. ......|++|.+..........+.+|+.+++.++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3579999999999999999998764432 11235699999977665667788999999999999999999999987664
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc-------
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK------- 221 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~------- 221 (393)
.++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.
T Consensus 87 ----~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 87 ----NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp ----CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred ----CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccc
Confidence 489999999999999996532 3489999999999999999999999 9999999999999998887
Q ss_pred -eEEeeccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHH
Q 035862 222 -PKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW 299 (393)
Q Consensus 222 -~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~ 299 (393)
+||+|||++..... .....|++.|+|||++.+ ..++.++|||||||++|+|++|..|+.......... ..
T Consensus 159 ~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~--~~ 230 (289)
T 4fvq_A 159 FIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL--QF 230 (289)
T ss_dssp EEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH--HH
T ss_pred eeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH--HH
Confidence 99999999865422 123468899999999987 779999999999999999999655443332222111 11
Q ss_pred HhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
...... .+...+.++.+|+.+||+.||.+|||+.+++++|..++.
T Consensus 231 ~~~~~~----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 YEDRHQ----------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHTTCC----------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hhccCC----------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111000 000123568899999999999999999999999998875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=340.01 Aligned_cols=263 Identities=21% Similarity=0.291 Sum_probs=201.2
Q ss_pred hcCCccc-ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcC-CCCccceeeeeeecCCc
Q 035862 71 TNGFNRM-LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 148 (393)
.+.|++. +.||+|+||.||+|.+.. .+..||+|++..........+.+|+.++.++ +||||+++++++...+
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~- 84 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLI-----TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED- 84 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSS-----SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred ceeEEecCceecCCceEEEEEEEEcC-----CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC-
Confidence 3568885 789999999999998643 3446999999876656677889999999885 6999999999998776
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc---eEEe
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK---PKLS 225 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~---~kl~ 225 (393)
..++||||+++++|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++. +||+
T Consensus 85 ---~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~ 156 (316)
T 2ac3_A 85 ---RFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKIC 156 (316)
T ss_dssp ---EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEEC
T ss_pred ---EEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEE
Confidence 569999999999999999654 4689999999999999999999999 9999999999999998876 9999
Q ss_pred eccCCccCCCCCCc-----cccccccccCCccCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCccCCCCchh---
Q 035862 226 DFGLAREGPTGDHT-----HVSTAVVGTYGYAAPEYIET-----GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM--- 292 (393)
Q Consensus 226 Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslGvil~elltg~~pf~~~~~~~--- 292 (393)
|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 236 (316)
T 2ac3_A 157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGW 236 (316)
T ss_dssp CTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC
T ss_pred EccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccc
Confidence 99998764322111 11224569999999999875 568899999999999999999999997654321
Q ss_pred ---------hhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 293 ---------EQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 293 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
...+......... . ........++.++.+|+.+||+.||.+|||+.++++|.|..
T Consensus 237 ~~~~~~~~~~~~~~~~i~~~~~---~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~ 300 (316)
T 2ac3_A 237 DRGEACPACQNMLFESIQEGKY---E--------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300 (316)
T ss_dssp ----CCHHHHHHHHHHHHHCCC---C--------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred cccccchhHHHHHHHHHhccCc---c--------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence 1111111111000 0 00000012457899999999999999999999999998754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=353.13 Aligned_cols=258 Identities=22% Similarity=0.316 Sum_probs=195.7
Q ss_pred HHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--------ccHHHHHHHHHHhhcCCCCccceee
Q 035862 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--------QGHKQWLAEVQFLGVVSHPNLVKLL 140 (393)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~ 140 (393)
...++|.+.+.||+|+||+||+|.+..++ ..||+|++..... .....+.+|+.+|+.++||||++++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~ 206 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTC-----KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIK 206 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCC
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCC-----cEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEE
Confidence 45689999999999999999999976544 4699999865321 1123467899999999999999999
Q ss_pred eeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC
Q 035862 141 GYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF 220 (393)
Q Consensus 141 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~ 220 (393)
+++... ..++||||+.+++|.+++. ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++
T Consensus 207 ~~~~~~-----~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~ 276 (419)
T 3i6u_A 207 NFFDAE-----DYYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE 276 (419)
T ss_dssp EEEESS-----EEEEEEECCTTCBGGGGTS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS
T ss_pred EEEecC-----ceEEEEEcCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCC
Confidence 998543 3489999999999999883 456789999999999999999999998 999999999999997554
Q ss_pred ---ceEEeeccCCccCCCCCCccccccccccCCccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhh
Q 035862 221 ---KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET---GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ 294 (393)
Q Consensus 221 ---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~ 294 (393)
.+||+|||++....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 277 ~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~ 353 (419)
T 3i6u_A 277 EDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 353 (419)
T ss_dssp SSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH
T ss_pred CcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH
Confidence 59999999998754322 2345689999999999853 67889999999999999999999999754332111
Q ss_pred HHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.......... ........++..+.+|+.+||+.||++|||+.++++|.|.
T Consensus 354 --~~~i~~~~~~-----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~ 403 (419)
T 3i6u_A 354 --KDQITSGKYN-----------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403 (419)
T ss_dssp --HHHHHTTCCC-----------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred --HHHHhcCCCC-----------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence 1111110000 0000011246789999999999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=337.77 Aligned_cols=264 Identities=30% Similarity=0.454 Sum_probs=208.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-CcccHHHHHHHHHHhhcC-CCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 149 (393)
++|++.+.||+|+||.||+|.+..++ ....+++|.+... .......+.+|+.+++.+ +||||+++++++...+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~-- 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDG---LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-- 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETT---EEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--
T ss_pred HHccceeeeecCCCceEEEEEEccCC---cccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC--
Confidence 56999999999999999999976432 2234689988753 223445688999999999 8999999999998776
Q ss_pred cceEEEEEeecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeE
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRA--------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVL 215 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIl 215 (393)
..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+|||
T Consensus 100 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl 174 (327)
T 1fvr_A 100 --YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL 174 (327)
T ss_dssp --EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred --ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEE
Confidence 5699999999999999996432 24689999999999999999999999 9999999999999
Q ss_pred eCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhh
Q 035862 216 LDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQ 294 (393)
Q Consensus 216 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~ 294 (393)
++.++.+||+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 175 ~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-- 249 (327)
T 1fvr_A 175 VGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-- 249 (327)
T ss_dssp ECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--
T ss_pred EcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--
Confidence 999999999999998743221 12233467889999999998899999999999999999998 999997654321
Q ss_pred HHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCC
Q 035862 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQG 365 (393)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 365 (393)
....... ......+..++..+.+|+.+||+.||.+|||+.+++++|..+.......
T Consensus 250 -~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 305 (327)
T 1fvr_A 250 -LYEKLPQ--------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 305 (327)
T ss_dssp -HHHHGGG--------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred -HHHHhhc--------------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence 1111111 0011112234578999999999999999999999999999998866543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=339.01 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=208.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|.+.+.||+|+||.||++.+..++ ..||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTK-----EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 457999999999999999999975433 469999986542 234456788999999999999999999998766
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..++||||+.+++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 115 ----~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 185 (335)
T 2owb_A 115 ----FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF 185 (335)
T ss_dssp ----EEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred ----eEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeec
Confidence 569999999999999988543 4689999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||......... ........
T Consensus 186 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~--- 258 (335)
T 2owb_A 186 GLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY--LRIKKNEY--- 258 (335)
T ss_dssp TTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHHTCC---
T ss_pred cCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH--HHHhcCCC---
Confidence 99986543221 234467999999999999999999999999999999999999999765432211 11111100
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
..+..++..+.+|+.+||+.||++|||+.++++|.|...
T Consensus 259 -------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 259 -------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp -------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred -------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 011124567899999999999999999999999988753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=334.18 Aligned_cols=263 Identities=25% Similarity=0.378 Sum_probs=208.1
Q ss_pred cCCcccc-eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRML-KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|.+.. .||+|+||.||+|.+. ....+..||+|.+..... .....+.+|+.+++.++||||+++++++.. +
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~- 90 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E- 90 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEE---CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-S-
T ss_pred hhhhhccCccccccCeeeEeeeec---CCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC-C-
Confidence 4688888 9999999999999764 233457799999876532 235678899999999999999999999843 2
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||
T Consensus 91 ---~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg 162 (291)
T 1xbb_A 91 ---SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFG 162 (291)
T ss_dssp ---SEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCT
T ss_pred ---CcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCC
Confidence 35899999999999999954 34589999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCcc-ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 229 LAREGPTGDHTH-VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 229 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
++.......... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......... .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~~~-- 237 (291)
T 1xbb_A 163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT---AMLEKGE-- 237 (291)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHHTTC--
T ss_pred cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHHcCC--
Confidence 998654433221 2233456788999999998889999999999999999999 99999865443221 1111100
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcC
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 364 (393)
....+..++..+.+++.+||+.||.+||++.++++.|..++.....
T Consensus 238 ------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 238 ------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp ------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred ------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 0111223567899999999999999999999999999998875543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=351.91 Aligned_cols=270 Identities=21% Similarity=0.271 Sum_probs=206.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcC------CCCccceeeeeee
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV------SHPNLVKLLGYCS 144 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~ 144 (393)
.++|++.+.||+|+||+||+|.+..+ +..||+|++.... .....+.+|+.+++.+ +|+||+++++++.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~-----~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~ 169 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKV-----HQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT 169 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTT-----TEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCC-----CcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence 45799999999999999999986543 4579999997643 3345566788877775 5789999999998
Q ss_pred cCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc--e
Q 035862 145 TEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK--P 222 (393)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~--~ 222 (393)
..+ ..++||||+. ++|.+++.......+++..++.++.||+.||.|||+. +|+||||||+|||++.++. +
T Consensus 170 ~~~----~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~v 241 (429)
T 3kvw_A 170 FRN----HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGI 241 (429)
T ss_dssp ETT----EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCE
T ss_pred cCC----eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcce
Confidence 776 5699999995 6999999777666799999999999999999999999 9999999999999999987 9
Q ss_pred EEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhh
Q 035862 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ 302 (393)
Q Consensus 223 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (393)
||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|.+||.................
T Consensus 242 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~ 316 (429)
T 3kvw_A 242 KVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG 316 (429)
T ss_dssp EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 99999999764332 2346889999999999999999999999999999999999999987654332211111111
Q ss_pred cCcCC--------------cccc------ccc---------------------CcccccccCHHHHHHHHHHHHHhcccC
Q 035862 303 FPADG--------------KKFS------MMI---------------------DPRLRNQYSINAARRVAKLADNCLKKN 341 (393)
Q Consensus 303 ~~~~~--------------~~~~------~~~---------------------~~~~~~~~~~~~~~~l~~li~~~l~~d 341 (393)
.+... .... ... ...+........+..+.+||.+||+.|
T Consensus 317 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d 396 (429)
T 3kvw_A 317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD 396 (429)
T ss_dssp CCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred CCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence 10000 0000 000 000000001112577899999999999
Q ss_pred CCCCCCHHHHHHHHHHHH
Q 035862 342 PEERPTMNQVVESLKLAV 359 (393)
Q Consensus 342 p~~Rps~~~~l~~l~~~~ 359 (393)
|++|||+.++++|.|...
T Consensus 397 P~~Rpta~e~L~Hpw~~~ 414 (429)
T 3kvw_A 397 PAVRMTPGQALRHPWLRR 414 (429)
T ss_dssp TTTSCCHHHHHTSTTTC-
T ss_pred hhhCCCHHHHhCChhhcc
Confidence 999999999999998654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=333.42 Aligned_cols=269 Identities=23% Similarity=0.350 Sum_probs=200.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDG-----VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTC-----CEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCC-----ceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 357999999999999999999975433 469999987532 234456789999999999999999999998776
Q ss_pred cccceEEEEEeecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
..++||||+.+++|.+++.. .....+++..++.++.|++.||.|||+. |++||||||+||+++.++.+||+
T Consensus 106 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~ 178 (310)
T 2wqm_A 106 ----ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLG 178 (310)
T ss_dssp ----EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEEC
T ss_pred ----cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEE
Confidence 56999999999999999853 2345689999999999999999999999 99999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
|||++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||........... ........
T Consensus 179 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~ 255 (310)
T 2wqm_A 179 DLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-KKIEQCDY 255 (310)
T ss_dssp CC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH-HHHHTTCS
T ss_pred eccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH-HHhhcccC
Confidence 9999876433221 22345789999999999999999999999999999999999999975433222211 11111100
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCCCC
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSS 367 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~~ 367 (393)
.......++.++.+|+.+||+.||.+|||+.++++.|+.+........+
T Consensus 256 -------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 256 -------------PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp -------------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred -------------CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 0001123457899999999999999999999999999999876654433
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=339.59 Aligned_cols=275 Identities=25% Similarity=0.323 Sum_probs=201.0
Q ss_pred HHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-----cHHHHHHHHHHhhcCCCCccceeeee
Q 035862 68 REATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-----GHKQWLAEVQFLGVVSHPNLVKLLGY 142 (393)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~ 142 (393)
....++|++.+.||+|+||.||+|.+..+ +..||+|.+...... ....+.+|+.+++.++||||++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNT-----NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 80 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSC-----CSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCC-----CcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 34567899999999999999999986543 346999998753221 12467789999999999999999999
Q ss_pred eecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCce
Q 035862 143 CSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP 222 (393)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 222 (393)
+...+ ..++||||+++ +|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+
T Consensus 81 ~~~~~----~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 151 (346)
T 1ua2_A 81 FGHKS----NISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVL 151 (346)
T ss_dssp ECCTT----CCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred EeeCC----ceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCE
Confidence 98766 44999999976 898888543 34588899999999999999999999 99999999999999999999
Q ss_pred EEeeccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHh
Q 035862 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK 301 (393)
Q Consensus 223 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~ 301 (393)
||+|||++........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||................
T Consensus 152 kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~ 229 (346)
T 1ua2_A 152 KLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229 (346)
T ss_dssp EECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHc
Confidence 9999999986543221 2345678999999999865 458999999999999999999999998765432221111111
Q ss_pred hcCcCCc--c---cccccCccccc-----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 302 QFPADGK--K---FSMMIDPRLRN-----QYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 302 ~~~~~~~--~---~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
..+.... . ........... .....++.++.+||.+||+.||.+|||+.++++|.|..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~ 296 (346)
T 1ua2_A 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296 (346)
T ss_dssp CCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred CCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhh
Confidence 1111100 0 00000000000 01123457899999999999999999999999998874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=328.81 Aligned_cols=257 Identities=29% Similarity=0.455 Sum_probs=208.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.+.||+|+||.||+|.+.. +..||+|.+..... ....+.+|+.+++.++||||+++++++...+.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 77 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLN------KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--- 77 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT------TEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS---
T ss_pred hheeeeeEecCCCceeEEEEEecC------CCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC---
Confidence 569999999999999999998742 24699999987543 44678899999999999999999999987663
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.++||||+++++|.+++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 78 -~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 78 -ICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR 152 (267)
T ss_dssp -CEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred -eEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccc
Confidence 49999999999999999654 34589999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
...... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||......... .......
T Consensus 153 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~--~~i~~~~------- 222 (267)
T 3t9t_A 153 FVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV--EDISTGF------- 222 (267)
T ss_dssp GBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH--HHHHTTC-------
T ss_pred cccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH--HHHhcCC-------
Confidence 643211 112234467788999999998999999999999999999999 89999765432211 1111110
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
....+...+..+.+++.+||+.||.+|||+.+++++|..+.+.
T Consensus 223 --------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 223 --------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --------cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0011112457899999999999999999999999999998763
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=341.67 Aligned_cols=266 Identities=23% Similarity=0.319 Sum_probs=206.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+..........+.+|+.+++.++||||+++++++.......
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHD-----GHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK 102 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTT-----CCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCC-----CcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence 35799999999999999999997543 3469999987665566677889999999999999999999987543333
Q ss_pred ceEEEEEeecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSR--AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
...++||||+.+++|.+++... ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg 179 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLG 179 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecC
Confidence 4679999999999999998642 346689999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCcc-------ccccccccCCccCccccccCC---CCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHH
Q 035862 229 LAREGPTGDHTH-------VSTAVVGTYGYAAPEYIETGH---LKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLE 298 (393)
Q Consensus 229 ~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~ 298 (393)
++.......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.......... ..
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~ 258 (317)
T 2buj_A 180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV-AL 258 (317)
T ss_dssp SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH-HH
T ss_pred cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh-hH
Confidence 987543211110 112346799999999987554 6899999999999999999999995311110000 00
Q ss_pred HHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 299 WVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.... .........++.++.+++.+||+.||.+|||+.+++++|+.+.
T Consensus 259 ~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 259 AVQN--------------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHHC--------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred Hhhc--------------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 0100 0000111234578999999999999999999999999998874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=342.19 Aligned_cols=268 Identities=24% Similarity=0.292 Sum_probs=194.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCccceeeeeeecCC---
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTED--- 147 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--- 147 (393)
.+|++.+.||+|+||.||+|.+..++ ..||+|.+..........+.+|+.++..+. ||||+++++++....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSG-----REYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTC-----CEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCC-----cEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 46999999999999999999975443 469999987666566677889999999996 999999999985321
Q ss_pred -cccceEEEEEeecCCCChHHHHhh-cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCCeEeCCCCceE
Q 035862 148 -ERGIQRLLVYEYMPNRSLEDRLFS-RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQ--VIYRDFKTSNVLLDGNFKPK 223 (393)
Q Consensus 148 -~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~--ivH~Dikp~NIll~~~~~~k 223 (393)
......++||||+. |+|.+++.. .....+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+|
T Consensus 103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEE
T ss_pred ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEE
Confidence 22235799999995 699998854 3345699999999999999999999998 8 99999999999999999999
Q ss_pred EeeccCCccCCCCCCcc----------ccccccccCCccCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCccCCCCc
Q 035862 224 LSDFGLAREGPTGDHTH----------VSTAVVGTYGYAAPEYI---ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRP 290 (393)
Q Consensus 224 l~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslGvil~elltg~~pf~~~~~ 290 (393)
|+|||++.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 99999998754332211 11245689999999998 567789999999999999999999999975322
Q ss_pred hhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCCCCC
Q 035862 291 TMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGSSS 368 (393)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~~~ 368 (393)
.. ... ...........+..+.+|+.+||+.||.+|||+.+++++|+.+.+........
T Consensus 259 ~~---~~~-----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~ 316 (337)
T 3ll6_A 259 LR---IVN-----------------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316 (337)
T ss_dssp ---------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred HH---hhc-----------------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence 10 000 00000001112355889999999999999999999999999998766555443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=334.79 Aligned_cols=256 Identities=23% Similarity=0.357 Sum_probs=205.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|.+.+.||+|+||.||+|.+..+ +..||+|.+..........+.+|+.+++.++||||+++++++...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 79 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLT-----GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT--- 79 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTT-----CCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred hccceeeeeccCCCCceEEEEEECCC-----CCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC---
Confidence 46799999999999999999997543 3469999998765445566889999999999999999999998766
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe---CCCCceEEeec
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL---DGNFKPKLSDF 227 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~Df 227 (393)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||+. |++||||||+||++ +.++.+||+||
T Consensus 80 -~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Df 153 (304)
T 2jam_A 80 -HYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDF 153 (304)
T ss_dssp -EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred -EEEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccC
Confidence 569999999999999998543 4589999999999999999999999 99999999999999 78899999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|++...... ......|++.|+|||++.+..++.++||||||+++|+|++|..||........ ..........
T Consensus 154 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~-- 225 (304)
T 2jam_A 154 GLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL--FEKIKEGYYE-- 225 (304)
T ss_dssp STTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHCCCC--
T ss_pred CcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHcCCCC--
Confidence 998754322 22345789999999999999999999999999999999999999976543221 1111111100
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
........++..+.+|+.+||+.||++|||+.++++|.|..
T Consensus 226 ----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 266 (304)
T 2jam_A 226 ----------FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWID 266 (304)
T ss_dssp ----------CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred ----------CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccc
Confidence 00111123457899999999999999999999999999864
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=333.22 Aligned_cols=255 Identities=22% Similarity=0.341 Sum_probs=202.6
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+++.++||||+++++++.......
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTET-----TVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTT-----CCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred eEEeeeeccCCCCeEEEEeEecCC-----ceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 478888999999999999987543 3469999886542 234566889999999999999999999987654444
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCCeEeC-CCCceEEeec
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQ--VIYRDFKTSNVLLD-GNFKPKLSDF 227 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~--ivH~Dikp~NIll~-~~~~~kl~Df 227 (393)
...++||||+++++|.+++... ..+++..++.++.|++.||.|||+. + ++||||||+|||++ .++.+||+||
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence 4679999999999999999543 4589999999999999999999998 8 99999999999997 7899999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|++...... ......|++.|+|||++. ..++.++||||||+++|+|++|..||......... ........
T Consensus 177 g~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~---- 246 (290)
T 1t4h_A 177 GLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-YRRVTSGV---- 246 (290)
T ss_dssp TGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-HHHHTTTC----
T ss_pred CCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH-HHHHhccC----
Confidence 999754332 223457999999999886 45899999999999999999999999764432221 11111100
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.....+...++++.+|+.+||+.||.+|||+.++++|.|.
T Consensus 247 ----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f 286 (290)
T 1t4h_A 247 ----------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp ----------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred ----------CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccc
Confidence 0001111234679999999999999999999999998764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=340.47 Aligned_cols=252 Identities=31% Similarity=0.425 Sum_probs=203.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
+.|...+.||+|+||+||+|.+.. .+..||+|++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 127 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVR-----NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH- 127 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-
T ss_pred hheeeeeEEccCCCEEEEEEEEcc-----CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence 459999999999999999998653 345799999875432 22356789999999999999999999998776
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+. |+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 128 ---~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 199 (348)
T 1u5q_A 128 ---TAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 199 (348)
T ss_dssp ---EEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred ---eEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeecc
Confidence 5699999996 58888775433 4689999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIE---TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
++..... .....||+.|+|||++. +..++.++|||||||++|||++|..||........ .........
T Consensus 200 ~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~- 270 (348)
T 1u5q_A 200 SASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNES- 270 (348)
T ss_dssp TCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSCC-
T ss_pred CceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHhcCC-
Confidence 9976432 23457999999999984 56789999999999999999999999976543221 111111100
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
+ ......++..+.+||.+||+.||++|||+.++++|.|...
T Consensus 271 ----------~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 271 ----------P---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp ----------C---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ----------C---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 0 0011124577899999999999999999999999998753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=355.94 Aligned_cols=257 Identities=26% Similarity=0.359 Sum_probs=205.4
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||+||+|.+..++ ..||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 94 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQ-----QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS- 94 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTC-----CEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCC-----CEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC-
Confidence 457999999999999999999975443 46999998643 1234567889999999999999999999998766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC---CCCceEEe
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD---GNFKPKLS 225 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~ 225 (393)
..++||||+.+++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||+
T Consensus 95 ---~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 166 (486)
T 3mwu_A 95 ---SFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKII 166 (486)
T ss_dssp ---EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEEC
T ss_pred ---EEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEE
Confidence 569999999999999988544 4689999999999999999999999 999999999999995 45679999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
|||++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.............. .....
T Consensus 167 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~-~~~~~ 241 (486)
T 3mwu_A 167 DFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET-GKYAF 241 (486)
T ss_dssp SCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCCS
T ss_pred ECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCC
Confidence 999997654322 2345679999999999875 599999999999999999999999976544322111110 00000
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
. ......++.++.+||.+||+.||.+|||+.++++|.|...
T Consensus 242 ~-------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~ 282 (486)
T 3mwu_A 242 D-------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (486)
T ss_dssp C-------------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred C-------------CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence 0 0011134678999999999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=334.92 Aligned_cols=258 Identities=25% Similarity=0.369 Sum_probs=206.8
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCC--
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED-- 147 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-- 147 (393)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+.... ..+.+|+.+++.++||||+++++++...+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 79 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRID-----GKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYD 79 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTT-----CCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC
T ss_pred hccccceeeeeccCCceEEEEEEEcCC-----CeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccC
Confidence 346799999999999999999997543 3469999987653 34568999999999999999999875421
Q ss_pred ----------cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC
Q 035862 148 ----------ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD 217 (393)
Q Consensus 148 ----------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~ 217 (393)
......++||||+++++|.+++.......+++..++.++.|++.||.|||++ ||+||||||+||+++
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV 156 (284)
T ss_dssp ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence 1122569999999999999999766556799999999999999999999999 999999999999999
Q ss_pred CCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHH
Q 035862 218 GNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL 297 (393)
Q Consensus 218 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~ 297 (393)
.++.+||+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..|+.... ...
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~~~ 228 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----KFF 228 (284)
T ss_dssp ETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----HHH
T ss_pred CCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----HHH
Confidence 99999999999997654432 2234579999999999999999999999999999999999998874211 111
Q ss_pred HHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcC
Q 035862 298 EWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364 (393)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 364 (393)
..... .. .+..++..+.+++.+||+.||.+|||+.+++++|+.+....+.
T Consensus 229 ~~~~~-------------~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 229 TDLRD-------------GI----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp HHHHT-------------TC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred HHhhc-------------cc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 11111 00 1112346789999999999999999999999999998765443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=356.37 Aligned_cols=258 Identities=22% Similarity=0.329 Sum_probs=209.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|++.+.||+|+||.||+|.+..++ ..||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITG-----QECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCC-----CEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 356999999999999999999976443 469999986542 234567889999999999999999999998766
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe---CCCCceEE
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL---DGNFKPKL 224 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl 224 (393)
..++||||+.+++|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||
T Consensus 100 ----~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl 170 (484)
T 3nyv_A 100 ----YFYLVGEVYTGGELFDEII--SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRI 170 (484)
T ss_dssp ----EEEEEECCCCSCBHHHHHH--TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred ----EEEEEEecCCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEE
Confidence 5699999999999999884 345689999999999999999999999 99999999999999 56789999
Q ss_pred eeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcC
Q 035862 225 SDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP 304 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (393)
+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||......... .......
T Consensus 171 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~ 243 (484)
T 3nyv_A 171 IDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL---KKVEKGK 243 (484)
T ss_dssp CCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHCC
T ss_pred EeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHcCC
Confidence 9999997654332 2344579999999999876 6999999999999999999999999865443221 1111110
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
.. ........++.++.+||.+||+.||.+|||+.++++|.|....
T Consensus 244 ~~-----------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~ 288 (484)
T 3nyv_A 244 YT-----------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288 (484)
T ss_dssp CC-----------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred CC-----------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccc
Confidence 00 0000111346789999999999999999999999999998654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=343.32 Aligned_cols=270 Identities=23% Similarity=0.315 Sum_probs=201.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||.||+|.+..++ ..||+|++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTG-----AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTC-----CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCC-----CEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 357999999999999999999975443 469999986542 2334567899999999999999999999876542
Q ss_pred c--cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 149 R--GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 149 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
. ....|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 171 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD 171 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred cccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEe
Confidence 1 12458999999 8899999854 3589999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
||+++..... ....++|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+......+.
T Consensus 172 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~ 246 (367)
T 1cm8_A 172 FGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 246 (367)
T ss_dssp CTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred eecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9999865332 244678999999999877 6899999999999999999999999986654322111111100000
Q ss_pred CC-------c-------ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 306 DG-------K-------KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 306 ~~-------~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.. . .+.......+ ......++..+.+|+.+||..||.+|||+.++++|.+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~ 312 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 312 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHH
Confidence 00 0 0000000000 111123467899999999999999999999999998754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=349.08 Aligned_cols=278 Identities=24% Similarity=0.278 Sum_probs=200.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||.||+|.+..+ +..||+|++.... ......+.+|+.+|+.++||||+++++++...+.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~-----~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNT-----EKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTT-----TEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCC-----CcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence 35799999999999999999997543 4579999997642 2344678899999999999999999999876542
Q ss_pred -ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 149 -RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 149 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
.....|+||||+. ++|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+||
T Consensus 100 ~~~~~~~lv~e~~~-~~L~~~~~--~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DF 173 (432)
T 3n9x_A 100 LKFDELYIVLEIAD-SDLKKLFK--TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDF 173 (432)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHH--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred CcCCeEEEEEecCC-cCHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccC
Confidence 1125699999995 59999984 445689999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCc--------------------cccccccccCCccCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCcc-
Q 035862 228 GLAREGPTGDHT--------------------HVSTAVVGTYGYAAPEYI-ETGHLKSQSDIWSFGVVLYEILTGRRVL- 285 (393)
Q Consensus 228 g~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslGvil~elltg~~pf- 285 (393)
|+++........ ......+||++|+|||++ .+..++.++|||||||++|||++|..||
T Consensus 174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp TTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 999875433211 123567899999999986 5667999999999999999999854443
Q ss_pred ----------CCCCch---------------hhhHHHHHHhhcCcCCcc-cccc-----------cCcccc---cccCHH
Q 035862 286 ----------ERNRPT---------------MEQKLLEWVKQFPADGKK-FSMM-----------IDPRLR---NQYSIN 325 (393)
Q Consensus 286 ----------~~~~~~---------------~~~~~~~~~~~~~~~~~~-~~~~-----------~~~~~~---~~~~~~ 325 (393)
.+.... ....+............. +..+ ...... ......
T Consensus 254 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (432)
T 3n9x_A 254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS 333 (432)
T ss_dssp SSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTT
T ss_pred cccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCC
Confidence 332210 000000000000000000 0000 000000 000013
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 326 AARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 326 ~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
+++++.+||.+||+.||.+|||+.++++|.|..-
T Consensus 334 ~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 367 (432)
T 3n9x_A 334 ISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367 (432)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTT
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhh
Confidence 5688999999999999999999999999988653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=328.99 Aligned_cols=266 Identities=26% Similarity=0.359 Sum_probs=209.0
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
.|...++||+|+||+||+|.+.... .....+|+|.+..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--- 96 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQA--QNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEG--- 96 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSS--SCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS---
T ss_pred EEccCceeccCCCceEEEEEEecCC--CceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCC---
Confidence 4667789999999999999876432 3455799999876433 344678899999999999999999999976553
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+.+++|.+++.. ....+++..++.++.|++.||.|||++ |++||||||+|||++.++.+||+|||++.
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 172 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLAR 172 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred CcEEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence 33899999999999999854 345689999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCC--ccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCc-cCCCCchhhhHHHHHHhhcCcCCc
Q 035862 232 EGPTGDH--THVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRV-LERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 232 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
....... ........+++.|+|||.+.+..++.++||||||+++|+|++|..| |........... .....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~---~~~~~---- 245 (298)
T 3pls_A 173 DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF---LAQGR---- 245 (298)
T ss_dssp TTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH---HHTTC----
T ss_pred cccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH---hhcCC----
Confidence 6533221 1122345678899999999999999999999999999999995555 443332221111 11100
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcC
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 364 (393)
....+..++..+.+++.+||+.||.+|||+.++++.|..++.....
T Consensus 246 ----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 246 ----------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred ----------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 0111223457899999999999999999999999999999876543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=355.12 Aligned_cols=257 Identities=24% Similarity=0.359 Sum_probs=202.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++++.||+|+||+||+|.+..++ ..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 109 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTH-----VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR- 109 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTC-----CEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCC-----cEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-
Confidence 456999999999999999999975443 469999987643 233567889999999999999999999998766
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC---CceEEe
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN---FKPKLS 225 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~---~~~kl~ 225 (393)
..++||||+.+++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.. +.+||+
T Consensus 110 ---~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 181 (494)
T 3lij_A 110 ---NYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIV 181 (494)
T ss_dssp ---EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred ---EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEE
Confidence 569999999999999988543 4589999999999999999999999 99999999999999764 459999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
|||++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|..||......... ........
T Consensus 182 DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~ 254 (494)
T 3lij_A 182 DFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEIL---RKVEKGKY 254 (494)
T ss_dssp CCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHTCC
T ss_pred ECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhCCC
Confidence 999997654322 234567999999999886 56999999999999999999999999876543221 11111100
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
. ... .....++..+.+||.+||+.||.+|||+.++++|.|...
T Consensus 255 ~-------~~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 255 T-------FDS----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp C-------CCS----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred C-------CCc----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 0 000 001134578999999999999999999999999988754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=330.74 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=208.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|.+.+.||+|+||.||+|.+.. .+..||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQ-----NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcC-----CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 3679999999999999999998653 34579999986431 123456889999999999999999999998766
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+||
T Consensus 88 ----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Df 158 (284)
T 2vgo_A 88 ----RIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADF 158 (284)
T ss_dssp ----EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred ----EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecc
Confidence 569999999999999998544 4589999999999999999999998 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|++....... .....|++.|+|||++.+..++.++||||||+++|+|++|..||.......... ... ...
T Consensus 159 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~-~~~--- 228 (284)
T 2vgo_A 159 GWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR--RIV-NVD--- 228 (284)
T ss_dssp TTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--HHH-TTC---
T ss_pred cccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH--HHh-ccc---
Confidence 9987543321 234578999999999999999999999999999999999999997654322111 111 100
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
...+..++.++.+||.+||+.||.+||++.++++|.|....
T Consensus 229 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 229 ------------LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp ------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred ------------cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 01112345788999999999999999999999999987643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=341.42 Aligned_cols=260 Identities=17% Similarity=0.179 Sum_probs=205.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC---CCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS---HPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~ 147 (393)
.++|.+.+.||+|+||+||+|.+........+..||+|++.... ...+.+|+.++..++ |+||+.+++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 46799999999999999999975443344556679999997653 345667777777776 999999999998877
Q ss_pred cccceEEEEEeecCCCChHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC------
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSR---AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG------ 218 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~------ 218 (393)
..++||||+++|+|.+++... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.
T Consensus 141 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 141 ----GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ----CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-
T ss_pred ----CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcc
Confidence 459999999999999999642 345699999999999999999999998 9999999999999998
Q ss_pred -----CCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhh
Q 035862 219 -----NFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTME 293 (393)
Q Consensus 219 -----~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~ 293 (393)
++.+||+|||++...............+||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~- 292 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE- 292 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence 89999999999975432233334456789999999999999999999999999999999999999986432110
Q ss_pred hHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHHHHHhhh
Q 035862 294 QKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER-PTMNQVVESLKLAVQES 362 (393)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R-ps~~~~l~~l~~~~~~~ 362 (393)
.. ....+... ..++.+.+++..||+.+|.+| |++.++.+.|...+...
T Consensus 293 --------------~~----~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 --------------CK----PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp --------------EE----ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred --------------ee----echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 00 01111111 125678899999999999999 67888888888887653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=345.83 Aligned_cols=275 Identities=25% Similarity=0.388 Sum_probs=208.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|++.+.||+|+||.||+|.+..++ ..||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 104 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSG-----LVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-- 104 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT--
T ss_pred cccceeeeeecCCCCeEEEEEEECCCC-----cEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC--
Confidence 367999999999999999999976433 469999987653 233466889999999999999999999998766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE-GLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||+ + ||+||||||+|||++.++.+||+|||
T Consensus 105 --~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 177 (360)
T 3eqc_A 105 --EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG 177 (360)
T ss_dssp --EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred --EEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECC
Confidence 569999999999999999543 458999999999999999999997 5 89999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHh-----hc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK-----QF 303 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~-----~~ 303 (393)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||................ ..
T Consensus 178 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3eqc_A 178 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253 (360)
T ss_dssp CCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------
T ss_pred CCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCC
Confidence 98643211 2234579999999999999999999999999999999999999998654432211110000 00
Q ss_pred CcC----C-------------ccccc----ccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 304 PAD----G-------------KKFSM----MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 304 ~~~----~-------------~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
+.. + ..... .............++.++.+||.+||+.||.+|||+.++++|.|......
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp --------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred CCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 000 0 00000 00000000111124678999999999999999999999999999765544
Q ss_pred c
Q 035862 363 E 363 (393)
Q Consensus 363 ~ 363 (393)
+
T Consensus 334 ~ 334 (360)
T 3eqc_A 334 E 334 (360)
T ss_dssp S
T ss_pred h
Confidence 3
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=329.58 Aligned_cols=258 Identities=23% Similarity=0.358 Sum_probs=204.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc------ccHHHHHHHHHHhhcCCCCccceeeeeee
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL------QGHKQWLAEVQFLGVVSHPNLVKLLGYCS 144 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 144 (393)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTG-----KEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE 78 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCC-----CeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec
Confidence 356999999999999999999976433 4699999875422 13567889999999999999999999998
Q ss_pred cCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC----
Q 035862 145 TEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF---- 220 (393)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~---- 220 (393)
..+ ..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+. |++||||||+||+++.++
T Consensus 79 ~~~----~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~ 149 (283)
T 3bhy_A 79 NKT----DVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNP 149 (283)
T ss_dssp CSS----EEEEEEECCCSCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSC
T ss_pred CCC----eEEEEEeecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCC
Confidence 766 56999999999999999954 34689999999999999999999998 999999999999998887
Q ss_pred ceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHH
Q 035862 221 KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~ 300 (393)
.+||+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||........ ... .
T Consensus 150 ~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~-~ 223 (283)
T 3bhy_A 150 RIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET--LTN-I 223 (283)
T ss_dssp CEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHH-H
T ss_pred ceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH--HHH-h
Confidence 89999999997654322 22345789999999999999999999999999999999999999976543221 111 1
Q ss_pred hhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
..... .........++..+.+|+.+||..||++|||+.++++|.|...
T Consensus 224 ~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 224 SAVNY-----------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp HTTCC-----------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred Hhccc-----------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 11100 0000111124577899999999999999999999999987543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=354.73 Aligned_cols=258 Identities=26% Similarity=0.385 Sum_probs=208.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|.+.+.||+|+||.||+|++..++ ..||+|++.+... .....+.+|+.+++.++||||+++++++...+
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg-----~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATG-----KLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCC-----cEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence 368999999999999999999975433 4699999865321 23456788999999999999999999998776
Q ss_pred cccceEEEEEeecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRA--QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
.+|+||||++||+|.+++.... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+
T Consensus 259 ----~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~ 331 (543)
T 3c4z_A 259 ----DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRIS 331 (543)
T ss_dssp ----EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred ----EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEe
Confidence 5699999999999999986543 45699999999999999999999999 99999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchh-hhHHHHHHhhcC
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM-EQKLLEWVKQFP 304 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~-~~~~~~~~~~~~ 304 (393)
|||++........ .....+||+.|+|||++.+..++.++|||||||++|||++|..||....... ...+........
T Consensus 332 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~ 409 (543)
T 3c4z_A 332 DLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA 409 (543)
T ss_dssp CCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCC
T ss_pred ecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcc
Confidence 9999987543322 2234589999999999999999999999999999999999999997653321 111111111100
Q ss_pred cCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHH
Q 035862 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT-----MNQVVESLKL 357 (393)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~~l~~l~~ 357 (393)
..++..++..+.+||.+||+.||.+||+ +.++++|.|.
T Consensus 410 ---------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff 452 (543)
T 3c4z_A 410 ---------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452 (543)
T ss_dssp ---------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGG
T ss_pred ---------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccc
Confidence 0112235678999999999999999996 4889998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=358.96 Aligned_cols=264 Identities=25% Similarity=0.410 Sum_probs=207.6
Q ss_pred CCcccc-eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRML-KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++.+.. .||+|+||.||+|.++.. ..+..||+|++.... ......+.+|+.+++.++||||+++++++..+
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~---- 408 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMR---KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---- 408 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECS---SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS----
T ss_pred ceeEcCcEEecCCCcEEEEEEEecC---CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC----
Confidence 344444 799999999999987632 345679999997653 23567789999999999999999999998753
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 409 -~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla 483 (613)
T 2ozo_A 409 -ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLS 483 (613)
T ss_dssp -SEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTT
T ss_pred -CeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCc
Confidence 359999999999999998543 45689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCc-cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 231 REGPTGDHT-HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 231 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......... .....
T Consensus 484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~---~~i~~------ 554 (613)
T 2ozo_A 484 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFIEQ------ 554 (613)
T ss_dssp TTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH---HHHHT------
T ss_pred ccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHc------
Confidence 875433221 12223456689999999999999999999999999999998 99999865543221 11111
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCC
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQG 365 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 365 (393)
..+...+..++.++.+||.+||+.||++||++.++++.|..+....+..
T Consensus 555 --------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~ 603 (613)
T 2ozo_A 555 --------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603 (613)
T ss_dssp --------TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred --------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence 1111223345688999999999999999999999999999887765443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=331.27 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=207.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTK-----EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCC-----ceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC
Confidence 457999999999999999999975433 469999986542 233456788999999999999999999998766
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+||
T Consensus 89 ----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 159 (294)
T 2rku_A 89 ----FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF 159 (294)
T ss_dssp ----EEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred ----EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEec
Confidence 569999999999999988543 4689999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||......... .......
T Consensus 160 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~---- 231 (294)
T 2rku_A 160 GLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY--LRIKKNE---- 231 (294)
T ss_dssp TTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHTTC----
T ss_pred cCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHhhcc----
Confidence 99976543221 234467899999999999999999999999999999999999999765432211 1111100
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
...+..++..+.+++.+||+.||++|||+.++++|.+..
T Consensus 232 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~ 270 (294)
T 2rku_A 232 ------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 270 (294)
T ss_dssp ------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred ------------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhee
Confidence 001123457789999999999999999999999998875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=339.90 Aligned_cols=275 Identities=17% Similarity=0.219 Sum_probs=209.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCC---CCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccce----------
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGR---GEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK---------- 138 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 138 (393)
++|.+.+.||+|+||.||+|.+..+... ..+..||+|.+... ..+.+|+.+++.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 5799999999999999999997643110 02456999998754 35778999999999999988
Q ss_pred -----eeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCC
Q 035862 139 -----LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSN 213 (393)
Q Consensus 139 -----~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~N 213 (393)
+++++...+. ..++||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|
T Consensus 117 ~~i~~~~~~~~~~~~---~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 117 LAIPTCMGFGVHQDK---YRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp CSCCCCCEEEEETTT---EEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred cCccchhhccccCCc---EEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 4556554222 679999999 99999999765456799999999999999999999999 99999999999
Q ss_pred eEeCCCC--ceEEeeccCCccCCCCCCc-----cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccC
Q 035862 214 VLLDGNF--KPKLSDFGLAREGPTGDHT-----HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLE 286 (393)
Q Consensus 214 Ill~~~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~ 286 (393)
||++.++ .+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999765432211 11234589999999999999999999999999999999999999998
Q ss_pred CCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCC
Q 035862 287 RNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQG 365 (393)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 365 (393)
......... ......+......+ ..... ....++.++.+|+.+||+.||++||++.++++.|..+.+.....
T Consensus 270 ~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 270 NCLPNTEDI-MKQKQKFVDKPGPF---VGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp GGTTCHHHH-HHHHHHHHHSCCCE---ECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cCCcCHHHH-HHHHHhccCChhhh---hhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 654322221 11111111111100 00000 00123578999999999999999999999999999998876644
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-45 Score=334.87 Aligned_cols=265 Identities=21% Similarity=0.272 Sum_probs=200.2
Q ss_pred HHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc---cHHHHHHHHHHhhcCCCCccceeeeeeec
Q 035862 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ---GHKQWLAEVQFLGVVSHPNLVKLLGYCST 145 (393)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 145 (393)
...++|++.+.||+|+||.||+|.+.. .+..||+|++...... ....+.+|+.+++.++||||+++++++..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTV-----RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI 105 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETT-----TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcC-----CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence 345789999999999999999998653 3457999998754322 24668899999999999999999999987
Q ss_pred CCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 146 EDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
.+ ..++||||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 106 ~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~ 176 (309)
T 2h34_A 106 DG----QLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLV 176 (309)
T ss_dssp TT----EEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred CC----eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEe
Confidence 66 569999999999999999543 4689999999999999999999999 99999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
|||++........ .......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ...........
T Consensus 177 Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~ 252 (309)
T 2h34_A 177 DFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHINQAIP 252 (309)
T ss_dssp SCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHHSCCC
T ss_pred cCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhccCCC
Confidence 9999876543221 1233457899999999999999999999999999999999999999765332 11111111100
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHHhhhc
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-TMNQVVESLKLAVQESE 363 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~~l~~l~~~~~~~~ 363 (393)
. .......++.++.+++.+||+.||++|| +++++++.|+.++....
T Consensus 253 ~------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 253 R------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp C------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred C------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 0 0111223457799999999999999999 99999999998876543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=332.54 Aligned_cols=254 Identities=30% Similarity=0.445 Sum_probs=200.4
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.+.||+|+||.||+|.+. +..||+|.+.... ..+.+.+|+.+++.++||||+++++++...+.
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-- 88 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG-- 88 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC----
T ss_pred hhhceEEeEEecCCCceEEEEEEc-------CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC--
Confidence 357999999999999999999863 3469999987643 45678899999999999999999998765442
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+++++|.+++.......+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++
T Consensus 89 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 89 -GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 164 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred -ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccc
Confidence 359999999999999999655444478999999999999999999999 9999999999999999999999999998
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
...... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||........ ......
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~~~------- 229 (278)
T 1byg_A 165 KEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEK------- 229 (278)
T ss_dssp ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHHTT-------
T ss_pred cccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHhc-------
Confidence 754332 123467889999999999999999999999999999998 9999976543211 111110
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
......+..++..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 230 -------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 230 -------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp -------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 011112223567899999999999999999999999999988654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=340.31 Aligned_cols=270 Identities=19% Similarity=0.169 Sum_probs=200.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-----------cHHHHHHHHHHhhcCCCCccceee
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-----------GHKQWLAEVQFLGVVSHPNLVKLL 140 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~ 140 (393)
++|.+.+.||+|+||.||+|.+.... .....+|+|........ ....+.+|+.+++.++||||++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~--~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKP--EKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSC--GGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCC--CccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 56999999999999999999976421 23456999998765322 112356788899999999999999
Q ss_pred eeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC
Q 035862 141 GYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF 220 (393)
Q Consensus 141 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~ 220 (393)
+++..........++||||+ +++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 99987433334779999999 99999998543 3789999999999999999999999 999999999999998887
Q ss_pred --ceEEeeccCCccCCCCCC-----ccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhh
Q 035862 221 --KPKLSDFGLAREGPTGDH-----THVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTME 293 (393)
Q Consensus 221 --~~kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~ 293 (393)
.+||+|||++........ ........||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 999999999976532211 1122456899999999999999999999999999999999999999965322221
Q ss_pred hHH--H-HHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 294 QKL--L-EWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 294 ~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
... . ......+. ...... ....++.++.+++.+||+.||++||++.++++.|+.+.
T Consensus 269 ~~~~~~~~~~~~~~~---~~~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 269 AVQTAKTNLLDELPQ---SVLKWA-------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHHTTTH---HHHHHS-------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred HHHHHHHhhcccccH---HHHhhc-------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 111 1 11111100 000000 00124578999999999999999999999999998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=333.63 Aligned_cols=259 Identities=23% Similarity=0.337 Sum_probs=205.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||.||+|.+..+ +..|++|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSD-----GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 79 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTT-----CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGG
T ss_pred hhheeeehhccCCCCcEEEEEEECCC-----CcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCC
Confidence 46799999999999999999997543 3469999987543 2344568899999999999999999998865433
Q ss_pred ccceEEEEEeecCCCChHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC-----eEeccCCCCCeEeCCCCc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSR--AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQ-----VIYRDFKTSNVLLDGNFK 221 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~-----ivH~Dikp~NIll~~~~~ 221 (393)
. ..++||||+++++|.+++... ....+++..++.++.|++.||.|||+. + ++||||||+||+++.++.
T Consensus 80 ~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~ 154 (279)
T 2w5a_A 80 T--TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQN 154 (279)
T ss_dssp T--EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSC
T ss_pred c--eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCC
Confidence 3 569999999999999999643 334589999999999999999999998 7 999999999999999999
Q ss_pred eEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHh
Q 035862 222 PKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK 301 (393)
Q Consensus 222 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~ 301 (393)
+||+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ......
T Consensus 155 ~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~i~ 229 (279)
T 2w5a_A 155 VKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKIR 229 (279)
T ss_dssp EEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred EEEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHHHHh
Confidence 9999999987653322 12234578999999999999999999999999999999999999998654322 111111
Q ss_pred hcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.... ...+..++.++.+++.+||+.||.+|||+.+++++++..
T Consensus 230 ~~~~--------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 230 EGKF--------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp HTCC--------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred hccc--------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 1100 011123457899999999999999999999999987653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=355.19 Aligned_cols=258 Identities=22% Similarity=0.322 Sum_probs=205.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-------------ccHHHHHHHHHHhhcCCCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-------------QGHKQWLAEVQFLGVVSHPNLV 137 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv 137 (393)
.++|.+++.||+|+||+||+|.+..++ ..||+|++..... .....+.+|+.+++.++||||+
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~-----~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 109 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGH-----SEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTC-----CEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred ccceEEEeEecccCCeEEEEEEECCCC-----cEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence 578999999999999999999976443 4699999875431 2345688999999999999999
Q ss_pred eeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC
Q 035862 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD 217 (393)
Q Consensus 138 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~ 217 (393)
++++++.... ..++||||+++++|.+++... ..+++..++.++.||+.||.|||+. ||+||||||+|||++
T Consensus 110 ~~~~~~~~~~----~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~ 180 (504)
T 3q5i_A 110 KLFDVFEDKK----YFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLE 180 (504)
T ss_dssp CEEEEEECSS----EEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEES
T ss_pred eEEEEEEcCC----EEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEe
Confidence 9999998766 569999999999999988543 4689999999999999999999999 999999999999998
Q ss_pred CCC---ceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhh
Q 035862 218 GNF---KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ 294 (393)
Q Consensus 218 ~~~---~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~ 294 (393)
.++ .+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.........
T Consensus 181 ~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~ 256 (504)
T 3q5i_A 181 NKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII 256 (504)
T ss_dssp STTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 876 69999999998654332 234567999999999987 46899999999999999999999999865443221
Q ss_pred HHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
......... ... .....++.++.+||.+||+.||.+|||+.++++|.|....
T Consensus 257 ---~~i~~~~~~-------~~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 257 ---KKVEKGKYY-------FDF----NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp ---HHHHHCCCC-------CCH----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred ---HHHHcCCCC-------CCc----cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 111111000 000 0001245789999999999999999999999999997653
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=336.26 Aligned_cols=279 Identities=25% Similarity=0.386 Sum_probs=212.8
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.+.||+|+||.||+|.+.... ...+..||+|.+..........+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-- 117 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQ-DNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR-- 117 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTS-SSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHceeeeeeccCCCeEEEEEEecccc-CCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC--
Confidence 56999999999999999999864322 345678999999876666667889999999999999999999998765533
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 4589999999999999996543 4589999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCcc-ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc--
Q 035862 232 EGPTGDHTH-VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK-- 308 (393)
Q Consensus 232 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 308 (393)
......... ......++..|+|||++.+..++.++||||||+++|+|++|..||........ ...........
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~----~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM----RMIGNDKQGQMIV 269 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH----HHHCTTCCTHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH----HhhccccchhhhH
Confidence 764433221 22334677789999999988999999999999999999999998864211100 00000000000
Q ss_pred -ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 309 -KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 309 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
.+...+........+..++.++.+++.+||+.||++|||+.++++.|+.+...
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 270 FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 00000000111112234568899999999999999999999999999988754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=340.95 Aligned_cols=262 Identities=24% Similarity=0.359 Sum_probs=207.6
Q ss_pred HHHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc--------cHHHHHHHHHHhhcC-CCCc
Q 035862 65 QELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ--------GHKQWLAEVQFLGVV-SHPN 135 (393)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~n 135 (393)
.......++|.+.+.||+|+||.||+|.+..++ ..||+|++...... ....+.+|+.+++.+ +|||
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~ 161 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATG-----HEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCC-----cEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 345566778999999999999999999975433 46999998764311 134577899999998 7999
Q ss_pred cceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeE
Q 035862 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVL 215 (393)
Q Consensus 136 iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIl 215 (393)
|+++++++.... ..++||||+++++|.+++... ..+++..++.++.||+.||.|||+. |++||||||+|||
T Consensus 162 iv~~~~~~~~~~----~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl 232 (365)
T 2y7j_A 162 IITLIDSYESSS----FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENIL 232 (365)
T ss_dssp BCCEEEEEEBSS----EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred EeEEEEEEeeCC----EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 999999998765 569999999999999999543 4689999999999999999999998 9999999999999
Q ss_pred eCCCCceEEeeccCCccCCCCCCccccccccccCCccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCccCCCC
Q 035862 216 LDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET------GHLKSQSDIWSFGVVLYEILTGRRVLERNR 289 (393)
Q Consensus 216 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslGvil~elltg~~pf~~~~ 289 (393)
++.+|.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 233 ~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 233 LDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp ECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999998654432 2345689999999999863 358899999999999999999999997654
Q ss_pred chhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 290 PTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
..... ......... ..... ....+..+.+|+.+||+.||++|||+.++++|.|.
T Consensus 310 ~~~~~---~~i~~~~~~-------~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f 363 (365)
T 2y7j_A 310 QILML---RMIMEGQYQ-------FSSPE----WDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF 363 (365)
T ss_dssp HHHHH---HHHHHTCCC-------CCHHH----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHHH---HHHHhCCCC-------CCCcc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 32211 111110000 00000 01235679999999999999999999999998764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=330.99 Aligned_cols=272 Identities=20% Similarity=0.222 Sum_probs=206.7
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
..++|++.+.||+|+||.||+|.+..+ +..||+|++..... ...+.+|+.+++.++|++++..+..+...+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~- 78 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAA-----GEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD- 78 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTT-----TEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETT-
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCC-----CceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCC-
Confidence 357899999999999999999996543 45699998765432 2347789999999999888877776654332
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe---CCCCceEEee
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL---DGNFKPKLSD 226 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~D 226 (393)
..++||||+ +++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|
T Consensus 79 --~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~D 151 (296)
T 4hgt_A 79 --YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp --EEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred --ceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEec
Confidence 569999999 99999998543 34589999999999999999999999 99999999999999 7889999999
Q ss_pred ccCCccCCCCCCc-----cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHh
Q 035862 227 FGLAREGPTGDHT-----HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK 301 (393)
Q Consensus 227 fg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~ 301 (393)
||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||................
T Consensus 152 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 4hgt_A 152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp CTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred CccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence 9999865443221 12235689999999999999999999999999999999999999997654322111111100
Q ss_pred hcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCCC
Q 035862 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQGS 366 (393)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~~ 366 (393)
...... ........++.++.+|+.+||+.||++|||+.++++.|..+.+......
T Consensus 232 ~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 232 EKKMST----------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp HHHHHS----------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred cccccc----------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 000000 0000001235789999999999999999999999999999988766443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=338.01 Aligned_cols=278 Identities=22% Similarity=0.319 Sum_probs=207.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||.||+|.+..++ ..||+|++..... .....+.+|+.+++.++||||+++++++.....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTG-----QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 90 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTC-----CEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCC-----CEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence 467999999999999999999975443 4699999865432 234567899999999999999999999877542
Q ss_pred c----cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEE
Q 035862 149 R----GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKL 224 (393)
Q Consensus 149 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 224 (393)
. ....++||||+.+ +|.+.+... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl 165 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL 165 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEE
Confidence 1 2256999999965 787777433 34589999999999999999999999 9999999999999999999999
Q ss_pred eeccCCccCCCCCC--ccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHH-
Q 035862 225 SDFGLAREGPTGDH--THVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV- 300 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~- 300 (393)
+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...............
T Consensus 166 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 245 (351)
T 3mi9_A 166 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 245 (351)
T ss_dssp CCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred ccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 99999976543221 112345678999999999876 56899999999999999999999999876554333222221
Q ss_pred hhcCcCCcc-cc--cccC-----cccccccCH-----HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 301 KQFPADGKK-FS--MMID-----PRLRNQYSI-----NAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 301 ~~~~~~~~~-~~--~~~~-----~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
...+..... .. .... ......... ..++.+.+||.+||+.||++|||+.++++|.|..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 316 (351)
T 3mi9_A 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 316 (351)
T ss_dssp CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence 111111000 00 0000 000000000 1246789999999999999999999999998874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=328.94 Aligned_cols=255 Identities=29% Similarity=0.416 Sum_probs=208.8
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+.|++.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 93 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRT-----QKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT--- 93 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTT-----CCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---
T ss_pred HHHHHhhhhcccCCeEEEEEEECCC-----CcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC---
Confidence 4699999999999999999986543 3469999987543 234577889999999999999999999998766
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+++|.+++. ...+++..++.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++
T Consensus 94 -~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~ 166 (303)
T 3a7i_A 94 -KLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA 166 (303)
T ss_dssp -EEEEEEECCTTEEHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred -eEEEEEEeCCCCcHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccc
Confidence 5699999999999999984 24689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||............ ....+
T Consensus 167 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~------ 236 (303)
T 3a7i_A 167 GQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI--PKNNP------ 236 (303)
T ss_dssp EECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--HHSCC------
T ss_pred eecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh--hcCCC------
Confidence 76543221 224567899999999999999999999999999999999999999765433221111 11100
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
+ .....++..+.+|+.+||+.||.+|||+.+++++.+....
T Consensus 237 -----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 237 -----P----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp -----C----CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred -----C----CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 0 1111235779999999999999999999999999987653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=338.33 Aligned_cols=270 Identities=24% Similarity=0.308 Sum_probs=199.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||.||+|.+..+ +..||+|++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 98 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAIL-----ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 98 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCS
T ss_pred hhheeEeeeeEecCCEEEEEEEECCC-----CceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccc
Confidence 46899999999999999999986533 4569999987542 2334567899999999999999999999876542
Q ss_pred --ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 149 --RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 149 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
.....++||||+.+ +|.+++. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 99 ~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 170 (371)
T 2xrw_A 99 LEEFQDVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 170 (371)
T ss_dssp TTTCCEEEEEEECCSE-EHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECC
T ss_pred cccccceEEEEEcCCC-CHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEE
Confidence 12356999999965 8888873 3488999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc---
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF--- 303 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~--- 303 (393)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .......
T Consensus 171 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~i~~~~~~~ 245 (371)
T 2xrw_A 171 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW--NKVIEQLGTP 245 (371)
T ss_dssp CCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHC-CCCC
T ss_pred eeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCC
Confidence 99997643321 234568999999999999999999999999999999999999999865442211 1111100
Q ss_pred -------------------Cc-CCcccccccCccc---ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 304 -------------------PA-DGKKFSMMIDPRL---RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 304 -------------------~~-~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
+. .+..+........ ........+.++.+||.+||+.||.+|||+.++++|.|..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 00 0000111111100 0111223578899999999999999999999999999875
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=346.07 Aligned_cols=269 Identities=26% Similarity=0.340 Sum_probs=201.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCC--cc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED--ER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~ 149 (393)
.+|++.+.||+|+||.||+|.+..++ ..||+|++..... ...+|+++++.++||||+++++++.... ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~-----~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSG-----ELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCC-----cEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 46999999999999999999976443 4699999865432 2346999999999999999999885432 22
Q ss_pred cceEEEEEeecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC-CceEEee
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN-FKPKLSD 226 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~-~~~kl~D 226 (393)
..++++||||+.+ +|.+.+.. .....+++..++.++.||+.||.|||++ ||+||||||+|||++.+ +.+||+|
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEecc
Confidence 3356899999965 67666532 3456799999999999999999999998 99999999999999965 6789999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +.........
T Consensus 201 FG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~ 275 (420)
T 1j1b_A 201 FGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGT 275 (420)
T ss_dssp CTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCS
T ss_pred chhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCC
Confidence 999986543322 2346789999999998764 799999999999999999999999987643322 1111111000
Q ss_pred C-------------CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 306 D-------------GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 306 ~-------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
. ...+.......+...+....+.++.+||.+||..||.+||++.++++|.|..
T Consensus 276 p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~ 341 (420)
T 1j1b_A 276 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341 (420)
T ss_dssp CCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred CCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence 0 0000001111111112223467899999999999999999999999998763
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=335.33 Aligned_cols=266 Identities=20% Similarity=0.302 Sum_probs=205.1
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 150 (393)
++|++.+.||+|+||+||+|.+..++ ..||+|++... ....+.+|+.+++.++ ||||+++++++......
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~- 106 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNN-----EKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSR- 106 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC-
T ss_pred CceEEEEEecccCCeEEEEEEECCCC-----cEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC-
Confidence 57999999999999999999875443 46999998753 3467889999999997 99999999999875443
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC-ceEEeeccC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF-KPKLSDFGL 229 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~ 229 (393)
..++||||+.+++|.+++. .+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus 107 -~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 107 -TPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp -CEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred -ceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 5699999999999999883 378999999999999999999999 999999999999999776 899999999
Q ss_pred CccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHH-----------
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL----------- 297 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~----------- 297 (393)
+........ .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.......+....
T Consensus 178 a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 254 (330)
T 3nsz_A 178 AEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 254 (330)
T ss_dssp CEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred ceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhh
Confidence 986543332 234578999999999877 67899999999999999999999999655443222111
Q ss_pred HHHhhcCcC-Ccccccc--------cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 298 EWVKQFPAD-GKKFSMM--------IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 298 ~~~~~~~~~-~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.+....... ...+... ............++.++.+||.+||+.||.+|||+.++++|.|..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~ 324 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHh
Confidence 111100000 0000000 000011111223568899999999999999999999999998753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=329.27 Aligned_cols=256 Identities=23% Similarity=0.378 Sum_probs=186.2
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecC
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTE 146 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 146 (393)
..++|++.+.||+|+||.||+|.+..++ ..||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTG-----LEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS 83 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS
T ss_pred ccccceeeeeecCCCceEEEEEEEccCC-----ceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC
Confidence 3567999999999999999999875433 469999986432 12346688999999999999999999999876
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
+ ..++||||+++++|.+++... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|
T Consensus 84 ~----~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~d 155 (278)
T 3cok_A 84 N----YVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIAD 155 (278)
T ss_dssp S----EEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECC
T ss_pred C----eEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEe
Confidence 6 569999999999999998543 35689999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..||......... ...
T Consensus 156 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~--- 224 (278)
T 3cok_A 156 FGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------NKV--- 224 (278)
T ss_dssp CTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------C---
T ss_pred ecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------HHH---
Confidence 999986543221 123457899999999999989999999999999999999999999754321100 000
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.... ...+..++.++.+|+.+||+.||++|||+.++++|.|..
T Consensus 225 -------~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 267 (278)
T 3cok_A 225 -------VLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267 (278)
T ss_dssp -------CSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC
T ss_pred -------hhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcccc
Confidence 0000 011223457899999999999999999999999988754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=329.18 Aligned_cols=266 Identities=20% Similarity=0.236 Sum_probs=209.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.+.||+|+||.||+|.+.. .+..||+|++..... ...+.+|+.+++.++|++++..+.++...+.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-- 78 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIA-----AGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD-- 78 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETT--
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcC-----CCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCC--
Confidence 4689999999999999999999653 345799999876532 3467889999999999888777766654332
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC---CCCceEEeec
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD---GNFKPKLSDF 227 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~Df 227 (393)
..++||||+ +++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++ .++.+||+||
T Consensus 79 -~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 79 -YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp -EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred -ceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 569999999 89999998543 34689999999999999999999999 999999999999994 8899999999
Q ss_pred cCCccCCCCCCcc-----ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHH-HHH-
Q 035862 228 GLAREGPTGDHTH-----VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL-EWV- 300 (393)
Q Consensus 228 g~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~-~~~- 300 (393)
|++.......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............ ...
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T 3uzp_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHH
T ss_pred CCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcc
Confidence 9998654432211 124568999999999999999999999999999999999999999864332111111 110
Q ss_pred --hhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcCC
Q 035862 301 --KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQG 365 (393)
Q Consensus 301 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~~ 365 (393)
...+. ......++.++.+|+.+||+.||.+|||+.++++.|..+.......
T Consensus 233 ~~~~~~~--------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 233 KKMSTPI--------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp HHHHSCH--------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cccCCch--------------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 01000 0001124578999999999999999999999999999998876544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=331.54 Aligned_cols=276 Identities=26% Similarity=0.367 Sum_probs=205.4
Q ss_pred HHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcC--CCCccceeeeeee
Q 035862 67 LREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV--SHPNLVKLLGYCS 144 (393)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~ 144 (393)
.....++|++.+.||+|+||.||+|.+. +..||+|++.... .....+|.+++..+ +||||+++++++.
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~ 101 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-------GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADI 101 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-------TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-------CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEc
Confidence 3344578999999999999999999864 3469999986432 33445566666554 8999999999998
Q ss_pred cCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----CCCeEeccCCCCCeEeCCC
Q 035862 145 TEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGL-----EIQVIYRDFKTSNVLLDGN 219 (393)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~-----~~~ivH~Dikp~NIll~~~ 219 (393)
.........++||||+++++|.+++... .+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.+
T Consensus 102 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 102 KGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp ESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred cCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence 7754334679999999999999999543 5899999999999999999999741 2389999999999999999
Q ss_pred CceEEeeccCCccCCCCCCcc--ccccccccCCccCccccccCCCCch------hhHHHHHHHHHHHHhC----------
Q 035862 220 FKPKLSDFGLAREGPTGDHTH--VSTAVVGTYGYAAPEYIETGHLKSQ------SDIWSFGVVLYEILTG---------- 281 (393)
Q Consensus 220 ~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslGvil~elltg---------- 281 (393)
+.+||+|||++.......... ......||+.|+|||++.+..++.. +|||||||++|||++|
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 999999999997654332211 1234579999999999987766654 9999999999999999
Q ss_pred CCccCCCCchhh--hHHHHHHhhcCcCCcccccccCcccc-cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 282 RRVLERNRPTME--QKLLEWVKQFPADGKKFSMMIDPRLR-NQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 282 ~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
..||........ .......... ...+... ......++.++.+|+.+||+.||.+|||+.+++++|+.+
T Consensus 259 ~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 259 QLPYHDLVPSDPSYEDMREIVCIK---------KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTS---------CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cccHhhhcCCCCchhhhHHHHhhh---------ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 555543222110 1111111000 0011111 111236788999999999999999999999999999999
Q ss_pred HhhhcC
Q 035862 359 VQESEQ 364 (393)
Q Consensus 359 ~~~~~~ 364 (393)
.+..+.
T Consensus 330 ~~~~~~ 335 (337)
T 3mdy_A 330 SESQDI 335 (337)
T ss_dssp HHTTTC
T ss_pred Hhhccc
Confidence 876543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=360.92 Aligned_cols=260 Identities=28% Similarity=0.415 Sum_probs=210.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.+.||+|+||.||+|.+.. ...||+|++.... .....+.+|+.+|+.++||||+++++++.. +
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~--- 334 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E--- 334 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S---
T ss_pred hhhhhhheecccCCCeEEEEEEECC------CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-c---
Confidence 4578999999999999999998753 2359999998654 345678999999999999999999999865 2
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+++|.+++.......+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 335 -~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 410 (535)
T 2h8h_A 335 -PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 410 (535)
T ss_dssp -SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred -cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence 348999999999999999654445689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+...... ........++..|+|||++.+..++.++|||||||++|||++ |..||........ ......
T Consensus 411 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~---~~~i~~------- 479 (535)
T 2h8h_A 411 RLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQVER------- 479 (535)
T ss_dssp TTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH---HHHHHT-------
T ss_pred eecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHc-------
Confidence 8654221 112233456788999999999999999999999999999999 9999976543221 111111
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
..+...+..++..+.+||.+||+.||++|||+.++++.|+.+....+
T Consensus 480 -------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 480 -------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp -------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 01111223456789999999999999999999999999998865443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=366.13 Aligned_cols=254 Identities=25% Similarity=0.374 Sum_probs=207.8
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC---CcccHHHHHHHHHHhhcC-CCCccceeeeeeec
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH---GLQGHKQWLAEVQFLGVV-SHPNLVKLLGYCST 145 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 145 (393)
..++|++++.||+|+||.||+|.+..++ ..||+|++.+. .......+..|..++..+ +||||+.+++++..
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~-----~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTD-----ELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSC-----CEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCC-----cEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe
Confidence 3578999999999999999999976443 46999998753 123345677899999987 69999999999987
Q ss_pred CCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 146 EDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
.+ .+|+||||++||+|.+++... ..+++..++.++.||+.||.|||+. +|+||||||+||||+.+|.+||+
T Consensus 414 ~~----~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~ 484 (674)
T 3pfq_A 414 MD----RLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA 484 (674)
T ss_dssp SS----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEEC
T ss_pred CC----EEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEe
Confidence 66 569999999999999999643 4689999999999999999999999 99999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
|||++........ .....+||+.|+|||++.+..|+.++|||||||++|||++|..||........ +......
T Consensus 485 DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~--~~~i~~~--- 557 (674)
T 3pfq_A 485 DFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--FQSIMEH--- 557 (674)
T ss_dssp CCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHSS---
T ss_pred ecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH--HHHHHhC---
Confidence 9999986433222 23567899999999999999999999999999999999999999986543221 1111110
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM-----NQVVESLKL 357 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~~l~~l~~ 357 (393)
. ..++..++.++.+||.+||+.||.+||++ .++++|.+.
T Consensus 558 -~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff 601 (674)
T 3pfq_A 558 -N------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601 (674)
T ss_dssp -C------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGG
T ss_pred -C------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccc
Confidence 0 11222456889999999999999999997 899998654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=327.80 Aligned_cols=258 Identities=24% Similarity=0.334 Sum_probs=202.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|.....||+|+||.||+|.+..+ +..||+|.+..........+.+|+.+++.++||||+++++++...+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 92 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSN-----QVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG---- 92 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTT-----CCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT----
T ss_pred cCCCCcEEEeecCcEEEEEEEECCC-----CeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC----
Confidence 3466667999999999999997543 3469999998766556677889999999999999999999998766
Q ss_pred eEEEEEeecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC-CCceEEeeccC
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRA-QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG-NFKPKLSDFGL 229 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~-~~~~kl~Dfg~ 229 (393)
..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. |++||||||+||+++. ++.+||+|||+
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccc
Confidence 5699999999999999996543 23567889999999999999999998 9999999999999987 89999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCC--CCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGH--LKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
+........ ......|++.|+|||++.+.. ++.++||||||+++|+|++|..||.................
T Consensus 170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----- 242 (295)
T 2clq_A 170 SKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK----- 242 (295)
T ss_dssp CEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC-----
T ss_pred ccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc-----
Confidence 976543221 223457899999999997643 88999999999999999999999975433222111110100
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.....+..++.++.+|+.+||+.||++||++.++++|.+..
T Consensus 243 ----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~ 283 (295)
T 2clq_A 243 ----------VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK 283 (295)
T ss_dssp ----------CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGC
T ss_pred ----------ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence 00111223457899999999999999999999999987764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=332.25 Aligned_cols=262 Identities=27% Similarity=0.351 Sum_probs=202.1
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcC-CCCccceeeeeeecCCc
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 148 (393)
..++|++.+.||+|+||.||+|.+..++ ..||+|++.... .....+.+|+.+++.+ +||||+++++++.....
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTG-----QLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCC-----CeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 4578999999999999999999975433 469999987653 3456788999999998 79999999999976431
Q ss_pred c--cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 149 R--GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 149 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
. ....++||||+++++|.+++.......+++..++.++.||+.||.|||++ |++||||||+|||++.++.+||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEee
Confidence 1 22679999999999999999765556789999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHh
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE-----TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK 301 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~ 301 (393)
||++........ ......|++.|+|||++. +..++.++|||||||++|+|++|..||.......... ...
T Consensus 173 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~- 247 (326)
T 2x7f_A 173 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF--LIP- 247 (326)
T ss_dssp CTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--HHH-
T ss_pred CcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH--Hhh-
Confidence 999876433211 223457899999999986 5678999999999999999999999997654332211 111
Q ss_pred hcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
..+.. . .....++..+.+||.+||..||.+||++.++++|.|..
T Consensus 248 ~~~~~----------~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~ 291 (326)
T 2x7f_A 248 RNPAP----------R---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR 291 (326)
T ss_dssp HSCCC----------C---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred cCccc----------c---CCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence 11100 0 00112357899999999999999999999999998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=335.40 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=198.9
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--------ccHHHHHHHHHHhhcCCCCccceeee
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--------QGHKQWLAEVQFLGVVSHPNLVKLLG 141 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~ 141 (393)
..++|.+.+.||+|+||.||+|.+.. .+..||+|.+..... .....+.+|+.+++.++||||+++++
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 82 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERK-----TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN 82 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEE
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcC-----CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEee
Confidence 34679999999999999999999754 345699999875421 12234778999999999999999999
Q ss_pred eeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc
Q 035862 142 YCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK 221 (393)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~ 221 (393)
++...+ .++||||+.+++|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.
T Consensus 83 ~~~~~~-----~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~ 152 (322)
T 2ycf_A 83 FFDAED-----YYIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEE 152 (322)
T ss_dssp EEESSS-----EEEEEECCTTEETHHHHS--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSS
T ss_pred EEcCCc-----eEEEEecCCCCcHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCC
Confidence 986543 489999999999999884 456789999999999999999999998 9999999999999987665
Q ss_pred ---eEEeeccCCccCCCCCCccccccccccCCccCccccc---cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH
Q 035862 222 ---PKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE---TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK 295 (393)
Q Consensus 222 ---~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~ 295 (393)
+||+|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|..||.........
T Consensus 153 ~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~- 228 (322)
T 2ycf_A 153 DCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL- 228 (322)
T ss_dssp SCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH-
T ss_pred CCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH-
Confidence 9999999998653321 233457899999999874 567899999999999999999999999765432111
Q ss_pred HHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.......... ..+ .....++..+.+|+.+||+.||++||++.++++|.|
T Consensus 229 -~~~~~~~~~~-------~~~----~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~ 277 (322)
T 2ycf_A 229 -KDQITSGKYN-------FIP----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 277 (322)
T ss_dssp -HHHHHHTCCC-------CCH----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred -HHHHHhCccc-------cCc----hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcC
Confidence 1111110000 000 001124578999999999999999999999998765
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=329.37 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=203.7
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
..++|++.+.||+|+||.||+|.+..+ +..||+|.+.... ....+.+|+.+++.++||||+++++++...+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKET-----GQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT-- 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTT-----CCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT--
T ss_pred chhhhhhheeeccCCCeEEEEEEECCC-----CCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC--
Confidence 356899999999999999999987543 3469999987653 3467889999999999999999999998766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||+. |++|+||||+||+++.++.+||+|||+
T Consensus 98 --~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 171 (314)
T 3com_A 98 --DLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGV 171 (314)
T ss_dssp --EEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred --EEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeeccc
Confidence 569999999999999998533 35689999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||........... ..... .. .
T Consensus 172 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~-~~--~ 244 (314)
T 3com_A 172 AGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM--IPTNP-PP--T 244 (314)
T ss_dssp CEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH--HHHSC-CC--C
T ss_pred chhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HhcCC-Cc--c
Confidence 976433211 23345789999999999999999999999999999999999999976543322111 11110 00 0
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
...+..++..+.+|+.+||..||.+|||+.++++|.|..
T Consensus 245 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~ 283 (314)
T 3com_A 245 ----------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283 (314)
T ss_dssp ----------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred ----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 001122457899999999999999999999999998864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=344.43 Aligned_cols=270 Identities=24% Similarity=0.331 Sum_probs=200.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc--c
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE--R 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~ 149 (393)
.+|.+.+.||+|+||.||+|.+..++ .+|+|++...... ..+|+.+++.++||||+++++++...+. .
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~------~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESD------EVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTE------EEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCC------eEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 46999999999999999999875332 3788877554321 2369999999999999999999865442 2
Q ss_pred cceEEEEEeecCCCChHHHHh--hcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC-CCCceEEee
Q 035862 150 GIQRLLVYEYMPNRSLEDRLF--SRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD-GNFKPKLSD 226 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~-~~~~~kl~D 226 (393)
..++++||||+.+ ++...+. ......+++..++.++.||+.||.|||+. ||+||||||+|||++ .++.+||+|
T Consensus 110 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 110 EVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp CEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECC
T ss_pred ceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEee
Confidence 3357899999976 4444332 23356789999999999999999999999 999999999999998 799999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+......+.
T Consensus 186 FG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 262 (394)
T 4e7w_A 186 FGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS 262 (394)
T ss_dssp CTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred CCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999986543322 2356789999999998764 589999999999999999999999987654322211111100000
Q ss_pred -----------CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 306 -----------DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 306 -----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
....+.......+.......++.++.+|+.+||+.||.+|||+.++++|.|.-
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~ 326 (394)
T 4e7w_A 263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326 (394)
T ss_dssp HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence 00011111111111122223567899999999999999999999999998764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=361.48 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=202.5
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLL 155 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~l 155 (393)
+.||+|+||.||+|.+.. ...+..||+|++..... .....+.+|+.+++.++||||+++++++... ..++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~---~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-----~~~l 446 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQM---KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-----SWML 446 (635)
T ss_dssp EEEEECSSEEEEEEEEEC---SSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----SEEE
T ss_pred CEeccCCCEEEEEEEEcC---CCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CEEE
Confidence 479999999999997652 33456799999976432 3356789999999999999999999998643 2489
Q ss_pred EEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCC
Q 035862 156 VYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPT 235 (393)
Q Consensus 156 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 235 (393)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 447 v~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred EEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 9999999999999953 45689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCc-cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 236 GDHT-HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 236 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
.... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||........... ...
T Consensus 522 ~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~---i~~----------- 587 (635)
T 4fl3_A 522 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM---LEK----------- 587 (635)
T ss_dssp -------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---HHT-----------
T ss_pred CccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHc-----------
Confidence 3221 12334467788999999999999999999999999999998 9999987654322111 111
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
......+..++.++.+||..||+.||++||++.++++.|..+..+.
T Consensus 588 ---~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 588 ---GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 0111222345688999999999999999999999999999887653
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=331.25 Aligned_cols=251 Identities=21% Similarity=0.286 Sum_probs=199.9
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcC-CCCccceeeeeeecC
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTE 146 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 146 (393)
..++|++.+.||+|+||+||+|.+..++ ..||+|.+.... ......+.+|+..+..+ +||||+++++++...
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~ 83 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDG-----CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED 83 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCC-----ceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC
Confidence 3567999999999999999999975443 469999987642 23455678899999998 899999999999877
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC-----
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRA--QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN----- 219 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~----- 219 (393)
+ ..++||||+++++|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.+
T Consensus 84 ~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~ 156 (289)
T 1x8b_A 84 D----HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNA 156 (289)
T ss_dssp T----EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-------
T ss_pred C----eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcc
Confidence 6 5699999999999999996432 25689999999999999999999999 99999999999999844
Q ss_pred --------------CceEEeeccCCccCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCc
Q 035862 220 --------------FKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRV 284 (393)
Q Consensus 220 --------------~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~p 284 (393)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.++
T Consensus 157 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~ 230 (289)
T 1x8b_A 157 ASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230 (289)
T ss_dssp -------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence 479999999998654322 24589999999999765 667899999999999999999987
Q ss_pred cCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 285 LERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 285 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
+..... ........ ....+..++.++.+|+.+||+.||++|||+.++++|.|..
T Consensus 231 ~~~~~~-----~~~~~~~~---------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 284 (289)
T 1x8b_A 231 PRNGDQ-----WHEIRQGR---------------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284 (289)
T ss_dssp CSSSHH-----HHHHHTTC---------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred CcchhH-----HHHHHcCC---------------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence 653311 11111100 0111223457899999999999999999999999998754
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=339.13 Aligned_cols=276 Identities=25% Similarity=0.323 Sum_probs=207.4
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc-
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE- 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 148 (393)
.++|++.+.||+|+||.||+|.+.. .+..||+|++..... .....+.+|+.+++.++||||+++++++.....
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNL-----NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred cccEEEEEEeecCCCeEEEEEEECC-----CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 3579999999999999999998653 345799999975432 334668899999999999999999999876542
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
.....++||||+. ++|.+++.. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 101 ~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 173 (364)
T 3qyz_A 101 QMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG 173 (364)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCc
Confidence 2235699999996 599998854 3589999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCc-cccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 229 LAREGPTGDHT-HVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 229 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..................+..
T Consensus 174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 253 (364)
T ss_dssp TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 99865432211 12345689999999998754 55899999999999999999999999776543322211111000000
Q ss_pred Cccccccc------------Ccc--cccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 307 GKKFSMMI------------DPR--LRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 307 ~~~~~~~~------------~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
....... .+. ........++.++.+||.+||+.||++|||+.++++|.|...
T Consensus 254 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 319 (364)
T 3qyz_A 254 -EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319 (364)
T ss_dssp -HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred -HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence 0000000 000 000011234578999999999999999999999999988653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=330.57 Aligned_cols=278 Identities=24% Similarity=0.368 Sum_probs=207.4
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcC---CCCccceeeeeee
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVV---SHPNLVKLLGYCS 144 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~ 144 (393)
..++|++.+.||+|+||.||+|.+.. ..+..||+|.+..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecC----CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence 34789999999999999999998742 2345799998864321 1223455677776665 8999999999986
Q ss_pred cCC-cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceE
Q 035862 145 TED-ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPK 223 (393)
Q Consensus 145 ~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~k 223 (393)
... ......++||||+. ++|.+++.......+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp EEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred ecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEE
Confidence 321 11236799999997 5999999776666799999999999999999999999 999999999999999999999
Q ss_pred EeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 224 LSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 224 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
|+|||++...... .......|++.|+|||++.+..++.++|||||||++|+|++|..||..................
T Consensus 161 l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (326)
T 1blx_A 161 LADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237 (326)
T ss_dssp ECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence 9999999764322 1234567899999999999999999999999999999999999999876543222111111111
Q ss_pred CcCCc-c-----ccccc---CcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 304 PADGK-K-----FSMMI---DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 304 ~~~~~-~-----~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
+.... . ..... ...........++..+.+|+.+||+.||.+|||+.++++|.|..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 301 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccc
Confidence 10000 0 00000 00001112224567899999999999999999999999998764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=332.77 Aligned_cols=257 Identities=24% Similarity=0.385 Sum_probs=201.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.+.||+|+||.||+|.+..+ +..|++|.+..........+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~-----~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 89 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKET-----GALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG--- 89 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTT-----CCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC----
T ss_pred ccceeecceeccCCCeEEEEEEEcCC-----CcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC---
Confidence 46799999999999999999997543 3469999998766666778899999999999999999999998766
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++
T Consensus 90 -~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 90 -KLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred -eEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCC
Confidence 4599999999999999886433 4589999999999999999999999 9999999999999999999999999987
Q ss_pred ccCCCCCCccccccccccCCccCcccc-----ccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYI-----ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
...... ........|++.|+|||++ .+..++.++||||||+++|+|++|..||........ ........+.
T Consensus 165 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~ 240 (302)
T 2j7t_A 165 AKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIAKSDPP 240 (302)
T ss_dssp HHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSCCC
T ss_pred cccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHHHhccCCc
Confidence 531110 0112345789999999988 366789999999999999999999999986543321 1111111100
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
....+..++..+.+|+.+||+.||.+|||+.++++|.|.
T Consensus 241 -------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 279 (302)
T 2j7t_A 241 -------------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFV 279 (302)
T ss_dssp -------------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTT
T ss_pred -------------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHH
Confidence 001112345789999999999999999999999998664
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=338.75 Aligned_cols=281 Identities=23% Similarity=0.277 Sum_probs=204.1
Q ss_pred HHHHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-----------cHHHHHHHHHHhhcCC
Q 035862 64 MQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-----------GHKQWLAEVQFLGVVS 132 (393)
Q Consensus 64 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~ 132 (393)
..++....++|.+.+.||+|+||.||+|.+.. +..||+|++...... ....+.+|+.+++.++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 87 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSE------GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTT------SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCC------CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC
Confidence 45677788999999999999999999998532 456999988643211 1267889999999999
Q ss_pred CCccceeeeeeecCC-cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCC
Q 035862 133 HPNLVKLLGYCSTED-ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKT 211 (393)
Q Consensus 133 h~niv~~~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp 211 (393)
||||+++++++...+ ......++||||+. ++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||
T Consensus 88 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 162 (362)
T 3pg1_A 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHP 162 (362)
T ss_dssp CTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCG
T ss_pred CcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCCh
Confidence 999999999986543 22336799999996 588888753 334689999999999999999999999 999999999
Q ss_pred CCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCc
Q 035862 212 SNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRP 290 (393)
Q Consensus 212 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~ 290 (393)
+|||++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 163 GNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp GGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999997543322 2345678999999999877 6789999999999999999999999987554
Q ss_pred hhhhHHH-HHHhhcCcC------Cccccccc-------CcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 291 TMEQKLL-EWVKQFPAD------GKKFSMMI-------DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 291 ~~~~~~~-~~~~~~~~~------~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
....... ......... ........ ............+..+.+||.+||+.||.+|||+.++++|.|
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY 319 (362)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence 3222111 111000000 00000000 000001111234577999999999999999999999999987
Q ss_pred HH
Q 035862 357 LA 358 (393)
Q Consensus 357 ~~ 358 (393)
.-
T Consensus 320 f~ 321 (362)
T 3pg1_A 320 FE 321 (362)
T ss_dssp GT
T ss_pred hh
Confidence 64
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=323.13 Aligned_cols=253 Identities=28% Similarity=0.373 Sum_probs=197.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTG-----HKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCC-----ceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 367999999999999999999975433 469999986432 233457889999999999999999999998766
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..++||||+.+++|.+++... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+||
T Consensus 85 ----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~df 155 (276)
T 2h6d_A 85 ----DFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF 155 (276)
T ss_dssp ----EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCC
T ss_pred ----eEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeec
Confidence 569999999999999999543 4589999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHL-KSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
|++....... ......|++.|+|||.+.+..+ +.++||||||+++|+|++|..||........ .........
T Consensus 156 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~- 228 (276)
T 2h6d_A 156 GLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---FKKIRGGVF- 228 (276)
T ss_dssp CGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHCCC-
T ss_pred ccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HHHhhcCcc-
Confidence 9998654332 2234578999999999987765 6899999999999999999999976533211 111111000
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
..+..++..+.+++.+||+.||.+|||+.++++|.|..
T Consensus 229 --------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~ 266 (276)
T 2h6d_A 229 --------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266 (276)
T ss_dssp --------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHH
T ss_pred --------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhc
Confidence 01112357789999999999999999999999998864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-45 Score=339.43 Aligned_cols=267 Identities=23% Similarity=0.347 Sum_probs=206.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCccc-----------------HHHHHHHHHHhhcCCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-----------------HKQWLAEVQFLGVVSH 133 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h 133 (393)
.++|.+.+.||+|+||.||+|.+ .+..||+|.+....... ...+.+|+.+++.++|
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 46899999999999999999986 34579999986432111 1678899999999999
Q ss_pred CccceeeeeeecCCcccceEEEEEeecCCCChHHH------HhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEe
Q 035862 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDR------LFSRAQPTLPWKTRLEIILGAAEGLAYLHE-GLEIQVIY 206 (393)
Q Consensus 134 ~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH 206 (393)
|||+++++++...+ ..++||||+++++|.++ +.......+++..++.++.|++.||.|||+ . |++|
T Consensus 103 ~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H 175 (348)
T 2pml_X 103 EYCLTCEGIITNYD----EVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICH 175 (348)
T ss_dssp TTBCCCSEEEESSS----EEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred CCcceEEEEEeeCC----eEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEee
Confidence 99999999998776 56999999999999998 644436779999999999999999999998 8 9999
Q ss_pred ccCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccC-CCCc-hhhHHHHHHHHHHHHhCCCc
Q 035862 207 RDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKS-QSDIWSFGVVLYEILTGRRV 284 (393)
Q Consensus 207 ~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslGvil~elltg~~p 284 (393)
|||||+||+++.++.+||+|||++...... ......|++.|+|||++.+. .++. ++||||||+++|+|++|..|
T Consensus 176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 251 (348)
T 2pml_X 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251 (348)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999765332 23456799999999999877 6666 99999999999999999999
Q ss_pred cCCCCchhhhHHHHHHhh----cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 285 LERNRPTMEQKLLEWVKQ----FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 285 f~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
|.......+ ....... .+.....+...............++.++.+|+.+||+.||.+|||+.++++|.|.
T Consensus 252 f~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f 326 (348)
T 2pml_X 252 FSLKISLVE--LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326 (348)
T ss_dssp SCCSSCSHH--HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGG
T ss_pred CCCCCcHHH--HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence 986544211 1111111 1111000000000000011113456789999999999999999999999998764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=341.90 Aligned_cols=276 Identities=24% Similarity=0.364 Sum_probs=189.6
Q ss_pred cCCcc-cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNR-MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+.|.+ .++||+|+||+||+|.+... ..+..||+|.+.... ....+.+|+.+|+.++||||+++++++......
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~- 93 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDG---KDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADR- 93 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSS---SCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT-
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccC---CCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC-
Confidence 45766 45799999999999997532 234469999997653 235678999999999999999999999764433
Q ss_pred ceEEEEEeecCCCChHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe----CCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSR-------AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL----DGN 219 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll----~~~ 219 (393)
..++||||+. ++|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||+ +.+
T Consensus 94 -~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 94 -KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp -EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTT
T ss_pred -eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCC
Confidence 6799999996 5888877421 223589999999999999999999999 99999999999999 677
Q ss_pred CceEEeeccCCccCCCCCCc-cccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchh-----
Q 035862 220 FKPKLSDFGLAREGPTGDHT-HVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM----- 292 (393)
Q Consensus 220 ~~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~----- 292 (393)
+.+||+|||++......... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.......
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 89999999999865432111 12345689999999999987 458999999999999999999999997654321
Q ss_pred --hhHHHHHHhh--cCcCCcccccc------------cCcccccccC---------HHHHHHHHHHHHHhcccCCCCCCC
Q 035862 293 --EQKLLEWVKQ--FPADGKKFSMM------------IDPRLRNQYS---------INAARRVAKLADNCLKKNPEERPT 347 (393)
Q Consensus 293 --~~~~~~~~~~--~~~~~~~~~~~------------~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps 347 (393)
...+...... .+... .+..+ +......... ...+..+.+||.+||+.||.+|||
T Consensus 249 ~~~~~l~~i~~~~g~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t 327 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADK-DWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTT-TCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC
T ss_pred chHHHHHHHHHhhCCCChh-hcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC
Confidence 1111111111 11110 00000 0000000000 011567889999999999999999
Q ss_pred HHHHHHHHHHHH
Q 035862 348 MNQVVESLKLAV 359 (393)
Q Consensus 348 ~~~~l~~l~~~~ 359 (393)
+.++++|.|...
T Consensus 328 a~e~L~hp~f~~ 339 (405)
T 3rgf_A 328 SEQAMQDPYFLE 339 (405)
T ss_dssp HHHHHTSGGGTS
T ss_pred HHHHhcChhhcc
Confidence 999999999753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=348.32 Aligned_cols=251 Identities=18% Similarity=0.189 Sum_probs=191.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC---CcccHHHHHHHH---HHhhcCCCCccceee----
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH---GLQGHKQWLAEV---QFLGVVSHPNLVKLL---- 140 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~~~---- 140 (393)
.++|.+.+.||+|+||+||+|.+..+ +..||+|++... .....+.+.+|+ ++++.++||||++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQET-----GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CC-----CCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred CceEEEcceeecCCCEEEEEEEECCC-----CcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 46799999999999999999996433 346999998743 223456788999 555556899999998
Q ss_pred ---eeeecCCc----------cc---ceEEEEEeecCCCChHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHhhcC
Q 035862 141 ---GYCSTEDE----------RG---IQRLLVYEYMPNRSLEDRLFSRAQ-----PTLPWKTRLEIILGAAEGLAYLHEG 199 (393)
Q Consensus 141 ---~~~~~~~~----------~~---~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH~~ 199 (393)
+++...+. .. ...++||||+ +|+|.+++..... ..+++..++.++.||+.||+|||++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 225 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 55544421 10 1258999999 6799999964321 1233578888999999999999999
Q ss_pred CCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccC-----------CCCchhhH
Q 035862 200 LEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG-----------HLKSQSDI 268 (393)
Q Consensus 200 ~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Di 268 (393)
||+||||||+|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.++||
T Consensus 226 ---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 226 ---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp ---TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred ---CeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 999999999999999999999999999985322 2345567 999999999887 89999999
Q ss_pred HHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCH
Q 035862 269 WSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM 348 (393)
Q Consensus 269 wslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 348 (393)
|||||++|||++|+.||........ ....... ...++.++.+||.+||+.||++|||+
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~~~----------------~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~ 354 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAALGG----------------SEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLP 354 (377)
T ss_dssp HHHHHHHHHHHHSSCCC------CC----------------SGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred HHHHHHHHHHHHCCCCCcccccccc----------------hhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCH
Confidence 9999999999999999965432110 0000000 01245789999999999999999999
Q ss_pred HHHHHHHHHH
Q 035862 349 NQVVESLKLA 358 (393)
Q Consensus 349 ~~~l~~l~~~ 358 (393)
.++++|.|..
T Consensus 355 ~e~l~hp~f~ 364 (377)
T 3byv_A 355 LQAMETPEYE 364 (377)
T ss_dssp HHHHTSHHHH
T ss_pred HHHhhChHHH
Confidence 9999987754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=332.29 Aligned_cols=270 Identities=27% Similarity=0.379 Sum_probs=209.0
Q ss_pred HHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhc--CCCCccceeeeeeec
Q 035862 68 REATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGV--VSHPNLVKLLGYCST 145 (393)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~ 145 (393)
....++|.+.+.||+|+||.||+|.+. +..||+|.+... ....+.+|.+++.. ++||||+++++++..
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWR-------GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEET-------TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEc-------CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 344578999999999999999999863 346999998653 34567788888887 789999999999987
Q ss_pred CCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh--------cCCCCCeEeccCCCCCeEeC
Q 035862 146 EDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH--------EGLEIQVIYRDFKTSNVLLD 217 (393)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH--------~~~~~~ivH~Dikp~NIll~ 217 (393)
.+......++||||+.+++|.+++.. ..+++..++.++.|++.||.||| +. +|+||||||+|||++
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVK 181 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEEC
T ss_pred cCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEEC
Confidence 76443467999999999999999954 35899999999999999999999 77 999999999999999
Q ss_pred CCCceEEeeccCCccCCCCCCcc--ccccccccCCccCccccccC------CCCchhhHHHHHHHHHHHHhC--------
Q 035862 218 GNFKPKLSDFGLAREGPTGDHTH--VSTAVVGTYGYAAPEYIETG------HLKSQSDIWSFGVVLYEILTG-------- 281 (393)
Q Consensus 218 ~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslGvil~elltg-------- 281 (393)
.++.+||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 99999999999997644332211 22445799999999999765 334789999999999999999
Q ss_pred --CCccCCCCchh--hhHHHHHHhhcCcCCcccccccCcccccc-cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 282 --RRVLERNRPTM--EQKLLEWVKQFPADGKKFSMMIDPRLRNQ-YSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 282 --~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
..||....... ........... ...+.+... ....++..+.+|+.+||+.||++|||+.+++++|+
T Consensus 262 ~~~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~ 332 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPSVEEMRKVVCEQ---------KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332 (342)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTS---------CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred ccccCccccCcCcccHHHHHHHHHHH---------HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence 67776543211 11111111000 011111111 12367788999999999999999999999999999
Q ss_pred HHHhhh
Q 035862 357 LAVQES 362 (393)
Q Consensus 357 ~~~~~~ 362 (393)
.+.+..
T Consensus 333 ~i~~~~ 338 (342)
T 1b6c_B 333 QLSQQE 338 (342)
T ss_dssp HHHHTT
T ss_pred HHHHHh
Confidence 988754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=341.36 Aligned_cols=261 Identities=25% Similarity=0.356 Sum_probs=204.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC----cccHHHHHHHHHHhhcC-CCCccceeeeeeec
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG----LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCST 145 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 145 (393)
.++|++.+.||+|+||.||+|+... ....+..||+|++.... ......+.+|+.+++.+ +||||+++++++..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKIS--GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECS--STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccceEEEEEeccCCCEEEEEEEEcc--cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 3579999999999999999998742 12355689999986532 12334566799999999 69999999999987
Q ss_pred CCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 146 EDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
.+ ..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 131 ~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~ 201 (355)
T 1vzo_A 131 ET----KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLT 201 (355)
T ss_dssp TT----EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEES
T ss_pred Cc----eEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEe
Confidence 76 569999999999999999644 4589999999999999999999998 99999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhh-hHHHHHHhh
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET--GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTME-QKLLEWVKQ 302 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~-~~~~~~~~~ 302 (393)
|||++....... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ..+......
T Consensus 202 DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 280 (355)
T 1vzo_A 202 DFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 280 (355)
T ss_dssp CSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred eCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc
Confidence 999997643322 122345679999999999985 3578999999999999999999999975432211 111111111
Q ss_pred cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHHH
Q 035862 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKLA 358 (393)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~~ 358 (393)
. ....+..++..+.+||.+||..||.+|| ++.++++|++..
T Consensus 281 ~---------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~ 326 (355)
T 1vzo_A 281 S---------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326 (355)
T ss_dssp C---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred c---------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence 0 0112223457789999999999999999 999999998764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=335.02 Aligned_cols=282 Identities=25% Similarity=0.369 Sum_probs=198.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHH--hhcCCCCccceeeeeeecCC-
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQF--LGVVSHPNLVKLLGYCSTED- 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~- 147 (393)
.++|++.+.||+|+||.||+|.+. +..||+|++.... ...+..|.++ +..++||||+++++.+....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 81 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLD-------ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTA 81 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEET-------TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred hHHhheeeecccCCCeEEEEEEEC-------CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence 467999999999999999999752 3469999986532 2334444444 55589999999998654321
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC------CCCeEeccCCCCCeEeCCCCc
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGL------EIQVIYRDFKTSNVLLDGNFK 221 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~------~~~ivH~Dikp~NIll~~~~~ 221 (393)
......++||||+++++|.+++... ..++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.
T Consensus 82 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 82 DGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp TSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred CCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 1223568999999999999999543 3588899999999999999999752 128999999999999999999
Q ss_pred eEEeeccCCccCCCCCC------ccccccccccCCccCcccccc-------CCCCchhhHHHHHHHHHHHHhCCCccCCC
Q 035862 222 PKLSDFGLAREGPTGDH------THVSTAVVGTYGYAAPEYIET-------GHLKSQSDIWSFGVVLYEILTGRRVLERN 288 (393)
Q Consensus 222 ~kl~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~elltg~~pf~~~ 288 (393)
+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 99999999976543211 112334579999999999976 45677999999999999999998777543
Q ss_pred Cchhhh--HHHHHHhhcCcCCcc----cccccCccccc--ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 289 RPTMEQ--KLLEWVKQFPADGKK----FSMMIDPRLRN--QYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 289 ~~~~~~--~~~~~~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
....+. .........+..... ......+.+.. .....++.++.+||.+||+.||++|||+.++++.|..++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 221110 000000000000000 00000011111 1122467889999999999999999999999999999886
Q ss_pred hhcCC
Q 035862 361 ESEQG 365 (393)
Q Consensus 361 ~~~~~ 365 (393)
.-+.+
T Consensus 319 ~~~~~ 323 (336)
T 3g2f_A 319 IWERN 323 (336)
T ss_dssp CCCC-
T ss_pred HHHhc
Confidence 54433
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=332.33 Aligned_cols=268 Identities=26% Similarity=0.379 Sum_probs=189.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-- 86 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPK-----KEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-- 86 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC---------CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS--
T ss_pred hhhhhhhheeccccceEEEEEEECCC-----CcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC--
Confidence 46899999999999999999985433 3469999886543 233456788999999999999999999998776
Q ss_pred cceEEEEEeecCCCChHHHHhh------cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceE
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFS------RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPK 223 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~k 223 (393)
..++||||+++++|.+++.. .....+++..++.++.|++.||.|||++ |++||||||+||+++.++.+|
T Consensus 87 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 87 --ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEE
T ss_pred --CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEE
Confidence 45999999999999999853 1345689999999999999999999998 999999999999999999999
Q ss_pred EeeccCCccCCCCCC---ccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHH
Q 035862 224 LSDFGLAREGPTGDH---THVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW 299 (393)
Q Consensus 224 l~Dfg~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~ 299 (393)
|+|||++........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||......... ...
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~ 239 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL--MLT 239 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HHH
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH--HHH
Confidence 999999876543221 112234579999999999876 57899999999999999999999999865443221 111
Q ss_pred HhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
....+.. ......+... ...++.++.+|+.+||+.||.+|||+.++++|.|..
T Consensus 240 ~~~~~~~--~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 292 (303)
T 2vwi_A 240 LQNDPPS--LETGVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292 (303)
T ss_dssp HTSSCCC--TTC-----CC----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-
T ss_pred hccCCCc--cccccccchh----hhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhh
Confidence 1111100 0000011111 112457789999999999999999999999987654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=340.78 Aligned_cols=270 Identities=26% Similarity=0.351 Sum_probs=189.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++++.||+|+||.||+|.+.. .+..||+|++.... ......+.+|+.+++.++||||+++++++.....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTK-----TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 102 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETT-----TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCceEEeeEEeecCCeEEEEEEECC-----CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCc
Confidence 3679999999999999999998653 34579999987542 2344667899999999999999999999875421
Q ss_pred --ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 149 --RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 149 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
.....++|||++ +++|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|
T Consensus 103 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~D 175 (367)
T 2fst_X 103 LEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 175 (367)
T ss_dssp GGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEee
Confidence 112458999999 7899998843 4689999999999999999999998 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+......+.
T Consensus 176 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~ 250 (367)
T 2fst_X 176 FGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 250 (367)
T ss_dssp --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred cccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999764321 244689999999999877 6889999999999999999999999987654322221111111110
Q ss_pred CCccccccc-----------Ccccc---cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 306 DGKKFSMMI-----------DPRLR---NQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 306 ~~~~~~~~~-----------~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
. .....+. ..... ......++..+.+||.+||+.||.+|||+.++++|.|..
T Consensus 251 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~ 316 (367)
T 2fst_X 251 A-ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316 (367)
T ss_dssp H-HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred H-HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence 0 0000000 00000 000112457899999999999999999999999998864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=325.09 Aligned_cols=262 Identities=24% Similarity=0.328 Sum_probs=192.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-c-HHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-G-HKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||+||+|.+.. .+..||+|.+...... . ...+.++...++.++||||+++++++...+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~- 79 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVP-----SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG- 79 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecC-----CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-
Confidence 4679999999999999999999753 3457999998764322 2 223445555688899999999999998766
Q ss_pred ccceEEEEEeecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
..++||||+++ +|.+++.. .....+++..++.++.|++.||.|||++ .|++||||||+||+++.++.+||+|
T Consensus 80 ---~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~D 153 (290)
T 3fme_A 80 ---DVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCD 153 (290)
T ss_dssp ---SEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCC
T ss_pred ---CEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEee
Confidence 45999999964 88887743 3456799999999999999999999983 2899999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhh
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYI----ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ 302 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (393)
||++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||........... .....
T Consensus 154 fg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~ 229 (290)
T 3fme_A 154 FGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK-QVVEE 229 (290)
T ss_dssp C------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHH-HHHHS
T ss_pred cCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHH-HHhcc
Confidence 99997654322 22344799999999996 566789999999999999999999999976433322211 11111
Q ss_pred cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
... ......++.++.+|+.+||+.||++|||+.++++|.|......
T Consensus 230 ~~~--------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~ 275 (290)
T 3fme_A 230 PSP--------------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES 275 (290)
T ss_dssp CCC--------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred CCC--------------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence 100 0011134578999999999999999999999999998876543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=330.24 Aligned_cols=270 Identities=21% Similarity=0.294 Sum_probs=208.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCC------ccceeeeeee
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHP------NLVKLLGYCS 144 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~ 144 (393)
.++|++.+.||+|+||.||+|.+. ...+..||+|++.... .....+.+|+.+++.++|+ +++++++++.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDH----KAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET----TTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEec----CCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 367999999999999999999863 2344679999997543 3346677899998887655 4999999998
Q ss_pred cCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC------
Q 035862 145 TEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG------ 218 (393)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~------ 218 (393)
..+ ..++||||+ +++|.+++.......+++..++.++.|++.||+|||++ ||+||||||+|||++.
T Consensus 88 ~~~----~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 159 (339)
T 1z57_A 88 HHG----HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEA 159 (339)
T ss_dssp ETT----EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEE
T ss_pred cCC----cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccc
Confidence 776 569999999 88999999776666789999999999999999999999 9999999999999987
Q ss_pred -------------CCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCcc
Q 035862 219 -------------NFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVL 285 (393)
Q Consensus 219 -------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf 285 (393)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 160 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 234 (339)
T 1z57_A 160 YNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVF 234 (339)
T ss_dssp EC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCC
Confidence 678999999999764332 23457899999999999999999999999999999999999999
Q ss_pred CCCCchhhhHHHHHH-hhcCcCC------cc--------cc----------cccCc-ccccccCHHHHHHHHHHHHHhcc
Q 035862 286 ERNRPTMEQKLLEWV-KQFPADG------KK--------FS----------MMIDP-RLRNQYSINAARRVAKLADNCLK 339 (393)
Q Consensus 286 ~~~~~~~~~~~~~~~-~~~~~~~------~~--------~~----------~~~~~-~~~~~~~~~~~~~l~~li~~~l~ 339 (393)
............... ...+..- .. .. ....+ ..........++++.+|+.+||+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 235 PTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp CCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 876544322222111 1111000 00 00 00000 00011223567889999999999
Q ss_pred cCCCCCCCHHHHHHHHHHH
Q 035862 340 KNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 340 ~dp~~Rps~~~~l~~l~~~ 358 (393)
.||.+|||+.++++|.|..
T Consensus 315 ~dP~~Rpt~~ell~hp~f~ 333 (339)
T 1z57_A 315 YDPAKRITLREALKHPFFD 333 (339)
T ss_dssp SSTTTSCCHHHHTTSGGGG
T ss_pred cCcccccCHHHHhcCHHHH
Confidence 9999999999999997754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=340.84 Aligned_cols=263 Identities=12% Similarity=0.051 Sum_probs=186.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHH---HHHhhcCCCCccceee-----
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAE---VQFLGVVSHPNLVKLL----- 140 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E---~~~l~~l~h~niv~~~----- 140 (393)
.+|.+.+.||+|+||.||+|.+..+ +..||+|++..... .....+.+| +.+|+. +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~ 135 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVER-----LEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLL 135 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCC
T ss_pred eeeeeeeeccCCCCEEEEEEEECCC-----CceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEe
Confidence 3589999999999999999997543 45799999987543 223456677 455555 799988755
Q ss_pred --eeeecCCcc-------------cceEEEEEeecCCCChHHHHhhcCCCCCCHHHH------HHHHHHHHHHHHHhhcC
Q 035862 141 --GYCSTEDER-------------GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTR------LEIILGAAEGLAYLHEG 199 (393)
Q Consensus 141 --~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~------~~i~~ql~~~l~~LH~~ 199 (393)
+++...... ....++||||++ ++|.+++.... ..+++..+ +.++.||+.||+|||++
T Consensus 136 p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~ 213 (371)
T 3q60_A 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSK 213 (371)
T ss_dssp CCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence 344332210 024799999998 79999996542 22355555 67789999999999999
Q ss_pred CCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCcccccc--CCCCchhhHHHHHHHHHH
Q 035862 200 LEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET--GHLKSQSDIWSFGVVLYE 277 (393)
Q Consensus 200 ~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~e 277 (393)
||+||||||+|||++.+|.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+
T Consensus 214 ---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e 285 (371)
T 3q60_A 214 ---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285 (371)
T ss_dssp ---TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred ---CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence 9999999999999999999999999999865321 124567799999999987 789999999999999999
Q ss_pred HHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 278 ILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 278 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
|++|+.||....+...... ....................++..+.+||.+||+.||++|||+.++++|.|.
T Consensus 286 lltg~~Pf~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 356 (371)
T 3q60_A 286 VWCLFLPFGLVTPGIKGSW---------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356 (371)
T ss_dssp HHHSSCSTTBCCTTCTTCC---------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHH
T ss_pred HHhCCCCCCCcCcccccch---------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHH
Confidence 9999999986643211100 0000000001111111112456889999999999999999999999999876
Q ss_pred HH
Q 035862 358 AV 359 (393)
Q Consensus 358 ~~ 359 (393)
..
T Consensus 357 ~~ 358 (371)
T 3q60_A 357 LQ 358 (371)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=333.61 Aligned_cols=280 Identities=26% Similarity=0.341 Sum_probs=197.6
Q ss_pred HHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecC
Q 035862 67 LREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTE 146 (393)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 146 (393)
.....++|++.+.||+|+||.||+|.+..++ ..||+|++.... .......++++.+..++||||+++++++...
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~ 91 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTG-----MSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTL 91 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTC-----CEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEE
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcc
Confidence 4455789999999999999999999976443 469999886543 2334566788888999999999999998653
Q ss_pred Cc---ccceEEEEEeecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhh--cCCCCCeEeccCCCCCeEeCC-
Q 035862 147 DE---RGIQRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEGLAYLH--EGLEIQVIYRDFKTSNVLLDG- 218 (393)
Q Consensus 147 ~~---~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~ql~~~l~~LH--~~~~~~ivH~Dikp~NIll~~- 218 (393)
+. ...+.++||||+.+ +|...+.. .....+++..++.++.|++.||.||| +. ||+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 92 GERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEA 167 (360)
T ss_dssp CSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETT
T ss_pred ccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCC
Confidence 32 22357899999976 66554432 34567899999999999999999999 87 9999999999999996
Q ss_pred CCceEEeeccCCccCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHH
Q 035862 219 NFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL 297 (393)
Q Consensus 219 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~ 297 (393)
++.+||+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||............
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~ 244 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244 (360)
T ss_dssp TTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHH
Confidence 8999999999998654432 22345789999999998654 4899999999999999999999999876543222111
Q ss_pred HHHhhcC---------cCCcccccccCcc-----cccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 298 EWVKQFP---------ADGKKFSMMIDPR-----LRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 298 ~~~~~~~---------~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
......+ ............. .........+.++.+|+.+||+.||.+|||+.++++|.|...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 320 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDE 320 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGG
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccc
Confidence 1110000 0000000000000 001111235688999999999999999999999999988754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=340.86 Aligned_cols=273 Identities=23% Similarity=0.303 Sum_probs=208.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC--------CCccceeeee
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS--------HPNLVKLLGY 142 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~ 142 (393)
.++|++.+.||+|+||+||+|++.. .+..||+|++.... .....+.+|+.+++.++ |+||++++++
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQ-----GKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecC-----CCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 3679999999999999999998653 34579999997542 34566788999999885 7889999999
Q ss_pred eecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC--
Q 035862 143 CSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF-- 220 (393)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-- 220 (393)
+..........++||||+ +++|.+++.......+++..++.++.||+.||.|||++ .||+||||||+|||++.++
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTK--CRIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECCCCSGGGEEECCCHHH
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCCHHHeeEeccchh
Confidence 875443334779999999 66887777666556799999999999999999999984 2899999999999999776
Q ss_pred -----------------------------------------------ceEEeeccCCccCCCCCCccccccccccCCccC
Q 035862 221 -----------------------------------------------KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAA 253 (393)
Q Consensus 221 -----------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 253 (393)
.+||+|||++...... .....||+.|+|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~a 261 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCC
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccC
Confidence 7999999999765332 234578999999
Q ss_pred ccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchh----hh---HHHHHHhhcCcC--------------Cccccc
Q 035862 254 PEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM----EQ---KLLEWVKQFPAD--------------GKKFSM 312 (393)
Q Consensus 254 PE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~----~~---~~~~~~~~~~~~--------------~~~~~~ 312 (393)
||++.+..++.++|||||||++|+|++|+.||....... .. .........+.. ......
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 999999999999999999999999999999997654321 11 111111111100 000000
Q ss_pred ccCcc---------cccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 313 MIDPR---------LRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 313 ~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
..... -....+...+..+.+||.+||+.||++|||+.++++|.|.
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~ 395 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGG
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccc
Confidence 00000 0112345778899999999999999999999999998764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=325.34 Aligned_cols=262 Identities=29% Similarity=0.420 Sum_probs=199.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++.+.||+|+||+||+|.+... .+....||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECT--TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred hHeeeeeeecCCCceeEEEEEeccC--CCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 5699999999999999999986532 2344568999887542 234567889999999999999999999987654
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
.++||||+.+++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||
T Consensus 95 ----~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg 166 (291)
T 1u46_A 95 ----MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG 166 (291)
T ss_dssp ----CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ----ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccc
Confidence 389999999999999986543 4589999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCcc-ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 229 LAREGPTGDHTH-VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 229 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
++.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||........ .......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~~---- 240 (291)
T 1u46_A 167 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--LHKIDKE---- 240 (291)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--HHHHHTS----
T ss_pred ccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH--HHHHHcc----
Confidence 998764433221 2234567788999999998899999999999999999999 9999976543221 1111110
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
.. ....+..++.++.+++.+||..||.+|||+.+++++|..+..
T Consensus 241 ~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 241 GE----------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp CC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CC----------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 00 011122346789999999999999999999999999988754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-44 Score=325.40 Aligned_cols=259 Identities=26% Similarity=0.344 Sum_probs=206.1
Q ss_pred HHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---------ccHHHHHHHHHHhhcCC-CCccce
Q 035862 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---------QGHKQWLAEVQFLGVVS-HPNLVK 138 (393)
Q Consensus 69 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~ 138 (393)
...++|++.+.||+|+||.||+|.+.. .+..||+|.+..... .....+.+|+.+++.+. ||||++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKP-----TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQ 88 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred chhhccceeeeecCCCceEEEEEEEcC-----cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEee
Confidence 345789999999999999999999753 345699999875431 12345778999999996 999999
Q ss_pred eeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC
Q 035862 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG 218 (393)
Q Consensus 139 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~ 218 (393)
+++++...+ ..++||||+++++|.+++... ..+++..++.++.|++.||.|||++ |++||||||+||+++.
T Consensus 89 ~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~ 159 (298)
T 1phk_A 89 LKDTYETNT----FFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDD 159 (298)
T ss_dssp EEEEEECSS----EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECT
T ss_pred eeeeeccCC----eEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcC
Confidence 999997765 569999999999999999543 4689999999999999999999999 9999999999999999
Q ss_pred CCceEEeeccCCccCCCCCCccccccccccCCccCccccc------cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchh
Q 035862 219 NFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE------TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTM 292 (393)
Q Consensus 219 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~ 292 (393)
++.+||+|||++....... ......|++.|+|||++. ...++.++||||||+++|+|++|..||.......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 236 (298)
T 1phk_A 160 DMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 236 (298)
T ss_dssp TCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH
Confidence 9999999999997654332 223457899999999885 4568899999999999999999999997654322
Q ss_pred hhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 293 EQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
... ........ ........++..+.+|+.+||+.||.+|||+.++++|.|..
T Consensus 237 ~~~--~~~~~~~~------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~ 288 (298)
T 1phk_A 237 MLR--MIMSGNYQ------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 288 (298)
T ss_dssp HHH--HHHHTCCC------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHH--HHhcCCcc------------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhh
Confidence 111 11111000 00001113457899999999999999999999999987753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=357.69 Aligned_cols=263 Identities=25% Similarity=0.355 Sum_probs=208.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|++.+.||+|+||.||+|.+...+ .....||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~--- 463 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPE--NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN--- 463 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSS--SCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCC--CccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence 467999999999999999999876432 345689999987643 23346788999999999999999999998532
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++||||+++|+|.+++... ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 464 --~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 464 --PVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp --SCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred --ceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCC
Confidence 348999999999999999644 34589999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+......... ......+++.|+|||++.+..++.++|||||||++|||++ |..||......... .......
T Consensus 538 a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~---~~i~~~~---- 609 (656)
T 2j0j_A 538 SRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIENGE---- 609 (656)
T ss_dssp CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHHHTC----
T ss_pred CeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHcCC----
Confidence 9875433221 2234567789999999999999999999999999999997 99999765443221 1111100
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
....+..++..+.+|+.+||..||.+|||+.++++.|..+++..
T Consensus 610 ----------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 610 ----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 01112235678999999999999999999999999999987653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=333.98 Aligned_cols=276 Identities=24% Similarity=0.310 Sum_probs=205.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCC-c
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED-E 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~ 148 (393)
.++|++.+.||+|+||.||+|.+.. .+..||+|.+..... .....+.+|+.+++.++||||+++++++.... .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKP-----TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred ccceEEeeEEcCCCCeEEEEEEECC-----CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 4679999999999999999999753 345799999975432 33456779999999999999999999886542 1
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
.....++||||+. ++|.+++.. ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 85 NFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp TCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred ccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecc
Confidence 1125699999996 599998854 3589999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCcc--------ccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHH
Q 035862 229 LAREGPTGDHTH--------VSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW 299 (393)
Q Consensus 229 ~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~ 299 (393)
++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||..............
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 998654322111 1223578999999998754 7789999999999999999999999987654332222111
Q ss_pred HhhcCcCCcccccccCc--------------ccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 300 VKQFPADGKKFSMMIDP--------------RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 300 ~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
....+............ .........++.++.+|+.+||+.||++|||+.++++|.|..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 11111111110000000 000001123567899999999999999999999999998864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=336.15 Aligned_cols=272 Identities=22% Similarity=0.240 Sum_probs=204.9
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CC-----ccceeeeee
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HP-----NLVKLLGYC 143 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~ 143 (393)
..++|++.+.||+|+||+||+|.+.. .+..||+|++.... .....+..|+.+++.++ |+ +|+++++++
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRV-----EQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETT-----TTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcC-----CCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 35789999999999999999998653 34579999997542 33456677888888775 44 499999999
Q ss_pred ecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC--CCCc
Q 035862 144 STEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD--GNFK 221 (393)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~--~~~~ 221 (393)
...+ ..++||||+. ++|.+++.......+++..++.++.|++.||.|||.+ ..||+||||||+|||++ .++.
T Consensus 126 ~~~~----~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 126 MFRN----HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp EETT----EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCC
T ss_pred ccCC----ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCc
Confidence 8776 5699999995 5999999776666799999999999999999999952 23999999999999995 4788
Q ss_pred eEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHh
Q 035862 222 PKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK 301 (393)
Q Consensus 222 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~ 301 (393)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....
T Consensus 200 ~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~ 274 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVL 274 (382)
T ss_dssp EEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 999999999865332 234678999999999999999999999999999999999999998765432221111111
Q ss_pred hcCcCC-----c----ccccccC-----------------cc--------------------cccccCHHHHHHHHHHHH
Q 035862 302 QFPADG-----K----KFSMMID-----------------PR--------------------LRNQYSINAARRVAKLAD 335 (393)
Q Consensus 302 ~~~~~~-----~----~~~~~~~-----------------~~--------------------~~~~~~~~~~~~l~~li~ 335 (393)
..+... . .+..+.+ +. -..........++.+||.
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 354 (382)
T 2vx3_A 275 GIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL 354 (382)
T ss_dssp CSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHH
Confidence 100000 0 0000000 00 000111234468999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHH
Q 035862 336 NCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 336 ~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
+||+.||++|||+.++++|.|..
T Consensus 355 ~mL~~dP~~Rpta~e~L~hp~f~ 377 (382)
T 2vx3_A 355 RMLDYDPKTRIQPYYALQHSFFK 377 (382)
T ss_dssp HHTCSCTTTSCCHHHHTTSGGGC
T ss_pred HhcCCChhhCCCHHHHhcCcccc
Confidence 99999999999999999998753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=329.42 Aligned_cols=274 Identities=22% Similarity=0.312 Sum_probs=201.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCC---
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED--- 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 147 (393)
.++|++.+.||+|+||.||+|.+.. .+..||+|.+..........+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDND-----CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETT-----TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred CCceeEEEEeccCCCeEEEEEEECC-----CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 4679999999999999999999753 34569999998766566677889999999999999999999875432
Q ss_pred -------cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC-CC
Q 035862 148 -------ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD-GN 219 (393)
Q Consensus 148 -------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~-~~ 219 (393)
......++||||+. ++|.+++. ...+++..++.++.|++.||+|||++ ||+||||||+|||++ ++
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLE---QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTED 157 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTT
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhh---cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence 11236799999997 59999884 34689999999999999999999999 999999999999997 56
Q ss_pred CceEEeeccCCccCCCCCC-ccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHH
Q 035862 220 FKPKLSDFGLAREGPTGDH-THVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL 297 (393)
Q Consensus 220 ~~~kl~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~ 297 (393)
+.+||+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ..
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~ 235 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--MQ 235 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--HH
Confidence 7999999999986533211 112234567999999998865 6789999999999999999999999986654322 11
Q ss_pred HHHhhcCcCCccc-cc-------cc----C-c-ccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 298 EWVKQFPADGKKF-SM-------MI----D-P-RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 298 ~~~~~~~~~~~~~-~~-------~~----~-~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
......+...... .. .. . + .........++.++.+|+.+||+.||.+|||+.++++|.|..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (320)
T 2i6l_A 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310 (320)
T ss_dssp HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence 1111111110000 00 00 0 0 000011123568899999999999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=330.54 Aligned_cols=263 Identities=22% Similarity=0.273 Sum_probs=180.4
Q ss_pred hcCCcccc-eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRML-KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|.+.+ .||+|+||+||+|.+..++ ..||+|++.... ....+....++.++||||+++++++......
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~-----~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 97 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTG-----QKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHG 97 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCC-----CEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCC
Confidence 45788865 6999999999999976443 469999986532 1222233345667899999999998764433
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC---CCceEEee
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG---NFKPKLSD 226 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~D 226 (393)
....++||||+++++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||++. ++.+||+|
T Consensus 98 ~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~D 174 (336)
T 3fhr_A 98 KRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD 174 (336)
T ss_dssp EEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred CceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEec
Confidence 34679999999999999999766666799999999999999999999999 9999999999999976 45599999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
||++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........... ........
T Consensus 175 fg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~ 248 (336)
T 3fhr_A 175 FGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRRIRLG 248 (336)
T ss_dssp CTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred cccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHhhhcc
Confidence 9999764322 22345789999999999888999999999999999999999999975433211000 00000000
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
...........++.++.+|+.+||+.||.+|||+.++++|.|...
T Consensus 249 --------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 249 --------QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp ----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred --------ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 000011111234678999999999999999999999999999754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=342.26 Aligned_cols=266 Identities=21% Similarity=0.233 Sum_probs=204.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccc-eeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLV-KLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~ 149 (393)
.++|++.++||+|+||.||+|.+..++ ..||||++..... ...+.+|+++++.++|++.+ .+..++...+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~-----~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~-- 76 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN-----EEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGD-- 76 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTC-----CEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETT--
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCC-----cEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCC--
Confidence 468999999999999999999975443 4699998875432 23477899999999875544 4444444433
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe---CCCCceEEee
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL---DGNFKPKLSD 226 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll---~~~~~~kl~D 226 (393)
..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||| +.++.+||+|
T Consensus 77 --~~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~D 149 (483)
T 3sv0_A 77 --YNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIID 149 (483)
T ss_dssp --EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECC
T ss_pred --EEEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEe
Confidence 569999999 99999998543 34689999999999999999999999 99999999999999 5889999999
Q ss_pred ccCCccCCCCCCc-----cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHh
Q 035862 227 FGLAREGPTGDHT-----HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK 301 (393)
Q Consensus 227 fg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~ 301 (393)
||++......... .......||+.|+|||++.+..++.++|||||||++|||++|+.||................
T Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (483)
T 3sv0_A 150 FGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (483)
T ss_dssp CTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH
T ss_pred CCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh
Confidence 9999865443221 12235689999999999999999999999999999999999999998754432222221111
Q ss_pred hcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
...... . .......++.++.+|+..||+.||++||++.+|++.|..++...
T Consensus 230 ~~~~~~-----~-----~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 230 EKKVAT-----S-----IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHHHS-----C-----HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hccccc-----c-----HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 100000 0 00001123578999999999999999999999999999887644
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=338.77 Aligned_cols=274 Identities=20% Similarity=0.303 Sum_probs=208.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-----------CCccceee
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-----------HPNLVKLL 140 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~ 140 (393)
++|.+.+.||+|+||+||+|.+.. .+..||+|++.... .....+.+|+.+++.++ ||||++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMV-----NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CeEEEEEeeeecCCeEEEEEEecC-----CCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 579999999999999999999653 34579999997543 33456778999988876 89999999
Q ss_pred eeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC---
Q 035862 141 GYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD--- 217 (393)
Q Consensus 141 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~--- 217 (393)
+++...+......++||||+ +++|.+++.......+++..++.++.||+.||.|||++ .||+||||||+|||++
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEE
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccC
Confidence 99987655555779999999 88999999776666799999999999999999999983 2899999999999994
Q ss_pred ---CCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCch---
Q 035862 218 ---GNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPT--- 291 (393)
Q Consensus 218 ---~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~--- 291 (393)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred CCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 4458999999999765332 23457899999999999999999999999999999999999999765321
Q ss_pred -hhhHH---HHHHhhcCcC--------------CcccccccCc---------ccccccCHHHHHHHHHHHHHhcccCCCC
Q 035862 292 -MEQKL---LEWVKQFPAD--------------GKKFSMMIDP---------RLRNQYSINAARRVAKLADNCLKKNPEE 344 (393)
Q Consensus 292 -~~~~~---~~~~~~~~~~--------------~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~ 344 (393)
....+ .......|.. .......... ......+...+.++.+||.+||+.||.+
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 11111 1111111100 0000000000 0011244678899999999999999999
Q ss_pred CCCHHHHHHHHHHHH
Q 035862 345 RPTMNQVVESLKLAV 359 (393)
Q Consensus 345 Rps~~~~l~~l~~~~ 359 (393)
|||+.++++|.|...
T Consensus 325 Rpt~~ell~hp~f~~ 339 (373)
T 1q8y_A 325 RADAGGLVNHPWLKD 339 (373)
T ss_dssp CBCHHHHHTCGGGTT
T ss_pred cCCHHHHhhChhhhc
Confidence 999999999988653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=332.51 Aligned_cols=268 Identities=25% Similarity=0.344 Sum_probs=202.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|.+.+.||+|+||.||+|.+.. .+..||+|++..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKR-----SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 115 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred cccEEEEeEEecCCCeEEEEEEECC-----CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence 4679999999999999999999754 345799999976432 234667899999999999999999999977654
Q ss_pred cc--ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 149 RG--IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 149 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
.. ...++||||+. ++|.+++ ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 116 ~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~D 187 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQ-TDLQKIM----GMEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILD 187 (371)
T ss_dssp STTCCCCEEEEECCC-EEHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECS
T ss_pred cccceeEEEEEcccc-ccHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEe
Confidence 21 12389999996 5888876 23489999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ ......
T Consensus 188 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i--~~~~~~ 260 (371)
T 4exu_A 188 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI--LKVTGV 260 (371)
T ss_dssp TTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCC
T ss_pred cCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH--HHHhCC
Confidence 9999754322 234678999999999877 78999999999999999999999999865543221111 111100
Q ss_pred CCcccccccC------------cccc---cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 306 DGKKFSMMID------------PRLR---NQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 306 ~~~~~~~~~~------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
....+...+. .... ......++..+.+||.+||+.||.+|||+.++++|.|..
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 328 (371)
T 4exu_A 261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328 (371)
T ss_dssp CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence 0000000000 0000 001113467899999999999999999999999998864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=320.36 Aligned_cols=260 Identities=26% Similarity=0.348 Sum_probs=205.7
Q ss_pred HHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeec
Q 035862 68 REATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCST 145 (393)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 145 (393)
+...++|++.+.||+|+||.||+|.+..++ ..||+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~-----~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQ-----QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED 92 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCC-----cEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC
Confidence 344578999999999999999999975433 469999986532 2345678899999999999999999999987
Q ss_pred CCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC---Cce
Q 035862 146 EDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN---FKP 222 (393)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~---~~~ 222 (393)
.+ ..++||||+.+++|.+++... ..+++..++.++.|++.||.|||++ |++||||||+||+++.+ +.+
T Consensus 93 ~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~ 163 (287)
T 2wei_A 93 SS----SFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDI 163 (287)
T ss_dssp SS----EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCE
T ss_pred CC----eEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccE
Confidence 66 569999999999999988543 4589999999999999999999999 99999999999999764 469
Q ss_pred EEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhh
Q 035862 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ 302 (393)
Q Consensus 223 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (393)
||+|||++....... ......|++.|+|||++.+ .++.++||||||+++|+|++|..||........ ......
T Consensus 164 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~ 236 (287)
T 2wei_A 164 KIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI---LKRVET 236 (287)
T ss_dssp EECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH
T ss_pred EEeccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHc
Confidence 999999987653322 1234468999999998875 489999999999999999999999976543321 111111
Q ss_pred cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.... .+ ......++.++.+|+.+||+.||.+|||+.+++++.|...
T Consensus 237 ~~~~-------~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 237 GKYA-------FD----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp CCCC-------CC----SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred CCCC-------CC----chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 1000 00 0001134578999999999999999999999999987654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=327.68 Aligned_cols=271 Identities=20% Similarity=0.274 Sum_probs=206.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCc------cceeeeeee
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPN------LVKLLGYCS 144 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~ 144 (393)
.++|++.+.||+|+||+||+|.+...+ +..||+|++.... .....+.+|+.+++.++|++ ++.+++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARG----KSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTT----TEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCC----ceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 367999999999999999999875332 3579999997543 34456778999999887655 889999888
Q ss_pred cCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe--------
Q 035862 145 TEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL-------- 216 (393)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll-------- 216 (393)
..+ ..++||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||+
T Consensus 93 ~~~----~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 93 FHG----HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp ETT----EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEE
T ss_pred eCC----eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccc
Confidence 766 569999999 66888888766656799999999999999999999998 99999999999999
Q ss_pred -----------CCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCcc
Q 035862 217 -----------DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVL 285 (393)
Q Consensus 217 -----------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf 285 (393)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 239 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF 239 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 56789999999999764332 23457999999999999999999999999999999999999999
Q ss_pred CCCCchhhhHHHHHH-hhcCcCC----cccccccCc---------------------ccccccCHHHHHHHHHHHHHhcc
Q 035862 286 ERNRPTMEQKLLEWV-KQFPADG----KKFSMMIDP---------------------RLRNQYSINAARRVAKLADNCLK 339 (393)
Q Consensus 286 ~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~---------------------~~~~~~~~~~~~~l~~li~~~l~ 339 (393)
............... ...|... ......... ..........+.++.+||.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 240 QTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 876543322221111 1111000 000000000 00001122456789999999999
Q ss_pred cCCCCCCCHHHHHHHHHHHH
Q 035862 340 KNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 340 ~dp~~Rps~~~~l~~l~~~~ 359 (393)
.||.+|||+.++++|.|..-
T Consensus 320 ~dP~~Rpt~~e~l~hp~f~~ 339 (355)
T 2eu9_A 320 FDPAQRITLAEALLHPFFAG 339 (355)
T ss_dssp SSTTTSCCHHHHTTSGGGGG
T ss_pred CChhhCcCHHHHhcChhhcC
Confidence 99999999999999987653
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=325.59 Aligned_cols=258 Identities=22% Similarity=0.371 Sum_probs=197.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCC--CCccceeeeeeecC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVS--HPNLVKLLGYCSTE 146 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~ 146 (393)
.++|++.+.||+|+||.||+|.+.. +..||+|.+.... ......+.+|+.+++.++ ||||+++++++...
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEK------KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred cceEEEEEEecCCCCEEEEEEEcCC------CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 4579999999999999999998532 4469999986543 234466889999999997 59999999999876
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
+ ..++||| +.+++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++ ++.+||+|
T Consensus 101 ~----~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~D 169 (313)
T 3cek_A 101 Q----YIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID 169 (313)
T ss_dssp S----EEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECC
T ss_pred C----EEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEee
Confidence 6 5699999 4588999999543 4689999999999999999999999 999999999999996 48999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-----------GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK 295 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~ 295 (393)
||++................|++.|+|||++.+ ..++.++||||||+++|+|++|..||.........
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~- 248 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK- 248 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH-
Confidence 999986544333223345679999999999875 47888999999999999999999999765433221
Q ss_pred HHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
...... .......+...+.++.+|+.+||+.||.+||++.+++++.|....
T Consensus 249 ~~~~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 249 LHAIID--------------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHHHC--------------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHHHh--------------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 111111 001111111234678999999999999999999999999987643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=322.24 Aligned_cols=261 Identities=22% Similarity=0.362 Sum_probs=196.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc--
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE-- 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-- 148 (393)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+.... .....+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALD-----SRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTT-----CCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred cccchhhheeccCCcEEEEEEEEcCC-----CeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 46799999999999999999996543 3469999986432 345668899999999999999999998865321
Q ss_pred -------ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc
Q 035862 149 -------RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK 221 (393)
Q Consensus 149 -------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~ 221 (393)
.....++||||+++++|.+++... ...+++..++.++.|++.||.|||++ +++||||||+|||++.++.
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence 123679999999999999999653 34578889999999999999999999 9999999999999999999
Q ss_pred eEEeeccCCccCCCCCC------------ccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCC
Q 035862 222 PKLSDFGLAREGPTGDH------------THVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERN 288 (393)
Q Consensus 222 ~kl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~ 288 (393)
+||+|||++........ ........|++.|+|||++.+. .++.++|||||||++|+|++ ||...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 99999999976532210 1122345789999999999764 78999999999999999998 44321
Q ss_pred CchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 289 RPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
. ............. .......+...+..+.+++.+||+.||.+|||+.++++|.|.
T Consensus 232 ~--~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (303)
T 1zy4_A 232 M--ERVNILKKLRSVS-----------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287 (303)
T ss_dssp H--HHHHHHHHHHSTT-----------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred h--hHHHHHHhccccc-----------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence 1 1111111111110 011112223445778999999999999999999999998775
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=326.64 Aligned_cols=267 Identities=25% Similarity=0.326 Sum_probs=201.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|.+.+.||+|+||.||+|.+.. .+..||+|.+..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKR-----SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 97 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CceEEEeeeEecCCCeEEEEEEECC-----CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence 3579999999999999999999753 345799999876432 234567899999999999999999999876653
Q ss_pred c--cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 149 R--GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 149 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
. ....++||||+. ++|.+++. ..+++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~D 169 (353)
T 3coi_A 98 LRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILD 169 (353)
T ss_dssp GGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECS
T ss_pred cccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEee
Confidence 2 123489999996 58888762 3489999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||........... .......
T Consensus 170 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~--i~~~~~~ 242 (353)
T 3coi_A 170 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ--ILKVTGV 242 (353)
T ss_dssp TTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHH--HHHHHCB
T ss_pred cccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHHhCC
Confidence 9999764322 234578999999999877 6789999999999999999999999987654322111 1111000
Q ss_pred CCccccccc----------------CcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 306 DGKKFSMMI----------------DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 306 ~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
....+...+ ...+ ......++.++.+|+.+||+.||++|||+.++++|.|..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 310 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 000000000 0000 111124568899999999999999999999999998864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=323.02 Aligned_cols=261 Identities=22% Similarity=0.321 Sum_probs=197.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||.||+|.+.. . +++|.+.... ......+.+|+.+++.++||||+++++++...+
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~-----~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~- 102 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---E-----VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP- 102 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---S-----EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS-
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---e-----EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-
Confidence 4679999999999999999998642 1 8999886542 223345678999999999999999999998776
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+.+++|.+++... ...+++..++.++.|++.||.|||++ |++||||||+|||++ ++.+||+|||
T Consensus 103 ---~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 103 ---HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp ---CEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCS
T ss_pred ---ceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecC
Confidence 459999999999999998543 34689999999999999999999999 999999999999998 6899999999
Q ss_pred CCccCCCCC---CccccccccccCCccCcccccc---------CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHH
Q 035862 229 LAREGPTGD---HTHVSTAVVGTYGYAAPEYIET---------GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKL 296 (393)
Q Consensus 229 ~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~ 296 (393)
++....... .........|++.|+|||++.+ ..++.++||||||+++|+|++|..||..........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~- 253 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW- 253 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH-
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-
Confidence 987543211 1112234568999999999864 457889999999999999999999998654332211
Q ss_pred HHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcC
Q 035862 297 LEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364 (393)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 364 (393)
....... +.. ....++.++.+++.+||..||.+|||+.++++.|+.+......
T Consensus 254 -~~~~~~~-----------~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 254 -QMGTGMK-----------PNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp -HHHTTCC-----------CCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred -HhccCCC-----------CCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1111100 000 0012346789999999999999999999999999988765433
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=321.09 Aligned_cols=262 Identities=27% Similarity=0.411 Sum_probs=182.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHH-HhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQ-FLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|.+.+.||+|+||.||+|.+.. .+..||+|.+..... .....+..|+. +++.++||||+++++++...+
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~-- 94 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKP-----SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG-- 94 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETT-----TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS--
T ss_pred HHhhehheeccCCCEEEEEEEEcC-----CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC--
Confidence 579999999999999999999653 345799999976532 23344555665 777889999999999998776
Q ss_pred cceEEEEEeecCCCChHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFS---RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
..++||||+.+ +|.+++.. .....+++..++.++.|++.||.|||++ .|++||||||+|||++.++.+||+|
T Consensus 95 --~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~D 169 (327)
T 3aln_A 95 --DCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCD 169 (327)
T ss_dssp --EEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECC
T ss_pred --ceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEcc
Confidence 56999999975 88877742 2356789999999999999999999984 3899999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhh
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYI----ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ 302 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (393)
||++....... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||.......+. ...
T Consensus 170 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~ 241 (327)
T 3aln_A 170 FGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-----LTQ 241 (327)
T ss_dssp CSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC
T ss_pred CCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----HHH
Confidence 99997654322 22334799999999998 4567899999999999999999999999754321110 000
Q ss_pred cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
... + ..+.+.......++..+.+|+.+||+.||.+|||+.++++|.|....
T Consensus 242 ~~~-~------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 242 VVK-G------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCC-S------CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred Hhc-C------CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 000 0 00111111112346789999999999999999999999999887654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=316.05 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=183.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-c-HHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-G-HKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+...... . ...+.++..+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~- 97 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTG-----HVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT- 97 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTC-----CEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-
T ss_pred hccccccceeeecCCeeEEEEEEecCC-----eEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-
Confidence 467999999999999999999976433 46999999765332 2 223444556788889999999999998776
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE-GLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..++||||+ ++.+..+. ......+++..++.++.|++.||.|||+ . |++||||||+||+++.++.+||+||
T Consensus 98 ---~~~lv~e~~-~~~~~~l~-~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~df 169 (318)
T 2dyl_A 98 ---DVFIAMELM-GTCAEKLK-KRMQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDF 169 (318)
T ss_dssp ---EEEEEECCC-SEEHHHHH-HHHTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCC
T ss_pred ---cEEEEEecc-CCcHHHHH-HHhccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEEC
Confidence 569999999 54555544 3334568999999999999999999998 5 8999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhh
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIE-----TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ 302 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (393)
|++....... ......|++.|+|||++. ...++.++|||||||++|+|++|..||.......+. .......
T Consensus 170 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~ 245 (318)
T 2dyl_A 170 GISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-LTKVLQE 245 (318)
T ss_dssp TTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-HHHHHHS
T ss_pred CCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH-HHHHhcc
Confidence 9997643322 223457899999999984 567889999999999999999999999764433221 1111111
Q ss_pred cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.+. ... ....++.++.+|+.+||+.||.+||++.++++|.+...
T Consensus 246 ~~~-----------~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 246 EPP-----------LLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CCC-----------CCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CCC-----------CCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 100 000 00124578999999999999999999999999987543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=323.87 Aligned_cols=249 Identities=25% Similarity=0.406 Sum_probs=193.6
Q ss_pred HHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc------cHHHHHHHHHHhhcC----CCCccc
Q 035862 68 REATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ------GHKQWLAEVQFLGVV----SHPNLV 137 (393)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv 137 (393)
....++|++.+.||+|+||.||+|.+..+ +..||+|.+...... ....+.+|+.++..+ +||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~ 101 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTD-----RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVI 101 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTT-----CCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBC
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccC-----CeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCee
Confidence 34467899999999999999999986433 446999999765321 122345688888888 899999
Q ss_pred eeeeeeecCCcccceEEEEEee-cCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEe
Q 035862 138 KLLGYCSTEDERGIQRLLVYEY-MPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLL 216 (393)
Q Consensus 138 ~~~~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll 216 (393)
++++++...+ ..++|||+ +.+++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+||++
T Consensus 102 ~~~~~~~~~~----~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 172 (312)
T 2iwi_A 102 RLLDWFETQE----GFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILI 172 (312)
T ss_dssp CEEEEC---------CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEE
T ss_pred eEEEEEecCC----eEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEE
Confidence 9999987766 34899999 7899999999653 4589999999999999999999999 99999999999999
Q ss_pred C-CCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCC-chhhHHHHHHHHHHHHhCCCccCCCCchhhh
Q 035862 217 D-GNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLK-SQSDIWSFGVVLYEILTGRRVLERNRPTMEQ 294 (393)
Q Consensus 217 ~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltg~~pf~~~~~~~~~ 294 (393)
+ .++.+||+|||++....... .....|++.|+|||++.+..+. .++||||||+++|+|++|+.||.....
T Consensus 173 ~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---- 244 (312)
T 2iwi_A 173 DLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---- 244 (312)
T ss_dssp ETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----
T ss_pred eCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH----
Confidence 8 88999999999998654322 2345789999999999877664 589999999999999999999964311
Q ss_pred HHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.. ... ...+..++..+.+|+.+||+.||++|||+.++++|.|..
T Consensus 245 -~~---~~~----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~ 288 (312)
T 2iwi_A 245 -IL---EAE----------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288 (312)
T ss_dssp -HH---HTC----------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTC
T ss_pred -Hh---hhc----------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 10 000 001123457789999999999999999999999998754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=327.16 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=200.0
Q ss_pred HHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc------cHHHHHHHHHHhhcCC--CCccce
Q 035862 67 LREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ------GHKQWLAEVQFLGVVS--HPNLVK 138 (393)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~ 138 (393)
.....++|++.+.||+|+||.||+|.+.. .+..||+|.+...... ....+.+|+.+++.++ ||||++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~ 112 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVS-----DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETT-----TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECC-----CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceE
Confidence 33446789999999999999999998653 3457999998754221 1234567999999986 599999
Q ss_pred eeeeeecCCcccceEEEEEeecCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC
Q 035862 139 LLGYCSTEDERGIQRLLVYEYMPN-RSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD 217 (393)
Q Consensus 139 ~~~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~ 217 (393)
+++++...+ ..++|||++.+ ++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++
T Consensus 113 ~~~~~~~~~----~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~ 183 (320)
T 3a99_A 113 LLDWFERPD----SFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILID 183 (320)
T ss_dssp EEEEEECSS----EEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEE
T ss_pred EEEEEecCC----cEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEe
Confidence 999998776 55999999976 8999998543 4689999999999999999999998 999999999999998
Q ss_pred -CCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCccCCCCchhhhH
Q 035862 218 -GNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHL-KSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK 295 (393)
Q Consensus 218 -~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltg~~pf~~~~~~~~~~ 295 (393)
+++.+||+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 184 ~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----- 254 (320)
T 3a99_A 184 LNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----- 254 (320)
T ss_dssp TTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----
T ss_pred CCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----
Confidence 78999999999998654322 234579999999999987666 6889999999999999999999964311
Q ss_pred HHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
...... ..+..++.++.+|+.+||+.||++|||+.+++++.|.
T Consensus 255 ---~~~~~~----------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~ 297 (320)
T 3a99_A 255 ---IIRGQV----------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297 (320)
T ss_dssp ---HHHCCC----------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred ---hhcccc----------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhh
Confidence 000000 0111235778999999999999999999999998764
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=343.15 Aligned_cols=270 Identities=25% Similarity=0.338 Sum_probs=200.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc-
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE- 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 148 (393)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+... .......+.+|+.+++.++||||+++++++.....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg-----~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTG-----EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTT-----CCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCC-----cEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence 468999999999999999999865443 35999998764 23345668899999999999999999998755211
Q ss_pred -ccceEEEEEeecCCCChHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCc---eE
Q 035862 149 -RGIQRLLVYEYMPNRSLEDRLFSRA-QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFK---PK 223 (393)
Q Consensus 149 -~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~---~k 223 (393)
.....++||||+++++|.+++.... ...+++..++.++.|++.||.|||+. ||+||||||+||+++.++. +|
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vK 164 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHK 164 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEE
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEE
Confidence 1224589999999999999996533 23688999999999999999999998 9999999999999997765 99
Q ss_pred EeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 224 LSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 224 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ |....
T Consensus 165 L~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~-----~~~~i 236 (676)
T 3qa8_A 165 IIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ-----WHGKV 236 (676)
T ss_dssp ECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH-----SSTTC
T ss_pred Eccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh-----hhhhh
Confidence 99999998754433 23456899999999999999999999999999999999999999976532211 10000
Q ss_pred Cc---------C--CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 304 PA---------D--GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 304 ~~---------~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
.. + ...................++..+.+|+.+||..||++|||+.++++|.|
T Consensus 237 ~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~ 300 (676)
T 3qa8_A 237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300 (676)
T ss_dssp C------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTT
T ss_pred hcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHH
Confidence 00 0 00000000001122234457889999999999999999999999665543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.42 Aligned_cols=255 Identities=23% Similarity=0.314 Sum_probs=186.8
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcC-CCCccceeeeeeecCCcccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 151 (393)
.|...+.||+|+||+||.+... .+..||+|.+... ....+.+|+.+++.+ +||||+++++++...+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~------~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~---- 82 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSF------QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDR---- 82 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEES------SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS----
T ss_pred eeeccCeEeeCCCeEEEEEEEE------CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCC----
Confidence 4556788999999999865422 2457999998653 235677899999876 7999999999987765
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCC-----CCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC-------
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPT-----LPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN------- 219 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~------- 219 (393)
..++||||+. ++|.+++....... .++..++.++.||+.||+|||++ +|+||||||+|||++.+
T Consensus 83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCC
T ss_pred eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCccccccc
Confidence 5699999995 59999996433211 13345678999999999999998 99999999999999754
Q ss_pred ------CceEEeeccCCccCCCCCCcc--ccccccccCCccCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCC
Q 035862 220 ------FKPKLSDFGLAREGPTGDHTH--VSTAVVGTYGYAAPEYIET-------GHLKSQSDIWSFGVVLYEILT-GRR 283 (393)
Q Consensus 220 ------~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslGvil~ellt-g~~ 283 (393)
+.+||+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|||++ |..
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 489999999998764432211 1234689999999999975 678999999999999999999 999
Q ss_pred ccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 284 VLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 284 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
||......... . ...... .+.........++.++.+||.+||+.||.+|||+.++++|.|.
T Consensus 239 Pf~~~~~~~~~-i---~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f 299 (434)
T 2rio_A 239 PFGDKYSRESN-I---IRGIFS---------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299 (434)
T ss_dssp TTCSTTTHHHH-H---HHTCCC---------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred CCCCchhhHHH-H---hcCCCC---------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCcc
Confidence 99765433211 1 111100 0111112234678899999999999999999999999998654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=307.40 Aligned_cols=242 Identities=22% Similarity=0.286 Sum_probs=186.3
Q ss_pred hcCCccc-ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHh-hcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRM-LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFL-GVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|.+. +.||+|+||.||+|.+..++ ..||+|.+... ..+.+|+.++ +..+||||+++++++.....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQ-----EKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCC-----cEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 4568887 77999999999999975443 46999998642 4566788887 56689999999999876222
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC---CCceEEe
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG---NFKPKLS 225 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~ 225 (393)
.....++||||+++++|.+++.......+++..++.++.|++.||.|||+. +|+||||||+|||++. ++.+||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEe
Confidence 223679999999999999999876666799999999999999999999999 9999999999999998 7889999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
|||++.... +..++.++|||||||++|+|++|..||.........
T Consensus 163 Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----------- 207 (299)
T 3m2w_A 163 DFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------- 207 (299)
T ss_dssp CCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------
T ss_pred ccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-----------
Confidence 999886421 245678999999999999999999999754321100
Q ss_pred CCcccccccCccc--ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 306 DGKKFSMMIDPRL--RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 306 ~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
............ .......++.++.+|+.+||+.||.+|||+.++++|.|.....
T Consensus 208 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 208 -PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp -CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred -HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 000000000000 0000023568899999999999999999999999999986543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=325.15 Aligned_cols=253 Identities=22% Similarity=0.322 Sum_probs=186.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcC-CCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 150 (393)
.+|.+.+.||+|+||+||..... .+..||||++...... .+.+|+.+|+.+ +||||+++++++....
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~------~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~--- 91 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMF------DNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQ--- 91 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEES------SSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETT---
T ss_pred EEEecCCeeecCcCEEEEEEEEe------CCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCC---
Confidence 45889999999999996543221 2346999999765432 345799999998 7999999999988766
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC---C--CceEEe
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG---N--FKPKLS 225 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~--~~~kl~ 225 (393)
..++||||+. ++|.+++.... ....+..++.++.||+.||.|||++ +|+||||||+|||++. + ..+||+
T Consensus 92 -~~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~ 165 (432)
T 3p23_A 92 -FQYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMIS 165 (432)
T ss_dssp -EEEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEEC
T ss_pred -EEEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEe
Confidence 5699999995 59999986543 3355556789999999999999999 9999999999999953 2 357899
Q ss_pred eccCCccCCCCCCc-cccccccccCCccCccccc---cCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHH
Q 035862 226 DFGLAREGPTGDHT-HVSTAVVGTYGYAAPEYIE---TGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWV 300 (393)
Q Consensus 226 Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~ 300 (393)
|||++......... .......||+.|+|||++. ...++.++|||||||++|||++ |..||........... .
T Consensus 166 DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~---~ 242 (432)
T 3p23_A 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL---L 242 (432)
T ss_dssp CTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH---T
T ss_pred cccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH---h
Confidence 99999865433211 2234567999999999997 4567889999999999999999 9999965433221111 1
Q ss_pred hhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
..... . . .......+..+.+||.+||+.||.+|||+.++++|.|.
T Consensus 243 ~~~~~-----~-----~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f 287 (432)
T 3p23_A 243 GACSL-----D-----C--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287 (432)
T ss_dssp TCCCC-----T-----T--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTT
T ss_pred ccCCc-----c-----c--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccc
Confidence 00000 0 0 00112456778999999999999999999999988653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=300.76 Aligned_cols=233 Identities=14% Similarity=0.106 Sum_probs=182.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc---cHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ---GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++.+.||+|+||.||+|.+.. .+..||+|++...... ....+.+|+.++..++||||+++++++...+
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~- 104 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTA-----LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA- 104 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETT-----TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-
T ss_pred CcEEEEEEEcccCCeEEEEEEecC-----CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC-
Confidence 579999999999999999999753 3456999999865332 2366889999999999999999999998776
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..|+||||++|++|.+++.. . .....+..++.|++.||.|||++ ||+||||||+|||++.+|.+||+++|
T Consensus 105 ---~~~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~ 174 (286)
T 3uqc_A 105 ---GGLVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA 174 (286)
T ss_dssp ---EEEEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred ---cEEEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc
Confidence 56999999999999999832 2 35557888999999999999999 99999999999999999999998543
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
|++ .++.++|||||||++|+|++|+.||......... .
T Consensus 175 ----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-------------~ 212 (286)
T 3uqc_A 175 ----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-------------A 212 (286)
T ss_dssp ----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-------------E
T ss_pred ----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-------------H
Confidence 222 3688999999999999999999999765331100 0
Q ss_pred ccccccCccc--ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 309 KFSMMIDPRL--RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 309 ~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
.......... .......++.++.+|+.+||+.||++| |+.++++.|..+.....
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 213 PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0000000000 011122456889999999999999999 99999999999876544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=336.03 Aligned_cols=246 Identities=24% Similarity=0.380 Sum_probs=193.3
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|++.+.||+|+||.||+|.+... .+..||+|.+..... .....+.+|+.+++.++||||+++++++...+..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNV----NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGG----TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCC----CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 36899999999999999999997532 235799999875432 3345678999999999999999999999876542
Q ss_pred c-ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 150 G-IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 150 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
+ ...|+||||++|++|.+++.. .+++..++.++.||+.||.|||++ ||+||||||+|||++.+ .+||+|||
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred CCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence 2 225999999999999987732 689999999999999999999999 99999999999999875 89999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||...... ..+
T Consensus 227 ~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~---- 285 (681)
T 2pzi_A 227 AVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLP---- 285 (681)
T ss_dssp TCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCC----
T ss_pred cchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc----------ccc----
Confidence 99865432 345799999999998765 489999999999999999999887632100 000
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT-MNQVVESLKLAV 359 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~~l~~l~~~~ 359 (393)
........+..+.+||.+||+.||.+||+ ++++.+.+..++
T Consensus 286 ----------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 286 ----------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp ----------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00111234578999999999999999996 555555555544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=314.62 Aligned_cols=248 Identities=19% Similarity=0.177 Sum_probs=183.1
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCC-Ccccee--------
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSH-PNLVKL-------- 139 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~~-------- 139 (393)
..|...+.||+|+||.||+|.+..++ ..||||++..... ...+.+.+|+.+++.+.| +|...+
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g-----~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETG-----ESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred eeEEEecccccCCCEEEEEEEecCCC-----CceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 45778889999999999999976444 3699999874322 235678899999999986 321111
Q ss_pred -eeee------------ecCC-cccceEEEEEeecCCCChHHHHh-----hcCCCCCCHHHHHHHHHHHHHHHHHhhcCC
Q 035862 140 -LGYC------------STED-ERGIQRLLVYEYMPNRSLEDRLF-----SRAQPTLPWKTRLEIILGAAEGLAYLHEGL 200 (393)
Q Consensus 140 -~~~~------------~~~~-~~~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ 200 (393)
.+.+ .... ......+++|+++ +++|.+++. ......+++..++.++.|++.||+|||++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~- 230 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY- 230 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence 1111 1111 0012346677766 679999884 23345578889999999999999999999
Q ss_pred CCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCcccc----------ccCCCCchhhHHH
Q 035862 201 EIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYI----------ETGHLKSQSDIWS 270 (393)
Q Consensus 201 ~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Diws 270 (393)
+|+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++||||
T Consensus 231 --~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 231 --GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp --TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred --CcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 9999999999999999999999999998764322 344577 999999999 5566889999999
Q ss_pred HHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 035862 271 FGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQ 350 (393)
Q Consensus 271 lGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 350 (393)
|||++|||++|+.||........ ....+... ..++.++.+||.+||+.||++||++.+
T Consensus 303 lGvil~elltg~~Pf~~~~~~~~----------------~~~~~~~~------~~~~~~~~~li~~~l~~dP~~Rpt~~~ 360 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAALGG----------------SEWIFRSC------KNIPQPVRALLEGFLRYPKEDRLLPLQ 360 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGGSC----------------SGGGGSSC------CCCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHHCCCCCCCcchhhh----------------HHHHHhhc------ccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999999999999975432110 00011100 023578999999999999999999999
Q ss_pred HHHHHH
Q 035862 351 VVESLK 356 (393)
Q Consensus 351 ~l~~l~ 356 (393)
++++.|
T Consensus 361 ~l~~~~ 366 (413)
T 3dzo_A 361 AMETPE 366 (413)
T ss_dssp HTTSHH
T ss_pred HHhCHH
Confidence 987754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=309.32 Aligned_cols=249 Identities=17% Similarity=0.134 Sum_probs=185.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--------ccHHHHHHHHHHhhcCC---------CC
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--------QGHKQWLAEVQFLGVVS---------HP 134 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~ 134 (393)
++|++.+.||+|+||+||+|++. +..||+|++..... .....+.+|+.+++.++ ||
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ 92 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIAD-------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTE 92 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEET-------TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCC
T ss_pred ccchheeeecccCceEEEEEEeC-------CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCC
Confidence 56999999999999999999862 35799999976431 23367788999888875 66
Q ss_pred ccceeeeeeecCC--------------------------cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHH
Q 035862 135 NLVKLLGYCSTED--------------------------ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILG 188 (393)
Q Consensus 135 niv~~~~~~~~~~--------------------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~q 188 (393)
||+++.+++...+ ......++||||+.+|++.+.+.. ..+++..++.++.|
T Consensus 93 niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~q 169 (336)
T 2vuw_A 93 GFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQ 169 (336)
T ss_dssp CBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHH
T ss_pred chhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHH
Confidence 6666665543110 002267999999999977766632 45899999999999
Q ss_pred HHHHHHHhh-cCCCCCeEeccCCCCCeEeCCCC--------------------ceEEeeccCCccCCCCCCccccccccc
Q 035862 189 AAEGLAYLH-EGLEIQVIYRDFKTSNVLLDGNF--------------------KPKLSDFGLAREGPTGDHTHVSTAVVG 247 (393)
Q Consensus 189 l~~~l~~LH-~~~~~~ivH~Dikp~NIll~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~g 247 (393)
|+.||.||| +. +|+||||||+|||++.++ .+||+|||+++.... ...+|
T Consensus 170 i~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~g 239 (336)
T 2vuw_A 170 LTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVF 239 (336)
T ss_dssp HHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEEC
T ss_pred HHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEE
Confidence 999999999 88 999999999999999887 899999999986432 23489
Q ss_pred cCCccCccccccCCCCchhhHHHHHHH-HHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHH
Q 035862 248 TYGYAAPEYIETGHLKSQSDIWSFGVV-LYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINA 326 (393)
Q Consensus 248 t~~y~aPE~~~~~~~~~~~DiwslGvi-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (393)
|+.|+|||++.+.. +.++||||+|++ .+++++|..||.... ................ ..........+
T Consensus 240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-~~~~~~~~~~~~~~~~---------~~~~~~~~~~~ 308 (336)
T 2vuw_A 240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-WLHYLTDKMLKQMTFK---------TKCNTPAMKQI 308 (336)
T ss_dssp CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-HHHHHHHHHHHTCCCS---------SCCCSHHHHHH
T ss_pred eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh-hhhHHHHhhhhhhccC---------cccchhhhhhc
Confidence 99999999998766 899999998777 778999999985310 0000111111111111 11112233468
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHH-HHHH
Q 035862 327 ARRVAKLADNCLKKNPEERPTMNQVV-ESLK 356 (393)
Q Consensus 327 ~~~l~~li~~~l~~dp~~Rps~~~~l-~~l~ 356 (393)
++++.+||.+||++| |+.+++ +|.|
T Consensus 309 s~~~~dli~~~L~~d-----sa~e~l~~Hp~ 334 (336)
T 2vuw_A 309 KRKIQEFHRTMLNFS-----SATDLLCQHSL 334 (336)
T ss_dssp HHHHHHHHHHGGGSS-----SHHHHHHHCGG
T ss_pred CHHHHHHHHHHhccC-----CHHHHHhcCCC
Confidence 899999999999977 999999 8876
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.1e-33 Score=273.19 Aligned_cols=186 Identities=17% Similarity=0.104 Sum_probs=126.5
Q ss_pred ecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc----------ccHHHHHHHHHHhhcC-CCCccceeeeeeecCCc
Q 035862 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL----------QGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 80 lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 148 (393)
.+.|++|.+..++....++ .+++|.+..... ...+++.+|+++|+++ .|+||+++++++.++.
T Consensus 242 ~~~~~~~~h~~~rr~~fg~-----~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~- 315 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGE-----DYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ- 315 (569)
T ss_dssp -C--------CCEEEEECS-----SEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS-
T ss_pred cccCCcccccccccccccc-----eeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC-
Confidence 4555555555444322222 389999875421 2235688999999999 5999999999998877
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..||||||++|++|.++|.. ...+++. .|+.||+.||+|+|++ |||||||||+|||++++|.+||+|||
T Consensus 316 ---~~yLVMEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFG 384 (569)
T 4azs_A 316 ---SGWLVMEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFG 384 (569)
T ss_dssp ---EEEEEEECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCT
T ss_pred ---EEEEEEecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecc
Confidence 56999999999999999953 4456654 5889999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCcc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVL 285 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf 285 (393)
+|+....... .....+||+.|+|||++.+ .+..++|+||+|++++++.++..++
T Consensus 385 lAr~~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 385 SIVTTPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp TEESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred cCeeCCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 9987543322 2345789999999999875 4677899999999988887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.3e-29 Score=243.92 Aligned_cols=185 Identities=21% Similarity=0.260 Sum_probs=139.5
Q ss_pred cccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc--------cHHHHHHHHHHhhcCCCCccceeeeeeecC
Q 035862 75 NRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ--------GHKQWLAEVQFLGVVSHPNLVKLLGYCSTE 146 (393)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 146 (393)
...+.||+|+||.||+|.... ..+++|........ ..+++.+|+++++.++||||+++..++...
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~-------~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLD-------FDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL 411 (540)
T ss_dssp ---------CCEEEEEEECSS-------CEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET
T ss_pred CCCCEEeeCCCEEEEEEEECC-------CeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC
Confidence 345689999999999995432 24788876443211 124478999999999999999555555544
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
+. .++||||+++++|.+++.. +..++.|++.||.|||++ +|+||||||+|||++. .+||+|
T Consensus 412 ~~----~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~D 472 (540)
T 3en9_A 412 DN----KRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIID 472 (540)
T ss_dssp TT----TEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECC
T ss_pred Cc----cEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEE
Confidence 43 3999999999999999843 568999999999999999 9999999999999998 999999
Q ss_pred ccCCccCCCCCCcc-----ccccccccCCccCcccccc--CCCCchhhHHHHHHHHHHHHhCCCcc
Q 035862 227 FGLAREGPTGDHTH-----VSTAVVGTYGYAAPEYIET--GHLKSQSDIWSFGVVLYEILTGRRVL 285 (393)
Q Consensus 227 fg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltg~~pf 285 (393)
||+++......... ......||+.|+|||++.. ..|+..+|+|+..+-..+.+.++.+|
T Consensus 473 FGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 473 FGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 99998764432211 1246789999999999987 66888899999998888888777655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.3e-25 Score=198.10 Aligned_cols=150 Identities=15% Similarity=0.041 Sum_probs=116.3
Q ss_pred HHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc------------------ccHHHHHHHHHHh
Q 035862 67 LREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL------------------QGHKQWLAEVQFL 128 (393)
Q Consensus 67 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l 128 (393)
+......|.+.+.||+|+||.||+|.+ . .+..||+|.+..... .....+.+|+.++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~-----~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l 158 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYS-E-----KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRAL 158 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEE-T-----TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHH
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEe-C-----CCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHH
Confidence 334445677779999999999999986 2 234699999864321 1245578999999
Q ss_pred hcCCCCccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 035862 129 GVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRD 208 (393)
Q Consensus 129 ~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~D 208 (393)
+.++ | +++.+++.. + ..++||||++|++|.+ +. ......++.|++.||.|||+. ||+|||
T Consensus 159 ~~l~--~-~~v~~~~~~-~----~~~lvmE~~~g~~L~~-l~--------~~~~~~i~~qi~~~l~~lH~~---giiHrD 218 (282)
T 1zar_A 159 QKLQ--G-LAVPKVYAW-E----GNAVLMELIDAKELYR-VR--------VENPDEVLDMILEEVAKFYHR---GIVHGD 218 (282)
T ss_dssp HHTT--T-SSSCCEEEE-E----TTEEEEECCCCEEGGG-CC--------CSCHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred Hhcc--C-CCcCeEEec-c----ceEEEEEecCCCcHHH-cc--------hhhHHHHHHHHHHHHHHHHHC---CCEeCC
Confidence 9999 4 666665433 2 2399999999999988 41 123557999999999999998 999999
Q ss_pred CCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccc
Q 035862 209 FKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE 258 (393)
Q Consensus 209 ikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 258 (393)
|||+|||++ +|.+||+|||++.. +..+.|||++.
T Consensus 219 lkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 219 LSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp CSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred CCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 999999999 99999999999863 34578898774
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=5.3e-21 Score=170.65 Aligned_cols=137 Identities=17% Similarity=0.072 Sum_probs=103.3
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceE--EEEEEecCCCcc------------------------cHHHHHHHHHH
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLV--VAVKKLNNHGLQ------------------------GHKQWLAEVQF 127 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~ 127 (393)
|.+.+.||+|+||.||+|.+.. .+.. ||+|++...... ....+.+|+.+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~-----~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 123 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVF-----DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRN 123 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEE-----TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcC-----CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHH
Confidence 6788999999999999998632 2345 999987543111 01256789999
Q ss_pred hhcCCCCcc--ceeeeeeecCCcccceEEEEEeecCC-C----ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhh-cC
Q 035862 128 LGVVSHPNL--VKLLGYCSTEDERGIQRLLVYEYMPN-R----SLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH-EG 199 (393)
Q Consensus 128 l~~l~h~ni--v~~~~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH-~~ 199 (393)
|..+.|+++ ..++++ . ..++||||+.+ | +|.++... .++..+..++.|++.||.||| +.
T Consensus 124 l~~l~~~~i~~p~~~~~--~------~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~ 190 (258)
T 1zth_A 124 LERAKEAGVSVPQPYTY--M------KNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA 190 (258)
T ss_dssp HHHHHHTTCCCCCEEEE--E------TTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHhCCCCCCeEEEc--C------CCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC
Confidence 999988764 334332 1 22899999932 3 67766522 235577899999999999999 88
Q ss_pred CCCCeEeccCCCCCeEeCCCCceEEeeccCCccC
Q 035862 200 LEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREG 233 (393)
Q Consensus 200 ~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 233 (393)
||+||||||+|||+++ .++|+|||+|...
T Consensus 191 ---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 191 ---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred ---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999999998 9999999999653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=3.7e-18 Score=158.45 Aligned_cols=146 Identities=11% Similarity=0.077 Sum_probs=99.3
Q ss_pred HHHHHHHhcC---CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc--------------cHHH------
Q 035862 64 MQELREATNG---FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ--------------GHKQ------ 120 (393)
Q Consensus 64 ~~~~~~~~~~---y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------------~~~~------ 120 (393)
...+....++ |++...||.|++|.||+|.+. .+..||||+++..... ....
T Consensus 84 ~LAL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~r 157 (397)
T 4gyi_A 84 YLALHTHAARKDVYSVGSRIGVGKESDIMIVADE------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSR 157 (397)
T ss_dssp HHHHHHHHHTTSCSEEEEEEEECSSEEEEEEECT------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHH
T ss_pred HHHHHHHHHCCCEEEecCEeeeCCceEEEEEECC------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHH
Confidence 3344444444 999999999999999999853 2456999987532110 0111
Q ss_pred --HHHHHHHhhcCCCCccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc
Q 035862 121 --WLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198 (393)
Q Consensus 121 --~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~ 198 (393)
..+|...|..+.+.++.-..-+.... .++||||++|++|..+. .......++.|++.+|.+||+
T Consensus 158 l~A~kE~~nL~rL~~~gv~vp~p~~~~~------~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~ 223 (397)
T 4gyi_A 158 LAAIKEFAFMKALYEEGFPVPEPIAQSR------HTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAK 223 (397)
T ss_dssp HHHHHHHHHHHHHHHTTCSCCCEEEEET------TEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeeeccC------ceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHH
Confidence 13455566665443332111111111 17999999998886543 112345788999999999999
Q ss_pred CCCCCeEeccCCCCCeEeCCCCc----------eEEeeccCCcc
Q 035862 199 GLEIQVIYRDFKTSNVLLDGNFK----------PKLSDFGLARE 232 (393)
Q Consensus 199 ~~~~~ivH~Dikp~NIll~~~~~----------~kl~Dfg~a~~ 232 (393)
. |||||||||.|||++++|. +.|+||+-+..
T Consensus 224 ~---gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 224 H---GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp T---TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred C---CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 8 9999999999999988773 89999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=2.7e-13 Score=120.82 Aligned_cols=146 Identities=13% Similarity=0.036 Sum_probs=109.3
Q ss_pred HHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCccceeeeeeecC
Q 035862 68 REATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTE 146 (393)
Q Consensus 68 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 146 (393)
....++|.+...++.|+.+.||++... +..+++|............+.+|+.+++.+. +..+.++++++...
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-------~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~ 82 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-------NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD 82 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-------SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-------CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC
Confidence 445678999999999999999998632 2358999986422122335778999998885 67788888887765
Q ss_pred CcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC---------------------------
Q 035862 147 DERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEG--------------------------- 199 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~--------------------------- 199 (393)
+ ..++||||++|.+|.+.+. +......++.+++.+|..||+.
T Consensus 83 ~----~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (263)
T 3tm0_A 83 G----WSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLA 151 (263)
T ss_dssp T----EEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCS
T ss_pred C----ceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccc
Confidence 4 4599999999999987641 1223457888999999999981
Q ss_pred -----------------------------CCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 200 -----------------------------LEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 200 -----------------------------~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.+..++|+|++|+|||+++++.+.|+||+.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 152 DVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01359999999999999876666799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.22 E-value=1.9e-11 Score=108.54 Aligned_cols=136 Identities=15% Similarity=0.124 Sum_probs=93.0
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCc--cceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPN--LVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~ 150 (393)
+|.+....+.|..+.||++... ++..+++|..... ....+.+|+.+++.+.+.+ +.+++++....+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~------~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~--- 88 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQ------GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAG--- 88 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECT------TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS---
T ss_pred CCceEecccCCCCceEEEEecC------CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCC---
Confidence 4554434445666999998632 1123888987654 2234667888888886444 456777766554
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC------------------------------
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGL------------------------------ 200 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~------------------------------ 200 (393)
..++||||++|.+|. +. . .. ...++.+++..|..||+..
T Consensus 89 -~~~~v~e~i~G~~l~--~~--~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (264)
T 1nd4_A 89 -RDWLLLGEVPGQDLL--SS--H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDD 157 (264)
T ss_dssp -CEEEEEECCSSEETT--TS--C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTS
T ss_pred -CCEEEEEecCCcccC--cC--c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchh
Confidence 359999999998884 21 1 11 2356777888888888641
Q ss_pred -------------------------CCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 201 -------------------------EIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 201 -------------------------~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
+..++|+|++|+||++++++.+.|+|||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 158 LDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999877667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.14 E-value=1.9e-10 Score=107.18 Aligned_cols=147 Identities=14% Similarity=0.184 Sum_probs=104.1
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEec--CCC-cccHHHHHHHHHHhhcCC--CCccceeeeeeecCCc
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN--NHG-LQGHKQWLAEVQFLGVVS--HPNLVKLLGYCSTEDE 148 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~ 148 (393)
...++.|+.|.++.||+..... ..+++|... ... ......+.+|+.+++.+. +..+.+++.++.....
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~~-------~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~ 112 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTPG-------QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV 112 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECSS-------CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT
T ss_pred CceEEEcCCcccceEEEEEECC-------ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc
Confidence 3456789999999999987431 247777765 321 112345678999998887 4557888888765532
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC----------------------------
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGL---------------------------- 200 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---------------------------- 200 (393)
.+ ..++||||++|.++.+.. ...++......++.+++.+|..||+..
T Consensus 113 ~g-~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (359)
T 3dxp_A 113 IG-RAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYK 187 (359)
T ss_dssp TS-SCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHH
T ss_pred cC-CeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHH
Confidence 11 348999999998875421 234677888899999999999999720
Q ss_pred ---------------------------CCCeEeccCCCCCeEeCCCCc--eEEeeccCCcc
Q 035862 201 ---------------------------EIQVIYRDFKTSNVLLDGNFK--PKLSDFGLARE 232 (393)
Q Consensus 201 ---------------------------~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~ 232 (393)
...++|+|++|+|||++.++. +.|+||+.+..
T Consensus 188 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 188 LSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.12 E-value=4.3e-11 Score=108.96 Aligned_cols=186 Identities=18% Similarity=0.199 Sum_probs=119.1
Q ss_pred cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCc--cceeeeeeecCCcccceE
Q 035862 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPN--LVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~~~~~~~ 153 (393)
++.++.|....||+.. .. +++|..... .....+.+|..+|+.+. +.. +..++......+ .....
T Consensus 25 i~~~~~G~~n~v~~v~-----~~-----~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~-~~~~~ 91 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RD-----FIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE-TYQMS 91 (304)
T ss_dssp CCEEEECSSEEEEEST-----TS-----EEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS-SCSCS
T ss_pred eEecCCCCcceEEEEC-----CE-----EEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC-CCCcc
Confidence 4568999999999863 11 888886532 33456788999998874 332 334444332222 11234
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEG---------------------------------- 199 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---------------------------------- 199 (393)
|+||++++|.+|.+... ..++......++.+++..+..||+.
T Consensus 92 ~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (304)
T 3sg8_A 92 FAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG 167 (304)
T ss_dssp CEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred eEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence 88999999988875332 2356677778888888888888851
Q ss_pred ---------------------CCCCeEeccCCCCCeEeCC--CCceEEeeccCCccCCCCCCccccccccccCCc---cC
Q 035862 200 ---------------------LEIQVIYRDFKTSNVLLDG--NFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGY---AA 253 (393)
Q Consensus 200 ---------------------~~~~ivH~Dikp~NIll~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y---~a 253 (393)
....++|+|++|+||++++ ++.+.|+||+.+......... .....+ ..
T Consensus 168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl------~~~~~~~~~~~ 241 (304)
T 3sg8_A 168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF------ISLMEDDEEYG 241 (304)
T ss_dssp HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH------HTTCCTTTSCC
T ss_pred ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH------HHHHhhccccC
Confidence 1135899999999999988 456889999988653221100 000011 22
Q ss_pred cccccc-----CCC---------CchhhHHHHHHHHHHHHhCCCcc
Q 035862 254 PEYIET-----GHL---------KSQSDIWSFGVVLYEILTGRRVL 285 (393)
Q Consensus 254 PE~~~~-----~~~---------~~~~DiwslGvil~elltg~~pf 285 (393)
|+.... +.. ....+.|++|.++|.+.+|..+|
T Consensus 242 ~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 242 MEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 222110 111 12368999999999999998766
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=7e-07 Score=79.38 Aligned_cols=142 Identities=18% Similarity=0.133 Sum_probs=94.5
Q ss_pred hcCCcccceecccCCc-eEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFG-SVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g-~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 148 (393)
..+|+.. .+..|..| .||+...... +..+++|.-.. .....+.+|...|+.+. +--+.++++++...+
T Consensus 24 l~g~~~~-~~~~G~S~~~v~rl~~~~~-----~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~- 93 (272)
T 4gkh_A 24 LYGYRWA-RDNVGQSGATIYRLYGKPN-----APELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD- 93 (272)
T ss_dssp HTTCEEE-EEECSSSSCEEEEEECCTT-----CCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT-
T ss_pred ccCCeEE-EccCCCcCCeEEEEEecCC-----CeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECC-
Confidence 3445433 34455554 6888764322 22377887543 23455778998888775 333567777776665
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC----------------------------
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGL---------------------------- 200 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---------------------------- 200 (393)
..++|||+++|.++.+.... .......+..+++..|..||+..
T Consensus 94 ---~~~lvme~l~G~~~~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (272)
T 4gkh_A 94 ---DAWLLTTAIPGKTAFQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDA 164 (272)
T ss_dssp ---EEEEEEECCCSEEHHHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCG
T ss_pred ---eEEEEEEeeCCccccccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhh
Confidence 45999999999888776522 12233456677777777777521
Q ss_pred ---------------------------CCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 201 ---------------------------EIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 201 ---------------------------~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
+..++|+|+.+.|||+++++.+-|+||+.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 165 SDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp GGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999987777899998774
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.51 E-value=8.1e-07 Score=80.58 Aligned_cols=137 Identities=19% Similarity=0.177 Sum_probs=89.6
Q ss_pred cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCC---ccceeeeeeecCCcccceE
Q 035862 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHP---NLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~~~ 153 (393)
+..++.|....||+. +.. +++|.... ......+.+|..+|+.+.+. .+.+++.+....+ . ..
T Consensus 24 v~~l~~G~~n~v~~v-----g~~-----~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~-g--~~ 88 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGD-----WVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD-G--NP 88 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTT-----EEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTT-S--CE
T ss_pred eeecCCCcceeEEEE-----CCE-----EEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCC-C--ce
Confidence 456888888899986 122 78887532 23345678899999998742 2455565554222 1 45
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 035862 154 LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEG---------------------------------- 199 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---------------------------------- 199 (393)
++||||++|.+|.+... ..++......++.++...|..||+.
T Consensus 89 ~~v~e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l 164 (306)
T 3tdw_A 89 FVGYRKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL 164 (306)
T ss_dssp EEEEECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred EEEEeccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence 89999999988876321 1234444445555555555555532
Q ss_pred -----------------------CCCCeEeccCCCCCeEeCC---CCc-eEEeeccCCcc
Q 035862 200 -----------------------LEIQVIYRDFKTSNVLLDG---NFK-PKLSDFGLARE 232 (393)
Q Consensus 200 -----------------------~~~~ivH~Dikp~NIll~~---~~~-~kl~Dfg~a~~ 232 (393)
.+..++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1235799999999999987 455 48999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=2.4e-06 Score=80.43 Aligned_cols=77 Identities=13% Similarity=0.071 Sum_probs=46.8
Q ss_pred ccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-------ccHHHHHHHHHHhhcCCC--Cc-cceeeeeeec
Q 035862 76 RMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-------QGHKQWLAEVQFLGVVSH--PN-LVKLLGYCST 145 (393)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~~~~~~~~ 145 (393)
..+.||.|..+.||++..... +..+++|....... ....++..|.++++.+.. |. +.+++.+.
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~-----~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-- 106 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEH-----DRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-- 106 (397)
T ss_dssp EEEECCSSSSEEEEEEEC---------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--
T ss_pred EEEECCCCceEEEEEEEECCC-----CcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--
Confidence 356799999999999964321 23588887653211 123456678888887642 33 34555432
Q ss_pred CCcccceEEEEEeecCCC
Q 035862 146 EDERGIQRLLVYEYMPNR 163 (393)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~ 163 (393)
.+. .++|||++++.
T Consensus 107 ~~~----~~lvmE~l~g~ 120 (397)
T 2olc_A 107 TEM----AVTVMEDLSHL 120 (397)
T ss_dssp TTT----TEEEECCCTTS
T ss_pred CCc----cEEEEEeCCCc
Confidence 222 28999999763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=1.9e-06 Score=79.89 Aligned_cols=89 Identities=12% Similarity=0.056 Sum_probs=51.5
Q ss_pred ccee-cccCCceEEEEEEcCC-CCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCC-C--CccceeeeeeecCCc
Q 035862 77 MLKI-GEGGFGSVYKGTIRPL-DGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVS-H--PNLVKLLGYCSTEDE 148 (393)
Q Consensus 77 ~~~l-g~G~~g~Vy~~~~~~~-~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~ 148 (393)
.+.| +.|....+|+...... +....+..+++|...... ......+.+|+.+++.+. + -.+.+++.++.....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 7888889998764200 000013357788765422 101234567888888775 2 246677776654421
Q ss_pred ccceEEEEEeecCCCChH
Q 035862 149 RGIQRLLVYEYMPNRSLE 166 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~ 166 (393)
.+ ..++||||++|.++.
T Consensus 105 ~g-~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LG-TPFFLMDYVEGVVPP 121 (357)
T ss_dssp TS-SCEEEEECCCCBCCC
T ss_pred cC-CceEEEEecCCCChh
Confidence 11 348999999987764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=7.6e-05 Score=68.35 Aligned_cols=30 Identities=23% Similarity=0.241 Sum_probs=27.3
Q ss_pred CCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 202 IQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 202 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++|+|++++|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 489999999999999888899999999764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.91 E-value=6.3e-05 Score=63.23 Aligned_cols=100 Identities=15% Similarity=0.034 Sum_probs=65.6
Q ss_pred CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCcccc
Q 035862 163 RSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS 242 (393)
Q Consensus 163 ~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 242 (393)
.+|.+.|.... .+++++++|.++.|.+.+|.-+-... .-..+=+.|..|++..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 48899886555 56999999999999999988762210 111233457899999999998763 1110
Q ss_pred ccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhC
Q 035862 243 TAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTG 281 (393)
Q Consensus 243 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg 281 (393)
.....+.|||... ...+.+.=|||||+++|..+--
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 1123466888763 3456788999999999988864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.85 E-value=9.1e-05 Score=66.28 Aligned_cols=79 Identities=15% Similarity=0.167 Sum_probs=52.7
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCC---ccceeeeeeecCCcc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHP---NLVKLLGYCSTEDER 149 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~ 149 (393)
...-+..+|.|..+.||+....+ +..|.+|+...........+..|+..|+.+... -+.+++++ ..+
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~D------G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~~-- 85 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELAD------GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DDR-- 85 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETT------SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ETT--
T ss_pred CeEEEEecCCCCCeEEEEEEECC------CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cCc--
Confidence 35556779999999999998542 235889987654444445677898888877421 23444443 222
Q ss_pred cceEEEEEeecCCCCh
Q 035862 150 GIQRLLVYEYMPNRSL 165 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L 165 (393)
++||||+.++..
T Consensus 86 ----~lv~e~l~~~~~ 97 (288)
T 3f7w_A 86 ----TLAMEWVDERPP 97 (288)
T ss_dssp ----EEEEECCCCCCC
T ss_pred ----eEEEEeecccCC
Confidence 889999987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.66 E-value=0.00027 Score=63.87 Aligned_cols=77 Identities=16% Similarity=0.152 Sum_probs=54.5
Q ss_pred cccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC---CCccceeeeeeecCCcccc
Q 035862 75 NRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS---HPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~ 151 (393)
...+.|+.|....+|+.... +..+++|..... ....+..|+..|+.+. ...+.+++.+....+
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~-------~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g---- 104 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDE-------VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQG---- 104 (312)
T ss_dssp CEEEEECCSSSSEEEEEESS-------SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSS----
T ss_pred eeeEEeCCccceeeeEEEEC-------CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCC----
Confidence 34567899999999998631 224778876542 2456778888888774 356778887776544
Q ss_pred eEEEEEeecCCCCh
Q 035862 152 QRLLVYEYMPNRSL 165 (393)
Q Consensus 152 ~~~lv~e~~~~~~L 165 (393)
..++||||++|.++
T Consensus 105 ~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 105 HSFLLLEALNKSKN 118 (312)
T ss_dssp EEEEEEECCCCCCC
T ss_pred ceEEEEEeccCCCC
Confidence 45999999998765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00024 Score=63.88 Aligned_cols=30 Identities=17% Similarity=0.090 Sum_probs=25.6
Q ss_pred CCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 202 IQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 202 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
..++|+|+.++||+ ..++.+.|+||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 46899999999999 5667789999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00028 Score=66.76 Aligned_cols=77 Identities=14% Similarity=0.124 Sum_probs=46.2
Q ss_pred CCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccc-cccCCccCccccccC---CCCchhhHHHHHHHHHH
Q 035862 202 IQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAV-VGTYGYAAPEYIETG---HLKSQSDIWSFGVVLYE 277 (393)
Q Consensus 202 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~~~DiwslGvil~e 277 (393)
..++|+|++|+|||++.++ ++|+||+.+........ ..... .-...|++|+..... ......++.++...+|+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 3899999999999998877 99999998875321100 00000 001235555544211 11223555677778887
Q ss_pred HHhC
Q 035862 278 ILTG 281 (393)
Q Consensus 278 lltg 281 (393)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7765
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.41 E-value=0.0013 Score=59.56 Aligned_cols=160 Identities=17% Similarity=0.119 Sum_probs=79.7
Q ss_pred cHHHHHHHhcCCcc-----cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCc--
Q 035862 63 DMQELREATNGFNR-----MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPN-- 135 (393)
Q Consensus 63 ~~~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-- 135 (393)
+..++.....+|.+ ++.|+.|....+|+...... .+++|...... ....+..|+.++..+...+
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-------~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~ 78 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-------PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLS 78 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-------CEEEEEECC-----CCHHHHHHHHHHHHHHTTCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-------cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCC
Confidence 34455555555654 34466787788999864321 27888876521 1223445677666654212
Q ss_pred cceeeeeeecCC--cccceEEEEEeecCCCChHH-----------H---Hhhc-CC---CC---CC---HHHHHH-----
Q 035862 136 LVKLLGYCSTED--ERGIQRLLVYEYMPNRSLED-----------R---LFSR-AQ---PT---LP---WKTRLE----- 184 (393)
Q Consensus 136 iv~~~~~~~~~~--~~~~~~~lv~e~~~~~~L~~-----------~---l~~~-~~---~~---~~---~~~~~~----- 184 (393)
+.+++....... ......+++|+|++|..+.. . ++.. .. .. .. +.....
T Consensus 79 vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~ 158 (322)
T 2ppq_A 79 CPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEER 158 (322)
T ss_dssp CCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGG
T ss_pred CCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHH
Confidence 223322100000 00013588999998865421 0 1111 00 00 01 111000
Q ss_pred -------HHHHHHHHHHHhhcC----CCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 185 -------IILGAAEGLAYLHEG----LEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 185 -------i~~ql~~~l~~LH~~----~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
+...+...+..++.. .+.+++|+|+.++|||+++++.+.|+||+.+.
T Consensus 159 ~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 159 ADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp GGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001133344444421 23489999999999999887666899998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0021 Score=58.59 Aligned_cols=33 Identities=27% Similarity=0.403 Sum_probs=28.1
Q ss_pred CCCeEeccCCCCCeEeCCC----CceEEeeccCCccC
Q 035862 201 EIQVIYRDFKTSNVLLDGN----FKPKLSDFGLAREG 233 (393)
Q Consensus 201 ~~~ivH~Dikp~NIll~~~----~~~kl~Dfg~a~~~ 233 (393)
+..++|||+.++|||++.+ +.+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3489999999999999875 67899999988653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0017 Score=61.97 Aligned_cols=75 Identities=12% Similarity=0.042 Sum_probs=44.5
Q ss_pred cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCcc-ceeeeeeecCCcccceEEE
Q 035862 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNL-VKLLGYCSTEDERGIQRLL 155 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~l 155 (393)
+..|+.|-...+|++.... .+..+++|+.......... ..+|..+++.+...++ .++++.+ .+ .+
T Consensus 113 i~~lsgG~tN~~y~v~~~~-----~~~~~vLRi~g~~~~~~id-R~~E~~vl~~L~~~gl~P~ll~~~--~~------G~ 178 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMS-----KQAKYLIRLYGPKTDEIIN-REREKKISCILYNKNIAKKIYVFF--TN------GR 178 (458)
T ss_dssp EEEECC--CEEEEEEEETT-----TTEEEEEEEECC-CCSCSC-HHHHHHHHHHHTTSSSBCCEEEEE--TT------EE
T ss_pred EEEcCCCeEeEEEEEEECC-----CCceEEEEECCCChhhhcC-HHHHHHHHHHHHhcCCCCCEEEEe--CC------eE
Confidence 4567778888999987532 1235778876543211111 2468888888774444 4666665 22 35
Q ss_pred EEeecCCCCh
Q 035862 156 VYEYMPNRSL 165 (393)
Q Consensus 156 v~e~~~~~~L 165 (393)
||||++|.+|
T Consensus 179 v~e~I~G~~l 188 (458)
T 2qg7_A 179 IEEFMDGYAL 188 (458)
T ss_dssp EEECCCSEEC
T ss_pred EEEeeCCccC
Confidence 9999987554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.002 Score=59.79 Aligned_cols=146 Identities=16% Similarity=0.213 Sum_probs=79.5
Q ss_pred cceecccCCceEEEEEEcCC--CCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCccceeeeeeecCCcccceE
Q 035862 77 MLKIGEGGFGSVYKGTIRPL--DGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~--~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 153 (393)
++.|..|-...+|++..... ........+++++.... ........+|..+++.+. +.-..++++.+. +
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~------ 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E------ 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T------
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C------
Confidence 34576677788999875321 01122346888876432 123455568988888775 322355665543 2
Q ss_pred EEEEeecCCCChHHH--------------H---hhcC---CCCC--CHHHHHHHHHHHHH-------------------H
Q 035862 154 LLVYEYMPNRSLEDR--------------L---FSRA---QPTL--PWKTRLEIILGAAE-------------------G 192 (393)
Q Consensus 154 ~lv~e~~~~~~L~~~--------------l---~~~~---~~~~--~~~~~~~i~~ql~~-------------------~ 192 (393)
.+||||++|.+|..- | +... .... -+.++..+..++.. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 379999988655310 1 1111 1111 13444444444321 1
Q ss_pred HHHhh----c-CCCCCeEeccCCCCCeEeCCC----CceEEeeccCCc
Q 035862 193 LAYLH----E-GLEIQVIYRDFKTSNVLLDGN----FKPKLSDFGLAR 231 (393)
Q Consensus 193 l~~LH----~-~~~~~ivH~Dikp~NIll~~~----~~~kl~Dfg~a~ 231 (393)
+..|. . ..+..++|+|+.++||+++.+ +.+.|+||..+.
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22222 1 123479999999999999876 789999998774
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0024 Score=60.51 Aligned_cols=80 Identities=26% Similarity=0.339 Sum_probs=47.9
Q ss_pred ccceecccCCceEEEEEEcCCCC--CCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCcc-ceeeeeeecCCcccce
Q 035862 76 RMLKIGEGGFGSVYKGTIRPLDG--RGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNL-VKLLGYCSTEDERGIQ 152 (393)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~ 152 (393)
.+..|+.|....+|++....... ...+..+++|+..... ....+.+|..+++.+...++ .++++.+. +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~----- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G----- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T-----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C-----
Confidence 34567888888999987542110 1123457888874321 11445578888887753333 56665542 2
Q ss_pred EEEEEeecCCCCh
Q 035862 153 RLLVYEYMPNRSL 165 (393)
Q Consensus 153 ~~lv~e~~~~~~L 165 (393)
.+|+||++|.+|
T Consensus 148 -g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 -GRLEEYIPSRPL 159 (429)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEeCCccc
Confidence 479999987444
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.91 E-value=0.003 Score=58.47 Aligned_cols=29 Identities=21% Similarity=0.338 Sum_probs=24.5
Q ss_pred CCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 202 IQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 202 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++|+|+.+.|||+++++ +.|+||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 4799999999999998655 8999998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.022 Score=51.49 Aligned_cols=29 Identities=24% Similarity=0.387 Sum_probs=25.3
Q ss_pred CCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 202 IQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 202 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
..++|+|++++|||++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 4789999999999999 4 899999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.20 E-value=0.081 Score=49.68 Aligned_cols=29 Identities=14% Similarity=0.302 Sum_probs=26.0
Q ss_pred CCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 202 IQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 202 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..++|+|+.++||+ +.++.+.|+||..+.
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 46899999999999 778899999998875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.20 E-value=0.1 Score=47.45 Aligned_cols=31 Identities=16% Similarity=0.128 Sum_probs=27.8
Q ss_pred CCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 202 IQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 202 ~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.20 E-value=0.91 Score=37.95 Aligned_cols=117 Identities=9% Similarity=0.064 Sum_probs=75.8
Q ss_pred CCCCccceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCC
Q 035862 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFK 210 (393)
Q Consensus 131 l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dik 210 (393)
..||+++.. .+-..++ -++..|-...+...+- .-..++....+.++.+|+....+++. -+|--|.
T Consensus 42 ~~~~~Fl~~-~I~e~eD------~v~~~y~~~~~~~~f~---~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~ 106 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRD------SFQIHYDINDNHTPFD---NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLA 106 (215)
T ss_dssp SCCTTBCCE-EEEECSS------EEEEEECCCTTSEEGG---GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCS
T ss_pred ccCCcccce-EEEEccc------EEEEEEEcCcccCCHH---HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEe
Confidence 458888876 3444454 2333333232232221 12346788899999999987766654 4677899
Q ss_pred CCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccC
Q 035862 211 TSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLE 286 (393)
Q Consensus 211 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~ 286 (393)
|+||+++.++.+++.-.|+-.. ++|. .++...=.-.+=+++..+++++..|+
T Consensus 107 P~NL~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 107 PDELFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GGGEEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cceEEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999999987775432 2221 12333334466788889999988774
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.15 E-value=0.27 Score=45.74 Aligned_cols=30 Identities=27% Similarity=0.278 Sum_probs=25.2
Q ss_pred CeEeccCCCCCeEe------CCCCceEEeeccCCcc
Q 035862 203 QVIYRDFKTSNVLL------DGNFKPKLSDFGLARE 232 (393)
Q Consensus 203 ~ivH~Dikp~NIll------~~~~~~kl~Dfg~a~~ 232 (393)
.++|+|+.++|||+ +++..+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999998753
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.83 E-value=3.1 Score=34.85 Aligned_cols=82 Identities=7% Similarity=0.147 Sum_probs=58.7
Q ss_pred CCCHHHHHHHHHHHHHHHH-HhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCc
Q 035862 176 TLPWKTRLEIILGAAEGLA-YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP 254 (393)
Q Consensus 176 ~~~~~~~~~i~~ql~~~l~-~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 254 (393)
.++...++.++.+|+.... +++ .-+|--|.|+||+++.++.+++.-.|+-.. ++|
T Consensus 81 ~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~f~~~~~p~i~hRGi~~~-------------------lpP 136 (219)
T 4ano_A 81 KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLMFNRALEPFFLHVGVKES-------------------LPP 136 (219)
T ss_dssp TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEEECTTCCEEESCCEETTT-------------------BSS
T ss_pred hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEEEeCCCcEEEEEcCCccc-------------------CCC
Confidence 4678888999999888666 555 447778999999999999999997775432 233
Q ss_pred cccccCCCCchhhHHHHHHHHHHHHhCCCccC
Q 035862 255 EYIETGHLKSQSDIWSFGVVLYEILTGRRVLE 286 (393)
Q Consensus 255 E~~~~~~~~~~~DiwslGvil~elltg~~pf~ 286 (393)
.- .+...=.-++=|++..++.++..|+
T Consensus 137 ~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 137 DE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred CC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 21 2222334466778888999887764
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.38 E-value=0.22 Score=47.38 Aligned_cols=62 Identities=8% Similarity=0.093 Sum_probs=16.9
Q ss_pred cccceecccCCceEEEEEEcCCCCCCCceEEEE------EEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeee
Q 035862 75 NRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAV------KKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCS 144 (393)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 144 (393)
.+.+.|| ||.||+|.+... ...||+ |...... ......+.+|..+++..+|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~-----~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKK-----HMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC--------------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhccccccc-----CCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3455676 999999987532 123677 6554322 122345778888988899999999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 393 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-72 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-67 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-67 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-66 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-66 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-66 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-66 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-64 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-64 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-63 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-63 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-63 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-63 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-63 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-63 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-62 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-59 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-58 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-57 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-57 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-56 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-55 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-54 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-53 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-51 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-50 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-49 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-48 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-45 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-44 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-44 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-39 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-38 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 1e-72
Identities = 75/283 (26%), Positives = 117/283 (41%), Gaps = 34/283 (12%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNL 136
+IG G FG+VYKG VAVK LN Q + + EV L H N+
Sbjct: 15 RIGSGSFGTVYKGKWHG--------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 66
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
+ +GY + Q +V ++ SL L ++I A+G+ YL
Sbjct: 67 LLFMGYSTAP-----QLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYL 120
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
H +I+RD K++N+ L + K+ DFGLA +H + G+ + APE
Sbjct: 121 HAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 257 IET---GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313
I QSD+++FG+VLYE++TG+ + + D K
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
++ L CLKK +ERP Q++ S++
Sbjct: 238 CPKAMKR------------LMAECLKKKRDERPLFPQILASIE 268
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 4e-67
Identities = 73/303 (24%), Positives = 132/303 (43%), Gaps = 31/303 (10%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
IG+G FG V++G G VAVK ++ + + AE+ ++ H N++
Sbjct: 10 SIGKGRFGEVWRGK---WRGE----EVAVKIFSSREERSWFR-EAEIYQTVMLRHENILG 61
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
+ + ++ Q LV +Y + SL D L T+ + +++ L A GLA+LH
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHM 118
Query: 199 GL-----EIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHT--HVSTAVVGTYGY 251
+ + + +RD K+ N+L+ N ++D GLA + T VGT Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 252 AAPEYIET------GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305
APE ++ ++DI++ G+V +EI + + + V P+
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG-IHEDYQLPYYDLVPSDPS 237
Query: 306 DGKKFSMMIDPRLR-----NQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL-KLAV 359
+ ++ + +LR S A R +AK+ C N R T ++ ++L +L+
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
Query: 360 QES 362
QE
Sbjct: 298 QEG 300
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 212 bits (541), Expect = 5e-67
Identities = 73/312 (23%), Positives = 135/312 (43%), Gaps = 39/312 (12%)
Query: 62 FDMQELREATNGFNRML---------KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN- 111
F ++ EA F + + IG G FG V G ++ R + VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKRE--IFVAIKTLKS 64
Query: 112 NHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFS 171
+ + + +L+E +G HPN++ L G + +++ E+M N SL D
Sbjct: 65 GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV----MIITEFMENGSL-DSFLR 119
Query: 172 RAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231
+ + ++ G A G+ YL + + ++RD N+L++ N K+SDFGL+R
Sbjct: 120 QNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 176
Query: 232 EGPTGDHTHVSTAVVG---TYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERN 288
T+ +G + APE I+ S SD+WS+G+V++E+++
Sbjct: 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE----- 231
Query: 289 RPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTM 348
RP + + + I+ R ++ + +L +C +K+ RP
Sbjct: 232 RPYWDMTNQDVINA-----------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKF 280
Query: 349 NQVVESLKLAVQ 360
Q+V +L ++
Sbjct: 281 GQIVNTLDKMIR 292
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 4e-66
Identities = 69/281 (24%), Positives = 121/281 (43%), Gaps = 30/281 (10%)
Query: 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH-KQWLAEVQFLGVVSHPNL 136
+++G G FGSV +G R R + + VA+K L + ++ + E Q + + +P +
Sbjct: 15 IELGCGNFGSVRQGVYR---MRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 71
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
V+L+G C + +LV E L L + + +P E++ + G+ YL
Sbjct: 72 VRLIGVC-----QAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYL 125
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE-GPTGDHTHVSTAVVGTYGYAAPE 255
E ++RD NVLL K+SDFGL++ G + +A + APE
Sbjct: 126 EE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMID 315
I S+SD+WS+GV ++E L+ + +P + K E + I+
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMA-----------FIE 226
Query: 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
R + + L +C E+RP V + ++
Sbjct: 227 QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 4e-66
Identities = 76/278 (27%), Positives = 122/278 (43%), Gaps = 32/278 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
++G G FG V+ G VAVK L G +LAE + + H LV+
Sbjct: 20 RLGAGQFGEVWMGYYN--GHT----KVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L + E ++ EYM N SL D L + + L L++ AEG+A++ E
Sbjct: 73 LYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE 258
I+RD + +N+L+ K++DFGLAR + + APE I
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAIN 183
Query: 259 TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRL 318
G +SD+WSFG++L EI+T R+ E +++ +++ M+ P
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLERGYR-------MVRPD- 233
Query: 319 RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
N + +L C K+ PE+RPT + + L+
Sbjct: 234 ------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 6e-66
Identities = 72/302 (23%), Positives = 118/302 (39%), Gaps = 40/302 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ-WLAEVQFLG-VVSHPNL 136
+G G FG V + T L + VAVK L ++ ++E++ L + +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR----------------AQPTLPWK 180
V LLG C+ L++ EY L + L + + L +
Sbjct: 90 VNLLGACTIGGPT----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 181 TRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTH 240
L A+G+A+L I+RD N+LL K+ DFGLAR+ +
Sbjct: 146 DLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 241 VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300
V + APE I +SD+WS+G+ L+E+ + P +
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK------ 256
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360
F MI R +A + + C +P +RPT Q+V+ ++ +
Sbjct: 257 ---------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
Query: 361 ES 362
ES
Sbjct: 308 ES 309
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 6e-66
Identities = 77/278 (27%), Positives = 116/278 (41%), Gaps = 36/278 (12%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
IG+G FG V G G VAVK + N + +LAE + + H NLV+
Sbjct: 14 TIGKGEFGDVMLGD---YRGN----KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 64
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
LLG E +V EYM SL D L SR + L L+ L E + YL
Sbjct: 65 LLGVIVEEKGG---LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE 258
++RD NVL+ + K+SDFGL +E + T + APE +
Sbjct: 122 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALR 173
Query: 259 TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRL 318
++SD+WSFG++L+EI + RV P + ++ V++
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEK----------GYKMDA 221
Query: 319 RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
+ V ++ NC + RP+ Q+ E L+
Sbjct: 222 PDGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 1e-65
Identities = 65/301 (21%), Positives = 112/301 (37%), Gaps = 45/301 (14%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH-KQWLAEVQFLG-VVSHPNL 136
+G G FG V T + G + VAVK L + ++E++ + + SH N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQP--------------------- 175
V LLG C+ L++EY L + L S+ +
Sbjct: 104 VNLLGACTLSG----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 159
Query: 176 TLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPT 235
L ++ L A+G+ +L ++RD NVL+ K+ DFGLAR+ +
Sbjct: 160 VLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216
Query: 236 GDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK 295
+ V + APE + G +SD+WS+G++L+EI + P
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN- 275
Query: 296 LLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESL 355
F +I + A + + +C + +RP+ + L
Sbjct: 276 --------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321
Query: 356 K 356
Sbjct: 322 G 322
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 8e-65
Identities = 82/284 (28%), Positives = 135/284 (47%), Gaps = 33/284 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+IG G FG V+ G + VA+K + G + ++ E + + +SHP LV+
Sbjct: 12 EIGSGQFGLVHLGYWL--NKD----KVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L G C + LV+E+M + L D L ++ +T L + L EG+AYL E
Sbjct: 65 LYGVCLEQAPI----CLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGMAYLEE 119
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE 258
VI+RD N L+ N K+SDFG+ R +T ST +A+PE
Sbjct: 120 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFS 175
Query: 259 TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRL 318
S+SD+WSFGV+++E+ + ++ NR E ++E + + PRL
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVEDISTGF-------RLYKPRL 226
Query: 319 RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362
A+ V ++ ++C K+ PE+RP ++++ L + ES
Sbjct: 227 -------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLA-EIAES 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 2e-64
Identities = 67/278 (24%), Positives = 115/278 (41%), Gaps = 32/278 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
++G G FG V G R VA+K + G +++ E + + +SH LV+
Sbjct: 11 ELGTGQFGVVKYGKWR--GQY----DVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L G C+ + ++ EYM N L + L + LE+ E + YL
Sbjct: 64 LYGVCTKQRPI----FIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLES 118
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE 258
Q ++RD N L++ K+SDFGL+R ++T S ++ PE +
Sbjct: 119 ---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLM 174
Query: 259 TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRL 318
S+SDIW+FGV+++EI + ++ E I L
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA----------------EHIAQGL 218
Query: 319 RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
R A+ +V + +C + +ERPT ++ ++
Sbjct: 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 4e-64
Identities = 82/311 (26%), Positives = 134/311 (43%), Gaps = 35/311 (11%)
Query: 49 PELYKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVK 108
PEL + +H + + FN IG G FG VY GT+ DG+ AVK
Sbjct: 11 PELVQAVQHVVIGPSSLIVH-----FNE--VIGRGHFGCVYHGTLLDNDGKKI--HCAVK 61
Query: 109 KLNNHGLQGH-KQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLED 167
LN G Q+L E + SHPN++ LLG C + L+V YM + L +
Sbjct: 62 SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS---PLVVLPYMKHGDLRN 118
Query: 168 RLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227
K + L A+G+ +L + ++RD N +LD F K++DF
Sbjct: 119 -FIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADF 174
Query: 228 GLARE--GPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVL 285
GLAR+ D H T + A E ++T ++SD+WSFGV+L+E++T
Sbjct: 175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234
Query: 286 ERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEER 345
+ T + + ++ Q G++ ++ P + ++ C E R
Sbjct: 235 YPDVNTFD--ITVYLLQ----GRR---LLQPE-------YCPDPLYEVMLKCWHPKAEMR 278
Query: 346 PTMNQVVESLK 356
P+ +++V +
Sbjct: 279 PSFSELVSRIS 289
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 4e-64
Identities = 72/311 (23%), Positives = 130/311 (41%), Gaps = 44/311 (14%)
Query: 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-HKQWLAEVQFL 128
+ F ++ ++G G G V+K + +P G V+A K ++ Q + E+Q L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKP-SGL----VMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 129 GVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILG 188
+ P +V G ++ E + E+M SL+ L + +P + ++ +
Sbjct: 59 HECNSPYIVGFYGAFYSDGEI----SICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIA 112
Query: 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT 248
+GL YL E +I ++RD K SN+L++ + KL DFG++ + ++ + VGT
Sbjct: 113 VIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGT 166
Query: 249 YGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308
Y +PE ++ H QSDIWS G+ L E+ GR + + + + A
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226
Query: 309 KFSMMIDPRLRNQYSINAARRVAK--------------------------LADNCLKKNP 342
R + Y +++ +A + CL KNP
Sbjct: 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 286
Query: 343 EERPTMNQVVE 353
ER + Q++
Sbjct: 287 AERADLKQLMV 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 205 bits (521), Expect = 4e-64
Identities = 76/317 (23%), Positives = 117/317 (36%), Gaps = 46/317 (14%)
Query: 63 DMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-HKQW 121
+ L N + IGEG FG V++ L +VAVK L +
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 122 LAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR--------- 172
E + +PN+VKLLG C+ L++EYM L + L S
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPM----CLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 173 -------------AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN 219
P L +L I A G+AYL E + ++RD T N L+ N
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGEN 176
Query: 220 FKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEIL 279
K++DFGL+R + D+ + PE I ++SD+W++GVVL+EI
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236
Query: 280 TGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLK 339
+ E ++ +V+ N + L C
Sbjct: 237 SYGLQPYYGMAHEE--VIYYVRDGN--------------ILACPENCPLELYNLMRLCWS 280
Query: 340 KNPEERPTMNQVVESLK 356
K P +RP+ + L+
Sbjct: 281 KLPADRPSFCSIHRILQ 297
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 9e-64
Identities = 71/281 (25%), Positives = 113/281 (40%), Gaps = 32/281 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--HKQWLAEVQFLGVVSHPNL 136
++G G FG+V KG + + VAVK L N + LAE + + +P +
Sbjct: 14 ELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
V+++G C E +LV E L L + K +E++ + G+ YL
Sbjct: 71 VRMIGICEAES-----WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYL 123
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG-DHTHVSTAVVGTYGYAAPE 255
E ++RD NVLL K+SDFGL++ ++ T + APE
Sbjct: 124 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMID 315
I S+SD+WSFGV+++E + + +P K E M++
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSEVTA-----------MLE 224
Query: 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
R R + L + C + E RP V L+
Sbjct: 225 KGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 1e-63
Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 30/282 (10%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPN 135
K+G+G FG V +G G+ VAVK L L + ++ EV + + H N
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVS--VAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAY 195
L++L G T + +V E P SL DRL Q T + AEG+ Y
Sbjct: 73 LIRLYGVVLTPPMK-----MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGY 126
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTG-DHTHVSTAVVGTYGYAAP 254
L + I+RD N+LL K+ DFGL R P DH + + + AP
Sbjct: 127 LES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMI 314
E ++T SD W FGV L+E+ T + P + + + + +G++
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERLP--- 235
Query: 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
+ + + + C PE+RPT + + L
Sbjct: 236 -------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-63
Identities = 60/278 (21%), Positives = 111/278 (39%), Gaps = 31/278 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNL 136
+IG G F +VYKG + VA +L + L +++ E + L + HPN+
Sbjct: 16 EIGRGSFKTVYKGLDTETT-----VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
V+ + + +LV E M + +L+ L + K +GL +L
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFL 128
Query: 197 HEGLEIQVIYRDFKTSNVLLDG-NFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPE 255
H +I+RD K N+ + G K+ D GLA + AV+GT + APE
Sbjct: 129 HT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPE 183
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMID 315
E D+++FG+ + E+ T + + + V F +
Sbjct: 184 MYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVKP-ASFDKVAI 239
Query: 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
P ++ + + C+++N +ER ++ ++
Sbjct: 240 PEVKE------------IIEGCIRQNKDERYSIKDLLN 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 2e-63
Identities = 75/278 (26%), Positives = 113/278 (40%), Gaps = 32/278 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
K+G+G FG V+ GT VA+K L G + +L E Q + + H LV+
Sbjct: 24 KLGQGCFGEVWMGTWNGTT------RVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L S E +V EYM SL D L L +++ A G+AY+
Sbjct: 77 LYAVVSEEP-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE 258
+ ++RD + +N+L+ N K++DFGLAR ++T + APE
Sbjct: 132 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAAL 187
Query: 259 TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRL 318
G +SD+WSFG++L E+ T RV E ++
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL----------------DQVERGY 231
Query: 319 RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
R + L C +K PEERPT + L+
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 3e-63
Identities = 76/292 (26%), Positives = 129/292 (44%), Gaps = 27/292 (9%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHK-QWLAEVQFLGVVS 132
R IG G FG VYKG ++ G+ E + VA+K L + + +L E +G S
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKE-VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 133 HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEG 192
H N+++L G S +++ EYM N +L+ L + + ++ G A G
Sbjct: 68 HHNIIRLEGVISKYKPM----MIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAG 122
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE-GPTGDHTHVSTAVVGTYGY 251
+ YL + ++RD N+L++ N K+SDFGL+R + T+ ++ +
Sbjct: 123 MKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 252 AAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311
APE I S SD+WSFG+V++E++T RP E E +K
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGE-----RPYWELSNHEVMK---------- 224
Query: 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363
I+ R ++ + +L C ++ RP +V L ++ +
Sbjct: 225 -AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 202 bits (514), Expect = 4e-63
Identities = 74/285 (25%), Positives = 122/285 (42%), Gaps = 30/285 (10%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
K+G G +G VY+G + L VAVK L ++ +++L E + + HPNLV+
Sbjct: 24 KLGGGQYGEVYEGVWKKYS-----LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 77
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
LLG C+ E I E+M +L D L + + L + + + YL +
Sbjct: 78 LLGVCTREPPFYII----TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE 258
I+RD N L+ N K++DFGL+R GD + APE +
Sbjct: 134 ---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 189
Query: 259 TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRL 318
+SD+W+FGV+L+EI T L V + +++
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYG------MSPYPGIDLSQVYE----------LLEKDY 233
Query: 319 RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363
R + +V +L C + NP +RP+ ++ ++ + QES
Sbjct: 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 6e-63
Identities = 66/292 (22%), Positives = 122/292 (41%), Gaps = 27/292 (9%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVS 132
F ++ +G G FG+VYKG P +G + VA+K+L + +K+ L E + V
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 133 HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEG 192
+P++ +LLG C T + L+ + MP L D + + L + A+G
Sbjct: 70 NPHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKG 123
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA 252
+ YL + ++++RD NVL+ K++DFGLA+ + + + +
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSM 312
A E I QSD+WS+GV ++E++T P E S
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISS 224
Query: 313 MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364
+++ R V + C + + RP +++ ++ ++
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 276
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 7e-62
Identities = 63/277 (22%), Positives = 106/277 (38%), Gaps = 31/277 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
+GEG +G V R VAVK ++ + + E+ +++H N+V
Sbjct: 12 TLGEGAYGEVQLAVNRV-TEE----AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
K G+ + + L EY L DR+ +P G+ YLH
Sbjct: 67 KFYGHRREGNIQ----YLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH 120
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYI 257
I + +RD K N+LLD K+SDFGLA + + + GT Y APE +
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 258 ETGHLKSQ-SDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDP 316
+ ++ D+WS G+VL +L G ++ + ++ +S +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YSDWKEK 222
Query: 317 RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
+ L L +NP R T+ + +
Sbjct: 223 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 3e-61
Identities = 66/281 (23%), Positives = 114/281 (40%), Gaps = 32/281 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNL 136
IG G +G K + DG+ ++ K+L+ + + ++EV L + HPN+
Sbjct: 11 TIGTGSYGRCQKIRRKS-DGK----ILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLF--SRAQPTLPWKTRLEIILGAAEGLA 194
V+ + +V EY L + ++ + L + L ++ L
Sbjct: 66 VRYYDRIIDRTNTTL--YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 195 YLHEGLEI--QVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYA 252
H + V++RD K +NV LDG KL DFGLAR T + A VGT Y
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYM 181
Query: 253 APEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSM 312
+PE + +SDIWS G +LYE+ ++L +++
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIREGK-------- 230
Query: 313 MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
R+ +YS + ++ L RP++ +++E
Sbjct: 231 --FRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-60
Identities = 77/307 (25%), Positives = 127/307 (41%), Gaps = 45/307 (14%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVS-HPNL 136
IGEG FG V K I+ G + A+K++ + H+ + E++ L + HPN+
Sbjct: 17 VIGEGNFGQVLKARIK---KDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 73
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRL--------------FSRAQPTLPWKTR 182
+ LLG C L EY P+ +L D L + TL +
Sbjct: 74 INLLGACEHRGYL----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 183 LEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS 242
L A G+ YL + Q I+RD N+L+ N+ K++DFGL+R
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--- 183
Query: 243 TAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ 302
T + A E + + SD+WS+GV+L+EI++ P E ++
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCAELYEK 238
Query: 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362
+ R + +N V L C ++ P ERP+ Q++ SL ++E
Sbjct: 239 -----------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287
Query: 363 EQGSSST 369
+ ++T
Sbjct: 288 KTYVNTT 294
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-60
Identities = 58/280 (20%), Positives = 114/280 (40%), Gaps = 35/280 (12%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
++G+G FG VYK + ++ A K ++ + + ++ E+ L HPN+VK
Sbjct: 19 ELGDGAFGKVYKAQNKETS-----VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
LL E+ ++ E+ +++ + +P L + + L YLH+
Sbjct: 74 LLDAFYYENNL----WILIEFCAGGAVDAVMLELERP-LTESQIQVVCKQTLDALNYLHD 128
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIE 258
++I+RD K N+L + KL+DFG++ + + +GT + APE +
Sbjct: 129 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVM 183
Query: 259 TGHLKSQ-----SDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313
K + +D+WS G+ L E+ P ++L + +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP---MRVLLKIAKSEPPTLAQPSR 240
Query: 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
++ CL+KN + R T +Q+++
Sbjct: 241 WSSNFKD------------FLKKCLEKNVDARWTTSQLLQ 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-59
Identities = 71/279 (25%), Positives = 112/279 (40%), Gaps = 41/279 (14%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPN 135
+G+G FG+VY + ++A+K L L Q EV+ + HPN
Sbjct: 13 PLGKGKFGNVYLAREKQ-SKF----ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAY 195
+++L GY + + EY P ++ L + + I A L+Y
Sbjct: 68 ILRLYGYFHDATRVYL----ILEYAPLGTVYREL--QKLSKFDEQRTATYITELANALSY 121
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPE 255
H +VI+RD K N+LL + K++DFG + P+ T + GT Y PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTLDYLPPE 174
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVLE-RNRPTMEQKLLEWVKQFPADGKKFSMMI 314
IE + D+WS GV+ YE L G+ E +++ FP +
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF-------V 227
Query: 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
R+ L LK NP +RP + +V+E
Sbjct: 228 TEGARD------------LISRLLKHNPSQRPMLREVLE 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (490), Expect = 3e-59
Identities = 76/286 (26%), Positives = 121/286 (42%), Gaps = 42/286 (14%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQFLGV 130
F+ + +IG G FG+VY + VVA+KK++ G Q +++W + EV+FL
Sbjct: 17 FSDLREIGHGSFGAVYFARDVR-NSE----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQK 71
Query: 131 VSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA 190
+ HPN ++ G E LV EY + + + L + GA
Sbjct: 72 LRHPNTIQYRGCYLREHTA----WLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGAL 125
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYG 250
+GLAYLH +I+RD K N+LL KL DFG A + + VGT
Sbjct: 126 QGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANSFVGTPY 176
Query: 251 YAAPEYIET---GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307
+ APE I G + D+WS G+ E+ + P + + +
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK------PPLFNMNAMSALYHIAQNE 230
Query: 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
P L++ + R D+CL+K P++RPT +++
Sbjct: 231 -------SPALQSGHWSEYFR---NFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 5e-58
Identities = 68/286 (23%), Positives = 109/286 (38%), Gaps = 29/286 (10%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-HKQWLAEVQFLGVVSHPNLV 137
IGEG FG V++G + VA+K N +++L E + HP++V
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPAL--AVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
KL+G + ++ E L L R L + + + LAYL
Sbjct: 72 KLIGVITEN-----PVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLE 125
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYI 257
+ ++RD NVL+ N KL DFGL+R + ++ + APE I
Sbjct: 126 S---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLPIKWMAPESI 181
Query: 258 ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPR 317
S SD+W FGV ++EIL +P K + + + I+
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGR-----------IENG 225
Query: 318 LRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363
R N + L C +P RP ++ L ++E +
Sbjct: 226 ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-57
Identities = 65/287 (22%), Positives = 123/287 (42%), Gaps = 32/287 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLN-NHGLQGHKQWLAEVQFLGVVSHPNLV 137
++G+G FG VY+G + + VA+K +N ++ ++L E + + ++V
Sbjct: 27 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 86
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR--------AQPTLPWKTRLEIILGA 189
+LLG S L++ E M L+ L S +++
Sbjct: 87 RLLGVVSQGQPT----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142
Query: 190 AEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
A+G+AYL+ + ++RD N ++ +F K+ DFG+ R+ D+ +
Sbjct: 143 ADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 250 GYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309
+ +PE ++ G + SD+WSFGVVL+EI T + + +L +V +
Sbjct: 200 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VLRFVMEGG----- 252
Query: 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
N + +L C + NP+ RP+ +++ S+K
Sbjct: 253 ---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 6e-57
Identities = 68/296 (22%), Positives = 122/296 (41%), Gaps = 38/296 (12%)
Query: 64 MQELREATNG------FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG 117
+++LR + + R KIG+G G+VY G+ VA++++N
Sbjct: 6 LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVA-TGQ----EVAIRQMNLQQQPK 60
Query: 118 HKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTL 177
+ + E+ + +PN+V L DE +V EY+ SL D +
Sbjct: 61 KELIINEILVMRENKNPNIVNYLDSYLVGDEL----WVVMEYLAGGSLTDVVTETCMD-- 114
Query: 178 PWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGD 237
+ + L +LH QVI+RD K+ N+LL + KL+DFG +
Sbjct: 115 -EGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170
Query: 238 HTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL 297
+ +VGT + APE + + DIWS G++ E++ G P + + L
Sbjct: 171 SKR--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------PPYLNENPL 222
Query: 298 EWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
+ +G P L+N ++A + CL + E+R + ++++
Sbjct: 223 RALYLIATNGT-------PELQNPEKLSAI--FRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-56
Identities = 67/299 (22%), Positives = 113/299 (37%), Gaps = 35/299 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-HKQWLAEVQFLGVVSHPNLV 137
+G G FG V + +D VAVK L H+ ++E++ L + H V
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSR--------------AQPTLPWKTRL 183
L T+ + +++ E+ +L L S+ + L + +
Sbjct: 80 VNLLGACTKPGGPL--MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137
Query: 184 EIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVST 243
A+G+ +L + I+RD N+LL K+ DFGLAR+
Sbjct: 138 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194
Query: 244 AVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303
+ APE I QSD+WSFGV+L+EI + P K+ E +
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEEFCR- 248
Query: 304 PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362
+ R + + + +C P +RPT +++VE L +Q +
Sbjct: 249 ---------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 7e-55
Identities = 77/296 (26%), Positives = 119/296 (40%), Gaps = 41/296 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLD--GRGEPLVVAVKKLNNHGLQGH-KQWLAEVQFLG-VVSHP 134
+GEG FG V LD VAVK L + + ++E++ + + H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQP--------------TLPWK 180
N++ LLG C+ + ++ EY +L + L +R P L K
Sbjct: 80 NIINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 135
Query: 181 TRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTH 240
+ A G+ YL + I+RD NVL+ + K++DFGLAR+ D+
Sbjct: 136 DLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 241 VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300
+T + APE + QSD+WSFGV+L+EI T P E L + +
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LFKLL 250
Query: 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
K+ R N + + +C P +RPT Q+VE L
Sbjct: 251 KE--------------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 178 bits (451), Expect = 6e-54
Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 29/282 (10%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG---HKQWLAEVQFLGVVSHPN 135
+G GG V+ R VAVK L + + ++ E Q ++HP
Sbjct: 14 ILGFGGMSEVHLARDLR-LHR----DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAY 195
+V + E G +V EY+ +L D + + + K +E+I A + L +
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADACQALNF 126
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE-GPTGDHTHVSTAVVGTYGYAAP 254
H+ +I+RD K +N+++ K+ DFG+AR +G+ + AV+GT Y +P
Sbjct: 127 SHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMI 314
E + ++SD++S G VLYE+LTG + P + V++ P +
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--VSVAYQHVREDPIPPSARHEGL 241
Query: 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERP-TMNQVVESL 355
L + L KNPE R T ++ L
Sbjct: 242 SADLDA------------VVLKALAKNPENRYQTAAEMRADL 271
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 8e-54
Identities = 56/283 (19%), Positives = 98/283 (34%), Gaps = 37/283 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPN 135
+GEG F +V R A+K L + E + + HP
Sbjct: 15 ILGEGSFSTVVLARELA-TSR----EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAY 195
VKL +++ Y N L + + L Y
Sbjct: 70 FVKLYFTFQDDEKL----YFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEY 123
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPE 255
LH +I+RD K N+LL+ + +++DFG A+ + + VGT Y +PE
Sbjct: 124 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVLE-RNRPTMEQKLLEWVKQFPADGKKFSMMI 314
+ SD+W+ G ++Y+++ G N + QK+++ FP
Sbjct: 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK-------F 233
Query: 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357
P+ R+ L + L + +R ++ L
Sbjct: 234 FPKARD------------LVEKLLVLDATKRLGCEEMEGYGPL 264
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 178 bits (452), Expect = 3e-53
Identities = 63/277 (22%), Positives = 108/277 (38%), Gaps = 32/277 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
++G G FG V++ T R G A K + + E+Q + V+ HP LV
Sbjct: 33 ELGTGAFGVVHRVTERA-TGN----NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L ++E +++YE+M L +++ + +E + +GL ++HE
Sbjct: 88 LHDAFEDDNEM----VMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHE 142
Query: 199 GLEIQVIYRDFKTSNVLL--DGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
++ D K N++ + + KL DFGL V GT +AAPE
Sbjct: 143 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEV 196
Query: 257 IETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDP 316
E + +D+WS GV+ Y +L+G + L VK D
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND---DETLRNVKS-----------CDW 242
Query: 317 RLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
+ + + L +P R T++Q +E
Sbjct: 243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (452), Expect = 4e-53
Identities = 60/278 (21%), Positives = 112/278 (40%), Gaps = 34/278 (12%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
++G G FG V++ + GR V K +N E+ + + HP L+
Sbjct: 36 ELGSGAFGVVHRCVEKA-TGR----VFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L + E +L+ E++ L DR+ + + + + A EGL ++HE
Sbjct: 91 LHDAFEDKYEM----VLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHE 145
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKP--KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
+++ D K N++ + K+ DFGLA + + V T +AAPE
Sbjct: 146 ---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEI 199
Query: 257 IETGHLKSQSDIWSFGVVLYEILTGRRVLE-RNRPTMEQKLLEWVKQFPADGKKFSMMID 315
++ + +D+W+ GV+ Y +L+G + Q + +F D +
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS---VS 256
Query: 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
P ++ N L+K P +R T++ +E
Sbjct: 257 PEAKD------------FIKNLLQKEPRKRLTVHDALE 282
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 8e-51
Identities = 66/289 (22%), Positives = 119/289 (41%), Gaps = 24/289 (8%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH-----KQWLAEVQFLGVVSH 133
+IGEG +G V+K GR VA+K++ + + +A ++ L H
Sbjct: 14 EIGEGAYGKVFKARDLKNGGR----FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGL 193
PN+V+L C+ +L + ++ L L +P +P +T +++ GL
Sbjct: 70 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAA 253
+LH +V++RD K N+L+ + + KL+DFGLAR T+VV T Y A
Sbjct: 130 DFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRA 183
Query: 254 PEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP--------- 304
PE + + D+WS G + E+ + + + + + V P
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
A ++ + ++ + L CL NP +R + +
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 1e-50
Identities = 58/276 (21%), Positives = 105/276 (38%), Gaps = 29/276 (10%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH-KQWLAEVQFLGVVSHPNLV 137
+G G F V + + +VA+K + L+G E+ L + HPN+V
Sbjct: 16 VLGTGAFSEVILAEDKR-TQK----LVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 138 KLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLH 197
L + L+ + + L DR+ + + +I + + YLH
Sbjct: 71 ALDDIYESGGHL----YLIMQLVSGGELFDRI--VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 198 EGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYI 257
+ + + LD + K +SDFGL++ D V + GT GY APE +
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVL 181
Query: 258 ETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPR 317
D WS GV+ Y +L G P ++ + +Q + +
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQI--------LKAEYE 227
Query: 318 LRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
+ Y + + + ++K+PE+R T Q ++
Sbjct: 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 6e-50
Identities = 49/278 (17%), Positives = 106/278 (38%), Gaps = 35/278 (12%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+G G FG V++ + K + G E+ L + H N++
Sbjct: 12 DLGRGEFGIVHRCVETS-SKK----TYMAKFVKVKGTD-QVLVKKEISILNIARHRNILH 65
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
L + +E ++++E++ + +R+ + A L + + + E L +LH
Sbjct: 66 LHESFESMEEL----VMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS 120
Query: 199 GLEIQVIYRDFKTSNVLLD--GNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
+ + D + N++ + K+ +FG AR+ GD+ + + Y APE
Sbjct: 121 ---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEV 174
Query: 257 IETGHLKSQSDIWSFGVVLYEILTGRRVLE-RNRPTMEQKLLEWVKQFPADGKKFSMMID 315
+ + + +D+WS G ++Y +L+G + + ++ F + K I
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE---IS 231
Query: 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
+ D L K + R T ++ ++
Sbjct: 232 IEAMD------------FVDRLLVKERKSRMTASEALQ 257
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-49
Identities = 71/301 (23%), Positives = 119/301 (39%), Gaps = 27/301 (8%)
Query: 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH-KQWLAEVQF 127
+ + + IGEG +G V + VA+KK++ Q + ++ L E++
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNK-----VRVAIKKISPFEHQTYCQRTLREIKI 59
Query: 128 LGVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIIL 187
L H N++ + ++ + + ++ L L ++ L +
Sbjct: 60 LLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLY 116
Query: 188 GAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE-GPTGDHTHVSTAVV 246
GL Y+H V++RD K SN+LL+ K+ DFGLAR P DHT T V
Sbjct: 117 QILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173
Query: 247 GTYGYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGR-------------RVLERNRPTM 292
T Y APE + ++S DIWS G +L E+L+ R +L
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233
Query: 293 EQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVV 352
++ L + + + N+ NA + L D L NP +R + Q +
Sbjct: 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
Query: 353 E 353
Sbjct: 294 A 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 166 bits (420), Expect = 3e-49
Identities = 74/292 (25%), Positives = 116/292 (39%), Gaps = 49/292 (16%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---------QGHKQWLAEVQFLG 129
+G G V + +P + AVK ++ G + + L EV L
Sbjct: 10 ILGRGVSSVVRRCIHKP-TCK----EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 130 VVS-HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILG 188
VS HPN+++L T LV++ M L D L + TL K +I+
Sbjct: 65 KVSGHPNIIQLKDTYETNTFF----FLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRA 118
Query: 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT 248
E + LH+ + +++RD K N+LLD + KL+DFG + + G+ V GT
Sbjct: 119 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---REVCGT 172
Query: 249 YGYAAPEYIETGHLKSQ------SDIWSFGVVLYEILTGRRVL-ERNRPTMEQKLLEWVK 301
Y APE IE + D+WS GV++Y +L G R + M + ++
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232
Query: 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
QF + YS V L L P++R T + +
Sbjct: 233 QFG-----------SPEWDDYS----DTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 4e-48
Identities = 59/276 (21%), Positives = 100/276 (36%), Gaps = 38/276 (13%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQFLG-VVSHP 134
+G+G FG V+ + + A+K L + + E + L HP
Sbjct: 9 MLGKGSFGKVFLAEFKK-TNQ----FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 135 NLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLA 194
L + T++ EY+ L + ++ GL
Sbjct: 64 FLTHMFCTFQTKENLFFV----MEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQ 117
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP 254
+LH ++YRD K N+LLD + K++DFG+ +E GD GT Y AP
Sbjct: 118 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAP 172
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMI 314
E + D WSFGV+LYE+L G+ ++L ++ D + +
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE---EELFHSIRM---DNPFYPRWL 226
Query: 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQ 350
+ ++ L + PE+R +
Sbjct: 227 EKEAKD------------LLVKLFVREPEKRLGVRG 250
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-47
Identities = 67/291 (23%), Positives = 113/291 (38%), Gaps = 32/291 (10%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG-----HKQWLAEVQFLGVVSH 133
+GEG F +VYK + + +VA+KK+ ++ L E++ L +SH
Sbjct: 5 FLGEGQFATVYKARDKN-TNQ----IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 59
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGL 193
PN++ LL + LV+++M + L +L +GL
Sbjct: 60 PNIIGLLDAFGHKSNI----SLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGL 113
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAA 253
YLH+ +++RD K +N+LLD N KL+DFGLA+ + + + T V T Y A
Sbjct: 114 EYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRA 168
Query: 254 PEYIETGHLKSQ-SDIWSFGVVLYEILTGRRVLERNRPTMEQKLL----------EWVKQ 302
PE + + D+W+ G +L E+L L + + + +W
Sbjct: 169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 228
Query: 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
+ A + L NP R T Q ++
Sbjct: 229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 4e-47
Identities = 63/285 (22%), Positives = 115/285 (40%), Gaps = 41/285 (14%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA------EVQFLGVVS 132
++G G F V K + G A K + + ++ ++ EV L +
Sbjct: 17 ELGSGQFAVVKKCREKS-TGL----QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 133 HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEG 192
HPN++ L + + +L+ E + L D L + +L + E + G
Sbjct: 72 HPNVITLHEVYENKTDV----ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNG 125
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKP----KLSDFGLAREGPTGDHTHVSTAVVGT 248
+ YLH +Q+ + D K N++L P K+ DFGLA + G+ + GT
Sbjct: 126 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGT 179
Query: 249 YGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308
+ APE + L ++D+WS GV+ Y +L+G + Q+ L V
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK---QETLANVSA------ 230
Query: 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
++ ++Y N + L K+P++R T+ ++
Sbjct: 231 -----VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (402), Expect = 2e-46
Identities = 58/286 (20%), Positives = 98/286 (34%), Gaps = 33/286 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
KIG G FG +Y GT G VA+K H Q E + ++ +
Sbjct: 14 KIGSGSFGDIYLGTDIA-AGE----EVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIP 66
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
+ +C E + ++V E + + LF+ KT L + + Y+H
Sbjct: 67 TIRWCGAEGDY---NVMVMELLGP--SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 199 GLEIQVIYRDFKTSNVL---LDGNFKPKLSDFGLAR-----EGPTGDHTHVSTAVVGTYG 250
I+RD K N L + DFGLA+ + + GT
Sbjct: 122 ---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 251 YAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310
YA+ + D+ S G VL G + + +++ E + + KK
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-----KKM 233
Query: 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
S I L Y A + C +++P + + + +
Sbjct: 234 STPI-EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 160 bits (405), Expect = 4e-46
Identities = 67/286 (23%), Positives = 109/286 (38%), Gaps = 40/286 (13%)
Query: 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFL 128
N F+ IG GGFG VY G+ + A+K L+ + QG L E L
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKAD-TGK----MYAMKCLDKKRIKMKQGETLALNERIML 58
Query: 129 GVVS---HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEI 185
+VS P +V + T D+ + + M L L
Sbjct: 59 SLVSTGDCPFIVCMSYAFHTPDKL----SFILDLMNGGDLHYHL--SQHGVFSEADMRFY 112
Query: 186 ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAV 245
GL ++H V+YRD K +N+LLD + ++SD GLA +
Sbjct: 113 AAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----S 165
Query: 246 VGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP 304
VGT+GY APE ++ G S +D +S G +L+++L G +++ + ++
Sbjct: 166 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 225
Query: 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQ 350
+ P LR+ L + L+++ R
Sbjct: 226 V---ELPDSFSPELRS------------LLEGLLQRDVNRRLGCLG 256
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-45
Identities = 70/293 (23%), Positives = 124/293 (42%), Gaps = 27/293 (9%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVV 131
F ++ KIGEG +G VYK + G VVA+KK+ + E+ L +
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKL-TGE----VVALKKIRLDTETEGVPSTAIREISLLKEL 58
Query: 132 SHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAE 191
+HPN+VKLL TE++ LV+E++ ++ L+ + + A +P + +
Sbjct: 59 NHPNIVKLLDVIHTENKL----YLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 192 GLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGY 251
GLA+ H +V++RD K N+L++ KL+DFGLAR + VV +
Sbjct: 114 GLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYR 169
Query: 252 AAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311
A + + + DIWS G + E++T R + + + + P +
Sbjct: 170 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG 229
Query: 312 MMIDPRLRNQYSINAARRVAK-----------LADNCLKKNPEERPTMNQVVE 353
+ P + + A + +K L L +P +R + +
Sbjct: 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 1e-45
Identities = 69/295 (23%), Positives = 111/295 (37%), Gaps = 29/295 (9%)
Query: 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH 133
+ IG G FG VY+ + G +VA+KK+ + E+Q + + H
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCD-SGE----LVAIKKVLQD----KRFKNRELQIMRKLDH 72
Query: 134 PNLVKLLGYCSTEDERG--IQRLLVYEYMPNRSLED-RLFSRAQPTLPWKTRLEIILGAA 190
N+V+L + + E+ + LV +Y+P R +SRA+ TLP +
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGN-FKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
LAY+H + +RD K N+LLD + KL DFG A++ G+ + + Y
Sbjct: 133 RSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRY 187
Query: 250 GYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP----- 304
A S D+WS G VL E+L G+ + + + + V P
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 305 ------ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
KF + + L L+ P R T +
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 156 bits (395), Expect = 1e-45
Identities = 43/288 (14%), Positives = 83/288 (28%), Gaps = 35/288 (12%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVK 138
+IGEG FG +++GT L+ + VA+K Q E + +++ +
Sbjct: 12 RIGEGSFGVIFEGT-NLLNNQ----QVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIP 64
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
+ Y E + LV + + + L KT + +HE
Sbjct: 65 NVYYFGQEGLHNV---LVIDLLGP--SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKP-----KLSDFGLAR-----EGPTGDHTHVSTAVVGT 248
++YRD K N L+ + DFG+ + + GT
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 249 YGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308
Y + + D+ + G V L G + + ++ E + +
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE------ 230
Query: 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356
+ K + P + +
Sbjct: 231 ----KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-45
Identities = 61/278 (21%), Positives = 97/278 (34%), Gaps = 30/278 (10%)
Query: 80 IGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLG-VVSHPNLVK 138
+G G G V + + A+K L + + EV+ P++V+
Sbjct: 20 LGLGINGKVLQIFNKR-TQE----KFALKMLQDC-----PKARREVELHWRASQCPHIVR 69
Query: 139 LLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE 198
++ L+V E + L R+ R + EI+ E + YLH
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH- 128
Query: 199 GLEIQVIYRDFKTSNVLLDGNFKP---KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPE 255
I + +RD K N+L KL+DFG A+E + + T Y APE
Sbjct: 129 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYVAPE 183
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMID 315
+ D+WS GV++Y +L G N + K M
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----------KTRIRMGQ 233
Query: 316 PRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
N + V L N LK P +R T+ + +
Sbjct: 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 155 bits (393), Expect = 7e-45
Identities = 69/276 (25%), Positives = 109/276 (39%), Gaps = 42/276 (15%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQ---WLAEVQFLGVVSHPN 135
+G G FG V+ R +GR A+K L + KQ E L +V+HP
Sbjct: 11 TLGTGSFGRVHLIRSRH-NGR----YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAY 195
++++ G Q ++ +Y+ L L + P L Y
Sbjct: 66 IIRMWGTFQDAQ----QIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLALEY 119
Query: 196 LHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPE 255
LH +IYRD K N+LLD N K++DFG A+ P +T + GT Y APE
Sbjct: 120 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAPE 171
Query: 256 YIETGHLKSQSDIWSFGVVLYEILTGRRVL-ERNRPTMEQKLLEWVKQFPADGKKFSMMI 314
+ T D WSFG+++YE+L G + N +K+L +FP
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF-------F 224
Query: 315 DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQ 350
+ +++ L + ++ +R Q
Sbjct: 225 NEDVKD------------LLSRLITRDLSQRLGNLQ 248
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 152 bits (384), Expect = 6e-44
Identities = 68/289 (23%), Positives = 111/289 (38%), Gaps = 31/289 (10%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNL 136
KIGEG +G VYK G A+KK+ + E+ L + H N+
Sbjct: 9 KIGEGTYGVVYKAQNN--YGE----TFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
VKL T+ +LV+E++ + L T +L G+AY
Sbjct: 63 VKLYDVIHTKKRL----VLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYC 116
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
H+ +V++RD K N+L++ + K++DFGLAR + +V + A
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVL 172
Query: 257 IETGHLKSQSDIWSFGVVLYEILTGR------------RVLERNRPTMEQKLLEWVKQFP 304
+ + + DIWS G + E++ G + R T K V + P
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232
Query: 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
F++ +P + L LK +P +R T Q +E
Sbjct: 233 KYDPNFTVY-EPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 7e-44
Identities = 62/285 (21%), Positives = 102/285 (35%), Gaps = 51/285 (17%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGH------KQWLAEVQFLGVVS 132
+G GGFGSVY G D VA+K + + + EV L VS
Sbjct: 11 LLGSGGFGSVYSGIRVS-DNL----PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 133 --HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAA 190
+++LL + D +L+ E + L +
Sbjct: 66 SGFSGVIRLLDWFERPD----SFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVL 120
Query: 191 EGLAYLHEGLEIQVIYRDFKTSNVLLDGN-FKPKLSDFGLAREGPTGDHTHVSTAVVGTY 249
E + + H V++RD K N+L+D N + KL DFG +T GT
Sbjct: 121 EAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF----DGTR 173
Query: 250 GYAAPEYIETGHLKSQS-DIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308
Y+ PE+I +S +WS G++LY+++ G E + + ++
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF----------- 222
Query: 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
F + ++ L CL P +RPT ++
Sbjct: 223 -FRQRVSSECQH------------LIRWCLALRPSDRPTFEEIQN 254
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-43
Identities = 64/298 (21%), Positives = 119/298 (39%), Gaps = 33/298 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQG--HKQWLAEVQFLGVVSHPNL 136
KIG+G FG V+K R G+ VA+KK+ + L E++ L ++ H N+
Sbjct: 17 KIGQGTFGEVFKARHRK-TGQ----KVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 137 VKLLGYCSTEDERGIQR----LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEG 192
V L+ C T+ + LV+++ + + TL R+
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-----MQML 126
Query: 193 LAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVS--TAVVGTYG 250
L L+ ++++RD K +NVL+ + KL+DFGLAR ++ + T V T
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 251 YAAPEYIETGHLKSQ-SDIWSFGVVLYEILTGRRVLERNRP------------TMEQKLL 297
Y PE + D+W G ++ E+ T +++ N ++ ++
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246
Query: 298 EWVKQFPADGK-KFSMMIDPRLRNQYSINAARRVAK-LADNCLKKNPEERPTMNQVVE 353
V + K + +++++ A L D L +P +R + +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-40
Identities = 59/289 (20%), Positives = 105/289 (36%), Gaps = 29/289 (10%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNL 136
KIGEG +G+V+K R +VA+K++ L E+ L + H N+
Sbjct: 9 KIGEGTYGTVFKAKNRE-THE----IVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 137 VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYL 196
V+L ++ + + V+E+ + + + +GL +
Sbjct: 64 VRLHDVLHSDKKLTL----VFEFCDQDLKKYFDSCNGDL--DPEIVKSFLFQLLKGLGFC 117
Query: 197 HEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEY 256
H V++RD K N+L++ N + KL++FGLAR + S VV +
Sbjct: 118 HS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVL 173
Query: 257 IETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ--KLLEWVKQFP---------- 304
+ D+WS G + E+ R L +Q ++ +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 305 ADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
D K + M L N LK NP +R + + ++
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-39
Identities = 70/283 (24%), Positives = 106/283 (37%), Gaps = 39/283 (13%)
Query: 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQFL 128
N F+ + +G+G FG V + GR A+K L + + + E + L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKA-TGR----YYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 129 GVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILG 188
HP L L T D EY L L + +
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFV----MEYANGGELFFHL--SRERVFTEERARFYGAE 113
Query: 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGT 248
L YLH V+YRD K N++LD + K++DFGL +EG + T GT
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGT 168
Query: 249 YGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLE-RNRPTMEQKLLEWVKQFPADG 307
Y APE +E D W GVV+YE++ GR ++ + + +L +FP
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT- 227
Query: 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQ 350
+ P ++ L LKK+P++R
Sbjct: 228 ------LSPEAKS------------LLAGLLKKDPKQRLGGGP 252
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-39
Identities = 59/292 (20%), Positives = 115/292 (39%), Gaps = 33/292 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNL 136
+G G +G+V G VA+KKL K+ E++ L + H N+
Sbjct: 25 PVGSGAYGAVCSAVDGR-TGA----KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 137 VKLLGYCSTEDERGIQR--LLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLA 194
+ LL + ++ LV +M +L L ++ +GL
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGT--DLGKLMKH--EKLGEDRIQFLVYQMLKGLR 135
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP 254
Y+H +I+RD K N+ ++ + + K+ DFGLAR+ + ++ VV + A
Sbjct: 136 YIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPE 188
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILTGRRVLE-RNRPTMEQKLLEWVKQFPAD------- 306
+ DIWS G ++ E++TG+ + + + +++++ PA+
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 248
Query: 307 -----GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVE 353
K ++ + NA+ L + L + E+R T + +
Sbjct: 249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 137 bits (345), Expect = 6e-38
Identities = 61/328 (18%), Positives = 115/328 (35%), Gaps = 50/328 (15%)
Query: 49 PELYKEKEHHLRVFDMQELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVK 108
P Y + E H+ + Q+ + + K+G G + V++ I + V VK
Sbjct: 18 PREYWDYESHVVEWGNQD------DYQLVRKLGRGKYSEVFEA-INITNNE----KVVVK 66
Query: 109 KLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLED 167
L K+ E++ L + PN++ L R LV+E++ N +
Sbjct: 67 ILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA--LVFEHVNNTDFKQ 121
Query: 168 RLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG-NFKPKLSD 226
TL + + L Y H + +++RD K NV++D + K +L D
Sbjct: 122 LY-----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLID 173
Query: 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQ-SDIWSFGVVLYEILTGRRVL 285
+GLA G +V V + + PE + + D+WS G +L ++ +
Sbjct: 174 WGLAEFYHPGQEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
Query: 286 ERNRPTMEQKLL-------EWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAK------ 332
+Q + E + + + ++S R
Sbjct: 231 FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHL 290
Query: 333 -------LADNCLKKNPEERPTMNQVVE 353
D L+ + + R T + +E
Sbjct: 291 VSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-36
Identities = 70/303 (23%), Positives = 115/303 (37%), Gaps = 44/303 (14%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNL 136
IG G G V LD VA+KKL+ K+ E+ + V+H N+
Sbjct: 24 PIGSGAQGIVCAAYDAVLD-----RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 137 VKLLGYCSTED--ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLA 194
+ LL + + E LV E M + + ++ G+
Sbjct: 79 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIK 133
Query: 195 YLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAP 254
+LH +I+RD K SN+++ + K+ DFGLAR T + + T V T Y AP
Sbjct: 134 HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAP 187
Query: 255 EYIETGHLKSQSDIWSFGVVLYEILTGR----------------RVLERNRPTMEQKLLE 298
E I K DIWS G ++ E++ + L P +KL
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247
Query: 299 WVKQFPADGKKFSMMIDPRLRNQYSINAARRVAK--------LADNCLKKNPEERPTMNQ 350
V+ + + K++ + P+L A K L L +P +R +++
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307
Query: 351 VVE 353
++
Sbjct: 308 ALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 1e-35
Identities = 68/299 (22%), Positives = 118/299 (39%), Gaps = 31/299 (10%)
Query: 69 EATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQ 126
E + + +G G +GSV G VAVKKL+ K+ E++
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTK-TGL----RVAVKKLSRPFQSIIHAKRTYRELR 69
Query: 127 FLGVVSHPNLVKLLGYCSTEDE-RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEI 185
L + H N++ LL + + + ++ L + + + L +
Sbjct: 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFL 126
Query: 186 ILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAV 245
I GL Y+H +I+RD K SN+ ++ + + K+ DFGLAR +V+T
Sbjct: 127 IYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT-- 181
Query: 246 VGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR------------RVLERNRPTME 293
+ A + H DIWS G ++ E+LTGR +++ R T
Sbjct: 182 --RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 239
Query: 294 QKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAK-LADNCLKKNPEERPTMNQV 351
+LL+ + A S+ P++ A +A L + L + ++R T Q
Sbjct: 240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-34
Identities = 64/279 (22%), Positives = 106/279 (37%), Gaps = 33/279 (11%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL----QGHKQWLAEVQFLGVVSH- 133
+G G +G V+ G+ + A+K L + + + E Q L +
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGK--LYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88
Query: 134 PNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGL 193
P LV L TE + + +Y+ L L R + T + + E +
Sbjct: 89 PFLVTLHYAFQTETKLHLI----LDYINGGELFTHLSQRERFTEHE-----VQIYVGEIV 139
Query: 194 AYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAA 253
L ++ +IYRD K N+LLD N L+DFGL++E D T + GT Y A
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEYMA 198
Query: 254 PEYIETGHLK--SQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311
P+ + G D WS GV++YE+LTG + + E ++ +
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD--GEKNSQAEISRRILKSEPPYP 256
Query: 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQ 350
+ ++ L L K+P++R
Sbjct: 257 QEMSALAKD------------LIQRLLMKDPKKRLGCGP 283
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (321), Expect = 3e-34
Identities = 72/319 (22%), Positives = 117/319 (36%), Gaps = 43/319 (13%)
Query: 32 NSALNRTARSLPSPRSIPELYKEKEHHLRVFDMQELREAT-NGFNRMLKIGEGGFGSVYK 90
N+A + S + L K KE L+ ++ A + F+R+ +G G FG V
Sbjct: 2 NAAAAKKGSEQESVKEF--LAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVML 59
Query: 91 GTIRPLDGRGEPLVVAVKKLNNHGLQGHKQW---LAEVQFLGVVSHPNLVKLLGYCSTED 147
+ G A+K L+ + KQ L E + L V+ P LVKL
Sbjct: 60 VKHKE-SGN----HYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114
Query: 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYR 207
+ V EY+ + L YLH + +IYR
Sbjct: 115 NLYM----VMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHS---LDLIYR 165
Query: 208 DFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSD 267
D K N+L+D +++DFG A+ T + GT APE I + D
Sbjct: 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVD 220
Query: 268 IWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAA 327
W+ GV++YE+ G ++P ++ E + + R + +S +
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQP---IQIYEKI-----------VSGKVRFPSHFSSDLK 266
Query: 328 RRVAKLADNCLKKNPEERP 346
L N L+ + +R
Sbjct: 267 D----LLRNLLQVDLTKRF 281
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (292), Expect = 3e-30
Identities = 58/317 (18%), Positives = 113/317 (35%), Gaps = 51/317 (16%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNL-- 136
K+G G F +V+ + VA+K + + + E++ L V+ +
Sbjct: 20 KLGWGHFSTVWLAKDMV-NNT----HVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTK 73
Query: 137 ---------VKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIIL 187
+KLL + + + G+ ++V+E + L + P +I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI-PLIYVKQISK 132
Query: 188 GAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN-FKPKLSDFGLAREGPTGDHTHVSTAVV 246
GL Y+H I I+ D K NVL++ L +A G + T +
Sbjct: 133 QLLLGLDYMHRRCGI--IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 247 GTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQ---- 302
T Y +PE + +DIWS +++E++TG + E + K + + Q
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 303 -------FPADGKKFSMMIDPR-------------------LRNQYSINAARRVAKLADN 336
+GK + R + ++S + A+ ++
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310
Query: 337 CLKKNPEERPTMNQVVE 353
L+ +P +R +V
Sbjct: 311 MLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.8 bits (196), Expect = 3e-18
Identities = 35/212 (16%), Positives = 65/212 (30%), Gaps = 39/212 (18%)
Query: 79 KIGEGGFGSVYKGTIRPLDGRGEPLVVAVK----------KLNNHGLQGHKQWLAEVQFL 128
+GEG +V+ + VK K+ G +
Sbjct: 7 LMGEGKESAVFNCY----SEKFGE--CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 129 GVVSHPNLVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILG 188
L KL G + Y + N L + + ++ + + E++
Sbjct: 61 ARNEFRALQKLQGLAVPKV---------YAWEGNAVLMELIDAKELYRVRVENPDEVLDM 111
Query: 189 AAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE-GPTGDHTHVSTAVVG 247
E +A + +++ D NVL+ + DF + E G G + V
Sbjct: 112 ILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRN 167
Query: 248 TYGYAAPEYIETGHLKSQSDIWSFGVVLYEIL 279
Y + Y +++ DI S + IL
Sbjct: 168 IITYFSRTY------RTEKDINS---AIDRIL 190
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 393 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.78 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.05 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.02 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.97 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.83 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.7 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-58 Score=412.86 Aligned_cols=258 Identities=24% Similarity=0.353 Sum_probs=209.4
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|++++.||+|+||+||+|+++.++ ..||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~-- 76 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTE-----EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-- 76 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT--
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc--
Confidence 457999999999999999999976544 4699999876532 23456889999999999999999999998876
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..|+||||+++|+|.+++ .....+++..++.++.||+.||+|||++ ||+||||||+|||+++++.+||+|||+
T Consensus 77 --~~~ivmEy~~gg~L~~~l--~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~ 149 (271)
T d1nvra_ 77 --IQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 149 (271)
T ss_dssp --EEEEEEECCTTEEGGGGS--BTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred --eeEEEEeccCCCcHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchh
Confidence 569999999999999998 4456799999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHL-KSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
|...............+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.......... ........
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~~~~~~~~---- 224 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDWKEKKT---- 224 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-HHHHTTCT----
T ss_pred heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-HHHhcCCC----
Confidence 987654443334556789999999999988776 578999999999999999999997654432221 11111100
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.......+++++.+|+.+||+.||++|||++++++|.|.
T Consensus 225 ----------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf 263 (271)
T d1nvra_ 225 ----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263 (271)
T ss_dssp ----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred ----------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 001112346788999999999999999999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-57 Score=408.41 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=213.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++++.||+|+||+||+|.+..++ ..||+|++........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~-----~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---- 90 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATG-----QEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD---- 90 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTC-----CEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred cccEEEEEEecCcCcEEEEEEECCCC-----CEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC----
Confidence 47999999999999999999965443 469999997665556678899999999999999999999998877
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
..|+||||++||+|.+++.. ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||+|.
T Consensus 91 ~~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 91 ELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp EEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhhe
Confidence 56999999999999998754 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (393)
....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||......... .........
T Consensus 165 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~~~~~~------ 234 (293)
T d1yhwa1 165 QITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIATNGTP------ 234 (293)
T ss_dssp ECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHHHHCSC------
T ss_pred eeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH--HHHHhCCCC------
Confidence 7543322 235568999999999999999999999999999999999999999765443221 111111100
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
....+..++.++.+||.+||++||++|||+.|+++|.|.-
T Consensus 235 -------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~ 274 (293)
T d1yhwa1 235 -------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274 (293)
T ss_dssp -------CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGG
T ss_pred -------CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhC
Confidence 0111224568899999999999999999999999998764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-57 Score=403.82 Aligned_cols=252 Identities=28% Similarity=0.452 Sum_probs=210.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC---CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH---GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++.+.||+|+||+||+|+++.++ ..||+|++.+. .......+.+|+.+++.++||||+++++++.+++
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~- 79 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSK-----FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT- 79 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCC-----cEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC-
Confidence 56999999999999999999976443 46999998643 2234567889999999999999999999998776
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||
T Consensus 80 ---~~~ivmEy~~~g~L~~~l~~--~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG 151 (263)
T d2j4za1 80 ---RVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 151 (263)
T ss_dssp ---EEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred ---EEEEEEeecCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccc
Confidence 56999999999999999954 34689999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+|....... .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||........ . .......
T Consensus 152 ~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~-~~i~~~~---- 220 (263)
T d2j4za1 152 WSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--Y-KRISRVE---- 220 (263)
T ss_dssp SCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H-HHHHTTC----
T ss_pred eeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH--H-HHHHcCC----
Confidence 998654332 2456899999999999999999999999999999999999999976543221 1 1111110
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
...+..+++++.+|+.+||++||++|||++|+++|.|..-
T Consensus 221 -----------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 221 -----------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -----------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 0112235678999999999999999999999999998753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-56 Score=400.22 Aligned_cols=262 Identities=30% Similarity=0.453 Sum_probs=205.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|++.+.||+|+||+||+|++. . .||||++... .....+.+.+|+.++++++|||||++++++...
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~-----~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~-- 76 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---G-----DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-- 76 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---S-----EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS--
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---C-----EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc--
Confidence 357999999999999999999743 1 2999998754 234456788999999999999999999987543
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
.+++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 77 ---~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFG 149 (276)
T d1uwha_ 77 ---QLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFG 149 (276)
T ss_dssp ---SCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred ---EEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccc
Confidence 3489999999999999996443 4589999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIET---GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
+|+...............||+.|+|||++.+ ..|+.++|||||||++|||+||+.||.......... ........
T Consensus 150 la~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~--~~~~~~~~ 227 (276)
T d1uwha_ 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII--FMVGRGYL 227 (276)
T ss_dssp CSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHHHTSC
T ss_pred ceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH--HHHhcCCC
Confidence 9987654444334456789999999999864 358999999999999999999999998755432221 11111100
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
. + .....+..+++++.+|+.+||+.||++|||+.+++++|+.+.+.
T Consensus 228 ~---------p-~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 228 S---------P-DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp C---------C-CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred C---------C-cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 0 0 01112234568899999999999999999999999999988753
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-57 Score=405.29 Aligned_cols=259 Identities=23% Similarity=0.343 Sum_probs=197.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|++++.||+|+||+||+|+++.++ ..||+|.+..... .....+.+|+++++.++||||+++++++.+....
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 78 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDG-----KILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCC-----CEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCC
Confidence 57999999999999999999976544 4699999876532 3345678999999999999999999998765433
Q ss_pred cceEEEEEeecCCCChHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHhhcCC--CCCeEeccCCCCCeEeCCCCceEEe
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFS--RAQPTLPWKTRLEIILGAAEGLAYLHEGL--EIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~ql~~~l~~LH~~~--~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
.+|+||||+++|+|.+++.. .....+++..++.++.||+.||.|||+.. ..+|+||||||+|||++.+|.+||+
T Consensus 79 --~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~ 156 (269)
T d2java1 79 --TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 156 (269)
T ss_dssp --CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred --EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEe
Confidence 56999999999999999853 23467999999999999999999999861 0139999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
|||+++...... ......+||+.|+|||++.+..|+.++|||||||++|||+||+.||...+... +.........
T Consensus 157 DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~~i~~~~~ 231 (269)
T d2java1 157 DFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKIREGKF 231 (269)
T ss_dssp CHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHTCC
T ss_pred eccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHHHHHcCCC
Confidence 999998754322 22345789999999999999999999999999999999999999997654322 1111111100
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
...+..+++++.+|+.+||+.||++|||+.|+++|.|
T Consensus 232 --------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~ 268 (269)
T d2java1 232 --------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268 (269)
T ss_dssp --------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred --------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence 0112235678999999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=405.13 Aligned_cols=256 Identities=23% Similarity=0.388 Sum_probs=210.8
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
+.|++++.||+|+||+||+|.+..++ ..||+|++........+.+.+|+++|+.++|||||++++++.+.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---- 82 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETS-----VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN---- 82 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT----
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCC-----eEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC----
Confidence 46899999999999999999976444 469999998776666778899999999999999999999998877
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.+++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||+|||+|.
T Consensus 83 ~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 83 NLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp EEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhh
Confidence 5699999999999999875443 4599999999999999999999999 99999999999999999999999999997
Q ss_pred cCCCCCCccccccccccCCccCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIE-----TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
..... ........||+.|+|||++. +..|+.++|||||||++|||+||+.||........ +.......+.
T Consensus 159 ~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~~~i~~~~~~- 233 (288)
T d2jfla1 159 KNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--LLKIAKSEPP- 233 (288)
T ss_dssp ECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHHHHSCCC-
T ss_pred ccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--HHHHHcCCCC-
Confidence 53221 11234578999999999984 45689999999999999999999999986544322 2222211110
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
....+..+++++.+||.+||+.||++|||+.|+++|.|.
T Consensus 234 ------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~ 272 (288)
T d2jfla1 234 ------------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272 (288)
T ss_dssp ------------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred ------------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 011122456889999999999999999999999999765
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-56 Score=404.70 Aligned_cols=260 Identities=27% Similarity=0.433 Sum_probs=214.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.+.||+|+||+||+|.+..+ +..||+|++.... ...+++.+|+.+|+.++|||||++++++.+.+.
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~--- 87 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKY-----SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP--- 87 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGG-----TEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS---
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCC-----CeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCe---
Confidence 4688999999999999999997643 3569999997654 446778999999999999999999999987764
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.++||||+++|+|.+++.......+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+
T Consensus 88 -~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 88 -FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp -CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred -eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccccee
Confidence 49999999999999999877777899999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (393)
....... .......|++.|+|||++.+..|+.++|||||||++|||++|..||........ +......
T Consensus 164 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~~i~~--------- 231 (287)
T d1opja_ 164 LMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELLEK--------- 231 (287)
T ss_dssp TCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHHT---------
T ss_pred ecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHHHHhc---------
Confidence 7544322 233445689999999999999999999999999999999997776654433221 1111111
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
..+...+..+++++.+|+.+||+.||++|||+.++++.|+.+.++
T Consensus 232 -----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 232 -----DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred -----CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 111222334568899999999999999999999999999887653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-55 Score=400.10 Aligned_cols=264 Identities=25% Similarity=0.445 Sum_probs=203.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|++.++||+|+||+||+|.++.++ .....||+|.+..... ...+.+.+|+++|++++|||||++++++...+.
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-- 101 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPG--KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP-- 101 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS--
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCC--CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE--
Confidence 56888899999999999999976433 2345789999876433 345678999999999999999999999987764
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
.++||||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 102 --~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 102 --VMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp --CEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred --EEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccc
Confidence 49999999999999988543 34689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCcc---ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 231 REGPTGDHTH---VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 231 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
+......... ......||+.|+|||.+.+..++.++|||||||++|||+| |..||....... +......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~~i~~---- 248 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VINAIEQ---- 248 (299)
T ss_dssp --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHT----
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----
Confidence 8754332221 1223467899999999999999999999999999999998 899998654432 2121111
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
..+...+..++.++.+|+.+||+.||++|||+.++++.|+.++++.
T Consensus 249 ----------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 249 ----------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp ----------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ----------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 0111123345688999999999999999999999999999988754
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=410.72 Aligned_cols=272 Identities=26% Similarity=0.392 Sum_probs=209.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|++++.||+|+||+||+|++.. ++..||+|++.... ......+.+|+.+|+.++|||||+++++|...+
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 77 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKP-----SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-- 77 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETT-----TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS--
T ss_pred ccCCEEEEEEecCCCeEEEEEEECC-----CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence 4679999999999999999999754 34579999987653 233467889999999999999999999998877
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE-GLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..|+||||++||+|.+++... ..+++..++.++.|++.||.|||+ + ||+||||||+|||++++|.+||+|||
T Consensus 78 --~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFG 150 (322)
T d1s9ja_ 78 --EISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG 150 (322)
T ss_dssp --EEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred --EEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCC
Confidence 569999999999999999543 468999999999999999999996 6 89999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHH-HhhcCc--
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW-VKQFPA-- 305 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~-~~~~~~-- 305 (393)
+|..... ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||........+..... ....+.
T Consensus 151 la~~~~~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
T d1s9ja_ 151 VSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226 (322)
T ss_dssp CCHHHHH----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------
T ss_pred CccccCC----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccC
Confidence 9975422 123456899999999999999999999999999999999999999976544322111000 000000
Q ss_pred --C----Ccccc-------------c----ccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 306 --D----GKKFS-------------M----MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 306 --~----~~~~~-------------~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
. ..... . ..............+.++.+|+.+||+.||++|||++|+++|.|....
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0 00000 0 000000000111245789999999999999999999999999887543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-56 Score=410.18 Aligned_cols=263 Identities=24% Similarity=0.402 Sum_probs=215.2
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcC-CCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 149 (393)
++|++.+.||+|+||+||+|++...+.......||+|.+.... ......+.+|+.++.++ +|||||++++++...+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~- 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP- 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe-
Confidence 5699999999999999999999877777777889999986543 23446688999999998 79999999999988774
Q ss_pred cceEEEEEeecCCCChHHHHhhcCC---------------------CCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEecc
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQ---------------------PTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRD 208 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~D 208 (393)
+++||||+++|+|.++|..... ..+++..++.++.|++.||+|||++ +|+|||
T Consensus 116 ---~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 116 ---IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp ---CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred ---EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 4999999999999999965432 3588999999999999999999999 999999
Q ss_pred CCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCC
Q 035862 209 FKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLER 287 (393)
Q Consensus 209 ikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~ 287 (393)
|||+|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |..||..
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987555444434456678999999999999999999999999999999998 8999976
Q ss_pred CCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 288 NRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
...... +...... ..+...+..+++++.+||.+||+.||++|||+++|+++|..
T Consensus 270 ~~~~~~--~~~~~~~--------------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 270 IPVDAN--FYKLIQN--------------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CCCSHH--HHHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHH--HHHHHhc--------------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 543221 1221111 11112233456889999999999999999999999999953
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-56 Score=396.95 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=201.0
Q ss_pred cccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccce
Q 035862 75 NRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQ 152 (393)
Q Consensus 75 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 152 (393)
++..+||+|+||+||+|.+..++ ..||+|.+.... ......+.+|+++|++++|||||++++++.........
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~-----~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETT-----VEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred EeeeEEecCcCcEEEEEEECCCC-----eEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 56678999999999999976443 469999987542 23345688999999999999999999998764443446
Q ss_pred EEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCC--eEeccCCCCCeEeC-CCCceEEeeccC
Q 035862 153 RLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQ--VIYRDFKTSNVLLD-GNFKPKLSDFGL 229 (393)
Q Consensus 153 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~--ivH~Dikp~NIll~-~~~~~kl~Dfg~ 229 (393)
+++||||+++|+|.+++... ..+++..++.++.||+.||+|||++ + |+||||||+|||++ +++.+||+|||+
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 79999999999999999543 4689999999999999999999998 7 99999999999996 579999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+...... .....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.......+ +.........
T Consensus 162 a~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~~i~~~~~---- 230 (270)
T d1t4ha_ 162 ATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTSGVK---- 230 (270)
T ss_dssp GGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHTTTCC----
T ss_pred ceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHHHHHcCCC----
Confidence 9764322 2345689999999999865 599999999999999999999999976543222 1111111000
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
....+...++++.+||.+||++||++|||+.|+++|.|
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 231 ---------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268 (270)
T ss_dssp ---------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred ---------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence 01111223567899999999999999999999999876
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-56 Score=403.92 Aligned_cols=253 Identities=19% Similarity=0.267 Sum_probs=204.6
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++++.||+|+||+||+|.+..++ ..||+|++.+.. ......+.+|+++++.++||||+++++++.+++
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~- 81 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATS-----REYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE- 81 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS-
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCC-----CEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC-
Confidence 46999999999999999999976544 469999986432 234467889999999999999999999998776
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..|+||||++||+|.+++... ..+++..++.++.|++.||+|||++ +|+||||||+|||++++|.+||+|||
T Consensus 82 ---~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG 153 (288)
T d1uu3a_ 82 ---KLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 153 (288)
T ss_dssp ---EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred ---EEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccc
Confidence 569999999999999988543 5689999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+|+..............+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..... ...... ..
T Consensus 154 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~--~~i~~~-~~--- 227 (288)
T d1uu3a_ 154 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF--QKIIKL-EY--- 227 (288)
T ss_dssp TCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHTT-CC---
T ss_pred cceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH--HHHHcC-CC---
Confidence 998765444333445678999999999999999999999999999999999999999865433211 111110 00
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLK 356 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~ 356 (393)
..+..+++++.+||.+||+.||++|||++|++++.+
T Consensus 228 ------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 228 ------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp ------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred ------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 112234678999999999999999999999766655
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-55 Score=393.53 Aligned_cols=256 Identities=29% Similarity=0.458 Sum_probs=198.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.+.||+|+||+||+|.+.. +..||||++.... ...+.+.+|+++++.++||||+++++++...+.
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~------~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~--- 74 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN------KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP--- 74 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT------TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS---
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC------CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCc---
Confidence 468899999999999999998752 2359999998654 445778999999999999999999999987764
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+++
T Consensus 75 -~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 149 (263)
T d1sm2a_ 75 -ICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR 149 (263)
T ss_dssp -CEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred -eEEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchhe
Confidence 49999999999999988543 35688999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhC-CCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTG-RRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ ......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||....... +.......
T Consensus 150 ~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~~i~~~------- 218 (263)
T d1sm2a_ 150 FVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTG------- 218 (263)
T ss_dssp ----------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHHHHHHT-------
T ss_pred eccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHHHHHhc-------
Confidence 65443222 23346789999999999999999999999999999999995 55554433211 11111110
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
.+...+..+++++.+|+.+||+.||++|||+++++++|+++.+
T Consensus 219 -------~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 219 -------FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 0111122345789999999999999999999999999999865
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-55 Score=402.23 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=194.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.+.|++.+.||+|+||+||+|.++.++ ..||+|++..... .....+.+|+.+|+.++||||+++++++.+.+
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 80 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQ-----KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG-- 80 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTC-----CEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS--
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCC-----CEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC--
Confidence 467999999999999999999976444 4699999876532 23355778999999999999999999998776
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC---CCCceEEee
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD---GNFKPKLSD 226 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~---~~~~~kl~D 226 (393)
.+|+||||++||+|.+++. ....+++..+..++.||+.||+|||++ +|+||||||+|||+. +++.+||+|
T Consensus 81 --~~~lvmE~~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 81 --HLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp --EEEEEECCCCSCBHHHHHH--TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred --EEEEEEeccCCCcHHHhhh--cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEec
Confidence 5699999999999999994 456799999999999999999999999 999999999999994 578999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
||++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||......... ........
T Consensus 154 FG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~--~~i~~~~~-- 226 (307)
T d1a06a_ 154 FGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF--EQILKAEY-- 226 (307)
T ss_dssp C---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHTTCC--
T ss_pred cceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH--HHHhccCC--
Confidence 99998654332 234568999999999999999999999999999999999999999865433211 11111100
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.........+++++.+||.+||++||++|||+.|+++|.|.
T Consensus 227 ----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 267 (307)
T d1a06a_ 227 ----------EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267 (307)
T ss_dssp ----------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTT
T ss_pred ----------CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 01111122456889999999999999999999999999775
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-55 Score=393.28 Aligned_cols=264 Identities=25% Similarity=0.420 Sum_probs=211.6
Q ss_pred cCCcccc-eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRML-KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|.+.. +||+|+||+||+|.++.. ..+..||||++.... ....+.+.+|+++|++++|||||++++++..+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~---~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--- 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMR---KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE--- 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS---
T ss_pred cCeEECCcEEecccCeEEEEEEEecC---CCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC---
Confidence 3566666 499999999999987532 345679999997653 23456789999999999999999999998653
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
.+++||||+++|+|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 82 --~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 82 --ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp --SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred --eEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchh
Confidence 358999999999999987433 35689999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCcc-ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 230 AREGPTGDHTH-VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 230 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
++......... ......||+.|+|||++.+..++.++|||||||++|||+| |..||........ ......
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~---~~~i~~----- 227 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAFIEQ----- 227 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HHHHHT-----
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH---HHHHHc-----
Confidence 98765433222 2334578999999999999999999999999999999998 8999986543321 111111
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcC
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 364 (393)
..+...+..+++++.+||.+||+.||++|||+.++.+.|+........
T Consensus 228 ---------~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 228 ---------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp ---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred ---------CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence 111122334668899999999999999999999999988877654433
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.1e-55 Score=405.47 Aligned_cols=258 Identities=22% Similarity=0.324 Sum_probs=212.7
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++++.||+|+||+||+|+++.+ +..||+|++........+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~-----g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--- 96 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERAT-----GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN--- 96 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT-----TEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT---
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCC-----CCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC---
Confidence 46899999999999999999997543 4569999998776666677889999999999999999999998876
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC--CCceEEeecc
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG--NFKPKLSDFG 228 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~--~~~~kl~Dfg 228 (393)
.+|+|||||+||+|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++. ++.+||+|||
T Consensus 97 -~~~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG 171 (350)
T d1koaa2 97 -EMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 171 (350)
T ss_dssp -EEEEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred -EEEEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecc
Confidence 569999999999999988543 34699999999999999999999999 9999999999999964 5889999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
++....... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||........ +...... ..
T Consensus 172 ~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--~~~i~~~-~~--- 242 (350)
T d1koaa2 172 LTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET--LRNVKSC-DW--- 242 (350)
T ss_dssp TCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHT-CC---
T ss_pred hheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH--HHHHHhC-CC---
Confidence 998754432 23456899999999999999999999999999999999999999976543221 1111111 00
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.........+++++.+||.+||+.||++|||+.|+++|.|..
T Consensus 243 --------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~ 284 (350)
T d1koaa2 243 --------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 284 (350)
T ss_dssp --------CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTS
T ss_pred --------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 001111123567899999999999999999999999997753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-55 Score=393.41 Aligned_cols=259 Identities=29% Similarity=0.443 Sum_probs=209.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++.+.||+|+||+||+|.++. +..||||++.... ...+.+.+|+.++++++|||||++++++..+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~------~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~---- 80 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNG------HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE---- 80 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT------TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred HHHeEEeEEEecCCCcEEEEEEECC------CCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeeccC----
Confidence 3578999999999999999999642 3469999997654 4457789999999999999999999987543
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+++|+|.+++.......+++..++.++.||+.||.|||++ +|+||||||+||||++++.+||+|||+|
T Consensus 81 -~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 81 -PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp -SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred -CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccce
Confidence 248999999999999988655555689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
+....... .......||+.|+|||++.+..++.++|||||||++|||+||..|+.......+ .......
T Consensus 157 ~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~--~~~~i~~-------- 225 (272)
T d1qpca_ 157 RLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNLER-------- 225 (272)
T ss_dssp EECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHT--------
T ss_pred EEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH--HHHHHHh--------
Confidence 87644322 233456789999999999999999999999999999999996655543332221 1111111
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
..+...+..+++++.+|+.+||+.||++|||+.++++.|+.....
T Consensus 226 ------~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 226 ------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 011112234567899999999999999999999999999887653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.8e-55 Score=404.31 Aligned_cols=257 Identities=21% Similarity=0.340 Sum_probs=212.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.++|++++.||+|+||+||+|.+..++ ..||+|++..........+.+|+.+|+.++|||||++++++.+++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~--- 99 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATG-----RVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY--- 99 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS---
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC---
Confidence 457999999999999999999976444 469999998776556667889999999999999999999998776
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeC--CCCceEEeecc
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLD--GNFKPKLSDFG 228 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~--~~~~~kl~Dfg 228 (393)
.+|+|||||+||+|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||
T Consensus 100 -~~~ivmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFG 174 (352)
T d1koba_ 100 -EMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 174 (352)
T ss_dssp -EEEEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred -EEEEEEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecc
Confidence 56999999999999987743 334699999999999999999999999 999999999999997 67899999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+|....... ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.......... . ......
T Consensus 175 la~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~--~-i~~~~~--- 245 (352)
T d1koba_ 175 LATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ--N-VKRCDW--- 245 (352)
T ss_dssp TCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH--H-HHHCCC---
T ss_pred cceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHhCCC---
Confidence 998765432 2345689999999999999999999999999999999999999998654432211 1 111100
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.........+++++.+||.+||++||.+|||+.|+++|.|.
T Consensus 246 --------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~ 286 (352)
T d1koba_ 246 --------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWL 286 (352)
T ss_dssp --------CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred --------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 01111122356889999999999999999999999998764
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=389.34 Aligned_cols=252 Identities=27% Similarity=0.415 Sum_probs=201.5
Q ss_pred ceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEE
Q 035862 78 LKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLL 155 (393)
Q Consensus 78 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~l 155 (393)
++||+|+||+||+|.++. ......||+|++.... ....+.+.+|+.+|++++|||||++++++..+. .++
T Consensus 13 k~iG~G~fG~Vy~~~~~~---~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~-----~~l 84 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQM---KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-----WML 84 (277)
T ss_dssp EEEEECSSEEEEEEEEEC---SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSS-----EEE
T ss_pred CCcccCCCeEEEEEEEcc---CCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCC-----EEE
Confidence 469999999999998753 3355789999987542 233467899999999999999999999986442 489
Q ss_pred EEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCC
Q 035862 156 VYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPT 235 (393)
Q Consensus 156 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 235 (393)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 vmE~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~ 159 (277)
T d1xbba_ 85 VMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 159 (277)
T ss_dssp EEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEcCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccc
Confidence 9999999999999854 45689999999999999999999998 999999999999999999999999999987544
Q ss_pred CCCcc-ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 236 GDHTH-VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 236 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
..... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||....... +......
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~~i~~----------- 225 (277)
T d1xbba_ 160 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEK----------- 225 (277)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHT-----------
T ss_pred cccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HHHHHHc-----------
Confidence 33222 2344678999999999999999999999999999999998 899998654332 1121111
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
..+...+..++.++.+|+.+||+.||++|||+.++++.|....
T Consensus 226 ---~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 226 ---GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 1111223345688999999999999999999999987776554
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.5e-55 Score=396.45 Aligned_cols=250 Identities=29% Similarity=0.404 Sum_probs=204.7
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.|+.++.||+|+||+||+|++..+ +..||+|++..... ...+.+.+|+.+|+.++|||||++++++.+.+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-- 88 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRN-----SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-- 88 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTT-----TEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred hcEeeEEEecCCCeEEEEEEECCC-----CcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC--
Confidence 499999999999999999997543 45799999876543 23356789999999999999999999998776
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++|||||.+|+|..++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 89 --~~~iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~ 161 (309)
T d1u5ra_ 89 --TAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGS 161 (309)
T ss_dssp --EEEEEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred --EEEEEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeeccc
Confidence 56999999999999776633 35689999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCcccccc---CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIET---GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
|..... .....||+.|+|||++.+ ..|+.++|||||||++|||++|..||........ +........
T Consensus 162 a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~--~~~i~~~~~-- 231 (309)
T d1u5ra_ 162 ASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQNES-- 231 (309)
T ss_dssp CBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSCC--
T ss_pred ccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHhCCC--
Confidence 986432 234689999999999864 4689999999999999999999999976544321 111111100
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
....+..+++++.+||.+||+.||++|||+.++++|.|..
T Consensus 232 ------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~ 271 (309)
T d1u5ra_ 232 ------------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (309)
T ss_dssp ------------CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred ------------CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhc
Confidence 0001123467899999999999999999999999998764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=399.13 Aligned_cols=253 Identities=26% Similarity=0.349 Sum_probs=210.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|++++.||+|+||.||+|++..++ ..||+|++.+.. ......+.+|+.+|+.++||||+++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~-----~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATG-----RYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence 467999999999999999999976444 469999997532 234567889999999999999999999999877
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
.+|+||||++||+|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+||
T Consensus 79 ----~~~iv~ey~~gg~L~~~~~~--~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DF 149 (337)
T d1o6la_ 79 ----RLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp ----EEEEEEECCTTCBHHHHHHH--HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ----ccccceeccCCCchhhhhhc--ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeec
Confidence 66999999999999999854 35689999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|+|+....... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||...+..... .......
T Consensus 150 G~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~---~~i~~~~--- 221 (337)
T d1o6la_ 150 GLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF---ELILMEE--- 221 (337)
T ss_dssp TTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHCC---
T ss_pred ccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH---HHHhcCC---
Confidence 99986543222 345678999999999999999999999999999999999999999876543221 1111110
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT-----MNQVVESLKL 357 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~~l~~l~~ 357 (393)
...+..++.++.+||.+||++||.+|++ ++++++|.|.
T Consensus 222 ------------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f 264 (337)
T d1o6la_ 222 ------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264 (337)
T ss_dssp ------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred ------------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccc
Confidence 0112235678999999999999999994 9999999764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=390.44 Aligned_cols=267 Identities=25% Similarity=0.430 Sum_probs=205.6
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+.|++.++||+|+||+||+|.++..+ ......||||++..... .....+.+|+.++++++|||||++++++...+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~--- 82 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSS-GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK--- 82 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS---
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCC-CEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC---
Confidence 45888899999999999999987543 23456799999976433 33456889999999999999999999998776
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.+++|.+++... ...+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||++
T Consensus 83 -~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla 157 (283)
T d1mqba_ 83 -PMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLS 157 (283)
T ss_dssp -SEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred -ceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchh
Confidence 459999999999999877543 35689999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCCCCc-cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHT-HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+........ .......||+.|+|||++.+..++.++|||||||++|||++|..|+....... .+......
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~~~~i~~------- 228 (283)
T d1mqba_ 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMKAIND------- 228 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHT-------
T ss_pred hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--HHHHHHhc-------
Confidence 875433222 12334578999999999999999999999999999999999766654433221 11221111
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
..+...+..++.++.+|+.+||+.||++|||+.++++.|+.+++..+
T Consensus 229 -------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 229 -------GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp -------TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred -------cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence 11122233456789999999999999999999999999999887543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-54 Score=383.40 Aligned_cols=253 Identities=28% Similarity=0.444 Sum_probs=209.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.++||+|+||+||+|+++ ++..||||.++... ...+.+.+|+.+++.++||||+++++++..++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~---- 72 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR------GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR---- 72 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET------TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSS----
T ss_pred HHCEEeEEEecCCCeEEEEEEEC------CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCC----
Confidence 57999999999999999999974 23469999998754 34577899999999999999999999998766
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.+++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ ||+||||||+|||+++++.+||+|||+++
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 148 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred ceEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhhe
Confidence 4599999999999999875443 4588999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......... ..... +
T Consensus 149 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~---~~i~~----~--- 217 (258)
T d1k2pa_ 149 YVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---EHIAQ----G--- 217 (258)
T ss_dssp BCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH---HHHHT----T---
T ss_pred eccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHH---HHHHh----C---
Confidence 65443322 3345678999999999999999999999999999999998 89999866543221 11111 0
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.+...+..+++++.+||.+||+.||++|||+.+++++|.+
T Consensus 218 -------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 218 -------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -------CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 1111222455789999999999999999999999999853
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=392.64 Aligned_cols=257 Identities=24% Similarity=0.356 Sum_probs=209.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc------ccHHHHHHHHHHhhcCCCCccceeeeeee
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL------QGHKQWLAEVQFLGVVSHPNLVKLLGYCS 144 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 144 (393)
.++|++++.||+|+||+||+|+++.++ ..||+|++.+... ...+.+.+|+.+|+.++|||||++++++.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~-----~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTG-----LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTC-----CEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCC-----CEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 367999999999999999999976444 4699999865322 23567889999999999999999999998
Q ss_pred cCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC----
Q 035862 145 TEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF---- 220 (393)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~---- 220 (393)
+.+ .+|+|||||++|+|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++
T Consensus 84 ~~~----~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~ 154 (293)
T d1jksa_ 84 NKT----DVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP 154 (293)
T ss_dssp CSS----EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSC
T ss_pred ECC----EEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCccc
Confidence 876 569999999999999999543 4699999999999999999999999 999999999999998877
Q ss_pred ceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHH
Q 035862 221 KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWV 300 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~ 300 (393)
.+||+|||++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... .
T Consensus 155 ~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--~~~-i 228 (293)
T d1jksa_ 155 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LAN-V 228 (293)
T ss_dssp CEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-H
T ss_pred ceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH--HHH-H
Confidence 49999999998754433 23456899999999999999999999999999999999999999986543221 111 1
Q ss_pred hhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 301 KQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
..... .........++.++.+||.+||+.||++|||++++++|.|..
T Consensus 229 ~~~~~-----------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 275 (293)
T d1jksa_ 229 SAVNY-----------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275 (293)
T ss_dssp HTTCC-----------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTC
T ss_pred HhcCC-----------CCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 11100 011111123467899999999999999999999999998763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-54 Score=393.48 Aligned_cols=270 Identities=26% Similarity=0.356 Sum_probs=209.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcC-CCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 148 (393)
.++|++.++||+|+||.||+|.+.........+.||+|++..... ...+.+.+|..++.++ +|+||+.+++++...+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 467999999999999999999998777777788999999975432 3345677788877776 58999999998876553
Q ss_pred ccceEEEEEeecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCe
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRA--------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNV 214 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NI 214 (393)
.+++|||||++|+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+||
T Consensus 92 ---~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NI 165 (299)
T d1ywna1 92 ---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 165 (299)
T ss_dssp ---CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred ---eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccce
Confidence 4589999999999999996432 23588999999999999999999999 999999999999
Q ss_pred EeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCC-CccCCCCchhh
Q 035862 215 LLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR-RVLERNRPTME 293 (393)
Q Consensus 215 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~-~pf~~~~~~~~ 293 (393)
|+++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+||. +||........
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999998765544444455678999999999999999999999999999999999875 57765433221
Q ss_pred hHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 294 QKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
+....... .+...+..+++++.+|+.+||+.||++|||+.++++||+.+++.+
T Consensus 246 --~~~~~~~~--------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 246 --FCRRLKEG--------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp --HHHHHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --HHHHHhcC--------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 11111110 111122235678999999999999999999999999999988643
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-54 Score=392.98 Aligned_cols=264 Identities=25% Similarity=0.401 Sum_probs=209.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.+|+++++||+|+||+||+|.+..++ +.....||+|.+... .....+.+.+|+.+++.++|||||++++++.+.+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~--- 84 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEG-EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--- 84 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS---
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCC-CEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 46999999999999999999986544 234457899998654 3345677899999999999999999999998654
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
.+++|||+.+++|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 85 --~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla 158 (317)
T d1xkka_ 85 --VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 158 (317)
T ss_dssp --EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred --eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccc
Confidence 37889999999999987654 45689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+...............||+.|+|||++.+..|+.++|||||||++|||+| |.+||............. .
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~---~------- 228 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---K------- 228 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH---H-------
T ss_pred eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---c-------
Confidence 87655444444455678999999999999999999999999999999998 788887654332221111 1
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
..+...+..++.++.+|+.+||+.||++|||+.+++++|+.+.++.
T Consensus 229 -------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~ 274 (317)
T d1xkka_ 229 -------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274 (317)
T ss_dssp -------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred -------CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence 1111222345678999999999999999999999999999887654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=383.92 Aligned_cols=262 Identities=26% Similarity=0.375 Sum_probs=202.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|++.+.||+|+||.||+|.+...+ .....||+|.+..... .....+.+|+.+++.++||||+++++++.. +
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~--~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~--- 80 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPE--NPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-N--- 80 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S---
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCC--ceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C---
Confidence 57999999999999999999876432 3456799999875433 335668899999999999999999999854 2
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
.+++||||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+||++++++.+||+|||++
T Consensus 81 -~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a 155 (273)
T d1mp8a_ 81 -PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 155 (273)
T ss_dssp -SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----
T ss_pred -eEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhh
Confidence 349999999999999987543 45689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCcc
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKK 309 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (393)
+....... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.......... .... +
T Consensus 156 ~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~---~i~~----~-- 225 (273)
T d1mp8a_ 156 RYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RIEN----G-- 225 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---HHHT----T--
T ss_pred eeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH---HHHc----C--
Confidence 87543322 23345678999999999999999999999999999999998 899997665432211 1111 0
Q ss_pred cccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 310 FSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
.+...+..+++++.+||.+||+.||++|||+.+++++|..++++.
T Consensus 226 --------~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 226 --------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp --------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 011123345688999999999999999999999999999987654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.6e-54 Score=391.57 Aligned_cols=249 Identities=25% Similarity=0.384 Sum_probs=207.4
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC---CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH---GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++++.||+|+||+||+|+++.++ ..||+|++.+. .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~- 77 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNG-----RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ- 77 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCC-----CEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC-
Confidence 56999999999999999999976443 46999998643 2234567889999999999999999999998776
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
.+|+||||+.||+|..++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+||+|||
T Consensus 78 ---~~~ivmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG 149 (316)
T d1fota_ 78 ---QIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG 149 (316)
T ss_dssp ---EEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred ---eeeeEeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCc
Confidence 66999999999999998843 45678899999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+|...... ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+...... ..... .
T Consensus 150 ~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~i~~~-~---- 217 (316)
T d1fota_ 150 FAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE--KILNA-E---- 217 (316)
T ss_dssp SCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--HHHHC-C----
T ss_pred cceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH--HHHcC-C----
Confidence 99875432 235689999999999999999999999999999999999999998654432211 11111 0
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKL 357 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~ 357 (393)
...+..+++++.+++.+||.+||.+|+ |++++++|.|.
T Consensus 218 -----------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f 260 (316)
T d1fota_ 218 -----------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260 (316)
T ss_dssp -----------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred -----------CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccc
Confidence 011223457899999999999999996 99999999763
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-53 Score=388.04 Aligned_cols=266 Identities=28% Similarity=0.409 Sum_probs=216.0
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-cHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
..++|++++.||+|+||+||+|+++......++..||||++...... ...++.+|+.+|+.++||||+++++++...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 35679999999999999999999876666667788999999765433 35678999999999999999999999987764
Q ss_pred ccceEEEEEeecCCCChHHHHhhcC----------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEe
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRA----------------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIY 206 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH 206 (393)
.++||||+.+|+|.+++.... ...+++..++.++.|++.||+|||++ +|+|
T Consensus 91 ----~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH 163 (301)
T d1lufa_ 91 ----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 163 (301)
T ss_dssp ----CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred ----eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence 499999999999999996432 23478899999999999999999999 9999
Q ss_pred ccCCCCCeEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCC-Ccc
Q 035862 207 RDFKTSNVLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR-RVL 285 (393)
Q Consensus 207 ~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~-~pf 285 (393)
|||||+|||++.++.+||+|||+|+...............|++.|+|||++.+..|+.++|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999997654443333445667899999999999999999999999999999999986 567
Q ss_pred CCCCchhhhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 286 ERNRPTMEQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
........ ...+.... ....+..++.++.+|+.+||+.||++|||+.+|++.|+++.
T Consensus 244 ~~~~~~e~---~~~v~~~~--------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEEV---IYYVRDGN--------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHHH---HHHHHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHHH---HHHHHcCC--------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 65543321 12121110 11122345678999999999999999999999999998875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-54 Score=385.95 Aligned_cols=259 Identities=29% Similarity=0.417 Sum_probs=205.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.+.||+|+||+||+|+++.+ ..||||++.... ...+.+.+|+.++++++|||||++++++...+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~------~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~---- 85 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP---- 85 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT------EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS----
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC------CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEecCC----
Confidence 5699999999999999999997532 359999997654 44577999999999999999999999985432
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.++||||+++|+|.+++.......+++..++.++.||+.||+|||++ +|+||||||+||||++++++||+|||+++
T Consensus 86 -~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~ 161 (285)
T d1fmka3 86 -IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLAR 161 (285)
T ss_dssp -CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred -eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhh
Confidence 38999999999999998766556799999999999999999999999 99999999999999999999999999998
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFS 311 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (393)
....... .......||+.|+|||++.+..++.++|||||||++|||++|..|+.......+ .......
T Consensus 162 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~i~~--------- 229 (285)
T d1fmka3 162 LIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVER--------- 229 (285)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHT---------
T ss_pred hccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHHh---------
Confidence 6543322 233446789999999999999999999999999999999997766654433221 1221111
Q ss_pred cccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 312 MMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
..+...+..+++++.+||.+||+.||++|||+++|++.|+......
T Consensus 230 -----~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 230 -----GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp -----TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred -----cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 0111223345678999999999999999999999999888776543
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=391.50 Aligned_cols=262 Identities=23% Similarity=0.284 Sum_probs=206.6
Q ss_pred hcCCcccc-eecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhc-CCCCccceeeeeeecCCc
Q 035862 71 TNGFNRML-KIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGV-VSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~ 148 (393)
.++|.++. .||+|+||+||+|++..++ ..||+|++... ..+.+|+.++.+ .+||||+++++++.+...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQ-----EKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCC-----CEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 46798875 5999999999999976444 46999998643 456789988655 579999999999876433
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC---CCceEEe
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG---NFKPKLS 225 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~ 225 (393)
....+|+|||||+||+|.++|.......+++..++.++.||+.||+|||++ ||+||||||+|||+++ ++.+||+
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence 334679999999999999999766566799999999999999999999999 9999999999999985 5679999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
|||+++...... .....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||........... .......
T Consensus 157 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~--~~~~i~~ 231 (335)
T d2ozaa1 157 DFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRIRM 231 (335)
T ss_dssp CCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCS
T ss_pred ccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH--HHHHHhc
Confidence 999998654433 23456899999999999999999999999999999999999999976543211100 0000000
Q ss_pred CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 306 DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
. ...........+++++.+||.+||+.||++|||+.++++|.|..
T Consensus 232 ~--------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 276 (335)
T d2ozaa1 232 G--------QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276 (335)
T ss_dssp C--------SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred C--------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence 0 00011112235678899999999999999999999999998864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.3e-53 Score=381.11 Aligned_cols=265 Identities=26% Similarity=0.359 Sum_probs=207.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHHHHHHHHhhcCCCCccceeeeeeecCC
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 147 (393)
.++|++.+.||+|+||+||+|.+..+ +..||+|++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRL-----HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCC-----CCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc
Confidence 36799999999999999999997543 45699999976532 23456889999999999999999999998877
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
......|+||||++|++|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.++|+||
T Consensus 81 ~~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~ 155 (277)
T d1o6ya_ 81 PAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 155 (277)
T ss_dssp SSSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCC
T ss_pred CCCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehh
Confidence 6555679999999999999988543 4689999999999999999999998 9999999999999999999999999
Q ss_pred cCCccCCCCCC-ccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 228 GLAREGPTGDH-THVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 228 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
|.+........ .......+||+.|+|||++.+..++.++|||||||++|||+||+.||....+... ........+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~~~~~~~~~~ 233 (277)
T d1o6ya_ 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVREDPIP 233 (277)
T ss_dssp TTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHCCCCC
T ss_pred hhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH--HHHHHhcCCCC
Confidence 99875433322 2234456899999999999999999999999999999999999999986543321 12222211111
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-TMNQVVESLKLAV 359 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~~l~~l~~~~ 359 (393)
.......+++++.+||.+||++||.+|| |++++++.|..+.
T Consensus 234 ------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 ------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0111123568899999999999999999 8999998887764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-53 Score=388.38 Aligned_cols=258 Identities=17% Similarity=0.267 Sum_probs=210.1
Q ss_pred HhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 70 ATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 70 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.+++|++++.||+|+||+||+|.+..+ +..||+|.+.... .....+.+|+++|+.++||||+++++++.+.+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~-----~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-- 74 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSS-----KKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESME-- 74 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT--
T ss_pred CccceEEEEEEecCCCeEEEEEEECCC-----CcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC--
Confidence 467899999999999999999997544 3569999998764 33456789999999999999999999998776
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCC--CceEEeec
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGN--FKPKLSDF 227 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~--~~~kl~Df 227 (393)
.+|+|||||+||+|.+++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+ +.+||+||
T Consensus 75 --~~~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DF 148 (321)
T d1tkia_ 75 --ELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEF 148 (321)
T ss_dssp --EEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCC
T ss_pred --EEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEccc
Confidence 569999999999999998533 33689999999999999999999998 99999999999999854 57999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|++....... ......+|+.|+|||.+.+..|+.++|||||||++|+|++|..||........ +....... .
T Consensus 149 G~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~--~~~i~~~~-~-- 220 (321)
T d1tkia_ 149 GQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI--IENIMNAE-Y-- 220 (321)
T ss_dssp TTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHHTC-C--
T ss_pred chhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhCC-C--
Confidence 9998754332 23456889999999999999999999999999999999999999986544321 11111110 0
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
.........++.++.+||.+||.+||++|||+.|+++|.|..
T Consensus 221 ---------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~ 262 (321)
T d1tkia_ 221 ---------TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp ---------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred ---------CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence 000001112467899999999999999999999999998864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.4e-53 Score=392.77 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=207.8
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++++.||+|+||.||+|+++.++ ..||+|++.+.. ......+.+|+.+|+.++||||+++++++....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g-----~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~- 114 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESG-----NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS- 114 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCC-----CEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc-
Confidence 57999999999999999999976444 469999986431 233466889999999999999999999998877
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||
T Consensus 115 ---~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG 186 (350)
T d1rdqe_ 115 ---NLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp ---EEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ---ccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeece
Confidence 569999999999999998544 4689999999999999999999999 99999999999999999999999999
Q ss_pred CCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
+|+..... .....||+.|+|||++.+..|+.++|||||||++|||+||+.||........ ........+
T Consensus 187 ~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~i~~~~~---- 255 (350)
T d1rdqe_ 187 FAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI--YEKIVSGKV---- 255 (350)
T ss_dssp TCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCCC----
T ss_pred eeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH--HHHHhcCCC----
Confidence 99875432 2356899999999999999999999999999999999999999986543321 111111110
Q ss_pred ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHH
Q 035862 309 KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKL 357 (393)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~ 357 (393)
..+..+++++.+||.+||++||.+|+ |++++++|.|.
T Consensus 256 ------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f 297 (350)
T d1rdqe_ 256 ------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297 (350)
T ss_dssp ------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred ------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccc
Confidence 11123567899999999999999994 99999998764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=379.04 Aligned_cols=252 Identities=30% Similarity=0.451 Sum_probs=200.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.+.||+|+||.||+|.+. +..||+|+++... ..+.+.+|++++++++||||+++++++...+.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~--- 74 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG--- 74 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC-----
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-------CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC---
Confidence 56889999999999999999864 2359999997643 44678999999999999999999999865432
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.+++||||+++|+|.+++.......+++..++.++.||+.||.|||+. +|+||||||+|||++.+|.+||+|||+++
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 151 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccce
Confidence 348999999999999999765555689999999999999999999998 99999999999999999999999999998
Q ss_pred cCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcCCccc
Q 035862 232 EGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPADGKKF 310 (393)
Q Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (393)
..... .....++..|+|||++.+..++.++|||||||++|||+| |++||....... +.....
T Consensus 152 ~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~--------- 214 (262)
T d1byga_ 152 EASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVE--------- 214 (262)
T ss_dssp ---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHT---------
T ss_pred ecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH---------
Confidence 64332 234568899999999999999999999999999999998 677776543322 111111
Q ss_pred ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 311 SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
...+...+..+++++.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus 215 -----~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 215 -----KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -----TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----cCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 111222333456789999999999999999999999999988754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-53 Score=385.27 Aligned_cols=268 Identities=26% Similarity=0.409 Sum_probs=219.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcC-CCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 149 (393)
++|++.+.||+|+||.||+|++....+......||||++..... .....+.+|+.+++.+ +|||||++++++...+.
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~- 101 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP- 101 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE-
Confidence 56889999999999999999987666667888999999976533 3445688999999998 69999999999987764
Q ss_pred cceEEEEEeecCCCChHHHHhhcC----------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRA----------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSN 213 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~N 213 (393)
.++||||+++|+|.+++.... ...+++..++.++.||+.||+|||++ +++||||||+|
T Consensus 102 ---~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N 175 (311)
T d1t46a_ 102 ---TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (311)
T ss_dssp ---CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred ---EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence 499999999999999996533 23588999999999999999999999 99999999999
Q ss_pred eEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchh
Q 035862 214 VLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTM 292 (393)
Q Consensus 214 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~ 292 (393)
||++.++.+|++|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||.......
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999997765555445566789999999999999999999999999999999999 555554433322
Q ss_pred hhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 293 EQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
. +...... ..+...+..++..+.+||.+||+.||++|||+.++++.|+.++.++
T Consensus 256 ~--~~~~i~~--------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 256 K--FYKMIKE--------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp H--HHHHHHH--------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred H--HHHHHhc--------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 1 1111111 1111222335688999999999999999999999999999888764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-52 Score=391.22 Aligned_cols=254 Identities=24% Similarity=0.326 Sum_probs=203.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc---ccHHHH---HHHHHHhhcCCCCccceeeeeee
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL---QGHKQW---LAEVQFLGVVSHPNLVKLLGYCS 144 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~h~niv~~~~~~~ 144 (393)
.++|++.+.||+|+||.||+|++..++ ..||+|++.+... .....+ .+|+.+++.++||||+++++++.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~-----~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTG-----KMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTC-----CEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCC-----CEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE
Confidence 367999999999999999999976544 4699999864321 112223 34577888889999999999998
Q ss_pred cCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEE
Q 035862 145 TEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKL 224 (393)
Q Consensus 145 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 224 (393)
..+ .+|+||||++||+|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+|.+||
T Consensus 78 ~~~----~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl 148 (364)
T d1omwa3 78 TPD----KLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI 148 (364)
T ss_dssp CSS----EEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEE
T ss_pred ECC----EEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEE
Confidence 876 569999999999999999543 5688999999999999999999999 9999999999999999999999
Q ss_pred eeccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 225 SDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
+|||+|....... ....+||+.|+|||++.. ..|+.++|||||||++|||+||+.||..........+.......
T Consensus 149 ~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~ 224 (364)
T d1omwa3 149 SDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224 (364)
T ss_dssp CCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC
T ss_pred eeeceeeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 9999998654332 234689999999999864 56899999999999999999999999865443322222211110
Q ss_pred CcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHHHHH
Q 035862 304 PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPT-----MNQVVESLKL 357 (393)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~~l~~l~~ 357 (393)
....+..+++++.+||.+||++||++||| ++++++|.|.
T Consensus 225 ---------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f 268 (364)
T d1omwa3 225 ---------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268 (364)
T ss_dssp ---------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGG
T ss_pred ---------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccc
Confidence 01112235678999999999999999999 7999999764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.5e-53 Score=377.48 Aligned_cols=256 Identities=27% Similarity=0.355 Sum_probs=208.2
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc---------cHHHHHHHHHHhhcCC-CCccceee
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ---------GHKQWLAEVQFLGVVS-HPNLVKLL 140 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~~~ 140 (393)
.++|++.+.||+|+||+||+|++.. ++..||+|++...... ....+.+|+.+++.++ ||||++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~-----~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 76 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKP-----TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred cccCEEceEEecCcCeEEEEEEECC-----CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEE
Confidence 4689999999999999999999653 3457999998765322 1235788999999997 99999999
Q ss_pred eeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC
Q 035862 141 GYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF 220 (393)
Q Consensus 141 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~ 220 (393)
+++.+.+ ..|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 77 ~~~~~~~----~~~ivmE~~~~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~ 147 (277)
T d1phka_ 77 DTYETNT----FFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDM 147 (277)
T ss_dssp EEEECSS----EEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred eecccCc----ceEEEEEcCCCchHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCC
Confidence 9998776 56999999999999999954 34689999999999999999999999 999999999999999999
Q ss_pred ceEEeeccCCccCCCCCCccccccccccCCccCcccccc------CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhh
Q 035862 221 KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET------GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ 294 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~ 294 (393)
.+||+|||++....... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||....+....
T Consensus 148 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~ 224 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 224 (277)
T ss_dssp CEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH
Confidence 99999999998764432 2345689999999998853 35788999999999999999999999876543222
Q ss_pred HHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.. ...... .........+++++.+|+.+||++||++|||+.++++|.|.
T Consensus 225 ~~--i~~~~~------------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~ 273 (277)
T d1phka_ 225 RM--IMSGNY------------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273 (277)
T ss_dssp HH--HHHTCC------------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred HH--HHhCCC------------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHH
Confidence 11 111100 00111122466889999999999999999999999998764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=379.49 Aligned_cols=266 Identities=29% Similarity=0.433 Sum_probs=211.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCC--CCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcC-CCCccceeeeeeecCC
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDG--RGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTED 147 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 147 (393)
++|++.+.||+|+||.||+|++..++. ......||+|++..... .....+.+|...+..+ +|||||++++++..++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 579999999999999999998765543 24557899999976543 3346678898888887 7999999999998776
Q ss_pred cccceEEEEEeecCCCChHHHHhhcC--------------CCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCC
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRA--------------QPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSN 213 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~N 213 (393)
..++||||+++|+|.++|.... ...+++..++.++.||+.||+|||++ +||||||||+|
T Consensus 93 ----~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~N 165 (299)
T d1fgka_ 93 ----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 165 (299)
T ss_dssp ----SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred ----eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccc
Confidence 4599999999999999996443 24589999999999999999999999 99999999999
Q ss_pred eEeCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchh
Q 035862 214 VLLDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTM 292 (393)
Q Consensus 214 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~ 292 (393)
||++.++.+||+|||++................|++.|+|||.+.++.|+.++|||||||++|||++ |.+||.......
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 9999999999999999987655444444556789999999999999999999999999999999998 688887654332
Q ss_pred hhHHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhh
Q 035862 293 EQKLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQE 361 (393)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~ 361 (393)
+...... + .+...+..+++++.+||.+||+.||++|||+.++++.|+.+.+.
T Consensus 246 ---~~~~i~~----~----------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 246 ---LFKLLKE----G----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp ---HHHHHHT----T----------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHHc----C----------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 2222211 0 11112223567899999999999999999999999999988763
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=379.66 Aligned_cols=266 Identities=25% Similarity=0.297 Sum_probs=199.4
Q ss_pred ccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc-----cHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 76 RMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ-----GHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 76 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
.+++||+|+||+||+|++..+ +..||+|++...... ....+.+|+.+++.++|||||++++++...+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~--- 73 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNT-----NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS--- 73 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSC-----CSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT---
T ss_pred cceEeccCcCeEEEEEEECCC-----CcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC---
Confidence 467899999999999996543 446999998654322 2346789999999999999999999998877
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLA 230 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 230 (393)
..++||||+.++++..+. .....+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 74 -~~~ivmE~~~~~~~~~~~--~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a 147 (299)
T d1ua2a_ 74 -NISLVFDFMETDLEVIIK--DNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 147 (299)
T ss_dssp -CCEEEEECCSEEHHHHHT--TCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred -ceeehhhhhcchHHhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccc
Confidence 459999999887776655 3456689999999999999999999999 9999999999999999999999999999
Q ss_pred ccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC--
Q 035862 231 REGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG-- 307 (393)
Q Consensus 231 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-- 307 (393)
........ .....+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||...........+......+...
T Consensus 148 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~ 225 (299)
T d1ua2a_ 148 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW 225 (299)
T ss_dssp STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 86544322 2345689999999998865 468999999999999999999999998765433221111111111100
Q ss_pred ---ccccccc-Ccccc----cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 308 ---KKFSMMI-DPRLR----NQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 308 ---~~~~~~~-~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
....... ..... .......++++.+|+.+||+.||++|||+.|+++|.|.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f 283 (299)
T d1ua2a_ 226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283 (299)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred cchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhh
Confidence 0000000 00000 00111346789999999999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=375.00 Aligned_cols=260 Identities=28% Similarity=0.421 Sum_probs=200.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC---CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH---GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
++|++.+.||+|+||+||+|++... .+....||+|++.+. .....+.+.+|+.+|+.++||||+++++++.+.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~--~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-- 83 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAP--SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-- 83 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECT--TSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred HHeEEEEEEecCCCeEEEEEEEECC--CCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec--
Confidence 4699999999999999999987533 235567999998754 223346789999999999999999999999654
Q ss_pred ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeecc
Q 035862 149 RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFG 228 (393)
Q Consensus 149 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg 228 (393)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 84 ---~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfG 156 (273)
T d1u46a_ 84 ---PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFG 156 (273)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ---chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccch
Confidence 2389999999999999886543 4589999999999999999999998 99999999999999999999999999
Q ss_pred CCccCCCCCCcc-ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHh-CCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 229 LAREGPTGDHTH-VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILT-GRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 229 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
+++......... ......|+..|+|||++.+..++.++|||||||++|||+| |..||........ ...... .
T Consensus 157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~---~~~i~~---~ 230 (273)
T d1u46a_ 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI---LHKIDK---E 230 (273)
T ss_dssp TCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHT---S
T ss_pred hhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH---HHHHHh---C
Confidence 998765443322 2334567889999999999999999999999999999998 8999976543321 111111 1
Q ss_pred CcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 307 GKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
..+...+..++.++.+|+.+||+.||++|||+.+|.+.|.++
T Consensus 231 ----------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 ----------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ----------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111122234567899999999999999999999999888764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-53 Score=386.27 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=205.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC---cccHHHHHHHHHHhh-cCCCCccceeeeeeecCC
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG---LQGHKQWLAEVQFLG-VVSHPNLVKLLGYCSTED 147 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~ 147 (393)
++|++++.||+|+||+||+|++..+ +..||+|++.+.. ......+..|..++. .++||||+++++++.+.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t-----~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKT-----NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTT-----TEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCC-----CCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC
Confidence 5799999999999999999997644 4579999996531 233445666777665 689999999999998877
Q ss_pred cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 148 ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 148 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
..|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++++|.+||+||
T Consensus 77 ----~~yivmEy~~~g~L~~~i~~--~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DF 147 (320)
T d1xjda_ 77 ----NLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF 147 (320)
T ss_dssp ----EEEEEEECCTTCBHHHHHHH--HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ----ceeEEEeecCCCcHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecccc
Confidence 56999999999999999954 34689999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
|+++....... ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.......+ ....+
T Consensus 148 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i--~~~~~--- 220 (320)
T d1xjda_ 148 GMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI--RMDNP--- 220 (320)
T ss_dssp TTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHCCC---
T ss_pred chhhhcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH--HcCCC---
Confidence 99986543322 334568999999999999999999999999999999999999999866543221111 11100
Q ss_pred cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHHHHHH
Q 035862 308 KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMN-QVVESLKL 357 (393)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~~l~~l~~ 357 (393)
..+..+++++.+||.+||++||.+|||+. ++++|.|.
T Consensus 221 -------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff 258 (320)
T d1xjda_ 221 -------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258 (320)
T ss_dssp -------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred -------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchh
Confidence 11223567899999999999999999995 79887653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-52 Score=377.49 Aligned_cols=269 Identities=26% Similarity=0.353 Sum_probs=205.7
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|++++.||+|+||+||+|.+..++ ..||+|++..... .....+.+|+++|++++||||+++++++.+.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~-- 74 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTG-----EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-- 74 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT--
T ss_pred CCCEeccEEecCcCeEEEEEEECCCC-----CEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc--
Confidence 57999999999999999999976444 4699999865432 23567889999999999999999999998876
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
.+|+||||+.+ ++.+++.......+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 75 --~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 75 --KLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp --EEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred --ceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCc
Confidence 56999999965 666666666667799999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCc
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGH-LKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGK 308 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (393)
|....... .......||+.|+|||++.... ++.++|||||||++|+|++|+.||...+..............+. ..
T Consensus 149 a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~-~~ 225 (298)
T d1gz8a_ 149 ARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPD-EV 225 (298)
T ss_dssp HHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC-TT
T ss_pred ceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCc-hh
Confidence 97653322 2344568999999999887655 57899999999999999999999986544322111111000111 00
Q ss_pred cccc-------------ccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 309 KFSM-------------MIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 309 ~~~~-------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.... ...... ......++.++.+|+.+||++||++|||+.|+++|.|.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff 286 (298)
T d1gz8a_ 226 VWPGVTSMPDYKPSFPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286 (298)
T ss_dssp TSTTGGGSTTCCTTSCCCCCCCH-HHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred hccccccccccccccccccccch-hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhh
Confidence 0000 000000 00111346789999999999999999999999999775
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=380.81 Aligned_cols=262 Identities=30% Similarity=0.461 Sum_probs=208.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-CcccHHHHHHHHHHhhcC-CCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQGHKQWLAEVQFLGVV-SHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 149 (393)
++|++.++||+|+||+||+|.++.+ +....||||.+... .....+.+.+|+++|+.+ +||||+++++++...+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-- 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKD---GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-- 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEET---TEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT--
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCC---CeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC--
Confidence 5799999999999999999998643 33456889988654 223456789999999998 6999999999998776
Q ss_pred cceEEEEEeecCCCChHHHHhhc--------------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeE
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSR--------------AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVL 215 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIl 215 (393)
.+++||||+++|+|.++|... ....+++..++.++.||+.||.|||++ +|+||||||+|||
T Consensus 85 --~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL 159 (309)
T d1fvra_ 85 --YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNIL 159 (309)
T ss_dssp --EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred --eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEE
Confidence 569999999999999999643 235789999999999999999999999 9999999999999
Q ss_pred eCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCC-ccCCCCchhhh
Q 035862 216 LDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRR-VLERNRPTMEQ 294 (393)
Q Consensus 216 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~-pf~~~~~~~~~ 294 (393)
++.++.+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||......
T Consensus 160 ~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--- 233 (309)
T d1fvra_ 160 VGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--- 233 (309)
T ss_dssp ECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---
T ss_pred EcCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH---
Confidence 9999999999999997643322 2234578999999999999999999999999999999999765 56544322
Q ss_pred HHHHHHhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 295 KLLEWVKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
.+...+.. ..+...+..+++++.+||.+||+.||++|||+.+++++|+.+++...
T Consensus 234 ~~~~~i~~--------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 234 ELYEKLPQ--------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp HHHHHGGG--------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHHHHHh--------------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 11111111 11112233456889999999999999999999999999999987554
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=374.16 Aligned_cols=261 Identities=28% Similarity=0.440 Sum_probs=205.8
Q ss_pred cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccceEEE
Q 035862 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGIQRLL 155 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~l 155 (393)
.++||+|+||+||+|++...+ +....||||.+... ......++.+|+++|++++||||++++|++...+. ..++
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~---~~~l 106 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDND--GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG---SPLV 106 (311)
T ss_dssp EEEEEEETTEEEEEEEECC------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT---EEEE
T ss_pred ceEEeecCCeEEEEEEEECCC--CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC---ceEE
Confidence 468999999999999986432 34567999999753 33455778999999999999999999999875443 4689
Q ss_pred EEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccCCccCCC
Q 035862 156 VYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAREGPT 235 (393)
Q Consensus 156 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 235 (393)
||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 107 v~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EEEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 99999999999988543 34577888999999999999999998 999999999999999999999999999987544
Q ss_pred CCCcc--ccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCCcccccc
Q 035862 236 GDHTH--VSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADGKKFSMM 313 (393)
Q Consensus 236 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (393)
..... ......||+.|+|||.+.+..++.++||||||+++|||+||..||.......+ ....... +
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~i~~----g------ 250 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYLLQ----G------ 250 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHT----T------
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHHHHHc----C------
Confidence 33221 23345789999999999999999999999999999999998888765432211 1111111 0
Q ss_pred cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 314 IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 314 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
.+...+..+++++.+|+.+||+.||++||++.||+++|+.+++..
T Consensus 251 ----~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 251 ----RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ----CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 011122235678999999999999999999999999999998653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-51 Score=372.39 Aligned_cols=276 Identities=24% Similarity=0.349 Sum_probs=206.0
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcC---CCCccceeeeeeec
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVV---SHPNLVKLLGYCST 145 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~ 145 (393)
.++|++++.||+|+||+||+|++..+ .+..||+|++.... ......+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~ 81 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKN----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 81 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT----TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECC----CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecc
Confidence 46899999999999999999997533 24579999986432 12233455677776654 79999999999864
Q ss_pred CC-cccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEE
Q 035862 146 ED-ERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKL 224 (393)
Q Consensus 146 ~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 224 (393)
.. ....+.+++|||+.++.+.. ........+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||
T Consensus 82 ~~~~~~~~~~~~~e~~~~~~~~~-~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 82 SRTDRETKLTLVFEHVDQDLTTY-LDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp EECSSEEEEEEEEECCSCBHHHH-HHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCceEEEEEEeccCCchhh-hhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeee
Confidence 32 22236799999998766554 3345556799999999999999999999999 9999999999999999999999
Q ss_pred eeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcC
Q 035862 225 SDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFP 304 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (393)
+|||++..... ........||+.|+|||++.+..|+.++||||+||++|||++|++||...++......+......+
T Consensus 158 ~dfg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 158 ADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234 (305)
T ss_dssp CSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cchhhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 99999875432 224456789999999999999999999999999999999999999998765433222211111111
Q ss_pred cC------Cccccccc---CcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 305 AD------GKKFSMMI---DPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 305 ~~------~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.. ........ ...........+++.+.+||.+||++||++|||+.|+++|.|.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff 296 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 10 00000000 0011112223456789999999999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=374.21 Aligned_cols=265 Identities=25% Similarity=0.404 Sum_probs=213.8
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc-ccHHHHHHHHHHhhcCCCCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL-QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
++|++.+.||+|+||+||+|.+...........||||++..... .....+.+|+.++++++||||+++++++...+.
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~-- 97 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP-- 97 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS--
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc--
Confidence 57899999999999999999886544444556799999976432 333467899999999999999999999987764
Q ss_pred ceEEEEEeecCCCChHHHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCce
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSR--------AQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKP 222 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~ 222 (393)
.++||||+.+|+|.+++... ....+++..+..++.|++.||.|||++ +|+||||||+|||+++++++
T Consensus 98 --~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 98 --TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp --CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCE
T ss_pred --eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceE
Confidence 49999999999999988532 224578899999999999999999998 99999999999999999999
Q ss_pred EEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCC-CccCCCCchhhhHHHHHHh
Q 035862 223 KLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGR-RVLERNRPTMEQKLLEWVK 301 (393)
Q Consensus 223 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~-~pf~~~~~~~~~~~~~~~~ 301 (393)
||+|||+++...............||+.|+|||.+.+..++.++|||||||++|||+||. +||........ + ....
T Consensus 173 Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~--~-~~i~ 249 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV--L-RFVM 249 (308)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH--H-HHHH
T ss_pred EEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH--H-HHHH
Confidence 999999998655444444455668999999999999999999999999999999999985 66755433221 1 1111
Q ss_pred hcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHh
Q 035862 302 QFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQ 360 (393)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~ 360 (393)
. +. ....+..++..+.++|.+||+.||++|||+.+++++|...++
T Consensus 250 ~----~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 E----GG----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp T----TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred h----CC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1 10 111222456789999999999999999999999999977654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=373.00 Aligned_cols=245 Identities=25% Similarity=0.393 Sum_probs=197.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc------cHHHHHHHHHHhhcCC--CCccceeeee
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ------GHKQWLAEVQFLGVVS--HPNLVKLLGY 142 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~ 142 (393)
.++|++.+.||+|+||+||+|++..++ ..||+|++.+.... ...++.+|+.+++.++ ||||++++++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~ 77 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDN-----LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCC-----CEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEE
Confidence 467999999999999999999976443 46999998753211 1233567999999987 8999999999
Q ss_pred eecCCcccceEEEEEeecCC-CChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC-CC
Q 035862 143 CSTEDERGIQRLLVYEYMPN-RSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG-NF 220 (393)
Q Consensus 143 ~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~-~~ 220 (393)
+...+ ..++||||+.+ +++.+++.. ...+++..++.++.||+.||+|||++ +|+||||||+|||++. ++
T Consensus 78 ~~~~~----~~~lv~e~~~~~~~l~~~~~~--~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~ 148 (273)
T d1xwsa_ 78 FERPD----SFVLILERPEPVQDLFDFITE--RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRG 148 (273)
T ss_dssp EECSS----EEEEEEECCSSEEEHHHHHHH--HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTT
T ss_pred EeeCC----eEEEEEEeccCcchHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCC
Confidence 98877 56999999976 577787744 35689999999999999999999999 9999999999999985 57
Q ss_pred ceEEeeccCCccCCCCCCccccccccccCCccCccccccCCC-CchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHH
Q 035862 221 KPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHL-KSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW 299 (393)
Q Consensus 221 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~ 299 (393)
.+||+|||+|...... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... .
T Consensus 149 ~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i--- 216 (273)
T d1xwsa_ 149 ELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I--- 216 (273)
T ss_dssp EEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H---
T ss_pred eEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----H---
Confidence 9999999999764332 2345689999999999987765 5779999999999999999999974311 1
Q ss_pred HhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
..... ..+..+++++.+||.+||+.||++|||++|+++|.|.
T Consensus 217 ~~~~~----------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 258 (273)
T d1xwsa_ 217 IRGQV----------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258 (273)
T ss_dssp HHCCC----------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred hhccc----------------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence 11000 0111245789999999999999999999999999774
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.2e-50 Score=365.20 Aligned_cols=269 Identities=24% Similarity=0.321 Sum_probs=202.5
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|+++++||+|+||+||+|.+. .+..||+|++..... .....+.+|+.+|+.++||||+++++++...+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-- 73 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-- 73 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS--
T ss_pred CCceeccEEecCCCcEEEEEEeC------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC--
Confidence 68999999999999999999864 234699999976432 23567889999999999999999999998877
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..+++||++.++.+..+. .....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.
T Consensus 74 --~~~i~~e~~~~~~~~~~~--~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~ 146 (286)
T d1ob3a_ 74 --RLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL 146 (286)
T ss_dssp --CEEEEEECCSEEHHHHHH--TSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred --ceeEEEEeehhhhHHHHH--hhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccccc
Confidence 459999999776666655 4456799999999999999999999998 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc-CC
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA-DG 307 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~ 307 (393)
+........ ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||..................+. ..
T Consensus 147 a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 224 (286)
T d1ob3a_ 147 ARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224 (286)
T ss_dssp HHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhh
Confidence 976433222 2344578999999999865 4578999999999999999999999986554322211111111110 00
Q ss_pred ----cccccc------cCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 308 ----KKFSMM------IDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 308 ----~~~~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
...... ..+.........+++++.+|+.+||++||++|||+.|+++|.|.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f 284 (286)
T d1ob3a_ 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (286)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 000000 00111111222456789999999999999999999999998764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-50 Score=363.97 Aligned_cols=272 Identities=26% Similarity=0.342 Sum_probs=202.5
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHH--HHHHhhcCCCCccceeeeeeecCCccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLA--EVQFLGVVSHPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~h~niv~~~~~~~~~~~~~ 150 (393)
+|.+.+.||+|+||+||+|++. +..||||++.... ...+.+ |+..+..++||||+++++++..++...
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~-------g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWR-------GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-------TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-------CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence 5778889999999999999863 3469999986542 233333 555556789999999999998877655
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC-----CCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEG-----LEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~-----~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
..+++||||+++|+|.+++... .+++..++.++.|++.||+|||+. ...||+||||||+||||+.++.+||+
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence 5789999999999999999643 589999999999999999999962 12399999999999999999999999
Q ss_pred eccCCccCCCCCCcc--ccccccccCCccCccccccC------CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhh---
Q 035862 226 DFGLAREGPTGDHTH--VSTAVVGTYGYAAPEYIETG------HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQ--- 294 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~--- 294 (393)
|||++.......... ......||+.|+|||++.+. .++.++|||||||++|||+||..||.........
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~ 230 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence 999998654332221 23456899999999998764 2677999999999999999999888543221100
Q ss_pred ------HHHHHHhhcCcCCcccccccCcccccc-cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhc
Q 035862 295 ------KLLEWVKQFPADGKKFSMMIDPRLRNQ-YSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESE 363 (393)
Q Consensus 295 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~ 363 (393)
.......... ....++.+... ........+.+|+.+||+.||++|||+.|+++.|.++.+...
T Consensus 231 ~~~~~~~~~~~~~~~~------~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 231 LVPSDPSVEEMRKVVC------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp TSCSSCCHHHHHHHHT------TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cccccchHHHHHHHHh------ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 0000000000 00111111111 122466779999999999999999999999999999887654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-50 Score=370.77 Aligned_cols=276 Identities=24% Similarity=0.322 Sum_probs=203.6
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC-cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG-LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
.++|+++++||+|+||+||+|++..++ ..||||++.... ....+.+++|+.+|+.++||||+++++++......
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNK-----VRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTC-----SEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCC-----cEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccc
Confidence 357999999999999999999976444 469999997643 23456788999999999999999999998766543
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
....+++++++.+++|.+++... .+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCc
Confidence 22234556667799999999543 589999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCc-cccccccccCCccCccccc-cCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcCC
Q 035862 230 AREGPTGDHT-HVSTAVVGTYGYAAPEYIE-TGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPADG 307 (393)
Q Consensus 230 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (393)
+......... ......+||+.|+|||++. +..++.++||||+||++|+|++|+.||..................+...
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235 (345)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred eeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence 9765433221 1234567999999999984 4567899999999999999999999997665433222211111111100
Q ss_pred cc----------cccccCcccc---cccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 308 KK----------FSMMIDPRLR---NQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 308 ~~----------~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.. .......... .......+.++.+|+.+||+.||.+|||+.++++|.|.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~ 298 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 00 0000000000 00111345689999999999999999999999999764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=366.49 Aligned_cols=270 Identities=25% Similarity=0.332 Sum_probs=200.9
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCC--ccc
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTED--ERG 150 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~ 150 (393)
+|+.+++||+|+||+||+|++..++ ..||+|++...... ..+|+.+|+.++||||++++++|.... ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~-----~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSG-----ELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTC-----CEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCC-----CEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 4888999999999999999976443 46999999765422 236999999999999999999986543 223
Q ss_pred ceEEEEEeecCCCChHHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC-ceEEeecc
Q 035862 151 IQRLLVYEYMPNRSLEDRLF-SRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF-KPKLSDFG 228 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg 228 (393)
.++++||||+.++.+..+.. ......+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG 168 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFG 168 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCT
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEeccc
Confidence 46799999997654333322 24556799999999999999999999998 999999999999999775 89999999
Q ss_pred CCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHH-HHH------
Q 035862 229 LAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL-EWV------ 300 (393)
Q Consensus 229 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~-~~~------ 300 (393)
++....... ......|++.|+|||.+.+ ..|+.++||||+||++|||++|+.||...........+ ...
T Consensus 169 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 169 SAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245 (350)
T ss_dssp TCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred chhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence 998654332 2345689999999998765 57899999999999999999999999766543221111 100
Q ss_pred --hh-cCc-CCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 301 --KQ-FPA-DGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 301 --~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.. .+. ....+................++++.+|+.+||++||++|||+.|+++|.|.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f 306 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 00 000 0000111111111111222456789999999999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=362.01 Aligned_cols=277 Identities=22% Similarity=0.300 Sum_probs=203.8
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC--CcccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH--GLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|+++++||+|+||+||+|++..++ ..||||++... ......++.+|+.+|+.++||||+++++++.....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~ 83 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTG-----QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 83 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCC-----CEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence 468999999999999999999976443 46999998644 22345678899999999999999999999865432
Q ss_pred c----cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEE
Q 035862 149 R----GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKL 224 (393)
Q Consensus 149 ~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl 224 (393)
. ....++||||+.++.+..+. .....+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl 158 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKL 158 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEE
T ss_pred cccccCceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEe
Confidence 1 12569999999876665444 4456789999999999999999999999 9999999999999999999999
Q ss_pred eeccCCccCCCCCCc--cccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHh
Q 035862 225 SDFGLAREGPTGDHT--HVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVK 301 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~ 301 (393)
+|||++......... ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||....+...........
T Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~ 238 (318)
T d3blha1 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238 (318)
T ss_dssp CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhc
Confidence 999999765432211 123346799999999998765 68999999999999999999999998765543333222221
Q ss_pred hcCcCCcccccc--------cCccc--ccccC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 302 QFPADGKKFSMM--------IDPRL--RNQYS-----INAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 302 ~~~~~~~~~~~~--------~~~~~--~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
..+... ..... ..... ..... ...+.++.+||.+||++||++|||++|+++|.|.-
T Consensus 239 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~ 309 (318)
T d3blha1 239 GSITPE-VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW 309 (318)
T ss_dssp CCCCTT-TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred CCCChh-hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence 111110 00000 00000 00000 12246788999999999999999999999999853
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5e-49 Score=363.27 Aligned_cols=265 Identities=20% Similarity=0.298 Sum_probs=205.0
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCccceeeeeeecCCccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDERG 150 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 150 (393)
++|+++++||+|+||+||+|++.. .+..||+|++... ..+++.+|+.+|+.++ ||||+++++++......
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~-----~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~- 105 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINIT-----NNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSR- 105 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-----TTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC-
T ss_pred cCeEEEEEEecCcCeEEEEEEECC-----CCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC-
Confidence 579999999999999999999754 3457999999754 3467889999999996 99999999999865544
Q ss_pred ceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCC-ceEEeeccC
Q 035862 151 IQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNF-KPKLSDFGL 229 (393)
Q Consensus 151 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~ 229 (393)
.+++||||+.+++|..+. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus 106 -~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 106 -TPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp -SEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred -ceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccc
Confidence 569999999999997654 4589999999999999999999999 999999999999998655 699999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHH--H--------
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLL--E-------- 298 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~--~-------- 298 (393)
|....... ......+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||........+... .
T Consensus 177 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 177 AEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp CEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred ceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence 98754433 23456899999999998765 5799999999999999999999999776554332111 0
Q ss_pred -HHhhcCcCC-cccccccC--------cccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 299 -WVKQFPADG-KKFSMMID--------PRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 299 -~~~~~~~~~-~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
+........ ..+..... ..........+++++.+||.+||++||++|||++|+++|.|.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F 322 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 111100000 00000000 001111222456789999999999999999999999999875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=367.89 Aligned_cols=269 Identities=24% Similarity=0.323 Sum_probs=200.5
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|+++++||+|+||+||+|.+..++ ..||+|++..... ...+.+.+|+++|+.++|||||+++++|...+.
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTG-----AKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTC-----CEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCC-----CEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 468999999999999999999976443 4699999976432 334568899999999999999999999977653
Q ss_pred --ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEee
Q 035862 149 --RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSD 226 (393)
Q Consensus 149 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 226 (393)
.....|+||||+ +.+|..++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 92 ~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~D 164 (346)
T d1cm8a_ 92 LDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD 164 (346)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred ccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccc
Confidence 223469999999 6678776633 4599999999999999999999999 999999999999999999999999
Q ss_pred ccCCccCCCCCCccccccccccCCccCcccccc-CCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCc
Q 035862 227 FGLAREGPTGDHTHVSTAVVGTYGYAAPEYIET-GHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPA 305 (393)
Q Consensus 227 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (393)
||++...... .+...||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..................+.
T Consensus 165 fg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 165 FGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp CTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence 9999865432 245689999999999876 4578999999999999999999999987654322211111111000
Q ss_pred CC--------------cccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 306 DG--------------KKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 306 ~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
.. ..........+ ......+++++.+||.+||+.||.+|||+.++++|.|.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f 304 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHHhhhcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence 00 00000000000 11122356788999999999999999999999999775
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=353.24 Aligned_cols=270 Identities=23% Similarity=0.299 Sum_probs=208.3
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC--cccHHHHHHHHHHhhcCCCCccceeeeeeecCCcc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG--LQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDER 149 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 149 (393)
++|+++++||+|+||+||+|++..++ ..||+|++.... .....++.+|+.+|+.++||||+++++++...+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-- 74 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETH-----EIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-- 74 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTC-----CEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCC-----cEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc--
Confidence 57999999999999999999976443 469999986543 234567889999999999999999999998887
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeeccC
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDFGL 229 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 229 (393)
..++|++++.+++|..++ .....+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.
T Consensus 75 --~~~iv~~~~~~~~l~~~~--~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 75 --KLTLVFEFCDQDLKKYFD--SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp --EEEEEEECCSEEHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred --ceeEEeeecccccccccc--ccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecch
Confidence 559999999998888877 3456789999999999999999999999 999999999999999999999999999
Q ss_pred CccCCCCCCccccccccccCCccCccccccCC-CCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHH-HHHHhhcCcCC
Q 035862 230 AREGPTGDHTHVSTAVVGTYGYAAPEYIETGH-LKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKL-LEWVKQFPADG 307 (393)
Q Consensus 230 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~-~~~~~~~~~~~ 307 (393)
+........ ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||.......+... .......+...
T Consensus 148 a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (292)
T d1unla_ 148 ARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225 (292)
T ss_dssp CEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred hhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChh
Confidence 987544332 233456788999999887654 68999999999999999999999765444332211 11111111100
Q ss_pred --ccc---------ccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHH
Q 035862 308 --KKF---------SMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKL 357 (393)
Q Consensus 308 --~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~ 357 (393)
... ................+..+.+|+.+||++||++|||++|+++|.|.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f 286 (292)
T d1unla_ 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred hhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence 000 00000111112223456789999999999999999999999999765
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-48 Score=360.23 Aligned_cols=272 Identities=25% Similarity=0.308 Sum_probs=198.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc-
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE- 148 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~- 148 (393)
++|+++++||+|+||+||+|++..+ +..||||++..... ....++.+|+.+|+.++||||+++++++...+.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t-----~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~ 91 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVL-----DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 91 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTT-----TEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred CCeEEEEEeecCcCeEEEEEEECCC-----CCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccc
Confidence 5799999999999999999997543 45799999976532 334567899999999999999999999976542
Q ss_pred -ccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 149 -RGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 149 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
...++|+||||+.++ +.+.+ ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|++||
T Consensus 92 ~~~~~~~iv~Ey~~~~-l~~~~----~~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 92 EEFQDVYLVMELMDAN-LCQVI----QMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp TTCCEEEEEEECCSEE-HHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred ccCceeEEEEeccchH-HHHhh----hcCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeech
Confidence 234789999999664 44444 23589999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHH-HHH-------
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKL-LEW------- 299 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~-~~~------- 299 (393)
|+++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+....... ...
T Consensus 164 ~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 164 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp CC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred hhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence 9988654332 33566899999999999999999999999999999999999999976544322111 100
Q ss_pred ------------Hhhc-CcCCcccccccCccc---ccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Q 035862 300 ------------VKQF-PADGKKFSMMIDPRL---RNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAV 359 (393)
Q Consensus 300 ------------~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~ 359 (393)
.... ...+........... ........+.++.+||.+||.+||++|||++|+++|.|...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 0000 001111111111111 11122356889999999999999999999999999988753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=361.09 Aligned_cols=260 Identities=25% Similarity=0.351 Sum_probs=205.9
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCC----cccHHHHHHHHHHhhcCCC-Cccceeeeeeec
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHG----LQGHKQWLAEVQFLGVVSH-PNLVKLLGYCST 145 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~ 145 (393)
.++|++++.||+|+||+||+|+.... +..+..||+|.+.+.. ......+.+|++++++++| |||+++++++..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~--~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISG--HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSS--TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred hhceEEEEEEecCCCeEEEEEEECcc--CCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 35699999999999999999986432 3456689999986532 1234567789999999976 899999999988
Q ss_pred CCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEe
Q 035862 146 EDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLS 225 (393)
Q Consensus 146 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 225 (393)
.. ..+++|||+.+++|.+++... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.+|.+||+
T Consensus 101 ~~----~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~ 171 (322)
T d1vzoa_ 101 ET----KLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLT 171 (322)
T ss_dssp TT----EEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEES
T ss_pred CC----ceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEe
Confidence 77 569999999999999998544 4568899999999999999999999 99999999999999999999999
Q ss_pred eccCCccCCCCCCccccccccccCCccCccccccC--CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhH-HHHHHhh
Q 035862 226 DFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG--HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQK-LLEWVKQ 302 (393)
Q Consensus 226 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~-~~~~~~~ 302 (393)
|||++......... ......|++.|+|||.+.+. .++.++|||||||++|+|++|..||.......... +......
T Consensus 172 DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~ 250 (322)
T d1vzoa_ 172 DFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250 (322)
T ss_dssp CSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred eccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc
Confidence 99999765433222 34456899999999999764 46889999999999999999999997654332211 1111101
Q ss_pred cCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHH
Q 035862 303 FPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERP-----TMNQVVESLKL 357 (393)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~~l~~l~~ 357 (393)
. ....+..++.++.+|+.+||++||.+|| +++|+++|.|.
T Consensus 251 ~---------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff 295 (322)
T d1vzoa_ 251 S---------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295 (322)
T ss_dssp C---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred C---------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence 0 0112224568899999999999999999 58999999774
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.5e-48 Score=350.76 Aligned_cols=266 Identities=20% Similarity=0.234 Sum_probs=198.9
Q ss_pred cCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCCCccceeeeeeecCCcccc
Q 035862 72 NGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDERGI 151 (393)
Q Consensus 72 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 151 (393)
++|++.+.||+|+||+||+|++..+ +..||+|++..... ..++..|+++++.++|+|++..+..+...+.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~-----~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~--- 76 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAA-----GEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD--- 76 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTT-----TEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETT---
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCC-----CCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCC---
Confidence 5799999999999999999997543 45799999876532 2457789999999997776655554433332
Q ss_pred eEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC---CCceEEeecc
Q 035862 152 QRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG---NFKPKLSDFG 228 (393)
Q Consensus 152 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~---~~~~kl~Dfg 228 (393)
..++||||+ +++|.+.+.. ....+++..+..++.|++.||+|||++ ||+||||||+|||++. +..+||+|||
T Consensus 77 ~~~ivme~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 77 YNVMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp EEEEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred EEEEEEEEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccC
Confidence 558999999 5677766643 345689999999999999999999999 9999999999999864 4579999999
Q ss_pred CCccCCCCCCc-----cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhc
Q 035862 229 LAREGPTGDHT-----HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQF 303 (393)
Q Consensus 229 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (393)
+|+........ .......||+.|+|||++.+..++.++|||||||++|||++|..||..................
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHH
T ss_pred cceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc
Confidence 99875443221 1234568999999999999999999999999999999999999999765443222111110000
Q ss_pred CcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhh
Q 035862 304 PADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQES 362 (393)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~ 362 (393)
... .........+++++.+|+..||+.+|++||++.++.+.|+.+....
T Consensus 232 ~~~----------~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 232 KMS----------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHH----------SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred cCC----------CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 000 0000111135678999999999999999999999988888776544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2e-47 Score=346.30 Aligned_cols=268 Identities=16% Similarity=0.162 Sum_probs=208.1
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCC-CccceeeeeeecCCcc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH-PNLVKLLGYCSTEDER 149 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~ 149 (393)
.++|++.+.||+|+||+||+|++..+ +..||+|++..... ...+.+|+++++.++| +|++.+++++....
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~-----~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-- 74 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLN-----NQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-- 74 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTT-----TEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT--
T ss_pred CCceEEEEEEecCCCeEEEEEEECCC-----CCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCC--
Confidence 35799999999999999999997543 45799999865432 2346678899988875 89999999987766
Q ss_pred cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCC-----CCceEE
Q 035862 150 GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDG-----NFKPKL 224 (393)
Q Consensus 150 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~-----~~~~kl 224 (393)
..++||||+ +++|.+++... ...+++..+..++.|++.||+|||++ ||+||||||+|||++. ++.+||
T Consensus 75 --~~~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl 147 (293)
T d1csna_ 75 --HNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV 147 (293)
T ss_dssp --EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred --ccEEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEE
Confidence 559999999 78999988543 34689999999999999999999999 9999999999999964 578999
Q ss_pred eeccCCccCCCCCCc-----cccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHH
Q 035862 225 SDFGLAREGPTGDHT-----HVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEW 299 (393)
Q Consensus 225 ~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~ 299 (393)
+|||+|+........ ......+||+.|+|||++.+..++.++|||||||++|||+||..||..............
T Consensus 148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~ 227 (293)
T d1csna_ 148 VDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 227 (293)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHH
T ss_pred cccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHH
Confidence 999999865432211 123456899999999999999999999999999999999999999976544322221111
Q ss_pred HhhcCcCCcccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHHHhhhcC
Q 035862 300 VKQFPADGKKFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLAVQESEQ 364 (393)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~~~~~~~ 364 (393)
....... .. .......+++++.+++..|+..+|++||+++.+.+.+..+++....
T Consensus 228 i~~~~~~-~~---------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 228 IGEKKQS-TP---------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp HHHHHHH-SC---------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHhccCC-CC---------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence 1100000 00 0001113457899999999999999999999999999888765543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=356.49 Aligned_cols=271 Identities=25% Similarity=0.342 Sum_probs=201.4
Q ss_pred hcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCc--ccHHHHHHHHHHhhcCCCCccceeeeeeecCCc
Q 035862 71 TNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGL--QGHKQWLAEVQFLGVVSHPNLVKLLGYCSTEDE 148 (393)
Q Consensus 71 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 148 (393)
.++|+++++||+|+||+||+|++..+ +..||+|++..... ...+.+.+|+.+|+.++||||+++++++.....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKT-----GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTT-----TEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCC-----CCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 35799999999999999999997543 45799999976532 334567899999999999999999999865432
Q ss_pred c-cceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeEeCCCCceEEeec
Q 035862 149 R-GIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVLLDGNFKPKLSDF 227 (393)
Q Consensus 149 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIll~~~~~~kl~Df 227 (393)
. ....+++|+|+.+|+|.+++.. ..+++..++.++.||+.||+|||++ ||+||||||+|||++.+|.+|++||
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~df 165 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 165 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred cccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccccccccccc
Confidence 1 1123567778889999998843 4599999999999999999999999 9999999999999999999999999
Q ss_pred cCCccCCCCCCccccccccccCCccCccccccC-CCCchhhHHHHHHHHHHHHhCCCccCCCCchhhhHHHHHHhhcCcC
Q 035862 228 GLAREGPTGDHTHVSTAVVGTYGYAAPEYIETG-HLKSQSDIWSFGVVLYEILTGRRVLERNRPTMEQKLLEWVKQFPAD 306 (393)
Q Consensus 228 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (393)
|++..... ......|++.|+|||.+.+. .++.++|||||||++|+|++|..||...+.......+......+..
T Consensus 166 g~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 166 GLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp ----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred chhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 99875432 23456899999999987665 5689999999999999999999999876544332222111110000
Q ss_pred C-----c---------ccccccCcccccccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHHH
Q 035862 307 G-----K---------KFSMMIDPRLRNQYSINAARRVAKLADNCLKKNPEERPTMNQVVESLKLA 358 (393)
Q Consensus 307 ~-----~---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~l~~l~~~ 358 (393)
. . .........+. .....++.++.+||.+||+.||++|||+.|+++|.|..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~ 305 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHhhhccchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhC
Confidence 0 0 00000000000 00113467889999999999999999999999998864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.4e-43 Score=326.79 Aligned_cols=270 Identities=20% Similarity=0.253 Sum_probs=195.7
Q ss_pred CCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-----------CCccceeee
Q 035862 73 GFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-----------HPNLVKLLG 141 (393)
Q Consensus 73 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~ 141 (393)
+|+++++||+|+||+||+|++..+ +..||||+++... .....+.+|+.+++.++ |+||+++++
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~-----g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVN-----NTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTT-----TEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCC-----CCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 599999999999999999997543 4579999998653 23456678888888765 578999999
Q ss_pred eeecCCcccceEEEEEeecCCC-ChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhc-CCCCCeEeccCCCCCeEeCCC
Q 035862 142 YCSTEDERGIQRLLVYEYMPNR-SLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHE-GLEIQVIYRDFKTSNVLLDGN 219 (393)
Q Consensus 142 ~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~Dikp~NIll~~~ 219 (393)
++...... ..+++|+++..+ .............+++..++.++.|++.||.|||+ . ||+||||||+|||++.+
T Consensus 88 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~ 162 (362)
T d1q8ya_ 88 HFNHKGPN--GVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIV 162 (362)
T ss_dssp EEEEEETT--EEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEE
T ss_pred Eeeecccc--ceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeecc
Confidence 88765544 335555555443 33344445566778999999999999999999997 6 99999999999999866
Q ss_pred Cc------eEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHHHHHHhCCCccCCCCchhh
Q 035862 220 FK------PKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVLYEILTGRRVLERNRPTME 293 (393)
Q Consensus 220 ~~------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltg~~pf~~~~~~~~ 293 (393)
+. ++++|||.+...... ....+||+.|+|||++.+..++.++||||+||++++|++|+.||........
T Consensus 163 ~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 163 DSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp ETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence 53 999999998764332 2456899999999999999999999999999999999999999975432211
Q ss_pred ----hHHHHHHh---hcCcC-------------CcccccccCc----------ccccccCHHHHHHHHHHHHHhcccCCC
Q 035862 294 ----QKLLEWVK---QFPAD-------------GKKFSMMIDP----------RLRNQYSINAARRVAKLADNCLKKNPE 343 (393)
Q Consensus 294 ----~~~~~~~~---~~~~~-------------~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~ 343 (393)
........ ..+.. .......+.. ..........+.++.+|+.+||.+||.
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 317 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence 11111110 00000 0000000000 012223456788999999999999999
Q ss_pred CCCCHHHHHHHHHHH
Q 035862 344 ERPTMNQVVESLKLA 358 (393)
Q Consensus 344 ~Rps~~~~l~~l~~~ 358 (393)
+|||++|+++|.|..
T Consensus 318 ~Rpta~e~L~Hp~f~ 332 (362)
T d1q8ya_ 318 KRADAGGLVNHPWLK 332 (362)
T ss_dssp TCBCHHHHHTCGGGT
T ss_pred HCcCHHHHhcCcccC
Confidence 999999999998765
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=5.6e-25 Score=185.37 Aligned_cols=170 Identities=15% Similarity=0.041 Sum_probs=117.6
Q ss_pred CcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcc------------------cHHHHHHHHHHhhcCCCCc
Q 035862 74 FNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQ------------------GHKQWLAEVQFLGVVSHPN 135 (393)
Q Consensus 74 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~n 135 (393)
+.+.++||+|+||+||+|.+. ++..||+|+++..... ......+|...+..+.|.+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 75 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA 75 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred chhCCEeeeCcceEEEEEECC------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC
Confidence 456789999999999999863 2346999987532110 0122356888999999999
Q ss_pred cceeeeeeecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCCCCCeEeccCCCCCeE
Q 035862 136 LVKLLGYCSTEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGLEIQVIYRDFKTSNVL 215 (393)
Q Consensus 136 iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~Dikp~NIl 215 (393)
++..+++. .. +++|||+++..+.+ ++...+..++.|++.+|.|||++ ||+||||||+|||
T Consensus 76 v~~~~~~~--~~------~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NIL 135 (191)
T d1zara2 76 VPKVYAWE--GN------AVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 135 (191)
T ss_dssp SCCEEEEE--TT------EEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred cceEEEec--CC------EEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhhee
Confidence 99887653 11 79999998865533 34455678999999999999998 9999999999999
Q ss_pred eCCCCceEEeeccCCccCCCCCCccccccccccCCccCccccccCCCCchhhHHHHHHHH
Q 035862 216 LDGNFKPKLSDFGLAREGPTGDHTHVSTAVVGTYGYAAPEYIETGHLKSQSDIWSFGVVL 275 (393)
Q Consensus 216 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 275 (393)
+++++ ++|+|||.|...............+.. -.+ +....|+.++|+||+.--+
T Consensus 136 v~~~~-~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 136 VSEEG-IWIIDFPQSVEVGEEGWREILERDVRN----IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EETTE-EEECCCTTCEETTSTTHHHHHHHHHHH----HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred eeCCC-EEEEECCCcccCCCCCcHHHHHHHHHH----HHH-HHcCCCCCcccHHHHHHHH
Confidence 98655 899999998764322111000000000 001 1135678899999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.78 E-value=1.9e-08 Score=86.99 Aligned_cols=149 Identities=14% Similarity=0.049 Sum_probs=97.1
Q ss_pred HHHHHHhcCCcccceecccCCceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCccceeeeee
Q 035862 65 QELREATNGFNRMLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYC 143 (393)
Q Consensus 65 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 143 (393)
.++......|+..+..+.++.+.||+.... +..+.+|............+.+|...+..+. +--+.+++.+.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-------~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~ 79 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-------NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE 79 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-------SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-------CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE
Confidence 345566677887776655556789987521 1236777765443333344667888877664 33355666666
Q ss_pred ecCCcccceEEEEEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcCC-----------------------
Q 035862 144 STEDERGIQRLLVYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEGL----------------------- 200 (393)
Q Consensus 144 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~----------------------- 200 (393)
...+ ..++||++++|.++.+... +......++.+++..+..||+..
T Consensus 80 ~~~~----~~~lv~~~l~G~~~~~~~~-------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (263)
T d1j7la_ 80 RHDG----WSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN 148 (263)
T ss_dssp EETT----EEEEEEECCSSEEHHHHTT-------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred ecCC----ceEEEEEeccccccccccc-------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHH
Confidence 5554 4599999999988866541 11123345566666666676421
Q ss_pred ---------------------------------CCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 201 ---------------------------------EIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 201 ---------------------------------~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
...++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999987667799998774
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.05 E-value=6.9e-06 Score=74.87 Aligned_cols=78 Identities=13% Similarity=0.049 Sum_probs=46.3
Q ss_pred cceecccCCceEEEEEEcCCCCCCCceEEEEEEecCC-------CcccHHHHHHHHHHhhcCC-C--CccceeeeeeecC
Q 035862 77 MLKIGEGGFGSVYKGTIRPLDGRGEPLVVAVKKLNNH-------GLQGHKQWLAEVQFLGVVS-H--PNLVKLLGYCSTE 146 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~ 146 (393)
.+.||.|....||++.... .+..+++|..... -.....+...|...|+.+. + ..+.+++.+..
T Consensus 31 ~~eig~G~~N~vfrV~~~~-----~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~-- 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQE-----HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT-- 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC---------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET--
T ss_pred EEEeCCCceEeEEEEEeCC-----CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcC--
Confidence 4578999999999987432 2235788865421 1112344556888887653 2 34556665433
Q ss_pred CcccceEEEEEeecCCCCh
Q 035862 147 DERGIQRLLVYEYMPNRSL 165 (393)
Q Consensus 147 ~~~~~~~~lv~e~~~~~~L 165 (393)
+.. ++|||++.+..+
T Consensus 104 ~~~----~lvmE~L~~~~~ 118 (392)
T d2pula1 104 EMA----VTVMEDLSHLKI 118 (392)
T ss_dssp TTT----EEEECCCTTSEE
T ss_pred CCC----EEEEeccCCccc
Confidence 222 789999976543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.02 E-value=1.2e-05 Score=68.29 Aligned_cols=130 Identities=17% Similarity=0.128 Sum_probs=77.6
Q ss_pred eecccC-CceEEEEEEcCCCCCCCceEEEEEEecCCCcccHHHHHHHHHHhhcCCC--CccceeeeeeecCCcccceEEE
Q 035862 79 KIGEGG-FGSVYKGTIRPLDGRGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVSH--PNLVKLLGYCSTEDERGIQRLL 155 (393)
Q Consensus 79 ~lg~G~-~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~l 155 (393)
.+..|. .+.||+..... +..+++|....... ..+..|...++.+.. -.+.+++.+....+ ..++
T Consensus 17 ~~~~G~s~~~v~r~~~~~------~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~----~~~~ 83 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQG------RPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAG----RDWL 83 (255)
T ss_dssp ECSCTTSSCEEEEEECTT------SCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSS----CEEE
T ss_pred EcCCcccCCeEEEEEeCC------CCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeeccccc----ceEE
Confidence 344444 36789876321 22377787655432 234567777766542 23556676665544 4589
Q ss_pred EEeecCCCChHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 035862 156 VYEYMPNRSLEDRLFSRAQPTLPWKTRLEIILGAAEGLAYLHEG------------------------------------ 199 (393)
Q Consensus 156 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~------------------------------------ 199 (393)
||++++|.++.+.. ... ...+.++...|.-||+.
T Consensus 84 v~~~i~G~~~~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (255)
T d1nd4a_ 84 LLGEVPGQDLLSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 153 (255)
T ss_dssp EEECCSSEETTTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEeeecccccccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchh
Confidence 99999887664311 111 11223344444444421
Q ss_pred -------------------CCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 200 -------------------LEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 200 -------------------~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.+..++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 154 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 01248999999999999987767899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.97 E-value=0.002 Score=58.11 Aligned_cols=79 Identities=24% Similarity=0.271 Sum_probs=48.7
Q ss_pred cceecccCCceEEEEEEcCCCC--CCCceEEEEEEecCCCcccHHHHHHHHHHhhcCC-CCccceeeeeeecCCcccceE
Q 035862 77 MLKIGEGGFGSVYKGTIRPLDG--RGEPLVVAVKKLNNHGLQGHKQWLAEVQFLGVVS-HPNLVKLLGYCSTEDERGIQR 153 (393)
Q Consensus 77 ~~~lg~G~~g~Vy~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 153 (393)
++.|+.|-.=.+|++....... ......|.+++..... ......+|..+++.+. +.-..++++++. +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~------ 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G------ 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C------
Confidence 4567777778899987643221 1233456677765332 2234457888888876 433347776653 2
Q ss_pred EEEEeecCCCCh
Q 035862 154 LLVYEYMPNRSL 165 (393)
Q Consensus 154 ~lv~e~~~~~~L 165 (393)
.+||||++|.+|
T Consensus 117 g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 GRLEEYIPSRPL 128 (395)
T ss_dssp EEEECCCCEEEC
T ss_pred ceEEEEeccccC
Confidence 679999987554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.83 E-value=0.003 Score=54.84 Aligned_cols=32 Identities=34% Similarity=0.330 Sum_probs=28.1
Q ss_pred CCCCeEeccCCCCCeEeCCCCceEEeeccCCc
Q 035862 200 LEIQVIYRDFKTSNVLLDGNFKPKLSDFGLAR 231 (393)
Q Consensus 200 ~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 231 (393)
.+.|++|+|+.++||+++.+...-|+||+.+.
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccccCCcchhhhhcccccceeEecccccc
Confidence 35689999999999999988877899999774
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.70 E-value=0.0061 Score=53.14 Aligned_cols=31 Identities=23% Similarity=0.377 Sum_probs=25.0
Q ss_pred CCCCeEeccCCCCCeEeCCCCceEEeeccCCcc
Q 035862 200 LEIQVIYRDFKTSNVLLDGNFKPKLSDFGLARE 232 (393)
Q Consensus 200 ~~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 232 (393)
.+.+++|+|+.++|||++++ ..++||+-+..
T Consensus 190 ~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp SCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 34689999999999999743 45899997764
|